PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sobel, E; Papp, JC; Lange, K				Sobel, E; Papp, JC; Lange, K			Detection and integration of genotyping errors in statistical genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; RECOMBINATION FRACTIONS; PEDIGREE ANALYSIS; LOCATION SCORES; PAIR LINKAGE; LIKELIHOOD; INCOMPATIBILITIES; IDENTIFICATION; FISHER; LOCUS	Detection of genotyping errors and integration of such errors in statistical analysis are relatively neglected topics, given their importance in gene mapping. A few inopportunely placed errors, if ignored, can tremendously affect evidence for linkage. The present study takes a fresh look at the calculation of pedigree likelihoods in the presence of genotyping error. To accommodate genotyping error, we present extensions to the Lander-Green-Kruglyak deterministic algorithm for small pedigrees and to the Markov-chain Monte Carlo stochastic algorithm for large pedigrees. These extensions can accommodate a variety of error models and refrain from simplifying assumptions, such as allowing, at most, one error per pedigree. In principle, almost any statistical genetic analysis can be performed taking errors into account, without actually correcting or deleting suspect genotypes. Three examples illustrate the possibilities. These examples make use of the full pedigree data, multiple linked markers, and a prior error model. The first example is the estimation of genotyping error rates from pedigree data. The second-and currently most useful-example is the computation of posterior mistyping probabilities. These probabilities cover both Mendelian-consistent and Mendelian-inconsistent errors. The third example is the selection of the true pedigree structure connecting a group of people from among several competing pedigree structures. Paternity testing and twin zygosity testing are typical applications.	Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sobel, E (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	esobel@ucla.edu	Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Sobel, Eric/0000-0002-1718-0031	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490, R01MH064205] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; BUETOW KH, 1991, AM J HUM GENET, V49, P985; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; Constable JL, 2001, MOL ECOL, V10, P1279, DOI 10.1046/j.1365-294X.2001.01262.x; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Douglas JA, 2002, AM J HUM GENET, V70, P487, DOI 10.1086/338919; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; Ehm MG, 1996, AM J HUM GENET, V58, P225; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Gagneux P, 1997, NATURE, V387, P358, DOI 10.1038/387358a0; Goldstein DR, 1997, HUM HERED, V47, P86, DOI 10.1159/000154396; Gordon D, 2001, Pac Symp Biocomput, P18; Gordon D, 1999, HUM HERED, V49, P65, DOI 10.1159/000022846; Gordon D, 1999, GENET EPIDEMIOL, V17, pS587; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; GUO SW, 1992, AM J HUM GENET, V51, P1111; Heath S.C., 1998, AM J HUM GENET S, V63, pA292; KEENER JP, 1988, PRINCIPLES APPL MATH; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kumm J, 1999, AM J HUM GENET, V65, pA208; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1989, AM J HUM GENET, V45, P959; Lange K., 1997, MATH STAT METHODS GE; LATHROP GM, 1983, AM J HUM GENET, V35, P241; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LUNETTA KL, 1995, GENOME RES, V5, P151, DOI 10.1101/gr.5.2.151; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Nijenhuis A., 1978, COMBINATORIAL ALGORI; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Connell JR, 1999, AM J HUM GENET, V65, P1733, DOI 10.1086/302663; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1993, HUM HERED, V43, P25, DOI 10.1159/000154109; Ott J., 1991, ANAL HUMAN GENETIC L; Papp JC, 2000, AM J HUM GENET, V67, P301; Smith HF, 1937, ANN EUGENIC, V8, P94, DOI 10.1111/j.1469-1809.1937.tb02163.x; Sobel E, 1993, Stat Methods Med Res, V2, P263, DOI 10.1177/096228029300200305; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stringham HM, 1996, AM J HUM GENET, V59, P946; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; Thompson EA, 1996, ANN STAT, V24, P449; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; THOMPSON EA, 1994, STAT SCI, V9, P355, DOI 10.1214/ss/1177010381; Thompson EA, 1986, PEDIGREE ANAL HUMAN; Weir B., 1996, GENETIC DATA ANAL; [No title captured]; [No title captured]; [No title captured]; [No title captured]	63	277	282	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					496	508		10.1086/338920	http://dx.doi.org/10.1086/338920			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11791215	Green Published, Bronze			2022-12-18	WOS:000173254300020
J	Escayg, A; De Waard, M; Lee, DD; Bichet, D; Wolf, P; Mayer, T; Johnston, J; Baloh, R; Sander, T; Meisler, MH				Escayg, A; De Waard, M; Lee, DD; Bichet, D; Wolf, P; Mayer, T; Johnston, J; Baloh, R; Sander, T; Meisler, MH			Coding and noncoding variation of the human calcium-channel beta(4)-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CA2+ CHANNEL; BETA-SUBUNIT; FEBRILE SEIZURES; NEUROLOGICAL DISEASE; ALPHA(1C) SUBUNIT; GABA(B) RECEPTOR; N-TYPE; MUTATION; MOUSE; LOCUS	Inactivation of the beta(4) subunit of the calcium channel in the mouse neurological mutant lethargic results in a complex neurological disorder that includes absence epilepsy and ataxia. To determine the role of the calcium-channel beta(4)-subunit gene CACNB4 on chromosome 2q22-23 in related human disorders, we screened for mutations in small pedigrees with familial epilepsy and ataxia. The premature-termination mutation R482X was identified in a patient with juvenile myoclonic epilepsy. The R482X protein lacks the 38 C-terminal amino acids containing part of an interaction domain for the alpha(1) subunit, The missense mutation C104F was identified both in a German family with generalized epilepsy and praxis-induced seizures and in a French Canadian family with episodic ataxia. These coding mutations were not detected in 255 unaffected control individuals (510 chromosomes), and they may be considered candidate disease mutations, The results of functional tests of the truncated protein R482X in Xenopus laevis oocytes demonstrated a small decrease in the fast time constant for inactivation of the cotransfected alpha(1), subunit, Further studies will be required to evaluate the in vivo consequences of these mutations. We also describe eight noncoding single-nucleotide substitutions, two of which are present at polymorphic frequency, and a previously unrecognized first intron of CACNB4 that interrupts exon 1 at codon 21.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Fac Med Nord, Inst Federat Jean Roche, INSERM U464, Marseille, France; Epilepsy Ctr Bethel, Clin Mara, Bielefeld, Germany; Univ Manitoba, Dept Neurol, Winnipeg, MB, Canada; Univ Calif Los Angeles, Sch Med, Reed Neurol Res Ctr, Dept Neurol, Los Angeles, CA USA; Humboldt Univ, Hosp Charite, Dept Neurol, Berlin, Germany	University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Manitoba; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, 4708 Med Sci 2, Ann Arbor, MI 48109 USA.	meislerm@umich.edu	Lee, David/ABH-1406-2021; De Waard, Michel/G-7406-2014	Lee, David/0000-0002-2086-0150; De Waard, Michel/0000-0002-2782-9615; Bichet, Delphine/0000-0002-9601-089X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002952] Funding Source: NIH RePORTER; NIDCD NIH HHS [P01DC02952] Funding Source: Medline; NINDS NIH HHS [NS34709] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Burgess DL, 1999, ANN NY ACAD SCI, V868, P199, DOI 10.1111/j.1749-6632.1999.tb11287.x; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; Cens T, 1999, FEBS LETT, V450, P17, DOI 10.1016/S0014-5793(99)00463-9; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chien AJ, 1998, J BIOENERG BIOMEMBR, V30, P377, DOI 10.1023/A:1021941706726; Cooper EC, 1999, P NATL ACAD SCI USA, V96, P4759, DOI 10.1073/pnas.96.9.4759; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DEWAARD M, 1995, J PHYSIOL-LONDON, V485, P619, DOI 10.1113/jphysiol.1995.sp020757; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 1998, GENOMICS, V50, P14, DOI 10.1006/geno.1998.5311; Gerster U, 1999, J PHYSIOL-LONDON, V517, P353, DOI 10.1111/j.1469-7793.1999.0353t.x; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hartmann HA, 1999, NAT NEUROSCI, V2, P593, DOI 10.1038/10147; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Hosford D A, 1999, Adv Neurol, V79, P239; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; INOUE Y, 1992, J JPN EPILEPSY SOC, V10, P1; Lopes-Cendes I, 2000, AM J HUM GENET, V66, P698, DOI 10.1086/302768; McEnery MW, 1998, J BIOL CHEM, V273, P21435, DOI 10.1074/jbc.273.34.21435; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Meisler MH, 1997, ANN MED, V29, P569, DOI 10.3109/07853899709007484; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Peiffer A, 1999, ANN NEUROL, V46, P671, DOI 10.1002/1531-8249(199910)46:4<671::AID-ANA20>3.0.CO;2-5; PEREZREYES E, 1994, DRUG DEVELOP RES, V33, P295, DOI 10.1002/ddr.430330311; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; RITACCIO AL, 1994, NEUROL CLIN, V12, P57, DOI 10.1016/S0733-8619(18)30111-7; Sander T, 1999, AM J MED GENET, V88, P305, DOI 10.1002/(SICI)1096-8628(19990820)88:4<305::AID-AJMG5>3.0.CO;2-X; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sprunger LK, 1999, HUM MOL GENET, V8, P471, DOI 10.1093/hmg/8.3.471; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Walker D, 1999, J BIOL CHEM, V274, P12383, DOI 10.1074/jbc.274.18.12383; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WEI XY, 1994, J BIOL CHEM, V269, P1635; Yamaguchi H, 1998, J BIOL CHEM, V273, P19348, DOI 10.1074/jbc.273.30.19348; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	44	277	288	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1531	1539		10.1086/302909	http://dx.doi.org/10.1086/302909			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762541	Green Published, Bronze			2022-12-18	WOS:000088373700007
J	Carlson, C; Sirotkin, H; Pandita, R; Goldberg, R; McKie, J; Wadey, R; Patanjali, SR; Weissman, SM; AnyaneYeboa, K; Warburton, D; Scambler, P; Shprintzen, R; Kucherlapati, R; Morrow, BE				Carlson, C; Sirotkin, H; Pandita, R; Goldberg, R; McKie, J; Wadey, R; Patanjali, SR; Weissman, SM; AnyaneYeboa, K; Warburton, D; Scambler, P; Shprintzen, R; Kucherlapati, R; Morrow, BE			Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME CRITICAL REGION; BALANCED TRANSLOCATION BREAKPOINT; DIGEORGE-SYNDROME; VELOCARDIOFACIAL SYNDROME; CHROMOSOME 22Q11; GENE; CLONING; IDENTIFICATION; MICRODELETIONS; DROSOPHILA	Velo-cardio-facial syndrome (VCFS) is a relatively common developmental disorder characterized by craniofacial anomalies and conotruncal heart defects, Many VCFS patients have hemizygous deletions for a parr of 22q11, suggesting that haploinsufficiency in this region is responsible for its etiology, Because most cases of VCFS are sporadic, portions of 22q11 may be prone to rearrangement, To understand the molecular basis for chromosomal deletions, we defined the extent of the deletion, by genotyping 151 VCFS patients and performing haplotype analysis on 105, using 15 consecutive polymorphic markers in 22q11, We found that 83% had a deletion and >90% of these had a similar similar to 3 Mb deletion, suggesting that sequences flanking the common breakpoints are susceptible to rearrangement. We found no correlation between the presence or size of the deletion and the phenotype. To further define the chromosomal breakpoints among the VCFS patients, we developed somatic hybrid cell lines from a set of VCFS patients. An 11-kb resolution physical map of a 1,080-kb region that includes deletion breakpoints was constructed, incorporating genes and expressed sequence tags (ESTs) isolated by the hybridization selection method, The ordered markers were used to examine the two separated copies of chromosome 22 in the somatic hybrid cell lines. Ln some cases, we were able to map the chromosome breakpoints within a single cosmid, A 480-kb critical region for VCFS has been delineated, including the genes for GSCL, CTP, CLTD, HIRA, and TMVCF, as well as a number of novel ordered ESTs.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MOL GENET, BRONX, NY 10461 USA; MONTEFIORE MED CTR, CTR CRANIOFACIAL DISORDERS, NEW YORK, NY USA; COLUMBIA PRESBYTERIAN MED CTR, DEPT PEDIAT, DIV CLIN GENET, NEW YORK, NY 10032 USA; INST CHILD HLTH, MOL MED UNIT, LONDON, ENGLAND; YALE UNIV, SCH MED, BOYER CTR MOL MED, NEW HAVEN, CT 06520 USA; SUNY HLTH SCI CTR, CTR DIAG TREATMENT & STUDY VELO CARDIO FACIAL SYN, COMMUN DISORDER UNIT, SYRACUSE, NY 13210 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; University of London; University College London; Yale University			Kucherlapati, Raju/ABC-8807-2021; Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Anyane-Yeboa, Kwame/0000-0002-4977-9719; Morrow, Bernice/0000-0002-8076-4726	NICHD NIH HHS [P0-1, HD 34980-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BLUM M, 1994, GENOMICS, V21, P388, DOI 10.1006/geno.1994.1281; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BURN J, 1996, EMERY RIMOINS PRINCI, V1, P767; Carlson C, 1997, AM J HUM GENET, V60, P851; Chieffo C., 1996, American Journal of Human Genetics, V59, pA33; CHOW EWC, 1994, AM J MED GENET, V54, P107, DOI 10.1002/ajmg.1320540205; COLLINS JE, 1995, NATURE, V377, P367; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DEMCZUK S, 1995, HUM MOL GENET, V4, P551, DOI 10.1093/hmg/4.4.551; Demczuk S, 1996, HUM MOL GENET, V5, P633, DOI 10.1093/hmg/5.5.633; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; FIREMAN P, 1965, J PEDIATR-US, V67, P907; FU WN, 1976, CLIN GENET, V10, P329; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; GOLDBERG R, 1985, American Journal of Human Genetics, V37, pA54; Goldmuntz E, 1996, GENOMICS, V33, P271, DOI 10.1006/geno.1996.0191; Gong WK, 1996, HUM MOL GENET, V5, P789, DOI 10.1093/hmg/5.6.789; Gong WL, 1997, HUM MOL GENET, V6, P267, DOI 10.1093/hmg/6.2.267; Gottlieb S, 1997, AM J HUM GENET, V60, P1194; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; HEISTERKAMP N, 1995, GENOMICS, V29, P451, DOI 10.1006/geno.1995.9982; Holmes SE, 1997, HUM MOL GENET, V6, P357, DOI 10.1093/hmg/6.3.357; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kedra D, 1996, HUM MOL GENET, V5, P625, DOI 10.1093/hmg/5.5.625; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; Lindsay EA, 1996, GENOMICS, V32, P104, DOI 10.1006/geno.1996.0082; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; MORROW B, 1995, AM J HUM GENET, V56, P1391; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; Papolos DF, 1996, AM J PSYCHIAT, V153, P1541; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Roberts C, 1997, HUM MOL GENET, V6, P237, DOI 10.1093/hmg/6.2.237; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; Sirotkin H, 1996, HUM MOL GENET, V5, P617, DOI 10.1093/hmg/5.5.617; Sirotkin H, 1997, GENOMICS, V41, P75, DOI 10.1006/geno.1997.4627; Sirotkin H, 1997, GENOMICS, V42, P245, DOI 10.1006/geno.1997.4734; STEVENS CA, 1990, PEDIATRICS, V85, P526; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; Wilming LG, 1997, HUM MOL GENET, V6, P247, DOI 10.1093/hmg/6.2.247; WILSON TA, 1993, AM J MED GENET, V47, P1078, DOI 10.1002/ajmg.1320470729; YAMADA G, 1995, DEVELOPMENT, V121, P2917	54	277	300	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					620	629		10.1086/515508	http://dx.doi.org/10.1086/515508			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326327	Green Published, hybrid			2022-12-18	WOS:A1997XY52300019
J	Brinkman, RR; Mezei, MM; Theilmann, J; Almqvist, E; Hayden, MR				Brinkman, RR; Mezei, MM; Theilmann, J; Almqvist, E; Hayden, MR			The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE REPEAT EXPANSION; MACHADO-JOSEPH DISEASE; DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; OF-ONSET; PHENOTYPIC VARIATION; MOLECULAR ANALYSIS; CLINICAL-FEATURES; INTERMEDIATE ALLELES; (CAG)(N) REPEATS; (GAG)(N) REPEAT	Prior studies describing the relationship between CAG size and the age at onset of Huntington disease (HD) have focused on affected persons. To further define the relationship between CAG repeat size and age at onset of HD, we now have analyzed a large cohort of affected and asymptomatic at-risk persons with CAG expansion. This cohort numbered 1,049 persons, including 321 at-risk and 728 affected individuals with a CAG size of 29-121 repeats. Kaplan-Meier analysis has provided curves for determining the likelihood of onset at a given age, for each CAG repeat length in the 39-50 range. The curves were significantly different (P < .0005), with relatively narrow 95% confidence intervals (95% CI) (+/-10%). Penetrance of the mutation for HD also was examined. Although complete penetrance of HD was observed for CAG sizes of greater than or equal to 42, only a proportion of those with a CAG repeat length of 36-41 showed signs or symptoms of HD within a normal life span. These data provide information concerning the likelihood of being affected, by a specific age, with a particular CAG size, and they may be useful in predictive-testing programs and for the design of clinical trials for persons at increased risk for HD.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V6T 1Z4,CANADA; UNIV BRITISH COLUMBIA,DEPT MED,DIV NEUROL,VANCOUVER,BC V6T 1Z4,CANADA; KAROLINSKA INST,DEPT MOL MED,STOCKHOLM,SWEDEN; KAROLINSKA INST,DEPT CLIN NEUROSCI,DIV GERIATR MED,STOCKHOLM,SWEDEN	University of British Columbia; University of British Columbia; Karolinska Institutet; Karolinska Institutet			Brinkman, Ryan/B-1108-2008; Hayden, Michael R/D-8581-2011	Brinkman, Ryan/0000-0002-9765-2990; Hayden, Michael R/0000-0001-5159-1419				ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASHIZAWA T, 1994, NEUROLOGY, V44, P1137, DOI 10.1212/WNL.44.6.1137; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; BENITEZ J, 1994, HUM GENET, V94, P563; Brandt J, 1996, NEUROLOGY, V46, P527, DOI 10.1212/WNL.46.2.527; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; CLAES S, 1995, ARCH NEUROL-CHICAGO, V52, P749, DOI 10.1001/archneur.1995.00540320021009; CRAUFURD D, 1993, J MED GENET, V30, P1008, DOI 10.1136/jmg.30.12.1008; DEROOIJ KE, 1993, J MED GENET, V30, P996, DOI 10.1136/jmg.30.12.996; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOLDBERG YP, 1995, HUM MOL GENET, V4, P1911, DOI 10.1093/hmg/4.10.1911; Harper PS, 1991, HUNTINGTONS DIS; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; *HUNT DIS COLL RES, 1993, CELL, V72, P971; *HUNT STUD GROUP, 1995, HUNT STUD GROUP HSG; Huntington G., 1872, MED SURG REP, V26, P320; JODICE C, 1994, AM J HUM GENET, V54, P959; KIEBURTZ K, 1994, J MED GENET, V31, P872, DOI 10.1136/jmg.31.11.872; KING RA, 1992, OXF MONOGR MED GENET, V20, P3; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; Legius Eric, 1994, European Journal of Human Genetics, V2, P44; LUCOTTE G, 1995, HUM GENET, V95, P231; MACIEL P, 1995, AM J HUM GENET, V57, P54; MACMILLAN JC, 1993, LANCET, V342, P954, DOI 10.1016/0140-6736(93)92002-B; MARSHALL FJ, 1996, NEUROLOGY, V46, P258; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MASUDA N, 1995, J MED GENET, V32, P701, DOI 10.1136/jmg.32.9.701; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nance MA, 1996, AM J HUM GENET, V59, P1; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; NOVELLETTO A, 1994, HUM MOL GENET, V3, P93, DOI 10.1093/hmg/3.1.93; RANEN NG, 1995, AM J HUM GENET, V57, P593; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; SIMPSON SA, 1993, J MED GENET, V30, P1014, DOI 10.1136/jmg.30.12.1014; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; SOONG BW, 1995, J MED GENET, V32, P404, DOI 10.1136/jmg.32.5.404; *STAT CAN, 1995, 84537 STAT CAN; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; VALDES JM, 1993, HUM MOL GENET, V2, P633, DOI 10.1093/hmg/2.6.633; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; YAPIJAKIS C, 1995, EUR J HUM GENET, V3, P228; ZUHLKE C, 1993, HUM MOL GENET, V2, P1467	57	277	285	2	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1202	1210						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150168				2022-12-18	WOS:A1997WX76000021
J	Pemberton, TJ; Absher, D; Feldman, MW; Myers, RM; Rosenberg, NA; Li, JZ				Pemberton, Trevor J.; Absher, Devin; Feldman, Marcus W.; Myers, Richard M.; Rosenberg, Noah A.; Li, Jun Z.			Genomic Patterns of Homozygosity in Worldwide Human Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; WIDE PATTERNS; COPY-NUMBER; EXTENDED HOMOZYGOSITY; HAPLOTYPE VARIATION; DIVERSITY; EVOLUTION; REGIONS; RUNS; IDENTIFICATION	Genome-wide patterns of homozygosity runs and their variation across individuals provide a valuable and often untapped resource for studying human genetic diversity and evolutionary history. Using genotype data at 577,489 autosomal SNPs, we employed a likelihood-based approach to identify runs of homozygosity (ROH) in 1,839 individuals representing 64 worldwide populations, classifying them by length into three classes-short, intermediate, and long-with a model-based clustering algorithm. For each class, the number and total length of ROH per individual show considerable variation across individuals and populations. The total lengths of short and intermediate ROH per individual increase with the distance of a population from East Africa, in agreement with similar patterns previously observed for locus-wise homozygosity and linkage disequilibrium. By contrast, total lengths of long ROH show large interindividual variations that probably reflect recent inbreeding patterns, with higher values occurring more often in populations with known high frequencies of consanguineous unions. Across the genome, distributions of ROH are not uniform, and they have distinctive continental patterns. ROH frequencies across the genome are correlated with local genomic variables such as recombination rate, as well as with signals of recent positive selection. In addition, long ROH are more frequent in genomic regions harboring genes associated with autosomal-dominant diseases than in regions not implicated in Mendelian diseases. These results provide insight into the way in which homozygosity patterns are produced, and they generate baseline homozygosity patterns that can be used to aid homozygosity mapping of genes associated with recessive diseases.	[Pemberton, Trevor J.; Feldman, Marcus W.; Rosenberg, Noah A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Absher, Devin; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	Stanford University; HudsonAlpha Institute for Biotechnology; University of Michigan System; University of Michigan	Pemberton, TJ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	trevorp@stanford.edu	Pemberton, Trevor/F-9206-2018	Li, Jun/0000-0001-6727-0812; Rosenberg, Noah/0000-0002-1829-8664; Pemberton, Trevor/0000-0003-1224-1146	National Institutes of Health [GM081441, GM28016, HG005855]; Burroughs Wellcome Fund; NARSAD Abramson Family Foundation Investigator award; University of Michigan Center for Genetics in Health and Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016, R01GM081441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NARSAD Abramson Family Foundation Investigator award; University of Michigan Center for Genetics in Health and Medicine(University of Michigan System); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM081441 (N.A.R.), GM28016 (M.W.F.), and HG005855 (N.A.R.); a grant from the Burroughs Wellcome Fund (N.A.R.); a NARSAD Abramson Family Foundation Investigator award (J.Z.L.); and a University of Michigan Center for Genetics in Health and Medicine postdoctoral fellowship (T.J.P.). The authors thank L. Huang and E. Jewett for assistance.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bittles AH, 2010, ANNU REV ANTHROPOL, V39, P193, DOI 10.1146/annurev.anthro.012809.105051; Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Cann HM, 2002, SCIENCE, V296, P261; Collin RWJ, 2011, INVEST OPHTH VIS SCI, V52, P2227, DOI 10.1167/iovs.10-6185; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Curtis D, 2008, ANN HUM GENET, V72, P261, DOI 10.1111/j.1469-1809.2007.00411.x; Darwin CR, 1876, EFFECTS CROSS SELF F; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garrod AE, 1902, LANCET, V2, P1616; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Griffith AJ, 1998, AM J HUM GENET, V62, P816, DOI 10.1086/301789; Gross A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-67; Hagiwara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025059; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Huang L, 2011, GENET EPIDEMIOL, V35, P766, DOI 10.1002/gepi.20626; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim SH, 2007, GENETICA, V131, P151, DOI 10.1007/s10709-006-9125-2; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Leutenegger AL, 2011, EUR J HUM GENET, V19, P583, DOI 10.1038/ejhg.2010.205; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li LH, 2006, HUM MUTAT, V27, P1115, DOI 10.1002/humu.20399; Lui VCH, 1996, GENOMICS, V32, P401, DOI 10.1006/geno.1996.0135; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nails M. A., 2009, PLOS GENET, V5; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Ropers HH, 2007, AM J HUM GENET, V81, P199, DOI 10.1086/520679; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2006, PLOS GENET, V2, P2052, DOI 10.1371/journal.pgen.0020215; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schuurs-Hoeijmakers JHM, 2011, EUR J HUM GENET, V19, P597, DOI 10.1038/ejhg.2010.167; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Teo SM, 2012, J HUM GENET, V57, P101, DOI 10.1038/jhg.2011.132; Teo SM, 2011, J HUM GENET, V56, P524, DOI 10.1038/jhg.2011.52; Teshima KM, 2006, GENETICS, V172, P713, DOI 10.1534/genetics.105.044065; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang CL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1493; Wang S, 2009, GENET EPIDEMIOL, V33, P172, DOI 10.1002/gepi.20344; Weir B., 1996, GENETIC DATA ANAL; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	74	276	283	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					275	292		10.1016/j.ajhg.2012.06.014	http://dx.doi.org/10.1016/j.ajhg.2012.06.014			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22883143	Green Published, Bronze			2022-12-18	WOS:000307608700006
J	Stankiewicz, P; Sen, P; Bhatt, SS; Storer, M; Xia, ZL; Bejjani, BA; Ou, ZS; Wiszniewska, J; Driscoll, DJ; Bolivar, J; Bauer, M; Zackai, EH; McDonald-McGinn, D; Nowaczyk, MMJ; Murray, M; Shaikh, TH; Martin, V; Tyreman, M; Simonic, I; Willatt, L; Paterson, J; Mehta, S; Rajan, D; Fitzgerald, T; Gribble, S; Prigmore, E; Patel, A; Shaffer, LG; Carter, NP; Cheung, SW; Langston, C; Shaw-Smith, C				Stankiewicz, Pawel; Sen, Partha; Bhatt, Samarth S.; Storer, Mekayla; Xia, Zhilian; Bejjani, Bassem A.; Ou, Zhishuo; Wiszniewska, Joanna; Driscoll, Daniel J.; Bolivar, Juan; Bauer, Mislen; Zackai, Elaine H.; McDonald-McGinn, Donna; Nowaczyk, Malgorzata M. J.; Murray, Mitzi; Shaikh, Tamim H.; Martin, Vicki; Tyreman, Matthew; Simonic, Ingrid; Willatt, Lionel; Paterson, Joan; Mehta, Sarju; Rajan, Diana; Fitzgerald, Tomas; Gribble, Susan; Prigmore, Elena; Patel, Ankita; Shaffer, Lisa G.; Carter, Nigel P.; Cheung, Sau Wai; Langston, Claire; Shaw-Smith, Charles			Genomic and Genic Deletions of the FOX Gene Cluster on 16q24.1 and Inactivating Mutations of FOXF1 Cause Alveolar Capillary Dysplasia and Other Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PULMONARY VEINS; LUNG; MISALIGNMENT; EXPRESSION; VESSELS; HAPLOINSUFFICIENCY; HYPERTENSION; SURVIVAL; DEFECTS	Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV) is a rare, neonatally lethal developmental disorder of the lung with defining histologic abnormalities typically associated with multiple congenital anomalies (MCA). Using array CGH analysis, we have identified six overlapping microdeletions encompassing the FOX transcription factor gene cluster in chromosome 16q24.1q24.2 in patients with ACD/MPV and MCA. Subsequently, we have identified four different heterozygous mutations (frameshift, nonsense, and no-stop) in the candidate FOXF1 gene in unrelated patients with sporadic ACD/MPV and MCA. Custom-designed, high-resolution microarray analysis of additional ACD/MPV samples revealed one microdeletion harboring FOXF1 and two distinct microdeletions upstream of FOXF1, implicating a position effect. DNA sequence analysis revealed that in six of nine deletions, both breakpoints occurred in the portions of Alu elements showing eight to 43 base pairs of perfect microhomology, suggesting replication error Microhomology-Mediated Break-Induced Replication (MMBIR)/Fork Stalling and Template Switching (FoSTeS) as a mechanism of their formation. In contrast to the association of point mutations in FOXF1 with bowel malrotation, microdeletions of FOXF1 were associated with hypoplastic left heart syndrome and gastrointestinal atresias, probably due to haploinsufficiency for the neighboring FOXC2 and FOXL1 genes. These differences reveal the phenotypic consequences of gene alterations in cis.	[Stankiewicz, Pawel; Bhatt, Samarth S.; Xia, Zhilian; Ou, Zhishuo; Wiszniewska, Joanna; Patel, Ankita; Cheung, Sau Wai] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stankiewicz, Pawel] Inst Mother & Child Hlth, Dept Med Genet, PL-01211 Warsaw, Poland; [Sen, Partha] Baylor Coll Med, Dept Pediat Nutr, Houston, TX 77030 USA; [Storer, Mekayla; Martin, Vicki; Shaw-Smith, Charles] Inst Child Hlth, London WC1N 1EH, England; [Storer, Mekayla; Martin, Vicki; Rajan, Diana; Fitzgerald, Tomas; Gribble, Susan; Prigmore, Elena; Carter, Nigel P.; Shaw-Smith, Charles] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Bejjani, Bassem A.; Shaffer, Lisa G.] Signature Genom Labs LLC, Spokane, WA 99207 USA; [Driscoll, Daniel J.] Univ Florida, Div Pediat Genet & Metab, Coll Med, Gainesville, FL 32610 USA; [Bolivar, Juan] Miami Childrens Hosp, Dept Cardiol, Miami, FL 33155 USA; [Bauer, Mislen] Miami Childrens Hosp, Dept Genet, Miami, FL 33155 USA; [Zackai, Elaine H.; McDonald-McGinn, Donna; Shaikh, Tamim H.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Nowaczyk, Malgorzata M. J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 3K9, Canada; [Murray, Mitzi] Univ Washington, Dept Med Genet, Seattle, WA 98195 USA; [Tyreman, Matthew; Simonic, Ingrid; Willatt, Lionel; Paterson, Joan; Mehta, Sarju] Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 0QQ, England; [Langston, Claire] Baylor Coll Med, Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of London; University College London; Wellcome Trust Sanger Institute; State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McMaster University; University of Washington; University of Washington Seattle; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Baylor College of Medicine	Stankiewicz, P (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	pawels@bcm.edu	Bhatt, Samarth/H-2892-2019; Stankiewicz, Paweł/AAP-7906-2021; McDonald-McGinn, Donna/L-8643-2019	Bhatt, Samarth/0000-0001-5706-4572; Stankiewicz, Paweł/0000-0002-6456-7490; Fitzgerald, Tomas/0000-0002-2370-8496; McDonald-McGinn, Donna/0000-0003-4077-250X; Storer, Mekayla/0000-0003-0242-1418	Polish Ministry of Science and Higher Education [R13-0005-04/2008]; National Association of Rare Disorders (NORD); Wellcome Trust; National Institute for Health Research (NIHR), UK; Addenbrooke's Charitable Trust; Tracheo-Oesophageal Fistula	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Association of Rare Disorders (NORD); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR), UK(National Institute for Health Research (NIHR)); Addenbrooke's Charitable Trust; Tracheo-Oesophageal Fistula	The authors thank all of the families who participated in this study and the Alveolar Capillary Dysplasia Association, the parent organization, for help in recruitment of patients. We thank A.L. Beaudet, J.W. Belmont, M. Jamrich, M. Justice, J.R. Lupski, F.J. Probst, D. Scott, and M. Shinawi for helpful discussion. P. Sen would like to thank M. Haymond for support and encouragement. We acknowledge J. Rosenfeld for collecting clinical information on the patients and helping with data collection. P.St. was supported in part by grant R13-0005-04/2008 from the Polish Ministry of Science and Higher Education. Part of this study was supported by a National Association of Rare Disorders (NORD) grant to P. Sen. We thank T.F. Beck for technical assistance. M.S., V.M., D.R., T.F., S.G., E.P., N.RC., and C.S.-S. are funded by the Wellcome Trust; C.S.-S. is the recipient of a Wellcome Trust Intermediate Clinical Fellowship. M.T., I.S., L.W., J.P., and S.M. gratefully acknowledge funding from the Biomedical Research Centre Grant from the National Institute for Health Research (NIHR), UK. C.S.-S., V.M., and M.S. gratefully acknowledge additional funding from the Addenbrooke's Charitable Trust and Tracheo-Oesophageal Fistula Support, the UK patient support group for patients with esophageal atresia and tracheo-esophageal fistula. C.S.-S. thanks N. Conte, A. Bradley, R. Hennekam, and P. Scambler for helpful discussion; and C. Hall, H. Martin, and B. Treacy for technical assistance. Some authors are based in the Department of Molecular and Human Genetics at Baylor College of Medicine (BCM), which offers extensive genetic laboratory testing, including use of arrays for genomic copy number analysis, and derives revenue from this activity. B.A.B. and L.G.S. have ownership and sit on the Members' Board of Signature Genomic Laboratories, LLC. The UK authors declare no competing interest.	Ahmed Sheikh, 2008, Pediatr Crit Care Med, V9, pe43, DOI 10.1097/PCC.0b013e31818e383e; Al-Hathlol K, 2000, EARLY HUM DEV, V57, P85, DOI 10.1016/S0378-3782(99)00065-1; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Bell R, 2001, HUM GENET, V108, P546, DOI 10.1007/s004390100528; BOGGS S, 1994, J PEDIATR-US, V124, P125, DOI 10.1016/S0022-3476(94)70267-5; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Chang VWH, 2001, GENE, V267, P201, DOI 10.1016/S0378-1119(01)00400-0; Eulmesekian P, 2005, J PERINAT MED, V33, P347, DOI 10.1515/JPM.2005.067; Fukamachi H, 2001, BIOCHEM BIOPH RES CO, V280, P1069, DOI 10.1006/bbrc.2001.4247; Fukuda K, 2003, DEV BIOL, V255, P278, DOI 10.1016/S0012-1606(02)00088-X; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Gutierrez C, 2000, PEDIATR DEVEL PATHOL, V3, P271, DOI 10.1007/s100249910035; Hellqvist M, 1996, J BIOL CHEM, V271, P4482; Iida K, 1997, DEVELOPMENT, V124, P4627; Kalinichenko VV, 2004, AM J PHYSIOL-LUNG C, V286, pL521, DOI 10.1152/ajplung.00212.2003; Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kanzaki-Kato N, 2005, CARDIOVASC RES, V65, P711, DOI 10.1016/j.cardiores.2004.10.017; Kohlhase J, 2000, AM J MED GENET, V91, P190, DOI 10.1002/(SICI)1096-8628(20000320)91:3<190::AID-AJMG6>3.0.CO;2-I; LANGSTON C, 1991, Pediatric Pathology, V11, P163; Licht C, 2004, EUR J PEDIATR, V163, P181, DOI 10.1007/s00431-003-1385-6; Lim L, 2002, AM J PHYSIOL-LUNG C, V282, pL1012, DOI 10.1152/ajplung.00371.2001; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Michalsky MP, 2005, J PEDIATR SURG, V40, P1100, DOI 10.1016/j.jpedsurg.2005.03.067; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P167, DOI 10.1007/s100240010125; Sen P, 2004, J PEDIATR-US, V145, P646, DOI 10.1016/j.jpeds.2004.06.081; Shaw-Smith C, 2006, J MED GENET, V43, P545, DOI 10.1136/jmg.2005.038158; SIMOS TE, 1993, APPL MATH LETT, V6, P9, DOI 10.1016/0893-9659(93)90090-A; Steinhorn RH, 1997, J PEDIATR-US, V130, P417, DOI 10.1016/S0022-3476(97)70203-8; Takano-Maruyama M, 2006, AM J PHYSIOL-GASTR L, V291, pG163, DOI 10.1152/ajpgi.00019.2006; Tseng HT, 2004, DEVELOPMENT, V131, P3637, DOI 10.1242/dev.01234; Vassal HB, 1998, J MED GENET, V35, P58, DOI 10.1136/jmg.35.1.58; WAGENVOORT CA, 1986, HUM PATHOL, V17, P727, DOI 10.1016/S0046-8177(86)80182-4	38	276	289	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					780	791		10.1016/j.ajhg.2009.05.005	http://dx.doi.org/10.1016/j.ajhg.2009.05.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19500772	Green Published, hybrid			2022-12-18	WOS:000267042800008
J	Hudson, G; Carelli, V; Spruijt, L; Gerards, M; Mowbray, C; Achilli, A; Pyle, A; Elson, J; Howell, N; La Morgia, C; Valentino, ML; Huoponen, K; Savontaus, ML; Nikoskelainen, E; Sadun, AA; Salomao, SR; Belfort, R; Griffiths, P; Man, PYW; de Coo, RFM; Horvath, R; Zeviani, M; Smeets, HJT; Torroni, A; Chinnery, PF				Hudson, Gavin; Carelli, Valerio; Spruijt, Liesbeth; Gerards, Mike; Mowbray, Catherine; Achilli, Alessandro; Pyle, Angela; Elson, Joanna; Howell, Neil; La Morgia, Chiara; Valentino, Maria Lucia; Huoponen, Kirsi; Savontaus, Marja-Liisa; Nikoskelainen, Eeva; Sadun, Alfredo A.; Salomao, Solange R.; Belfort, Rubens, Jr.; Griffiths, Philip; Man, Patrick Yu Wai; de Coo, Rene F. M.; Horvath, Rita; Zeviani, Massimo; Smeets, Hubert J. T.; Torroni, Antonio; Chinnery, Patrick F.			Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-B GENE; CHAIN COMPLEX-I; MAMMALIAN MITOCHONDRIA; MUTATION; HAPLOTYPE; PEDIGREE; DISEASE; HETEROPLASMY; PENETRANCE; QUESTIONS	Leber hereditary optic neuropathy (LHON) is due primarily to one of three common point mutations of mitochondrial DNA (mtDNA), but the incomplete penetrance implicates additional genetic or environmental factors in the pathophysiology of the disorder. Both the 11778G -> A and 14484T -> C LHON mutations are preferentially found on a specific mtDNA genetic background, but 3460G -> A is not. However, there is no clear evidence that any background influences clinical penetrance in any of these mutations. By studying 3,613 subjects from 159 LHON-affected pedigrees, we show that the risk of visual failure is greater when the 11778G -> A or 14484T -> C mutations are present in specific subgroups of haplogroup J (J2 for 11778G -> A and J1 for 14484T -> C) and when the 3460G -> A mutation is present in haplogroup K. By contrast, the risk of visual failure is significantly less when 11778G -> A occurs in haplogroup H. Substitutions on MTCYB provide an explanation for these findings, which demonstrate that common genetic variants have a marked effect on the expression of an ostensibly monogenic mtDNA disorder.	Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Ophthalmol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, Italy; Univ So Calif, Sch Med, Doheny Eye Inst, Los Angeles, CA 90089 USA; Univ Nijmegen, Radboud Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Univ Maastricht, Dept Genet & Cell Biol, Maastricht, Netherlands; Univ Pavia, Dipartiemnto Genet & Microbiol, I-27100 Pavia, Italy; Univ Turku, Dept Med Genet, SF-20500 Turku, Finland; MIGENIX, San Diego, CA USA; Univ Turku, Cent Hosp, Dept Ophthalmol, SF-20500 Turku, Finland; Univ Sao Paulo, Dept Oftalmol, BR-05508 Sao Paulo, Brazil; Erasmus Univ, Med Ctr, Dept Child Neurol, NL-3000 DR Rotterdam, Netherlands; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Med Genet Ctr Munich, Munich, Germany; C Besta Neurol Inst, IRCCS, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, Milan, Italy	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Bologna; Doheny Eye Institute; University of Southern California; Radboud University Nijmegen; Maastricht University; University of Pavia; University of Turku; University of Turku; Universidade de Sao Paulo; Erasmus University Rotterdam; Erasmus MC; University of Munich	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	P.F.Chinnery@ncl.ac.uk	Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Horvath, Rita/AAY-7042-2020; Spruijt, L./L-4664-2015; Mowbray, Catherine/X-6269-2019; Salomao, Solange R/G-9500-2012; Belfort, Rubens/E-2252-2012; Zeviani, Massimo/AAU-2632-2021; Salomao, Solange/AAB-3234-2021; La Morgia, Chiara/H-6765-2012; Zeviani, Massimo/K-2891-2014; Hudson, Gavin/E-7117-2017	Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Mowbray, Catherine/0000-0001-8234-0276; Salomao, Solange R/0000-0002-3436-5599; Belfort, Rubens/0000-0002-8422-3898; Zeviani, Massimo/0000-0002-9067-5508; Salomao, Solange/0000-0002-3436-5599; CARELLI, VALERIO/0000-0003-4923-6404; VALENTINO, MARIA LUCIA/0000-0001-5323-0115; Horvath, Rita/0000-0002-9841-170X; Chinnery, Patrick/0000-0002-7065-6617; Hudson, Gavin/0000-0001-7210-2733; LA MORGIA, Chiara/0000-0002-4639-8929; /0000-0002-3551-5624; de Coo, Irenaeus/0000-0003-0533-7422	MRC [G90/63] Funding Source: UKRI; Medical Research Council [G90/63] Funding Source: Medline; Telethon [GGP06233] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon)		Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Brown MD, 1997, AM J HUM GENET, V60, P381; Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O; De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.3.CO;2-Q; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; HARDING AE, 1995, AM J HUM GENET, V57, P77; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135; Howell N, 1999, INT REV CYTOL, V186, P49; Hudson G, 2005, AM J HUM GENET, V77, P1086, DOI 10.1086/498176; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6; Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Newman NJ, 2002, J NEURO-OPHTHALMOL, V22, P257, DOI 10.1097/00041327-200212000-00001; NIKOSKELAINEN EK, 1994, CLIN NEUROSCI, V2, P115; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9; Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; Torroni A, 1997, AM J HUM GENET, V60, P1107; Torroni A, 1996, AM J HUM GENET, V59, P248; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Tsao K, 1999, BRIT J OPHTHALMOL, V83, P577, DOI 10.1136/bjo.83.5.577; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739	34	276	293	1	21	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					228	233		10.1086/519394	http://dx.doi.org/10.1086/519394			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668373	Green Published, Bronze			2022-12-18	WOS:000248540400003
J	di Barletta, MR; Ricci, E; Galluzzi, G; Tonali, P; Mora, M; Morandi, L; Romorini, A; Voit, T; Orstavik, KH; Merlini, L; Trevisan, C; Biancalana, V; Housmanowa-Petrusewicz, I; Bione, S; Ricotti, R; Schwartz, K; Bonne, G; Toniolo, D				di Barletta, MR; Ricci, E; Galluzzi, G; Tonali, P; Mora, M; Morandi, L; Romorini, A; Voit, T; Orstavik, KH; Merlini, L; Trevisan, C; Biancalana, V; Housmanowa-Petrusewicz, I; Bione, S; Ricotti, R; Schwartz, K; Bonne, G; Toniolo, D			Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMATIN BINDING-SITE; NUCLEAR-ENVELOPE; HUMEROPELVIC DISTRIBUTION; ROD DOMAIN; LAMIN-A; DISEASE; EXPRESSION; IDENTIFICATION; CARDIOMYOPATHY; MEMBRANE	Emery-Dreifuss muscular dystrophy (EMD) is a condition characterized by the clinical triad of early-onset contractures, progressive weakness in humeroperoneal muscles, and cardiomyopathy with conduction block. The disease was described for the first time as an X-linked muscular dystrophy, but autosomal dominant and autosomal recessive forms were reported. The genes for X-linked EMD and autosomal dominant EMD (AD-EMD) were identified. We report here that heterozygote mutations in LMNA, the gene for AD-EMD, may cause diverse phenotypes ranging from typical EMD to no phenotypic effect. Our results show that LMNA mutations are also responsible for the recessive form of the disease. Our results give further support to the notion that different genetic forms of EMD have a common pathophysiological background. The distribution of the mutations in AD-EMD patients (in the tail and in the 2A rod domain) suggests that unique interactions between lamin A/C and other nuclear components exist that have an important role in cardiac and skeletal muscle function.	CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy; Catholic Univ, Inst Neurol, Rome, Italy; UILDM, Ctr Neuromuscular Dis, Rome Sect, Rome, Italy; CNR, Inst Cell Biol, I-27100 Pavia, Italy; Ist Neurol Besta, Milan, Italy; Legnano Hosp, Legnano, Italy; Univ Essen, Dept Pediat, Essen, Germany; Ulleval Hosp, Dept Med Genet, Oslo, Norway; Rizzoli Inst, Bologna, Italy; Univ Padua, Dept Clin Neurol, Padua, Italy; Polish Acad Sci, Med Res Ctr, Warsaw, Poland; GH Pitie Salpetriere, Inst Myol, Paris, France; GH Pitie Salpetriere, INSERM, UR153, Paris, France; Strasbourg Univ, Sch Med, Serv Genet, Strasbourg, France	Consiglio Nazionale delle Ricerche (CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituto Neurologico Besta; University of Duisburg Essen; University of Oslo; University of Padua; Polish Academy of Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Franche-Comte	Toniolo, D (corresponding author), CNR, Inst Genet Biochem & Evolut, Via Abbiategrasso 207, I-27100 Pavia, Italy.		Toniolo, Daniela/AAE-2969-2019; Biancalana, Valerie/O-2351-2016; Merlini, Luciano/N-6478-2019; Bonne, Gisèle/G-3121-2013; Ricci, Enzo/AAC-4448-2020; Mora, Marina/J-2883-2018	Toniolo, Daniela/0000-0001-9545-6032; Merlini, Luciano/0000-0002-1108-1198; Bonne, Gisèle/0000-0002-2516-3258; Bione, Silvia/0000-0002-3924-4606; Mora, Marina/0000-0002-5765-2320; RICCI, Enzo/0000-0003-3092-3597				BIONE S, 1995, HUM MOL GENET, V4, P1859; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BRODSKY GL, 2000, HUM MOL GENET, V101, P473; Cartegni L, 1997, HUM MOL GENET, V6, P2257, DOI 10.1093/hmg/6.13.2257; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FENICHEL GM, 1982, NEUROLOGY, V32, P1399, DOI 10.1212/WNL.32.12.1399; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Furukawa K, 1997, BIOCHEM BIOPH RES CO, V238, P240, DOI 10.1006/bbrc.1997.7235; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; HOGER TH, 1991, EXP CELL RES, V197, P280, DOI 10.1016/0014-4827(91)90434-V; LIN F, 1993, J BIOL CHEM, V268, P16321; Manilal S, 1998, HUM MOL GENET, V7, P855, DOI 10.1093/hmg/7.5.855; MARTIN GJ, 1995, METHODS DETECT ADULT, V1, P1; MILLER RG, 1985, NEUROLOGY, V35, P1230, DOI 10.1212/WNL.35.8.1230; Morris GE, 1999, HUM MOL GENET, V8, P1847, DOI 10.1093/hmg/8.10.1847; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; OEFNER PJ, 1995, AM J HUM GENET, V57, P266; OEFNER PJ, 1998, CURRENT PROTOCOLS HU; ORSTAVIK KH, 1990, CLIN GENET, V38, P447; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TAKAMOTO K, 1984, ARCH NEUROL-CHICAGO, V41, P1292, DOI 10.1001/archneur.1984.04050230078024; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Taylor J, 1998, NEUROLOGY, V51, P1116, DOI 10.1212/WNL.51.4.1116; Toniolo D, 1999, CURR OPIN GENET DEV, V9, P275, DOI 10.1016/S0959-437X(99)80041-0; TONIOLO D, 1998, NEUROMUSCULAR DISORD, P87; VOIT T, 1988, NEUROPEDIATRICS, V19, P62, DOI 10.1055/s-2008-1052404; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Yates JRW, 1997, NEUROMUSCULAR DISORD, V7, P67, DOI 10.1016/S0960-8966(96)00403-8	32	276	293	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1407	1412		10.1086/302869	http://dx.doi.org/10.1086/302869			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739764	Bronze, Green Published			2022-12-18	WOS:000088373400022
J	Easton, DF; Steele, L; Fields, P; Ormiston, W; Averill, D; Daly, PA; McManus, R; Neuhausen, SL; Ford, D; Wooster, R; CannonAlbright, LA; Stratton, MR; Goldgar, DE				Easton, DF; Steele, L; Fields, P; Ormiston, W; Averill, D; Daly, PA; McManus, R; Neuhausen, SL; Ford, D; Wooster, R; CannonAlbright, LA; Stratton, MR; Goldgar, DE			Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; LINKAGE ANALYSIS; LOCUS; SEGREGATION; CARRIERS	The penetrance of the BRCA2 gene on chromosome 13q12-13 has been estimated in two large, systematically ascertained, linked families, by use of a maximum-likelihood method to incorporate both cancer-incidence data and 13q marker typings in the families. The cumulative risk of breast cancer in female gene carriers was estimated to be 59.8% by age 50 years (95% confidence interval [95%CI] 25.9%-78.5%) and 79.5% by age 70 years (95%CI 28.9%-97.5%). The cumulative risk of breast cancer in male carriers was estimated to be 6.3% (35%CI 1.4%-25.6%) by age 70 years. There was no evidence of any risk difference between the two families. These results indicate that the lifetime breast cancer risk in BRCA2 carriers, for at least a subset of mutations, is comparable to that for BRCA1. A significant excess of ovarian cancer in gene carriers was observed (relative risk 17.69, based on three cases), but the absolute risk of ovarian cancer was less than that reported for BRCA1. Significant excesses of laryngeal cancer (relative risk 7.67, based on two possible carriers) and prostate cancer (relative risk 2.89, based on five possible carriers) were also observed. One case of ocular melanoma, as well as a second eye cancer of unspecified histology, occurred in obligate gene carriers.	UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112; TRINITY COLL DUBLIN,SCH MED,DEPT MED,DUBLIN,IRELAND; INST CANC RES,EPIDEMIOL SECT,BELMONT,SURREY,ENGLAND; INST CANC RES,SECT MOL CARCINOGENESIS,BELMONT,SURREY,ENGLAND	Utah System of Higher Education; University of Utah; Trinity College Dublin; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Easton, DF (corresponding author), UNIV CAMBRIDGE,INST PUBL HLTH,DEPT COMMUNITY MED,CRC GENET EPIDEMIOL UNIT,ROBINSON WAY,CAMBRIDGE CB2 2SR,ENGLAND.		McManus, Ross/AAE-9236-2020	McManus, Ross/0000-0002-0529-9617; albright, lisa/0000-0003-2602-3668				BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; BISHOP DT, 1980, BANBURY REPORT, V4; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLERGETDARPOUX F, 1992, ANN HUM GENET, V46, P145; COLEMAN MP, 1989, 89006 INT AG RES CAN; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1995, AM J HUM GENET, V57, P1457; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; GARDNER EJ, 1950, AM J HUM GENET, V2, P30; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MUIR CS, 1987, IARC SCI PUBL, V88; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Peto J, 1996, INT J CANCER, V65, P275, DOI 10.1002/(SICI)1097-0215(19960126)65:3&lt;275::AID-IJC1&gt;3.0.CO;2-X; RISCH N, 1984, AM J HUM GENET, V36, P363; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; STREUWING JP, 1997, NEW ENGL J MED, V336, P1401; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thompson EA, 1986, PEDIGREE ANAL HUMAN; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TULINIUS H, 1992, BRIT MED J, V305, P855, DOI 10.1136/bmj.305.6858.855; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	28	276	282	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					120	128		10.1086/513891	http://dx.doi.org/10.1086/513891			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245992	Green Published			2022-12-18	WOS:A1997XM72800019
J	BAIRD, PA; ANDERSON, TW; NEWCOMBE, HB; LOWRY, RB				BAIRD, PA; ANDERSON, TW; NEWCOMBE, HB; LOWRY, RB			GENETIC-DISORDERS IN CHILDREN AND YOUNG-ADULTS - A POPULATION STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALGARY,CALGARY T2N 1N4,ALBERTA,CANADA; UNIV BRITISH COLUMBIA,DEPT HLTH CARE & EPIDEMIOL,VANCOUVER V6T 1W5,BC,CANADA; ALBERTA CHILDRENS PROV GEN HOSP,RES INST,CALGARY T2T 5C7,ALBERTA,CANADA	University of Calgary; University of British Columbia; Alberta Childrens Hospital; University of Calgary	BAIRD, PA (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,226-6174 UNIV BLVD,VANCOUVER V6T 1W5,BC,CANADA.							BAIRD PA, 1985, AM J MENT DEF, V89, P323; BAIRD PA, 1987, CAN MED ASSOC J, V136, P109; BAIRD PA, 1981, AM J HUM GENET, V33, P470; BAIRD PA, 1987, J PEDIATR-US, V110, P849, DOI 10.1016/S0022-3476(87)80395-5; BAIRD PA, 1968, BRIT J PREV SOC MED, V22, P81; BAIRD PA, 1983, AM J MED GENET, V16, P49, DOI 10.1002/ajmg.1320160109; CZEIZEL A, 1984, MUTAT RES, V128, P73, DOI 10.1016/0027-5107(84)90049-6; HAMERTON JL, 1975, CLIN GENET, V8, P223; JACOBS PA, 1977, AM J EPIDEMIOL, V105, P180, DOI 10.1093/oxfordjournals.aje.a112374; LEUNG TJ, 1985, AM J MED GENET, V21, P43; LOWRY RB, 1975, CAN J PUBLIC HEALTH, V66, P322; LOWRY RB, 1977, TERATOLOGY, V16, P277, DOI 10.1002/tera.1420160306; LOWRY RB, 1986, GENET EPIDEMIOL, V3, P455, DOI 10.1002/gepi.1370030609; LOWRY RB, 1972, CAN MED ASSOC J, V106, P1299; LOWRY RB, 1976, TERATOLOGY, V14, P29, DOI 10.1002/tera.1420140105; MYRIANTHOPOULOS N C, 1974, Birth Defects Original Article Series, V10, P1; RENWICK DHG, 1968, BRIT J PREV SOC MED, V22, P61; SEARLE AG, 1986, J MED GENET, V23, P220, DOI 10.1136/jmg.23.3.220; SPOUGE D, 1985, TERATOLOGY, V32, P171, DOI 10.1002/tera.1420320204; TRIMBLE BK, 1977, CAN J GENET CYTOL, V19, P375, DOI 10.1139/g77-041; TRIMBLE BK, 1978, AM J MED GENET, V2, P1, DOI 10.1002/ajmg.1320020102; TRIMBLE BK, 1974, ANN HUM GENET, V38, P199, DOI 10.1111/j.1469-1809.1974.tb01951.x; Vogel F., 1986, HUMAN GENETICS PROBL; WILSON RD, 1985, AM J MED GENET, V21, P153, DOI 10.1002/ajmg.1320210123; 1986, UNSCEAR REPORT GENET; 1982, UNSCEAR IONIZING RAD; 1977, UNSCEAR SOURCES EFFE; 1966, 17TH GEN ASS OFF R S, V16; 1981, 1981 MIN HLTH DIV VI	29	276	291	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					677	693						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	3358420				2022-12-18	WOS:A1988N143800003
J	Li, MX; Gui, HS; Kwan, JSH; Sham, PC				Li, Miao-Xin; Gui, Hong-Sheng; Kwan, Johnny S. H.; Sham, Pak C.			GATES: A Rapid and Powerful Gene-Based Association Test Using Extended Simes Procedure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; COMPLEX TRAITS; SUSCEPTIBILITY; METAANALYSIS; INTERACTOME; HAPLOTYPE; VARIANTS; NETWORK; LOCI	The gene has been proposed as an attractive unit of analysis for association studies, but a simple yet valid, powerful, and sufficiently fast method of evaluating the statistical significance of all genes in large, genome-wide datasets has been lacking. Here we propose the use of an extended Simes test that integrates functional information and association evidence to combine the p values of the single nucleotide polymorphisms within a gene to obtain an overall p value for the association of the entire gene. Our computer simulations demonstrate that this test is more powerful than the SNP-based test, offers effective control of the type 1 error rate regardless of gene size and linkage-disequilibrium pattern among markers, and does not need permutation or simulation to evaluate empirical significance. Its statistical power in simulated data is at least comparable, and often superior, to that of several alternative gene-based tests. When applied to real genome-wide association study (GWAS) datasets on Crohn disease, the test detected more significant genes than SNP-based tests and alternative gene-based tests. The proposed test, implemented in an open-source package, has the potential to identify additional novel disease-susceptibility genes for complex diseases from large GWAS datasets.	[Li, Miao-Xin; Gui, Hong-Sheng; Kwan, Johnny S. H.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Li, Miao-Xin; Gui, Hong-Sheng; Kwan, Johnny S. H.; Sham, Pak C.] Univ Hong Kong, State Key Lab Cognit & Brain Sci, Pokfulam, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.] Univ Hong Kong, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Li, Miao-Xin; Sham, Pak C.] Univ Hong Kong, Genome Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Sham, PC (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China.	pcsham@hkucc.hku.hk	Gui, Hongsheng/D-1063-2013; Li, Miaoxin/B-7079-2013	Gui, Hongsheng/0000-0002-0460-7446; 	Hong Kong Research Grants Council [GRF HKU 774707]; European Community [HEALTH-F2-2009-241909]; University of Hong Kong Strategic Research Theme on Genomics;  [HKU 201007176166]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); European Community(European Commission); University of Hong Kong Strategic Research Theme on Genomics; 	We are grateful to Mark J. Daly for sharing data on CD.<SUP>30</SUP> This work was funded by Hong Kong Research Grants Council GRF HKU 774707, the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI), the Small Project Funding HKU 201007176166, and The University of Hong Kong Strategic Research Theme on Genomics. We also thank two anonymous reviewers for their useful comments, which improved this paper significantly.	Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; CURTIS D, 2008, ADV APPL BIOINFORMAT, P1; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Fisher R., 1954, OLIVER BOYD, DOI DOI 10.1007/BF01603396; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Galwey NW, 2009, GENET EPIDEMIOL, V33, P559, DOI 10.1002/gepi.20408; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOLM S, 1979, SCAND J STAT, V6, P65; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Latiano A, 2010, INFLAMM BOWEL DIS, V16, P1108, DOI 10.1002/ibd.21176; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marquez A, 2009, GENES IMMUN, V10, P631, DOI 10.1038/gene.2009.56; McCabe ERB, 2002, LANCET, V359, P1169, DOI 10.1016/S0140-6736(02)08249-1; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Michelsen KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004719; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Nakagome S, 2010, ANN HUM GENET, V74, P126, DOI 10.1111/j.1469-1809.2010.00567.x; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RISCH N, 1990, AM J HUM GENET, V46, P222; Roeder K, 2007, GENET EPIDEMIOL, V31, P741, DOI 10.1002/gepi.20237; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang HC, 2009, BMC P S7, V3, pS135; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zintzaras E, 2008, J HUM GENET, V53, P1, DOI 10.1007/s10038-007-0223-5	52	275	279	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					283	293		10.1016/j.ajhg.2011.01.019	http://dx.doi.org/10.1016/j.ajhg.2011.01.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21397060	Bronze, Green Published			2022-12-18	WOS:000288589000006
J	Jensen, LR; Amende, M; Gurok, U; Moser, B; Gimmel, V; Tzschach, A; Janecke, AR; Tariverdian, G; Chelly, J; Fryns, JP; Van Esch, H; Kleefstra, T; Hamel, B; Moraine, C; Gecz, J; Turner, G; Reinhardt, R; Kalscheuer, VM; Ropers, HH; Lenzner, S				Jensen, LR; Amende, M; Gurok, U; Moser, B; Gimmel, V; Tzschach, A; Janecke, AR; Tariverdian, G; Chelly, J; Fryns, JP; Van Esch, H; Kleefstra, T; Hamel, B; Moraine, C; Gecz, J; Turner, G; Reinhardt, R; Kalscheuer, VM; Ropers, HH; Lenzner, S			Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARID PROTEINS; MOUSE; DECAY; PREVALENCE; CHROMOSOME; EXPRESSION; FREQUENCY; INTERACTS; HOMOLOG; FAMILY	In families with nonsyndromic X-linked mental retardation (NS-XLMR), >30% of mutations seem to cluster on proximal Xp and in the pericentric region. In a systematic screen of brain-expressed genes from this region in 210 families with XLMR, we identified seven different mutations in JARID1C, including one frameshift mutation and two nonsense mutations that introduce premature stop codons, as well as four missense mutations that alter evolutionarily conserved amino acids. In two of these families, expression studies revealed the almost complete absence of the mutated JARID1C transcript, suggesting that the phenotype in these families results from functional loss of the JARID1C protein. JARID1C (Jumonji AT-rich interactive domain 1C), formerly known as "SMCX," is highly similar to the Y-chromosomal gene JARID1D/SMCY, which encodes the H-Y antigen. The JARID1C protein belongs to the highly conserved ARID protein family. It contains several DNA-binding motifs that link it to transcriptional regulation and chromatin remodeling, processes that are defective in various other forms of mental retardation. Our results suggest that JARID1C mutations are a relatively common cause of XLMR and that this gene might play an important role in human brain function.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Innsbruck Med Univ, Dept Med Biol & Human Genet, Innsbruck, Austria; Heidelberg Univ, Inst Human Genet, D-6900 Heidelberg, Germany; CHU Cochin, Inst Cochin Genet Mol, CNRS, INSERM, Paris, France; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; CHU Bretonneau, Serv Genet, INSERM, U316, F-37044 Tours, France; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Adelaide, SA, Australia; Univ Newcastle, Hunter Genet, Genet Learning Disabil Serv, Newcastle, NSW 2308, Australia	Max Planck Society; Medical University of Innsbruck; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Radboud University Nijmegen; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Womens & Childrens Hospital Australia; University of Adelaide; University of Newcastle	Lenzner, S (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	Lenzner@molgen.mpg.de	Gecz, Jozef/X-3469-2019; Kleefstra, Tjitske/G-2619-2012; Janecke, Andreas/AAA-5227-2019; Chelly, Jamel/J-7528-2015; Van+Esch, Hilde/AAU-5688-2020; Tzschach, Andreas/I-2648-2019	Gecz, Jozef/0000-0002-7884-6861; Chelly, Jamel/0000-0002-0939-8719; Tzschach, Andreas/0000-0002-6840-965X; Kalscheuer, Vera/0000-0001-6898-3259; Van Esch, Hilde/0000-0002-9604-5726; Janecke, Andreas/0000-0001-7155-0315; Reinhardt, Richard/0000-0001-9376-2132				AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Asselta R, 2001, BLOOD, V98, P3685, DOI 10.1182/blood.V98.13.3685; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Chelly J, 2003, CONTEMPORARY CLIN NE, P263; Claes S, 2000, AM J MED GENET, V94, P1, DOI 10.1002/1096-8628(20000904)94:1<1::AID-AJMG1>3.0.CO;2-V; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FATTAEY AR, 1993, ONCOGENE, V8, P3149; FISHBURN J, 1983, AM J MED GENET, V14, P713, DOI 10.1002/ajmg.1320140413; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Sheardown S, 1996, HUM MOL GENET, V5, P1355, DOI 10.1093/hmg/5.9.1355; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	30	275	283	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					227	236		10.1086/427563	http://dx.doi.org/10.1086/427563			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15586325	Green Published, Bronze			2022-12-18	WOS:000226215100008
J	McPeek, MS; Sun, L				McPeek, MS; Sun, L			Statistical tests for detection of misspecified relationships by use of genome-screen data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; INTERFERENCE; RECOMBINATION; IDENTITY; DESCENT; ERRORS; MAPS	Misspecified relationships can have serious consequences for linkage studies, resulting in either reduced power or false-positive evidence for linkage. If some individuals in the pedigree are untyped, then Mendelian errors may not be observed. Previous approaches to detection of misspecified relationships by use of genotype data mere developed for sib and half-sib pairs. We extend the likelihood calculations of Goring and Ott and Boehnke and Cox to more-general relative pairs, for which identity-by-descent (IBD) status is no longer a Markov chain, and me propose a likelihood-ratio test. We also extend the identity-by-state (IBS)-based test of Ehm and Wagner to nonsib relative pairs. The Likelihood-ratio test has high power, but its drawbacks include the need to construct and apply a separate Markov chain for each possible alternative relationship and the need for simulation to assess significance. The IBS-based test is simpler but has lower power. We propose two new test Statistics-conditional expected IBD (EIBD) and adjusted IBS (AIBS)-designed to retain the simplicity of IBS while increasing power by taking into account chance sharing. In simulations, the power of EIBD is generally close to that of the likelihood-ratio test. The power of AIBS is higher than that of IBS, in all cases considered. We suggest a strategy of initial screening by use of EIBD and AIBS, followed by application of the likelihood-ratio test to only a subset of relative pairs, identified by use of EIBD and AIBS. We apply the methods to a Genetic Analysis Workshop 11 data set from the Collaborative Study on the Genetics of Alcoholism.	Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago	McPeek, MS (corresponding author), Univ Chicago, Dept Stat, 5734 S Univ Ave, Chicago, IL 60637 USA.				NHGRI NIH HHS [R29 HG001645, R01 HG001645, HG01645] Funding Source: Medline; NIGMS NIH HHS [R01 GM031575, GM31575] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001645, R29HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baum LE, 1972, INEQUALITIES, V3, P1; Begleiter H, 1999, GENET EPIDEMIOL, V17, pS25; BISHOP DT, 1990, AM J HUM GENET, V46, P254; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; COBBS G, 1978, GENETICS, V89, P563; DENNISTON C, 1975, ANN HUM GENET, V39, P89, DOI 10.1111/j.1469-1809.1975.tb00110.x; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; FOSS E, 1993, GENETICS, V133, P681; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Jacquard A., 1974, GENETIC STRUCTURE PO; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lin SL, 1996, HUM HERED, V46, P315, DOI 10.1159/000154371; MCPEEK MS, 1995, GENETICS, V139, P1031; STAM P, 1979, GENETICS, V92, P573; THOMPSON EA, 1988, IMA J MATH APPL MED, V5, P261; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; Thompson EA, 1986, PEDIGREE ANAL HUMAN; TIWARI H, 1999, GENET EPIDEMIOL, V17, P216; ZHAO HY, 1995, GENETICS, V139, P1045	25	275	277	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1076	1094		10.1086/302800	http://dx.doi.org/10.1086/302800			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712219	Green Published, Bronze			2022-12-18	WOS:000088373200027
J	Amendola, LM; Jarvik, GP; Leo, MC; McLaughlin, HM; Akkari, Y; Amaral, MD; Berg, JS; Biswas, S; Bowling, KM; Conlin, LK; Cooper, GM; Dorschner, MO; Dulik, MC; Ghazani, AA; Ghosh, R; Green, RC; Hart, R; Horton, C; Johnston, JJ; Lebo, MS; Milosavljevic, A; Ou, J; Pak, CM; Patel, RY; Punj, S; Richards, CS; Salama, J; Strande, NT; Yang, YP; Plon, SE; Biesecker, LG; Rehm, HL				Amendola, Laura M.; Jarvik, Gail P.; Leo, Michael C.; McLaughlin, Heather M.; Akkari, Yassmine; Amaral, Michelle D.; Berg, Jonathan S.; Biswas, Sawona; Bowling, Kevin M.; Conlin, Laura K.; Cooper, Greg M.; Dorschner, Michael O.; Dulik, Matthew C.; Ghazani, Arezou A.; Ghosh, Rajarshi; Green, Robert C.; Hart, Ragan; Horton, Carrie; Johnston, Jennifer J.; Lebo, Matthew S.; Milosavljevic, Aleksandar; Ou, Jeffrey; Pak, Christine M.; Patel, Ronak Y.; Punj, Sumit; Richards, Carolyn Sue; Salama, Joseph; Strande, Natasha T.; Yang, Yaping; Plon, Sharon E.; Biesecker, Leslie G.; Rehm, Heidi L.			Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPASTIC PARAPLEGIA; GENE; MUTATION; RECOMMENDATIONS; PHENOTYPE; STANDARDS; TESTS; SPG7	Evaluating the pathogenicity of a variant is challenging given the plethora of types of genetic evidence that laboratories consider. Deciding how to weigh each type of evidence is difficult, and standards have been needed. In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) published guidelines for the assessment of variants in genes associated with Mendelian diseases. Nine molecular diagnostic laboratories involved in the Clinical Sequencing Exploratory Research (CSER) consortium piloted these guidelines on 99 variants spanning all categories (pathogenic, likely pathogenic, uncertain significance, likely benign, and benign). Nine variants were distributed to all laboratories, and the remaining 90 were evaluated by three laboratories. The laboratories classified each variant by using both the laboratory's own method and the ACMG-AMP criteria. The agreement between the two methods used within laboratories was high (K-alpha = 0.91) with 79% concordance. However, there was only 34% concordance for either classification system across laboratories. After consensus discussions and detailed review of the ACMG=AMP criteria, concordance increased to 71%. Causes of initial discordance in ACMG-AMP classifications were identified, and recommendations on clarification and increased specification of the ACMG-AMP criteria were made. In summary, although an initial pilot of the ACMG-AMP guidelines did not lead to increased concordance in variant interpretation, comparing variant interpretations to identify differences and having a common framework to facilitate resolution of those differences were beneficial for improving agreement, allowing iterative movement toward increased reporting consistency for variants in genes associated with monogenic disease.	[Amendola, Laura M.; Jarvik, Gail P.; Hart, Ragan; Ou, Jeffrey; Salama, Joseph] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Leo, Michael C.] Kaiser Permanente, Ctr Hlth Res, Portland, OR 97227 USA; [McLaughlin, Heather M.; Green, Robert C.; Lebo, Matthew S.; Rehm, Heidi L.] Partners HealthCare Personalized Med, Mol Med Lab, Cambridge, MA 02139 USA; [Akkari, Yassmine; Pak, Christine M.; Punj, Sumit; Richards, Carolyn Sue] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Amaral, Michelle D.; Bowling, Kevin M.; Cooper, Greg M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Berg, Jonathan S.; Strande, Natasha T.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Biswas, Sawona; Conlin, Laura K.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Dorschner, Michael O.] Univ Washington, Dept Pathol, Ctr Precis Diagnost, Seattle, WA 98195 USA; [Dulik, Matthew C.] Childrens Hosp Philadelphia, Dept Pathol & LaboratoryMedicine, Philadelphia, PA 19104 USA; [Ghazani, Arezou A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Ghosh, Rajarshi; Milosavljevic, Aleksandar; Patel, Ronak Y.; Yang, Yaping; Plon, Sharon E.] Baylor Coll Med, Houston, TX 77030 USA; [Green, Robert C.; Lebo, Matthew S.; Rehm, Heidi L.] Brigham & Womens Hosp, Cambridge, MA 02115 USA; [Green, Robert C.; Lebo, Matthew S.; Rehm, Heidi L.] Harvard Univ, Sch Med, Cambridge, MA 02115 USA; [Horton, Carrie] Ambry Genet, Clin Diagnost, Aliso Viejo, CA 92656 USA; [Johnston, Jennifer J.; Biesecker, Leslie G.] NHGRI, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Green, Robert C.; Rehm, Heidi L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	University of Washington; University of Washington Seattle; Kaiser Permanente; Partners Healthcare System; Oregon Health & Science University; HudsonAlpha Institute for Biotechnology; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Dana-Farber Cancer Institute; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jarvik, GP (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.; Rehm, HL (corresponding author), Partners HealthCare Personalized Med, Mol Med Lab, Cambridge, MA 02139 USA.; Rehm, HL (corresponding author), Brigham & Womens Hosp, Cambridge, MA 02115 USA.; Rehm, HL (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02115 USA.; Rehm, HL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	pair@u.washington.edu; hrehm@partners.org	Ghazani, Arezou A./AAS-6871-2021; Cooper, Gregory/D-6914-2011	Lebo, Matthew/0000-0002-9733-5207; Rehm, Heidi L./0000-0002-6025-0015; Hart, Ragan/0000-0003-3758-8082; Strande, Natasha/0000-0001-5148-9772; Cooper, Gregory/0000-0001-5509-9923; Ou, Jeffrey/0000-0002-7067-0056	National Human Genome Research Institute (NHGRI); National Cancer Institute [UO1HG0006546, U01HG006485, U01HG006500, U01HG006492, UM1HG007301, UM1HG007292, UM1HG006508, U01HG006487, U01HG006507, U01HG007307, U41HG006834]; NIH NHGRI; The National Cancer Institute [R21HG006596, P50HG007257, R01HG006600, R01HG004500, R01CA154517, R01HG006618, R21HG006594-01, R01HG006615-01, R21HG006612, 5R21HG006613-02]; NATIONAL CANCER INSTITUTE [R01CA154517] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006507, R21HG006613, R01HG006600, U01HG007292, U01HG007307, UM1HG007292, U01HG006487, ZIAHG200387, P50HG007257, R01HG004500, U41HG006834, R21HG006612, RM1HG007257, U01HG006492, UM1HG006508, R01HG006615, U01HG008657, R21HG006594, UM1HG007301, R21HG006596, R01HG006618, U01HG006485, U01HG006546, U01HG006500] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); The National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Human Genome Research Institute (NHGRI) and National Cancer Institute (UO1HG0006546, U01HG006485, U01HG006500, U01HG006492, UM1HG007301, UM1HG007292, UM1HG006508, U01HG006487, U01HG006507, U01HG007307, U41HG006834, R21HG006596, R01HG006600, P50HG007257, R01HG006600, R01HG004500, R01CA154517, R01HG006618, R21HG006594-01, R01HG006615-01, R21HG006612, and 5R21HG006613-02) and additional support from the participating laboratories. This research was supported in part by the Intramural Research Program of the NIH NHGRI. We thank the following individuals for contributing to variant assessment at the sites: Hana Zouk, PhD; Steven M. Harrison, PhD; Jillian G. Buchan, PhD; Jessica Booker, PhD; Jim Evans, MD, PhD, Kate Foreman, MS; Gloria Haskell, PhD; Kristy Lee, MS; Julianne O'Daniel, MS; Bradford Powell, MD, PhD; Bryce Seifert, PhD; and Karen Weck, MD.	Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Evans BJ, 2015, NEW ENGL J MED, V372, P2258, DOI 10.1056/NEJMsr1501194; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Hwu WL, 2009, HUM MUTAT, V30, P1397, DOI 10.1002/humu.21074; Hymes J, 2001, HUM MUTAT, V18, P375, DOI 10.1002/humu.1208; Ishii S, 2002, AM J HUM GENET, V70, P994, DOI 10.1086/339431; Karbassi I, 2016, HUM MUTAT, V37, P127, DOI 10.1002/humu.22918; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x; Krippendorff K., 2004, CONTENT ANAL INTRO I; Krippendorff K., 2013, BOOTSTRAPPING DISTRI; Lin HY, 2010, J INHERIT METAB DIS, V33, P619, DOI 10.1007/s10545-010-9166-7; Norrgard KJ, 1997, BIOCHEM MOL MED, V61, P22, DOI 10.1006/bmme.1997.2597; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roxburgh RH, 2013, J NEUROL, V260, P1286, DOI 10.1007/s00415-012-6792-z; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224; Yorczyk A, 2015, CLIN GENET, V88, P278, DOI 10.1111/cge.12488; ZWICK R, 1988, PSYCHOL BULL, V103, P374, DOI 10.1037/0033-2909.103.3.374	26	274	278	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1067	1076		10.1016/j.ajhg.2016.03.024	http://dx.doi.org/10.1016/j.ajhg.2016.03.024			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27181684	Green Published, Bronze			2022-12-18	WOS:000377286000002
J	JEFFREYS, AJ; WILSON, V; THEIN, SL; WEATHERALL, DJ; PONDER, BAJ				JEFFREYS, AJ; WILSON, V; THEIN, SL; WEATHERALL, DJ; PONDER, BAJ			DNA FINGERPRINTS AND SEGREGATION ANALYSIS OF MULTIPLE MARKERS IN HUMAN PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; ROYAL CANC HOSP,INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND	University of Oxford; University of London; Institute of Cancer Research - UK	JEFFREYS, AJ (corresponding author), UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,ENGLAND.							BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CAVANEE WK, 1983, NATURE, V305, P779; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; EMERY AEH, 1976, METHODOLOGY MED GENE; GIANNI AM, 1983, EMBO J, V2, P921, DOI 10.1002/j.1460-2075.1983.tb01522.x; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Haldane JBS, 1919, J GENET, V8, P291, DOI 10.1007/BF02983270; Hope D G, 1981, Adv Neurol, V29, P33; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; RENWICK JH, 1969, BRIT MED BULL, V25, P65, DOI 10.1093/oxfordjournals.bmb.a070673; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; SMITH CAB, 1968, ANN HUM GENET, V32, P127, DOI 10.1111/j.1469-1809.1968.tb00058.x; SOUTHERN EM, 1980, METHOD ENZYMOL, V68, P152; SPENCE MA, 1983, J MED GENET, V20, P334, DOI 10.1136/jmg.20.5.334; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; [No title captured]	22	274	284	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					11	24						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3019128				2022-12-18	WOS:A1986D961500002
J	Coffee, B; Keith, K; Albizua, I; Malone, T; Mowrey, J; Sherman, SL; Warren, ST				Coffee, Bradford; Keith, Krayton; Albizua, Igor; Malone, Tamika; Mowrey, Julie; Sherman, Stephanie L.; Warren, Stephen T.			Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-ABNORMALITIES; KLINEFELTER-SYNDROME; CYTOGENETIC SURVEY; FAMILY EXPERIENCES; CGG REPEAT; GENE; DIAGNOSIS; CHILDREN; IDENTIFICATION; PREVALENCE	Fragile X syndrome (FXS) results from a CGG-repeat expansion that triggers hypermethylation and silencing of the FMR1 gene. FXS is referred to as the most common form of inherited intellectual disability, yet its true incidence has never been measured directly by large population screening. Here, we developed an inexpensive and high-throughput assay to quantitatively assess FMR1 methylation in DNA isolated from the dried blood spots of 36,124 deidentified newborn mates. This assay displays 100% specificity and 100% sensitivity for detecting FMR1 methylation, Successfully distinguishing normal males from males with full-mutation FXS. Furthermore, the assay can detect excess FMR1 methylation in 82% of females with full mutations, although the methylation did not correlate with intellectual disability. With amelogenin PCR used for detecting the presence of a Y chromosome, this assay can also detect males with Klinefelter syndrome (KS) (47, XXY). We identified 64 males with FMR1 methylation and, after confirmatory testing, found seven to have full-mutation FXS and 57 to have KS. Because the precise incidence of KS is known, we used our observed KS incidence as a sentinel to assess ascertainment quality and showed that our KS incidence of 1 in 633 newborn males was not significantly different from the literature incidence of 1 in 5 76 (p = 0.79). The seven FXS males revealed an FXS incidence in males of 1 in 5161 (95% confidence interval of 1 in 10,653-1 in 2500), consistent with some earlier indirect estimates. Given the trials now underway for possible FXS treatments, this method could be used in newborn or infant screening as a way of ensuring early interventions for FXS.	[Coffee, Bradford; Keith, Krayton; Albizua, Igor; Malone, Tamika; Mowrey, Julie; Sherman, Stephanie L.; Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012		National Institutes of Health [HD020521, HD024064]; Centers for Disease Control and Prevention [AAMC MM-0937-06/06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020521, R37HD020521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Kasinathan Muraliclharan for assistance in assay development, Elizabeth Franco and M. Ramachandran from the Georgia Public Health Laboratory Newborn Screening Program for their critical assistance, and Fuping Zhang for technical assistance. We also thank Michael Friez and Roger Stephenson for providing DNA samples from phenotyped full-mutation females. This work was supported by National Institutes of Health grants HD020521 and HD024064 and by Centers for Disease Control and Prevention grant AAMC MM-0937-06/06 (to S.T.W.).	Abramsky L, 1997, PRENATAL DIAG, V17, P363, DOI 10.1002/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O; Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Bailey DB, 2003, PEDIATRICS, V111, P407, DOI 10.1542/peds.111.2.407; Bailey DB, 2000, J DEV BEHAV PEDIATR, V21, P315, DOI 10.1097/00004703-200010000-00001; Bailey DB, 2008, PEDIATRICS, V121, pE693, DOI 10.1542/peds.2007-0820; BUCKTON KE, 1980, ANN HUM GENET, V43, P227, DOI 10.1111/j.1469-1809.1980.tb01556.x; Carmichael B, 1999, J INTELL DISABIL RES, V43, P47, DOI 10.1046/j.1365-2788.1999.43120157.x; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Crawford DC, 2002, AM J MED GENET, V110, P226, DOI 10.1002/ajmg.10427; Eberhart DE, 1996, SOMAT CELL MOLEC GEN, V22, P435, DOI 10.1007/BF02369435; Fernandez LS, 2009, ORG LETT, V11, P329, DOI 10.1021/ol802506n; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; FREUND LS, 1993, PEDIATRICS, V91, P321; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gurian EA, 2006, PEDIATRICS, V117, P1915, DOI 10.1542/peds.2005-2294; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; HAMERTON JL, 1975, CLIN GENET, V8, P223; HANSTEEN IL, 1982, CLIN GENET, V21, P309; IDZELENE IP, 1978, GENETIKA+, V14, P2193; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; KIRCHGESSNER CU, 1995, J MED GENET, V32, P925, DOI 10.1136/jmg.32.12.925; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; LIN CC, 1976, HUM GENET, V31, P315, DOI 10.1007/BF00270861; MAEDA T, 1991, JPN J HUM GENET, V36, P117, DOI 10.1007/BF01876812; Morris JK, 2008, EUR J HUM GENET, V16, P163, DOI 10.1038/sj.ejhg.5201956; Nelson RM, 2001, PEDIATRICS, V107, P1451; NIELSEN J, 1982, HUM GENET, V61, P98, DOI 10.1007/BF00274195; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Nygren AOH, 2008, J MOL DIAGN, V10, P496, DOI 10.2353/jmoldx.2008.080053; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Rife M, 2003, GENET TEST, V7, P339, DOI 10.1089/109065703322783725; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; Saul RA, 2008, GENET MED, V10, P714, DOI 10.1097/GIM.0b013e3181862a76; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Strom CM, 2007, GENET MED, V9, P199, DOI 10.1097/GIM.0b013e31803d3ac9; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Visootsak J, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-42; WEBB TP, 1986, J MED GENET, V23, P396, DOI 10.1136/jmg.23.5.396; Youings SA, 2000, J MED GENET, V37, P415, DOI 10.1136/jmg.37.6.415; PEDIATRICS, V106, P1494	51	273	293	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					503	514		10.1016/j.ajhg.2009.09.007	http://dx.doi.org/10.1016/j.ajhg.2009.09.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19804849	Green Published, Bronze			2022-12-18	WOS:000270836000007
J	Cunningham, JM; Kim, CY; Christensen, ER; Tester, DJ; Parc, Y; Burgart, LJ; Halling, KC; McDonnell, SK; Schaid, DJ; Vockley, CW; Kubly, V; Nelson, H; Michels, VV; Thibodeau, SN				Cunningham, JM; Kim, CY; Christensen, ER; Tester, DJ; Parc, Y; Burgart, LJ; Halling, KC; McDonnell, SK; Schaid, DJ; Vockley, CW; Kubly, V; Nelson, H; Michels, VV; Thibodeau, SN			The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPORADIC ENDOMETRIAL CARCINOMA; NONPOLYPOSIS COLON-CANCER; MICROSATELLITE INSTABILITY; MOLECULAR-GENETICS; GERMLINE MUTATIONS; FAMILY HISTORY; GASTRIC-CANCER; HMLH1 PROMOTER; EARLY-ONSET; HNPCC	A comprehensive analysis of somatic and germline mutations related to DNA mismatch-repair (MMR) genes can clarify the prevalence and mechanism of inactivation in colorectal carcinoma (CRC). In the present study, 257 unselected patients referred for CRC resection were examined for evidence of defective DNA MMR. In particular, we sought to determine the frequency of hereditary defects in DNA MMR in this cohort of patients. MMR status was assessed by testing of tumors for the presence or absence of hMLH1, hMSH2, and hMSH6 protein expression and for microsatellite instability (MSI). Of the 257 patients, 51 (20%) had evidence of defective MMR, demonstrating high levels of MSI (MSI-H) and an absence of either hMLH1 (n=48) or hMSH2 (n=3). All three patients lacking hMSH2, as well as one patient lacking hMLH1, also demonstrated an absence of hMSH6. DNA sequence analysis of the 51 patients with defective MMR revealed seven germline mutations-four in hMLH1 (two truncating and two missense) and three in hMSH2 (all truncating). A detailed family history was available for 225 of the 257 patients. Of the seven patients with germline mutations, only three had family histories consistent with hereditary nonpolyposis colorectal cancer. Of the remaining patients who had tumors with defective MMR, eight had somatic mutations in hMLH1. In addition, hypermethylation of the hMLH1 gene promoter was present in 37 (88%) of the 42 hMLH1-negative cases available for study and in all MSI-H tumors that showed loss of hMLH1 expression but no detectable hMLH1 mutations. Our results suggest that, although defective DNA MMR occurs in 20% of unselected patients presenting for CRC resection, hereditary CRC due to mutations in the MMR pathway account for only a small proportion of patients. Of the 257 patients, only 5 (1.9%) appear to have unequivocal evidence of hereditary defects in MMR. The epigenetic (nonhereditary) mechanism of hMLH1 promoter hypermethylation appears to be responsible for the majority of the remaining patients whose tumors are characterized by defective DNA MMR.	Mayo Clin & Mayo Fdn, Genet Lab, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Thibodeau, SN (corresponding author), Mayo Clin & Mayo Fdn, Genet Lab, Dept Lab Med & Pathol, HI 970,200 1st St SW, Rochester, MN 55905 USA.	sthibodeau@mayo.edu		McDonnell, Shannon/0000-0001-6201-369X	NCI NIH HHS [R01 CA68535] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068535] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; AALTONEN LA, 1994, CANCER DETECT PREV, V18, P57; Akiyama Y, 1996, JPN J CANCER RES, V87, P595, DOI 10.1111/j.1349-7006.1996.tb00265.x; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; Bapat BV, 1999, HUM GENET, V104, P167, DOI 10.1007/s004390050931; Battista P, 1997, INT J ONCOL, V10, P65; Beck NE, 1997, BRIT J SURG, V84, P233, DOI 10.1002/bjs.1800840228; Beck NE, 1997, GUT, V41, P235, DOI 10.1136/gut.41.2.235; Bellacosa A, 1996, AM J MED GENET, V62, P353, DOI 10.1002/(SICI)1096-8628(19960424)62:4<353::AID-AJMG7>3.0.CO;2-S; Boland CR, 1998, CANCER RES, V58, P5248; Brassett C, 1996, J MED GENET, V33, P981, DOI 10.1136/jmg.33.12.981; BURKS RT, 1994, ONCOGENE, V9, P1163; Caduff RF, 1996, AM J PATHOL, V148, P1671; Craanen ME, 1996, SCAND J GASTROENTERO, V31, P92, DOI 10.3109/00365529609094737; Cunningham JM, 1998, CANCER RES, V58, P3455; DUGGAN BD, 1994, J NATL CANCER I, V86, P1216, DOI 10.1093/jnci/86.16.1216; Evans DGR, 1997, BRIT J SURG, V84, P1281; Fante R, 1997, AM J GASTROENTEROL, V92, P1505; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL R, 1994, CELL, V77, P167; Fujita S, 1996, JPN J CLIN ONCOL, V26, P351, DOI 10.1093/oxfordjournals.jjco.a023244; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Gurin CC, 1999, CANCER RES, V59, P462; HAN HJ, 1993, CANCER RES, V53, P5087; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Iino H, 2000, GUT, V47, P37, DOI 10.1136/gut.47.1.37; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KELLER G, 1995, AM J PATHOL, V147, P593; Khine K., 1996, Annals Academy of Medicine Singapore, V25, P64; Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; Lipkin SM, 2001, HUM MUTAT, V17, P389, DOI 10.1002/humu.1114; LYNCH HT, 1995, TUMORI, V81, P19; Lynch HT, 1997, CANCER GENET CYTOGEN, V93, P84, DOI 10.1016/S0165-4608(96)00290-7; Lynch HT, 1998, NEW ENGL J MED, V338, P1537, DOI 10.1056/NEJM199805213382109; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; Nakashima H, 1997, ONCOL REP, V4, P387; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Parc YR, 2000, CANCER RES, V60, P2225; Peel DJ, 2000, J NATL CANCER I, V92, P1517, DOI 10.1093/jnci/92.18.1517; Pistorius SR, 2000, INT J COLORECTAL DIS, V15, P255; Planck M, 2000, GENE CHROMOSOME CANC, V29, P33, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1004>3.0.CO;2-R; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Sankila R, 1996, GASTROENTEROLOGY, V110, P682, DOI 10.1053/gast.1996.v110.pm8608876; Soravia C, 1997, SCHWEIZ MED WSCHR, V127, P682; Thibodeau SN, 1998, CANCER RES, V58, P1713; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612; Yin J, 1997, HUM MUTAT, V10, P474, DOI 10.1002/(SICI)1098-1004(1997)10:6<474::AID-HUMU9>3.0.CO;2-D	55	273	279	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					780	790		10.1086/323658	http://dx.doi.org/10.1086/323658			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11524701	Bronze, Green Published			2022-12-18	WOS:000171008200011
J	Liao, DQ				Liao, DQ			Concerted evolution: Molecular mechanism and biological implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL NUCLEAR-RNA; GENE CONVERSION; RIBOSOMAL DNA; RNU2 LOCUS; MULTIGENE FAMILIES; REPETITIVE DNA; U2 SNRNA; SEQUENCE; GENOME; HOMOGENIZATION		Univ Sherbrooke, Dept Microbiol & Infect Dis, Fac Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Liao, DQ (corresponding author), Univ Sherbrooke, Dept Microbiol & Infect Dis, Fac Med, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	dliao@courrier.usherb.ca	Liao, Daiqing/A-8941-2008					Abdulkarim F, 1996, J MOL BIOL, V260, P506, DOI 10.1006/jmbi.1996.0418; AMSTUTZ H, 1985, CELL, V40, P879, DOI 10.1016/0092-8674(85)90347-2; Benedict MQ, 1996, INSECT MOL BIOL, V5, P73, DOI 10.1111/j.1365-2583.1996.tb00042.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRUNNER AM, 1986, BIOCHEMISTRY-US, V25, P5028, DOI 10.1021/bi00366a009; Carranza S, 1996, MOL BIOL EVOL, V13, P824, DOI 10.1093/oxfordjournals.molbev.a025643; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; DOVER GA, 1993, CURR OPIN GENET DEV, V3, P902, DOI 10.1016/0959-437X(93)90012-E; DOVER GA, 1993, METHOD ENZYMOL, V224, P525, DOI 10.1016/0076-6879(93)24039-W; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; HEIX J, 1995, CURR OPIN GENET DEV, V5, P652, DOI 10.1016/0959-437X(95)80035-2; HIBNER BL, 1991, GENETICS, V128, P595; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; JINKSROBERTSON S, 1993, METHOD ENZYMOL, V224, P631; KOOP BF, 1986, J MOL EVOL, V24, P94, DOI 10.1007/BF02099956; Lan RT, 1998, MICROBIOL-UK, V144, P1213, DOI 10.1099/00221287-144-5-1213; Liao DQ, 1998, J MOL EVOL, V46, P649, DOI 10.1007/PL00006345; Liao DQ, 1995, GENOMICS, V30, P583, DOI 10.1006/geno.1995.1280; Liao DQ, 1997, EMBO J, V16, P588, DOI 10.1093/emboj/16.3.588; MATERA AG, 1990, MOL CELL BIOL, V10, P5876, DOI 10.1128/MCB.10.11.5876; MURTI JR, 1994, GENETICS, V137, P837; MURTI JR, 1992, MOL CELL BIOL, V12, P2545, DOI 10.1128/MCB.12.6.2545; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nenoi M, 1998, GENETICS, V148, P867; OHTA T, 1983, P NATL ACAD SCI-BIOL, V80, P4079, DOI 10.1073/pnas.80.13.4079; PAVELITZ T, 1995, EMBO J, V14, P169, DOI 10.1002/j.1460-2075.1995.tb06987.x; Polanco C, 1998, GENETICS, V149, P243; Schimenti JC, 1999, AM J HUM GENET, V64, P40, DOI 10.1086/302220; SCHLOTTERER C, 1994, CURR BIOL, V4, P777, DOI 10.1016/S0960-9822(00)00175-5; Swanson WJ, 1998, SCIENCE, V281, P710, DOI 10.1126/science.281.5377.710	35	273	286	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					24	30		10.1086/302221	http://dx.doi.org/10.1086/302221			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915939	Green Published, Bronze			2022-12-18	WOS:000078477400005
J	Stoilov, I; Akarsu, AN; Alozie, I; Child, A; Barsoum-Homsy, M; Turacli, ME; Or, M; Lewis, RA; Ozdemir, N; Brice, G; Aktan, SG; Chevrette, L; Coca-Prados, M; Sarfarazi, M				Stoilov, I; Akarsu, AN; Alozie, I; Child, A; Barsoum-Homsy, M; Turacli, ME; Or, M; Lewis, RA; Ozdemir, N; Brice, G; Aktan, SG; Chevrette, L; Coca-Prados, M; Sarfarazi, M			Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROLINE-RICH REGION; CRYSTAL-STRUCTURE; SECONDARY STRUCTURE; GENE; BUPHTHALMOS; METABOLISM; RESOLUTION; ENZYMES; GROWTH; MAPS	We recently reported three truncating mutations of the cytochrome P4501B1 gene (CYP1B1) in five families with primary congenital glaucoma (PCG) linked to the GLC3A locus on chromosome 2p21. This could be the first direct evidence supporting the hypothesis that members of the cytochrome P450 superfamily may control the processes of growth and differentiation. We present a comprehensive sequence analysis of the translated regions of the CYP1B1 gene in 22 PCG families and 100 randomly selected normal individuals. Sixteen mutations and six polymorphisms were identified, illustrating an extensive allelic heterogeneity. The positions affected by these changes were evaluated by building a three-dimensional homology model of the conserved C-terminal half of CYP1B1. These mutations may interfere with heme incorporation, by affecting the hinge region and/or the conserved core structures (CCS) that determine the proper folding and heme-binding ability of P450 molecules. In contrast, all polymorphic sites were poorly conserved and located outside the CCS. Northern hybridization analysis showed strong expression of CYP1B1. in the anterior uveal tract, which is involved in secretion of the aqueous humor and in regulation of outflow facility, processes that could contribute to the elevated intraocular pressure characteristic of PCG.	Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA; Hacettepe Univ, Inst Child Hlth, DNA Cell Bank & Gene Res Lab, Jerusalem, Israel; Ankara Univ, Fac Med, Dept Ophthalmol, TR-06100 Ankara, Turkey; Gazi Univ, Dept Ophthalmol, Ankara, Turkey; St George Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Univ Montreal, Hosp St Justine, Dept Ophthalmol, Montreal, PQ, Canada; Univ Calif Davis, Dept Ophthalmol, Sacramento, CA 95817 USA; Cukurova Univ, Dept Ophthalmol, Adana, Turkey; Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA	University of Connecticut; Ankara University; Gazi University; St Georges University London; Universite de Montreal; University of California System; University of California Davis; Cukurova University; Yale University	Sarfarazi, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, 263 Farmington Ave, Farmington, CT 06030 USA.	msarfara@cortex.uchc.edu	Akarsu, Nurten/E-9758-2013	Akarsu, Nurten/0000-0001-5432-0032	NCRR NIH HHS [M01-RR-06192] Funding Source: Medline; NEI NIH HHS [EY-11095] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006192] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011095] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; ALLEN L, 1955, ARCH OPHTHALMOL-CHIC, V53, P783, DOI 10.1001/archopht.1955.00930010791002; Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458; BARKAN O, 1955, AM J OPHTHALMOL, V40, P1; BARSOUMHOMSY M, 1986, OPHTHALMOLOGY, V93, P1323; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Chen CD, 1996, J BIOL CHEM, V271, P28607, DOI 10.1074/jbc.271.45.28607; DELUISE VP, 1983, SURV OPHTHALMOL, V28, P1, DOI 10.1016/0039-6257(83)90174-1; FRANCOIS J, 1980, OPHTHALMOLOGICA, V181, P61, DOI 10.1159/000309028; GENCIK A, 1989, DEV OPHTHALMOL, V16, P75; GrahamLorence SE, 1996, METHOD ENZYMOL, V272, P315, DOI 10.1016/S0076-6879(96)72037-2; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; HOSKINS HD, 1984, ARCH OPHTHALMOL-CHIC, V102, P1331; JAFFAR MS, 1988, OPHTHALMOLOGY ANN; KUPFER C, 1979, AM J OPHTHALMOL, V88, P424, DOI 10.1016/0002-9394(79)90643-3; MARTINVASALLO P, 1989, J CELL PHYSIOL, V141, P243, DOI 10.1002/jcp.1041410203; MAUMENEE A E, 1958, Trans Am Ophthalmol Soc, V56, P507; Murray GI, 1997, CANCER RES, V57, P3026; NEBERT DW, 1990, NATURE, V347, P709, DOI 10.1038/347709a0; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Plasilova M, 1998, HUM HERED, V48, P30; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; Shaffer R, 1970, CONGENITAL PEDIAT GL; SMITH RF, 1992, PROTEIN ENG, V5, P35, DOI 10.1093/protein/5.1.35; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Tang WM, 1996, J BIOL CHEM, V271, P28324, DOI 10.1074/jbc.271.45.28324; TURACLI ME, 1992, INT OPHTHALMOL, V16, P359; Wo YYP, 1997, J BIOL CHEM, V272, P26702, DOI 10.1074/jbc.272.42.26702; YAMAZAKI S, 1993, J BIOCHEM-TOKYO, V114, P652, DOI 10.1093/oxfordjournals.jbchem.a124232	36	273	291	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					573	584		10.1086/301764	http://dx.doi.org/10.1086/301764			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497261	Green Published, hybrid			2022-12-18	WOS:000072894400010
J	GAEDIGK, A; BLUM, M; GAEDIGK, R; EICHELBAUM, M; MEYER, UA				GAEDIGK, A; BLUM, M; GAEDIGK, R; EICHELBAUM, M; MEYER, UA			DELETION OF THE ENTIRE CYTOCHROME-P450 CYP2D6 GENE AS A CAUSE OF IMPAIRED DRUG-METABOLISM IN POOR METABOLIZERS OF THE DEBRISOQUINE SPARTEINE POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTIVE N-OXIDATION; DNA; DEFICIENT; SEQUENCE; AMPLIFICATION; VECTORS; COMPLEX	The debrisoquine/sparteine polymorphism is associated with a clinically important genetic deficiency of oxidative drug metabolism. Form 5% to 10% of Caucasians designated as poor metabolizers (PMs) of the debrisoquine/sparteine polymorphism have a severely impaired capacity to metabolize more than 25 therapeutically used drugs. The impaired drug metabolism in PMs is due to the absence of cytochrome P450IID6 protein. The gene controlling the P450IID6 protein, CYP2D6, is located on the long arm of chromosome 22. A pseudogene CYP2D8P and a related gene CYP2D7 are located upstream from CYP2D6. This gene locus is highly polymorphic. After digestion of genomic DNA with XbaI endonuclease, restriction fragments of 11.5 kb and 44 kb represent mutant alleles of the cytochrome CYP2D6 gene locus associated with the PM phenotype. In order to elucidate the molecular mechanism of the mutant allele reflected by the XbaI 11.5-kb fragment, a genomic library was constructed from leukocyte DNA of one individual homozygous for this fragment and screened with the human IID6 cDNA. The CYP2D genes were isolated and characterized by restriction mapping and partial sequencing. We demonstrate that the mutant 11.5-kb allele results from a deletion involving the entire functional CYP2D6 gene. This result provides an explanation for the total absence of P450IID6 protein in the liver of these PMs.	DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,AUERBACHSTR 112,W-7000 STUTTGART 50,GERMANY; UNIV BASEL,BIOCTR,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND; UNIV MUNICH,GENECTR,MOLEC BIOL LAB,MARTINSRIED,GERMANY	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel; University of Munich				Gaedigk, Roger/0000-0001-5942-1609				ALVAN G, 1990, EUROPEAN CONSENSUS C, P83; BERTILSSON L, 1980, EUR J CLIN PHARMACOL, V17, P153, DOI 10.1007/BF00562624; BROSEN K, 1989, EUR J CLIN PHARMACOL, V36, P537, DOI 10.1007/BF00637732; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EICHELBAUM M, 1988, ISI ATLAS-PHARMACOL, V2, P243; EICHELBAUM M, 1987, BRIT J CLIN PHARMACO, V23, P455, DOI 10.1111/j.1365-2125.1987.tb03075.x; EICHELBAUM M, 1990, PHARMACOL THERAPEUT, V46, P377, DOI 10.1016/0163-7258(90)90025-W; EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; EICHELBAUM M, 1982, CLIN PHARMACOL THER, V31, P184, DOI 10.1038/clpt.1982.29; EVANS DAP, 1980, J MED GENET, V17, P102, DOI 10.1136/jmg.17.2.102; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5194, DOI 10.1073/pnas.83.14.5194; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIMURA S, 1989, AM J HUM GENET, V45, P889; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MEYER UA, 1989, ADV DRUG RES, V19, P197; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; RACKWITZ HR, 1984, GENE, V30, P195, DOI 10.1016/0378-1119(84)90120-3; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; STROKER NG, 1985, NUCLEIC ACIDS RES, V13, P4613; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; YANG R, 1983, GENE, V25, P59, DOI 10.1016/0378-1119(83)90167-1; ZANGER UM, 1988, BIOCHEMISTRY-US, V27, P5447, DOI 10.1021/bi00415a010; ZEHETNER G, 1986, NUCLEIC ACIDS RES, V14, P335, DOI 10.1093/nar/14.1.335	34	273	279	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					943	950						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673290				2022-12-18	WOS:A1991FK89700013
J	ARDINGER, HH; BUETOW, KH; BELL, GI; BARDACH, J; VANDEMARK, DR; MURRAY, JC				ARDINGER, HH; BUETOW, KH; BELL, GI; BARDACH, J; VANDEMARK, DR; MURRAY, JC			ASSOCIATION OF GENETIC-VARIATION OF THE TRANSFORMING GROWTH FACTOR-ALPHA GENE WITH CLEFT-LIP AND PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CHICAGO, DEPT BIOCHEM & MOLEC BIOL, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA; UNIV IOWA, DEPT OTOLARYNGOL, IOWA CITY, IA 52242 USA; FOX CHASE CANC INST, PHILADELPHIA, PA 19111 USA; UNIV CHICAGO, DEPT MED, HOWARD HUGHES MED INST, CHICAGO, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Iowa; Fox Chase Cancer Center; Howard Hughes Medical Institute; University of Chicago	ARDINGER, HH (corresponding author), UNIV IOWA, DEPT PEDIAT, DIV MED GENET, IOWA CITY, IA 52242 USA.				NIDCR NIH HHS [DE05837, DE08556, DE05506] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R13DE008556, P01DE005837, F32DE005506] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CASTAGNOLI A, 1987, NUCLEIC ACIDS RES, V15, P866, DOI 10.1093/nar/15.2.866; CHUNG CS, 1986, AM J HUM GENET, V39, P603; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSON MWJ, 1987, IRISH J MED SCI, V156, P309, DOI 10.1007/BF02951261; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; FREZAL J, 1987, CYTOGENET CELL GENET, V46, P1, DOI 10.1159/000132469; HAYWARD NK, 1987, NUCLEIC ACIDS RES, V15, P5503, DOI 10.1093/nar/15.13.5503; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MURRAY JC, 1987, NUCLEIC ACIDS RES, V15, P6765, DOI 10.1093/nar/15.16.6765; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P5117, DOI 10.1093/nar/14.12.5117; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; Pratt R., 1980, CURRENT RES TRENDS P, P235; SMITH RF, 1987, NUCLEIC ACIDS RES, V15, P6764, DOI 10.1093/nar/15.16.6764	14	273	293	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					348	353						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2570526				2022-12-18	WOS:A1989AN87900002
J	Perry, GH; Ben-Dor, A; Tsalenko, A; Sampas, N; Rodriguez-Revenga, L; Tran, CW; Scheffer, A; Steinfeld, I; Tsang, P; Yamada, NA; Park, HS; Kim, JI; Seo, JS; Yakhini, Z; Laderman, S; Bruhn, L; Lee, C				Perry, George H.; Ben-Dor, Amir; Tsalenko, Anya; Sampas, Nick; Rodriguez-Revenga, Laia; Tran, Charles W.; Scheffer, Alicia; Steinfeld, Israel; Tsang, Peter; Yamada, N. Alice; Park, Han Soo; Kim, Jong-Il; Seo, Jeong-Sun; Yakhini, Zohar; Laderman, Stephen; Bruhn, Laurakay; Lee, Charles			The fine-scale and complex architecture of human copy-number variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRAND BREAK REPAIR; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; COMPREHENSIVE ANALYSIS; DELETION POLYMORPHISM; ALPHA-THALASSEMIA; GENE DELETION; VARIANTS; DEFENSIN	Despite considerable excitement over the potential functional significance of copy-number variants (CNVs), we still lack knowledge of the fine-scale architecture of the large majority of CNV regions in the human genome. In this study, we used a high-resolution array-based comparative genomic hybridization (aCGH) platform that targeted known CNV regions of the human genome at approximately 1 kb resolution to interrogate the genomic DNAs of 30 individuals from four HapMap populations. Our results revealed that 1020 of 1153 CNV loci (88%) were actually smaller in size than what is recorded in the Database of Genomic Variants based on previously published studies. A reduction in size of more than 50% was observed for 876 CNV regions (76%). We conclude that the total genomic content of currently known common human CNVs is likely smaller than previously thought. In addition, approximately 8% of the CNV regions observed in multiple individuals exhibited genomic architectural complexity in the form of smaller CNVs within larger ones and CNVs with interindividual variation in breakpoints. Future association studies that aim to capture the potential influences of CNVs on disease phenotypes will need to consider how to best ascertain this previously uncharacterized complexity.	[Perry, George H.; Rodriguez-Revenga, Laia; Tran, Charles W.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Perry, George H.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Ben-Dor, Amir; Tsalenko, Anya; Sampas, Nick; Scheffer, Alicia; Steinfeld, Israel; Tsang, Peter; Yamada, N. Alice; Yakhini, Zohar; Laderman, Stephen; Bruhn, Laurakay] Agilent Technol, Santa Clara, CA 95051 USA; [Park, Han Soo; Kim, Jong-Il; Seo, Jeong-Sun] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Arizona State University; Arizona State University-Tempe; Agilent Technologies; Seoul National University (SNU); Harvard University; Harvard Medical School	Lee, C (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	clee@rics.bwh.harvard.edu	Seo, Jeong-Sun/J-2763-2012; Tran, Charles/AAL-4841-2021; KIM, JONG-IL/D-1019-2011	KIM, JONG-IL/0000-0002-7240-3744; Yakhini, Zohar/0000-0002-0420-5412; rodriguez-revenga, laia/0000-0002-6332-3929	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004221] Funding Source: NIH RePORTER; NHGRI NIH HHS [P41 HG004221, HG004221] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; COLIN Y, 1991, BLOOD, V78, P2747; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Goidts V, 2006, HUM GENET, V120, P270, DOI 10.1007/s00439-006-0217-y; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; LIPSON D, 2005, WORKSH GEN SIGN PROC; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; OTTOLENGHI S, 1974, NATURE, V251, P389, DOI 10.1038/251389a0; OTTOLENGHI S, 1976, CELL, V9, P71, DOI 10.1016/0092-8674(76)90053-2; Park J, 2006, CANCER EPIDEM BIOMAR, V15, P1473, DOI 10.1158/1055-9965.EPI-06-0141; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; SIMONSANCHEZ J, 2007, HUM MUTAT       1109; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TAYLOR JM, 1974, NATURE, V251, P392, DOI 10.1038/251392a0; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	63	272	311	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					685	695		10.1016/j.ajhg.2007.12.010	http://dx.doi.org/10.1016/j.ajhg.2007.12.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18304495	Green Published, Bronze			2022-12-18	WOS:000254067800013
J	Rice, G; Newman, WG; Dean, J; Patrick, T; Parmar, R; Flintoff, K; Robins, P; Harvey, S; Hollis, T; O'Hara, A; Herrick, AL; Bowden, AP; Perrino, FW; Lindahl, T; Barnes, DE; Crow, YJ				Rice, Gillian; Newman, William G.; Dean, John; Patrick, Teresa; Parmar, Rekha; Flintoff, Kim; Robins, Peter; Harvey, Scott; Hollis, Thomas; O'Hara, Ann; Herrick, Ariane L.; Bowden, Andrew P.; Perrino, Fred W.; Lindahl, Tomas; Barnes, Deborah E.; Crow, Yanick J.			Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECOMBINANT PROTEINS; EXONUCLEASE TREX1; INTERFERON-ALPHA; CELL-DEATH; ERYTHEMATOSUS; DNA; IDENTIFICATION; INFECTION; CATALYSIS; LOCUS	TREX1 constitutes the major 3'-> 5' DNA exonuclease activity measured in mammalian cells. Recently, biallelic mutations in TREX1 have been shown to cause Aicardi-Goutieres syndrome at the AGS1 locus. Interestingly, Aicardi-Goutieres syndrome shows overlap with systemic lupus erythematosus at both clinical and pathological levels. Here, we report a heterozygous TREX1 mutation causing familial chilblain lupus. Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutieres syndrome.	St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, DNA Lab, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; St Marys Hosp, Acad Unit Med Genet, Manchester, NH USA; Natl Hlth Serv Grampian, Dept Med Genet, Aberdeen, Scotland; Royal Aberdeen Childrens Hosp, Dept Paediat Neurol, Aberdeen, Scotland; Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms, Herts, England; Wake Forest Univ, Dept Biochem, Winston Salem, NC 27109 USA; Hope Hosp, Rheumat Dis Ctr, Salford M6 8HD, Lancs, England; Rochdale Royal Infirm, Dept Rheumatol, Rochdale, England; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Aberdeen; University of Aberdeen; Cancer Research UK; Wake Forest University	Crow, YJ (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Level 9 Wellcome Trust Benner Bldg, Leeds LS9 7TF, W Yorkshire, England.	Yanickcrow@mac.com	Rice, Gillian I/G-3128-2015; Crow, Yanick J/N-6120-2014	Rice, Gillian I/0000-0002-4223-0571; Crow, Yanick J/0000-0001-7211-7564; Newman, William/0000-0002-6382-4678; Dean, John/0000-0003-3841-0841; Herrick, Ariane/0000-0003-4941-7926	NIGMS NIH HHS [GM069962, R01 GM069962] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cohen PL, 2006, SPRINGER SEMIN IMMUN, V28, P145, DOI 10.1007/s00281-006-0038-z; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2000, AM J HUM GENET, V67, P213, DOI 10.1086/302955; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; De Laet C, 2005, NEUROPEDIATRICS, V36, P399, DOI 10.1055/s-2005-873058; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Perrino FW, 2004, ADV ENZYME REGUL, V44, P37, DOI 10.1016/j.advenzreg.2003.11.010; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Rasmussen M, 2005, NEUROPEDIATRICS, V36, P40, DOI 10.1055/s-2004-830532; TOLMIE JL, 1995, J MED GENET, V32, P881, DOI 10.1136/jmg.32.11.881; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	23	272	284	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					811	815		10.1086/513443	http://dx.doi.org/10.1086/513443			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357087	Bronze, Green Published			2022-12-18	WOS:000245465200022
J	Finnila, S; Lehtonen, MS; Majamaa, K				Finnila, S; Lehtonen, MS; Majamaa, K			Phylogenetic network for European mtDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL-REGION; POPULATION; SEQUENCE; FINLAND; GENOME; ORIGIN	The sequence in the first hypervariable segment (HVS-I) of the control region has been used as a source of evolutionary information in most phylogenetic analyses of mtDNA. Population genetic inference would benefit from a better understanding of the variation in the mtDNA coding region, but, thus far, complete mtDNA sequences have been rare. We determined the nucleotide sequence in the coding region of mtDNA from 121 Finns, by conformation-sensitive gel electrophoresis and subsequent sequencing and by direct sequencing of the D loop. Furthermore, 71 sequences from our previous reports were included, so that the samples represented all the mtDNA haplogroups present in the Finnish population. We found a total of 297 variable sites in the coding region, which allowed the compilation of unambiguous phylogenetic networks. The D loop harbored 104 variable sites, and, in most cases, these could be localized within the coding-region networks, without discrepancies. Interestingly, many homoplasies were detected in the coding region. Nucleotide variation in the rRNA and tRNA genes was 6%, and that in the third nucleotide positions of structural genes amounted to 22% of that in the HVS-I. The complete networks enabled the relationships between the mtDNA haplogroups to be analyzed. Phylogenetic networks based on the entire coding-region sequence in mtDNA provide a rich source for further population genetic studies, and complete sequences make it easier to differentiate between disease-causing mutations and rare polymorphisms.	Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem, FIN-90014 Oulu, Finland; Univ Oulu, Bioctr, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Majamaa, K (corresponding author), Univ Oulu, Dept Neurol, POB 5000, FIN-90014 Oulu, Finland.		Majamaa, Kari/A-1344-2012	Majamaa, Kari/0000-0002-9070-3791				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; BANDELT HJ, 1995, GENETICS, V141, P743; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Finnila S, 2001, J HUM GENET, V46, P64, DOI 10.1007/s100380170110; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; FINNILA S, IN PRESS MUTAT RES; Hedges SB, 2000, NATURE, V408, P652, DOI 10.1038/35047193; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; MEINILA M, IN PRESS HUM HERED; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Zerjal T, 1997, AM J HUM GENET, V60, P1174	26	272	282	2	44	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1475	1484		10.1086/320591	http://dx.doi.org/10.1086/320591			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349229	Bronze, Green Published			2022-12-18	WOS:000169094600018
J	Guldberg, P; Rey, F; Zschocke, J; Romano, V; Francois, B; Michiels, L; Ullrich, K; Hoffmann, GF; Burgard, P; Schmidt, H; Meli, C; Riva, E; Dianzani, I; Ponzone, A; Rey, J; Guttler, F				Guldberg, P; Rey, F; Zschocke, J; Romano, V; Francois, B; Michiels, L; Ullrich, K; Hoffmann, GF; Burgard, P; Schmidt, H; Meli, C; Riva, E; Dianzani, I; Ponzone, A; Rey, J; Guttler, F			A European multicenter study of phenylalanine hydroxylase deficiency: Classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-BASIS; MILD HYPERPHENYLALANINEMIA; RESIDUAL ACTIVITY; PHENYLKETONURIA; POPULATION; HETEROGENEITY; INHERITANCE; EXPRESSION; DIAGNOSIS; FAMILIES	Phenylketonuria (PKU) and mild hyperphenylalaninemia (MHP) are allelic disorders caused by mutations in the gene encoding phenylalanine hydroxylase (PAH). Previous studies have suggested that the highly variable metabolic phenotypes of PAH deficiency correlate with PAH genotypes, We identified both causative mutations in 686 patients from seven European centers. On the basis of the phenotypic characteristics of 297 functionally hemizygous patients, 105 of the mutations were assigned to one of four arbitrary phenotype categories. We proposed and tested a simple model for correlation between genotype and phenotypic outcome. The observed phenotype matched the predicted phenotype in 79% of the cases, and in only 5 of 184 patients was the observed phenotype more than one category away from that expected. Among the seven contributing centers, the proportion of patients for whom the observed phenotype did not match the predicted phenotype was 4%-23% (P <.0001), suggesting that differences in methods used for mutation detection or phenotype classification may account for a considerable proportion of genotype-phenotype inconsistencies. Our data indicate that the PAH-mutation genotype is the main determinant of metabolic phenotype in most patients with PAH deficiency. In the present study, the classification of 105 PAH mutations may allow the prediction of the biochemical phenotype in >10,000 genotypes, which may be useful for the management of hyperphenylalaninemia in newborns.	John F Kennedy Inst, DK-2600 Glostrup, Denmark; Hop Necker Enfants Malad, Paris, France; Univ Marburg, Childrens Hosp, Dept Neuropaediat & Metab Dis, Marburg, Germany; Ist Ric Ritardo Mentale & Involuz Cerebrale, Mol Genet Lab, Troina, Italy; Limburgs Univ Ctr, Dr L Willems Inst, Diepenbeek, Belgium; Univ Hamburg, Krankenhaus Eppendorf, D-2000 Hamburg, Germany; Heidelberg Univ, Dept Gen Paediat, Heidelberg, Germany; Univ Catania, Pediat Clin, Catania, Italy; Univ Milan, Osped S Paolo, Pediat Clin, Milan, Italy; Univ Turin, Dipartimento Sci Pediat & Adolescenza, Turin, Italy; Univ Turin, Dipartimento Genet, Turin, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Philipps University Marburg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Hasselt University; University of Hamburg; Ruprecht Karls University Heidelberg; University of Catania; University of Milan; University of Turin; University of Turin	Guttler, F (corresponding author), John F Kennedy Inst, Gl Landevej 7, DK-2600 Glostrup, Denmark.	flg@kennedy.dk	Zschocke, Johannes/C-5885-2013; Michiels, Luc/AGH-3847-2022; Scavuzzo, Cataldo/D-5048-2017	Zschocke, Johannes/0000-0002-0046-8274; Michiels, Luc/0000-0001-5065-2048; Scavuzzo, Cataldo/0000-0002-3905-4191; Romano, Valentino/0000-0003-3238-5702	Telethon [E.0427] Funding Source: Medline	Telethon(Fondazione Telethon)		Antonarakis SE, 1998, HUM MUTAT, V11, P1; Burgard P, 1996, EUR J PEDIATR, V155, pS11, DOI 10.1007/PL00014222; CUPPENS H, 1995, EUR J HUM GENET, V3, P235; Desviat LR, 1996, J INHERIT METAB DIS, V19, P227, DOI 10.1007/BF01799436; DESVIAT LR, 1995, AM J HUM GENET, V57, P337; Desviat LR, 1997, EUR J HUM GENET, V5, P196, DOI 10.1159/000484763; DIANZANI I, 1995, EUR J HUM GENET, V3, P294; Eiken HG, 1996, EUR J PEDIATR, V155, P554; Eiken HG, 1996, HUM MUTAT, V7, P228, DOI 10.1002/(SICI)1098-1004(1996)7:3<228::AID-HUMU7>3.0.CO;2-6; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; Eisensmith RC, 1996, PEDIATRICS, V97, P512; GULDBERG P, 1994, J INHERIT METAB DIS, V17, P645, DOI 10.1007/BF00712004; Guldberg P, 1996, J MED GENET, V33, P161, DOI 10.1136/jmg.33.2.161; GULDBERG P, 1994, GENOMICS, V21, P453, DOI 10.1006/geno.1994.1296; GULDBERG P, 1995, EUR J PEDIATR, V154, P551, DOI 10.1007/BF02074833; Guttler F, 1996, EUR J PEDIATR, V155, pS6, DOI 10.1007/PL00014253; GUTTLER F, 1980, ACTA PAEDIATR SCAND, P1; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; John Simon W. M., 1992, Human Mutation, V1, P147, DOI 10.1002/humu.1380010210; Kayaalp E, 1997, AM J HUM GENET, V61, P1309, DOI 10.1086/301638; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEDLEY FD, 1986, NEW ENGL J MED, V314, P1276, DOI 10.1056/NEJM198605153142002; Nollau P, 1997, CLIN CHEM, V43, P1114; Nowacki PM, 1998, NUCLEIC ACIDS RES, V26, P220, DOI 10.1093/nar/26.1.220; OKANO Y, 1991, NEW ENGL J MED, V324, P1232, DOI 10.1056/NEJM199105023241802; REY F, 1992, ARCH FR PEDIATR, V49, P705; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; Romano V, 1996, J INHERIT METAB DIS, V19, P15, DOI 10.1007/BF01799343; SAVOV A, 1995, HUM MOL GENET, V4, P1169, DOI 10.1093/hmg/4.7.1169; SRIVER CR, 1995, METABOLIC MOL BASES, P1015; SVENSSON E, 1993, EUR J PEDIATR, V152, P132, DOI 10.1007/BF02072490; Svensson Elisabeth, 1992, Human Mutation, V1, P129; ZSCHOCKE J, 1994, HUM MUTAT, V4, P114, DOI 10.1002/humu.1380040204	33	272	299	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					71	79		10.1086/301920	http://dx.doi.org/10.1086/301920			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634518	Bronze, Green Published			2022-12-18	WOS:000074761000012
J	Berthon, P; Valeri, A; Cohen-Akenine, A; Drelon, E; Paiss, T; Wohr, G; Latil, A; Millasseau, P; Mellah, I; Cohen, N; Blanche, H; Bellane-Chantelot, C; Demenais, F; Teillac, P; Le Duc, A; de Petriconi, R; Hautmann, R; Chumakov, I; Bachner, L; Maitland, NJ; Lidereau, R; Vogel, W; Fournier, G; Mangin, P; Cohen, D; Cussenot, O				Berthon, P; Valeri, A; Cohen-Akenine, A; Drelon, E; Paiss, T; Wohr, G; Latil, A; Millasseau, P; Mellah, I; Cohen, N; Blanche, H; Bellane-Chantelot, C; Demenais, F; Teillac, P; Le Duc, A; de Petriconi, R; Hautmann, R; Chumakov, I; Bachner, L; Maitland, NJ; Lidereau, R; Vogel, W; Fournier, G; Mangin, P; Cohen, D; Cussenot, O			Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; FAMILY HISTORY; BREAST-CANCER; LOD SCORE; RISK; INHERITANCE; FREQUENCIES; CARCINOMA	There is genetic predisposition associated with greater than or equal to 10% of all cancer of the prostate (CaP). By means of a genomewide search on a selection of 47 French and German families, parametric and nonparametric linkage (NPL) analysis allowed identification of a locus, on chromosome 1q42.2-43, carrying a putative predisposing gene for CaP (PCaP). The primary localization was confirmed with several markers, by use of three different genetic models. We obtained a maximum two-point LOD score of 2.7 with marker D1S2785. Multipoint parametric and NPL analysis yielded maximum HLOD and NPL scores of 2.2 and 3.1, respectively, with an associated P value of .001. Homogeneity analysis with multipoint LOD scores gave an estimate of the proportion of families with linkage to this locus of 50%, with a likelihood ratio of 157/1 in favor of heterogeneity, Furthermore, the 9/47 families with early-onset CaP at age <60 years gave multipoint LOD and NPL scores of 3.31 and 3.32, respectively, with P = .001.	Univ Paris 07, Hop St Louis, Dept Urol, Lab Genet & Pathobiol Tumeurs Prostat,CEREPP, F-75475 Paris, France; Hop St Louis, Genset, Paris, France; Hop St Louis, CEPH, Paris, France; Hop St Louis, INSERM, U358, Paris, France; Univ Paris, Inst France, F-75252 Paris, France; CHU Cavale Blanche, Serv Urol, Brest, BELARUS; Univ Ulm, Abt Med Genet, Ulm, Germany; Univ Ulm, Urol Klin, Ulm, Germany; Ctr Rene Huguenin, Lab Oncogenet, St Cloud, France; Infobiogen, Villejuif, France; Univ York, Canc Res Unit, YCR, York YO1 5DD, N Yorkshire, England; CHU Nancy Brabois, Serv Urol, Vandoeuvre Les Nancy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Ulm University; Ulm University; Rene Huguenin Hospital; University of York - UK; CHU de Nancy	Berthon, P (corresponding author), Univ Paris 07, Hop St Louis, Dept Urol, Lab Genet & Pathobiol Tumeurs Prostat,CEREPP, F-75475 Paris, France.	p.berthon@chu-stlouis.fr	Demenais, Florence/G-3298-2013	Demenais, Florence/0000-0001-8361-0936; cussenot, olivier/0000-0002-9912-0533; Maitland, Norman/0000-0003-1607-9035				APRIKIAN AG, 1995, J UROLOGY, V154, P404, DOI 10.1016/S0022-5347(01)67063-0; Boyle P, 1996, EUR UROL, V29, P3; Cannon L., 1982, CANCER SURV, V1, P47; CANNONALBRIGHT L, 1997, GEN APPR BREAST PROS; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eeles R, 1997, AM J HUM GENET, V61, pA64; FEICHTINGER W, 1989, HUM GENET, V83, P145, DOI 10.1007/BF00286707; FREIMER NB, 1993, AM J HUM GENET, V52, P1102; GENIN E, 1995, ANN HUM GENET, V59, P123, DOI 10.1111/j.1469-1809.1995.tb01610.x; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Latil A, 1997, INT J CANCER, V71, P1118, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1118::AID-IJC33>3.3.CO;2-L; Lesko SM, 1996, AM J EPIDEMIOL, V144, P1041, DOI 10.1093/oxfordjournals.aje.a008876; Li YS, 1995, CANCER GENET CYTOGEN, V84, P46, DOI 10.1016/0165-4608(95)00065-8; LYN D, 1993, AM J HUM GENET, V52, P124; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MCWHORTER WP, 1992, J UROLOGY, V148, P826, DOI 10.1016/S0022-5347(17)36733-2; MEIKLE AW, 1985, PROSTATE, V6, P121; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; MORGANTI G, 1956, Acta Genet Stat Med, V6, P304; MORTON NE, 1956, AM J HUM GENET, V8, P80; MURTY VVVS, 1994, CANCER RES, V54, P3983; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1986, GENET EPIDEMIOL, P251; ROUSSEAUMERCK MF, 1991, HUM GENET, V86, P350; SELLERS TA, 1994, J NATL CANCER I, V86, P1860, DOI 10.1093/jnci/86.24.1860; SKOLNICK M, 1979, SOCIOL SOC RES, V63, P506; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Su ZZ, 1996, P NATL ACAD SCI USA, V93, P7252, DOI 10.1073/pnas.93.14.7252; Thibodeau SN, 1997, AM J HUM GENET, V61, pA297; TULINIUS H, 1992, BRIT MED J, V305, P855, DOI 10.1136/bmj.305.6858.855; Valeri A, 1996, Prog Urol, V6, P226; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WHITTEMORE AS, 1995, JNCI-J NATL CANCER I, V87, P652, DOI 10.1093/jnci/87.9.652; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E	47	272	284	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1416	1424		10.1086/301879	http://dx.doi.org/10.1086/301879			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585607	Green Published, Bronze			2022-12-18	WOS:000074174700018
J	Jordan, CT; Cao, L; Roberson, EDO; Pierson, KC; Yang, CF; Joyce, CE; Ryan, C; Duan, SH; Helms, CA; Liu, Y; Chen, YQ; McBride, AA; Hwu, WL; Wu, JY; Chen, YT; Menter, A; Goldbach-Mansky, R; Lowes, MA; Bowcock, AM				Jordan, Catherine T.; Cao, Li; Roberson, Elisha D. O.; Pierson, Katherine C.; Yang, Chi-Fan; Joyce, Cailin E.; Ryan, Caitriona; Duan, Shenghui; Helms, Cynthia A.; Liu, Yin; Chen, Yongqing; McBride, Alison A.; Hwu, Wuh-Liang; Wu, Jer-Yuarn; Chen, Yuan-Tsong; Menter, Alan; Goldbach-Mansky, Raphaela; Lowes, Michelle A.; Bowcock, Anne M.			PSORS2 Is Due to Mutations in CARD14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; PSORIASIS SUSCEPTIBILITY LOCI; IDENTIFICATION; PATHOGENESIS; REGULATOR; PROMOTER; VARIANT; FAMILY; GENES	Psoriasis is a common, immune-mediated genetic disorder of the skin and is associated with arthritis in approximately 30% of cases. Previously, we localized PSORS2 (psoriasis susceptibility locus 2) to chromosomal region 17q25.3-qter after a genome-wide linkage scan in a family of European ancestry with multiple cases of psoriasis and psoriatic arthritis. Linkage to PSORS2 was also observed in a Taiwanese family with multiple psoriasis-affected members. In caspase recruitment domain family, member 14 (CARD14), we identified unique gain-of-function mutations that segregated with psoriasis by using genomic capture and DNA sequencing. The mutations c.349G>A (p.Gly117Ser) (in the family of European descent) and c.349+5G>A (in the Taiwanese family) altered splicing between CARD14 exons 3 and 4. A de novo CARD14 mutation, c.413A>C (p.Glu138Ala), was detected in a child with sporadic, early-onset, generalized pustular psoriasis. CARD14 activates nuclear factor kappa B (NF-kB), and compared with wild-type CARD14, the p.Gly117Ser and p.Glu138Ala substitutions were shown to lead to enhanced NF-kB activation and upregulation of a subset of psoriasis-associated genes in keratinocytes. These genes included chemokine (C-C motif) ligand 20 (CCL20) and interleukin 8 (IL8). CARD14 is localized mainly in the basal and suprabasal layers of healthy skin epidermis, whereas in lesional psoriatic skin, it is reduced in the basal layer and more diffusely upregulated in the suprabasal layers of the epidermis. We propose that, after a triggering event that can include epidermal injury, rare gain-of-function mutations in CARD14 initiate a process that includes inflammatory cell recruitment by keratinocytes. This perpetuates a vicious cycle of epidermal inflammation and regeneration, a cycle which is the hallmark of psoriasis.	[Jordan, Catherine T.; Cao, Li; Roberson, Elisha D. O.; Joyce, Cailin E.; Duan, Shenghui; Helms, Cynthia A.; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; [Pierson, Katherine C.; Lowes, Michelle A.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10065 USA; [Yang, Chi-Fan; Wu, Jer-Yuarn; Chen, Yuan-Tsong] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Ryan, Caitriona; Menter, Alan] Baylor Univ, Med Ctr, Psoriasis Res Inst, Dallas, TX 75246 USA; [Liu, Yin; Chen, Yongqing; Goldbach-Mansky, Raphaela] NIAMSD, NIH, Bethesda, MD 20892 USA; [McBride, Alison A.] NIAID, NIH, Bethesda, MD 20892 USA; [Hwu, Wuh-Liang] Natl Taiwan Univ Hosp, Dept Pediat & Med Genet, Taipei 100, Taiwan; [Hwu, Wuh-Liang] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan	Washington University (WUSTL); Rockefeller University; Academia Sinica - Taiwan; Baylor University; Baylor University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Taiwan University; National Taiwan University Hospital; National Taiwan University	Bowcock, AM (corresponding author), Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA.	bowcock@genetics.wustl.edu	Goldbach-Mansky, Raphaela/N-5917-2017; Roberson, Elisha D.O./J-1747-2012; Wu, Jer-Yuarn/S-7010-2018; Roberson, Elisha/ABC-1810-2020; Lowes, Michelle A/G-9585-2016	Roberson, Elisha D.O./0000-0001-5921-2399; Roberson, Elisha/0000-0001-5921-2399; Bowcock, Anne/0000-0001-8691-9090; Ryan, Caitriona/0000-0003-1915-546X; HWU, WUH-LIANG/0000-0001-6690-4879; McBride, Alison/0000-0001-5607-5157; Lowes, Michelle A/0000-0003-4256-478X	National Institutes of Health [AR050266, 5RC1AR058681, T32AR007279, T32HL083822, T32GM07200, AR060222, T32HG000045]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; Academia Sinica; National Science Council (National Clinical Core, National Genotyping Core) of Taiwan; National Psoriasis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083822] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060222, ZIAAR041138, RC1AR058681, ZIEAR041176, ZIDAR041180, T32AR007279, R01AR050266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Academia Sinica(Academia Sinica - Taiwan); National Science Council (National Clinical Core, National Genotyping Core) of Taiwan; National Psoriasis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the following grants from the National Institutes of Health: AR050266 and 5RC1AR058681 (A.M.B.), T32AR007279 (E.D.O.R.), T32HL083822 and T32GM07200 (C.T.J), AR060222 (M.A.L and K.C.P), and T32HG000045 (C.E.J). R.G.M., Y.L., and Y.C. are supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. A.A.M. was supported by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases. Additional funding came from the Academia Sinica and National Science Council (National Clinical Core, National Genotyping Core) of Taiwan. The authors thank the many individuals with psoriasis and the controls who participated in this study. Mike Lovett provided helpful comments on the manuscript. The authors are indebted to the National Psoriasis Foundation for continuing support during the course of this study.	Abecasis G, 2005, J INVEST DERMATOL, V124, P921, DOI 10.1111/j.0022-202X.2005.23729.x; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; KAUR P, 1989, J GEN VIROL, V70, P1261, DOI 10.1099/0022-1317-70-5-1261; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nograles KE, 2009, NAT CLIN PRACT RHEUM, V5, P83, DOI 10.1038/ncprheum0987; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Prots I, 2006, ARTHRITIS RHEUM-US, V54, P1491, DOI 10.1002/art.21832; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Singh G, 2006, BIOTECHNIQUES, V41, P177, DOI 10.2144/000112208; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Sticherling M, 1999, ACTA DERM-VENEREOL, V79, P4; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Vineis P, 2011, CARCINOGENESIS, V32, P1295, DOI 10.1093/carcin/bgr087; Yang CF, 2008, J INVEST DERMATOL, V128, P1662, DOI 10.1038/jid.2008.1	50	271	283	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					784	795		10.1016/j.ajhg.2012.03.012	http://dx.doi.org/10.1016/j.ajhg.2012.03.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22521418	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000303907500003
J	HORAI, S; HAYASAKA, K				HORAI, S; HAYASAKA, K			INTRASPECIFIC NUCLEOTIDE-SEQUENCE DIFFERENCES IN THE MAJOR NONCODING REGION OF HUMAN MITOCHONDRIAL-DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HORAI, S (corresponding author), NATL INST GENET,DEPT HUMAN GENET,YATA 1111,MISHIMA,SHIZUOKA 411,JAPAN.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; AQUADRO CF, 1983, GENETICS, V103, P287; BIBB MJ, 1981, CELL, V6, P43; BLANC H, 1983, AM J HUM GENET, V35, P167; BREGA A, 1986, AM J HUM GENET, V39, P502; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BROWN WM, 1979, ICN UCLA S, P485; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P6319, DOI 10.1073/pnas.78.10.6319; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GILES RE, 1980, P NATL ACAD SCI USA, V77, P715; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1986, JPN J GENET, V61, P271, DOI 10.1266/jjg.61.271; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1987, HUM GENET, P177; HORAI S, 1989, IN PRESS P CIRCUM PA; HUTCHINSON SA, 1974, NATURE, V251, P536; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1985, POPULATION GENETICS, P421; POTTER SS, 1975, P NATL ACAD SCI USA, V72, P4496, DOI 10.1073/pnas.72.11.4496; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sokal R, 1963, PRINCIPLES NUMERICAL; STONEKING M, 1989, COLONIZATION PACIFIC, P215; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202	35	271	286	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					828	842						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2316527				2022-12-18	WOS:A1990CW54900023
J	LOWDEN, JA; OBRIEN, JS				LOWDEN, JA; OBRIEN, JS			SIALIDOSIS - REVIEW OF HUMAN NEURAMINIDASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LOWDEN, JA (corresponding author), UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093, USA.							ANDERSON B, 1958, AM J OPHTHALMOL, V45, P23, DOI 10.1016/0002-9394(58)90219-8; ARONSON NN, 1968, J BIOL CHEM, V243, P4564; BERARD M, 1968, Pathologia Europaea, V3, P172; BERMAN ER, 1974, CLIN CHIM ACTA, V52, P115; BIGNAMI A, 1969, ACTA NEUROPATHOL, V12, P50, DOI 10.1007/BF00685310; CANTZ M, 1977, BIOCHEM BIOPH RES CO, V74, P732, DOI 10.1016/0006-291X(77)90363-1; CHAMPION MJ, 1977, AM J HUM GENET, V29, P149; DERRY DM, 1968, NEUROLOGY, V18, P340, DOI 10.1212/WNL.18.4.340; DURAND P, 1977, HELV PAEDIATR ACTA, V32, P391; ENGEL J, 1977, EPILEPSIA, V18, P73, DOI 10.1111/j.1528-1157.1977.tb05589.x; FUKUNAGA H, 1976, CLIN NEUROL TOKYO, V16, P566; GALJAARD H, 1975, NATURE, V257, P60, DOI 10.1038/257060a0; GAUZZI GC, 1973, ACTA NEUROL NAPOLI, V28, P542; GLASGOW GAVIN L., 1957, AUSTRALASIAN ANN MED, V6, P295; GOLDBERG MF, 1971, ARCH INTERN MED, V128, P387, DOI 10.1001/archinte.128.3.387; Goldstein M L, 1974, Trans Am Neurol Assoc, V99, P110; GONATAS NK, 1963, J NEUROPATH EXP NEUR, V22, P557, DOI 10.1097/00005072-196310000-00001; HAMBERT O, 1970, ACTA NEUROL SCAND, V46, P149, DOI 10.1111/j.1600-0404.1970.tb05614.x; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; HOLMES E, ANAL BIOCH; HOROUPIAN DS, 1977, CAN J NEUROL SCI, V4, P67, DOI 10.1017/S0317167100120438; HORVAT A, 1968, J BIOL CHEM, V243, P4380; JERVIS GA, 1952, J NEUROPATH EXP NEUR, V11, P4, DOI 10.1097/00005072-195201000-00002; JUSTICE RM, 1977, PEDIATR RES, V11, P407; KELLY TE, 1977, AM J MED GENET, V1, P31, DOI 10.1002/ajmg.1320010105; KISHORE GS, 1975, J BIOL CHEM, V250, P2655; KRESS BC, 1978, BIOCHEM BIOPH RES CO, V81, P756, DOI 10.1016/0006-291X(78)91416-X; KURIYAMA M, 1975, CLIN NEUROL TOKYO, V15, P580; LEROY JG, 1972, PEDIATR RES, V6, P752, DOI 10.1203/00006450-197210000-00002; LOONEN MCB, 1974, LANCET, V2, P785; LOWDEN JA, UNPUBLISHED; MONTREUIL J, 1975, PURE APPL CHEM, V42, P431, DOI 10.1351/pac197542030431; NISHIGAK.M, 1974, BIOCHEM BIOPH RES CO, V59, P638, DOI 10.1016/S0006-291X(74)80027-6; OBRIEN JS, 1975, CLIN GENET, V8, P303; OBRIEN JS, 1977, AM J HUM GENET, V29, P184; OBRIEN JS, 1978, CLIN GENET, V14, P55; OBRIEN JS, 1977, BIOCHEM BIOPH RES CO, V79, P1136, DOI 10.1016/0006-291X(77)91124-X; OBRIEN JS, AM J HUM GENET; OBRIEN JS, 1978, INHERITED BASIS META, P841; OHMAN R, 1970, BIOCHEMISTRY-US, V9, P3774, DOI 10.1021/bi00821a017; OKADA S, 1978, CLIN CHIM ACTA, V86, P159, DOI 10.1016/0009-8981(78)90129-8; ORII T, 1972, TOHOKU J EXP MED, V107, P303, DOI 10.1620/tjem.107.303; RAPIN I, 1978, ANN NEUROL, V3, P234, DOI 10.1002/ana.410030309; SCHENGRUND CL, 1972, J BIOL CHEM, V247, P2742; SHAUER R, 1976, HOPPESEYLERS Z PHYSL, V357, P559; SOGG RL, AM J OPTHALMOL; SPRANGER J, 1977, AM J MED GENET, V1, P21, DOI 10.1002/ajmg.1320010104; SPRANGER J, 1968, Z KINDERHEILKD, V103, P285, DOI 10.1007/BF00439910; SPRANGER JW, 1970, HUMANGENETIK, V9, P113, DOI 10.1007/BF00278928; STRECKER G, 1977, EUR J BIOCHEM, V75, P391, DOI 10.1111/j.1432-1033.1977.tb11540.x; STRECKER G, 1976, BIOMED EXPRESS, V25, P238; SUZUKI Y, 1977, ARCH NEUROL-CHICAGO, V34, P157, DOI 10.1001/archneur.1977.00500150043008; SUZUKI Y, 1977, HUM GENET, V36, P219, DOI 10.1007/BF00273261; SYMONDS C, 1954, MED J AUSTRALIA, V1, P765; TARENTINO AL, 1976, J BIOL CHEM, V251, P6537; THOMAS GH, 1976, BIOCHEM BIOPH RES CO, V71, P188, DOI 10.1016/0006-291X(76)90267-9; THOMAS GH, 1973, PEDIATR RES, V7, P751, DOI 10.1203/00006450-197309000-00004; THOMAS GH, 1978, CLIN GENET, V13, P369; THOMAS JJ, 1978, ANAL BIOCHEM, V88, P461, DOI 10.1016/0003-2697(78)90445-1; TITTARELLI R, 1966, BRIT J OPHTHALMOL, V50, P414, DOI 10.1136/bjo.50.7.414; TULSIANI DR, 1970, J BIOL CHEM, V245, P1821; TUPPY H, 1969, FEBS LETT, V3, P72, DOI 10.1016/0014-5793(69)80100-6; VENERANDO B, 1975, BIOCHIM BIOPHYS ACTA, V403, P461, DOI 10.1016/0005-2744(75)90074-1; VLADUTIU GD, 1975, BIOCHEM BIOPH RES CO, V67, P956, DOI 10.1016/0006-291X(75)90768-8; VLADUTIU GD, 1977, AM J HUM GENET, V29, pA110; WEISMANN UN, 1974, PEDIATR RES, V8, P865; WENGER DA, 1978, BIOCHEM BIOPH RES CO, V82, P589, DOI 10.1016/0006-291X(78)90915-4; WYNBURNMASON R, 1943, BRIT J OPHTHALMOL, V27, P193; YAMAMOTO A, 1974, ARCH INTERN MED, V134, P627, DOI 10.1001/archinte.134.4.627; YEH AK, 1971, J LAB CLIN MED, V78, P771	70	271	272	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					1	18						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	107795				2022-12-18	WOS:A1979GR11500001
J	Yamaguchi-Kabata, Y; Nakazono, K; Takahashi, A; Saito, S; Hosono, N; Kubo, M; Nakamura, Y; Kamatani, N				Yamaguchi-Kabata, Yumi; Nakazono, Kazuyuki; Takahashi, Atsushi; Saito, Susumu; Hosono, Naoya; Kubo, Michiaki; Nakamura, Yusuke; Kamatani, Naoyuki			Japanese Population Structure, Based on SNP Genotypes from 7003 Individuals Compared to Other Ethnic Groups: Effects on Population-Based Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DNA VARIATION; GENE; STRATIFICATION; POLYMORPHISM; SELECTION; PATTERNS; ORIGINS; ASIA; MAP	Because population stratification can cause spurious associations in case-control Studies, understanding the population structure is important. Here, we examined Japanese population structure by "Eigenanalysis," using the genotypes for 140,387 SNPs in 7003 Japanese individuals, along with 60 European, 60 African, and 90 East-Asian individuals, in the HapMap project. Most Japanese individuals fell into two main clusters, Hondo and Ryukyu; the Hondo cluster includes most of the individuals from the main islands in Japan, and the Ryukyu cluster includes most of the individuals from Okinawa. The SNPs with the greatest frequency differences between the Hondo and Ryukyu clusters were found in the HLA region in chromosome 6. The nonsynonymous SNPs with the greatest frequency differences between the Hondo and Ryukyu clusters were the Val/Ala polymorphism (rs3827760) in the EDAR gene, associated with hair thickness, and the Gly/Ala polymorphism (rs17822931) in the ABCC11 gene, associated with ear-wax type. Genetic differentiation was observed, even among different regions in Honshu Island, the largest island of Japan. Simulation studies showed that the inclusion of different proportions of individuals from different regions of Japan in case and control groups can lead to an inflated rate of false-positive results when the sample sizes are large.	[Yamaguchi-Kabata, Yumi; Nakazono, Kazuyuki; Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Stat Anal,Minato Ku, Tokyo 1088639, Japan; [Nakamura, Yusuke] RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Genotyping,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kamatani, Naoyuki] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo 1620054, Japan	RIKEN; RIKEN; Tokyo Women's Medical University	Yamaguchi-Kabata, Y (corresponding author), RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Stat Anal,Minato Ku, 4-6-1 Shirokane Dai, Tokyo 1088639, Japan.	yyamaguc@src.riken.jp	Kubo, Michiaki/N-7947-2015					Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bannai M, 2000, TISSUE ANTIGENS, V55, P128, DOI 10.1034/j.1399-0039.2000.550204.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Horai S, 1996, AM J HUM GENET, V59, P579; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nakamura T, 2005, J HUM GENET, V50, P53, DOI 10.1007/s10038-004-0220-x; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peacock E, 2005, PHARMACOGENOMICS, V6, P439, DOI 10.1517/14622416.6.4.439; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733; [No title captured]	37	270	276	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					445	456		10.1016/j.ajhg.2008.08.019	http://dx.doi.org/10.1016/j.ajhg.2008.08.019			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18817904	Green Published			2022-12-18	WOS:000260239200002
J	Vella, A; Cooper, JD; Lowe, CE; Walker, N; Nutland, S; Widmer, B; Jones, R; Ring, SM; McArdle, W; Pembrey, ME; Strachan, DP; Dunger, DB; Twells, RCJ; Clayton, DG; Todd, JA				Vella, A; Cooper, JD; Lowe, CE; Walker, N; Nutland, S; Widmer, B; Jones, R; Ring, SM; McArdle, W; Pembrey, ME; Strachan, DP; Dunger, DB; Twells, RCJ; Clayton, DG; Todd, JA			Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPHOID TYROSINE PHOSPHATASE; ALPHA-CHAIN GENE; COMMON DISEASE; GENOME ASSOCIATION; T-CELLS; SUSCEPTIBILITY; EPIDEMIOLOGY; VARIANTS; IL-2	As part of an ongoing search for genes associated with type 1 diabetes (T1D), a common autoimmune disease, we tested the biological candidate gene IL2RA (CD25), which encodes a subunit (IL-2R alpha) of the high-affinity interleukin-2 (IL-2) receptor complex. We employed a tag single-nucleotide polymorphism ( tag SNP) approach in large T1D sample collections consisting of 7,457 cases and controls and 725 multiplex families. Tag SNPs were analyzed using a multilocus test to provide a regional test for association. We found strong statistical evidence in the case-control collection (P = 6.5 x 10(-8)) for a T1D locus in the CD25 region of chromosome 10p15 and replicated the association in the family collection (P = 7.3 x 10(-3); combined P = 1.3 x 10(-10)). These results illustrate the utility of tag SNPs in a chromosome-regional test of disease association and justify future fine mapping of the causal variant in the region.	Univ Cambridge, Cambridge Inst Med Res, Addenbrookes Hosp,Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Univ Bristol, Dept Community Based Med, Bristol, Avon, England; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1E 6BT, England; St George Hosp, Sch Med, Dept Community Hlth Sci, London, England; Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; University of London; University College London; St Georges University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Addenbrookes Hosp,Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Wellcome Trust Med Res Council Bldg,Hills Rd, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Dunger, Professor David/0000-0002-2566-9304; Walker, Neil/0000-0001-9796-7688	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anjos S, 2004, MOL GENET METAB, V81, P187, DOI 10.1016/j.ymgme.2003.11.010; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Fan RZ, 2003, AM J HUM GENET, V72, P850, DOI 10.1086/373966; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Hills, 1993, STAT MODELS EPIDEMIO; Hirschhorn Joel N, 2003, Pediatr Diabetes, V4, P87, DOI 10.1034/j.1399-5448.2001.00013.x; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2005, NAT GENET, V37, P110, DOI 10.1038/ng0205-110; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; TOLEDANO MB, 1990, P NATL ACAD SCI USA, V87, P1830, DOI 10.1073/pnas.87.5.1830; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2004, DIABETES, V53, P1158, DOI 10.2337/diabetes.53.4.1158; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392	35	270	283	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					773	779		10.1086/429843	http://dx.doi.org/10.1086/429843			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15776395	Bronze, Green Published			2022-12-18	WOS:000228198300005
J	FERNANDEZSALGUERO, P; HOFFMAN, SMG; CHOLERTON, S; MOHRENWEISER, H; RAUNIO, H; RAUTIO, A; PELKONEN, O; HUANG, JD; EVANS, WE; IDLE, JR; GONZALEZ, FJ				FERNANDEZSALGUERO, P; HOFFMAN, SMG; CHOLERTON, S; MOHRENWEISER, H; RAUNIO, H; RAUTIO, A; PELKONEN, O; HUANG, JD; EVANS, WE; IDLE, JR; GONZALEZ, FJ			A GENETIC-POLYMORPHISM IN COUMARIN 7-HYDROXYLATION - SEQUENCE OF THE HUMAN CYP2A GENES AND IDENTIFICATION OF VARIANT CYP2A6 ALLELES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-LIVER-MICROSOMES; CYTOCHROME-P450; SUPERFAMILY; METABOLISM; EVOLUTION; SUBFAMILY; MOUSE; RAT	A group of human cytochrome P450 genes encompassing the CYP2A, CYP2B, and CYP2F subfamilies were cloned and assembled into a 350-kb contig localized on the long arm of chromosome 19. Three complete CYP2A genes-CYP2A6, CYP2A7, and CYP2A13-plus two pseudogenes truncated after exon 5, were identified and sequenced, A variant CYP2A6 allele that differed from the corresponding CYP2A6 and CYP2A7 cDNAs previously sequenced was found and was designated CYP2A6v2. Sequence differences in the CYP2A6v2 gene are restricted to regions encompassing exons 3, 6, and 8, which bear sequence relatedness with the corresponding exons of the CYP2A7 gene, located downstream and centromeric of CYP2A6v2, suggesting recent gene-conversion events, The sequencing of all the CYP2A genes allowed the design of a PCR diagnostic test for the normal CYP2A6 allele, the CYP2A6v2 allele, and a variant-designated CYP2A6v1-that encodes an enzyme with a single inactivating amino acid change. These variant alleles were found in individuals who were deficient in their ability to metabolize the CYP2A6 probe drug coumarin, The allelic frequencies of CYP2A6v1 and CYP2A6v2 differed significantly between Caucasian, Asian, and African-American populations, These studies establish the existence of a new cytochrome P450 genetic polymorphism.	NCI, BETHESDA, MD 20892 USA; LAWRENCE LIVERMORE NATL LAB, LIVERMORE, CA USA; UNIV NEWCASTLE UPON TYNE, SCH MED, DEPT PHARMACOL SCI, NEWCASTLE UPON TYNE, TYNE & WEAR, ENGLAND; UNIV OULU, DEPT PHARMACOL & TOXICOL, OULU, FINLAND; NATL CHENG KUNG UNIV, DEPT PHARMACOL, TAINAN 70101, TAIWAN; ST JUDE CHILDRENS RES HOSP, DEPT PHARMACEUT, MEMPHIS, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Newcastle University - UK; University of Oulu; National Cheng Kung University; St Jude Children's Research Hospital			Hoffman, Susan/K-1995-2019; Fernandez-Salguero, Pedro M./J-8437-2014; Pelkonen, Olavi R/F-7740-2012; Evans, William E./C-2069-2012; Idle, Jeff/B-1152-2012	Fernandez-Salguero, Pedro M./0000-0003-2839-5027; Evans, William E./0000-0002-9333-5322; Idle, Jeff/0000-0002-6143-1520				BALE AE, 1991, GENOMICS, V10, P284, DOI 10.1016/0888-7543(91)90514-F; CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; CASHMAN JR, 1992, CHEM RES TOXICOL, V5, P639, DOI 10.1021/tx00029a008; CHOLERTON S, 1992, J CHROMATOGR-BIOMED, V575, P325, DOI 10.1016/0378-4347(92)80166-N; DING SH, 1995, BIOCHEM J, V306, P161, DOI 10.1042/bj3060161; EVANS WE, 1993, J CLIN INVEST, V91, P2150, DOI 10.1172/JCI116441; FERNANDEZSALGUE.P, 1995, PHARMACOGENETICS, V5, P123; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; GONZALEZ FJ, 1995, CANCER RES, V55, P710; GONZALEZ FJ, 1992, TRENDS PHARMACOL SCI, V13, P346, DOI 10.1016/0165-6147(92)90107-H; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; HOFFMAN SMG, IN PRESS J MOL EVOL; KAPITULNIK J, 1977, CLIN PHARMACOL THER, V21, P166; KEULS M., 1952, Euphytica, V1, P112, DOI 10.1007/BF01908269; LEVY KJ, 1975, EDUC PSYCHOL MEAS, V35, P599, DOI 10.1177/001316447503500308; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; MATSUNAGA E, 1990, J MOL EVOL, V30, P155, DOI 10.1007/BF02099942; MAURICE M, 1991, EUR J BIOCHEM, V200, P511, DOI 10.1111/j.1432-1033.1991.tb16212.x; McCracken N. W., 1992, Medical Science Research, V20, P877; MILES JS, 1990, BIOCHEM J, V267, P365, DOI 10.1042/bj2670365; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Newman D, 1939, BIOMETRIKA, V31, P20, DOI 10.1093/biomet/31.1-2.20; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; PELKONEN O, 1985, BRIT J CLIN PHARMACO, V19, P59, DOI 10.1111/j.1365-2125.1985.tb02613.x; RAUNIO H, 1988, BIOCHEM PHARMACOL, V37, P3889, DOI 10.1016/0006-2952(88)90070-6; RAUTIO A, 1992, PHARMACOGENETICS, V2, P227, DOI 10.1097/00008571-199210000-00005; TURKEY JW, 1953, PRINCETON U PRINCETO; YAMANO S, 1990, BIOCHEMISTRY-US, V29, P1322, DOI 10.1021/bi00457a031; YUN CH, 1991, MOL PHARMACOL, V40, P679; Zar, 2001, BIOSTAT ANAL	30	270	283	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					651	660						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668294				2022-12-18	WOS:A1995RR60500015
J	BOULET, L; KARPATI, G; SHOUBRIDGE, EA				BOULET, L; KARPATI, G; SHOUBRIDGE, EA			DISTRIBUTION AND THRESHOLD EXPRESSION OF THE TRANS RNALYS MUTATION IN SKELETAL-MUSCLE OF PATIENTS WITH MYOCLONIC EPILEPSY AND RAGGED-RED FIBERS (MERRF)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL ENCEPHALOMYOPATHY MERRF; KEARNS-SAYRE SYNDROME; RESPIRATORY-CHAIN; DNA MUTATION; HELA-CELLS; DISEASE; GENOMES; SEGREGATION; SEQUENCE; MYOPATHY	We investigated the distribution and expression of mutant mtDNAs carrying the A-to-G mutation at position 8344 in the tRNA(Lys) gene in the skeletal muscle of four patients with myoclonus epilepsy and ragged-red fibers (MERRF). The proportion of mutant genomes was greater than 80% of total mtDNAs in muscle samples of all patients and was associated with a decrease in the activity of cytochrome c oxidase (COX). The vast majority of myoblasts, cloned from the satellite-cell population in the same muscles, were homoplasmic for the mutation. The overall proportion of mutant mtDNAs in this population was similar to that in differentiated muscle, suggesting that the ratio of mutant to wild-type mtDNAs in skeletal muscle is determined either in the ovum or during early development and changes little with age. Translation of all mtDNA-encoded genes was severely depressed in homoplasmic mutant myoblast clones but not in heteroplasmic or wild-type clones. The threshold for biochemical expression of the mutation was determined in heteroplasmic myotubes formed by fusion of different proportions of mutant and wild-type myoblasts. The magnitude of the decrease in translation in myotubes containing mutant mtDNAs was protein specific. Complex I and IV subunits were more affected than complex V subunits, and there was a rough correlation with both protein size and number of lysine residues. Approximately 15% wild-type mtDNAs restored translation and COX activity to near normal levels. These results show that the A-to-G substitution in tRNA(Lys) is a functionally recessive mutation that can be rescued by intraorganellar complementation with a small proportion of wild-type mtDNAs and explain the steep threshold for expression of the MERRF clinical phenotype.	MCGILL UNIV,MONTREAL NEUROL INST,3801 UNIV ST,MONTREAL H3A 2B4,QUEBEC,CANADA; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA	McGill University; McGill University	SHOUBRIDGE, EA (corresponding author), MCGILL UNIV,MONTREAL NEUROL INST,3801 UNIV ST,MONTREAL H3A 2B4,QUEBEC,CANADA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Attardi G, 1979, Methods Enzymol, V56, P66; ATTARDI G, 1990, BIOCHEM SOC T, V18, P509, DOI 10.1042/bst0180509; BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; HAM RG, 1988, IN VITRO CELL DEV B, V24, P833; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; MANZANET R, 1986, MYOLOGY, P285; MATSUOKA T, 1991, J NEUROL SCI, V106, P193, DOI 10.1016/0022-510X(91)90257-8; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6; NOER AS, 1991, AM J HUM GENET, V49, P715; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z; SHIH KD, 1991, BIOCHEM BIOPH RES CO, V174, P1109, DOI 10.1016/0006-291X(91)91535-K; SHMOOKLERREIS RJ, 1983, J BIOL CHEM, V258, P9078; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SMITH CA, 1971, J MOL BIOL, V59, P255, DOI 10.1016/0022-2836(71)90050-7; Srere P.A., 1969, METHODS ENZYM, V13, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WEBSTER C, 1988, EXP CELL RES, V174, P252, DOI 10.1016/0014-4827(88)90159-0; Wharton DC., 1967, METHOD ENZYMOL, P245; YONEDA M, 1991, PROG NEUROPATH, V7, P169; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	40	270	272	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1187	1200						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1334369				2022-12-18	WOS:A1992KC99500002
J	Orstavik, KH; Eiklid, K; van der Hagen, CB; Spetalen, S; Kierulf, K; Skjeldal, O; Buiting, K				Orstavik, KH; Eiklid, K; van der Hagen, CB; Spetalen, S; Kierulf, K; Skjeldal, O; Buiting, K			Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic sperm injection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PRADER-WILLI-SYNDROME; DIAGNOSIS		Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway; Univ Oslo, Rikshosp, Dept Pediat, N-0027 Oslo, Norway; Univ Oslo, Inst Med Genet, Oslo 3, Norway; Univ Oslo, Inst Grp Clin Med, Oslo 3, Norway; Univ Oslo, Ulleval Hosp, Dept Med Genet, Oslo, Norway; Univ Oslo, Ulleval Hosp, Dept Gynecol, Oslo, Norway; Huseby Resource Ctr, Oslo, Norway; Univ Essen Gesamthsch, Inst Humangenet, Essen, Germany	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Duisburg Essen	Orstavik, KH (corresponding author), Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway.			Spetalen, Signe/0000-0002-2426-5316				Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; Manning M, 2000, MOL HUM REPROD, V6, P1049, DOI 10.1093/molehr/6.11.1049; Sutcliffe AG, 2001, LANCET, V357, P2080, DOI 10.1016/S0140-6736(00)05180-1; Zeschnigk M, 1997, EUR J HUM GENET, V5, P94, DOI 10.1159/000484740	6	269	287	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					218	219		10.1086/346030	http://dx.doi.org/10.1086/346030			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12549484	Green Published, Bronze			2022-12-18	WOS:000180186800025
J	Mackey, DA; Oostra, RJ; Rosenberg, T; Nikoskelainen, E; BronteStewart, J; Poulton, J; Harding, AE; Govan, G; Bolhuis, PA; Norby, S; BleekerWagemakers, EM; Savontaus, ML; Chan, C; Howell, N				Mackey, DA; Oostra, RJ; Rosenberg, T; Nikoskelainen, E; BronteStewart, J; Poulton, J; Harding, AE; Govan, G; Bolhuis, PA; Norby, S; BleekerWagemakers, EM; Savontaus, ML; Chan, C; Howell, N			Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA MUTATION; COMPLEX-I; GENE; FEATURES		UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL 0656,GALVESTON,TX 77555; UNIV MELBOURNE,MURDOCH INST,PARKVILLE,VIC 3052,AUSTRALIA; UNIV MELBOURNE,DEPT OPHTHALMOL,PARKVILLE,VIC 3052,AUSTRALIA; NETHERLANDS OPHTHALM RES INST,NL-1100 AC AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,LAB NEUROZINTUIGEN,NL-1105 AZ AMSTERDAM,NETHERLANDS; NATL EYE CLIN VISUALLY IMPAIRED,HELLERUP,DENMARK; UNIV TURKU,DEPT OPHTHALMOL,TURKU,FINLAND; TURKU UNIV CENT HOSP,DEPT MED GENET,TURKU,FINLAND; WESTERN INFIRM & ASSOCIATED HOSP,TENNENT INST OPHTHALMOL,GLASGOW G11 6NT,LANARK,SCOTLAND; JOHN RADCLIFFE HOSP,DEPT PAEDIAT,OXFORD OX3 9DU,ENGLAND; INST NEUROL,LONDON WC1N 3BG,ENGLAND; UNIV COPENHAGEN,DEPT FORENS PATHOL,COPENHAGEN,DENMARK; UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550	University of Texas System; University of Texas Medical Branch Galveston; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; University of Turku; University of Turku; University of Oxford; University of London; University College London; University of Copenhagen; University of Texas System; University of Texas Medical Branch Galveston			Mackey, David A/H-5340-2014; Poulton, Joanna/AAB-4828-2021	Mackey, David A/0000-0001-7914-4709; Poulton, Joanna/0000-0002-2460-5587; Oostra, Roelof-Jan/0000-0002-2452-8307				Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P; BROWN MD, 1994, CLIN NEUROSCI, V2, P138; BROWN MD, 1992, GENETICS, V130, P163; Chan C, 1996, AUST NZ J OPHTHALMOL, V24, P7, DOI 10.1111/j.1442-9071.1996.tb01545.x; DeVries DD, 1996, AM J HUM GENET, V58, P703; HOWELL N, 1994, CLIN NEUROSCI, V2, P130; HOWELL N, 1995, GENETICS, V140, P285; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1993, GENETICS, V133, P133; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1994, CLIN NEUROSCI, V2, P146; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1551; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Leber T., 1871, GRAEFES ARCH OPHTHAL, V17, P249, DOI 10.1007/BF01694557; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MASHIMA Y, 1993, HUM GENET, V92, P101, DOI 10.1007/BF00216156; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160; OBERMAIERKUSSER B, 1994, AM J HUM GENET, V55, P1063; OOSTRA RJ, 1994, HUM GENET, V94, P265, DOI 10.1007/BF00208281; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	26	269	294	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					481	485						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755941				2022-12-18	WOS:A1996VM28800031
J	NEALE, MC; KENDLER, KS				NEALE, MC; KENDLER, KS			MODELS OF COMORBIDITY FOR MULTIFACTORIAL DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENERALIZED ANXIETY DISORDER; DEPRESSION; TWIN; AGE	We develop several formal models for comorbidity between multifactorial disorders. Based on the work of D. N. Klein and L. P. Rise, the models include (i) alternate forms, where the two disorders have the same underlying continuum of liability; (ii) random multiformity, in which affection status on one disorder abruptly increases risk for the second; (iii) extreme multiformity, where only extreme cases have an abruptly increased risk for the second disorder; (iv) three independent disorders, in which excess comorbid cases are due to a separate, third disorder; (v) correlated liabilities, where the risk factors for the two disorders correlate; and (vi) direct causal models, where the liability for one disorder is a cause of the other disorder. These models are used to make quantitative predictions about the relative proportions of pairs of relatives who are classified according to whether each relative has neither disorder, disorder A but not B, disorder B but not A, or both A and B. For illustration, we analyze data on major depression (MD) and generalized anxiety disorder (GAD) assessed in adult female MZ and DZ twins, which enable estimation of the relative impact of genetic and environmental factors. Several models are rejected-that comorbid cases are due to chance; multiformity of GAD; a third independent disorder; and GAD being a cause of MD, Of the models that fit the data, correlated liabilities, MD causes GAD, and reciprocal causation seem best. MD appears to be a source of liability for GAD. Possible extensions to the models are discussed.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	Virginia Commonwealth University	NEALE, MC (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,BOX 980710,RICHMOND,VA 23298, USA.		Kendler, Kenneth/AAF-2876-2019; Neale, Michael C/B-1418-2008; Neale, Michael/AAD-5056-2020		NCRR NIH HHS [RR-08123] Funding Source: Medline; NIAAA NIH HHS [AA-09095] Funding Source: Medline; NIMH NIH HHS [MH/AA-49492] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009095] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; [Anonymous], BEST METHODS ANAL CH; Bagozzi RP, 1994, STRUCT EQU MODELING, V1, P35, DOI 10.1080/10705519409539961; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V48, P633; Bollen K. A., 1989, J STAT ASS; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; BRADY EU, 1992, PSYCHOL BULL, V111, P244, DOI 10.1037/0033-2909.111.2.244; BRESLAU N, 1985, PSYCHIAT RES, V1, P231; BROWNE MW, 1984, BRIT J MATH STAT PSY, V37, P62, DOI 10.1111/j.2044-8317.1984.tb00789.x; CARMELLI D, 1994, AM J HUM GENET, V55, P566; CARON C, 1991, J CHILD PSYCHOL PSYC, V32, P1063, DOI 10.1111/j.1469-7610.1991.tb00350.x; Docherty J, 1986, AM PSYCHIATRIC ASS A, V5, P315; DUFFY DL, 1994, GENET EPIDEMIOL, V11, P483, DOI 10.1002/gepi.1370110606; EAVES L, 1993, NATURE NURTURE PSYCH; EAVES LJ, 1987, BEHAV GENET, V17, P331, DOI 10.1007/BF01068135; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; GUNDERSON JG, 1991, AM J PSYCHIAT, V148, P967; HEATH AC, 1993, BEHAV GENET, V23, P29, DOI 10.1007/BF01067552; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; Joreskog K. G., 1989, LISREL 7 GUIDE PROGR; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P267; KENDLER KS, 1995, BEHAV GENET, V25, P217, DOI 10.1007/BF02197180; KENDLER KS, 1986, ANN HUM GENET, V50, P83, DOI 10.1111/j.1469-1809.1986.tb01941.x; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P374; KENDLER KS, IN PRESS BR J PSYCHI; KLEIN DN, 1994, BASIC ISSUES PSYCHOP, P19; MARTIN NG, 1982, BEHAV GENET, V12, P467, DOI 10.1007/BF01065638; Maser J.D., 1990, COMORBIDITY MOOD ANX; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1994, MULTIVAR BEHAV RES, V29, P33, DOI 10.1207/s15327906mbr2901_2; NEALE MC, 1989, BEHAV GENET, V19, P63, DOI 10.1007/BF01065884; NEALE MC, 1989, AM J HUM GENET, V45, P226; NEALE MC, 1994, GENET EPIDEMIOL, V11, P503, DOI 10.1002/gepi.1370110607; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; NEALE MC, 1994, MX STATISTICAL MODEL; Pearson K., 1903, BIOMETRIKA, V2, P357; ROY M, IN PRESS PSYCHOL MED; Spitzer R. L., 1987, STRUCTURED CLIN INTE; Williams LJ, 1994, STRUCT EQU MODELING, V1, P161, DOI 10.1080/10705519409539970; 1980, DIAGNOSTIC STATISTIC; 1987, DIAGNOSTIC STATISTIC	47	269	271	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					935	953						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RV793	7573055				2022-12-18	WOS:A1995RV79300025
J	Tartaglia, M; Martinelli, S; Stella, L; Bocchinfuso, G; Flex, E; Cordeddu, V; Zampino, G; van der Burgt, I; Palleschi, A; Petrucci, TC; Sorcini, M; Schoch, C; Foa, R; Emanuel, PD; Gelb, BD				Tartaglia, M; Martinelli, S; Stella, L; Bocchinfuso, G; Flex, E; Cordeddu, V; Zampino, G; van der Burgt, I; Palleschi, A; Petrucci, TC; Sorcini, M; Schoch, C; Foa, R; Emanuel, PD; Gelb, BD			Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; JUVENILE MYELOMONOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GENOTYPE-PHENOTYPE CORRELATION; LENTIGINES LEOPARD-SYNDROME; NOONAN-SYNDROME; MYELODYSPLASTIC SYNDROMES; MOLECULAR-DYNAMICS; DELETION MUTATION; 3-BP DELETION	Germline mutations in PTPN11, the gene encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome ( NS) and the clinically related LEOPARD syndrome ( LS), whereas somatic mutations in the same gene contribute to leukemogenesis. On the basis of our previously gathered genetic and biochemical data, we proposed a model that splits NS- and leukemia-associated PTPN11 mutations into two major classes of activating lesions with differential perturbing effects on development and hematopoiesis. To test this model, we investigated further the diversity of germline and somatic PTPN11 mutations, delineated the association of those mutations with disease, characterized biochemically a panel of mutant SHP-2 proteins recurring in NS, LS, and leukemia, and performed molecular dynamics simulations to determine the structural effects of selected mutations. Our results document a strict correlation between the identity of the lesion and disease and demonstrate that NS- causative mutations have less potency for promoting SHP-2 gain of function than do leukemia-associated ones. Furthermore, we show that the recurrent LS-causing Y279C and T468M amino acid substitutions engender loss of SHP-2 catalytic activity, identifying a previously unrecognized behavior for this class of missense PTPN11 mutations.	Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Rome, Italy; Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-20123 Milan, Italy; Univ Roma La Sapienza, Dipartmento Biotecnol Cellulari & Ematol, Rome, Italy; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Univ Munich, Dept Internal Med 3, Munich, Germany; Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY USA	Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; Catholic University of the Sacred Heart; Sapienza University Rome; Radboud University Nijmegen; University of Munich; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it	cordeddu, viviana/J-2272-2014; Bocchinfuso, Gianfranco/E-9014-2011; Flex, Elisabetta/A-5958-2017; Stella, Lorenzo/A-7996-2010; palleschi, antonio/G-5464-2012; Martinelli, Simone/J-9432-2018; cordeddu, viviana/A-5612-2016; Tartaglia, Marco/K-2955-2018; Zampino, Giuseppe/AAC-2152-2019	Bocchinfuso, Gianfranco/0000-0002-5556-7691; Flex, Elisabetta/0000-0002-6802-1356; Stella, Lorenzo/0000-0002-5489-7381; Martinelli, Simone/0000-0002-5843-419X; cordeddu, viviana/0000-0001-7159-7383; Tartaglia, Marco/0000-0001-7736-9672; Emanuel, Peter/0000-0002-9764-2434	NCI NIH HHS [R01 CA095621, CA095621] Funding Source: Medline; NHLBI NIH HHS [HL074728, HL71207, P50 HL074728, R01 HL071207] Funding Source: Medline; NICHD NIH HHS [HD01294, K24 HD001294] Funding Source: Medline; Telethon [GGP04172] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095621] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074728, R01HL071207] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7; BENE MC, 1995, LEUKEMIA, V9, P1783; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, V14, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21]; Bertola DR, 2005, AM J MED GENET A, V136A, P242, DOI 10.1002/ajmg.a.30813; Bertola DR, 2004, AM J MED GENET A, V130A, P378, DOI 10.1002/ajmg.a.30270; Binder G, 2005, J CLIN ENDOCR METAB, V90, P5377, DOI 10.1210/jc.2005-0995; Bradshaw JM, 2003, ADV PROTEIN CHEM, V61, P161; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Choong K, 1999, J PEDIAT HEMATOL ONC, V21, P523, DOI 10.1097/00043426-199911000-00014; Conti E, 2003, Hum Mutat, V21, P654, DOI 10.1002/humu.9149; Digilio MC, 2004, BIRTH DEFECTS RES A, V70, P95, DOI 10.1002/bdra.10148; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Emanuel Peter D, 2004, Curr Hematol Rep, V3, P203; Ferreira LV, 2005, J CLIN ENDOCR METAB, V90, P5156, DOI 10.1210/jc.2004-2559; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Fukuda M, 1997, J PEDIAT HEMATOL ONC, V19, P177, DOI 10.1097/00043426-199703000-00019; Goemans BF, 2005, BRIT J HAEMATOL, V130, P801, DOI 10.1111/j.1365-2141.2005.05685.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasegawa D, 2005, BRIT J HAEMATOL, V128, P805, DOI 10.1111/j.1365-2141.2005.05392.x; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; HUGUES L, 2005, HAEMATOLOGICA, V90, P853; Jafarov T, 2005, CLIN GENET, V68, P190, DOI 10.1111/j.1399-0004.2005.00475.x; Johan MF, 2004, BRIT J HAEMATOL, V124, P843, DOI 10.1111/j.1365-2141.2004.04862.x; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; Kalidas K, 2005, J HUM GENET, V50, P21, DOI 10.1007/s10038-004-0212-x; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Keren B, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.021451; Kondoh T, 2003, EUR J PEDIATR, V162, P548, DOI 10.1007/s00431-003-1227-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kosaki K, 2002, J CLIN ENDOCR METAB, V87, P3529, DOI 10.1210/jc.87.8.3529; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Lee JS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024091; Lee WH, 2005, PROTEINS, V58, P7, DOI 10.1002/prot.20296; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loh ML, 2005, LEUKEMIA RES, V29, P459, DOI 10.1016/j.leukres.2004.10.001; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Maheshwari M, 2002, HUM MUTAT, V20, P298, DOI 10.1002/humu.10129; Matsubara K, 2005, AM J HEMATOL, V79, P171, DOI 10.1002/ajh.20326; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Musante L, 2003, EUR J HUM GENET, V11, P201, DOI 10.1038/sj.ejhg.5200935; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niihori T, 2005, J HUM GENET, V50, P192, DOI 10.1007/s10038-005-0239-7; Nomdedeu J, 2005, HAEMATOLOGICA, V90, P412; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Sarkozy A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013466; Sarkozy A, 2004, EUR J HUM GENET, V12, P1069, DOI 10.1038/sj.ejhg.5201290; Sarkozy A, 2003, J MED GENET, V40, P704, DOI 10.1136/jmg.40.9.704; Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schluter G, 2005, PRENATAL DIAG, V25, P574, DOI 10.1002/pd.1189; Schollen E, 2003, GENET COUNSEL, V14, P259; Schollen E, 2003, EUR J HUM GENET, V11, P85, DOI 10.1038/sj.ejhg.5200915; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Shimada H, 2004, LEUKEMIA, V18, P1142, DOI 10.1038/sj.leu.2403374; Smith ML, 2005, BRIT J HAEMATOL, V128, P318, DOI 10.1111/j.1365-2141.2004.05324.x; Stella L, 1998, J CHEM PHYS, V109, P10115, DOI 10.1063/1.477703; Stella L, 1999, PROTEINS, V37, P1; Takahashi K, 2005, EUR J PEDIATR, V164, P497, DOI 10.1007/s00431-005-1679-y; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2004, CURR OPIN HEMATOL, V11, P44, DOI 10.1097/00062752-200401000-00007; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; Weismann CG, 2005, AM J MED GENET A, V136A, P146, DOI 10.1002/ajmg.a.30789; Yoshida R, 2004, AM J MED GENET A, V130A, P432, DOI 10.1002/ajmg.a.30281; Yoshida R, 2004, J CLIN ENDOCR METAB, V89, P3359, DOI 10.1210/jc.2003-032091; Yoshida R, 2004, AM J MED GENET A, V128A, P63, DOI 10.1002/ajmg.a.30029; Zenker M, 2004, J PEDIATR-US, V144, P368, DOI 10.1016/j.jpeds.2003.11.032; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	87	268	286	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					279	290		10.1086/499925	http://dx.doi.org/10.1086/499925			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16358218	Bronze, Green Published			2022-12-18	WOS:000236744900009
J	Schmidt, LS; Nickerson, ML; Warren, MB; Glenn, GM; Toro, JR; Merino, MJ; Turner, ML; Choyke, PL; Sharma, N; Peterson, J; Morrison, P; Maher, ER; Walther, MM; Zbar, B; Linehan, WM				Schmidt, LS; Nickerson, ML; Warren, MB; Glenn, GM; Toro, JR; Merino, MJ; Turner, ML; Choyke, PL; Sharma, N; Peterson, J; Morrison, P; Maher, ER; Walther, MM; Zbar, B; Linehan, WM			Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL-CELL CARCINOMA; GERMAN-SHEPHERD DOG; NIHON RAT MODEL; SPONTANEOUS PNEUMOTHORAX; INTESTINAL POLYPOSIS; NODULAR DERMATOFIBROSIS; PERIFOLLICULAR FIBROMAS; KIDNEY NEOPLASIA; MESSENGER-RNA; GENE	Birt-Hogg-Dube syndrome (BHD), a genodermatosis characterized by multiple hamartomas of the hair follicle (fibrofolliculoma), predisposes individuals to an increased risk of developing renal neoplasms and spontaneous pneumothorax. Previously, we localized the BHD locus (also known as FLCN) to chromosome 17p11.2 by linkage analysis and subsequently identified germline mutations in a novel gene in probands from eight of the nine families with BHD in our screening panel. Affected members of five of the families inherited an insertion/deletion of a cytosine in a C-8 tract in exon 11. This mutation was also identified by exon 11 screening in probands from 22 of 52 additional families with BHD and therefore represents a hypermutable "hotspot" for mutation in BHD. Here, we screened the remaining 30 families from this large BHD cohort by direct sequence analysis and identified germline BHD mutations in 84% (51/61) of all families with BHD recruited to our study. Mutations were located along the entire length of the coding region, including 16 insertion/deletion, 3 nonsense, and 3 splice-site mutations. The majority of BHD mutations were predicted to truncate the BHD protein, folliculin. Among patients with a mutation in the exon 11 hotspot, significantly fewer renal tumors were observed in patients with the C-deletion than those with the C-insertion mutation. Coding-sequence mutations were not found, however, in probands from two large families with BHD whose affected members shared their family's BHD-affected haplotype. Of the 53 families with BHD whose members inherited either a germline mutation or the affected haplotype, 24 (45%) had at least one member with renal neoplasms. Three families classified with familial renal oncocytoma were identified with BHD mutations, which represents the first disease gene associated with this rare form of renal neoplasm. This study expands the BHD-mutation spectrum and evaluates genotype-phenotype correlations among families with BHD.	NCI, Immunobiol Lab, Ctr Canc Res, Frederick, MD 21702 USA; Sci Applicat Int Corp Frederick Inc, Basic Res Program, Frederick, MD USA; NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Belfast City Hosp Trust, Belfast, Antrim, North Ireland; Univ Birmingham, Inst Biomed Res, Sect Med & Mol Genet, Birmingham, W Midlands, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Belfast City Hospital; University of Birmingham	Schmidt, LS (corresponding author), NCI, Immunobiol Lab, Ctr Canc Res, Bldg 560,Room 12-69, Frederick, MD 21702 USA.	schmidtl@ncifcrf.gov	MAHER, EAMONN R/A-9507-2008	MAHER, EAMONN R/0000-0002-6226-6918; Sharma, Nirmala/0000-0001-9781-880X	NATIONAL CANCER INSTITUTE [Z01SC006659, Z01BC010696, Z01BC010688, ZIDBC010688, Z01SC009392, ZIASC009392, ZIABC010696] Funding Source: NIH RePORTER; PHS HHS [N01-C0-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BINET O, 1986, ANN DERMATOL VENER, V113, P928; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Chung JY, 1996, INT J DERMATOL, V35, P365, DOI 10.1111/j.1365-4362.1996.tb03642.x; Hino O, 2001, JPN J CANCER RES, V92, P1147, DOI 10.1111/j.1349-7006.2001.tb02133.x; HORNSTEIN OP, 1975, ARCH DERMATOL FORSCH, V253, P161, DOI 10.1007/BF00582068; HORNSTEIN OP, 1976, HUM GENET, V33, P193; Jonasdottir TJ, 2000, P NATL ACAD SCI USA, V97, P4132, DOI 10.1073/pnas.070053397; Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; Khoo SK, 2001, ONCOGENE, V20, P5239, DOI 10.1038/sj.onc.1204703; Le Guyadec T, 1998, ANN DERMATOL VENER, V125, P717; Lindor NM, 2001, INT J DERMATOL, V40, P653, DOI 10.1046/j.1365-4362.2001.01287-4.x; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Liu V, 2000, J AM ACAD DERMATOL, V43, P1120, DOI 10.1067/mjd.2000.109288; LIUM B, 1985, VET PATHOL, V22, P447, DOI 10.1177/030098588502200503; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Okimoto K, 2000, JPN J CANCER RES, V91, P1096, DOI 10.1111/j.1349-7006.2000.tb00890.x; Pavlovich CP, 2005, J UROLOGY, V173, P1482, DOI 10.1097/01.ju.0000154629.45832.30; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; RONGIOLETTI F, 1989, CLIN EXP DERMATOL, V14, P72, DOI 10.1111/j.1365-2230.1989.tb00890.x; ROTH JS, 1993, J AM ACAD DERMATOL, V29, P1055, DOI 10.1016/S0190-9622(08)82049-X; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tickoo SK, 1999, AM J SURG PATHOL, V23, P1094, DOI 10.1097/00000478-199909000-00013; Toro JR, 1999, ARCH DERMATOL, V135, P1195, DOI 10.1001/archderm.135.10.1195; VOCKE C, IN PRESS J NATL CANC; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393	29	268	279	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1023	1033		10.1086/430842	http://dx.doi.org/10.1086/430842			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15852235	Green Published, Bronze			2022-12-18	WOS:000229047900008
J	Howard, TD; Koppelman, GH; Xu, JF; Zheng, SQL; Postma, DS; Meyers, DA; Bleecker, ER				Howard, TD; Koppelman, GH; Xu, JF; Zheng, SQL; Postma, DS; Meyers, DA; Bleecker, ER			Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKIN-TEST REACTIVITY; SERUM IGE LEVELS; INTERLEUKIN-4 RECEPTOR; AIRWAY INFLAMMATION; BRONCHIAL RESPONSIVENESS; IL4-RECEPTOR GENE; ATOPIC ASTHMA; ALPHA-GENE; ASSOCIATION; IL-4	Asthma is a common respiratory disease that is characterized by variable airways obstruction caused by acute and chronic bronchial inflammation; associated phenotypes include bronchial hyperresponsiveness (BHR), elevated total serum immunoglobulin E (IgE) levels, and skin tests positive to common allergens. Binding of interleukin-13 (IL13) or interleukin-4 (IL4) to the IL4 receptor (IL4R) induces the initial response for Th2 lymphocyte polarization. Both IL13 and IL4 are produced by Th2 cells and are capable of inducing isotype class-switching of B-cells to produce IgE after allergen exposure. These cytokines also share a common receptor component, IL4R. We have investigated five IL4RA single-nucleotide polymorphisms in a population of Dutch families ascertained through a proband with asthma. By considering the probands and their spouses as an unrelated sample, we observed significant associations of atopy and asthma-related phenotypes with several IL4RA polymorphisms, including S478P and total serum IgE levels (P=.0007). A significant gene-gene interaction between S478P in IL4RA and the - 1111 promoter variation in IL13, previously shown to be associated with BHR (P = .003), was detected. Individuals with the risk genotype for both genes were at almost five times greater risk for the development of asthma compared to individuals with both nonrisk genotypes (P = .0004). These data suggest that variations in IL4RA contribute to elevated total serum IgE levels, and interaction between IL4RA and IL13 markedly increases an individual's susceptibility to asthma.	Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Winston Salem, NC 27157 USA; Univ Groningen Hosp, Dept Pulmonol, Groningen, Netherlands; Beatrixoord, Dept Pulm Rehabil, Haren, Netherlands	Wake Forest University; Wake Forest Baptist Medical Center; University of Groningen; University of Groningen	Bleecker, ER (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252	NHLBI NIH HHS [R01 HL048341, R01 HL066393, R01HL/66393, R01HL/48341] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066393, R01HL048341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; BURROWS B, 1995, J ALLERGY CLIN IMMUN, V95, P548, DOI 10.1016/S0091-6749(95)70317-9; Deichmann K, 1997, BIOCHEM BIOPH RES CO, V231, P696, DOI 10.1006/bbrc.1997.6115; Deichmann KA, 1998, CLIN EXP ALLERGY, V28, P151; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Gauchat JF, 1997, EUR J IMMUNOL, V27, P971, DOI 10.1002/eji.1830270425; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hackstein H, 2001, IMMUNOGENETICS, V53, P264, DOI 10.1007/s002510100324; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Henderson WR, 2000, J IMMUNOL, V164, P1086, DOI 10.4049/jimmunol.164.2.1086; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; Howard TD, 1999, BIOTECHNIQUES, V26, P380, DOI 10.2144/99263bm01; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Kruse S, 1999, IMMUNOLOGY, V96, P365; Kruse S, 1999, INT IMMUNOL, V11, P1965, DOI 10.1093/intimm/11.12.1965; Liu X, 2000, J ALLERGY CLIN IMMUN, V106, P167, DOI 10.1067/mai.2000.107935; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Panhuysen CIM, 1998, AM J RESP CRIT CARE, V157, P1734, DOI 10.1164/ajrccm.157.6.9606088; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	29	268	298	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					230	236		10.1086/338242	http://dx.doi.org/10.1086/338242			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11709756	Green Published, Bronze			2022-12-18	WOS:000172571900020
J	Pasutto, F; Sticht, H; Hammersen, G; Gillessen-Kaesbach, G; FitzPatrick, DR; Nurnberg, G; Brasch, F; Schirmer-Zimmermann, H; Tolmie, JL; Chitayat, D; Houge, G; Fernandez-Martinez, L; Keating, S; Mortier, G; Hennekam, RCM; von der Wense, A; Slavotinek, A; Meinecke, P; Bitoun, P; Becker, C; Nurnberg, P; Reis, A; Rauch, A				Pasutto, Francesca; Sticht, Heinrich; Hammersen, Gerhard; Gillessen-Kaesbach, Gabriele; FitzPatrick, David R.; Nuernberg, Gudrun; Brasch, Frank; Schirmer-Zimmermann, Heidemarie; Tolmie, John L.; Chitayat, David; Houge, Gunnar; Fernandez-Martinez, Lorena; Keating, Sarah; Mortier, Geert; Hennekam, Raoul C. M.; von der Wense, Axel; Slavotinek, Anne; Meinecke, Peter; Bitoun, Pierre; Becker, Christian; Nuernberg, Peter; Reis, Andre; Rauch, Anita			Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LINKAGE ANALYSIS; PULMONARY HYPOPLASIA; MEMBRANE-PROTEIN; MICROPHTHALMIA; GENES; EXPRESSION; ETIOLOGY; PROGRAM; CHX10	We observed two unrelated consanguineous families with malformation syndromes sharing anophthalmia and distinct eyebrows as common signs, but differing for alveolar capillary dysplasia or complex congenital heart defect in one and diaphragmatic hernia in the other family. Homozygosity mapping revealed linkage to a common locus on chromosome 15, and pathogenic homozygous mutations were identified in STRA6, a member of a large group of "stimulated by retinoic acid" genes encoding novel transmembrane proteins, transcription factors, and secreted signaling molecules or proteins of largely unknown function. Subsequently, homozygous STRA6 mutations were also demonstrated in 3 of 13 patients chosen on the basis of significant phenotypic overlap to the original cases. While a homozygous deletion generating a premature stop codon (p.G50AfsX22) led to absence of the immunoreactive protein in patient's fibroblast culture, structural analysis of three missense mutations (P90L, P293L, and T321P) suggested significant effects on the geometry of the loops connecting the transmembrane helices of STRA6. Two further variations in the C-terminus (T644M and R655C) alter specific functional sites, an SH2-binding motif and a phosphorylation site, respectively. STRA6 mutations thus define a pleiotropic malformation syndrome representing the first human phenotype associated with mutations in a gene from the "STRA" group.	Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; Cnopfs Pediat Hosp, Nurnberg, Germany; Univ Klinikum Schleswig Holstein, Inst Human Genet, Lubeck, Germany; MRC, Human Genet Unit, Med Genet Sect, Edinburgh, Midlothian, Scotland; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; Univ Cologne, Inst Genet, D-5000 Cologne, Germany; RZPD Deutsch Ressourcenzentrum Genomforsch GmbH, Berlin, Germany; Univ Associated Hosp Bremen Mitte, Dept Pathol, Bremen, Germany; Yorkhill Hosp, Glasgow, Lanark, Scotland; Univ Toronto, Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; UCL, Great Ormond St Hosp Children, Inst Child Hlth, London, England; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Altonaer Childrens Hosp, Dept Neonatal & Pediat Intens Care, Hamburg, Germany; Altonaer Kinderkrankenhaus, Abt Med Genet, Hamburg, Germany; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Hosp Jean Verdier, Dept Med Genet, Bondy, France	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Kiel; Schleswig Holstein University Hospital; University of Edinburgh; University of Cologne; University of Cologne; Klinikum Bremen-Mitte; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Bergen; Haukeland University Hospital; Ghent University; Ghent University Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP	Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	arauch@humgenet.uni-erlangen.de	Rauch, Anita/C-5568-2014; FitzPatrick, David R/B-8311-2008; Slavotinek, Anne/AAK-6794-2020; Mortier, Geert/D-2542-2012; FitzPatrick, David R/C-7301-2013; Reis, André/D-2309-2009	Rauch, Anita/0000-0003-2930-3163; Mortier, Geert/0000-0001-9871-4578; Reis, André/0000-0002-6301-6363; Bitoun, Pierre/0000-0001-6557-6826; Sticht, Heinrich/0000-0001-5644-045X; FitzPatrick, David R./0000-0003-4861-969X	MRC [MC_U127561093] Funding Source: UKRI; Medical Research Council [MC_U127561093] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Bar-Yosef U, 2004, HUM GENET, V115, P302, DOI 10.1007/s00439-004-1154-2; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Gallot D, 2005, BIRTH DEFECTS RES A, V73, P523, DOI 10.1002/bdra.20151; Greer JJ, 2003, PEDIATR RES, V53, P726, DOI 10.1203/01.PDR.0000062660.12769.E6; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; KAWAGUCHI R, 2007, MEMBRANE RECEPTOR RE; Klaassens M, 2005, AM J HUM GENET, V76, P877, DOI 10.1086/429842; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar VH, 2005, ADV CLIN CHEM, V40, P261, DOI 10.1016/S0065-2423(05)40007-4; Langham MR, 1996, CLIN PERINATOL, V23, P671, DOI 10.1016/S0095-5108(18)30201-X; Lee SYR, 2006, CLIN DYSMORPHOL, V15, P43, DOI 10.1097/01.mcd.0000181604.78252.29; Lurie IW, 2003, GENET COUNSEL, V14, P75; Michalsky MP, 2005, J PEDIATR SURG, V40, P1100, DOI 10.1016/j.jpedsurg.2005.03.067; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sapin V, 2000, MECH DEVELOP, V92, P295, DOI 10.1016/S0925-4773(00)00241-0; Seller MJ, 1996, AM J MED GENET, V62, P227, DOI 10.1002/(SICI)1096-8628(19960329)62:3<227::AID-AJMG5>3.3.CO;2-R; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Slavotinek AM, 2006, EUR J HUM GENET, V14, P999, DOI 10.1038/sj.ejhg.5201652; Smith S A, 1994, Clin Dysmorphol, V3, P287; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Vogt G, 2005, EUR J EPIDEMIOL, V20, P939, DOI 10.1007/s10654-005-2382-z; Zile MH, 2004, EXP BIOL MED, V229, P598, DOI 10.1177/153537020422900703	36	267	274	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					550	560		10.1086/512203	http://dx.doi.org/10.1086/512203			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273977	Green Published, Bronze			2022-12-18	WOS:000244403300017
J	Wang, E; Ding, YC; Flodman, P; Kidd, JR; Kidd, KK; Grady, DL; Ryder, OA; Spence, MA; Swanson, JM; Moyzis, RK				Wang, E; Ding, YC; Flodman, P; Kidd, JR; Kidd, KK; Grady, DL; Ryder, OA; Spence, MA; Swanson, JM; Moyzis, RK			The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; 7-REPEAT ALLELE; POSITIVE SELECTION; PROMOTER REGION; NOVELTY SEEKING; HUMAN GENOME; POLYMORPHISM; ASSOCIATION; ATTENTION; EVOLUTION	Associations of the seven-repeat (7R) allele of the human dopamine receptor D4 (DRD4) gene with both the personality trait of novelty seeking and attention deficit/hyperactivity disorder have been reported. Recently, on the basis of the unusual DNA sequence organization of the DRD4 7R 48-bp tandem repeat ( VNTR), we proposed that the 7R allele originated as a rare mutational event that increased to high frequency by positive selection. We now have resequenced the entire DRD4 locus from 103 individuals homozygous for 2R, 4R, or 7R variants of the VNTR, a method developed to directly estimate haplotype diversity. DNA from individuals of African, European, Asian, North and South American, and Pacific Island ancestry were used. 4R/4R homozygotes exhibit little linkage disequilibrium (LD) over the region examined, with more polymorphisms observed in DNA samples from African individuals. In contrast, the evidence for strong LD surrounding the 7R allele is dramatic, with all 7R/7R individuals ( including those from Africa) exhibiting the same alleles at most polymorphic sites. By intra-allelic comparison at 18 high-heterozygosity sites spanning the locus, we estimate that the 7R allele arose prior to the upper Paleolithic era (similar to40,000-50,000 years ago). Further, the pattern of recombination at these polymorphic sites is the pattern expected for selection acting at the 7R VNTR itself, rather than at an adjacent site. We propose a model for selection at the DRD4 locus consistent with these observed LD patterns and with the known biochemical and physiological differences between receptor variants.	Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Child Dev Ctr, Irvine, CA USA; Univ Calif Irvine, Dept Pediat, Orange, CA 92668 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Yale University; Zoological Society of San Diego	Moyzis, RK (corresponding author), Univ Calif Irvine, Coll Med, Dept Biol Chem, Sprague Hall, Irvine, CA 92697 USA.	rmoyzis@uci.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060660] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH060660, MH60660] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BETZIG L, 1993, SOCIAL STRATIFICATIO, P37; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Buss D. M., 1999, EVOLUTIONARY PSYCHOL; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Darwin C., 1871, P423; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Fay JC, 2000, GENETICS, V155, P1405; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FU YX, 1993, GENETICS, V133, P693; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; HARTMAN T, 1993, ATTENTION DEFICIT DI; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1672, DOI 10.1097/00004583-199712000-00015; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langley K, 2004, AM J PSYCHIAT, V161, P133, DOI 10.1176/appi.ajp.161.1.133; LEUNG PWL, IN PRESS AM J MED GE; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; Maynard Smith J., 1982, pi; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ronai Z, 2001, MOL PSYCHIATR, V6, P35, DOI 10.1038/sj.mp.4000832; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Swanson J, 2000, P NATL ACAD SCI USA, V97, P4754, DOI 10.1073/pnas.080070897; Swanson J, 2001, CLIN NEUROSCI RES, V1, P207, DOI 10.1016/S1566-2772(01)00007-X; Swanson WJ, 2003, CURR OPIN GENET DEV, V13, P617, DOI 10.1016/j.gde.2003.10.007; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Volkow ND, 2003, AM J PSYCHIAT, V160, P1909, DOI 10.1176/appi.ajp.160.11.1909	59	267	269	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					931	944		10.1086/420854	http://dx.doi.org/10.1086/420854			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077199	Green Published, Bronze			2022-12-18	WOS:000220926100013
J	Halliday, J; Oke, K; Breheny, S; Algar, E; Amor, DJ				Halliday, J; Oke, K; Breheny, S; Algar, E; Amor, DJ			Beckwith-Wiedemann syndrome and IVF: A case-control study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							INTRACYTOPLASMIC SPERM INJECTION; IN-VITRO FERTILIZATION; EPIGENETIC ALTERATIONS; RISK; TECHNOLOGY; INCREASE; DEFECTS; CANCER; LIT1; H19		Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Pediat, Parkville, Vic 3052, Australia; Dept Human Serv, Victorian Birth Defects Register, Perinatal Data Collect Unit, Melbourne, Vic, Australia; Melbourne IVF, Melbourne, Australia; Monash IVF, Clayton, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Halliday, J (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	jane.halliday@mcri.edu.au	Algar, Elizabeth/B-3770-2012; Amor, David J/A-6478-2018; halliday, jane/T-1476-2019	Amor, David J/0000-0001-7191-8511; 				Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897; Orstavik KH, 2003, AM J HUM GENET, V72, P218, DOI 10.1086/346030	8	266	282	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					526	528		10.1086/423902	http://dx.doi.org/10.1086/423902			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15284956	Green Published, Bronze			2022-12-18	WOS:000223272200022
J	Hansen, JJ; Durr, A; Cournu-Rebeix, I; Georgopoulos, C; Ang, D; Nielsen, MN; Davoine, CS; Brice, A; Fontaine, B; Gregersen, N; Bross, P				Hansen, JJ; Durr, A; Cournu-Rebeix, I; Georgopoulos, C; Ang, D; Nielsen, MN; Davoine, CS; Brice, A; Fontaine, B; Gregersen, N; Bross, P			Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESCHERICHIA-COLI; PROTEINS	SPG13, an autosomal dominant form of pure hereditary spastic paraplegia, was recently mapped to chromosome 2q24-34 in a French family. Here we present genetic data indicating that SPG13 is associated with a mutation, in the gene encoding the human mitochondrial chaperonin Hsp60, that results in the V72I substitution. A complementation assay showed that wild-type HSP60 (also known as "HSPD1"), but not HSP60 (V72I), together with the co-chaperonin HSP10 (also known as "HSPE1"), can support growth of Escherichia coli cells in which the homologous chromosomal groESgroEL chaperonin genes have been deleted. Taken together, our data strongly indicate that the V72I variation is the first disease-causing mutation that has been identified in HSP60.	Arhus Univ Hosp, Res Unit Mol Med, Aarhus, Denmark; Fac Hlth Sci, Aarhus, Denmark; Grp Hosp Pitie Salpetriere, Federat Neurol, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, INSERM, U289, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Dept Genet Cytogenet & Embryol, F-75634 Paris, France; Fac Med, INSERM, U546, Paris, France; Ctr Med Univ Geneva, CH-1211 Geneva, Switzerland	Aarhus University; Aarhus University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva	Bross, P (corresponding author), Skejby Sygehus, Res Unit Mol Med, DK-8200 Aarhus N, Denmark.		brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Bross, Peter/B-7219-2013	brice, alexis/0000-0002-0941-3990; Bross, Peter/0000-0001-9526-8525				BROSS P, 1995, J BIOL CHEM, V270, P10284, DOI 10.1074/jbc.270.17.10284; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; Castanie HP, 1997, ANAL BIOCHEM, V254, P150, DOI 10.1006/abio.1997.2423; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fontaine B, 2000, AM J HUM GENET, V66, P702, DOI 10.1086/302776; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; Tallaksen CME, 2001, CURR OPIN NEUROL, V14, P457, DOI 10.1097/00019052-200108000-00005; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	13	266	276	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1328	1332		10.1086/339935	http://dx.doi.org/10.1086/339935			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11898127	Green Published, Bronze			2022-12-18	WOS:000175012400022
J	Wallace, RH; Scheffer, IE; Barnett, S; Richards, M; Dibbens, L; Desai, RR; Lerman-Sagie, T; Lev, D; Mazarib, A; Brand, N; Ben-Zeev, B; Goikhman, I; Singh, R; Kremmidiotis, G; Gardner, A; Sutherland, GR; George, AL; Mulley, JC; Berkovic, SF				Wallace, RH; Scheffer, IE; Barnett, S; Richards, M; Dibbens, L; Desai, RR; Lerman-Sagie, T; Lev, D; Mazarib, A; Brand, N; Ben-Zeev, B; Goikhman, I; Singh, R; Kremmidiotis, G; Gardner, A; Sutherland, GR; George, AL; Mulley, JC; Berkovic, SF			Neuronal sodium-channel alpha 1-subunit mutations in generalized epilepsy with febrile seizures plus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS; MAPS; ORGANIZATION	Generalized epilepsy with febrile seizures plus (GEFS+) is a familial epilepsy syndrome characterized by the presence of febrile and afebrile seizures. The first gene, GEFS1, was mapped to chromosome 19q and was identified as the sodium-channel beta1-subunit, SCN1B. A second locus on chromosome 2q, GEFS2, was recently identified as the sodium-channel alpha1-subunit, SCN1A. Single-stranded conformation analysis (SSCA) of SCN1A was performed in 53 unrelated index cases to estimate the frequency of mutations in patients with GEFS+. No mutations were found in 17 isolated cases of GEFS+. Three novel SCN1A mutations-D188V, V1353L, and I1656M-were found in 36 familial cases; of the remaining 33 families, 3 had mutations in SCN1B. On the basis of SSCA, the combined frequency of SCN1A and SCN1B mutations in familial cases of GEFS+ was found to be 17%.	Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, N Adelaide, SA, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Univ Melbourne, Austin & Repatriat Med Ctr, Heidelberg, Vic, Australia; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Pharmacol, Nashville, TN 37212 USA; Wolfson Med Ctr, Metab Neurogenet Clin, Holon, Israel; Tel Aviv Sourasky Med Ctr, Dept Neurol, Tel Aviv, Israel; Chaim Sheba Med Ctr, Dept Pediat Neurol, Ramat Gan, Israel; Carmel Hosp, Dept Pediat, Haifa, Israel	University of Adelaide; University of Adelaide; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Vanderbilt University; Vanderbilt University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Chaim Sheba Medical Center; Clalit Health Services; Carmel Medical Center	Wallace, RH (corresponding author), Bion Womens & Childrens Hosp Res Facil, 28 Dalgliesh St, Thebarton, SA 5031, Australia.		Sutherland, Grant Robert/D-2606-2012; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013; Lerman-Sagie, Tally/AAY-7598-2021	Scheffer, Ingrid E/0000-0002-2311-2174; Lerman-Sagie, Tally/0000-0001-6641-6875; Berkovic, Samuel/0000-0003-4580-841X; Dibbens, Leanne/0000-0002-5824-3342; Wallace, Robyn/0000-0001-6141-3317	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032387, R01NS032387] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS032387, R37 NS032387, NS 32387] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baulac S, 1999, AM J HUM GENET, V65, P1078, DOI 10.1086/302593; Bendahhou S, 1999, J NEUROSCI, V19, P4762; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Lopes-Cendes I, 2000, AM J HUM GENET, V66, P698, DOI 10.1086/302768; Moulard B, 1999, AM J HUM GENET, V65, P1396, DOI 10.1086/302621; Peiffer A, 1999, ANN NEUROL, V46, P671, DOI 10.1002/1531-8249(199910)46:4<671::AID-ANA20>3.0.CO;2-5; Plummer NW, 1998, GENOMICS, V54, P287, DOI 10.1006/geno.1998.5550; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Scheffer IE, 2000, ANN NEUROL, V47, P840, DOI 10.1002/1531-8249(200006)47:6<840::AID-ANA28>3.0.CO;2-V; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236	16	266	289	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					859	865		10.1086/319516	http://dx.doi.org/10.1086/319516			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254444	Green Published, Bronze			2022-12-18	WOS:000167666000007
J	Pennarun, G; Escudier, E; Chapelin, C; Bridoux, AM; Cacheux, V; Roger, G; Clement, A; Goossens, M; Amselem, S; Duriez, B				Pennarun, G; Escudier, E; Chapelin, C; Bridoux, AM; Cacheux, V; Roger, G; Clement, A; Goossens, M; Amselem, S; Duriez, B			Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OUTER-ARM DYNEIN; HEAVY-CHAIN GENES; INTERMEDIATE-CHAIN; IMMOTILE-CILIA; LIGHT-CHAIN; MOLECULAR ANALYSIS; BINDING SITES; PROTEIN; IDENTIFICATION; EXPRESSION	Primary ciliary dyskinesia (PCD) is a group of heterogeneous disorders of unknown origin, usually inherited as an autosomal recessive trait. Its phenotype is characterized by axonemal abnormalities of respiratory cilia and sperm tails leading to bronchiectasis and sinusitis, which are sometimes associated with situs inversus (Kartagener syndrome) and male sterility. The main ciliary defect in PCD is an absence of dynein arms. We have isolated the first gene involved in PCD, using a candidate-gene approach developed on the basis of documented abnormalities of immotile strains of Chlamydomonas reinhardtii, which carry axonemal ultrastructural defects reminiscent of PCD. Taking advantage of the evolutionary conservation of genes encoding axonemal proteins, we have isolated a human sequence (DNAI1) related to IC78, a C. reinhardtii gene encoding a dynein intermediate chain in which mutations are associated with the absence of outer dynein arms. DNAI1 is highly expressed in trachea and testis and is composed of 20 exons located at 9p13-p21. Two loss-of-function mutations of DNAI1 have been identified in a patient with PCD characterized by immotile respiratory cilia lacking outer dynein arms. In addition, we excluded linkage between this gene and similar PCD phenotypes in five other affected families, providing a clear demonstration of locus heterogeneity. These data reveal the critical role of DNAI1 in the development of human axonemal structures and open up new means for identification of additional genes involved in related developmental defects.	Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France; Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Serv Histol Embryol, Paris, France; Assistance Publ Hop Paris, Serv Otorhinolaryngol, Paris, France; Assistance Publ Hop Paris, Hop Armand Trousseau, Serv Pneumol Pediat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Amselem, S (corresponding author), Hop Henri Mondor, INSERM, U468, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	amselem@im3.inserm.fr	Duriez, Benedicte/Z-4690-2019; Pennarun, Gaelle/AAX-6579-2021	Pennarun, Gaelle/0000-0001-9881-9345				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; AFZELIUS BA, 1985, CRC CR REV BIOCH MOL, V19, P63, DOI 10.3109/10409238509086788; Andrews KL, 1996, MOL BIOL CELL, V7, P71, DOI 10.1091/mbc.7.1.71; ASAI DJ, 1994, J CELL SCI, V107, P839; Blair DF, 1992, CURR OPIN GENET DEV, V2, P756, DOI 10.1016/S0959-437X(05)80136-4; CHAO J, 1982, AM REV RESPIR DIS, V126, P302; Chapelin C, 1997, FEBS LETT, V412, P325, DOI 10.1016/S0014-5793(97)00800-4; Chaplin JA, 1997, MOL ECOL, V6, P155, DOI 10.1046/j.1365-294X.1997.00168.x; Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; ESCUDIER E, 1990, AM REV RESPIR DIS, V142, P674, DOI 10.1164/ajrccm/142.3.674; GIBBONS BH, 1994, MOL BIOL CELL, V5, P57, DOI 10.1091/mbc.5.1.57; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Kastury K, 1997, J CLIN ENDOCR METAB, V82, P3047, DOI 10.1210/jc.82.9.3047; KING SM, 1991, J BIOL CHEM, V266, P8401; KING SM, 1995, J CELL BIOL, V131, P399, DOI 10.1083/jcb.131.2.399; LEDIZET M, 1995, MOL BIOL CELL, V6, P713, DOI 10.1091/mbc.6.6.713; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; LEMIEUX N, 1992, CYTOGENET CELL GENET, V59, P311, DOI 10.1159/000133277; Milisav I, 1996, MAMM GENOME, V7, P667, DOI 10.1007/s003359900202; MITCHELL DR, 1991, J CELL BIOL, V113, P835, DOI 10.1083/jcb.113.4.835; Myster SH, 1997, MOL BIOL CELL, V8, P607, DOI 10.1091/mbc.8.4.607; NARAYAN D, 1994, J MED GENET, V31, P493, DOI 10.1136/jmg.31.6.493; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neesen J, 1997, GENE, V200, P193, DOI 10.1016/S0378-1119(97)00417-4; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Ogawa K, 1996, MOL BIOL CELL, V7, P1895, DOI 10.1091/mbc.7.12.1895; OGAWA K, 1995, MOL BIOL CELL, V6, P685, DOI 10.1091/mbc.6.6.685; OGAWA K, 1991, NATURE, V352, P643, DOI 10.1038/352643a0; PASCHAL BM, 1992, J CELL BIOL, V118, P1133, DOI 10.1083/jcb.118.5.1133; Perrone CA, 1998, MOL BIOL CELL, V9, P3351, DOI 10.1091/mbc.9.12.3351; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Porter ME, 1996, GENETICS, V144, P569; PORTER ME, 1994, J CELL BIOL, V126, P1495, DOI 10.1083/jcb.126.6.1495; Porter ME, 1996, CURR OPIN CELL BIOL, V8, P10, DOI 10.1016/S0955-0674(96)80042-1; RASMUSSON K, 1994, MOL BIOL CELL, V5, P45, DOI 10.1091/mbc.5.1.45; ROSSMAN CM, 1980, CHEST, V78, P580, DOI 10.1378/chest.78.4.580; Rupp G, 1996, J CELL BIOL, V135, P1853, DOI 10.1083/jcb.135.6.1853; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAKIBARA H, 1991, J CELL BIOL, V113, P615, DOI 10.1083/jcb.113.3.615; SAKAKIBARA H, 1993, J CELL BIOL, V122, P653, DOI 10.1083/jcb.122.3.653; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; STURGESS JM, 1986, AM J MED GENET, V25, P149, DOI 10.1002/ajmg.1320250117; TANAKA Y, 1995, J CELL SCI, V108, P1883; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; Vaughan KT, 1996, GENOMICS, V36, P29, DOI 10.1006/geno.1996.0422; WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169; WILKERSON CG, 1994, J CELL SCI, V107, P497; WITMAN G B, 1992, Current Opinion in Cell Biology, V4, P74; Witt M, 1999, AM J HUM GENET, V64, P313, DOI 10.1086/302203; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335	53	266	276	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1508	1519		10.1086/302683	http://dx.doi.org/10.1086/302683			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577904	Bronze, Green Published			2022-12-18	WOS:000084282500005
J	Shao, YJ; Cuccaro, ML; Hauser, ER; Raiford, KL; Menold, MM; Wolpert, CM; Ravan, SA; Elston, L; Decena, K; Donnelly, SL; Abramson, RK; Wright, HH; Delong, GR; Gilbert, JR; Pericak-Vance, MA				Shao, YJ; Cuccaro, ML; Hauser, ER; Raiford, KL; Menold, MM; Wolpert, CM; Ravan, SA; Elston, L; Decena, K; Donnelly, SL; Abramson, RK; Wright, HH; Delong, GR; Gilbert, JR; Pericak-Vance, MA			Fine mapping of Autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; BLOOD-PRESSURE; GENOME SCAN; LINKAGE-DISEQUILIBRIUM; ISODICENTRIC CHROMOSOME-15; DIAGNOSTIC INTERVIEW; MULTIPLE-SCLEROSIS; ANGELMAN SYNDROME; GENETICS FUSION; COMPLEX TRAITS	Autistic disorder (AutD) is a complex genetic disease. Available evidence suggests that several genes contribute to the underlying genetic risk for the development of AutD. However, both etiologic heterogeneity and genetic heterogeneity confound the discovery of AutD-susceptibility genes. Chromosome 15q11-q13 has been identified as a strong candidate region on the basis of both the frequent occurrence of chromosomal abnormalities in that region and numerous suggestive linkage and association findings. Ordered-subset analysis (OSA) is a novel statistical method to identify a homogeneous subset of families that contribute to overall linkage at a given chromosomal location and thus to potentially help in the fine mapping and localization of the susceptibility gene within a chromosomal area. For the present analysis, a factor that represents insistence on sameness (IS)-derived from a principal-component factor analysis using data on 221 patients with AutD from the repetitive behaviors/stereotyped patterns domain in the Autism Diagnostic Interview-Revised-was used as a covariate in OSA. Analysis of families sharing high scores on the IS factor increased linkage evidence for the 15q11-q13 region, at the GABRB3 locus, from a LOD score of 1.45 to a LOD score of 4.71. These results narrow our region of interest on chromosome 15 to an area surrounding the gamma-aminobutyric acid-receptor subunit genes, in AutD, and support the hypothesis that the analysis of phenotypic homogeneous subtypes may be a powerful tool for the mapping of disease-susceptibility genes in complex traits.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Univ S Carolina, WS Hall Psychiat Inst, Columbia, SC 29208 USA	Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Box 3445, Durham, NC 27710 USA.	mpv@chg.duhs.duke.edu		Hauser, Elizabeth/0000-0003-0367-9189	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS036768] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD36701] Funding Source: Medline; NINDS NIH HHS [P01 NS026630, NS26630, R01 NS036768, R01 NS36768] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allayee H, 2001, HYPERTENSION, V38, P773, DOI 10.1161/hy1001.092617; Arrieta I., 1994, Psychiatric Genetics, V4, P63, DOI 10.1097/00041444-199421000-00009; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Bass MP, 2000, NEUROGENETICS, V2, P219, DOI 10.1007/s100489900081; Boyar FZ, 2001, CLIN GENET, V60, P421, DOI 10.1034/j.1399-0004.2001.600604.x; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Cook EH, 1997, AM J HUM GENET, V60, P928; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; CUCCARO ML, IN PRESS J AUTISM DE; DEMB HB, 1995, J AM ACAD CHILD PSY, V34, P539, DOI 10.1097/00004583-199505000-00006; DILAVORE PC, 1995, J AUTISM DEV DISORD, V25, P355, DOI 10.1007/BF02179373; Dykens EM, 1997, AM J MENT RETARD, V102, P228, DOI 10.1352/0895-8017(1997)102<0228:MBICWP>2.0.CO;2; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; FOLSTEIN SE, 1991, PEDIATRICS, V87, P767; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 1998, BIOMETRICS, V54, P1238, DOI 10.2307/2533653; Hauser ER, 2001, AM J HUM GENET, V69, P529; HINDS D, 1998, ASPEX PACKAGE AFFECT; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kanner L, 1943, NERV CHILD, V2, P217; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KNOLL JHM, 1993, AM J MED GENET, V46, P2, DOI 10.1002/ajmg.1320460103; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 1997, J AUTISM DEV DISORD, V27, P501, DOI 10.1023/A:1025873925661; LOTSPEICH LJ, 1993, INT REV NEUROBIOL, V35, P87, DOI 10.1016/S0074-7742(08)60569-3; Maddox LO, 1999, GENOMICS, V62, P325, DOI 10.1006/geno.1999.6017; Maestrini E, 1998, J AUTISM DEV DISORD, V28, P427, DOI 10.1023/A:1026056522602; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Menold MM, 2001, J NEUROGENET, V15, P245, DOI 10.3109/01677060109167380; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Rimmler JB, 1999, AM J HUM GENET, V65, pA442; Rineer S, 1998, AM J MED GENET, V81, P428, DOI 10.1002/(SICI)1096-8628(19980907)81:5<428::AID-AJMG12>3.0.CO;2-E; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; Salmon B, 1999, AM J MED GENET, V88, P551, DOI 10.1002/(SICI)1096-8628(19991015)88:5<551::AID-AJMG21>3.3.CO;2-R; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Silverman JM, 2002, AM J MED GENET, V114, P64, DOI 10.1002/ajmg.10048; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; Smith M, 2000, AM J MED GENET, V96, P765, DOI 10.1002/1096-8628(20001204)96:6<765::AID-AJMG13>3.0.CO;2-L; Sparrow SS, 1984, VINELAND ADAPTIVE BE; Steffenburg S, 1996, PEDIATR NEUROL, V14, P131, DOI 10.1016/0887-8994(96)00011-2; SUMMERS JA, 1995, J INTELL DISABIL RES, V39, P97, DOI 10.1111/j.1365-2788.1995.tb00477.x; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Vance Jeffery M., 1998, P201; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Wolpert CM, 2000, AM J MED GENET, V96, P365, DOI 10.1002/1096-8628(20000612)96:3<365::AID-AJMG25>3.0.CO;2-X; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405	75	265	274	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					539	548		10.1086/367846	http://dx.doi.org/10.1086/367846			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12567325	Green Published, Bronze			2022-12-18	WOS:000181152600004
J	Digilio, MC; Conti, E; Sarkozy, A; Mingarelli, R; Dottorini, T; Marino, B; Pizzuti, A; Dallapiccola, B				Digilio, MC; Conti, E; Sarkozy, A; Mingarelli, R; Dottorini, T; Marino, B; Pizzuti, A; Dallapiccola, B			Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEOPARD-SYNDROME; LENTIGINOSIS; FEATURES; FAMILY	Multiple-lentigines (ML)/LEOPARD (multiple (l) under bar entigines, (e) under bar lectrocardiographic-conduction abnormalities, (o) under bar cular hypertelorism, (p) under bar ulmonary stenosis, (a) under bar bnormal genitalia, (r) under bar etardation of growth, and sensorineural (d) under bar eafness) syndrome is an autosomal dominant condition-characterized by lentigines and cafe' au lait spots, facial anomalies, cardiac defects-that shares several clinical features with Noonan syndrome (NS). We screened nine patients with ML/LEOPARD syndrome (including a mother-daughter pair) and two children with NS who had multiple cafe' au lait spots, for mutations in the NS gene, PTPN11, and found, in 10 of 11 patients, one of two new missense mutations, in exon 7 or exon 12. Both mutations affect the PTPN11 phosphotyrosine phosphatase domain, which is involved in <30% of the NS PTPN11 mutations. The study demonstrates that ML/LEOPARD syndrome and NS are allelic disorders. The detected mutations suggest that distinct molecular and pathogenetic mechanisms cause the peculiar cutaneous manifestations of the ML/LEOPARD-syndrome subtype of NS.	Univ Roma La Sapienza, Ist CSS Mendel, I-00198 Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, Med Genet Sect, I-00198 Rome, Italy; Univ Roma La Sapienza, Inst Pediat, Div Pediat Cardiol, I-00198 Rome, Italy; Bambino Gesu Pediat Hosp, Ist Ricovero & Cura & Carattere Sci, Div Med Genet, San Giovanni Rotondo, Italy; Casa Sollievo Sofferenza Hosp, Ist Ricovero & Cura & Carattere Sci, San Giovanni Rotondo, Italy	IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Pizzuti, A (corresponding author), Univ Roma La Sapienza, Ist CSS Mendel, Viale Regina Margherita 261, I-00198 Rome, Italy.	a.pizzuti@css-mendel.it	Digilio, Maria Cristina/AAI-2434-2019; Dallapiccola, Bruno/K-8692-2016	Dottorini, Tania/0000-0001-7733-906X; PIZZUTI, Antonio/0000-0003-3245-1925; Dallapiccola, Bruno/0000-0002-5031-1013				AHLBOM BE, 1995, CLIN GENET, V48, P85; ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; BLIEDEN LC, 1983, PEDIATR CARDIOL, V4, P168, DOI 10.1007/BF02076346; CARNEY JA, 1986, ARCH DERMATOL, V122, P790, DOI 10.1001/archderm.122.7.790; Coppin BD, 1997, J MED GENET, V34, P582, DOI 10.1136/jmg.34.7.582; DOCIU I, 1976, BRIT J DERMATOL, V94, P39, DOI 10.1111/j.1365-2133.1976.tb04339.x; GORLIN JR, 1990, SYNDROMES HEAD NECK, P461; GORLIN RJ, 1969, AM J DIS CHILD, V117, P652, DOI 10.1001/archpedi.1969.02100030654006; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; Legius E, 1998, EUR J HUM GENET, V6, P32, DOI 10.1038/sj.ejhg.5200150; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; MENDEZ HMM, 1985, AM J MED GENET, V21, P493, DOI 10.1002/ajmg.1320210312; Noonan JA, 1999, J PEDIATR-US, V135, P667, DOI 10.1016/S0022-3476(99)70082-X; PIPKIN AC, 1950, J HERED, V41, P79, DOI 10.1093/oxfordjournals.jhered.a106092; SCHIEVINK WI, 1995, NEW ENGL J MED, V332, P576, DOI 10.1056/NEJM199503023320905; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; VORON DA, 1976, AM J MED, V60, P447, DOI 10.1016/0002-9343(76)90764-6; WATSON GH, 1967, ARCH DIS CHILD, V42, P303, DOI 10.1136/adc.42.223.303; Wu R, 1996, HUM MUTAT, V8, P51, DOI 10.1002/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S	20	265	287	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					389	394		10.1086/341528	http://dx.doi.org/10.1086/341528			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12058348	Green Published, Bronze			2022-12-18	WOS:000176977700016
J	THOMPSON, EA; DEEB, S; WALKER, D; MOTULSKY, AG				THOMPSON, EA; DEEB, S; WALKER, D; MOTULSKY, AG			THE DETECTION OF LINKAGE DISEQUILIBRIUM BETWEEN CLOSELY LINKED MARKERS - RFLPS AT THE AI-CIII APOLIPOPROTEIN GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON, SCH MED, DEPT MED, RG-25, SEATTLE, WA 98195 USA; UNIV WASHINGTON, CTR INHERITED DIS, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT STAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT GENET, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454, P50GM015253] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30086] Funding Source: Medline; NIGMS NIH HHS [GM 07454, GM 15253] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVOGARO P, 1980, ATHEROSCLEROSIS, V37, P69, DOI 10.1016/0021-9150(80)90094-5; BARKER D, 1984, AM J HUM GENET, V36, P1159; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BODMER WF, 1978, BRIT MED BULL, V34, P309, DOI 10.1093/oxfordjournals.bmb.a071518; BRESLOW JL, 1982, P NATL ACAD SCI-BIOL, V79, P6861, DOI 10.1073/pnas.79.22.6861; BROWN AHD, 1975, THEOR POPUL BIOL, V8, P184, DOI 10.1016/0040-5809(75)90031-3; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CHAKRABORTY R, 1984, GENETICS, V108, P719; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHEUNG P, 1984, P NATL ACAD SCI-BIOL, V81, P508, DOI 10.1073/pnas.81.2.508; COX DW, 1985, NATURE, V316, P79, DOI 10.1038/316079a0; DEEB S, 1986, COLD SPRING HARB SYM, V51, P403, DOI 10.1101/SQB.1986.051.01.048; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; GOLDING GB, 1984, GENETICS, V108, P257; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; HUDSON RR, 1985, GENETICS, V109, P611; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KARATHANASIS SK, 1983, NATURE, V304, P371, DOI 10.1038/304371a0; KESSLING AM, 1985, CLIN GENET, V28, P296; LAW SW, 1984, BIOCHEM BIOPH RES CO, V118, P934, DOI 10.1016/0006-291X(84)91485-2; LITT M, 1986, AM J HUM GENET, V39, P166; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MANIATIS T., 1982, MOL CLONING LABORATO, P382; MILLER GJ, 1975, LANCET, V1, P16; MORRIS SW, 1985, LANCET, V2, P1127; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; OHTA T, 1969, GENETICS, V63, P229; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; REES A, 1986, HUM GENET, V72, P168; REES A, 1983, LANCET, V1, P444; SEILHAMER JJ, 1984, DNA-J MOLEC CELL BIO, V3, P309, DOI 10.1089/dna.1.1984.3.309; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WEIR BS, 1978, GENETICS, V88, P633; WEIR BS, 1986, AM J HUM GENET, V38, P776; WEIR BS, 1980, GENETICS, V95, P477	40	265	272	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					113	124						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2892394				2022-12-18	WOS:A1988L869700016
J	Ballantyne, KN; Goedbloed, M; Fang, RX; Schaap, O; Lao, O; Wollstein, A; Choi, Y; van Duijn, K; Vermeulen, M; Brauer, S; Decorte, R; Poetsch, M; von Wurmb-Schwark, N; de Knijff, P; Labuda, D; Vezina, H; Knoblauch, H; Lessig, R; Roewer, L; Ploski, R; Dobosz, T; Henke, L; Henke, J; Furtado, MR; Kayser, M				Ballantyne, Kaye N.; Goedbloed, Miriam; Fang, Rixun; Schaap, Onno; Lao, Oscar; Wollstein, Andreas; Choi, Ying; van Duijn, Kate; Vermeulen, Mark; Brauer, Silke; Decorte, Ronny; Poetsch, Micaela; von Wurmb-Schwark, Nicole; de Knijff, Peter; Labuda, Damian; Vezina, Helene; Knoblauch, Hans; Lessig, Ruediger; Roewer, Lutz; Ploski, Rafal; Dobosz, Tadeusz; Henke, Lotte; Henke, Juegen; Furtado, Manohar R.; Kayser, Manfred			Mutability of Y-Chromosomal Microsatellites: Rates, Characteristics, Molecular Bases, and Forensic Implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT TANDEM REPEATS; MUTATION-RATES; HAPLOGROUP TREE; DNA-SEQUENCES; HUMAN GENOME; EVOLUTION; LENGTH; HUMANS; LOCI; SLIPPAGE	Nonrecombining Y-chromosomal microsatellites (Y-STRs) are widely used to infer population histories, discover genealogical relationships, and identify males for criminal justice purposes. Although a key requirement for their application is reliable mutability knowledge, empirical data are only available for a small number of Y-STRs thus far. To rectify this, we analyzed a large number of 186 Y-STR markers in nearly 2000 DNA-confirmed father-son pairs, covering an overall number of 352,999 meiotic transfers. Following confirmation by DNA sequence analysis, the retrieved mutation data were modeled via a Bayesian approach, resulting in mutation rates from 3.78 x 10(-4) (95% credible interval [CI], 1.38 x 10(-5) - 2.02 x 10(-3)) to 7.44 x 10(-2) (95% Cl, 6.51 x 10(-2) - 9.09 x 10(-2)) per marker per generation. With the 924 mutations at 120 Y-STR markers, a nonsignificant excess of repeat losses versus gains (1.16:1), as well as a strong and significant excess of single-repeat versus multirepeat changes (25.23:1), was observed. Although the total repeat number influenced Y-STR locus mutability most strongly, repeat complexity, the length in base pairs of the repeated motif, and the father's age also contributed to Y-STR mutability. To exemplify how to practically utilize this knowledge, we analyzed the 13 most mutable Y-STRs in an independent sample set and empirically proved their suitability for distinguishing close and distantly related males. This finding is expected to revolutionize Y-chromosomal applications in forensic biology, from previous male lineage differentiation toward future male individual identification.	[Ballantyne, Kaye N.; Goedbloed, Miriam; Schaap, Onno; Lao, Oscar; Choi, Ying; van Duijn, Kate; Vermeulen, Mark; Brauer, Silke; Kayser, Manfred] Erasmus MC, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands; [Fang, Rixun; Furtado, Manohar R.] Life Technol, Foster City, CA 94404 USA; [Wollstein, Andreas] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Brauer, Silke] Netherlands Forens Inst, NL-2497 GB The Hague, Netherlands; [Decorte, Ronny] Univ Hosp KU Leuven, Dept Forens Med, B-3000 Louvain, Belgium; [Decorte, Ronny] Univ Hosp KU Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Poetsch, Micaela] Univ Hosp Essen, Inst Legal Med, D-45122 Essen, Germany; [von Wurmb-Schwark, Nicole] Univ Schleswig Holstein, Inst Legal Med, D-24105 Kiel, Germany; [de Knijff, Peter] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Forens Lab DNA Res, NL-2300 RC Leiden, Netherlands; [Labuda, Damian] Univ Montreal, Dept Pediat, CHU St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Vezina, Helene] Univ Quebec Chicoutimi, Interdisciplinary Res Grp Demog & Genet Epidemiol, Chicoutimi, PQ G7H 2B1, Canada; [Knoblauch, Hans] Charite, Abt Myol, Expt & Clin Res Ctr, D-10117 Berlin, Germany; [Lessig, Ruediger] Univ Leipzig, Inst Legal Med, D-04103 Leipzig, Germany; [Roewer, Lutz] Charite, Abt Forens Genet, Inst Rechtsmed & Forens Wissensch, D-10115 Berlin, Germany; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, PL-02007 Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Forens Med, PL-02007 Warsaw, Poland; [Dobosz, Tadeusz] Wroclaw Med Univ, Dept Forens Med, PL-50368 Wroclaw, Poland; [Henke, Lotte; Henke, Juegen] Inst Blutgruppenforsch LGC GmbH, D-50933 Cologne, Germany	Erasmus University Rotterdam; Erasmus MC; Thermo Fisher Scientific; University of Cologne; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of Duisburg Essen; University of Kiel; Schleswig Holstein University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Quebec; University of Quebec Chicoutimi; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Warsaw; Medical University of Warsaw; Wroclaw Medical University	Kayser, M (corresponding author), Erasmus MC, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands.	m.kayser@erasmusmc.nl	Dobosz, Tadeusz/ABE-9988-2021; Decorte, Ronny/AAG-1365-2021; de Knijff, Peter/Y-2519-2018; Schneider, Peter M./A-6661-2011; Lao, Oscar/N-9930-2017; Dobosz, Tadeusz/T-8250-2018	de Knijff, Peter/0000-0002-0899-771X; Lao, Oscar/0000-0002-8525-9649; Ploski, Rafal/0000-0001-6286-5526; Roewer, Lutz/0000-0001-9383-4941; Furtado, Manohar/0000-0001-6016-1357; Dobosz, Tadeusz/0000-0003-0413-9109; Decorte, Ronny/0000-0002-0001-386X	Netherlands Forensic Institute; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Polish Ministry of Science and Higher Education [N404 032 31/1892]; Life Technologies	Netherlands Forensic Institute; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Life Technologies	We would like to thank Damla Arslantunali, Ines Correia Rosa, Paul Dekkers, Sevgi Deniz, Kristiaan van der Gaag, Anita van den Heuvel, Diana van den Heuvel, Cissi Jonsson-Glans, Tomas Petten, Arwin Ralf, and Melike Yuksel for expert technical assistance. Pieter van Oers (Life Technologies) is thanked for infrastructural support. This work was supported by funds from the Netherlands Forensic Institute to M.K. and was additionally supported by a grant from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research within the framework of the Forensic Genomics Consortium Netherlands to M.K. and P.d.K. R.P. is supported by a Polish Ministry of Science and Higher Education grant N404 032 31/1892. R.F. and M.R.F. are employees and shareholders of Life Technologies. This work was supported in part by Life Technologies.	*AM ASS BLOOD BANK, 2006, ANN REP SUMM PAR TES; Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bell GI, 1997, J MOL EVOL, V44, P414, DOI 10.1007/PL00006161; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Dettlaff-Kakol A, 2002, INT J LEGAL MED, V116, P289, DOI 10.1007/s00414-002-0320-0; Dupuy BM, 2004, HUM MUTAT, V23, P117, DOI 10.1002/humu.10294; Eckert KA, 2009, MOL CARCINOGEN, V48, P379, DOI 10.1002/mc.20499; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Ge JY, 2009, FORENSIC SCI INT-GEN, V3, P179, DOI 10.1016/j.fsigen.2009.01.007; Gelman A., 2003, BAYESIAN DATA ANAL, DOI 10.1201/b16018; Goedbloed M, 2009, INT J LEGAL MED, V123, P471, DOI 10.1007/s00414-009-0342-y; Gusmao L, 2005, HUM MUTAT, V26, P520, DOI 10.1002/humu.20254; Hammer MF, 2002, ANNU REV ANTHROPOL, V31, P303, DOI 10.1146/annurev.anthro.31.040402.085413; Hanson EK, 2006, J FORENSIC SCI, V51, P1298, DOI 10.1111/j.1556-4029.2006.00263.x; HEDMAN M, 2010, FORENSIC SC IN PRESS; Henke J, 1999, AM J HUM GENET, V64, P1473, DOI 10.1086/302373; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hoboff C, 2007, INT J LEGAL MED, V121, P359, DOI 10.1007/s00414-006-0123-9; Huang QY, 2002, AM J HUM GENET, V70, P625, DOI 10.1086/338997; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2004, AM J HUM GENET, V74, P1183, DOI 10.1086/421531; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kayser M, 2001, FORENSIC SCI INT, V118, P116, DOI 10.1016/S0379-0738(00)00480-1; Kayser M., 2007, BIOTECHNIQUES, V43, P3042; Kayser M, 2007, FORENSIC SCI INT-GEN, V1, P125, DOI 10.1016/j.fsigen.2007.02.004; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; Leopoldino AM, 2003, HUM MUTAT, V21, P71, DOI 10.1002/humu.10153; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; Novelletto A, 2007, ANN HUM BIOL, V34, P139, DOI 10.1080/03014460701206843; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pemberton TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-612; Pollin TI, 2008, HUM HERED, V65, P91, DOI 10.1159/000108941; Pumpernik D, 2008, MOL GENET GENOMICS, V279, P53, DOI 10.1007/s00438-007-0294-1; Roewer L, 2009, FORENSIC SCI MED PAT, V5, P77, DOI 10.1007/s12024-009-9089-5; Sainudiin R, 2004, GENETICS, V168, P383, DOI 10.1534/genetics.103.022665; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Vermeulen M, 2009, FORENSIC SCI INT-GEN, V3, P205, DOI 10.1016/j.fsigen.2009.01.009; Webster MT, 2002, P NATL ACAD SCI USA, V99, P8748, DOI 10.1073/pnas.122067599; Whittaker JC, 2003, GENETICS, V164, P781; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	58	264	283	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					341	353		10.1016/j.ajhg.2010.08.006	http://dx.doi.org/10.1016/j.ajhg.2010.08.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20817138	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-18	WOS:000281923500003
J	Xu, SH; Yin, XY; Li, SL; Jin, WF; Lou, HY; Yang, L; Gong, XH; Wang, HY; Shen, YP; Pan, XD; He, YG; Yang, YJ; Wang, Y; Fu, WQ; An, Y; Wang, JC; Tan, JZ; Qian, J; Chen, XL; Zhang, X; Sun, YF; Zhang, XJ; Wu, BL; Jin, L				Xu, Shuhua; Yin, Xianyong; Li, Shilin; Jin, Wenfei; Lou, Haiyi; Yang, Ling; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; He, Yungang; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Chen, Xiaoli; Zhang, Xin; Sun, Yangfei; Zhang, Xuejun; Wu, Bailin; Jin, Li			Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE-POLYMORPHISMS; GENETIC-STRUCTURE; WIDE ANALYSIS; BLOOD-PRESSURE; HAPLOTYPE MAP; EAST-ASIA; DISEASE; VARIANTS; PATTERNS; STRATIFICATION	To date, most genome-wide association studies (GWAS) and studies of fine-scale population structure have been conducted primarily on Europeans. Han Chinese, the largest ethnic group in the world, composing 20% of the entire global human population, is largely under-represented in such studies. A well-recognized challenge is the fact that population structure can cause spurious associations in GWAS. In this study, we examined population substructures in a diverse set of over 1700 Han Chinese samples collected from 26 regions across China, each genotyped at similar to 160K single-nucleotide polymorphisms (SNPs). Our results showed that the Han Chinese population is intricately substructured, with the main observed clusters corresponding roughly to northern Han, central Han, and southern Han. However, simulated case-control studies showed that genetic differentiation among these clusters, although very small (F-ST = 0.0002 similar to 0.0009), is sufficient to lead to an inflated rate of false-positive results even when the sample size is moderate. The top two SNPs with the greatest frequency differences between the northern Han and southern Han clusters (F-ST > 0.06) were found in the FADS2 gene, which associates with the fatty acid composition in phospholipids, and in the HLA complex PS gene (HCP5), which associates with HIV infection, psoriasis, and psoriatic arthritis. Ingenuity Pathway Analysis (IPA) showed that most differentiated genes among clusters are involved in cardiac arteriopathy (p < 10(-101)). These signals indicating significant differences among Han Chinese subpopulations should be carefully explained in case they are also detected in association studies, especially when sample sources are diverse.	[Xu, Shuhua; Jin, Wenfei; Lou, Haiyi; Yang, Ling; He, Yungang; Jin, Li] Chinese Acad Sci, Max Planck Soc, MPG, Partner Inst Computat Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xu, Shuhua; Jin, Wenfei; Lou, Haiyi; Yang, Ling; He, Yungang; Jin, Li] Chinese Acad Sci, Key Lab Computat Biol, MPG, Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Li, Shilin; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Zhang, Xin; Sun, Yangfei; Wu, Bailin; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Shilin; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Zhang, Xin; Sun, Yangfei; Wu, Bailin; Jin, Li] Fudan Univ, MOE, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Li, Shilin; Gong, Xiaohong; Wang, Hongyan; Shen, Yiping; Pan, Xuedong; Yang, Yajun; Wang, Yi; Fu, Wenqing; An, Yu; Wang, Jiucun; Tan, Jingze; Qian, Ji; Zhang, Xin; Sun, Yangfei; Wu, Bailin; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yin, Xianyong; Zhang, Xuejun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Yin, Xianyong; Zhang, Xuejun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Shen, Yiping; Chen, Xiaoli; Wu, Bailin] Harvard Univ, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Jin, Li] Inst Hlth Sci, CMC, Taizhou 225300, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Fudan University; Fudan University; Fudan University; Anhui Medical University; Anhui Medical University; Harvard University; Boston Children's Hospital; Harvard Medical School	Jin, L (corresponding author), Chinese Acad Sci, Max Planck Soc, MPG, Partner Inst Computat Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	ljin007@gmail.com	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Jin, Wenfei/V-9944-2019; Wang, Jiucun/J-8744-2012; Chen, Gang/G-2722-2010; Jin, Wenfei/H-5330-2011; XU, SHUHUA/D-5345-2009; Xu, Shuhua/AAH-7620-2020; Anthropology, MOE KeyLab Fudan/A-9454-2010	Jin, Li/0000-0002-4546-2415; Jin, Wenfei/0000-0002-0028-3739; Wang, Jiucun/0000-0003-2765-0620; Jin, Wenfei/0000-0002-0028-3739; XU, SHUHUA/0000-0002-1975-1002; Xu, Shuhua/0000-0002-1975-1002; He, Yungang/0000-0002-2931-2871	National Outstanding Youth Science Foundation of China [30625016]; National Science Foundation of China [30890034, 30971577]; 863 Program [2007AA02Z312]; Shanghai Leading Academic Discipline Project [B111]; Center for Evolutionary Biology; Science and Technology Commission of Shanghai Municipality [09ZRI436400]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2008KIP311]; SA-SIBS Scholarship Program and the K.C.Wong Education Foundation, Hong Kong	National Outstanding Youth Science Foundation of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Center for Evolutionary Biology; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); SA-SIBS Scholarship Program and the K.C.Wong Education Foundation, Hong Kong	This is a report of a joint effort of three research groups with equal contribution. L.J. is the senior author for the data analysis group, and B.W. and X.J.Z. are the senior authors for two genotyping teams. The authors are grateful to many people in L.J., B.W., and X-J.Z.'s lab for their help in collecting samples. This work was supported by grants from the National Outstanding Youth Science Foundation of China (30625016), the National Science Foundation of China (30890034, 30971577), and the 863 Program (2007AA02Z312). L.J. was also Supported by the Shanghai Leading Academic Discipline Project (B111) and the Center for Evolutionary Biology. S.X. was also supported by the Science and Technology Commission of Shanghai Municipality (09ZRI436400) and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2008KIP311). S.X. gratefully acknowledges the support of the SA-SIBS Scholarship Program and the K.C.Wong Education Foundation, Hong Kong.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brahmachari SK, 2008, J GENET, V87, P3; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cann HM, 2002, SCIENCE, V296, P261; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Cavalli Sforza LL, 1993, HIST GEOGRAPHY HUMAN; Chen R, 1993, Yi Chuan Xue Bao, V20, P389; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Colombo S, 2008, J INFECT DIS, V198, P864, DOI 10.1086/591184; Conen D, 2009, J HYPERTENS, V27, P476, DOI 10.1097/HJH.0b013e32832104c8; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; DU R, 1998, SCI CHINA SER C, V28, P83; Fox AA, 2009, ANESTHESIOLOGY, V110, P738, DOI 10.1097/ALN.0b013e31819c7496; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; *HUGO PAN AS SNP C, 2008, SCIENCE IN PRESS; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shaw GM, 2005, AM J MED GENET A, V138A, P21, DOI 10.1002/ajmg.a.30924; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Xiao CJ, 2000, SCI CHINA SER C, V43, P472; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhao WY, 2007, J HYPERTENS, V25, P1821, DOI 10.1097/HJH.0b013e328244e119	62	264	308	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					762	774		10.1016/j.ajhg.2009.10.015	http://dx.doi.org/10.1016/j.ajhg.2009.10.015			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19944404	Green Published, Bronze			2022-12-18	WOS:000272797100001
J	Kivisild, T; Rootsi, S; Metspalu, M; Mastana, S; Kaldma, K; Parik, J; Metspalu, E; Adojaan, M; Tolk, HV; Stepanov, V; Golge, M; Usanga, E; Papiha, SS; Cinnioglu, C; King, R; Cavalli-Sforza, L; Underhill, PA; Villems, R				Kivisild, T; Rootsi, S; Metspalu, M; Mastana, S; Kaldma, K; Parik, J; Metspalu, E; Adojaan, M; Tolk, HV; Stepanov, V; Golge, M; Usanga, E; Papiha, SS; Cinnioglu, C; King, R; Cavalli-Sforza, L; Underhill, PA; Villems, R			The genetic heritage of the earliest settlers persists both in Indian tribal and caste populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA LINEAGES; Y-CHROMOSOME HAPLOTYPES; HOMO-SAPIENS SAPIENS; SEQUENCE VARIATION; ADMIXTURE PROPORTIONS; MTDNA VARIATION; 9-BP DELETION; MODERN HUMANS; SOUTH-INDIA; ORIGINS	Two tribal groups from southern India-the Chenchus and Koyas-were analyzed for variation in mitochondrial DNA (mtDNA), the Y chromosome, and one autosomal locus and were compared with six caste groups from different parts of India, as well as with western and central Asians. In mtDNA phylogenetic analyses, the Chenchus and Koyas coalesce at Indian-specific branches of haplogroups M and N that cover populations of different social rank from all over the subcontinent. Coalescence times suggest early late Pleistocene settlement of southern Asia and suggest that there has not been total replacement of these settlers by later migrations. H, L, and R2 are the major Indian Y-chromosomal haplogroups that occur both in castes and in tribal populations and are rarely found outside the subcontinent. Haplogroup R1a, previously associated with the putative Indo-Aryan invasion, was found at its highest frequency in Punjab but also at a relatively high frequency (26%) in the Chenchu tribe. This finding, together with the higher R1a-associated short tandem repeat diversity in India and Iran compared with Europe and central Asia, suggests that southern and western Asia might be the source of this haplogroup. Haplotype frequencies of the MX1 locus of chromosome 21 distinguish Koyas and Chenchus, along with Indian caste groups, from European and eastern Asian populations. Taken together, these results show that Indian tribal and caste populations derive largely from the same genetic heritage of Pleistocene southern and western Asians and have received limited gene flow from external regions since the Holocene. The phylogeography of the primal mtDNA and Y-chromosome founders suggests that these southern Asian Pleistocene coastal settlers from Africa would have provided the inocula for the subsequent differentiation of the distinctive eastern and western Eurasian gene pools.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Newcastle Upon Tyne, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Kuwait Univ, Dept Med Lab Sci, Sulibikhat, Kuwait; Univ Kiel, Dept Physiol, Kiel, Germany; Inst Med Genet, Tomsk, Russia; Univ Loughborough, Dept Human Sci, Loughborough, Leics, England; Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Stanford University; Newcastle University - UK; Kuwait University; University of Kiel; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Loughborough University; University of Tartu	Kivisild, T (corresponding author), Estonian Bioctr, Riia 23, EE-51010 Tartu, Estonia.		Stepanov, Vadim/G-4320-2013; Metspalu, Mait/G-8671-2015; Stepanov, Vadim A./N-7657-2014; Kivisild, Toomas/P-5889-2017; Mastana, Sarabjit/A-1405-2011	Stepanov, Vadim/0000-0002-5166-331X; Metspalu, Mait/0000-0003-3099-9161; Kivisild, Toomas/0000-0002-6297-7808; Mastana, Sarabjit/0000-0002-9553-4886	NIGMS NIH HHS [GM28428, P01 GM028428, GM55273] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Bhattacharyya NP, 1999, GENOME RES, V9, P711; Bhowmick P. K., 1992, CHENCHUS FORESTS PLA; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chikhi L, 2001, GENETICS, V158, P1347; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Edwin D, 2002, CURR SCI INDIA, V83, P158; Ellis N, 2002, GENOME RES, V12, P339; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Forster P, 1996, AM J HUM GENET, V59, P935; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kivisild Toomas, 2000, ARCHAEOGENETICS DNA, P267; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Majumder PP, 2001, EUR J HUM GENET, V9, P794, DOI 10.1038/sj.ejhg.5200705; Majumder PP, 2001, GENOME RES, V11, P931, DOI 10.1101/gr.192401; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nebel A, 2002, AM J HUM GENET, V70, P1594, DOI 10.1086/340669; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; NEI M, 1993, MOL BIOL EVOL, V10, P927; Papiha SS, 1996, HUM BIOL, V68, P607; Passarino G, 1996, ANN HUM BIOL, V23, P121, DOI 10.1080/03014469600004342; Passarino G, 2001, HUM IMMUNOL, V62, P922, DOI 10.1016/S0198-8859(01)00291-9; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Raitio M, 2001, GENOME RES, V11, P471, DOI 10.1101/gr.156301; Ramana GV, 2001, EUR J HUM GENET, V9, P695, DOI 10.1038/sj.ejhg.5200708; Redd AJ, 2002, CURR BIOL, V12, P673, DOI 10.1016/S0960-9822(02)00789-3; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Saillard J, 2000, HUM BIOL, V72, P1065; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sambrook J, 1989, MOL CLONING LAB MANU; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shouse B, 2001, SCIENCE, V294, P988, DOI 10.1126/science.294.5544.988; Shriver MD, 1997, AM J HUM GENET, V60, P957; SINGH KS, 1997, PEOPLE INDIA, V3; Soodyall H, 1996, AM J HUM GENET, V58, P595; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; TARN W, 1951, GREEKS BACTR INDIA; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; THURIN M, 1999, CAMBRIDGE ENCY HUNTE, P252; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; WALTER H, 1991, ANTHR INDIENS; Watkins WS, 1999, AM J PHYS ANTHROPOL, V109, P147, DOI 10.1002/(SICI)1096-8644(199906)109:2<147::AID-AJPA1>3.0.CO;2-C; Weale ME, 2001, HUM GENET, V109, P659, DOI 10.1007/s00439-001-0627-9; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 1999, GENOMIC DIVERSITY, P91	82	264	279	1	37	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					313	332		10.1086/346068	http://dx.doi.org/10.1086/346068			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12536373	Green Published, Bronze			2022-12-18	WOS:000180680000012
J	Aksentijevich, I; Galon, J; Soares, M; Mansfield, E; Hull, K; Oh, HH; Goldbach-Mansky, R; Dean, J; Athreya, B; Reginato, AJ; Henrickson, M; Pons-Estel, B; O'Shea, JJ; Kastner, DL				Aksentijevich, I; Galon, J; Soares, M; Mansfield, E; Hull, K; Oh, HH; Goldbach-Mansky, R; Dean, J; Athreya, B; Reginato, AJ; Henrickson, M; Pons-Estel, B; O'Shea, JJ; Kastner, DL			The tumor-necrosis-factor receptor-associated periodic syndrome: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL MEDITERRANEAN FEVER; ENCODING MEVALONATE KINASE; TNF RECEPTOR; HIBERNIAN FEVER; AA AMYLOIDOSIS; COMPLEX; IDENTIFICATION; LOCALIZATION; LINKAGE; DOMAIN	Mutations in the extracellular domain of the 55-kD tumor-necrosis factor (TNF) receptor (TNFRSF1A), a key regulator of inflammation, define a periodic-fever syndrome, TRAPS (TNF receptor-associated periodic syndrome [MIM 142680]), which is characterized by attacks of fever, sterile peritonitis, arthralgia, myalgia, skin rash, and/or conjunctivitis; some patients also develop systemic amyloidosis. Elsewhere we have described six disease-associated TNFRSF1A mutations, five of which disrupt extracellular cysteines involved in disulfide bonds; four other mutations have subsequently been reported. Among 150 additional patients with unexplained periodic fevers, we have identified four novel TNFRSF1A mutations (H22Y, C33G, S86P, and c. 193-14 G-->A), one mutation (C30S) described by another group, and two substitutions (P46L and R92Q) present in similar to1% of control chromosomes. The increased frequency of P46L and R92Q among patients with periodic fever, as well as functional studies of TNFRSF1A, argue that these are low- penetrance mutations rather than benign polymorphisms. The c. 193-14 G-->A mutation creates a splice-acceptor site upstream of exon 3, resulting in a transcript encoding four additional extracellular amino acids. T50M and c. 193-14 G-->A occur at CpG hotspots, and haplotype analysis is consistent with recurrent mutations at these sites. In contrast, although R92Q also arises at a CpG motif, we identified a common founder chromosome in unrelated individuals with this substitution. Genotype-phenotype studies identified, as carriers of cysteine mutations, 13 of 14 patients with TRAPS and amyloidosis and indicated a lower penetrance of TRAPS symptoms in individuals with noncysteine mutations. In two families with dominantly inherited disease and in 90 sporadic cases that presented with a compatible clinical history, we have not identified any TNFRSF1A mutation, despite comprehensive genomic sequencing of all of the exons, therefore suggesting further genetic heterogeneity of the periodic-fever syndromes.	NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; NIAMSD, Sect Lymphocyte Cell Biol, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; NIAMSD, Off Clin Director, NIH, Bethesda, MD 20892 USA; Inst Curie, Lab Immunol Cellulaire & Clin, INSERM, U255, Paris, France; duPont Hosp Children, Div Rheumatol, Wilmington, DE USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Univ Med Ctr, Dept Med,Rheumatol Sect, Camden, NJ 08103 USA; Valley Childrens Hosp, Pediat Arthrit Ctr, Madera, CA USA; Sanatorio Parque, Rosario, Santa Fe, Argentina	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Nemours Alfred I. duPont Hospital for Children; Rutgers State University New Brunswick; Rutgers State University Medical Center	Aksentijevich, I (corresponding author), NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bldg 10,Room 9N214, Bethesda, MD 20892 USA.	aksentii@exchange.nih.gov	Soares, Miguel/M-1968-2019; Henrickson, Mark/C-3499-2008; Galon, Jerome/G-9838-2019; Henrickson, Michael/AAE-8221-2022; Aksentijevich, Ivona/AAF-1335-2019; Goldbach-Mansky, Raphaela/N-5917-2017	Soares, Miguel/0000-0002-1812-6117; Henrickson, Mark/0000-0003-2769-5132; Galon, Jerome/0000-0001-9635-1339; Pons-Estel, Bernardo/0000-0003-2518-0266	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106, Z01AR041123, ZIAAR041106, ZIAAR041123] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aganna E, 2001, EUR J HUM GENET, V9, P63, DOI 10.1038/sj.ejhg.5200573; Aksentijevich I, 1997, CELL, V90, P797; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bazzoni F, 2000, IMMUNOGENETICS, V51, P159, DOI 10.1007/s002510050025; Beckmann JS, 1996, AM J HUM GENET, V59, P1400; Bernot A, 1997, NAT GENET, V17, P25; Centola M, 1998, HUM MOL GENET, V7, P1581, DOI 10.1093/hmg/7.10.1581; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cuisset L, 1999, AM J HUM GENET, V65, P1054, DOI 10.1086/302589; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dode C, 2000, ARTHRITIS RHEUM-US, V43, P1535, DOI 10.1002/1529-0131(200007)43:7<1535::AID-ANR18>3.0.CO;2-C; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Drenth JPH, 2000, BRIT MED J, V320, P1091, DOI 10.1136/bmj.320.7242.1091; Eskdale J, 2000, GENES IMMUN, V1, P228, DOI 10.1038/sj.gene.6363663; FUCHS P, 1992, GENOMICS, V13, P219, DOI 10.1016/0888-7543(92)90226-I; GERTZ MA, 1987, MAYO CLIN PROC, V62, P1095, DOI 10.1016/S0025-6196(12)62502-6; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Jadoul M, 2001, KIDNEY INT, V59, P1677, DOI 10.1046/j.1523-1755.2001.0590051677.x; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; McDermott EM, 1997, MAYO CLIN PROC, V72, P806, DOI 10.4065/72.9.806; McDermott MF, 1998, AM J HUM GENET, V62, P1446, DOI 10.1086/301886; McDermott MF, 2000, ARTHRITIS RHEUM-US, V43, P2034, DOI 10.1002/1529-0131(200009)43:9<2034::AID-ANR14>3.0.CO;2-J; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Mulley J, 1998, AM J HUM GENET, V62, P884, DOI 10.1086/301793; Naismith JH, 1996, STRUCTURE, V4, P1251, DOI 10.1016/S0969-2126(96)00134-7; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Simon A, 2001, AM J MED, V110, P313, DOI 10.1016/S0002-9343(00)00716-6; WILLIAMSON LM, 1982, Q J MED, V51, P469; ZAKS N, 1997, FAMILIAL MEDITERRANE, P211	33	264	278	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					301	314		10.1086/321976	http://dx.doi.org/10.1086/321976			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443543	Green Published, Bronze			2022-12-18	WOS:000170108200006
J	Abecasis, GR; Noguchi, E; Heinzmann, A; Traherne, JA; Bhattacharyya, S; Leaves, NI; Anderson, GG; Zhang, YM; Lench, NJ; Carey, A; Cardon, LR; Moffatt, MF; Cookson, WOC				Abecasis, GR; Noguchi, E; Heinzmann, A; Traherne, JA; Bhattacharyya, S; Leaves, NI; Anderson, GG; Zhang, YM; Lench, NJ; Carey, A; Cardon, LR; Moffatt, MF; Cookson, WOC			Extent and distribution of linkage disequilibrium in three genomic regions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIATION; POPULATION; DISEASES; MAP	The positional cloning of genes underlying common complex diseases relies on the identification of linkage disequilibrium (LD) between genetic markers and disease. We have examined 127 polymorphisms in three genomic regions in a sample of 575 chromosomes from unrelated individuals of British ancestry. To establish phase, 800 individuals were genotyped in 160 families. The fine structure of LD was found to be highly irregular. Forty-five percent of the variation in disequilibrium measures could be explained by physical distance. Additional factors, such as allele frequency, type of polymorphism, and genomic location, explained <5 % of the variation. Nevertheless, disequilibrium was occasionally detectable at 500 kb and was present for over one-half of marker pairs separated by <50 kb. Although these findings are encouraging for the prospects of a genomewide LD map, they suggest caution in interpreting localization due to allelic association.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Oxagen Ltd, Abingdon, Oxon, England	University of Oxford; Wellcome Centre for Human Genetics; Oxagen Limited	Cookson, WOC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	william.cookson@ndm.ox.ac.uk	Cookson, William/HHC-1790-2022; Abecasis, Goncalo R/B-7840-2010; Lench, Nicholas/AAB-1791-2021	Abecasis, Goncalo/0000-0003-1509-1825; Lench, Nicholas/0000-0002-6108-0759				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BHATTACHARYYA S, 1998, DISSECTING GENETICS; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Eaves IA, 2000, NAT GENET, V25, P320; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Farrall M, 1999, NAT GENET, V23, P270, DOI 10.1038/15449; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Hard D. L, 1997, PRINCIPLES POPULATIO; HEDRICK PW, 1987, GENETICS, V117, P331; Huttley GA, 1999, GENETICS, V152, P1711; JORDE LB, 1994, AM J HUM GENET, V54, P884; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; KIMURA M, 1973, GENETICS, V75, P199; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; MOFFATT F, 1994, LANCET, V343, P1597, DOI 10.1016/S0140-6736(94)93057-0; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sobel E, 1996, AM J HUM GENET, V58, P1323; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Thompson EA, 1997, AM J HUM GENET, V60, P197; Tu IP, 1999, AM J HUM GENET, V64, P641, DOI 10.1086/302253; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	33	264	278	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					191	197		10.1086/316944	http://dx.doi.org/10.1086/316944			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11083947	Green Published, Bronze			2022-12-18	WOS:000166399900017
J	Majamaa, K; Moilanen, JS; Uimonen, S; Remes, AM; Salmela, PI; Karppa, M; Majamaa-Voltti, KAM; Rusanen, H; Sorri, M; Peuhkurinen, KJ; Hassinen, IE				Majamaa, K; Moilanen, JS; Uimonen, S; Remes, AM; Salmela, PI; Karppa, M; Majamaa-Voltti, KAM; Rusanen, H; Sorri, M; Peuhkurinen, KJ; Hassinen, IE			Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER RNALEU(UUR) GENE; DIABETES-MELLITUS; POINT MUTATION; DNA; DISEASES; PHENOTYPE; ENCEPHALOPATHY; MYOPATHY; GENOTYPE; FINLAND	Mitochondrial diseases are characterized by considerable clinical variability and are most often caused by mutations in mtDNA. Because of the phenotypic variability, epidemiological studies of the frequency of these disorders have been difficult to perform. We studied the prevalence of the mtDNA mutation at nucleotide 3243 in an adult population of 245,201 individuals. This mutation is the most common molecular etiology of MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes), one of the clinical entities among the mitochondrial disorders. Patients with diabetes mellitus, sensorineural hearing impairment, epilepsy, occipital brain infarct, ophthalmoplegia, cerebral white-matter disease, basal-ganglia calcifications, hypertrophic cardiomyopathy, or ataxia were ascertained on the basis of defined clinical criteria and family-history data. A total of 615 patients were identified, and 480 samples were examined for the mutation. The mutation was found in 11 pedigrees, and its frequency was calculated to be greater than or equal to 16.3/100,000 in the adult population (95% confidence interval 11.3-21.4/100,000). The mutation had arisen in the population at least nine times, as determined by mtDNA haplotyping. Clinical evaluation of the probands revealed a syndrome that most frequently consisted of hearing impairment, cognitive decline, and short stature. The high prevalence of the common MELAS mutation in the adult population suggests that mitochondrial disorders constitute one of the largest diagnostic categories of neurogenetic diseases.	Oulu Univ, Dept Neurol, FIN-90220 Oulu, Finland; Oulu Univ, Dept Biochem Med, FIN-90220 Oulu, Finland; Oulu Univ, Dept Otorhinolaryngol, FIN-90220 Oulu, Finland; Oulu Univ, Dept Internal Med, FIN-90220 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Majamaa, K (corresponding author), Oulu Univ, Dept Neurol, Kajaanintie 52 A, FIN-90220 Oulu, Finland.		Majamaa, Kari/A-1344-2012; Moilanen, Jukka S/G-2604-2012	Moilanen, Jukka S/0000-0002-8041-3205; Majamaa, Kari/0000-0002-9070-3791				DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Hutchin TP, 1997, GENETICS, V145, P771; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; Liu VWS, 1997, HUM MUTAT, V9, P265, DOI 10.1002/(SICI)1098-1004(1997)9:3<265::AID-HUMU8>3.3.CO;2-6; Maassen JA, 1996, DIABETOLOGIA, V39, P375; Majamaa K, 1997, NEUROLOGY, V49, P1331, DOI 10.1212/WNL.49.5.1331; MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873; MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5; MORTEN KJ, 1995, HUM MOL GENET, V4, P1689; *NAWH NAT RES DEV, 1994, HEALTH, V2; NORIO R, 1973, ANN CLIN RES, V5, P109; PASSARINO G, 1993, AM J HUM GENET, V53, P609; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Shoffner JM, 1996, LANCET, V348, P1283, DOI 10.1016/S0140-6736(96)09138-6; Smith ML, 1997, J CLIN ENDOCR METAB, V82, P2826, DOI 10.1210/jc.82.9.2826; Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; Torroni A, 1996, GENETICS, V144, P1835; Tully G, 1996, GENOMICS, V34, P107, DOI 10.1006/geno.1996.0247; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wong LJC, 1997, CLIN CHEM, V43, P1241	29	264	278	1	23	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					447	454		10.1086/301959	http://dx.doi.org/10.1086/301959			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683591	Green Published, Bronze			2022-12-18	WOS:000075360800020
J	Cantagrel, V; Silhavy, JL; Bielas, SL; Swistun, D; Marsh, SE; Bertrand, JY; Audollent, S; Attie-Bitach, T; Holden, KR; Dobyns, WB; Traver, D; Al-Gazali, L; Ali, BR; Lindner, TH; Caspary, T; Otto, EA; Hildebrandt, F; Glass, IA; Logan, CV; Johnson, CA; Bennett, C; Brancati, F; Valente, EM; Woods, CG; Gleeson, JG				Cantagrel, Vincent; Silhavy, Jennifer L.; Bielas, Stephanie L.; Swistun, Dominika; Marsh, Sarah E.; Bertrand, Julien Y.; Audollent, Sophie; Attie-Bitach, Tania; Holden, Kenton R.; Dobyns, William B.; Traver, David; Al-Gazali, Lihadh; Ali, Bassam R.; Lindner, Tom H.; Caspary, Tamara; Otto, Edgar A.; Hildebrandt, Friedhelm; Glass, Ian A.; Logan, Clare V.; Johnson, Colin A.; Bennett, Christopher; Brancati, Francesco; Valente, Enza Maria; Woods, C. Geoffrey; Gleeson, Joseph G.		Int Joubert Syndrome Related Disor	Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME-RELATED DISORDERS; BASAL BODY PROTEIN; MOLAR TOOTH SIGN; SONIC HEDGEHOG; CENTROSOMAL PROTEIN; PROGENITOR POOL; RENAL SYNDROME; CEREBELLUM; FLAGELLAR; EXPANSION	Joubert syndrome US) and related disorders are a group of autosomal-recessive conditions sharing the "molar tooth sign" on axial brain MRI, together with cerebellar vermis hypoplasia, ataxia, and psychomotor delay. JS is suggested to be a disorder of cilia function and is part of a spectrum of disorders involving retinal, renal, digital, oral, hepatic, and cerebral organs. We identified mutations in ARL13B in two families with the classical form of JS. ARL13B belongs to the Ras GTPase family, and in other species is required for ciliogenesis, body axis formation, and renal function. The encoded Arl13b protein was expressed in developing murine cerebellum and localized to the cilia in primary neurons. Overexpression of human wild-type but not patient mutant ARL13B rescued the Arl13b scorpion zebrafish mutant. Thus, ARL13B has an evolutionarily conserved role mediating cilia function in multiple organs.	[Cantagrel, Vincent; Silhavy, Jennifer L.; Bielas, Stephanie L.; Swistun, Dominika; Marsh, Sarah E.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Neurogenet Lab, La Jolla, CA 92093 USA; [Bertrand, Julien Y.; Traver, David] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Audollent, Sophie; Attie-Bitach, Tania] Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France; [Audollent, Sophie; Attie-Bitach, Tania] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris 15, France; [Holden, Kenton R.] Greenwood Genet Ctr, Neurosci Sect, Greenwood, SC 29646 USA; [Holden, Kenton R.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Holden, Kenton R.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Dobyns, William B.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Ali, Bassam R.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Lindner, Tom H.] Univ Clin Leipzig, Dept Internal Med 3, Div Nephrol, D-04103 Leipzig, Germany; [Caspary, Tamara] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Glass, Ian A.] Univ Washington, Sch Med, Childrens Hosp Reg Med Ctr, Dept Pediat & Med, Seattle, WA 98105 USA; [Logan, Clare V.; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Bennett, Christopher] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [Brancati, Francesco; Valente, Enza Maria] Mendel Inst Med Genet & Twin Res, Inst Ricovero & Cura Carattere Sci, I-00198 Rome, Italy; [Woods, C. Geoffrey] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Greenwood Genetic Center; Medical University of South Carolina; Medical University of South Carolina; University of Chicago; United Arab Emirates University; United Arab Emirates University; Leipzig University; Emory University; University of Michigan System; University of Michigan; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Neurogenet Lab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Marsh, Sarah/E-9164-2010; woods, christopher g/A-1361-2010; Dobyns, William Brian/ABC-6525-2021; Caspary, Tamara/AAH-5625-2020; Ali, Bassam/J-7014-2012; Dobyns, William/AAI-2768-2020; Brancati, Francesco/AAC-3778-2022; ATTIE-BITACH, Tania/K-1453-2017; Valente, Enza Maria/G-2942-2017; Vincent, Cantagrel/H-8698-2017; BERTRAND, Julien/O-3655-2019	Caspary, Tamara/0000-0002-6579-7589; Dobyns, William/0000-0002-7681-2844; Brancati, Francesco/0000-0003-3624-2354; ATTIE-BITACH, Tania/0000-0002-1155-3626; Valente, Enza Maria/0000-0002-0600-6820; Vincent, Cantagrel/0000-0002-5180-4848; BERTRAND, Julien/0000-0001-6570-4082; Logan, Clare/0000-0003-4323-1602; Marsh, Sarah/0000-0003-4194-043X; Johnson, Colin/0000-0002-2979-8234; Bielas, Stephanie/0000-0003-0567-5632; Otto, Edgar/0000-0002-2387-9973; Ali, Bassam R/0000-0003-1306-6618	National Institutes of Health [N01-HG-65403]; NIH [R01-DK068306, R01-DK064614, R01-DK069272]; French Foundation for Medical Research (FRM); Neuroplasticity of Aging Postdoctoral Training Grant [T32 AG00216]; Cancer Research Institute; US National Institute of Neurological Disease and Stroke; Simons Foundation; Burroughs Wellcome Fund Award; UCSD Neurosciences Microscopy Core [P30 NS047101]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, R01DK064614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS052455, P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER; MRC [G9900837, G0700073, G9826762] Funding Source: UKRI; Medical Research Council [G9900837, G9826762, G0700073] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale); Neuroplasticity of Aging Postdoctoral Training Grant; Cancer Research Institute; US National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; Burroughs Wellcome Fund Award(Burroughs Wellcome Fund); UCSD Neurosciences Microscopy Core; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Marshfield Clinic Research Foundation and the US National Heart, Lung, and Blood Institute for genotyping support; the UCSD Neurosciences Microscopy Core for imaging (P30 NS047101); Jeong-Soo Lee (Dana Farber Cancer Institute) for the zebrafish arl13b clone; Mark Lawson (UCSD) for help with Sigma-Plot and statistical analysis; Daniel O'Connor (UCSD) for control DNA samples; and members of the Gleeson laboratory for helpful discussions. Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number N01-HG-65403. F.H. is supported by NIH grants R01-DK068306, ROI-DK064614, and R01-DK069272 and is a Doris Duke Distinguished Clinical Scientist. V.C. was supported by a French Foundation for Medical Research (FRM) fellowship. S.L.B. was supported by the Neuroplasticity of Aging Postdoctoral Training Grant (T32 AG00216). J.Y.B. was supported by the Irvington Institute Fellowship Program of the Cancer Research Institute. This work was supported by grants from the US National Institute of Neurological Disease and Stroke, the Simons Foundation, and the Burroughs Wellcome Fund Award in Translational Research (to J.G.G.). The authors report no conflict of interest.	Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Brancati F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Castori M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027375; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; DELCERRO MP, 1972, J COMP NEUROL, V144, P131, DOI 10.1002/cne.901440202; DELCERRO MP, 1969, ANAT RECORD, V165, P127, DOI 10.1002/ar.1091650202; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Haug K, 2000, AM J MED GENET, V91, P135, DOI 10.1002/(SICI)1096-8628(20000313)91:2<135::AID-AJMG11>3.0.CO;2-1; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KING MD, 1984, ARCH DIS CHILD, V59, P709, DOI 10.1136/adc.59.8.709; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Satran D, 1999, AM J MED GENET, V86, P459; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837, DOI 10.1091/mbc.10.6.1837; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VERLOES A, 1989, AM J MED GENET, V32, P227, DOI 10.1002/ajmg.1320320217; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zaki MS, 2008, NEUROLOGY, V70, P556, DOI 10.1212/01.wnl.0000277644.12087.fd; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P3965, DOI 10.1073/pnas.0637349100	60	263	267	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					170	179		10.1016/j.ajhg.2008.06.023	http://dx.doi.org/10.1016/j.ajhg.2008.06.023			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18674751	Green Published, Bronze			2022-12-18	WOS:000258418200002
J	Ridker, PM; Pare, G; Parker, A; Zee, RYL; Danik, JS; Buring, JE; Kwiatkowski, D; Cook, NR; Miletich, JP; Chasman, DI				Ridker, Paul M.; Pare, Guillaume; Parker, Alex; Zee, Robert Y. L.; Danik, Jacqueline S.; Buring, Julie E.; Kwiatkowski, David; Cook, Nancy R.; Miletich, Joseph P.; Chasman, Daniel I.			Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: The women's genome health study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E GENOTYPES; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; GENE POLYMORPHISMS; SOLUBLE RECEPTOR; CRP LEVELS; RISK; INTERLEUKIN-6; EVENTS; LEPTIN	Although elevated levels of C-reactive protein (CRP) independently predict increased risk of development of metabolic syndrome, diabetes, myocardial infarction, and stroke, comprehensive analysis of the influence of genetic variation on CRP is not available. To address this issue, we performed a genome-wide association study among 6345 apparently healthy women in which we evaluated 336,108 SNPs as potential determinants of plasma CRP concentration. Overall, seven loci that associate with plasma CRP at levels achieving genome-wide statistical significance were found (range of p values for lead SNPs within the seven loci: 1.9 x 10(-8) to 6.2 x 10(-28)). Two of these loci (GCKR and HNF1A) are suspected or known to be associated with maturity-onset diabetes of the young, one is a gene-desert region on 12q23.2, and the remaining four loci are in or near the leptin receptor protein gene, the apolipoprotein E gene, the interleukin-6 receptor protein gene, or the CRP gene itself. The protein products of six of these seven loci are directly involved in metabolic syndrome, insulin resistance, beta cell function, weight homeostasis, and/or premature atherothrombosis. Thus, common variation in several genes involved in metabolic and inflammatory regulation have significant effects on CRP levels, consistent with CRP's identification as a useful biomarker of risk for incident vascular disease and diabetes.	[Ridker, Paul M.; Pare, Guillaume; Zee, Robert Y. L.; Danik, Jacqueline S.; Buring, Julie E.; Cook, Nancy R.; Chasman, Daniel I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Ridker, Paul M.; Zee, Robert Y. L.; Danik, Jacqueline S.; Kwiatkowski, David; Cook, Nancy R.; Chasman, Daniel I.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02115 USA; [Parker, Alex; Miletich, Joseph P.] Amgen Inc, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Amgen	Ridker, PM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA.	pridker@partners.org	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760; Venkatasubramanian, Siddharth/0000-0002-5860-0768				Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Chasman DI, 2006, GENES IMMUN, V7, P211, DOI 10.1038/sj.gene.6364289; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016; Judson R, 2004, ATHEROSCLEROSIS, V177, P345, DOI 10.1016/j.atherosclerosis.2004.07.012; Kado S, 1999, ACTA DIABETOL, V36, P67, DOI 10.1007/s005920050147; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sima A, 2007, CLIN CHEM LAB MED, V45, P1149, DOI 10.1515/CCLM.2007.258; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; TONIATTI C, 1990, EMBO J, V9, P4467, DOI 10.1002/j.1460-2075.1990.tb07897.x; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Zhang YY, 2007, ATHEROSCLEROSIS, V191, P121, DOI 10.1016/j.atherosclerosis.2006.02.043	33	263	265	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1185	1192		10.1016/j.ajhg.2008.03.015	http://dx.doi.org/10.1016/j.ajhg.2008.03.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439548	Bronze, Green Published			2022-12-18	WOS:000255923600019
J	Cichon, S; Martin, L; Hennies, HC; Mueller, F; Van Driessche, K; Karpushova, A; Stevens, W; Colombo, R; Renne, T; Drouet, C; Bork, K; Nothen, MM				Cichon, Sven; Martin, Ludovic; Hennies, Hans Christian; Mueller, Felicitas; Van Driessche, Karen; Karpushova, Anna; Stevens, Wim; Colombo, Roberto; Renne, Thomas; Drouet, Christian; Bork, Konrad; Noethen, Markus M.			Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORMAL C1-INHIBITOR; FRENCH-CANADIANS; C1 INHIBITOR; HUMAN GENOME; MUTATIONS; GENE; POPULATIONS; ACTIVATION; PLASMA; SYSTEM	Hereditary angioedema (HAE) is characterized clinically by recurrent acute skin swelling, abdominal pain, and potentially life-threatening laryngeal edema. Three forms of HAE have been described. The classic forms, HAE types I and II, occur as a consequence of mutations in the C1-inhibitor gene. In contrast to HAE types I and II, HAE type III has been observed exclusively in women, where it appears to be correlated with conditions of high estrogen levels - for example, pregnancy or the use of oral contraceptives. A recent report proposed two missense mutations (c.1032C -> A and c. 1032C -> G) in F12, the gene encoding human coagulation factor XII (FXII, or Hageman factor) as a possible cause of HAE type III. Here, we report the occurrence of the c.1032C -> A (p.Thr328Lys) mutation in an HAE type III - affected family of French origin. Investigation of the F12 gene in a large German family did not reveal a coding mutation. Haplotype analysis with use of microsatellite markers is compatible with locus heterogeneity in HAE type III. To shed more light on the pathogenic relevance of the HAE type III-associated p. Thr328Lys mutation, we compared FXII activity and plasma levels in patients carrying the mutation with that of healthy control individuals. Our data strongly suggest that p. Thr328Lys is a gain-of-function mutation that markedly increases FXII amidolytic activity but that does not alter FXII plasma levels. We conclude that enhanced FXII enzymatic plasma activity in female mutation carriers leads to enhanced kinin production, which results in angioedema. Transcription of F12 is positively regulated by estrogens, which may explain why only women are affected with HAE type III. The results of our study represent an important step toward an understanding of the molecular processes involved in HAE type III and provide diagnostic and possibly new therapeutic opportunities.	Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; Hop Porte Madeleine, Dept Dermatol, Orleans, France; Univ Cologne, Cologne Ctr Genom, D-5000 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-5000 Cologne 41, Germany; Univ Wurzburg, Inst Clin Chem & Pathobiochem, D-97070 Wurzburg, Germany; Univ Antwerp, Dept Immunol, B-2020 Antwerp, Belgium; Univ Sacred Heart, Lab Human Mol Biol & Genet, I-20123 Milan, Italy; Univ Grenoble 1, Immunol Lab, Grenoble, France; CHU Grenoble, F-38043 Grenoble, France; Univ Mainz, Dept Dermatol, D-6500 Mainz, Germany	University of Bonn; University of Bonn; Centre Hospitalier Regional d'Orleans; University of Cologne; University of Cologne; University of Wurzburg; University of Antwerp; Catholic University of the Sacred Heart; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Johannes Gutenberg University of Mainz	Cichon, S (corresponding author), Univ Bonn, Life & Brain Ctr, Dept Genom, Sigmund Freud Str 25, D-53127 Bonn, Germany.	sven.cichon@uni-bonn.de	DROUET, Christian/J-8775-2019; Hennies, Hans C/G-9424-2014; DROUET, Christian/AAE-5682-2020; Nöthen, Markus/B-2027-2009; Bork, Konrad/AAE-4985-2022; Cichon, Sven/H-8803-2013; Cichon, Sven/B-9618-2014	DROUET, Christian/0000-0003-1318-4278; Hennies, Hans C/0000-0001-7210-2389; DROUET, Christian/0000-0003-1318-4278; Nöthen, Markus/0000-0002-8770-2464; Bork, Konrad/0000-0002-6084-4577; Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Renne, Thomas/0000-0003-4594-5975				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Binkley KE, 2000, J ALLERGY CLIN IMMUN, V106, P546; Bork K, 2006, BRIT J DERMATOL, V154, P542, DOI 10.1111/j.1365-2133.2005.07048.x; Bork K, 2000, LANCET, V356, P213, DOI 10.1016/S0140-6736(00)02483-1; Bowen B, 2001, CLIN IMMUNOL, V98, P157, DOI 10.1006/clim.2000.4947; Cicardi M, 1999, AM J MED, V106, P650, DOI 10.1016/S0002-9343(99)00123-0; Citarella F, 1996, EUR J BIOCHEM, V238, P240, DOI 10.1111/j.1432-1033.1996.0240q.x; COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326; Dewald G, 2006, BIOCHEM BIOPH RES CO, V343, P1286, DOI 10.1016/j.bbrc.2006.03.092; FARSETTI A, 1995, ENDOCRINOLOGY, V136, P5076, DOI 10.1210/en.136.11.5076; Gupta S, 2004, ALLERGY, V59, P557, DOI 10.1111/j.1398-9995.2004.00428.x; HOJIMA Y, 1984, BLOOD, V63, P1453; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Labuda M, 1996, AM J HUM GENET, V59, P633; Luria SE, 1943, GENETICS, V28, P491; Martin L, 2001, J ALLERGY CLIN IMMUN, V107, P747, DOI 10.1067/mai.2001.114242; Nussberger J, 2002, NEW ENGL J MED, V347, P621, DOI 10.1056/NEJM200208223470820; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; REICH DE, 1999, MICROSATELLITES EVOL, P129; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Tosi M, 1998, IMMUNOBIOLOGY, V199, P358, DOI 10.1016/S0171-2985(98)80040-5; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	27	263	274	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1098	1104		10.1086/509899	http://dx.doi.org/10.1086/509899			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186468	Green Published, Bronze			2022-12-18	WOS:000242131600011
J	Nolin, SL; Brown, WT; Glicksman, A; Houck, GE; Gargano, AD; Sullivan, A; Biancalana, V; Brondum-Nielsen, K; Hjalgrim, H; Holinski-Feder, E; Kooy, F; Longshore, J; Macpherson, J; Mandel, JL; Matthijs, G; Rousseau, F; Steinbach, P; Vaisanen, ML; von Koskull, H; Sherman, SL				Nolin, SL; Brown, WT; Glicksman, A; Houck, GE; Gargano, AD; Sullivan, A; Biancalana, V; Brondum-Nielsen, K; Hjalgrim, H; Holinski-Feder, E; Kooy, F; Longshore, J; Macpherson, J; Mandel, JL; Matthijs, G; Rousseau, F; Steinbach, P; Vaisanen, ML; von Koskull, H; Sherman, SL			Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FMR1 GENE; CLINICAL PHENOTYPE; DELETION; INSTABILITY; MUTATION; IDENTIFICATION; METHYLATION; POPULATION; PREVALENCE; DIAGNOSIS	The CGG repeat in the 5 untranslated region of the fragile X mental retardation 1 gene (FMR1) exhibits remarkable instability upon transmission from mothers with premutation alleles. A collaboration of 13 laboratories in eight countries was established to examine four issues concerning FMR1 CGG-repeat instability among females with premutation (similar to55-200 repeats) and intermediate (similar to46-60 repeats) alleles. Our central findings were as follows: (1) The smallest premutation alleles that expanded to a full mutation (>200 repeats) in one generation contained 59 repeats; sequence analysis of the 59-repeat alleles from these two females revealed no AGG interruptions within the FMR1 CGG repeat. (2) When we corrected for ascertainment and recalculated the risks of expansion to a full mutation, we found that the risks for premutation alleles with <100 repeats were lower than those previously published. (3) When we examined the possible influence of sex of offspring on transmission of a full mutation-by analysis of 567 prenatal fragile X studies of 448 mothers with premutation and full-mutation alleles-we found no significant differences in the proportion of full-mutation alleles in male or female fetuses. (4) When we examined 136 transmissions of intermediate alleles from 92 mothers with no family history of fragile X, we found that, in contrast to the instability observed in families with fragile X, most (99/136 [72.8%]) transmissions of intermediate alleles were stable. The unstable transmissions (37/136 [27.2%]) in these families included both expansions and contractions in repeat size. The instability increased with the larger intermediate alleles (19% for 49-54 repeats, 30.9% for 55-59, and 80% for 60-65 repeats). These studies should allow improved risk assessments for genetic counseling of women with premutation or intermediate-size alleles.	New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Fac Med Strasbourg, Lab Diagnost Genet, Strasbourg, France; Ctr Hosp Reg Univ, Strasbourg, France; John F Kennedy Inst, DK-2600 Glostrup, Denmark; Univ Munich, Abt Med Genet, Munich, Germany; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Wessex Reg Genet Lab, Salisbury, Wilts, England; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Laval, Quebec City, PQ, Canada; Univ Ulm, Abt Humangenet, Ulm, Germany; Oulu Univ Hosp, Dept Clin Genet, Oulu, Finland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland	Institute for Basic Research in Developmental Disabilities; Emory University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; University of Munich; University of Antwerp; Greenwood Genetic Center; Universite Catholique Louvain; Laval University; Ulm University; University of Oulu; University of Helsinki; Helsinki University Central Hospital	Nolin, SL (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Human Genet, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.		Brown, William/GXN-2777-2022; Kooy, Frank/F-5276-2014; Biancalana, Valerie/O-2351-2016; Mandel, Jean Louis/Q-2668-2016	Kooy, Frank/0000-0003-2024-0485; Mandel, Jean Louis/0000-0002-0535-6589; Matthijs, Gert/0000-0001-6710-1912	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029909] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29909, R01 HD029909] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ashley-Koch AE, 1998, AM J HUM GENET, V63, P776, DOI 10.1086/302018; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brown WT, 1996, AM J MED GENET, V64, P287, DOI 10.1002/(SICI)1096-8628(19960809)64:2<287::AID-AJMG11>3.0.CO;2-B; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Crawford DC, 2002, AM J MED GENET, V110, P226, DOI 10.1002/ajmg.10427; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HIRST M, 1995, AM J HUM GENET, V56, P67; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LEVINSON G, 1994, AM J MED GENET, V51, P527, DOI 10.1002/ajmg.1320510448; LOESCH DZ, 1995, AM J HUM GENET, V57, P1408; MEIJER H, 1994, HUM MOL GENET, V3, P615; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; Nolin SL, 1996, AM J HUM GENET, V59, P1252; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Parvari R, 1999, AM J MED GENET, V83, P302, DOI 10.1002/(SICI)1096-8628(19990402)83:4<302::AID-AJMG13>3.0.CO;2-P; Pesso R, 2000, PRENATAL DIAG, V20, P611, DOI 10.1002/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; QUAN F, 1995, AM J HUM GENET, V56, P1042; Rousseau F., 1994, American Journal of Human Genetics, V55, pA240; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; Sullivan AK, 2002, AM J HUM GENET, V70, P1532, DOI 10.1086/340846; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Toledano-Alhadef H, 2001, AM J HUM GENET, V69, P351, DOI 10.1086/321974; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VAISANEN ML, 1994, HUM GENET, V93, P143; VANDENOUWELAND AMW, 1994, HUM MOL GENET, V3, P1823, DOI 10.1093/hmg/3.10.1823; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VITS L, 1994, HUM GENET, V94, P523, DOI 10.1007/BF00211019; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; ZHONG N, 1995, AM J HUM GENET, V57, P351	39	263	277	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					454	464		10.1086/367713	http://dx.doi.org/10.1086/367713			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12529854	Bronze, Green Published			2022-12-18	WOS:000180680000025
J	van Bokhoven, H; Hamel, BCJ; Bamshad, M; Sangiorgi, E; Gurrieri, F; Duijf, PHG; Vanmolkot, KRJ; van Beusekom, E; van Beersum, SEC; Celli, J; Merkx, GFM; Tenconi, R; Fryns, JP; Verloes, A; Newbury-Ecob, RA; Raas-Rotschild, A; Majewski, F; Beemer, FA; Janecke, A; Chitayat, D; Crisponi, G; Kayserili, H; Yates, JRW; Neri, G; Brunner, HG				van Bokhoven, H; Hamel, BCJ; Bamshad, M; Sangiorgi, E; Gurrieri, F; Duijf, PHG; Vanmolkot, KRJ; van Beusekom, E; van Beersum, SEC; Celli, J; Merkx, GFM; Tenconi, R; Fryns, JP; Verloes, A; Newbury-Ecob, RA; Raas-Rotschild, A; Majewski, F; Beemer, FA; Janecke, A; Chitayat, D; Crisponi, G; Kayserili, H; Yates, JRW; Neri, G; Brunner, HG			p63 gene mutations in EEC syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P53 HOMOLOG; MISSENSE MUTATIONS; CELL-LINES; CHROMOSOME; DOMINANT; HOTSPOTS; DEFECTS; CANCER; MAPS; 5-METHYLCYTOSINE	p63 mutations have been associated with EEC syndrome (ectrodactyly, ectodermal dysplasia, and cleft lip/palate), as well as with nonsyndromic split hand-split foot malformation (SHFM). We performed p63 mutation analysis in a sample of 43 individuals and families affected with EEC syndrome, in 35 individuals affected with SHFM, and in three families with the EEC-like condition limb-mammary syndrome (LMS), which is characterized by ectrodactyly, cleft palate, and mammary-gland abnormalities. The results differed for these three conditions. p63 gene mutations were detected in almost all (40/43) individuals affected with EEC syndrome. Apart from a frameshift mutation in exon 13, all other EEC mutations were missense, predominantly involving codons 204, 227, 279, 280, and 304. In contrast, p63 mutations were detected in only a small proportion (4/35) of patients with isolated SHFM. p63 mutations in SHFM included three novel mutations: a missense mutation (K193E), a nonsense mutation (Q634X), and a mutation in the 3' splice site for exon 5. The fourth SHFM mutation (R280H) in this series was also found in a patient with classical EEC syndrome, suggesting partial overlap between the EEC and SHFM mutational spectra. The original family with LMS (van Bokhoven et al. 1999) had no detectable p63 mutation, although it clearly localizes to the p63 locus in 3q27. In two other small kindreds affected with LMS, frameshift mutations were detected in exons 13 and 14, respectively. The combined data show that p63 is the major gene for EEC syndrome, and that it makes a modest contribution to SHFM. There appears to be a genotype-phenotype correlation, in that there is a specific pattern of missense mutations in EEC syndrome that are not generally found in SHFM or LMS.	Univ Nijmegen, Med Ctr, Dept Human Genet, Univ Med Ctr 417, NL-6500 HB Nijmegen, Netherlands; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT USA; Shriners Hosp Children, Intermt Unit, Salt Lake City, UT USA; Univ Cattolica Sacro Cuore, Fac Med, Ist Genet Med, Rome, Italy; Univ Padua, Dept Pediat, Clin Genet Serv, Padua, Italy; Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Liege, Wallonia Ctr Human Genet, Liege, Belgium; Bristol Royal Hosp Sick Children, Clin Genet Serv, Bristol, Avon, England; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel; Univ Dusseldorf, Inst Human Genet, D-4000 Dusseldorf, Germany; Univ Utrecht, Med Ctr, Dept Med Genet, Utrecht, Netherlands; Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; Univ Cagliari, Dipartimento Chim Inorgan & Analit, Monserrato, Italy; Istanbul Fac Med, Dept Pediat, Div Med Genet, Istanbul, Turkey; Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England	Radboud University Nijmegen; Utah System of Higher Education; University of Utah; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua; KU Leuven; University Hospital Leuven; University of Liege; Bristol Royal Hospital For Children; Hebrew University of Jerusalem; Hadassah University Medical Center; Heinrich Heine University Dusseldorf; Utrecht University; University of Innsbruck; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Cagliari; Istanbul University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	van Bokhoven, H (corresponding author), Univ Nijmegen, Med Ctr, Dept Human Genet, Univ Med Ctr 417, POB 9101, NL-6500 HB Nijmegen, Netherlands.	H.vanbokhoven@ANTRG.AZN.NL	Kayserili, Hülya/AAA-5593-2021; Sangiorgi, Eugenio/AAP-9836-2020; Duijf, Pascal H.G./E-7110-2012; /AAK-8500-2021; Janecke, Andreas/AAA-5227-2019; van Bokhoven, Hans/D-8764-2012; van Beusekom, Ellen/AAF-2687-2019; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013; Gurrieri, Fiorella/K-3214-2016; van Beersum, Sylvia E.C./P-8653-2015; VERLOES, Alain/E-7287-2014	Kayserili, Hülya/0000-0003-0376-499X; Sangiorgi, Eugenio/0000-0001-9079-9175; Duijf, Pascal H.G./0000-0001-8646-9843; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Gurrieri, Fiorella/0000-0002-6775-5972; van Beersum, Sylvia E.C./0000-0002-4552-2908; Janecke, Andreas/0000-0001-7155-0315; VERLOES, Alain/0000-0003-4819-0264				BELLUS GA, 1995, AM J HUM GENET, V56, P368; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chitayat D, 1996, AM J MED GENET, V61, P45, DOI 10.1002/(SICI)1096-8628(19960102)61:1<45::AID-AJMG9>3.0.CO;2-W; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; CZEIZEL AE, 1993, J MED GENET, V30, P593, DOI 10.1136/jmg.30.7.593; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; EVANS JA, 1994, AM J MED GENET, V49, P52, DOI 10.1002/ajmg.1320490111; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Gorlin RJ, 1990, PLAST RECONSTR SURG; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Hagiwara K, 1999, CANCER RES, V59, P4165; HAQUE MFU, 1993, HUM GENET, V91, P17; HAY RJ, 1976, BRIT J DERMATOL, V94, P277, DOI 10.1111/j.1365-2133.1976.tb04384.x; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; HOLLISTER DW, 1973, J PEDIATR-US, V83, P438, DOI 10.1016/S0022-3476(73)80268-9; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; NUNES ME, 1995, HUM MOL GENET, V4, P2165, DOI 10.1093/hmg/4.11.2165; O'Quinn JR, 1998, AM J HUM GENET, V62, P130, DOI 10.1086/301687; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; PROPPING P, 1993, AM J MED GENET, V45, P642, DOI 10.1002/ajmg.1320450525; RaasRothschild A, 1996, J MED GENET, V33, P996, DOI 10.1136/jmg.33.12.996; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; RODINI ESO, 1990, AM J MED GENET, V37, P42, DOI 10.1002/ajmg.1320370112; Roelfsema NM, 1996, CLIN DYSMORPHOL, V5, P115, DOI 10.1097/00019605-199604000-00003; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHECHTMAN M, 1994, PHILOS PSYCHOL, V7, P3, DOI 10.1080/09515089408573107; Senoo M, 1998, BIOCHEM BIOPH RES CO, V248, P603, DOI 10.1006/bbrc.1998.9013; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; SUIJKERBUIJK RF, 1991, AM J HUM GENET, V48, P269; Tartaglia M, 1997, HUM GENET, V101, P47, DOI 10.1007/s004390050584; TORNALETTI S, 1994, SCIENCE, V263, P1436, DOI 10.1126/science.8128225; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; van Bokhoven H, 1999, AM J HUM GENET, V64, P538, DOI 10.1086/302246; WAYE JS, 1989, CHROMOSOMA, V97, P475, DOI 10.1007/BF00295032; WITTERS I, IN PRESS PRENATAL DI; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	46	263	272	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					481	492		10.1086/323123	http://dx.doi.org/10.1086/323123			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11462173	Green Published, Bronze			2022-12-18	WOS:000170271400002
J	Ober, C; Weitkamp, LR; Cox, N; Dytch, H; Kostyu, D; Elias, S				Ober, C; Weitkamp, LR; Cox, N; Dytch, H; Kostyu, D; Elias, S			HLA and mate choice in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY TYPES; MATING PREFERENCES; MOUSE STRAINS; MICE; HUTTERITES; ISOLATE; RECOGNITION; COMPLEX; LOCUS	Evidence from studies in rodents suggests that mate selection is influenced by major-histocompatibility-complex haplotypes, with preferences for dissimilar partners. This study was initiated to determine whether avoidance of a mate with the same HLA haplotype as one's own might be occurring in the Hutterites, a North American reproductive isolate of European ancestry, notable for their large sibships, communal lifestyle, and limited number of five-locus HLA haplotypes (HLA-A, -B, -C, -DR, and -DQ). HLA haplotypes were known for 411 Hutterite couples. The number of couples expected to match for a haplotype was calculated in two ways: first, from population genotype frequencies, with account being taken of the nonrandom mating pattern with respect to colony lineages, and, second, from computer simulations using conservative founder assumptions and the exact genealogy of the 411 couples. We observed fewer matches for HLA haplotypes between spouses than expected (first method, P =.005; second method, P =.020-.067). Among couples who did match for a haplotype, the matched haplotype was inherited from the mother in 29 cases and from the father in 50 cases (P =.018). These results are consistent with the conclusion that Hutterite mate choice is influenced by HLA haplotypes, with an avoidance of spouses with haplotypes that are the same as one's own.	UNIV CHICAGO, DEPT MED, CHICAGO, IL 60637 USA; UNIV ROCHESTER, MED CTR, DEPT PSYCHIAT, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, MED CTR, DIV GENET, ROCHESTER, NY 14642 USA; DUKE UNIV, MED CTR, DEPT IMMUNOL, DURHAM, NC 27706 USA; BAYLOR COLL MED, DEPT OBSTET & GYNECOL, HOUSTON, TX 77030 USA	University of Chicago; University of Rochester; University of Rochester; Duke University; Baylor College of Medicine	Ober, C (corresponding author), UNIV CHICAGO, CTR MED GENET, DEPT OBSTET & GYNECOL, 924 E 57TH ST, CHICAGO, IL 60637 USA.				NICHD NIH HHS [R01 HD021244, HD21244] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEAUCHAMP GK, 1985, P NATL ACAD SCI USA, V82, P4186, DOI 10.1073/pnas.82.12.4186; Bleibtreu H., 1964, THESIS HARVARD U CAM; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; DAWSON DV, 1995, GENET EPIDEMIOL, V12, P47, DOI 10.1002/gepi.1370120106; EGID K, 1989, ANIM BEHAV, V38, P548, DOI 10.1016/S0003-3472(89)80051-X; GILBERT AN, 1986, J COMP PSYCHOL, V100, P262, DOI 10.1037/0735-7036.100.3.262; Hostetler J, 1974, HUTTERITE SOC; JIN K, 1995, BIOMETRICS, V51, P1064, DOI 10.2307/2533005; KOSTYU DD, 1989, AM J HUM GENET, V45, P261; KOSTYU DD, 1993, HUM IMMUNOL, V37, P135, DOI 10.1016/0198-8859(93)90178-4; MANGE AP, 1964, HUM BIOL, V36, P104; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; OBER C, 1992, AM J HUM GENET, V50, P6; OBER C, 1995, PLACENTA, V16, P569, DOI 10.1016/0143-4004(95)90026-8; OBRIEN E, 1987, MAMMALIAN DISPERSAL, P193; POLLACK MS, 1982, IMMUNOGENETICS, V15, P579; PORTER RH, 1990, CHEM SIGNAL, V5, P289; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; ROSENBERG LT, 1983, IMMUNOGENETICS, V17, P89, DOI 10.1007/BF00364292; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; VOGEL F, 1996, HUMAN GENETICS; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1979, J EXP MED, V150, P755, DOI 10.1084/jem.150.4.755; YAMAZAKI K, 1990, CHEM SIGNAL, V5, P255; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818; YAMAZAKI K, 1978, IMMUNOGENETICS, V6, P253, DOI 10.1007/BF01563915	28	263	277	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					497	504		10.1086/515511	http://dx.doi.org/10.1086/515511			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326314	Green Published, hybrid			2022-12-18	WOS:A1997XY52300006
J	Kleefstra, T; Brunner, HG; Amiel, J; Oudakker, AR; Nillesen, WM; Magee, A; Genevieve, D; Cormier-Daire, V; van Esch, H; Fryns, JP; Hamel, BCJ; Sistermans, EA; de Vries, BBA; van Bokhoven, H				Kleefstra, Tjitske; Brunner, Han G.; Amiel, Jeanne; Oudakker, Astrid R.; Nillesen, Willy M.; Magee, Alex; Genevieve, David; Cormier-Daire, Valerie; van Esch, Hilde; Fryns, Jean-Pierre; Hamel, Ben C. J.; Sistermans, Erik A.; de Vries, Bert B. A.; van Bokhoven, Hans			Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; DEPENDENT PROBE AMPLIFICATION; HISTONE LYSINE METHYLATION; CHROMOSOME 9Q; GENE; METHYLTRANSFERASE; G9A; REARRANGEMENTS; FEATURES; PATIENT	A clinically recognizable 9q subtelomeric deletion syndrome has recently been established. Common features seen in these patients are severe mental retardation, hypotonia, brachycephaly, flat face with hypertelorism, synophrys, anteverted nares, cupid bow or tented upper lip, everted lower lip, prognathism, macroglossia, conotruncal heart defects, and behavioral problems. The minimal critical region responsible for this 9q subtelomeric deletion (9q(-)) syndrome has been estimated to be < 1 Mb and comprises the euchromatin histone methyl transferase 1 gene (EHMT1). Previous studies suggested that haploinsufficiency for EHMT1 is causative for 9q subtelomeric deletion syndrome. We have performed a comprehensive mutation analysis of the EHMT1 gene in 23 patients with clinical presentations reminiscent of 9q subtelomeric deletion syndrome. This analysis revealed three additional microdeletions that comprise the EHMT1 gene, including one interstitial deletion that reduces the critical region for this syndrome. Most importantly, we identified two de novo mutations-a nonsense mutation and a frameshift mutation-in the EHMT1 gene in patients with a typical 9q(-) phenotype. These results establish that haploinsufficiency of EHMT1 is causative for 9q subtelomeric deletion syndrome.	Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; Belfast City Hosp, Reg Genet Serv, Belfast BT9 7AD, Antrim, North Ireland; Hop Necker Enfants Malad, Dept Human Genet, Paris, France	Radboud University Nijmegen; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Belfast City Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Kleefstra, T (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, 849,POB 9101, NL-6500 HB Nijmegen, Netherlands.	T.Kleefstra@antrg.umcn.nl	Kleefstra, Tjitske/G-2619-2012; Van+Esch, Hilde/AAU-5688-2020; van Bokhoven, Hans/D-8764-2012; Oudakker, Astrid/AAB-7890-2019; amiel, jeanne/H-3501-2017; Sistermans, Erik/B-1109-2009; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013; amiel, jeanne/AGX-1124-2022; cormier-daire, valerie/H-6520-2017	amiel, jeanne/0000-0001-5973-4728; Sistermans, Erik/0000-0001-7187-4563; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; cormier-daire, valerie/0000-0002-2839-9856; Van Esch, Hilde/0000-0002-9604-5726				Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Harada N, 2004, J HUM GENET, V49, P440, DOI 10.1007/s10038-004-0166-z; Harada N, 2004, J MED GENET, V41, P130, DOI 10.1136/jmg.2003.014639; Iwakoshi M, 2004, AM J MED GENET A, V126A, P278, DOI 10.1002/ajmg.a.20602; Kleefstra T, 2006, AM J MED GENET A, V140A, P618, DOI 10.1002/ajmg.a.31123; Kleefstra T, 2005, J MED GENET, V42, P299, DOI 10.1136/jmg.2004.028464; Kleefstra T, 2004, J MED GENET, V41, P394, DOI 10.1136/jmg.2003.016972; Koolen DA, 2004, J MED GENET, V41, P892, DOI 10.1136/jmg.2004.023671; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lugtenberg D, 2006, AM J HUM GENET, V78, P265, DOI 10.1086/500306; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Neas KR, 2005, AM J MED GENET A, V132A, P425, DOI 10.1002/ajmg.a.30496; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; RAVNAN JB, 2005, J MED GENET; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Stewart DR, 2004, AM J MED GENET A, V128A, P340, DOI 10.1002/ajmg.a.30136; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200; Yatsenko SA, 2005, J MED GENET, V42, P328, DOI 10.1136/jmg.2004.028258	28	262	273	0	17	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					370	377		10.1086/505693	http://dx.doi.org/10.1086/505693			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826528	Bronze, Green Published			2022-12-18	WOS:000239040400019
J	Rivera, A; White, K; Stohr, H; Steiner, K; Hemmrich, N; Grimm, T; Jurklies, B; Lorenz, B; Scholl, HPN; Apfelstedt-Sylla, E; Weber, BHF				Rivera, A; White, K; Stohr, H; Steiner, K; Hemmrich, N; Grimm, T; Jurklies, B; Lorenz, B; Scholl, HPN; Apfelstedt-Sylla, E; Weber, BHF			A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNDUS FLAVIMACULATUS; RETINITIS-PIGMENTOSA; TRANSPORTER GENE; DYSTROPHY; MUTATIONS; ELECTROPHORESIS; CLASSIFICATION; MACULOPATHY; PHENOTYPE; MEMBRANE	Stargardt disease (STGD) is a common autosomal recessive maculopathy of early and young-adult onset and is caused by alterations in the gene encoding the photoreceptor-specific ATP-binding cassette (ABC) transporter (ABCA4). We have studied 144 patients with STGD and 220 unaffected individuals ascertained from the German population, to complete a comprehensive, population-specific survey of the sequence variation in the ABCA4 gene. In addition, we have assessed the proposed role for ABCA4 in age-related macular degeneration (AMD), a common cause of late-onset blindness, by studying 200 affected individuals with late-stage disease. Using a screening strategy based primarily on denaturing gradient gel electrophoresis, me have identified in the three study groups a total of 127 unique alterations, of which 90 have not been previously reported, and have classified 72 as probable pathogenic mutations. Of the 288 STGD chromosomes studied, mutations were identified in 166, resulting in a detection rate of similar to 58%. Eight different alleles account for 61% of the identified disease alleles, and at least one of these, the L541P-A1038V complex allele, appears to be a founder mutation in the German population. When the group with AMD and the control group were analyzed with the same methodology, 18 patients with AMD and 12 controls were found to harbor possible disease-associated alterations. This represents no significant difference between the two groups; however, for detection of modest effects of rare alleles in complex diseases, the analysis of larger cohorts of patients may be required.	Univ Wurzburg, Inst Humangenet, Biozentrum, D-97074 Wurzburg, Germany; Augenklin, Essen, Germany; Univ Regensburg, Klinikum, D-8400 Regensburg, Germany; Univ Tubingen, Augenklin, D-7400 Tubingen, Germany	University of Wurzburg; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Weber, BHF (corresponding author), Univ Wurzburg, Inst Humangenet, Biozentrum, Hubland, D-97074 Wurzburg, Germany.			Weber, Bernhard H.F./0000-0002-8808-7723				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; CIBIS GW, 1980, ARCH OPHTHALMOL-CHIC, V98, P1785; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; DEAN M, 1998, SCIENCE, V279, pA1107; Dryja T. P., 1998, SCIENCE, V279; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; KLAVER CCW, 1998, SCIENCE, V279, P1107; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kniazeva M, 1999, AM J HUM GENET, V64, P1394, DOI 10.1086/302377; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Liu WG, 1998, NUCLEIC ACIDS RES, V26, P1396, DOI 10.1093/nar/26.6.1396; Lois N, 1999, INVEST OPHTH VIS SCI, V40, P2668; LOPEZ PF, 1990, OPHTHALMOLOGY, V97, P798; MANSOUR AM, 1992, OPHTHALMOLOGICA, V205, P138, DOI 10.1159/000310329; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Papaioannou M, 2000, INVEST OPHTH VIS SCI, V41, P16; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Simonelli F, 2000, INVEST OPHTH VIS SCI, V41, P892; Souied EH, 2000, INVEST OPHTH VIS SCI, V41, P244; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035	38	262	273	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					800	813		10.1086/303090	http://dx.doi.org/10.1086/303090			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10958763	Bronze, Green Published			2022-12-18	WOS:000089651100004
J	TORRONI, A; LOTT, MT; CABELL, MF; CHEN, YS; LAVERGNE, L; WALLACE, DC				TORRONI, A; LOTT, MT; CABELL, MF; CHEN, YS; LAVERGNE, L; WALLACE, DC			MTDNA AND THE ORIGIN OF CAUCASIANS - IDENTIFICATION OF ANCIENT CAUCASIAN-SPECIFIC HAPLOGROUPS, ONE OF WHICH IS PRONE TO A RECURRENT SOMATIC DUPLICATION IN THE D-LOOP REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ENDONUCLEASE CLEAVAGE PATTERNS; HEREDITARY OPTIC NEUROPATHY; BASE PAIR RECOGNITION; PAPUA-NEW-GUINEA; RESTRICTION ENZYMES; NONCODING REGION; POPULATION-DATA; HUMAN-EVOLUTION; COMPLEX-I	mtDNA sequence variation was examined in 175 Caucasians from the United States and Canada by PCR amplification and high-resolution restriction-endonuclease analysis. The majority of the Caucasian mtDNAs were subsumed within four mtDNA lineages (haplogroups) defined by mutations that are rarely seen in Africans and Mongoloids. The sequence divergence of these haplogroups indicates that they arose early in Caucasian radiation and gave raise to modern European mtDNAs. Although ancient, none of these haplogroups is old enough to be compatible with a Neanderthal origin, suggesting that Home sapiens sapiens displaced H. s. neanderthaliensis, rather than mixed with it. The mtDNAs of one of these haplogroups have a unique homoplasmic insertion between nucleotide pair (np) 573 and np 574, within the D-loop control region. This insertion makes these mtDNAs prone to a somatic mutation that duplicates a 270-bp portion of the D-loop region between np 309 and np 572. This finding suggests that certain nonpathogenic mtDNA mutations could predispose individuals to mtDNA rearrangements.	EMORY UNIV, SCH MED, DEPT MED & MOLEC GENET, ATLANTA, GA 30322 USA; MINIST SECURITE PUBL, DIRECT EXPERTISES JUDICLARES, MONTREAL, PQ, CANADA	Emory University			Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; Lott, Marie/0000-0003-2035-479X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46915] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ammerman A.J., 1984, NEOLITHIC TRANSITION; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; BALLINGER SW, 1992, GENETICS, V130, P139; BARYOSEF O, 1993, SCI AM, V268, P94, DOI 10.1038/scientificamerican0493-94; BENERECETTI ASS, 1988, ANN HUM GENET, V52, P39, DOI 10.1111/j.1469-1809.1988.tb01076.x; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; BREGA A, IN PRESS GENE GEOGR; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; BROWN MD, 1992, GENETICS, V130, P163; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; De Benedictis G, 1989, Gene Geogr, V3, P33; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; DIONNE FT, 1991, MED SCI SPORT EXER, V23, P177; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; MIGNOTTE F, 1990, EUR J BIOCHEM, V194, P561, DOI 10.1111/j.1432-1033.1990.tb15653.x; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; NEI M, 1983, GENETICS, V105, P207; PASSARINO G, 1993, AM J HUM GENET, V53, P609; PIAZZA A, 1993, SCIENCE, V260, P1767, DOI 10.1126/science.8511584; RIGAUD JP, 1990, WORLD 18000 BP; RITTE U, 1993, HUM BIOL, V65, P359; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SARTORIS S, 1988, ANN HUM GENET, V52, P327, DOI 10.1111/j.1469-1809.1988.tb01112.x; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEMINO O, 1991, ANN HUM GENET, V55, P123, DOI 10.1111/j.1469-1809.1991.tb00405.x; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1986, COLD SPRING HARB SYM, V51, P433, DOI 10.1101/SQB.1986.051.01.052; SWOFFORD D, 1992, PHYLOGENETIC ANAL US; THORNE AG, 1992, SCI AM, V266, P76, DOI 10.1038/scientificamerican0492-76; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TORRONI A, 1990, INT J ANTHR, V5, P97; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WALLACE DC, 1993, GENOME PRIORITY REPO, V1, P727; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	67	262	267	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					760	776						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942855				2022-12-18	WOS:A1994PJ02700020
J	GREENBERG, F; GUZZETTA, V; DEOCALUNA, RM; MAGENIS, RE; SMITH, ACM; RICHTER, SF; KONDO, I; DOBYNS, WB; PATEL, PI; LUPSKI, JR				GREENBERG, F; GUZZETTA, V; DEOCALUNA, RM; MAGENIS, RE; SMITH, ACM; RICHTER, SF; KONDO, I; DOBYNS, WB; PATEL, PI; LUPSKI, JR			MOLECULAR ANALYSIS OF THE SMITH-MAGENIS SYNDROME - A POSSIBLE CONTIGUOUS-GENE SYNDROME ASSOCIATED WITH DEL(17)(P11.2)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH DISEASE; PRADER-WILLI SYNDROME; NEUROPATHY TYPE-I; INTERSTITIAL DELETION; SHORT ARM; PERICENTROMERIC REGION; HEREDITARY MOTOR; CHROMOSOME-17; LINKAGE; MARKERS	We undertook clinical evaluation (32 cases) and molecular evaluation (31 cases) of unrelated patients affected with Smith-Magenis syndrome (SMS) associated with an interstitial deletion of band p11.2 of chromosome 17. Patients were evaluated both clinically and electrophysiologically for peripheral neuropathy, since markers showing close linkage to one form of Charcot-Marie-Tooth disease (CMT1A) map to this chromosomal region. The common clinical findings were broad flat midface with brachycephaly, broad nasal bridge, brachydactyly, speech delay, and hoarse, deep voice. Fifty-five percent of the patients showed clinical signs (e.g., decreased or absent deep tendon reflexes, pes planus or pes cavus, decreased sensitivity to pain, and decreased leg muscle mass) suggestive of peripheral neuropathy. However, unlike patients with CMT1A, these patients demonstrated normal nerve conduction velocities. Self-destructive behaviors, primarily onychotillomania and polyembolokoilamania, were observed in 67% of the patients, and significant symptoms of sleep disturbance were observed in 62%. The absence of REM sleep was demonstrated by polysomnography in two patients. Southern analysis indicated that most patients were deleted for five 17p11.2 markers - FG1 (D17S446), 1516 (D17S258), pYNM67-R5 (D17S29), pA10-41 (D17S71), and pS6.1-HN2 (D17S445) - thus defining a region which appears to be critical to SMS. The deletion was determined to be of paternal origin in nine patients and of maternal origin in six patients. The apparent random parental origin of deletion documented in 15 patients suggests that genomic imprinting does not play a role in the expression of the SMS clinical phenotype. Our findings suggest that SMS is likely a contiguous-gene deletion syndrome which comprises characteristic clinical features, developmental delay, clinical signs of peripheral neuropathy, abnormal sleep function, and specific behavioral anomalies.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,T-905,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,TEXAS CHILDRENS HOSP,HOUSTON,TX 77030; OREGON HLTH SCI UNIV,DEPT MOLEC GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,CHILD DEV REHABIL CTR,PORTLAND,OR 97201; CHILDRENS HOSP,DENVER,CO 80218; UNIV ARIZONA,DEPT PEDIAT,TUCSON,AZ 85721; UNIV RYUKYUS,DEPT HUMAN ECOL & GENET,NAHA,OKINAWA 903,JAPAN; INDIANA UNIV,SCH MED,DEPT NEUROL,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MOLEC GENET,INDIANAPOLIS,IN 46202	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Oregon Health & Science University; Oregon Health & Science University; Children's Hospital Colorado; University of Arizona; University of the Ryukyus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	LUPSKI, JR (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,T-905,HOUSTON,TX 77030, USA.		Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021; Patel, Pragna/H-9129-2017	Dobyns, William/0000-0002-7681-2844; Patel, Pragna/0000-0003-3584-1072	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00188] Funding Source: Medline; NICHD NIH HHS [HD24064-02] Funding Source: Medline; NINDS NIH HHS [R01 NS-27042] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BURD L, 1990, AM J MED GENET, V37, P97, DOI 10.1002/ajmg.1320370122; CHANCE PF, 1990, AM J HUM GENET, V47, P915; COLLEY AF, 1990, J PAEDIATR CHILD H, V26, P17, DOI 10.1111/j.1440-1754.1990.tb02372.x; COLVER GB, 1987, BRIT J DERMATOL, V117, P397, DOI 10.1111/j.1365-2133.1987.tb04150.x; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRANCO B, 1990, NUCLEIC ACIDS RES, V18, P7196, DOI 10.1093/nar/18.23.7196-a; FRANCO B, 1991, HUM GENET, V87, P269, DOI 10.1007/BF00200903; GUZZETTA V, 1991, GENOMICS, V9, P31, DOI 10.1016/0888-7543(91)90217-3; HALL JG, 1990, AM J HUM GENET, V46, P857; HAMILL MA, 1988, ANN GENET-PARIS, V31, P36; HOBSON JA, 1990, J NEUROSCI, V10, P371; IVENS A, 1990, HUM GENET, V84, P473; Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd; LEDBETTER DH, 1989, METABOLIC BASIS INHE, P343; LOCKWOOD D, 1988, J MED GENET, V25, P732, DOI 10.1136/jmg.25.11.732; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; MCALPINE PJ, 1990, GENOMICS, V7, P408, DOI 10.1016/0888-7543(90)90175-T; MIDDLETONPRICE HR, 1990, AM J HUM GENET, V46, P92; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATIL SR, 1984, HUM GENET, V67, P237, DOI 10.1007/BF00273011; POPP DW, 1987, AM J MED GENET, V26, P493, DOI 10.1002/ajmg.1320260228; RAEYMAEKERS P, 1989, AM J HUM GENET, V45, P953; RAY R, 1990, NUCLEIC ACIDS RES, V18, P4958, DOI 10.1093/nar/18.16.4958; SAIT MA, 1985, DERMATOLOGICA, V171, P200, DOI 10.1159/000249420; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHRANDERSTUMPEL C, 1990, CLIN GENET, V37, P148; Smith A.C.M.M.L., 1982, AM J HUM GENET, V34; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; TANDAN R, 1990, NEUROLOGY, V40, P773, DOI 10.1212/WNL.40.5.773; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X	47	262	268	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1207	1218						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746552				2022-12-18	WOS:A1991GU67200008
J	Allison, DB; Neale, MC; Zannolli, R; Schork, NJ; Amos, CI; Blangero, J				Allison, DB; Neale, MC; Zannolli, R; Schork, NJ; Amos, CI; Blangero, J			Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSESSING GENETIC-LINKAGE; DISCORDANT SIB PAIRS; MATRIX MIXED MODELS; FAMILIES; MULTIVARIATE; SELECTION; PEDIGREES; POWER; DISTRIBUTIONS; EFFICIENCY	Detection of linkage to genes for quantitative traits remains a challenging task. Recently, variance components (VC) techniques have emerged as among the more powerful of available methods. As often implemented, such techniques require assumptions about the phenotypic distribution. Usually, multivariate normality is assumed. However, several factors may lead to markedly nonnormal phenotypic data, including (a) the presence of a major gene (not necessarily linked to the markers under study), (b) some types of gene x environment interaction, (c) use of a dichotomous phenotype (i.e., affected vs, unaffected), (d) nonnormality of the population within-genotype (residual) distribution, and (e) selective (extreme) sampling. Using simulation, we have investigated, for sib-pair studies, the robustness of the likelihood-ratio test for a VC quantitative-trait locus-detection procedure to violations of normality that are due to these factors. Results showed (d) that some types of nonnormality, such as leptokurtosis, produced type I error rates in excess of the nominal, or alpha, levels whereas others did not; and (b) that the degree of type I error-rate inflation appears to be directly related to the residual sibling correlation. Potential solutions to this problem are discussed. Investigators contemplating use of this VC procedure are encouraged to provide evidence that their trait data are normally distributed, to employ a procedure that allows for nonnormal data, or to consider implementation of permutation tests.	Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10032 USA; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychol, Richmond, VA USA; Univ Siena, Policlin LeScotte, Dept Pediat, I-53100 Siena, Italy; Case Western Reserve Univ, Dept Biostat & Epidemiol, Cleveland, OH 44106 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Virginia Commonwealth University; Virginia Commonwealth University; University of Siena; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Jackson Laboratory; University of Texas System; UTMD Anderson Cancer Center; Texas Biomedical Research Institute	Allison, DB (corresponding author), Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Obes Res Ctr, 1090 Amsterdam Ave,14th Floor, New York, NY 10032 USA.		Neale, Michael C/B-1418-2008; Blangero, John/ABA-7175-2021; Neale, Michael/AAD-5056-2020	Schork, Nicholas/0000-0003-0920-5013; Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051716, P30DK026687, R29DK047256] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47256, DK51716, DK26687] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Amos CI, 1997, GENET EPIDEMIOL, V14, P743, DOI 10.1002/(SICI)1098-2272(1997)14:6<743::AID-GEPI30>3.0.CO;2-O; ASTEMBORSKI JA, 1985, AM J MED GENET, V21, P741, DOI 10.1002/ajmg.1320210417; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; BEATY TH, 1987, GENET EPIDEMIOL, V4, P203, DOI 10.1002/gepi.1370040305; BEATY TH, 1987, GENET EPIDEMIOL, V4, P211, DOI 10.1002/gepi.1370040306; BENTLER PM, 1991, P 23 S INT INT FDN N, P463; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOX GEP, 1953, BIOMETRIKA, V40, P318, DOI 10.1093/biomet/40.3-4.318; CHERNOFF H, 1954, ANN MATH STAT, V25, P579, DOI 10.1214/aoms/1177728726; Christiaens GCML, 1997, OBSTET GYNECOL, V90, P546, DOI 10.1016/S0029-7844(97)00349-9; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; CRAWFORD DHG, 1993, HEPATOLOGY, V17, P833, DOI 10.1016/0270-9139(93)90160-O; de Andrade M, 1997, GENET EPIDEMIOL, V14, P773, DOI 10.1002/(SICI)1098-2272(1997)14:6<773::AID-GEPI35>3.0.CO;2-L; Dolan CV, 1998, BEHAV GENET, V28, P197, DOI 10.1023/A:1021423214032; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Dunn G., 1993, MODELING COVARIANCES; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; ELSTON RC, IN PRESS GENET EPIDE; EVANS M, 1993, STAT DISTRIBUTIONS, P92; FOUTZ RV, 1977, ANN STAT, V5, P1183, DOI 10.1214/aos/1176344003; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GEORGE VT, 1988, COMMUN STAT-THEOR M, V17, P2933, DOI 10.1080/03610928808829781; GOLDBERGER J, 1994, AM J CARDIOL, V73, P43, DOI 10.1016/0002-9149(94)90725-0; Good P.I., 1994, PERMUTATION TESTS PR; Guerra R, 1999, HUM HERED, V49, P146, DOI 10.1159/000022863; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOPPER JL, 1983, AM J EPIDEMIOL, V117, P344, DOI 10.1093/oxfordjournals.aje.a113547; HU LT, 1992, PSYCHOL BULL, V112, P351, DOI 10.1037//0033-2909.112.2.351; ITURRIA SJ, IN PRESS GENET EPIDE; KEITH RA, 1983, CLIN PHARMACOL THER, V34, P521, DOI 10.1038/clpt.1983.208; KRUGLYAK L, 1995, GENETICS, V139, P1421; LANDER ES, 1989, GENETICS, V121, P185; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Little RJ, 1987, STAT ANAL MISSING DA; MATTHYSSE S, 1979, P NATL ACAD SCI USA, V76, P2862, DOI 10.1073/pnas.76.6.2862; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; MOTUM PI, 1993, AM J HEMATOL, V43, P37, DOI 10.1002/ajh.2830430109; National Center for Health Statistics, 1997, NAT HLTH NUTR EX SUR; NEALE MC, 1992, NATO ASI SERIES D, V47; NEALE MC, 1997, MX STAT MODELING; NEALE MC, IN PRESS L ERLBAUM; POONI HS, 1976, HEREDITY, V36, P215, DOI 10.1038/hdy.1976.26; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1996, AM J HUM GENET, V58, P836; SCHORK N, 1989, AM J HUM GENET, V45, P803; SCHORK N, 1991, GENET EPIDEMIOL, V8, P29, DOI 10.1002/gepi.1370080104; Schork N J, 1996, Stat Methods Med Res, V5, P155, DOI 10.1177/096228029600500204; SCHORK NJ, 1990, STAT MED, V9, P301, DOI 10.1002/sim.4780090313; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SCHORK NJ, 1992, GENET EPIDEMIOL, V9, P73, DOI 10.1002/gepi.1370090202; SCHORK NJ, 1990, GENET EPIDEMIOL, V7, P427, DOI 10.1002/gepi.1370070605; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Wan Y, 1997, ANN HUM GENET, V61, P79; Wang J, 1998, ANN HUM GENET, V62, P349, DOI 10.1046/j.1469-1809.1998.6240349.x; White H., 1994, ESTIMATION INFERENCE; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Wilcox RR, 2022, INTRO ROBUST ESTIMAT; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6; Wright FA, 1997, AM J HUM GENET, V60, P740; Wright FA, 1997, GENETICS, V146, P417	69	261	263	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					531	544		10.1086/302487	http://dx.doi.org/10.1086/302487			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417295	Green Published, Bronze			2022-12-18	WOS:000081836900028
J	Henske, EP; Scheithauer, BW; Short, MP; Wollmann, R; Nahmias, J; Hornigold, N; vanSlegtenhorst, M; Welsh, CT; Kwiatkowski, DJ				Henske, EP; Scheithauer, BW; Short, MP; Wollmann, R; Nahmias, J; Hornigold, N; vanSlegtenhorst, M; Welsh, CT; Kwiatkowski, DJ			Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE MAP; INTERNATIONAL WORKSHOP; GROWTH SUPPRESSOR; HUMAN 9Q34.1; REGION; GENE; HETEROZYGOSITY; TSC1; CHROMOSOME-9; 16P13	Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by seizures, mental retardation, and hamartomatous lesions. Although hamartomas can occur in almost any organ, they are most common in the brain, kidney, heart, and skin. Allelic loss or loss of heterozygosity (LOH) in TSC lesions has previously been reported on chromosomes 16p13 and 9q34, the locations of the TSC2 and TSC1 genes, respectively, suggesting that the TSC genes act as tumor-suppressor genes. In our study, 87 lesions from 47 TSC patients were analyzed for LOH in the TSC1 and TSC2 chromosomal regions. Three findings resulted hem this analysis, First, we confirmed that the TSC1 critical region is distal to D9S149. Second, we found LOH more frequently on chromosome 16p13 than on 9q34. Of the 28 patients with angiomyolipomas or rhabdomyomas, 16p13 LOH was detected in lesions from 12 (57%) of 21 informative patients, while 9q34 LOH was detected in lesions from only 1 patient (4%). This could indicate that TSC2 tumors are more likely than TSC1 tumors to require surgical resection or that TSC2 is more common than TSC1 in out patient population. It is also possible that small regions of 9q34 LOH were missed. Lastly, LOH was found in 56% of renal angiomyolipomas and cardiac rhabdomyomas but in only 4% of TSC brain lesions. This suggests that brain lesions can result from different pathogenic mechanisms than kidney and heart lesions.	BRIGHAM & WOMENS HOSP, DIV EXPT MED, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA; MAYO CLIN, DEPT PATHOL, ROCHESTER, MN USA; UNIV CHICAGO, MED CTR, SECT NEUROPATHOL, CHICAGO, IL 60637 USA; UCL, MRC, HUMAN BIOCHEM GENET UNIT, LONDON, ENGLAND; UCL, DEPT GENET & BIOMETRY, LONDON, ENGLAND; ERASMUS UNIV ROTTERDAM, ROTTERDAM, NETHERLANDS; UNIV UTAH, DEPT PATHOL, SALT LAKE CITY, UT USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Mayo Clinic; University of Chicago; University of Chicago Medical Center; University of London; University College London; University of London; University College London; Erasmus University Rotterdam; Utah System of Higher Education; University of Utah					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001571, R01NS031535] Funding Source: NIH RePORTER; NINDS NIH HHS [NS01571, NS31535] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CARBONARA C, 1994, HUM MOL GENET, V3, P1829, DOI 10.1093/hmg/3.10.1829; Carbonara C, 1996, GENE CHROMOSOME CANC, V15, P18, DOI 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; Gomez MR, 1988, TUBEROUS SCLEROSIS; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HENSKE EP, 1995, GENOMICS, V28, P105, DOI 10.1006/geno.1995.1113; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; HENSKE EP, 1993, GENOMICS, V17, P587, DOI 10.1006/geno.1993.1376; HIROSE T, 1995, ACTA NEUROPATHOL, V90, P387; KWIATKOWSKI DJ, 1994, ARCH DERMATOL, V130, P348, DOI 10.1001/archderm.130.3.348; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; MURRELL J, 1995, GENOMICS, V25, P59, DOI 10.1016/0888-7543(95)80109-Y; NAYLOR SL, 1994, CYTOGENET CELL GENET, V65, P2; NELLIST M, 1993, CELL, V75, P1305; NORTHRUP H, 1992, AM J HUM GENET, V51, P709; POVEY S, 1994, ANN HUM GENET, V58, P107, DOI 10.1111/j.1469-1809.1994.tb01881.x; POVEY S, 1994, ANN HUM GENET, V58, P177, DOI 10.1111/j.1469-1809.1994.tb01887.x; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; SNAREY A, 1994, AM J HUM GENET, V55, P365; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; [No title captured]	25	261	268	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					400	406						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755927				2022-12-18	WOS:A1996VM28800016
J	Edvardson, S; Shaag, A; Kolesnikova, O; Gomori, JM; Tarassov, I; Einbinder, T; Saada, A; Elpeleg, O				Edvardson, Simon; Shaag, Avraham; Kolesnikova, Olga; Gomori, John Moshe; Tarassov, Ivan; Einbinder, Tom; Saada, Ann; Elpeleg, Orly			Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLATION; DEFICIENCY; MYOPATHY; IMPORT; MTDNA; YEAST	Homozygosity mapping was performed in a consanguineous Sephardic Jewish family with three patients who presented with severe infantile encephalopathy associated with pontocerebellar hypoplasia and multiple mitochondrial respiratory-chain defects. This resulted in the identification of an intronic mutation in RARS2, the gene encoding mitochondrial arginine-transfer RNA (tRNA) synthetase. The mutation was associated with the production of an abnormally short RARS2 transcript and a marked reduction of the mitochondrial tRNA(Arg) transcript in the patients' fibroblasts. We speculate that missplicing mutations in mitochondrial aminoacy1-tRNA synthethase genes preferentially affect the brain because of a tissue-specific vulnerability of the splicing machinery.	Hebrew Univ Jerusalem, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Radiol, IL-91120 Jerusalem, Israel; Univ Strasbourg 1, CNRS, UMR 7156, Dept Genet Mol & Cellulaire, Strasbourg, France	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Elpeleg, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.	Elpeleg@hadassah.org.il	Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656; Tarassov, Ivan/0000-0001-8763-6703; Edvardson, Simon/0000-0003-2878-1278				Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; de Koning TJ, 1999, NEUROPEDIATRICS, V30, P93, DOI 10.1055/s-2007-973467; Entelis N, 2002, GENET ENG P, V24, P191; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Patel MS, 2006, AM J MED GENET A, V140A, P594, DOI 10.1002/ajmg.a.31095; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; TZAGOLOFF A, 1995, EUR J BIOCHEM, V230, P582; Uusimaa J, 2004, PEDIATRICS, V114, P443, DOI 10.1542/peds.114.2.443; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	20	260	267	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					857	862		10.1086/521227	http://dx.doi.org/10.1086/521227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847012	Green Published, Bronze			2022-12-18	WOS:000249307600028
J	Hulsebos, TJM; Plomp, AS; Wolterman, RA; Robanus-Maandag, EC; Baas, F; Wesseling, P				Hulsebos, Theo J. M.; Plomp, Astrid S.; Wolterman, Ruud A.; Robanus-Maandag, Els C.; Baas, Frank; Wesseling, Pieter			Germline mutation of INI1/SMARCB1 in familial schwannomatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; NF2 LOCUS; CANCER; HSNF5/INI1; INI1	Patients with schwannomatosis develop multiple schwannomas but no vestibular schwannomas diagnostic of neurofibromatosis type 2. We report an inactivating germline mutation in exon 1 of the tumor-suppressor gene INI1 in a father and daughter who both had schwannomatosis. Inactivation of the wild-type INI1 allele, by a second mutation in exon 5 or by clear loss, was found in two of four investigated schwannomas from these patients. All four schwannomas displayed complete loss of nuclear INI1 protein expression in part of the cells. Although the exact oncogenetic mechanism in these schwannomas remains to be elucidated, our findings suggest that INI1 is the predisposing gene in familial schwannomatosis.	Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Netherlands Inst Neurosci, KNAW, Amsterdam, Netherlands; Leiden Univ, Ctr Med, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Radoud Univ Nijmegen, Ctr Med, Nijmegen Ctr Mol Life Sci, Dept Pathol, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen	Hulsebos, TJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.j.hulsebos@amc.uva.nl	Baas, Frank/F-9574-2010; Wesseling, P./H-8114-2014	Baas, Frank/0000-0003-3912-5428; Wesseling, P./0000-0001-5453-5201; /0000-0002-4903-8232				Biegel JA, 1999, CANCER RES, V59, P74; Biegel Jaclyn A, 2006, Neurosurg Focus, V20, pE11; Bruder CEG, 1999, BIOCHEM BIOPH RES CO, V257, P886, DOI 10.1006/bbrc.1999.0563; Buckley PG, 2005, HUM MUTAT, V26, P540, DOI 10.1002/humu.20255; Jacoby LB, 1997, AM J HUM GENET, V61, P1293, DOI 10.1086/301633; Janson K, 2006, PEDIATR BLOOD CANCER, V47, P279, DOI 10.1002/pbc.20622; Judkins AR, 2004, AM J SURG PATHOL, V28, P644, DOI 10.1097/00000478-200405000-00013; Kaufman DL, 2003, ARCH NEUROL-CHICAGO, V60, P1317, DOI 10.1001/archneur.60.9.1317; Kluwe L, 1999, GENE CHROMOSOME CANC, V24, P283, DOI 10.1002/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; MacCollin M, 2005, NEUROLOGY, V64, P1838, DOI 10.1212/01.WNL.0000163982.78900.AD; MacCollin M, 2003, NEUROLOGY, V60, P1968, DOI 10.1212/01.WNL.0000070184.08740.E0; MacCollin M, 1996, NEUROLOGY, V46, P1072, DOI 10.1212/WNL.46.4.1072; Modena P, 2005, CANCER RES, V65, P4012, DOI 10.1158/0008-5472.CAN-04-3050; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Rutkowski JL, 2000, HUM MOL GENET, V9, P1059, DOI 10.1093/hmg/9.7.1059; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212	19	260	270	1	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					805	810		10.1086/513207	http://dx.doi.org/10.1086/513207			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357086	Green Published, Bronze			2022-12-18	WOS:000245465200021
J	Syrris, P; Ward, D; Evans, A; Asimaki, A; Gandjbakhch, E; Sen-Chowdhry, S; McKenna, WJ				Syrris, Petros; Ward, Deirdre; Evans, Alison; Asimaki, Angeliki; Gandjbakhch, Estelle; Sen-Chowdhry, Srijita; McKenna, William J.			Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLAKOPHILIN-2 MUTATIONS; RECESSIVE MUTATION; WOOLLY HAIR; CARDIOMYOPATHY; PLAKOGLOBIN; IDENTIFICATION; DIAGNOSIS; FAMILIES; DELETION; CADHERIN	Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited myocardial disorder associated with arrhythmias, heart failure, and sudden death. To date, mutations in four genes encoding major desmosomal proteins (plakoglobin, desmoplakin, plakophilin-2, and desmoglein-2) have been implicated in the pathogenesis of ARVD/C. We screened 77 probands with ARVD/C for mutations in desmocollin-2 (DSC2), a gene coding for a desmosomal cadherin. Two heterozygous mutations-a deletion and an insertion-were identified in four probands. Both mutations result in frameshifts and premature truncation of the desmocollin-2 protein. For the first time, we have identified mutations in desmocollin-2 in patients with ARVD/C, a finding that is consistent with the hypothesis that ARVD/C is a disease of the desmosome.	UCL Hosp Trust, Heart Hosp, London W1G 8PH, England; UCL, Dept Med, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	McKenna, WJ (corresponding author), UCL Hosp Trust, Heart Hosp, 16-18 Westmoreland St, London W1G 8PH, England.	william.mckenna@uclh.org	McKenna, William J/C-3243-2008; SYRRIS, PETROS/C-1703-2008; ASIMAKI, ANGELIKI/J-7140-2016	McKenna, William J/0000-0001-7994-2460; SYRRIS, PETROS/0000-0002-2363-8758; ASIMAKI, ANGELIKI/0000-0001-9886-6870				Alcalai R, 2003, J AM COLL CARDIOL, V42, P319, DOI 10.1016/S0735-1097(03)00628-4; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Bauce B, 2005, EUR HEART J, V26, P1666, DOI 10.1093/eurheartj/ehi341; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Corrado D, 2000, CIRCULATION, V101, pE101, DOI 10.1161/01.CIR.101.11.e101; Corrado D, 2000, HEART, V83, P588, DOI 10.1136/heart.83.5.588; Dalal D, 2006, CIRCULATION, V113, P1641, DOI 10.1161/CIRCULATIONAHA.105.568642; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Greenwood MD, 1997, GENOMICS, V44, P330, DOI 10.1006/geno.1997.4894; Hamid MS, 2002, J AM COLL CARDIOL, V40, P1445, DOI 10.1016/S0735-1097(02)02307-0; Hashimoto T, 1997, J INVEST DERMATOL, V109, P127, DOI 10.1111/1523-1747.ep12319025; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; Hunt DM, 2001, EUR J HUM GENET, V9, P197, DOI 10.1038/sj.ejhg.5200605; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Moss C, 2004, J INVEST DERMATOL, V123, P607, DOI 10.1111/j.0022-202X.2004.23311.x; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Norman M, 2005, CIRCULATION, V112, P636, DOI 10.1161/CIRCULATIONAHA.104.532234; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Protonotarios N, 2001, J AM COLL CARDIOL, V38, P1477, DOI 10.1016/S0735-1097(01)01568-6; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; TROYANOVSKY SM, 1994, P NATL ACAD SCI USA, V91, P10790, DOI 10.1073/pnas.91.23.10790; van Tintelen JP, 2006, CIRCULATION, V113, P1650, DOI 10.1161/CIRCULATIONAHA.105.609719	37	260	267	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					978	984		10.1086/509122	http://dx.doi.org/10.1086/509122			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033975	Green Published, Bronze			2022-12-18	WOS:000241667400020
J	Lalani, SR; Safiullah, AM; Fernbach, SD; Harutyunyan, KG; Thaller, C; Peterson, LE; McPherson, JD; Gibbs, RA; White, LD; Hefner, M; Davenport, SLH; Graham, JM; Bacino, CA; Glass, NL; Towbin, JA; Craigen, WJ; Neish, SR; Lin, AE; Belmont, JW				Lalani, SR; Safiullah, AM; Fernbach, SD; Harutyunyan, KG; Thaller, C; Peterson, LE; McPherson, JD; Gibbs, RA; White, LD; Hefner, M; Davenport, SLH; Graham, JM; Bacino, CA; Glass, NL; Towbin, JA; Craigen, WJ; Neish, SR; Lin, AE; Belmont, JW			Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE ANOMALIES; CHOANAL ATRESIA; HEART-DISEASE; ASSOCIATION; CRITERIA; COMPLEX; METHYLATION; DELETION; CHILD	CHARGE syndrome is a well-established multiple-malformation syndrome with distinctive consensus diagnostic criteria. Characteristic associated anomalies include ocular coloboma, choanal atresia, cranial nerve defects, distinctive external and inner ear abnormalities, hearing loss, cardiovascular malformations, urogenital anomalies, and growth retardation. Recently, mutations of the chromodomain helicase DNA-binding protein gene CHD7 were reported to be a major cause of CHARGE syndrome. We sequenced the CHD7 gene in 110 individuals who had received the clinical diagnosis of CHARGE syndrome, and we detected mutations in 64 ( 58%). Mutations were distributed throughout the coding exons and conserved splice sites of CHD7. Of the 64 mutations, 47 ( 73%) predicted premature truncation of the protein. These included nonsense and frameshift mutations, which most likely lead to haploinsufficiency. Phenotypically, the mutation-positive group was more likely to exhibit cardiovascular malformations ( 54 of 59 in the mutation-positive group vs. 30 of 42 in the mutation-negative group; P = .014), coloboma of the eye ( 55 of 62 in the mutation-positive group vs. 30 of 43 in the mutation-negative group; P = .022) and facial asymmetry, often caused by seventh cranial nerve abnormalities ( 36 of 56 in the mutation-positive group vs. 13 of 39 in the mutation-negative group; P = .004) Mouse embryo whole-mount and section in situ hybridization showed the expression of Chd7 in the outflow tract of the heart, optic vesicle, facioacoustic preganglion complex, brain, olfactory pit, and mandibular component of the first branchial arch. Microarray gene-expression analysis showed a signature pattern of gene-expression differences that distinguished the individuals with CHARGE syndrome with CHD7 mutation from the controls. We conclude that cardiovascular malformations, coloboma, and facial asymmetry are common findings in CHARGE syndrome caused by CHD7 mutation.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; St Louis Univ, Dept Pediat, St Louis, MO 63103 USA; Sensory Genet NeuroDev, Bloomington, MN USA; Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Dept Pediat,Med Genet Inst, Los Angeles, CA USA; Massachusetts Gen Hosp Children, Genet & Teratol Unit, Boston, MA 02114 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Saint Louis University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Belmont, JW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,T826, Houston, TX 77030 USA.	jbelmont@bcm.tmc.edu	Towbin, Jeffrey A./J-5595-2019; Belmont, John/AAH-6084-2021; Lalani, Seema/AAI-5090-2020; McPherson, John D/D-2633-2017; Neish, Steven/AAJ-7974-2021; Graham, John M./J-1429-2019; Belmont, John W/AAI-2494-2019	Towbin, Jeffrey A./0000-0002-6585-714X; McPherson, John D/0000-0001-8049-9347; Belmont, John W/0000-0001-7409-3578; Peterson, Leif/0000-0002-1187-0883	NICHD NIH HHS [R01HD39056, R01 HD039056, P01 HD022657, HD22657] Funding Source: Medline; NIGMS NIH HHS [T32 GM008243, GM08243] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657, R01HD039056] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amiel J, 2001, AM J MED GENET, V99, P124, DOI 10.1002/1096-8628(20010301)99:2<124::AID-AJMG1114>3.0.CO;2-9; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; BLAKE KD, 1989, INT J CARDIOL, V25, P339, DOI 10.1016/0167-5273(89)90225-8; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; CLEMENTI M, 1991, AM J MED GENET, V41, P246, DOI 10.1002/ajmg.1320410223; De Krijger RR, 1999, PEDIATR DEVEL PATHOL, V2, P577, DOI 10.1007/s100249900165; Devriendt K, 1998, CLIN GENET, V53, P408; Feng Q, 2001, GENE DEV, V15, P827; Graham JM, 2001, AM J MED GENET, V99, P120, DOI 10.1002/1096-8628(2000)9999:999<00::AID-AJMG1132>3.0.CO;2-J; HALL BD, 1979, J PEDIATR-US, V95, P395, DOI 10.1016/S0022-3476(79)80513-2; HITTNER HM, 1979, J PEDIAT OPHTH STRAB, V16, P122; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Issekutz KA, 2005, AM J MED GENET A, V133A, P309, DOI 10.1002/ajmg.a.30560; Kaufman M.H., 1992, ATLAS MOUSE DEV; Lalani SR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-8; Lalani SR, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.017640; Lalani SR, 2003, AM J MED GENET A, V118A, P260, DOI 10.1002/ajmg.a.20002; Lee Wang-Tso, 1995, Journal of the Formosan Medical Association, V94, P60; Lev D, 2000, J MED GENET, V37, P231, DOI 10.1136/jmg.37.3.231; LUBINSKY MS, 1994, AM J MED GENET, V49, P21, DOI 10.1002/ajmg.1320490106; Mitchell J A, 1985, Ophthalmic Paediatr Genet, V6, P271; NORTH KN, 1995, AM J MED GENET, V57, P610, DOI 10.1002/ajmg.1320570419; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Sanlaville D, 2002, CLIN GENET, V61, P135, DOI 10.1034/j.1399-0004.2002.610208.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Studer M, 2001, DEVELOPMENT, V128, P3707; Tellier AL, 1996, CLIN GENET, V50, P548; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Verloes A, 2005, AM J MED GENET A, V133A, P306, DOI 10.1002/ajmg.a.30559; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	36	260	272	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					303	314		10.1086/500273	http://dx.doi.org/10.1086/500273			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400610	Green Published, Bronze			2022-12-18	WOS:000236744900011
J	Carlson, CS; Aldred, SF; Lee, PK; Tracy, RP; Schwartz, SM; Rieder, M; Liu, KA; Williams, OD; Iribarren, C; Lewis, EC; Fornage, M; Boerwinkle, E; Gross, M; Jaquish, C; Nickerson, DA; Myers, RM; Siscovick, DS; Reiner, AP				Carlson, CS; Aldred, SF; Lee, PK; Tracy, RP; Schwartz, SM; Rieder, M; Liu, KA; Williams, OD; Iribarren, C; Lewis, EC; Fornage, M; Boerwinkle, E; Gross, M; Jaquish, C; Nickerson, DA; Myers, RM; Siscovick, DS; Reiner, AP			Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR-DISEASE; HAPLOTYPE RECONSTRUCTION; RISK-FACTORS; INFLAMMATION; GENE; MARKERS; PREDICTION; RECRUITMENT; PHASE	Elevated plasma levels of C- reactive protein ( CRP), an inflammation- sensitive marker, have emerged as an important predictor of future cardiovascular disease and metabolic abnormalities in apparently healthy men and women. Here, we performed a systematic survey of common nucleotide variation across the genomic region encompassing the CRP gene locus. Of the common single- nucleotide polymorphisms ( SNPs) identified, several in the CRP promoter region are strongly associated with CRP levels in a large cohort study of cardiovascular risk in European American and African American young adults. We also demonstrate the functional importance of these SNPs in vitro.	Univ Washington, Ctr Hlth Sci, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Vermont, Burlington, VT USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; Kaiser Permanente, Div Res, Oakland, CA USA; Univ Texas, Houston, TX USA; Univ Minnesota, Minneapolis, MN USA; NHLBI, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; University of Vermont; Northwestern University; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; University of Texas System; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Carlson, CS (corresponding author), Univ Washington, Ctr Hlth Sci, Dept Genome Sci, Room K-322,1705 NE Pacific St, Seattle, WA 98195 USA.	csc47@u.washington.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005187, N01HC048049, N01HC048048, N01HC048047, N01HC045134, N01HC095095, N01HC048050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL071017, R01HL048049, R01HL048048, R01HL048050, U01HL066682, U01HL066642] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01HC48047, N01-HC-48048, N01HC48048, U01 HL066682, N01HC05187, N01HC48050, N01 HC045134, HL66642, N01-HC-48049, N01HC95095, N01-HC-48050, N01-HC-95095, N01HC48049, U01 HL066642, R01 HL071017, N01-HC-05187, HL71017, N01-HC-48047, HL66682] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abernethy TJ, 1941, J EXP MED, V73, P173, DOI 10.1084/jem.73.2.173; Albert MA, 2004, AM J CARDIOL, V93, P1238, DOI 10.1016/j.amjcard.2004.01.067; Anand SS, 2004, ARTERIOSCL THROM VAS, V24, P1509, DOI 10.1161/01.ATV.0000135845.95890.4e; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Kleemann R, 2004, BLOOD, V103, P4188, DOI 10.1182/blood-2003-11-3791; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; LI SP, 1990, J BIOL CHEM, V265, P4136; MacGregor AJ, 2004, CLIN CHEM, V50, P130, DOI 10.1373/clinchem.2003.028258; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Retterstol L, 2003, ATHEROSCLEROSIS, V169, P279, DOI 10.1016/S0021-9150(03)00192-8; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; SHINE B, 1981, CLIN CHIM ACTA, V117, P13, DOI 10.1016/0009-8981(81)90005-X; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2002, GENES IMMUN, V3, P14, DOI 10.1038/sj.gene.6363820; SZALAI AJ, IN PRESS J MOL MED; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Watkins Laurence O, 2004, Rev Cardiovasc Med, V5 Suppl 3, pS3; Wener MH, 2000, J RHEUMATOL, V27, P2351; Wolford JK, 2003, MOL GENET METAB, V78, P136, DOI 10.1016/S1096-7192(02)00230-5; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	37	260	268	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					64	77		10.1086/431366	http://dx.doi.org/10.1086/431366			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15897982	Bronze, Green Published			2022-12-18	WOS:000229794500006
J	Toomes, C; Bottomley, HM; Jackson, RM; Towns, KV; Scott, S; Mackey, DA; Craig, JE; Jiang, L; Yang, ZL; Trembath, R; Woodruff, G; Gregory-Evans, CY; Gregory-Evans, K; Parker, MJ; Black, GCM; Downey, LM; Zhang, K; Inglehearn, CF				Toomes, C; Bottomley, HM; Jackson, RM; Towns, KV; Scott, S; Mackey, DA; Craig, JE; Jiang, L; Yang, ZL; Trembath, R; Woodruff, G; Gregory-Evans, CY; Gregory-Evans, K; Parker, MJ; Black, GCM; Downey, LM; Zhang, K; Inglehearn, CF			Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR-RELATED PROTEIN-5; GENETIC-HETEROGENEITY; DICKKOPF PROTEINS; WNT CORECEPTOR; BONE-DENSITY; LINKAGE; D11S533; LIGAND; DOMAIN; MICE	Familial exudative vitreoretinopathy (FEVR) is an inherited blinding disorder of the retinal vascular system. Autosomal dominant FEVR is genetically heterogeneous, but its principal locus, EVR1, is on chromosome 11q13-q23. The gene encoding the Wnt receptor frizzled-4 (FZD4) was recently reported to be the EVR1 gene, but our mutation screen revealed fewer patients harboring mutations than expected. Here, we describe mutations in a second gene at the EVR1 locus, low-density-lipoprotein receptor-related protein 5 (LRP5), a Wnt coreceptor. This finding further underlines the significance of Wnt signaling in the vascularization of the eye and highlights the potential dangers of using multiple families to refine genetic intervals in gene-identification studies.	Univ Leeds, Mol Med Unit, Leeds, W Yorkshire, England; Univ Leeds, Sch Biochem & Mol Biol, Leeds, W Yorkshire, England; Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA, Australia; Univ Utah, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT USA; Univ Leicester, Leicester Royal Infirm, Dept Clin Genet, Leicester, Leics, England; Univ Leicester, Leicester Royal Infirm, Dept Ophthalmol, Leicester, Leics, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; Univ Manchester, Manchester Royal Eye Hosp, Acad Unit Ophthalmol, Manchester M13 9PL, Lancs, England; St Marys Hosp, Univ Dept Med Genet, Manchester M13 0JH, Lancs, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England	University of Leeds; University of Leeds; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; Flinders Medical Centre; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Leicester; University of Leicester; Imperial College London; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Manchester Royal Eye Hospital; University of Manchester; University of Manchester; University of Manchester	Toomes, C (corresponding author), St Jamess Univ Hosp, Mol Med Unit, Level 6,Clin Sci Bldg, Leeds LS9 7TF, W Yorkshire, England.	c.toomes@leeds.ac.uk	Jiang, Li/C-9537-2012; Gregory-Evans, Kevin/G-9551-2011; Inglehearn, Chris/GYD-9783-2022; Mackey, David A/H-5340-2014; Zhang, Kang/Y-2740-2019; Gregory-Evans, Cheryl Y/G-9550-2011; Black, Graeme/K-7374-2015	Mackey, David A/0000-0001-7914-4709; Zhang, Kang/0000-0002-4549-1697; Toomes, Carmel/0000-0001-8373-9545; Craig, Jamie/0000-0001-9955-9696; Black, Graeme/0000-0001-8727-6592; Trembath, Richard/0000-0003-0550-3400	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014448] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064, M01 RR000064] Funding Source: Medline; NEI NIH HHS [R01 EY014448, R01EY14448, R01EY14438] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Benson W E, 1995, Trans Am Ophthalmol Soc, V93, P473; BIERI S, 1995, BIOCHEMISTRY-US, V34, P13059, DOI 10.1021/bi00040a017; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; de Crecchio G, 1998, CLIN GENET, V54, P315, DOI 10.1034/j.1399-0004.1998.5440409.x; Downey LM, 2001, AM J HUM GENET, V68, P778, DOI 10.1086/318790; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GOW J, 1971, ARCH OPHTHALMOL-CHIC, V86, P150, DOI 10.1001/archopht.1971.01000010152007; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; Kondo H, 2003, BRIT J OPHTHALMOL, V87, P1291, DOI 10.1136/bjo.87.10.1291; Kondo H, 2001, HUM GENET, V108, P368, DOI 10.1007/s004390100503; LAQUA H, 1980, A GRAEF ARCH KLIN EX, V213, P121, DOI 10.1007/BF00413539; LI Y, 1992, AM J HUM GENET, V51, P749; LI Y, 1992, AM J OPHTHALMOL, V113, P712, DOI 10.1016/S0002-9394(14)74800-7; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; MULLER B, 1994, GENOMICS, V20, P317, DOI 10.1006/geno.1994.1176; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OBER RR, 1980, BRIT J OPHTHALMOL, V64, P112, DOI 10.1136/bjo.64.2.112; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; PLAGER DA, 1992, AM J OPHTHALMOL, V114, P145, DOI 10.1016/S0002-9394(14)73977-7; Price SM, 1996, OPHTHALMIC GENET, V17, P53, DOI 10.3109/13816819609057871; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shastry BS, 1997, GENOMICS, V44, P247, DOI 10.1006/geno.1997.4863; Shastry BS, 2000, CLIN GENET, V58, P329, DOI 10.1034/j.1399-0004.2000.580412.x; Shastry BS, 1997, AM J MED GENET, V69, P217, DOI 10.1002/(SICI)1096-8628(19970317)69:2<217::AID-AJMG19>3.0.CO;2-O; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Toomes C, 2004, MOL VIS, V10, P37; Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369; TOOMES C, IN PRESS INVEST OPHT; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; VANNOUHUYS CE, 1991, AM J OPHTHALMOL, V111, P34, DOI 10.1016/S0002-9394(14)76893-X; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X	48	260	295	2	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					721	730		10.1086/383202	http://dx.doi.org/10.1086/383202			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15024691	Green Published, Bronze			2022-12-18	WOS:000220280800011
J	Edwards, SM; Kote-Jarai, Z; Meitz, J; Hamoudi, R; Hope, Q; Osin, P; Jackson, R; Southgate, C; Singh, R; Falconer, A; Dearnaley, DP; Ardern-Jones, A; Murkin, A; Dowe, A; Kelly, J; Williams, S; Oram, R; Stevens, M; Teare, DM; Ponder, BAJ; Gayther, SA; Easton, DF; Eeles, RA				Edwards, SM; Kote-Jarai, Z; Meitz, J; Hamoudi, R; Hope, Q; Osin, P; Jackson, R; Southgate, C; Singh, R; Falconer, A; Dearnaley, DP; Ardern-Jones, A; Murkin, A; Dowe, A; Kelly, J; Williams, S; Oram, R; Stevens, M; Teare, DM; Ponder, BAJ; Gayther, SA; Easton, DF; Eeles, RA		Canc Res UK British Prostate Grp U; British Assoc Urological Surg Sect	Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELIC LOSS; SUSCEPTIBILITY LOCUS; DISTINCT REGIONS; OVARIAN-CANCER; BREAST; FAMILIES; PREDISPOSITION; INDIVIDUALS; PREVALENCE; EXPRESSION	Studies of families with breast cancer have indicated that male carriers of BRCA2 mutations are at increased risk of prostate cancer, particularly at an early age. To evaluate the contribution of BRCA2 mutations to early-onset prostate cancer, we screened the complete coding sequence of BRCA2 for germline mutations, in 263 men with diagnoses of prostate cancer who were less than or equal to55 years of age. Protein-truncating mutations were found in six men (2.3%; 95% confidence interval 0.8%-5.0%), and all of these mutations were clustered outside the ovarian-cancer cluster region. The relative risk of developing prostate cancer by age 56 years from a deleterious germline BRCA2 mutation was 23-fold. Four of the patients with mutations did not have a family history of breast or ovarian cancer. Twenty-two variants of uncertain significance were also identified. These results confirm that BRCA2 is a high-risk prostate-cancer-susceptibility gene and have potential implications for the management of early-onset prostate cancer, in both patients and their relatives.	Inst Canc Res, Translat Canc Genet Team, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Inst Canc Res, Mol Genet Team, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Royal Marsden Natl Hlth Serv Trust Hosp, Sutton, Surrey, England; UCL, Dept Histopathol, London, England; Univ Cambridge, Addenbrookes Hosp, Strangeways Res Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Canc Res UK Human Canc Genet Res Grp, Cambridge CB2 2QQ, England	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cancer Research UK; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Eeles, RA (corresponding author), Inst Canc Res, Translat Canc Genet Team, Sect Canc Genet, Orchard House,15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	ros@icr.ac.uk	Dearnaley, David P/J-2318-2014; Meitz-Hopkins, Julia/M-3938-2016	Dearnaley, David P/0000-0002-3954-2806; Meitz-Hopkins, Julia/0000-0002-8127-6978; Oram, Richard/0000-0003-3581-8980; Hamoudi, Rifat/0000-0002-1402-0868; Teare, Marion Dawn/0000-0003-3994-0051; Eeles, Rosalind/0000-0002-3698-6241				Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; ARASON A, 1993, AM J HUM GENET, V52, P711; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Connor F, 1997, HUM MOL GENET, V6, P291, DOI 10.1093/hmg/6.2.291; Cooney KA, 1996, CANCER RES, V56, P1142; Edwards SM, 1998, INT J CANCER, V78, P1; Edwards SM, 1997, BRIT J CANCER, V76, P992, DOI 10.1038/bjc.1997.498; Edwards SM, 2001, HUM MUTAT, V17, P220, DOI 10.1002/humu.7; Eeles RA, 1999, PROSTATE CANCER P D, V2, P9, DOI 10.1038/sj.pcan.4500279; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gayther SA, 2000, CANCER RES, V60, P4513; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Healey CS, 2000, NAT GENET, V26, P362, DOI 10.1038/81691; Hubert A, 1999, AM J HUM GENET, V65, P921, DOI 10.1086/302525; Hyytinen ER, 1999, GENE CHROMOSOME CANC, V25, P108, DOI 10.1002/(SICI)1098-2264(199906)25:2<108::AID-GCC6>3.0.CO;2-Y; Johannesdottir G, 1996, CANCER RES, V56, P3663; Lehrer S, 1998, BRIT J CANCER, V78, P771, DOI 10.1038/bjc.1998.576; Melamed J, 1997, CLIN CANCER RES, V3, P1867; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Nastiuk KL, 1999, PROSTATE, V40, P172; PARKIN DM, 1992, IARC SCI PUBLICATION, V120; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Sigurdsson S, 1997, J MOL MED-JMM, V75, P758, DOI 10.1007/s001090050162; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Vezina A, 2000, BRIT J CANCER, V83, P463, DOI 10.1054/bjoc.2000.1249; Wagner TMU, 1999, HUM MOL GENET, V8, P413, DOI 10.1093/hmg/8.3.413; Watanabe M, 1998, ONCOLOGY-BASEL, V55, P569, DOI 10.1159/000011914; Wilkens EP, 1999, PROSTATE, V39, P280; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	36	260	265	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					1	12		10.1086/345310	http://dx.doi.org/10.1086/345310			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12474142	Green Published, Bronze			2022-12-18	WOS:000180186800001
J	Richard, G; Rouan, F; Willoughby, CE; Brown, N; Chung, P; Ryynanen, M; Jabs, EW; Bale, SJ; DiGiovanna, JJ; Uitto, J; Russell, L				Richard, G; Rouan, F; Willoughby, CE; Brown, N; Chung, P; Ryynanen, M; Jabs, EW; Bale, SJ; DiGiovanna, JJ; Uitto, J; Russell, L			Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAP JUNCTION PROTEINS; KID-SYNDROME; ERYTHROKERATODERMIA VARIABILIS; CHANNELS; CELLS; KERATODERMA; EXPRESSION; FAMILY; GENE	Keratitis-ichthyosis-deafness syndrome (KID) is a rare ectodermal dysplasia characterized by vascularizing keratitis, profound sensorineural hearing loss (SNHL), and progressive erythrokeratoderma, a clinical triad that indicates a failure in development and differentiation of multiple stratifying epithelia. Here, we provide compelling evidence that KID is caused by heterozygous missense mutations in the connexin-26 gene, GJB2. In each of 10 patients with KID, we identified a point mutation leading to substitution of conserved residues in the cytoplasmic amino terminus or first extracellular domain of Cx26. One of these mutations was detected in six unrelated sporadic case subjects and also segregated in one family with vertical transmission of KID. These results indicate the presence of a common, recurrent mutation and establish its autosomal dominant nature. Cx26 and the closely related Cx30 showed differential expression in epidermal, adnexal, and corneal epithelia but were not significantly altered in lesional skin. However, mutant Cx26 was incapable of inducing intercellular coupling in vitro, which indicates its functional impairment. Our data reveal striking genotype-phenotype correlations and demonstrate that dominant GJB2 mutations can disturb the gap junction system of one or several ectodermal epithelia, thereby producing multiple phenotypes: nonsyndromic SNHL, syndromic SNHL with palmoplantar keratoderma, and KID. Decreased host defense and increased carcinogenic potential in KID illustrate that gap junction communication plays not only a crucial role in epithelial homeostasis and differentiation but also in immune response and epidermal carcinogenesis.	Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, BLSB, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; Univ Liverpool, Dept Med, Expt Ophthalmol Unit, Liverpool L69 3BX, Merseyside, England; Oulu Univ Hosp, Dept Obstet & Gynecol, Oulu, Finland; Johns Hopkins Univ Hosp, Dept Pediat Med & Plast Surg, Inst Med Genet, Baltimore, MD 21287 USA; NIAMSD, Genet Studies Sect, NIH, Bethesda, MD 20892 USA; GeneDx, Rockville, MD USA; Brown Univ, Rhode Isl Hosp, Dept Dermatol, Providence, RI 02903 USA; Montreal Childrens Hosp, Div Med Genet, Montreal, PQ H3H 1P3, Canada	Jefferson University; Jefferson University; University of Liverpool; University of Oulu; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; McGill University	Richard, G (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, BLSB, Suite 450,233 S 10th St, Philadelphia, PA 19107 USA.			Willoughby, Colin/0000-0002-1246-4166; Jabs, Ethylin/0000-0001-8983-5466; DiGiovanna, John J./0000-0002-2750-2313	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002141, P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08-AR02141, P01-AR38923, K08 AR002141, P01 AR038923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; CaceresRios H, 1996, PEDIATR DERMATOL, V13, P105; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; GROB JJ, 1987, ARCH DERMATOL, V123, P777, DOI 10.1001/archderm.123.6.777; Hu J, 1997, J CLIN INVEST, V99, P2312, DOI 10.1172/JCI119410; KAMIBAYASHI Y, 1995, CARCINOGENESIS, V16, P1287, DOI 10.1093/carcin/16.6.1287; Kelsell DP, 2001, AM J HUM GENET, V68, P559, DOI 10.1086/318803; Kone-Paut I, 1998, PEDIATR DERMATOL, V15, P219, DOI 10.1046/j.1525-1470.1998.1998015219.x; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; LEGRAND J, 1982, J FR OPHTALMOL, V5, P441; Macari F, 2000, AM J HUM GENET, V67, P1296; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Martin PEM, 1999, HUM MOL GENET, V8, P2369, DOI 10.1093/hmg/8.13.2369; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; MESNIL M, 1995, CANCER RES, V55, P629; NAZZARO V, 1990, J AM ACAD DERMATOL, V23, P385, DOI 10.1016/0190-9622(90)70229-B; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Ratkay-Traub I, 2001, EXP EYE RES, V73, P291, DOI 10.1006/exer.2001.1040; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Richard G, 2001, Adv Dermatol, V17, P243; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rouan F, 2001, J CELL SCI, V114, P2105; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; Saez JC, 2000, BRAZ J MED BIOL RES, V33, P447, DOI 10.1590/S0100-879X2000000400011; Sawey MJ, 1996, MOL CARCINOGEN, V17, P49, DOI 10.1002/(SICI)1098-2744(199610)17:2<49::AID-MC1>3.3.CO;2-8; Szymko-Bennett YM, 2002, LARYNGOSCOPE, V112, P272, DOI 10.1097/00005537-200202000-00014; TUPPURAINEN K, 1988, ACTA OPHTHALMOL, V66, P692; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; White TW, 1996, J BIOENERG BIOMEMBR, V28, P339, DOI 10.1007/BF02110110	30	260	282	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1341	1348		10.1086/339986	http://dx.doi.org/10.1086/339986			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11912510	Green Published, Bronze			2022-12-18	WOS:000175012400024
J	Grimbacher, B; Schaffer, AA; Holland, SM; Davis, J; Gallin, JI; Malech, HL; Atkinson, TP; Belohradsky, BH; Buckley, RH; Cossu, F; Espanol, T; Garty, BZ; Matamoros, N; Myers, LA; Nelson, RP; Ochs, HD; Renner, ED; Wellinghausen, N; Puck, JM				Grimbacher, B; Schaffer, AA; Holland, SM; Davis, J; Gallin, JI; Malech, HL; Atkinson, TP; Belohradsky, BH; Buckley, RH; Cossu, F; Espanol, T; Garty, BZ; Matamoros, N; Myers, LA; Nelson, RP; Ochs, HD; Renner, ED; Wellinghausen, N; Puck, JM			Genetic linkage of hyper-IgE syndrome to chromosome 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERFERON-GAMMA PRODUCTION; INFECTION JOBS SYNDROME; HYPERIMMUNOGLOBULIN-E; INTERLEUKIN-4 RECEPTOR; T-CELLS; RECURRENT; DEFICIENCY; ASSOCIATION; CHEMOTAXIS	The hyper-IgE syndrome (HIES) is a rare primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and highly elevated levels of serum IgE. HIES is now recognized as a multisystem disorder, with nonimmunologic abnormalities of the dentition, bones, and connective tissue. HIES can be transmitted as an autosomal dominant trait with variable expressivity. Nineteen kindreds with multiple cases of HIES were scored for clinical and laboratory findings and were genotyped with polymorphic markers in a candidate region on human chromosome 4. Linkage analysis showed a maximum two-point LOD score of 3.61 at recombination fraction of 0 with marker D4S428. Multipoint analysis and simulation testing confirmed that the proximal 4q region contains a disease locus for HIES.	Natl Human Genome Res Inst, Immunol Genet Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NIAID, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA; NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Univ Alabama, Dept Pediat, Birmingham, AL USA; Duke Univ, Med Ctr, Dept Pediat & Immunol, Durham, NC USA; Univ S Florida, All Childrens Hosp, Div Clin Immunol & Allergy, St Petersburg, FL 33701 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Hosp Gen Valle Hebron, Immunol Unit, Barcelona, Spain; Hosp Son Dureta, Dept Immunol, Palma de Mallorca, Spain; Osped Microcitemico, Bone Marrow Transplant Unit, Cagliari, Italy; Tel Aviv Univ, Sackler Fac Med, Schneiders Children Med Ctr Israel, IL-69978 Tel Aviv, Israel; Univ Munich, Dr Von Haunerschen Kinderspital, Sect Infect Dis & Clin Immunol, D-80337 Munich, Germany; Univ Ulm, Sect Infect Dis & Clin Immunol, Ulm, Germany	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Alabama System; University of Alabama Birmingham; Duke University; State University System of Florida; University of South Florida; University of Washington; University of Washington Seattle; Hospital Universitari Vall d'Hebron; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Tel Aviv University; Sackler Faculty of Medicine; University of Munich; Ulm University	Puck, JM (corresponding author), Natl Human Genome Res Inst, Immunol Genet Sect, Genet & Mol Biol Branch, NIH, Bldg 49,Room 3A14,49 Convent Dr, Bethesda, MD 20892 USA.		Schaffer, Alejandro A/F-2902-2012; Buckley, Rebecca/AAB-1578-2019; Schaffer, Alejandro/N-1222-2019; Renner, Ellen/R-7168-2016	Renner, Ellen/0000-0001-9816-8538; Malech, Harry/0000-0001-5874-5775; Cossu, Fausto/0000-0001-5485-2098	NICHD NIH HHS [HD17427] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017427, R01HD017427] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Belohradsky B H, 1987, Ergeb Inn Med Kinderheilkd, V55, P1; BLUM R, 1977, J PEDIATR-US, V90, P607, DOI 10.1016/S0022-3476(77)80380-6; Borges WG, 1998, J PEDIATR-US, V133, P303, DOI 10.1016/S0022-3476(98)70243-4; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUCKLEY R H, 1991, Journal of Allergy and Clinical Immunology, V87, P313, DOI 10.1016/0091-6749(91)91978-3; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; BUCKLEY RH, 1982, ANN ALLERGY, V49, P67; BUCKLEY RH, 1978, IMMUNOL REV, V41, P288, DOI 10.1111/j.1600-065X.1978.tb01469.x; BUCKLEY RH, 1996, IMMUNOLOGIC DISORDER, P413; BUCKLEY RH, 1981, CLIN IMMUNOLOGY UPDA, P147; CLAASSEN JJ, 1991, J ALLERGY CLIN IMMUN, V88, P713, DOI 10.1016/0091-6749(91)90177-P; Cohen M M Jr, 1988, Am J Med Genet Suppl, V4, P99; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIS SD, 1966, LANCET, V1, P1013; DONABEDIAN H, 1983, MEDICINE, V62, P195, DOI 10.1097/00005792-198307000-00001; DRESKIN SC, 1987, J CLIN INVEST, V79, P1764, DOI 10.1172/JCI113017; DRESKIN SC, 1985, J CLIN INVEST, V75, P26, DOI 10.1172/JCI111683; DRESKIN SC, 1987, J ALLERGY CLIN IMMUN, V80, P746, DOI 10.1016/0091-6749(87)90297-1; FARKAS LG, 1994, ANTHR HEAD FACE MED, P286; GAHR M, 1987, HELV PAEDIATR ACTA, V42, P185; GEHA RS, 1981, J CLIN INVEST, V68, P783, DOI 10.1172/JCI110315; Grimbacher B, 1998, NEW ENGL J MED, V338, P1073; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; GRIMBACHER B, 1999, IN PRESS GENETICS ME; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; HILL HR, 1974, LANCET, V2, P617; HILL HR, 1974, LANCET, V1, P183; Holland SM, 1998, HARRISONS PRINCIPLES, P351; KING CL, 1989, P NATL ACAD SCI USA, V86, P10085, DOI 10.1073/pnas.86.24.10085; KIRCHNER SG, 1985, RADIOLOGY, V156, P362, DOI 10.1148/radiology.156.2.4011897; KRAEMER MJ, 1981, CLIN RES, V29, pA123; KRAEMER MJ, 1982, CLIN IMMUNOL IMMUNOP, V25, P157, DOI 10.1016/0090-1229(82)90178-7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Ochs H D, 1983, Birth Defects Orig Artic Ser, V19, P57; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P49; PAGANELLI R, 1991, CLIN EXP IMMUNOL, V84, P28; ROUSSET F, 1991, J ALLERGY CLIN IMMUN, V87, P58, DOI 10.1016/0091-6749(91)90213-8; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P77; VANEPPS DE, 1983, CLIN EXP IMMUNOL, V53, P678; VANSCOY RE, 1975, ANN INTERN MED, V82, P766, DOI 10.7326/0003-4819-82-6-766; VERCELLI D, 1990, J CLIN INVEST, V85, P1666, DOI 10.1172/JCI114618; Weeks DE., 1990, AM J HUM GENET, V47, pA203	46	260	274	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					735	744		10.1086/302547	http://dx.doi.org/10.1086/302547			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441580	Green Published, Bronze			2022-12-18	WOS:000082426400018
J	VanCamp, G; Willems, PJ; Smith, RJH				VanCamp, G; Willems, PJ; Smith, RJH			Nonsyndromic hearing impairment: Unparalleled heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							NON-SYNDROMIC DEAFNESS; LINKED MIXED DEAFNESS; RECESSIVE DEAFNESS; POU-DOMAIN; PERICENTROMERIC REGION; SENSORINEURAL DEAFNESS; GENETIC-HETEROGENEITY; TRANSCRIPTION FACTORS; DFNB1 LOCUS; MAPS		UNIV IOWA, DEPT OTOLARYNGOL, MOL OTOLARYNGOL RES LABS, IOWA CITY, IA 52242 USA	University of Iowa	VanCamp, G (corresponding author), UNIV ANTWERP, DEPT MED GENET, UNIVERSITEITSPLEIN 1, B-2610 ANTWERP, BELGIUM.		Van Camp, Guy/F-3386-2013	Van Camp, Guy/0000-0001-5105-9000; Smith, Richard/0000-0003-1201-6731	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842] Funding Source: NIH RePORTER; NIDCD NIH HHS [1RO1 DC02842] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AYADI M, 1996, EUR J HUM GENET, V4, P6; BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BITNERGLINDZICZ M, 1995, HUM MOL GENET, V4, P1467, DOI 10.1093/hmg/4.8.1467; BonneTamir B, 1996, AM J HUM GENET, V58, P1254; Brown KA, 1996, HUM MOL GENET, V5, P169, DOI 10.1093/hmg/5.1.169; BRUNNER HG, 1988, HUM GENET, V80, P337, DOI 10.1007/BF00273647; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; Chaib H, 1996, HUM MOL GENET, V5, P155, DOI 10.1093/hmg/5.1.155; CHAIB H, 1994, HUM MOL GENET, V3, P2219, DOI 10.1093/hmg/3.12.2219; CHEN AH, 1995, HUM MOL GENET, V4, P1073, DOI 10.1093/hmg/4.6.1073; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; CHUNG C S, 1970, American Journal of Human Genetics, V22, P630; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; Cohen M. M., 1995, HEREDITARY HEARING L, P9; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; delCastillo I, 1996, HUM MOL GENET, V5, P1383, DOI 10.1093/hmg/5.9.1383; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Fagerheim T, 1996, HUM MOL GENET, V5, P1187, DOI 10.1093/hmg/5.8.1187; FISCHELGHODSIAN N, 1995, AM J OTOLARYNG, V16, P403, DOI 10.1016/0196-0709(95)90078-0; FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L; Fraser G. R, 1976, BIG 4 CAUSES POVERTY; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; FUKUSHIMA K, 1995, GENOME RES, V5, P305, DOI 10.1101/gr.5.3.305; FUKUSHIMA K, 1995, HUM MOL GENET, V4, P1643, DOI 10.1093/hmg/4.9.1643; GORLIN RJ, 1995, HEREDITARY HEARING L, P43; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; HU DN, 1987, J MED GENET, V24, P589, DOI 10.1136/jmg.24.10.589; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; INGRAHAM HA, 1990, ANNU REV PHYSIOL, V52, P773; JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86; JAIN PK, 1995, HUM MOL GENET, V4, P2391, DOI 10.1093/hmg/4.12.2391; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KIRSCHHOFER K, 1996, 2 WORKSH EUR WORKGR; LALWANI AK, 1994, AM J HUM GENET, V55, P685; LEON PE, 1992, P NATL ACAD SCI USA, V89, P5181, DOI 10.1073/pnas.89.11.5181; LESPERANCE MM, 1995, HUM MOL GENET, V4, P1967, DOI 10.1093/hmg/4.10.1967; Manolis EN, 1996, HUM MOL GENET, V5, P1047, DOI 10.1093/hmg/5.7.1047; Matthijs G, 1996, EUR J HUM GENET, V4, P46; MAW MA, 1995, AM J HUM GENET, V57, P629; MOHR JAN, 1960, ACTA GENET ET STATIST MED, V10, P54; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; ONeill ME, 1996, HUM MOL GENET, V5, P853, DOI 10.1093/hmg/5.6.853; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REARDON W, 1991, GENOMICS, V11, P885, DOI 10.1016/0888-7543(91)90011-3; REARDON W, 1995, J AUDIOL MED, V4, P40; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; SCOTT DA, 1995, AM J HUM GENET, V57, P965; Scott DA, 1996, AM J HUM GENET, V59, P385; STEVENSON AC, 1956, ANN HUM GENET, V20, P177; Tamagawa Y, 1996, HUM MOL GENET, V5, P849, DOI 10.1093/hmg/5.6.849; TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257; Tyson J, 1996, HUM MOL GENET, V5, P2055, DOI 10.1093/hmg/5.12.2055; VANCAMP G, 1995, HUM MOL GENET, V4, P2159; VANCAMP G, 1996, E COMMUNICATION; VANCAMP G, IN PRESS GENOMICS; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165; WALLIS C, 1988, GENOMICS, V3, P299, DOI 10.1016/0888-7543(88)90119-X; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	66	260	277	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					758	764						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106521				2022-12-18	WOS:A1997WT61400004
J	Schmidt, S; Hauser, MA; Scott, WK; Postel, EA; Agarwal, A; Gallins, P; Wong, F; Chen, YS; Spencer, K; Schnetz-Boutaud, N; Haines, JL; Pericak-Vance, MA				Schmidt, S; Hauser, MA; Scott, WK; Postel, EA; Agarwal, A; Gallins, P; Wong, F; Chen, YS; Spencer, K; Schnetz-Boutaud, N; Haines, JL; Pericak-Vance, MA			Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; GENETIC ASSOCIATION; GENOMEWIDE-SCAN; CHOROIDAL NEOVASCULARIZATION; LINKAGE DISEQUILIBRIUM; GEOGRAPHIC ATROPHY; PARENTAL GENOTYPES; EXTENDED FAMILIES; CHROMOSOME 10Q26; GRADING SYSTEM	We used iterative association mapping to identify a susceptibility gene for age-related macular degeneration (AMD) on chromosome 10q26, which is one of the most consistently implicated linkage regions for this disorder. We employed linkage analysis methods, followed by family-based and case-control association analyses, using two independent data sets. To identify statistically the most likely AMD-susceptibility allele, we used the Genotype-IBD Sharing Test (GIST) and conditional haplotype analysis. To incorporate the two most important known AMD risk factors-smoking and the Y402H variant of the complement factor H gene (CFH) - we used logistic regression modeling to test for gene-gene and gene-environment interactions in the case-control data set and used the ordered-subset analysis to account for genetic linkage heterogeneity in the family-based data set. Our results strongly implicate a coding change (Ala69Ser) in the LOC387715 gene as the second major identified AMD-susceptibility allele, confirming earlier suggestions. This variant's effect on AMD is statistically independent of CFH and is of similar magnitude to the effect of Y402H. The overall effect is driven primarily by a strong association in smokers, since we observed significant evidence for a statistical interaction between the LOC387715 variant and a history of cigarette smoking. This gene-environment interaction is supported by statistically independent family-based and case-control analysis methods. We estimate that CFH, LOC387715, and cigarette smoking together explain 61% of the population-attributable risk (PAR) of AMD. The adjusted PAR percentage estimates are 20% for smoking, 36% for LOC387715, and 43% for CFH. We demonstrate, for the first time, that a genetic susceptibility coupled with a modifiable lifestyle factor such as cigarette smoking confers a significantly higher risk of AMD than either factor alone.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Eye Ctr, Durham, NC 27710 USA; Vanderbilt Univ, Med Ctr, Dept Ophthalmol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA	Duke University; Duke University; Vanderbilt University; Vanderbilt University	Schmidt, S (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA.	silke.schmidt@duke.edu	Haines, Jonathan/C-3374-2012; Scott, William/A-7593-2009	Haines, Jonathan/0000-0002-4351-4728; Scott, William/0000-0001-9336-6404	NCRR NIH HHS [RR 00095, M01 RR000095] Funding Source: Medline; NEI NIH HHS [EY12118, R01 EY012118, R03 EY015216, EY015216, U10 EY012118] Funding Source: Medline; NIA NIH HHS [AG11268, P60 AG011268] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012118, U10EY012118, R03EY015216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG011268] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kenealy SJ, 2004, MOL VIS, V10, P57; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klaver CCW, 2001, INVEST OPHTH VIS SCI, V42, P2237; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; Oliveira SA, 2005, AM J HUM GENET, V77, P252, DOI 10.1086/432588; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SCHMIDT M, 2005, STAT APPL GENET MOL, P4; Schmidt S, 2000, MOL VIS, V6, P287; SCOTT WK, 2005, AM SOC HUM GEN 55 AN; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Xu H, 2005, BIOINFORMATICS, V21, P4181, DOI 10.1093/bioinformatics/bti682; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	44	259	271	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					852	864		10.1086/503822	http://dx.doi.org/10.1086/503822			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642439	Green Published, Bronze			2022-12-18	WOS:000236756200010
J	Colige, A; Sieron, AL; Li, SW; Schwarze, U; Petty, E; Wertelecki, W; Wilcox, W; Krakow, D; Cohn, DH; Reardon, W; Byers, PH; Lapiere, CM; Prockop, DJ; Nusgens, BV				Colige, A; Sieron, AL; Li, SW; Schwarze, U; Petty, E; Wertelecki, W; Wilcox, W; Krakow, D; Cohn, DH; Reardon, W; Byers, PH; Lapiere, CM; Prockop, DJ; Nusgens, BV			Human Ehlers-Danlos syndrome type VIIC and bovine dermatosparaxis are caused by mutations in the procollagen IN-proteinase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE MORPHOGENETIC PROTEIN-1; C-PROTEINASE; N-PROTEINASE; COL5A1 GENE; PHENOTYPE; THROMBOSPONDIN; ACTIVATION; PROPEPTIDE; SEQUENCES; COLLAGEN	Ehlers-Danlos syndrome (EDS) type WC is a recessively inherited connective-tissue disorder, characterized by extreme skin fragility, characteristic facies, joint laxity, droopy skin, umbilical hernia, and blue sclera, Like the animal model dermatosparaxis, EDS type WC results from the absence of activity of procollagen I N-proteinase (pNPI), the enzyme that excises the N-propeptide of type I and type II procollagens. The pNPI enzyme is a metalloproteinase containing properdin repeats and a cysteine-rich domain with similarities to the disintegrin domain of reprolysins. We used bovine cDNA to isolate human pNPI. The human enzyme exists in two forms: a long version similar to the bovine enzyme and a short version that contains the Zn++-binding catalytic site but lacks the entire C-terminal domain in which the properdin repeats are located. We have identified the mutations that cause EDS type WC in the six known affected human individuals and also in one strain of dermatosparactic calf. Five of the individuals with EDS type WC were homozygous for a C-->T transition that results in a premature termination codon, Q225X. Four of these five patients were homozygous at three downstream polymorphic sites. The sixth patient was homozygous for a different transition that results in a premature termination codon, W735X. In the dermatosparactic calf, the mutation is a 17-bp deletion that changes the reading frame of the message. These data provide direct evidence that EDS type WC and dermatosparaxis result from mutations in the pNPI gene.	Univ Liege, CHU Sart Tilman, Lab Connect Tissues Biol, B-4000 Liege, Belgium; Allegheny Univ Hlth Sci, MCP Hahnemann Sch Med, Ctr Gene Therapy, Philadelphia, PA 19102 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ S Alabama, Dept Med Genet, Mobile, AL 36688 USA; Univ Calif Los Angeles, Sch Med,Burns & Allen Cedars Sinai Res Inst, Steven Spielberg Pediat Res Ctr, Ahmanson Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; Great Ormond St Hosp Sick Children, Dept Paediat Genet, London, England	University of Liege; Drexel University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of South Alabama; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Colige, A (corresponding author), Univ Liege, CHU Sart Tilman, Lab Connect Tissues Biol, B-4000 Liege, Belgium.	LCTB@ulg.ac.be	Sieron, Aleksander L/G-1700-2013	Byers, Peter H./0000-0001-7786-7030; Reardon, Willie/0000-0001-7329-9179; Sieron, Aleksander L./0000-0002-3894-9508	NIAMS NIH HHS [AR 21557, AR 39837] Funding Source: Medline; NICHD NIH HHS [HD 22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R01AR039837, R29AR039837] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; DePaepe A, 1997, AM J HUM GENET, V60, P547; Fujimoto A, 1997, AM J MED GENET, V68, P25, DOI 10.1002/(SICI)1096-8628(19970110)68:1<25::AID-AJMG5>3.0.CO;2-X; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; HANSET R, 1967, ANN MED VET, V7, P451; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; LEVINSON B, 1993, NAT GENET, V3, P6, DOI 10.1038/ng0193-6; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; NUSGENS BV, 1992, NAT GENET, V1, P214, DOI 10.1038/ng0692-214; PETTY EM, 1993, ARCH DERMATOL, V129, P1310, DOI 10.1001/archderm.129.10.1310; PIERARD GE, 1976, J INVEST DERMATOL, V66, P2, DOI 10.1111/1523-1747.ep12477969; Reardon W, 1995, Clin Dysmorphol, V4, P1; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; SMITH LT, 1992, AM J HUM GENET, V51, P235; Steinmann Beat, 1993, P351; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; TUSZYNSKI GP, 1992, J CELL BIOL, V116, P209, DOI 10.1083/jcb.116.1.209; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WERTELECKI W, 1992, J PEDIATR-US, V121, P558, DOI 10.1016/S0022-3476(05)81144-8	31	259	274	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					308	317		10.1086/302504	http://dx.doi.org/10.1086/302504			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417273	Bronze, Green Published			2022-12-18	WOS:000081836900006
J	NAROD, SA; FORD, D; DEVILEE, P; BARKARDOTTIR, RB; LYNCH, HT; SMITH, SA; PONDER, BAJ; WEBER, BL; GARBER, JE; BIRCH, JM; CORNELIS, RS; KELSELL, DP; SPURR, NK; SMYTH, E; HAITES, N; SOBOL, H; BIGNON, YJ; CHANGCLAUDE, J; HAMANN, U; LINDBLOM, A; BORG, A; PIVER, MS; GALLION, HH; STRUEWING, JP; WHITTEMORE, A; TONIN, P; GOLDGAR, DE; EASTON, DF; MILNER, B; ALLAN, L; SIMARD, J; ROMMENS, J; MCGILLIVRAY, B; GREEN, R; IVES, E; BOYD, N; ROSEN, B; COLE, D; MORGAN, K; MOSLEHI, R; PONDER, B; PETO, J; SMITH, S; STRATTON, M; DICIOCCIO, RA; GALLION, H; SANTIBANEZKOREF, MS; TEARE, MD; EVANS, DG; STOPPALYONNET, D; LALLE, P; BONAITI, C; ESSIOUX, L; GIRODET, C; MAUGARDLOUBOUTIN, C; NICOLLEAU, G; LONGY, M; TOULOUSE, C; HORSTEIN, I; BIRNBAUM, D; EISINGER, F; KARENGUEVEN, F; NOGUCHI, T; HARDOUIN, A; RIO, P; MACHELARDROUMAGNAC, M; NOGUES, C; COHENHAGUENAUER, O; LORTHOLARY, A; BAY, JO; ARASON, A; BARKDARDOTTIR, RB; EGILSSON, V; BISHOP, DT; KELSELL, D; MURDAY, VA; SOLOMON, E; SPURR, N; TURNER, G; LENOIR, G; FEUNTEUN, J; LYNCH, H; LYNCH, J; WATSON, P; CONWAY, T; BONNARDEL, C; SEROVA, O; TORCHARD, D; LARSSON, C; VASEN, H; VANLEEUWEN, I; CORNELISSE, CJ; STEEL, M; PORTER, D; COHEN, BB; CAROTHERS, A; CANNONALBRIGHT, LA; GOLDGAR, D; SKOLNICK, M; BECHER, H; JOHANNSSON, O; WEBER, B; COLLINS, F; BOEHNKE, M; GARBER, J; LI, F				NAROD, SA; FORD, D; DEVILEE, P; BARKARDOTTIR, RB; LYNCH, HT; SMITH, SA; PONDER, BAJ; WEBER, BL; GARBER, JE; BIRCH, JM; CORNELIS, RS; KELSELL, DP; SPURR, NK; SMYTH, E; HAITES, N; SOBOL, H; BIGNON, YJ; CHANGCLAUDE, J; HAMANN, U; LINDBLOM, A; BORG, A; PIVER, MS; GALLION, HH; STRUEWING, JP; WHITTEMORE, A; TONIN, P; GOLDGAR, DE; EASTON, DF; MILNER, B; ALLAN, L; SIMARD, J; ROMMENS, J; MCGILLIVRAY, B; GREEN, R; IVES, E; BOYD, N; ROSEN, B; COLE, D; MORGAN, K; MOSLEHI, R; PONDER, B; PETO, J; SMITH, S; STRATTON, M; DICIOCCIO, RA; GALLION, H; SANTIBANEZKOREF, MS; TEARE, MD; EVANS, DG; STOPPALYONNET, D; LALLE, P; BONAITI, C; ESSIOUX, L; GIRODET, C; MAUGARDLOUBOUTIN, C; NICOLLEAU, G; LONGY, M; TOULOUSE, C; HORSTEIN, I; BIRNBAUM, D; EISINGER, F; KARENGUEVEN, F; NOGUCHI, T; HARDOUIN, A; RIO, P; MACHELARDROUMAGNAC, M; NOGUES, C; COHENHAGUENAUER, O; LORTHOLARY, A; BAY, JO; ARASON, A; BARKDARDOTTIR, RB; EGILSSON, V; BISHOP, DT; KELSELL, D; MURDAY, VA; SOLOMON, E; SPURR, N; TURNER, G; LENOIR, G; FEUNTEUN, J; LYNCH, H; LYNCH, J; WATSON, P; CONWAY, T; BONNARDEL, C; SEROVA, O; TORCHARD, D; LARSSON, C; VASEN, H; VANLEEUWEN, I; CORNELISSE, CJ; STEEL, M; PORTER, D; COHEN, BB; CAROTHERS, A; CANNONALBRIGHT, LA; GOLDGAR, D; SKOLNICK, M; BECHER, H; JOHANNSSON, O; WEBER, B; COLLINS, F; BOEHNKE, M; GARBER, J; LI, F			AN EVALUATION OF GENETIC-HETEROGENEITY IN 145 BREAST-CANCER OVARIAN-CANCER FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRCA1 REGION; ALLELE LOSS; CHROMOSOME-17Q21; SUSCEPTIBILITY; LINKAGE; ONSET; MAPS; INTERVAL; MARKERS; RISKS	The breast-ovary cancer-family syndrome is a dominant predisposition to cancer of the breast and ovaries which has been mapped to chromosome region 17q12-q21. The majority, but not all, of breast-ovary cancer families show linkage to this susceptibility locus, designated BRCA1. We report here the results of a linkage analysis of 145 families with both breast and ovarian cancer. These families contain either a total of three or more cases of early-onset (before age 60 years) breast cancer or ovarian cancer. All families contained at least one case of ovarian cancer, Overall, an estimated 76% of the 145 families are linked to the BRCA1 locus. None of 13 families with cases of male breast cancer appear to be linked, but it is estimated that 92% (95% confidence interval 76%-100%) of families with no male breast cancer and with two or more ovarian cancers are linked to BRCA1. These data suggest that the breast-ovarian cancer-family syndrome is genetically heterogeneous. However, the large majority of families with early-onset breast cancer and with two or more cases of ovarian cancer are likely to be due to BRCA1 mutations.	MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; INST CANC RES,EPIDEMIOL SECT,SUTTON,SURREY,ENGLAND; LEIDEN UNIV,DEPT PATHOL,LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; UNIV HOSP ICELAND,DEPT PATHOL,REYKJAVIK,ICELAND; CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE 68178; UNIV CAMBRIDGE,DEPT PATHOL,HUMAN CANC GENET RES GRP,CANC RES CAMPAIGN,CAMBRIDGE,ENGLAND; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; UNIV MANCHESTER,PEDIAT & FAMILIAL CANC RES GRP,CANC RES CAMPAIGN,MANCHESTER,LANCS,ENGLAND; IMPERIAL CANC RES FUND,HUMAN GENET RESOURCES LAB,POTTERS BAR,HERTS,ENGLAND; WESTERN GEN HOSP,HUMAN GENET UNIT,MRC,EDINBURGH,MIDLOTHIAN,SCOTLAND; UNIV ABERDEEN,DEPT MOLEC & CELL BIOL,ABERDEEN,SCOTLAND; INST J PAOLI I CALMETTES,DEPT ONCOL GENET,MARSEILLE,FRANCE; CTR JEAN PERRIN,MOLEC ONCOL LAB,CLERMONT FERRAND,FRANCE; GERMAN CANC RES CTR,DIV EPIDEMIOL,HEIDELBERG,GERMANY; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN; UNIV LUND HOSP,LUND,SWEDEN; ROSWELL PK CANC INST,BUFFALO,NY; NIH,GENET EPIDEMIOL BRANCH,BETHESDA,MD; STANFORD UNIV,SCH MED,DIV EPIDEMIOL,STANFORD,CA; UNIV UTAH,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT	McGill University; McGill University; University of London; Institute of Cancer Research - UK; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Landspitali National University Hospital; Creighton University; CRUK Cambridge Institute; University of Cambridge; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Manchester; University of Edinburgh; University of Aberdeen; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Jean Perrin; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; Stanford University; Utah System of Higher Education; University of Utah			Narod, Steven A/AAA-6112-2022; , bignon/Y-3243-2019; LALLE, Philippe/G-7734-2018; DEVILEE, PETER/ABR-2140-2022; Evans, D Gareth/AAB-4308-2022; Struewing, Jeffery P/I-7502-2013; Kelsell, David P/F-8767-2011; Struewing, Jeffery P/C-3221-2008; Becher, Heiko/ABI-1234-2020; Feunteun, Jean/AAZ-1267-2020	Evans, D Gareth/0000-0002-8482-5784; Struewing, Jeffery P/0000-0002-4848-3334; Kelsell, David/0000-0002-9910-7144; Bishop, Tim/0000-0002-8752-8785				AMOS CI, 1992, JAMA-J AM MED ASSOC, V268, P1896, DOI 10.1001/jama.268.14.1896; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BEWTRA C, 1992, INT J GYNECOL PATHOL, V11, P180, DOI 10.1097/00004347-199207000-00003; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; BULLER RE, 1993, GYNECOL ONCOL, V51, P160, DOI 10.1006/gyno.1993.1265; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CORNELIS RS, 1993, ONCOGENE, V8, P781; EASTON D, 1993, CANCER SURV, V18, P95; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FOULKES W, 1991, LANCET, V338, P444, DOI 10.1016/0140-6736(91)91065-3; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; GOLDGAR DE, 1993, AM J HUM GENET, V52, P743; GREGGI S, 1990, GYNECOL ONCOL, V39, P300, DOI 10.1016/0090-8258(90)90256-K; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JOLLY KW, 1994, ONCOGENE, V9, P97; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LYNCH HT, 1993, ARCH INTERN MED, V153, P1979; NAROD S, 1994, LANCET, V343, P236, DOI 10.1016/S0140-6736(94)91021-9; NAROD S, 1993, CLIN INVEST MED, V16, P314; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; NAROD SA, 1991, LANCET, V338, P82; OTT J, 1985, ANAL HUMAN GENETIC L; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P582; SAITO H, 1993, CANCER RES, V53, P3382; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; SMITH SA, 1994, GENE CHROMOSOME CANC, V10, P71, DOI 10.1002/gcc.2870100112; SMITH SA, 1993, AM J HUM GENET, V52, P767; SOBOL H, 1992, HUM GENET, V89, P381; STEICHENGERSDOR.E, 1994, AM J HUM GENET, V55, P870; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; TONIN P, 1994, HUM MOL GENET, V3, P1679, DOI 10.1093/hmg/3.9.1679; VARESCO L, 1992, GENE CHROMOSOME CANC, V4, P84, DOI 10.1002/gcc.2870040113; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	39	259	266	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					254	264						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825586				2022-12-18	WOS:A1995QC10100033
J	Palanichamy, MG; Sun, C; Agrawal, S; Bandelt, HJ; Kong, QP; Khan, F; Wang, CY; Chaudhuri, TK; Palla, V; Zhang, YP				Palanichamy, MG; Sun, C; Agrawal, S; Bandelt, HJ; Kong, QP; Khan, F; Wang, CY; Chaudhuri, TK; Palla, V; Zhang, YP			Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: Implications for the peopling of South Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CODING REGION SNPS; GENOME VARIATION; GENETIC-EVIDENCE; WEST; POPULATION; LINEAGES; HISTORY; PHYLOGEOGRAPHY; POLYMORPHISMS; DISPERSAL	To resolve the phylogeny of the autochthonous mitochondrial DNA (mtDNA) haplogroups of India and determine the relationship between the Indian and western Eurasian mtDNA pools more precisely, a diverse subset of 75 macrohaplogroup N lineages was chosen for complete sequencing from a collection of >1800 control-region sequences sampled across India. We identified five new autochthonous haplogroups (R7, R8, R30, R31, and N5) and fully characterized the autochthonous haplogroups (R5, R6, N1d, U2a, U2b, and U2c) that were previously described only by first hypervariable segment (HVS-I) sequencing and coding-region restriction-fragment-length polymorphism analysis. Our findings demonstrate that the Indian mtDNA pool, even when restricted to macrohaplogroup N, harbors at least as many deepest-branching lineages as the western Eurasian mtDNA pool. Moreover, the distribution of the earliest branches within haplogroups M, N, and R across Eurasia and Oceania provides additional evidence for a three-founder-mtDNA scenario and a single migration route out of Africa.	Chinese Acad Sci, Kunming Inst Zool, Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China; Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; Sanjay Gandhi Postgrad Inst Med Sci, Dept Med Genet, Lucknow, Uttar Pradesh, India; Univ Hamburg, Fachbereich Math, Hamburg, Germany; N Bengal Univ, Dept Zool, Siliguri W Bengal, India; Sri Venkateswara Univ, Dept Anthropol, Tirupati 517502, Andhra Pradesh, India	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sanjay Gandhi Postgraduate Institute of Medical Sciences; University of Hamburg; University of North Bengal; Sri Venkateswara University	Zhang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China.	zhangyp1@263.net.cn	Sun, Chang/I-6326-2012					Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Allard Marc W, 2004, Leg Med (Tokyo), V6, P11, DOI 10.1016/j.legalmed.2003.08.004; Allard MW, 2002, J FORENSIC SCI, V47, P1215; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BAIG M, IN PRESS ANN HUM GEN; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Brandstatter A, 2003, INT J LEGAL MED, V117, P291, DOI 10.1007/s00414-003-0395-2; Bulayeva K, 2003, HUM BIOL, V75, P837, DOI 10.1353/hub.2004.0003; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Crimi Marco, 2002, Hum Mutat, V20, P409, DOI 10.1002/humu.9079; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, RUSS J GENET+, V38, P1316, DOI 10.1023/A:1021111530654; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Hedges SB, 2000, NATURE, V408, P652, DOI 10.1038/35047193; Herrnstadt, 2002, AM J HUM GENET, V71, P448; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kaur I, 2002, HUM BIOL, V74, P819; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2003, EXAMINING FARMING LA, P215; Kivisild Toomas, 2000, ARCHAEOGENETICS DNA, P267; Kong QP, 2004, J HUM GENET, V49, P414, DOI 10.1007/s10038-004-0170-3; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; KONG QP, 2003, AM J HUM GENET, V75, P157; LOOGVALI EL, 2004, MOL BIOL EVOL; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; McElreavey K, 2002, Community Genet, V5, P153, DOI 10.1159/000066328; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Oppenheimer S., 2003, OUT EDEN PEOPLING WO; Passarino G, 1996, AM J HUM GENET, V59, P927; Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rocha H, 1999, AM J HUM GENET, V65, P1457, DOI 10.1086/302641; Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703; Roy S, 2003, ANN HUM BIOL, V30, P443, DOI 10.1080/0301446031000111410; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; TAYLOR RW, 2002, NUCLEIC ACIDS RES, V29, pE85; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511	56	258	270	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					966	978		10.1086/425871	http://dx.doi.org/10.1086/425871			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15467980	Green Published, Bronze			2022-12-18	WOS:000224866400003
J	Hollox, EJ; Armour, JAL; Barber, JCK				Hollox, EJ; Armour, JAL; Barber, JCK			Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME REGION 8P23.1; HUMAN-GENOME; SEGMENTAL DUPLICATIONS; HOST-DEFENSE; PEPTIDE; VARIANT; HYBRIDIZATION; POLYMORPHISMS; POPULATIONS; EXPRESSION	Using a combination of multiplex amplifiable probe hybridization and semiquantitative fluorescence in situ hybridization (SQ-FISH), we analyzed DNA copy number variation across chromosome band 8p23.1, a region that is frequently involved in chromosomal rearrangements. We show that a cluster of at least three antimicrobial beta-defensin genes (DEFB4, DEFB103, and DEFB104) at 8p23.1 are polymorphic in copy number, with a repeat unit greater than or equal to 240 kb long. Individuals have 2 - 12 copies of this repeat per diploid genome. By segregation, microsatellite dosage, and SQ-FISH chromosomal signal intensity ratio analyses, we deduce that individual chromosomes can have one to eight copies of this repeat unit. Chromosomes with seven or eight copies of this repeat unit are identifiable by cytogenetic analysis as a previously described 8p23.1 euchromatic variant. Analysis of RNA from different individuals by semiquantitative reverse-transcriptase polymerase chain reaction shows a significant correlation between genomic copy number of DEFB4 and levels of its messenger RNA ( mRNA) transcript. The peptides encoded by these genes are potent antimicrobial agents, especially effective against clinically important pathogens, such as Pseudomonas aeruginosa and Staphylococcus aureus, and DEFB4 has been shown to act as a cytokine linking the innate and adaptive immune responses. Therefore, a copy number polymorphism involving these genes, which is reflected in mRNA expression levels, is likely to have important consequences for immune system function.	Univ Nottingham, Inst Genet, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England; Salisbury Dist Hosp, Salisbury, England; Southampton Univ Hosp Trust, Div Human Genet, Southampton, Hants, England	University of Nottingham; Salisbury District Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust	Hollox, EJ (corresponding author), Univ Nottingham, Inst Genet, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England.			Hollox, Edward/0000-0002-0115-2298; Armour, John/0000-0002-8558-8506				Armour JAL, 2000, NUCLEIC ACIDS RES, V28, P605, DOI 10.1093/nar/28.2.605; Ausubel F, 1997, SHORT PROTOCOLS MOL; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Barber JCK, 1998, J MED GENET, V35, P491, DOI 10.1136/jmg.35.6.491; Barber JCK, 1999, HUM GENET, V104, P211, DOI 10.1007/s004390050938; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Engelen JJM, 2000, AM J MED GENET, V91, P18, DOI 10.1002/(SICI)1096-8628(20000306)91:1<18::AID-AJMG3>3.3.CO;2-V; Fan YS, 2001, AM J MED GENET, V103, P231, DOI 10.1002/ajmg.1534.abs; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gu X, 1999, MOL BIOL EVOL, V16, P147, DOI 10.1093/oxfordjournals.molbev.a026097; Harada N, 2002, AM J MED GENET, V111, P285, DOI 10.1002/ajmg.10584; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hollox EJ, 2002, J MED GENET, V39, P790, DOI 10.1136/jmg.39.11.790; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Jurevic RJ, 2002, GENET TEST, V6, P261, DOI 10.1089/10906570260471787; Kennedy SJ, 2001, AM J MED GENET, V104, P79, DOI 10.1002/1096-8628(20011115)104:1<79::AID-AJMG1598>3.0.CO;2-T; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Mars WM, 1995, J BIOL CHEM, V270, P30371, DOI 10.1074/jbc.270.51.30371; Morrison GM, 2003, MOL BIOL EVOL, V20, P460, DOI 10.1093/molbev/msg060; MURPHY LD, 1990, BIOCHEMISTRY-US, V29, P10351, DOI 10.1021/bi00497a009; O'Malley DP, 1999, PRENATAL DIAG, V19, P183; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Pramanik S, 2002, AM J HUM GENET, V71, P1342, DOI 10.1086/344713; Robledo R, 2002, GENOMICS, V80, P585, DOI 10.1006/geno.2002.7014; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Singh PK, 1999, P NATL ACAD SCI USA, V96, P2569; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Siniscalco M, 2000, TRENDS GENET, V16, P435, DOI 10.1016/S0168-9525(00)02101-6; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Tsai CH, 2002, J MED GENET, V39, P769, DOI 10.1136/jmg.39.10.769; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yu CE, 2002, AM J HUM GENET, V71, P100, DOI 10.1086/341291; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	46	258	293	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					591	600		10.1086/378157	http://dx.doi.org/10.1086/378157			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12916016	Green Published, Bronze			2022-12-18	WOS:000185134000011
J	Ensenauer, RE; Adeyinka, A; Flynn, HC; Michels, VV; Lindor, NM; Dawson, DB; Thorland, EC; Lorentz, CP; Goldstein, JL; McDonald, MT; Smith, WE; Simon-Fayard, E; Alexander, AA; Kulharya, AS; Ketterling, RP; Clark, RD; Jalal, SM				Ensenauer, RE; Adeyinka, A; Flynn, HC; Michels, VV; Lindor, NM; Dawson, DB; Thorland, EC; Lorentz, CP; Goldstein, JL; McDonald, MT; Smith, WE; Simon-Fayard, E; Alexander, AA; Kulharya, AS; Ketterling, RP; Clark, RD; Jalal, SM			Microduplication 22q11.2, an emerging syndrome: Clinical, cytogenetic, and molecular analysis of thirteen patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAT-EYE SYNDROME; LOW-COPY REPEATS; CARDIO-FACIAL SYNDROME; INTERSTITIAL DUPLICATION; GENOMIC DISORDERS; DELETION SYNDROME; TANDEM DUPLICATION; CHROMOSOME 22Q11; PROXIMAL 22Q; MECHANISMS	Chromosome 22, particularly band 22q11.2, is predisposed to rearrangements due to misalignments of low-copy repeats (LCRs). DiGeorge/velocardiofacial syndrome (DG/VCFS) is a common disorder resulting from microdeletion within the same band. Although both deletion and duplication are expected to occur in equal proportions as reciprocal events caused by LCR-mediated rearrangements, very few microduplications have been identified. We have identified 13 cases of microduplication 22q11.2, primarily by interphase fluorescence in situ hybridization (FISH). The size of the duplications, determined by FISH probes from bacterial artificial chromosomes and P-1 artificial chromosomes, range from 3-4 Mb to 6 Mb, and the exchange points seem to involve an LCR. Molecular analysis based on 15 short tandem repeats confirmed the size of the duplications and indicated that at least 1 of 15 loci has three alleles present. The patients' phenotypes ranged from mild to severe, sharing a tendency for velopharyngeal insufficiency with DG/VCFS but having other distinctive characteristics, as well. Although the present series of patients was ascertained because of some overlapping features with DG/VCF syndromes, the microduplication of 22q11.2 appears to be a new syndrome.	Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Cytogenet Lab, Rochester, MN 55905 USA; Mayo Clin, Dept Med Genet, Rochester, MN USA; Mayo Clin, Dept Lab Med & Pathol, Mol Genet Lab, Rochester, MN USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Barbara Bush Childrens Hosp, Maine Med Ctr, Div Genet, Portland, ME USA; Loma Linda Univ, Med Ctr, Dept Pediat, Div Neonatol, Loma Linda, CA USA; Loma Linda Univ, Childrens Hosp, Div Genet, Loma Linda, CA 92350 USA; Desert Pediat Inc, Palm Desert, CA USA; Med Coll Georgia, Dept Pediat & Pathol, Augusta, GA 30912 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Duke University; Maine Medical Center; Loma Linda University; Children's Hospital Los Angeles; Loma Linda University; University System of Georgia; Augusta University	Jalal, SM (corresponding author), Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Cytogenet Lab, Rochester, MN 55905 USA.	sjalal@mayo.edu		Ketterling, Rhett/0000-0001-6479-7897				Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Collins JE, 1997, GENOME RES, V7, P522, DOI 10.1101/gr.7.5.522; CRIFASI PA, 1995, MAYO CLIN PROC, V70, P1148, DOI 10.4065/70.12.1148; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Emanuel B S, 2001, Adv Pediatr, V48, P39; Fujimoto A, 1996, AM J MED GENET, V62, P300, DOI 10.1002/(SICI)1096-8628(19960329)62:3<300::AID-AJMG19>3.3.CO;2-3; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; Hassed SJ, 2002, AM J HUM GENET, V71, P297; Kato T, 2003, GENET MED, V5, P113, DOI 10.1097/01.GIM.0000056828.03164.30; KNOLL JHM, 1995, AM J MED GENET, V55, P221, DOI 10.1002/ajmg.1320550214; Krepischi-Santos ACV, 2003, AM J MED GENET A, V117A, P41, DOI 10.1002/ajmg.a.10634; LINDSAY EA, 1995, AM J MED GENET, V56, P296, DOI 10.1002/ajmg.1320560316; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; Meins M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e62; Papenhausen PR, 2002, AM J HUM GENET, V71, P302; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; PRASHER VP, 1995, J MED GENET, V32, P306, DOI 10.1136/jmg.32.4.306; REISS JA, 1985, AM J MED GENET, V20, P165, DOI 10.1002/ajmg.1320200120; Rosias PPR, 2001, GENET COUNSEL, V12, P273; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaikh TH, 2001, GENET MED, V3, P6, DOI 10.1097/00125817-200101000-00003; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; TAYLOR KM, 1977, AM J MED GENET, V1, P3, DOI 10.1002/ajmg.1320010103; Thomas JA, 2003, AM J MED GENET A, V119A, P111, DOI 10.1002/ajmg.a.10176; Worthington S, 1997, J MED GENET, V34, P79, DOI 10.1136/jmg.34.1.79	31	257	275	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1027	1040		10.1086/378818	http://dx.doi.org/10.1086/378818			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14526392	Green Published, Bronze			2022-12-18	WOS:000186493400005
J	Buxbaum, JD; Silverman, JM; Smith, CJ; Kilifarski, M; Reichert, J; Hollander, E; Lawlor, BA; Fitzgerald, M; Greenberg, DA; Davis, KL				Buxbaum, JD; Silverman, JM; Smith, CJ; Kilifarski, M; Reichert, J; Hollander, E; Lawlor, BA; Fitzgerald, M; Greenberg, DA; Davis, KL			Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-LOCUS APPROXIMATIONS; FAMILY-HISTORY; LINKAGE ANALYSES; GENOMIC SCREEN; TWIN; PHENOTYPE; ADEQUACY; DISORDER; POWER; 7Q	Although there is considerable evidence for a strong genetic component to idiopathic autism, several genomewide screens for susceptibility genes have been performed with limited concordance of linked loci, reflecting either numerous genes of weak effect and/or sample heterogeneity. Because decreasing sample heterogeneity would increase the power to identify genes, the effect on evidence for linkage of restricting a sample of autism-affected relative pairs to those with delayed onset (at age >36 mo) of phrase speech (PSD, for phrase speech delay) was studied. In the second stage of a two-stage genome screen for susceptibility loci involving 95 families with two or more individuals with autism or related disorders, a maximal multipoint heterogeneity LOD score (HLOD) of 1.96 and a maximal multipoint nonparametric linkage (NPL) score of 2.39 was seen on chromosome 2q. Restricting the analysis to the subset of families (n = 49) with two or more individuals having a narrow diagnosis of autism and PSD generated a maximal multipoint HLOD score of 2.99 and an NPL score of 3.32. The increased scores in the restricted sample, together with evidence for heterogeneity in the entire sample, indicate that the restricted sample comprises a population that is more genetically homogeneous, which could therefore increase the likelihood of positional cloning of susceptibility loci.	CUNY Mt Sinai Sch Med, Dept Psychiat, Lab Mol Neuropsychiat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Seaver Autism Res Ctr, New York, NY 10029 USA; St James Hosp, Dept Psychiat Elderly, Dublin 8, Ireland; Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland; St Patricks Hosp, Dublin, Ireland	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Buxbaum, JD (corresponding author), CUNY Mt Sinai Sch Med, Dept Psychiat, Lab Mol Neuropsychiat, 1 Gustave L Levy Pl,Box 1230, New York, NY 10029 USA.	buxbaj01@doc.mssm.edu	Buxbaum, Joseph D/G-6001-2010; Silverman, Jeremy M./AAO-4268-2020	Buxbaum, Joseph/0000-0001-8898-8313				Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Auranen M, 2000, MOL PSYCHIATR, V5, P320, DOI 10.1038/sj.mp.4000708; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Bass MP, 2000, AM J HUM GENET, V67, P349; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2000, AM J HUM GENET, V67, P349; Folstein SE, 1999, J CHILD PSYCHOL PSYC, V40, P1117, DOI 10.1111/1469-7610.00528; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; *INT MOL GEN STUD, 2000, COLL INT NEUR 22 C B; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MacLean JE, 1999, J AM ACAD CHILD PSY, V38, P746, DOI 10.1097/00004583-199906000-00023; MORTON NE, 1956, AM J HUM GENET, V8, P80; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Piven J, 1997, AM J PSYCHIAT, V154, P185; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPIKER D, 1994, AM J MED GENET, V54, P27, DOI 10.1002/ajmg.1320540107; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; VIELAND V, 1992, CYTOGENET CELL GENET, V59, P145, DOI 10.1159/000133229; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155	35	257	268	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1514	1520		10.1086/320588	http://dx.doi.org/10.1086/320588			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	439DB	11353400	Bronze, Green Published			2022-12-18	WOS:000169094600023
J	Duggirala, R; Blangero, J; Almasy, L; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP				Duggirala, R; Blangero, J; Almasy, L; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP			Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SULFONYLUREA RECEPTOR GENE; MAJOR SUSCEPTIBILITY LOCUS; ACID-BINDING PROTEIN; GENOME DATA-BASE; INSULIN-RESISTANCE; QUANTITATIVE TRAITS; CARDIOVASCULAR RISK; EXTENDED PEDIGREES; SAN-ANTONIO; NIDDM	Since little is known about chromosomal locations harboring type 2 diabetes-susceptibility genes, we conducted a genomewide scan for such genes in a Mexican American population. We used data from 27 low-income extended Mexican American pedigrees consisting of 440 individuals for whom genotypic data are available for 379 markers. We used a variance-components technique to conduct multipoint linkage analyses for two phenotypes: type 2 diabetes (a discrete trait) and age at onset of diabetes (a truncated quantitative trait). For the multipoint analyses, a subset of 295 markers was selected on the basis of optimal spacing and informativeness. We found significant evidence that a susceptibility locus near the marker D10S587 on chromosome 10q influences age at onset of diabetes (LOD score 3.75) and is also linked with type 2 diabetes itself (LOD score 2.88). This susceptibility locus explains 63.8% +/- 9.9% (P = .000016) of the total phenotypic variation in age at onset of diabetes and 65.7% +/- 10.9% (P = .000135) of the total variation in liability to type 2 diabetes. Weaker evidence was found for linkage of diabetes and of age at onset to regions on chromosomes 3p, 4q, and 9p. In conclusion, our strongest evidence for linkage to both age at onset of diabetes and type 2 diabetes itself in the Mexican American population was for a region on chromosome 10q.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78284 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute	Duggirala, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78284 USA.		Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019	Leach, Robin/0000-0002-3201-5579	NIDDK NIH HHS [DK47482, DK44297, DK42273] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042273, R01DK047482, R29DK044297] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; BROSSEAU JD, 1979, AM J PUBLIC HEALTH, V69, P1277, DOI 10.2105/AJPH.69.12.1277; CANNINGS C, 1977, CLIN GENET, V12, P208; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CNATOR A, 1997, EXTENDING SAS SURVIV; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Davis S, 1996, AM J HUM GENET, V58, P867; Diehl A K, 1989, Adv Intern Med, V34, P73; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Duggirala R, 1996, AM J HUM GENET, V59, P694; Dyke B, 1996, PEDSYS PEDIGREE DATA; ELBEIN S, 1997, DIABETES S1, V57, pA51; Elbein SC, 1997, J NUTR, V127, pS1891, DOI 10.1093/jn/127.9.1891S; Elston RC, 1998, AM J HUM GENET, V63, P931, DOI 10.1086/302073; ELSTON RC, 1974, AM J HUM GENET, V26, P13; Farrall M, 1997, AM J HUM GENET, V60, P735; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; FROUGEL P, 1992, NATURE, V356, P162; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Ghosh S, 1996, DIABETES, V45, P1, DOI 10.2337/diabetes.45.1.1; Green P., 1990, DOCUMENTATION CRIMAP; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Greenberg DA, 1997, AM J HUM GENET, V60, P738; Hani E, 1997, DIABETES, V46, P688, DOI 10.2337/diabetes.46.4.688; Hani EH, 1997, DIABETES, V46, P1225, DOI 10.2337/diab.46.7.1225; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HANSON RL, 1995, AM J HUM GENET, V57, P160; Hanson RL, 1997, DIABETES S1, V46, pA51; Inoue H, 1996, DIABETES, V45, P825, DOI 10.2337/diabetes.45.6.825; Kahn CR, 1996, ANNU REV MED, V47, P509; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kong A, 1997, NAT GENET, V17, P148, DOI 10.1038/ng1097-148; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lindner T, 1997, DIABETES, V46, P1227, DOI 10.2337/diab.46.7.1227; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MCCARTHY M, 1997, DIABETES S1, V46, pA52; MCCARTHY MI, 1994, DIABETOLOGIA, V37, P959, DOI 10.1007/s001250050205; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; MITCHELL BD, 1995, DIABETES, V44, P1046, DOI 10.2337/diabetes.44.9.1046; Mitchell BD, 1998, DIABETES, V47, pA170; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; OCONNELL P, 1994, GENOMICS, V24, P557, DOI 10.1006/geno.1994.1666; Ohta Y, 1998, DIABETES, V47, P476, DOI 10.2337/diabetes.47.3.476; PILLAY TS, 1995, ADV GENET, V32, P51; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; REWERS M, 1995, NIH PUBLICATION, P179; Sakul H, 1998, DIABETES, V47, pA71; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Serjeantson S, 1984, DIABETES MELLITUS RE, P23; Stern MP, 1996, DIABETES, V45, P563, DOI 10.2337/diabetes.45.5.563; STERN MP, 1984, AM J EPIDEMIOL, V120, P834, DOI 10.1093/oxfordjournals.aje.a113956; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; STIRLING B, 1995, DIABETOLOGIA, V38, P1479, DOI 10.1007/BF00400610; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Verge CF, 1998, DIABETES, V47, pA220; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; *WHO, 1985, WHO TECH REP SER, V277, P1; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Zimmet P, 1979, Diabetes Care, V2, P144, DOI 10.2337/diacare.2.2.144	73	257	273	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1127	1140		10.1086/302316	http://dx.doi.org/10.1086/302316			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090898	Bronze, Green Published			2022-12-18	WOS:000079632900024
J	Comas, D; Calafell, F; Mateu, E; Perez-Lezaun, A; Bosch, E; Martinez-Arias, R; Clarimon, J; Facchini, F; Fiori, G; Luiselli, D; Pettener, D; Bertranpetit, J				Comas, D; Calafell, F; Mateu, E; Perez-Lezaun, A; Bosch, E; Martinez-Arias, R; Clarimon, J; Facchini, F; Fiori, G; Luiselli, D; Pettener, D; Bertranpetit, J			Trading genes along the silk road: mtDNA sequences and the origin of central Asian populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL REGION SEQUENCE; EUROPEAN POPULATIONS; HIGH-ALTITUDE; BODY-WATER; DIVERSITY; POLYMORPHISM; AFRICAN; GENOME; AMERINDS	Central Asia is a vast region at the crossroads of different habitats, cultures, and trade routes. Little is known about the genetics and the history of the population of this region. We present the analysis of mtDNA control-region sequences in samples of the Kazakh, the Uighurs, the lowland Kirghiz, and the highland Kirghiz, which we have used to address both the population history of the region and the possible selective pressures that high altitude has on mtDNA genes. Central Asian mtDNA sequences present features intermediate between European and eastern Asian sequences, in several parameters-such as the frequencies of certain nucleotides, the levels of nudeotide diversity, mean pairwise differences, and genetic distances. Several hypotheses could explain the intermediate position of central Asia between Europe and eastern Asia, but the most plausible would involve extensive levels of admixture between Europeans and eastern Asians in central Asia, possibly enhanced during the Silk Road trade and clearly after the eastern and western Eurasian human groups had diverged. Lowland and highland Kirghiz mtDNA sequences are very similar, and the analysis of molecular variance has revealed that the fraction of mitochondrial genetic variance due to altitude is not significantly different from zero. Thus, it seems unlikely that altitude has exerted a major selective pressure on mitochondrial genes in central Asian populations.	Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Barcelona 08003, Catalonia, Spain; Univ Helsinki, Dept Forens Med, Helsinki, Finland; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Edith Cowan Univ, Ctr Human Genet, Joondalup, WA, Australia; Univ Bologna, Unita Antropol, Dipartimento Biol, Bologna, Italy	Pompeu Fabra University; University of Helsinki; Yale University; Edith Cowan University; University of Bologna	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Doctor Aiguader 80, Barcelona 08003, Catalonia, Spain.	jaumeb.bertranpetit@cexs.upf.es	Comas, David/D-5382-2014; Bosch, Elena/N-7603-2019; Calafell, Francesc/C-8595-2014; Pettener, Davide/E-1576-2017; Bosch, Elena/D-8681-2014; Bertranpetit, Jaume/F-8550-2012	Comas, David/0000-0002-5075-0956; Bosch, Elena/0000-0003-2848-103X; Calafell, Francesc/0000-0002-1083-9438; Bosch, Elena/0000-0003-2848-103X; Bertranpetit, Jaume/0000-0003-0100-0590; Martinez-Arias, Rosa/0000-0003-4272-1298; Clarimon, Jordi/0000-0002-6824-6942				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANTHONY DW, 1995, ARCHAEOLOGY, V48, P36; ANTHONY DW, 1991, ANTIQUITY, V65, P22, DOI 10.1017/S0003598X00079278; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; BALLINGER SW, 1992, GENETICS, V130, P139; Bandelt HJ, 1997, AM J HUM GENET, V61, P980, DOI 10.1086/514878; BANDELT HJ, 1995, GENETICS, V141, P743; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BATTISTINI N, 1995, ANN HUM BIOL, V22, P315, DOI 10.1080/03014469500003982; Bedogni G, 1997, ANN HUM BIOL, V24, P533, DOI 10.1080/03014469700005292; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; BOWLES G, 1977, PEOPLES ASIA; CABOT EL, 1988, ESEE EYEBALL SEQUENC; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Comas D, 1997, HUM GENET, V99, P443, DOI 10.1007/s004390050386; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Efron B, 1982, JACKKNIFE BOOTSTRAP; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Facchini F, 1998, AM J HUM BIOL, V10, P241, DOI 10.1002/(SICI)1520-6300(1998)10:2<241::AID-AJHB9>3.0.CO;2-N; Facchini F, 1997, HUM BIOL, V69, P97; FELSENSTEIN J, 1985, EVOLUTION, V35, P785; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2001, CLADISTICS; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Horai S, 1996, AM J HUM GENET, V59, P579; Howell N, 1997, AM J HUM GENET, V61, P986; Howell N, 1996, AM J HUM GENET, V59, P501; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; LUM JK, 1994, HUM BIOL, V66, P567; Macaulay VA, 1997, AM J HUM GENET, V61, P983; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, MOL EVOLUTIONARY GEN; Paabo S, 1996, AM J HUM GENET, V59, P493; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PETTENER D, 1997, ACTA ANDINA, V6, P217; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; PULT I, 1994, BIOL CHEM H-S, V375, P837; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Richards M, 1996, AM J HUM GENET, V59, P185; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SANTOS M, 1994, HUM BIOL, V66, P963; Schneider S, 1996, ARLEQUIN SOFTWARE EN; Sellier J., 1993, ATLAS PEUPLES ORIENT; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Stenico M, 1996, AM J HUM GENET, V59, P1363; TAJIMA F, 1989, GENETICS, V123, P585; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P591; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Watson E, 1996, AM J HUM GENET, V59, P437	73	257	280	1	43	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1824	1838		10.1086/302133	http://dx.doi.org/10.1086/302133			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	151EL	9837835	Green Published, hybrid			2022-12-18	WOS:000077707700028
J	ECKERSON, HW; ROMSON, J; WYTE, C; LADU, BN				ECKERSON, HW; ROMSON, J; WYTE, C; LADU, BN			THE HUMAN-SERUM PARAOXONASE POLYMORPHISM - IDENTIFICATION OF PHENOTYPES BY THEIR RESPONSE TO SALTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ECKERSON, HW (corresponding author), UNIV MICHIGAN,DEPT PHARMACOL,ANN ARBOR,MI 48109, USA.				NIGMS NIH HHS [GM-27028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM027028] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; ALDRIDGE WN, 1975, ENZYME INHIBITORS SU, P176; CARROCIAMPI G, 1981, CAN J PHYSIOL PHARM, V59, P904, DOI 10.1139/y81-138; CLELAND WW, 1963, NATURE, V198, P463, DOI 10.1038/198463a0; ECKERSON HW, 1979, PHARMACOLOGIST, V21, P236; ECKERSON HW, 1981, FED PROC, V40, P724; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; ERDOES EG, 1961, NATURE, V190, P716, DOI 10.1038/190716a0; FLUGEL M, 1978, KLIN WOCHENSCHR, V56, P911, DOI 10.1007/BF01489217; Geldermacher-Von M.M, 1978, HUM GENET S, V1, P65; GELDMACH.M, 1972, H-S Z PHYSIOL CHEM, V353, P217, DOI 10.1515/bchm2.1972.353.1.217; GELDMACHER M, 1973, H-S Z PHYSIOL CHEM, V354, P337, DOI 10.1515/bchm2.1973.354.1.337; Geldmacher-von Mallinck, 1973, Humangenetik, V17, P331; GELDMACHERVONMALLINCKRODT M, 1979, HUM GENET, V50, P313, DOI 10.1007/BF00399398; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; MAIN AR, 1960, BIOCHEM J, V74, P10, DOI 10.1042/bj0740010; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; SIMPSON NE, 1971, AM J HUM GENET, V23, P375; SKRINJAR.M, 1968, BIOCHIM BIOPHYS ACTA, V165, P289, DOI 10.1016/0304-4165(68)90059-7; SOKAL RR, 1966, BIOMETRY PRINCIPLES; Sorensen SPL, 1909, BIOCHEM Z, V21, P131; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6	23	257	268	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					214	227						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6301268				2022-12-18	WOS:A1983QJ26500005
J	Locke, DP; Sharp, AJ; McCarroll, SA; McGrath, SD; Newman, TL; Cheng, Z; Schwartz, S; Albertson, DG; Pinkel, D; Altshuler, DM; Eichler, EE				Locke, Devin P.; Sharp, Andrew J.; McCarroll, Steven A.; McGrath, Sean D.; Newman, Tera L.; Cheng, Ze; Schwartz, Stuart; Albertson, Donna G.; Pinkel, Daniel; Altshuler, David M.; Eichler, Evan E.			Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT SEGMENTAL DUPLICATIONS; DELETION POLYMORPHISMS; IDENTIFICATION	Studies of copy-number variation and linkage disequilibrium (LD) have typically excluded complex regions of the genome that are rich in duplications and prone to rearrangement. In an attempt to assess the heritability and LD of copy-number polymorphisms (CNPs) in duplication-rich regions of the genome, we profiled copy-number variation in 130 putative "rearrangement hotspot regions" among 269 individuals of European, Yoruba, Chinese, and Japanese ancestry analyzed by the International HapMap Consortium. Eighty-four hotspot regions, corresponding to 257 bacterial artificial chromosome (BAC) probes, showed evidence of copy-number differences. Despite a predisposing genetic architecture, no polymorphism was ever observed in the remaining 46 "rearrangement hotspots," and we suggest these represent excellent candidate sites for pathogenic rearrangements. We used a combination of BAC-based and high-density customized oligonucleotide arrays to resolve the molecular basis of structural rearrangements. For common variants (frequency > 10%), we observed a distinct bias against copy-number losses, suggesting that deletions are subject to purifying selection. Heritability estimates did not differ significantly from 1.0 among the majority (30 of 34) of loci analyzed, consistent with normal Mendelian inheritance. Some of the CNPs in duplication-rich regions showed strong LD with nearby single-nucleotide polymorphisms (SNPs) and were observed to segregate on ancestral SNP haplotypes. However, LD with the best available SNP markers was weaker than has been reported for deletion polymorphisms in less complex regions of the genome. These observations may be accounted for by a low density of SNP data in duplicated regions, challenges in mapping and typing the CNPs, and the possibility that CNPs in these regions have rearranged on multiple haplotype backgrounds. Our results underscore the need for complete maps of genetic variation in duplication-rich regions of the genome.	Univ Washington, Dept Gen Sci, Sch Med, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; MIT, Cambridge, MA 02139 USA; Univ Chicago, Dept Genet, Chicago, IL 60637 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Chicago; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Eichler, EE (corresponding author), Univ Washington, Dept Gen Sci, Sch Med, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	McCarroll, Steven A/A-8433-2009; Sharp, Andrew/A-5783-2008; McGrath, Sean David/AAT-3540-2020; Altshuler, David M/A-4476-2009	McGrath, Sean David/0000-0001-9064-8449; Altshuler, David M/0000-0002-7250-4107; Locke, Devin/0000-0002-2527-0475	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002385, HG002385] Funding Source: Medline; NICHD NIH HHS [HD043569, R01 HD043569] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Fisher R., 1930, GENETICAL THEORY NAT; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wirtenberger M, 2006, AM J HUM GENET, V78, P520, DOI 10.1086/500793	20	256	260	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					275	290		10.1086/505653	http://dx.doi.org/10.1086/505653			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826518	Green Published, Bronze			2022-12-18	WOS:000239040400009
J	ROUSSEAU, F; HEITZ, D; TARLETON, J; MACPHERSON, J; MALMGREN, H; DAHL, N; BARNICOAT, A; MATHEW, C; MORNET, E; TEJADA, I; MADDALENA, A; SPIEGEL, R; SCHINZEL, A; MARCOS, JAG; SCHORDERET, DF; SCHAAP, T; MACCIONI, L; RUSSO, S; JACOBS, PA; SCHWARTZ, C; MANDEL, JL				ROUSSEAU, F; HEITZ, D; TARLETON, J; MACPHERSON, J; MALMGREN, H; DAHL, N; BARNICOAT, A; MATHEW, C; MORNET, E; TEJADA, I; MADDALENA, A; SPIEGEL, R; SCHINZEL, A; MARCOS, JAG; SCHORDERET, DF; SCHAAP, T; MACCIONI, L; RUSSO, S; JACOBS, PA; SCHWARTZ, C; MANDEL, JL			A MULTICENTER STUDY ON GENOTYPE-PHENOTYPE CORRELATIONS IN THE FRAGILE-X-SYNDROME, USING DIRECT DIAGNOSIS WITH PROBE STB-12.3 - THE FIRST 2,253 CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; FULL MUTATION; FMR-1 GENE; ABNORMAL METHYLATION; FOUNDER CHROMOSOMES; FETAL TISSUES; DNA; INSTABILITY; REPEAT; EXPRESSION	We report the results of a 14-center collaborative study of genotype-phenotype correlations in 318 fragile X families; these families comprised 2,253 individuals, 1,344 of whom carried a fragile X mutation and 693 of whom had a typical full fragile X mutation. This study demonstrates that direct DNA diagnosis establishes the genotype at the FRAXA-FMR-1 locus. There was a significantly higher prevalence of ''mosaic'' cases among males who carry a full mutation (12%) than among females who carry a full mutation (6%); the mosaic males had a larger expansion than did the mosaic females. Mental status of premutated individuals did not differ from that of those with a normal genotype. Both the abnormal methylation of the FMR-1-EagI site and the size of the expansion were highly correlated with cytogenetics, facial dysmorphism, macroorchidism, and mental retardation (MR). Among female carriers of a full mutation, those with MR had significantly larger expansion than did those without MR. Among 164 independent couples, 3 unrelated husbands carried a premutation that suggests that the prevalence of fragile X premutations in the general population is similar to 0.9% of the X chromosomes. Our data validate the use of direct DNA testing for fragile X diagnosis as well as for carrier identification and support and complete the established relationships among the DNA results and the cytogenetic, physical, and psychological aspects of the disease.	INSERM,U184,CNRS,LGME,STRASBOURG,FRANCE; GREENWOOD GENET CTR,GREENWOOD,SC 29646; WESSEX REG GENET LAB,SALISBURY,WILTS,ENGLAND; UPPSALA UNIV,DEPT MED GENET,UPPSALA,SWEDEN; UPPSALA UNIV,DEPT CLIN GENET,UPPSALA,SWEDEN; UNITED MED & DENT SCH,DIV MED & MOLEC GENET,LONDON,ENGLAND; CTR ETUD BIOL PRENATALE,PARIS,FRANCE; GENET & IVF INST,FAIRFAX,VA 22039; INST MED GENET,ZURICH,SWITZERLAND; HOSP RAMON Y CAJAL,UNIDAD GENET MOLEC,E-28034 MADRID,SPAIN; CHU VAUDOIS,INST MED GENET,CH-1011 LAUSANNE,SWITZERLAND; HADASSAH UNIV HOSP,DEPT HUMAN GENET,IL-91120 JERUSALEM,ISRAEL; IST CLIN & BIOL EVOLUTIVA,CAGLIARI,ITALY; IST CLIN PERFEZIONAMENTO ANAT & ISTOL PATOL,MILAN,ITALY	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Greenwood Genetic Center; Uppsala University; Uppsala University; University of London; King's College London; Hospital Universitario Ramon y Cajal; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Hebrew University of Jerusalem	ROUSSEAU, F (corresponding author), HOP ST FRANCOIS ASSISE,CTR RECH,UNITE RECH GENET HUMAINE & MOLEC,10 RUE ESPINAY,QUEBEC CITY G1L 3L5,PQ,CANADA.		Mathew, Christopher G/G-3434-2015; M Isabel, Tejada/E-2394-2012	Mathew, Christopher G/0000-0003-4178-1838; Russo, Silvia/0000-0002-5893-0193				DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVRIES BBA, 1993, EUR J HUM GENET, V1, P72; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; FRYNS JP, 1984, HUM GENET, V65, P400, DOI 10.1007/BF00291567; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1991, J MED GENET, V28, P824, DOI 10.1136/jmg.28.12.824; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAIRD C, 1992, 3RD INT FRAG X C ASP; LEDBETTER DH, 1986, NATURE, V324, P161, DOI 10.1038/324161a0; LOESCH DZ, 1993, AM J HUM GENET, V53, P1064; MACPHERSON J, 1992, AM J MED GENET, V43, P905, DOI 10.1002/ajmg.1320430535; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; NELSON DL, 1993, NAT GENET, V4, P107, DOI 10.1038/ng0693-107; NIELSEN KB, 1983, HUM GENET, V64, P240, DOI 10.1007/BF00279401; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OUDET C, 1993, AM J HUM GENET, V52, P297; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1993, AM J HUM GENET, V52, P884; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SATTLER JM, 1988, ASSESSMENT CHILDRENS; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; TURNER G, 1983, ADV HUM GENET, V13, P83; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB T, 1990, J MED GENET, V27, P627, DOI 10.1136/jmg.27.10.627; WEBB T, 1989, FRAGILE X SYNDROME, P40; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1992, AM J HUM GENET, V51, P299; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	38	256	257	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					225	237						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037202				2022-12-18	WOS:A1994NZ33600002
J	HOWELL, N; KUBACKA, I; XU, M; MCCULLOUGH, DA				HOWELL, N; KUBACKA, I; XU, M; MCCULLOUGH, DA			LEBER HEREDITARY OPTIC NEUROPATHY - INVOLVEMENT OF THE MITOCHONDRIAL NDI GENE AND EVIDENCE FOR AN INTRAGENIC SUPPRESSOR MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; NADH DEHYDROGENASE; READING FRAMES; DNA MUTATION; ORGANIZATION; GENOME; SUBUNIT; NEURORETINOPATHY; HETEROGENEITY; VERTEBRATES	A large Queensland family has an extreme form of Leber hereditary optic neuropathy (LHON) in which several neurological abnormalities and an infantile encephalopathy are present in addition to the characteristic ophthalmological changes. Sequence analysis of the seven mitochondrial genes encoding subunits of respiratory chain complex I (NADH-ubiquinone oxidoreductase) reveals two novel features of the etiology of this mitochondrial genetic disease. The first conclusion from these studies is that the ophthalmological and neurological deficits in this family are produced by a mutation at nucleotide 4160 of the ND1 gene. This nucleotide alteration results in the substitution of proline for the highly conserved leucine residue at position 285 of the ND1 protein. Secondary-structure analysis predicts that the proline replacement disrupts a small alpha helix in a hydrophilic loop. All nine family members analyzed were homoplasmic for this mutation. The second major result from these studies is that the members of one branch of this family carry, at nucleotide 4136 of the same gene, a second mutation, also homoplasmic, which produces a cysteine-for-tyrosine replacement at position 277. The clinical and biochemical phenotypes of the family members indicate that this second nucleotide substitution may function as an intragenic suppressor mutation which ameliorates the neurological abnormalities and complex I deficiency.			HOWELL, N (corresponding author), UNIV TEXAS, MED BRANCH, DEPT RADIAT THERAPY, DIV BIOL, GALVESTON, TX 77550 USA.				NICHD NIH HHS [P01 HD08315] Funding Source: Medline; NIGMS NIH HHS [R01 GM33683] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033683] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JH, 1966, BRAIN, V89, P15, DOI 10.1093/brain/89.1.15; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BOER PH, 1988, EMBO J, V7, P3501, DOI 10.1002/j.1460-2075.1988.tb03226.x; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; BROWN TA, 1983, EMBO J, V2, P427, DOI 10.1002/j.1460-2075.1983.tb01440.x; BRUYN GW, 1964, J NEUROL SCI, V1, P59, DOI 10.1016/0022-510X(64)90054-1; BURGER G, 1985, J MOL BIOL, V186, P231, DOI 10.1016/0022-2836(85)90100-7; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CUMMINGS DJ, 1988, CURR GENET, V14, P253, DOI 10.1007/BF00376746; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; EARLEY FGP, 1987, FEBS LETT, V219, P108, DOI 10.1016/0014-5793(87)81200-0; FRIEDRICH T, 1990, FEBS LETT, V265, P37, DOI 10.1016/0014-5793(90)80878-M; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GARNIER J, 1990, PREDICTION PROTEIN S, P417; HENSGENS LAM, 1984, NUCLEIC ACIDS RES, V12, P7327, DOI 10.1093/nar/12.19.7327; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1990, AM J HUM GENET, V47, P629; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; KOHCHI T, 1988, J MOL BIOL, V203, P353, DOI 10.1016/0022-2836(88)90004-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEES F, 1964, J NEUROL NEUROSUR PS, V27, P415, DOI 10.1136/jnnp.27.5.415; LUNDSGARD R, 1944, ACTA OPHTHALMOL S3, V21, P3; MONDELLI M, 1990, ACTA NEUROL SCAND, V81, P349; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; PALAN A, 1989, DOC OPHTHALMOL, V71, P77, DOI 10.1007/BF00155135; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; PRITCHARD AE, 1990, NUCLEIC ACIDS RES, V18, P163, DOI 10.1093/nar/18.1.163; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; ROE BA, 1985, J BIOL CHEM, V260, P9759; ROSE FC, 1970, BRIT J OPHTHALMOL, V54, P388, DOI 10.1136/bjo.54.6.388; SEEDORFF T, 1985, ACTA OPHTHALMOL, V63, P135; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WEERDT CJD, 1971, ACTA NEUROL SCAND, V47, P541, DOI 10.1111/j.1600-0404.1971.tb07507.x	41	256	260	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					935	942						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018041				2022-12-18	WOS:A1991FK89700012
J	Appenzeller, S; Balling, R; Barisic, N; Baulac, S; Caglayan, H; Craiu, D; De Jonghe, P; Depienne, C; Dimova, P; Djemie, T; Gormley, P; Guerrini, R; Helbig, I; Hjalgrim, H; Hoffman-Zacharska, D; Jahn, J; Klein, KM; Koeleman, B; Komarek, V; Krause, R; Kuhlenbaumer, G; Leguern, E; Lehesjoki, AE; Lemke, JR; Lerche, H; Linnankivi, T; Marini, C; May, P; Moller, RS; Muhle, H; Pal, D; Palotie, A; Pendziwiat, M; Robbiano, A; Roelens, F; Rosenow, F; Selmer, K; Serratosa, JM; Sisodiya, S; Stephani, U; Sterbova, K; Striano, P; Suls, A; Talvik, T; von Spiczak, S; Weber, Y; Weckhuysen, S; Zara, F; Abou-Khalil, B; Alldredge, BK; Andermann, E; Andermann, F; Amron, D; Bautista, JF; Berkovic, SF; Bluvstein, J; Boro, A; Cascino, G; Consalvo, D; Crumrine, P; Devinsky, O; Dlugos, D; Epstein, MP; Fiol, M; Fountain, NB; French, J; Friedman, D; Geller, EB; Glauser, T; Glynn, S; Haas, K; Haut, SR; Hayward, J; Helmers, SL; Joshi, S; Kanner, A; Kirsch, HE; Knowlton, RC; Kossoff, EH; Kuperman, R; Kuzniecky, R; Lowenstein, DH; McGuire, SM; Motika, PV; Novotny, EJ; Ottman, R; Paolicchi, JM; Parent, J; Park, K; Poduri, A; Sadleir, L; Scheffer, IE; Shellhaas, RA; Sherr, E; Shih, JJ; Singh, R; Sirven, J; Smith, MC; Sullivan, J; Thio, LL; Venkat, A; Vining, EPG; Von Allmen, GK; Weisenberg, JL; Widdess-Walsh, P; Winawer, MR; Allen, AS; Berkovic, SF; Cassette, P; Delanty, N; Dlugos, D; Eichler, EE; Epstein, MP; Glauser, T; Goldstein, DB; Han, YJ; Heinzen, EL; Johnson, MR; Kuzniecky, R; Lowenstein, DH; Marson, AG; Mefford, HC; Nieh, SE; O'Brien, TJ; Ottman, R; Petrou, S; Petrovski, S; Poduri, A; Ruzzo, EK; Scheffer, IE; Sherr, E				Appenzeller, Silke; Balling, Rudi; Barisic, Nina; Baulac, Stephanie; Caglayan, Hande; Craiu, Dana; De Jonghe, Peter; Depienne, Christel; Dimova, Petia; Djemie, Tania; Gormley, Padhraig; Guerrini, Renzo; Helbig, Ingo; Hjalgrim, Helle; Hoffman-Zacharska, Dorota; Jaehn, Johanna; Klein, Karl Martin; Koeleman, Bobby; Komarek, Vladimir; Krause, Roland; Kuhlenbaeumer, Gregor; Leguern, Eric; Lehesjoki, Anna-Elina; Lemke, Johannes R.; Lerche, Holger; Linnankivi, Tarja; Marini, Carla; May, Patrick; Moller, Rikke S.; Muhle, Hiltrud; Pal, Deb; Palotie, Aarno; Pendziwiat, Manuela; Robbiano, Angela; Roelens, Filip; Rosenow, Felix; Selmer, Kaja; Serratosa, Jose M.; Sisodiya, Sanjay; Stephani, Ulrich; Sterbova, Katalin; Striano, Pasquale; Suls, Arvid; Talvik, Tiina; von Spiczak, Sarah; Weber, Yvonne; Weckhuysen, Sarah; Zara, Federico; Abou-Khalil, Bassel; Alldredge, Brian K.; Andermann, Eva; Andermann, Frederick; Amron, Dina; Bautista, Jocelyn F.; Berkovic, Samuel F.; Bluvstein, Judith; Boro, Alex; Cascino, Gregory; Consalvo, Damian; Crumrine, Patricia; Devinsky, Orrin; Dlugos, Dennis; Epstein, Michael P.; Fiol, Miguel; Fountain, Nathan B.; French, Jacqueline; Friedman, Daniel; Geller, Eric B.; Glauser, Tracy; Glynn, Simon; Haas, Kevin; Haut, Sheryl R.; Hayward, Jean; Helmers, Sandra L.; Joshi, Sucheta; Kanner, Andres; Kirsch, Heidi E.; Knowlton, Robert C.; Kossoff, Eric H.; Kuperman, Rachel; Kuzniecky, Ruben; Lowenstein, Daniel H.; McGuire, Shannon M.; Motika, Paul V.; Novotny, Edward J.; Ottman, Ruth; Paolicchi, Juliann M.; Parent, Jack; Park, Kristen; Poduri, Annapurna; Sadleir, Lynette; Scheffer, Ingrid E.; Shellhaas, Renee A.; Sherr, Elliott; Shih, Jerry J.; Singh, Rani; Sirven, Joseph; Smith, Michael C.; Sullivan, Joe; Thio, Liu Lin; Venkat, Anu; Vining, Eileen P. G.; Von Allmen, Gretchen K.; Weisenberg, Judith L.; Widdess-Walsh, Peter; Winawer, Melodie R.; Allen, Andrew S.; Berkovic, Samuel F.; Cassette, Patrick; Delanty, Norman; Dlugos, Dennis; Eichler, Evan E.; Epstein, Michael P.; Glauser, Tracy; Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Johnson, Michael R.; Kuzniecky, Ruben; Lowenstein, Daniel H.; Marson, Anthony G.; Mefford, Heather C.; Nieh, Sahar Esmaeeli; O'Brien, Terence J.; Ottman, Ruth; Petrou, Stephen; Petrovski, Slave; Poduri, Annapurna; Ruzzo, Elizabeth K.; Scheffer, Ingrid E.; Sherr, Elliott		EuroEPINOMICS-RES Consortium; EuroEPINOMICS-RES Consortium; Epilepsy Phenome Genome Project; Epi4K Consortium	De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; GRIN2A MUTATIONS; SCHIZOPHRENIA; EPILEPSIES; DYNAMIN-1; PATTERNS; APHASIA; PROTEIN; STXBP1	Emerging evidence indicates that epileptic encephalopathies are genetically highly heterogeneous, underscoring the need for large cohorts of well-characterized individuals to further define the genetic landscape. Through a collaboration between two consortia (EuroEPINOMICS and Epi4K/EPGP), we analyzed exome-sequencing data of 356 trios with the "classical" epileptic encephalopathies, infantile spasms and Lennox Gastaut syndrome, including 264 trios previously analyzed by the Epi4K/EPGP consortium. In this expanded cohort, we find 429 de nova mutations, including de novo mutations in DNM1 in five individuals and de nova mutations in GABBR2, FASN, and RYR3 in two individuals each. Unlike previous studies, this cohort is sufficiently large to show a significant excess of de nova mutations in epileptic encephalopathy probands compared to the general population using a likelihood analysis (p = 8.2 x 10(-4)), supporting a prominent role for de novo mutations in epileptic encephalopathies. We bring statistical evidence that mutations in DNM1 cause epileptic encephalopathy, find suggestive evidence for a role of three additional genes, and show that at least 12% of analyzed individuals have an identifiable causal de novo mutation. Strikingly, 75% of mutations in these probands are predicted to disrupt a protein involved in regulating synaptic transmission, and there is a significant enrichment of de nova mutations in genes in this pathway in the entire cohort as well. These findings emphasize an important role for synaptic dysregulation in epileptic encephalopathies, above and beyond that caused by ion channel dysfunction.					Thio, Liu Lin/A-4318-2008; Zara, Federico/U-3477-2017; Ottman, Ruth/O-2371-2013; O'Brien, Terence/L-8102-2013; Scheffer, Ingrid E/G-1668-2013; Resource Center, NINDS Human Genetics/AGF-2474-2022; Depienne, Christel/AAL-3835-2021; Muhle, Hiltrud/F-5715-2010; Marini, Carla/AAC-2413-2022; Craiu, Dana/ABE-4886-2020; Gormley, Padhraig/L-1949-2018; Helbig, Ingo/G-8467-2018; Suls, Arvid/M-2694-2013; May, Patrick/N-1019-2019; May, Patrick/B-1238-2010; Stephani, Ulrich/D-1004-2010; Goldstein, David/AAY-8125-2020; Sander-Effron, Samuel/AAX-2231-2020; Striano, Pasquale/F-9117-2014; Marson, Anthony/AAW-9776-2020; Caglayan, Hande S/A-2368-2016; Baulac, Stéphanie/O-2099-2016; jiang, yu/HGU-0029-2022; Craiu, Dana/ABC-2986-2020; Shellhaas, Renee/H-6697-2019; Weckhuysen, Sarah/HGB-9957-2022; Novotny, Edward J./ABG-9577-2021; Bautista, Jocelyn F./AAP-6901-2021; French, Jacqueline A/G-6795-2013; O'Brien, Terence/AAU-5525-2021; Selmer, Kaja/AAM-7284-2021	Thio, Liu Lin/0000-0002-9779-7903; Zara, Federico/0000-0001-9744-5222; Ottman, Ruth/0000-0001-7074-242X; O'Brien, Terence/0000-0002-7198-8621; Scheffer, Ingrid E/0000-0002-2311-2174; Depienne, Christel/0000-0002-7212-9554; Marini, Carla/0000-0002-9212-2691; Gormley, Padhraig/0000-0002-8908-6968; Helbig, Ingo/0000-0001-8486-0558; Suls, Arvid/0000-0003-0328-198X; May, Patrick/0000-0001-8698-3770; May, Patrick/0000-0001-8698-3770; Striano, Pasquale/0000-0002-6065-1476; Marson, Anthony/0000-0002-6861-8806; Caglayan, Hande S/0000-0001-6402-3306; Baulac, Stéphanie/0000-0001-6430-4693; Shellhaas, Renee/0000-0002-3175-3908; Weckhuysen, Sarah/0000-0003-2878-1147; French, Jacqueline A/0000-0003-2242-8027; Allen, Andrew/0000-0002-7232-2143; Berkovic, Samuel/0000-0003-4580-841X	National Institute of Neurological Disorders and Stroke (The Epilepsy Phenome/Genome Project) [NS053998, Epi4K NS077364, NS077274, NS077303, NS077276]; Andrew's Foundation; Finding a Cure for Epilepsy and Seizures; Richard Thalheimer Philanthropic Fund; Eurocores program EuroEPINOMICS-RES of the European Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS077303, U01NS053998, U01NS077364, U01NS077276, U01NS077274] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (The Epilepsy Phenome/Genome Project); Andrew's Foundation; Finding a Cure for Epilepsy and Seizures; Richard Thalheimer Philanthropic Fund; Eurocores program EuroEPINOMICS-RES of the European Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (The Epilepsy Phenome/Genome Project NS053998; Epi4K NS077364, NS077274, NS077303, and NS077276), The Andrew's Foundation, Finding a Cure for Epilepsy and Seizures, the Richard Thalheimer Philanthropic Fund, and the Eurocores program EuroEPINOMICS-RES of the European Science Foundation. Additional funding sources are summarized in the Supplemental Acknowledgments. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Boumil RM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001046; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kodera H, 2013, HUM MUTAT, V34, P1708, DOI 10.1002/humu.22446; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ogiwara I, 2009, NEUROLOGY, V73, P1046, DOI 10.1212/WNL.0b013e3181b9cebc; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; TORRE E, 1994, J BIOL CHEM, V269, P32411; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	33	255	262	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					360	370		10.1016/j.ajhg.2014.08.013	http://dx.doi.org/10.1016/j.ajhg.2014.08.013			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW		Bronze, Green Published			2022-12-18	WOS:000342654300002
J	Quadri, M; Federico, A; Zhao, T; Breedveld, GJ; Battisti, C; Delnooz, C; Severijnen, LA; Mammarella, LDT; Mignarri, A; Monti, L; Sanna, A; Lu, P; Punzo, F; Cossu, G; Willemsen, R; Rasi, F; Oostra, BA; van de Warrenburg, BP; Bonifati, V				Quadri, Marialuisa; Federico, Antonio; Zhao, Tianna; Breedveld, Guido J.; Battisti, Carla; Delnooz, Catherine; Severijnen, Lies-Anne; Mammarella, Lara Di Toro; Mignarri, Andrea; Monti, Lucia; Sanna, Antioco; Lu, Peng; Punzo, Francesca; Cossu, Giovanni; Willemsen, Rob; Rasi, Fabrizio; Oostra, Ben A.; van de Warrenburg, Bart P.; Bonifati, Vincenzo			Mutations in SLC30A10 Cause Parkinsonism and Dystonia with Hypermanganesemia, Polycythemia, and Chronic Liver Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANGANESE; ZINC; TRANSPORTER; EXPRESSION; FAMILY; IDENTIFICATION; CIRRHOSIS; GENES; ZNT-1	Manganese is essential for several metabolic pathways but becomes toxic in excessive amounts. Manganese levels in the body are therefore tightly regulated, but the responsible protein(s) remain incompletely known. We studied two consanguineous families with neurologic disorders including juvenile-onset dystonia, adult-onset parkinsonism, severe hypermanganesemia, polycythemia, and chronic hepatic disease, including steatosis and cirrhosis. We localized the genetic defect by homozygosity mapping and then identified two different homozygous frameshift SLC30A10 mutations, segregating with disease. SLC30A10 is highly expressed in the liver and brain, including in the basal ganglia. Its encoded protein belongs to a large family of membrane transporters, mediating the efflux of divalent cations from the cytosol. We show the localization of SLC30A10 in normal human liver and nervous system, and its depletion in liver from one affected individual. Our in silico analyses suggest that SLC30A10 possesses substrate specificity different from its closest (zinc-transporting) homologs. We also show that the expression of SLC30A10 and the levels of the encoded protein are markedly induced by manganese in vitro. The phenotype associated with SLC30A10 mutations is broad, including neurologic, hepatic, and hematologic disturbances. Intrafamilial phenotypic variability is also present. Chelation therapy can normalize the manganesemia, leading to marked clinical improvements. In conclusion, we show that SLC30A10 mutations cause a treatable recessive disease with pleomorphic phenotype, and provide compelling evidence that SLC30A10 plays a pivotal role in manganese transport. This work has broad implications for understanding of the manganese biology and pathophysiology in multiple human organs.	[Quadri, Marialuisa; Zhao, Tianna; Breedveld, Guido J.; Severijnen, Lies-Anne; Punzo, Francesca; Willemsen, Rob; Oostra, Ben A.; Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Federico, Antonio; Battisti, Carla; Mammarella, Lara Di Toro; Mignarri, Andrea] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Delnooz, Catherine; van de Warrenburg, Bart P.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Monti, Lucia; Sanna, Antioco] Santa Maria Scotte Gen Hosp, Azienda Osped Univ Senese, Dept Neurol & Sensorial Sci, Unit Neuroimaging & Neurointervent, I-53100 Siena, Italy; [Lu, Peng] Erasmus MC Sophia, Lab Pediat, NL-3015 GE Rotterdam, Netherlands; [Punzo, Francesca] Univ Naples 2, Dept Pediat, I-80138 Naples, Italy; [Cossu, Giovanni] Gen Hosp S Michele, AOB G Brotzu, Neurol Serv, I-09134 Cagliari, Italy; [Rasi, Fabrizio] Santa Maria Croci Hosp, Neurol Unit, I-48100 Ravenna, Italy	Erasmus University Rotterdam; Erasmus MC; University of Siena; Radboud University Nijmegen; University of Siena; University Hospital of Siena; Erasmus University Rotterdam; Erasmus MC; Universita della Campania Vanvitelli	Bonifati, V (corresponding author), Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands.	v.bonifati@erasmusmc.nl	van de Warrenburg, Bart PC/D-1935-2010; cossu, giovanni/AAC-6331-2022; MONTI, LUCIA/ABF-7076-2021	van de Warrenburg, Bart PC/0000-0003-4412-1616; federico, antonio/0000-0002-5246-1621	Internationaal Parkinson Fonds-Netherlands; Netherlands Organization for Scientific Research VIDI	Internationaal Parkinson Fonds-Netherlands; Netherlands Organization for Scientific Research VIDI(Netherlands Organization for Scientific Research (NWO))	The authors thank all the individuals involved for their contributions and Tom de Vries-Lentsch, Erasmus MC, Rotterdam, for artwork. This study was supported by the Internationaal Parkinson Fonds-Netherlands and the Netherlands Organization for Scientific Research VIDI grant (to V.B.).	Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Brna P, 2011, J CHILD NEUROL, V26, P891, DOI 10.1177/0883073810393962; Butterworth RF, 2010, NEUROTOX RES, V18, P100, DOI 10.1007/s12640-010-9185-z; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Chalela JA, 2011, NEUROCRIT CARE, V14, P456, DOI 10.1007/s12028-010-9476-5; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Devergnas S, 2004, BIOCHEM PHARMACOL, V68, P699, DOI 10.1016/j.bcp.2004.05.024; Ebert BL, 1999, BLOOD, V94, P1864; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gospe SM, 2000, ARCH DIS CHILD, V83, P439, DOI 10.1136/adc.83.5.439; Huang CC, 2007, PARKINSONISM RELAT D, V13, P143, DOI 10.1016/j.parkreldis.2006.09.002; HUANG CC, 1989, ARCH NEUROL-CHICAGO, V46, P1104, DOI 10.1001/archneur.1989.00520460090018; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Pfeiffer Ronald F, 2011, Handb Clin Neurol, V100, P681, DOI 10.1016/B978-0-444-52014-2.00049-5; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Sanotsky Y, 2007, MOVEMENT DISORD, V22, P1337, DOI 10.1002/mds.21378; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Stepens A, 2008, NEW ENGL J MED, V358, P1009, DOI 10.1056/NEJMoa072488; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Urani C, 2010, TOXICOL IN VITRO, V24, P370, DOI 10.1016/j.tiv.2009.11.003; [No title captured]	24	255	262	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					467	477		10.1016/j.ajhg.2012.01.017	http://dx.doi.org/10.1016/j.ajhg.2012.01.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22341971	Bronze, Green Published			2022-12-18	WOS:000301762800012
J	Potocki, L; Bi, WM; Treadwell-Deering, D; Carvalho, CMB; Eifert, A; Friedman, EM; Glaze, D; Krull, K; Lee, JA; Lewis, RA; Mendoza-Londono, R; Robbins-Furman, P; Shaw, C; Shi, X; Weissenberger, G; Withers, M; Yatsenko, SA; Zackai, EH; Stankiewicz, P; Lupski, JR				Potocki, Lorraine; Bi, Weimin; Treadwell-Deering, Diane; Carvalho, Claudia M. B.; Eifert, Anna; Friedman, Ellen M.; Glaze, Daniel; Krull, Kevin; Lee, Jennifer A.; Lewis, Richard Alan; Mendoza-Londono, Roberto; Robbins-Furman, Patricia; Shaw, Chad; Shi, Xin; Weissenberger, George; Withers, Marjorie; Yatsenko, Svetlana A.; Zackai, Elaine H.; Stankiewicz, Pawel; Lupski, James R.			Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; TOOTH DISEASE TYPE-1A; SUPERNUMERARY MARKER CHROMOSOME; PELIZAEUS-MERZBACHER-DISEASE; GENOME ARCHITECTURE; HOMOLOGOUS RECOMBINATION; PROXIMAL 17P; SEGMENTAL DUPLICATIONS; MOLECULAR-MECHANISM; TANDEM DUPLICATION	The duplication 17p11.2 syndrome, associated with dup(17)(p11.2p11.2), is a recently recognized syndrome of multiple congenital anomalies and mental retardation and is the first predicted reciprocal microduplication syndrome described the homologous recombination reciprocal of the Smith-Magenis syndrome (SMS) microdeletion (del(17)(p11.2p11.2)). We previously described seven subjects with dup( 17)( p11.2p11.2) and noted their relatively mild phenotype compared with that of individuals with SMS. Here, we molecularly analyzed 28 additional patients, using multiple independent assays, and also report the phenotypic characteristics obtained from extensive multidisciplinary clinical study of a subset of these patients. Whereas the majority of subjects (22 of 35) harbor the homologous recombination reciprocal product of the common SMS microdeletion (similar to 3.7 Mb), 13 subjects (similar to 37%) have nonrecurrent duplications ranging in size from 1.3 to 15.2 Mb. Molecular studies suggest potential mechanistic differences between nonrecurrent duplications and nonrecurrent genomic deletions. Clinical features observed in patients with the common dup( 17)( p11.2p11.2) are distinct from those seen with SMS and include infantile hypotonia, failure to thrive, mental retardation, autistic features, sleep apnea, and structural cardiovascular anomalies. We narrow the critical region to a 1.3-Mb genomic interval that contains the dosage-sensitive RAI1 gene. Our results refine the critical region for Potocki-Lupski syndrome, provide information to assist in clinical diagnosis and management, and lend further support for the concept that genomic architecture incites genomic instability.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Speech Language & Learning, Houston, TX 77030 USA; Baylor Coll Med, Dept Otolaryngol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Allied Hlth, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Univ Toronto, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5S 1A1, Canada; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Toronto; University of Pennsylvania	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 604B,Baylor Plaza 1, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Stankiewicz, Paweł/AAP-7906-2021; Warfield, Simon/B-3352-2009; Krull, Kevin R/N-3882-2018	Stankiewicz, Paweł/0000-0002-6456-7490; Warfield, Simon/0000-0002-7659-3880; Krull, Kevin R/0000-0002-0476-7001; Mendoza-Londono, Roberto/0000-0003-3542-8106; Shaw, Chad/0000-0001-7267-5398	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420, K08HD001149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000188, M01RR00188] Funding Source: Medline; NICHD NIH HHS [HD2406407, K08 HD01149, P01 HD39420, P01 HD039420] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; Arcos-Burgos M, 2004, AM J HUM GENET, V75, P998, DOI 10.1086/426154; Balarin MAS, 1999, AM J MED GENET, V82, P183, DOI 10.1002/(SICI)1096-8628(19990115)82:2<183::AID-AJMG16>3.3.CO;2-8; Barber G, 2004, CALL CENT MAG, V17, P10; Bartlett CW, 2005, AM J HUM GENET, V76, P688, DOI 10.1086/429345; Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Brown A, 1996, AM J MED GENET, V63, P373, DOI 10.1002/(SICI)1096-8628(19960517)63:2<373::AID-AJMG9>3.0.CO;2-U; CHEN KS, 1995, AM J HUM GENET, V56, P175; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; DOCHERTY Z, 1983, J MED GENET, V20, P138, DOI 10.1136/jmg.20.2.138; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Goldman AM, 2006, J CHILD NEUROL, V21, P93, DOI 10.1177/08830738060210021201; Goldstein DR, 2006, TRANSPL IMMUNOL, V17, P11, DOI 10.1016/j.trim.2006.09.012; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; KOZMA C, 1991, AM J MED GENET, V41, P446, DOI 10.1002/ajmg.1320410413; Lee BH, 2006, J HIGH ENERGY PHYS; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Madduri N, 2006, J DEV BEHAV PEDIATR, V27, P188, DOI 10.1097/00004703-200606000-00002; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; MATISE TC, 1994, AM J HUM GENET, V54, P1110; Mendrzyk F, 2006, GENE CHROMOSOME CANC, V45, P401, DOI 10.1002/gcc.20304; Moog U, 2004, GENET COUNSEL, V15, P73; MULLEN E, 1995, MULLEN SCLAES EARLY; Ogdie MN, 2004, AM J HUM GENET, V75, P661, DOI 10.1086/424387; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Potocki L, 2000, J MED GENET, V37, P428, DOI 10.1136/jmg.37.6.428; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Roa BB, 1996, HUM GENET, V97, P642; Schneider MC, 2000, AM J MED GENET, V94, P296, DOI 10.1002/1096-8628(20001002)94:4<296::AID-AJMG6>3.0.CO;2-B; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Shaw CJ, 2004, J MED GENET, V41, P113, DOI 10.1136/jmg.2003.012831; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2004, HUM GENET, V115, P1, DOI 10.1007/s00439-004-1119-5; Shaw CJ, 2004, AM J MED GENET A, V124A, P173, DOI 10.1002/ajmg.a.20355; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Sparrow SS, 1984, VINELAND ADAPTIVE BE; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2001, CLIN GENET, V60, P336, DOI 10.1034/j.1399-0004.2001.600503.x; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; THORNDIKE RL, 1986, STANFORDBINET INTELL; TRILOCHAN S, 2006, GENET MED, V8, P719; Vlangos CN, 2005, AM J MED GENET A, V132A, P278, DOI 10.1002/ajmg.a.30461; Walz K, 2004, HUM MOL GENET, V13, P367, DOI 10.1093/hmg/ddh044; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Yatsenko SA, 2005, AM J MED GENET A, V138A, P175, DOI 10.1002/ajmg.a.30948; Zhao Q, 1998, GENOMICS, V49, P394, DOI 10.1006/geno.1998.5285; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	72	255	257	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					633	649		10.1086/512864	http://dx.doi.org/10.1086/512864			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357070	Green Published, Bronze			2022-12-18	WOS:000245465200005
J	Fang, Y; van Meurs, JBJ; d'Alesio, A; Jhamai, M; Zhao, HY; Rivadeneira, F; Hofman, A; van Leeuwen, JPT; Jehan, F; Pols, HAP; Uitterlinden, AG				Fang, Y; van Meurs, JBJ; d'Alesio, A; Jhamai, M; Zhao, HY; Rivadeneira, F; Hofman, A; van Leeuwen, JPT; Jehan, F; Pols, HAP; Uitterlinden, AG			Promoter and 3 '-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: The Rotterdam study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE-MINERAL DENSITY; SP1 BINDING-SITE; LINKAGE DISEQUILIBRIUM; I-ALPHA-1 GENE; MESSENGER-RNA; POLYMORPHISMS; ASSOCIATION; WOMEN; SUSCEPTIBILITY; EXPRESSION	Polymorphisms of the vitamin D receptor gene (VDR) have been shown to be associated with several complex diseases, including osteoporosis, but the mechanisms are unknown and study results have been inconsistent. We therefore determined sequence variation across the major relevant parts of VDR, including construction of linkage disequilibrium blocks and identification of haplotype alleles. We analyzed 15 haplotype-tagging SNPs in relation to 937 clinical fractures recorded in 6,148 elderly whites over a follow-up period of 7.4 years. Haplotype alleles of the 5' 1a/1e, 1b promoter region and of the 3' untranslated region (UTR) were strongly associated with increased fracture risk. For the 16% of subjects who had risk genotypes at both regions, their risk increased 48% for clinical fractures (P=.0002), independent of age, sex, height, weight, and bone mineral density. The population-attributable risk varied between 1% and 12% for each block and was 4% for the combined VDR risk genotypes. Functional analysis of the variants demonstrated 53% lower expression of a reporter construct with the 1e/1a promoter risk haplotype (P = 5 x 10(-7)) in two cell lines and 15% lower mRNA level of VDR expression constructs carrying 3'-UTR risk haplotype 1 in five cell lines (P = 2 x 10(-6)). In a further analysis, we showed 30% increased mRNA decay in an osteoblast cell line for the construct carrying the 3'-UTR risk haplotype (P = 2 x 10(-6)). This comprehensive candidate-gene analysis demonstrates that the risk allele of multiple VDR polymorphisms results in lower VDR mRNA levels. This could impact the vitamin D signaling efficiency and might contribute to the increased fracture risk we observed for these risk haplotype alleles.	Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Hop St Vincent de Paul, Inserm U561, F-75674 Paris, France	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Uitterlinden, AG (corresponding author), Erasmus MC, Dept Internal Med, Room Ee575,POB 1738, NL-3000 DR Rotterdam, Netherlands.	a.g.uitterlinden@erasmusmc.nl	Jehan, Frederic/P-1568-2014; Rivadeneira, Fernando/O-5385-2015; van Leeuwen, Johannes/D-5015-2014	Jehan, Frederic/0000-0003-1271-6594; Rivadeneira, Fernando/0000-0001-9435-9441; van Leeuwen, Johannes/0000-0002-2282-4006; van Meurs, Joyce/0000-0001-6245-2123				Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Brown SB, 2000, J CLIN ENDOCR METAB, V85, P868, DOI 10.1210/jc.85.2.868; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; Carling T, 1997, J CLIN ENDOCR METAB, V82, P1772, DOI 10.1210/jc.82.6.1772; Crofts LA, 1998, P NATL ACAD SCI USA, V95, P10529, DOI 10.1073/pnas.95.18.10529; DAME MC, 1985, P NATL ACAD SCI USA, V82, P7825, DOI 10.1073/pnas.82.23.7825; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; Fang RX, 2001, AM J PHYSIOL-GASTR L, V280, pG58, DOI 10.1152/ajpgi.2001.280.1.G58; Fang Y, 2003, J BONE MINER RES, V18, P1632, DOI 10.1359/jbmr.2003.18.9.1632; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Halsall JA, 2005, PHARMACOGENET GENOM, V15, P349, DOI 10.1097/01213011-200505000-00011; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; Lambert JC, 2003, J MED GENET, V40, P424, DOI 10.1136/jmg.40.6.424; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; MORRISON NA, 1992, P NATL ACAD SCI USA, V89, P6665, DOI 10.1073/pnas.89.15.6665; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Ogunkolade BW, 2002, DIABETES, V51, P2294, DOI 10.2337/diabetes.51.7.2294; SAIJO T, 1991, AM J HUM GENET, V49, P668; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Uitterlinden AG, 1996, J BONE MINER RES, V11, P1241; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Uitterlinden AG, 2001, J BONE MINER RES, V16, P379, DOI 10.1359/jbmr.2001.16.2.379; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359/jbmr.2002.17.6.1051; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Yamamoto H, 1999, J BONE MINER RES, V14, P240, DOI 10.1359/jbmr.1999.14.2.240; Young RP, 1996, LANCET, V348, P688, DOI 10.1016/S0140-6736(05)65116-1; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	36	255	271	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					807	823		10.1086/497438	http://dx.doi.org/10.1086/497438			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252240	Green Published, Bronze			2022-12-18	WOS:000232569600010
J	Hamblin, MT; Di Rienzo, A				Hamblin, MT; Di Rienzo, A			Detection of the signature of natural selection in humans: Evidence from the Duffy blood group locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA POLYMORPHISM; NEGATIVE INDIVIDUALS; MOLECULAR EVOLUTION; POSITIVE SELECTION; STATISTICAL TESTS; MITOCHONDRIAL-DNA; GENE; POPULATIONS; MALARIA; RECOMBINATION	The Duffy blood group locus, which encodes a chemokine receptor, is characterized by three alleles-FY*A, FY*B, and FY*O. The frequency of the FY*O allele, which corresponds to the absence of Fy antigen on red blood cells, is at or near fixation in most sub-Saharan African populations but is very rare outside Africa. The F-ST value for the FY*O allele is the highest observed for any allele in humans, providing strong evidence for the action of natural selection at this locus. Homozygosity for the FY*O allele confers complete resistance to vivax malaria, suggesting that this allele has been the target of selection by Plasmodium vivax or some other infectious agent. To characterize the signature of directional selection at this locus, we surveyed DNA sequence variation, both in a 1.9-kb region centered on the FY*O mutation site and in a 1-kb region 5-6 kb away from it, in 17 Italians and in a total of 24 individuals from five sub-Saharan African populations. The level of variation across both regions is two- to threefold lower in the Africans than in the Italians. As a result, the pooled African sample shows a significant departure from the neutral expectation for the number of segregating sites, whereas the Italian sample does not. The FY*O allele occurs on two major haplotypes in three of the five African populations. This finding could be due to recombination, recurrent mutation, population structure, and/or mutation accumulation and drift. Although we are unable to distinguish among these alternative hypotheses, it is likely that the two major haplotypes originated prior to selection on the FY*O mutation.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	dirienzo@genetics.uchicago.edu		Di Rienzo, Anna/0000-0002-8982-9098	NHGRI NIH HHS [HG02098-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002098] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aguade M, 1998, GENETICS, V150, P1079; [Anonymous], 1984, AM NAT; BAILEY WJ, 1991, MOL BIOL EVOL, V8, P155; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; COLUZZI M, 1996, 23 SEM EV BIOL GRAND, P263; FU YX, 1993, GENETICS, V133, P693; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Harinasuta T., 1988, Malaria: principles and practice of malariology. Volume 1., P709; Hill AVS, 1999, EVOLUTION IN HEALTH AND DISEASE, P50; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENETICS, V116, P153; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; KREITMAN M, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P204; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; Metz EC, 1998, P NATL ACAD SCI USA, V95, P10676, DOI 10.1073/pnas.95.18.10676; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Nachman MW, 1998, GENETICS, V150, P1133; Olsson ML, 1998, BRIT J HAEMATOL, V103, P1184, DOI 10.1046/j.1365-2141.1998.01083.x; Pease JE, 1998, SEMIN IMMUNOL, V10, P169, DOI 10.1006/smim.1998.0129; PRZEWORSKI M, IN PRESS TRENDS GENE; Rozas J, 1997, COMPUT APPL BIOSCI, V13, P307; SIMONSEN KL, 1995, GENETICS, V141, P413; SLATKIN M, 1991, GENETICS, V129, P555; Slatkin M, 1998, GENET RES, V71, P155, DOI 10.1017/S001667239800319X; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Tsaur SC, 1998, MOL BIOL EVOL, V15, P1040, DOI 10.1093/oxfordjournals.molbev.a026002; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0	40	255	263	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1669	1679		10.1086/302879	http://dx.doi.org/10.1086/302879			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762551	Green Published, Bronze			2022-12-18	WOS:000088373700020
J	Bjorses, P; Halonen, M; Palvimo, JJ; Kolmer, M; Aaltonen, J; Ellonen, P; Perheentupa, J; Ulmanen, I; Peltonen, L				Bjorses, P; Halonen, M; Palvimo, JJ; Kolmer, M; Aaltonen, J; Ellonen, P; Perheentupa, J; Ulmanen, I; Peltonen, L			Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-1 APS1; HUMAN DNA; LOCALIZATION; REGULATOR; DOMAIN; COMMON; EXPRESSION; RECEPTOR; DISEASE; BINDING	Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a monogenic autosomal disease with recessive inheritance. It is characterized by multiple autoimmune endocrinopathies, chronic mucocutaneous candidiasis, and ectodermal dystrophies. The defective gene responsible for this disease was recently isolated, and several different mutations in the novel gene, AIRE, have been identified, by us and by others, in patients with APECED. We have shown that the APECED protein is mainly localized, both in vitro and in vivo, to the cell nucleus, where it forms distinct speckles. This accords with the predicted structural features of the protein, which suggest involvement of AIRE in the regulation of gene transcription. Here, we report the results of mutational analyses of a series of 112 patients with APECED who were from various ethnic backgrounds. A total of 16 different mutations, covering 91% of disease alleles, were observed; of these, 8 were novel. The mutations are spread throughout the coding region of AIRE, yet four evident mutational hotspots were observed. In vitro expression of four different naturally occurring nonsense and missense mutations revealed a dramatically altered subcellular location of the protein in cultured cells. Interestingly, the wild-type APECED protein tethered to the Gal4 DNA-binding domain acted as a strong transcriptional activator of reporter genes in mammalian cells, whereas most of the analyzed mutant polypeptides had lost this capacity.	Univ Helsinki, Inst Biomed, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Inst Biomed, Dept Physiol, Helsinki, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Helsinki Univ Hosp, Hosp Children & Adolescence, Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Peltonen, L (corresponding author), Univ Calif Los Angeles, Sch Med, Gonda Ctr, 695 Charles E Young Dr S, Los Angeles, CA 90024 USA.		Hurskainen, Maria/CAF-0221-2022	Hurskainen, Maria/0000-0003-1818-0647; Palvimo, Jorma/0000-0003-2373-0578				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Bjorses P, 1999, HUM MOL GENET, V8, P259, DOI 10.1093/hmg/8.2.259; Bjorses P, 1996, AM J HUM GENET, V59, P879; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Blechschmidt K, 1999, GENOME RES, V9, P158; BORDEN KLB, 1995, EMBO J, V14, P5947, DOI 10.1002/j.1460-2075.1995.tb00283.x; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Cao TY, 1997, J CELL SCI, V110, P1563; Engelkamp D, 1996, CURR OPIN GENET DEV, V6, P334, DOI 10.1016/S0959-437X(96)80011-6; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heino M, 1999, HUM MUTAT, V13, P69, DOI 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Mittaz L, 1999, BIOCHEM BIOPH RES CO, V255, P483, DOI 10.1006/bbrc.1999.0223; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Myhre AG, 1998, J CLIN ENDOCR METAB, V83, P4204, DOI 10.1210/jc.83.12.4204; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Pearce SHS, 1998, AM J HUM GENET, V63, P1675, DOI 10.1086/302145; Rinderle C, 1999, HUM MOL GENET, V8, P277, DOI 10.1093/hmg/8.2.277; Rosatelli MC, 1998, HUM GENET, V103, P428, DOI 10.1007/s004390050846; Scott HS, 1998, MOL ENDOCRINOL, V12, P1112, DOI 10.1210/me.12.8.1112; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; STACEY A, 1990, NUCLEIC ACIDS RES, V18, P2829, DOI 10.1093/nar/18.9.2829; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Wang CY, 1998, HUM GENET, V103, P681, DOI 10.1007/s004390050891; Wang CY, 1999, GENOMICS, V55, P322, DOI 10.1006/geno.1998.5656; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Zakeri H, 1998, BIOTECHNIQUES, V25, P406, DOI 10.2144/98253st01; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	38	255	262	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					378	392		10.1086/302765	http://dx.doi.org/10.1086/302765			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677297	Green Published, Bronze			2022-12-18	WOS:000088373100004
J	Gibbs, M; Stanford, JL; McIndoe, RA; Jarvik, GP; Kolb, S; Goode, EL; Chakrabarti, L; Schuster, EF; Buckley, VA; Miller, EL; Brandzel, S; Li, S; Hood, L; Ostrander, EA				Gibbs, M; Stanford, JL; McIndoe, RA; Jarvik, GP; Kolb, S; Goode, EL; Chakrabarti, L; Schuster, EF; Buckley, VA; Miller, EL; Brandzel, S; Li, S; Hood, L; Ostrander, EA			Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LINKAGE ANALYSIS; FAMILY HISTORY; ALLELIC LOSS; OLIGODENDROGLIAL TUMORS; BREAST-CANCER; RISK; NEUROBLASTOMA; GENE; HETEROZYGOSITY	Combining data from a genomic screen in 70 families with a high risk for prostate cancer (PC) with data from candidate-region mapping in these families and an additional 71 families, we have localized a potential hereditary PC-susceptibility locus to chromosome 1p36. Because an excess of cases of primary brain cancer (BC) have been observed in some studies of families with a high risk for PC, and because loss of heterozygosity at 1p36 is frequently observed in BC, we further evaluated 12 families with both a history of PC and a blood relative with primary BC. The overall LOD score in these 12 families was 3.22 at a recombination fraction (theta) of .06, with marker D1S507. On the basis of an a priori hypothesis, this group was stratified by age at diagnosis of PC. In the younger age group (mean age at diagnosis <66 years), a maximum two-point LOD score of 3.65 at theta = .0 was observed, with D1S407. This linkage was rejected in both early- and late-onset families without a history of BC (LOD scores -7.12 and -6.03, respectively, at theta = .0). After exclusion of 3 of the 12 families that had better evidence of linkage to previously described PC-susceptibility loci, linkage to the 1p36 region was suggested by a two-point LOD score of 4.74 at theta = .0, with marker D1S407. We conclude that a significant proportion of these families with both a high risk for PC and a family member with BC show linkage to the 1p36 region.	Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ostrander, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N,D2-190, Seattle, WA 98109 USA.		Chakrabarti, Lisa/G-4236-2011; Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708; McIndoe, Richard/0000-0002-3040-3631; Chakrabarti, Lisa/0000-0001-7213-6837; Ostrander, Elaine/0000-0001-6075-9738; Kolb, Suzanne/0000-0002-6443-644X	NATIONAL CANCER INSTITUTE [R01CA056678] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA56678] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Airewele G, 1998, J NATL CANCER I, V90, P543, DOI 10.1093/jnci/90.7.543; BELLO MJ, 1995, INT J CANCER, V64, P207; BELLO MJ, 1994, INT J CANCER, V57, P172, DOI 10.1002/ijc.2910570207; BELLO MJ, 1995, CANCER GENET CYTOGEN, V83, P160, DOI 10.1016/0165-4608(95)00064-V; BELLO MJ, 1994, GENE CHROMOSOME CANC, V9, P296, DOI 10.1002/gcc.2870090411; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; BOVA GS, 1993, CANCER RES, V53, P3869; CANNONALBRIGHT L, 1995, NAT GENET, V9, P336, DOI 10.1038/ng0495-336; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Cher ML, 1996, CANCER RES, V56, P3091; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Gronberg H, 1997, JAMA-J AM MED ASSOC, V278, P1251, DOI 10.1001/jama.278.15.1251; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; ISAACS SD, 1995, J NATL CANCER I, V87, P991, DOI 10.1093/jnci/87.13.991; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; KRAUS JA, 1995, J NEUROPATH EXP NEUR, V54, P91, DOI 10.1097/00005072-199501000-00011; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Laniado ME, 1998, JAMA-J AM MED ASSOC, V279, P507, DOI 10.1001/jama.279.7.507; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOVE RR, 1985, J CHRON DIS, V38, P289, DOI 10.1016/0021-9681(85)90074-8; MARIS JM, 1995, CANCER RES, V55, P4664; MARTINSSON T, 1995, CANCER RES, V55, P5681; MASSENKEIL G, 1994, ANTICANCER RES, V14, P2785; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; Ott J., 1991, ANAL HUMAN GENETIC L; RANSOM DT, 1992, GENE CHROMOSOME CANC, V5, P357, DOI 10.1002/gcc.2870050412; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RUDDON RW, 1981, CANC BIOL; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; SCHLICHT W, 1994, ANXIETY STRESS COPIN, V6, P275, DOI 10.1080/10615809408248802; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; STANFORD JL, IN PRESS NCI PUBL; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; VanRoy N, 1997, CANCER GENET CYTOGEN, V97, P135, DOI 10.1016/S0165-4608(96)00362-7; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Williams BJ, 1996, J UROLOGY, V155, P720, DOI 10.1016/S0022-5347(01)66509-1; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	48	255	263	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					776	787		10.1086/302287	http://dx.doi.org/10.1086/302287			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053012	Bronze, Green Published			2022-12-18	WOS:000079204700015
J	Boissel, S; Reish, O; Proulx, K; Kawagoe-Takaki, H; Sedgwick, B; Yeo, GSH; Meyre, D; Golzio, C; Molinari, F; Kadhom, N; Etchevers, HC; Saudek, V; Farooqi, IS; Froguel, P; Lindahl, T; O'Rahilly, S; Munnich, A; Colleaux, L				Boissel, Sarah; Reish, Orit; Proulx, Karine; Kawagoe-Takaki, Hiroko; Sedgwick, Barbara; Yeo, Giles S. H.; Meyre, David; Golzio, Christelle; Molinari, Florence; Kadhom, Noman; Etchevers, Heather C.; Saudek, Vladimir; Farooqi, I. Sadaf; Froguel, Philippe; Lindahl, Tomas; O'Rahilly, Stephen; Munnich, Arnold; Colleaux, Laurence			Loss-of-Function Mutation in the Dioxygenase-Encoding FTO Gene Causes Severe Growth Retardation and Multiple Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OXIDATIVE DEMETHYLATION; ENERGY-EXPENDITURE; ALKYLATION DAMAGE; ESCHERICHIA-COLI; ADULT OBESITY; FUSED-TOES; DNA; ALKB; MOUSE; MICE	FTO is a nuclear protein belonging to the AlkB-related non-haem iron- and 2-oxoglutarate-dependent dioxygenase family. Although polymorphisms within the first intron of the FTO gene have been associated with obesity, the physiological role of FTO remains unknown. Here we show that a R316Q mutation, inactivating FTO enzymatic activity, is responsible for an autosomal-recessive lethal syndrome. Cultured skin fibroblasts from affected subjects showed impaired proliferation and accelerated senescence. These findings indicate that FTO is essential for normal development of the central nervous and cardiovascular systems in human and establish that a mutation in a human member of the AlkB-related dioxygenase family results in a severe polymal formation syndrome.	[Boissel, Sarah; Golzio, Christelle; Molinari, Florence; Kadhom, Noman; Etchevers, Heather C.; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Boissel, Sarah; Golzio, Christelle; Molinari, Florence; Kadhom, Noman; Etchevers, Heather C.; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Reish, Orit] Assaf Harofeh Med Ctr, Dept Med Genet, IL-70300 Zerifin, Israel; [Reish, Orit] Tel Aviv Univ, Sackler Sch Med, IL-70300 Zerifin, Israel; [Proulx, Karine; Yeo, Giles S. H.; Saudek, Vladimir; Farooqi, I. Sadaf; O'Rahilly, Stephen] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England; [Kawagoe-Takaki, Hiroko; Sedgwick, Barbara; Lindahl, Tomas] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, S Mimms EN6 3LD, Herts, England; [Meyre, David; Froguel, Philippe] Inst Pasteur, CNRS, Inst Biol 8090, F-59019 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London W12 0NN, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Imperial College London	Colleaux, L (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.	laurence.colleaux@inserm.fr	Molinari, Florence/M-7683-2016; Farooqi, Ismaa Sadaf/AAZ-3046-2020; FROGUEL, Philippe/O-6799-2017; COLLEAUX, Laurence/H-6455-2017; O'Rahilly, Stephen/ABF-6509-2020; Etchevers, Heather C./B-5813-2012; Meyre, David/D-7315-2011; COLLEAUX, LAURENCE/AAA-8144-2022	Molinari, Florence/0000-0001-5111-7215; FROGUEL, Philippe/0000-0003-2972-0784; O'Rahilly, Stephen/0000-0003-2199-4449; Etchevers, Heather C./0000-0003-0201-3799; Meyre, David/0000-0003-4850-7444; COLLEAUX, LAURENCE/0000-0002-0987-7648; Yeo, Giles See How/0000-0001-8823-3615; Farooqi, Sadaf/0000-0001-7609-3504; Golzio, Christelle/0000-0002-4420-3921; reish, orit/0000-0002-9483-238X	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche; Region Ile-de-France; EU [LSHM-CT-2004-512013]; Medical Research Council UK; Cancer Research UK; Wellcome Trust; NIHR Cambridge Biomedical Research Centre; Medical Research Council [G0600331, G0600717B] Funding Source: researchfish; MRC [G0600331] Funding Source: UKRI	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Ile-de-France(Region Ile-de-France); EU(European Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the patients for their participation in the study. We acknowledge Jean Philippe Jais for LOD score calculation, Carron Sher for participation to clinical evaluation, Uli Ruther for kindly providing FTO antibodies, Celine Cluzeau for help with western blotting, Peter Robins for purification of FFO protein, and Marcella Ma and Debbie Lyon for additional technical assistance. This study was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche, the Region Ile-de-France, EU FP6 EUGENE2 (LSHM-CT-2004-512013), EC FP6 Marie Curie, the Medical Research Council UK, Cancer Research UK, the Wellcome Trust, and NIHR Cambridge Biomedical Research Centre.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Anselme I, 2007, DEV BIOL, V304, P208, DOI 10.1016/j.ydbio.2006.12.025; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gotz K, 2005, DEV DYNAM, V233, P623, DOI 10.1002/dvdy.20354; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; KAULE G, 1990, ANAL BIOCHEM, V184, P291, DOI 10.1016/0003-2697(90)90683-Z; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	25	254	274	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					106	111		10.1016/j.ajhg.2009.06.002	http://dx.doi.org/10.1016/j.ajhg.2009.06.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19559399	Bronze, Green Published			2022-12-18	WOS:000267997600012
J	den Hollander, AI; Heckenlively, JR; van den Born, LI; de Kok, YJM; van der Velde-Visser, SD; Kellner, U; Jurklies, B; van Schooneveld, MJ; Blankenagel, A; Rohrschneider, K; Wissinger, B; Cruysberg, JRM; Deutman, AF; Brunner, HG; Apfeldstedt-Sylla, E; Hoyng, CB; Cremers, FPM				den Hollander, AI; Heckenlively, JR; van den Born, LI; de Kok, YJM; van der Velde-Visser, SD; Kellner, U; Jurklies, B; van Schooneveld, MJ; Blankenagel, A; Rohrschneider, K; Wissinger, B; Cruysberg, JRM; Deutman, AF; Brunner, HG; Apfeldstedt-Sylla, E; Hoyng, CB; Cremers, FPM			Leber congenital amaurosis and retinitis pigmentosa with coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRX; PHENOTYPES	Mutations in the crumbs homologue 1 (CRB1) gene cause a specific form of retinitis pigmentosa (RP) that is designated "RP12" and is characterized by a preserved para-arteriolar retinal pigment epithelium (PPRPE) and by severe loss of vision at age <20 years. Because of the early onset of disease in patients who have RP with PPRPE, we considered CRB1 to be a good candidate gene for Leber congenital amaurosis (LCA). Mutations were detected in 7 (13%) of 52 patients with LCA from the Netherlands, Germany, and the United States. In addition, CRB1 mutations were detected in five of nine patients who had RP with Coats-like exudative vasculopathy, a relatively rare complication of RP that may progress to partial or total retinal detachment. Given that four of five patients had developed the complication in one eye and that not all siblings with RP have the complication, CRB1 mutations should be considered an important risk factor for the Coats-like reaction, although its development may require additional genetic or environmental factors. Although no clear-cut genotype-phenotype correlation could be established, patients with LCA, which is the most severe retinal dystrophy, carry null alleles more frequently than do patients with RP. Our findings suggest that CRB1 mutations are a frequent cause of LCA and are strongly associated with the development of Coats-like exudative vasculopathy in patients with RP.	Univ Med Ctr Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; Rotterdam Eye Hosp, Rotterdam, Netherlands; Free Univ Berlin, Univ Clin Benjamin Franklin, Dept Ophthalmol, D-1000 Berlin, Germany; Univ Essen Gesamthsch, Augenklin, Essen, Germany; Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands; Heidelberg Univ, Augenklin, Heidelberg, Germany; Univ Tubingen, Augenklin, D-7400 Tubingen, Germany	Radboud University Nijmegen; Radboud University Nijmegen; University of California System; University of California Los Angeles; Rotterdam Eye Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Utrecht University; Utrecht University Medical Center; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	den Hollander, AI (corresponding author), Univ Med Ctr Nijmegen, Dept Human Genet, POB 9101,Geert Grootepl 10, NL-6500 HB Nijmegen, Netherlands.	A.denHollander@antrg.azn.nl	Cruysberg, Johannes R. M./D-4313-2009; Cremers, Frans/A-5625-2014; Hoyng, C.B./H-8050-2014; Hollander, Anneke den/N-4911-2014; Brunner, Han/C-9928-2013	Cruysberg, Johannes R. M./0000-0002-5330-0774; Cremers, Frans/0000-0002-4954-5592; Rohrschneider, Klaus/0000-0003-1996-7935				den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HECKENLIVELY JR, 1982, BRIT J OPHTHALMOL, V66, P26, DOI 10.1136/bjo.66.1.26; KHAN JA, 1988, SURV OPHTHALMOL, V32, P317, DOI 10.1016/0039-6257(88)90094-X; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; VANDENBORN LI, 1994, AM J OPHTHALMOL, V118, P430, DOI 10.1016/S0002-9394(14)75792-7	22	254	258	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					198	203						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11389483				2022-12-18	WOS:000170108100019
J	Richards, A; Buddles, MR; Donne, RL; Kaplan, BS; Kirk, E; Venning, MC; Tielemans, CL; Goodship, JA; Goodship, THJ				Richards, A; Buddles, MR; Donne, RL; Kaplan, BS; Kirk, E; Venning, MC; Tielemans, CL; Goodship, JA; Goodship, THJ			Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; HEPARIN-BINDING DOMAIN; DEFICIENCY; FAMILY; HYPOCOMPLEMENTEMIA; IDENTIFICATION; HEREDITARY; SECRETION; PROTEINS; DISEASE	Several recent studies have established an association between abnormalities of complement factor H (FH) and the development of hemolytic uremic syndrome (HUS). To identify the relative importance of mutations in FH as a cause of HUS, we have undertaken mutation screening of the FH gene in 19 familial and 31 sporadic patients with FH. Mutations were found in two familial and three sporadic patients, and these clustered in exons 18-20, a domain important for host recognition. Moreover, this study demonstrates that familial HUS is likely to be a heterogeneous condition.	Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Biochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA; Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW, Australia; Free Univ Brussels, Erasme Hosp, Dept Nephrol, B-1050 Brussels, Belgium	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Goodship, THJ (corresponding author), Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	t.h.j.goodship@ncl.ac.uk	Richards, Anna/E-8337-2013; Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768; Kirk, Edwin/0000-0002-4662-0024				Ault BH, 1997, J BIOL CHEM, V272, P25168, DOI 10.1074/jbc.272.40.25168; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; deVillena FPM, 1996, CYTOGENET CELL GENET, V72, P339; Diaz-Guillen MA, 1999, IMMUNOGENETICS, V49, P549, DOI 10.1007/s002510050534; Fijen CAP, 1996, CLIN EXP IMMUNOL, V105, P511, DOI 10.1046/j.1365-2249.1996.d01-777.x; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; LEVY M, 1986, KIDNEY INT, V30, P949, DOI 10.1038/ki.1986.278; Liu Q, 1996, HUM MOL GENET, V5, P107, DOI 10.1093/hmg/5.1.107; LOPEZLARREA C, 1987, BIOCHEM SOC T, V15, P648, DOI 10.1042/bst0150648; Male DA, 2000, MOL IMMUNOL, V37, P41, DOI 10.1016/S0161-5890(00)00024-9; NIELSEN HE, 1989, SCAND J IMMUNOL, V30, P711, DOI 10.1111/j.1365-3083.1989.tb02480.x; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; ROODHOOFT AM, 1990, PEDIATR NEPHROL, V4, P597, DOI 10.1007/BF00858631; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; Sanchez-Corral P, 2000, IMMUNOGENETICS, V51, P366, DOI 10.1007/s002510050631; Schmidt BZ, 1999, J BIOL CHEM, V274, P11782, DOI 10.1074/jbc.274.17.11782; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Ying LH, 1999, AM J HUM GENET, V65, P1538, DOI 10.1086/302673; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	28	254	263	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					485	490		10.1086/318203	http://dx.doi.org/10.1086/318203			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170896	Green Published, Bronze			2022-12-18	WOS:000166524800018
J	Carvalho-Silva, DR; Santos, FR; Rocha, J; Pena, SDJ				Carvalho-Silva, DR; Santos, FR; Rocha, J; Pena, SDJ			The phylogeography of Brazilian Y-chromosome lineages	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; POPULATION	We examined DNA polymorphisms in the nonrecombining portion of the Y-chromosome to investigate the contribution of distinct patrilineages to the present-day white Brazilian population. Twelve unique-event polymorphisms were typed in 200 unrelated males from four geographical regions of Brazil and in 93 Portuguese males. In our Brazilian sample, the vast majority of Y-chromosomes proved to be of European origin. Indeed, there were no significant differences when the haplogroup frequencies in Brazil and Portugal were compared by means of an exact test of population differentiation. Y-chromosome typing was quite sensitive in the detection of regional immigration events. Distinct footprints of Italian immigration to southern Brazil, migration of Moroccan Jews to the Amazon region, and possible relies of the 17th-century Dutch invasion of northeast Brazil could be seen in the data. In sharp contrast with our mtDNA data in white Brazilians, which showed that greater than or equal to 60% of the matrilineages were Amerindian or African, only 2.5% of the Y-chromosome lineages were from sub-Saharan Africa, and none were Amerindian. Together, these results configure a picture of strong directional mating between European males and Amerindian and African females, which agrees with the known history of the peopling of Brazil since 1500.	Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-30161970 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Biol Geral, BR-30161970 Belo Horizonte, MG, Brazil; Univ Porto, Inst Patol & Imunol Mol, P-4100 Porto, Portugal	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade do Porto	Pena, SDJ (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bioquim, Caixa Postal 486, BR-30161970 Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	Santos, Fabrício Rodrigues/H-2370-2011	Santos, Fabrício Rodrigues/0000-0001-9088-1750; rocha, jorge/0000-0001-5460-7615; Carvalho-Silva, Dr D/0000-0001-5662-1840				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; EXCOFFIER L, 1992, GENETICS, V131, P479; GRINBERG K, 2000, BRASIL 500 ANOS POVO, P125; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; *IBGE I BRAS GEOGR, 2000, BRAS 500 AN POV; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PANDYA A, 1998, THESIS OXFORD U; Pereira L, 2000, INT CONGR SER, P281; Previdere C, 2000, INT CONGR SER, P257; Ribeiro D., 1995, POVO BRASILEIRO FORM; ROSSER Z, 2000, IN PRESS AM J HUM GE; SANTOS FR, 1993, HUM GENET, V90, P655; SANTOS FR, 1999, DNA PROFILING DNA FI, P133; Schneider S., 1997, ARLEQUIN VER 1 1 SOF; Semino O, 1996, AM J HUM GENET, V59, P964; Shinka T, 1999, J HUM GENET, V44, P240, DOI 10.1007/s100380050151; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Zerjal T, 1999, GENOMIC DIVERSITY, P91	22	254	267	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					281	286		10.1086/316931	http://dx.doi.org/10.1086/316931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11090340	Green Published, Bronze			2022-12-18	WOS:000166399900032
J	Haack, TB; Hogarth, P; Kruer, MC; Gregory, A; Wieland, T; Schwarzmayr, T; Graf, E; Sanford, L; Meyer, E; Kara, E; Cuno, SM; Harik, SI; Dandu, VH; Nardocci, N; Zorzi, G; Dunaway, T; Tarnopolsky, M; Skinner, S; Frucht, S; Hanspal, E; Schrander-Stumpel, C; Heron, D; Mignot, C; Garavaglia, B; Bhatia, K; Hardy, J; Strom, TM; Boddaert, N; Houlden, HH; Kurian, MA; Meitinger, T; Prokisch, H; Hayflick, SJ				Haack, Tobias B.; Hogarth, Penelope; Kruer, Michael C.; Gregory, Allison; Wieland, Thomas; Schwarzmayr, Thomas; Graf, Elisabeth; Sanford, Lynn; Meyer, Esther; Kara, Eleanna; Cuno, Stephan M.; Harik, Sami I.; Dandu, Vasuki H.; Nardocci, Nardo; Zorzi, Giovanna; Dunaway, Todd; Tarnopolsky, Mark; Skinner, Steven; Frucht, Steven; Hanspal, Era; Schrander-Stumpel, Connie; Heron, Delphine; Mignot, Cyril; Garavaglia, Barbara; Bhatia, Kailash; Hardy, John; Strom, Tim M.; Boddaert, Nathalie; Houlden, Henry H.; Kurian, Manju A.; Meitinger, Thomas; Prokisch, Holger; Hayflick, Susan J.			Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOPHAGY; REPEAT	Neurodegeneration with brain iron accumulation (NBIA) is a group of genetic disorders characterized by abnormal iron deposition in the basal ganglia. We report that de novo mutations in WDR45, a gene located at Xp11.23 and encoding a beta-propeller scaffold protein with a putative role in autophagy, cause a distinctive NBIA phenotype. The clinical features include early-onset global developmental delay and further neurological deterioration (parkinsonism, dystonia, and dementia developing by early adulthood). Brain MRI revealed evidence of iron deposition in the substantia nigra and globus pallidus. Males and females are phenotypically similar, an observation that might be explained by somatic mosaicism in surviving males and germline or somatic mutations in females, as well as skewing of X chromosome inactivation. This clinically recognizable disorder is among the more common forms of NBIA, and we suggest that it be named accordingly as beta-propeller protein-associated neurodegeneration.	[Hogarth, Penelope; Hayflick, Susan J.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Haack, Tobias B.; Cuno, Stephan M.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-85748 Munich, Germany; [Haack, Tobias B.; Wieland, Thomas; Schwarzmayr, Thomas; Graf, Elisabeth; Cuno, Stephan M.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Hogarth, Penelope; Gregory, Allison; Sanford, Lynn; Hayflick, Susan J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Kruer, Michael C.] Sanford Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Meyer, Esther; Kurian, Manju A.] UCL, Inst Child Hlth, Neurosci Unit, London WC1N 3BG, England; [Meyer, Esther; Kurian, Manju A.] Great Ormond St Hosp Sick Children, Dept Paediat Neurol, London WC1N 3BG, England; [Kara, Eleanna; Hardy, John; Houlden, Henry H.] UCL, Dept Mol Neurosci, Inst Neurol, London WC1N 3BG, England; [Kara, Eleanna; Hardy, John] UCL, Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England; [Harik, Sami I.; Dandu, Vasuki H.] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA; [Nardocci, Nardo; Zorzi, Giovanna] Ist Ricovero & Cura Carattere Sci Fdn Neurol Inst, Unit Child Neurol, Dept Pediat Neurosci, I-20133 Milan, Italy; [Dunaway, Todd] Private Practice, Tulsa, OK 74104 USA; [Tarnopolsky, Mark] McMaster Univ, Med Ctr, Div Neuromuscular & Neurometab Disorders, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Skinner, Steven] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Frucht, Steven] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Hanspal, Era] Albany Med Ctr, Parkinsons Dis & Movement Disorders Ctr, Albany, NY 12208 USA; [Hanspal, Era] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA; [Schrander-Stumpel, Connie] Univ Limburg, Acad Hosp Maastricht, Dept Clin Genet, NL-6229 GT Maastricht, Netherlands; [Heron, Delphine; Mignot, Cyril] Grp Hosp Pitie Salpetriere, Clin Genet Unit, Ctr Reference Deficiences Intellectuelles Causes, F-75651 Paris, France; [Garavaglia, Barbara] Ist Ricovero & Cura Carattere Sci Fdn Neurol Inst, Unit Mol Neurogenet, I-20133 Milan, Italy; [Bhatia, Kailash] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Boddaert, Nathalie] Hop Necker Enfants Malad, Dept Paediat Radiol, F-75743 Paris, France; [Hayflick, Susan J.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Oregon Health & Science University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Oregon Health & Science University; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Arkansas System; University of Arkansas Medical Sciences; McMaster University; Greenwood Genetic Center; Icahn School of Medicine at Mount Sinai; Albany Medical College; Albany Medical College; Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Oregon Health & Science University	Hayflick, SJ (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA.	hayflick@ohsu.edu	Meitinger, Thomas/O-1318-2015; Prokisch, Holger/N-8964-2013; boddaert, nathalie/GWV-2865-2022; Zorzi, Giovanna/AAM-4138-2021; Nardocci, Nardo/AAB-9903-2019; Kara, Eleanna/E-1630-2013; Hardy, John/C-2451-2009; Garavaglia, Barbara/J-5257-2018; Houlden, Henry J/C-1532-2008	Zorzi, Giovanna/0000-0001-7041-5365; Nardocci, Nardo/0000-0001-5863-5592; Hardy, John/0000-0002-3122-0423; Garavaglia, Barbara/0000-0003-4323-9145; Houlden, Henry J/0000-0002-2866-7777; Bhatia, Kailash/0000-0001-8185-286X; Kara, Eleanna/0000-0001-5428-6743; boddaert, nathalie/0000-0003-0991-7774; Prokisch, Holger/0000-0003-2379-6286; Meitinger, Thomas/0000-0002-8838-8403; Frucht, Steven/0000-0002-4653-0491	NBIA Disorders Association; Hoffnungsbaum e.V.; Associazione Italiana Sindromi Neurodegenerative da Accumulo di Ferro; Oregon Clinical and Translational Research Institute, a component of the National Institutes of Health (NIH) [UL1 RR024140 NCRR]; NIH Roadmap for Medical Research; European Commission [277984, 261123]; German Federal Ministry of Education and Research (Systems Biology of Metabotypes) [SysMBo 0315494A]; German Network for Mitochondrial Disorders [mitoNET 01GM0867]; Genetic European Variation in Disease Consortium; German Ministry for Education and Research [01GR0804-4]; American Academy of Neurology; American Philosophical Society; Action Medical Research; Fondazione Telethon Funding Source: Custom; MRC [G108/638, G0802760, G1001253] Funding Source: UKRI; Medical Research Council [G0802760, G108/638, G1001253] Funding Source: researchfish; Action Medical Research [1722] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER	NBIA Disorders Association; Hoffnungsbaum e.V.; Associazione Italiana Sindromi Neurodegenerative da Accumulo di Ferro; Oregon Clinical and Translational Research Institute, a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research (Systems Biology of Metabotypes); German Network for Mitochondrial Disorders; Genetic European Variation in Disease Consortium; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); American Academy of Neurology; American Philosophical Society; Action Medical Research; Fondazione Telethon(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors gratefully acknowledge the study participants and families, as well as the support of our advocacy partners: the NBIA Disorders Association, Hoffnungsbaum e.V., and Associazione Italiana Sindromi Neurodegenerative da Accumulo di Ferro. This work was funded by the NBIA Disorders Association and was made possible with support from the Oregon Clinical and Translational Research Institute (UL1 RR024140 NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. P.H., N.N., T.M., H.P., and S.J.H. participate in the TIRCON consortium (European Commission Seventh Framework Program, FP7/2007-2013, HEALTH-F2-2011, grant agreement 277984). We thank Evelyn Botz and Carola Fischer for technical support. T.M. and H.P. were supported by the German Federal Ministry of Education and Research (Systems Biology of Metabotypes grant SysMBo 0315494A) and the German Network for Mitochondrial Disorders (mitoNET 01GM0867). T.M. and T.M.S. were supported by the European Commission Seventh Framework Program (N. 261123), Genetic European Variation in Disease Consortium, and German Ministry for Education and Research (01GR0804-4). M.C.K. receives support from the American Academy of Neurology and American Philosophical Society. We thank the Cell line and DNA bank of pediatric movement disorders of the Telethon Genetic Biobank Network (GTB07001). M.A.K.'s research is supported by Action Medical Research. We thank the UK Parkinson's Disease Consortium, University College London Institute of Neurology, University of Sheffield, University of Dundee, Medical Research Council, Parkinson's Disease Foundation, Dystonia Medical Research Foundation, and Brain Research Trust.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005; Moog UTE, 2003, EUR J PAEDIATR NEURO, V7, P5, DOI 10.1016/S1090-3798(02)00134-4; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331	9	253	260	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1144	1149		10.1016/j.ajhg.2012.10.019	http://dx.doi.org/10.1016/j.ajhg.2012.10.019			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23176820	Green Published, Bronze			2022-12-18	WOS:000312417400020
J	Sturm, RA; Duffy, DL; Zhao, ZZ; Leite, FPN; Stark, MS; Hayward, NK; Martin, NG; Montgomery, GW				Sturm, Richard A.; Duffy, David L.; Zhao, Zhen Zhen; Leite, Fabio P. N.; Stark, Mitchell S.; Hayward, Nicholas K.; Martin, Nicholas G.; Montgomery, Grant W.			A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DILUTION P LOCUS; TRANSCRIPTION FACTOR; OCULOCUTANEOUS ALBINISM; MELANOMA; OCA2; IDENTIFICATION; PIGMENTATION; ASSOCIATION; QUEENSLAND; MUTATIONS	We have previously demonstrated that haplotypes of three single nucleotide polymorphisms (SNPs) within the first intron of the OCA2 gene are extremely strongly associated with variation in human eye color. In the present work, we describe additional fine association mapping of eye color SNPs in the intergenic region upstream of OCA2 and within the neighboring HERC2 (hect domain and RLD2) gene. We screened an additional 92 SNPs in 300-3000 European individuals and found that a single SNP in intron 86 of HERC2, rs12913832, predicted eye color significantly better (ordinal logistic regression R-2 = 0.68, association LOD = 444) than our previous best OCA2 haplotype. Comparison of sequence alignments of multiple species showed that this SNP lies in the center of a short highly conserved sequence and that the blue-eye-associated allele (frequency 78%) breaks Lip this conserved sequence, part of which forms a consensus binding site for the helicase-like transcription factor (HLTF). We were also able to demonstrate the OCA2 R419Q, rs1800407, coding SNP acts as a penetrance modifier of this new HERC2 SNP for eye color, and somewhat independently, of melanoma risk. We conclude that the conserved region around rs12913832 represents a regulatory region controlling constitutive expression of OCA2 and that the C allele at rs12913832 leads to decreased expression of OCA2, particularly within iris melanocytes, which we postulate to be the ultimate cause of blue eye color.	[Duffy, David L.; Zhao, Zhen Zhen; Leite, Fabio P. N.; Stark, Mitchell S.; Hayward, Nicholas K.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Montgomery, GW (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	grant.montgomery@qimr.edu.au	Duffy, David L/B-7392-2013; Sturm, Richard A/C-9943-2009; hayward, nicholas k/C-1367-2015; Stark, Mitchell/K-3874-2019; Montgomery, Grant W/B-7148-2008; Stark, Mitchell/K-6794-2019; hayward, nick/AAV-8802-2020; Stark, Mitchell S/E-3542-2010	Duffy, David L/0000-0001-7227-632X; Sturm, Richard A/0000-0003-1301-0294; hayward, nicholas k/0000-0003-4760-1033; Montgomery, Grant W/0000-0002-4140-8139; Stark, Mitchell/0000-0002-4510-2161; Stark, Mitchell S/0000-0002-4510-2161; Martin, Nicholas/0000-0003-4069-8020	NCI NIH HHS [R01 CA088363, CA88363] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA088363] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Eiberg H, 1996, EUR J HUM GENET, V4, P237; Frudakis T, 2003, GENETICS, V165, P2071; Frudakis T, 2007, HUM GENET, V122, P311, DOI 10.1007/s00439-007-0401-8; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Gong XH, 1997, DEV BIOL, V183, P166, DOI 10.1006/dbio.1996.8486; HASSTEDT SJ, 1995, GENET EPIDEMIOL, V12, P109, DOI 10.1002/gepi.1370120202; Hewetson A, 2002, MOL ENDOCRINOL, V16, P2101, DOI 10.1210/me.2002-0064; Hothorn T, 2004, UNBIASED RECURSIVE P; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerr R, 2000, HUM MUTAT, V15, P166, DOI 10.1002/(SICI)1098-1004(200002)15:2<166::AID-HUMU5>3.0.CO;2-Z; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; LYON MF, 1992, P NATL ACAD SCI USA, V89, P6968, DOI 10.1073/pnas.89.15.6968; Mahajan MC, 2002, BLOOD, V99, P348, DOI 10.1182/blood.V99.1.348; Oetting W S, 1998, Hum Mutat, V12, P434, DOI 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU15>3.0.CO;2-A; PHILLIPS R, 1965, MOUSE NEWS LETT, V32, P39; Posthuma D, 2006, BEHAV GENET, V36, P12, DOI 10.1007/s10519-005-9007-x; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; RAMSAY M, 1992, AM J HUM GENET, V51, P879; Rebbeck TR, 2002, CANCER EPIDEM BIOMAR, V11, P782; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; RUSSELL LB, 1995, GENETICS, V141, P1547; SHERIDAN PL, 1995, J BIOL CHEM, V270, P4575, DOI 10.1074/jbc.270.9.4575; Siskind V, 2002, INT J CANCER, V97, P90, DOI 10.1002/ijc.1563; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Sturm RA, 2006, TRENDS GENET, V22, P464, DOI 10.1016/j.tig.2006.06.010; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Suzuki T, 2003, AM J MED GENET A, V118A, P402, DOI 10.1002/ajmg.a.20044; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walkowicz M, 1999, MAMM GENOME, V10, P870, DOI 10.1007/s003359901106; Wang H, 2006, GENOME RES, V16, P1480, DOI 10.1101/gr.5353806; Zhao ZZ, 2006, MOL HUM REPROD, V12, P671, DOI 10.1093/molehr/gal078; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494	53	253	261	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					424	431		10.1016/j.ajhg.2007.11.005	http://dx.doi.org/10.1016/j.ajhg.2007.11.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252222	Green Published, Bronze			2022-12-18	WOS:000253223900014
J	Souto, JC; Almasy, L; Borrell, M; Blanco-Vaca, F; Mateo, J; Soria, JM; Coll, I; Felices, R; Stone, W; Fontcuberta, J; Blangero, J				Souto, JC; Almasy, L; Borrell, M; Blanco-Vaca, F; Mateo, J; Soria, JM; Coll, I; Felices, R; Stone, W; Fontcuberta, J; Blangero, J			Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEEP-VEIN THROMBOSIS; CORONARY-ARTERY DISEASE; TRAIT LINKAGE ANALYSIS; CLOTTING FACTOR-VIII; MYOCARDIAL-INFARCTION; VENOUS THROMBOSIS; PLASMINOGEN-ACTIVATOR; QUANTITATIVE TRAITS; HEART-DISEASE; PROTEIN-C	Although there are a number of well-characterized genetic defects that lead to increased risk of thrombosis, little information is available on the relative importance of genetic factors in thrombosis risk in the general population We performed a family-based study of the genetics of thrombosis in the Spanish population to assess the heritability of thrombosis and to identify the joint actions of genes on thrombosis risk and related quantitative hemostasis phenotypes. We examined 338 individuals in 21 extended pedigrees. Twelve pedigrees were ascertained through a proband with idiopathic thrombosis, and the remaining pedigrees were randomly ascertained. The heritability of thrombosis liability and the genetic correlations between thrombosis and each of the quantitative risk factors were estimated by means of a novel variance component method that used a multivariate threshold model. More than 60% of the variation in susceptibility to common thrombosis is attributable to genetic factors. Several quantitative risk factors exhibited significant genetic correlations with thrombosis, indicating that some of the genes that influence quantitative variation in these physiological correlates also influence the risk of thrombosis. Traits that exhibited significant genetic correlations with thrombosis included levels of several coagulation factors (factors VII, VIII, IX, XI, XII, and von Willebrand), tissue plasminogen activator, homocysteine, and the activated protein C ratio. This is the first study that quantifies the genetic component of susceptibility to common thrombosis. The high heritability of thrombosis risk and the significant genetic correlations between thrombosis and related risk factors suggest that the exploitation of correlated quantitative phenotypes will aid the search for susceptibility genes.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78284 USA; Hosp Santa Creu & St Pau, Unitat Trombosi & Hemostasia, Dept Hematol, Barcelona, Spain; Hosp Santa Creu & St Pau, Serv Bioquim, Inst Recerca, Barcelona, Spain; Trinity Univ, Dept Biol, San Antonio, TX 78212 USA	Texas Biomedical Research Institute; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Trinity University	Blangero, J (corresponding author), SW Fdn Biomed Res, Dept Genet, POB 760549, San Antonio, TX 78284 USA.		Almasy, Laura/V-3156-2019; Soria Fernández, José Manuel/AAD-6761-2019; Blanco-Vaca, Francisco/AAC-2600-2022; Blangero, John/ABA-7175-2021	Soria Fernández, José Manuel/0000-0002-6226-4293; Mateo, Jose/0000-0002-4227-3256; Blanco-Vaca, Francisco/0000-0001-7380-5385	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH059490, MH59490, R37 MH059490] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; Brooks R, 2000, NATURE, V406, P67, DOI 10.1038/35017552; Carter AM, 1998, THROMB HAEMOSTASIS, V80, P632; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1996, J CLIN ENDOCR METAB, V81, P597, DOI 10.1210/jc.81.2.597; COON WW, 1973, CIRCULATION, V48, P839, DOI 10.1161/01.CIR.48.4.839; de Visser MCH, 1999, BLOOD, V93, P1271, DOI 10.1182/blood.V93.4.1271.404k22_1271_1276; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; Doggen CJM, 1998, THROMB HAEMOSTASIS, V80, P281, DOI 10.1055/s-0037-1615188; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Duggirala R, 1999, GENET EPIDEMIOL, V16, P191, DOI 10.1002/(SICI)1098-2272(1999)16:2<191::AID-GEPI6>3.0.CO;2-6; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; HAMSTEN A, 1987, LANCET, V2, P3; Hasstedt SJ, 1998, AM J HUM GENET, V63, P569, DOI 10.1086/301947; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; HYLAND K, 1992, J CHROMATOGR-BIOMED, V579, P55, DOI 10.1016/0378-4347(92)80362-T; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Kendall M, 1972, ADV THEORY STAT; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P14, DOI 10.1055/s-0037-1614210; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; MACCALLUM PK, 1995, LANCET, V345, P804, DOI 10.1016/S0140-6736(95)90689-4; Mahaney MC, 2000, ARTERIOSCL THROM VAS, V20, P683, DOI 10.1161/01.ATV.20.3.683; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; RIDKER PM, 1993, LANCET, V341, P1165, DOI 10.1016/0140-6736(93)90998-V; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal FR, 1997, SEMIN HEMATOL, V34, P171; Rosendaal FR, 1997, BLOOD, V90, P1747, DOI 10.1182/blood.V90.5.1747; SANDSET PM, 1991, BLOOD COAGUL FIBRIN, V2, P425, DOI 10.1097/00001721-199106000-00004; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Stern MP, 2000, DIABETES-METAB RES, V16, P88, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<88::AID-DMRR81>3.0.CO;2-M; Vlieg AV, 2000, BLOOD, V95, P3678; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571	46	253	264	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1452	1459		10.1086/316903	http://dx.doi.org/10.1086/316903			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11038326	Bronze, Green Published			2022-12-18	WOS:000165607600010
J	Shah, AB; Chernov, I; Zhang, HT; Ross, BM; Das, K; Lutsenko, S; Parano, E; Pavone, L; Evgrafov, O; IvanovaSmolenskaya, IA; Anneren, G; Westermark, K; Urrutia, FH; Penchaszadeh, GK; Sternlieb, I; Scheinberg, IH; Gilliam, TC; Petrukhin, K				Shah, AB; Chernov, I; Zhang, HT; Ross, BM; Das, K; Lutsenko, S; Parano, E; Pavone, L; Evgrafov, O; IvanovaSmolenskaya, IA; Anneren, G; Westermark, K; Urrutia, FH; Penchaszadeh, GK; Sternlieb, I; Scheinberg, IH; Gilliam, TC; Petrukhin, K			Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPPER-TRANSPORTING ATPASE; OCCIPITAL HORN SYNDROME; MENKES DISEASE; CANDIDATE GENE; CONSEQUENCES; HAPLOTYPE; ENCODES; PROTEIN; CLONING; LOCUS	Wilson disease (WD) is an autosomal recessive disorder characterized by toxic accumulation of copper in the liver and subsequently in the brain and other organs. On the basis of sequence homology to known genes, the WD gene (ATP7B) appears to be a copper-transporting P-type ATPase. A search for ATB7B mutations in WD patients from five population samples, including 109 North American patients, revealed 27 distinct mutations, 18 of which are novel. A composite of published findings shows missense mutations in all exons-except in exons 1-5, which encode the six copper-binding motifs, and in exon 21, which spans the carboxy-terminus and the poly(A) tail. Over one-half of all WD mutations occur only rarely in any population sample. A splice-site mutation in exon 12 accounts for 3% of the WD mutations in our sample and produces an in-frame, 39-bp insertion in mRNA of patients homozygous, but not heterozygous, for the mutation. The most common WD mutation (His1069Glu) was represented in similar to 38% of all the WD chromosomes from the North American, Russian, and Swedish samples. In several population cohorts, this mutation deviated from Hardy-Weinberg equilibrium, with an overrepresentation of homozygotes. We did not find a significant correlation between His1069Glu homozygosity and several clinical indices, including age of onset, clinical manifestation, ceruloplasmin activity, hepatic copper levels, and the presence of Kayser-Fleischer rings. Finally, lymphoblast cell lines from individuals homozygous for His1069Glu and 4 other mutations all demonstrated significantly decreased copper-stimulated ATPase activity.	COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; ST LUKES ROOSEVELT HOSP,NEW YORK,NY 10025; NATL CTR STUDY WILSONS DIS,NEW YORK,NY; OREGON HLTH SCI UNIV,PORTLAND,OR 97201; CATANIA UNIV,PEDIAT CLIN,CATANIA,ITALY; CNR,IBFSNC,CATANIA,ITALY; RUSSIAN ACAD MED SCI,MED GENET RES CTR,MOSCOW,RUSSIA; RUSSIAN ACAD MED SCI,NEUROL INST,MOSCOW,RUSSIA; UNIV UPPSALA HOSP,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN; UNIV UPPSALA HOSP,DEPT MED,S-75185 UPPSALA,SWEDEN	Columbia University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Oregon Health & Science University; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Research Center of Neurology; Russian Academy of Medical Sciences; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital			Ivanova-Smolenskaya, Irina A/C-9041-2012	PARANO, ENRICO/0000-0002-0713-7339; Petrukhin, Konstantin/0000-0002-5545-6924; Chernov, Igor/0000-0002-8879-1964	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047383] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47383] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN JP, 1995, FEBS LETT, V359, P105; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; DAS S, 1994, AM J HUM GENET, V55, P883; DAS S, 1995, AM J HUM GENET, V56, P570; DECASTRO JAL, 1984, METHOD ENZYMOL, V108, P582; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FIGUS A, 1995, AM J HUM GENET, V57, P1318; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; HOUWEN RHJ, 1995, J MED GENET, V32, P480, DOI 10.1136/jmg.32.6.480; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kemppainen R, 1997, J INVEST DERMATOL, V108, P35, DOI 10.1111/1523-1747.ep12285622; KRAWCZAK M, 1992, HUM GENET, V90, P41; Loudianos G, 1996, HUM GENET, V98, P640, DOI 10.1007/s004390050275; Luza Sandra C., 1996, American Journal of Clinical Nutrition, V63, p812S; Maniatis T, 1989, DECONTAMINATION DILU; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MORELL AG, 1968, LABORATORY DIAGNOSIS, P193; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Petrukhin Konstantin, 1994, Current Opinion in Pediatrics, V6, P698, DOI 10.1097/00008480-199412000-00015; SCHEINBERG IH, 1984, WILSONS DISEASE, V23; SHIMIZU N, 1995, BIOCHEM BIOPH RES CO, V217, P16, DOI 10.1006/bbrc.1995.2739; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS L, 1995, PAEDIATR PERINAT EP, V9, P250, DOI 10.1111/j.1365-3016.1995.tb00140.x; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Waldenstrom E, 1996, GENOMICS, V37, P303, DOI 10.1006/geno.1996.0564; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; ZHANG Y, 1991, NUCLEIC ACIDS RES, V19, P3929, DOI 10.1093/nar/19.14.3929	33	253	271	1	20	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					317	328		10.1086/514864	http://dx.doi.org/10.1086/514864			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311736	Green Published, hybrid			2022-12-18	WOS:A1997XX70100009
J	NEEL, JV; SALZANO, FM; KEITER, F; MAYBURYL.D; JUNQUEIRA, PCC				NEEL, JV; SALZANO, FM; KEITER, F; MAYBURYL.D; JUNQUEIRA, PCC			STUDIES ON XAVANTE INDIANS OF BRAZILIAN MATO GROSSO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					Abbie AA, 1953, AM J PHYS ANTHROP-NE, V11, P339, DOI 10.1002/ajpa.1330110310; ABBIE AA, 1960, OCEANIA, V31, P140, DOI 10.1002/j.1834-4461.1960.tb00747.x; ABBIE AA, 1960, MED J AUSTRALIA, V2, P493; ADAMS ARD, 1960, CLINICAL TROPICAL DI; ADELS BR, 1962, AM J DIS CHILD, V103, P255, DOI 10.1001/archpedi.1962.02080020267015; ADELS BR, 1963, AM J HYG, V77, P317, DOI 10.1093/oxfordjournals.aje.a120322; AICHEL OTTO, 1932, ZEITSCHR MORPH U ANTHROP, V31, P1; ARENDS T, 1962, 8 P C INT SOC BLOOD, P379; ARENS L, 1954, S Afr J Clin Sci, V5, P20; ARETAS R. E., 1959, BULL SOC PATHOL EXOT, V52, P404; ARROYAVE G, 1960, AM J TROP MED HYG, V9, P81, DOI 10.4269/ajtmh.1960.9.81; BAKKER A W, 1957, Doc Med Geogr Trop, V9, P1; Barrett M.J., 1953, AUST DENT J, V57, P127; BEST WR, 1962, AM J PHYS ANTHROPOL, V20, P321, DOI 10.1002/ajpa.1330200315; BIRDSELL JB, 1950, COLD SPRING HARB SYM, V15, P259, DOI 10.1101/SQB.1950.015.01.028; BISWAS PC, 1961, 2 INT C HUM GENET, pE105; BLACK FL, 1962, AM J DIS CHILD, V103, P242, DOI 10.1001/archpedi.1962.02080020254011; BLOMBERG R, 1960, CHAVANTE EXPEDITION; BOAS F, 1895, 65 REP M BRIT ASS AD, P523; Boyd MF., 1949, MALARIOLOGY, P3; BOYD MF, 1949, MALARIOLOGY, P764; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; BOZEMAN FM, 1963, P SOC EXP BIOL MED, V112, P568, DOI 10.3181/00379727-112-28107; BREINL A., 1917, Annals of Tropical Medicine and Parasitology, V10, P427; [Anonymous], 1960, South African Journal of Laboratory and Clinical Medicine, V6, P187; BRONTESTEWART B, 1961, AM J CLIN NUTR, V9, P596, DOI 10.1093/ajcn/9.5.596; BRONTESTEWART B, 1955, LANCET, V2, P1103; Campbell T. D., 1953, AUSTR J DENT, V57, P1; Campbell TD, 1938, AUST J DENT, V42, P121; CARRSAUNDERS AM, 1922, POPULATION PROBLEM L; CASLEY-SMITH J R, 1959, Med J Aust, V46, P627; CASLEY-SMITH J. R., 1959, AUSTRALIAN JOUR EXPTL BIOL AND MED, V37, P481, DOI 10.1038/icb.1959.49; CASLEY-SMITH J. R., 1960, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V38, P37, DOI 10.1038/icb.1960.5; CAUSEY OR, 1958, AM J TROP MED HYG, V7, P36, DOI 10.4269/ajtmh.1958.7.36; Chown B, 1955, AM J PHYS ANTHROP-NE, V13, P181, DOI 10.1002/ajpa.1330130202; Chown B, 1953, AM J PHYS ANTHROP-NE, V11, P369, DOI 10.1002/ajpa.1330110312; CLEVE H, 1961, AM J HUM GENET, V13, P372; CLOSE J, 1955, Ann Soc Belg Med Trop (1920), V35, P129; COHEN BM, 1962, AM J HUM GENET, V14, P238; CONNERTY HV, 1961, CLIN CHEM, V7, P37; CONNERTY HV, 1961, CLIN CHEM, V7, P589; Cook RP., 1958, CHOLESTEROL CHEM BIO; Coon C. S., 1962, ORIGIN RACES; COUVEE L M, 1962, Trop Geogr Med, V14, P27; COUVEE L. M. J., 1962, TROP AND GEOGR MED, V14, P325; COUVEE L. M. J., 1962, TROP AND GEOGR MED, V14, P314; COWELL A, 1961, HEART FOREST; CRAN JA, 1955, AUSTRALIAN J DENT, V59, P356; CROW JF, 1958, AM ANTHROPOL, V60, P1; Cummins H, 1943, FINGERPRINTS PALMS S, V1st; Cummins H, 1935, AM J PHYS ANTHROPOL, V20, P19, DOI 10.1002/ajpa.1330200106; CUMMINS HAROLD, 1941, HUMAN BIOL, V13, P177; Cummins H, 1930, AM J PHYS ANTHROPOL, V15, P123, DOI 10.1002/ajpa.1330150105; Cummins H, 1932, AM J PHYS ANTHROPOL, V17, P229, DOI 10.1002/ajpa.1330170215; CURNOW D. H., 1957, MED JOUR AUSTRALIA II, V44, P608; CURTAIN CC, 1961, AM J TROP MED HYG, V10, P92, DOI 10.4269/ajtmh.1961.10.92; DANOWSKI TS, 1963, METABOLISM, V12, P117; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; DAVIDSON W. S., 1957, Medical Journal of Australia, V2, P601; DAVILA JB, 1950, HANDBOOK SOUTH AMERI, V6, P71; DAVIS R. E., 1957, MED JOUR AUSTRALIA II, V44, P605; de LIMA P E, 1950, Rev Bras Med, V7, P787; DEFREITAS AS, 1955, 1954 REP IND PROT SE; ELLIS FR, 1963, HUM BIOL, V35, P26; FERNANDES JL, 1957, ANN HUM GENET, V22, P16, DOI 10.1111/j.1469-1809.1957.tb01294.x; FINN SB, 1952, 225 NAT AC SCIENC NA, P119; FOX JOHN P., 1959, ARCH INST PASTEUR TUNIS, V36, P449; GABALDON A, 1949, MALARIOLOGY, P764; GAJDUSEK DC, 1959, PEDIATRICS, V23, P121; GAJDUSEK DC, 1955, PEDIATRICS, V16, P819; GEIPEL G, 1935, ANLEITUNG ERBBIOLOGI; GERSHOWITZ H, IN PRESS; GIBLETT ER, 1961, NATURE, V192, P1300, DOI 10.1038/1921300a0; GREY G, 1941, J 2 EXPEDITIONS DISC; Hart C. W. M., 1960, TIWI N AUSTR; HEITHERSAY G, 1959, Med J Aust, V1, P721; HENRY L, 1961, EUGEN QUART, V8, P81, DOI 10.1080/19485565.1961.9987465; HICKS SC, 1933, AUSTRALIAN J EXP BIO, V11, P177; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V46, P229; HUXLEY F, 1957, AFFABLE SAVAGES; JELLIFFE D B, 1953, Doc Med Geogr Trop, V5, P286; JOUBERT SM, 1959, J LAB CLIN MED, V5, P1; JUILLAN M., 1960, Arch. Inst. Pasteur d'Algerie, V38, P151; JUNQUEIRA PC, 1957, ANN HUM GENET, V22, P22, DOI 10.1111/j.1469-1809.1957.tb01295.x; Kean B. H., 1944, AMER JOUR TROP MED, V24, P341; KEAN BH, 1949, ARCH INTERN MED, V83, P355, DOI 10.1001/archinte.1949.00220320109009; KEITER F., 1960, MITTEIL ANTHROPOL GES WIEN, V90, P55; KEITER F, 1957, ARZTL FORSCH, V11, P537; Keiter F, 1954, Z MORPHOL ANTHROPOL, V46, P170; Keiter F, 1950, Z MORPHOL ANTHROPOL, V42, P169; KENDRICK PL, 1961, AM J DIS CHILD, V101, P149, DOI 10.1001/archpedi.1961.04020030013003; KENDRICK PL, IN PRESS; KIDDY CA, 1961, SCIENCE, V134, P615, DOI 10.1126/science.134.3479.615; KLEIN GC, 1962, P SOC EXP BIOL MED, V111, P298, DOI 10.3181/00379727-111-27773; KRITCHEVSKY D, 1958, CHOLESTEROL; KRZYWICKI L, 1934, PRIMITIVE SOCIETY VI; LAPICCIRELLA V, 1962, B WORLD HEALTH ORGAN, V27, P681; LASKER GW, 1960, 5 SEL PAP INT C ANTH; LAYRISSE M, 1958, AM J PHYS ANTHROPOL, V16, P307, DOI 10.1002/ajpa.1330160304; LAYRISSE M, 1963, HUM BIOL, V35, P140; LAYRISSE M, 1962, SOUTHWEST J ANTHROP, V18, P78, DOI 10.1086/soutjanth.18.1.3629125; LAYRISSE M, 1961, SCIENCE, V134, P1077, DOI 10.1126/science.134.3485.1077; LEISSRING JC, 1962, AM J DIS CHILD, V103, P160, DOI 10.1001/archpedi.1962.02080020166009; LEVINE P, 1951, P SOC EXP BIOL MED, V78, P218; LIEKHINGTING, 1960, TROP GEOG MED, V12, P293; LINNET-JEPSEN P, 1958, Acta Genet Stat Med, V8, P164; LIVINGSTONE FB, 1960, AM J PHYS ANTHROPOL, V18, P161, DOI 10.1002/ajpa.1330180302; LOWENSTEIN F, 1961, LANCET, V1, P389; LUYKEN R, 1960, Trop Geogr Med, V12, P145; LUYKEN R, 1960, Trop Geogr Med, V12, P313; LUYKEN R., 1960, TROP GEOGR MED, V12, P233; LUYKEN R, 1958, Trop Geogr Med, V10, P385; MACCLUER JW, 1963, AM J HUM GENET, V15, P191; MANN GV, 1955, BRIT MED J, V2, P1008, DOI 10.1136/bmj.2.4946.1008; MANN I, 1956, AM J OPHTHALMOL, V41, P797, DOI 10.1016/0002-9394(56)91772-X; MANN IDA, 1957, MED JOUR AUSTRALIA II, V44, P610; Manson-Bahr PH., 1960, MANSONS TROPICAL DIS; Mason J.A., 1950, HDB S AM INDIANS, V6, P157; MATHUR KS, 1962, INDIAN J MED RES, V50, P195; MATTOS RB, 1958, ARQUIV BRASIL OFT, V21, P105; MAYBURYLEWIS D, IN PRESS; MENDEZ J, 1962, AM J CLIN NUTR, V10, P403, DOI 10.1093/ajcn/10.5.403; MORTARA G, 1957, FECUNDIDADE MULHER B; Murphy R.F., 1960, HEADHUNTERS HERITAGE; NAGEL R, 1963, NATURE, V197, P187, DOI 10.1038/197187a0; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEEL JV, 1958, AM ANTHROPOL, V60, P43; Neel JV, 1954, HUMAN HEREDITY; NEMOTO H, 1960, AM J HUM GENET, V12, P67; NEWMAN MT, 1960, AM J PHYS ANTHROPOL, V18, P45, DOI 10.1002/ajpa.1330180106; NEWMAN MT, 1953, INDIAN TRIBES NORTHE; NYE LJJ, 1937, MED J AUSTRALIA, V2, P1000; OBERG K, 1953, 15 SMITHS INST I SOC; OOMEN H A, 1961, Trop Geogr Med, V13, P321; ORR JB, 1931, 155 GREAT BRIT MED R, P82; OSBORNE RH, 1958, AM J PHYS ANTHROPOL, V16, P187, DOI 10.1002/ajpa.1330160204; PACKER AD, 1961, OCEANIA, V32, P60, DOI 10.1002/j.1834-4461.1961.tb00446.x; PARKER WC, 1961, SCIENCE, V134, P106, DOI 10.1126/science.134.3472.106; PAUL JR, 1952, AM J HYG, V55, P402, DOI 10.1093/oxfordjournals.aje.a119532; PAUL JR, 1955, AM J TROP MED HYG, V4, P512, DOI 10.4269/ajtmh.1955.4.512; POLLITZER WS, 1962, AM J PHYS ANTHROPOL, V20, P33, DOI 10.1002/ajpa.1330200120; POST RH, 1962, EUGEN QUART, V9, P189, DOI 10.1080/19485565.1962.9987526; POST RH, 1962, EUGEN QUART, V9, P131, DOI 10.1080/19485565.1962.9987517; POWELL S J, 1958, S Afr J Lab Clin Med, V4, P273; PRICE WA, 1939, NUTRITION PHYSICAL D; QUEVAL R., 1959, BULL SOC PATHOL EXOT, V52, P385; RACE RR, 1962, BLOOD GROUPS MAN; RANKE KE, 1898, DEUTSCH GES ANTHROPO, V29, P123; RATNOFF OD, 1951, J LAB CLIN MED, V37, P316; REINHARD KR, 1963, JAMA-J AM MED ASSOC, V183, P410, DOI 10.1001/jama.1963.03700060052007; RIBEIRO D, 1957, EDUCACAO CIENCIAS SO, V2, P5; RIGGS JL, 1962, P SOC EXP BIOL MED, V110, P833, DOI 10.3181/00379727-110-27664; RIGGS JL, 1962, J IMMUNOL, V89, P868; SABIN AB, 1962, PEDIATRICS, V29, P105; SABIN AB, 1957, NY ACAD SCI, V5, P113; SALLER K, 1956, LEHRBUCH ANTHROPOLOG; SALZANO FM, 1961, HUM BIOL, V33, P110; SALZANO FM, 1957, AM J PHYS ANTHROPOL, V15, P555, DOI 10.1002/ajpa.1330150407; SALZANO FM, 1961, AM J PHYS ANTHROPOL, V19, P391, DOI 10.1002/ajpa.1330190412; SALZANO FM, 1963, ACTA GENET STAT MED, V13, P1; SCHAAD J D, 1960, Trop Geogr Med, V12, P38; SCHAEFFER M, 1959, AM J TROP MED HYG, V8, P372, DOI 10.4269/ajtmh.1959.8.372; SCHOFIELD F. D., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P332, DOI 10.1016/0035-9203(57)90124-4; SCHULL WJ, IN PRESS; SCHWARTZ C J, 1958, Med J Aust, V2, P84; SCRIMSHAW N, 1961, AM J CLIN NUTR, V9, P206, DOI 10.1093/ajcn/9.2.206; SHAPER AG, 1959, LANCET, V2, P534; SHARP R. LAURISTON, 1940, HUMAN BIOL, V12, P481; SIMMONS RT, 1962, AM J PHYS ANTHROPOL, V20, P303, DOI 10.1002/ajpa.1330200314; SIMOES MT, 1955, 1954 REP IND PROT SE; SMIT AM, 1962, OVER EOSINOFILIE BIJ; SMITHIES O, 1959, ADV PROTEIN CHEM, V14, P65, DOI 10.1016/S0065-3233(08)60609-9; SNYDER MJ, 1962, AM J DIS CHILD, V103, P250, DOI 10.1001/archpedi.1962.02080020262012; SONNET J, 1959, Ann Soc Belg Med Trop (1920), V39, P495; STEGGERDA M, 1950, HANDBOOK SOUTH AMERI, V6, P57; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG AG, 1960, NATURE, V185, P324, DOI 10.1038/185324a0; STEWARD JH, 1950, HANDBOOK SOUTH AMERI, V6, P57; STEWARD JH, 1950, HANDBOOK SOUTH AMERI, V6, P71; STEWARD JH, 1946, HANDBOOK SOUTH AMERI, V7; STEWART JH, 1950, HANDBOOK SOUTH AMERI, V6, P157; SUTTON HE, 1960, AM J HUM GENET, V12, P338; SYMUL F, 1950, Ann Soc Belg Med Trop (1920), V30, P295; TABRAH FL, 1962, SCIENCE, V138, P38, DOI 10.1126/science.138.3536.38; TASHIAN RE, 1961, P SOC EXP BIOL MED, V108, P364; THOMPSON M. D., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P77, DOI 10.1016/0035-9203(56)90012-8; TINDALE MB, 1953, HUM BIOL, V25, P169; Vahlquist B., 1958, ADV PEDIATR, V10, P305; van TONGEREN H, 1960, Trop Geogr Med, V12, P208; VANDONGEN R, 1962, MED J AUSTRALIA, V2, P286; VESELL ES, 1962, J GEN PHYSIOL, V45, P553, DOI 10.1085/jgp.45.3.553; WALLACE AFC, 1960, 5 SEL PAP INT C ANTH; WARMER P, 1957, MED J AUSTRALIA, V2, P857; WHEELER AH, 1961, 12 ANN S REC ADV STU; Wilder HH, 1922, AM J PHYS ANTHROPOL, V5, P143, DOI 10.1002/ajpa.1330050210; WILKINSON Gwendoline K., 1958, Medical Journal of Australia, V2, P158; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; 1957, 650 USPHS PUBL SER E; 1950, J IMMUN, V65, P347; [No title captured]; [No title captured]; [No title captured]; [No title captured]; 1961, LABORATORY PROCEDURE	204	253	262	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1964	16	1					52	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2971A	14131874				2022-12-18	WOS:A19642971A00003
J	Matsuo, H; Chiba, T; Nagamori, S; Nakayama, A; Domoto, H; Phetdee, K; Wiriyasermkul, P; Kikuchi, Y; Oda, T; Nishiyama, J; Nakamura, T; Morimoto, Y; Kamakura, K; Sakurai, Y; Nonoyama, S; Kanai, Y; Shinomiya, N				Matsuo, Hirotaka; Chiba, Toshinori; Nagamori, Shushi; Nakayama, Akiyoshi; Domoto, Hideharu; Phetdee, Kanokporn; Wiriyasermkul, Pattama; Kikuchi, Yuichi; Oda, Takashi; Nishiyama, Junichiro; Nakamura, Takahiro; Morimoto, Yuji; Kamakura, Keiko; Sakurai, Yutaka; Nonoyama, Shigeaki; Kanai, Yoshikatsu; Shinomiya, Nariyoshi			Mutations in Glucose Transporter 9 Gene SLC2A9 Cause Renal Hypouricemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAROXYSMAL DYSTONIC CHOREOATHETOSIS; AMINO-ACID TRANSPORTER; URIC-ACID; URATE TRANSPORTER; ANION-EXCHANGER; IDENTIFICATION; FAMILY; GLUT1; HAPLOINSUFFICIENCY; EXCRETION	Renal hypouricemia is an inherited disorder characterized by impaired renal urate (uric acid) reabsorption and subsequent low serum urate levels, with severe complications such as exercise-induced acute renal failure and nephrolithiasis. We previously identified SLC22A12, also known as URAT1, as a causative gene of renal hypouricemia. However, hypouricemic patients without URAT1 mutations, as well as genome-wide association studies between urate and SLC2A9 (also called GLUT9), imply that GLUT9 could be another causative gene of renal hypouricemia. With a large human database, we identified two loss-of-function heterozygous mutations in GLUT9, which occur in the highly conserved "sugar transport proteins signatures 1/2." Both mutations result in loss of positive charges, one of which is reported to be an important membrane topology determinant. The oocyte expression study revealed that both GLUT9 isoforms showed high urate transport activities, whereas the mutated GLUT9 isoforms markedly reduced them. Our findings, together with previous reports on GLUT9 localization, suggest that these GLUT9 mutations cause renal hypouricemia by their decreased urate reabsorption on both sides of the renal proximal tubules. These findings also enable us to propose a physiological model of the renal urate reabsorption in which GLUT9 regulates serum urate levels in humans and can be a promising therapeutic target for gout and related cardiovascular diseases.	[Matsuo, Hirotaka; Chiba, Toshinori; Nakayama, Akiyoshi; Morimoto, Yuji; Shinomiya, Nariyoshi] Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama 3598513, Japan; [Kikuchi, Yuichi; Oda, Takashi; Kamakura, Keiko] Natl Def Med Coll, Dept Internal Med, Tokorozawa, Saitama 3598513, Japan; [Nakamura, Takahiro; Kanai, Yoshikatsu] Natl Def Med Coll, Math Lab, Tokorozawa, Saitama 3598513, Japan; [Sakurai, Yutaka] Natl Def Med Coll, Dept Publ Hlth & Prevent Med, Tokorozawa, Saitama 3598513, Japan; [Nonoyama, Shigeaki] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 3598513, Japan; [Nagamori, Shushi; Phetdee, Kanokporn; Wiriyasermkul, Pattama] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, Suita, Osaka 5650871, Japan; [Nakayama, Akiyoshi] JASDF, Med Platoon, Kagoshima 8961411, Japan; [Domoto, Hideharu] JMSDF Med Serv Unit Kure, Hiroshima 7378554, Japan; [Nishiyama, Junichiro] JSDF Hosp Yokosuka, Kanagawa 2370071, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; Osaka University	Matsuo, H (corresponding author), Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama 3598513, Japan.	hmatsuo@ndmc.ac.jp	Nakayama, Akiyoshi/ABC-6820-2020; Nagamori, Shushi/P-4530-2018; Shinomiya, Nariyoshi/I-9666-2014	Nakayama, Akiyoshi/0000-0002-6654-0726; Nagamori, Shushi/0000-0003-0203-2754; Matsuo, Hirotaka/0000-0003-4302-8719; Chiba, Toshinori/0000-0002-2173-4519; Oda, Takashi/0000-0002-6131-7752	Ministry of Defense of Japan; Kawano Masanori Memorial Foundation for Promotion of Pediatrics; Uehara Memorial Foundation	Ministry of Defense of Japan; Kawano Masanori Memorial Foundation for Promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics); Uehara Memorial Foundation(Uehara Memorial Foundation)	We would like to thank all the patients involved in this Study. The authors thank Y. Kusanagi, S. Tadokoro, K. Nakanishi, M. Nudejima, M. Kobayashi, T. Iwamoto, A. Kudo, M. Miyazawa, J. Inoue, M. Watanabe, and M. Wakai for genetic analysis; H. Horikoshi, S. Kubo, M. Yoshida, S. Watanabe, O. Tajima, M. Fujita, and Y. Tadano for patient analysis; T. Kasahara, M. Kasahara, Y. Kobayashi, and J. Fukuda for helpful discussion; and D.E. Nadzielka for technical editing of this manuscript. This work was supported in part by grants from the Ministry of Defense of Japan (to H.M. and K.K.), the Kawano Masanori Memorial Foundation for Promotion of Pediatrics, and the Uehara Memorial Foundation (to H.M.). All authors declare absence of conflict of interests. The opinions and assertions contained herein are the private ones of the authors and not to be constructed as official or reflecting the views of the Japan Maritime Self-Defense Force.	Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; DIAMOND HS, 1973, J CLIN INVEST, V52, P1491, DOI 10.1172/JCI107323; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Ho YY, 2001, PEDIATR RES, V50, P254, DOI 10.1203/00006450-200108000-00015; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Kikuchi Y, 2000, CLIN NEPHROL, V53, P467; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Matsuo H, 1999, AM J MED GENET, V88, P733, DOI 10.1002/(SICI)1096-8628(19991215)88:6<733::AID-AJMG27>3.0.CO;2-3; Matsuo H, 2002, J BIOL CHEM, V277, P21017, DOI 10.1074/jbc.M200019200; Matsuo H, 1999, ARCH NEUROL-CHICAGO, V56, P721, DOI 10.1001/archneur.56.6.721; McArdle PF, 2008, ARTHRITIS RHEUM-US, V58, P2874, DOI 10.1002/art.23752; Pascual JM, 2008, J BIOL CHEM, V283, P16732, DOI 10.1074/jbc.M801403200; Sato M, 1999, J BIOL CHEM, V274, P24721, DOI 10.1074/jbc.274.35.24721; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wakida N, 2005, J CLIN ENDOCR METAB, V90, P2169, DOI 10.1210/jc.2004-1111; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412	27	252	275	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					744	751		10.1016/j.ajhg.2008.11.001	http://dx.doi.org/10.1016/j.ajhg.2008.11.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19026395	Green Published, Bronze			2022-12-18	WOS:000261822100009
J	Schwartz, CE; May, MM; Carpenter, NJ; Rogers, RC; Martin, J; Bialer, MG; Ward, J; Sanabria, J; Marsa, S; Lewis, JA; Echeverri, R; Lubs, HA; Voeller, K; Simensen, RJ; Stevenson, RE				Schwartz, CE; May, MM; Carpenter, NJ; Rogers, RC; Martin, J; Bialer, MG; Ward, J; Sanabria, J; Marsa, S; Lewis, JA; Echeverri, R; Lubs, HA; Voeller, K; Simensen, RJ; Stevenson, RE			Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; MUTATIONS; LINKAGE; DEFECT; TRANSPORTER; PEDIGREE	Allan- Herndon- Dudley syndrome was among the first of the X- linked mental retardation syndromes to be described ( in 1944) and among the first to be regionally mapped on the X chromosome ( in 1990). Six large families with the syndrome have been identified, and linkage studies have placed the gene locus in Xq13.2. Mutations in the monocarboxylate transporter 8 gene ( MCT8) have been found in each of the six families. One essential function of the protein encoded by this gene appears to be the transport of triiodothyronine into neurons. Abnormal transporter function is reflected in elevated free triiodothyronine and lowered free thyroxine levels in the blood. Infancy and childhood in the Allan- Herndon- Dudley syndrome are marked by hypotonia, weakness, reduced muscle mass, and delay of developmental milestones. Facial manifestations are not distinctive, but the face tends to be elongated with bifrontal narrowing, and the ears are often simply formed or cupped. Some patients have myopathic facies. Generalized weakness is manifested by excessive drooling, forward positioning of the head and neck, failure to ambulate independently, or ataxia in those who do ambulate. Speech is dysarthric or absent altogether. Hypotonia gives way in adult life to spasticity. The hands exhibit dystonic and athetoid posturing and fisting. Cognitive development is severely impaired. No major malformations occur, intrauterine growth is not impaired, and head circumference and genital development are usually normal. Behavior tends to be passive, with little evidence of aggressive or disruptive behavior. Although clinical signs of thyroid dysfunction are usually absent in affected males, the disturbances in blood levels of thyroid hormones suggest the possibility of systematic detection through screening of high- risk populations.	Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; Ctr Genet Testing, Tulsa, OK USA; Inland NW Genet Clin, Spokane, WA USA; Univ Hosp Manhasset, N Shore Long Isl Jewish Hlth Syst, Div Med Genet, Manhasset, NY USA; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Div Med Genet, Memphis, TN 38163 USA; Univ Nacl San Luis, Fac Quim Bioquim & Farm, San Luis, Argentina; WW Hastings Indian Hosp, Tahlequah, OK USA; Univ Miami, Miami, FL 33152 USA	Greenwood Genetic Center; Northwell Health; University of Tennessee System; University of Tennessee Health Science Center; Universidad Nacional de San Luis; University of Miami	Stevenson, RE (corresponding author), Greenwood Genet Ctr, JC Self Res Inst Human Genet, 1 Gregor Mendel Circle, Greenwood, SC 29646 USA.	res@ggc.org	, WaNgtJ/AAR-7045-2020		NICHD NIH HHS [R01 HD026202, HD 26202] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Allan W, 1944, AM J MENT DEF, V48, P325; BIALER MG, 1992, AM J MED GENET, V43, P491, DOI 10.1002/ajmg.1320430173; DAVIS JG, 1981, AM J HUM GENET, V33, pA75; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; DUNN HG, 1963, AM J MENT DEF, V67, P827; Friesema ECH, 2005, BIOCHEM SOC T, V33, P228, DOI 10.1042/BST0330228; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; LENZNER S, 2004, EUR SOC HUM GEN CONC; LOSOWSKY MS, 1961, J MENT DEFIC RES, V5, P60, DOI 10.1111/jir.1961.5.1.60; LUBS HA, 1969, AM J HUM GENET, V21, P231; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHWARTZ CE, 1990, AM J HUM GENET, V47, P454; STEVENSON R.E., 2000, X LINKED MENTAL RETA; STEVENSON RE, 1990, AM J HUM GENET, V47, P446; Stevenson RE, 2002, CYTOGENET GENOME RES, V99, P265, DOI 10.1159/000071603; VITS L, 1994, NAT GENET, V7, P408, DOI 10.1038/ng0794-408; Zorick TS, 2004, AM J MED GENET A, V127A, P321, DOI 10.1002/ajmg.a.30009	18	252	260	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					41	53		10.1086/431313	http://dx.doi.org/10.1086/431313			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15889350	Green Published, Bronze			2022-12-18	WOS:000229794500004
J	Zhao, H; Li, RH; Wang, QJ; Yan, QF; Deng, JH; Han, DY; Bai, YD; Young, WY; Guan, MX				Zhao, H; Li, RH; Wang, QJ; Yan, QF; Deng, JH; Han, DY; Bai, YD; Young, WY; Guan, MX			Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large chinese family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; HEREDITARY OPTIC NEUROPATHY; NADH DEHYDROGENASE; A1555G MUTATION; POINT MUTATION; DNA MUTATION; HEARING-LOSS; MTDNA; SUSCEPTIBILITY; IDENTIFICATION	We report here the characterization of a large Chinese family with maternally transmitted aminoglycoside-induced and nonsyndromic deafness. In the absence of aminoglycosides, some matrilineal relatives in this family exhibited late-onset/progressive deafness, with a wide range of severity and age at onset. Notably, the average age at onset of deafness has changed from 55 years ( generation II) to 10 years ( generation IV). Clinical data reveal that the administration of aminoglycosides can induce or worsen deafness in matrilineal relatives. The age at the time of drug administration appears to be correlated with the severity of hearing loss experienced by affected individuals. Sequence analysis of mitochondrial DNA in this pedigree identified a homoplasmic C-to-T transition at position 1494 (C1494T) in the 12S rRNA gene. The C1494T mutation is expected to form a novel U1494-1555A base pair, which is in the same position as the C1494-1555G pair created by the deafness-associated A1555G mutation, at the highly conserved A site of 12S rRNA. Exposure to a high concentration of paromomycin or neomycin caused a variable but significant average increase in doubling time in lymphoblastoid cell lines derived from four symptomatic and two asymptomatic individuals in this family carrying the C1494T mutation when compared to four control cell lines. Furthermore, a significant decrease in the rate of total oxygen consumption was observed in the mutant cell lines. Thus, our data strongly support the idea that the A site of mitochondrial 12S rRNA is the primary target for aminoglycoside-induced deafness. These results also strongly suggest that the nuclear background plays a role in the aminoglycoside ototoxicity and in the development of the deafness phenotype associated with the C1494T mutation in the mitochondrial 12S rRNA gene.	Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Program Human Genet, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Ctr Hearing & Deafness Res, Cincinnati, OH 45229 USA; Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Chinese People's Liberation Army General Hospital; University of Texas System; University of Texas Health San Antonio	Guan, MX (corresponding author), Childrens Hosp, Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	min-xin.guan@chmcc.org	yan, qing/GZN-2287-2022	Guan, Min-Xin/0000-0001-5067-6736	NIDCD NIH HHS [R01 DC005230, DC05230, DC04958, R03 DC004958] Funding Source: Medline; NINDS NIH HHS [NS44015, R01 NS044015] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004958, R01DC005230] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BACINO C, 1995, PHARMACOGENETICS, V5, P165, DOI 10.1097/00008571-199506000-00005; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Casano RAMS, 1999, AM J OTOLARYNG, V20, P151, DOI 10.1016/S0196-0709(99)90062-5; DESTASIO EA, 1990, J MOL BIOL, V212, P127, DOI 10.1016/0022-2836(90)90309-A; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; FISCHELGHODSIAN N, 1995, AM J OTOLARYNG, V16, P403, DOI 10.1016/0196-0709(95)90078-0; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HOWELL N, 1991, AM J HUM GENET, V48, P935; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kogelnik AM, 1998, NUCLEIC ACIDS RES, V26, P112, DOI 10.1093/nar/26.1.112; LI M, 1982, J BIOL CHEM, V257, P5921; Li RH, 2004, AM J MED GENET A, V124A, P113, DOI 10.1002/ajmg.a.20305; Li W, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P415; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Matthijs G, 1996, EUR J HUM GENET, V4, P46; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Morton CC, 2002, HUM MOL GENET, V11, P1229, DOI 10.1093/hmg/11.10.1229; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; NANCE WE, 1975, OTOLARYNG CLIN N AM, V8, P19; NEEFS JM, 1991, NUCLEIC ACIDS RES, V19, P1987, DOI 10.1093/nar/19.suppl.1987; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; PUROHIT P, 1994, NATURE, V370, P659, DOI 10.1038/370659a0; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; ROE BA, 1985, J BIOL CHEM, V260, P9759; SPANGLER EA, 1985, J BIOL CHEM, V260, P6334; Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905; TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421; Torroni A, 1997, AM J HUM GENET, V60, P1107; Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x; Verhoeven K, 1999, EUR J HUM GENET, V7, P45, DOI 10.1038/sj.ejhg.5200247; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yuan H, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P141; ZIMMERMANN RA, 1990, RIBOSOME, P331; ZWIEB C, 1986, MOL GEN GENET, V203, P256, DOI 10.1007/BF00333963	49	252	328	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					139	152		10.1086/381133	http://dx.doi.org/10.1086/381133			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14681830	Bronze, Green Published			2022-12-18	WOS:000187723500013
J	Hobbs, CA; Sherman, SL; Yi, P; Hopkins, SE; Torfs, CP; Hine, RJ; Pogribna, M; Rozen, R; James, SJ				Hobbs, CA; Sherman, SL; Yi, P; Hopkins, SE; Torfs, CP; Hine, RJ; Pogribna, M; Rozen, R; James, SJ			Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURAL-TUBE DEFECTS; METHIONINE SYNTHASE REDUCTASE; FOLATE/METHYL-DEFICIENT RATS; DNA METHYLTRANSFERASE GENE; MAMMALIAN FEMALE MEIOSIS; METHYLENETETRAHYDROFOLATE REDUCTASE; CHROMOSOME SEGREGATION; HISTONE DEACETYLASE; IMMUNODEFICIENCY SYNDROME; POSTMENOPAUSAL WOMEN	Down syndrome is a complex genetic and metabolic disorder attributed to the presence of three copies of chromosome 21. The extra chromosome derives from the mother in 93% of cases and is due to abnormal chromosome segregation during meiosis (nondisjunction). Except for advanced age at conception, maternal risk factors for meiotic nondisjunction are not well established. A recent preliminary study suggested that abnormal folate metabolism and the 677C-->T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for Down syndrome. The present study was undertaken with a larger sample size to determine whether the MTHFR 677C-->T polymorphism was associated with increased risk of having a child with Down syndrome. Methionine synthase reductase (MTRR) is another enzyme essential for normal folate metabolism. A common polymorphism in this gene was recently associated with increased risk of neural tube defects and might also contribute to increased risk for Down syndrome. The frequencies of the MTHFR 677C-->T and MTRR 66A-->G mutations were evaluated in DNA samples from 157 mothers of children with Down syndrome and 144 control mothers. Odds ratios were calculated for each genotype separately and for potential gene-gene interactions. The results are consistent with the preliminary observation that the MTHFR 677C-->T polymorphism is more prevalent among mothers of children with Down syndrome than among control mothers, with an odds ratio of 1.91 (95% confidence interval [CT] 1.19-3.05). In addition, the homozygous MTRR 66A-->G polymorphism was independently associated with a 2.57-fold increase in estimated risk (95% CI 1.33-4.99). The combined presence of both polymorphisms was associated with a greater risk of Down syndrome than was the presence of either alone, with an odds ratio of 4.08 (95% CI 1.94-8.56). The two polymorphisms appear to act without a multiplicative interaction.	US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA; Arkansas Childrens Hosp, Arkansas Ctr Birth Defects Res & Prevent, Little Rock, AR 72202 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Emory Univ, Sch Med, Dept Genet, Atlanta, GA USA; Calif Birth Defects Monitoring Program, Emeryville, CA USA; McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3H 1P3, Canada	US Food & Drug Administration (FDA); Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Emory University; McGill University	James, SJ (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.		Rozen, Rima/AAE-9294-2020		NHLBI NIH HHS [HL 58955-01, R01 HL058955] Funding Source: Medline; NICHD NIH HHS [P01-HD32111] Funding Source: Medline; PHS HHS [U50/CCU613236-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058955] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Botto LD, 1998, CLIN GENET, V53, P456; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; Brooks PJ, 1996, J NEUROSCI, V16, P939; Chen J, 1998, CARCINOGENESIS, V19, P2129, DOI 10.1093/carcin/19.12.2129; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO;2-T; Clarke L, 1998, CURR OPIN GENET DEV, V8, P212, DOI 10.1016/S0959-437X(98)80143-3; Cobb J, 1999, CHROMOSOMA, V108, P412, DOI 10.1007/s004120050393; DECABO SF, 1995, CYTOGENET CELL GENET, V71, P187, DOI 10.1159/000134104; Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646; EDMONDS LD, 1981, INT J EPIDEMIOL, V10, P247, DOI 10.1093/ije/10.3.247; Fowler BM, 1998, CANCER EPIDEM BIOMAR, V7, P901; FREEMAN S, 1991, AM J HUM GENET S A, V49, P916; Gonzalgo ML, 1997, MUTAT RES-REV MUTAT, V386, P107, DOI 10.1016/S1383-5742(96)00047-6; Grewal SIS, 1998, GENETICS, V150, P563; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hunt PA, 1998, J ASSIST REPROD GEN, V15, P246, DOI 10.1023/A:1022580024402; Hunt PA, 1998, CURR TOP DEV BIOL, V37, P359; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; James SJ, 1999, AM J CLIN NUTR, V70, P495; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KNUUTILA S, 1978, HEREDITAS, V89, P175; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Lewis DP, 1998, ANN PHARMACOTHER, V32, P947, DOI 10.1345/aph.17298; LEYTON C, 1995, CELL PROLIFERAT, V28, P481, DOI 10.1111/j.1365-2184.1995.tb00087.x; LIBBUS BL, 1990, CANCER GENET CYTOGEN, V46, P231, DOI 10.1016/0165-4608(90)90108-M; MacGregor JT, 1997, MUTAT RES-FUND MOL M, V377, P125, DOI 10.1016/S0027-5107(97)00070-5; Melnyk S, 2000, CLIN CHEM, V46, P265; Miniou P, 1997, HUM GENET, V99, P738, DOI 10.1007/s004390050441; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.3.CO;2-Y; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; PIYATHILAKE CJ, 1994, AM J CLIN NUTR, V60, P559, DOI 10.1093/ajcn/60.4.559; Pogribny IP, 1997, CARCINOGENESIS, V18, P2071, DOI 10.1093/carcin/18.11.2071; POGRIBNY IP, 1995, CANCER RES, V55, P1894; Renauld H, 1997, TRENDS CELL BIOL, V7, P201, DOI 10.1016/S0962-8924(97)01034-9; Rosenblatt DS, 1999, AM J CLIN NUTR, V70, P429; SMITH GF, 1976, DOWNS ANOMALY; Titenko-Holland N, 1998, MUTAT RES-GEN TOX EN, V417, P101, DOI 10.1016/S1383-5718(98)00104-1; Torfs CP, 1999, EPIDEMIOLOGY, V10, P264, DOI 10.1097/00001648-199905000-00013; Vig BK, 1998, ENVIRON MOL MUTAGEN, V32, P197, DOI 10.1002/(SICI)1098-2280(1998)32:3<197::AID-EM1>3.3.CO;2-M; Vig BK, 2000, MUTAT RES-GEN TOX EN, V466, P79, DOI 10.1016/S1383-5718(00)00006-1; Vilain A, 1999, FEBS LETT, V460, P231, DOI 10.1016/S0014-5793(99)01358-7; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang QH, 1999, GENET MED, V1, P80	54	252	279	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					623	630		10.1086/303055	http://dx.doi.org/10.1086/303055			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10930360	Green Published, Bronze			2022-12-18	WOS:000089002300009
J	Aksentijevich, I; Torosyan, Y; Samuels, J; Centola, M; Pras, E; Chae, JJ; Oddoux, C; Wood, G; Azzaro, MP; Palumbo, G; Giustolisi, R; Pras, M; Ostrer, H; Kastner, DL				Aksentijevich, I; Torosyan, Y; Samuels, J; Centola, M; Pras, E; Chae, JJ; Oddoux, C; Wood, G; Azzaro, MP; Palumbo, G; Giustolisi, R; Pras, M; Ostrer, H; Kastner, DL			Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH GENE-FREQUENCY; PERIODIC FEVER; ETHNIC-GROUPS; FMF; INHERITANCE; LINKAGE; 12P13	Familial Mediterranean fever (FMF) is a recessive disorder characterized by episodes of fever with serositis or synovitis. The FMF gene (MEFV) was cloned recently, and four missense mutations were identified. Here we present data from non-Ashkenazi Jewish and Arab patients in whom we had not originally found mutations and from a new, more ethnically diverse panel. Among 90 symptomatic mutation-positive individuals, 11 mutations accounted for 79% of carrier chromosomes. Of the two mutations that are novel, one alters the same residue (680) as a previously known mutation, and the other (P369S) is located in exon 3. Consistent with another recent report, the E148Q mutation was observed in patients of several ethnicities and on multiple microsatellite haplotypes, but haplotype data indicate an ancestral relationships between non-Jewish Italian and Ashkenazi Jewish patients with FMF and other affected populations. Among similar to 200 anonymous Ashkenazi Jewish DNA samples, the MEFV carrier frequency was 21%, with E148Q the most common mutation. Several lines of evidence indicate reduced penetrance among Ashkenazi Jews, especially for E148Q, P369S, and K695R. Nevertheless, E148Q helps account for recessive inheritance in an Ashkenazi family previously reported as an unusual case of dominantly inherited FMF The presence of three frequent MEFV mutations in multiple Mediterranean populations strongly suggests a heterozygote advantage in this geographic region.	NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; NYU Med Ctr, Dept Pediat, Human Genet Program, New York, NY 10016 USA; Chaim Sheba Med Ctr, Dept Med C, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Heller Inst Med Res, IL-52621 Tel Hashomer, Israel; Univ Catania, Inst Hematol, Catania, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); New York University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Catania	Aksentijevich, I (corresponding author), NIAMSD, Genet Sect, Arthrit & Rheumatism Branch, NIH, Bldg 10,Room 9N-214, Bethesda, MD 20892 USA.	aksentii@exchange.nih.gov	Aksentijevich, Ivona/AAF-1335-2019; Palumbo, Giuseppe/W-7072-2019	Palumbo, Giuseppe/0000-0003-1859-6319; samuels, jonathan/0000-0002-1513-770X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041083, Z01AR041083] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akarsu AN, 1997, J MED GENET, V34, P573, DOI 10.1136/jmg.34.7.573; Aksentijevich I, 1997, CELL, V90, P797; Balow JE, 1997, GENOMICS, V44, P280, DOI 10.1006/geno.1997.4860; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 1998, QJM-INT J MED, V91, P603, DOI 10.1093/qjmed/91.9.603; Breda L, 1998, PANMINERVA MED, V40, P157; BRENNERULLMAN A, 1994, AM J MED GENET, V53, P172, DOI 10.1002/ajmg.1320530210; Centola M, 1998, HUM MOL GENET, V7, P1581, DOI 10.1093/hmg/7.10.1581; DANIELS M, 1995, AM J MED GENET, V55, P311, DOI 10.1002/ajmg.1320550313; Gentiloni N, 1992, Minerva Med, V83, P307; GOODMAN RM, 1979, GENETIC DISORDERS JE, P1; Janeway TC, 1908, T ASSOC AM PHYSICIAN, V23, P504; Kastner DL, 1998, HOSP PRACT, V33, P131, DOI 10.3810/hp.1998.04.90; Kronn D, 1998, ARCH INTERN MED, V158, P777, DOI 10.1001/archinte.158.7.777; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Marinone C, 1992, Ann Ital Med Int, V7, P114; McDermott MF, 1998, AM J HUM GENET, V62, P1446, DOI 10.1086/301886; Mulley J, 1998, AM J HUM GENET, V62, P884, DOI 10.1086/301793; Passiu G, 1984, Minerva Med, V75, P1147; PRAS M, 1982, JOHNS HOPKINS MED J, V150, P22; REICH CB, 1970, ARCH INTERN MED, V125, P337, DOI 10.1001/archinte.125.2.337; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; ROSENSTEIN ED, 1994, CLIN EXP RHEUMATOL, V12, P96; Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005; SECCHI GC, 1981, PANMINERVA MED, V23, P249; SIEGAL S, 1964, AM J MED, V36, P893, DOI 10.1016/0002-9343(64)90119-6; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; SOHAR E, 1961, ARCH INTERN MED, V107, P529, DOI 10.1001/archinte.1961.03620040055006; YUVAL Y, 1995, AM J MED GENET, V57, P455, DOI 10.1002/ajmg.1320570319	30	252	257	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					949	962		10.1086/302327	http://dx.doi.org/10.1086/302327			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090880	Green Published, Bronze			2022-12-18	WOS:000079632900006
J	Edelmann, L; Pandita, RK; Morrow, BE				Edelmann, L; Pandita, RK; Morrow, BE			Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLUTAMYL-TRANSFERASE GENES; WILLIAMS-BEUREN-SYNDROME; CAT EYE SYNDROME; DIGEORGE-SYNDROME; 22Q11 DELETIONS; MOLECULAR DEFINITION; MAMMALIAN-CELLS; RECOMBINATION; IDENTIFICATION; REARRANGEMENTS	Velo-cardio-facial syndrome (VCFS) is the most common microdeletion syndrome in humans. It occurs with an estimated frequency of 1 in 4,000 live births. Most cases occur sporadically, indicating that the deletion is recurrent in the population. More than 90% of patients with VCFS and a 22q11 deletion have a similar 3-Mb hemizygous deletion, suggesting that sequences at the breakpoints confer susceptibility to rearrangements. To define the region containing the chromosome breakpoints, we constructed an 8-kb-resolution physical map. We identified a low-copy repeat in the vicinity of both breakpoints. A set of genetic markers were integrated into the physical map to determine whether the deletions occur within the repeat. Haplotype analysis with genetic markers that flank the repeats showed that most patients with VCFS had deletion breakpoints in the repeat. Within the repeat is a 200-kb duplication of sequences, including a tandem repeat of genes/pseudogenes, surrounding the breakpoints. The genes in the repeat are GGT, BCRL, V7-rel, POM121-like, and GGT-rel. Physical mapping and genomic fingerprint analysis showed that the repeats are virtually identical in the 200-kb region, suggesting that the deletion is mediated,by homologous recombination.,Examination of two three-generation families showed that meiotic intrachromosomal recombination mediated the deletion.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Morrow, BE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.			Morrow, Bernice/0000-0002-8076-4726	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD034980] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009060] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09060] Funding Source: Medline; NICHD NIH HHS [P0-1 HD 34980-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; BUDARF M, 1988, Genomics, V3, P168, DOI 10.1016/0888-7543(88)90149-8; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BURN J, 1996, EMERY RIMOINS PRINCI, V1, P767; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Collins JE, 1997, GENOME RES, V7, P522, DOI 10.1101/gr.7.5.522; COLLINS JE, 1995, NATURE, V377, P367; COURTAY C, 1994, BIOCHEM J, V297, P503, DOI 10.1042/bj2970503; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; Dutly F, 1996, HUM MOL GENET, V5, P1893, DOI 10.1093/hmg/5.12.1893; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HEISTERKAMP N, 1991, P NATL ACAD SCI USA, V88, P6303, DOI 10.1073/pnas.88.14.6303; HEISTERKAMP N, 1988, NUCLEIC ACIDS RES, V16, P8045, DOI 10.1093/nar/16.16.8045; IAONNOU PA, 1994, NAT GENET, V6, P84; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; KAWASAKI K, 1995, GENOME RES, V5, P125, DOI 10.1101/gr.5.2.125; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; LISKAY RM, 1986, P NATL ACAD SCI USA, V83, P1802, DOI 10.1073/pnas.83.6.1802; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; MORROW B, 1995, AM J HUM GENET, V56, P1391; Osborne LR, 1996, GENOMICS, V36, P328, DOI 10.1006/geno.1996.0469; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; RUEGG CL, 1995, J IMMUNOL, V154, P4434; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SCHINZEL A, 1981, HUM GENET, V57, P148; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Soderqvist H, 1996, EXP CELL RES, V225, P75, DOI 10.1006/excr.1996.0158; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; Wandstrat AE, 1998, AM J HUM GENET, V62, P925, DOI 10.1086/301777	44	252	261	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1076	1086		10.1086/302343	http://dx.doi.org/10.1086/302343			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090893	Green Published, Bronze			2022-12-18	WOS:000079632900019
J	Kuokkanen, S; Gschwend, M; Rioux, JD; Daly, MJ; Terwilliger, JD; Tienari, PJ; Wikstrom, J; Palo, J; Stein, LD; Hudson, TJ; Lander, ES; Peltonen, L				Kuokkanen, S; Gschwend, M; Rioux, JD; Daly, MJ; Terwilliger, JD; Tienari, PJ; Wikstrom, J; Palo, J; Stein, LD; Hudson, TJ; Lander, ES; Peltonen, L			Genomewide scan of multiple sclerosis in Finnish multiplex families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASIC-PROTEIN GENE; BETA-CHAIN GENES; LINKAGE ANALYSIS; SUSCEPTIBILITY LOCUS; GUIDELINES; FINLAND; COMPLEX; HLA	Multiple sclerosis (MS) is a neurological, demyelinating disorder with a putative autoimmune etiology. It is thought to be a multifactorial disease with a complex mode of inheritance. Here we report the results of a two-stage genomewide scan for loci predisposing to MS. The first stage of the screen, with a low-resolution map, was performed in a selection of 16 pedigrees collected from an isolated Finnish population. Multipoint, nonparametric linkage analysis of the 328 markers did not reveal statistically significant results. However, 10 slightly interesting regions (P = .1-.15) emerged, including our previous findings of the HLA complex on Gp21. and a putative locus on 5p14-p12. Fight of these novel regions were further analyzed by use of denser marker maps, in the second stage of the scan. For the chromosomal regions 4cen, 11tel, and 17q, the statistical significance increased, but not conclusively; for 2q32 and 10q21, the statistical significance did not change. Accordingly, genotyping of the high-density markers in these regions was performed, and the data were analyzed by use of two-point, parametric linkage analysis using the complete pedigree information of the 21 Finnish multiplex families. We detected suggestive evidence for a predisposing locus on chromosomal region 17q22-q24. Several markers on 17q22-q24 yielded positive LOD scores, with the maximum LOD score (Z(max)) occurring with D17S807 (Z(max) = 2.8, theta = .04; dominant model). Interestingly, a suggestive linkage between MS and the markers on 17q22-q24 was also revealed by a recent genomewide scan in MS families from the United Kingdom.	Natl Publ Hlth Inst, Dept Human Mol Genet, FIN-00300 Helsinki, Finland; Inst Biomed, FIN-00300 Helsinki, Finland; Univ Helsinki, Dept Neurol, Helsinki, Finland; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA USA; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA	Finland National Institute for Health & Welfare; University of Helsinki; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Columbia University; Columbia University	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	Leena.Peltonen@ktl.fi	Tienari, Pentti J/A-4893-2012; Rioux, John D/A-9599-2015; Daly, Mark J/B-2453-2017	Rioux, John D/0000-0001-7560-8326; Daly, Mark J/0000-0002-0949-8752	NHGRI NIH HHS [HG00098] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BEALL SS, 1989, J NEUROIMMUNOL, V21, P59, DOI 10.1016/0165-5728(89)90159-8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; EBERS GC, 1981, NEUROLOGY, V31, P1138, DOI 10.1212/WNL.31.9.1138; EOLI M, 1994, J NEUROL, V241, P615, DOI 10.1007/BF00920626; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HILLERT J, 1991, J NEUROIMMUNOL, V31, P141; KINNUNEN E, 1983, ACTA NEUROL SCAND, V67, P255, DOI 10.1111/j.1600-0404.1983.tb04574.x; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYNCH SG, 1991, ANN NEUROL, V30, P402, DOI 10.1002/ana.410300313; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Ott J., 1991, ANAL HUMAN GENETIC L; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; ROSE J, 1993, LANCET, V341, P1179, DOI 10.1016/0140-6736(93)91003-5; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Tienari Pentti J., 1993, European Journal of Human Genetics, V1, P257; TIENARI PJ, 1992, LANCET, V340, P987, DOI 10.1016/0140-6736(92)93007-A; TIENARI PJ, 1992, J NEUROL NEUROSUR PS, V55, P883, DOI 10.1136/jnnp.55.10.883; VANDEVYVER C, 1994, J NEUROIMMUNOL, V52, P97, DOI 10.1016/0165-5728(94)90167-8; WIKSTROM J, 1975, ACTA NEUROL SCAND, V51, P173, DOI 10.1111/j.1600-0404.1975.tb07598.x; WOOD NW, 1994, J NEUROL NEUROSUR PS, V57, P1191, DOI 10.1136/jnnp.57.10.1191	36	252	254	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1379	1387		10.1086/301637	http://dx.doi.org/10.1086/301637			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399895	Green Published, hybrid			2022-12-18	WOS:000071555900022
J	CHEN, YS; TORRONI, A; EXCOFFIER, L; SANTACHIARABENERECETTI, AS; WALLACE, DC				CHEN, YS; TORRONI, A; EXCOFFIER, L; SANTACHIARABENERECETTI, AS; WALLACE, DC			ANALYSIS OF MTDNA VARIATION IN AFRICAN POPULATIONS REVEALS THE MOST ANCIENT OF ALL HUMAN CONTINENT-SPECIFIC HAPLOGROUPS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; ENDONUCLEASE CLEAVAGE PATTERNS; LENGTH MUTATIONS; HUMAN-EVOLUTION; 9-BP DELETION; POLYMORPHISMS; AFFINITIES; MIGRATIONS; RADIATION; AMERICANS	mtDNA sequence variation was examined in 140 Africans, including Pygmies from Zaire and Central African Republic (C.A.R.) and Mandenkalu, Wolof, and Pular from Senegal. More than 76% of the African mtDNAs (100% of the Pygmies and 67.3% of the Senegalese) formed one major mtDNA cluster (haplogroup L) defined by an African-specific HpaI site gain at nucleotide pair (np) 3592. Additional mutations subdivided haplogroup L into two subhaplogroups, each encompassing both Pygmy and Senegalese mtDNAs. A novel 12-bp homoplasmic insertion in the intergenic region between tRNA(Tyr) and cytochrome oxidase I (COI) genes was also observed in 17.6% of the Pygmies from C.A.R. This insertion is one of the largest observed in human mtDNAs. Another 25% of the Pygmy mtDNAs harbored a 9-bp deletion between the cytochrome oxidase II (COII) and tRNA(Lys) genes, a length polymorphism previously reported in non-African populations. In addition to haplogroup L, other haplogroups were observed in the Senegalese. These haplogroups were more similar to those observed in Europeans and Asians than to haplogroup L mtDNAs, suggesting that the African mtDNAs without the HpaI np 3592 site could be the ancestral types from which European and Asian mtDNAs were derived. Comparison of the intrapopulation sequence divergence in African and non-African populations confirms that African populations exhibit the largest extent of mtDNA variation, a result that further supports the hypothesis that Africans represent the most ancient human group and that all modem humans have a common and recent African origin. The age of the total African variation was estimated to be 101,000-133,000 years before present (YBP), while the age of haplogroup L was estimated at 98,000-130,000 YBP. These values substantially exceed the ages of all Asian- and European-specific mtDNA haplogroups.	EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322; UNIV GENEVA,DEPT ANTHROPOL & ECOL,GENEVA,SWITZERLAND; UNIV PAVIA,DEPT GENET & MICROBIOL,I-27100 PAVIA,ITALY	Emory University; University of Geneva; University of Pavia			Torroni, Antonio/E-1557-2011; Excoffier, Laurent/D-3498-2013	Torroni, Antonio/0000-0002-4163-4478; Excoffier, Laurent/0000-0002-7507-6494	NIGMS NIH HHS [GM 46915] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BROWN MD, 1994, AM J HUM GENET, V55, P410; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES, P23; Cavalli-Sforza LL, 1986, AFRICAN PYGMIES, P361; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; DEBENEDICTIS G, 1989, ANN HUM GENET, V53, P311, DOI 10.1111/j.1469-1809.1989.tb01800.x; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; GRAVEN L, IN PRESS MOL BIOL EV; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Hiernaux J., 1977, POPULATION STRUCTURE, P187; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; MCDERMOTT F, 1993, NATURE, V363, P252, DOI 10.1038/363252a0; MERRIWETHER DA, 1993, AM J HUM GENET, V53, P833; NEI M, 1983, GENETICS, V105, P207; NEWMAN NJ, 1994, AM J OPHTHALMOL, V118, P158, DOI 10.1016/S0002-9394(14)72895-8; PASSARINO G, 1993, AM J HUM GENET, V53, P609; RITTE U, 1993, HUM BIOL, V65, P359; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SCOZZARI R, 1994, HUM BIOL, V66, P1; SCOZZARI R, 1988, AM J HUM GENET, V43, P534; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SOODYALL H, 1993, ANN HUM BIOL, V20, P477, DOI 10.1080/03014469300002872; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; Swofford D, 1993, PHYLOGENETIC ANAL US; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1995, AM J HUM GENET, V56, P1234; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TORRONI A, IN PRESS HUM MUTAT; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wallace DC, 1994, HUMAN GENE MAPPING 1, P813; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	46	252	260	1	31	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					133	149						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611282				2022-12-18	WOS:A1995RE62900017
J	MORAES, CT; RICCI, E; BONILLA, E; DIMAURO, S; SCHON, EA				MORAES, CT; RICCI, E; BONILLA, E; DIMAURO, S; SCHON, EA			THE MITOCHONDRIAL TERT-RNA LEU(UUR) MUTATION IN MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC-ACIDOSIS, AND STROKE-LIKE EPISODES (MELAS) - GENETIC, BIOCHEMICAL, AND MORPHOLOGICAL CORRELATIONS IN SKELETAL-MUSCLE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; RAGGED-RED FIBERS; MYOCLONIC EPILEPSY; OXIDASE DEFICIENCY; DNA DELETIONS; DISEASE; MYOPATHIES; GENOMES; IDENTIFICATION; TRANSCRIPTION	Mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) has recently been associated with an A --> G transition at position 3243 within the mitochondrial tRNA(Leu(UUR)) gene. Besides altering the tRNA(Leu(UUR)) sequence, this point mutation lies within a DNA segment responsible for transcription termination of the rRNA genes. We have studied the distribution and expression of mutant mtDNAs in muscle biopsies from MELAS patients. Histochemical, immunohistochemical, and single-fiber PCR analysis showed that ragged-red fibers (RRF) are associated both with high levels of mutant mitochondrial genomes (> 85% mutant mtDNA) and with a partial cytochrome c oxidase deficiency. By quantitative in situ hybridization, the steady-state ratios of mRNAs:rRNAs were found to be similar to controls in six of eight patients studied. In two other patients the relative levels of heavy-strand mRNAs were slightly increased, but a patient with myoclonic epilepsy and RRF also exhibited a similar increase. These results directly correlate the A --> G transition at mtDNA position 3243 with muscle mitochondrial proliferation, partial respiratory-chain impairment, decreased mitochondrially synthesized protein content, and no specific alterations in mitochondrial ratios of mRNAs:rRNAs.	COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, 630 W 168TH ST, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; H HOUSTON MERRITT CLIN RES CTR MUSCULAR DYSTROPHY, NEW YORK, NY USA	Columbia University; Columbia University			Moraes, Carlos/AAT-3818-2021; Ricci, Enzo/AAC-4448-2020	RICCI, Enzo/0000-0003-3092-3597	NINDS NIH HHS [NS28828, NS11766] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028828, P50NS011766, P01NS011766] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; Dubowitz V., 1973, MUSCLE BIOPSY MODERN; EVIANI M, 1991, LANCET, V338, P143; GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497; GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E; GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HASEGAWA H, 1991, ANN NEUROL, V29, P601, DOI 10.1002/ana.410290606; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOWELL N, 1991, AM J HUM GENET, V48, P935; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; KARPATI G, 1973, J NEUROL SCI, V19, P133, DOI 10.1016/0022-510X(73)90158-5; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; KOGA Y, 1988, ANN NEUROL, V24, P749, DOI 10.1002/ana.410240609; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631; MORAES CT, 1991, CURRENT NEUROLOGY, V11, P83; NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117; OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; ROMERO NB, 1989, J NEUROL SCI, V93, P297, DOI 10.1016/0022-510X(89)90199-8; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; SEIBEL P, 1990, BIOCHEM BIOPH RES CO, V173, P561, DOI 10.1016/S0006-291X(05)80071-3; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SUDOYO H, 1990, J NEUROL SCI, V98, P185, DOI 10.1016/0022-510X(90)90259-P; TANAKA M, 1991, BIOCHEM BIOPH RES CO, V174, P861, DOI 10.1016/0006-291X(91)91497-Z; TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YONEDA M, 1990, BIOCHEM INT, V21, P789	45	252	255	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					934	949						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1315123				2022-12-18	WOS:A1992HR47300007
J	Nyegaard, M; Overgaard, MT; Sondergaard, MT; Vranas, M; Behr, ER; Hildebrandt, LL; Lund, J; Hedley, PL; Camm, AJ; Wettrell, G; Fosdal, I; Christiansen, M; Borglum, AD				Nyegaard, Mette; Overgaard, Michael T.; Sondergaard, Mads T.; Vranas, Marta; Behr, Elijah R.; Hildebrandt, Lasse L.; Lund, Jacob; Hedley, Paula L.; Camm, A. John; Wettrell, Goeran; Fosdal, Inger; Christiansen, Michael; Borglum, Anders D.			Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac Death	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RYANODINE RECEPTOR; CALCIUM-BINDING; CA2+ RELEASE; COMPLEX; DIAGNOSIS; MAPS; TOOL	Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a devastating inherited disorder characterized by episodic syncope and/or sudden cardiac arrest during exercise or acute emotion in individuals without structural cardiac abnormalities. Although rare, CPVT is suspected to cause a substantial part of sudden cardiac deaths in young individuals. Mutations in RYR2, encoding the cardiac sarcoplasmic calcium channel, have been identified as causative in approximately half of all dominantly inherited CPVT cases. Applying a genome-wide linkage analysis in a large Swedish family with a severe dominantly inherited form of CPVT-like arrhythmias, we mapped the disease locus to chromosome 14q31-32. Sequencing CALM1 encoding calmodulin revealed a heterozygous missense mutation (c.161A>T [p.Asn53Ile]) segregating with the disease. A second, de novo, missense mutation (c.293A>G [p.Asn97Ser]) was subsequently identified in an individual of Iraqi origin; this individual was diagnosed with CPVT from a screening of 61 arrhythmia samples with no identified RYR2 mutations. Both CALM1 substitutions demonstrated compromised calcium binding, and p.Asn97Ser displayed an aberrant interaction with the RYR2 calmodulin-binding-domain peptide at low calcium concentrations. We conclude that calmodulin mutations can cause severe cardiac arrhythmia and that the calmodulin genes are candidates for genetic screening of individual cases and families with idiopathic ventricular tachycardia and unexplained sudden cardiac death.	[Nyegaard, Mette; Vranas, Marta; Borglum, Anders D.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Overgaard, Michael T.; Sondergaard, Mads T.; Hildebrandt, Lasse L.; Lund, Jacob] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [Behr, Elijah R.; Camm, A. John] St Georges Univ London, Div Cardiac & Vasc Sci, London SW17 0RE, England; [Hedley, Paula L.; Christiansen, Michael] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Hedley, Paula L.] Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa; [Wettrell, Goeran] Univ Lund Hosp, Div Paediat Cardiol, SE-22185 Lund, Sweden; [Fosdal, Inger] Visby Hosp, Dept Paediat, SE-62184 Visby, Sweden	Aarhus University; Aalborg University; St Georges University London; Statens Serum Institut; Stellenbosch University; Lund University; Skane University Hospital	Nyegaard, M (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark.	nyegaard@hum-gen.au.dk; anders@hum-gen.au.dk	Hedley, Paula L/E-6156-2011; Lund, Jacob/G-9885-2013; Christiansen, Michael/B-4588-2009; Overgaard, Michael Toft/E-1354-2011; Nyegaard, Mette/M-3379-2019	Hedley, Paula L/0000-0001-5801-960X; Lund, Jacob/0000-0001-8627-7382; Christiansen, Michael/0000-0003-4713-755X; Overgaard, Michael Toft/0000-0002-1423-2481; Nyegaard, Mette/0000-0003-4973-8543; Borglum, Anders/0000-0001-8627-7219; Behr, Elijah/0000-0002-8731-2853; Sondergaard, Mads Toft/0000-0001-6779-5109	Obelske Family Foundation; Fraenkel Foundation; Edith Agnete Stern Foundation; Carlsberg Foundation; Novo Nordisk Foundation	Obelske Family Foundation; Fraenkel Foundation; Edith Agnete Stern Foundation; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank all participants and their families for their cooperation. We thank Anne Hedemand and Hanne K. Nielsen for expert technical assistance. This study was supported by the Obelske Family Foundation, the Fraenkel Foundation, the Edith Agnete Stern Foundation, the Carlsberg Foundation, and the Novo Nordisk Foundation.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aizawa Y, 2006, INT HEART J, V47, P381, DOI 10.1536/ihj.47.381; Badhwar N, 2007, CURR PROB CARDIOLOGY, V32, P7, DOI 10.1016/j.cpcardiol.2006.10.002; Behr ER, 2008, EUR HEART J, V29, P1670, DOI 10.1093/eurheartj/ehn219; Bhuiyan ZA, 2007, J CARDIOVASC ELECTR, V18, P1060, DOI 10.1111/j.1540-8167.2007.00913.x; Cerrone M, 2009, HEART RHYTHM, V6, P1652, DOI 10.1016/j.hrthm.2009.06.033; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Coumel P., 1978, BRIT HEART J, V40, P28; Fisher JD, 1999, J AM COLL CARDIOL, V34, P2015, DOI 10.1016/S0735-1097(99)00438-6; Kontula K, 2005, CARDIOVASC RES, V67, P379, DOI 10.1016/j.cardiores.2005.04.027; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Liu NA, 2008, PROG CARDIOVASC DIS, V51, P23, DOI 10.1016/j.pcad.2007.10.005; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mohler PJ, 2007, PHYSIOLOGY, V22, P342, DOI 10.1152/physiol.00018.2007; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Napolitano C, 2007, HEART RHYTHM, V4, P675, DOI 10.1016/j.hrthm.2006.12.048; Ono M, 2010, CARDIOVASC RES, V87, P609, DOI 10.1093/cvr/cvq108; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Peersen OB, 1997, PROTEIN SCI, V6, P794; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Rozen S, 2000, Methods Mol Biol, V132, P365; Suetomi T, 2011, CIRCULATION, V124, P682, DOI 10.1161/CIRCULATIONAHA.111.023259; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tester DJ, 2006, HEART RHYTHM, V3, P800, DOI 10.1016/j.hrthm.2006.03.025; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; VanScyoc WS, 2006, BIOCHEMISTRY-US, V45, P14311, DOI 10.1021/bi061134d; Viitasalo M, 2008, HEART RHYTHM, V5, P1382, DOI 10.1016/j.hrthm.2008.06.011; Xu XJ, 2010, BIOCHEM BIOPH RES CO, V394, P660, DOI 10.1016/j.bbrc.2010.03.046; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	37	251	260	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					703	712		10.1016/j.ajhg.2012.08.015	http://dx.doi.org/10.1016/j.ajhg.2012.08.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23040497	hybrid, Green Published			2022-12-18	WOS:000309568500012
J	Becker, J; Semler, O; Gilissen, C; Li, Y; Bolz, HJ; Giunta, C; Bergmann, C; Rohrbach, M; Koerber, F; Zimmermann, K; de Vries, P; Wirth, B; Schoenau, E; Wollnik, B; Veltman, JA; Hoischen, A; Netzer, C				Becker, Jutta; Semler, Oliver; Gilissen, Christian; Li, Yun; Bolz, Hanno Joern; Giunta, Cecilia; Bergmann, Carsten; Rohrbach, Marianne; Koerber, Friederike; Zimmermann, Katharina; de Vries, Petra; Wirth, Brunhilde; Schoenau, Eckhard; Wollnik, Bernd; Veltman, Joris A.; Hoischen, Alexander; Netzer, Christian			Exome Sequencing Identifies Truncating Mutations in Human SERPINF1 in Autosomal-Recessive Osteogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPITHELIUM-DERIVED FACTOR; I COLLAGEN; PROLYL 3-HYDROXYLATION; NEUROTROPHIC ACTIVITY; MOLECULAR CHAPERONE; BONE-FORMATION; LETHAL FORM; PEDF; ANGIOGENESIS; PROCOLLAGEN	Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder characterized by bone fragility and susceptibility to fractures after minimal trauma. After mutations in all known OI genes had been excluded by Sanger sequencing, we applied next-generation sequencing to analyze the exome of a single individual who has a severe form of the disease and whose parents are second cousins. A total of 26,922 variations from the human reference genome sequence were subjected to several filtering steps. In addition, we extracted the genotypes of all dbSNP130-annotated SNPs from the exome sequencing data and used these 299,494 genotypes as markers for the genome-wide identification of homozygous regions. A single homozygous truncating mutation, affecting SERPINF1 on chromosome 17p13.3, that was embedded into a homozygous stretch of 2.99 Mb remained. The mutation was also homozygous in the affected brother of the index patient. Subsequently, we identified homozygosity for two different truncating SERPINF1 mutations in two unrelated patients with OI and parental consanguinity. All four individuals with SERPINF1 mutations have severe OI. Fractures of long bones and severe vertebral compression fractures with resulting deformities were observed as early as the first year of life in these individuals. Collagen analyses with cultured dermal fibroblasts displayed no evidence for impaired collagen folding, posttranslational modification, or secretion. SERPINF1 encodes pigment epithelium-derived factor (PEDF), a secreted glycoprotein of the serpin superfamily. PEDF is a multifunctional protein and one of the strongest inhibitors of angiogenesis currently known in humans. Our data provide genetic evidence for PEDF involvement in human bone homeostasis.	[Becker, Jutta; Li, Yun; Bolz, Hanno Joern; Zimmermann, Katharina; Wirth, Brunhilde; Wollnik, Bernd; Netzer, Christian] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Semler, Oliver; Schoenau, Eckhard] Univ Cologne, Childrens Hosp, D-50931 Cologne, Germany; [Gilissen, Christian; de Vries, Petra; Veltman, Joris A.; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Gilissen, Christian; de Vries, Petra; Veltman, Joris A.; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6500 HB Nijmegen, Netherlands; [Li, Yun; Wirth, Brunhilde; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Bolz, Hanno Joern; Bergmann, Carsten] Bioscientia, Ctr Human Genet, D-55218 Ingelheim, Germany; [Giunta, Cecilia; Rohrbach, Marianne] Univ Childrens Hosp, Connect Tissue Unit, Div Metab, CH-8032 Zurich, Switzerland; [Giunta, Cecilia; Rohrbach, Marianne] Pediat Res Ctr, CH-8032 Zurich, Switzerland; [Bergmann, Carsten] Rhein Westfal TH Aachen, Dept Human Genet, D-52074 Aachen, Germany; [Koerber, Friederike] Univ Cologne, Dept Radiol, D-50931 Cologne, Germany; [Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne; Radboud University Nijmegen; Radboud University Nijmegen; University of Cologne; University Children's Hospital Zurich; RWTH Aachen University; University of Cologne; University of Cologne; University of Cologne	Netzer, C (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	christian.netzer@uk-koeln.de	Gilissen, Christian/E-5246-2012; Giunta, Cecilia/T-8222-2019; Veltman, Joris A/F-5128-2010; Hoischen, Alexander/AGF-7293-2022; Wollnik, Bernd/GRY-6062-2022; Wirth, Brunhilde/H-3192-2019; Hoischen, Alexander/D-1282-2013	Gilissen, Christian/0000-0003-1693-9699; Giunta, Cecilia/0000-0002-9313-8257; Veltman, Joris A/0000-0002-3218-8250; Hoischen, Alexander/0000-0002-8072-4476; Wollnik, Bernd/0000-0003-2589-0364; Hoischen, Alexander/0000-0002-8072-4476; Wirth, Brunhilde/0000-0003-4051-5191; Rohrbach, Marianne/0000-0002-4013-6012	Cologne Medical Faculty; German Federal Ministry of Education and Research (BMBF) [01GM0880 (SKELNET)]; Netherlands Organization for Health Research and Development (ZonMW) [917-66-36, 911-08-025]; EU [Health-F5-2009-223143]; AnEUploidy project [LSHG-CT-2006-37627]	Cologne Medical Faculty; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); EU(European Commission); AnEUploidy project	We are grateful to our patients and their families for participating in this study. We would like to thank Angelika Schwarze for support in collagen biochemical analysis, Angelika Stabrey for preparing Figure 3, Figure 4, and Figure S5, Barbel Tutlewski for performing the DXA scans, and Karin Boss for critically reading the manuscript. C.N. was supported by the "Koln Fortune" program of the Cologne Medical Faculty. This work was partially supported by the German Federal Ministry of Education and Research (BMBF) by grant number 01GM0880 (SKELNET) to B.W. The next-generation sequencing platforms and bioinformatics pipeline have been funded in part by the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J.V). Part of this work was funded by the EU-project TECHGENE (grant Health-F5-2009-223143 to J.A.V.) and by the AnEUploidy project (grant LSHG-CT-2006-37627 to A.H. and J.A.V.).	Akiyama T, 2010, BIOCHEM BIOPH RES CO, V391, P789, DOI 10.1016/j.bbrc.2009.11.139; Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; BARSH GS, 1981, P NATL ACAD SCI-BIOL, V78, P5142, DOI 10.1073/pnas.78.8.5142; Basel D, 2009, GENET MED, V11, P375, DOI 10.1097/GIM.0b013e3181a1ff7b; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Broadhead ML, 2010, CURR MOL MED, V10, P296, DOI 10.2174/156652410791065345; BYERS PH, 1988, AM J HUM GENET, V42, P237; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Chang WZ, 2010, HUM MOL GENET, V19, P223, DOI 10.1093/hmg/ddp481; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; CHU ML, 1983, NATURE, V304, P78, DOI 10.1038/304078a0; Cintas HL, 2003, AM J PHYS MED REHAB, V82, P33, DOI 10.1097/00002060-200301000-00006; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Gatti D, 2005, J BONE MINER RES, V20, P758, DOI 10.1359/JBMR.041232; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Marini JC, 2010, CELL TISSUE RES, V339, P59, DOI 10.1007/s00441-009-0872-0; Marini JC, 2009, NAT REV ENDOCRINOL, V5, P241, DOI 10.1038/nrendo.2009.58; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Phillipi CA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005088.pub2; Quan GMY, 2005, CALCIFIED TISSUE INT, V76, P146, DOI 10.1007/s00223-004-0068-2; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rasmussen H, 2001, Hum Gene Ther, V12, P2029; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Shao HS, 2003, EUR J BIOCHEM, V270, P822, DOI 10.1046/j.1432-1033.2003.03374.x; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Tombran-Tink J, 2005, J STRUCT BIOL, V151, P130, DOI 10.1016/j.jsb.2005.05.005; Tombran-Tink J, 2003, TRENDS MOL MED, V9, P244, DOI 10.1016/S1471-4914(03)00074-1; Tombran-Tink J, 2010, CURR MOL MED, V10, P267, DOI 10.2174/156652410791065336; Tombran-Tink J, 1996, Mol Vis, V2, P11; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; WILLIAMS CJ, 1983, J BIOL CHEM, V258, P5915; Xu XM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-248	60	251	267	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					362	371		10.1016/j.ajhg.2011.01.015	http://dx.doi.org/10.1016/j.ajhg.2011.01.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21353196	Bronze, Green Published			2022-12-18	WOS:000288589000013
J	Zweier, C; de Jong, EK; Zweier, M; Orrico, A; Ousager, LB; Collins, AL; Bijlsma, EK; Oortveld, MAW; Ekici, AB; Reis, A; Schenck, A; Rauch, A				Zweier, Christiane; de Jong, Eiko K.; Zweier, Markus; Orrico, Alfredo; Ousager, Lilian B.; Collins, Amanda L.; Bijlsma, Emilia K.; Oortveld, Merel A. W.; Ekici, Arif B.; Reis, Andre; Schenck, Annette; Rauch, Anita			CNTNAP2 and NRXN1 Are Mutated in Autosomal-Recessive Pitt-Hopkins-like Mental Retardation and Determine the Level of a Common Synaptic Protein in Drosophila	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDERS; LA-TOURETTE-SYNDROME; MYELINATED AXONS; NEUREXIN IV; TRANSCRIPTION FACTOR; STRUCTURAL VARIANTS; CA2+ CHANNELS; K+ CHANNELS; GENE; FAMILY	Heterozygous copy-number variants and SNPs of CNTNAP2 and NRXN1, two distantly related members of the neurexin superfamily, have been repeatedly associated with a wide spectrum of neuropsychiatric disorders, such as developmental language disorders, autism spectrum disorders, epilepsy, and schizophrenia. We now identified homozygous and compound-heterozygous deletions and mutations via molecular karyotyping and mutational screening in CNTNAP2 and NRXN1 in four patients with severe mental retardation (MR) and variable features, such as autistic behavior, epilepsy, and breathing anomalies, phenotypically overlapping with Pitt-Hopkins syndrome. With a frequency of at least 1% in our cohort of 179 patients, recessive defects in CNTNAP2 appear to significantly contribute to severe MR. Whereas the established synaptic role of NRXN1 suggests that synaptic defects contribute to the associated neuropsychiatric disorders and to severe MR as reported here, evidence for a synaptic role of the CNTNAP2-encoded protein CASPR2 has so far been lacking. Using Drosophila as a model, we now show that, as known for fly Nrx-1, the CASPR2 ortholog Nrx-IV might also localize to synapses. Overexpression of either protein can reorganize synaptic morphology and induce increased density of active zones, the synaptic domains of neurotransmitter release. Moreover, both Nrx-I and Nrx-IV determine the level of the presynaptic active-zone protein bruchpilot, indicating a possible common molecular mechanism in Nrx-1 and Nrx-IV mutant conditions. We therefore propose that an analogous shared synaptic mechanism contributes to the similar clinical phenotypes resulting from defects in human NRXN1 and CNTNAP2.	[Zweier, Christiane; Zweier, Markus; Ekici, Arif B.; Reis, Andre; Rauch, Anita] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Zweier, Christiane; de Jong, Eiko K.; Oortveld, Merel A. W.; Schenck, Annette] Nijmegen Ctr Mol Life Sci, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Zweier, Christiane; de Jong, Eiko K.; Oortveld, Merel A. W.; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Orrico, Alfredo] Azienda Osped Univ Senese, Policlin S Maria Scotte, Unita Operat Med Mol, I-53100 Siena, Italy; [Ousager, Lilian B.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense C, Denmark; [Collins, Amanda L.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Bijlsma, Emilia K.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Zurich Schwerzenbach, Switzerland	University of Erlangen Nuremberg; Radboud University Nijmegen; Radboud University Nijmegen; University of Siena; University Hospital of Siena; University of Southern Denmark; Odense University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zurich	Zweier, C (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	czweier@humgenet.uni-erlangen.de	Zweier, Christiane/F-2202-2015; Schenck, Annette/E-4514-2012; Ekici, Arif B/C-3971-2013; Reis, André/D-2309-2009; Oortveld, Merel/P-5042-2015; Rauch, Anita/C-5568-2014; de Jong, Eiko/P-3407-2015; Ousager, Lilian Bomme/F-7119-2015	Zweier, Christiane/0000-0001-8002-2020; Schenck, Annette/0000-0002-6918-3314; Ekici, Arif B/0000-0001-6099-7066; Reis, André/0000-0002-6301-6363; Rauch, Anita/0000-0003-2930-3163; de Jong, Eiko/0000-0001-6520-0407; Ousager, Lilian Bomme/0000-0001-9936-2201	Deutsche Forschungsgemeinschaft (DFG); German Federal Ministry of Education and Research (BMBF); National Genome Research Network (NGFNplus); Netherlands Organisation for Scientific Research (NWO)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network (NGFNplus); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank the patients and families for participation in this study and Christine Zeck-Papp, Michaela Kirsch, and Daniela Schweitzer for excellent technical assistance. We are grateful to Wei Xie (Genetics Research Center, Southeast University Medical School, Nanjing, China) and to Christian Klambt (Institute for Neurobiology, Munster, Germany) for providing the pUAST-Nrx-I flies and the Nrx-IV antibody, respectively. We thank H. Brunner and H. van Bokhoven for critical reading of the manuscript. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) to C.Z.; by a grant from the German Mental Retardation Network (MRNET) funded by the German Federal Ministry of Education and Research (BMBF) as a part of the National Genome Research Network (NGFNplus), to A.Re,, A.Ra., and A.S.; and by a VIDI grant from the Netherlands Organisation for Scientific Research (NWO) to A.S.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Arroyo EJ, 2001, CELL TISSUE RES, V305, P53, DOI 10.1007/s004410100403; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Belloso JM, 2007, EUR J HUM GENET, V15, P711, DOI 10.1038/sj.ejhg.5201824; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brockschmidt A, 2007, HUM MOL GENET, V16, P1488, DOI 10.1093/hmg/ddm099; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; de Pontual L, 2009, HUM MUTAT, V30, P669, DOI 10.1002/humu.20935; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Giurgea I, 2008, HUM MUTAT, V29, pE242, DOI 10.1002/humu.20859; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Humeau Y, 2009, J NEUROCHEM, V109, P1, DOI 10.1111/j.1471-4159.2009.05881.x; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jackman C, 2009, PEDIATR NEUROL, V40, P310, DOI 10.1016/j.pediatrneurol.2008.10.013; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Orrico A, 2001, AM J MED GENET, V103, P157, DOI 10.1002/ajmg.1523; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Stork T, 2009, DEVELOPMENT, V136, P1251, DOI 10.1242/dev.032847; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Vaillend C, 2008, BEHAV BRAIN RES, V192, P88, DOI 10.1016/j.bbr.2008.01.009; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wheeler SR, 2009, DEVELOPMENT, V136, P1147, DOI 10.1242/dev.030254; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zweier C, 2008, J MED GENET, V45, P738, DOI 10.1136/jmg.2008.060129; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	51	251	260	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					655	666		10.1016/j.ajhg.2009.10.004	http://dx.doi.org/10.1016/j.ajhg.2009.10.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19896112	Green Published, Bronze			2022-12-18	WOS:000271916500012
J	Liu, H; Prugnolle, F; Manica, A; Balloux, F				Liu, Hua; Prugnolle, Franck; Manica, Andrea; Balloux, Francois			A geographically explicit genetic model of worldwide human-settlement history	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ORIGINS; DIVERSITY; POPULATIONS; EVOLUTION; EXPANSION; DISTANCE; DNA	Currently available genetic and archaeological evidence is generally interpreted as supportive of a recent single origin of modern humans in East Africa. However, this is where the near consensus on human settlement history ends, and considerable uncertainty clouds any more detailed aspect of human colonization history. Here, we present a dynamic genetic model of human settlement history coupled with explicit geographical distances from East Africa, the likely origin of modern humans. We search for the best-supported parameter space by fitting our analytical prediction to genetic data that are based on 52 human populations analyzed at 783 autosomal microsatellite markers. This framework allows us to jointly estimate the key parameters of the expansion of modern humans. Our best estimates suggest an initial expansion of modern humans similar to 56,000 years ago from a small founding population of similar to 1,000 effective individuals. Our model further points to high growth rates in newly colonized habitats. The general fit of the model with the data is excellent. This suggests that coupling analytical genetic models with explicit demography and geography provides a powerful tool for making inferences on human-settlement history.	Univ Cambridge, Dept Genet, Theoret & Mol Populat Genet Grp, Cambridge CB2 3EH, England; Univ Cambridge, Evolutionary Ecol Grp, Dept Zool, Cambridge, England; Ctr Inst Rech & Dev Montpellier, UMR 2724, Montpellier, France	University of Cambridge; University of Cambridge; Institut de Recherche pour le Developpement (IRD)	Balloux, F (corresponding author), Univ Cambridge, Dept Genet, Theoret & Mol Populat Genet Grp, Downing St, Cambridge CB2 3EH, England.	fb255@gen.cam.ac.uk	Peng, Bo/A-6920-2009; Balloux, Francois/D-4783-2009; Manica, Andrea/B-5497-2008; Balloux, Francois/X-7856-2019; Manica, Andrea/N-9013-2019	Peng, Bo/0000-0001-8225-2284; Balloux, Francois/0000-0003-1978-7715; Manica, Andrea/0000-0003-1895-450X; Balloux, Francois/0000-0003-1978-7715; Manica, Andrea/0000-0003-1895-450X; Prugnolle, Franck/0000-0001-8519-1253	Biotechnology and Biological Sciences Research Council [BB/C007123/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; BINFORD LR, 2001, COSTRUCTING FRAMES R; Bocquet-Appel JP, 2000, ANTIQUITY, V74, P544, DOI 10.1017/S0003598X00059901; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Burnham KP, 2003, MODEL SELECTION MULT, DOI DOI 10.1007/B97636; Cann HM, 2002, SCIENCE, V296, P261; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Foley R, 1998, GENOME RES, V8, P339, DOI 10.1101/gr.8.4.339; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Kimmel M, 1996, THEOR POPUL BIOL, V50, P345, DOI 10.1006/tpbi.1996.0035; LAHR MM, 1998, EVOL ANTHROPOL, V3, P48; LARAIA RB, 1979, INDOS CASTANHEIROS E, P208; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; MCDERMOTT F, 1993, NATURE, V363, P252, DOI 10.1038/363252a0; Pennington R, 2001, BIOSOCIAL S, V13, P170; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Satta Y, 2004, MOL ECOL, V13, P877, DOI 10.1046/j.1365-294X.2003.02069.x; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Steele J, 1998, WORLD ARCHAEOL, V30, P286, DOI 10.1080/00438243.1998.9980411; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	38	251	255	3	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					230	237		10.1086/505436	http://dx.doi.org/10.1086/505436			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826514	Bronze, Green Published			2022-12-18	WOS:000239040400005
J	Quinzii, C; Naini, A; Salviati, L; Trevisson, E; Navas, P; DiMauro, S; Hirano, M				Quinzii, C; Naini, A; Salviati, L; Trevisson, E; Navas, P; DiMauro, S; Hirano, M			A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q(10) deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR-ATAXIA; MITOCHONDRIAL ENCEPHALOMYOPATHY; ONSET ATAXIA; GENE; PROTEIN; BIOSYNTHESIS; EXPRESSION; DISEASES; ENCODES	Ubiquinone ( coenzyme Q(10) or CoQ(10)) is a lipid-soluble component of virtually all cell membranes, where it functions as a mobile electron and proton carrier. CoQ(10) deficiency is inherited as an autosomal recessive trait and has been associated with three main clinical phenotypes: a predominantly myopathic form with central nervous system involvement, an infantile encephalomyopathy with renal dysfunction, and an ataxic form with cerebellar atrophy. In two siblings of consanguineous parents with the infantile form of CoQ(10) deficiency, we identified a homozygous missense mutation in the COQ2 gene, which encodes para-hydroxybenzoate-polyprenyl transferase. The A -> G transition at nucleotide 890 changes a highly conserved tyrosine to cysteine at amino acid 297 within a predicted transmembrane domain. Radioisotope assays confirmed a severe defect of CoQ(10) biosynthesis in the fibroblasts of one patient. This mutation in COQ2 is the first molecular cause of primary CoQ(10) deficiency.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Univ Padua, Dept Pediat, Serv Genet Clin & Epidemiol, Padua, Italy; Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain	Columbia University; University of Padua; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St,P&S 4-443, New York, NY 10032 USA.	mh29@columbia.edu	NAVAS, PLACIDO/R-5943-2019; Trevisson, Eva/K-8462-2016	NAVAS, PLACIDO/0000-0002-4115-7966; Trevisson, Eva/0000-0002-5380-6265	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766] Funding Source: NIH RePORTER; NINDS NIH HHS [P01NS11766, P01 NS011766] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aure K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2; Boitier E, 1998, J NEUROL SCI, V156, P41, DOI 10.1016/S0022-510X(98)00006-9; BREACALVO G, IN PRESS FREE RADIC; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Di Giovanni S, 2001, NEUROLOGY, V57, P515, DOI 10.1212/WNL.57.3.515; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7; Holthofer H, 1999, FASEB J, V13, P523, DOI 10.1096/fasebj.13.3.523; KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T; KALEN A, 1990, J BIOL CHEM, V265, P1158; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; Naini A, 2003, BIOFACTORS, V18, P145, DOI 10.1002/biof.5520180217; NEALE TJ, 1994, J CLIN INVEST, V94, P1577, DOI 10.1172/JCI117499; Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8; Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098	32	251	264	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					345	349		10.1086/500092	http://dx.doi.org/10.1086/500092			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400613	Bronze, Green Published			2022-12-18	WOS:000236744900015
J	Ma, DQ; Whitehead, PL; Menold, MM; Martin, ER; Ashley-Koch, AE; Mei, H; Ritchie, MD; DeLong, GR; Abramson, RK; Wright, HH; Cuccaro, ML; Hussman, JP; Gilbert, JR; Pericak-Vance, MA				Ma, DQ; Whitehead, PL; Menold, MM; Martin, ER; Ashley-Koch, AE; Mei, H; Ritchie, MD; DeLong, GR; Abramson, RK; Wright, HH; Cuccaro, ML; Hussman, JP; Gilbert, JR; Pericak-Vance, MA			Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; FAMILY-BASED TESTS; GENOMEWIDE SCREEN; LINKAGE-DISEQUILIBRIUM; GENOMIC SCREEN; SUSCEPTIBILITY; DISORDER; DUPLICATION; PEDIGREES; HISTORY	Autism is a common neurodevelopmental disorder with a significant genetic component. Existing research suggests that multiple genes contribute to autism and that epigenetic effects or gene-gene interactions are likely contributors to autism risk. However, these effects have not yet been identified. Gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the adult brain, has been implicated in autism etiology. Fourteen known autosomal GABA receptor subunit genes were studied to look for the genes associated with autism and their possible interactions. Single-nucleotide polymorphisms (SNPs) were screened in the following genes: GABRG1, GABRA2, GABRA4, and GABRB1 on chromosome 4p12; GABRB2, GABRA6, GABRA1, GABRG2, and GABRP on 5q34-q35.1; GABRR1 and GABRR2 on 6q15; and GABRA5, GABRB3, and GABRG3 on 15q12. Intronic and/or silent mutation SNPs within each gene were analyzed in 470 white families with autism. Initially, SNPs were used in a family-based study for allelic association analysis-with the pedigree disequilibrium test and the family-based association test-and for genotypic and haplotypic association analysis-with the genotype- pedigree disequilibrium test (geno-PDT), the association in the presence of linkage (APL) test, and the haplotype family-based association test. Next, with the use of five refined independent marker sets, extended multifactor-dimensionality reduction (EMDR) analysis was employed to identify the models with locus joint effects, and interaction was further verified by conditional logistic regression. Significant allelic association was found for markers RS1912960 (in GABRA4; P = .01) and HCV9866022 (in GABRR2; P =.04). The geno-PDT found significant genotypic association for HCV8262334 (in GABRA2), RS1912960 and RS2280073 (in GABRA4), and RS2617503 and RS12187676 (in GABRB2). Consistent with the allelic and genotypic association results, EMDR confirmed the main effect at RS1912960 (in GABRA4). EMDR also identified a significant two-locus gene-gene effect model involving RS1912960 in GABRA4 and RS2351299 in GABRB1. Further support for this two-locus model came from both the multilocus geno-PDT and the APL test, which indicated a common genotype and haplotype combination positively associated with disease. Finally, these results were also consistent with the results from the conditional logistic regression, which confirmed the interaction between GABRA4 and GABRB1 (odds ratio = 2.9 for interaction term; P = .002). Through the convergence of all analyses, we conclude that GABRA4 is involved in the etiology of autism and potentially increases autism risk through interaction with GABRB1. These results support the hypothesis that GABA receptor subunit genes are involved in autism, most likely via complex gene-gene interactions.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Div Pediat Neurol, Durham, NC 27710 USA; N Carolina State Univ, Raleigh, NC 27695 USA; Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; Univ S Carolina, Sch Med, Columbia, SC 29208 USA; Hussman Fdn, Ellicott City, MD USA	Duke University; Duke University; University of North Carolina; North Carolina State University; Vanderbilt University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Box 3445,595 LaSalle St, Durham, NC 27710 USA.	mpericak.vance@duke.edu	Ritchie, Marylyn/C-1114-2012	Ashley-Koch, Allison/0000-0001-5409-9155; Hussman, John/0000-0002-0673-0106	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS042165, R01NS036768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG020135, R01 AG20135] Funding Source: Medline; NINDS NIH HHS [R01 NS36768, R01 NS42165, R01 NS036768, NS26630, P01 NS026630, R01 NS042165] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; ASHLEYKOCH AE, 2004, 12 WORLD C PSYCH GEN; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Auranen M, 2000, MOL PSYCHIATR, V5, P320, DOI 10.1038/sj.mp.4000708; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bass MP, 2000, NEUROGENETICS, V2, P219, DOI 10.1007/s100489900081; Blatt GJ, 2001, J AUTISM DEV DISORD, V31, P537, DOI 10.1023/A:1013238809666; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Boyar FZ, 2001, CLIN GENET, V60, P421, DOI 10.1034/j.1399-0004.2001.600604.x; BUNDEY S, 1994, DEV MED CHILD NEUROL, V36, P736; Buxbaum JD, 2002, MOL PSYCHIATR, V7, P311, DOI 10.1038/sj.mp.4001011; CHOUFANI S, 2003, AM J HUM GENET, V73, pA1990; Chugani DC, 2001, ANN NEUROL, V49, P618, DOI 10.1002/ana.1003; Coffey CS, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-49; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Dhossche Dirk, 2002, Med Sci Monit, V8, pPR1; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; HAYNES C, 1995, AM J HUM GENET, V57, P1106; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lord C, 1997, J AUTISM DEV DISORD, V27, P501, DOI 10.1023/A:1025873925661; Ma LM, 2004, J BIOL CHEM, V279, P40451, DOI 10.1074/jbc.M406827200; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; Martin ER, 2000, AM J MED GENET, V96, P43, DOI 10.1002/(SICI)1096-8628(20000207)96:1<43::AID-AJMG9>3.0.CO;2-3; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; MEI H, IN PRESS BMC GENET; Menold MM, 2001, J NEUROGENET, V15, P245, DOI 10.3109/01677060109167380; MEYERS RM, 1998, AM J HUM GENET, V63, pA302; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pujana MA, 2002, EUR J HUM GENET, V10, P26, DOI 10.1038/sj.ejhg.5200760; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sabaratnam M, 2000, EUR CHILD ADOLES PSY, V9, P307, DOI 10.1007/s007870070035; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Smith M, 2000, AM J MED GENET, V96, P765, DOI 10.1002/1096-8628(20001204)96:6<765::AID-AJMG13>3.0.CO;2-L; Sparrow SS, 1984, VINELAND ADAPTIVE BE; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Sullivan PF, 2001, ARCH GEN PSYCHIAT, V58, P1015, DOI 10.1001/archpsyc.58.11.1015; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; VANCE JM, 1998, APPROACHES GENE MAPP; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Wolpert CM, 2000, AM J MED GENET, V96, P365, DOI 10.1002/1096-8628(20000612)96:3<365::AID-AJMG25>3.0.CO;2-X; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	65	251	261	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					377	388		10.1086/433195	http://dx.doi.org/10.1086/433195			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	956QE	16080114	Bronze, Green Published			2022-12-18	WOS:000231314100005
J	Bartels, CF; Bukulmez, H; Padayatti, P; Rhee, DK; van Ravenswaaij-Arts, C; Pauli, RM; Mundlos, S; Chitayat, D; Shih, LY; Al-Gazali, LI; Kant, S; Cole, T; Morton, J; Cormier-Daire, V; Faivre, L; Lees, M; Kirk, J; Mortier, GR; Leroy, J; Zabel, B; Kim, CA; Crow, Y; Braverman, NE; van den Akker, F; Warman, ML				Bartels, CF; Bukulmez, H; Padayatti, P; Rhee, DK; van Ravenswaaij-Arts, C; Pauli, RM; Mundlos, S; Chitayat, D; Shih, LY; Al-Gazali, LI; Kant, S; Cole, T; Morton, J; Cormier-Daire, V; Faivre, L; Lees, M; Kirk, J; Mortier, GR; Leroy, J; Zabel, B; Kim, CA; Crow, Y; Braverman, NE; van den Akker, F; Warman, ML			Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GUANYLYL CYCLASE-B; PROTEIN-KINASE-II; ENDOCHONDRAL OSSIFICATION; CLEARANCE RECEPTOR; MICE; DWARFISM; HORMONE; CHONDROCYTES; HYPERTENSION; ACTIVATION	The homodimeric transmembrane receptor natriuretic peptide receptor B (NPR-B [ also known as guanylate cyclase B, GC-B, and GUC2B]; gene name NPR2) produces cytoplasmic cyclic GMP from GTP on binding its extracellular ligand, C-type natriuretic peptide (CNP). CNP has previously been implicated in the regulation of skeletal growth in transgenic and knockout mice. The autosomal recessive skeletal dysplasia known as "acromesomelic dysplasia, type Maroteaux" (AMDM) maps to an interval that contains NPR2. We sequenced DNA from 21 families affected by AMDM and found 4 nonsense mutations, 4 frameshift mutations, 2 splice-site mutations, and 11 missense mutations. Molecular modeling was used to examine the putative protein change brought about by each missense mutation. Three missense mutations were tested in a functional assay and were found to have markedly deficient guanylyl cyclase activity. We also found that obligate carriers of NPR2 mutations have heights that are below the mean for matched controls. We conclude that, although NPR-B is expressed in a number of tissues, its major role is in the regulation of skeletal growth.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Metro Hlth Med Ctr, Dept Pediat, Cleveland, OH USA; Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Univ Wisconsin, Dept Pediat, Madison, WI USA; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Inst Med Genet Charite, Berlin, Germany; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Med & Dent New Jersey, Ctr Human & Mol Genet, Newark, NJ 07103 USA; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; Birmingham Womens Healthcare, Clin Genet Unit, Birmingham, W Midlands, England; Birmingham Childrens Hosp, Dept Pediat Endocrinol, Birmingham, W Midlands, England; Hop Necker Enfants Malad, Dept Med Genet, Paris, France; Hop Enfants, Genet Ctr, Dijon, France; Great Ormond St Hosp Children, Dept Clin Genet, London WC1N 3JH, England; State Univ Ghent Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany; Univ Sao Paulo, Dept Genet, Sao Paulo, Brazil; Leeds Teaching Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; MetroHealth System; Radboud University Nijmegen; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Rutgers State University New Brunswick; Rutgers State University Medical Center; United Arab Emirates University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Ghent University; Ghent University Hospital; Johannes Gutenberg University of Mainz; Universidade de Sao Paulo; University of Leeds; Johns Hopkins University	Warman, ML (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, 2109 Adelbert Rd,BRB-719, Cleveland, OH 44106 USA.	mlw14@case.edu	Mortier, Geert/D-2542-2012; Crow, Yanick J/N-6120-2014; Mundlos, Stefan/ABH-9585-2020; Kant, Sarina/F-8596-2010; cormier-daire, valerie/H-6520-2017	Mortier, Geert/0000-0001-9871-4578; Crow, Yanick J/0000-0001-7211-7564; Faivre, Laurence/0000-0001-9770-444X; cormier-daire, valerie/0000-0002-2839-9856; Bukulmez, Hulya/0000-0002-2256-9068; Padayatti, Pius/0000-0002-1384-3774; Kim, Chong/0000-0002-1754-1300				Abbey SE, 2003, ENDOCRINOLOGY, V144, P240, DOI 10.1210/en.2002-220702; BARNARD R, 1988, ENDOCRINOLOGY, V122, P2562, DOI 10.1210/endo-122-6-2562; BORRELLI P, 1983, PEDIATR RADIOL, V13, P165, DOI 10.1007/BF01624409; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; James W. P. T., 1990, HUMAN ENERGY REQUIRE; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kant SG, 1998, AM J HUM GENET, V63, P155, DOI 10.1086/301917; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGER LO, 1980, RADIOLOGY, V137, P349, DOI 10.1148/radiology.137.2.7433666; Laron Z, 1999, J CLIN ENDOCR METAB, V84, P4397, DOI 10.1210/jc.84.12.4397; LEVIN ER, 1993, AM J PHYSIOL, V264, pE483, DOI 10.1152/ajpendo.1993.264.4.E483; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; MAROTEAUX P, 1971, PRESSE MED, V79, P1839; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Mericq V, 2000, PEDIATR RES, V47, P189, DOI 10.1203/00006450-200002000-00007; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Miyazawa T, 2002, ENDOCRINOLOGY, V143, P3604, DOI 10.1210/en.2002-220307; Oliver PM, 1998, P NATL ACAD SCI USA, V95, P2547, DOI 10.1073/pnas.95.5.2547; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200; Pena-Almazan S, 2001, J CLIN ENDOCR METAB, V86, P5691, DOI 10.1210/jc.86.12.5691; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Sandberg DE, 2000, ENDOCRINE, V12, P173, DOI 10.1385/ENDO:12:2:173; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; Tamura N, 2003, J BIOL CHEM, V278, P48880, DOI 10.1074/jbc.M308680200; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Xu JF, 2002, AM J HUM GENET, V71, P646, DOI 10.1086/342216; Yamashita Y, 2000, J BIOCHEM-TOKYO, V127, P177, DOI 10.1093/oxfordjournals.jbchem.a022591; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659	38	251	263	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					27	34		10.1086/422013	http://dx.doi.org/10.1086/422013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15146390	Bronze, Green Published			2022-12-18	WOS:000222031300004
J	Rossman, MD; Thompson, B; Frederick, M; Maliarik, M; Iannuzzi, MC; Rybicki, BA; Pandey, JP; Newman, LS; Magira, E; Beznik-Cizman, B; Monos, D				Rossman, MD; Thompson, B; Frederick, M; Maliarik, M; Iannuzzi, MC; Rybicki, BA; Pandey, JP; Newman, LS; Magira, E; Beznik-Cizman, B; Monos, D		ACCESS Grp	HLA-DRB1*1101: A significant risk factor for sarcoidosis in blacks and whites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR POPULATION GROUPS; CONVERTING ENZYME GENE; AMINO-ACID EPITOPES; CLASS-II ALLELES; T-CELL-RECEPTOR; HLA-DR; HAPLOTYPE FREQUENCIES; RHEUMATOID-ARTHRITIS; RELATIVE FREQUENCIES; PEPTIDE BINDING	Sarcoidosis is a granulomatous disorder of unknown etiology, associated with an accumulation of CD4+ T cells and a TH1 immune response. Since previous studies of HLA associations with sarcoidosis were limited by serologic or low-resolution molecular identification, we performed high-resolution typing for the HLA-DPB1, HLA-DQB1, HLA-DRB1, and HLA-DRB3 loci and the presence of the DRB4 or DRB5 locus, to define HLA class II associations with sarcoidosis. A Case Control Etiologic Study of Sarcoidosis (ACCESS) enrolled biopsy-confirmed cases (736 total) from 10 centers in the United States. Seven hundred six (706) controls were case matched for age, race, sex, and geographic area. We studied the first 474 ACCESS patients and case-matched controls. The HLA-DRB1 alleles were differentially distributed between cases and controls (P < .0001). The HLA-DRB1*1101 allele was associated (P < .01) with sarcoidosis in blacks and whites and had a population attributable risk of 16% in blacks and 9% in whites. HLA-DRB1-F-47 was the amino acid residue most associated with sarcoidosis and independently associated with sarcoidosis in whites. The HLA-DPB1 locus also contributed to susceptibility for sarcoidosis and, in contrast to chronic beryllium disease, a non-E-69-containing allele, HLA-DPB1*0101, conveyed most of the risk. Although significant differences were observed in the distribution of HLA class II alleles between blacks and whites, only HLA-DRB1*1501 was differentially associated with sarcoidosis (P < .003). In addition to being susceptibility markers, HLA class II alleles may be markers for different phenotypes of sarcoidosis (DRB1*0401 for eye in blacks and whites, DRB3 for bone marrow in blacks, and DPB1*0101 for hypercalcemia in whites). These studies confirm a genetic predisposition for sarcoidosis and present evidence for the allelic variation at the HLA-DRB1 locus as a major contributor.	Hosp Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Clin Trials & Surveys Corp, Baltimore, MD USA; Henry Ford Hlth Sci Ctr, Dept Internal Med, Div Pulm & Crit Care, Detroit, MI USA; Henry Ford Hlth Sci Ctr, Div Biostat & Res Epidemiol, Detroit, MI USA; Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; Natl Jewish Med & Res Ctr, Div Environm & Occupat Hlth Sci, Denver, CO USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Medical University of South Carolina; National Jewish Health	Rossman, MD (corresponding author), Univ Penn, Med Ctr, 421 Curie Blvd,851 BRB 2-3, Philadelphia, PA 19104 USA.	rossmanm@mail.med.upenn.edu	Magira, Eleni/AAF-8494-2019; Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	NHLBI NIH HHS [N01-HR-56072, N01-HR-56066, N01-HR-56070, N01-HR-56068, N01-HR-56074, N01HR56075, N01-HR-56065, N01-HR-56073, N01-HR-56067, N01-HR-56069, N01-HR-56071, N01-HR-56075] Funding Source: Medline; NIDDK NIH HHS [T32 DK007785] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR056068, N01HR056066, N01HR056070, N01HR056067, N01HR056072, N01HR056071, N01HR056073, N01HR056065, N01HR056074, N01HR056069, N01HR056075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007785] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Androulakis IP, 1997, PROTEINS, V29, P87, DOI 10.1002/(SICI)1097-0134(199709)29:1<87::AID-PROT7>3.3.CO;2-E; Arbustini E, 1996, AM J RESP CRIT CARE, V153, P851, DOI 10.1164/ajrccm.153.2.8564143; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baumgartner KB, 2000, AM J EPIDEMIOL, V152, P307, DOI 10.1093/aje/152.4.307; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; Berlin M, 1997, AM J RESP CRIT CARE, V156, P1601, DOI 10.1164/ajrccm.156.5.9704069; Bogunia-Kubik K, 2001, TISSUE ANTIGENS, V57, P87, DOI 10.1034/j.1399-0039.2001.057001087.x; BRESLOW NE, 1980, IARC SCI PUBL, V32, P84; Chelvanayagam G, 1997, HUM IMMUNOL, V58, P61, DOI 10.1016/S0198-8859(97)00185-7; Chen DS, 2002, HUM IMMUNOL, V63, P665, DOI 10.1016/S0198-8859(02)00418-4; Collins MM, 2000, TISSUE ANTIGENS, V55, P48, DOI 10.1034/j.1399-0039.2000.550108.x; Dorman JS, 2000, EPIDEMIOL REV, V22, P218, DOI 10.1093/oxfordjournals.epirev.a018034; Dubaniewicz  A, 2000, Int J Infect Dis, V4, P129, DOI 10.1016/S1201-9712(00)90073-0; Dubaniewicz Anna, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P55; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; Foley PJ, 1999, AM J RESP CRIT CARE, V160, P1009, DOI 10.1164/ajrccm.160.3.9810032; Foley PJ, 2001, AM J RESP CELL MOL, V25, P272, DOI 10.1165/ajrcmb.25.3.4261; GROUP AR, 1999, J CLIN EPIDEMIOL, V52, P1173; Grunewald J, 2001, EUR RESPIR J, V17, P1046, DOI 10.1183/09031936.01.17510460; Grutters JC, 2002, AM J RESP CRIT CARE, V165, P1119, DOI 10.1164/ajrccm.165.8.200110-0320; Hansen Ted H., 1993, P577; Hellier JP, 2001, ANN RHEUM DIS, V60, P531, DOI 10.1136/ard.60.5.531; HSU BL, 1995, J EXP MED, V181, P805, DOI 10.1084/jem.181.2.805; HUNNINGHAKE GW, 1981, NEW ENGL J MED, V305, P429, DOI 10.1056/NEJM198108203050804; Ishihara M, 1996, HUM IMMUNOL, V49, P144, DOI 10.1016/0198-8859(96)82496-7; ISHIHARA M, 1994, TISSUE ANTIGENS, V43, P238, DOI 10.1111/j.1399-0039.1994.tb02331.x; Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75; Just JJ, 1997, TISSUE ANTIGENS, V49, P546, DOI 10.1111/j.1399-0039.1997.tb02801.x; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; KRAUSE A, 1987, J CLIN LAB IMMUNOL, V24, P25; KUNIKANE H, 1987, AM REV RESPIR DIS, V135, P688; LENHART K, 1990, DIS MARKERS, V8, P23; Maliarik MJ, 1998, AM J RESP CRIT CARE, V158, P111, DOI 10.1164/ajrccm.158.1.9708111; MARTINETTI M, 1995, AM J RESP CRIT CARE, V152, P557, DOI 10.1164/ajrccm.152.2.7633707; Martinetti M, 2002, SARCOIDOSIS VASC DIF, V19, P83; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; *MHC SEQ CONS, 1999, NATURE, V401, P829; Moller D R, 1998, Semin Respir Infect, V13, P174; Naruse TK, 2000, TISSUE ANTIGENS, V56, P52, DOI 10.1034/j.1399-0039.2000.560107.x; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Pandey JP, 2002, HUM IMMUNOL, V63, P485, DOI 10.1016/S0198-8859(02)00399-3; PASTURENZI L, 1993, CHEST, V104, P1170, DOI 10.1378/chest.104.4.1170; PINKSTON P, 1983, NEW ENGL J MED, V308, P793, DOI 10.1056/NEJM198304073081401; Planck A, 2002, J INTERN MED, V251, P217, DOI 10.1046/j.1365-2796.2002.00946.x; Ravikumar M., 1999, Tubercle and Lung Disease, V79, P309, DOI 10.1054/tuld.1999.0213; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Rossman M, 2002, CHEST, V121, p14S, DOI 10.1378/chest.121.3_suppl.14S; Rossman MD, 2002, AM J RESP CRIT CARE, V165, P788, DOI 10.1164/ajrccm.165.6.2104002; Rybicki BA, 1999, HUM IMMUNOL, V60, P867, DOI 10.1016/S0198-8859(99)00050-6; Rybicki BA, 2001, AM J EPIDEMIOL, V153, P188, DOI 10.1093/aje/153.2.188; Rybicki BA, 2003, AM J RESP CRIT CARE, V167, P444, DOI 10.1164/rccm.2112060; SCHILDKRAUT JM, 1998, EXAMINING COMPLEX GE; Schipper RF, 1997, HUM IMMUNOL, V52, P54, DOI 10.1016/S0198-8859(96)00257-1; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0; Sintasath DM, 1999, HUM IMMUNOL, V60, P1001, DOI 10.1016/S0198-8859(99)00085-3; SPAIN LM, 1994, J IMMUNOL, V152, P1709; STEINBERG AG, 1969, ANNU REV GENET, V3, P25, DOI 10.1146/annurev.ge.03.120169.000325; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Swider C, 1999, EUR CYTOKINE NETW, V10, P143; Tang TF, 2000, HUM IMMUNOL, V61, P820, DOI 10.1016/S0198-8859(00)00145-2; Tang TF, 2002, HUM IMMUNOL, V63, P221, DOI 10.1016/S0198-8859(01)00379-2; Vejbaesya S, 2002, EUR J IMMUNOGENET, V29, P431, DOI 10.1046/j.1365-2370.2002.00352.x; Vos K, 2001, HUM IMMUNOL, V62, P1217, DOI 10.1016/S0198-8859(01)00315-9; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wang ZL, 1999, J IMMUNOL, V163, P1647; Yenigun A, 2002, J VIROL, V76, P1787, DOI 10.1128/JVI.76.4.1787-1789.2002; Zachary AA, 2001, HUM IMMUNOL, V62, P1127, DOI 10.1016/S0198-8859(01)00305-6; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255; Zorzetto M, 2002, AM J RESP CELL MOL, V27, P17, DOI 10.1165/ajrcmb.27.1.4805	71	251	256	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					720	735		10.1086/378097	http://dx.doi.org/10.1086/378097			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14508706	Green Published, Bronze			2022-12-18	WOS:000185676100002
J	Bacanu, SA; Devlin, B; Roeder, K				Bacanu, SA; Devlin, B; Roeder, K			The power of genomic control	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX HUMAN-DISEASES; LINKAGE DISEQUILIBRIUM; ASSOCIATION; GENE	Although association analysis is a useful tool for uncovering the genetic underpinnings of complex traits, its utility is diminished by population substructure, which can produce spurious association between phenotype and genotype within population-based samples. Because family-based designs are robust against substructure, they have risen to the fore of association analysis. Yet, if population substructure could be ignored, this robustness can come at the price of power. Unfortunately it is rarely evident when population substructure can be ignored. Devlin and Roeder recently have proposed a method, termed "genomic control" (GC), which has the robustness of family-based designs even though it uses population-based data. GC uses the genome itself to determine appropriate corrections for population-based association tests. Using the GC method, we contrast the power of two study designs, family trios (i.e., father, mother, and affected progeny) versus case-control. For analysis of trios, we use the TDT test. When population substructure is absent, we find GC is always more powerful than TDT; furthermore, contrary to previous results, we show that as a disease becomes more prevalent the discrepancy in power becomes more extreme. When population substructure is present, however, the results are more complex: TDT is more powerful when population substructure is substantial, and GC is more powerful otherwise. We also explore general issues of power and implementation of GC within the case-control setting and find that, economically, CC is at least comparable to and often less expensive than family-based methods. Therefore, CC methods should prove a useful complement to family-based methods for the genetic analysis of complex traits.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Bacanu, SA (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.		Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Roeder, Kathryn/0000-0002-8869-6254; Bacanu, Silviu-Alin/0000-0002-4364-1583	NIMH NIH HHS [MH56193, MH57881] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, R01MH057881, P01MH056193] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Barnett V., 1978, OUTLIERS STAT DATA; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1993, HUMAN POPULATION GENETICS, P189; CHAMBERS JM, 1991, STAT MODELS; CHASE GR, 1968, BIOMETRIKA, V55, P365, DOI 10.1093/biomet/55.2.365; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; DEVLIN B, 1993, SCIENCE, V259, P748, DOI 10.1126/science.8430323; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DEVLIN B, IN PRESS BIOSTATISTI; EWENS WJ, 1995, AM J HUM GENET, V57, P455; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; Leemis LM., 1995, RELIABILITY PROBABIL; LI CC, 1972, ANN HUM GENET, V33, P23; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P2556, DOI 10.1073/pnas.89.7.2556; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Rice JA, 1988, MATH STAT DATA ANAL; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roychoudhury AK, 1988, HUMAN POLYMORPHIC GE; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; *US DHEW, 1980, US DHEW PUBL; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weir BS, 1990, GENETIC DATA ANAL; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	31	251	258	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1933	1944		10.1086/302929	http://dx.doi.org/10.1086/302929			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10801388	Green Published, Bronze			2022-12-18	WOS:000088373800021
J	Waterham, HR; Koster, J; Romeijn, GJ; Hennekam, RCM; Vreken, P; Andersson, HC; FitzPatrick, DR; Kelley, RI; Wanders, RJA				Waterham, HR; Koster, J; Romeijn, GJ; Hennekam, RCM; Vreken, P; Andersson, HC; FitzPatrick, DR; Kelley, RI; Wanders, RJA			Mutations in the 3 beta-hydroxysterol Delta(24)-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEMLI-OPITZ-SYNDROME; DELTA-7-STEROL REDUCTASE GENE; ENCODING MEVALONATE KINASE; PERIODIC FEVER SYNDROME; FAD-BINDING DOMAIN; MOLECULAR-CLONING; HEDGEHOG; DISEASE; ARABIDOPSIS; PATHWAY	Desmosterolosis is a rare autosomal recessive disorder characterized by multiple congenital anomalies. Patients with desmosterolosis have elevated levels of the cholesterol precursor desmosterol, in plasma, tissue, and cultured cells; this abnormality suggests a deficiency of the enzyme 3 beta -hydroxysterol Delta (24)-reductase (DHCR24), which, in cholesterol biosynthesis, catalyzes the reduction of the Delta (24) double bond of sterol intermediates. We identified the human DHCR24 cDNA, by the similarity between the encoded protein and a recently characterized plant enzyme-DWF1/DIM, from Arabidopsis thaliana-catalyzing a different but partially similar reaction in steroid/sterol biosynthesis in plants. Heterologous expression, in the yeast Saccharomyces cerevisiae, of the DHCR24 cDNA, followed by enzyme-activity measurements, confirmed that it encodes DHCR24. The encoded DHCR24 protein has a calculated molecular weight of 60.1 kD, contains a potential N-terminal secretory-signal sequence as well as at least one putative transmembrane helix, and is a member of a recently defined family of flavin adenine dinucleotide (FAD)-dependent oxidoreductases. Conversion of desmosterol to cholesterol by DHCR24 in vitro is strictly dependent on reduced nicotinamide adenine dinucleotide phosphate and is increased twofold by the addition of FAD to the assay. The corresponding gene, DHCR24, was identified by database searching, spans similar to 46.4 kb, is localized to chromosome 1p31.1-p33, and comprises nine exons and eight introns. Sequence analysis of DHCR24 in two patients with desmosterolosis revealed four different missense mutations, which were shown, by functional expression, in yeast, of the patient alleles, to be disease causing. Our data demonstrate that desmosterolosis is a cholesterol-biosynthesis disorder caused by mutations in DHCR24.	Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat,Lab Genet Metab Dis F0 224, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem, NL-1100 DE Amsterdam, Netherlands; Tulane Univ, Sch Med, New Orleans, LA 70112 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Kennedy Krieger Inst, Baltimore, MD USA	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Tulane University; University of Edinburgh; Kennedy Krieger Institute	Waterham, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat,Lab Genet Metab Dis F0 224, POB 22700, NL-1100 DE Amsterdam, Netherlands.		FitzPatrick, David R/B-8311-2008; FitzPatrick, David R/C-7301-2013	FitzPatrick, David R./0000-0003-4861-969X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson H. C., 2000, Journal of Inherited Metabolic Disease, V23, P200; Bae SH, 1997, BIOCHEM J, V326, P609, DOI 10.1042/bj3260609; BARIK S, 1995, MOL BIOTECHNOL, V3, P1, DOI 10.1007/BF02821329; Bergmeyer H., 1983, METHODS ENZYM ANAL, Vsecond, P126; Braverman N, 1999, NAT GENET, V22, P291, DOI 10.1038/10357; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; CROCE CM, 1974, P NATL ACAD SCI USA, V71, P110, DOI 10.1073/pnas.71.1.110; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; FitzPatrick DR, 1998, AM J MED GENET, V75, P145, DOI 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; FRANTZ ID, 1967, ANNU REV BIOCHEM, V36, P691, DOI 10.1146/annurev.bi.36.070167.003355; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Greeve I, 2000, J NEUROSCI, V20, P7345; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Herman GE, 2000, BBA-MOL CELL BIOL L, V1529, P357, DOI 10.1016/S1388-1981(00)00160-8; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Keller AM, 2000, J EUKARYOT MICROBIOL, V47, P1, DOI 10.1111/j.1550-7408.2000.tb00001.x; Kelley RI, 2000, J MED GENET, V37, P321, DOI 10.1136/jmg.37.5.321; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Konig A, 2000, AM J MED GENET, V90, P339; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; MUSHEGIAN AR, 1995, PROTEIN SCI, V4, P1243, DOI 10.1002/pro.5560040623; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; SCHAFER BL, 1992, J BIOL CHEM, V267, P13229; STEINBERG D, 1969, METHOD ENZYMOL, V15, P514; TAKAHASHI T, 1995, GENE DEV, V9, P97, DOI 10.1101/gad.9.1.97; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Waterham HR, 2000, BBA-MOL CELL BIOL L, V1529, P340, DOI 10.1016/S1388-1981(00)00159-1; Waterham HR, 1998, AM J HUM GENET, V63, P329, DOI 10.1086/301982; Witsch-Baumgartner M, 2000, AM J HUM GENET, V66, P402, DOI 10.1086/302760; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolozin B, 2001, P NATL ACAD SCI USA, V98, P5371, DOI 10.1073/pnas.101123198	43	250	268	0	20	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					685	694		10.1086/323473	http://dx.doi.org/10.1086/323473			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11519011	Green Published, Bronze			2022-12-18	WOS:000171008200002
J	SCHAID, DJ; SOMMER, SS				SCHAID, DJ; SOMMER, SS			GENOTYPE RELATIVE RISKS - METHODS FOR DESIGN AND ANALYSIS OF CANDIDATE-GENE ASSOCIATION STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE; LINKAGE	Design and analysis methods are presented for studying the association of a candidate gene with a disease by using parental data in place of nonrelated controls. This alternative design eliminates spurious differences in allele frequencies between cases and nonrelated controls resulting from different ethnic origins and population stratification for these two groups. We present analysis methods which are based on two genetic relative risks: (1) the relative risk of disease for homozygotes with two copies of the candidate gene versus homozygotes without the candidate gene and (2) the relative risk for heterozygotes with one copy of the candidate gene versus homozygotes without the candidate gene. In addition to estimating the magnitude of these relative risks, likelihood methods allow specific hypotheses to be tested, namely, a test for overall association of the candidate gene with disease, as well as specific genetic hypotheses, such as dominant or recessive inheritance. Two likelihood methods are presented: (1) a likelihood method appropriate when Hardy-Weinberg equilibrium holds and (2) a likelihood method in which we condition on parental genotype data when Hardy-Weinberg equilibrium does not hold. The results for the relative efficiency of these two methods suggest that the conditional approach may at times be preferable, even when equilibrium holds. Sample-size and power calculations are presented for a multitiered design. The purpose of tier 1 is to detect the presence of an abnormal sequence for a postulated candidate gene among a small group of cases. The purpose of tier 2 is to test for association of the abnormal variant with disease, such as by the likelihood methods presented. The purpose of tier 3 is to confirm positive results from tier 2. Results indicate that required sample sizes are smaller when expression of disease is recessive, rather than dominant, and that, for recessive disease and large relative risks, necessary sample sizes may be feasible, even if only a small percentage of the disease can be attributed to the candidate gene.	MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,BIOSTAT SECT,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic					NHLBI NIH HHS [HL07567] Funding Source: Medline; NIMH NIH HHS [MH44276] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044276] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMOS CI, 1990, AM J HUM GENET, V47, P842; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; LATHROP GM, 1983, TISSUE ANTIGENS, V22, P160, DOI 10.1111/j.1399-0039.1983.tb01183.x; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LI CC, 1978, 1ST COURSE POPULATIO; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Ott J., 1991, ANAL HUMAN GENETIC L; RAO CR, 1973, LINEAR STATISTICAL I; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SOBELL JL, 1992, GENOMICS, V12, P1, DOI 10.1016/0888-7543(92)90398-C; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stuart A., 1991, KENDALLS ADV THEORY, V2; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096	19	250	257	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1114	1126						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213835				2022-12-18	WOS:A1993MC33300016
J	PAULS, DL; RAYMOND, CL; STEVENSON, JM; LECKMAN, JF				PAULS, DL; RAYMOND, CL; STEVENSON, JM; LECKMAN, JF			A FAMILY STUDY OF GILLES-DE-LA-TOURETTE SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR GENE; DELATOURETTE SYNDROME; MULTIPLE TICS; TRANSMISSION; INTERVIEW; DIAGNOSIS; DISORDER; PATTERN; HISTORY	Previous studies have demonstrated that Gilles de la Tourette syndrome (TS) is a familial disorder and that chronic tics (CT) and obsessive compulsive disorder (OCD) appear to be etiologically related to the syndrome. In the present study we report the results from a study of 338 biological relatives of 86 TS probands, 21 biologically unrelated relatives of adopted TS probands, and 22 relatives of normal subjects. The 43 first-degree relatives of the adopted TS and normal probands constituted a control sample. The rates of TS, CT, and OCD in the total sample of biological relatives of TS probands were significantly greater than in the relatives of controls. In addition, the morbid risks of TS, OCD, and CT were not significantly different in families of probands with OCD when compared to relatives of probands without OCD. These findings provide further evidence that OCD is etiologically related to TS.			PAULS, DL (corresponding author), YALE UNIV,SCH MED,CTR CHILD STUDY,230 S FRONTAGE RD,POB 3333,NEW HAVEN,CT 06510, USA.		Leckman, James/O-2426-2015		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016648] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-00508, MH-24393] Funding Source: Medline; NINDS NIH HHS [NS-16648] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARON M, 1981, AM J HUM GENET, V33, P767; COMINGS DE, 1984, AM J HUM GENET, V36, P586; DEVOR EJ, 1984, AM J HUM GENET, V36, P704; ELDRIDGE R, 1977, NEUROLOGY, V27, P115, DOI 10.1212/WNL.27.2.115; Gilles de la Tourette G., 1885, ARCH NEUROL-CHICAGO, V9, P158; GOLDEN GS, 1978, ANN NEUROL, V4, P145, DOI 10.1002/ana.410040208; Goodman WK, 1986, YALE BROWN OBSESSIVE; GREEN RC, 1986, OBSESSIVE COMPULSIVE; HARCHERIK DF, 1984, J AM ACAD CHILD PSY, V23, P153, DOI 10.1097/00004583-198403000-00006; JAGGER J, 1982, SCHIZOPHRENIA BULL, V8, P267, DOI 10.1093/schbul/8.2.267; Kidd K K, 1982, Adv Neurol, V35, P243; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; KIM SW, 1988, MAY ANN M SOC BIOL P; Leckman J. F, 1988, TOURETTES SYNDROME T; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; ORVASCHEL H, 1982, J AFFECT DISORDERS, V4, P49, DOI 10.1016/0165-0327(82)90019-2; PAULS D L, 1988, American Journal of Human Genetics, V43, pA64; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1177; PAULS DL, 1984, J AM ACAD CHILD PSY, V23, P134, DOI 10.1097/00004583-198403000-00003; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1180; PAULS DL, 1981, ARCH GEN PSYCHIAT, V38, P1091; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1981, SCHEDULE TOURETTE OT; PAULS DL, 1989, MAY ANN M AM PSYCH A; PAULS DL, 1988, MAY ANN M SOC BIOL P; PRICE RA, 1988, PSYCHIAT RES, V24, P251; Puig-Antich J., 1980, SCHEDULE AFFECTIVE D; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SHAPIRO A, 1988, G DELATOURETTE SYNDR; SHAPIRO AK, 1978, G DELATOURETTE SYNDR; THOMPSON WD, 1979, J PSYCHIAT RES, V15, P291; 1985, STATISTICAL ANAL SYS	33	250	257	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					154	163						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ET188	1985456				2022-12-18	WOS:A1991ET18800021
J	CHRISTIAN, JC; KANG, KW; NORTON, JA				CHRISTIAN, JC; KANG, KW; NORTON, JA			CHOICE OF AN ESTIMATE OF GENETIC VARIANCE FROM TWIN DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV, SCH MED, DEPT MED GENET, INIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT PSYCHIAT, SECT BIOSTATIST, INDIANAPOLIS, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis								ANDERSON RL, 1952, STATISTICAL THEORY R; COCHRAN WG, 1951, BIOMETRICS, V7, P17, DOI 10.2307/3001601; FALCONER DS, 1960, QUANTITATIVE GENETIC; HASEMAN JK, 1970, BEHAV GENET, V1, P11, DOI 10.1007/BF01067367; HJORTLAND MC, 1972, THESIS U MINNESOTA; KEMPTHORNE O, 1961, AM J HUM GENET, V13, P320	6	249	249	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	2					154	161						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S7582	4856692				2022-12-18	WOS:A1974S758200004
J	Botkin, JR; Belmont, JW; Berg, JS; Berkman, BE; Bombard, Y; Holm, IA; Levy, HP; Ormond, KE; Saal, HM; Spinner, NB; Wilfond, BS; McInerney, JD				Botkin, Jeffrey R.; Belmont, John W.; Berg, Jonathan S.; Berkman, Benjamin E.; Bombard, Yvonne; Holm, Ingrid A.; Levy, Howard P.; Ormond, Kelly E.; Saal, Howard M.; Spinner, Nancy B.; Wilfond, Benjamin S.; McInerney, Joseph D.		ASHG Workgrp Pediat Genetic Genomi	Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAY-SACHS-DISEASE; INCIDENTAL FINDINGS; REPRODUCTIVE BENEFIT; CARRIER STATUS; DEVELOPMENTAL-DISABILITIES; PRENATAL-DIAGNOSIS; SCREENING-PROGRAM; CYSTIC-FIBROSIS; CARE; HEALTH	In 1995, the American Society of Human Genetics (ASHG) and American College of Medical Genetics and Genomics (ACMG) jointly published a statement on genetic testing in children and adolescents. In the past 20 years, much has changed in the field of genetics, including the development of powerful new technologies, new data from genetic research on children and adolescents, and substantial clinical experience. This statement represents current opinion by the ASHG on the ethical, legal, and social issues concerning genetic testing in children. These recommendations are relevant to families, clinicians, and investigators. After a brief review of the 1995 statement and major changes in genetic technologies in recent years, this statement offers points to consider on a broad range of test technologies and their applications in clinical,medicine and research. Recommendations are also made for record and communication issues in this domain and for professional education.	[Botkin, Jeffrey R.] Univ Utah, Salt Lake City, UT 84112 USA; [Belmont, John W.] Baylor Coll Med, Houston, TX 77030 USA; [Berg, Jonathan S.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Berkman, Benjamin E.] NHGRI, Bethesda, MD 20892 USA; [Bombard, Yvonne] Univ Toronto, Toronto, ON M5B 1T8, Canada; [Bombard, Yvonne] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Holm, Ingrid A.] Boston Childrens Hosp, Boston, MA 02115 USA; [Levy, Howard P.] Johns Hopkins Univ, Baltimore, MD 21205 USA; [Ormond, Kelly E.] Stanford Univ, Stanford, CA 94305 USA; [Saal, Howard M.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Spinner, Nancy B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Wilfond, Benjamin S.] Seattle Childrens Hosp, Seattle, WA 98101 USA; [McInerney, Joseph D.] Amer Soc Human Genet, Bethesda, MD 20814 USA	Utah System of Higher Education; University of Utah; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Harvard University; Boston Children's Hospital; Johns Hopkins University; Stanford University; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Seattle Children's Hospital	Botkin, JR (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	jeffrey.botkin@hsc.utah.edu	Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021; Ormond, Kelly E/I-5676-2019	Belmont, John W/0000-0001-7409-3578; Ormond, Kelly E/0000-0002-1033-0818; Holm, Ingrid/0000-0003-4712-8821; Berg, Jonathan/0000-0003-2360-2664; Saal, Howard/0000-0002-0277-4777	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG007249] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001067] Funding Source: Medline; NHGRI NIH HHS [P20 HG007249, U01 HG006487] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alexander D, 2006, PEDIATRICS, V117, pS350, DOI 10.1542/peds.2005-2633O; American Academy of Pediatrics, 2015, GEN PRIM CAR I; American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1497; American Nurses Association, 2008, ESS GEN GEN NURS COM; American Society of Human Genetics and Jackson Laboratory, 2014, CANC GEN MAN PRIM CA; [Anonymous], 2010, EUR J HUM GENET, V18, P1271, DOI DOI 10.1038/EJHG.2010.129; [Anonymous], 2014, COMMUNICATION; Bailey DB, 2005, AM J PUBLIC HEALTH, V95, P1889, DOI 10.2105/AJPH.2004.051110; Barlow-Stewart K, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e45; Beaudet AL, 2008, ANNU REV MED, V59, P113, DOI 10.1146/annurev.med.59.012907.101800; Bejjani BA, 2008, ANNU REV GENOM HUM G, V9, P71, DOI 10.1146/annurev.genom.9.081307.164207; Berkman BE, 2014, PERS MED, V11, P285, DOI 10.2217/pme.14.3; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; Bloss CS, 2014, J MED GENET, V51, P83, DOI 10.1136/jmedgenet-2013-101909; Bloss CS, 2013, J MED GENET, V50, P393, DOI 10.1136/jmedgenet-2012-101207; Bombard Y, 2013, JAMA-J AM MED ASSOC, V310, P795, DOI 10.1001/jama.2013.276573; Bombard Y, 2012, EUR J HUM GENET, V20, P498, DOI 10.1038/ejhg.2011.188; Bombard Y, 2012, PEDIATRICS, V129, P239, DOI 10.1542/peds.2011-2572; Bombard Y, 2010, EUR J HUM GENET, V18, P751, DOI 10.1038/ejhg.2010.13; Bombard Y, 2009, NAT REV GENET, V10, P666, DOI 10.1038/nrg2666; Borry P, 2006, EUR J HUM GENET, V14, P133, DOI 10.1038/sj.ejhg.5201509; Borry P, 2005, GENET COUNSEL, V16, P341; Borry P, 2007, NAT REV GENET, V8, P828, DOI 10.1038/nrg2222; Borry P, 2012, EUR J HUM GENET, V20, P715, DOI 10.1038/ejhg.2011.278; Borry P, 2010, J COMMUN GENET, V1, P101, DOI 10.1007/s12687-010-0023-z; Botkin JR, 2014, AM J MED GENET A, V164, P2739, DOI 10.1002/ajmg.a.36694; Botkin JR, 2012, PEDIATRICS, V129, P231, DOI 10.1542/peds.2011-0970; Caulfield T, 2010, CLIN GENET, V77, P101, DOI 10.1111/j.1399-0004.2009.01291.x; Cheok MH, 2006, NAT REV CANCER, V6, P117, DOI 10.1038/nrc1800; Davis TC, 2006, PEDIATRICS, V117, pS326, DOI 10.1542/peds.2005-2633M; Dougherty J.M., 2014, CURR GENET MED REP, V2, P48, DOI [10.1007/s40142-014-0037-7, DOI 10.1007/S40142-014-0037-7]; FADEN R, 1982, AM J PUBLIC HEALTH, V72, P1347, DOI 10.2105/AJPH.72.12.1347; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; FANOS JH, 1995, AM J HUM GENET, V57, P431; Francke U, 2013, PEERJ, V1, DOI 10.7717/peerj.8; Freundlich MD, 1998, CHILD WELFARE, V77, P663; Ross LF, 2006, J LAW MED ETHICS, V34, P753, DOI 10.1111/j.1748-720X.2006.00096.x; Gliwa C, 2013, AM J BIOETHICS, V13, P32, DOI 10.1080/15265161.2012.754062; Godard B, 2003, EUR J HUM GENET, V11, pS13, DOI 10.1038/sj.ejhg.5201111; Goldsmith L, 2012, EUR J HUM GENET, V20, P811, DOI 10.1038/ejhg.2012.18; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Haga SB, 2013, GENET MED, V15, P513, DOI 10.1038/gim.2012.168; Hamilton AB, 2014, GENET MED, V16, P238, DOI 10.1038/gim.2013.101; Hawcutt DB, 2013, ARCH DIS CHILD, V98, P232, DOI 10.1136/archdischild-2012-302852; Hayeems RZ, 2009, PEDIATRICS, V124, P950, DOI 10.1542/peds.2008-3148; Howard HC, 2011, EUR J HUM GENET, V19, P1122, DOI 10.1038/ejhg.2011.94; Hudson K, 2007, OBSTET GYNECOL, V110, P1392, DOI 10.1097/01.AOG.0000292086.98514.8b; Hyland K, 2013, MED SCH CORE CURRICU; *I MED, 1994, ASS GEN RISKS IMPL H; Jansen LA, 2001, AM J MED GENET, V104, P214, DOI 10.1002/ajmg.10057; Jarvik GP, 2014, AM J HUM GENET, V94, P818, DOI 10.1016/j.ajhg.2014.04.009; Jarvinen O, 2000, PEDIATRICS, V106, P1460, DOI 10.1542/peds.106.6.1460; Jarvinen O, 2000, CLIN GENET, V58, P447, DOI 10.1034/j.1399-0004.2000.580604.x; KAN YW, 1976, NEW ENGL J MED, V294, P1039, DOI 10.1056/NEJM197605062941905; Kaufman DJ, 2012, J GENET COUNS, V21, P413, DOI 10.1007/s10897-012-9483-0; Kemper AR, 2014, GENET MED, V16, P183, DOI 10.1038/gim.2013.98; KENEN RH, 1978, AM J PUBLIC HEALTH, V68, P1116, DOI 10.2105/AJPH.68.11.1116; Kerr SM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-38; Knight M., 2014, WILL FDA REGULATIONS; Leeder JS, 2012, CLIN PHARMACOL THER, V92, P434, DOI 10.1038/clpt.2012.130; LEJEUNE J., 1959, ARCH FRANC PEDIATRIE, V16, P962; Lew RM, 2015, J PAEDIATR CHILD H, V51, P271, DOI 10.1111/jpc.12632; Lew RM, 2012, MED J AUSTRALIA, V197, P652, DOI 10.5694/mja12.11010; Liebl B, 2002, PREV MED, V34, P127, DOI 10.1006/pmed.2001.0952; Lucast EK, 2007, BIOETHICS, V21, P41, DOI 10.1111/j.1467-8519.2007.00522.x; Manickaraj AK, 2012, CURR OPIN PEDIATR, V24, P584, DOI 10.1097/MOP.0b013e328357a4ea; Maruotti GM, 2013, CLIN CHEM LAB MED, V51, P2211, DOI 10.1515/cclm-2013-0194; Mcconkie-Rosell A, 2008, AM J MED GENET C, V148C, P56, DOI 10.1002/ajmg.c.30161; McConkie-Rosell A, 2012, J GENET COUNS, V21, P59, DOI 10.1007/s10897-011-9391-8; McGowan ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108484; McGuire AL, 2012, J LAW MED ETHICS, V40, P1040, DOI 10.1111/j.1748-720X.2012.00731.x; McInerney JD, 2012, PERS MED, V9, P529, DOI [10.2217/pme.12.46, 10.2217/PME.12.46]; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Miller FA, 2010, PUBLIC HEALTH GENOM, V13, P181, DOI 10.1159/000240966; Miller FA, 2009, AM J PUBLIC HEALTH, V99, P210, DOI 10.2105/AJPH.2008.136614; Murray ABV, 2010, TRENDS GENET, V26, P459, DOI 10.1016/j.tig.2010.08.001; National Coalition for Health Professional Education in Genetics, 2007, COR COMP GEN HLTH PR; National Coalition for Health Professional Education in Genetics, 2010, MED FUT GEN PRACT DO; National Human Genome Research Institute, 2014, PHARM COMP PHARM; Orme NM, 2010, ARCH INTERN MED, V170, P1525, DOI 10.1001/archinternmed.2010.317; Palmor M, 2014, PEDIATRICS, V134, P163, DOI 10.1542/peds.2013-4182; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Rackover M, 2007, J PHYS ASSIST ED, V18, P47; Rassekh SR, 2013, PEDIATR DRUGS, V15, P71, DOI 10.1007/s40272-013-0021-9; Rehder CW, 2013, GENET MED, V15, P150, DOI 10.1038/gim.2012.169; Rieder M, 2012, PEDIATR CLIN N AM, V59, P1071, DOI 10.1016/j.pcl.2012.07.010; Roberts J Scott, 2013, Curr Genet Med Rep, V1, P182; Ross LF, 1996, BIOETHICS, V10, P114, DOI 10.1111/j.1467-8519.1996.tb00111.x; Rothstein MA, 2000, AM J HUM GENET, V66, P761; Schaaf CP, 2011, LANCET, V377, P555, DOI 10.1016/S0140-6736(11)60201-8; Secretary's Advisory Committee on Genetics Health and Society, 2010, GEN ED TRAIN HLTH CA; Skirton H, 2012, CLIN GENET, V82, P210, DOI 10.1111/j.1399-0004.2012.01863.x; Sorenson JR, 2003, AM J MED GENET C, V119C, P3, DOI 10.1002/ajmg.c.10001; Tabor HK, 2011, AM J MED GENET A, V155A, P2916, DOI 10.1002/ajmg.a.34357; The Human Genomics Strategy Group, 2012, BUILD OUR INH GEN TE; Tonniges TF, 2000, PEDIATRICS, V106, P389; Van Riper M, 2005, J MIDWIFERY WOM HEAL, V50, P227, DOI 10.1016/j.jmwh.2005.02.008; Venne VL, 2003, AM J MED GENET A, V119A, P41, DOI 10.1002/ajmg.a.20071; Wade CH, 2010, GENET MED, V12, P317, DOI 10.1097/GIM.0b013e3181de695c; Wall CA, 2012, CHILD ADOL PSYCH CL, V21, P773, DOI 10.1016/j.chc.2012.07.001; Wasson K, 2013, J COMMUN GENET, V4, P495, DOI 10.1007/s12687-013-0156-y; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; WERTZ DC, 1990, AM J HUM GENET, V46, P1200; Wilfond B, 2009, J PEDIATR PSYCHOL, V34, P639, DOI 10.1093/jpepsy/jsn075; WILFOND BS, 1995, AM J HUM GENET, V57, P1233	109	248	257	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					6	21		10.1016/j.ajhg.2015.05.022	http://dx.doi.org/10.1016/j.ajhg.2015.05.022			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	CN1OO	26140447	Green Published, Bronze			2022-12-18	WOS:000358189500002
J	Grundberg, E; Meduri, E; Sandling, JK; Hedman, AK; Keildson, S; Buil, A; Busche, S; Yuan, W; Nisbet, J; Sekowska, M; Wilk, A; Barrett, A; Small, KS; Ge, B; Caron, M; Shin, SY; Lathrop, M; Dermitzakis, ET; McCarthy, MI; Spector, TD; Bell, JT; Deloukas, P				Grundberg, Elin; Meduri, Eshwar; Sandling, Johanna K.; Hedman, Asa K.; Keildson, Sarah; Buil, Alfonso; Busche, Stephan; Yuan, Wei; Nisbet, James; Sekowska, Magdalena; Wilk, Alicja; Barrett, Amy; Small, Kerrin S.; Ge, Bing; Caron, Maxime; Shin, So-Youn; Lathrop, Mark; Dermitzakis, Emmanouil T.; McCarthy, Mark I.; Spector, Timothy D.; Bell, Jordana T.; Deloukas, Panos		Multiple Tissue Human Expression R	Global Analysis of DNA Methylation Variation in Adipose Tissue from Twins Reveals Links to Disease-Associated Variants in Distal Regulatory Elements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CPG ISLAND SHORES; GENE-EXPRESSION; MOUSE GENOME; SNP ANALYSIS; SEQUENCE; PATTERNS; LOCI; RESOLUTION; METHYLOME	Epigenetic modifications such as DNA methylation play a key role in gene regulation and disease susceptibility. However, little is known about the genome-wide frequency, localization, and function of methylation variation and how it is regulated by genetic and environmental factors. We utilized the Multiple Tissue Human Expression Resource (MuTHER) and generated Illumina 450K adipose methylome data from 648 twins. We found that individual CpGs had low variance and that variability was suppressed in promoters. We noted that DNA methylation variation was highly heritable (h(median)(2) = 0.34) and that shared environmental effects correlated with metabolic phenotype-associated CpGs. Analysis of methylation quantitative-trait loci (metQTL) revealed that 28% of CpGs were associated with nearby SNPs, and when overlapping them with adipose expression quantitative-trait loci (eQTL) from the same individuals, we found that 6% of the loci played a role in regulating both gene expression and DNA methylation. These associations were bidirectional, but there were pronounced negative associations for promoter CpGs. Integration of metQTL with adipose reference epigenomes and disease associations revealed significant enrichment of metQTL overlapping metabolic-trait or disease loci in enhancers (the strongest effects were for high-density lipoprotein cholesterol and body mass index [BMI]). We followed up with the BMI SNP rs713586, a cg01884057 metQTL that overlaps an enhancer upstream of ADCY3, and used bisulphite sequencing to refine this region. Our results showed widespread population invariability yet sequence dependence on adipose DNA methylation but that incorporating maps of regulatory elements aid in linking CpG variation to gene regulation and disease risk in a tissue-dependent manner.	[Grundberg, Elin; Meduri, Eshwar; Sandling, Johanna K.; Nisbet, James; Sekowska, Magdalena; Wilk, Alicja; Shin, So-Youn; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Grundberg, Elin; Meduri, Eshwar; Yuan, Wei; Small, Kerrin S.; Spector, Timothy D.; Bell, Jordana T.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Hedman, Asa K.; Keildson, Sarah; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Buil, Alfonso; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Buil, Alfonso; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Busche, Stephan; Ge, Bing; Caron, Maxime; Lathrop, Mark] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A5, Canada; [Busche, Stephan; Ge, Bing; Caron, Maxime; Lathrop, Mark] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A5, Canada; [Barrett, Amy; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Sandling, Johanna K.] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden; [Sandling, Johanna K.] Uppsala Univ, Sci Life Lab, S-75123 Uppsala, Sweden; [Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England	Wellcome Trust Sanger Institute; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Geneva; University of Geneva; McGill University; McGill University; University of Oxford; University of Oxford; Uppsala University; Uppsala University; University of London; Queen Mary University London	Grundberg, E (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A5, Canada.	elin.grundberg@mcgill.ca; p.deloukas@qmul.ac.uk	Deloukas, Panos/B-2922-2013; Sandling, Johanna/AAG-6376-2019; Bell, Jordana/AAH-7312-2019; Zondervan, Krina T/M-1143-2013; Sandling, Johanna K/B-2973-2016; McCarthy, Mark/M-3763-2015	Deloukas, Panos/0000-0001-9251-070X; Sandling, Johanna/0000-0003-1382-2321; Zondervan, Krina T/0000-0002-0275-9905; Sandling, Johanna K/0000-0003-1382-2321; Buil, Alfonso/0000-0002-3097-1014; Bell, Jordana/0000-0002-3858-5986; Hedman, Asa/0000-0001-5413-204X; Meduri, Eshwar/0000-0002-3821-312X; Lindgren, Cecilia/0000-0002-4903-9374; Small, Kerrin/0000-0003-4566-0005; McCarthy, Mark/0000-0002-4393-0510	Wellcome Trust (WT) [098051]; Center for Inherited Disease Research as part of a National Eye Institute, National Institutes of Health (NIH); WT [081917/Z/07/Z, 083270/Z/07/Z]; European Community; core funding for the WT Centre for Human Genetics [090532]; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St. Thomas' National Health Service (NHS) Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust; King's College London; European Research Council; Swedish Research Council [C0025601]; Canadian Institutes of Health Research Canadian Epigenetics, Environment, and Health Research Consortium [EP1-120608]; MRC [G9824984, MC_UU_12012/1, G0600717] Funding Source: UKRI; Medical Research Council [MC_UU_12012/5/B, G9824984, MC_UU_12012/1, G0600717, G0600717B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10140] Funding Source: researchfish	Wellcome Trust (WT)(Wellcome Trust); Center for Inherited Disease Research as part of a National Eye Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WT; European Community(European Commission); core funding for the WT Centre for Human Genetics; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St. Thomas' National Health Service (NHS) Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust; King's College London; European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes of Health Research Canadian Epigenetics, Environment, and Health Research Consortium(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	P.D. is supported by Wellcome Trust (WT) core grant 098051 to the WT Sanger Institute (WTSI), which covered genotyping and DNA methylation analysis. We thank the Genotyping Facilities and Variation Informatics at the WTSI for sample preparation, quality control, and genotyping. Genotyping was also performed by the Center for Inherited Disease Research as part of a National Eye Institute, National Institutes of Health (NIH) project grant. The MuTHER Study was funded by the WT (081917/Z/07/Z) and core funding for the WT Centre for Human Genetics (090532). TwinsUK was funded by the WT and European Community's Seventh Framework Programme (FP7/2007-2013). The study also received support from the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St. Thomas' National Health Service (NHS) Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London. T.D.S. is an NIHR senior investigator and holder of a European Research Council Advanced Principal Investigator award. M.I.M. is supported by the WT (083270/Z/07/Z), and J.K.S. is supported by a Swedish Research Council postdoc grant (C0025601). The authors thank the McGill University Epigenome Mapping Centre, funded by the Canadian Institutes of Health Research Canadian Epigenetics, Environment, and Health Research Consortium (EP1-120608), and NIH Roadmap Epigenomics Mapping Consortium and Mapping Centers for the production of publicly available reference epigenomes. Specifically, we thank the mapping center at Massachusetts General Hospital and the Broad Institute of MIT and Harvard for generating human adipose reference epigenomes used in this study.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bates D., 2011, LME4 LINEAR MIXED EF; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/EPI.12.18, 10.2217/epi.12.18]; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Drong AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055923; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; del Pozo CH, 2011, BBA-MOL CELL BIOL L, V1811, P1194, DOI 10.1016/j.bbalip.2011.07.016; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Johansson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054357; Johnson M.D., 2012, CURR PROTOC MOL BIOL, P23; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKay JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033290; Paul DS, 2013, GENOME RES, V23, P1130, DOI 10.1101/gr.155127.113; R Development Core Team, 2010, R LANG ENV STAT COMP, DOI DOI 10.[HTTP://WWW.R-PR0JECT0RG]; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shoulders CC, 2004, TRENDS MOL MED, V10, P362, DOI 10.1016/j.molmed.2004.06.011; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Visscher PM, 2004, TWIN RES, V7, P670, DOI 10.1375/twin.7.6.670; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	61	248	250	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					876	890		10.1016/j.ajhg.2013.10.004	http://dx.doi.org/10.1016/j.ajhg.2013.10.004			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24183450	hybrid, Green Published			2022-12-18	WOS:000326996600008
J	Hamdan, FF; Gauthier, J; Araki, Y; Lin, DT; Yoshizawa, Y; Higashi, K; Park, AR; Spiegelman, D; Dobrzeniecka, S; Piton, A; Tomitori, H; Daoud, H; Massicotte, C; Henrion, E; Diallo, O; Shekarabi, M; Marineau, C; Shevell, M; Maranda, B; Mitchell, G; Nadeau, A; D'Anjou, G; Vanasse, M; Srour, M; Lafreniere, RG; Drapeau, P; Lacaille, JC; Kim, E; Lee, JR; Igarashi, K; Huganir, RL; Rouleau, GA; Michaud, JL				Hamdan, Fadi F.; Gauthier, Julie; Araki, Yoichi; Lin, Da-Ting; Yoshizawa, Yuhki; Higashi, Kyohei; Park, A-Reum; Spiegelman, Dan; Dobrzeniecka, Sylvia; Piton, Amelie; Tomitori, Hideyuki; Daoud, Hussein; Massicotte, Christine; Henrion, Edouard; Diallo, Ousmane; Shekarabi, Masoud; Marineau, Claude; Shevell, Michael; Maranda, Bruno; Mitchell, Grant; Nadeau, Amelie; D'Anjou, Guy; Vanasse, Michel; Srour, Myriam; Lafreniere, Ronald G.; Drapeau, Pierre; Lacaille, Jean Claude; Kim, Eunjoon; Lee, Jae-Ran; Igarashi, Kazuei; Huganir, Richard L.; Rouleau, Guy A.; Michaud, Jacques L.		S2D Grp	Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SCAFFOLDING PROTEIN SHANK3; SWISS-MODEL WORKSPACE; KINESIN MOTOR KIF1A; MENTAL-RETARDATION; NMDA RECEPTORS; AMPA RECEPTORS; COGNITIVE IMPAIRMENT; CULTURED NEURONS; CELL-DEATH; PLASTICITY	Little is known about the genetics of nonsyndromic intellectual disability (NSID). We hypothesized that de novo mutations (DNMs) in synaptic genes explain an important fraction of sporadic NSID cases. In order to investigate this possibility, we sequenced 197 genes encoding glutamate receptors and a large subset of their known interacting proteins in 95 sporadic cases of NSID. We found 11 DNMs, including ten potentially deleterious mutations (three nonsense, two splicing, one frameshift, four missense) and one neutral mutation (silent) in eight different genes. Calculation of point-substitution DNM rates per functional and neutral site showed significant excess of functional DNMs compared to neutral ones. De novo truncating and/or splicing mutations in SYNGAP1, STXBP1, and SHANK3 were found in six patients and are likely to be pathogenic. De novo missense mutations were found in KIF1A, GRIN1, CACNG2, and EPB41L1. Functional studies showed that all these missense mutations affect protein function in cell culture systems, suggesting that they may be pathogenic. Sequencing these four genes in 50 additional sporadic cases of NSID identified a second DNM in GRIN1 (c.1679_1681dup/p.Ser560dup). This mutation also affects protein function, consistent with structural predictions. None of these mutations or any other DNMs were identified in these genes in 285 healthy controls. This study highlights the importance of the glutamate receptor complexes in NSID and further supports the role of DNMs in this disorder.	[Hamdan, Fadi F.; Massicotte, Christine; Mitchell, Grant; Nadeau, Amelie; D'Anjou, Guy; Vanasse, Michel; Srour, Myriam; Michaud, Jacques L.] Univ Montreal, St Justine Hosp Res Ctr, Ctr Excellence Neur, Montreal, PQ H3T 1C5, Canada; [Gauthier, Julie; Spiegelman, Dan; Dobrzeniecka, Sylvia; Piton, Amelie; Daoud, Hussein; Henrion, Edouard; Diallo, Ousmane; Shekarabi, Masoud; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.] Univ Montreal, Ctr Hosp Univ Montreal Res Ctr, Ctr Excellence Neur, Montreal, PQ H2L2W5, Canada; [Gauthier, Julie; Spiegelman, Dan; Dobrzeniecka, Sylvia; Piton, Amelie; Daoud, Hussein; Henrion, Edouard; Diallo, Ousmane; Shekarabi, Masoud; Marineau, Claude; Lafreniere, Ronald G.; Rouleau, Guy A.; S2D Grp] Univ Montreal, Dept Med, Montreal, PQ H2L2W5, Canada; [Araki, Yoichi; Lin, Da-Ting; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Araki, Yoichi; Lin, Da-Ting; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Yoshizawa, Yuhki; Higashi, Kyohei; Tomitori, Hideyuki; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Park, A-Reum; Lee, Jae-Ran] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Shevell, Michael] McGill Univ, Montreal Childrens Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3H 1P3, Canada; [Maranda, Bruno] CHU Laval, Dept Pediat, Quebec City, PQ G1V 4G2, Canada; [Drapeau, Pierre] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Lacaille, Jean Claude] Univ Montreal, Grp Rech Syst Nerveux Cent, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Chiba University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); McGill University; Laval University; Universite de Montreal; Universite de Montreal; Korea Advanced Institute of Science & Technology (KAIST)	Michaud, JL (corresponding author), Univ Montreal, St Justine Hosp Res Ctr, Ctr Excellence Neur, Montreal, PQ H3T 1C5, Canada.	jacques.michaud@recherche-ste-justine.qc.ca	Lin, Da-Ting/D-1699-2018; Kim, Eunjoon/C-1566-2011; piton, amelie/F-1201-2013	Lin, Da-Ting/0000-0003-0538-7892; piton, amelie/0000-0003-0408-7468; Higashi, Kyohei/0000-0002-2622-4825; spiegelman, dan/0000-0003-4971-8868	Canadian Institute of Health Research; Reseau de Medecine Genetique Appliquee (FRSQ); Genome Canada; Genome Quebec; Universite de Montreal	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Reseau de Medecine Genetique Appliquee (FRSQ)(Fonds de la Recherche en Sante du Quebec); Genome Canada(Genome Canada); Genome Quebec; Universite de Montreal	Supported by grants from the Canadian Institute of Health Research (to J.C.L., G.A.R., and J.L.M.), Reseau de Medecine Genetique Appliquee (FRSQ; to J.L.M.), Genome Canada, and Genome Quebec, with cofunding by Universite de Montreal (to P.D. and G.A.R.). J.L.M. holds a FRSQ National Scientist Award. The S2D group includes Yan Yang, Anne Noreau, Annie Raymond, Annie Levert, Pascale Thibodeau, Melanie Cote, Frederic Kuku, Sandra Laurent, Philippe Jolivet, Joannie Duguay, Karine Lachapelle, and Isabelle Bachand. We thank the patients and their parents for participating in this study. We thank Philip Awadalla for useful discussions. We are thankful to the members of McGill University and Genome Quebec Innovation Centre Sequencing (Pierre Lepage, Sebastien Brunet, and Hao Fan Yam) and Bioinformatic (Louis Letourneau and Louis Dumond Joseph) groups.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Galasso C, 2008, J CHILD NEUROL, V23, P802, DOI 10.1177/0883073808314150; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Hamdan FF, 2009, ANN NEUROL, V65, P748, DOI 10.1002/ana.21625; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Jin LH, 2008, J PHARMACOL EXP THER, V327, P68, DOI 10.1124/jpet.108.140459; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lee JR, 2004, EMBO J, V23, P1506, DOI 10.1038/sj.emboj.7600164; Lee JR, 2003, J BIOL CHEM, V278, P2624, DOI 10.1074/jbc.M211152200; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Li B, 2009, J NEUROSCI, V29, P11965, DOI 10.1523/JNEUROSCI.2109-09.2009; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; MacDonald JF, 2006, TRENDS NEUROSCI, V29, P75, DOI 10.1016/j.tins.2005.12.001; Mi RF, 2004, NEURON, V44, P335, DOI 10.1016/j.neuron.2004.09.029; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Nakamura T, 2007, CELL DEATH DIFFER, V14, P1305, DOI 10.1038/sj.cdd.4402138; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Rao VR, 2007, TRENDS NEUROSCI, V30, P284, DOI 10.1016/j.tins.2007.03.012; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Simonyi A, 2005, DRUG NEWS PERSPECT, V18, P353, DOI 10.1358/dnp.2005.18.6.927927; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Uchino S, 2006, J NEUROCHEM, V97, P1203, DOI 10.1111/j.1471-4159.2006.03831.x; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	56	248	261	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					306	316		10.1016/j.ajhg.2011.02.001	http://dx.doi.org/10.1016/j.ajhg.2011.02.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21376300	Green Published, Bronze			2022-12-18	WOS:000288589000008
J	Liu, JJ; Nyholt, DR; Magnussen, P; Parano, E; Pavone, P; Geschwind, D; Lord, C; Iversen, P; Hoh, J; Ott, J; Gilliam, TC				Liu, JJ; Nyholt, DR; Magnussen, P; Parano, E; Pavone, P; Geschwind, D; Lord, C; Iversen, P; Hoh, J; Ott, J; Gilliam, TC		Autism Genetic Resource Exchange C	A genomewide screen for autism susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB-PAIR LINKAGE; GENETICALLY COMPLEX TRAITS; ALZHEIMERS-DISEASE; SEROTONIN TRANSPORTER; GENOMIC SCREEN; CHROMOSOME; LOCUS; DISORDER; STRATEGIES; REGION	We report the analysis of 335 microsatellite markers genotyped in 110 multiplex families with autism. All families include at least two "affected" siblings, at least one of whom has autism; the remaining affected sibs carry diagnoses of either Asperger syndrome or pervasive developmental disorder. Affected sib-pair analysis yielded multipoint maximum LOD scores (MLS) that reach the accepted threshold for suggestive linkage on chromosomes 5, X, and 19. Nominal evidence for linkage (point-wise) was obtained on chromosomes 2, 3, 4, 8, 10, 11, 12, 15, 16, 18, and 20, and secondary loci were found on chromosomes 5 and 19. Analysis of families sharing alleles at the putative X chromosomal linked locus and one or more other putative linked loci produced an MLS of 3.56 for the DXS470-D19S174 marker combination. In an effort to increase power to detect linkage, scan statistics were used to evaluate the significance of peak LOD scores based on statistical evidence at adjacent marker loci. This analysis yielded impressive evidence for linkage to autism and autism-spectrum disorders with significant genome-wide P values <.05 for markers on chromosomes 5 and 8 and with suggestive linkage evidence for a marker on chromosome 19.	Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Univ Catania, Dept Pediat, I-95124 Catania, Italy; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; Cure Autism Now Fdn, Los Angeles, CA USA	Columbia University; Columbia University; Columbia University; Rockefeller University; University of Catania; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Gilliam, TC (corresponding author), Columbia Univ, Columbia Genome Ctr, 1150 St Nicholas Ave,Room 508, New York, NY 10032 USA.	tcg1@columbia.edu	Nyholt, Dale Robert/J-3174-2017; Liu, Jianjun/AAK-4989-2020; Pavone, Piero/H-5097-2019	Nyholt, Dale Robert/0000-0001-7159-3040; Liu, Jianjun/0000-0002-3255-3019; Pavone, Piero/0000-0002-5600-9560; Buxbaum, Joseph/0000-0001-8898-8313; PARANO, ENRICO/0000-0002-0713-7339	Telethon [E.0811] Funding Source: Medline	Telethon(Fondazione Telethon)		ADAMS P, 1994, GENET EPIDEMIOL, V11, P87, DOI 10.1002/gepi.1370110109; Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; ANDERSON GM, 1987, J CHILD PSYCHOL PSYC, V28, P885, DOI 10.1111/j.1469-7610.1987.tb00677.x; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Baur MP, 1997, GENETIC MAPPING OF DISEASE GENES, P159; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Brodkin ES, 1997, J CHILD ADOL PSYCHOP, V7, P109, DOI 10.1089/cap.1997.7.109; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Buxbaum JD, 1999, MOL PSYCHIATR, V4, pS13; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Cook EH, 1997, MOL PSYCHIATR, V2, P247; CORDELL HJ, 1995, ANN HUM GENET, V59, P435, DOI 10.1111/j.1469-1809.1995.tb00761.x; Creswell CS, 1999, NEUROCASE, V5, P511, DOI 10.1080/13554799908402746; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P225, DOI 10.1002/gepi.1370100403; Fatemi SH, 1998, J AUTISM DEV DISORD, V28, P303, DOI 10.1023/A:1026008602540; Feinstein C, 1998, J AUTISM DEV DISORD, V28, P393, DOI 10.1023/A:1026000404855; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Gillberg C, 1999, ACTA PSYCHIAT SCAND, V99, P399, DOI 10.1111/j.1600-0447.1999.tb00984.x; GILLBERG C, 1989, DEV MED CHILD NEUROL, V31, P520; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hoh J, 2000, P NATL ACAD SCI USA, V97, P9615, DOI 10.1073/pnas.170179197; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; JORDE LB, 1991, AM J HUM GENET, V49, P932; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestrini E, 1999, AM J MED GENET, V88, P492, DOI 10.1002/(SICI)1096-8628(19991015)88:5<492::AID-AJMG11>3.0.CO;2-X; Maestrini E, 1999, AM J HUM GENET, V65, pA106; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; SHAM P, 1998, STAT HUMAN GENETICS, P110; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Smalley SL, 1998, J AUTISM DEV DISORD, V28, P407, DOI 10.1023/A:1026052421693; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P245; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Zhong N, 1999, NEUROGENETICS, V2, P129, DOI 10.1007/s100480050064	55	248	259	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					327	340		10.1086/321980	http://dx.doi.org/10.1086/321980			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	456XN	11452361	Green Published, Bronze			2022-12-18	WOS:000170108200008
J	Wu, Y; Berends, MJW; Mensink, RGJ; Kempinga, C; Sijmons, RH; van der Zee, AGJ; Hollema, H; Kleibeuker, JH; Buys, CHCM; Hofstra, RMW				Wu, Y; Berends, MJW; Mensink, RGJ; Kempinga, C; Sijmons, RH; van der Zee, AGJ; Hollema, H; Kleibeuker, JH; Buys, CHCM; Hofstra, RMW			Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISMATCH REPAIR GENE; 2-DIMENSIONAL DNA ELECTROPHORESIS; II RECEPTOR GENE; CELLS; EXPRESSION; GTBP; CARCINOMA; HNPCC	Hereditary nonpolyposis colorectal cancer (HNPCC) (Amsterdam criteria) is often caused by mutations in mismatch repair (MMR) genes, and tumors of patients with HNPCC show microsatellite instability (MSI-high phenotype), Germline mutations of MMR genes have rarely been found in families that have HNPCC or suspected HNPCC and that do not show microsatellite instability (MSI-low phenotype). Therefore, an MSI-high phenotype is often used as an inclusion criterion for mutation testing of MMR genes. Correction of base-base mismatches is the major function of MSH6. Since mismatches present with an MSI-low phenotype, we assumed that the phenotype in patients with HNPCC-related tumors might be associated with MSH6 germline mutations. We divided 36 patients with suspected HNPCC into an MSI-low group (n = 18) and an MSI-high group (n = 18), on the basis of the results of MSI testing. Additionally, three unrelated patients from Amsterdam families with MSI-low tumors were investigated. All patients were screened for MSH2, MLH1, and MSH6 mutations. Four presumably causative MSH6 mutations were detected in the patients (22%) who had suspected HNPCC and MSI-low tumors. Furthermore, we detected one frameshift mutation in one of the three patients with HNPCC and MSI-low tumors. In the MSI-high group, one MSH6 missense mutation was found, but the same patient also had an MLH1 mutation, which may explain the MSI-high phenotype. These results suggest that MSHG may be involved in a substantial proportion of patients with HNPCC or suspected HNPCC and MSI-low tumors. Our data emphasize that an MSI-low phenotype cannot be considered an exclusion criterion for mutation testing of MMR genes in general.	Univ Groningen, Dept Med Genet, NL-9713 AW Groningen, Netherlands; Univ Groningen, Dept Gastroenterol, NL-9713 AW Groningen, Netherlands; Univ Groningen, Dept Pathol, NL-9713 AW Groningen, Netherlands; Univ Groningen, Dept Gynaecol, NL-9713 AW Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Hofstra, RMW (corresponding author), Univ Groningen, Dept Med Genet, Antonius Deusinglaan 4, NL-9713 AW Groningen, Netherlands.		Sijmons, Rolf/E-5829-2012	Sijmons, Rolf/0000-0001-8446-2779; Hofstra, Robert/0000-0001-7498-3829				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Akiyama Y, 1997, CANCER RES, V57, P3920; Boland CR, 1998, CANCER RES, V58, P5248; CHEN JS, 1995, CANCER RES, V55, P174; Corradi A, 1996, GENOMICS, V36, P288, DOI 10.1006/geno.1996.0464; Dietmaier W, 1997, CANCER RES, V57, P4749; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Lu SL, 1998, NAT GENET, V19, P17, DOI 10.1038/ng0598-17; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; PARSONS R, 1995, CANCER RES, V55, P5548; PELTOMAKI P, 1993, CANCER RES, V53, P5853; Peltomaki P, 1997, ADV CANCER RES, V71, P93, DOI 10.1016/S0065-230X(08)60097-4; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wu Y, 1997, GENE CHROMOSOME CANC, V18, P269, DOI 10.1002/(SICI)1098-2264(199704)18:4<269::AID-GCC4>3.0.CO;2-Z; Wu Y, 1999, Nucleic Acids Res, V27, pe9, DOI 10.1093/nar/27.15.e9; Wu Y, 1996, HUM MUTAT, V8, P160	26	248	256	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1291	1298		10.1086/302612	http://dx.doi.org/10.1086/302612			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521294	Green Published, Bronze			2022-12-18	WOS:000083531000010
J	Strande, NT; Riggs, ER; Buchanan, AH; Ceyhan-Birsoy, O; DiStefano, M; Dwight, SS; Goldstein, J; Ghosh, R; Seifert, BA; Sneddon, TP; Wright, MW; Milko, LV; Cherry, JM; Giovanni, MA; Murray, MF; O'Daniel, JM; Ramos, EM; Santani, AB; Scott, AF; Plon, SE; Rehm, HL; Martin, CL; Berg, JS				Strande, Natasha T.; Riggs, Erin Rooney; Buchanan, Adam H.; Ceyhan-Birsoy, Ozge; DiStefano, Marina; Dwight, Selina S.; Goldstein, Jenny; Ghosh, Rajarshi; Seifert, Bryce A.; Sneddon, Tam P.; Wright, Matt W.; Milko, Laura V.; Cherry, J. Michael; Giovanni, Monica A.; Murray, Michael F.; O'Daniel, Julianne M.; Ramos, Erin M.; Santani, Avni B.; Scott, Alan F.; Plon, Sharon E.; Rehm, Heidi L.; Martin, Christa L.; Berg, Jonathan S.			Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GUIDELINES	With advances in genomic sequencing technology, the number of reported gene-disease relationships has rapidly expanded. However, the evidence supporting these claims varies widely, confounding accurate evaluation of genomic variation in a clinical setting. Despite the critical need to differentiate clinically valid relationships from less well-substantiated relationships, standard guidelines for such evaluation do not currently exist. The NIH-funded Clinical Genome Resource (ClinGen) has developed a framework to define and evaluate the clinical validity of gene-disease pairs across a variety of Mendelian disorders. In this manuscript we describe a proposed framework to evaluate relevant genetic and experimental evidence supporting or contradicting a gene-disease relationship and the subsequent validation of this framework using a set of representative gene-disease pairs. The framework provides a semiquantitative measurement for the strength of evidence of a gene-disease relationship that correlates to a qualitative classification: "Definitive," "Strong," "Moderate," "Limited," "No Reported Evidence," or "Conflicting Evidence." Within the ClinGen structure, classifications derived with this framework are reviewed and confirmed or adjusted based on clinical expertise of appropriate disease experts. Detailed guidance for utilizing this framework and access to the curation interface is available on our website. This evidence-based, systematic method to assess the strength of gene-disease relationships will facilitate more knowledgeable utilization of genomic variants in clinical and research settings.	[Strande, Natasha T.; Goldstein, Jenny; Seifert, Bryce A.; Milko, Laura V.; O'Daniel, Julianne M.; Berg, Jonathan S.] Univ North Carolina Chapel Hill, Sch Med, Dept Genet, Chapel Hill, NC 27514 USA; [Riggs, Erin Rooney; Martin, Christa L.] Geisinger Hlth Syst, Autism & Dev Med Inst, Danville, PA 17837 USA; [Buchanan, Adam H.; Giovanni, Monica A.; Murray, Michael F.; Martin, Christa L.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA; [Ceyhan-Birsoy, Ozge; DiStefano, Marina; Rehm, Heidi L.] Partners Personalized Med, Mol Med Lab, Boston, MA 02139 USA; [Ceyhan-Birsoy, Ozge; Rehm, Heidi L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Ceyhan-Birsoy, Ozge; Rehm, Heidi L.] Harvard Med Sch, Boston, MA 02115 USA; [Ceyhan-Birsoy, Ozge; Rehm, Heidi L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Dwight, Selina S.; Sneddon, Tam P.; Wright, Matt W.; Cherry, J. Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ghosh, Rajarshi; Plon, Sharon E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Ramos, Erin M.] NHGRI, NIH, Bethesda, MD 20892 USA; [Santani, Avni B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Santani, Avni B.] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA 19104 USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Geisinger Health System; Geisinger Health System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Stanford University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University	Berg, JS (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Genet, Chapel Hill, NC 27514 USA.; Martin, CL (corresponding author), Geisinger Hlth Syst, Autism & Dev Med Inst, Danville, PA 17837 USA.; Martin, CL (corresponding author), Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA.	clmartin1@geisinger.edu; jonathan_berg@med.unc.edu	Seifert, Bryce/R-6071-2019; O'Daniel, Julianne/AAU-8165-2020	Seifert, Bryce/0000-0001-7970-3611; O'Daniel, Julianne/0000-0001-5843-4432; Dwight, Selina/0000-0002-8546-7798; GHOSH, RAJARSHI/0000-0001-7368-8940; Cherry, J. Michael/0000-0001-9163-5180; Sneddon, Tam Paterson/0000-0003-1137-8992; Rehm, Heidi L./0000-0002-6025-0015; DiStefano, Marina/0000-0002-8218-5111; Wright, Mathew/0000-0002-2650-2426; Strande, Natasha/0000-0001-5148-9772	National Human Genome Research Institute (NHGRI) [U41 HG006834-01A1, U01 HG007437-01, U01 HG007436-01]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI) [HHSN261200800001E]; Intramural Research Program of the NIH, National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG009650, U01HG007437, U01HG007436, U41HG006834] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants U41 HG006834-01A1, U01 HG007437-01, and U01 HG007436-01 from the National Human Genome Research Institute (NHGRI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and through contract HHSN261200800001E from the National Cancer Institute (NCI). ClinVar is supported by the Intramural Research Program of the NIH, National Library of Medicine. We would like to thank the following groups and individuals for contributing their disease expertise to review the examples included in this manuscript: Alan Beggs, Alison Bertuch, Rebecca H. Buckley, Eugene Chung, Bill Craigen, Jennifer M. Puck, Sharon A. Savage, Fergus J. Couch, the ClinGen Hereditary Breast and Ovarian Cancer gene curation working group, Birgit H. Funke and the ClinGen Cardiomyopathy gene curation working group, and the ClinGen RASopathy curation working group. Input on the framework was also provided by the ClinGen Hereditary Breast and Ovarian Cancer gene curation working group and Ray Hershberger, Mike Gollob, and the ClinGen Channelopathy gene curation working group. We would also like to thank Scott Goehringer for his invaluable help in preparing the curated examples for the ClinGen website and supplemental figures.	[Anonymous], 2003, HUMAN GENOME EPIDEMI; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Eisenberger T, 2014, HUM MUTAT, V35, P565, DOI 10.1002/humu.22532; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Wilfert AB, 2016, NAT GENET, V48, P1455, DOI 10.1038/ng.3697	12	247	254	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					895	906		10.1016/j.ajhg.2017.04.015	http://dx.doi.org/10.1016/j.ajhg.2017.04.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28552198	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000402700600006
J	Norton, N; Li, DX; Rieder, MJ; Siegfried, JD; Rampersaud, E; Zuchner, S; Mangos, S; Gonzalez-Quintana, J; Wang, LB; McGee, S; Reiser, J; Martin, E; Nickerson, DA; Hershberger, RE				Norton, Nadine; Li, Duanxiang; Rieder, Mark J.; Siegfried, Jill D.; Rampersaud, Evadnie; Zuechner, Stephan; Mangos, Steve; Gonzalez-Quintana, Jorge; Wang, Libin; McGee, Sean; Reiser, Jochen; Martin, Eden; Nickerson, Deborah A.; Hershberger, Ray E.			Genome-wide Studies of Copy Number Variation and Exome Sequencing Identify Rare Variants in BAG3 as a Cause of Dilated Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; GENES	Dilated cardiomyopathy commonly causes heart failure and is the most frequent precipitating cause of heart transplantation. Familial dilated cardiomyopathy has been shown to be caused by rare variant mutations in more than 30 genes but only similar to 35% of its genetic cause has been identified, principally by using linkage-based or candidate gene discovery approaches. In a multigenerational family with autosomal dominant transmission, we employed whole-exome sequencing in a proband and three of his affected family members, and genome-wide copy number variation in the proband and his affected father and unaffected mother. Exome sequencing identified 428 single point variants resulting in missense, nonsense, or splice site changes. Genome-wide copy number analysis identified 51 insertion deletions and 440 copy number variants > 1 kb. Of these, a 8733 bp deletion, encompassing exon 4 of the heat shock protein cochaperone BCL2-associated athanogene 3 (BAG3), was found in seven affected family members and was absent in 355 controls. To establish the relevance of variants in this protein class in genetic DCM, we sequenced the coding exons in BAG3 in 311 other unrelated DCM probands and identified one frameshift, two nonsense, and four missense rare variants absent in 355 control DNAs, four of which were familial and segregated with disease. Knockdown of bag3 in a zebrafish model recapitulated DCM and heart failure. We conclude that new comprehensive genomic approaches have identified rare variants in BAG3 as causative of DCM.	[Norton, Nadine; Li, Duanxiang; Siegfried, Jill D.; Gonzalez-Quintana, Jorge; Wang, Libin; Hershberger, Ray E.] Univ Miami, Miller Sch Med, Dept Med, Div Cardiovasc, Miami, FL 33136 USA; [Rieder, Mark J.; McGee, Sean; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Rampersaud, Evadnie; Zuechner, Stephan; Martin, Eden] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Mangos, Steve; Reiser, Jochen] Univ Miami, Miller Sch Med, Dept Med, Div Nephrol, Miami, FL 33136 USA	University of Miami; University of Washington; University of Washington Seattle; University of Miami; University of Miami	Hershberger, RE (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Cardiovasc, Miami, FL 33136 USA.	rhershberger@med.miami.edu		Mangos, Steve/0000-0003-1402-1008; Hershberger, Ray/0000-0001-5683-6526	National Institutes of Health [HL58626, HL094976]; Florida Heart Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976, R01HL058626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Heart Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank all the family members who participated, without whom this study would not be a success. This work was supported by National Institutes of Health awards HL58626 (R.E.H.) and HL094976 (D.A.N., SeattleSeq), and the Florida Heart Research Institute (N.N.). We also thank and recognize the following ongoing studies that produced and provided exome variant calls for filtering purposes: National Heart Lung and Blood Institute Lung Cohort Sequencing Project (HL 1029230), NHLBI Women's Health Initiative Sequencing Project (HL 102924), and the Northwest Genomics Center (HL 102926).	Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hershberger RE, 2010, CIRC-CARDIOVASC GENE, V3, P155, DOI 10.1161/CIRCGENETICS.109.912345; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Hishiya A, 2010, CIRC RES, V107, P1220, DOI 10.1161/CIRCRESAHA.110.225649; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kushner JD, 2006, J CARD FAIL, V12, P422, DOI 10.1016/j.cardfail.2006.03.009; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maloyan A, 2010, CIRC RES, V106, P1524, DOI 10.1161/CIRCRESAHA.109.212639; Mangos S, 2010, DIS MODEL MECH, V3, P354, DOI 10.1242/dmm.003194; McCollum Andrea K, 2009, Biochem J, V425, pe1, DOI 10.1042/BJ20091739; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004; Parks SB, 2008, AM HEART J, V156, P161, DOI 10.1016/j.ahj.2008.01.026; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Shin JT, 2010, PHYSIOL GENOMICS, V42, P300, DOI 10.1152/physiolgenomics.00206.2009; Westerfield M, 1995, ZEBRAFISH BOOK; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832	27	247	258	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					273	282		10.1016/j.ajhg.2011.01.016	http://dx.doi.org/10.1016/j.ajhg.2011.01.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21353195	Green Published, Bronze			2022-12-18	WOS:000288589000005
J	Mears, AJ; Jordan, T; Mirzayans, F; Dubois, S; Kume, P; Parlee, M; Ritch, R; Koop, B; Kuo, WL; Collins, C; Marshall, J; Gould, DB; Pearce, W; Carlsson, P; Enerback, S; Morissette, J; Bhattacharya, S; Hogan, B; Raymond, V; Walter, MA				Mears, AJ; Jordan, T; Mirzayans, F; Dubois, S; Kume, P; Parlee, M; Ritch, R; Koop, B; Kuo, WL; Collins, C; Marshall, J; Gould, DB; Pearce, W; Carlsson, P; Enerback, S; Morissette, J; Bhattacharya, S; Hogan, B; Raymond, V; Walter, MA			Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CONGENITAL GLAUCOMA; AUTOSOMAL-DOMINANT IRIDOGONIODYSGENESIS; OPEN-ANGLE GLAUCOMA; FORK HEAD DOMAIN; HUMAN PAX6 GENE; DNA-BINDING; ALVEOLAR RHABDOMYOSARCOMA; TRANSCRIPTION FACTORS; RING CHROMOSOME-6; FAMILY	Genetic linkage, genome mismatch scanning, and analysis of patients with alterations of chromosome 6 have indicated that a major locus for development of the anterior segment of the eye, IRID1, is located at 6p25. Abnormalities of this locus lead to glaucoma. FKHL7 (also called "FREAC3"), a member of the forkhead/winged-helix transcription-factor family, has also been mapped to 6p25. DNA sequencing of FKHL7 in five IRID1 families and 16 sporadic patients with anterior-segment defects revealed three mutations: a 10-bp deletion predicted to cause a frameshift and premature protein truncation prior to the FKHL7 forkhead DNA-binding domain, as well as two missense mutations of conserved amino acids within the FKHL7 forkhead domain. Mf1, the murine homologue of FKHL7, is expressed in the developing brain, skeletal system, and eye, consistent with FKHL7 having a role in ocular development. However, mutational screening and genetic-linkage analyses excluded FKHL7 from underlying the anterior-segment disorders in two IRID1 families with linkage to 6p25. Our findings demonstrate that, although mutations of FKHIL7 result in anterior-segment defects and glaucoma in some patients, it is probable that at least one more locus involved in the regulation of eye development is also located at 6p25.	Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; Inst Ophthalmol, Dept Mol Genet, London, ON, Canada; CHU Laval, Res Ctr, Mol Endocrinol Lab, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Quebec City, PQ G1K 7P4, Canada; Vanderbilt Univ, Med Ctr, Howard Hughes Med Inst, Nashville, TN USA; Univ Victoria, Dept Biol, Ctr Environm Hlth, Victoria, BC V8W 2Y2, Canada; New York Eye & Ear Infirm, Dept Ophthalmol, New York, NY 10003 USA; Univ Calif San Francisco, Canc Genet Program, San Francisco, CA 94143 USA; Lawrence Berkeley Lab, Berkeley, CA USA; Univ Gothenburg, Dept Biol Mol, Gothenburg, Sweden	University of Alberta; University of Alberta; Laval University; Laval University; Howard Hughes Medical Institute; Vanderbilt University; University of Victoria; New York Eye & Ear Infirmary of Mount Sinai; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Gothenburg	Walter, MA (corresponding author), Univ Alberta, Ocular Genet Lab, 832 Med Sci Bldg, Edmonton, AB, Canada.		Bhattacharya, Shom/N-2926-2016; Koop, Ben F./A-8151-2008; Carlsson, Peter/B-5551-2008	Bhattacharya, Shom/0000-0002-1601-6344; Koop, Ben F./0000-0003-0045-5200; Carlsson, Peter/0000-0001-6535-5927				ALASHARI M, 1995, PEDIATR PATHOL LAB M, V15, P941, DOI 10.3109/15513819509027030; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Berg F., 1932, ACTA OPHTHALMOL, V10, P568, DOI [10.1111/j.1755-3768.1932.tb07210.x, DOI 10.1111/J.1755-3768.1932.TB07210.X]; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Gould DB, 1997, AM J HUM GENET, V61, P765; Graff C, 1997, HUM GENET, V101, P130, DOI 10.1007/s004390050601; HANSON IM, 1993, HUM MOL GENET, V2, P915; Hoch M, 1996, MECH DEVELOP, V58, P3, DOI 10.1016/S0925-4773(96)00541-2; JERNDAL T, 1972, AM J OPHTHALMOL, V74, P28, DOI 10.1016/0002-9394(72)91121-X; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KAISERKUPFER MI, 1989, AM J OPHTHALMOL, V107, P671, DOI 10.1016/0002-9394(89)90266-3; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; LEVIN H, 1986, AM J MED GENET, V25, P281, DOI 10.1002/ajmg.1320250212; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; LI J, 1993, P NATL ACAD SCI USA, V90, P4490, DOI 10.1073/pnas.90.10.4490; Mears AJ, 1996, AM J HUM GENET, V59, P1321; Mirzayans F, 1997, AM J HUM GENET, V61, P111, DOI 10.1086/513894; Morissette J, 1997, AM J HUM GENET, V61, pA286; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NGUYEN TD, 1993, BASIC ASPECTS GLAUCO, V3, P331; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 1997, AM J HUM GENET, V61, pA21; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; PEARCE WG, 1983, CAN J OPHTHALMOL, V18, P7; PEEDEN JN, 1983, AM J MED GENET, V16, P563, DOI 10.1002/ajmg.1320160413; Phillips JC, 1996, AM J HUM GENET, V59, P613; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; QIAN XB, 1995, NUCLEIC ACIDS RES, V23, P1184, DOI 10.1093/nar/23.7.1184; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Raymond V, 1997, AM J HUM GENET, V60, P272; Reid CS, 1983, PEDIATR RES, V17, p217A; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SHAPIRO DN, 1993, CANCER RES, V53, P5108; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; WEATHERI.JR, 1969, BRIT J OPHTHALMOL, V53, P433, DOI 10.1136/bjo.53.7.433; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; ZURCHER VL, 1990, AM J MED GENET, V35, P261, DOI 10.1002/ajmg.1320350223	51	247	260	1	12	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1316	1328		10.1086/302109	http://dx.doi.org/10.1086/302109			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792859	Bronze, Green Published			2022-12-18	WOS:000076985200008
J	Niemitz, EL; Feinberg, AP				Niemitz, EL; Feinberg, AP			Epigenetics and assisted reproductive technology: A call for investigation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							BECKWITH-WIEDEMANN-SYNDROME; IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; DNA METHYLTRANSFERASE GENE; UBIQUITIN-PROTEIN LIGASE; METHYLATION IMPRINT; ANGELMAN-SYNDROME; CONGENITAL-MALFORMATIONS; PREIMPLANTATION EMBRYOS; TRUNCATING MUTATIONS	A surprising set of recent observations suggests a link between assisted reproductive technology ( ART) and epigenetic errors - that is, errors involving information other than DNA sequence that is heritable during cell division. An apparent association with ART was found in registries of children with Beckwith-Wiedemann syndrome, Angelman syndrome, and retinoblastoma. Here, we review the epidemiology and molecular biology behind these studies and those of relevant model systems, and we highlight the need for investigation of two major questions: (1) large-scale case-control studies of ART outcomes, including long-term assessment of the incidence of birth defects and cancer, and ( 2) investigation of the relationship between epigenetic errors in both offspring and parents, the specific methods of ART used, and the underlying infertility diagnoses. In addition, the components of proprietary commercial media used in ART procedures must be fully and publicly disclosed, so that factors such as methionine content can be assessed, given the relationship in animal studies between methionine exposure and epigenetic changes.	Johns Hopkins Univ, Sch Med, Predoctoral Program Human Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Epigenet Unit, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Epigenet Unit, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Predoctoral Program Human Genet, 1064 Ross,720 Rutland Ave, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [R37 CA54358, R01 CA054358, R37 CA054358, R37 CA054358-14] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; [Anonymous], REP PAN EV US STAND; Anthony S, 2002, HUM REPROD, V17, P2089, DOI 10.1093/humrep/17.8.2089; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BLANQUET V, 1991, GENOMICS, V10, P350, DOI 10.1016/0888-7543(91)90319-A; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CATT JW, 1994, CELL BIOL INT, V18, P1155, DOI 10.1006/cbir.1994.1042; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; DEBAUN MR, 2003, INBORN ERRORS DEV; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dhont M, 1997, J ASSIST REPROD GEN, V14, P575, DOI 10.1023/A:1022576500894; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; DSouza SW, 1997, ARCH DIS CHILD-FETAL, V76, pF70, DOI 10.1136/fn.76.2.F70; Elgar G, 1996, HUM MOL GENET, V5, P1437, DOI 10.1093/hmg/5.Supplement_1.1437; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; *FDA, 2001, CLASS II SPEC CONTR; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Giannoukakis N, 1996, BIOCHEM BIOPH RES CO, V220, P1014, DOI 10.1006/bbrc.1996.0524; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Hata K, 2002, DEVELOPMENT, V129, P1983; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; KIESS W, 1988, J BIOL CHEM, V263, P9339; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; LEACH RJ, 1990, CELL GROWTH DIFFER, V1, P401; Lee J, 2002, DEVELOPMENT, V129, P1807; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Moll AC, 2003, LANCET, V361, P309, DOI 10.1016/S0140-6736(03)12332-X; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; NAUMOVA A, 1994, AM J HUM GENET, V54, P264; NAUMOVA A, 1994, AM J HUM GENET, V54, P274; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OhtaniFujita N, 1997, CANCER GENET CYTOGEN, V98, P43, DOI 10.1016/S0165-4608(96)00395-0; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Olivennes F, 1997, FERTIL STERIL, V67, P284, DOI 10.1016/S0015-0282(97)81912-7; Onyango P, 2000, GENOME RES, V10, P1697, DOI 10.1101/gr.161800; Orstavik KH, 2003, AM J HUM GENET, V72, P218, DOI 10.1086/346030; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Place I, 2003, FERTIL STERIL, V80, P1388, DOI 10.1016/j.fertnstert.2003.06.004; REDFEARN S, 2003, WASHINGTON POST 0114, pF1; Robinson WP, 2000, CLIN GENET, V57, P349, DOI 10.1034/j.1399-0004.2000.570505.x; ROSSANT J, 1986, DEV BIOL, V117, P567, DOI 10.1016/0012-1606(86)90325-8; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; RUFAT P, 1994, FERTIL STERIL, V61, P324; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Saunders K, 1996, PEDIATRICS, V97, P688; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Shibata H, 1998, GENOMICS, V49, P30, DOI 10.1006/geno.1998.5218; Sinclair KD, 2000, HUM REPROD, V15, P68, DOI 10.1093/humrep/15.suppl_5.68; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Summers MC, 2003, HUM REPROD UPDATE, V9, P557, DOI 10.1093/humupd/dmg039; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Sutcliffe AG, 1995, HUM REPROD, V10, P3332, DOI 10.1093/oxfordjournals.humrep.a135915; THIBIER M, 1998, IETS EMBRYO TRANSFER, V16; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Wan MM, 2001, HUM MOL GENET, V10, P1085, DOI 10.1093/hmg/10.10.1085; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wennerholm U B, 1991, Acta Obstet Gynecol Scand, V70, P565, DOI 10.3109/00016349109007918; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wright Victoria C, 2003, MMWR Surveill Summ, V52, P1; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Young L E, 2001, Twin Res, V4, P307, DOI 10.1375/twin.4.5.307; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/ror.0.0030155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	106	246	257	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					599	609		10.1086/382897	http://dx.doi.org/10.1086/382897			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	14991528	Green Published, Bronze			2022-12-18	WOS:000220280800001
J	Bayes, M; Magano, LF; Rivera, N; Flores, R; Jurado, LAP				Bayes, M; Magano, LF; Rivera, N; Flores, R; Jurado, LAP			Mutational mechanisms of Williams-Beuren syndrome deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC GRANULOMATOUS-DISEASE; LOW-COPY REPEATS; GENOMIC DISORDERS; P47-PHOX PSEUDOGENE; 7Q11.23 DELETIONS; ALU REPEATS; RECOMBINATION; REGION; GENE; ORIGIN	Williams-Beuren syndrome (WBS) is a segmental aneusomy syndrome that results from a heterozygous deletion of contiguous genes at 7q11.23. Three large region-specific low-copy repeat elements (LCRs), composed of different blocks (A, B, and C), flank the WBS deletion interval and are thought to predispose to misalignment and unequal crossing-over, causing the deletions. In this study, we have determined the exact deletion size and LCR copy number in 74 patients with WBS, as well as precisely defined deletion breakpoints in 30 of them, using LCR-specific nucleotide differences. Most patients (95%) exhibit a 1.55-Mb deletion caused by recombination between centromeric and medial block B copies, which share similar to99.6% sequence identity along 105 - 143 kb. In these cases, deletion breakpoints were mapped at several sites within the recombinant block B, with a cluster (>27%) occurring at a 12 kb region within the GTF2I/GTF2IP1 gene. Almost one-third (28%) of the transmitting progenitors were found to be heterozygous for an inversion between centromeric and telomeric LCRs. All deletion breakpoints in the patients with the inversion occurred in the distal 38-kb block B region only present in the telomeric and medial copies. Finally, only four patients (5%) displayed a larger deletion (similar to1.84 Mb) caused by recombination between centromeric and medial block A copies. We propose models for the specific pairing and precise aberrant recombination leading to each of the different germline rearrangements that occur in this region, including inversions and deletions associated with WBS. Chromosomal instability at 7q11.23 is directly related to the genomic structure of the region.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Unitat Genet, Barcelona 08003, Spain	Pompeu Fabra University	Jurado, LAP (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Unitat Genet, Doctor Aiguader 80, Barcelona 08003, Spain.	luis.perez@cexs.upf.es	Pérez Jurado, Luis Alberto/M-7706-2015	Flores Peirats, Raquel/0000-0002-5844-470X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; BURN J, 1986, J MED GENET, V23, P389, DOI 10.1136/jmg.23.5.389; CASIMIR CM, 1991, P NATL ACAD SCI USA, V88, P2753, DOI 10.1073/pnas.88.7.2753; Castorina P, 1997, AM J MED GENET, V69, P107, DOI 10.1002/(SICI)1096-8628(19970303)69:1<107::AID-AJMG21>3.0.CO;2-S; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gorlach A, 1997, J CLIN INVEST, V100, P1907, DOI 10.1172/JCI119721; GREEN JE, 1990, AIDS RES HUM RETROV, V6, P85; Heyworth PG, 2002, BLOOD, V100, P1845, DOI 10.1182/blood-2002-03-0861; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jurado LAP, 2003, HORM RES, V59, P106, DOI 10.1159/000067836; Jurado LAP, 1996, AM J HUM GENET, V59, P781; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Kara-Mostefa A, 1999, AM J HUM GENET, V64, P1475, DOI 10.1086/302362; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Lopes J, 1996, AM J HUM GENET, V58, P1223; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Magano LF, 2001, EUR J HUM GENET, V9, P244; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Mervis CB, 2000, MENT RETARD DEV D R, V6, P148; MORRIS CA, 1993, AM J MED GENET, V47, P478, DOI 10.1002/ajmg.1320470409; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Robinson NE, 2002, EQUINE VET J, V34, P17, DOI 10.2746/042516402776181105; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a; Urban Z, 1996, AM J HUM GENET, V59, P958; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; VNENCAKJONES CL, 1990, SCIENCE, V250, P1745, DOI 10.1126/science.1980158; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; Wang YK, 1998, GENOMICS, V48, P163, DOI 10.1006/geno.1997.5182	49	246	260	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					131	151		10.1086/376565	http://dx.doi.org/10.1086/376565			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12796854	Bronze, Green Published			2022-12-18	WOS:000183904900012
J	Lewis, RA; Shroyer, NF; Singh, N; Allikmets, R; Hutchinson, A; Li, YX; Lupski, JR; Leppert, M; Dean, M				Lewis, RA; Shroyer, NF; Singh, N; Allikmets, R; Hutchinson, A; Li, YX; Lupski, JR; Leppert, M; Dean, M			Genotype/phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ROD OUTER SEGMENTS; FUNDUS-FLAVIMACULATUS; MACULAR DYSTROPHY; CHROMOSOME 1P; RIM PROTEIN; SUPERFAMILY; DATABASE; MUTATION; MEMBRANE; MAPS	Mutation scanning and direct DNA sequencing of all 50 exons of ABCR were completed for 150 families segregating recessive Stargardt disease (STGD1). ABCR variations were identified in 173 (57%) disease chromosomes, the majority of which represent missense amino acid substitutions. These ABCR variants were not found in 220 unaffected control individuals (440 chromosomes) but do cosegregate with the disease in these families with STGD1, and many occur in conserved functional domains. Missense amino acid substitutions located in the amino terminal one-third of the protein appear to be associated with earlier onset of the disease and may represent misfolding alleles. The two most common mutant alleles, G1961E and A1038V, each identified in 16 of 173 disease chromosomes, composed 18.5% of mutations identified. G1961E has been associated previously, at a statistically significant level in the heterozygous state, with age-related macular degeneration (AMD). Clinical evaluation of these 150 families with STGD1 revealed a high frequency of AMD in first- and second-degree relatives. These findings support the hypothesis that compound heterozygous ABCR mutations are responsible for STGD1 and that some heterozygous ABCR mutations may enhance susceptibility to AMD.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT USA; NCI, Sci Applicat Int Corp, Frederick Intramural Res Support Program, Frederick Canc Res & Dev Ctr, Frederick, MD USA; NCI, Lab Genome Divers, Frederick Canc Res & Dev Ctr, Frederick, MD USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Lupski, JR (corresponding author), Baylor Coll Med, Dept Pediat, 1 Baylor Plaza,609-E, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Allikmets, Rando/ABD-4533-2021; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; Shroyer, Noah/0000-0002-5934-2852	NATIONAL CANCER INSTITUTE [Z01BC005725] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-56000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; ALLIKMETS R, 1995, MAMM GENOME, V6, P114, DOI 10.1007/BF00303254; Allikmets R, 1998, GENE, V215, P111, DOI 10.1016/S0378-1119(98)00269-8; Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; ANDERSON KL, 1995, AM J HUM GENET, V57, P1351; Armstrong JD, 1998, OPHTHALMOLOGY, V105, P448, DOI 10.1016/S0161-6420(98)93026-3; Azarian SM, 1998, HUM GENET, V102, P699, DOI 10.1007/s004390050765; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Blacharski P.A., 1988, RETINAL DYSTROPHY DE, P135; Cooper D. N., 1993, HUMAN GENE MUTATION; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; DEAN M, 1998, SCIENCE, V279, P1107; Franceschetti A., 1963, ENTWICKLUNG FORTSCHR, P107; GELISKEN O, 1985, INT OPHTHALMOL, V8, P225, DOI 10.1007/BF00137651; Gerber S, 1998, GENOMICS, V48, P139, DOI 10.1006/geno.1997.5164; GERBER S, 1995, AM J HUM GENET, V56, P396; HADDEN OB, 1976, AM J OPHTHALMOL, V82, P527, DOI 10.1016/0002-9394(76)90539-0; Hoyng CB, 1996, HUM GENET, V98, P500, DOI 10.1007/s004390050247; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; KLEIN BA, 1967, AM J OPHTHALMOL, V64, P3; KLEIN R, 1978, ARCH OPHTHALMOL-CHIC, V96, P2054; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Martinez DM, 1997, STRENGTH COND J, V19, P13, DOI 10.1519/1073-6840(1997)019<0013:ISACNF>2.3.CO;2; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; McKusick V.A., 1998, MENDELIAN INHERITANC; McKusick V.A., 1992, MENDELIAN INHERITANC; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; NOBLE KG, 1979, ARCH OPHTHALMOL-CHIC, V97, P1281; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Savary S, 1997, GENOMICS, V41, P275, DOI 10.1006/geno.1997.4658; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Weber BHF, 1996, BRIT J OPHTHALMOL, V80, P745, DOI 10.1136/bjo.80.8.745; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	41	246	271	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					422	434		10.1086/302251	http://dx.doi.org/10.1086/302251			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973280	Green Published, Bronze			2022-12-18	WOS:000078740600012
J	Handt, O; Krings, M; Ward, RH; Paabo, S				Handt, O; Krings, M; Ward, RH; Paabo, S			The retrieval of ancient human DNA sequences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMERINDIAN MITOCHONDRIAL DNAS; POLYMERASE CHAIN-REACTION; ENZYMATIC AMPLIFICATION; CONTROL REGION; MTDNA; GENE; PCR; HETEROPLASMY; EXTRACTION; LINEAGES	DNA was extracted from similar to 600-year-old human remains found at an archaeological site in the southwestern United States, and mtDNA fragments were amplified by PCR. When these fragments were sequenced directly, multiple sequences seemed to be present. From three representative individuals, DNA fragments of different lengths were quantified and short overlapping amplification products cloned. When amplifications started from <40 molecules, clones contained several different sequences. In contrast, when they were initiated by a few thousand molecules, unambiguous and reproducible results were achieved. These results show that more experimental work than is often applied is necessary to ensure that DNA sequences amplified from ancient human remains are authentic. Iu particular, quantitation of the numbers of amplifiable molecules is a useful tool to determine the role of contaminating contemporary molecules and PCR errors in amplifications from ancient DNA.	UNIV MUNICH, INST ZOOL, D-80021 MUNICH, GERMANY; UNIV UTAH, ECCLES INST HUMAN GENET, SALT LAKE CITY, UT USA	University of Munich; Utah System of Higher Education; University of Utah								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BENDALL KE, 1995, AM J HUM GENET, V57, P248; BERAUDCOLOMB E, 1995, AM J HUM GENET, V57, P1267; Cockburn A, 1980, MUMMIES DIS ANCIENT; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; COOPER A, 1992, P NATL ACAD SCI USA, V89, P8741, DOI 10.1073/pnas.89.18.8741; FORSTER E, 1994, BIOTECHNIQUES, V16, P18; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; GOLOUBINOFF P, 1993, P NATL ACAD SCI USA, V90, P1997, DOI 10.1073/pnas.90.5.1997; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAVIDI W, 1992, AM J HUM GENET, V50, P347; PAABO S, 1988, NATURE, V334, P387, DOI 10.1038/334387b0; PAABO S, 1989, J BIOL CHEM, V264, P9709; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1990, J BIOL CHEM, V265, P4718; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; RICHARDS MB, 1995, J ARCHAEOL SCI, V22, P291, DOI 10.1006/jasc.1995.0031; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SIDOW A, 1991, PHILOS T ROY SOC B, V333, P429, DOI 10.1098/rstb.1991.0093; THOMAS RH, 1989, NATURE, V340, P465, DOI 10.1038/340465a0; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; VANDERKUYL AC, 1995, J MOL EVOL, V40, P652, DOI 10.1007/BF00160513; VIGILANT L, 1990, THESIS U CALIFORNIA; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; ZISCHLER H, 1995, SCIENCE, V268, P1192, DOI 10.1126/science.7605504; ZULLO S, 1991, J MOL BIOL, V221, P1223	41	246	262	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					368	376						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755923				2022-12-18	WOS:A1996VM28800012
J	BOEHNKE, M				BOEHNKE, M			ALLELE FREQUENCY ESTIMATION FROM DATA ON RELATIVES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HYPERVARIABLE REGION; PEDIGREE ANALYSIS; B GENE	Given genetic marker data on unrelated individuals, maximum-likelihood allele-frequency estimates and their standard errors are easily calculated from sample proportions. When marker phenotypes are observed on relatives, this method cannot be used without either discarding a subset of the data or incorrectly assuming that all individuals are unrelated. Here, I describe a method for allele frequency estimation for data on relatives that is based on standard methods of pedigree analysis. This method makes use of all available marker information while correctly taking into account the dependence between relatives. I illustrate use of the method with family data for a VNTR polymorphism near the apolipoprotein B locus.			BOEHNKE, M (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109, USA.				NHGRI NIH HHS [R29-HG00376] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bird T D, 1987, Alzheimer Dis Assoc Disord, V1, P251, DOI 10.1097/00002093-198701040-00004; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; CUNY G, 1989, CYTOGENET CELL GENET, V51, P982; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1983, HUM HERED, V33, P291, DOI 10.1159/000153393; LUDWIG EH, 1989, AM J HUM GENET, V45, P458; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; RAO CR, 1973, LINEAR STATISTICAL I, P364; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; WEBER JL, 1989, AM J HUM GENET, V44, P388	11	246	248	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					22	25						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985459				2022-12-18	WOS:A1991ET18800003
J	Himes, BE; Hunninghake, GM; Baurley, JW; Rafaels, NM; Sleiman, P; Strachan, DP; Wilk, JB; Willis-Owen, SAG; Klanderman, B; Lasky-Su, J; Lazarus, R; Murphy, AJ; Soto-Quiros, ME; Avila, L; Beaty, T; Mathias, RA; Ruczinski, I; Barnes, KC; Celedon, JC; Cookson, WOC; Gauderman, WJ; Gilliland, FD; Hakonarson, H; Lange, C; Moffatt, MF; O'Connor, GT; Raby, BA; Silverman, EK; Weiss, ST				Himes, Blanca E.; Hunninghake, Gary M.; Baurley, James W.; Rafaels, Nicholas M.; Sleiman, Patrick; Strachan, David P.; Wilk, Jemma B.; Willis-Owen, Saffron A. G.; Klanderman, Barbara; Lasky-Su, Jessica; Lazarus, Ross; Murphy, Amy J.; Soto-Quiros, Manuel E.; Avila, Lydiana; Beaty, Terri; Mathias, Rasika A.; Ruczinski, Ingo; Barnes, Kathleen C.; Celedon, Juan C.; Cookson, William O. C.; Gauderman, W. James; Gilliland, Frank D.; Hakonarson, Hakon; Lange, Christoph; Moffatt, Miriam F.; O'Connor, George T.; Raby, Benjamin A.; Silverman, Edwin K.; Weiss, Scott T.			Genome-wide Association Analysis Identifies PDE4D as an Asthma-Susceptibility Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHODIESTERASE 4D GENE; CHILDHOOD ASTHMA; ORMDL3 EXPRESSION; RISK; POLYMORPHISMS; LINKAGE; INHIBITORS; MARKERS; DESIGN; HEART	Asthma, a chronic airway disease with known heritability, affects more than 300 million people around the world. A genome-wide association (GWA) study of asthma with 359 cases from the Childhood Asthma Management Program (CAMP) and 846 genetically matched controls from the Illumina ICONdb public resource was performed. The strongest region of association seen was on chromosome 5q12 in PDE4D. The phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) gene (PDE4D) is a regulator of airway smooth-muscle contractility, and PDE4 inhibitors have been developed as medications for asthma. Allelic p values for top SNPs in this region were 4.3 x 10(-07) for rs1588265 and 9.7 x 10(-07) for rs1544791. Replications were investigated in ten independent populations with different ethnicities, study designs, and definitions of asthma. In seven white and Hispanic replication populations, two PDE4D SNPs had significant results with p values less than 0.05, and five had results in the same direction as the original population but had p values greater than 0.05. Combined p values for 18,891 white and Hispanic individuals (4,342 cases) in our replication populations were 4.1 x 10(-04) for rs1588265 and 9.2 x 10(-04) for rs1544791. In three black replication populations, which had different linkage disequilibrium patterns than the other populations, original findings were not replicated. Further study of PDE4D variants might lead to improved understanding of the role of PDE4D in asthma pathophysiology and the efficacy of PDE4 inhibitor medications.	[Himes, Blanca E.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02138 USA; [Himes, Blanca E.; Hunninghake, Gary M.; Klanderman, Barbara; Lasky-Su, Jessica; Lazarus, Ross; Murphy, Amy J.; Celedon, Juan C.; Lange, Christoph; Silverman, Edwin K.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Himes, Blanca E.; Hunninghake, Gary M.; Klanderman, Barbara; Lasky-Su, Jessica; Lazarus, Ross; Murphy, Amy J.; Celedon, Juan C.; Lange, Christoph; Raby, Benjamin A.; Silverman, Edwin K.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Himes, Blanca E.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Himes, Blanca E.] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Baurley, James W.; Gauderman, W. James; Gilliland, Frank D.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA; [Rafaels, Nicholas M.; Beaty, Terri; Ruczinski, Ingo; Barnes, Kathleen C.] Johns Hopkins Univ, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA; [Sleiman, Patrick; Hakonarson, Hakon] Univ Philadelphia, Childrens Hosp Philadelphia, Ctr Appl Genom, Div Human Genet,Sch Med, Philadelphia, PA 19104 USA; [Strachan, David P.] Univ London, London SW17 0RE, England; [Wilk, Jemma B.; O'Connor, George T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Willis-Owen, Saffron A. G.; Cookson, William O. C.; Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Soto-Quiros, Manuel E.; Avila, Lydiana] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Div Pediat Pulmonol, San Jose, Costa Rica; [Mathias, Rasika A.] NHGRI, Inherited Dis Res Inst, NIH, Baltimore, MD 21224 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; Boston University; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA)	Himes, BE (corresponding author), Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02138 USA.	blanca_himes@hms.harvard.edu	Cookson, William/HHC-1790-2022; Avila, Lydiana/D-5638-2015; Raby, Benjamin/AAK-3866-2021	Avila, Lydiana/0000-0002-9579-1591; Willis-Owen, Saffron/0000-0003-2633-1150; lazarus, ross/0000-0003-3939-1961; O'Connor, George/0000-0002-6476-3926	NHLBI National Institutes of Health (NIH) [U01 HL075419, U01 HL65899, P01 HL083069, R01 HL086601, T32 HL07427]; NIH [R37 HL066289, 5R01HL087680, 5P01ES011627, 5P30ES007048, 2T15LM007092-16]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL066289, R01HL086601, R01HL087680, U01HL075419, P01HL083069, T32HL007427, U01HL065899, K08HL092222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, P01ES011627] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	NHLBI National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank all CAMP subjects for their ongoing participation in this study. We acknowledge the CAMP investigators and research team, supported by the National Heart, Lung, and Blood Institute (NHLBI), for collection of CAMP Genetic Ancillary Study data. All work on data collected from the CAMP Genetic Ancillary Study was conducted at the Charming Laboratory of the Brigham and Women's Hospital under appropriate CAMP policies and human subject protections. The CAMP Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, p01 HL083069, R01 HL086601, and T32 HL07427 from the NHLBI National Institutes of Health (NIH). Additional support was provided by the following NIH grants: R37 HL066289, 5R01HL087680 (NHLBI); 5P01ES011627, and 5P30ES007048 (National Institute of Environmental Health Sciences); and 2T15LM007092-16 (National Library of Medicine). We acknowledge use of genotype data from the B58C DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. We are grateful to John Todd, Diabetes & Inflammation Laboratory, University of Cambridge, and Panos Deloukas, Wellcome Trust Sanger Institute, for depositing genotype data on the B58C. K.C.B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program. R.A.M. was supported by the Intramural Research Program of the National Human Genoine Research Institute, NIH. We thank Georgia Dunston and Mezbah Faruque from Howard University, Washington, DC, for their vital contribution in the recruitment of the GRAADI cohort.	*AM LUNG ASS, 2006, TRENDS ASTHM MORB MO; Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Butland BK, 2007, ANN ALLERG ASTHMA IM, V98, P337, DOI 10.1016/S1081-1206(10)60879-4; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; DeMeo DL, 2002, GENET EPIDEMIOL, V23, P335, DOI 10.1002/gepi.10182; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fisher RA., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; *GLOB IN ASTHM MA, 1995, NHLBI WHO WORKSH REP; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Homma S, 2006, INT J MOL MED, V18, P933; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V119, P654, DOI 10.1016/j.jaci.2006.12.609; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Leung TF, 2009, ALLERGY, V64, P621, DOI 10.1111/j.1398-9995.2008.01873.x; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Ly NP, 2008, CHEST, V133, P107, DOI 10.1378/chest.07-2130; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Munshi A, 2008, INT J STROKE, V3, P188, DOI 10.1111/j.1747-4949.2008.00199.x; *NAT ASTHM ED PROG, 2007, 3 US DEP HHS NAT AST; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Reneland RH, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-9; Rosand J, 2006, NAT GENET, V38, P1091, DOI 10.1038/ng1006-1091; Silverman EK, 2003, J ALLERGY CLIN IMMUN, V112, P870, DOI 10.1016/S0091-6749(03)02023-2; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Strachan DP, 2007, INT J EPIDEMIOL, V36, P522, DOI 10.1093/ije/dyl309; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x	50	245	253	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					581	593		10.1016/j.ajhg.2009.04.006	http://dx.doi.org/10.1016/j.ajhg.2009.04.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19426955	Green Published, Bronze			2022-12-18	WOS:000266338800003
J	Fagundes, NJR; Kanitz, R; Eckert, R; Valls, ACS; Bogo, MR; Salzano, FM; Smith, DG; Silva, WA; Zago, MA; Ribeiro-Dos-Santos, AK; Santos, SEB; Petzl-Erler, ML; Bonatto, SL				Fagundes, Nelson J. R.; Kanitz, Ricardo; Eckert, Roberta; Valls, Ana C. S.; Bogo, Mauricio R.; Salzano, Francisco M.; Smith, David Glenn; Silva, Wilson A.; Zago, Marco A.; Ribeiro-dos-Santos, Andrea K.; Santos, Sidney E. B.; Petzl-Erler, Maria Luiza; Bonatto, Sandro L.			Mitochondrial population genomics supports a single pre-Clovis origin with a coastal route for the peopling of the Americas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LAST GLACIAL MAXIMUM; MTDNA HAPLOGROUP X; NATIVE-AMERICANS; MOLECULAR VARIABILITY; GENETIC HISTORY; DNA DIVERSITY; ALU INSERTION; NEW-WORLD; MIGRATION; IDENTIFICATION	It is well accepted that the Americas were the last continents reached by modern humans, most likely through Beringia. However, the precise time and mode of the colonization of the New World remain hotly disputed issues. Native American populations exhibit almost exclusively five mitochondrial DNA (mtDNA) haplogroups (A-D and X). Haplogroups A-D are also frequent in Asia, suggesting a northeastern Asian origin of these lineages. However, the differential pattern of distribution and frequency of haplogroup X led some to suggest that it may represent an independent migration to the Americas. Here we show, by using 86 complete mitochondrial genomes, that all Native American haplogroups, including haplogroup X, were part of a single founding population, thereby refuting multiple-migration models. A detailed demographic history of the mtDNA sequences estimated with a Bayesian coalescent method indicates a complex model for the peopling of the Americas, in which the initial differentiation from Asian populations ended with a moderate bottleneck in Beringia during the last glacial maximum (LGM), around similar to 23,000 to similar to 19,000 years ago. Toward the end of the LGM, a strong population expansion started similar to 18,000 and finished similar to 15,000 years ago. These results support a pre-Clovis occupation of the New World, suggesting a rapid settlement of the continent along a Pacific coastal route.	[Fagundes, Nelson J. R.; Kanitz, Ricardo; Eckert, Roberta; Valls, Ana C. S.; Bogo, Mauricio R.; Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, BR-91619900 Porto Alegre, RS, Brazil; [Fagundes, Nelson J. R.; Salzano, Francisco M.] Univ Fed Rio Grande do Sul, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil; [Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Mol Anthropol Lab, Davis, CA 95616 USA; [Silva, Wilson A.; Zago, Marco A.] Univ Sao Paulo, Fac Med, BR-14049900 Ribeirao Preto, SP, Brazil; [Ribeiro-dos-Santos, Andrea K.; Santos, Sidney E. B.] Fed Univ Para, Dept Patol, BR-66075970 Belem, Para, Brazil; [Petzl-Erler, Maria Luiza] Univ Fed Parana, Dept Genet, BR-81531990 Curitiba, Parana, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; University of California System; University of California Davis; Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal do Parana	Bonatto, SL (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, BR-91619900 Porto Alegre, RS, Brazil.	slbonatto@pucrs.br	Salzano, Francisco M/L-7916-2015; Bogo, Mauricio R/D-7537-2013; Santos, Ândrea Ribeiro dos/B-6061-2013; Bonatto, Sandro L/A-1240-2010; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Petzl-Erler, Maria Luiza/H-8221-2012; ZAGO, MARCO A/E-9442-2017; Santos, Sidney/B-6064-2013; Kanitz, Ricardo/F-4177-2012; Silva Jr, Wilson Araújo/E-9487-2011; Fagundes, Nelson/F-7490-2014	Bogo, Mauricio R/0000-0002-5728-9576; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Bonatto, Sandro L/0000-0002-0064-467X; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Kanitz, Ricardo/0000-0003-4759-0207; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Fagundes, Nelson/0000-0003-0456-0323				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Battilana J, 2007, ANN HUM GENET, V71, P64, DOI 10.1111/j.1469-1809.2006.00296.x; Battilana J, 2006, ANN HUM BIOL, V33, P142, DOI 10.1080/03014460500487347; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Brubaker LB, 2005, J BIOGEOGR, V32, P833, DOI 10.1111/j.1365-2699.2004.01203.x; Clarkson PM, 2002, AUDITING-J PRACT TH, V21, P7, DOI 10.2308/aud.2002.21.2.7; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derenko MV, 2001, AM J HUM GENET, V69, P237, DOI 10.1086/321266; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Dillehay TD, 1997, ARCHAEOLOGICAL CONTE, V2; Dixon E.J., 1993, QUEST ORIGINS 1 AM; Dixon EJ, 2001, QUATERNARY SCI REV, V20, P277; Dornelles CL, 2005, AM J PHYS ANTHROPOL, V127, P439, DOI 10.1002/ajpa.20103; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Elias SA, 2001, QUATERNARY SCI REV, V20, P7, DOI 10.1016/S0277-3791(00)00135-9; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAGAN BM, 1944, GREAT JOURNEY PEOPLI; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; FLADMARK KR, 1979, AM ANTIQUITY, V44, P55, DOI 10.2307/279189; Forster P, 1996, AM J HUM GENET, V59, P935; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Heller AH, 2004, HUM BIOL, V76, P591, DOI 10.1353/hub.2004.0056; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; Kelly RL, 2003, QUATERN INT, V109, P133, DOI 10.1016/S1040-6182(02)00209-4; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; KIDD JR, 1991, HUM BIOL, V63, P775; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malhi RS, 2002, AM J PHYS ANTHROPOL, V119, P84, DOI 10.1002/ajpa.10106; Merriwether DA, 1996, AM J HUM GENET, V59, P204; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; O'Rourke DH, 2000, HUM BIOL, V72, P15; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schaefer JM, 2006, SCIENCE, V312, P1510, DOI 10.1126/science.1122872; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Stanford D., 2002, MEMOIRS CALIFORNIA A, P255; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Straus LG, 2005, WORLD ARCHAEOL, V37, P507, DOI 10.1080/00438240500395797; Surovell TA, 2003, CURR ANTHROPOL, V44, P580, DOI 10.1086/377651; Swofford D.L., 2003, PAUP PHYLOGENETIC AN; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tarazona-Santos E, 2002, AM J HUM GENET, V70, P1377, DOI 10.1086/340388; VASILEV SA, 2000, HUNTERS GOLDEN AGE M, P173; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	73	245	259	0	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					583	592		10.1016/j.ajhg.2007.11.013	http://dx.doi.org/10.1016/j.ajhg.2007.11.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18313026	Green Published, Bronze			2022-12-18	WOS:000254067800003
J	Lorenz-Depiereux, B; Benet-Pages, A; Eckstein, G; Tenenbaum-Rakover, Y; Wagenstaller, J; Tiosano, D; Gershoni-Baruch, R; Albers, N; Lichtner, P; Schnabel, D; Hochberg, Z; Strom, TM				Lorenz-Depiereux, B; Benet-Pages, A; Eckstein, G; Tenenbaum-Rakover, Y; Wagenstaller, J; Tiosano, D; Gershoni-Baruch, R; Albers, N; Lichtner, P; Schnabel, D; Hochberg, Z; Strom, TM			Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; OSTEOMALACIA; ABLATION; PROGRAM; CLONING; MAPS	Hypophosphatemia due to isolated renal phosphate wasting results from a heterogeneous group of disorders. Hereditary hypophosphatemic rickets with hypercalciuria ( HHRH) is an autosomal recessive form that is characterized by reduced renal phosphate reabsorption, hypophosphatemia, and rickets. It can be distinguished from other forms of hypophosphatemia by increased serum levels of 1,25-dihydroxyvitamin D resulting in hypercalciuria. Using SNP array genotyping, we mapped the disease locus in two consanguineous families to the end of the long arm of chromosome 9. The candidate region contained a sodium-phosphate cotransporter gene, SLC34A3, which has been shown to be expressed in proximal tubulus cells. Sequencing of this gene revealed disease-associated mutations in five families, including two frameshift and one splice-site mutation. Loss of function of the SLC34A3 protein presumably results in a primary renal tubular defect and is compatible with the HHRH phenotype. We also show that the phosphaturic factor FGF23 ( fibroblast growth factor 23), which is increased in X-linked hypophosphatemic rickets and carries activating mutations in autosomal dominant hypophosphatemic rickets, is at normal or low-normal serum levels in the patients with HHRH, further supporting a primary renal defect. Identification of the gene mutated in a further form of hypophosphatemia adds to the understanding of phosphate homeostasis and may help to elucidate the interaction of the proteins involved in this pathway.	Inst Human Genet, GSF Natl Res Ctr, D-85764 Neuherberg, Germany; HaEmek Med Ctr, Pediat Endocrine Unit, Afula, Israel; Meyer Childrens Hosp, Haifa, Israel; Technion Israel Inst Technol, Haifa, Israel; Childrens Hosp, Osnabruck, Germany; Charite, Dept Pediat Endocrinol, Berlin, Germany; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany	Emek Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Strom, TM (corresponding author), Inst Human Genet, GSF Natl Res Ctr, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	TimStrom@gsf.de		Schnabel, Dirk/0000-0002-7944-7790				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beret-Pages A, 2004, BONE, V35, P455, DOI 10.1016/j.bone.2004.04.002; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HOCHBERG Z, 2004, PEDIAT ENDOCRINOLOGY, P614; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; LOBAUGH B, 1983, J CLIN INVEST, V71, P400, DOI 10.1172/JCI110783; MAGAGNIN S, 1993, P NATL ACAD SCI USA, V90, P5979, DOI 10.1073/pnas.90.13.5979; Matise TC, 1999, AM J HUM GENET, V65, pA435; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; NISHIYAMA S, 1986, J PEDIATR GASTR NUTR, V5, P826, DOI 10.1097/00005176-198609000-00029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Russmann H, 2005, REGUL CHAOTIC DYN, V10, P21, DOI 10.1070/RD2005v010n01ABEH000297; Schnabel D., 1996, Hormone Research (Basel), V46, P84; SCRIVER CR, 1978, NEW ENGL J MED, V299, P976, DOI 10.1056/NEJM197811022991803; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; Tenenhouse HS, 2003, AM J PHYSIOL-RENAL, V285, pF1271, DOI 10.1152/ajprenal.00252.2003; TENENHOUSE HS, 1994, J CLIN INVEST, V93, P671, DOI 10.1172/JCI117019; TIEDER M, 1992, NEPHRON, V62, P176, DOI 10.1159/000187029; TIEDER M, 1987, NEW ENGL J MED, V316, P125, DOI 10.1056/NEJM198701153160302; van den Heuvel L, 2001, NEPHROL DIAL TRANSPL, V16, P48, DOI 10.1093/ndt/16.1.48; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664	35	245	262	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					193	201		10.1086/499410	http://dx.doi.org/10.1086/499410			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16358215	Bronze, Green Published			2022-12-18	WOS:000236744900002
J	Siegel, DH; Ashton, GHS; Penagos, HG; Lee, JV; Feiler, HS; Wilhelmsen, KC; South, AP; Smith, FJD; Prescott, AR; Wessagowit, V; Oyama, N; Akiyama, M; Al Aboud, D; Al Aboud, K; Al Githami, A; Al Hawsawi, K; Al Ismaily, A; Al-Suwaid, R; Atherton, DJ; Caputo, R; Fine, JD; Frieden, IJ; Fuchs, E; Haber, RM; Harada, T; Kitajima, Y; Mallory, SB; Ogawa, H; Sahin, S; Shimizu, H; Suga, Y; Tadini, G; Tsuchiya, K; Wiebe, CB; Wojnarowska, F; Zaghloul, AB; Hamada, T; Mallipeddi, R; Eady, RAJ; McLean, WHI; McGrath, JA; Epstein, EH				Siegel, DH; Ashton, GHS; Penagos, HG; Lee, JV; Feiler, HS; Wilhelmsen, KC; South, AP; Smith, FJD; Prescott, AR; Wessagowit, V; Oyama, N; Akiyama, M; Al Aboud, D; Al Aboud, K; Al Githami, A; Al Hawsawi, K; Al Ismaily, A; Al-Suwaid, R; Atherton, DJ; Caputo, R; Fine, JD; Frieden, IJ; Fuchs, E; Haber, RM; Harada, T; Kitajima, Y; Mallory, SB; Ogawa, H; Sahin, S; Shimizu, H; Suga, Y; Tadini, G; Tsuchiya, K; Wiebe, CB; Wojnarowska, F; Zaghloul, AB; Hamada, T; Mallipeddi, R; Eady, RAJ; McLean, WHI; McGrath, JA; Epstein, EH			Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA; MUSCULAR-DYSTROPHY; LINKAGE ANALYSIS; MEMBRANE; PLECTIN; GENE; IDENTIFICATION; LOCALIZATION; ADHESIONS/; DOMAINS	Kindler syndrome is an autosomal recessive disorder characterized by neonatal blistering, sun sensitivity, atrophy, abnormal pigmentation, and fragility of the skin. Linkage and homozygosity analysis in an isolated Panamanian cohort and in additional inbred families mapped the gene to 20p12.3. Loss-of-function mutations were identified in the FLJ20116 gene ( renamed "KIND1" [ encoding kindlin-1]). Kindlin-1 is a human homolog of the Caenorhabditis elegans protein UNC-112, a membrane-associated structural/signaling protein that has been implicated in linking the actin cytoskeleton to the extracellular matrix (ECM). Thus, Kindler syndrome is, to our knowledge, the first skin fragility disorder caused by a defect in actin-ECM linkage, rather than keratin-ECM linkage.	Univ Calif San Francisco, San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94143 USA; St Thomas Hosp, Guys Kings Coll & St Thomas Hosp Med Sch, St Johns Inst Dermatol, Dept Cell & Mol Pathol, London, England; Hosp Sick Children, Dept Dermatol, London WC1N 3JH, England; Social Secur Bur Panama, Dept Dermatol, David, Chiriqui, Panama; Univ Calif, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; Univ Dundee, Ninewells Hosp & Med Sch, Human Genet Unit, Epithelial Genet Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Sch Life Sci, Ctr High Resolut Imaging & Proc, Dundee, Scotland; Hokkaido Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido 060, Japan; Sapporo City Hosp, Dept Dermatol, Sapporo, Hokkaido, Japan; King Faisal Hosp, Dept Dermatol, At Taif, Saudi Arabia; King Khalid Natl Guard Hosp, Jeddah, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; Al Nahdha Hosp, Dept Dermatol, Ruwi, Oman; Univ Milan, Inst Dermatol Sci, Ctr Inherited Cutaneous Dis,Dept Dermatol, Inst Ricovero & Cura Carattere Sci Osped Maggiore, Milan, Italy; Univ Kentucky, Coll Med, Dept Dermatol,Dermatol Associates Kentucky, Natl Epidermolysis Bullosa Registry, Lexington, KY USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Daini Hosp, Tokyo Womens Med Sch, Dept Dermatol, Tokyo, Japan; Juntendo Univ, Sch Med, Dept Dermatol, Tokyo 113, Japan; Gifu Univ, Sch Med, Dept Dermatol, Gifu 500, Japan; Washington Univ, Sch Med, Div Dermatol, St Louis, MO USA; Hacettepe Univ, Sch Med, Dept Dermatol, Ankara, Turkey; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England; Cairo Skin VD Hosp, Cairo, Egypt	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of Dundee; University of Dundee; Hokkaido University; King Faisal Specialist Hospital & Research Center; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; King Faisal Specialist Hospital & Research Center; University of Milan; University of Kentucky; Howard Hughes Medical Institute; Rockefeller University; Tokyo Women's Medical University; Juntendo University; Gifu University; Washington University (WUSTL); Hacettepe University; University of British Columbia; University of Oxford	Siegel, DH (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94143 USA.		Fuchs, Elaine/G-1565-2016; McLean, William HI/C-6352-2009; Shimizu, Hiroshi/A-5193-2012; Akiyama, Masashi/I-1122-2012; McGrath, John/N-3529-2019; Prescott, Alan/Y-5956-2018; McGrath, John/D-6824-2012	Prescott, Alan/0000-0002-0747-7317; McLean, William Henry Irwin/0000-0001-5539-5757; McGrath, John/0000-0002-3708-9964; Oyama, Noritaka/0000-0003-4934-5205; Frieden, Ilona/0000-0001-7305-5940	NIAMS NIH HHS [AR 123456] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Al Aboud K, 2002, CLIN EXP DERMATOL, V27, P673, DOI 10.1046/j.1365-2230.2002.01127.x; Bleck O, 1999, J INVEST DERMATOL, V113, P894, DOI 10.1046/j.1523-1747.1999.00809.x; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Haber RM, 1996, ARCH DERMATOL, V132, P1487, DOI 10.1001/archderm.132.12.1487; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; KINDLER T, 1954, BRIT J DERMATOL, V66, P104, DOI 10.1111/j.1365-2133.1954.tb12598.x; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Navasaria HA, 1994, KERATINOCYTE METHODS, P5; Nei M., 1987, MOL EVOLUTIONARY GEN; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Senturk N, 1999, J AM ACAD DERMATOL, V40, P335, DOI 10.1016/S0190-9622(99)70480-9; Shimizu H, 1997, ARCH DERMATOL, V133, P1111, DOI 10.1001/archderm.133.9.1111; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Sobel E, 1996, AM J HUM GENET, V58, P1323; Suga Y, 2000, INT J DERMATOL, V39, P284, DOI 10.1046/j.1365-4362.2000.00962.x; WEBER JL, 1989, AM J HUM GENET, V44, P388; WICK M, 1994, J CELL SCI, V107, P227; Wiebe CB, 1996, J PERIODONTOL, V67, P1004, DOI 10.1902/jop.1996.67.10.1004; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2001, J CELL SCI, V114, P3577; ZHANG Y, 1995, CYTOGENET CELL GENET, V68, P235, DOI 10.1159/000133921; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	33	245	258	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					174	187		10.1086/376609	http://dx.doi.org/10.1086/376609			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12789646	Green Published, Bronze			2022-12-18	WOS:000183904900015
J	Ebersberger, I; Metzler, D; Schwarz, C; Paabo, S				Ebersberger, I; Metzler, D; Schwarz, C; Paabo, S			Genomewide comparison of DNA sequences between humans and chimpanzees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-CHROMOSOME; MOLECULAR EVOLUTION; MUTATION-RATE; PHYLOGENY; HOMINOIDS; REGION; LOCUS	A total of 8,859 DNA sequences encompassing similar to1.9 million base pairs of the chimpanzee genome were sequenced and compared to corresponding human DNA sequences. Although the average sequence difference is low (1.24%), the extent of changes is markedly different among sites and types of substitutions. Whereas similar to15% of all CpG sites have experienced changes between humans and chimpanzees, owing to a 23-fold excess of transitions and a 7-fold excess of transversions, substitutions at other sites vary in frequency, between 0.1% and 0.5%. If the nucleotide diversity in the common ancestral species of humans and chimpanzees is assumed to have been about fourfold higher than in contemporary humans, all possible comparisons between autosomes and X and Y chromosomes result in estimates of the ratio between male and female mutation rates of similar to3. Thus, the relative time spent in the male and female germlines may be a major determinant of the overall accumulation of nucleotide substitutions. However, since the extent of divergence differs significantly among autosomes, additional unknown factors must also influence the accumulation of substitutions in the human genome.	Max Planck Inst Evolut Anthropol, D-04103 Leipzig, Germany; Univ Frankfurt, Dept Math, D-6000 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Paabo, S (corresponding author), Max Planck Inst Evolut Anthropol, Inselstr 22, D-04103 Leipzig, Germany.		Metzler, Dirk/K-2797-2014	Metzler, Dirk/0000-0003-1027-135X				Agnez-Lima LF, 2001, NUCLEIC ACIDS RES, V29, P2899, DOI 10.1093/nar/29.13.2899; Anagnostopoulos T, 1999, AM J HUM GENET, V64, P508, DOI 10.1086/302250; BAILEY WJ, 1991, MOL BIOL EVOL, V8, P155; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Casane D, 1997, J MOL EVOL, V45, P216, DOI 10.1007/PL00006223; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; GOODMAN M, 1990, J MOL EVOL, V30, P260, DOI 10.1007/BF02099995; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Hurst LD, 1998, TRENDS GENET, V14, P446, DOI 10.1016/S0168-9525(98)01577-7; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lercher MJ, 2001, MOL BIOL EVOL, V18, P2032, DOI 10.1093/oxfordjournals.molbev.a003744; LI WH, 1977, GENETICS, V85, P331; Matassi G, 1999, CURR BIOL, V9, P786, DOI 10.1016/S0960-9822(99)80361-3; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Rice J. A., 1995, MATH STAT DATA ANAL; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980	26	245	253	0	19	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1490	1497		10.1086/340787	http://dx.doi.org/10.1086/340787			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992255	Bronze, Green Published			2022-12-18	WOS:000175445700010
J	MCINNIS, MG; MCMAHON, FJ; CHASE, GA; SIMPSON, SG; ROSS, CA; DEPAULO, JR				MCINNIS, MG; MCMAHON, FJ; CHASE, GA; SIMPSON, SG; ROSS, CA; DEPAULO, JR			ANTICIPATION IN BIPOLAR AFFECTIVE-DISORDER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY; DEPRESSIVE-DISORDERS; REPEAT; TRANSMISSION; RELATIVES; ILLNESS	Anticipation refers to the increase in disease severity or decrease in age at onset in succeeding generations. This phenomenon, formerly ascribed to observation biases, correlates with the expansion of trinucleotide repeat sequences (TNRs) in some disorders. If present in bipolar affective disorder (BPAD), anticipation could provide clues to its genetic etiology. We compared age at onset and disease severity between two generations of 34 unilineal families ascertained for a genetic linkage study of BPAD. Life-table analyses showed a significant decrease in survival to first mania or depression from the first to the second generation (P < .001). Intergenerational pairwise comparisons showed both a significantly earlier age at onset (P < .001) and a significantly increased disease severity (P < .001) in the second generation. This difference was significant under each of four data-sampling schemes which excluded probands in the second generation. The second generation experienced onset 8.9-13.5 years earlier and illness 1.8-3.4 times more severe than did the first generation. In additional analyses, drug abuse, deaths of affected individuals prior to interview, decreased fertility, censoring of age at onset, and the cohort effect did not affect our results. We conclude that genetic anticipation occurs in this sample of unilineal BPAD families. These findings may implicate genes with expanding TNRs in the genetic etiology of BPAD.			MCINNIS, MG (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PSYCHIATR & BEHAV SCI, 600 N WOLFE ST, BALTIMORE, MD 21287 USA.		McMahon, Francis J/A-7290-2009; McInnis, Melvin G/F-6963-2012	McMahon, Francis J/0000-0002-9469-305X; McInnis, Melvin G/0000-0002-0375-6247; DePaulo, J Raymond/0000-0001-9221-9226	NIMH NIH HHS [NIMHMH 42243, NIMH MH 15330-14] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015330] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERTELSEN A, 1977, BRIT J PSYCHIAT, V130, P330, DOI 10.1192/bjp.130.4.330; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CORYELL W, 1984, BRIT J PSYCHIAT, V145, P49, DOI 10.1192/bjp.145.1.49; COX DR, 1972, J R STAT SOC B, V34, P187; EGELAND JA, 1987, J AFFECT DISORDERS, V12, P159, DOI 10.1016/0165-0327(87)90009-7; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fleiseher B., 1918, ALBRECHT GRAEFES ARC, V96, P91, DOI DOI 10.1007/BF02018704; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GERSHON ES, 1987, ARCH GEN PSYCHIAT, V44, P314; HARPER PS, 1992, AM J HUM GENET, V51, P10; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; Kraepelin E., 1921, MANIC DEPRESSIVE INS; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MENDLEWICZ J, 1977, NATURE, V268, P327, DOI 10.1038/268327a0; Morel BA, 1857, TRAITE DEGENERSCENCE; Mott FW, 1911, LANCET, V1, P1251; Mott FW, 1910, BRIT MED J, V1910, P1013, DOI 10.1136/bmj.2.2597.1013; PENROSE LS, 1948, ANN EUGENIC, V14, P125; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SIMPSON SG, 1992, AM J PSYCHIAT, V149, P1660; Spitzer R.L., 1975, RES DIAGNOSTIC CRITE, V2; WARSHAW MG, 1991, J PSYCHIAT RES, V25, P141, DOI 10.1016/0022-3956(91)90007-W; WINOKUR G, 1982, AM J PSYCHIAT, V139, P209	24	245	247	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					385	390						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328456				2022-12-18	WOS:A1993LN82000010
J	HALL, JM; FRIEDMAN, L; GUENTHER, C; LEE, MK; WEBER, JL; BLACK, DM; KING, MC				HALL, JM; FRIEDMAN, L; GUENTHER, C; LEE, MK; WEBER, JL; BLACK, DM; KING, MC			CLOSING IN ON A BREAST-CANCER GENE ON CHROMOSOME-17Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE	Linkage of early-onset familial breast and ovarian cancer to 11 markers on chromosome 17q12-q21 defines an 8-cM region which is very likely to include the disease gene BRCA 1. The most closely linked marker is D17S579, a highly informative CA repeat polymorphism. D17S579 has no recombinants with inherited breast or ovarian cancer in 79 informative meioses in the seven families with early-onset disease (lod score 9.12 at zero recombination). There is no evidence for linkage heterogeneity in the families with early-onset disease. The proportion of older-onset breast cancer attributable to BRCA 1 is not yet determinable, because both inherited and sporadic cases occur in older-onset families.	UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; MARSHFIELD CLIN FDN MED RES & EDUC,MARSHFIELD,WI 54449	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cancer Research UK; Marshfield Clinic				King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [CA27632] Funding Source: Medline; NHGRI NIH HHS [HG00248] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000248] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CLAUS EB, 1991, AM J HUM GENET, V48, P232; FOULKES W, 1991, LANCET, V338, P444, DOI 10.1016/0140-6736(91)91065-3; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HALL JM, 1989, AM J HUM GENET, V44, P577; HALL JM, 1991, NUCLEIC ACIDS RES, V19, P2515, DOI 10.1093/nar/19.9.2515-a; JOHNSON TL, 1990, NUCLEIC ACIDS RES, V19, P4312; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEONE A, 1991, CANCER RES, V51, P2490; MARGARITTE P, 1992, AM J HUMG ENET, V50; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Ott J., 1991, ANAL HUMAN GENETIC L; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; SATO T, 1991, CANCER RES, V51, P5794; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; ZUPPAN P, 1991, AM J HUM GENET, V48, P1065	16	245	248	1	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1235	1242						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598904				2022-12-18	WOS:A1992HY65400011
J	SCHROEDER, WT; CHAO, LY; DAO, DD; STRONG, LC; PATHAK, S; RICCARDI, V; LEWIS, WH; SAUNDERS, GF				SCHROEDER, WT; CHAO, LY; DAO, DD; STRONG, LC; PATHAK, S; RICCARDI, V; LEWIS, WH; SAUNDERS, GF			NONRANDOM LOSS OF MATERNAL CHROMOSOME-11 ALLELES IN WILMS-TUMORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOCHEM & MOLEC BIOL,TEXAS MED CTR,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT GENET,HOUSTON,TX 77030; BAYLOR COLL MED,RES CYTOGENET LAB,HOUSTON,TX 77030; UNIV TORONTO,DEPT SURG,TORONTO M5S 1A1,ONTARIO,CANADA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Toronto					NATIONAL CANCER INSTITUTE [P01CA034936, P01CA033624] Funding Source: NIH RePORTER; NCI NIH HHS [CA33624, CA34936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOND JV, 1975, CANCER-AM CANCER SOC, V36, P1202, DOI 10.1002/1097-0142(197510)36:4<1202::AID-CNCR2820360404>3.0.CO;2-L; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; DAO DD, 1987, IN PRESS AM J HUM GE, V41; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; GOLDMAN SM, 1981, RADIOLOGY, V141, P87, DOI 10.1148/radiology.141.1.6270728; GONZALEZCRUSSI F, 1981, AM J SURG PATHOL, V5, P525, DOI 10.1097/00000478-198109000-00001; GRAY KM, 1985, NUCLEIC ACIDS RES, V13, P521, DOI 10.1093/nar/13.2.521; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HENDY GN, 1981, P NATL ACAD SCI-BIOL, V78, P7365, DOI 10.1073/pnas.78.12.7365; KANTOR AF, 1979, J EPIDEMIOL COMMUN H, V33, P253, DOI 10.1136/jech.33.4.253; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KORNELUK RG, 1984, J BIOL CHEM, V259, P3819; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; QUAN F, 1985, NUCLEIC ACIDS RES, V13, P8288, DOI 10.1093/nar/13.22.8288; RAIZIS AM, 1985, HUM GENET, V70, P344, DOI 10.1007/BF00295375; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Strong L. C., 1984, CLIN PEDIATRIC ONCOL, P14; TAGGART RT, 1985, P NATL ACAD SCI USA, V82, P6240, DOI 10.1073/pnas.82.18.6240; VOGEL F, 1975, ADV HUM GENET, V5, P223; WIGGER HJ, 1976, HUM PATHOL, V7, P613; WILKINS JR, 1984, J EPIDEMIOL COMMUN H, V38, P7, DOI 10.1136/jech.38.1.7; 1985, CYTOGENET CELL GENET, V40, P1	28	245	246	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1987	40	5					413	420						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H5759	2883892				2022-12-18	WOS:A1987H575900003
J	BOUGHMAN, JA; CONNEALLY, PM; NANCE, WE				BOUGHMAN, JA; CONNEALLY, PM; NANCE, WE			POPULATION GENETIC-STUDIES OF RETINITIS PIGMENTOSA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis	BOUGHMAN, JA (corresponding author), VIRGINIA COMMONWEALTH UNIV,DEPT MED GENET,RICHMOND,VA 23298, USA.							Adams A, 1972, Trans Ophthalmol Soc U K, V92, P233; Ammann F, 1965, J Neurol Sci, V2, P183, DOI 10.1016/0022-510X(65)90079-1; ARDEN GB, 1962, ARCH OPHTHALMOL-CHIC, V68, P369, DOI 10.1001/archopht.1962.00960030373012; BARRAI I, 1965, AM J HUM GENET, V17, P221; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P58; BOTERMANS CHG, 1972, HDB CLIN NEUROLOGY, V13, P148; BOUGHMAN JA, UNPUBLISHED; Carr R E, 1972, Trans Ophthalmol Soc U K, V92, P289; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, P368; DEWEY WJ, 1965, AM J HUM GENET, V17, P237; DUKEELDER S, 1967, DISEASES RETINA, V5, P574; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FRANCESCHETTI A, 1974, CHOROIDORETINAL HERE; FRANCOIS J, 1961, HEREDITY OPHTHALMOLO, P441; FRASER GR, 1965, ANN HUM GENET, V29, P171, DOI 10.1111/j.1469-1809.1965.tb00512.x; Jay B, 1972, Trans Ophthalmol Soc U K, V92, P173; KRILL AE, 1970, AM J OPHTHALMOL, V69, P683; MCKUSICK VA, 1975, MENDELIAN INHERITANC, P654; MERIN S, 1974, ACTA GENET MED GEMEL, V23, P49, DOI 10.1017/S1120962300023623; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; MORTON NE, 1969, COMPUTER APPLICATION, P129; OTT J, 1974, AM J HUM GENET, V26, P588; PENTELEEVA OA, 1969, VESTN OFTALMOL, V1, P53; SCHMIDT SY, 1976, INVEST OPHTH VISUAL, V15, P47; SPENCE MA, 1974, CLIN GENET, V5, P338; VOIPIO H, 1964, HEREDITAS-GENETISK A, V52, P247	27	245	249	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	2					223	235						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JS405	7386458				2022-12-18	WOS:A1980JS40500010
J	HOPKINSON, DA; HARRIS, H; SPENCER, N				HOPKINSON, DA; HARRIS, H; SPENCER, N			GENETICAL STUDIES ON HUMAN RED CELL ACID PHOSPHATASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABULFADL MAM, 1949, BIOCHEM J, V45, P51, DOI 10.1042/bj0450051; ANGELETTI PU, 1962, BLOOD, V20, P51, DOI 10.1182/blood.V20.1.51.51; BESSEY OA, 1946, J BIOL CHEM, V164, P321; CROSBY W H, 1954, U S Armed Forces Med J, V5, P693; HOPKINSON DA, 1963, NATURE, V199, P969, DOI 10.1038/199969a0; OSKI FA, 1963, SCIENCE, V139, P409, DOI 10.1126/science.139.3553.409; SPENCER N, 1964, NATURE, V201, P299, DOI 10.1038/201299a0; VALENTINE W, 1961, AM J CLIN PATHOL, V36, P328	8	245	245	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	1					141	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2971A	14131868				2022-12-18	WOS:A19642971A00002
J	Lederer, D; Grisart, B; Digilio, MC; Benoit, V; Crespin, M; Ghariani, SC; Maystadt, I; Dallapiccola, B; Verellen-Dumoulin, C				Lederer, Damien; Grisart, Bernard; Digilio, Maria Cristina; Benoit, Valerie; Crespin, Marianne; Ghariani, Sophie Claire; Maystadt, Isabelle; Dallapiccola, Bruno; Verellen-Dumoulin, Christine			Deletion of KDM6A, a Histone Demethylase Interacting with MLL2, in Three Patients with Kabuki Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RING CHROMOSOME-X; MAKE-UP SYNDROME; GENE-EXPRESSION; ARRAY-CGH; MENTAL-RETARDATION; UTX; MUTATIONS; CANCER; IDENTIFICATION; PHENOTYPE	Kabuki syndrome (KS) is a rare genetic disease that causes developmental delay and congenital anomalies. Since the identification of MLL2 mutations as the primaly cause of KS, such mutations have been identified in 56%-76% of affected individuals, suggesting that there may be additional genes associated with KS. Here, we describe three KS individuals with de novo partial or complete deletions of an X chromosome gene, KDM6A, that encodes a histone demethylase that interacts with MLL2. Although KDM6A escapes X inactivation, we found a skewed X inactivation pattern, in which the deleted X chromosome was inactivated in the majority of the cells. This study identifies KDM6A mutations as another cause of KS and highlights the growing role of histone methylases and histone demethylases in multiple-congenital-anomaly and intellectual-disability syndromes.	[Lederer, Damien; Grisart, Bernard; Benoit, Valerie; Crespin, Marianne; Maystadt, Isabelle; Verellen-Dumoulin, Christine] Inst Pathol & Genet, Ctr Genet Humaine, B-6041 Gosselies, Belgium; [Digilio, Maria Cristina; Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, Dept Med Genet, Ist Ricovero & Cura Carattere Sci, I-00165 Rome, Italy; [Ghariani, Sophie Claire] Ctr Neurol William Lennox, B-1340 Ottignies, Belgium; [Verellen-Dumoulin, Christine] Catholic Univ Louvain, Unite Genet Med, B-1200 Brussels, Belgium; [Verellen-Dumoulin, Christine] Catholic Univ Louvain, Ctr Genet Humaine, B-1200 Brussels, Belgium	IRCCS Bambino Gesu; Universite Catholique Louvain; Universite Catholique Louvain	Lederer, D (corresponding author), Inst Pathol & Genet, Ctr Genet Humaine, B-6041 Gosselies, Belgium.	damien.lederer@ipg.be	Maystadt, Isabelle/AAH-1483-2021; Digilio, Maria Cristina/AAI-2434-2019; Dallapiccola, Bruno/K-8692-2016	BENOIT, Valerie/0000-0002-1098-9452; Dallapiccola, Bruno/0000-0002-5031-1013	Fonds Marguerite-Marie Delacroix; Institut de Recherche Scientifique en Pathologie et Genetique	Fonds Marguerite-Marie Delacroix; Institut de Recherche Scientifique en Pathologie et Genetique	We thank the families for their participation, the "Fonds Marguerite-Marie Delacroix" for the research grant provided to DL, and Isabelle Leroy for the neurologic evaluation of the patients. Our work was supported by the Institut de Recherche Scientifique en Pathologie et Genetique. We thank Judith Goodship for her critical reading of the article.	Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Aziz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014534; Casanova M, 2011, AM J MED GENET A, V155A, P1504, DOI 10.1002/ajmg.a.33711; Cusco I, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-27; DENNIS NR, 1993, J MED GENET, V30, P482, DOI 10.1136/jmg.30.6.482; Digilio MC, 2010, PEDIATR CARDIOL, V31, P1111, DOI 10.1007/s00246-010-9773-y; Digilio MC, 2001, AM J MED GENET, V100, P269, DOI 10.1002/ajmg.1265; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ElAbd S, 1997, DEV MED CHILD NEUROL, V39, P119, DOI 10.1111/j.1469-8749.1997.tb07394.x; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Hannibal MC, 2011, AM J MED GENET A, V155A, P1511, DOI 10.1002/ajmg.a.34074; Herz HM, 2010, MOL CELL BIOL, V30, P2485, DOI 10.1128/MCB.01633-09; Hoffman JD, 2005, J MED GENET, V42, P49, DOI 10.1136/jmg.2004.024372; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; HUGHES HE, 1994, ARCH DIS CHILD, V70, P512, DOI 10.1136/adc.70.6.512; Kuniba H, 2009, J HUM GENET, V54, P304, DOI 10.1038/jhg.2009.30; KUROKI Y, 1981, J PEDIATR-US, V99, P570, DOI 10.1016/S0022-3476(81)80256-9; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Li Y, 2011, HUM GENET, V130, P715, DOI 10.1007/s00439-011-1004-y; Maas NMC, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049510; McGinniss MJ, 1997, AM J MED GENET, V70, P37, DOI 10.1002/(SICI)1096-8628(19970502)70:1<37::AID-AJMG8>3.3.CO;2-F; Micale L, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-38; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Miyake N, 2006, AM J MED GENET A, V140A, P291, DOI 10.1002/ajmg.a.31012; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; NIIKAWA N, 1988, AM J MED GENET, V31, P565, DOI 10.1002/ajmg.1320310312; NIIKAWA N, 1981, J PEDIATR-US, V99, P565, DOI 10.1016/S0022-3476(81)80255-7; Paulussen ADC, 2011, HUM MUTAT, V32, pE2018, DOI 10.1002/humu.21416; Rodriguez L, 2008, AM J MED GENET A, V146A, P2816, DOI 10.1002/ajmg.a.32521; Schoumans J, 2005, EUR J HUM GENET, V13, P260, DOI 10.1038/sj.ejhg.5201309; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Stankiewicz P, 2001, AM J MED GENET, V102, P286, DOI 10.1002/ajmg.1462; Su Pen-Hua, 2007, Acta Paediatr Taiwan, V48, P272; Tumino M, 2010, AM J MED GENET A, V152A, P1536, DOI 10.1002/ajmg.a.33405; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008	37	244	258	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					119	124		10.1016/j.ajhg.2011.11.021	http://dx.doi.org/10.1016/j.ajhg.2011.11.021			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22197486	Green Published, hybrid			2022-12-18	WOS:000299409100012
J	Gorlov, IP; Gorlova, OY; Sunyaev, SR; Spitz, MR; Amos, CI				Gorlov, Ivan P.; Gorlova, Olga Y.; Sunyaev, Shamil R.; Spitz, Margaret R.; Amos, Christopher I.			Shifting paradigm of association studies: Value of rare single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENVIRONMENTAL GENOME PROJECT; INTERNATIONAL HAPMAP PROJECT; GENE-MUTATION-DATABASE; FACTOR-H POLYMORPHISM; COMPLEX DISEASES; CANCER SUSCEPTIBILITY; BREAST-CANCER; MACULAR DEGENERATION; SEQUENCE VALIDATION; FUNCTIONAL-ANALYSIS	Currently, single-nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) of >5% are preferentially used in case-control association studies of common human diseases. Recent technological developments enable inexpensive and accurate genotyping of a large number of SNPs in thousands of cases and controls, which can provide adequate statistical power to analyze SNPs with MAF <5%. Our purpose was to determine whether evaluating rare SNPs in case-control association studies could help identify causal SNPs for common diseases. We suggest that slightly deleterious SNPs (sdSNPs) subjected to weak purifying selection are major players in genetic control of susceptibility to common diseases. We compared the distribution of MAFs of synonymous SNPs with that of nonsynonymous SNPs (1) predicted to be benign, (2) predicted to be possibly damaging, and (3) predicted to be probably damaging by PolyPhen. Our sources of data were the International HapMap Project, ENCODE, and the SeattleSNPs project. We found that the MAF distribution of possibly and probably damaging SNPs was shifted toward rare SNPs compared with the MAF distribution of benign and synonymous SNPs that are not likely to be functional. We also found an inverse relationship between MAF and the proportion of nsSNPs predicted to be protein disturbing. On the basis of this relationship, we estimated the joint probability that a SNP is functional and would be detected as significant in a case-control study. Our analysis suggests that including rare SNPs in genotyping platforms will advance identification of causal SNPs in case-control association studies, particularly as sample sizes increase.	[Gorlov, Ivan P.; Gorlova, Olga Y.; Spitz, Margaret R.; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Amos, CI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	camos@mdanderson.org			NCI NIH HHS [P01 CA034936, P01 CA 34936-14A1] Funding Source: Medline; NIEHS NIH HHS [ES09912, R01 ES009912] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abushamaa AM, 2002, AM J PHYSIOL-LUNG C, V283, pL336, DOI 10.1152/ajplung.00012.2002; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Cantor CR, 2005, ANN NY ACAD SCI, V1055, P48, DOI 10.1196/annals.1323.009; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlini DB, 2006, J MOL EVOL, V62, P89, DOI 10.1007/s00239-005-0055-x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Denecke J, 2004, HUM MUTAT, V23, P477, DOI 10.1002/humu.20026; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fan JB, 2002, GENOMICS, V80, P351, DOI 10.1006/geno.2002.6832; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gorlov IP, 2006, HUM MOL GENET, V15, P1143, DOI 10.1093/hmg/ddl029; Guengerich FP, 1998, ENVIRON HEALTH PERSP, V106, P365, DOI 10.2307/3434062; Horng JT, 2004, IEEE T INF TECHNOL B, V8, P59, DOI 10.1109/TITB.2004.824738; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; LI YY, 2006, ZHENG, V25, P906; Long AD, 1997, SCIENCE, V275, P1328; Mooney S, 2005, BRIEF BIOINFORM, V6, P44, DOI 10.1093/bib/6.1.44; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Nachman MW, 2000, GENETICS, V156, P297; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Park J, 2007, NUCLEIC ACIDS RES, V35, pD711, DOI 10.1093/nar/gkl962; Peng B, 2007, GENETICS, V175, P763, DOI 10.1534/genetics.106.058164; Pfarr N, 2005, J IMMUNOL, V174, P4172, DOI 10.4049/jimmunol.174.7.4172; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Schubert EL, 1999, J STEROID BIOCHEM, V71, P21, DOI 10.1016/S0960-0760(99)00126-0; Scott WK, 1997, SCIENCE, V275, P1327, DOI 10.1126/science.275.5304.1327; Sherry ST, 2000, HUM MUTAT, V15, P68, DOI 10.1002/(SICI)1098-1004(200001)15:1<68::AID-HUMU14>3.0.CO;2-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Taylor JA, 2006, CANCER EPIDEM BIOMAR, V15, P133, DOI 10.1158/1055-9965.EPI-05-0641; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Webb T, 2002, J NATL CANCER I, V94, P476; Wicklow BA, 2004, AM J MED GENET A, V127A, P158, DOI 10.1002/ajmg.a.20633; Wilson SH, 2004, MOL INTERV, V4, P147; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Xie JL, 2005, THROMB HAEMOSTASIS, V93, P897, DOI 10.1160/TH04-09-0633; Zhang XS, 2004, GENETICS, V166, P597, DOI 10.1534/genetics.166.1.597	64	244	251	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					100	112		10.1016/j.ajhg.2007.09.006	http://dx.doi.org/10.1016/j.ajhg.2007.09.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179889	Green Published, Bronze			2022-12-18	WOS:000253223800011
J	Cope, N; Harold, D; Hill, G; Moskvina, V; Stevenson, J; Holmans, P; Owen, MJ; O'Donovan, MC; Williams, J				Cope, N; Harold, D; Hill, G; Moskvina, V; Stevenson, J; Holmans, P; Owen, MJ; O'Donovan, MC; Williams, J			Strong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; READING-DISABILITY; SPELLING DISABILITY; CANADIAN FAMILIES; MAPPING PROVIDES; CANDIDATE GENES; LINKAGE; ASSOCIATION; PROTEIN; CONFIRMATION	Linkage between developmental dyslexia ( DD) and chromosome 6p has been replicated in a number of independent samples. Recent attempts to identify the gene responsible for the linkage have produced inconsistent evidence for association of DD with a number of genes in a 575-kb region of chromosome 6p22.2, including VMP, DCDC2, KIAA0319, TTRAP, and THEM2. We aimed to identify the specific gene or genes involved by performing a systematic, high-density (similar to 2 - 3- kb intervals) linkage disequilibrium screen of these genes in an independent sample, incorporating family-based and case-control designs in which dyslexia was defined as an extreme representation of reading disability. Using DNA pooling, we first observed evidence for association with 17 single-nucleotide polymorphisms ( SNPs), 13 of which were located in the KIAA0319 gene (P<.01-.003). After redundant SNPs were excluded, 10 SNPs were individually genotyped in 223 subjects with DD and 273 controls. Those SNPs that were significant at P <=.05 were next genotyped in a semi-independent sample of 143 trios of probands with DD and their parents, to control for possible population stratification. Six SNPs showed significant evidence of association in both samples (P <=.04-.002), including a SNP (rs4504469) in exon 4 of the KIAA0319 gene that changes an amino acid (P = .002; odds ratio 1.5). Logistic regression analysis showed that two SNPs ( rs4504469 and rs6935076) in the KIAA0319 gene best explained DD status. The haplotype composed of these two markers was significantly associated with DD ( global P = .00001 in the case-control sample; P = .02 in trios). This finding was largely driven by underrepresentation of the most common haplotype in cases (P = .00003 in the case-control sample; P = .006 in trios; 1-degree-of-freedom tests). Our data strongly implicate KIAA0319 as a susceptibility gene for dyslexia. The gene product is expressed in brain, but its specific function is currently unknown.	Cardiff Univ, Wales Coll Med, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales; Cardiff Univ, Wales Coll Med, Biostat & Bioinformat Unit, Cardiff CF14 4XN, S Glam, Wales; Univ Southampton, Sch Psychol, Southampton, Hants, England	Cardiff University; Cardiff University; University of Southampton	O'Donovan, MC (corresponding author), Cardiff Univ, Wales Coll Med, Dept Psychol Med, Henry Wellcome Bldg,Acad Ave,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	odonovanmc@cardiff.ac.uk	; Holmans, Peter/F-4518-2015; O'Donovan, Michael/P-7005-2018	Williams, Julie/0000-0002-4069-0259; Holmans, Peter/0000-0003-0870-9412; Cope, Natalie/0000-0003-2053-0474; Harold, Denise/0000-0001-5195-0143; Escott-Price, Valentina/0000-0003-1784-5483; O'Donovan, Michael/0000-0001-7073-2379				CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Chapman NH, 2004, AM J MED GENET B, V131B, P67, DOI 10.1002/ajmg.b.30018; Cheng C, 2002, MOL BIOL REP, V29, P281, DOI 10.1023/A:1020402410522; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; DeFries JC, 1991, LEARNING DISABILITIE, V2, P37; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Elliot C. D., 1983, BRIT ABILITY SCALES; Fagerheim T, 1999, J MED GENET, V36, P664; Fisher J. H., 1905, OPHTHALMIC REV, V24, P315; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Francks C, 2002, PSYCHIATR GENET, V12, P35, DOI 10.1097/00041444-200203000-00005; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; Grigorenko EL, 2003, AM J MED GENET B, V118B, P89, DOI 10.1002/ajmg.b.10032; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Grigorenko EL, 2001, AM J MED GENET, V105, P120, DOI 10.1002/1096-8628(20010108)105:1<120::AID-AJMG1075>3.3.CO;2-K; HINSHELWOOD J, 1907, BRIT MED J, V2, P1229; Hohnen B, 1999, DEV PSYCHOL, V35, P590, DOI 10.1037/0012-1649.35.2.590; Kaminen N, 2003, J MED GENET, V40, P340, DOI 10.1136/jmg.40.5.340; Kaplan DE, 2002, AM J HUM GENET, V70, P1287, DOI 10.1086/340449; Londin ER, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-25; Marlow AJ, 2003, AM J HUM GENET, V72, P561, DOI 10.1086/368201; Morris DW, 2000, HUM MOL GENET, V9, P843, DOI 10.1093/hmg/9.5.843; Neale M. D., 1989, ANAL READING ABILITY; Norton N, 2004, ANN MED, V36, P146, DOI 10.1080/07853890310021724; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; Petryshen TL, 2002, J MED GENET, V39, P125, DOI 10.1136/jmg.39.2.125; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; RABIN M, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91384-X; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P1, DOI 10.1054/plef.2000.0184; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P69, DOI 10.1054/plef.2000.0194; Schulte-Korne G, 1998, AM J HUM GENET, V63, P279, DOI 10.1086/301919; SchulteKorne G, 1996, J CHILD PSYCHOL PSYC, V37, P817, DOI 10.1111/j.1469-7610.1996.tb01477.x; SHAYWITZ BA, 1992, J LEARN DISABIL, V25, P639, DOI 10.1177/002221949202501003; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Taylor KE, 2000, PROSTAG LEUKOTR ESS, V63, P89, DOI 10.1054/plef.2000.0197; Turic D, 2003, MOL PSYCHIATR, V8, P176, DOI 10.1038/sj.mp.4001216; Tzenova J, 2004, AM J MED GENET B, V127B, P117, DOI 10.1002/ajmg.b.20139; Van den Eynde B, 1999, J EXP MED, V190, P1793, DOI 10.1084/jem.190.12.1793; WECHSLER D, 1992, WISC3 UK; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; Zsurka G, 2001, GENOMICS, V72, P158, DOI 10.1006/geno.2000.6407	52	244	257	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					581	591		10.1086/429131	http://dx.doi.org/10.1086/429131			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15717286	Green Published, Bronze			2022-12-18	WOS:000227516000005
J	Liquori, CL; Berg, MJ; Siegel, AM; Huang, E; Zawistowski, JS; Stoffer, T; Verlaan, D; Balogun, F; Hughes, L; Leedom, TP; Plummer, NW; Cannella, M; Maglione, V; Squitieri, F; Johnson, EW; Rouleau, GA; Ptacek, L; Marchuk, DA				Liquori, CL; Berg, MJ; Siegel, AM; Huang, E; Zawistowski, JS; Stoffer, T; Verlaan, D; Balogun, F; Hughes, L; Leedom, TP; Plummer, NW; Cannella, M; Maglione, V; Squitieri, F; Johnson, EW; Rouleau, GA; Ptacek, L; Marchuk, DA			Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VASCULAR MALFORMATIONS; CHROMOSOME 7Q; KRIT1; ANGIOMAS; BRAIN; CCM1; HETEROGENEITY; PATHOGENESIS; ASSOCIATION; FAMILIES	Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. Mutations in the gene KRIT1 are responsible for type 1 CCM (CCM1). We report that a novel gene, MGC4607, exhibits eight different mutations in nine families with type 2 CCM (CCM2). MGC4607, similar to the KRIT1 binding partner ICAP1alpha, encodes a protein with a phosphotyrosine-binding domain. This protein may be part of the complex pathway of integrin signaling that, when perturbed, causes abnormal vascular morphogenesis in the brain, leading to CCM formation.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Univ Rochester, Med Ctr, Dept Neurol, Strong Epilepsy Ctr, Rochester, NY 14642 USA; Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; Barrow Neurol Inst, Phoenix, AZ 85013 USA; Montreal Gen Hosp, Dept Neurol, Montreal, PQ H3G 1A4, Canada; Ist Ricovero & Cura Carattere Sci, Neurogenet Unit, Pozzilli, Italy; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Duke University; University of Rochester; University of Zurich; University Zurich Hospital; Barrow Neurological Institute; McGill University; IRCCS Neuromed; University of California System; University of California San Francisco	Marchuk, DA (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Box 3175, Durham, NC 27710 USA.		Squitieri, Ferdinando/N-1852-2019; Maglione, Vittorio/AAA-5455-2019	Squitieri, Ferdinando/0000-0002-7397-1727; Maglione, Vittorio/0000-0002-6906-7372; CANNELLA, Milena/0000-0001-6284-9374; Marchuk, Douglas/0000-0002-3110-6671; /0000-0003-2971-814X	NINDS NIH HHS [NS43543, R01 NS043543] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043543] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chandler J G, 1997, J Gastrointest Surg, V1, P138, DOI 10.1016/S1091-255X(97)80101-1; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; Denier C, 2002, MECH DEVELOP, V117, P363, DOI 10.1016/S0925-4773(02)00209-5; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Dupre N, 2003, CAN J NEUROL SCI, V30, P122, DOI 10.1017/S0317167100053385; Faisst AM, 1998, DEV DYNAM, V212, P293, DOI 10.1002/(SICI)1097-0177(199806)212:2<293::AID-AJA14>3.0.CO;2-5; GILNAGEL A, 1995, EPILEPSY RES, V21, P27, DOI 10.1016/0920-1211(95)00005-U; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Kehrer-Sawatzki H, 2002, ACTA NEUROPATHOL, V104, P231, DOI 10.1007/s00401-002-0552-6; Laberge S, 1999, EUR J HUM GENET, V7, P499, DOI 10.1038/sj.ejhg.5200324; MARCHUK DA, 1995, GENOMICS, V28, P311, DOI 10.1006/geno.1995.1147; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Squitieri F, 2000, NEUROL SCI, V21, P129, DOI 10.1007/s100720070087; STEICHENGERSDORF E, 1992, EUR J PEDIATR, V151, P861, DOI 10.1007/BF01957941; TOMLINSON FH, 1994, NEUROSURGERY, V34, P792, DOI 10.1227/00006123-199405000-00002; ZABRAMSKI JM, 1994, J NEUROSURG, V80, P422, DOI 10.3171/jns.1994.80.3.0422; Zabramski JM, 1999, NEUROSURG CLIN N AM, V10, P395, DOI 10.1016/S1042-3680(18)30174-8; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11	24	244	250	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1459	1464		10.1086/380314	http://dx.doi.org/10.1086/380314			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14624391	Green Published, Bronze			2022-12-18	WOS:000187491100021
J	Weber, JL; David, D; Heil, J; Fan, Y; Zhao, CF; Marth, G				Weber, JL; David, D; Heil, J; Fan, Y; Zhao, CF; Marth, G			Human diallelic insertion/deletion polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SEQUENCE VARIATION; GENOME SEQUENCE; GENETIC-DISEASE; MUTAGENESIS; MECHANISMS; DIVERSITY; DISCOVERY; RESOURCE; LOCUS	We report the identification and characterization of 2,000 human diallelic insertion/deletion polymorphisms (indels) distributed throughout the human genome. Candidate indels were identified by comparison of overlapping genomic or cDNA sequences. Average confirmation rate for indels with a greater than or equal to2-nt allele-length difference was 58%, but the confirmation rate for indels with a 1-nt length difference was only 14%. The vast majority of the human diallelic indels were monomorphic in chimpanzees and gorillas. The ratio of deletion: insertion mutations was 4.1. Allele frequencies for the indels were measured in Europeans, Africans, Japanese, and Native Americans. New alleles were generally lower in frequency than old alleles. This tendency was most pronounced for the Africans, who are likely to be closest among the four groups to the original modern human population. Diallelic indels comprise similar to8% of all human polymorphisms. Their abundance and ease of analysis make them useful for many applications.	Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Weber, JL (corresponding author), Marshfield Med Res Fdn, Ctr Med Genet, 1000 N Oak Ave, Marshfield, WI 54449 USA.	weberj@cmg.mfldclin.edu			NATIONAL LIBRARY OF MEDICINE [Z01LM000158] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01HV48141, HV48141, HL62681] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonarakis SE, 2000, EUR J PEDIATR, V159, pS173, DOI 10.1007/PL00014395; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Clark AG, 1997, P NATL ACAD SCI USA, V94, P7730, DOI 10.1073/pnas.94.15.7730; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; COOPER DN, 1991, HUM GENET, V87, P409; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; GELEHRTER TD, 1990, PRINCIPLES MED GENET, P55; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Halangoda A, 2001, ENVIRON MOL MUTAGEN, V37, P311, DOI 10.1002/em.1038; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KRAWCZAK M, 1991, HUM GENET, V86, P425; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lupski JR, 1996, AM J HUM GENET, V58, P21; Marth G, 2001, NAT GENET, V27, P371, DOI 10.1038/86864; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Miller RD, 2001, GENOMICS, V71, P78, DOI 10.1006/geno.2000.6417; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sherry ST, 2000, HUM MUTAT, V15, P68, DOI 10.1002/(SICI)1098-1004(200001)15:1<68::AID-HUMU14>3.0.CO;2-6; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082	27	244	290	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					854	862		10.1086/342727	http://dx.doi.org/10.1086/342727			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12205564	Green Published, Bronze			2022-12-18	WOS:000178613800013
J	Knight, SJL; Lese, CM; Precht, KS; Kuc, J; Ning, Y; Lucas, S; Regan, R; Brenan, M; Nicod, A; Lawrie, NM; Cardy, DLN; Nguyen, H; Hudson, TJ; Riethman, HC; Ledbetter, DH; Flint, J				Knight, SJL; Lese, CM; Precht, KS; Kuc, J; Ning, Y; Lucas, S; Regan, R; Brenan, M; Nicod, A; Lawrie, NM; Cardy, DLN; Nguyen, H; Hudson, TJ; Riethman, HC; Ledbetter, DH; Flint, J			An optimized set of human telomere clones for studying telomere integrity and architecture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDONUCLEASE RARE CLEAVAGE; MENTAL-RETARDATION; MOLECULAR-CLONING; DNA; SEQUENCE; YEAST; REGIONS; REARRANGEMENTS; GENE; MAP	Telomere-specific clones are a valuable resource for the characterization of chromosomal rearrangements. We previously reported a first-generation set of human telomere probes consisting of 34 genomic clones, which were a known distance from the end of the chromosome (similar to 300 kb), and 7 clones corresponding to the most distal markers on the integrated genetic/physical map (1p, 5p, 6p, 9p, 12p, 15q, and 20q). Subsequently, this resource has been optimized and completed: the size of the genomic clones has been expanded to a target size of 100-200 kb, which is optimal for use in genome-scanning methodologies, and additional probes for the remaining seven telomeres have been identified. For each clone we give an associated mapped sequence-tagged site and provide distances from the telomere estimated using a combination of fiberFISH, interphase FISH, sequence analysis, and radiation-hybrid mapping. This updated set of telomeric clones is an invaluable resource for clinical diagnosis and represents an important contribution to genetic and physical mapping efforts aimed at telomeric regions.	John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; George Washington Univ, Washington, DC USA; Gene Care Med Genet Ctr, Washington, DC USA; Cytocell Ltd, Adderbury, Oxon, England; MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA USA; McGill Univ, Ctr Hlth, Montreal Genome Ctr, Montreal, PQ, Canada; Wistar Inst, Philadelphia, PA 19104 USA	University of Oxford; University of Chicago; George Washington University; Massachusetts Institute of Technology (MIT); Whitehead Institute; McGill University; The Wistar Institute	Flint, J (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.			Knight, Samantha/0000-0002-6047-3462; Hudson, Thomas/0000-0002-1376-4849; Flint, Jonathan/0000-0002-9427-4429	NHGRI NIH HHS [F32 HG000174, 1 F32 HG00174-01] Funding Source: Medline; NICHD NIH HHS [1-R01-HD36715-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036715] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000174] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; BATES GP, 1990, AM J HUM GENET, V46, P762; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Buckle VJ, 1993, HUMAN GENETIC DISEAS, P59; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; FERRIN LJ, 1994, NAT GENET, V6, P379, DOI 10.1038/ng0494-379; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; Flint J, 1998, DNA SEQUENCE, V8, P241, DOI 10.3109/10425179809008458; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Heiskanen M, 1996, GENET ANAL-BIOMOL E, V12, P179, DOI 10.1016/1050-3862(95)00134-4; Holinski-Feder E, 2000, AM J HUM GENET, V66, P16, DOI 10.1086/302703; Horsley SW, 1998, J MED GENET, V35, P722, DOI 10.1136/jmg.35.9.722; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Knight SJL, 1997, EUR J HUM GENET, V5, P1; Lese CM, 1999, GENOME RES, V9, P888, DOI 10.1101/gr.9.9.888; MACINA RA, 1994, HUM MOL GENET, V3, P1847, DOI 10.1093/hmg/3.10.1847; MACINA RA, 1995, GENOME RES, V5, P225, DOI 10.1101/gr.5.3.225; Matsumoto N, 1997, GENOMICS, V45, P11, DOI 10.1006/geno.1997.4897; Monfouilloux S, 1998, GENOMICS, V51, P165, DOI 10.1006/geno.1998.5358; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; NEGOREV DG, 1994, GENOMICS, V22, P569, DOI 10.1006/geno.1994.1430; *NIH, 1996, COMPL SET HUM TEL PR, V14, P86; Ning Y, 1996, HUM GENET, V97, P765; Peterson ET, 1999, GENOME RES, V9, P1250, DOI 10.1101/gr.9.12.1250; RESTON JT, 1995, GENOMICS, V26, P31, DOI 10.1016/0888-7543(95)80079-2; Riethman H, 1997, GENOME ANAL, V1, P83; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; ROUYER F, 1990, EMBO J, V9, P505, DOI 10.1002/j.1460-2075.1990.tb08137.x; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Sambrook J, 1989, MOL CLONING LAB MANU; SONNHAMMER E, 1994, P INT SOC MOL BIOL, V94, P363; Tosi S, 1999, GENE CHROMOSOME CANC, V25, P384, DOI 10.1002/(SICI)1098-2264(199908)25:4<384::AID-GCC11>3.0.CO;2-D; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; van Genderen MHP, 1999, ADV DENDR MACROMOL, V4, P61; VoceroAkbani A, 1996, GENOMICS, V36, P492, DOI 10.1006/geno.1996.0495; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Wong ACC, 1997, AM J HUM GENET, V60, P113; Xiang Z, 1999, GENOMICS, V58, P207, DOI 10.1006/geno.1999.5826	43	244	257	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					320	332		10.1086/302998	http://dx.doi.org/10.1086/302998			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10869233	Bronze, Green Published			2022-12-18	WOS:000089357800009
J	Maquat, LE				Maquat, LE			Defects in RNA splicing and the consequence of shortened translational reading frames	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							GLOBIN MESSENGER-RNA; DUCHENNE MUSCULAR-DYSTROPHY; DOMINANT BETA-THALASSEMIA; CFTR NONSENSE MUTATIONS; NASAL EPITHELIAL-CELLS; ALPHA-L-IDURONIDASE; ERYTHROID TISSUES; CIS EFFECTORS; O THALASSEMIA; HALF-LIFE				Maquat, LE (corresponding author), ROSWELL PK CANC INST, DEPT HUMAN GENET, ELM & CARLTON ST, BUFFALO, NY 14263 USA.			Maquat, Lynne/0000-0002-2789-2075	NIDDK NIH HHS [DK 33938] Funding Source: Medline; NIGMS NIH HHS [GM 52822] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052822] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; BACH G, 1993, AM J HUM GENET, V53, P330; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; CHELLY J, 1991, J CLIN INVEST, V88, P1161, DOI 10.1172/JCI115417; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; FISHER CW, 1993, AM J HUM GENET, V52, P414; Gardella R, 1996, AM J HUM GENET, V59, P292; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; HALL GW, 1994, BLOOD, V83, P2031; HAMOSH A, 1992, HUM MOL GENET, V1, P542, DOI 10.1093/hmg/1.7.542; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HULL J, 1994, GENOMICS, V19, P362, DOI 10.1006/geno.1994.1070; KANTOR JA, 1980, CELL, V21, P149, DOI 10.1016/0092-8674(80)90122-1; KAZAZIAN HH, 1992, BLOOD, V79, P3014; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; LIM SK, 1992, EMBO J, V11, P3271, DOI 10.1002/j.1460-2075.1992.tb05405.x; LIM SK, 1989, EMBO J, V8, P2613, DOI 10.1002/j.1460-2075.1989.tb08401.x; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; LOZANO F, 1994, EMBO J, V13, P4617, DOI 10.1002/j.1460-2075.1994.tb06783.x; MAQUAT LE, 1980, P NATL ACAD SCI-BIOL, V77, P4287, DOI 10.1073/pnas.77.7.4287; MAQUAT LE, 1995, RNA, V1, P453; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; MARKIEWICZ S, 1994, GENOMICS, V21, P291, DOI 10.1006/geno.1994.1265; MENON KP, 1994, CELL MOL BIOL, V40, P999; Moore M., 1993, RNA WORLD, P303; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363; Ohno M, 1996, GENE DEV, V10, P997, DOI 10.1101/gad.10.8.997; ORKIN SH, 1984, ANNU REV GENET, V18, P131; QIAN LA, 1993, MOL CELL BIOL, V13, P1686, DOI 10.1128/MCB.13.3.1686; RedfordBadwal DA, 1996, J CLIN INVEST, V97, P1035, DOI 10.1172/JCI118495; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; SCOTT HS, 1991, P NATL ACAD SCI USA, V88, P9695, DOI 10.1073/pnas.88.21.9695; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; SIMPSON SB, 1994, MOL CELL BIOL, V14, P1835, DOI 10.1128/MCB.14.3.1835; TAKESHITA K, 1984, BLOOD, V64, P13; TARGOVNIK HM, 1993, J CLIN ENDOCR METAB, V77, P210, DOI 10.1210/jc.77.1.210; THANH LT, 1995, AM J HUM GENET, V56, P725; THEIN SL, 1992, BRIT J HAEMATOL, V80, P273, DOI 10.1111/j.1365-2141.1992.tb08132.x; WILL K, 1995, HUM MUTAT, V5, P210, DOI 10.1002/humu.1380050305; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Zhang J, 1996, RNA, V2, P235	58	244	252	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					279	286						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755945				2022-12-18	WOS:A1996VM28800001
J	UTERMANN, G; LANGENBECK, U; BEISIEGEL, U; WEBER, W				UTERMANN, G; LANGENBECK, U; BEISIEGEL, U; WEBER, W			GENETICS OF THE APOLIPOPROTEIN-E SYSTEM IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV GOTTINGEN,INST HUMAN GENET,D-3400 GOTTINGEN,FED REP GER	University of Gottingen	UTERMANN, G (corresponding author), UNIV MARBURG,INST HUMAN GENET,D-3550 MARBURG,FED REP GER.							Bernstein, 1930, Z INDUKTIVE ABSTAMMU, V56, P233; MATTIUZ PL, 1970, HISTOCOMPATIBILITY T, P193; McMichael A, 1977, Prog Med Genet, V2, P39; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; Race R. R, 1968, BLOOD GROUPS MAN; UTERMANN G, 1978, CLIN GENET, V14, P351; UTERMANN G, 1979, CLIN GENET, V15, P37; UTERMANN G, 1977, CLIN GENET, V12, P139, DOI 10.1111/j.1399-0004.1977.tb00917.x; UTERMANN G, 1975, H-S Z PHYSIOL CHEM, V356, P1113, DOI 10.1515/bchm2.1975.356.2.1113; UTERMANN G, 1975, FEBS LETT, V56, P352, DOI 10.1016/0014-5793(75)81125-2; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; UTERMANN G, 1979, CLIN GENET, V15, P63; UTERMANN G, 1979, FEBS LETT, V101, P21, DOI 10.1016/0014-5793(79)81286-7; UTERMANN G, 1977, PROTIDES BIOL FLUIDS, P285	14	244	248	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					339	347						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	7386461				2022-12-18	WOS:A1980JX05900004
J	Geschwind, DH; Sowinski, J; Lord, C; Iversen, P; Shestack, J; Jones, P; Ducat, L; Spence, SJ				Geschwind, DH; Sowinski, J; Lord, C; Iversen, P; Shestack, J; Jones, P; Ducat, L; Spence, SJ		AGRE Steering Comm	The Autism Genetic Resource Exchange: A resource for the study of autism and related neuropsychiatric conditions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							UTAH EPIDEMIOLOGIC SURVEY; GENOMIC SCREEN		Univ Calif Los Angeles, Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; Cure Autism Now Fdn, Los Angeles, CA USA; Human Biol Data Interchange, Philadelphia, PA USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Program Neurogenet, 710 Westwood Plaza, Los Angeles, CA 90095 USA.							American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; BROWN WT, 1986, AM J MED GENET, V23, P341, DOI 10.1002/ajmg.1320230126; BRYSON SE, 1988, J CHILD PSYCHOL PSYC, V29, P433, DOI 10.1111/j.1469-7610.1988.tb00735.x; GILLBERG C, 1991, BRIT J PSYCHIAT, V158, P403, DOI 10.1192/bjp.158.3.403; JORDE LB, 1990, AM J MED GENET, V36, P85, DOI 10.1002/ajmg.1320360116; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; RITVO ER, 1989, AM J PSYCHIAT, V146, P1032	15	243	252	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					463	466		10.1086/321292	http://dx.doi.org/10.1086/321292			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	456XN	11452364	Bronze, Green Published			2022-12-18	WOS:000170108200023
J	Lu, KM; Lee, MH; Hazard, S; Brooks-Wilson, A; Hidaka, H; Kojima, H; Ose, L; Stalenhoef, AFH; Mietinnen, T; Bjorkhem, I; Bruckert, E; Pandya, A; Brewer, HB; Salen, G; Dean, M; Srivastava, A; Patel, SB				Lu, KM; Lee, MH; Hazard, S; Brooks-Wilson, A; Hidaka, H; Kojima, H; Ose, L; Stalenhoef, AFH; Mietinnen, T; Bjorkhem, I; Bruckert, E; Pandya, A; Brewer, HB; Salen, G; Dean, M; Srivastava, A; Patel, SB			Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIETARY-CHOLESTEROL; ABSORPTION; XANTHOMATOSIS; IDENTIFICATION; PROTEINS; CLONING	Sitosterolemia is a rare autosomal recessive disorder characterized by (a) intestinal hyperabsorption of all sterols, including cholesterol and plant and shellfish sterols, and (b) impaired ability to excrete sterols into bile. Patients with this disease have expanded body pools of cholesterol and very elevated plasma plant-sterol species and frequently develop tendon and tuberous xanthomas, accelerated atherosclerosis, and premature coronary artery disease. In previous studies, we have mapped the STSL locus to human chromosome 2p21. Recently, we reported that a novel member of the ABC-transporter family, named "sterolin-1" and encoded by ABCG5, is mutated in 9 unrelated families with sitosterolemia; in the remaining 25 families, no mutations in sterolin-1 could be identified. We identified another ABC transporter, located <400 bp upstream of sterolin-1, in the opposite orientation. Mutational analyses revealed that this highly homologous protein, termed "sterolin-2" and encoded by ABCG8, is mutated in the remaining pedigrees. Thus, two highly homologous genes, located in a head-to-head configuration on chromosome 2p21, are involved as causes of sitosterolemia. These studies indicate that both sterolin-1 and sterolin-2 are indispensable for the regulation of sterol absorption and excretion. Identification of sterolin-1 and sterolin-2 as critical players in the regulation of dietary-sterol absorption and excretion identifies a new pathway of sterol transport.	Med Univ S Carolina, Div Endocrinol Diabet & Med Genet, STR 541, Charleston, SC 29403 USA; Med Univ S Carolina, Biomol Comp Resource, Charleston, SC 29403 USA; Xenon Genet Inc, Vancouver, BC, Canada; Sanyo Elect Grp Hlth Insurance Assoc, Osaka, Japan; Shiga Univ Med Sci, Dept Med 3, Otsu, Shiga 52021, Japan; Univ Oslo, Rikshosp, Lipid Res Clin, N-0027 Oslo, Norway; Univ Nijmegen Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands; Univ Helsinki, Cent Hosp, Dept Internal Med, Helsinki, Finland; Huddinge Univ, Karolinska Inst, Div Clin Chem, Huddinge, Sweden; Hop La Pitie Salpetriere, Dept Endocrinol, Paris, France; Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA USA; NHLBI, Mol Dis Branch, NIH, Bethesda, MD 20892 USA; Univ Med & Dent New Jersey, Div Gastroenterol, Newark, NJ 07103 USA; NCI, Lab Genom Divers, Frederick, MD 21701 USA; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA	Medical University of South Carolina; Medical University of South Carolina; Panasonic; Shiga University of Medical Science; University of Oslo; National Hospital Norway; Radboud University Nijmegen; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Greenwood Genetic Center	Patel, SB (corresponding author), Med Univ S Carolina, Div Endocrinol Diabet & Med Genet, STR 541, 114 Doughty St, Charleston, SC 29403 USA.		Brooks-Wilson, Angela/E-9399-2012; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Stalenhoef, A.F.H./H-8094-2014	Brooks-Wilson, Angela/0000-0003-1009-6408; Dean, Michael C/0000-0003-2234-0631; Patel, Shailendra/0000-0003-0046-5513; Bjorkhem, Ingemar/0000-0001-6087-9190; Bjorkhem, Ingemar/0000-0002-0575-9425	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060613] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR01070-25, M01 RR001070] Funding Source: Medline; NHLBI NIH HHS [HL60616, R01 HL060613] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BEST MM, 1955, AM J MED, V19, P61, DOI 10.1016/0002-9343(55)90274-6; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; BJORKHEM I, 1995, METABOLIC MOL BASES, V2, P2073; FARQUHAR JW, 1956, CIRCULATION, V14, P77, DOI 10.1161/01.CIR.14.1.77; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; GOULD RG, 1969, METABOLIS, V18, P652, DOI 10.1016/0026-0495(69)90078-X; GREGG RE, 1986, J CLIN INVEST, V77, P1864, DOI 10.1172/JCI112513; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; HIDAKA H, 1990, J LIPID RES, V31, P881; IKEDA I, 1988, J LIPID RES, V29, P1573; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; KUKSIS A, 1962, CAN J BIOCHEM PHYS, V40, P1493; Lawn RM, 2001, ARTERIOSCL THROM VAS, V21, P378, DOI 10.1161/01.ATV.21.3.378; Lee MH, 2001, EUR J HUM GENET, V9, P375, DOI 10.1038/sj.ejhg.5200628; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Lu KM, 2001, EUR J HUM GENET, V9, P364, DOI 10.1038/sj.ejhg.5200627; Mardones P, 2001, J LIPID RES, V42, P170; MOINGEON P, 1990, EUR J IMMUNOL, V20, P1741, DOI 10.1002/eji.1830200818; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patel SB, 1998, J LIPID RES, V39, P1055; Patel SB, 1998, J CLIN INVEST, V102, P1041, DOI 10.1172/JCI3963; POLLOCK OJ, 1953, CIRCULATION, V7, P703; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; ROGINA B, 1995, BIOCHEM MOL BIOL INT, V35, P825; SALEN G, 1992, J LIPID RES, V33, P945; Schulthess G, 2000, BIOCHEMISTRY-US, V39, P12623, DOI 10.1021/bi0011633; SHULENIN S, IN PRESS CYTOGENET C; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Sossey-Alaoui K, 1999, GENOMICS, V60, P330, DOI 10.1006/geno.1999.5924; Swofford D.L., 1996, MOL SYSTEMATICS, P411; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WU JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE1087; YEE D, 1989, J BIOL CHEM, V264, P21439; Yu HW, 2000, AM J MED GENET, V90, P347, DOI 10.1002/(SICI)1096-8628(20000214)90:4<347::AID-AJMG16>3.0.CO;2-7	35	243	263	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					278	290		10.1086/321294	http://dx.doi.org/10.1086/321294			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11452359	Bronze, Green Published			2022-12-18	WOS:000170108200004
J	Perez-Caballero, D; Gonzalez-Rubio, C; Gallardo, ME; Vera, M; Lopez-Trascasa, M; de Cordoba, SR; Sanchez-Corral, P				Perez-Caballero, D; Gonzalez-Rubio, C; Gallardo, ME; Vera, M; Lopez-Trascasa, M; de Cordoba, SR; Sanchez-Corral, P			Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; HEPARIN-BINDING DOMAIN; MONOCLONAL-ANTIBODIES; ALTERNATIVE PATHWAY; REGULATORY DOMAINS; C3B INACTIVATOR; PROTEIN BETA-1H; IDENTIFICATION; DEFICIENCY; SITE	Hemolytic-uremic syndrome (HUS) is a microvasculature disorder leading to microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Most cases of HUS are associated with epidemics of diarrhea caused by verocytotoxin-producing bacteria, but atypical cases of HUS not associated with diarrhea (aHUS) also occur. Early studies describing the association of aHUS with deficiencies of factor H suggested a role for this complement regulator in aHUS. Molecular evidence of factor H involvement in aHUS was first provided by Warwicker et al., who demonstrated that aHUS segregated with the chromosome 1q region containing the factor H gene (HF1) and who identified a mutation in HF1 in a case of familial aHUS with normal levels of factor H. We have performed the mutational screening of the HF1 gene in a novel series of 13 Spanish patients with aHUS who present normal complement profiles and whose plasma levels of factor H are, with one exception, within the normal range. These studies have resulted in the identification of five novel HF1 mutations in four of the patients. Allele HF1 Delta exon2, a genomic deletion of exon 2, produces a null HF1 allele and results in plasma levels of factor H that are 50% of normal. T956M, W1183L, L1189R, and V1197A are missense mutations that alter amino acid residues in the C-terminal portion of factor H, within a region-SCR16-SCR20-that is involved in the binding to solid-phase C3b and to negatively charged cellular structures. This remarkable clustering of mutations in HF1 suggests that a specific dysfunction in the protection of cellular surfaces by factor H is a major pathogenic condition underlying aHUS.	CSIC, Ctr Invest Biol, Dept Inmunol, E-28006 Madrid, Spain; Hosp Univ La Paz, Unidad Inmunol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario La Paz	de Cordoba, SR (corresponding author), CSIC, Ctr Invest Biol, Dept Inmunol, Velazquez 144, E-28006 Madrid, Spain.	SRdeCordoba@cib.csic.es	López-Trascasa, Margarita/L-2699-2014; Gallardo, M. Esther/AFK-7298-2022; de Cordoba, Santiago Rodriguez/K-6727-2014; Moreton, Auxiliadora/D-1334-2016	López-Trascasa, Margarita/0000-0001-8594-282X; Gallardo, M. Esther/0000-0002-8699-8734; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Vera, Maria/0000-0003-0845-8633; Moreton, Auxiliadora/0000-0003-4703-3435				ALSENZ J, 1985, BIOCHEM J, V232, P841, DOI 10.1042/bj2320841; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Ault BH, 1997, J BIOL CHEM, V272, P25168, DOI 10.1074/jbc.272.40.25168; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; Caprioli J., 2000, Immunopharmacology, V49, P13, DOI 10.1016/S0162-3109(00)80030-2; de Cordoba SR, 1999, MOL IMMUNOL, V36, P803, DOI 10.1016/S0161-5890(99)00100-5; DECORDOBA SR, 1985, J EXP MED, V161, P1189, DOI 10.1084/jem.161.5.1189; ESTALLER C, 1991, EUR J IMMUNOL, V21, P799, DOI 10.1002/eji.1830210337; GORDON DL, 1995, J IMMUNOL, V155, P348; Jokiranta TS, 1996, FEBS LETT, V393, P297; KUHN S, 1995, J IMMUNOL, V155, P5663; Male DA, 2000, MOL IMMUNOL, V37, P41, DOI 10.1016/S0161-5890(00)00024-9; MCRAE JL, 2000, IN PRESS J BIOL CHEM; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; RUGGENENTI P, 1998, SUKI MASSRYS THERAPY, P513; Sanchez-Corral P, 2000, IMMUNOGENETICS, V51, P366, DOI 10.1007/s002510050631; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WEIS JH, 1987, J IMMUNOL, V138, P312; WHALEY K, 1976, SCIENCE, V193, P1011, DOI 10.1126/science.948757; Ying LH, 1999, AM J HUM GENET, V65, P1538, DOI 10.1086/302673; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	36	243	253	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					478	484		10.1086/318201	http://dx.doi.org/10.1086/318201			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170895	Green Published, Bronze			2022-12-18	WOS:000166524800017
J	Soravia, C; Berk, T; Madlensky, L; Mitri, A; Cheng, H; Gallinger, S; Cohen, Z; Bapat, B				Soravia, C; Berk, T; Madlensky, L; Mitri, A; Cheng, H; Gallinger, S; Cohen, Z; Bapat, B			Genotype-phenotype correlations in attenuated adenomatous polyposis coli	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERM-LINE MUTATIONS; APC GENE TRANSCRIPTS; DESMOID TUMORS; BETA-CATENIN; LATE-ONSET; CANCER; PROTEIN; LOCUS; IDENTIFICATION; DATABASE	Germ-line mutations of the tumor suppressor APC are implicated in attenuated adenomatous polyposis coli (AAPC), a variant of familial adenomatous polyposis (FAP). AAPC is recognized by the occurrence of <100 colonic adenomas and a later onset of colorectal cancer (age >40 years). The aim of this study was to assess genotype-phenotype correlations in AAPC families. By protein-truncation test (PTT) assay, the entire coding region of the APC gene was screened in affected individuals from 11 AAPC kindreds,and their phenotypic differences were examined. Five novel germ-line APC mutations were identified in seven kindreds. Mutations were located in three different regions of the APC gene: (1) at the 5' end spanning exons 4 and 5, (2) within exon 9, and (3) at the 3' distal end of the gene. Variability in the number of colorectal adenomas was most apparent in individuals with mutations in region 1, and upper-gastrointestinal manifestations were more severe in them. In individuals with mutations in either region 2 or region 3, the average number of adenomas tended to be lower than those in individuals with mutations in region 1, although age at diagnosis was similar. In all AAPC kindreds, a predominance of right-sided colorectal adenomas and rectal polyp sparing was observed. Na desmoid tumors were found in these kindreds. Our data suggest that, in AAPC families, the location of the APC mutation may partially predict specific phenotypic expression. This should help in the design of tailored clinical-management protocols in this subset of 9;AP patients.	Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Familial Gastrointestinal Canc Registry, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Bapat, B (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, 600 Univ Ave,Suite 600-02, Toronto, ON M5G 1X5, Canada.		Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014					Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; BURT RW, 1995, GASTROENTEROLOGY, V108, pA453; Bussey H, 1975, FAMILIAL POLYPOSIS C; CAMA A, 1994, HUM MUTAT, V3, P305, DOI 10.1002/humu.1380030321; CASPARI R, 1994, LANCET, V343, P629, DOI 10.1016/S0140-6736(94)92634-4; CASPARI R, 1995, HUM MOL GENET, V4, P337, DOI 10.1093/hmg/4.3.337; DeVries EMG, 1996, HUM MUTAT, V7, P202, DOI 10.1002/(SICI)1098-1004(1996)7:3<202::AID-HUMU4>3.3.CO;2-5; Dobbie Z, 1997, HUM GENET, V99, P653, DOI 10.1007/s004390050423; DOBBIE Z, 1994, EUR J CANCER, V30A, P1709, DOI 10.1016/0959-8049(94)00294-F; Eccles DM, 1996, AM J HUM GENET, V59, P1193; Fodde Riccardo, 1995, Critical Reviews in Oncogenesis, V6, P291; Friedl W, 1996, HUM GENET, V97, P579; GARDNER EJ, 1953, AM J HUM GENET, V5, P139; GARDNER EJ, 1951, AM J HUM GENET, V3, P167; Gardner RJM, 1997, GASTROENTEROLOGY, V113, P326, DOI 10.1016/S0016-5085(97)70111-2; GARETH R, 1997, LANCET, V350, P1777; GAYTHER SA, 1994, HUM MOL GENET, V3, P53, DOI 10.1093/hmg/3.1.53; GIARDIELLO FM, 1994, GASTROENTEROLOGY, V106, P1542, DOI 10.1016/0016-5085(94)90408-1; Giardiello FM, 1997, ANN INTERN MED, V126, P514, DOI 10.7326/0003-4819-126-7-199704010-00003; GRODEN J, 1993, AM J HUM GENET, V52, P263; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hioki K, 1997, CARCINOGENESIS, V18, P1863, DOI 10.1093/carcin/18.10.1863; HODGSON SV, 1994, J MED GENET, V31, P55, DOI 10.1136/jmg.31.1.55; HORII A, 1993, HUM MOL GENET, V2, P283, DOI 10.1093/hmg/2.3.283; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; JASS JR, 1994, ANTICANCER RES, V14, P1631; JOSLYN G, 1993, P NATL ACAD SCI USA, V90, P11109, DOI 10.1073/pnas.90.23.11109; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEPPERT M, 1990, NEW ENGL J MED, V322, P904, DOI 10.1056/NEJM199003293221306; LYNCH HT, 1988, J NATL CANCER I, V80, P278, DOI 10.1093/jnci/80.4.278; LYNCH HT, 1995, CANCER, V76, P2427, DOI 10.1002/1097-0142(19951215)76:12<2427::AID-CNCR2820761205>3.0.CO;2-B; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NAGASE H, 1992, CANCER RES, V52, P4055; Nagase Hiroki, 1992, Human Mutation, V1, P467, DOI 10.1002/humu.1380010603; NUGENT KP, 1992, BRIT J SURG, V79, P1204, DOI 10.1002/bjs.1800791136; OLSCHWANG S, 1993, AM J HUM GENET, V52, P273; OLSCHWANG S, 1993, CELL, V75, P959, DOI 10.1016/0092-8674(93)90539-3; Peifer M, 1996, SCIENCE, V272, P974, DOI 10.1126/science.272.5264.974; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SAMOWITZ WS, 1995, CANCER RES, V55, P3732; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT RJ, 1995, GUT, V36, P731, DOI 10.1136/gut.36.5.731; Scott RJ, 1996, HUM MOL GENET, V5, P1921, DOI 10.1093/hmg/5.12.1921; SMITHRAVIN J, 1994, J MED GENET, V31, P888, DOI 10.1136/jmg.31.11.888; Soravia C, 1997, J Gastrointest Surg, V1, P474, DOI 10.1016/S1091-255X(97)80136-9; Soravia C, 1997, SCHWEIZ MED WSCHR, V127, P682; SPIRIO L, 1992, AM J HUM GENET, V51, P92; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tomlinson IPM, 1996, J MED GENET, V33, P268, DOI 10.1136/jmg.33.4.268; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VANDERLUIJT RB, 1995, HUM GENET, V96, P705, DOI 10.1007/BF00210303; vanderLuijt RB, 1996, HUM GENET, V98, P727, DOI 10.1007/s004390050293; VARESCO L, 1994, HUM GENET, V93, P281, DOI 10.1007/BF00212023; Vasen HFA, 1996, LANCET, V348, P433, DOI 10.1016/S0140-6736(96)01340-2; Yang K, 1997, J EXP ZOOL, V277, P245, DOI 10.1002/(SICI)1097-010X(19970215)277:3<245::AID-JEZ5>3.3.CO;2-N; Zwick A, 1997, GASTROENTEROLOGY, V113, P659, DOI 10.1053/gast.1997.v113.pm9247488	61	243	256	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1290	1301		10.1086/301883	http://dx.doi.org/10.1086/301883			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585611	Bronze, Green Published			2022-12-18	WOS:000074174700005
J	HARPER, PS; HARLEY, HG; REARDON, W; SHAW, DJ				HARPER, PS; HARLEY, HG; REARDON, W; SHAW, DJ			ANTICIPATION IN MYOTONIC-DYSTROPHY - NEW LIGHT ON AN OLD PROBLEM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review								The concept of anticipation, the occurrence of a genetic disorder at progressively earlier ages in successive generations, has been debated from the early years of this century, with myotonic dystrophy as the most striking example. Throughout most of this period there has been controversy as to whether the phenomenon resulted from observational and ascertainment biases or reflected a more fundamental mechanism. The recent discovery of inherited unstable DNA sequences, first in fragile-X mental retardation and now in myotonic dystrophy, not only confirms that anticipation indeed has a true biological basis but provides a specific molecular mechanism for it; this discovery can explain many of the puzzling anomalies in the inheritance of myotonic dystrophy and may prove relevant to comparable problems in other genetic disorders.			HARPER, PS (corresponding author), UNIV HOSP WALES,INST MED GENET,CARDIFF CF4 4XW,S GLAM,WALES.							ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BELL J, 1947, TREASURY HUMAN INHER, V4, P343; Bodmer W. F., 1976, GENETICS EVOLUTION M; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Caughey JE, 1963, DYSTROPHIA MYOTONICA; CLARK AG, 1990, GLUTATHIONE S TRANSF, P131; CURSCHMANN H, 1912, DTSCH Z NERVENHEILKD, V45, P161; DYKEN PR, 1973, NEUROLOGY, V23, P465, DOI 10.1212/WNL.23.5.465; FLEISCHER B, 1916, VERSAMMLUNG HEIDELBE, V46, P442; FLEISCHER B, 1922, ARCH RASSEN GESELLSC, V14, P13; Fleiseher B., 1918, ALBRECHT GRAEFES ARC, V96, P91, DOI DOI 10.1007/BF02018704; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1; Gardner E J, 1984, PRINCIPLES GENETICS, V7th; Goldschmidt R, 1938, J HERED, V29, P140, DOI 10.1093/oxfordjournals.jhered.a104479; Greenfield J., 1911, REV NEUROL PSYCHIAT, V9, P169; HALL JG, 1990, GENOMIC IMPRINTING S, P141; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1972, LANCET, V2, P53; HARPER PS, 1975, ARCH DIS CHILD, V50, P514, DOI 10.1136/adc.50.7.514; HENKE KARL, 1927, ZEITSCHR GES ANAT ZEITSCHR KONSTITUTIONSLEHRE, V13, P371; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; HOWELER CJ, 1986, THESIS U ROTTERDAM R; King R.C., 1990, DICT GENETICS, V4th ed.; Maas O, 1937, BRAIN, V60, P498, DOI 10.1093/brain/60.4.498; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; Mott FW, 1911, LANCET, V1, P1251; MOTT FW, 1910, BRIT MED J, V2, P1013; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PENROSE LS, 1933, MENTAL DEFECTS; RIDLEY RM, 1991, J MED GENET, V28, P224, DOI 10.1136/jmg.28.4.224; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; Stern C., 1960, PRINCIPLES HUMAN GEN; SUTHERLAND GR, 1991, LANCET, V338, P289, DOI 10.1016/0140-6736(91)90426-P; VANIER TM, 1960, BRIT MED J, V2, P1284, DOI 10.1136/bmj.2.5208.1284; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VOGEL F, 1986, HUMAN GENETICS; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	42	243	249	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					10	16						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609789				2022-12-18	WOS:A1992JA46700003
J	Chen, JM; Zheng, HF; Bei, JX; Sun, LD; Jia, WH; Li, T; Zhang, FR; Seielstad, M; Zeng, YX; Zhang, XJ; Liu, JJ				Chen, Jieming; Zheng, Houfeng; Bei, Jin-Xin; Sun, Liangdan; Jia, Wei-hua; Li, Tao; Zhang, Furen; Seielstad, Mark; Zeng, Yi-Xin; Zhang, Xuejun; Liu, Jianjun			Genetic Structure of the Han Chinese Population Revealed by Genome-wide SNP Variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; EAST-ASIA; ASSOCIATION; HISTORY; SUBSTRUCTURE; HAPLOTYPE; INFERENCE; PROGRAM; CLUSTER; DNA	Population stratification is a potential problem for genome-wide association studies (GWAS), confounding results and causing spurious associations. Hence, understanding how allele frequencies vary across geographic regions or among subpopulations is an important prelude to analyzing GWAS data. Using over 350,000 genome-wide autosomal SNPs in over 6000 Han Chinese samples from ten provinces of China, Our study revealed a one-dimensional "north-south" population structure and a close correlation between geography and the genetic structure of the Han Chinese. The north-south population structure is consistent with the historical migration pattern of the Han Chinese population. Metropolitan cities in China were, however, more diffused "outliers," probably because of the impact of modern migration of peoples. At a very local scale within the Guangdong province, we observed evidence of population structure among dialect groups, probably on account of endogamy within these dialects. Via simulation, we show that empirical levels of population structure observed across modern China can cause spurious associations in GWAS if not properly handled. In the Han Chinese, geographic matching is a good proxy for genetic matching, particularly in validation and candidate-gene studies in which population stratification cannot be directly accessed and accounted for because of the lack of genome-wide data, with the exception of the metropolitan cities, where geographical location is no longer a good indicator of ancestral origin. Our findings are important for designing GWAS in the Chinese population, an activity that is expected to intensify greatly in the near future.	[Chen, Jieming; Seielstad, Mark; Liu, Jianjun] Genome Inst Singapore, Singapore 138672, Singapore; [Seielstad, Mark; Liu, Jianjun] Natl Univ Singapore, Ctr Mol Epidemiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Zheng, Houfeng; Sun, Liangdan; Zhang, Xuejun; Liu, Jianjun] Anhui Med Univ, Inst Dermatol, Hefei 230032, Anhui, Peoples R China; [Zheng, Houfeng; Sun, Liangdan; Zhang, Xuejun; Liu, Jianjun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei 230032, Anhui, Peoples R China; [Zheng, Houfeng; Sun, Liangdan; Zhang, Xuejun] Anhui Med Univ, Dept Dermatol & Venereol, Hefei 230032, Anhui, Peoples R China; [Zheng, Houfeng; Sun, Liangdan; Zhang, Xuejun; Liu, Jianjun] Minist Educ & Anhui Prov, Key Lab Gene Resource Utilizat Severe Dis, Hefei 230032, Anhui, Peoples R China; [Bei, Jin-Xin; Jia, Wei-hua; Zeng, Yi-Xin] State Key Lab Oncol So China, Guangzhou 510060, Guangdong, Peoples R China; [Bei, Jin-Xin; Jia, Wei-hua; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Li, Tao] Sichuan Univ, W China Hosp, Dept Psychiat, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Psychiat Lab, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao] Kings Coll London, Dept Psychol Med & Psychiat, Inst Psychiat, London SE5 8AF, England; [Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China; [Seielstad, Mark] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Anhui Medical University; Anhui Medical University; Anhui Medical University; Sun Yat Sen University; Sichuan University; Sichuan University; University of London; King's College London; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Harvard University; Harvard T.H. Chan School of Public Health	Liu, JJ (corresponding author), Genome Inst Singapore, Singapore 138672, Singapore.	liuj3@gis.a-star.edu.sg	Seielstad, Mark/T-7841-2019; Zheng, Houfeng/K-4424-2012; Liu, Jianjun/AAK-4989-2020; Chen, Gang/G-2722-2010; Bei, Jin-Xin/AAO-1259-2020	Zheng, Houfeng/0000-0001-5681-8598; Liu, Jianjun/0000-0002-3255-3019; Seielstad, Mark/0000-0001-5783-1401; Chen, Jieming/0000-0003-3767-9486	General Program of National Natural Science Foundation of China [30530300, 30671895, 30771943/C030116]; Key Project of Natural Science Foundation of China [30530670, u0732005]; High-Tech Research and Development Program of China (863 Program) [2007AA02Z161]; National Basic Research Program of China (973 Program) [2004CB518604, 2006AA02A404, 2007CB512301]; Shandong Provincial Research Fund of Science and Technology [2006GG2302029]; Agency for Science & Technology and Research of Singapore (A*STAR)	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shandong Provincial Research Fund of Science and Technology; Agency for Science & Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR))	This is a report of a joint effort of three research groups with equal contribution. L.J. is the senior author of the data analysis team, and X.Z. and Y-X.Z. are the senior authors of the two genotyping teams. We want to thank C. Zhang, J.W. Han, C. Quan. X.B. Zuo, H. Cheng, Z. Zhang, and F.S. Zhou from the Institute of Dermatology and the Department of Dermatology at the No.1 Hospital, Anhui Medical University and X.Y. Chen, H.B. Toh, K.K. Heng, and Y.W. Meah from the Genome Institute of Singapore for their supports in genotyping analysis. We also want to thank Erwin Tantoso from the Genome institute of Singapore for his assistance in data analysis. This work was funded by the General Program of National Natural Science Foundation of China (30530300, 30671895, and 30771943/C030116), the Key Project of Natural Science Foundation of China (30530670 and u0732005), the High-Tech Research and Development Program of China (863 Program) (2007AA02Z161), the National Basic Research Program of China (973 Program) (2004CB518604, 2006AA02A404 and 2007CB512301), the Shandong Provincial Research Fund of Science and Technology (2006GG2302029), and the Agency for Science & Technology and Research of Singapore (A*STAR).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Falush D, 2003, GENETICS, V164, P1567; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; LEE KC, 2005, PIONEERS MODERN CHIN; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Piazza A, 1998, NATURE, V395, P636, DOI 10.1038/27071; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saw SH, 2007, POPULATION SINGAPORE; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; TONG CK, 2004, ENCY DIASPORAS IMMIG, V1, P723; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu S. D., 1997, ZHONGGUO YIMIN SHI; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2003, MOL BIOL EVOL, V20, P214, DOI 10.1093/molbev/msg026; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	31	242	259	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					775	785		10.1016/j.ajhg.2009.10.016	http://dx.doi.org/10.1016/j.ajhg.2009.10.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19944401	Bronze, Green Published			2022-12-18	WOS:000272797100002
J	Kirk, EP; Sunde, M; Costa, MW; Rankin, SA; Wolstein, O; Castro, ML; Butler, TL; Hyun, C; Guo, G; Otway, R; Mackay, JP; Waddell, LB; Cole, AD; Hayward, C; Keogh, A; Macdonald, P; Griffiths, L; Fatkin, D; Sholler, GF; Zorn, AM; Feneley, MP; Winlaw, DS; Harvey, RP				Kirk, Edwin P.; Sunde, Margaret; Costa, Mauro W.; Rankin, Scott A.; Wolstein, Orit; Castro, M. Leticia; Butler, Tanya L.; Hyun, Changbaig; Guo, Guanglan; Otway, Robyn; Mackay, Joel P.; Waddell, Leigh B.; Cole, Andrew D.; Hayward, Christopher; Keogh, Anne; Macdonald, Peter; Griffiths, Lyn; Fatkin, Diane; Sholler, Gary F.; Zorn, Aaron M.; Feneley, Michael P.; Winlaw, David S.; Harvey, Richard P.			Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiornyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DISEASE; PROTEIN SECONDARY STRUCTURE; TRANSCRIPTION FACTOR NKX2-5; HOLT-ORAM SYNDROME; CIRCULAR-DICHROISM; MYOCARDIAL-CELLS; PROLIFERATION; EXPRESSION; DIFFERENTIATION; SPECIFICATION	The T-box family transcription factor gene TBX20 acts in a conserved regulatory network, guiding heart formation and patterning in diverse species. Mouse Tbx20 is expressed in cardiac progenitor cells, differentiating cardiomyocytes, and developing valvular tissue, and its deletion or RNA interference-mediated knockdown is catastrophic for heart development. TBX20 interacts physically, functionally, and genetically with other cardiac transcription factors, including NKX25, GATA4, and TBX5, mutations of which cause congenital heart disease (CHD). Here, we report nonsense (Q195X) and missense (1152M) germline mutations within the T-box DNA-binding domain of human TBX20 that were associated with a family history of CHD and a complex spectrum of developmental anomalies, including defects in septation, chamber growth, and valvulogenesis. Biophysical characterization of wild-type and mutant proteins indicated how the missense mutation disrupts the structure and function of the TBX20 T-box. Dilated cardiomyopathy was a feature of the TBX20 mutant phenotype in humans and mice, suggesting that mutations in developmental transcription factors can provide a sensitized template for adult-onset heart disease. Our findings are the first to link TBX20 mutations to human pathology. They provide insights into how Mutation of different genes in an interactive regulatory circuit lead to diverse clinical phenotypes, with implications for diagnosis, genetic screening, and patient follow-up.	St Vincents Hosp, Voctor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; St Vincents Hosp, Dept Cardiol, Darlinghurst, NSW 2010, Australia; Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW, Australia; Univ New S Wales, Fac Med, Sch Womens & Childrens Hlth, Randwick, NSW, Australia; Univ Sydney, Fac Med, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; Univ Sydney, Fac Med, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; Univ Cincinnati, Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH 45221 USA; Childrens Hosp, Kids Heart Res, Westmead, NSW, Australia; Kangwon Natl Univ, Sch Vet Med, Sect Snall Anim Internal Med, Chucheon, South Korea; Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; Univ New S Wales, Fac Life Sci, Kensington, NSW 2033, Australia; Griffith Univ, Sch Med Sci, Southport, Qld, Australia	St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; Universidade Federal do Rio de Janeiro; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Sydney; Kangwon National University; University of New South Wales Sydney; University of New South Wales Sydney; Griffith University	Harvey, RP (corresponding author), Victor Chang Cardiac Res Inst, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	r.harvey@victorchang.edu.au	Sunde, Margaret/ABH-2584-2020; Sholler, Gary/AED-1023-2022; Winlaw, David S/F-8365-2016; Winlaw, David/B-9405-2019; Costa, Mauro W/S-9219-2018; Waddell, Leigh/L-3037-2017; Sunde, Margaret/A-5186-2016; Ward, Tanya/J-4882-2015; Mackay, Joel/D-6834-2011	Sunde, Margaret/0000-0002-0150-3203; Sholler, Gary/0000-0003-1501-8898; Winlaw, David S/0000-0001-8005-3361; Winlaw, David/0000-0001-8005-3361; Costa, Mauro W/0000-0003-3579-8625; Waddell, Leigh/0000-0003-2970-6624; Sunde, Margaret/0000-0002-0150-3203; Ward, Tanya/0000-0003-1576-521X; Griffiths, Lyn/0000-0002-6774-5475; Mackay, Joel/0000-0001-7508-8033; Kirk, Edwin/0000-0002-4662-0024; Harvey, Richard/0000-0002-9950-9792	NHLBI NIH HHS [R01 HL068885, R01HL68885-01] Funding Source: Medline; NICHD NIH HHS [R01 HD042572-05, R01 HD042572] Funding Source: Medline; NIDDK NIH HHS [R01 DK070858, R01 DK070858-01A2] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070858] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bajolle F, 2006, CIRC RES, V98, P421, DOI 10.1161/01.RES.0000202800.85341.6e; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Benson DW, 1998, CIRCULATION, V97, P2043, DOI 10.1161/01.CIR.97.20.2043; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Collantes E, 2002, BMC FAM PRACT, V3, P1; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Elliott DA, 2006, DEVELOPMENT, V133, P1311, DOI 10.1242/dev.02305; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gassner NC, 1996, P NATL ACAD SCI USA, V93, P12155, DOI 10.1073/pnas.93.22.12155; Gruber PJ, 2004, CIRC RES, V94, P273, DOI 10.1161/01.RES.0000116144.43797.3B; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Li QY, 1997, NAT GENET, V15, P21; Li TS, 1998, J PROTEIN CHEM, V17, P757, DOI 10.1023/A:1020770000344; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Ohmura T, 2001, PROTEIN ENG, V14, P421, DOI 10.1093/protein/14.6.421; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Szeto DP, 2002, DEVELOPMENT, V129, P5093; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Yamagishi H, 2003, TRENDS MOL MED, V9, P383, DOI 10.1016/S1471-4914(03)00141-2; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586	45	242	257	3	22	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					280	291		10.1086/519530	http://dx.doi.org/10.1086/519530			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668378	Green Published, Bronze			2022-12-18	WOS:000248540400008
J	Wiltshire, S; Hattersley, AT; Hitman, GA; Walker, M; Levy, JC; Sampson, M; O'Rahilly, S; Frayling, TM; Bell, JI; Lathrop, GM; Bennett, A; Dhillon, R; Fletcher, C; Groves, CJ; Jones, E; Prestwich, P; Simecek, N; Rao, PVS; Wishart, M; Foxon, R; Howell, S; Smedley, D; Cardon, LR; Menzel, S; McCarthy, MI				Wiltshire, S; Hattersley, AT; Hitman, GA; Walker, M; Levy, JC; Sampson, M; O'Rahilly, S; Frayling, TM; Bell, JI; Lathrop, GM; Bennett, A; Dhillon, R; Fletcher, C; Groves, CJ; Jones, E; Prestwich, P; Simecek, N; Rao, PVS; Wishart, M; Foxon, R; Howell, S; Smedley, D; Cardon, LR; Menzel, S; McCarthy, MI			A genomewide scan for loci predisposing to type 2 diabetes in a UK population (the Diabetes UK Warren 2 repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSULIN-DEGRADING ENZYME; GLUTAMIC-ACID DECARBOXYLASE; MELLITUS GENETICS FUSION; LINKAGE ANALYSIS; COMPLEX TRAITS; WIDE SEARCH; GENES REVEALS; ONSET; ASSOCIATION; MUTATIONS	Improved molecular understanding of the pathogenesis of type 2 diabetes is essential if current therapeutic and preventative options are to be extended. To identify diabetes-susceptibility genes, we have completed a primary (418-marker, 9-cM) autosomal-genome scan of 743 sib pairs (573 pedigrees) with type 2 diabetes who are from the Diabetes UK Warren 2 repository. Nonparametric linkage analysis of the entire data set identified seven regions showing evidence for linkage, with allele-sharing LOD scores greater than or equal to1.18 (P less than or equal to .01). The strongest evidence was seen on chromosomes 8p21-22 (near D8S258 [LOD score 2.55]) and 10q23.3 (near D10S1765 [LOD score 1.99]), both coinciding with regions identified in previous scans in European subjects. This was also true of two lesser regions identified, on chromosomes 5q13 (D5S647 [LOD score 1.22] and 5q32 (D5S436 [LOD score 1.22]). Loci on 7p15.3 (LOD score 1.31) and 8q24.2 (LOD score 1.41) are novel. The final region showing evidence for linkage, on chromosome 1q24-25 (near D1S218 [LOD score 1.50]), colocalizes with evidence for linkage to diabetes found in Utah, French, and Pima families and in the GK rat. After dense-map genotyping (mean marker spacing 4.4 cM), evidence for linkage to this region increased to a LOD score of 1.98. Conditional analyses revealed nominally significant interactions between this locus and the regions on chromosomes 10q23.3 (P = .01) and 5q32 ( P = .02). These data, derived from one of the largest genome scans undertaken in this condition, confirm that individual susceptibility-gene effects for type 2 diabetes are likely to be modest in size. Taken with genome scans in other populations, they provide both replication of previous evidence indicating the presence of a diabetes-susceptibility locus on chromosome 1q24-25 and support for the existence of additional loci on chromosomes 5, 8, and 10. These data should accelerate positional cloning efforts in these regions of interest.	Kings Coll London, Imperial Coll Genet & Genom Res Inst, London W12 0NN, England; Kings Coll London, Imperial Coll, Div Med, London W12 0NN, England; Kings Coll London, St Bartholomews & Royal London Sch Med & Dent, Dept Med, London W12 0NN, England; Kings Coll London, Sch Biomed Sci, London W12 0NN, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Oxford, Radcliffe Infirm, Oxford OX2 6HE, England; Univ Oxford, Buffield Dept Med, Oxford OX2 6HE, England; Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Diabet & Vasc Med, Exeter, Devon, England; Newcastle Univ, Sch Med, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Norfolk & Norwich Univ Hosp, Dept Endocrinol & Diabet, Norwich, Norfolk, England; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England	University of London; King's College London; Imperial College London; University of London; King's College London; University of London; King's College London; Queen Mary University London; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; University of Oxford; University of Exeter; Newcastle University - UK; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	McCarthy, MI (corresponding author), Kings Coll London, Imperial Coll Genet & Genom Res Inst, Imperial Coll Hammersmith Campus, London W12 0NN, England.	m.mccarthy@ic.ac.uk	Smedley, Damian/AAL-8172-2021; Menzel, Stephan/U-6906-2019; O'Rahilly, Stephen/ABF-6509-2020; McCarthy, Mark/M-3763-2015	O'Rahilly, Stephen/0000-0003-2199-4449; McCarthy, Mark/0000-0002-4393-0510; bennett, amanda/0000-0003-2140-8710; Menzel, Stephan/0000-0002-1590-9108; Levy, Jonathan/0000-0002-9486-1885; Hattersley, Andrew/0000-0001-5620-473X; Frayling, Timothy/0000-0001-8362-2603	NEI NIH HHS [R01 EY012562, EY-12562] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; AFFHOLTER JA, 1990, MOL ENDOCRINOL, V4, P1125, DOI 10.1210/mend-4-8-1125; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bektas A, 1999, DIABETES, V48, P2246, DOI 10.2337/diabetes.48.11.2246; Bingley PJ, 1997, DIABETES, V46, P1701, DOI 10.2337/diabetes.46.11.1701; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; BOEHNKE M, 1998, AM J HUM GENET S, V63, pA282; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; ESPINOSA R, 1991, CYTOGENET CELL GENET, V57, P184, DOI 10.1159/000133142; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Frayling TM, 2000, J CLIN ENDOCR METAB, V85, P853, DOI 10.1210/jc.85.2.853; Galli J, 1999, DIABETES, V48, P2463, DOI 10.2337/diabetes.48.12.2463; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hauser ER, 1997, AM J HUM GENET, V61, pA278; HAUSER ER, 1998, AM J HUM GENET S, V63, pA45; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; Kaisaki PJ, 2000, GENOMICS, V64, P32, DOI 10.1006/geno.1999.6107; K÷bberling J., 1982, GENETICS DIABETES ME, P201; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leal SM, 2000, AM J HUM GENET, V66, P567, DOI 10.1086/302748; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MCCARTY D, 1994, DIABETES 1994 2010; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ott J, 1999, ANAL HUMAN GENETIC L; Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681; PETERSEN JS, 1994, DIABETES, V43, P459, DOI 10.2337/diabetes.43.3.459; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; St Jean P, 2000, AM J HUM GENET, V67, P332; SUAREZ BK, 1979, CLIN GENET, V15, P126; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Watanabe RM, 1999, GENET EPIDEMIOL, V17, pS385; Watanabe TK, 1999, NAT GENET, V22, P27, DOI 10.1038/8737; *WHO STUD GROUP, 1985, WHO TECH REP, V727	70	242	249	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					553	569		10.1086/323249	http://dx.doi.org/10.1086/323249			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11484155	Green Published, Bronze			2022-12-18	WOS:000170271400008
J	SMITH, C				SMITH, C			CONCORDANCE IN TWINS - METHODS AND INTERPRETATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV EDINBURGH,WESTERN GEN HOSP,DEPT HUMAN GENET,EDINBURGH,SCOTLAND	University of Edinburgh								ALLEN G, 1967, ACTA GENET STAT MED, V17, P475; Boyden S.V., 1970, IMPACT CIVILIZATION; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CROW JF, 1965, GENETICS EPIDEMIOLOG; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; Falconer D.S., 1960, INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Holzinger KJ, 1929, J EDUC PSYCHOL, V20, P241, DOI 10.1037/h0072484; HRUBEC Z, 1973, AM J HUM GENET, V25, P15; KRUGER J, 1973, HUMANGENETIK, V17, P181, DOI 10.1007/BF00273637; MENDELL NR, 1974, BIOMETRICS, V30, P41, DOI 10.2307/2529616; MORTON NE, 1969, COMPUTER APPLICATION; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; SMITH C, 1970, ANN HUM GENET, V34, P85, DOI 10.1111/j.1469-1809.1970.tb00223.x; SMITH C, 1971, Clinical Genetics, V2, P303; SMITH C, 1972, HUM HERED, V22, P97, DOI 10.1159/000152476	17	242	244	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	4					454	466						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	T5051	4858380				2022-12-18	WOS:A1974T505100003
J	Carss, KJ; Arno, G; Erwood, M; Stephens, J; Sanchis-Juan, A; Hull, S; Megy, K; Grozeva, D; Dewhurst, E; Malka, S; Plagnol, V; Penkett, C; Stirrups, K; Rizzo, R; Wright, G; Josifova, D; Bitner-Glindzicz, M; Scott, RH; Clement, E; Allen, L; Armstrong, R; Brady, AF; Carmichael, J; Chitre, M; Henderson, RHH; Hurst, J; MacLaren, RE; Murphy, E; Paterson, J; Rosser, E; Thompson, DA; Wakeling, E; Ouwehand, WH; Michaelides, M; Moore, AT; Webster, AR; Raymond, FL				Carss, Keren J.; Arno, Gavin; Erwood, Marie; Stephens, Jonathan; Sanchis-Juan, Alba; Hull, Sarah; Megy, Karyn; Grozeva, Detelina; Dewhurst, Eleanor; Malka, Samantha; Plagnol, Vincent; Penkett, Christopher; Stirrups, Kathleen; Rizzo, Roberta; Wright, Genevieve; Josifova, Dragana; Bitner-Glindzicz, Maria; Scott, Richard H.; Clement, Emma; Allen, Louise; Armstrong, Ruth; Brady, Angela F.; Carmichael, Jenny; Chitre, Manali; Henderson, Robert H. H.; Hurst, Jane; MacLaren, Robert E.; Murphy, Elaine; Paterson, Joan; Rosser, Elisabeth; Thompson, Dorothy A.; Wakeling, Emma; Ouwehand, Willem H.; Michaelides, Michel; Moore, Anthony T.; Webster, Andrew R.; Raymond, F. Lucy		NIHR-BioResource Rare Dis	Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; STARGARDT DISEASE; EXOME; DYSTROPHY; MUTATION; GENE; DIAGNOSIS; REVEALS; PROTEIN; ACTIVATION	Inherited retinal disease is a common cause of visual impairment and represents a highly heterogeneous group of conditions. Here, we present findings from a cohort of 722 individuals with inherited retinal disease, who have had whole-genome sequencing (n = 605), whole-exome sequencing (n = 72), or both (n = 45) performed, as part of the NIHR-BioResource Rare Diseases research study. We identified pathogenic variants (single-nucleotide variants, indels, or structural variants) for 404/722 (56%) individuals. Whole-genome sequencing gives unprecedented power to detect three categories of pathogenic variants in particular: structural variants, variants in GC-rich regions, which have significantly improved coverage compared to whole-exome sequencing, and variants in non-coding regulatory regions. In addition to previously reported pathogenic regulatory variants, we have identified a previously unreported pathogenic intronic variant in CHM in two males with choroideremia. We have also identified 19 genes not previously known to be associated with inherited retinal disease, which harbor biallelic predicted protein-truncating variants in unsolved cases. Whole-genome sequencing is an increasingly important comprehensive method with which to investigate the genetic causes of inherited retinal disease.	[Carss, Keren J.; Erwood, Marie; Stephens, Jonathan; Sanchis-Juan, Alba; Megy, Karyn; Dewhurst, Eleanor; Penkett, Christopher; Stirrups, Kathleen; Ouwehand, Willem H.] Univ Cambridge, NHS Blood & Transplant Ctr, Dept Haematol, Cambridge CB2 0PT, England; [Carss, Keren J.; Arno, Gavin; Erwood, Marie; Stephens, Jonathan; Sanchis-Juan, Alba; Megy, Karyn; Grozeva, Detelina; Dewhurst, Eleanor; Penkett, Christopher; Stirrups, Kathleen; Josifova, Dragana; Bitner-Glindzicz, Maria; Scott, Richard H.; Clement, Emma; Allen, Louise; Armstrong, Ruth; Brady, Angela F.; Carmichael, Jenny; Chitre, Manali; Henderson, Robert H. H.; Hurst, Jane; MacLaren, Robert E.; Murphy, Elaine; Paterson, Joan; Rosser, Elisabeth; Thompson, Dorothy A.; Wakeling, Emma; Ouwehand, Willem H.; Michaelides, Michel; Moore, Anthony T.; Webster, Andrew R.; Raymond, F. Lucy] Cambridge Univ Hosp NHS Fdn Trust, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Arno, Gavin; Hull, Sarah; Malka, Samantha; Michaelides, Michel; Moore, Anthony T.; Webster, Andrew R.] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Arno, Gavin; Hull, Sarah; Malka, Samantha; Rizzo, Roberta; Wright, Genevieve; Henderson, Robert H. H.; MacLaren, Robert E.; Michaelides, Michel; Moore, Anthony T.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Grozeva, Detelina; Raymond, F. Lucy] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Josifova, Dragana] Guys Hosp, Clin Genet Dept, Great Maze Pond, London SE1 9RT, England; [Bitner-Glindzicz, Maria] UCL Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Scott, Richard H.] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Clement, Emma; Henderson, Robert H. H.; Hurst, Jane; Rosser, Elisabeth] Great Ormond St Hosp Sick Children, Great Ormond St, London WC1N 3JH, England; [Allen, Louise] Cambridge Univ Hosp NHS Fdn Trust, Dept Ophthalmol, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Armstrong, Ruth; Carmichael, Jenny; Chitre, Manali; Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, Dept Med Genet, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Armstrong, Ruth; Carmichael, Jenny; Chitre, Manali; Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, Dept Paediat Neurol, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Brady, Angela F.; Wakeling, Emma] London North West Healthcare NHS Trust, North West Thames Reg Genet Serv, Watford Rd, Harrow HA1 3UJ, Middx, England; [MacLaren, Robert E.] Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Murphy, Elaine] Natl Hosp Neurol & Neurosurg, Charles Dent Metab Unit, Queen Sq, London WC1N 3BG, England; [Thompson, Dorothy A.] Great Ormond St Hosp Sick Children, Clin & Acad Dept Ophthalmol, London WC1N 3JH, England; [Moore, Anthony T.] Univ Calif San Francisco, UCSF Sch Med, Dept Ophthalmol, San Francisco, CA 94158 USA	University of Cambridge; University of Cambridge; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of California System; University of California San Francisco	Raymond, FL (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, NIHR BioResource Rare Dis, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Raymond, FL (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England.	flr24@cam.ac.uk	Brown, Matthew A/E-5749-2010; Tischkowitz, Marc/O-4452-2018; Heemskerk, Johan/AAM-8323-2021; Lawrie, Allan/A-2708-2012; Gale, Daniel/D-5594-2013; Southgate, Laura/H-7924-2019; Allsup, David/H-2195-2017; Ponsford, Mark J/ABA-3891-2020; Henderson, Robert/AAA-2660-2020; Savic, Sinisa/Q-6217-2019; Booth, Claire/I-3667-2016; Sargur, Ravishankar/C-2270-2009	Brown, Matthew A/0000-0003-0538-8211; Tischkowitz, Marc/0000-0002-7880-0628; Heemskerk, Johan/0000-0002-2848-5121; Lawrie, Allan/0000-0003-4192-9505; Gale, Daniel/0000-0002-9170-1579; Southgate, Laura/0000-0002-2090-1450; Allsup, David/0000-0001-6159-6109; Ponsford, Mark J/0000-0002-0236-1059; Henderson, Robert/0000-0002-5250-6404; Savic, Sinisa/0000-0001-7910-0554; Gomez, Keith/0000-0002-8934-0700; Wakeling, Emma/0000-0001-5712-0044; Doffinger, R/0000-0002-9841-3617; Burns, Siobhan/0000-0002-3356-9506; Machado, Rajiv David/0000-0001-9247-0744; Megy, Karyn/0000-0002-2826-3879; Meacham, Stuart/0000-0002-3667-6059; Gissen, Paul/0000-0002-9712-6122; Lango Allen, Hana/0000-0002-7803-8688; james, roger/0000-0002-0058-1357; Westbury, Sarah/0000-0002-0950-8148; mumford, andrew/0000-0002-5523-511X; Chinnery, Patrick/0000-0002-7065-6617; Michaelides, Michel/0000-0002-1552-7046; Grozeva, Detelina/0000-0003-3239-8415; Clement, Emma/0000-0002-5562-6276; Haimel, Matthias/0000-0002-0320-0214; Thompson, Dorothy/0000-0001-5491-3911; Stephens, Jonathan/0000-0003-2020-9330; Caulfield, Mark/0000-0001-9295-3594; Erber, Wendy/0000-0002-1028-9376; freson, kathleen/0000-0002-4381-2442; Deevi, Sri Vishnu Vardhan/0000-0002-0405-4335; Hu, Fengyuan/0000-0002-1756-7551; vonk noordegraaf, anton/0000-0002-4057-758X; , Jesmeen/0000-0003-4169-8209; schulman, sol/0000-0002-5229-3592; /0000-0003-2885-4692; Bradley, John/0000-0002-7774-8805; Booth, Claire/0000-0002-2626-5037; Sargur, Ravishankar/0000-0002-8535-630X; MacLaren, Robert/0000-0002-3096-4682; Kingston, Nathalie/0000-0002-9190-2231; Toshner, Mark/0000-0002-3969-6143; Daugherty, Louise/0000-0003-4546-6667; Thaventhiran, James/0000-0001-8616-074X; Williamson, Catherine/0000-0002-6226-7611; QASIM, WASEEM/0000-0001-8353-4494; Matser, Vera/0000-0002-2010-6844; Aitman, Timothy/0000-0002-7875-4502; Carss, Keren/0000-0003-4939-156X	National Institute for Health Research England (NIHR) for the NIHR BioResource - Rare Diseases project [RG65966]; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; National Health Service Foundation Trust; UCL Institute of Ophthalmology; Moorfields Eye Hospital Special Trustees; Moorfields Eye Charity; Foundation Fighting Blindness (USA); Retinitis Pigmentosa Fighting Blindness; FFB Career Development Award; UCLH/UCL NIHR Biomedical Research Centre; Cambridge NIHR Biomedical Research Centre; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; Medical Research Council [MR/K023489/1, MR/L006197/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10047, RP-PG-0310-1002, NF-SI-0510-10214, NF-SI-0513-10151, NF-SI-0512-10014] Funding Source: researchfish; MRC [MR/L006197/1, MR/K023489/1] Funding Source: UKRI	National Institute for Health Research England (NIHR) for the NIHR BioResource - Rare Diseases project; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; National Health Service Foundation Trust; UCL Institute of Ophthalmology; Moorfields Eye Hospital Special Trustees; Moorfields Eye Charity; Foundation Fighting Blindness (USA); Retinitis Pigmentosa Fighting Blindness; FFB Career Development Award; UCLH/UCL NIHR Biomedical Research Centre; Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The National Institute for Health Research England (NIHR) for the NIHR BioResource - Rare Diseases project (grant number RG65966). The Moorfields Eye Hospital cohort of patients and clinical and imaging data were ascertained and collected with the support of grants from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital, National Health Service Foundation Trust, and UCL Institute of Ophthalmology, Moorfields Eye Hospital Special Trustees, Moorfields Eye Charity, the Foundation Fighting Blindness (USA), and Retinitis Pigmentosa Fighting Blindness. M.M. is a recipient of an FFB Career Development Award. E.M. is supported by UCLH/UCL NIHR Biomedical Research Centre. F.L.R. and D.G. are supported by Cambridge NIHR Biomedical Research Centre.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arno G, 2016, INVEST OPHTH VIS SCI, V57, P4806, DOI 10.1167/iovs.16-19687; Ba-Abbad R, 2016, OPHTHALMOLOGY, V123, P668, DOI 10.1016/j.ophtha.2015.09.045; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Braun TA, 2013, HUM MOL GENET, V22, P5136, DOI 10.1093/hmg/ddt367; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Chiang J, 2015, EXPERT REV MOL DIAGN, V15, P1269, DOI 10.1586/14737159.2015.1081057; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Ellingford JM, 2016, OPHTHALMOLOGY, V123, P1143, DOI 10.1016/j.ophtha.2016.01.009; Ellingford JM, 2015, LANCET, V385, P1916, DOI 10.1016/S0140-6736(15)60496-2; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Henderson RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/iovs.07-0207; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Huang XF, 2015, GENET MED, V17, P271, DOI 10.1038/gim.2014.138; Hull S, 2016, INVEST OPHTH VIS SCI, V57, P1053, DOI 10.1167/iovs.15-17976; Khan K.N., 2016, CLIN GENET; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2015, HUM MUTAT, V36, P815, DOI 10.1002/humu.22813; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Mayer AK, 2016, EUR J HUM GENET, V24, P459, DOI 10.1038/ejhg.2015.144; McRae J. F., 2016, BIORXIV; O'Sullivan J, 2012, J MED GENET, V49, P322, DOI 10.1136/jmedgenet-2012-100847; Patel N, 2016, GENET MED, V18, P554, DOI 10.1038/gim.2015.127; Patwardhan A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0197-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pusch Carsten M, 2002, Hum Mutat, V20, P405, DOI 10.1002/humu.9072; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Sangermano R, 2016, OPHTHALMOLOGY, V123, P1375, DOI 10.1016/j.ophtha.2016.01.053; Stavropoulos DJ, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.12; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tiwari A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28755; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Vache C, 2012, HUM MUTAT, V33, P104, DOI 10.1002/humu.21634; van den Hurk JAJM, 2003, HUM GENET, V113, P268, DOI 10.1007/s00439-003-0970-0; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Westbury SK, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0151-5; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	51	241	244	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					75	90		10.1016/j.ajhg.2016.12.003	http://dx.doi.org/10.1016/j.ajhg.2016.12.003			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28041643	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000391910500007
J	Tan, MH; Mester, J; Peterson, C; Yang, YR; Chen, JL; Rybicki, LA; Milas, K; Pederson, H; Remzi, B; Orloff, MS; Eng, C				Tan, Min-Han; Mester, Jessica; Peterson, Charissa; Yang, Yiran; Chen, Jin-Lian; Rybicki, Lisa A.; Milas, Kresimira; Pederson, Holly; Remzi, Berna; Orloff, Mohammed S.; Eng, Charis			A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 Probands	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIPID PHOSPHATASE-ACTIVITY; AUTISM SPECTRUM DISORDERS; HAMARTOMA TUMOR SYNDROME; SYNDROME PLEASE STAND; COWDEN-SYNDROME; ARTERIOVENOUS-MALFORMATIONS; PROMOTER MUTATIONS; PROTEIN; GENE; INDIVIDUALS	Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome are allelic, defined by germline PTEN mutations, and collectively referred to as PTEN hamartoma tumor syndrome. To date, there are no existing criteria based on large prospective patient cohorts to select patients for PTEN mutation testing. To address these issues, we conducted a multicenter prospective study in which 3042 probands satisfying relaxed CS clinical criteria were accrued. PTEN mutation scanning, including promoter and large deletion analysis, was performed for all subjects. Pathogenic mutations were identified in 290 individuals (9.5%). To evaluate clinical phenotype and PTEN genotype against protein expression, we performed immunoblotting (PTEN, P-AKT1, P-MAPK1/2) for a patient subset (n = 423). In order to obtain an individualized estimation of pretest probability of germline PTEN mutation, we developed an optimized clinical practice model to identify adult and pediatric patients. For adults, a semiquantitative score the Cleveland Clinic (CC) score resulted in a well-calibrated estimation of pretest probability of PTEN status. Overall, decreased PTEN protein expression correlated with PTEN mutation status; decreasing PTEN protein expression correlated with increasing CC score (p <0.001), but not with the National Comprehensive Cancer Network (NCCN) criteria (p = 0.11). For pediatric patients, we identified highly sensitive criteria to guide PTEN mutation testing, with phenotypic features distinct from the adult setting. Our model improved sensitivity and positive predictive value for germline PTEN mutation relative to the NCCN 2010 criteria in both cohorts. We present the first evidence-based clinical practice model to select patients for genetics referral and PTEN mutation testing, further supported biologically by protein correlation.	[Tan, Min-Han; Mester, Jessica; Peterson, Charissa; Yang, Yiran; Chen, Jin-Lian; Orloff, Mohammed S.; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Tan, Min-Han; Mester, Jessica; Peterson, Charissa; Yang, Yiran; Chen, Jin-Lian; Rybicki, Lisa A.; Orloff, Mohammed S.; Eng, Charis] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Rybicki, Lisa A.; Orloff, Mohammed S.; Eng, Charis] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Rybicki, Lisa A.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Mester, Jessica; Milas, Kresimira; Eng, Charis] Cleveland Clin, Endocrinol & Metab Inst, Thyroid Canc Ctr, Cleveland, OH 44195 USA; [Pederson, Holly] Cleveland Clin, Womens Hlth & Obstet Inst, High Risk Breast Canc Clin, Cleveland, OH 44195 USA; [Remzi, Berna] Cleveland Clin, Dept Dermatol, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Inst Nursing Excellence, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA.	engc@ccf.org	Tan, Min Han/D-9205-2014	Tan, Min Han/0000-0002-0644-3457; Eng, Charis/0000-0002-3693-5145	National Cancer Institute [P01CA124570, R01CA118989]; American Cancer Society [RPG-02-151-01-CCE]; William Randolph Hearst Foundations; Doris Duke Distinguished Clinical Scientist Award; F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE [P01CA124570, R01CA118980] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); William Randolph Hearst Foundations; Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank the Genomic Medicine Biorepository of the Cleveland Clinic Genomic Medicine Institute, as well as the Eng laboratory personnel over the last 14 years who have contributed technical assistance, technical advice, and helpful discussions. We would also like to express our gratitude to all the patients and clinical collaborators from all the centers around the world who have contributed their time and specimens over the last 10 years. This study is funded, in part, by the National Cancer Institute (P01CA124570 and R01CA118989), American Cancer Society (RPG-02-151-01-CCE), William Randolph Hearst Foundations, and Doris Duke Distinguished Clinical Scientist Award (all to C.E.). M.-H.T. is the Lee Foundation (Singapore) Fellow and an Ambrose Monell Foundation Canter Genomic Medicine Clinical Fellow at the Cleveland Clinic Genomic Medicine Institute. C.E. is the Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic. C.E. is the recipient of an American Cancer Society Clinical Research Professorship, generously funded, in part, by the F.M. Kirby Foundation.	Al-Shahi R, 2001, BRAIN, V124, P1900, DOI 10.1093/brain/124.10.1900; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Bennett KL, 2010, JAMA-J AM MED ASSOC, V304, P2724, DOI 10.1001/jama.2010.1877; Biesecker LG, 2001, LANCET, V358, P2079, DOI 10.1016/S0140-6736(01)07109-4; BOUQUOT JE, 1986, ORAL SURG ORAL MED O, V62, P284, DOI 10.1016/0030-4220(86)90010-1; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; DeWaay DJ, 2002, OBSTET GYNECOL, V100, P3, DOI 10.1016/S0029-7844(02)02007-0; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; HARRELL EE, 2001, REGRESSION MODELLING; Heald B, 2010, GASTROENTEROLOGY, V139, P1927, DOI 10.1053/j.gastro.2010.06.061; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Li DM, 1997, CANCER RES, V57, P2124; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; MATOVINOVIC J, 1983, ANNU REV NUTR, V3, P341, DOI 10.1146/annurev.nu.03.070183.002013; McBride KL, 2010, AUTISM RES, V3, P137, DOI 10.1002/aur.132; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; *NAT COMPR CANC NE, 2010, GEN FAM HIGH RISH AS; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237; Paltiel HJ, 2000, RADIOLOGY, V214, P747, DOI 10.1148/radiology.214.3.r00mr21747; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Pilarski R, 2009, J GENET COUNS, V18, P13, DOI 10.1007/s10897-008-9187-7; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Riegert-Johnson DL, 2010, HERED CANCER CLIN PR, V8, DOI 10.1186/1897-4287-8-6; Rosenberg SA, 2008, PEDIATRICS, V121, pE1503, DOI 10.1542/peds.2007-1680; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shiovitz S, 2010, BREAST CANCER RES TR, V124, P459, DOI 10.1007/s10549-010-0839-6; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tan MH, 2010, UROLOGY, V75, P1365, DOI 10.1016/j.urology.2009.07.1289; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Turnbull MM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.030569; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109	46	241	246	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					42	56		10.1016/j.ajhg.2010.11.013	http://dx.doi.org/10.1016/j.ajhg.2010.11.013			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21194675	Green Published, Bronze			2022-12-18	WOS:000286501500004
J	Huang, NW; Pandey, AV; Agrawal, V; Reardon, W; Lapunzina, PD; Mowat, D; Jabs, EW; Van Vliet, G; Sack, J; Fluck, CE; Miller, WL				Huang, NW; Pandey, AV; Agrawal, V; Reardon, W; Lapunzina, PD; Mowat, D; Jabs, EW; Van Vliet, G; Sack, J; Fluck, CE; Miller, WL			Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler Syndrome and disordered steroidogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; GROWTH-FACTOR RECEPTOR-2; NADPH-CYTOCHROME-P450 REDUCTASE GENE; MULTIPLE MALFORMATION SYNDROME; JACKSON-WEISS-SYNDROME; CROUZON-SYNDROME; CYTOCHROME-P450 OXIDOREDUCTASE; NADPH-P450 REDUCTASE; 17,20-LYASE ACTIVITY; PFEIFFER-SYNDROME	P450 oxidoreductase (POR) is the obligatory flavoprotein intermediate that transfers electrons from reduced nicotinamide adenine dinucleotide phosphate ( NADPH) to all microsomal cytochrome P450 enzymes. Although mouse Por gene ablation causes embryonic lethality, POR missense mutations cause disordered steroidogenesis, ambiguous genitalia, and Antley-Bixler syndrome (ABS), which has also been attributed to fibroblast growth factor receptor 2 (FGFR2) mutations. We sequenced the POR gene and FGFR2 exons 8 and 10 in 32 individuals with ABS and/or hormonal findings that suggested POR deficiency. POR and FGFR2 mutations segregated completely. Fifteen patients carried POR mutations on both alleles, 4 carried mutations on only one allele, 10 carried FGFR2 or FGFR3 mutations, and 3 patients carried no mutations. The 34 affected POR alleles included 10 with A287P ( all from whites) and 7 with R457H ( four Japanese, one African, two whites); 17 of the 34 alleles carried 16 "private" mutations, including 9 missense and 7 frameshift mutations. These 11 missense mutations, plus 10 others found in databases or reported elsewhere, were recreated by site-directed mutagenesis and were assessed by four assays: reduction of cytochrome c, oxidation of NADPH, support of 17 alpha-hydroxylase activity, and support of 17,20 lyase using human P450c17. Assays that were based on cytochrome c, which is not a physiologic substrate for POR, correlated poorly with clinical phenotype, but assays that were based on POR's support of catalysis by P450c17-the enzyme most closely associated with the hormonal phenotype-provided an excellent genotype/phenotype correlation. Our large survey of patients with ABS shows that individuals with an ABS-like phenotype and normal steroidogenesis have FGFR mutations, whereas those with ambiguous genitalia and disordered steroidogenesis should be recognized as having a distinct new disease: POR deficiency.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Our Ladys Hosp Sick Children, Dept Clin Genet, Dublin, Ireland; Hosp Univ La Paz, Dept Med Genet, Madrid, Spain; Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; Johns Hopkins Univ, Dept Pediat Med & Surg, Baltimore, MD USA; Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; Tel Aviv Univ, Dept Pediat, IL-69978 Tel Aviv, Israel; Univ Childrens Hosp, Bern, Switzerland	University of California System; University of California San Francisco; Our Ladys Children Hospital Crumlin; Hospital Universitario La Paz; University of Sydney; Johns Hopkins University; Universite de Montreal; Tel Aviv University; University of Bern; University Hospital of Bern	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Bldg MR4,Room 209,1466 4th Ave, San Francisco, CA 94143 USA.	wlmlab@itsa.ucsf.edu	Miller, Walter L/J-3696-2012; Pandey, Amit V/AAO-6442-2020; Pandey, Amit V/A-7223-2008; Lapunzina, Pablo/L-7075-2014	Pandey, Amit V/0000-0001-8331-5902; Pandey, Amit V/0000-0001-8331-5902; Lapunzina, Pablo/0000-0002-6324-4825; Agrawal, Vishal/0000-0003-1357-8605; Jabs, Ethylin/0000-0001-8983-5466; Flueck, Christa/0000-0002-4568-5504; Reardon, Willie/0000-0001-7329-9179	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002939, R01DK037922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073020] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00052, M01 RR000052] Funding Source: Medline; NICHD NIH HHS [R01 HD41958, R01 HD041958] Funding Source: Medline; NIDCR NIH HHS [P60 DE013078] Funding Source: Medline; NIDDK NIH HHS [KO1 DK02939, K01 DK002939, R01 DK37922, R01 DK037922] Funding Source: Medline; NIGMS NIH HHS [R01 GM073020, R01 GM73020] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi M, 2004, AM J MED GENET A, V128A, P333, DOI 10.1002/ajmg.a.30169; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Antley R, 1975, Birth Defects Orig Artic Ser, V11, P397; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; AUGARTEN A, 1992, J STEROID BIOCHEM, V41, P37, DOI 10.1016/0960-0760(92)90222-5; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chun K, 1998, AM J MED GENET, V77, P219, DOI 10.1002/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Crisponi G, 1997, CLIN DYSMORPHOL, V6, P61; Davydov DR, 2000, BIOCHEMISTRY-US, V39, P6489, DOI 10.1021/bi992936u; DELOZIER CD, 1980, AM J MED GENET, V7, P391, DOI 10.1002/ajmg.1320070322; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; Estabrook RW, 1996, ARCH BIOCHEM BIOPHYS, V333, P308, DOI 10.1006/abbi.1996.0395; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fisher CW, 1996, METHOD ENZYMOL, V272, P15, DOI 10.1016/S0076-6879(96)72004-9; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; GORRY MC, 1995, HUM MOL GENET, V4, P1387, DOI 10.1093/hmg/4.8.1387; Gripp KW, 1998, AM J MED GENET, V78, P356, DOI 10.1002/(SICI)1096-8628(19980724)78:4<356::AID-AJMG10>3.0.CO;2-H; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Guengerich FP, 2004, DRUG METAB REV, V36, P159, DOI 10.1081/DMR-120033996; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANIU M, 1984, J BIOL CHEM, V259, P3703; HANIU M, 1989, BIOCHEMISTRY-US, V28, P8639, DOI 10.1021/bi00447a054; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; HASSELL S, 1994, CLIN GENET, V46, P372; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Herman GE, 2003, HUM MOL GENET, V12, pR75, DOI 10.1093/hmg/ddg072; Hurley ME, 2004, PEDIATR RADIOL, V34, P148, DOI 10.1007/s00247-003-1066-7; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kelley RI, 2002, AM J MED GENET, V110, P95, DOI 10.1002/ajmg.10510; Kondo S, 1999, BIOCHEM BIOPH RES CO, V257, P273, DOI 10.1006/bbrc.1999.0455; Kress W, 2000, CYTOGENET CELL GENET, V91, P138, DOI 10.1159/000056834; Kumar D, 1997, CLIN GENET, V52, P30; LIN D, 1991, J BIOL CHEM, V266, P15992; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; LU AYH, 1969, J BIOL CHEM, V244, P3714; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Meyers GA, 1996, AM J HUM GENET, V58, P491; MILLER WL, 1994, J CLIN ENDOCR METAB, V78, P241, DOI 10.1210/jc.78.2.241; Miller WL, 2004, TRENDS ENDOCRIN MET, V15, P311, DOI 10.1016/j.tem.2004.07.005; MILLER WL, 1986, NEW ENGL J MED, V314, P1321; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; NADLER SG, 1988, ARCH BIOCHEM BIOPHYS, V261, P418, DOI 10.1016/0003-9861(88)90358-X; NADLER SG, 1991, ARCH BIOCHEM BIOPHYS, V290, P277, DOI 10.1016/0003-9861(91)90542-Q; Okajima K, 1999, AM J MED GENET, V85, P160, DOI 10.1002/(SICI)1096-8628(19990716)85:2<160::AID-AJMG11>3.0.CO;2-R; OMURA T, 1964, J BIOL CHEM, V239, P2370; ONO T, 1975, J BIOL CHEM, V250, P1571; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Pandey AV, 2003, J BIOL CHEM, V278, P2837, DOI 10.1074/jbc.M209527200; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PETERSON RE, 1985, NEW ENGL J MED, V313, P1182, DOI 10.1056/NEJM198511073131903; Pompon D, 1995, TOXICOL LETT, V82-3, P815, DOI 10.1016/0378-4274(95)03522-2; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; Pulleyn LJ, 1996, EUR J HUM GENET, V4, P283; Pursley TJ, 1996, CLIN INFECT DIS, V22, P336, DOI 10.1093/clinids/22.2.336; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Reardon W, 2000, J MED GENET, V37, P26, DOI 10.1136/jmg.37.1.26; Roman LJ, 2003, J BIOL CHEM, V278, P25700, DOI 10.1074/jbc.M212309200; Roth C, 2000, EUR J PEDIATR, V159, P189, DOI 10.1007/s004310050048; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SHEN AL, 1991, J BIOL CHEM, V266, P19976; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shen AL, 1996, BIOCHEMISTRY-US, V35, P9451, DOI 10.1021/bi960587n; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; STROBEL HW, 1989, DRUG METAB REV, V20, P519, DOI 10.3109/03602538909103558; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; VONHEIJNE G, 1984, EMBO J, V3, P2315, DOI 10.1002/j.1460-2075.1984.tb02132.x; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Warmann S, 2000, J PEDIATR SURG, V35, P528, DOI 10.1016/S0022-3468(00)90232-X; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wu L, 2005, J PHARMACOL EXP THER, V312, P35, DOI 10.1124/jpet.104.073353; Wu L, 2003, GENESIS, V36, P177, DOI 10.1002/gene.10214; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P8429; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619	93	241	250	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					729	749		10.1086/429417	http://dx.doi.org/10.1086/429417			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15793702	Bronze, Green Published			2022-12-18	WOS:000228198300002
J	Kong, QP; Yao, YG; Sun, C; Bandelt, HJ; Zhu, CL; Zhang, YP				Kong, QP; Yao, YG; Sun, C; Bandelt, HJ; Zhu, CL; Zhang, YP			Phylogeny of East Asian mitochondrial DNA lineages inferred from complete sequences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; MTDNA VARIATION; ETHNIC POPULATIONS; LONGEVITY; MUTATION; HUMANS; HAPLOGROUPS; DIVERSITY; NETWORK; CHINESE	The now-emerging mitochondrial DNA ( mtDNA) population genomics provides information for reconstructing a well-resolved mtDNA phylogeny and for discerning the phylogenetic status of the subcontinentally specific haplogroups. Although several major East Asian mtDNA haplogroups have been identified in studies elsewhere, some of the most basal haplogroups, as well as numerous minor subhaplogroups, were not yet determined or fully characterized. To fill the lacunae, we selected 48 mtDNAs from >2,000 samples across China for complete sequencing that cover virtually all ( sub) haplogroups discernible to date in East Asia. This East Asian mtDNA phylogeny can henceforth serve as a solid basis for phylogeographic analyses of mtDNAs, as well as for studies of mitochondrial diseases in East and Southeast Asia.	Chinese Acad Sci, Kunming Inst Zool, Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China; Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Yunnan, Peoples R China; Univ Hamburg, Fachbereich Math, Hamburg, Germany; Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; University of Hamburg; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China.		Yao, Yong-Gang/AAH-2303-2021; Sun, Chang/I-6326-2012	Yao, Yong-Gang/0000-0002-2955-0693; 				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; BANDELT HJ, IN PRESS ANN HUM GEN; Brown MD, 1997, AM J HUM GENET, V60, P381; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HERRNSTADT CP, AM J HUM GENET, V71, P448; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Rocha H, 1999, AM J HUM GENET, V65, P1457, DOI 10.1086/302641; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936; Torroni A, 1997, AM J HUM GENET, V60, P1107; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052; Yao YG, 2002, J HUM GENET, V47, P311, DOI 10.1007/s100380200042; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2003, CHINESE SCI BULL, V48, P826, DOI 10.1360/02wc0496; Yao YG, 2003, AM J HUM GENET, V72, P1341, DOI 10.1086/375119; Yao YG, 2003, MOL BIOL EVOL, V20, P214, DOI 10.1093/molbev/msg026; Yao YG, 2002, HUM GENET, V111, P462, DOI 10.1007/s00439-002-0826-z	30	241	266	0	20	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					671	676		10.1086/377718	http://dx.doi.org/10.1086/377718			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12870132	Green Published, Bronze			2022-12-18	WOS:000185134000021
J	Lidral, AC; Romitti, PA; Basart, AM; Doetschman, T; Leysens, NJ; Daack-Hirsch, S; Semina, EV; Johnson, LR; Machida, J; Burds, A; Parnell, TJ; Rubenstein, JLR; Murray, JC				Lidral, AC; Romitti, PA; Basart, AM; Doetschman, T; Leysens, NJ; Daack-Hirsch, S; Semina, EV; Johnson, LR; Machida, J; Burds, A; Parnell, TJ; Rubenstein, JLR; Murray, JC			Association of MSX1 and TGFB3 with nonsyndromic clefting in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-ALPHA; LINKAGE DISEQUILIBRIUM; TRANSGENIC MICE; DIFFERENTIAL EXPRESSION; GENETIC-VARIATION; PALATE FUSION; HAIR FOLLICLE; NULL MUTATION; EGF RECEPTOR; ORAL CLEFTS	Nonsyndromic cleft lip with or without cleft palate (CL/P) and nonsyndromic cleft palate only (CPO) are common congenital anomalies with significant medical, psychological, social, and economic ramifications. Both CL/ P and CPO are examples of complex genetic traits. There exists sufficient evidence to hypothesize that disease loci for CL/P and CPO can be identified by a candidate-gene linkage-disequilibrium (LD) strategy. Candidate genes for clefting, including TGFA, BCL3, DLX2, MSX1, and TGFB3, were screened for LD with either CL/P or CPO in a predominantly Caucasian population, with both case-control- and nuclear-family-based approaches. Previously reported LD for TGFA with both CL/P and CPO could not be confirmed, except in CL/P patients with a positive family history. Also, in contrast to previous studies, no LD was found between BCL3 and either CL/P or CPO. Significant LD was found between CL/P and both MSX1 and TGFB3 and between CPO and MSX1, suggesting that these genes are involved in the pathogenesis of clefting. In addition, a mutation search in the genes DLX2, MSX1, and TGFB3 was performed in 69 CPO patients and in a subset of the CL/P patients. No common mutations were found in the coding regions of these genes; however, several rare variants of MSX1 and TGFB3 were found that may alter the latters' normal function. These results form the basis for future research, including (a) mutation searches in the MSX1 and TGFB3 genes in Caucasian CL/P patients and (b) extension of the search for MSX1 mutations in CPO patients to the noncoding regions.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Genet Phd Program, Iowa City, IA 52242 USA; Ohio State Univ, Dept Orthodont, Columbus, OH 43210 USA; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Aichi Gakuin Univ, Dept Oral & Maxillofacial Surg 2, Nagoya, Aichi, Japan; Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA USA	University of Iowa; University of Iowa; University of Iowa; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati; Aichi Gakuin University; University of California System; University of California San Francisco	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.			Parnell, Timothy/0000-0002-3632-3691; Connor, Aurora/0000-0003-2705-5100; Daack-Hirsch, Sandra/0000-0003-1192-7154	NIDCR NIH HHS [DE 08559, DE 09170] Funding Source: Medline; NIDDK NIH HHS [DK 25295] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009170, R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amos C, 1996, AM J HUM GENET, V59, P743; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BASART AM, 1994, HUM MOL GENET, V3, P678, DOI 10.1093/hmg/3.4.678-a; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; CASTILLA EE, 1995, AM J MED GENET, V58, P106, DOI 10.1002/ajmg.1320580203; Christensen K, 1996, AM J HUM GENET, V58, P182; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; CURTIS D, 1995, AM J HUM GENET, V56, P811; Denhez F, 1990, GROWTH FACTORS, V3, P139, DOI 10.3109/08977199009108276; DERYNCK R, 1988, EMBO J, V7, P3737, DOI 10.1002/j.1460-2075.1988.tb03257.x; FENG H, 1994, AM J HUM GENET, V55, P9632; FERGUSON MWJ, 1994, NAT GENET, V6, P329, DOI 10.1038/ng0494-329; FITZPATRICK D, 1993, J CRAN GENET DEV BIO, V13, P230; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; Fogh-Andersen, 1942, INHERITANCE HARELIP; HECHT JT, 1991, AM J HUM GENET, V49, P682; HEWITT JE, 1991, GENOMICS, V11, P670, DOI 10.1016/0888-7543(91)90074-O; HWANG SJ, 1995, AM J EPIDEMIOL, V141, P629, DOI 10.1093/oxfordjournals.aje.a117478; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; JONES MC, 1993, CLIN PLAST SURG, V20, P599; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAFYATIS R, 1990, J BIOL CHEM, V265, P19128; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Lidral AC, 1997, CLEFT PALATE-CRAN J, V34, P1, DOI 10.1597/1545-1569(1997)034<0001:SOTCGT>2.3.CO;2; LONG JC, 1995, AM J HUM GENET, V56, P799; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MacKenzie A, 1997, MECH DEVELOP, V62, P29, DOI 10.1016/S0925-4773(96)00646-6; Maestri NE, 1997, AM J MED GENET, V73, P337, DOI 10.1002/(SICI)1096-8628(19971219)73:3<337::AID-AJMG21>3.0.CO;2-J; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Maquat LE, 1996, AM J HUM GENET, V59, P279; Mitchell LE, 1997, GENET EPIDEMIOL, V14, P231; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OMITTI PA, 1998, EUR J EPIDEMIOL, V14, P129; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; PELTON RW, 1990, DEV BIOL, V141, P456, DOI 10.1016/0012-1606(90)90401-4; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Pruessner J., 1995, American Journal of Human Genetics, V57, pA268; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; RANTA R, 1986, AM J ORTHOD DENTOFAC, V90, P11, DOI 10.1016/0889-5406(86)90022-3; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Scapoli L, 1997, GENOMICS, V43, P216, DOI 10.1006/geno.1997.4798; Scapoli L, 1998, AM J MED GENET, V75, P203, DOI 10.1002/(SICI)1096-8628(19980113)75:2<203::AID-AJMG17>3.3.CO;2-5; Shaw GM, 1996, AM J HUM GENET, V58, P551; SHIANG R, 1993, AM J HUM GENET, V53, P836; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Soto D, 1992, PCR Methods Appl, V2, P96; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEIN J, 1995, AM J HUM GENET, V57, P257; STGEORGEHYSLOP PH, 1992, NUCLEIC ACIDS RES, V20, P927, DOI 10.1093/nar/20.4.927; STOLL C, 1993, HUM GENET, V92, P81, DOI 10.1007/BF00216150; TEN DP, 1988, P NATL ACAD SCI USA, V85, P4715; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THOMSON G, 1995, AM J HUM GENET, V57, P487; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; VINTINER GM, 1992, J MED GENET, V29, P393, DOI 10.1136/jmg.29.6.393; Wyszynski DF, 1997, HUM GENET, V99, P22; Wyszynski DF, 1996, CLEFT PALATE-CRAN J, V33, P406, DOI 10.1597/1545-1569(1996)033<0406:GONOCR>2.3.CO;2; Wyszynski DF, 1997, HUM HERED, V47, P101, DOI 10.1159/000154397; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764	70	241	259	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					557	568		10.1086/301956	http://dx.doi.org/10.1086/301956			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683588	Green Published, Bronze			2022-12-18	WOS:000075360800032
J	Oksenberg, JR; Barcellos, LF; Cree, BAC; Baranzini, SE; Bugawan, TL; Khan, O; Lincoln, RR; Swerdlin, A; Mignot, E; Lin, L; Goodin, D; Erlich, HA; Schmidt, S; Thomson, G; Reich, DE; Pericak-Vance, MA; Haines, JL; Hauser, SL				Oksenberg, JR; Barcellos, LF; Cree, BAC; Baranzini, SE; Bugawan, TL; Khan, O; Lincoln, RR; Swerdlin, A; Mignot, E; Lin, L; Goodin, D; Erlich, HA; Schmidt, S; Thomson, G; Reich, DE; Pericak-Vance, MA; Haines, JL; Hauser, SL			Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELIN BASIC-PROTEIN; GENETIC SUSCEPTIBILITY; CLASS-I; ASSOCIATION; HAPLOTYPES; DISEQUILIBRIUM; PEPTIDE; POPULATION; DISSECTION; ASHKENAZI	An underlying complex genetic susceptibility exists in multiple sclerosis ( MS), and an association with the HLA-DRB1* 1501-DQB1* 0602 haplotype has been repeatedly demonstrated in high-risk ( northern European) populations. It is unknown whether the effect is explained by the HLA-DRB1 or the HLA-DQB1 gene within the susceptibility haplotype, which are in strong linkage disequilibrium (LD). African populations are characterized by greater haplotypic diversity and distinct patterns of LD compared with northern Europeans. To better localize the HLA gene responsible for MS susceptibility, case-control and family-based association studies were performed for DRB1 and DQB1 loci in a large and well-characterized African American data set. A selective association with HLA-DRB1* 15 was revealed, indicating a primary role for the DRB1 locus in MS independent of DQB1*0602. This finding is unlikely to be solely explained by admixture, since a substantial proportion of the susceptibility chromosomes from African American patients with MS displayed haplotypes consistent with an African origin.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Roche Mol Syst, Dept Human Genet, Alameda, CA USA; Wayne State Univ, Sch Med, Dept Neurol, Multiple Sclerosis Ctr, Detroit, MI 48201 USA; Stanford Univ, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA; Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Durham, NC 27710 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Program Human Genet, Nashville, TN 37232 USA	University of California System; University of California San Francisco; Roche Holding; Wayne State University; Stanford University; Duke University; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Whitehead Institute; Vanderbilt University	Oksenberg, JR (corresponding author), Univ Calif San Francisco, Dept Neurol, 513 Parnassus Ave,S-256, San Francisco, CA 94143 USA.	oksen@itsa.ucsf.edu	Haines, Jonathan/C-3374-2012; Cree, Bruce C/AAV-6109-2020; Baranzini, Sergio/A-9422-2013; Hauser, Stephen L/J-2978-2016	Haines, Jonathan/0000-0002-4351-4728; Cree, Bruce C/0000-0001-7689-2533; Baranzini, Sergio/0000-0003-0067-194X; 	NIGMS NIH HHS [R01 GM035326, GM35326] Funding Source: Medline; NINDS NIH HHS [R01 NS046297, R01 NS026799, NS 26799, NS 46297] Funding Source: Medline; CSR NIH HHS [RG3060] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046297, R01NS026799] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEGRETTA M, 1990, SCIENCE, V247, P718, DOI 10.1126/science.1689076; ALLEN M, 1994, HUM IMMUNOL, V39, P41, DOI 10.1016/0198-8859(94)90099-X; Bugawan TL, 2002, TISSUE ANTIGENS, V59, P452, DOI 10.1034/j.1399-0039.2002.590602.x; Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x; Chiang RA, 2003, NUCLEIC ACIDS RES, V31, P505, DOI 10.1093/nar/gkg127; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; COMPSTON A, 1998, MCALPINES MULTIPLE S, P63; de Jong BA, 2002, NEUROLOGY, V59, P549, DOI 10.1212/WNL.59.4.549; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; ELIAN M, 1987, J NEUROL NEUROSUR PS, V50, P327, DOI 10.1136/jnnp.50.3.327; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FERNANDEZVINA M, 1991, TISSUE ANTIGENS, V38, P235, DOI 10.1111/j.1399-0039.1991.tb01904.x; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Just JJ, 1997, TISSUE ANTIGENS, V49, P546, DOI 10.1111/j.1399-0039.1997.tb02801.x; KELLY MA, 1995, TISSUE ANTIGENS, V45, P197, DOI 10.1111/j.1399-0039.1995.tb02439.x; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; Kwon OJ, 1999, ARCH NEUROL-CHICAGO, V56, P555, DOI 10.1001/archneur.56.5.555; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; Lin L, 1997, TISSUE ANTIGENS, V50, P507, DOI 10.1111/j.1399-0039.1997.tb02907.x; LONG JC, 1995, AM J HUM GENET, V56, P799; Marriott JB, 2001, EXPERT OPIN BIOL TH, V1, P675, DOI 10.1517/14712598.1.4.675; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Modi G, 2001, J NEUROL NEUROSUR PS, V70, P500, DOI 10.1136/jnnp.70.4.500; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; Palacio LG, 2002, MULT SCLER, V8, P249, DOI 10.1191/1352458502ms804oa; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Quelvennec E, 2003, TISSUE ANTIGENS, V61, P166, DOI 10.1046/j.0001-2815.2002.00008.x; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sadovnick AD, 2000, CLIN GENET, V58, P431, DOI 10.1034/j.1399-0004.2000.580602.x; SERJEANTSON SW, 1992, EUR J IMMUNOGENET, V19, P11, DOI 10.1111/j.1744-313X.1992.tb00043.x; Shinar Y, 1998, J MOL NEUROSCI, V11, P265, DOI 10.1385/JMN:11:3:265; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Teutsch SM, 1999, HUM IMMUNOL, V60, P715, DOI 10.1016/S0198-8859(99)00033-6; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; VERRECK FAW, 1993, EUR J IMMUNOL, V23, P1346, DOI 10.1002/eji.1830230624; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Zachary AA, 1997, TRANSPLANT P, V29, P3706, DOI 10.1016/S0041-1345(97)01118-4; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493	47	240	243	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					160	167		10.1086/380997	http://dx.doi.org/10.1086/380997			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14669136	Bronze, Green Published			2022-12-18	WOS:000187723500015
J	Newton, JM; Cohen-Barak, O; Hagiwara, N; Gardner, JM; Davisson, MT; King, RA; Brilliant, MH				Newton, JM; Cohen-Barak, O; Hagiwara, N; Gardner, JM; Davisson, MT; King, RA; Brilliant, MH			Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TYROSINASE-RELATED PROTEIN; LOCUS; CDNA; EXPRESSION; CLONING; PIGMENTATION; MELANOCYTES; MELANIN; STRESS; MAPS	Oculocutaneous albinism (OCA) affects similar to1/20,000 people worldwide. All forms of OCA exhibit generalized hypopigmentation. Reduced pigmentation during eye development results in misrouting of the optic nerves, nystagmus, alternating strabismus, and reduced visual acuity. Loss of pigmentation in the skin leads to an increased risk for skin cancer. Two common forms and one infrequent form of OCA have been described. OCA1 (MIM 203100) is associated with mutations of the TYR gene encoding tyrosinase (the rate-limiting enzyme in the production of melanin pigment) and accounts for similar to 40% of OCA worldwide. OCA2 (MIM 203200), the most common form of OCA, is associated with mutations of the P gene and accounts for similar to 50% of OCA worldwide. OCA3 (MIM 203290), a rare form of OCA and also known as "rufous/red albinism," is associated with mutations in TYRP1 (encoding (ty) under bar rosinase-(r) under bar elated (p) under bar rotein (1) under bar). Analysis of the TYR and P genes in patients with OCA suggests that other genes may be associated with OCA. We have identified the mouse underwhite gene (uw) and its human orthologue, which underlies a new form of human OCA, termed "OCA4." The encoded protein, MATP (for "(m) under bar embrane-(a) under bar ssociated (t) under bar ransporter (p) under bar rotein") is predicted to span the membrane 12 times and likely functions as a transporter.	Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ 85724 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Arizona; Jackson Laboratory; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Brilliant, MH (corresponding author), Univ Arizona, Coll Med, Dept Pediat, Box 245073,1501 N Campbell Ave, Tucson, AZ 85724 USA.				NIAMS NIH HHS [AR4596] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Boissy RE, 1996, AM J HUM GENET, V58, P1145; Cooksey CJ, 1997, J BIOL CHEM, V272, P26226, DOI 10.1074/jbc.272.42.26226; FROHMAN MA, 1994, PCR METH APPL, V4, P40; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Harada M, 2001, CANCER RES, V61, P1089; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hill HZ, 1997, PIGM CELL RES, V10, P158, DOI 10.1111/j.1600-0749.1997.tb00478.x; HIROSE E, 1993, PIGM CELL RES, V6, P45, DOI 10.1111/j.1600-0749.1993.tb00580.x; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; Katayama H, 1998, GENE, V224, P1, DOI 10.1016/S0378-1119(98)00522-8; King RA, 1998, PIGMENTARY SYSTEM PH, P553; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; KWON HM, 1992, J BIOL CHEM, V267, P6297; Lehman AL, 2000, J INVEST DERMATOL, V115, P601, DOI 10.1046/j.1523-1747.2000.00107.x; Lemoine R, 2000, BBA-BIOMEMBRANES, V1465, P246, DOI 10.1016/S0005-2736(00)00142-5; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Oetting W S, 1998, Hum Mutat, V12, P433, DOI 10.1002/(SICI)1098-1004(1998)12:6<433::AID-HUMU14>3.3.CO;2-7; Oetting W S, 1998, Hum Mutat, V12, P434, DOI 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU15>3.0.CO;2-A; ORLOW SJ, 1994, J INVEST DERMATOL, V103, P196, DOI 10.1111/1523-1747.ep12392743; Passmore LA, 1999, HUM GENET, V105, P200; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; Stadler R, 1999, PLANT J, V19, P269, DOI 10.1046/j.1365-313X.1999.00527.x; Sweet HO, 1998, J HERED, V89, P546, DOI 10.1093/jhered/89.6.546; Teichmann U, 1998, MAMM GENOME, V9, P715, DOI 10.1007/s003359900852; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	31	240	262	1	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					981	988		10.1086/324340	http://dx.doi.org/10.1086/324340			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11574907	Bronze, Green Published			2022-12-18	WOS:000171413400006
J	Maugeri, A; Klevering, BJ; Rohrschneider, K; Blankenagel, A; Brunner, HG; Deutman, AF; Hoyng, CB; Cremers, FPM				Maugeri, A; Klevering, BJ; Rohrschneider, K; Blankenagel, A; Brunner, HG; Deutman, AF; Hoyng, CB; Cremers, FPM			Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASSETTE TRANSPORTER GENE; STARGARDT-DISEASE; RETINITIS-PIGMENTOSA; MACULAR DEGENERATION; IDENTIFICATION; PHENOTYPE; ALLOWS; MICE	The photoreceptor cell-specific ATP-binding cassette transporter gene (ABCA4; previously denoted "ABCR") is mutated in most patients with autosomal recessive (AR) Stargardt disease (STGD1) or fundus flavimaculatus (FFM). In addition, a few cases with AR retinitis pigmentosa (RP) and AR cone-rod dystrophy (CRD) have been found to have ABCA4 mutations. To evaluate the importance of the ABCA4 gene as a cause of Abi CRD, we selected 5 patients with AR CRD and 15 patients with isolated CRD, all from Germany and The Netherlands. Single-strand conformation-polymorphism analysis and sequencing revealed 19 ABCA4 mutations in 13 (65%) of 20 patients. In six patients, mutations were identified in both ABCA4 alleles; in seven patients, mutations were detected in one allele. One complex ABCA4 allele (L541P;A1038V) was found exclusively in German patients with CRD; one patient carried this complex allele homozygously and five others were compound heterozygous. These findings suggest that mutations in the ABCA4 gene are the major cause of AR CRD. A primary role of the ABCA4 gene in STGD1/FFM and AR CRD, together with the gene's involvement in an as-yet-unknown proportion of cases with AR RP, strengthens the idea that mutations in the ABCA4 gene could be the most frequent cause of inherited retinal dystrophy in humans.	Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Univ Heidelberg, Augenklin, Heidelberg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Maugeri, A (corresponding author), Univ Nijmegen, Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Klevering, B.J./L-4434-2015; Brunner, Han/C-9928-2013; Cremers, Frans/A-5625-2014; Hoyng, C.B./H-8050-2014	Cremers, Frans/0000-0002-4954-5592; Rohrschneider, Klaus/0000-0003-1996-7935				Allikmets R, 1999, EUR J OPHTHALMOL, V9, P255, DOI 10.1177/112067219900900401; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Dryja TP, 1997, P NATL ACAD SCI USA, V94, P12117, DOI 10.1073/pnas.94.22.12117; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; Gerber S, 1998, GENOMICS, V48, P139, DOI 10.1006/geno.1997.5164; Lewis RA, 2000, HOSP PRACT, V35, P41; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Papaioannou M, 2000, INVEST OPHTH VIS SCI, V41, P16; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Rozet JM, 1999, J MED GENET, V36, P447; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Shroyer NF, 2000, HUM GENET, V106, P244, DOI 10.1007/s004390051034; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Simonelli F, 2000, INVEST OPHTH VIS SCI, V41, P892; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; SZLYK JP, 1993, ARCH OPHTHALMOL-CHIC, V111, P781, DOI 10.1001/archopht.1993.01090060069025; VALLE D, 1989, METABOLIC BASIS INHE, P599; van Driel MA, 1998, OPHTHALMIC GENET, V19, P117, DOI 10.1076/opge.19.3.117.2187; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	30	240	255	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					960	966		10.1086/303079	http://dx.doi.org/10.1086/303079			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10958761	Green Published, Bronze			2022-12-18	WOS:000089651100017
J	ROBINSON, WP; BOTTANI, A; YAGANG, X; BALAKRISHMAN, J; BINKERT, F; MACHLER, M; PRADER, A; SCHINZEL, A				ROBINSON, WP; BOTTANI, A; YAGANG, X; BALAKRISHMAN, J; BINKERT, F; MACHLER, M; PRADER, A; SCHINZEL, A			MOLECULAR, CYTOGENETIC, AND CLINICAL INVESTIGATIONS OF PRADER-WILLI SYNDROME PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARENTAL ORIGIN; ANGELMAN SYNDROME; RING CHROMOSOME-15; 15Q DELETIONS; PROXIMAL 15Q; DNA MARKERS; PHENOTYPE; PROBES; GENE; ABNORMALITIES	Thirty-seven patients presenting features of the Prader-Willi syndrome (PWS) have been examined using cytogenetic and molecular techniques. Clinical evaluation showed that 29 of these patients fulfilled diagnostic criteria for PWS. A deletion of the 15q11.2-q12 region could be identified molecularly in 21 of these cases, including several cases where the cytogenetics results were inconclusive. One clinically typical patient is deleted at only two of five loci normally included in a PWS deletion. A patient carrying a de novo 13;X translocation was not deleted for the molecular markers tested but was clinically considered to bc "atypical" PWS. In addition, five cases of maternal heterodisomy and two of isodisomy for 15q11-q13 were observed. All of the eight patients who did not fulfill clinical diagnosis of PWS showed normal maternal and paternal inheritance of chromosome 15 markers; however, one of these carried a ring-15 chromosome. A comparison of clinical features between deletion patients and disomy patients shows no significant differences between the two groups. The parental ages at birth of disomic patients were significantly higher than those for deletion patients. As all typical PWS cases showed either a deletion or disomy of 15q11.2-q12, molecular examination should provide a reliable diagnostic tool. As the disomy patients do not show either any additional or more severe features than typical deletion patients do, it is likely that there is only one imprinted region on chromosome 15 (within 15q11.2-q12).	UNIV ZURICH,DEPT PEDIAT,CH-8001 ZURICH,SWITZERLAND	University of Zurich	ROBINSON, WP (corresponding author), UNIV ZURICH,INST MOLEC GENET,RAMISTR 74,CH-8001 ZURICH,SWITZERLAND.		Robinson, Wendy/AAB-6420-2020; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Robinson, Wendy P/0000-0002-2010-6174				ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ARMOUR JAL, 1990, GENOMICS, V8, P501, DOI 10.1016/0888-7543(90)90037-U; BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BUITING K, 1990, GENOMICS, V6, P521, DOI 10.1016/0888-7543(90)90481-9; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; Cassidy S B, 1984, Curr Probl Pediatr, V14, P1; DONLON TA, 1988, HUM GENET, V80, P322, DOI 10.1007/BF00273644; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FRYNS JP, 1986, ANN GENET-PARIS, V29, P45; GREGORY CA, 1990, AM J MED GENET, V35, P536, DOI 10.1002/ajmg.1320350420; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HODGSON SV, 1986, J MED GENET, V23, P477, DOI 10.1136/jmg.23.5.477; JACOBS P, 1989, MOL CYTOGENETIC STUD, P135; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; Kiss P, 1982, Acta Paediatr Acad Sci Hung, V23, P409; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KONDO I, 1990, CLIN GENET, V38, P422; KOUSSEFF BG, 1980, AM J DIS CHILD, V134, P798, DOI 10.1001/archpedi.1980.02130200066022; KUPKE KG, 1989, AM J HUM GENET, V45, P599; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; LEDBETTER DH, 1987, AM J MED GENET, V28, P779, DOI 10.1002/ajmg.1320280402; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MAGENIS R, 1987, AM J MED GENET, V64, P829; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MARTIN RH, 1990, CYTOGENET CELL GENET, V53, P103, DOI 10.1159/000132905; MAY KM, 1990, AM J HUM GENET, V46, P754; MOREAU N, 1982, CLIN GENET, V21, P272; NAKAMURA Y, 1988, GENOMICS, V3, P342, DOI 10.1016/0888-7543(88)90125-5; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; REYNOLDS JF, 1987, AM J MED GENET, V28, P55, DOI 10.1002/ajmg.1320280108; RICH DC, 1988, NUCLEIC ACIDS RES, V16, P8740, DOI 10.1093/nar/16.17.8740; SAPIENZA C, 1990, GENOMIC IMPRINTING S, P107; SCHINZEL A, 1983, CATALOGUE UNBALANCED, P556; SCHWARTZ S, 1985, AM J MED GENET, V20, P255, DOI 10.1002/ajmg.1320200208; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; WIESNER GL, 1987, AM J HUM GENET, V40, P431; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILLIAMS CA, 1989, AM J MED GENET, V32, P339, DOI 10.1002/ajmg.1320320313; YUNIS E, 1981, HUM GENET, V57, P207; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	54	240	242	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1219	1234						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1684085				2022-12-18	WOS:A1991GU67200009
J	HOLMQUIST, GP				HOLMQUIST, GP			ROLE OF REPLICATION TIME IN THE CONTROL OF TISSUE-SPECIFIC GENE-EXPRESSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review											HOLMQUIST, GP (corresponding author), CITY HOPE NATL MED CTR, BECKMAN RES INT, DIV BIOL, DEV BIOL SECT, DUARTE, CA 91010 USA.				NICHD NIH HHS [HD00323] Funding Source: Medline; NIGMS NIH HHS [GM35645] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANANIEV EV, 1977, CHROMOSOMA, V59, P259, DOI 10.1007/BF00292782; AXEL R, 1976, CELL, V7, P247, DOI 10.1016/0092-8674(76)90024-6; BAER D, 1965, GENETICS, V52, P275; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BLOCH DP, 1981, CHROMOSOMA, V82, P611, DOI 10.1007/BF00285771; BRAUNSTEIN JD, 1982, NUCLEIC ACIDS RES, V10, P6887, DOI 10.1093/nar/10.21.6887; CALZA RE, 1984, CELL, V36, P689, DOI 10.1016/0092-8674(84)90349-0; CAMARGO M, 1982, AM J HUM GENET, V34, P757; CAPLAN AI, 1978, SCIENCE, V201, P120, DOI 10.1126/science.351805; CAWOOD AH, 1985, CHROMOSOMA, V91, P164, DOI 10.1007/BF00294061; CAWOOD AH, 1981, CHROMOSOMA, V84, P365, DOI 10.1007/BF00286026; CHAFOULEAS JG, 1984, CELL, V36, P73, DOI 10.1016/0092-8674(84)90075-8; CHARNAY P, 1983, SCIENCE, V220, P1281, DOI 10.1126/science.6574602; CHAUDHARI N, 1983, SCIENCE, V220, P924, DOI 10.1126/science.6189184; CHIKARAISHI DM, 1979, BIOCHEMISTRY-US, V18, P3249, DOI 10.1021/bi00582a009; CHIKARAISHI DM, 1978, CELL, V13, P111, DOI 10.1016/0092-8674(78)90142-3; CLARK B, 1985, THESIS U S FLORIDA T; CLAUSEN OPF, 1985, CELL TISSUE KINET, V18, P445, DOI 10.1111/j.1365-2184.1985.tb00674.x; COLLINS JM, 1978, J BIOL CHEM, V253, P8570; Comings D E, 1972, Adv Hum Genet, V3, P237; COUTURIER J, 1979, HUM GENET, V49, P319, DOI 10.1007/BF00569351; DANDREA AD, 1983, NUCLEIC ACIDS RES, V11, P4753, DOI 10.1093/nar/11.14.4753; Davidson E. H., 1976, GENE ACTIVITY EARLY; DAVIS BK, 1979, P NATL ACAD SCI USA, V76, P2288, DOI 10.1073/pnas.76.5.2288; DELANY ME, 1984, J HERED, V75, P431, DOI 10.1093/oxfordjournals.jhered.a109979; DELFINI C, 1985, P NATL ACAD SCI USA, V82, P2220, DOI 10.1073/pnas.82.8.2220; DERMAN E, 1981, CELL, V23, P731, DOI 10.1016/0092-8674(81)90436-0; DISTECHE CM, 1979, P NATL ACAD SCI USA, V76, P5234, DOI 10.1073/pnas.76.10.5234; DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573; DUTRILLAUX B, 1976, CHROMOSOMA, V58, P51, DOI 10.1007/BF00293440; DWORKIN MB, 1984, DEV BIOL, V106, P289, DOI 10.1016/0012-1606(84)90227-6; DWORKIN MB, 1980, DEV BIOL, V76, P449, DOI 10.1016/0012-1606(80)90393-0; EPNER E, 1981, P NATL ACAD SCI-BIOL, V78, P3058, DOI 10.1073/pnas.78.5.3058; EPPLEN JT, 1975, HUMANGENETIK, V30, P337, DOI 10.1007/BF00275147; EPPLEN JT, 1975, CYTOGENET CELL GENET, V15, P177, DOI 10.1159/000130516; FAINSOD A, 1984, EXP CELL RES, V152, P77, DOI 10.1016/0014-4827(84)90231-3; FEINSTEIN SC, 1982, J MOL BIOL, V156, P549, DOI 10.1016/0022-2836(82)90266-2; FLICKINGER RA, 1982, INT REV CYTOL, V75, P229, DOI 10.1016/S0074-7696(08)61006-2; FLICKINGER RA, 1976, INT J BIOCHEM, V7, P85, DOI 10.1016/0020-711X(76)90001-X; FLICKINGER RA, 1983, CELL DIFFER DEV, V12, P233, DOI 10.1016/0045-6039(83)90033-7; FURST A, 1981, P NATL ACAD SCI-BIOL, V78, P1023, DOI 10.1073/pnas.78.2.1023; GILBERT DM, 1986, P NATL ACAD SCI USA, V83, P2924, DOI 10.1073/pnas.83.9.2924; GOLDBERG DA, 1983, CELL, V34, P59, DOI 10.1016/0092-8674(83)90136-8; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; GOTTESFELD J, 1982, CELL, V28, P781, DOI 10.1016/0092-8674(82)90057-5; GUINTA DR, 1986, P NATL ACAD SCI USA, V83, P5150, DOI 10.1073/pnas.83.14.5150; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; HAMEISTER H, 1984, CHROMOSOMA, V90, P389, DOI 10.1007/BF00294166; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; HARBERS K, 1981, NATURE, V293, P540, DOI 10.1038/293540a0; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; HEINTZ N, 1983, MOL CELL BIOL, V3, P539, DOI 10.1128/MCB.3.4.539; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; HOLMQUIST GP, 1986, IN PRESS CHROMOSOME; IQBAL MA, 1984, P NATL ACAD SCI-BIOL, V81, P7723, DOI 10.1073/pnas.81.24.7723; IVARIE RD, 1983, MOL CELL BIOL, V3, P1460, DOI 10.1128/MCB.3.8.1460; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; KAJIWARA K, 1964, BIOCHIM BIOPHYS ACTA, V91, P486, DOI 10.1016/0926-6550(64)90078-7; KAPP LN, 1982, RADIAT RES, V89, P424, DOI 10.2307/3575787; KASUPSKI GJ, 1977, EXP CELL RES, V106, P327, DOI 10.1016/0014-4827(77)90178-1; KEMP DJ, 1980, P NATL ACAD SCI-BIOL, V77, P2876, DOI 10.1073/pnas.77.5.2876; KIOUSSIS D, 1985, EMBO J, V4, P927, DOI 10.1002/j.1460-2075.1985.tb03720.x; KLEVECZ R R, 1974, P817; KLEVECZ RR, 1973, J CELL BIOL, V58, P564, DOI 10.1083/jcb.58.3.564; KLEVECZ RR, 1967, J EXP ZOOL, V165, P259, DOI 10.1002/jez.1401650210; KLEVECZ RR, 1975, CELL, V5, P195, DOI 10.1016/0092-8674(75)90027-6; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; LATT SA, 1975, SOMAT CELL GENET, V1, P293, DOI 10.1007/BF01538452; LAU YF, 1981, CHROMOSOMA, V83, P721, DOI 10.1007/BF00328530; LEVY LS, 1981, DEV BIOL, V85, P141, DOI 10.1016/0012-1606(81)90243-8; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; MANUELIDIS L, 1984, CHROMOSOMA, V91, P28, DOI 10.1007/BF00286482; MARCHIONNI MA, 1981, CELL, V26, P245, DOI 10.1016/0092-8674(81)90307-X; MARCUS M, 1985, ANNU REV GENET, V19, P389, DOI 10.1146/annurev.genet.19.1.389; MARIANI BD, 1984, J BIOL CHEM, V259, P1901; MARTIN RG, 1976, P NATL ACAD SCI USA, V73, P1655, DOI 10.1073/pnas.73.5.1655; MARTIN RG, 1977, CELL, V11, P859, DOI 10.1016/0092-8674(77)90297-5; MATSUMOTO LH, 1974, DEV BIOL, V37, P28, DOI 10.1016/0012-1606(74)90166-3; MCKNIGHT GS, 1983, CELL, V34, P335; MIGEON BR, 1986, P NATL ACAD SCI USA, V83, P2182, DOI 10.1073/pnas.83.7.2182; NORGARD MV, 1980, J BIOL CHEM, V255, P7665; OHNO S., 1963, CYTOGENETICS [BASEL], V2, P232, DOI 10.1159/000129781; PARDOLL DM, 1980, CELL, V19, P527, DOI 10.1016/0092-8674(80)90527-9; Pathak S., 1983, Progress and Topics in Cytogenetics, P67; PFEIFFER SE, 1968, J CELL PHYSIOL, V71, P95, DOI 10.1002/jcp.1040710111; PFEIFFER SE, 1968, J CELL PHYSIOL, V71, P77, DOI 10.1002/jcp.1040710110; PIMPINELLI S, 1985, GENETICS, V109, P701; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; REMINGTON JA, 1971, J CELL PHYSIOL, V77, P411, DOI 10.1002/jcp.1040770316; RUECKERT RR, 1960, CANCER RES, V20, P1584; SAGER R, 1975, SCIENCE, V189, P426, DOI 10.1126/science.1098145; SARGENT T D, 1983, Science (Washington D C), V222, P135, DOI 10.1126/science.6688681; SCHEMPP W, 1979, CHROMOSOMA, V73, P109, DOI 10.1007/BF00294850; SCHEMPP W, 1978, CHROMOSOMA, V67, P193, DOI 10.1007/BF00293176; SCHMIDT M, 1984, CHROMOSOMA, V89, P68, DOI 10.1007/BF00302353; SCHMIDT M, 1980, CHROMOSOMA, V76, P101, DOI 10.1007/BF00292230; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; SELDEN RF, 1986, NATURE, V321, P525, DOI 10.1038/321525a0; SHAFER DA, 1984, AM J HUM GENET, V36, P534; SHEPHERD GW, 1982, ROUX ARCH DEV BIOL, V191, P1, DOI 10.1007/BF00848540; SHEPHERD GW, 1969, BICOH BIOPHYS ACTA, V563, P413; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; SOMSSICH IE, 1984, CHROMOSOMA, V91, P39, DOI 10.1007/BF00286483; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; STAMBROOK PJ, 1970, J EXP ZOOL, V174, P101, DOI 10.1002/jez.1401740110; STAMBROOK PJ, 1978, DNA SYNTHESIS PRESEN, P174; STEINEMANN M, 1981, CHROMOSOMA, V82, P289, DOI 10.1007/BF00286112; STOCK AD, 1975, CHROMOSOMA, V50, P69; TAYLOR JH, 1984, MOL CELL BIOCHEM, V61, P99; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x; VIZARD DL, 1984, BIOCHIM BIOPHYS ACTA, V782, P402, DOI 10.1016/0167-4781(84)90046-0; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; WIBERG UH, 1983, CYTOGENET CELL GENET, V36, P589, DOI 10.1159/000131981; WILLARD HF, 1976, AM J HUM GENET, V28, P213; YAMAMURA K, 1986, P NATL ACAD SCI USA, V83, P2152, DOI 10.1073/pnas.83.7.2152; YUNIS JJ, 1981, HUM GENET, V56, P293, DOI 10.1007/BF00274682; ZEHNBAUER BA, 1985, BIOESSAYS, V2, P52, DOI 10.1002/bies.950020203	119	240	244	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1987	40	2					151	173						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G7740	3551593				2022-12-18	WOS:A1987G774000008
J	BIRD, TD; OTT, J; GIBLETT, ER				BIRD, TD; OTT, J; GIBLETT, ER			EVIDENCE FOR LINKAGE OF CHARCOT-MARIE-TOOTH NEUROPATHY TO THE DUFFY LOCUS ON CHROMOSOME-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT MED,DIV NEUROL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; VET ADM MED CTR,SEATTLE,WA 98108; PUGET SOUND BLOOD CTR,SEATTLE,WA 98104	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Puget Sound Blood Center					NIGMS NIH HHS [GM-15253, GM-07454] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454, P50GM015253] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRD TD, 1978, CLIN GENET, V14, P43; BIRD TD, 1980, AM J HUM GENET, V32, pA99; BIRD TD, 1980, 31ST AM SOC HUM GEN, pA99; HARPER PS, 1972, AM J HUM GENET, V24, P310; HEIMLER A, 1978, J MED GENET, V15, P288, DOI 10.1136/jmg.15.4.288; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; MORTON NE, 1977, HUMAN GENE MAPPING, V4; MORTON NE, 1978, BIRTH DEFECTS ORIG A, V14; OTT J, 1974, AM J HUM GENET, V26, P588; RAO DC, 1979, AM J HUM GENET, V31, P680; SUTTON JG, 1978, VOX SANG, V34, P97, DOI 10.1111/j.1423-0410.1978.tb03730.x; VANASSE M, 1981, MUSCLE NERVE, V4, P26, DOI 10.1002/mus.880040106	12	240	241	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					388	394						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	6952764				2022-12-18	WOS:A1982NR13300003
J	CHAPELLE, AD				CHAPELLE, AD			ANALYTIC REVIEW - NATURE AND ORIGIN OF MALES WITH XX SEX-CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		ARIASBERNAL L, 1967, AM J OBSTET GYNECOL, V99, P877, DOI 10.1016/0002-9378(67)90403-6; BARR ML, 1967, AM J OBSTET GYNECOL, V99, P1047, DOI 10.1016/0002-9378(67)90342-0; BASRUR PK, 1964, CYTOGENETICS, V3, P414, DOI 10.1159/000129830; BELL AG, 1970, CAN J GENET CYTOL, V12, P373; BENIRSCHKE K., 1963, CYTOGENETICS [BASEL], V2, P331, DOI 10.1159/000129790; BERG K, 1969, B EUR SOC HUM GENET, V3, P29; BERG K, 1966, J EXP MED, V123, P379, DOI 10.1084/jem.123.2.379; Berg K., 1968, ANNU REV GENET, V2, P341; Berger R, 1970, Rev Eur Etud Clin Biol, V15, P330; BERGMAN S, 1970, HEREDITAS-GENETISK A, V64, P148; BOCZKOWSKI K, 1969, HEREDITAS-GENETISK A, V62, P285; Bridges CB, 1939, SEX INTERNAL SECRETI, P15; BROGGER A, 1965, HEREDITAS-GENETISK A, V53, P231; BROWN WMC, 1969, BRIT MED B, V25, P74; BROWN WMC, 1964, 305 MED RES COUNC; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CASPERSSON T, 1970, EXP CELL RES, V62, P490, DOI 10.1016/0014-4827(70)90586-0; CASPERSSON T, 1970, EXP CELL RES, V61, P472, DOI 10.1016/0014-4827(70)90477-5; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CASPERSSON T, 1971, ANN GENET-PARIS, V14, P173; CATTANACH BM, IN PRESS; CHAPELLE AD, 1971, HUMANGENETIK, V11, P286, DOI 10.1007/BF00278655; CHAPELLE AD, 1963, ACTA ENDOCRINOL-COP, V44, P165, DOI 10.1530/acta.0.0440165; CHAPELLE ADL, 1964, ACTA MED SCAND  S412, P25; CHAPELLE ADL, 1971, ACTA PATH MICROBIO A, V79, P211; CHAPELLE ADL, 1969, SELECTED TOPICS GENI, P708; CHOWN B, 1964, CAN J GENET CYTOL, V6, P431, DOI 10.1139/g64-056; CLEVELAND WW, 1965, PEDIATRICS, V36, P892; COHEN MM, 1966, CYTOGENETICS, V5, P34, DOI 10.1159/000129883; DECOURT J, 1962, Sem Hop, V38, P1249; EDWARDS J. H., 1966, J MED GEMET, V3, P117, DOI 10.1136/jmg.3.2.117; FEDERMAN DANIEL D., 1967, J MED GENET, V4, P36, DOI 10.1136/jmg.4.1.36; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FERGUSON-SMITH MALCOLM A., 1966, P277; FERGUSONSMITH MA, 1964, LANCET, V1, P46; FERGUSONSMITH MA, 1966, LANCET, V2, P475; FERRIER PIERRE E., 1967, J MED GENET, V4, P288, DOI 10.1136/jmg.4.4.288; FORD CE, 1958, NATURE, V181, P1565, DOI 10.1038/1811565a0; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; FORD CE, 1969, BRIT MED BULL, V25, P104, DOI 10.1093/oxfordjournals.bmb.a070658; FRASER GR, 1963, ANN HUM GENET, V26, P297, DOI 10.1111/j.1469-1809.1963.tb01325.x; FREDGA K, 1970, PHILOS T R SOC B, V259, P15, DOI 10.1098/rstb.1970.0042; FREDGA K, 1965, HEREDITAS-GENETISK A, V52, P411; FROLAND A, 1961, ACTA PATHOL MIC SC, V53, P319; FROLAND A, 1965, ACTA GENET STAT MED, V15, P154; FROLAND A, 1968, Journal of Medical Genetics, V5, P161, DOI 10.1136/jmg.5.3.161; FROLAND A, 1967, NATURE, V213, P512, DOI 10.1038/213512a0; FROLAND A, 1969, KLINEFELTERS SYNDROM; GARTLER SM, 1962, P NATL ACAD SCI USA, V48, P332, DOI 10.1073/pnas.48.3.332; GARTLER SM, 1965, CYTOGENETICS, V4, P81, DOI 10.1159/000129846; GAVOSTO F, 1967, NATURE, V215, P535, DOI 10.1038/215535b0; GEORGE KP, 1970, NATURE, V228, P1215, DOI 10.1038/2281215b0; GERMAN J, 1967, 3 P INT C HUM GEN, P123; GERMAN JL, 1962, T NEW YORK ACAD SCI, V24, P395, DOI 10.1111/j.2164-0947.1962.tb01415.x; GIANNELLI F, 1963, LANCET, V1, P863; GIANNELLI F, 1970, MONOGRAPHS HUMAN GEN, V5; GILBERT CW, 1962, NATURE, V195, P869, DOI 10.1038/195869a0; GIORGI EP, 1963, J CLIN ENDOCR METAB, V23, P197, DOI 10.1210/jcem-23-2-197; GRIBOFF SI, 1961, AM J MED, V30, P544, DOI 10.1016/0002-9343(61)90079-1; GROUCHY JD, 1964, ANN GENET-PARIS, V7, P25; GROUCHY JD, 1963, ANN PEDIAT, V39, P181; GROUCHY JD, 1967, ANN GENET, V10, P193; GUINET P, 1969, SELECTED TOPICS GENI, P553; HAMBERT G, 1966, MALES POSITIVE SEX C; HAMERTON JL, 1969, J REPROD FERTIL    S, V7, P25; Hard W L, 1965, J Hered, V56, P254; HARNDEN DG, 1960, BRIT J EXP PATHOL, V41, P31; HECHT F, 1966, PEDIATRICS, V38, P982; HOLT SB, 1969, SELECTED TOPICS GENI, P375; HORTLING H, 1970, ACTA ENDOCRINOL-COP, V65, P229, DOI 10.1530/acta.0.0650229; HUNGERFORD DA, 1959, AM J HUM GENET, V11, P215; Klinefelter HF, 1942, J CLIN ENDOCRINOL, V2, P615, DOI 10.1210/jcem-2-11-615; Lebedeff GA, 1939, GENETICS, V24, P553; Lebedeff GA, 1934, P NATL ACAD SCI USA, V20, P613, DOI 10.1073/pnas.20.12.613; LEJEUNE J, 1969, ANN GENET, V9, P171; LEJEUNE J, 1966, ANN GENET, V9, P171; LEVAN A, 1964, HEREDITAS, V51, P378; LINDSTEN J, 1963, NATURE, V197, P648, DOI 10.1038/197648a0; LINDSTEN J, 1966, ACTA ENDOCRINOL-COP, V52, P91, DOI 10.1530/acta.0.0520091; LUBS HA, 1970, HUMAN POPULATION CYT, P119; LUCIANI JM, 1969, ANN ENDOCRINOL-PARIS, V30, P113; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MACLEAN N, 1968, Journal of Medical Genetics, V5, P165, DOI 10.1136/jmg.5.3.165; Matthey R, 1953, ARCH KLAUS STIFT VER, V28, P65; MATTONVANLEUVEN MT, 1970, B EUROP SOC HUM GENE, V4, P54; MCFEE AF, 1966, CAN J GENET CYTOL, V8, P502, DOI 10.1139/g66-059; MCFEELY RA, 1967, CYTOGENETICS, V6, P242, DOI 10.1159/000129945; MITTWOCH U, 1967, SEX CHROMOSOMES; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MORI Y, 1969, JAP J UROL, V60, P279; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; Moses M. J., 1968, Annual Review of Genetics, V2, P363, DOI 10.1146/annurev.ge.02.120168.002051; MULERT LV, 1966, DEUT MED WOCHENSCHR, V91, P2159; NEUHAUSER G, 1967, HUMANGENETIK, V3, P300; NOADES JEAN, 1966, J MED GENET, V3, P162, DOI 10.1136/jmg.3.3.162; OCKEY CH, 1966, HEREDITAS-GENETISK A, V54, P277; OHNO S, 1965, CYTOGENETICS, V4, P251, DOI 10.1159/000129862; OHNO S., 1962, CYTOGENETICS [BASEL], V1, P258, DOI 10.1159/000129735; Ohno S., 1967, SEX CHROMOSOMES SEX; OVERZIER C, 1961, INTERSEXUALITAT, P188; PASQUALINI RQ, 1957, LANCET, V2, P164; PEARSON PL, 1970, NATURE, V226, P959, DOI 10.1038/226959a0; PEARSON PL, 1970, NATURE, V226, P78, DOI 10.1038/226078a0; PENROSE L. S., 1966, ADVANCE TERATOLOGY, V1, P9; Penrose L.S., 1966, DOWNS ANOMALY; Penrose LS, 1933, J GENET, V27, P219, DOI 10.1007/BF02984413; POLANI PE, 1970, NATURE, V227, P613, DOI 10.1038/227613a0; POLANI PE, 1970, PHILOS T R SOC B, V259, P187, DOI 10.1098/rstb.1970.0058; RABOCH J, 1961, ACTA ENDOCRINOL-COP, V36, P404, DOI 10.1530/acta.0.0360404; Race R. R, 1968, BLOOD GROUPS MAN; RATCLIFFE SG, 1970, LANCET, V1, P121; ROBINSON A, 1969, AM J HUM GENET, V21, P466; ROSENBERG HS, 1963, J CLIN ENDOCR METAB, V23, P203, DOI 10.1210/jcem-23-2-203; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; RUSSELL LB, 1961, P NATL ACAD SCI USA, V47, P571, DOI 10.1073/pnas.47.4.571; SANGER R, 1964, LANCET, V1, P955; SASONOVA NS, 1967, GENETIKA, V9, P83; SCHMID W., 1963, CYTOGENETICS [BASEL], V2, P175, DOI 10.1159/000129778; SEBAOUN M, 1969, ANN ENDOCRINOL-PARIS, V30, P741; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; SHAH PN, 1961, BRIT MED J, V2, P474, DOI 10.1136/bmj.2.5250.474; SOHVAL AR, 1963, AM J HUM GENET, V15, P155; SOHVAL AR, 1969, SELECTED TOPICS GENI, P474; SOLARI AJ, 1970, J CELL BIOL, V45, P43, DOI 10.1083/jcb.45.1.43; SOLLER M, 1969, CYTOGENETICS, V8, P51, DOI 10.1159/000130022; SOLTAN H C, 1968, Journal of Medical Genetics, V5, P173, DOI 10.1136/jmg.5.3.173; SOMLEV B, 1970, HEREDITAS-GENETISK A, V64, P203; Stern C., 1929, Zeitschrift fuer Induktive Abstammungs- und Vererbungslehre, V51, P253, DOI 10.1007/BF01847139; STEWART AL, 1969, J PEDIATR, V74, P449, DOI 10.1016/S0022-3476(69)80203-9; STRAUCH G, 1965, ANN ENDOCRINOL-PARIS, V25, P727; STUBBLEFIELD E, 1966, JNCI-J NATL CANCER I, V37, P799; STURTEVANT AH, 1945, GENETICS, V30, P297; THERKELSEN AJ, 1964, CYTOGENETICS, V3, P207, DOI 10.1159/000129812; TJIO JH, 1962, STAIN TECHNOL, V37, P17, DOI 10.3109/10520296209114563; TURNER JH, 1970, HUMAN POPULATION CYT, P153; UNNERUS V, 1967, CYTOGENETICS, V6, P213, DOI 10.1159/000129943; WALZER S, 1969, J PEDIATR-US, V74, P438, DOI 10.1016/S0022-3476(69)80202-7; WEISS E, 1969, CYTOGENETICS, V8, P68, DOI 10.1159/000130023; WELSHONS W. J., 1959, PROC NATL ACAD SCI, V45, P560, DOI 10.1073/pnas.45.4.560; WENNSTROM J, 1967, HEREDITAS-GENETISK A, V57, P411; ZUELZER WW, 1964, AM J HUM GENET, V16, P38; ZUPPINGER K, 1967, ACTA ENDOCRINOL S113, V54, P1	143	240	241	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	1					71	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L6958	4622299				2022-12-18	WOS:A1972L695800010
J	Beck, J; Poulter, M; Hensman, D; Rohrer, JD; Mahoney, CJ; Adamson, G; Campbell, T; Uphill, J; Borg, A; Fratta, P; Orrell, RW; Malaspina, A; Rowe, J; Brown, J; Hodges, J; Sidle, K; Polke, JM; Houlden, H; Schott, JM; Fox, NC; Rossor, MN; Tabrizi, SJ; Isaacs, AM; Hardy, J; Warren, JD; Collinge, J; Mead, S				Beck, Jon; Poulter, Mark; Hensman, Davina; Rohrer, Jonathan D.; Mahoney, Colin J.; Adamson, Gary; Campbell, Tracy; Uphill, James; Borg, Aaron; Fratta, Pietro; Orrell, Richard W.; Malaspina, Andrea; Rowe, James; Brown, Jeremy; Hodges, John; Sidle, Katie; Polke, James M.; Houlden, Henry; Schott, Jonathan M.; Fox, Nick C.; Rossor, Martin N.; Tabrizi, Sarah J.; Isaacs, Adrian M.; Hardy, John; Warren, Jason D.; Collinge, John; Mead, Simon			Large C9orf72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DEMENTIA; DNA; ALS	Hexanucleotide repeat expansions in C9orf72 are a major cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Understanding the disease mechanisms and a method for clinical diagnostic genotyping have been hindered because of the difficulty in estimating the expansion size. We found 96 repeat-primed PCR expansions: 85/2,974 in six neurodegenerative diseases cohorts (FTLD, ALS, Alzheimer disease, sporadic Creutzfeldt-Jakob disease, Huntington disease-like syndrome, and other nonspecific neurodegenerative disease syndromes) and 11/7,579 (0.15%) in UK 1958 birth cohort (58BC) controls. With the use of a modified Southern blot method, the estimated expansion range (smear maxima) in cases was 800-4,400. Similarly, large expansions were detected in the population controls. Differences in expansion size and morphology were detected between DNA samples from tissue and cell lines. Of those in whom repeat-primed PCR detected expansions, 68/69 were confirmed by blotting, which was specific for greater than 275 repeats. We found that morphology in the expansion smear varied among different individuals and among different brain regions in the same individual. Expansion size correlated with age at clinical onset but did not differ between diagnostic groups. Evidence of instability of repeat size in control families, as well as neighboring SNP and microsatellite analyses, support multiple expansion events on the same haplotype background. Our method of estimating the size of large expansions has potential clinical utility. C9orf72-related disease might mimic several neurodegenerative disorders and, with potentially 90,000 carriers in the United Kingdom, is more common than previously realized.	[Beck, Jon; Poulter, Mark; Adamson, Gary; Campbell, Tracy; Uphill, James; Borg, Aaron; Collinge, John; Mead, Simon] UCL, MRC, Prion Unit, Dept Neurodegenerat Dis,Inst Neurol, London WC1N 3BG, England; [Hensman, Davina; Fratta, Pietro; Tabrizi, Sarah J.; Isaacs, Adrian M.] UCL, Dept Neurodegenerat Dis, Inst Neurol, London WC1N 3BG, England; [Rohrer, Jonathan D.; Mahoney, Colin J.; Schott, Jonathan M.; Fox, Nick C.; Rossor, Martin N.; Warren, Jason D.] UCL, Dementia Res Ctr, Dept Neurodegenerat Dis, Inst Neurol, London WC1N 3BG, England; [Sidle, Katie; Houlden, Henry; Hardy, John] UCL, Dept Mol Neurosci, Inst Neurol, London WC1N 3BG, England; [Rowe, James; Brown, Jeremy; Hodges, John] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Orrell, Richard W.] UCL, Dept Clin Neurosci, Inst Neurol, London NW3 2PF, England; [Malaspina, Andrea] Queen Mary Univ London, Ctr Neurosci & Trauma, Blizard Inst, North East London & Essex Reg MND Care Ctr, London E1 2AT, England; [Polke, James M.; Houlden, Henry] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England; [Hodges, John] Neurosci Res Australia, Randwick, NSW 2031, Australia; [Hodges, John] Univ New S Wales, Randwick, NSW 2052, Australia	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Cambridge; University of London; University College London; University of London; Queen Mary University London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Neuroscience Research Australia; University of New South Wales Sydney	Mead, S (corresponding author), UCL, MRC, Prion Unit, Dept Neurodegenerat Dis,Inst Neurol, Queen Sq, London WC1N 3BG, England.	s.mead@prion.ucl.ac.uk	Fratta, Pietro/G-1296-2019; Beck, Jon/GRX-8457-2022; Orrell, Richard/L-2123-2013; Fox, Nick C/AAE-1849-2021; Schott, Jonathan M/A-9065-2011; Mahoney, Colin/AAJ-5384-2021; Hardy, John/C-2451-2009; Tick, Beata/ABA-1728-2020; Fox, Nick C/B-1319-2009; Houlden, Henry J/C-1532-2008; Rossor, Martin/C-1598-2008; Rowe, James/C-3661-2013	Fratta, Pietro/0000-0002-8762-8188; Fox, Nick C/0000-0002-6660-657X; Schott, Jonathan M/0000-0003-2059-024X; Mahoney, Colin/0000-0002-5878-3859; Hardy, John/0000-0002-3122-0423; Fox, Nick C/0000-0002-6660-657X; Houlden, Henry J/0000-0002-2866-7777; Mead, Simon/0000-0002-4326-1468; Rohrer, Jonathan/0000-0002-6155-8417; Tabrizi, Sarah/0000-0003-2716-2045; Warren, Jason/0000-0002-5405-0826; Rowe, James/0000-0001-7216-8679; fratta, pietro/0000-0002-7554-1632; Hensman Moss, Davina/0000-0003-2467-0917; Rossor, Martin/0000-0001-8215-3120	Medical Research Council (MRC, UK); BRC; Wellcome Trust [091673/Z/10/Z, 088324, 068545/Z/02]; NIHR Cambridge Biomedical Research Centre; Motor Neuron Disease Association; MRC [G0000934]; MRC [MC_U105597119, G0801306, G1001253, G108/638, G1000287, G1100695, MR/J003832/1, MR/J004758/1, G0802760, MC_U123192748, G0601846, MC_U123160651, G1001799] Funding Source: UKRI; Alzheimers Research UK [ARUK-PPG2012A-14] Funding Source: researchfish; Medical Research Council [MC_U123160651, G1000287, G1100695, G1001253, G1001799, MR/J003832/1, MR/J004758/1, G0601846, G0000934, G0801306, MC_U105597119, MC_U123192748, G0802760, G108/638] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10123, ACF-2009-18-016, NF-SI-0512-10033] Funding Source: researchfish	Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BRC; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Motor Neuron Disease Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Medical Research Council (MRC, UK). We are grateful for the support of cohort individuals and their families and to numerous physicians for sending DNA samples to the MRC Prion Unit for research genetic studies. Some of the work was conducted at University College London Hospitals National Health Service Trust Biomedical Research Centre (BRC), supported by BRC funding of the National Prion Monitoring Cohort study and researchers at the National Institute for Health Research (NIHR) Queen Square Dementia BRU. J.D.W. is supported by a Wellcome Trust Senior Clinical Fellowship (091673/Z/10/Z). J.B.R. is supported by a Wellcome Trust Senior Research Fellowship (088324), and J.B.R. and J.M.B. are supported by the NIHR Cambridge Biomedical Research Centre. Ray Young assisted with figure design. Some of this work was supported by the Motor Neuron Disease Association. Nicole Gurunlian provided technical assistance related to the amyotrophic lateral sclerosis samples. We acknowledge the use of genotype data from the British 1958 Birth Cohort DNA collection, funded by MRC grant G0000934 and Wellcome Trust grant 068545/Z/02. We thank the MRC London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, King's College London and the Queen Square Brain Bank for Neurological Disorders, University College London Institute of Neurology, London for providing tissue.	Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x; Armon C, 2007, J NEUROL SCI, V262, P45, DOI 10.1016/j.jns.2007.06.021; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Hanby MF, 2011, BRAIN, V134, P3451, DOI 10.1093/brain/awr248; HERN JEC, 1992, J NEUROL NEUROSUR PS, V55, P536; Knopman DS, 2004, NEUROLOGY, V62, P506, DOI 10.1212/01.WNL.0000106827.39764.7E; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lindquist S., 2012, CLIN GENET; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Majounie E, 2012, NEW ENGL J MED, V366, P283, DOI 10.1056/NEJMc1113592; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mok K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.005; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; Rademakers R, 2012, LANCET NEUROL, V11, P297, DOI 10.1016/S1474-4422(12)70046-7; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Ryan JL, 2006, LAB INVEST, V86, P1193, DOI 10.1038/labinvest.3700472; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Smith B, 2012, DEMENT GERIATR COGN, V33, P87; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355	25	239	244	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2013	92	3					345	353		10.1016/j.ajhg.2013.01.011	http://dx.doi.org/10.1016/j.ajhg.2013.01.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106RF	23434116	Green Published, Bronze			2022-12-18	WOS:000316161700007
J	Jordan, CT; Cao, L; Roberson, EDO; Duan, SH; Helms, CA; Nair, RP; Duffin, KC; Stuart, PE; Goldgar, D; Hayashi, G; Olfson, EH; Feng, BJ; Pullinger, CR; Kane, JP; Wise, CA; Goldbach-Mansky, R; Lowes, MA; Peddle, L; Chandran, V; Liao, W; Rahman, P; Krueger, GG; Gladman, D; Elder, JT; Menter, A; Bowcock, AM				Jordan, Catherine T.; Cao, Li; Roberson, Elisha D. O.; Duan, Shenghui; Helms, Cynthia A.; Nair, Rajan P.; Duffin, Kristina Callis; Stuart, Philip E.; Goldgar, David; Hayashi, Genki; Olfson, Emily H.; Feng, Bing-Jian; Pullinger, Clive R.; Kane, John P.; Wise, Carol A.; Goldbach-Mansky, Raphaela; Lowes, Michelle A.; Peddle, Lynette; Chandran, Vinod; Liao, Wilson; Rahman, Proton; Krueger, Gerald G.; Gladman, Dafna; Elder, James T.; Menter, Alan; Bowcock, Anne M.			Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HLA-C; DISEASE; GENE; IDENTIFICATION; PATHOGENESIS; METAANALYSIS; HOMEOSTASIS; MUTATION	Psoriasis is a common inflammatory disorder of the skin and other organs. We have determined that mutations in CARD14, encoding a nuclear factor of kappa light chain enhancer in B cells (NF-kB) activator within skin epidermis, account for PSORS2. Here, we describe fifteen additional rare missense variants in CARD14, their distribution in seven psoriasis cohorts (>6,000 cases and >4,000 controls), and their effects on NF-kB activation and the transcriptome of keratinocytes. There were more CARD14 rare variants in cases than in controls (burden test p value = 0.0015). Some variants were only seen in a single case, and these included putative pathogenic mutations (c.424G>A [p.Glu142Lys] and c.425A>G [p.Glu142Gly]) and the generalized-pustular-psoriasis mutation, c.413A>C (p.Glu138Ala); these three mutations lie within the coiled-coil domain of CARD14. The c.349G>A (p.Gly117Ser) familial-psoriasis mutation was present at a frequency of 0.0005 in cases of European ancestry. CARD14 variants led to a range of NF-kB activities; in particular, putative pathogenic variants led to levels >2.5x higher than did wild-type CARD14. Two variants (c.511C>A [p.His171Asn] and c.536G>A [p.Arg179His]) required stimulation with tumor necrosis factor alpha (TNF-alpha) to achieve significant increases in NF-kB levels. Transcriptome profiling of wild-type and variant CARD14 transfectants in keratinocytes differentiated probably pathogenic mutations from neutral variants such as polymorphisms. Over 20 CARD 14 polymorphisms were also genotyped, and meta-analysis revealed an association between psoriasis and rs11652075 (c.2458C>T [p.Arg820Trp]; p value = 2.1 x 10(-6)). In the two largest psoriasis cohorts, evidence for association increased when rs11652075 was conditioned on HLA-Cw(star)0602 (PSORS1). These studies contribute to our understanding of the genetic basis of psoriasis and illustrate the challenges faced in identifying pathogenic variants in common disease.	[Jordan, Catherine T.; Cao, Li; Roberson, Elisha D. O.; Duan, Shenghui; Helms, Cynthia A.; Olfson, Emily H.; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; [Nair, Rajan P.; Stuart, Philip E.; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Duffin, Kristina Callis; Goldgar, David; Feng, Bing-Jian; Krueger, Gerald G.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84132 USA; [Hayashi, Genki; Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Kane, John P.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Kane, John P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Wise, Carol A.] Texas Scottish Rite Hosp Children, Sarah M & Charles E Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Goldbach-Mansky, Raphaela] NIAMSD, NIH, Bethesda, MD 20892 USA; [Lowes, Michelle A.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10065 USA; [Peddle, Lynette; Rahman, Proton] Mem Univ Newfoundland, Dept Med, Div Rheumatol, St John, NF A1C 5S7, Canada; [Chandran, Vinod; Gladman, Dafna] Univ Toronto, Toronto, ON M5T 2S8, Canada; [Chandran, Vinod; Gladman, Dafna] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Menter, Alan] Baylor Univ, Med Ctr, Psoriasis Res Inst, Dallas, TX 75246 USA	Washington University (WUSTL); University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas Scottish Rite Hospital for Children; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rockefeller University; Memorial University Newfoundland; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Baylor University; Baylor University Medical Center	Bowcock, AM (corresponding author), Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA.	bowcock@genetics.wustl.edu	Roberson, Elisha D.O./J-1747-2012; Goldbach-Mansky, Raphaela/N-5917-2017; Roberson, Elisha/ABC-1810-2020; Lowes, Michelle A/G-9585-2016	Roberson, Elisha D.O./0000-0001-5921-2399; Roberson, Elisha/0000-0001-5921-2399; Wise, Carol/0000-0002-6790-2194; Bowcock, Anne/0000-0001-8691-9090; Lowes, Michelle A/0000-0003-4256-478X	National Institutes of Health (NIH) [AR050266, 5RC1AR058681, T32AR007279, T32HL083822, T32 GM07200, AR060222, T32HG000045, K08AR057763, R01 AR042742, R01 AR050511, AR054966]; Babcock Memorial Trust; Ann Arbor Veterans Affairs Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Arthritis Society of Canada; Atlantic Innovation Fund; Canadian Institute of Health Research; Arthritis Society; Dana Foundation; Academia Sinica; National Science Council (National Clinical Core, National Genotyping Core) of Taiwan; National Psoriasis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083822] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279, ZIAAR041138, R01AR042742, ZIEAR041176, R01AR060222, ZIDAR041180, RC1AR058681, R01AR054966, R01AR050511, R01AR050266, K08AR057763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Babcock Memorial Trust; Ann Arbor Veterans Affairs Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Society of Canada; Atlantic Innovation Fund; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Society; Dana Foundation; Academia Sinica(Academia Sinica - Taiwan); National Science Council (National Clinical Core, National Genotyping Core) of Taiwan; National Psoriasis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH): AR050266 and 5RC1AR058681 (A.M.B.), T32AR007279 (E.D.O.R.), T32HL083822 and T32 GM07200 (C.T.J), AR060222 (M.A.L), T32HG000045 (C.E.J), and K08AR057763 (W.L.). J.T.E., R.N., and P.S. were supported by NIH grants R01 AR042742, R01 AR050511, and AR054966 and by the Babcock Memorial Trust. J.T.E. is supported by the Ann Arbor Veterans Affairs Hospital. R.G.M. is supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Additional funding came from the Arthritis Society of Canada, the Atlantic Innovation Fund, the Canadian Institute of Health Research, the Arthritis Society, the Dana Foundation, and the Academia Sinica and National Science Council (National Clinical Core, National Genotyping Core) of Taiwan. The authors thank the many individuals with psoriasis and the controls who participated in this study. We thank Linus Schwantes-An, Weimin Duan, and Nancy Saccone for advice on statistical analyses. We also thank Mayte Suarez-Farinas for biostatistical assistance, Haoyan Chen, Olivia Lai, Fawnda Pellet, and M.J. Malloy for assembling the control population, Pui-Yan Kwok for sample procurement, Trilokraj Tejasvi for clinical evaluation of study subjects, Nikki Plass for patient scheduling and study logistics, Damaris Garcia for the management of samples, and Debbie Stone and Dawn Chapelle for patient care. Mike Lovett provided helpful comments on the manuscript. The authors are indebted to the National Psoriasis Foundation for continuing support during the course of this study.	Abecasis G, 2005, J INVEST DERMATOL, V124, P921, DOI 10.1111/j.0022-202X.2005.23729.x; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Elder JT, 2006, J INVEST DERMATOL, V126, P1205, DOI 10.1038/sj.jid.5700357; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mehta NN, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.03.028; Moreno-Garcia ME, 2010, MOL CELL BIOL, V30, P922, DOI 10.1128/MCB.01129-09; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nograles KE, 2009, NAT CLIN PRACT RHEUM, V5, P83, DOI 10.1038/ncprheum0987; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2011, R LANG ENV STAT COMP; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Suarez-Farinas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010247; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Vineis P, 2011, CARCINOGENESIS, V32, P1295, DOI 10.1093/carcin/bgr087; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	40	239	248	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					796	808		10.1016/j.ajhg.2012.03.013	http://dx.doi.org/10.1016/j.ajhg.2012.03.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22521419	Green Published, Bronze			2022-12-18	WOS:000303907500004
J	Ostertag, EM; Goodier, JL; Zhang, Y; Kazazian, HH				Ostertag, EM; Goodier, JL; Zhang, Y; Kazazian, HH			SVA elements are nonautonomous retrotransposons that cause disease in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; HUMAN L1 RETROTRANSPOSITION; HUMAN ENDOGENOUS RETROVIRUS; LINE-1 RETROTRANSPOSITION; HUMAN-POPULATION; ALU REPEATS; INSERTION; RETROPOSON; MECHANISM; EVOLUTION	L1 elements are the only active autonomous retrotransposons in the human genome. The nonautonomous Alu elements, as well as processed pseudogenes, are retrotransposed by the L1 retrotransposition proteins working in trans. Here, we describe another repetitive sequence in the human genome, the SVA element. Our analysis reveals that SVA elements are currently active in the human genome. SVA elements, like Alus and L1s, occasionally insert into genes and cause disease. Furthermore, SVA elements are probably mobilized in trans by active L1 elements.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Kazazian, HH (corresponding author), 475 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	kazazian@mail.med.upenn.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Colombo R, 2000, HUM GENET, V107, P559, DOI 10.1007/s004390000421; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; HASSOUN H, 1994, J CLIN INVEST, V94, P643, DOI 10.1172/JCI117380; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kawai K, 2002, J MOL EVOL, V55, P284, DOI 10.1007/s00239-002-2326-0; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIM HS, 2000, INT NONWOVENS J, V9, P15; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; ONO M, 1987, NUCLEIC ACIDS RES, V15, P8725, DOI 10.1093/nar/15.21.8725; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Ovchinnikov I, 2002, P NATL ACAD SCI USA, V99, P10522, DOI 10.1073/pnas.152346799; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Rohrer J, 1999, CLIN IMMUNOL, V90, P28, DOI 10.1006/clim.1998.4629; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SHEN LM, 1994, J BIOL CHEM, V269, P8466; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; ZHU ZB, 1992, J EXP MED, V175, P1783, DOI 10.1084/jem.175.6.1783; ZHU ZB, 1994, HUM GENET, V93, P545	40	239	249	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1444	1451		10.1086/380207	http://dx.doi.org/10.1086/380207			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14628287	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000187491100019
J	Li, YJ; Scott, WK; Hedges, DJ; Zhang, FY; Gaskell, PC; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Pahwa, R; Stern, MB; Hiner, BC; Jankovic, J; Allen, AA; Goetz, CG; Mastaglia, F; Stajich, JM; Gibson, RA; Middleton, LT; Saunders, AM; Scott, BL; Small, GW; Nicodemus, KK; Reed, AD; Schmechel, DE; Welsh-Bohmer, KA; Conneally, PM; Roses, AD; Gilbert, JR; Vance, JM; Haines, JL; Pericak-Vance, MA				Li, YJ; Scott, WK; Hedges, DJ; Zhang, FY; Gaskell, PC; Nance, MA; Watts, RL; Hubble, JP; Koller, WC; Pahwa, R; Stern, MB; Hiner, BC; Jankovic, J; Allen, AA; Goetz, CG; Mastaglia, F; Stajich, JM; Gibson, RA; Middleton, LT; Saunders, AM; Scott, BL; Small, GW; Nicodemus, KK; Reed, AD; Schmechel, DE; Welsh-Bohmer, KA; Conneally, PM; Roses, AD; Gilbert, JR; Vance, JM; Haines, JL; Pericak-Vance, MA			Age at onset in two common neurodegenerative diseases is genetically controlled	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; FULL GENOME SCAN; PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; MISSENSE MUTATIONS; LINKAGE ANALYSIS; TRAIT LOCI; WORK GROUP; GENE; DEMENTIA	To identify genes influencing age at onset (AAO) in two common neurodegenerative diseases, a genomic screen was performed for AAO in families with Alzheimer disease (AD; n = 449) and Parkinson disease (PD; n = 174). Heritabilities between 40%- 60% were found in both the AD and PD data sets. For PD, significant evidence for linkage to AAO was found on chromosome 1p (LOD = 3.41). For AD, the AAO effect of APOE (LOD = 3.28) was confirmed. In addition, evidence for AAO linkage on chromosomes 6 and 10 was identified independently in both the AD and PD data sets. Subsequent unified analyses of these regions identified a single peak on chromosome 10q between D10S1239 and D10S1237, with a maximum LOD score of 2.62. These data suggest that a common gene affects AAO in these two common complex neurodegenerative diseases.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; Struthers Parkinson Ctr, Golden Valley, MN USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA; Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Carolina Neurol Clin, Charlotte, NC USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; GlaxoSmithKline Res & Dev Ltd, Greenford, Middx, England; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; GlaxoSmithKline, Genet Res Directorate, Res Triangle Pk, NC USA	Duke University; Duke University; Duke University; Emory University; University System of Ohio; Ohio State University; University of Miami; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Marshfield Clinic; Baylor College of Medicine; Rush University; University of Western Australia; GlaxoSmithKline; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vanderbilt University; Indiana University System; Indiana University-Purdue University Indianapolis; GlaxoSmithKline	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Box 3445, Durham, NC 27710 USA.	mpv@chg.mc.duke.edu	Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012; Zhang, Fengyu/M-1396-2019; Welsh-Bohmer, Kathleen/AAA-3178-2020; Scott, Burton/L-3951-2019	Haines, Jonathan/0000-0002-4351-4728; Zhang, Fengyu/0000-0001-8504-0770; Scott, William/0000-0001-9336-6404; Gibson, Rachel/0000-0002-1338-1290; Vance, Jeffery/0000-0003-3815-8199; Li, Yi-Ju/0000-0001-6996-4834	NCRR NIH HHS [M01 RR000865, M01 RR 00865] Funding Source: Medline; NIA NIH HHS [AG 10123, P60 AG011268, AG 13308, P50 AG 05128, P30 AG010123, U24 AG021886, AG 11268, P50 AG005128, R01 AG013308] Funding Source: Medline; NIMH NIH HHS [R01 MH052453, MH 52453] Funding Source: Medline; NINDS NIH HHS [NS 31153, P01 NS 26630, R01 NS031153, P01 NS026630, P50 NS039764, P50 NS 39764] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764, R01NS031153, P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P30AG010123, P60AG011268, P50AG005128, R01AG013308] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Daw EW, 1999, AM J HUM GENET, V64, P839, DOI 10.1086/302276; DeStefano AL, 2001, NEUROLOGY, V57, P1124, DOI 10.1212/WNL.57.6.1124; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; FULKER DW, 1995, AM J HUM GENET, V56, P1224; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; Haines JL, 2001, ALZHEIMER'S DISEASE, P33; Harhangi BS, 2000, NEUROLOGY, V54, P1272, DOI 10.1212/WNL.54.6.1272; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HULETTE CM, 2000, SOC NEUR 30 ANN M NE; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Khan N, 2001, ANN NEUROL, V49, P665; Korczyn A. D., 2001, J NEUROL S3, V248, P1, DOI DOI 10.1007/PL00022916; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lippa CF, 2001, ARCH NEUROL-CHICAGO, V58, P1817, DOI 10.1001/archneur.58.11.1817; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; Matise TC, 1999, AM J HUM GENET, V65, pA435; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; Vance Jeffery M., 1998, P213; WARD CD, 1990, ADV NEUROL, V53, P245; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Wilson RS, 2000, ARCH NEUROL-CHICAGO, V57, P855, DOI 10.1001/archneur.57.6.855	42	239	247	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					985	993		10.1086/339815	http://dx.doi.org/10.1086/339815			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11875758	Green Published, Bronze			2022-12-18	WOS:000174252100015
J	Szepetowski, P; Rochette, J; Berquin, P; Piussan, C; Lathrop, GM; Monaco, AP				Szepetowski, P; Rochette, J; Berquin, P; Piussan, C; Lathrop, GM; Monaco, AP			Familial infantile convulsions and paroxysmal choreoathetosis: A new neurological syndrome linked to the pericentromeric region of human chromosome 16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE MYOCLONIC EPILEPSY; IDIOPATHIC GENERALIZED EPILEPSY; FRONTAL-LOBE EPILEPSY; LINKAGE ANALYSIS; KINESIGENIC CHOREOATHETOSIS; NEONATAL CONVULSIONS; HUMAN GENOME; NO EVIDENCE; HLA REGION; GENE	Benign infantile familial convulsions is an autosomal dominant disorder characterized by nonfebrile seizures, with the first attack occurring at age 3-12 mo. It is one of the rare forms of epilepsy that are inherited as monogenic Mendelian traits, thus providing a powerful tool for mapping genes involved in epileptic syndromes. Paroxysmal choreoathetosis is an involuntary-movement disorder characterized by attacks that occur spontaneously or are induced by a variety of stimuli. Classification is still elusive, and the epileptic nature of this movement disorder has long been discussed and remains controversial. We have studied four families from northwestern France in which benign infantile convulsions was inherited as an autosomal dominant trait together with variably expressed paroxysmal choreoathetosis. The human genome was screened with microsatellite markers regularly spaced, and strong evidence of linkage for the disease gene was obtained in the pericentromeric region of chromosome 16, with a maximum two-point LOD score, for D16S3133, of 6.76 at a recombination fraction of 0. Critical recombinants narrowed the region of interest to a 10-cM interval around the centromere. Our study provides the first genetic evidence for a common basis of convulsive and choreoathetotic disorders and will help in the understanding and classification of paroxysmal neurological syndromes.	UNIV OXFORD, WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 7BN, ENGLAND; CHU AMIENS, CLIN GENET CTR, AMIENS, FRANCE; UNIV JULES VERNE, FAC MED, LAB GENET MOL MED, AMIENS, FRANCE	University of Oxford; Wellcome Centre for Human Genetics; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV)			Monaco, Anthony P/A-4495-2010	Monaco, Anthony P/0000-0001-7480-3197	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKSOY IA, 1994, GENOMICS, V23, P275, DOI 10.1006/geno.1994.1494; Auburger G, 1996, GENOMICS, V31, P90, DOI 10.1006/geno.1996.0013; Beaumanoir A, 1996, BRAIN DEV-JPN, V18, P139, DOI 10.1016/0387-7604(95)00112-3; CALLEN DF, 1995, GENOMICS, V29, P503, DOI 10.1006/geno.1995.9005; CALLEN DF, 1991, AM J HUM GENET, V49, P1372; *COMM CLASS TERM I, 1990, EPILEPSIA, V30, P389; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; ECHENNE B, 1994, BRAIN DEV-JPN, V16, P108, DOI 10.1016/0387-7604(94)90044-2; Elmslie FV, 1996, AM J HUM GENET, V59, P653; Fink JK, 1996, AM J HUM GENET, V59, P140; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Fouad GT, 1996, AM J HUM GENET, V59, P135; Fukuyama Y, 1968, Proc Aust Assoc Neurol, V5, P583; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; Hess EJ, 1996, CELL, V87, P1149, DOI 10.1016/S0092-8674(00)81809-7; HIRATA K, 1991, EPILEPSIA, V32, P492, DOI 10.1111/j.1528-1157.1991.tb04682.x; HUDGINS RL, 1966, BRAIN, V89, P199, DOI 10.1093/brain/89.2.199; JORDE LB, 1995, AM J HUM GENET, V56, P11; KINAST M, 1980, PEDIATRICS, V65, P74; KOZMAN HM, 1995, GENOMICS, V25, P44, DOI 10.1016/0888-7543(95)80108-X; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEE WL, 1993, J PEDIATR-US, V123, P588, DOI 10.1016/S0022-3476(05)80958-8; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; LEWIS TB, 1993, AM J HUM GENET, V53, P670; LIU AW, 1995, AM J HUM GENET, V57, P368; LOMBROSO CT, 1995, ITAL J NEUROL SCI, V16, P271; Mount LA, 1940, ARCH NEURO PSYCHIATR, V44, P841, DOI 10.1001/archneurpsyc.1940.02280100143011; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Ott J., 1991, ANAL HUMAN GENETIC L; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Ottman R, 1997, AM J HUM GENET, V60, P667; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; PRYLES CV, 1952, PEDIATRICS, V9, P44; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RICHARDS RN, 1968, NEUROLOGY, V18, P461, DOI 10.1212/WNL.18.5.461; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SERRATOSA JM, 1995, HUM MOL GENET, V4, P1657; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; STEVENS H, 1966, ARCH NEUROL-CHICAGO, V14, P415, DOI 10.1001/archneur.1966.00470100071009; VIGEVANO F, 1992, EUR J PEDIATR, V151, P608, DOI 10.1007/BF01957732; VOILLEY N, 1995, GENOMICS, V28, P560, DOI 10.1006/geno.1995.1188; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WELLS RG, 1993, GENOMICS, V17, P787, DOI 10.1006/geno.1993.1411; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	53	239	263	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					889	898		10.1086/514877	http://dx.doi.org/10.1086/514877			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382100	Green Published, Bronze			2022-12-18	WOS:A1997YA59100016
J	Jeunemaitre, X; Inoue, I; Williams, C; Charru, A; Tichet, J; Powers, M; Sharma, AM; GimenezRoqueplo, AP; Hata, A; Corvol, P; Lalouel, JM				Jeunemaitre, X; Inoue, I; Williams, C; Charru, A; Tichet, J; Powers, M; Sharma, AM; GimenezRoqueplo, AP; Hata, A; Corvol, P; Lalouel, JM			Haplotypes of angiotensinogen in essential hypertension	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENHANCER CORE ELEMENT; BLOOD-PRESSURE; MET(235)->THR VARIANT; FAMILIAL HYPERTENSION; MYOCARDIAL-INFARCTION; MOLECULAR VARIANT; GENE; POLYMORPHISM; ASSOCIATION; JAPANESE	The M235T polymorphism of the angiotensinogen gene (AGT) has been associated with essential and pregnancy-induced hypertension. Generation of haplotypes can help to resolve whether the T235 allele itself predisposes to the development of hypertension or acts as a marker of an unknown causal molecular variant. We identified 10 diallelic polymorphisms at the AGT locus and genotyped both a series of 477 probands of hypertensive families and 364 controls, all French Caucasians, as well as a series of 92 hypertensives and 122 controls from Japan. Despite a large ethnic difference in gene frequency, a significant association of T235 with hypertension was observed both in Caucasians (.46 vs. .38, P = .004) and in Japanese (.91 vs. .76, P = .002). In both groups, the G-->A substitution located at position -6 upstream of the initial transcription site occurred at the same frequency and in complete linkage disequilibrium with the T235 allele. No other polymorphism was found to be consistently associated with hypertension. Five informative haplotypes subdividing the T235 allele were generated. Whereas two of them were associated with hypertension in Caucasians, none of these two haplotypes (H3 and H4) reached statistical significance in Japanese. The analysis of the AGT-GT repeat revealed marked linkage disequilibriums between each of the diallelic polymorphisms and some (GT)(16) alleles, with similar patterns in the two populations. The strong disequilibrium between M235 and (GT)(16) explained the increased frequency of that particular allele in French controls compared with hypertensives (.42 vs. .36, P < .01). The haplotype combining the M235T and G-GA polymorphisms appears as the ancestral allele of the human AGT gene and as the one associated with hypertension.	COLL FRANCE,INSERM U36,F-75231 PARIS,FRANCE; UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; INST REG SANTE,LA RICHE,FRANCE; FREE UNIV BERLIN,DEPT GEN INTERNAL MED & NEPHROL,D-1000 BERLIN,GERMANY; HOKKAIDO UNIV,SCH MED,DEPT PUBL HLTH,SAPPORO,HOKKAIDO 060,JAPAN	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Utah System of Higher Education; University of Utah; Free University of Berlin; Hokkaido University	Jeunemaitre, X (corresponding author), HOP BROUSSAIS,GENET MOL LAB,ASSISTANCE PUBL HOP PARIS,96 RUE DIDOT,ILOT MARINIERS 2 ETAGE,F-75014 PARIS,FRANCE.		JEUNEMAITRE, Xavier/AAQ-4853-2021; GIMENEZ-ROQUEPLO, Anne-Paule/T-6752-2018	JEUNEMAITRE, Xavier/0000-0001-5925-381X; GIMENEZ-ROQUEPLO, Anne-Paule/0000-0002-4816-670X; Williams, Christopher/0000-0002-1541-579X	NHLBI NIH HHS [HL-45235] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNGRIMSSON R, 1993, NAT GENET, V4, P114, DOI 10.1038/ng0693-114; BARLEY J, 1994, J HUM HYPERTENS, V8, P639; BENNETT CL, 1993, BIOCHEM BIOPH RES CO, V197, P833, DOI 10.1006/bbrc.1993.2554; BLOEM LJ, 1995, J CLIN INVEST, V95, P948, DOI 10.1172/JCI117803; CAULFIELD M, 1995, J CLIN INVEST, V96, P687, DOI 10.1172/JCI118111; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; CHARRU A, 1994, J HYPERTENS, V12, P981; Cohen P, 1996, J CLIN ENDOCR METAB, V81, P3505, DOI 10.1210/jc.81.10.3505; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; DENTON D, 1984, HUNGER SALT, P53; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; FASOLA AF, 1968, J APPL PHYSIOL, V25, P410, DOI 10.1152/jappl.1968.25.4.410; FORNAGE M, 1995, HUM GENET, V96, P295; GAILLARD I, 1989, DNA-J MOLEC CELL BIO, V8, P87, DOI 10.1089/dna.1.1989.8.87; GARDES J, 1982, HYPERTENSION, V4, P185, DOI 10.1161/01.HYP.4.2.185; GimenezRoqueplo AP, 1996, J BIOL CHEM, V271, P9838, DOI 10.1074/jbc.271.16.9838; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; HATA A, 1994, J CLIN INVEST, V93, P1285, DOI 10.1172/JCI117083; HEGELE RA, 1994, CIRCULATION, V90, P2207, DOI 10.1161/01.CIR.90.5.2207; HENDERSON IW, 1993, RENIN ANGIOTENSIN SY, V1; HIXSON JE, 1995, HUM GENET, V96, P110, DOI 10.1007/BF00214197; HYER RN, 1991, AM J HUM GENET, V48, P243; INOUE I, 1995, J BIOL CHEM, V270, P11430, DOI 10.1074/jbc.270.19.11430; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; ISHIGAMI T, 1995, CIRCULATION, V91, P951, DOI 10.1161/01.CIR.91.4.951; IWAI N, 1995, HYPERTENSION, V25, P688, DOI 10.1161/01.HYP.25.4.688; JEUNEMAITRE X, 1993, J HYPERTENS, V11, pS80; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KAMITANI A, 1994, J HUM HYPERTENS, V8, P521; KAMITANI A, 1995, HYPERTENSION, V25, P950, DOI 10.1161/01.HYP.25.5.950; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; KOTELEVTSEV YV, 1991, NUCLEIC ACIDS RES, V19, P6978, DOI 10.1093/nar/19.24.6978; MCCARRON DA, 1983, ANN INTERN MED, V98, P715, DOI 10.7326/0003-4819-98-5-715; MENARD J, 1991, HYPERTENSION, V18, P705, DOI 10.1161/01.HYP.18.5.705; NEEL JV, 1970, SCIENCE, V170, P815, DOI 10.1126/science.170.3960.815; NIBU Y, 1994, J BIOL CHEM, V269, P28598; NIBU Y, 1994, BIOCHEM BIOPH RES CO, V205, P1102, DOI 10.1006/bbrc.1994.2779; NISHIUMA S, 1995, J HYPERTENS, V13, P717; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ROTIMI C, 1994, HYPERTENSION, V24, P591, DOI 10.1161/01.HYP.24.5.591; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; SCHMIDT S, 1995, NEPHROL DIAL TRANSPL, V10, P1145, DOI 10.1093/ndt/10.7.1145; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; TIRET L, 1995, J HYPERTENS, V13, P311; WALKER WG, 1979, HYPERTENSION, V1, P287, DOI 10.1161/01.HYP.1.3.287; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; WEATHERALL DJ, 1995, ANN NY ACAD SCI, V758, P245, DOI 10.1111/j.1749-6632.1995.tb24832.x; Yanai K, 1996, J BIOL CHEM, V271, P15981, DOI 10.1074/jbc.271.27.15981	50	239	262	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1448	1460		10.1086/515452	http://dx.doi.org/10.1086/515452			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199566	Bronze, Green Published			2022-12-18	WOS:A1997XE29400023
J	LevyLahad, E; Catane, R; Eisenberg, S; Kaufman, B; Hornreich, G; Lishinsky, E; Shohat, M; Weber, BL; Beller, U; Lahad, A; Halle, D				LevyLahad, E; Catane, R; Eisenberg, S; Kaufman, B; Hornreich, G; Lishinsky, E; Shohat, M; Weber, BL; Beller, U; Lahad, A; Halle, D			Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENE; 185DELAG	Germ-line BRCA1 and BRCA2 mutations account for most of familial breast-ovarian cancer. In Ashkenazi Jews, there is a high population frequency (similar to 2%) of three founder mutations: BRCA1 185delAG, BRCA1 5382insC, and BRCA2 6174delT. This study examined the frequency of these mutations in a series of Ashkenazi women with ovarian cancer unselected for family history, compared with the frequency of these mutations in families ascertained on the basis of family history of at least two affected women. Penetrance was compared, both according to the method of family ascertainment (i.e., on the basis of an unselected ovarian cancer proband vs. on the basis of family history) and for the BRCA1 founder mutations compared with the BRCA2 6174delT mutation. There was a high frequency (10/22; [45%]) of germ-line mutations in Ashkenazi women with ovarian cancer, even in those with minimal or no family history (7/18 [39%]). In high-risk Ashkenazi families, a founder mutation was found in 59% (25/42). Families with any case of ovarian cancer were significantly more likely to segregate a founder mutation than were families with site-specific breast cancer. Penetrance was higher in families ascertained on the basis of family history than in families ascertained on the basis of an unselected proband, but this difference was not significant. Penetrance of BRCA1 185delAG and BRCA1 5382insC was significantly higher than penetrance of BRCA2 6174delT (hazard ratio 2.1 [95% CI 1.2-3.8]; two-tailed P = .01). Thus, the high rate of germ-line BRCA1/BRCA2 mutations in Ashkenazi women and families with ovarian cancer is coupled with penetrance that is lower than previously estimated. This has been shown specifically for the BRCA2 6174delT mutation, but, because of ascertainment bias, it also may be true for BRCA1 mutations.	SHAARE ZEDEK MED CTR,INST ONCOL,IL-91031 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,DIV GYNECOL ONCOL,IL-91031 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,CELL CANC RES LAB,IL-91031 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT FAMILY MED,IL-91010 JERUSALEM,ISRAEL; KUPAT HOLIM,JERUSALEM,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,RABIN MED CTR,DIV MED GENET,IL-69978 TEL AVIV,ISRAEL; UNIV PENN,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Rambam Health Care Campus; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Pennsylvania; University of Pennsylvania	LevyLahad, E (corresponding author), SHAARE ZEDEK MED CTR,DEPT MED A,POB 3235,IL-91031 JERUSALEM,ISRAEL.		Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; Kaufman, Brian/0000-0002-4236-3374				Butler L. M., 1996, American Journal of Human Genetics, V59, pA28; Clarke G.M., 1996, DIS BREAST, P461; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Johannesdottir G, 1996, CANCER RES, V56, P3663; Knapp R. C., 1993, GYNECOLOGIC ONCOLOGY; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Modan B, 1996, JAMA-J AM MED ASSOC, V276, P1823, DOI 10.1001/jama.276.22.1823; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; NEWELL VA, 1961, J NATL CANCER I, V26, P405; Norusis M.J., 1994, SPSS 6 1 GUIDE DATA; Novakovic B, 1996, JNCI-J NATL CANCER I, V88, P1492, DOI 10.1093/jnci/88.20.1492; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Sher C, 1996, NEW ENGL J MED, V334, P1199; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STEINITZ R, 1981, IARC SCI PUBLICATION, V98; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	29	239	243	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1059	1067						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150153				2022-12-18	WOS:A1997WX76000006
J	KLINGER, K; LANDES, G; SHOOK, D; HARVEY, R; LOPEZ, L; LOCKE, P; LERNER, T; OSATHANONDH, R; LEVERONE, B; HOUSEAL, T; PAVELKA, K; DACKOWSKI, W				KLINGER, K; LANDES, G; SHOOK, D; HARVEY, R; LOPEZ, L; LOCKE, P; LERNER, T; OSATHANONDH, R; LEVERONE, B; HOUSEAL, T; PAVELKA, K; DACKOWSKI, W			RAPID DETECTION OF CHROMOSOME ANEUPLOIDIES IN UNCULTURED AMNIOCYTES BY USING FLUORESCENCE INSITU HYBRIDIZATION (FISH)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPPRESSION HYBRIDIZATION; ABERRATIONS; DNA; DIAGNOSIS; METAPHASE; LIBRARIES; PROBES; CELLS	Herein we report the results of the first major prospective study directly comparing aneuploidy detection by fluorescence in situ hybridization of interphase nuclei with the results obtained by cytogenetic analysis. We constructed probes derived from specific subregions of human chromosomes 21, 18, 13, X, and Y that give a single copy-like signal when used in conjunction with suppression hybridization. A total of 526 independent amniotic fluid samples were analyzed in a blind fashion. All five probes were analyzed on 117 samples, while subsets of these five probes were used on the remaining samples (because of insufficient sample size), for a total of over 900 autosomal hybridization reactions and over 400 sex chromosome hybridization reactions. In this blind series, 21 of 21 abnormal samples were correctly identified. The remaining samples were correctly classified as disomic for these five chromosomes. The combination of chromosome-specific probe sets composed primarily of cosmid contigs and optimized hybridization/detection allowed accurate chromosome enumeration in uncultured human amniotic fluid cells, consistent with the results obtained by traditional cytogenetic analysis.	BRIGHAM & WOMENS HOSP,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital	KLINGER, K (corresponding author), INTEGRATED GENET INC,1 MT RD,FRAMINGHAM,MA 01701, USA.		Pavelka, Karel/E-6578-2017	Pavelka, Karel/0000-0003-1952-8422	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG000302] Funding Source: NIH RePORTER; NHGRI NIH HHS [8-R44HG00302-03] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMOLDUS EPJ, 1991, GENE CHROMOSOME CANC, V3, P101; CREMER T, 1986, HUM GENET, V74, P346, DOI 10.1007/BF00280484; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; JAUCH A, 1990, HUM GENET, V85, P145; JORDAN CA, 1990, IN SITU HYBRIDIZATIO, P39; JULIEN C, 1986, LANCET, V2, P863; KLINGER KW, 1990, AM J HUM GENET S, V47, pA224; KLINGER KW, 1991, CYTOGENET CELL GENET, V58, P27344; KUO WL, 1991, AM J HUM GENET, V49, P112; LANDEGENT JE, 1987, HUM GENET, V77, P366, DOI 10.1007/BF00291428; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; LICHTER P, 1990, NATURE, V345, P93, DOI 10.1038/345093a0; LICHTER P, 1991, GENET ANAL-BIOMOL E, V8, P24, DOI 10.1016/1050-3862(91)90005-C; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LICHTER P, 1990, MOL GENETICS CHROMOS, P69; MANUELIDIS L, 1985, FOCUS, V7, P4; MCNEIL JA, 1991, GENET ANAL-BIOMOL E, V8, P41, DOI 10.1016/1050-3862(91)90049-W; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; PRICE JO, 1991, AM J OBSTET GYNECOL, V165, P1731, DOI 10.1016/0002-9378(91)90024-L; Sambrook J., 1989, MOL CLONING LAB MANU; Thompson J. S., 1986, GENETICS MED; TKACHUK DC, 1991, GENET ANAL-BIOMOL E, V8, P67, DOI 10.1016/1050-3862(91)90051-R; WHITEMAN DAH, 1991, AM J HUM GENET S, V49, pA1279; WIEGANT J, 1991, NUCLEIC ACIDS RES, V19, P3237, DOI 10.1093/nar/19.12.3237; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; YU LC, 1990, AM J HUM GENET S, V47, pA287	27	239	287	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1992	51	1					55	65						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JA467	1609805				2022-12-18	WOS:A1992JA46700007
J	Hoggart, CJ; Shriver, MD; Kittles, RA; Clayton, DG; McKeigue, PM				Hoggart, CJ; Shriver, MD; Kittles, RA; Clayton, DG; McKeigue, PM			Design and analysis of admixture mapping studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE DISEQUILIBRIUM; ADMIXED POPULATIONS; ALLELE FREQUENCIES; PROSTATE-CANCER; ASSOCIATION; INFERENCE; ANCESTRY; DISEASE; GENES	Admixture between populations originating on different continents can be exploited to detect disease susceptibility loci at which risk alleles are distributed differentially between these populations. We first examine the statistical power and mapping resolution of this approach in the limiting situation in which gamete admixture and locus ancestry are measured without uncertainty. We show that, for a rare disease, the most efficient design is to study affected individuals only. In a typical African American population (two-way admixture proportions 0.8/0.2, ancestry crossover rate 2 per 100 cM), a study of 800 affected individuals has 90% power to detect at P values <10(-5) a locus that generates a risk ratio of 2 between populations, with an expected mapping resolution (size of 95% confidence region for the position of the locus) of 4 cM. In practice, to infer locus ancestry from marker data requires Bayesian computationally intensive methods, as implemented in the program ADMIXMAP. Affected-only study designs require strong prior information on the frequencies of each allele given locus ancestry. We show how data from unadmixed and admixed populations can be combined to estimate these ancestry-specific allele frequencies within the admixed population under study, allowing for variation between allele frequencies in unadmixed and admixed populations. Using simulated data based on the genetic structure of the African American population, we show that 60% of information can be extracted in a test for linkage using markers with an ancestry information content of 36% at 3-cM spacing. As in classic linkage studies, the most efficient strategy is to use markers at a moderate density for an initial genome search and then to saturate regions of putative linkage with additional markers, to extract nearly all information about locus ancestry.	Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; Univ Cambridge, Cambridge Inst Med REs, Juvenile Diavet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge, England; Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	University of London; London School of Hygiene & Tropical Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard University; University of Cambridge; University College Dublin	Hoggart, CJ (corresponding author), Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	clive.hoggart@lshtm.ac.uk		Shriver, Mark/0000-0003-0006-0479	NCRR NIH HHS [G12 RR003048, RR03048] Funding Source: Medline; NHGRI NIH HHS [R01 HG002154, HG02154] Funding Source: Medline; NIDDK NIH HHS [R01 DK053958, DK53958] Funding Source: Medline; NIMH NIH HHS [MH60343] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060343] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Falush D, 2003, GENETICS, V164, P1567; GILKS WR, 1992, APPL STAT, V41, P337, DOI DOI 10.2307/2347565; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Jeffreys H., 1961, THEORY PROBABILITY, V3; Kilpikari R, 2003, GENET EPIDEMIOL, V25, P122, DOI 10.1002/gepi.10257; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kittles RA, 2001, CANCER EPIDEM BIOMAR, V10, P943; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lockwood JR, 2001, GENET EPIDEMIOL, V20, P17, DOI 10.1002/1098-2272(200101)20:1<17::AID-GEPI3>3.0.CO;2-Q; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Molokhia M, 2003, HUM GENET, V112, P310, DOI 10.1007/s00439-002-0883-3; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Sillanpaa MJ, 1999, GENETICS, V151, P1605; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Terwilliger JD, 2000, HUM BIOL, V72, P63; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Wright S., 1951, ANN EUGEN, V15, P159	27	238	247	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					965	978		10.1086/420855	http://dx.doi.org/10.1086/420855			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15088268	Green Published, Bronze			2022-12-18	WOS:000220926100016
J	Clayton, D; Jones, H				Clayton, D; Jones, H			Transmission/disequilibrium tests for extended marker haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATIONS; DISEASE; POPULATIONS; IDENTITY; DESCENT; RISKS	A generalization of the transmission/disequilibrium test to detect association between polymorphic markers and discrete or quantitative traits is discussed, with particular emphasis on marker haplotypes formed by several adjacent loci. Furthermore, strategies for testing haplotype association, using methods from spatial statistics, are developed. This approach compares the "similarity" of transmitted and untransmitted haplotypes, with the aim of determining the regions where there is greater similarity within the transmitted set. This arises from the fact that, although the original haplotypes carrying the mutation will be broken down by recombination, there may be a subset of markers near the mutation that are common to many of the recombinant haplotypes. Thus, by examination of each marker in turn and by measurement of the average size of the region shared identically by state in the transmitted and untransmitted haplotypes, it may be possible to detect regions of linkage disequilibrium that encompass the susceptibility gene.	Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England; Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA	MRC Biostatistics Unit; University of Cambridge; Stanford University	Clayton, D (corresponding author), Inst Publ Hlth, MRC, Biostat Unit, Univ Forvie Site,Robinson Way, Cambridge CB2 2SR, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allison DB, 1997, AM J HUM GENET, V60, P676; Becker R.A., 1988, NEW S LANGUAGE PROGR; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; Cliff A. D., 1973, SPATIAL AUTOCORRELAT; Cox DR., 1974, THEORETICAL STAT; Cressie N., 2011, STAT SPATIO TEMPORAL; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V35, P355; deVries HG, 1996, HUM GENET, V98, P304, DOI 10.1007/s004390050211; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Geary RC., 1954, INCORPORATED STATIST, V5, P115, DOI [10.2307/2986645, DOI 10.2307/2986645]; Lange K., 1997, MATH STAT METHODS GE; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; Little RJ, 1987, STAT ANAL MISSING DA; MAXWELL AE, 1970, BRIT J PSYCHIAT, V116, P651, DOI 10.1192/bjp.116.535.651; Merriman T, 1997, HUM MOL GENET, V6, P1003, DOI 10.1093/hmg/6.7.1003; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Morris AP, 1997, ANN HUM GENET, V61, P49; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STUART A, 1955, BIOMETRIKA, V42, P412, DOI 10.2307/2333387; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMAS D, 1995, GENET EPIDEMIOL, V12, P455, DOI 10.1002/gepi.1370120503	27	238	241	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1161	1169		10.1086/302566	http://dx.doi.org/10.1086/302566			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486335	Green Published, Bronze			2022-12-18	WOS:000082910000025
J	LOWERY, MC; MORRIS, CA; EWART, A; BROTHMAN, LJ; ZHU, XL; LEONARD, CO; CAREY, JC; KEATING, M; BROTHMAN, AR				LOWERY, MC; MORRIS, CA; EWART, A; BROTHMAN, LJ; ZHU, XL; LEONARD, CO; CAREY, JC; KEATING, M; BROTHMAN, AR			STRONG CORRELATION OF ELASTIN DELETIONS, DETECTED BY FISH, WITH WILLIAMS-SYNDROME - EVALUATION OF 235 PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; GENE; TRANSLOCATION; CHROMOSOME-7; DISORDER	Williams syndrome (WS) is generally characterized by mental deficiency, gregarious personality, dysmorphic facies, supravalvular aortic stenosis, and idiopathic infantile hypercalcemia. Patients with WS show allelic loss of elastin (ELN), exhibiting a submicroscopic deletion, at 7q11.23, detectable by FISH. Hemizygosity is likely the cause of vascular abnormalities in WS patients. A series of 235 patients was studied, and molecular cytogenetic deletions were seen in 96% of patients with classic WS. Patients included 195 solicited through the Williams Syndrome Association (WSA), plus 40 clinical cytogenetics cases referred by primary-care physicians. Photographs and medical records of most WSA subjects were reviewed, and patients were identified as ''classic'' (n = 114) of ''uncertain'' (n = 39). An additional 42 WSA patients were evaluated without clinical information. FISH was performed with biotinylated ELN cosmids on metaphase cells from immortalized lymphoblastoid lines from WSA patients and after high-resolution banding analysis on clinical referral patients. An alpha-satellite probe for chromosome 7 was included in hybridizations, as an internal control. Ninety-six percent of the patients with classic WS showed a deletion in one ELN allele; four of these did not show a deletion. Of the uncertain WS patients, only 3 of 39 showed a deletion. Of the 42 who were not classified phenotypically, because of lack of clinical information, 25 patients (60%) showed a deletion. Thirty-eight percent (15/40) of clinical cytogenetics cases showed an ELN deletion and no cytogenetic deletion by banded analysis. These results support the usefulness of FISH for the detection of elastin deletions as an initial diagnostic assay for WS.	UNIV UTAH,HLTH SCI CTR,DEPT PEDIAT,CYTOGENET LAB,SALT LAKE CITY,UT 84132; UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132; UNIV NEVADA,SCH MED,DEPT PEDIAT,LAS VEGAS,NV 89154; UNIV NEVADA,SCH MED,DEPT PATHOL & LAB MED,LAS VEGAS,NV 89154	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas					NCRR NIH HHS [M01 RR-00064] Funding Source: Medline; NHLBI NIH HHS [R01 HL-4807] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BEUREN AJ, 1964, AM J CARDIOL, V13, P471, DOI 10.1016/0002-9149(64)90154-7; BORAZ RA, 1991, J DENT CHILD, V58, P57; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; EWART AK, 1993, P NATL ACAD SCI USA, V90, P3226, DOI 10.1073/pnas.90.8.3226; FAZIO MJ, 1991, AM J HUM GENET, V48, P696; Jones KI, 1988, SMITHS RECOGNIZABLE, P106; MORRIS CA, 1993, AM J MED GENET, V46, P737, DOI 10.1002/ajmg.1320460634; MORRIS CA, 1993, AM J MED GENET, V47, P478, DOI 10.1002/ajmg.1320470409; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311	14	238	251	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					49	53						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611295				2022-12-18	WOS:A1995RE62900006
J	TSAI, MS; TANGALOS, EG; PETERSEN, RC; SMITH, GE; SCHAID, DJ; KOKMEN, E; IVNIK, RJ; THIBODEAU, SN				TSAI, MS; TANGALOS, EG; PETERSEN, RC; SMITH, GE; SCHAID, DJ; KOKMEN, E; IVNIK, RJ; THIBODEAU, SN			APOLIPOPROTEIN-E - RISK FACTOR FOR ALZHEIMER-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHOLESTEROL TRANSPORT; DIAGNOSIS; DEMENTIA; PROTEIN	The apolipoprotein E gene (APOE) has three common alleles (epsilon 2, epsilon 3, and epsilon 4) that determine six genotypes in the general population. In this study, we examined 77 patients with late-onset Alzheimer disease (AD), along with an equal number of age- and sex-matched controls, for an association with the APOE-epsilon 4 allele. We show that the frequency of this allele among AD patients was significantly higher than that among the control population (.351 vs. .130, P =.000006). The genotype frequencies also differed between the two groups (P = .0002), with the APOE-epsilon 4/epsilon 3 genotype being the most common in the AD group and the APOE-epsilon 3/epsilon 3 being the most common in the control group. In the AD group, homozygosity for epsilon 4 was found in nine individuals, whereas none was found in the control group. The odds ratio for AD, when associated with one or two epsilon 4 alleles, was 4.6 (95% confidence interval [CI] 1.9-12.3), while the odds ratio for AD, when associated with heterozygosity for APOE-epsilon 4, was 3.6 (95% CI 1.5-3.8). Finally, the median age at onset among the AD patients decreased from 83 to 78 to 74 years as the number of APOE-epsilon 4 alleles increased from 0 to 1 to 2, respectively (test for trend, P = .001). Our data, which are in agreement with recent reports, suggest that the APOE-epsilon 4 allele is associated with AD and that this allelic variant may be an important risk factor for susceptibility to AD in the general population.	MAYO CLIN & MAYO FDN,DEPT LAB MED & PATHOL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DIV COMMUNITY MED,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT NEUROL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT PSYCHIAT & PSYCHOL,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic			TSAI, MIN-SHAN/AHE-3825-2022	TSAI, MIN-SHAN/0000-0002-2862-7572; Smith, Glenn/0000-0003-1506-9484	NIA NIH HHS [AG 08031, AG 06786] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [U01AG006786, P30AG008031] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; BRESLOW NE, 1980, STATISTICAL METHODS; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CARLSSON J, 1991, CLIN CHIM ACTA, V196, P167, DOI 10.1016/0009-8981(91)90070-S; CAULEY JA, 1993, GENET EPIDEMIOL, V10, P27, DOI 10.1002/gepi.1370100104; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; FLIER JS, 1991, NEW ENGL J MED, V325, P1849; HAINES JL, 1991, AM J HUM GENET, V48, P1021; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; HIXON JE, 1990, J LIPID RES, V31, P545; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KOKMEN E, 1989, NEUROLOGY, V39, P773, DOI 10.1212/WNL.39.6.773; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MURPHY M, 1992, LANCET, V340, P1512, DOI 10.1016/0140-6736(92)92765-8; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; PAYAMI H, 1993, LANCET, V342, P738; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; 1987, DIAGNOSTIC STATISTIC	30	238	248	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					643	649						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128961				2022-12-18	WOS:A1994NC83600008
J	VOULLAIRE, LE; SLATER, HR; PETROVIC, V; CHOO, KHA				VOULLAIRE, LE; SLATER, HR; PETROVIC, V; CHOO, KHA			A FUNCTIONAL MARKER CENTROMERE WITH NO DETECTABLE ALPHA-SATELLITE, SATELLITE-III, OR CENP-B PROTEIN - ACTIVATION OF A LATENT CENTROMERE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-CHROMOSOMES; REPETITIVE DNA; SEQUENCE; IDENTIFICATION; SUBFAMILIES; FAMILY; REPEAT; P82H	We report the investigation of an unusual human supernumerary marker chromosome 10 designated ''mar del(10).'' This marker is present together with two other marker chromosomes in the karyotype of a boy with mild developmental delay. It has a functional centromere at a primary constriction and is mitotically stable. Fluorescence in situ hybridization (FISH) using alpha-satellite and satellite III DNA as probes failed to detect any signal at the primary constriction site. CENP-B protein could not be demonstrated, although the presence of at least some centromeric proteins was confirmed using a CREST antiserum. Consideration of these and other cytogenetic and FISH results supports a mechanism of formation of the mar del(10) chromosome involving the activation of a latent intercalary centromere at 10q25.	ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,FLEMINGTON RD,PARKVILLE,VIC 3052,AUSTRALIA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne								ALEIXANDRE C, 1987, HUM GENET, V77, P46; BALDINI A, 1991, CYTOGENET CELL GENET, V58, P1868; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; CHOO KH, 1987, DNA-J MOLEC CELL BIO, V6, P297, DOI 10.1089/dna.1987.6.297; CHOO KH, 1991, NUCLEIC ACIDS RES, V19, P1179, DOI 10.1093/nar/19.6.1179; CHOO KH, 1990, NUCLEIC ACIDS RES, V18, P5641, DOI 10.1093/nar/18.19.5641; CHOO KHA, 1992, AM J HUM GENET, V50, P706; Cooper Katrina F., 1992, Human Molecular Genetics, V1, P753, DOI 10.1093/hmg/1.9.753; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; DEWALD GW, 1979, CYTOGENET CELL GENET, V24, P15, DOI 10.1159/000131352; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; HADLACZKY G, 1991, P NATL ACAD SCI USA, V88, P8106, DOI 10.1073/pnas.88.18.8106; JORGENSEN A L, 1988, Genomics, V3, P100, DOI 10.1016/0888-7543(88)90139-5; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; KALITSIS P, IN PRESS GENOMICS; LAU YF, 1985, HUM GENET, V69, P102, DOI 10.1007/BF00293276; Magnani I., 1992, American Journal of Human Genetics, V51, pA317; MANUELIDIS L, 1978, CHROMOSOMA, V66, P23, DOI 10.1007/BF00285813; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; MCGILL MI, 1992, MOL GENET, V1, P749; MITCHELL AR, 1985, CHROMOSOMA, V92, P369, DOI 10.1007/BF00327469; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PLUTA AF, 1990, TRENDS BIOCHEM SCI, V15, P181, DOI 10.1016/0968-0004(90)90158-8; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; PROSSER J, 1986, J MOL BIOL, V187, P145, DOI 10.1016/0022-2836(86)90224-X; RAUCH A, 1992, CLIN GENET, V42, P84; Rooney D E, 1986, HUMAN CYTOGENETICS P, VFirst; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	33	238	246	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1153	1163						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	7684888				2022-12-18	WOS:A1993LG13300017
J	KAMINO, K; ORR, HT; PAYAMI, H; WIJSMAN, EM; ALONSO, ME; PULST, SM; ANDERSON, L; ODAHL, S; NEMENS, E; WHITE, JA; SADOVNICK, AD; BALL, MJ; KAYE, J; WARREN, A; MCINNIS, M; ANTONARAKIS, SE; KORENBERG, JR; SHARMA, V; KUKULL, W; LARSON, E; HESTON, LL; MARTIN, GM; BIRD, TD; SCHELLENBERG, GD				KAMINO, K; ORR, HT; PAYAMI, H; WIJSMAN, EM; ALONSO, ME; PULST, SM; ANDERSON, L; ODAHL, S; NEMENS, E; WHITE, JA; SADOVNICK, AD; BALL, MJ; KAYE, J; WARREN, A; MCINNIS, M; ANTONARAKIS, SE; KORENBERG, JR; SHARMA, V; KUKULL, W; LARSON, E; HESTON, LL; MARTIN, GM; BIRD, TD; SCHELLENBERG, GD			LINKAGE AND MUTATIONAL ANALYSIS OF FAMILIAL ALZHEIMER-DISEASE KINDREDS FOR THE APP GENE REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; HEREDITARY CEREBRAL-HEMORRHAGE; MESSENGER-RNA; DUTCH TYPE; REPEAT POLYMORPHISM; LOCUS; MARKERS; HETEROGENEITY; CHROMOSOME-21; DEMENTIA	A large number of familial Alzheimer disease (FAD) kindreds were examined to determine whether mutations in the amyloid precursor protein (APP) gene could be responsible for the disease. Previous studies have identified three mutations at APP codon 717 which are pathogenic for Alzheimer disease (AD). Samples from affected subjects were examined for mutations in exons 16 and 17 of the APP gene. A combination of direct sequencing and single-strand conformational polymorphism analysis was used. Sporadic AD and normal controls were also examined by the same methods. Five sequence variants were identified. One variant at APP codon 693 resulted in a Glu-->Gly change. This is the same codon as the hereditary cerebral hemorrhage with amyloidosis-Dutch type Glu-->Gln mutation. Another single-base change at APP codon 708 did not alter the amino acid encoded at this site. Two point mutations and a 6-bp deletion were identified in the intronic sequences surrounding exon 17. None of the variants could be unambiguously determined to be responsible for FAD. The larger families were also analyzed by testing for linkage of FAD to a highly polymorphic short tandem repeat marker (D21S210) that is tightly linked to APP. Highly negative LOD scores were obtained for the family groups tested, and linkage was formally excluded beyond theta = .10 for the Volga German kindreds, theta = .20 for early-onset non-Volga Germans, and theta = .10 for late-onset families. LOD scores for linkage of FAD to markers centromeric to APP (D21S1/S11, D21S13, and D21S215) were also negative in the three family groups. These studies show that APP mutations account for AD in only a small fraction of FAD kindreds.	UNIV WASHINGTON,DIV NEUROL,SEATTLE,WA 98195; UNIV WASHINGTON,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; VET ADM MED CTR,DIV NEUROL,SEATTLE,WA 98108; WASHINGTON INST MENT ILLNESS RES & TRAINING,STEILACOOM,WA; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PSYCHIAT,MINNEAPOLIS,MN 55455; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DIV NEUROPATHOL,PORTLAND,OR 97201; NATL INST NEUROL & NEUROSURG,MEXICO CITY,MEXICO; UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,DIV NEUROL,LOS ANGELES,CA 90048; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of British Columbia; Johns Hopkins University			Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Kukull, Walter/0000-0001-8761-9014; Kaye, Jeffrey/0000-0002-9971-3478; Orr, Harry/0000-0001-6118-741X	NIA NIH HHS [AG08017, AG05136, AG06781] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG008017, P50AG005136, U01AG006781] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; CHARTIERHARLIN MC, 1991, NEUROSCI LETT, V129, P134, DOI 10.1016/0304-3940(91)90738-F; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; COOK RH, 1979, NEUROLOGY, V29, P1402, DOI 10.1212/WNL.29.10.1402; CRAWFORD F, 1991, NEUROSCI LETT, V133, P1, DOI 10.1016/0304-3940(91)90042-R; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOUDSMIT J, 1981, J NEUROL SCI, V49, P79, DOI 10.1016/0022-510X(81)90190-8; GUO Z, 1990, NUCLEIC ACIDS RES, V18, P4967, DOI 10.1093/nar/18.16.4967-a; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAAN J, 1990, ARCH NEUROL-CHICAGO, V47, P649, DOI 10.1001/archneur.1990.00530060059018; HAAN J, 1990, ARCH NEUROL-CHICAGO, V47, P965, DOI 10.1001/archneur.1990.00530090035010; HESTON LL, 1991, AM J MED GENET, V40, P449, DOI 10.1002/ajmg.1320400415; HODGE SE, 1983, AM J HUM GENET, V35, P1139; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMAIRE HG, 1989, NUCLEIC ACIDS RES, V17, P517, DOI 10.1093/nar/17.2.517; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORTON NE, 1956, AM J HUM GENET, V8, P80; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; SCHELLENBERG GD, 1991, AM J HUM GENET, V49, P511; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SCHELLENBERG GD, 1992, ANN NEUROL, V31, P223, DOI 10.1002/ana.410310214; SHARMA V, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67-a; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STINISSEN P, 1991, NUCLEIC ACIDS RES, V19, P5089, DOI 10.1093/nar/19.18.5089; TANZI RE, 1991, NATURE, V350, P564, DOI 10.1038/350564a0; TANZI RE, 1992, AM J HUM GENET, V50, P551; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1991, J BIOL CHEM, V266, P20579; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; VALENCIA LG, 1986, REV INVEST CLIN, V38, P261; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; WARREN AC, 1992, GENOMICS, V13, P1365, DOI 10.1016/0888-7543(92)90072-Z; WARREN AC, UNPUB D21S210 CLOSEL; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	49	238	258	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					998	1014						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415269				2022-12-18	WOS:A1992JU84000010
J	Hoopes, RR; Shrimpton, AE; Knohl, SJ; Hueber, P; Hoppe, B; Matyus, J; Simckes, A; Tasic, V; Toenshoff, B; Suchy, SF; Nussbaum, RL; Scheinman, SJ				Hoopes, RR; Shrimpton, AE; Knohl, SJ; Hueber, P; Hoppe, B; Matyus, J; Simckes, A; Tasic, V; Toenshoff, B; Suchy, SF; Nussbaum, RL; Scheinman, SJ			Dent disease with mutations in OCRL1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCULOCEREBRORENAL SYNDROME; CHLORIDE CHANNEL; LOWE-SYNDROME; IMPAIRS ENDOCYTOSIS; RENAL-FAILURE; NEPHROLITHIASIS; 5-PHOSPHATASE; DEFICIENCY; ACTIN; GENE	Dent disease is an X-linked renal proximal tubulopathy associated with mutations in the chloride channel gene CLCN5. Lowe syndrome, a multisystem disease characterized by renal tubulopathy, congenital cataracts, and mental retardation, is associated with mutations in the gene OCRL1, which encodes a phosphatidylinositol 4,5-bisphosphate (PIP2) 5-phosphatase. Genetic heterogeneity has been suspected in Dent disease, but no other gene for Dent disease has been reported. We studied male probands in 13 families, all of whom met strict criteria for Dent disease but lacked mutations in CLCN5. Linkage analysis in the one large family localized the gene to a candidate region at Xq25-Xq27.1. Sequencing of candidate genes revealed a mutation in the OCRL1 gene. Of the 13 families studied, OCRL1 mutations were found in 5. PIP2 5-phosphatase activity was markedly reduced in skin fibroblasts cultured from the probands of these five families, and protein expression, measured by western blotting, was reduced or absent. Slit-lamp examinations performed in childhood or adulthood for all five probands showed normal results. Unlike patients with typical Lowe syndrome, none of these patients had metabolic acidosis. Three of the five probands had mild mental retardation, whereas two had no developmental delay or behavioral disturbance. These findings demonstrate that mutations in OCRL1 can occur with the isolated renal phenotype of Dent disease in patients lacking the cataracts, renal tubular acidosis, and neurological abnormalities that are characteristic of Lowe syndrome. This observation confirms genetic heterogeneity in Dent disease and demonstrates more-extensive phenotypic heterogeneity in Lowe syndrome than was previously appreciated. It establishes that the diagnostic criteria for disorders resulting from mutations in the Lowe syndrome gene OCRL1 need to be revised.	SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA; Univ Cologne, Cologne, Germany; Univ Debrecen, Sch Med, H-4012 Debrecen, Hungary; Childrens Mercy Hosp, Kansas City, MO 64108 USA; Univ Childrens Hosp, Skopje, North Macedonia; Univ Childrens Hosp, Heidelberg, Germany; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Cologne; University of Debrecen; Children's Mercy Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Scheinman, SJ (corresponding author), SUNY Upstate Med Univ, Dept Med, 1257 Weiskotten Hall,750 E Adams St, Syracuse, NY 13210 USA.	scheinms@upstate.edu	Tasic, Velibor/H-8714-2019	Tasic, Velibor/0000-0002-3377-1245	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000040, Z01HG200333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063936] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK063936, DK063936] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; CHARNAS LR, 1991, NEW ENGL J MED, V324, P1318, DOI 10.1056/NEJM199105093241904; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; Dressman MA, 2000, J HISTOCHEM CYTOCHEM, V48, P179, DOI 10.1177/002215540004800203; FRYMOYER PA, 1991, NEW ENGL J MED, V325, P681, DOI 10.1056/NEJM199109053251003; Hoopes RR, 2004, KIDNEY INT, V65, P1615, DOI 10.1111/j.1523-1755.2004.00571.x; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x; Nussbaum R., 2001, METABOLIC MOL BASIS, V4, P6257; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Roschinger W, 2000, MOL GENET METAB, V69, P213, DOI 10.1006/mgme.1999.2955; Scheinman SJ, 2000, GENETICS OF OSTEOPOROSIS AND METABOLIC BONE DISEASE, P133; Scheinman SJ, 1998, KIDNEY INT, V53, P3, DOI 10.1046/j.1523-1755.1998.00718.x; Shrimpton AE, 1999, AM J MED GENET, V84, P293, DOI 10.1002/(SICI)1096-8628(19990528)84:3<293::AID-AJMG26>3.0.CO;2-U; SLIMAN GA, 1995, J UROLOGY, V153, P1244, DOI 10.1016/S0022-5347(01)67575-X; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; WRONG OM, 1994, Q J MED, V87, P473	24	237	245	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					260	267		10.1086/427887	http://dx.doi.org/10.1086/427887			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15627218	Green Published, Bronze			2022-12-18	WOS:000226215100011
J	Weston, MD; Luijendijk, MWJ; Humphrey, KD; Moller, C; Kimberling, WJ				Weston, MD; Luijendijk, MWJ; Humphrey, KD; Moller, C; Kimberling, WJ			Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CALCIUM-CHANNEL BLOCKER; RETINITIS-PIGMENTOSA; PHOTORECEPTOR RESCUE; COUPLED RECEPTOR; HAIR-CELLS; INNER-EAR; RD MOUSE; LOCALIZATION; DOMAIN; HARMONIN	Usher syndrome type II (USH2) is a genetically heterogeneous autosomal recessive disorder with at least three genetic subtypes (USH2A, USH2B, and USH2C) and is classified phenotypically as congenital hearing loss and progressive retinitis pigmentosa. The VLGR1 (MASS1) gene in the 5q14.3-q21.1 USH2C locus was considered a likely candidate on the basis of its protein motif structure and expressed-sequence-tag representation from both cochlear and retinal subtracted libraries. Denaturing high-performance liquid chromatography and direct sequencing of polymerase-chain-reaction products amplified from 10 genetically independent patients with USH2C and 156 other patients with USH2 identified four isoform-specific VLGR1 mutations (Q2301X, I2906FS, M2931FS, and T6244X) from three families with USH2C, as well as two sporadic cases. All patients with VLGR1 mutations are female, a significant deviation from random expectations. The ligand(s) for the VLGR1 protein is unknown, but on the basis of its potential extracellular and intracellular protein-protein interaction domains and its wide mRNA expression profile, it is probable that VLGR1 serves diverse cellular and signaling processes. VLGR1 mutations have been previously identified in both humans and mice and are associated with a reflex-seizure phenotype in both species. The identification of additional VLGR1 mutations to test whether a phenotype/genotype correlation exists, akin to that shown for other Usher syndrome disease genes, is warranted.	Boys Town Natl Res Hosp, Dept Genet, Ctr Study & Treatment Usher Syndrome, Omaha, NE 68131 USA; Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; Creighton Univ, Dept Biol, Omaha, NE 68178 USA; Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands; Sahlgrens Univ Hosp, Dept Audiol, Gothenburg, Sweden	Boys Town National Research Hospital; Creighton University; Creighton University; Radboud University Nijmegen; Sahlgrenska University Hospital	Kimberling, WJ (corresponding author), Boys Town Natl Res Hosp, Dept Genet, Ctr Study & Treatment Usher Syndrome, 555 N 30th St, Omaha, NE 68131 USA.	kimber@boystown.org			NIDCD NIH HHS [5P01 DC01813-08] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510; Bhattacharya G, 2002, HEARING RES, V163, P1, DOI 10.1016/S0378-5955(01)00344-6; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Burgess DL, 2001, NEURON, V31, P507, DOI 10.1016/S0896-6273(01)00400-7; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Foord SM, 2002, BIOCHEM SOC T, V30, P473, DOI 10.1042/bst0300473; Frasson M, 1999, NAT MED, V5, P1183, DOI 10.1038/13508; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Heinrich UR, 1999, ORL J OTO-RHINO-LARY, V61, P321, DOI 10.1159/000027693; Hmani M, 1999, EUR J HUM GENET, V7, P363, DOI 10.1038/sj.ejhg.5200307; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Maurer J, 1998, J La State Med Soc, V150, P400; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Mustapha M, 2002, HUM GENET, V110, P348, DOI 10.1007/s00439-002-0690-x; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Pasantes-Morales H, 2002, METAB BRAIN DIS, V17, P183, DOI 10.1023/A:1019926122125; Pawlyk BS, 2002, INVEST OPHTH VIS SCI, V43, P1912; Pieke-Dahl S, 2000, J MED GENET, V37, P256, DOI 10.1136/jmg.37.4.256; Pons T, 2003, CURR MED CHEM, V10, P505, DOI 10.2174/0929867033368204; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Wayne S, 1997, AM J HUM GENET, V61, pA300; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	49	237	245	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					357	366		10.1086/381685	http://dx.doi.org/10.1086/381685			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14740321	Bronze, Green Published			2022-12-18	WOS:000188860000016
J							Cystic Fibrosis Genetic Anal Consortium	WORLDWIDE SURVEY OF THE DELTA-F508 MUTATION - REPORT FROM THE CYSTIC-FIBROSIS GENETIC-ANALYSIS CONSORTIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter													Savoia, Anna/B-6463-2014	Savoia, Anna/0000-0002-2407-2696				BALLABIO A, 1990, NATURE, V343, P220, DOI 10.1038/343220a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; ROMMENS J, 1990, AM J HUM GENET, V46, P395	3	237	243	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					354	359						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378364				2022-12-18	WOS:A1990DT87100028
J	Zhang, L; Zhou, Y; Cheng, CX; Cui, HY; Cheng, L; Kong, PZ; Wang, JQ; Li, Y; Chen, WL; Song, B; Wang, F; Jia, ZW; Li, L; Li, YP; Yang, B; Liu, J; Shi, RY; Bi, YH; Zhang, YY; Wang, J; Zhao, ZX; Hu, XL; Yang, J; Li, HY; Gao, ZB; Chen, G; Huang, XL; Yang, XK; Wan, SQ; Chen, C; Li, B; Tan, YK; Chen, LY; He, MH; Xie, S; Li, XC; Zhuang, XH; Wang, MY; Xia, Z; Luo, LH; Ma, J; Dong, B; Zhao, JZ; Song, YM; Ou, YW; Li, EM; Xu, LY; Wang, JF; Xi, YF; Li, GD; Xu, EW; Liang, JF; Yang, XF; Guo, JS; Chen, X; Zhang, YB; Li, QS; Liu, LX; Li, YR; Zhang, XQ; Yang, HM; Lin, DX; Cheng, XL; Guo, YJ; Wang, J; Zhan, QM; Cui, YP				Zhang, Ling; Zhou, Yong; Cheng, Caixia; Cui, Heyang; Cheng, Le; Kong, Pengzhou; Wang, Jiaqian; Li, Yin; Chen, Wenliang; Song, Bin; Wang, Fang; Jia, Zhiwu; Li, Lin; Li, Yaoping; Yang, Bin; Liu, Jing; Shi, Ruyi; Bi, Yanghui; Zhang, Yanyan; Wang, Juan; Zhao, Zhenxiang; Hu, Xiaoling; Yang, Jie; Li, Hongyi; Gao, Zhibo; Chen, Gang; Huang, Xuanlin; Yang, Xukui; Wan, Shengqing; Chen, Chao; Li, Bin; Tan, Yongkai; Chen, Longyun; He, Minghui; Xie, Sha; Li, Xiangchun; Zhuang, Xuehan; Wang, Mengyao; Xia, Zhi; Luo, Longhai; Ma, Jie; Dong, Bing; Zhao, Jiuzhou; Song, Yongmei; Ou, Yunwei; Li, Enming; Xu, Liyan; Wang, Jinfen; Xi, Yanfeng; Li, Guodong; Xu, Enwei; Liang, Jianfang; Yang, Xiaofeng; Guo, Jiansheng; Chen, Xing; Zhang, Yanbo; Li, Qingshan; Liu, Lixin; Li, Yingrui; Zhang, Xiuqing; Yang, Huanming; Lin, Dongxin; Cheng, Xiaolong; Guo, Yongjun; Wang, Jun; Zhan, Qimin; Cui, Yongping			Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOMATIC MUTATIONS; HUMAN CANCER; WIDE ASSOCIATION; BREAST; DNA; DIFFERENTIATION; SUSCEPTIBILITY; IDENTIFICATION; ARCHITECTURE; POPULATION	Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers world wide and the fourth most lethal cancer in China. However, although genomic studies have identified some mutations associated with ESCC, we know little of the mutational processes responsible. To identify genome-wide mutational signatures, we performed either whole-genome sequencing (WGS) or whole-exome sequencing (WES) on 104 ESCC individuals and combined our data with those of 88 previously reported samples. An APOBEC-mediated mutational signature in 47% of 192 tumors suggests that APOBEC-catalyzed deamination provides a source of DNA damage in ESCC. Moreover, PIK3CA hotspot mutations (c.1624G> A [p.Glu542Lys] and c.1633G>A [p.Glu545Lys]) were enriched in APOBEC-signature tumors, and no smoking associated signature was observed in ESCC. In the samples analyzed by WGS, we identified focal (<100 kb) amplifications of CBX4 and CBX8. In our combined cohort, we identified frequent in activating mutations in AJUBA, ZNF750, and PTCH1 and the chromatin-remodeling genes CREBBP and BAP1, in addition to known mutations. Functional analyses suggest roles for several genes (CBX4, CBX8, AJUBA, and ZNF750) in ESCC. Notably, high activity of hedgehog signaling and the PI3K pathway in approximately 60% of 104 ESCC tumors indicates that therapies targeting these pathways might be particularly promising strategies for ESCC. Collectively, our data provide comprehensive insights into the mutational signatures of ESCC and identify markers for early diagnosis and potential therapeutic targets.	[Zhang, Ling; Cheng, Caixia; Cui, Heyang; Kong, Pengzhou; Song, Bin; Wang, Fang; Jia, Zhiwu; Li, Yaoping; Yang, Bin; Liu, Jing; Shi, Ruyi; Bi, Yanghui; Zhang, Yanyan; Wang, Juan; Zhao, Zhenxiang; Hu, Xiaoling; Yang, Jie; Li, Hongyi; Cheng, Xiaolong; Cui, Yongping] Shanxi Med Univ, Translat Med Res Ctr, Taiyuan 030001, Shanxi, Peoples R China; [Zhang, Ling; Cheng, Caixia; Cui, Heyang; Kong, Pengzhou; Song, Bin; Wang, Fang; Jia, Zhiwu; Shi, Ruyi; Bi, Yanghui; Wang, Juan; Zhao, Zhenxiang; Hu, Xiaoling; Yang, Jie; Li, Hongyi; Cheng, Xiaolong; Cui, Yongping] Shanxi Med Univ, Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Shanxi, Peoples R China; [Zhou, Yong; Cui, Heyang; Wang, Jiaqian; Chen, Wenliang; Li, Lin; Gao, Zhibo; Chen, Gang; Huang, Xuanlin; Yang, Xukui; Wan, Shengqing; Chen, Chao; Li, Bin; Tan, Yongkai; Chen, Longyun; He, Minghui; Xie, Sha; Li, Xiangchun; Zhuang, Xuehan; Wang, Mengyao; Xia, Zhi; Luo, Longhai; Li, Yingrui; Zhang, Xiuqing; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Cheng, Caixia; Liang, Jianfang] Shanxi Med Univ, Hosp 1, Dept Pathol, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, Le] BGI Yunnan, Kunming 650000, Yunnan, Peoples R China; [Li, Yin] Henan Canc Hosp, Dept Thorac Surg, Zhengzhou 450008, Henan, Peoples R China; [Li, Yaoping; Yang, Bin] Shanxi Canc Hosp, Dept Tumor Surg, Taiyuan 030001, Shanxi, Peoples R China; [Zhang, Yanyan; Guo, Jiansheng] Shanxi Med Univ, Hosp 1, Dept Gen Surg, Taiyuan 030001, Shanxi, Peoples R China; [Ma, Jie; Dong, Bing; Zhao, Jiuzhou; Guo, Yongjun] Henan Canc Hosp, Dept Mol Pathol, Zhengzhou 450008, Henan, Peoples R China; [Song, Yongmei; Ou, Yunwei; Lin, Dongxin; Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Song, Yongmei; Ou, Yunwei; Lin, Dongxin; Zhan, Qimin] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Song, Yongmei; Ou, Yunwei; Lin, Dongxin; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Enming; Xu, Liyan] Shantou Univ, Inst Oncol Pathol, Coll Med, Shantou 515041, Peoples R China; [Wang, Jinfen; Xi, Yanfeng; Li, Guodong; Xu, Enwei] Shanxi Canc Hosp, Dept Pathol, Taiyuan 030001, Shanxi, Peoples R China; [Yang, Xiaofeng] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan 030001, Shanxi, Peoples R China; [Chen, Xing] Shanxi Prov Peoples Hosp, Dept Endoscopy, Taiyuan 030001, Shanxi, Peoples R China; [Zhang, Yanbo] Shanxi Med Univ, Dept Stat, Taiyuan 030001, Shanxi, Peoples R China; [Li, Qingshan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan 030001, Shanxi, Peoples R China; [Liu, Lixin] Shanxi Med Univ, Hosp 1, Expt Ctr Sci & Res, Taiyuan 030001, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Beijing Genomics Institute (BGI); Shanxi Medical University; Beijing Genomics Institute (BGI); Zhengzhou University; Shanxi Medical University; Zhengzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shantou University; Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Cui, YP (corresponding author), Shanxi Med Univ, Translat Med Res Ctr, Taiyuan 030001, Shanxi, Peoples R China.	zhanqimin@pumc.edu.cn; cuiy0922@yahoo.com	xu, li/GNH-3667-2022; Li, Yingrui/K-1064-2015; Wang, Jiaqian/AHA-3427-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	song, yongmei/0000-0002-7789-0158; Guo, Yongjun/0000-0003-1641-2969; ZHOU, Yong/0000-0002-4197-7809; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Lin, Dongxin/0000-0002-8723-8868	973 National Fundamental Research Program of China [2015CB553904]; National Natural Science Foundation of China [81021061, 81230047, 81330063, 81272189, 81272694, 81201956, 81402342]; Chinese Ministry of Education [NO213005A]; Specialized Research Fund for the Doctoral Program of Higher Education [20121417110001]; Shanxi Scholarship Council of China [2013-053]; Innovative Team in Science AMP; Technology of Shanxi [2013131023]; Program for the Outstanding Innovative Teams of Higher Learning Institutions of Shanxi	973 National Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanxi Scholarship Council of China; Innovative Team in Science AMP; Technology of Shanxi; Program for the Outstanding Innovative Teams of Higher Learning Institutions of Shanxi	This work was supported by funding from the 973 National Fundamental Research Program of China (2015CB553904 to Q.Z.), the National Natural Science Foundation of China (81021061 and 81230047 to Q.Z., 81330063 and 81272189 to Y.C., 81272694 to X. Cheng, 81201956 to J.L., and 81402342 to L.Z.), the Key Project of Chinese Ministry of Education (NO213005A to Y.C.), the Specialized Research Fund for the Doctoral Program of Higher Education (20121417110001 to Y.C.), a research project supported by the Shanxi Scholarship Council of China (2013-053 to Y.C.), the Innovative Team in Science & Technology of Shanxi (2013131023 to Y.C.), and the Program for the Outstanding Innovative Teams of Higher Learning Institutions of Shanxi (to Y.C.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Caval V, 2014, MOL BIOL EVOL, V31, P330, DOI 10.1093/molbev/mst195; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; Duan FJ, 2013, CANCER EPIDEMIOL, V37, P647, DOI 10.1016/j.canep.2013.04.009; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Fang Y, 2011, ASIAN PAC J CANCER P, V12, P1861; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gen Y, 2013, CANCER SCI, V104, P810, DOI 10.1111/cas.12155; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hoogstraat M, 2014, GENOME RES, V24, P200, DOI 10.1101/gr.161026.113; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Iwaya T, 1998, GASTROENTEROLOGY, V114, P1206, DOI 10.1016/S0016-5085(98)70426-3; James V, 2010, P NATL ACAD SCI USA, V107, P12499, DOI 10.1073/pnas.0914987107; Jia PL, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-11; Jiang Shoulei, 2010, Hormones & Cancer, V1, P11, DOI 10.1007/s12672-010-0006-x; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Lal S, 2012, J NEUROSCI RES, V90, P769, DOI 10.1002/jnr.22794; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080970; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu J, 2013, ONCOGENE, V32, P713, DOI 10.1038/onc.2012.94; Liu YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094136; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pandey A, 2014, WORLD J GASTROENTERO, V20, P6860, DOI 10.3748/wjg.v20.i22.6860; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Waters TR, 2000, MUTAT RES-REV MUTAT, V462, P137, DOI 10.1016/S1383-5742(00)00031-4; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang L, 2013, CANCER LETT, V337, P125, DOI 10.1016/j.canlet.2013.05.029	50	236	254	2	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					597	611		10.1016/j.ajhg.2015.02.017	http://dx.doi.org/10.1016/j.ajhg.2015.02.017			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25839328	Green Published, hybrid			2022-12-18	WOS:000352212600007
J	WALLACE, DC				WALLACE, DC			1994 WILLIAM-ALLAN-AWARD ADDRESS - MITOCHONDRIAL-DNA VARIATION IN HUMAN-EVOLUTION, DEGENERATIVE DISEASE, AND AGING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; KEARNS-SAYRE SYNDROME; ENDONUCLEASE CLEAVAGE PATTERNS; TRANSFER RNALEU(UUR) GENE; MARROW PANCREAS SYNDROME; LARGE RIBOSOMAL-RNA; HUMAN Y-CHROMOSOME; HUMAN CELL-LINES; CHLORAMPHENICOL RESISTANCE; MITOTIC SEGREGATION				WALLACE, DC (corresponding author), EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,1462 CLIFTON RD NE,ATLANTA,GA 30322, USA.				NIGMS NIH HHS [GM46915] Funding Source: Medline; NINDS NIH HHS [NS30164, NS21328] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS030164] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BALLINGER SW, 1992, GENETICS, V130, P139; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; BLANC H, 1981, P NATL ACAD SCI-BIOL, V78, P3789, DOI 10.1073/pnas.78.6.3789; BLANC H, 1981, NUCLEIC ACIDS RES, V9, P5785, DOI 10.1093/nar/9.21.5785; BLANC H, 1983, AM J HUM GENET, V35, P167; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099; BROWN MD, IN PRESS HUM MUTAT; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BUNN CL, 1977, SOMAT CELL GENET, V3, P71, DOI 10.1007/BF01550988; BUNN CL, 1974, P NATL ACAD SCI USA, V71, P1681, DOI 10.1073/pnas.71.5.1681; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASE JT, 1981, SOMAT CELL GENET, V7, P103, DOI 10.1007/BF01544751; CHEN YS, 1995, AM J HUM GENET, V57, P133; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Cortopassi G. A., 1994, American Journal of Human Genetics, V55, pA149; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319; DIRENZO A, 1991, P NATL ACAD SCI US, V88, P1597; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HEDGES SB, 1991, SCIENCE, V255, P737; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORTON TM, IN PRESS NEUROLOGY; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KEARSEY SE, 1981, NATURE, V290, P607, DOI 10.1038/290607a0; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LUCOTTE G, 1989, AM J HUM GENET, V45, P16; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; NEI M, 1983, GENETICS, V105, P207; NEWMAN NJ, 1994, AM J OPHTHALMOL, V118, P158, DOI 10.1016/S0002-9394(14)72895-8; NGO KY, 1986, AM J HUM GENET, V38, P407; NOVOTNY EJ, 1986, NEUROLOGY, V36, P1053, DOI 10.1212/WNL.36.8.1053; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; ORTIZ RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1525, DOI 10.1001/archopht.1993.01090110091031; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; POULTON J, 1994, NAT GENET, V8, P313, DOI 10.1038/ng1294-313; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; ROTIG A, 1989, LANCET, V1, P902; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTACHIARABENE.AS, 1993, ANN HUM GENET, V57, P55; SANTOS M, 1994, AM J HUM GENET, V55, P413; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535; SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SHOFFNER JM, 1995, NEUROLOGY, V44, P286; SHOFFNER JM, 1995, IN PRESS ANN NEUROL; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SOONG NW, 1992, NAT GENET, V2, P318; SPURDLE A, 1991, AM J HUM GENET, V50, P107; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; STONEKING M, 1990, GENETICS, V124, P717; Swofford D.L., 1993, PHYLOGENIC ANAL USIN; SZATHMARY E J E, 1984, Acta Anthropogenetica, V8, P79; TATENO Y, 1982, J MOL EVOL, V18, P387, DOI 10.1007/BF01840887; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1995, AM J HUM GENET, V56, P1234; TORRONI A, 1995, HUM MUTAT, V5, P310, DOI 10.1002/humu.1380050407; TORRONI A, 1990, ANN HUM GENET, V54, P287; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; TURNER CG, 1987, AM J PHYS ANTHROPOL, V73, P305, DOI 10.1002/ajpa.1330730304; Turner II C. G., 1983, EARLY MAN NEW WORLD, P147; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WALLACE DC, 1977, SOMAT CELL GENET, V3, P93, DOI 10.1007/BF01550989; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1994, EPILEPSIA, V35, pS43, DOI 10.1111/j.1528-1157.1994.tb05928.x; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1981, MOL CELL BIOL, V1, P697, DOI 10.1128/MCB.1.8.697; WALLACE DC, 1982, MICROBIOL REV, V46, P208, DOI 10.1128/MMBR.46.2.208-240.1982; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WALLACE DC, 1975, J CELL BIOL, V67, P174, DOI 10.1083/jcb.67.1.174; WALLACE DC, 1992, HUM BIOL, V64, P403; WALLACE DC, 1995, E COMMUNICATION; WALLACE DC, 1992, MITOCHONDRIAL DNA HU, P63; WALLACE DC, IN PRESS MOL ASPECTS; Wallace DC, 1982, TECHNIQUES SOMATIC C, P159; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	125	236	257	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					201	223						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	RL771	7668244				2022-12-18	WOS:A1995RL77100001
J	KAMBOH, MI; FERRELL, RE; KOTTKE, BA				KAMBOH, MI; FERRELL, RE; KOTTKE, BA			EXPRESSED HYPERVARIABLE POLYMORPHISM OF APOLIPOPROTEIN (A)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LP(A) GLYCOPROTEIN PHENOTYPES; CORONARY HEART-DISEASE; RISK FACTOR; QUANTITATIVE LP(A); MYOCARDIAL-INFARCTION; LIPOPROTEIN TRAIT; MESSENGER-RNA; PLASMA LP(A); PLASMINOGEN; GENETICS	Elevated plasma lipoprotein (a) (LP(a)) levels are an independent predictor of the development of premature atherosclerosis in humans. The LP(a) particle consists of two disulfide-linked proteins, apolipoprotein (APO) B and APO(a). The APO(a) is a highly glycosylated protein which carries the LP(a) antigen. Genetic polymorphism in the APO(a) molecule has been reported, and, depending on the sensitivity of the method used, 6-11 alleles at the APO(a) structural locus have been documented in the literature. In this investigation, we have used a high-resolution SDS-agarose electrophoresis method followed by immunoblotting to screen APO(a) polymorphism in 54 families with 130 offspring. This method identified a total of 23 different APO(a) isoforms, and their genetic basis was confirmed in families. In addition to the detectable products of 23 APO(a) alleles, the family data predict the existence of a "null" allele. Of the total 270 individuals tested, 209 (77.4%) revealed double-banded phenotypes and 61 (22.6%) revealed single-banded phenotypes. In the unrelated sample of 140 individuals, however, 114 (81.4%) and 26 (18.6%) had double- and single-banded phenotypes, respectively. When the segregation pattern of single-banded phenotypes in the unrelated sample was followed in families, only nine (6.4%) were found to be true homozygotes, and the remaining 17 (12.2%) were classified as heterozygotes for the null allele. Of the 276 possible phenotypes predicted for 23 alleles in a large population, we observed 115 (42%) phenotypes in our restricted sample. On the basis of our results from the family data, we hypothesize the existence of at least 24 alleles, including a null allele, at the APO(a) structural locus. The calculated frequencies of the APO(a)*N (null) and APO(a)*1-APO(a)*23 alleles in the unrelated sample are as follows: N = 6.1%; 1 = 0.7%; 2 = 4.3%; 3 = 1.4%; 4 = 6.1%; 5 = 8.9%; 6 = 4.3%; 7 = 2.5%; 8 = 11.8%; 9 = 3.9%; 10 = 9.3%; 11 = 4.6%; 12 = 2.9%; 13 = 5.7%; 14 = 2.1%; 15 = 8.2%; 16 = 3.2%; 17 = 5.4%; 18 = 4.6%; 19 = 1.4%; 20 = 0.4%; 21 = 0.4%; 22 = 1.4%; and 23 = 0.4%. The average heterozygosity at the APO(a) structural locus was 94%, which is the highest value for any protein polymorphism reported to date.	MAYO CLIN & MAYO FDN,DIV CARDIOVASC DIS,ROCHESTER,MN 55905	Mayo Clinic	KAMBOH, MI (corresponding author), UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15261, USA.			Kamboh, M. Ilyas/0000-0002-3453-1438	NHLBI NIH HHS [HL24489, HL39107, HL44672] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489, R01HL039107, R01HL044672] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1977, J LIPID RES, V18, P331; ARMSTRONG VW, 1986, ATHEROSCLEROSIS, V62, P249, DOI 10.1016/0021-9150(86)90099-7; BERG K, 1983, PROG MED GENET, V5, P35; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; BROWN MS, 1987, NATURE, V330, P113, DOI 10.1038/330113a0; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; DRAYNA DT, 1988, GENOMICS, V3, P230, DOI 10.1016/0888-7543(88)90084-5; DURRINGTON PN, 1988, LANCET, V1, P1070; EATON DL, 1987, P NATL ACAD SCI USA, V84, P3224, DOI 10.1073/pnas.84.10.3224; FLESS GM, 1986, J BIOL CHEM, V261, P8712; GAUBATZ JW, 1990, J LIPID RES, V31, P603; GONZALEZGRONOW M, 1989, BIOCHEMISTRY-US, V28, P2374, DOI 10.1021/bi00432a005; HAJJAR KA, 1989, NATURE, V339, P303, DOI 10.1038/339303a0; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3846; HASSTEDT SJ, 1983, AM J MED GENET, V16, P179, DOI 10.1002/ajmg.1320160208; HASSTEDT SJ, 1986, GENET EPIDEMIOL, V3, P53, DOI 10.1002/gepi.1370030106; HIXSON JE, 1989, J BIOL CHEM, V264, P6013; HOEFLER G, 1988, ARTERIOSCLEROSIS, V8, P398, DOI 10.1161/01.ATV.8.4.398; JURGENS G, 1987, NEUROLOGY, V37, P513, DOI 10.1212/WNL.37.3.513; KOSCHINSKY ML, 1990, BIOCHEMISTRY-US, V29, P640, DOI 10.1021/bi00455a007; KRAFT HG, 1988, ARTERIOSCLEROSIS, V8, P212, DOI 10.1161/01.ATV.8.3.212; KRATZIN H, 1987, BIOL CHEM H-S, V368, P1533, DOI 10.1515/bchm3.1987.368.2.1533; LACKNER C, 1990, AM J HUM GENET S, V47, pA225; LINDAHL G, 1989, HUM GENET, V81, P149, DOI 10.1007/BF00293891; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P672, DOI 10.1161/01.ATV.10.5.672; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; MOLL PP, 1989, AM J HUM GENET, V44, P124; MORRISETT JD, 1987, PLASMA LIPOPROTEINS, P129; MORTON N E, 1985, Genetic Epidemiology, V2, P113, DOI 10.1002/gepi.1370020202; MURAI A, 1986, ATHEROSCLEROSIS, V59, P199, DOI 10.1016/0021-9150(86)90048-1; RAINWATER DL, 1989, J LIPID RES, V30, P549; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; SANDKAMP M, 1990, CLIN CHEM, V36, P20; SING CF, 1974, ANN HUM GENET, V38, P47, DOI 10.1111/j.1469-1809.1974.tb01992.x; SWALLOW DM, 1987, NATURE, V328, P82, DOI 10.1038/328082a0; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; UTERMANN G, 1988, HUM GENET, V78, P47, DOI 10.1007/BF00291233; UTERMANN G, 1989, P NATL ACAD SCI USA, V86, P4171, DOI 10.1073/pnas.86.11.4171; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; UTERMANN G, 1988, HUM GENET, V78, P41, DOI 10.1007/BF00291232; WEITKAMP LR, 1988, HUM GENET, V79, P80, DOI 10.1007/BF00291716	44	236	238	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1063	1074						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928089				2022-12-18	WOS:A1991GM87300017
J	BOERWINKLE, E; UTERMANN, G				BOERWINKLE, E; UTERMANN, G			SIMULTANEOUS EFFECTS OF THE APOLIPOPROTEIN-E POLYMORPHISM ON APOLIPOPROTEIN-E, APOLIPOPROTEIN-B, AND CHOLESTEROL-METABOLISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV INNSBRUCK, INST MED BIOL & GENET, A-6020 INNSBRUCK, AUSTRIA	University of Innsbruck	BOERWINKLE, E (corresponding author), UNIV TEXAS, HLTH SCI CTR, CTR DEMOG & POPULAT GENET, HOUSTON, TX 77025 USA.				NCRR NIH HHS [RRO-7148] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BOERWINKLE E, 1986, AM J HUM GENET, V39, P137; BOERWINKLE E, 1987, ANN HUM GENET, V51, P211, DOI 10.1111/j.1469-1809.1987.tb00874.x; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BOUTHILLIER D, 1983, J LIPID RES, V24, P1060; BRESLOW JL, 1982, J BIOL CHEM, V257, P4639; CURRY MD, 1978, CLIN CHEM, V24, P280; EHNHOLM C, 1984, P NATL ACAD SCI-BIOL, V81, P5566, DOI 10.1073/pnas.81.17.5566; ETO M, 1986, CLIN GENET, V29, P477; Falconer D. S., 1981, INTRO QUANTITATIVE G; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; HANIS CL, 1983, AM J HUM GENET, V35, P1196; HUI DY, 1984, J BIOL CHEM, V259, P860; INNERARITY TL, 1978, J BIOL CHEM, V253, P6289; KESANIEMI YA, 1986, ARTERIOSCLEROSIS, V6, pA541; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; MAHLEY RW, 1983, KLIN WOCHENSCHR, V61, P225, DOI 10.1007/BF01496128; MCGUE M, 1983, GENET RES, V42, P117, DOI 10.1017/S0016672300021595; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; NETER J, 1985, APPLIED LINEAR STATI; RALL SC, 1982, J BIOL CHEM, V257, P4171; ROBERTSON FW, 1985, ARTERIOSCLEROSIS, V5, P283, DOI 10.1161/01.ATV.5.3.283; Scheffe H., 1959, ANAL VARIANCE; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; SING CF, 1985, AM J HUM GENET, V37, P268; Sokal R.R., 1981, BIOMETRY, V2nd ed.; Turner HN., 1969, QUANTITATIVE GENETIC; UTERMANN G, 1984, J LIPID RES, V25, P378; UTERMANN G, 1984, HUM GENET, V65, P232, DOI 10.1007/BF00286508; UTERMANN G, 1975, H-S Z PHYSIOL CHEM, V356, P1113, DOI 10.1515/bchm2.1975.356.2.1113; UTERMANN G, 1975, FEBS LETT, V56, P352, DOI 10.1016/0014-5793(75)81125-2; UTERMANN G, 1982, HUM GENET, V60, P344, DOI 10.1007/BF00569216; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; UTERMANN G, 1979, CLIN GENET, V15, P63; UTERMANN G, 1985, DIABETES OBESITY HYP, V3, P1; WARDELL MR, 1982, J LIPID RES, V23, P1174; WEISGRABER KH, 1978, J BIOL CHEM, V253, P6281; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059	38	236	237	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					104	112						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3337104				2022-12-18	WOS:A1988L869700015
J	GERMAN, J				GERMAN, J			BLOOMS SYNDROME .I. GENETICAL AND CLINICAL OBSERVATIONS IN FIRST 27 PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARONSON SM, 1967, INBORN DISORDERS  ED, P431; BLOOM D, 1954, AMA AM J DIS CHILD, V88, P754, DOI 10.1001/archpedi.1954.02050100756008; BLOOM D, 1966, J PEDIATR-US, V68, P103, DOI 10.1016/S0022-3476(66)80426-2; BLOOM D, 1965, MED CLIN N AM, V49, P695, DOI 10.1016/S0025-7125(16)33315-6; BLOOM D, 1954, AMA ARCH DERM SYPH, V69, P526; BLOOM GE, 1966, NEW ENGL J MED, V274, P8, DOI 10.1056/NEJM196601062740102; BLOOM GE, 1965, J PEDIATR-US, V67, P924, DOI 10.1016/S0022-3476(65)81810-8; BRUNSTING LA, 1957, ARCH DERMATOL, V75, P771; BRUTON OC, 1952, PEDIATRICS, V9, P722; CURTH HO, 1964, ARCH DERMATOL, V90, P349; DEFRIAS EC, 1966, B CATEDRA PEDIATR MA, V9, P9; DEGROUCHY J, 1966, ANN INTERN MED, V65, P603, DOI 10.7326/0003-4819-65-3-603; FISCHEL WJ, 1967, ENCYCLOPAEDIA BRITAN, V12, P1078; FITZPATRICK TB, 1962, ARCH DERMATOL, V86, P127; GELLIS SS, 1966, AM J DIS CHILD, V112, P581, DOI 10.1001/archpedi.1966.02090150125015; GERMAN J, 1965, SCIENCE, V148, P506, DOI 10.1126/science.148.3669.506; GERMAN J, 1966, J CELL BIOL, V31, pA38; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GERMAN J, 1966, ANN GENET, V9, P143; GERMAN J, IN PRESS; GERMAN J, 1969, 1 P C DEL CLIN SYNDR; GROPP A, 1967, HUMANGENETIK, V5, P77, DOI 10.1007/BF00286217; HECHT F, 1966, LANCET, V2, P1193; HILLMAN DA, 1957, PEDIATRICS, V20, P268; HOOFT R, 1967, ACTA PAEDIATR BELG, V21, P353; KARN MN, 1951, ANN EUGENIC, V16, P147, DOI 10.1111/j.1469-1809.1951.tb02469.x; KATZENELLENBOGEN I, 1960, Arch Dermatol, V82, P609; KEUTEL J, 1967, Z KINDERHEILKD, V101, P165, DOI 10.1007/BF00439698; LANDAU J, 1966, AM J OPHTHALMOL, V62, P753, DOI 10.1016/0002-9394(66)92204-5; LANDAU JW, 1966, ARCH DERMATOL, V94, P687, DOI 10.1001/archderm.94.6.687; LEWIS B, 1957, AMA ARCH DERMATOL, V75, P772; LI CC, 1968, AM J HUM GENET, V20, P61; LI CC, 1961, HUMAN GENETICS PRINC, pCH5; LI CC, 1966, 1965 P S MUT PROC PR, P155; LOHR GW, 1965, KLIN WOCHENSCHR, V43, P870, DOI 10.1007/BF01711251; LOHR GW, 1965, HUMANGENETIK, V1, P383, DOI 10.1007/BF00273980; MCKUSICK V, 1969, 1 P C DEL CLIN SY ED; MYRIANTHOPOULOS NC, 1967, INBORN DISORDERS SPH, P431; PASSARGE E, IN PRESS; SAWITSKY A, 1965, BLOOD-J HEMATOL, V26, P867; SAWITSKY A, 1966, ANN INTERN MED, V65, P487, DOI 10.7326/0003-4819-65-3-487; SCHMID W, 1965, SCHWEIZ MED WSCHR, V95, P1461; SCHOEN EJ, 1967, AM J DIS CHILD, V113, P594, DOI 10.1001/archpedi.1967.02090200126017; SCHROEDER TM, 1966, HUMANGENETIK, V2, P287, DOI 10.1007/BF00395947; SCHROEDER TM, 1964, HUMANGENETIK, V1, P194, DOI 10.1007/BF00389636; SIZONENKO P, 1967, ARCH FR PEDIATR, V24, P470; SIZONENKO P, 1967, ANN PEDIAT, V14, P640; STEINBERG AG, 1959, J MED EDUC, V34, P315; STRITZLER C, 1966, ARCH DERMATOL, V93, P775; STRITZLER C, 1958, ARCH DERMATOL, V77, P746; SWIFT MR, 1966, ANN INTERN MED, V65, P496, DOI 10.7326/0003-4819-65-3-496; SZALAY GC, 1963, J PEDIATR-US, V62, P686, DOI 10.1016/S0022-3476(63)80038-4; TORRE DP, 1954, AMA ARCH DERM SYPH, V69, P511; WOLF J, 1963, ARCH DERMATOL, V87, P764	54	236	236	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	2					196	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	D3696	5770175				2022-12-18	WOS:A1969D369600009
J	Moore, JH; Williams, SM				Moore, Jason H.; Williams, Scott M.			Epistasis and Its Implications for Personal Genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MULTIFACTOR-DIMENSIONALITY REDUCTION; GENOME-WIDE ASSOCIATION; ANT COLONY OPTIMIZATION; COLLABORATIVE CROSS; GENERAL PEDIGREES; EXPERT KNOWLEDGE; SYSTEMS BIOLOGY; COMPLEX TRAITS; HUMAN-DISEASE; SUSCEPTIBILITY	The widespread availability of high-throughput genotyping technology has opened the door to the era of personal genetics, which brings to consumers the promise of using genetic variations to predict individual susceptibility to common diseases. Despite easy access to commercial personal genetics services, our knowledge of the genetic architecture of common diseases is still very limited and has not yet fulfilled the promise of accurately predicting most people at risk. This is partly because of the complexity of the mapping relationship between genotype and phenotype that is a consequence of epistasis (gene-gene interaction) and other phenomena Such its gene-environment interaction and focus heterogeneity. Unfortunately, these aspects of genetic architecture have not been addressed in most of the genetic association studies that provide the knowledge base for interpreting large-scale genetic association results. We provide here an introductory review of how epistasis can affect human health and disease and how it can be detected in population-based studies. We provide some thoughts oil the implications of epistasis for personal genetics and some recommendations for improving personal genetics in light of this complexity.	[Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Computat Genet Lab, Lebanon, NH 03756 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH 03756 USA; [Moore, Jason H.] Univ New Hampshire, Dept Comp Sci, Durham, NH 03824 USA; [Moore, Jason H.] Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA; [Moore, Jason H.] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Moore, Jason H.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA	Dartmouth College; Dartmouth College; University System Of New Hampshire; University of New Hampshire; University of Vermont; Translational Genomics Research Institute; Brown University; Vanderbilt University; Vanderbilt University	Moore, JH (corresponding author), Dartmouth Med Sch, Dept Genet, Computat Genet Lab, Lebanon, NH 03756 USA.	jason.h.moore@dartmouth.edu	Williams, Scott/Q-4812-2019; Moore, Jason H./AAV-9645-2021	Williams, Scott/0000-0002-4835-9544; Moore, Jason H./0000-0002-5015-1099	National Institutes of Health [AI59694, LM009012, LM010098, HD047447]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059694] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012, R01LM010098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health grants AI59694, LM009012, LM010098, and HD047447. The authors would like to thank two anonymous referees for their thoughtful suggestions.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; [Anonymous], EVOLUTION MODERN SYN; Askland K, 2009, HUM GENET, V125, P63, DOI 10.1007/s00439-008-0600-y; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bateson P, 2002, J GENET, V81, P49, DOI 10.1007/BF02715900; Bateson W., 1909, MENDELS PRINCIPLES H; Brodie Edmund D. III, 2000, P3; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Bush WS, 2006, BIOINFORMATICS, V22, P2173, DOI 10.1093/bioinformatics/btl347; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; CHEVERUD JM, 1995, GENETICS, V139, P1455; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clark AG, 2005, GENOME RES, V15, P1463, DOI 10.1101/gr.4244005; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cordell HJ, 2001, GENETICS, V158, P357; CORDELL HJ, 2009, NAT REV GENET, DOI DOI 10.1038/NRG2S79; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Greene CS, 2008, LECT NOTES COMPUT SC, V5217, P37, DOI 10.1007/978-3-540-87527-7_4; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Greene CS, 2009, LECT NOTES COMPUT SC, V5483, P92, DOI 10.1007/978-3-642-01184-9_9; GREENE CS, 2009, NATURE INSPIRED INFO; GREENE CS, 2009, BIODATA MIN IN PRESS; GREENE CS, 2009, P IEEE C EV COMP, P1289; GREENE CS, 2009, P IEEE C EVOL COMP, P800; Hahn Lance W, 2004, In Silico Biol, V4, P183; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; HOLLANDER W. F., 1955, JOUR HEREDITY, V46, P222; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; *INT CONS BLADD CA, 2009, CANC RES IN PRESS; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Kardia SLR, 2003, AM J PREV MED, V24, P143, DOI 10.1016/S0749-3797(02)00587-1; Kaye J, 2008, HUM MOL GENET, V17, pR180, DOI 10.1093/hmg/ddn253; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kooperberg C, 2001, GENET EPIDEMIOL, V21, pS626, DOI 10.1002/gepi.2001.21.s1.s626; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Lee SY, 2007, BIOINFORMATICS, V23, P2589, DOI 10.1093/bioinformatics/btm396; Lewontin RC, 2006, INT J EPIDEMIOL, V35, P536, DOI 10.1093/ije/dyl070; LEWONTIN RC, 1974, AM J HUM GENET, V26, P400; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; McKinney BA, 2007, BIOINFORMATICS, V23, P2113, DOI 10.1093/bioinformatics/btm317; McKinney Brett A, 2006, Appl Bioinformatics, V5, P77, DOI 10.2165/00822942-200605020-00002; Mei H, 2007, AM J HUM GENET, V81, P1251, DOI 10.1086/522307; Michalewicz Z., 2004, SOLVE IT MODERN HEUR, DOI [10.1007/978-3-662-07807-5, DOI 10.1007/978-3-662-07807-5]; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; MILLER WJ, 1995, BIOSCIENCE, V45, P98, DOI 10.2307/1312612; Miller WJ, 1997, BRAZ J GENET, V20, P663; Millstein J, 2006, AM J HUM GENET, V78, P15, DOI 10.1086/498850; Mitchell TM., 1997, MACH LEARN; Moore JH, 2009, EUR J HUM GENET, V17, P1205, DOI 10.1038/ejhg.2009.39; Moore J. H., 2007, KNOWLEDGE DISCOVERY, P17; Moore JH, 2007, GENET EVOL COMPUT, V4, P11, DOI 10.1007/978-0-387-49650-4_2; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Moore JH, 2007, J CELL PHYSIOL, V213, P365, DOI 10.1002/jcp.21218; Moore JH, 2006, LECT NOTES COMPUT SC, V4193, P969; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2005, MOL GENET METAB, V84, P104, DOI 10.1016/j.ymgme.2004.10.006; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Moore JH, 2004, DISCRETE CONT DYN-B, V4, P275; MOORE JH, 2009, BIOL DATA MINING; Motsinger AA, 2007, PHARMACOGENOMICS, V8, P1229, DOI 10.2217/14622416.8.9.1229; Namkung J, 2009, GENET EPIDEMIOL, V33, P646, DOI 10.1002/gepi.20416; Namkung J, 2009, BIOINFORMATICS, V25, P338, DOI 10.1093/bioinformatics/btn629; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Rea TJ, 2006, PERSPECT BIOL MED, V49, P490, DOI 10.1353/pbm.2006.0063; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; Shriner D, 2007, SCIENCE, V316, P1840; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Sinnott-Armstrong Nicholas A, 2009, BMC Res Notes, V2, P149, DOI 10.1186/1756-0500-2-149; SNYDER LH, 1951, AM J HUM GENET, V3, P1; SNYDER LH, 1935, PRINCIPLES HEREDITY; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Tyler AL, 2009, BIOESSAYS, V31, P220, DOI 10.1002/bies.200800022; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wade MJ, 2001, GENETICA, V112, P59, DOI 10.1023/A:1013316611768; Wade MJ, 2001, TRENDS ECOL EVOL, V16, P498, DOI 10.1016/S0169-5347(01)02213-3; WAHISTEN D, 1990, BEHAV BRAIN SCI, V13, P109; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Weiss KM., 1995, GENETIC VARIATION HU; Wilke R. A., 2008, Current Pharmacogenomics & Personalized Medicine, V6, P150; Wilke RA, 2005, NAT REV DRUG DISCOV, V4, P911, DOI 10.1038/nrd1874; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	123	235	246	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					309	320		10.1016/j.ajhg.2009.08.006	http://dx.doi.org/10.1016/j.ajhg.2009.08.006			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19733727	Green Published, Bronze			2022-12-18	WOS:000270104500001
J	Friedman, JM; Baross, A; Delaney, AD; Ally, A; Arbour, L; Asano, J; Bailey, DK; Barber, S; Birch, P; Brown-John, M; Cao, MQ; Chan, S; Charest, DL; Farnoud, N; Fernandes, N; Flibotte, S; Go, A; Gibson, WT; Holt, RA; Jones, SJM; Kennedy, GC; Krzywinski, M; Langlois, S; Li, HYI; McGillivray, BC; Nayar, T; Pugh, TJ; Rajcan-Separovic, E; Schein, JE; Schnerch, A; Siddiqui, A; Van Allen, MI; Wilson, G; Yong, SL; Zahir, F; Eydoux, P; Marra, MA				Friedman, J. M.; Baross, Agnes; Delaney, Allen D.; Ally, Adrian; Arbour, Laura; Asano, Jennifer; Bailey, Dione K.; Barber, Sarah; Birch, Patricia; Brown-John, Mabel; Cao, Manqiu; Chan, Susanna; Charest, David L.; Farnoud, Noushin; Fernandes, Nicole; Flibotte, Stephane; Go, Anne; Gibson, William T.; Holt, Robert A.; Jones, Steven J. M.; Kennedy, Giulia C.; Krzywinski, Martin; Langlois, Sylvie; Li, Haiyan I.; McGillivray, Barbara C.; Nayar, Tarun; Pugh, Trevor J.; Rajcan-Separovic, Evica; Schein, Jacqueline E.; Schnerch, Angelique; Siddiqui, Asim; Van Allen, Margot I.; Wilson, Gary; Yong, Siu-Li; Zahir, Farah; Eydoux, Patrice; Marra, Marco A.			Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE CONGENITAL-ANOMALIES; COPY-NUMBER; STRUCTURAL VARIATION; ARRAY; POLYMORPHISM; INDIVIDUALS; REARRANGEMENTS; HYBRIDIZATION; DELETIONS; DUPLICATIONS	The cause of mental retardation in one-third to one-half of all affected individuals is unknown. Microscopically detectable chromosomal abnormalities are the most frequently recognized cause, but gain or loss of chromosomal segments that are too small to be seen by conventional cytogenetic analysis has been found to be another important cause. Array-based methods offer a practical means of performing a high-resolution survey of the entire genome for submicroscopic copy-number variants. We studied 100 children with idiopathic mental retardation and normal results of standard chromosomal analysis, by use of whole-genome sampling analysis with Affymetrix GeneChip Human Mapping 100K arrays. We found de novo deletions as small as 178 kb in eight cases, de novo duplications as small as 1.1 Mb in two cases, and unsuspected mosaic trisomy 9 in another case. This technology can detect at least twice as many potentially pathogenic de novo copy-number variants as conventional cytogenetic analysis can in people with mental retardation.	Univ British Columbia, Dept Med Genet, British Columbia Canc Agcy, Vancouver, BC V5Z 1M9, Canada; British Columbia Canc Agcy, Provincial Med Genet Program, Vancouver, BC V5Z 4E6, Canada; British Columbia Canc Agcy, Dept Pathol & Lab Med, Womens & Childrens Hosp, Vancouver, BC V5Z 4E6, Canada; British Columbia Canc Agcy, Gen Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Affymetrix, Santa Clara, CA USA	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; Affymetrix	Friedman, JM (corresponding author), Womens & Childrens Hosp, Med Genet Res Unit, 4500 Oak St,Box 153, Vancouver, BC V6H 3N1, Canada.	frid@interchange.ubc.ca	Marra, Marco A/B-5987-2008; Schein, Jacquie E/G-3674-2015; Langlois, Sylvie/AAR-7978-2021; Holt, Robert A/C-3303-2009; Pugh, Trevor/Y-2535-2019; Zahir, Farah R/AAF-8618-2021; Jones, Steven J/C-3621-2009	Marra, Marco A/0000-0001-7146-7175; Holt, Robert A/0000-0002-7259-1247; Pugh, Trevor/0000-0002-8073-5888; Zahir, Farah R/0000-0002-1810-3505; Jones, Steven J/0000-0003-3394-2208; Armstrong, Linlea/0000-0002-8191-6429; Arbour, Laura/0000-0002-9589-0880; Rajcan-Separovic, Evica/0000-0002-4528-7135; Gibson, William/0000-0002-6552-402X; Flibotte, Stephane/0000-0001-9613-7666; Birch, Patricia/0000-0003-3831-2344; Friedman, Jan/0000-0002-7482-9570				Altug-Teber O, 2005, HUM MUTAT, V26, P153, DOI 10.1002/humu.20198; Ariani F, 2004, HUM MUTAT, V24, P172, DOI 10.1002/humu.20065; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Brooks EM, 2001, MUTAT RES-FUND MOL M, V476, P43, DOI 10.1016/S0027-5107(01)00065-3; Bruce S, 2005, J MED GENET, V42, P847, DOI 10.1136/jmg.2005.032367; Cantu ES, 1996, AM J MED GENET, V62, P330, DOI 10.1002/(SICI)1096-8628(19960424)62:4<330::AID-AJMG1>3.0.CO;2-V; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Descheemaeker MJ, 2004, AM J MED GENET A, V131A, P325, DOI 10.1002/ajmg.a.30346; Devriendt Koen, 2004, Human Genomics, V1, P126; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FORD CE, 1959, LANCET, V1, P711; Fridman C, 2003, AM J MED GENET A, V119A, P180, DOI 10.1002/ajmg.a.20105; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kinning E, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033829; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Ming JRE, 2006, HUM MUTAT, V27, P467, DOI 10.1002/humu.20322; Miyake N, 2006, AM J MED GENET A, V140A, P205, DOI 10.1002/ajmg.a.31098; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Petrij F, 2000, J MED GENET, V37, P168, DOI 10.1136/jmg.37.3.168; POPE AM, 1991, DISABILITY AM NATL A; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Ren Y, 2003, GENES GENET SYST, V78, P93; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Schein Jacqueline, 2004, Methods Mol Biol, V255, P143; Schoumans J, 2005, J MED GENET, V42, P699, DOI 10.1136/jmg.2004.029637; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shelley BP, 2005, J NEUROPSYCH CLIN N, V17, P91, DOI 10.1176/appi.neuropsych.17.1.91; Slater HR, 2005, AM J HUM GENET, V77, P709, DOI 10.1086/497343; Sommer A, 2006, AM J MED GENET A, V140A, P174, DOI 10.1002/ajmg.a.31027; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stoughton RB, 2005, ANNU REV BIOCHEM, V74, P53, DOI 10.1146/annurev.biochem.74.082803.133212; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Tyson C, 2005, AM J MED GENET A, V139A, P173, DOI 10.1002/ajmg.a.31015; van Karnebeek CDM, 2005, EUR J HUM GENET, V13, P6, DOI 10.1038/sj.ejhg.5201279; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wirtenberger M, 2006, AM J HUM GENET, V78, P520, DOI 10.1086/500793; WOOLDRIDGE J, 1995, AM J MED GENET, V56, P258, DOI 10.1002/ajmg.1320560304; Xu J, 2003, AM J MED GENET C, V117C, P15, DOI 10.1002/ajmg.c.10016; Zanni G, 2005, NEUROLOGY, V65, P1364, DOI 10.1212/01.wnl.0000182813.94713.ee; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	60	235	247	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					500	513		10.1086/507471	http://dx.doi.org/10.1086/507471			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909388	Green Published, Bronze			2022-12-18	WOS:000239830700012
J	Hagerman, RJ; Leavitt, BR; Farzin, F; Jacquemont, S; Greco, CM; Brunberg, JA; Tassone, F; Hessl, D; Harris, SW; Zhang, L; Jardini, T; Gane, LW; Ferranti, J; Ruiz, L; Leehey, MA; Grigsby, J; Hagerman, PJ				Hagerman, RJ; Leavitt, BR; Farzin, F; Jacquemont, S; Greco, CM; Brunberg, JA; Tassone, F; Hessl, D; Harris, SW; Zhang, L; Jardini, T; Gane, LW; Ferranti, J; Ruiz, L; Leehey, MA; Grigsby, J; Hagerman, PJ			Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; FULL MUTATION; ELEVATED LEVELS; CARRIERS; CEREBELLAR; TREMOR; MALES; INVOLVEMENT; EXPANSIONS	We describe five female carriers of the FMR1 premutation who presented with symptoms of tremor and ataxia and who received a diagnosis of definite or probable fragile-X-associated tremor/ataxia syndrome (FXTAS). Unlike their male counterparts with FXTAS, none of the women had dementia. Females had not been reported in previous studies of FXTAS, suggesting that they may be relatively protected from this disorder. Brain tissue was available from one of the five subjects, a women who died at age 85 years; microscopic examination revealed intranuclear neuronal and astrocytic inclusions, in accord with the findings previously reported in males with FXTAS. The workup of families with the FMR1 mutation should include questions regarding neurological symptoms in both older male and female carriers, with the expectation that females may also manifest the symptoms of FXTAS, although more subtly and less often than their male counterparts.	Univ Calif Davis, Med Ctr, Med Invest Neurodev Disorders Inst, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Psychiat, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Med Pathol, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA; Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of British Columbia	Hagerman, PJ (corresponding author), Univ Calif Davis, Med Ctr, Med Invest Neurodev Disorders Inst, 2825 50th St, Sacramento, CA 95817 USA.	randi.hagerman@ucdmc.ucdavis.edu	Farzin, Faraz/I-6170-2012; Jacquemont, Sebastien/AAS-5060-2021; Leavitt, Blair R/G-1934-2012	Jacquemont, Sebastien/0000-0001-6838-8767; 	NICHD NIH HHS [HD40661, R01 HD036071, R01 HD040661, HD36071] Funding Source: Medline; NINDS NIH HHS [NS43532, R01 NS043532] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043532] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B; Berry-Kravis E, 2003, ANN NEUROL, V53, P616, DOI 10.1002/ana.10522; Brunberg JA, 2002, AM J NEURORADIOL, V23, P1757; Franke P, 1998, PSYCHIAT RES, V80, P113, DOI 10.1016/S0165-1781(98)00055-9; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Hagerman Paul J., 2003, Neurology, V60, pA469; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hagerman PJ, 2003, CYTOGENET GENOME RES, V100, P206, DOI 10.1159/000072856; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Jacquemont S, 2004, AM J MENT RETARD, V109, P154, DOI 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Leehey MA, 2003, ARCH NEUROL-CHICAGO, V60, P117, DOI 10.1001/archneur.60.1.117; LEEHEY MA, 2002, MOV DISORD S2, V17; Leehey MA, 2002, MOVEMENT DISORD, V17, P744; Murray A, 2000, EUR J HUM GENET, V8, P247, DOI 10.1038/sj.ejhg.5200451; REISS AL, 1993, AM J HUM GENET, V52, P884; Riddle JE, 1998, AM J MENT RETARD, V102, P590; SOBESKY WE, 1996, FRAGILE X SYNDROME D, P332; Tassone F, 2000, AM J MED GENET, V94, P232, DOI 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H; Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2001, J MED GENET, V38, P453, DOI 10.1136/jmg.38.7.453; TASSONE F, 2002, NAT FRAG X FDN 8 INT; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114	26	235	243	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1051	1056		10.1086/420700	http://dx.doi.org/10.1086/420700			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15065016	Bronze, Green Published			2022-12-18	WOS:000220926100023
J	Johnston, JJ; Kelley, RI; Crawford, TO; Morton, DH; Agarwala, R; Koch, T; Schaffer, AA; Francomano, CA; Biesecker, LG				Johnston, JJ; Kelley, RI; Crawford, TO; Morton, DH; Agarwala, R; Koch, T; Schaffer, AA; Francomano, CA; Biesecker, LG			A novel nemaline myopathy in the Amish caused by a mutation in troponin T1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; CAENORHABDITIS-ELEGANS; GENE TPM3; MUSCLE; TROPOMYOSIN; SKELETAL; STRATEGIES; SYSTEM; CELLS	The nemaline myopathies are characterized by weakness and eosinophilic, rodlike (nemaline) inclusions in muscle fibers. Amish nemaline myopathy is a form of nemaline myopathy common among the Old Order Amish. In the first months of life, affected infants have tremors with hypotonia and mild contractures of the shoulders and hips. Progressive worsening of the proximal contractures, weakness, and a pectus carinatum deformity develop before the children die of respiratory insufficiency, usually in the second year. The disorder has an incidence of similar to 1 in 500 among the Amish, and it is inherited in an autosomal recessive pattern. Using a genealogy database, automated pedigree software, and linkage analysis of DNA samples from four sibships, we identified an similar to 2-cM interval on chromosome 19q13.4 that was homozygous in all affected individuals. The gene for the sarcomeric thin-filament protein, slow skeletal muscle troponin T (TNNT1), maps to this interval and was sequenced. We identified a stop codon in exon 11, predicted to truncate the protein at amino acid 179, which segregates with the disease. We conclude that Amish nemaline myopathy is a distinct, heritable, myopathic disorder caused by a mutation in TNNT1.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NIH, Informat Engn Branch, Bethesda, MD 20892 USA; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD USA; Johns Hopkins Univ, Dept Neurol & Pediat, Baltimore, MD USA; Clin Special Children, Strasburg, PA USA; Konrad Zuse Zentrum Informat Tech, Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Zuse Institute Berlin	Johnston, JJ (corresponding author), NHGRI, Med Genet Branch, NIH, Rm 3D-45,Bldg 10,10 Ctr Dr, Bethesda, MD 20892 USA.		Biesecker, Leslie/AAG-2526-2021; Schaffer, Alejandro A/F-2902-2012; Crawford, Thomas/E-6307-2012; Schaffer, Alejandro/N-1222-2019	Koch, Thorsten/0000-0002-1967-0077				Agarwala R, 1999, AM J MED GENET, V86, P156, DOI 10.1002/(SICI)1096-8628(19990910)86:2<156::AID-AJMG13>3.0.CO;2-5; Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; BUTLER RM, 1994, PARALLEL COMPUT, V20, P547, DOI 10.1016/0167-8191(94)90028-0; COHEN C, 1975, SCI AM, V233, P36, DOI 10.1038/scientificamerican1175-36; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; GUPTA SK, 1995, COMPUT BIOMED RES, V28, P116, DOI 10.1006/cbmr.1995.1009; Jha PK, 1996, BIOCHEMISTRY-US, V35, P16573, DOI 10.1021/bi9622433; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; Johnston JJ, 1999, AM J HUM GENET, V65, pA256; Koch T, 1998, NETWORKS, V32, P207, DOI 10.1002/(SICI)1097-0037(199810)32:3<207::AID-NET5>3.0.CO;2-O; LAING NG, 1995, CURR OPIN NEUROL, V8, P391, DOI 10.1097/00019052-199510000-00012; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAQUAT LE, 1995, RNA, V1, P453; McArdle K, 1998, J CELL BIOL, V143, P1201, DOI 10.1083/jcb.143.5.1201; McKusick VA, 2000, NAT GENET, V24, P203, DOI 10.1038/73389; Michele DE, 1999, J CLIN INVEST, V104, P1575, DOI 10.1172/JCI7842; Myers CD, 1996, J CELL BIOL, V132, P1061, DOI 10.1083/jcb.132.6.1061; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; SAMSON F, 1994, BIOCHEM BIOPH RES CO, V199, P841, DOI 10.1006/bbrc.1994.1305; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Tan P, 1999, NEUROMUSCULAR DISORD, V9, P573, DOI 10.1016/S0960-8966(99)00053-X; Watkins H, 1996, J CLIN INVEST, V98, P2456, DOI 10.1172/JCI119063	29	235	245	1	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					814	821		10.1086/303089	http://dx.doi.org/10.1086/303089			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10952871	Green Published, Bronze			2022-12-18	WOS:000089651100005
J	Hamdan, FF; Myers, CT; Cossette, P; Lemay, P; Spiegelman, D; Laporte, AD; Nassif, C; Diallo, O; Monlong, J; Cadieux-Dion, M; Dobrzeniecka, S; Meloche, C; Retterer, K; Cho, MT; Rosenfeld, JA; Bi, WM; Massicotte, C; Miguet, M; Brunga, L; Regan, BM; Mo, K; Tam, C; Schneider, A; Hollingsworth, G; FitzPatrick, DR; Donaldson, A; Canham, N; Blair, E; Kerr, B; Fry, AE; Thomas, RH; Shelagh, J; Hurst, JA; Brittain, H; Blyth, M; Lebel, RR; Gerkes, EH; Davis-Keppen, L; Stein, Q; Chung, WK; Dorison, SJ; Benke, PJ; Fassi, E; Corsten-Janssen, N; Kamsteeg, EJ; Mau-Them, FT; Bruel, AL; Verloes, A; Ounap, K; Wojcik, MH; Albert, DVF; Venkateswaran, S; Ware, T; Jones, D; Liu, YC; Mohammad, SS; Bizargity, P; Bacino, CA; Leuzzi, V; Martinelli, S; Dallapiccola, B; Tartaglia, M; Blumkin, L; Wierenga, KJ; Purcarin, G; O'Byrne, JJ; Stockler, S; Lehman, A; Keren, B; Nougues, MC; Mignot, C; Auvin, S; Nava, C; Hiatt, SM; Bebin, M; Shao, YR; Scaglia, F; Lalani, SR; Frye, RE; Jarjour, IT; Jacques, S; Boucher, RM; Riou, E; Srour, M; Carmant, L; Lortie, A; Major, P; Diadori, P; Dubeau, F; D'Anjou, G; Bourque, G; Berkovic, SF; Sadleir, LG; Campeau, PM; Kibar, Z; Lafreniere, RG; Girard, SL; Mercimek-Mahmutoglu, S; Boelman, C; Rouleau, GA; Scheffer, IE; Mefford, HC; Andrade, DM; Rossignol, E; Minassian, BA; Michaud, JL				Hamdan, Fadi F.; Myers, Candace T.; Cossette, Patrick; Lemay, Philippe; Spiegelman, Dan; Laporte, Alexandre Dionne; Nassif, Christina; Diallo, Ousmane; Monlong, Jean; Cadieux-Dion, Maxime; Dobrzeniecka, Sylvia; Meloche, Caroline; Retterer, Kyle; Cho, Megan T.; Rosenfeld, Jill A.; Bi, Weimin; Massicotte, Christine; Miguet, Marguerite; Brunga, Ledia; Regan, Brigid M.; Mo, Kelly; Tam, Cory; Schneider, Amy; Hollingsworth, Georgie; FitzPatrick, David R.; Donaldson, Alan; Canham, Natalie; Blair, Edward; Kerr, Bronwyn; Fry, Andrew E.; Thomas, Rhys H.; Shelagh, Joss; Hurst, Jane A.; Brittain, Helen; Blyth, Moira; Lebel, Robert Roger; Gerkes, Erica H.; Davis-Keppen, Laura; Stein, Quinn; Chung, Wendy K.; Dorison, Sara J.; Benke, Paul J.; Fassi, Emily; Corsten-Janssen, Nicole; Kamsteeg, Erik-Jan; Mau-Them, Frederic T.; Bruel, Ange-Line; Verloes, Alain; Ounap, Katrin; Wojcik, Monica H.; Albert, Dara V. F.; Venkateswaran, Sunita; Ware, Tyson; Jones, Dean; Liu, Yu-Chi; Mohammad, Shekeeb S.; Bizargity, Peyman; Bacino, Carlos A.; Leuzzi, Vincenzo; Martinelli, Simone; Dallapiccola, Bruno; Tartaglia, Marco; Blumkin, Lubov; Wierenga, Klaas J.; Purcarin, Gabriela; O'Byrne, James J.; Stockler, Sylvia; Lehman, Anna; Keren, Boris; Nougues, Marie-Christine; Mignot, Cyril; Auvin, Stephane; Nava, Caroline; Hiatt, Susan M.; Bebin, Martina; Shao, Yunru; Scaglia, Fernando; Lalani, Seema R.; Frye, Richard E.; Jarjour, Imad T.; Jacques, Stephanie; Boucher, Renee-Myriam; Riou, Emilie; Srour, Myriam; Carmant, Lionel; Lortie, Anne; Major, Philippe; Diadori, Paola; Dubeau, Francois; D'Anjou, Guy; Bourque, Guillaume; Berkovic, Samuel F.; Sadleir, Lynette G.; Campeau, Philippe M.; Kibar, Zoha; Lafreniere, Ronald G.; Girard, Simon L.; Mercimek-Mahmutoglu, Saadet; Boelman, Cyrus; Rouleau, Guy A.; Scheffer, Ingrid E.; Mefford, Heather C.; Andrade, Danielle M.; Rossignol, Elsa; Minassian, Berge A.; Michaud, Jacques L.		Deciphering Dev Disorders Study	High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NOGO-B RECEPTOR; INTELLECTUAL DISABILITY; CIS-PRENYLTRANSFERASE; MEDICAL GENETICS; STRUCTURAL BASIS; VARIANTS; TRAFFICKING; RECRUITMENT; MATURATION; PLASTICITY	Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental plateauing or regression associated with frequent epileptiform activity. The cause of DEE remains unknown in the majority of cases. We performed whole-genome sequencing (WGS) in 197 individuals with unexplained DEE and pharmaco-resistant seizures and in their unaffected parents. We focused our attention on de novo mutations (DNMs) and identified candidate genes containing such variants. We sought to identify additional subjects with DNMs in these genes by performing targeted sequencing in another series of individuals with DEE and by mining various sequencing datasets. We also performed meta-analyses to document enrichment of DNMs in candidate genes by leveraging our WGS dataset with those of several DEE and ID series. By combining these strategies, we were able to provide a causal link between DEE and the following genes: NTRK2, GABRB2, CLTC, DHDDS, NUS1, RAB11A, GABBR2, and SNAP25. Overall, we established a molecular diagnosis in 63/197 (32%) individuals in our WGS series. The main cause of DEE in these individuals was de novo point mutations (53/63 solved cases), followed by inherited mutations (6/63 solved cases) and de novo CNVs (4/63 solved cases). De novo missense variants explained a larger proportion of individuals in our series than in other series that were primarily ascertained because of ID. Moreover, these DNMs were more frequently recurrent than those identified in ID series. These observations indicate that the genetic landscape of DEE might be different from that of ID without epilepsy.	[Hamdan, Fadi F.; Lemay, Philippe; Nassif, Christina; Massicotte, Christine; Miguet, Marguerite; Carmant, Lionel; Campeau, Philippe M.; Kibar, Zoha; Rossignol, Elsa; Michaud, Jacques L.] CHU, St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada; [Myers, Candace T.; Mefford, Heather C.] Univ Washington, Div Genet Med, Dept Pediat, Seattle, WA 98195 USA; [Cossette, Patrick; Cadieux-Dion, Maxime; Dobrzeniecka, Sylvia; Meloche, Caroline; Lafreniere, Ronald G.; Girard, Simon L.] CHU Montreal, Res Ctr, Montreal, PQ H2X 0A9, Canada; [Cossette, Patrick; Carmant, Lionel; Lortie, Anne; Major, Philippe; Diadori, Paola; D'Anjou, Guy; Kibar, Zoha; Rossignol, Elsa; Michaud, Jacques L.] Univ Montreal, Dept Neurosci, Montreal, PQ H3T 1J4, Canada; [Spiegelman, Dan; Laporte, Alexandre Dionne; Diallo, Ousmane; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Monlong, Jean; Bourque, Guillaume] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Monlong, Jean; Bourque, Guillaume] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Monlong, Jean; Bourque, Guillaume; Girard, Simon L.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Cadieux-Dion, Maxime] Childrens Mercy Kansas City, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Cadieux-Dion, Maxime] Childrens Mercy Kansas City, Dept Pathol & Lab Med, Kansas City, MO 64108 USA; [Retterer, Kyle; Cho, Megan T.] GeneDx, Gaithersburg, MD 20877 USA; [Rosenfeld, Jill A.; Bi, Weimin; Bizargity, Peyman; Bacino, Carlos A.; Shao, Yunru; Scaglia, Fernando; Lalani, Seema R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bi, Weimin] Baylor Coll Med, Baylor Miraca Genet Labs, Houston, TX 77021 USA; [Brunga, Ledia; Minassian, Berge A.] Hosp Sick Children, Div Neurol, Dept Pediat, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Brunga, Ledia; Minassian, Berge A.] Univ Toronto, Toronto, ON M5G 0A4, Canada; [Regan, Brigid M.; Mo, Kelly; Tam, Cory; Andrade, Danielle M.] Univ Toronto, Toronto Western Hosp, Epilepsy Genet Program, Krembil Neurosci Ctr,Div Neurol, Toronto, ON M5G 2C4, Canada; [Schneider, Amy; Hollingsworth, Georgie; Berkovic, Samuel F.; Scheffer, Ingrid E.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Austin Hlth, Heidelberg, Vic 3084, Australia; [Deciphering Dev Disorders Study] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [FitzPatrick, David R.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Donaldson, Alan] Univ Hosp Bristol NHS Fdn Trust, St Michaels Hosp, Clin Genet Serv, St Michaels Hill, Bristol BS2 8DT, Avon, England; [Canham, Natalie] London North West Healthcare NHS Trust, Northwick Pk Hosp, North West Thames Reg Genet Serv, Watford Rd, Harrow HA1 3UJ, Middx, England; [Blair, Edward] Oxford Univ Hosp NHS Fdn Trust, Nuffield Orthopaed Ctr, Oxford Ctr Genom Med, ACE Bldg, Oxford OX3 7HE, England; [Kerr, Bronwyn] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Fry, Andrew E.] Univ Hosp Wales, Inst Med Genet, Heath Pk, Cardiff CF14 4XW, S Glam, Wales; [Thomas, Rhys H.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Hadyn Ellis Bldg, Cardiff CF24 4HQ, S Glam, Wales; [Shelagh, Joss] Queen Elizabeth Univ Hosp, West Scotland Reg Genet Serv, Glasgow G51 4TF, Lanark, Scotland; [Hurst, Jane A.; Brittain, Helen] Great Ormond St Hosp Sick Children, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Blyth, Moira] Leeds Teaching Hosp NHS Trust, Chapel Allerton Hosp, Dept Clin Genet, Yorkshire Reg Genet Serv, Chapeltown Rd, Leeds LS7 4SA, W Yorkshire, England; [Lebel, Robert Roger] SUNY Upstate Med Univ, Med Genet Sect, Dept Pediat, Syracuse, NY 13210 USA; [Gerkes, Erica H.; Corsten-Janssen, Nicole] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Davis-Keppen, Laura] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD 57117 USA; [Stein, Quinn] Augustana Sanford Genet Counseling Grad Program, Sioux Falls, SD 57197 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Dorison, Sara J.] Baptist Hosp Miami, Miami, FL 33176 USA; [Benke, Paul J.] Joe DiMaggio Childrens Hosp, Hollywood, FL 33021 USA; [Fassi, Emily] Washington Univ, Dept Pediat, Sch Med, Div Genet & Genom Med, St Louis, MO 63110 USA; [Kamsteeg, Erik-Jan] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Brain Cognit & Behav, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Mau-Them, Frederic T.; Bruel, Ange-Line] CHU Dijon, Ctr Genet Anomalies Dev, F-21000 Dijon, France; [Mau-Them, Frederic T.; Bruel, Ange-Line] Univ Bourgogne, Equipe INSERM 1231, Genet Anomalies Dev, F-21000 Dijon, France; [Verloes, Alain] Robert Debre Univ Hosp, AP HP, Genet Dept, F-75000 Paris, France; [Ounap, Katrin] Tartu Univ Hosp, United Labs, Dept Clin Genet, EE-51014 Tartu, Estonia; [Ounap, Katrin] Univ Tartu, Inst Clin Med, EE-51014 Tartu, Estonia; [Wojcik, Monica H.] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Genet & Genom, Boston, MA 02115 USA; [Wojcik, Monica H.] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Wojcik, Monica H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Albert, Dara V. F.] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Albert, Dara V. F.] Ohio State Univ, Div Neurol, Dept Pediat, Columbus, OH 43205 USA; [Venkateswaran, Sunita] Childrens Hosp Eastern Ontario, Div Neurol, Ottawa, ON K1H 8L1, Canada; [Ware, Tyson] Univ Tasmania, Royal Hobart Hosp, Dept Paediat, Hobart, Tas 7000, Australia; [Jones, Dean] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia; [Liu, Yu-Chi] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic 3052, Australia; [Liu, Yu-Chi] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Austin Hlth, Heidelberg, Vic 3084, Australia; [Mohammad, Shekeeb S.] Univ Sydney, Childrens Hosp Westmead Clin Sch, Westmead, NSW 2145, Australia; [Bacino, Carlos A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Leuzzi, Vincenzo] Univ Roma La Sapienza, Dipartimento Pediat & Neuropsichiat Infantile, I-00185 Rome, Italy; [Martinelli, Simone] Ist Super Sanita, Dipartimento Oncol & Med Mol, I-00161 Rome, Italy; [Dallapiccola, Bruno; Tartaglia, Marco] Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carattere Sci, Genet & Rare Dis Res Div, I-00165 Rome, Italy; [Blumkin, Lubov] Wolfson Med Ctr, Metab Neurogenet Clin, IL-5822012 Holon, Israel; [Blumkin, Lubov] Wolfson Med Ctr, Pediat Movement Disorders Clin, IL-5822012 Holon, Israel; [Wierenga, Klaas J.; Purcarin, Gabriela] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [O'Byrne, James J.; Stockler, Sylvia] Univ British Columbia, BC Childrens Hosp, Vancouver, BC V6H 3N1, Canada; [Lehman, Anna] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Keren, Boris; Mignot, Cyril; Nava, Caroline] Univ Paris 06, Hop La Pitie Salpetriere,Dept Genet, Grp Rech Clin Deficiences Intellectuelles & Autis, Ctr Reference Deficiences Intellectuelles Causes, F-75013 Paris, France; [Keren, Boris; Mignot, Cyril; Nava, Caroline] Univ Paris 06, Univ Pierre & Marie Curie, Sorbonne Univ,Inst Cerveau & Moelle Epiniere, CNRS UMR 7225,INSEAM 1127,UMRS 1127, F-75013 Paris, France; [Nougues, Marie-Christine] Hop Enfants Armand Trousseau, AP HP, Serv Neuropediat, F-75012 Paris, France; [Auvin, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, INSERM UMR 1141, F-75019 Paris, France; [Auvin, Stephane] Hop Robert Debre, AP HP, Serv Neurol Pediat, F-75019 Paris, France; [Hiatt, Susan M.] HudsonAlpha Inst Biotechnol, 601 Genome Way, Huntsville, AL 35806 USA; [Bebin, Martina] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Frye, Richard E.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Frye, Richard E.] Arkansas Childrens Res Inst, Little Rock, AR 72205 USA; [Jarjour, Imad T.] Texas Childrens Hosp, Houston, TX 77030 USA; [Jarjour, Imad T.] Baylor Coll Med, Houston, TX 77030 USA; [Jacques, Stephanie] Ctr Hosp Rouyn Noranda, Rouyn Noranda, PQ J9X 2B2, Canada; [Boucher, Renee-Myriam] Ctr Hosp Univ Quebec, Div Neurol, Quebec City, PQ G1V 4G2, Canada; [Riou, Emilie] Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada; [Srour, Myriam] McGill Univ, Dept Pediat, Montreal, PQ H3A 1A4, Canada; [Srour, Myriam] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A4, Canada; [Carmant, Lionel; Lortie, Anne; Major, Philippe; Diadori, Paola; D'Anjou, Guy; Campeau, Philippe M.; Rossignol, Elsa; Michaud, Jacques L.] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Sadleir, Lynette G.] Univ Otago, Dept Pediat & Child Hlth, Wellington 9016, New Zealand; [Girard, Simon L.] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ G7H 2B1, Canada; [Mercimek-Mahmutoglu, Saadet] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Boelman, Cyrus] BC Childrens Hosp, Div Neurol, Vancouver, BC V6H 3N1, Canada; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Pediat, Parkville, Vic 3052, Australia; [Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3084, Australia; [Minassian, Berge A.] Univ Texas Southwestern, Dept Pediat, Div Child Neurol, Dallas, TX 75390 USA	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Washington; University of Washington Seattle; Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University; Children's Mercy Hospital; Children's Mercy Hospital; Baylor College of Medicine; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Wellcome Trust Sanger Institute; University of Edinburgh; University of Bristol; Imperial College London; Nuffield Orthopaedic Centre; Oxford University Hospitals NHS Foundation Trust; University of Manchester; Cardiff University; Cardiff University; Queen Elizabeth University Hospital (QEUH); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Chapel Allerton Hospital; University of Leeds; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Groningen; University of South Dakota; Columbia University; Columbia University; Baptist Hospital Miami; Washington University (WUSTL); Radboud University Nijmegen; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; University of Tartu; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Ottawa; Children's Hospital of Eastern Ontario; Royal Hobart Hospital; University of Tasmania; University of Tasmania; Walter & Eliza Hall Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; Baylor College of Medicine; Sapienza University Rome; Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; University of Oklahoma System; University of Oklahoma Health Sciences Center; BC Childrens Hospital; University of British Columbia; University of British Columbia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; HudsonAlpha Institute for Biotechnology; University of Alabama System; University of Alabama Birmingham; University of Arkansas System; University of Arkansas Medical Sciences; Baylor College of Medicine; Baylor College of Medicine; University of Sherbrooke; Laval University; University of Sherbrooke; McGill University; McGill University; Universite de Montreal; University of Otago; University of Quebec; University of Quebec Chicoutimi; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); BC Childrens Hospital; University of British Columbia; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Texas System; University of Texas Southwestern Medical Center Dallas	Michaud, JL (corresponding author), CHU, St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada.; Michaud, JL (corresponding author), Univ Montreal, Dept Neurosci, Montreal, PQ H3T 1J4, Canada.; Minassian, BA (corresponding author), Hosp Sick Children, Div Neurol, Dept Pediat, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada.; Minassian, BA (corresponding author), Univ Toronto, Toronto, ON M5G 0A4, Canada.; Michaud, JL (corresponding author), Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada.; Minassian, BA (corresponding author), Univ Texas Southwestern, Dept Pediat, Div Child Neurol, Dallas, TX 75390 USA.	berge.minassian@sickkids.ca; jacques.michaud@recherche-ste-justine.qc.ca	Scheffer, Ingrid E/G-1668-2013; Fry, Andrew/AAN-2730-2020; Auvin, Stéphane/AAB-7824-2021; Thomas, Rhys/I-3840-2019; Fry, Andrew/AFK-7448-2022; Lalani, Seema/AAI-5090-2020; Martinelli, Simone/J-9432-2018; Campeau, Philippe/J-8614-2015; Mohammad, Shekeeb/AAD-1282-2022; Tartaglia, Marco/K-2955-2018; Jones, Dean L/J-7900-2014; Kamsteeg, Erik-Jan/L-4421-2015; Monlong, Jean/AAZ-8589-2020; Stein, Quinn/AAJ-4738-2021; jiang, yu/HGU-0029-2022; Bourque, Guillaume/AFR-2927-2022; Mohammad, Shekeeb/Q-6928-2019; /AAK-8500-2021; O'Byrne, James/AAE-8182-2021; Frye, Richard/AAB-5543-2020; Fassi, Farida/F-3571-2016; Albert, Dara Victoria/AAG-4174-2021; OUNAP, KATRIN/Q-1103-2016; Dallapiccola, Bruno/K-8692-2016	Scheffer, Ingrid E/0000-0002-2311-2174; Fry, Andrew/0000-0001-9778-6924; Auvin, Stéphane/0000-0003-3874-9749; Thomas, Rhys/0000-0003-2062-8623; Fry, Andrew/0000-0001-9778-6924; Martinelli, Simone/0000-0002-5843-419X; Campeau, Philippe/0000-0001-9713-7107; Mohammad, Shekeeb/0000-0003-1219-4781; Tartaglia, Marco/0000-0001-7736-9672; Monlong, Jean/0000-0002-9737-5516; Stein, Quinn/0000-0002-7670-9281; Bourque, Guillaume/0000-0002-3933-9656; Fassi, Farida/0000-0002-6423-7213; Albert, Dara Victoria/0000-0002-3867-2297; Blyth, Moira/0000-0002-4312-413X; Berkovic, Samuel/0000-0003-4580-841X; Andrade, Danielle/0000-0003-0953-2698; spiegelman, dan/0000-0003-4971-8868; Tran Mau Them, Frederic/0000-0002-3795-9456; OUNAP, KATRIN/0000-0002-4594-6364; Dallapiccola, Bruno/0000-0002-5031-1013; Nava, Caroline/0000-0003-1272-0518; Girard, Simon/0000-0002-4089-2280; Rossignol, Elsa/0000-0002-9304-9385; Sadleir, Lynette/0000-0002-5355-7115; FitzPatrick, David R./0000-0003-4861-969X; Liu, Yu-Chi/0000-0002-3006-4940	Genome Canada; Genome Quebec; Jeanne and Jean-Louis Levesque Foundation; Michael Bahen Chair in Epilepsy Research; Ontario Brain Institute; McLaughlin Foundation; University of Toronto; National Institute of Neurological Disorders and Stroke [RO1 NS069605]; University of Toronto McLaughlin Accelerator Grant in Genomic Medicine [MC-2013-08]; MRC [MC_PC_U127561093] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009141, UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069605] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_U127561093] Funding Source: researchfish; Epilepsy Research UK [P1205] Funding Source: researchfish	Genome Canada(Genome Canada); Genome Quebec; Jeanne and Jean-Louis Levesque Foundation; Michael Bahen Chair in Epilepsy Research; Ontario Brain Institute; McLaughlin Foundation; University of Toronto(University of Toronto); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Toronto McLaughlin Accelerator Grant in Genomic Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Epilepsy Research UK	We thank the individuals participating in this study and their families for their contributions. This study was funded by grants from Genome Canada and Genome Quebec, the Jeanne and Jean-Louis Levesque Foundation (to J.L.M.), the Michael Bahen Chair in Epilepsy Research (to B.A.M.), the Ontario Brain Institute (EpLink), the McLaughlin Foundation and the University of Toronto (to D.M.A. and B.A.M.), and the National Institute of Neurological Disorders and Stroke (RO1 NS069605 to H.C.M.). We thank the members of the massive parallel sequencing and bioinformatics teams at the McGill University and Genome Quebec Innovation Center for their services. S.M.-M. was supported by the University of Toronto McLaughlin Accelerator Grant in Genomic Medicine (MC-2013-08). See Supplemental Data for additional acknowledgements.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Andero R, 2014, PROG MOL BIOL TRANSL, V122, P169, DOI 10.1016/B978-0-12-420170-5.00006-4; Antonucci Flavia, 2016, Front Synaptic Neurosci, V8, P7, DOI 10.3389/fnsyn.2016.00007; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Baldridge D, 2017, GENET MED, V19, P1040, DOI 10.1038/gim.2016.224; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Berko ER, 2017, J MED GENET, V54, P93, DOI 10.1136/jmedgenet-2016-103943; Blein S, 2000, CELL MOL LIFE SCI, V57, P635, DOI 10.1007/PL00000725; Bodrikov V, 2017, EXP NEUROL, V289, P31, DOI 10.1016/j.expneurol.2016.12.007; Bosch DGM, 2016, EUR J HUM GENET, V24, P660, DOI 10.1038/ejhg.2015.186; Brooks-Kayal A, 2011, EPILEPSIA, V52, P13, DOI 10.1111/j.1528-1167.2010.02906.x; Corradini I, 2014, CEREB CORTEX, V24, P364, DOI 10.1093/cercor/bhs316; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Dawidowski D, 2016, STRUCTURE, V24, P392, DOI 10.1016/j.str.2016.01.005; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeMari J, 2016, AM J MED GENET A, V170, P958, DOI 10.1002/ajmg.a.37506; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597; Grabinska KA, 2016, J BIOL CHEM, V291, P18582, DOI 10.1074/jbc.R116.739490; Halvardson J, 2016, J MED GENET, V53, P697, DOI 10.1136/jmedgenet-2016-103814; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Helbig KL, 2016, GENET MED, V18, P898, DOI 10.1038/gim.2015.186; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Hino-Fukuyo N, 2015, HUM GENET, V134, P649, DOI 10.1007/s00439-015-1553-6; Huang SH, 2013, J NEUROSCI, V33, P9214, DOI 10.1523/JNEUROSCI.3256-12.2013; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Ishii A, 2017, J MED GENET, V54, P202, DOI 10.1136/jmedgenet-2016-104083; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lopes F, 2016, J MED GENET, V53, P190, DOI 10.1136/jmedgenet-2015-103568; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Michaud JL, 2014, HUM MOL GENET, V23, P4846, DOI 10.1093/hmg/ddu199; Monlong J., 2016, BIORXIV; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rebl A, 2009, COMP BIOCHEM PHYS B, V152, P260, DOI 10.1016/j.cbpb.2008.12.003; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335; Rohena L, 2013, RARE DIS, V1, DOI 10.4161/rdis.26314; Sabry S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0468-1; Sajan SA, 2017, GENET MED, V19, P13, DOI 10.1038/gim.2016.42; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Shen XM, 2014, NEUROLOGY, V83, P2247, DOI 10.1212/WNL.0000000000001079; SHEPHERD C, 1989, J MENT DEFIC RES, V33, P511; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Shohat S, 2017, CELL REP, V18, P2217, DOI 10.1016/j.celrep.2017.02.007; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Srivastava S, 2014, AM J MED GENET A, V164, P2914, DOI 10.1002/ajmg.a.36714; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Szafranski P, 2015, EUR J HUM GENET, V23, P173, DOI 10.1038/ejhg.2014.75; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Ware J.S., 2015, CURR PROTOC HUM GENE, V87, P1; Watanabe S, 2015, EPILEPSY RES, V115, P30, DOI 10.1016/j.eplepsyres.2015.05.004; Webster E, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001172; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zelinger L, 2011, AM J HUM GENET, V88, P207, DOI 10.1016/j.ajhg.2011.01.002; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	79	234	240	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					664	685		10.1016/j.ajhg.2017.09.008	http://dx.doi.org/10.1016/j.ajhg.2017.09.008			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100083	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-18	WOS:000414251600002
J	Bogliolo, M; Schuster, B; Stoepker, C; Derkunt, B; Su, Y; Raams, A; Trujillo, JP; Minguillon, J; Ramirez, MJ; Pujol, R; Casado, JA; Banos, R; Rio, P; Knies, K; Zuniga, S; Benitez, J; Bueren, JA; Jaspers, NGJ; Scharer, OD; de Winter, JP; Schindler, D; Surralles, J				Bogliolo, Massimo; Schuster, Beatrice; Stoepker, Chantal; Derkunt, Burak; Su, Yan; Raams, Anja; Trujillo, Juan P.; Minguillon, Jordi; Ramirez, Maria J.; Pujol, Roser; Casado, Jose A.; Banos, Rocio; Rio, Paula; Knies, Kerstin; Zuniga, Sheila; Benitez, Javier; Bueren, Juan A.; Jaspers, Nicolaas G. J.; Schaerer, Orlando D.; de Winter, Johan P.; Schindler, Detlev; Surralles, Jordi			Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi Anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; CANCER SUSCEPTIBILITY; NUCLEAR ABNORMALITIES; GENE; DEFECT; SLX4; DISRUPTION; DEFICIENCY; DISORDERS; PROTEINS	Fanconi anemia (FA) is a rare genomic instability disorder characterized by progressive bone marrow failure and predisposition to cancer. FA-associated gene products are involved in the repair of DNA interstrand crosslinks (ICLs). Fifteen FA-associated genes have been identified, but the genetic basis in some individuals still remains unresolved. Here, we used whole-exome and Sanger sequencing on DNA of unclassified FA individuals and discovered biallelic germline mutations in ERCC4 (XPF), a structure-specific nuclease-encoding gene previously connected to xeroderma pigmentosum and segmental XFE progeroid syndrome. Genetic reversion and wild-type ERCC4 cDNA complemented the phenotype of the FA cell lines, providing genetic evidence that mutations in ERCC4 cause this FA subtype. Further biochemical and functional analysis demonstrated that the identified FA-causing ERCC4 mutations strongly disrupt the function of XPF in DNA ICL repair without severely compromising nucleotide excision repair. Our data show that depending on the type of ERCC4 mutation and the resulting balance between both DNA repair activities, individuals present with one of the three clinically distinct disorders, highlighting the multifunctional nature of the XPF endonuclease in genome stability and human disease.	[Bogliolo, Massimo; Trujillo, Juan P.; Minguillon, Jordi; Ramirez, Maria J.; Pujol, Roser; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Genome Instabil & DNA Repair Grp, E-08193 Barcelona, Spain; [Bogliolo, Massimo; Ramirez, Maria J.; Pujol, Roser; Casado, Jose A.; Banos, Rocio; Rio, Paula; Benitez, Javier; Bueren, Juan A.; Surralles, Jordi] Inst Salud Carlos III, Ctr Biomed Network Res Rare Dis, Barcelona 08193, Spain; [Schuster, Beatrice; Knies, Kerstin; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Stoepker, Chantal; de Winter, Johan P.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; [Derkunt, Burak; Su, Yan; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci & Chem, Stony Brook, NY 11794 USA; [Raams, Anja; Jaspers, Nicolaas G. J.] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands; [Casado, Jose A.; Banos, Rocio; Rio, Paula; Bueren, Juan A.] Ctr Invest Energet Medioambientales & Tecnol, Hematopoiesis & Gene Therapy Div, Madrid 28040, Spain; [Zuniga, Sheila] Sistemas Genom SL, Dept Bioinformat, Valencia 46980, Spain; [Benitez, Javier] Ctr Nacl Invest Oncol, Spanish Natl Canc Ctr, Human Genet Grp, E-28029 Madrid, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Wurzburg; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Erasmus University Rotterdam; Erasmus MC; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Centro Nacional de Investigaciones Oncologicas (CNIO)	Surralles, J (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Genome Instabil & DNA Repair Grp, E-08193 Barcelona, Spain.	schindler@biozentrum.uni-wuerzburg.de; jordi.surralles@uab.es	Baños, Rocío/L-6021-2014; Bueren, Juan/L-6112-2014; Rio, Paula/G-8681-2015; Surrallés, Jordi/AAE-7667-2020; Casado, José Antonio/H-5077-2015; Bogliolo, Massimo/J-1631-2019; Scharer, Orlando/B-8908-2008; Classen, Scott/AAY-8176-2020; Schärer, Orlando D./AAF-8613-2021	Baños, Rocío/0000-0002-5387-7485; Bueren, Juan/0000-0002-3228-7013; Rio, Paula/0000-0002-5424-5543; Casado, José Antonio/0000-0003-2479-1508; Scharer, Orlando/0000-0003-2425-2715; Minguillon, Jordi/0000-0003-2124-8294; Bogliolo, Massimo/0000-0001-8240-7784; Surralles, Jordi/0000-0002-4041-7519; Zuniga, Sheila/0000-0002-3272-7605; Ramirez de Haro, Maria Jose/0000-0003-1417-7731	European Program "7FWP, Health" (PERSIST) [222878]; Spanish Ministry of Science and Innovation [Refs110-90.1, SAP 2009-07164]; Fundacion Botin; National Institutes of Health [GM080454, CA092584]; CCA/V-ICI Amsterdam; Deutsche Fanconi-Anaemie-Hilfe; Aktionskreis Fanconi-Anaemie; Schroeder-Kurth Fund; Generalitat de Catalunya [SGR0489-2009]; ICREA-Academia award; Spanish Ministry of Science and Innovation (Centre for Biomedical Network Research on Rare Diseases [CIBERER]) [CB06/07/0023, SAF2009-11936, SAF2012-31881]; European Regional Development FEDER Funds;  [Programa RETICS-RD06/0010/0015 ISCIII]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	European Program "7FWP, Health" (PERSIST); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Botin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCA/V-ICI Amsterdam; Deutsche Fanconi-Anaemie-Hilfe; Aktionskreis Fanconi-Anaemie; Schroeder-Kurth Fund; Generalitat de Catalunya(Generalitat de Catalunya); ICREA-Academia award(ICREA); Spanish Ministry of Science and Innovation (Centre for Biomedical Network Research on Rare Diseases [CIBERER]); European Regional Development FEDER Funds(European Commission); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The use of FANCQ as an alias for ERCC4 was approved by the HUGO Gene Nomenclature Committee. We would like to thank the families affected by Fanconi anemia and their clinicians for providing samples and clinical data, as well as Maria A. Blasco (Centro Nacional de Investigaciones Oncologicas, Madrid) for providing Ercc4-deficient mouse embryonic fibroblasts. The J.A.B. laboratory is funded by grants from European Program "7FWP, Health" (PERSIST; agreement 222878), the Spanish Ministry of Science and Innovation (Refs110-90.1 and SAP 2009-07164), Programa RETICS-RD06/0010/0015 ISCIII, and Fundacion Botin. O.D.S. acknowledges funding from the National Institutes of Health (GM080454 and CA092584). C.S. is funded by CCA/V-ICI Amsterdam. D.S. and B.S. received grants from the Deutsche Fanconi-Anaemie-Hilfe, Aktionskreis Fanconi-Anaemie, and the Schroeder-Kurth Fund. J.S.'s laboratory is funded by the Generalitat de Catalunya (SGR0489-2009), the ICREA-Academia award, the Spanish Ministry of Science and Innovation (Centre for Biomedical Network Research on Rare Diseases [CIBERER] CB06/07/0023, SAF2009-11936, and SAF2012-31881), and the European Regional Development FEDER Funds. CIBERER is an initiative of the Instituto de Salud Carlos III, Spain.	Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Almarza E, 2007, MOL THER, V15, P1487, DOI 10.1038/sj.mt.6300213; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713; Gregg SQ, 2011, DNA REPAIR, V10, P781, DOI 10.1016/j.dnarep.2011.04.026; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Levy-Lahad E, 2010, NAT GENET, V42, P368, DOI 10.1038/ng0510-368; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Trujillo JP, 2012, BLOOD, V120, P86, DOI 10.1182/blood-2012-04-420604; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4	24	234	242	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					800	806		10.1016/j.ajhg.2013.04.002	http://dx.doi.org/10.1016/j.ajhg.2013.04.002			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23623386	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000318582800015
J	Lorenz-Depiereux, B; Schnabel, D; Tiosano, D; Hausler, G; Strom, TM				Lorenz-Depiereux, Bettina; Schnabel, Dirk; Tiosano, Dov; Haeusler, Gabriele; Strom, Tim M.			Loss-of-Function ENPP1 Mutations Cause Both Generalized Arterial Calcification of Infancy and Autosomal-Recessive Hypophosphatemic Rickets	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FGF23; DMP1	The analysis of rare genetic disorders affecting phosphate homeostasis led to the identification of several proteins that are essential for the renal regulation of phosphate homeostasis; for example, fibroblast growth factor 23 (FGF23), which inhibits renal phosphate reabsorption and 1,25-dihydroxy-vitamin D synthesis. Here, we report presumable loss-of-function mutations in the ENPP1 gene (ectonucleotide pyrophosphatase/phosphodiesterase) in members of four families affected with hypophosphatemic rickets. We provide evidence for the conclusion that ENPP1 is the fourth gene-in addition to PHEX, FGF23, and DMP1-that, if mutated, causes hypophosphatemic rickets resulting from elevated FGF23 levels. Surprisingly, ENPP1 loss-of-function Mutations have previously been described in generalized arterial calcification of infancy, suggesting an as yet elusive mechanism that balances arterial calcification with bone mineralization.	[Lorenz-Depiereux, Bettina; Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrurn Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Schnabel, Dirk] Charite, Dept Pediat Endocrinol, D-13353 Berlin, Germany; [Tiosano, Dov] Rambam Med Ctr, Meyer Childrens Hosp, IL-31096 Haifa, Israel; [Tiosano, Dov] Technion Israel Inst Technol, Fac Med, IL-31096 Haifa, Israel; [Haeusler, Gabriele] Med Univ Wien, Dept Pediat, A-1090 Vienna, Austria; [Strom, Tim M.] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Medical University of Vienna; Technical University of Munich	Strom, TM (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrurn Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.	timstrom@helmholtz-muenchen.de		Schnabel, Dirk/0000-0002-7944-7790; Haeusler, Gabriele/0000-0001-7919-3447	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the families for participation in this study. We also thank S. Losecke for technical assistance and Thomas Meitinger for discussions and comments. This work was supported by a grant of the Deutsche Forschungsgemeinschaft. B.L.-D., D.S., D.T., and G.H. declare that they do not have a financial interest related to this work. T.M.S. receives royalties from licensing FGF23 to Kirin Pharmaceuticals.	Dlamini N, 2009, AM J MED GENET A, V149A, P456, DOI 10.1002/ajmg.a.32646; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Imel EA, 2006, J CLIN ENDOCR METAB, V91, P2055, DOI 10.1210/jc.2005-2105; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; Strom TM, 2008, CURR OPIN NEPHROL HY, V17, P357, DOI 10.1097/MNH.0b013e3282fd6e5b; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105	16	234	243	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					267	272		10.1016/j.ajhg.2010.01.006	http://dx.doi.org/10.1016/j.ajhg.2010.01.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137773	Green Published, Bronze			2022-12-18	WOS:000274637200017
J	Fahsold, R; Hoffmeyer, S; Mischung, C; Gille, C; Ehlers, C; Kucukceylan, N; Abdel-Nour, M; Gewies, A; Peters, H; Kaufmann, D; Buske, A; Tinschert, S; Nurnberg, P				Fahsold, R; Hoffmeyer, S; Mischung, C; Gille, C; Ehlers, C; Kucukceylan, N; Abdel-Nour, M; Gewies, A; Peters, H; Kaufmann, D; Buske, A; Tinschert, S; Nurnberg, P			Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the CAP-related domain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; GRADIENT GEL-ELECTROPHORESIS; TUMOR-SUPPRESSOR GENE; BASE-PAIR SUBSTITUTIONS; GAP-RELATED DOMAIN; SOMATIC MOSAICISM; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; HEREDITARY RETINOBLASTOMA; PRODUCT NEUROFIBROMIN; BENIGN NEUROFIBROMAS	More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene. For each patient, the whole coding sequence and all splice sites were studied for aberrations, either by the protein truncation test (PTT), temperature-gradient gel electrophoresis (TGGE) of genomic PCR products, or, most often, by direct genomic sequencing (DGS) of all individual exons. A total of 301 sequence variants, including 278 bona fide pathogenic mutations, were identified. As many as 216 or 183 of the genuine mutations, comprising 179 or 161 different ones, can be considered novel when compared to the recent findings of Upadhyaya and Cooper, or to the NNFF mutation database. Mutation-detection efficiencies of the various screening methods were similar: 47.1% for MT, 53.7% for TGGE, and 54.9% for DGS. Some 224 mutations (80.2%) yielded directly or indirectly premature termination codons. These mutations showed even distribution over the whole gene from exon 1 to exon 47. Of all sequence variants determined in our study < 20% represent C->T or G->A transitions within a CpG dinucleotide, and only six different mutations also occur in NF1 pseudogenes, with five being typical C->T transitions in a CpG. Thus, neither frequent deamination of 5-methylcytosines nor interchromosomal gene conversion may account for the high mutation fate of the NF1 gene. As opposed to the truncating mutations, the 28 (10.1%) missense or single-amino-acid-deletion mutations identified clustered in two distinct regions, the GAP-related domain (GRD) and an upstream gene segment comprising exons 11-17. The latter forms a so-called cysteine/serine-rich domain with three cysteine pairs suggestive of ATP binding, as well as three potential cAMP-dependent protein kinase (PKA) recognition sites obviously phosphorylated by PKA. Coincidence of mutated amino acids and those conserved between human and Drosophila strongly suggest significant functional relevance of this region, with major roles played by exons 12a and 15 and part of exon 16.	Univ Klinikum Charite, Inst Med Genet, D-10098 Berlin, Germany; Gemeinschaftspraxis B Prager & A Junge, Dresden, Germany; Univ Klinikum Charite, Inst Biochem, Berlin, Germany; Univ Ulm, Abt Humangenetik, Ulm, Germany; Epidauros AG, Bernried, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University	Nurnberg, P (corresponding author), Univ Klinikum Charite, Inst Med Genet, D-10098 Berlin, Germany.	peter.nuernberg@charite.de		Gewies, Andreas/0000-0002-7606-6482				Abernathy CR, 1997, HUM MUTAT, V9, P548; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Ainsworth PJ, 1997, HUM MUTAT, V9, P452, DOI 10.1002/(SICI)1098-1004(1997)9:5<452::AID-HUMU12>3.3.CO;2-V; Andrews JD, 1996, HUM MOL GENET, V5, P503, DOI 10.1093/hmg/5.4.503; ANTONARAKIS SE, 1995, HUM MUTAT, V5, P1, DOI 10.1002/humu.1380050102; BODDRICH A, 1995, BIOCHEM BIOPH RES CO, V214, P895, DOI 10.1006/bbrc.1995.2371; Boddrich A, 1997, HUM MUTAT, V9, P374; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; CLEMENTI M, 1990, HUM GENET, V84, P116; Colman SD, 1996, AM J HUM GENET, V58, P484; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; Cooper D. N., 1993, HUMAN GENE MUTATION; Cowell John K., 1994, European Journal of Human Genetics, V2, P281; CUMMINGS LM, 1993, AM J HUM GENET, V53, P672; DANGLOT G, 1995, HUM MOL GENET, V4, P915, DOI 10.1093/hmg/4.5.915; Daschner K, 1997, BIOCHEM BIOPH RES CO, V234, P346, DOI 10.1006/bbrc.1997.6645; EASTON DF, 1993, AM J HUM GENET, V53, P305; EIKENBOOM JCJ, 1994, P NATL ACAD SCI USA, V91, P2221, DOI 10.1073/pnas.91.6.2221; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; GASPARINI P, 1993, MOL CELL PROBE, V7, P415, DOI 10.1006/mcpr.1993.1061; Gille C, 1998, ELECTROPHORESIS, V19, P1347, DOI 10.1002/elps.1150190824; GREENBLATT MS, 1994, CANCER RES, V54, P4855; GREGER V, 1994, HUM GENET, V94, P491; GREGORY PE, 1993, SOMAT CELL MOLEC GEN, V19, P265, DOI 10.1007/BF01233074; Guha A, 1996, ONCOGENE, V12, P507; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; HARDER A, 1999, HUM MUTAT, V13, P259; HEIM RA, 1995, HUM MOL GENET, V4, P975, DOI 10.1093/hmg/4.6.975; Hoffmeyer S, 1998, AM J HUM GENET, V62, P269, DOI 10.1086/301715; HOFFMEYER S, 1994, HUM GENET, V93, P481; HOFFMEYER S, 1995, HUM MOL GENET, V4, P1267, DOI 10.1093/hmg/4.8.1267; Horn D, 1996, ELECTROPHORESIS, V17, P1559, DOI 10.1002/elps.1150171011; Huson S. M., 1994, NEUROFIBROMATOSES CL; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; Izawa I, 1996, FEBS LETT, V382, P53, DOI 10.1016/0014-5793(96)00137-8; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; KehrerSawatzki H, 1997, HUM GENET, V100, P595, DOI 10.1007/s004390050559; KIM MR, 1998, NEUROFIBROMATOSIS TY, P89; Klose A, 1998, HUM GENET, V102, P367, DOI 10.1007/s004390050706; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; Klose A, 1999, AM J MED GENET, V83, P6, DOI 10.1002/(SICI)1096-8628(19990305)83:1<6::AID-AJMG3>3.3.CO;2-5; KLOSE A, 1998, HUM MUTAT, V12, P291; Korf BR., 1998, NEUROFIBROMATOSIS TY, P57; KRAWCZAK M, 1992, HUM GENET, V90, P41; Krkljus S, 1998, Hum Mutat, V11, P411, DOI 10.1002/(SICI)1098-1004(1998)11:5<411::AID-HUMU11>3.3.CO;2-U; LAZARO C, 1995, MED GENETIK, V7, P272; LEGIUS E, 1992, GENOMICS, V13, P1316, DOI 10.1016/0888-7543(92)90055-W; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; LI Y, 1995, GENOMICS, V25, P9, DOI 10.1016/0888-7543(95)80104-T; Lohmann DR, 1996, AM J HUM GENET, V58, P940; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; Maynard J, 1997, HUM GENET, V99, P674, DOI 10.1007/s004390050427; Messiaen L, 1997, HUM GENET, V101, P75, DOI 10.1007/s004390050590; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773; NEOTE K, 1990, J BIOL CHEM, V265, P20799; Osborn M, 1998, AM J HUM GENET S, V63, pA378; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Peters H, 1999, Hum Mutat, V13, P337, DOI 10.1002/(SICI)1098-1004(1999)13:4<337::AID-HUMU12>3.0.CO;2-F; Peters H, 1999, Hum Mutat, V13, P258, DOI 10.1002/(SICI)1098-1004(1999)13:3<258::AID-HUMU17>3.0.CO;2-1; PURANDARE SM, 1994, HUM MOL GENET, V3, P1109, DOI 10.1093/hmg/3.7.1109; Purandare SM, 1995, GENOMICS, V30, P476, DOI 10.1006/geno.1995.1268; Pyeritz RE, 1996, EMERY RIMOINS PRINCI, P1027; Rasmussen SA, 1998, J MED GENET, V35, P468, DOI 10.1136/jmg.35.6.468; Regnier V, 1997, HUM MOL GENET, V6, P9, DOI 10.1093/hmg/6.1.9; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; RICCARDI VM, 1993, AM J HUM GENET, V53, P301; RIESNER D, 1989, ELECTROPHORESIS, V10, P377, DOI 10.1002/elps.1150100516; Robinson PN, 1996, HUM MUTAT, V7, P85, DOI 10.1002/(SICI)1098-1004(1996)7:1<85::AID-HUMU17>3.0.CO;2-O; ROBINSON PN, 1995, HUM GENET, V96, P95, DOI 10.1007/BF00214193; RODENHISER D, 1998, AM J HUM GENET S, V63, pA190; RODENHISER DI, 1993, HUM MOL GENET, V2, P439, DOI 10.1093/hmg/2.4.439; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; SERGEYEV AS, 1975, HUMANGENETIK, V28, P129, DOI 10.1007/BF00735745; Serra E, 1997, AM J HUM GENET, V61, P512, DOI 10.1086/515504; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Suzuki T, 1998, GENE CHROMOSOME CANC, V21, P290, DOI 10.1002/(SICI)1098-2264(199804)21:4<290::AID-GCC2>3.0.CO;2-U; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Toliat MR, 2000, ELECTROPHORESIS, V21, P541, DOI 10.1002/(SICI)1522-2683(20000201)21:3<541::AID-ELPS541>3.0.CO;2-L; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; Upadhyaya M, 1997, HUM GENET, V99, P88; UPADHYAYA M, 1998, NEUROFIBROMATOSIS TY, P65; VALERO MC, 1994, HUM MOL GENET, V3, P639, DOI 10.1093/hmg/3.4.639; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Vogel F., 1997, HUMAN GENETICS PROBL; WARTELL RM, 1990, NUCLEIC ACIDS RES, V18, P2699, DOI 10.1093/nar/18.9.2699; White R, 1991, CURR OPIN GENET DEV, V1, P15, DOI 10.1016/0959-437X(91)80034-J; Wu BL, 1997, HUM GENET, V99, P209, DOI 10.1007/s004390050341; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Wu RN, 1999, GENE CHROMOSOME CANC, V26, P376, DOI 10.1002/(SICI)1098-2264(199912)26:4<376::AID-GCC13>3.3.CO;2-F; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	100	234	249	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					790	818		10.1086/302809	http://dx.doi.org/10.1086/302809			29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712197	Bronze, Green Published			2022-12-18	WOS:000088373200005
J	Teraoka, SN; Telatar, M; Becker-Catania, S; Liang, T; Onengut, S; Tolun, A; Chessa, L; Sanal, O; Bernatowska, E; Gatti, RA; Concannon, P				Teraoka, SN; Telatar, M; Becker-Catania, S; Liang, T; Onengut, S; Tolun, A; Chessa, L; Sanal, O; Bernatowska, E; Gatti, RA; Concannon, P			Splicing defects in the ataxia-telangiectasia gene, ATM: Underlying mutations and consequences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; MESSENGER-RNA; NONSENSE MUTATIONS; PROTEIN; EXPRESSION; STOP; SUSCEPTIBILITY; PHENOTYPES; DIVERSITY; JUNCTIONS	Mutations resulting in defective splicing constitute a significant proportion (30/62 [48%]) of a new series of mutations in the ATM gene in patients with ataxia-telangiectasia (AT) that were detected by the protein-truncation assay followed by sequence analysis of genomic DNA. Fewer than half of the splicing mutations involved the canonical AG splice-acceptor site or GT splice-donor site. A higher percentage of mutations occurred at less stringently conserved sites, including silent mutations of the last nucleotide of exons, mutations in nucleotides other than the conserved AG and GT in the consensus splice sites, and creation of splice-acceptor or splice-donor sites in either introns or exons. These splicing mutations led to a variety of consequences, including exon skipping and, to a lesser degree, intron retention, activation of cryptic splice sites, or creation of new splice sites. In addition, 5 of 12 nonsense mutations and 1 missense mutation were associated with deletion in the cDNA of the exons in which the mutations occurred. No ATM protein was detected by western blotting in any AT cell line in which splicing mutations were identified. Several cases of exon skipping in both normal controls and patients for whom no underlying defect could be found in genomic DNA were also observed, suggesting caution in the interpretation of exon deletions observed in ATM cDNA when there is no accompanying identification of genomic mutations.	Virginia Mason Res Ctr, Program Mol Genet, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA; Bogazici Univ, Istanbul, Turkey; Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; Hacettepe Univ, Sch Med, Dept Pediat, Ankara, Turkey; Childrens Mem Hosp, Warsaw, Poland	Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Bogazici University; Sapienza University Rome; Hacettepe University; Children's Memorial Health Institute	Concannon, P (corresponding author), Virginia Mason Res Ctr, Program Mol Genet, 1000 Seneca St, Seattle, WA 98101 USA.	patcon@u.washington.edu	Tolun, Aslihan/AAS-2250-2020	Tolun, Aslihan/0000-0002-0328-6046; Concannon, Patrick/0000-0002-5801-1859; Bernatowska, Ewa/0000-0002-0125-266X	NCI NIH HHS [CA57569, R01 CA057569] Funding Source: Medline; NINDS NIH HHS [NS35322] Funding Source: Medline; Telethon [E.0764] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035322] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; CURRY CJR, 1989, AM J HUM GENET, V45, P270; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Dork T, 1997, MOL CELL PROBE, V11, P71, DOI 10.1006/mcpr.1996.0079; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; GATTI RA, 1991, ADV CANCER RES, V56, P77; GATTI RA, 1998, METABOLIC MOL BASES; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Hoffmeyer S, 1998, AM J HUM GENET, V62, P269, DOI 10.1086/301715; HUE YK, 1994, CANCER RES, V54, P2544; HULL J, 1994, GENOMICS, V19, P362, DOI 10.1006/geno.1994.1070; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lakin ND, 1996, ONCOGENE, V13, P2707; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Maquat LE, 1996, AM J HUM GENET, V59, P279; MAQUAT LE, 1995, RNA, V1, P453; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; McConville CM, 1996, AM J HUM GENET, V59, P320; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Schwarze U, 1997, AM J HUM GENET, V61, P1276, DOI 10.1086/301641; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Telatar M, 1996, AM J HUM GENET, V59, P40; Telatar M, 1998, AM J HUM GENET, V62, P86, DOI 10.1086/301673; Uziel T, 1996, GENOMICS, V33, P317, DOI 10.1006/geno.1996.0201; Vorechovsky I, 1996, CANCER RES, V56, P2726; Wright J, 1996, AM J HUM GENET, V59, P839	42	234	237	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1617	1631		10.1086/302418	http://dx.doi.org/10.1086/302418			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330348	Green Published, Bronze			2022-12-18	WOS:000080696200013
J	Mackay, D; Ionides, A; Kibar, Z; Rouleau, G; Berry, V; Moore, A; Shiels, A; Bhattacharya, S				Mackay, D; Ionides, A; Kibar, Z; Rouleau, G; Berry, V; Moore, A; Shiels, A; Bhattacharya, S			Connexin46 mutations in autosomal dominant congenital cataract	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIDROTIC ECTODERMAL DYSPLASIA; ZONULAR PULVERULENT CATARACT; GAP JUNCTION PROTEIN; MISSENSE MUTATION; POLAR CATARACT; GENE; DEAFNESS; LINKAGE; LOCUS; LENS	Loci for autosomal dominant "zonular pulverulent" cataract have been mapped to chromosomes 1q(CZP1) and 13q (CZP3). Here we report genetic refinement of the CZP3 locus and identify underlying mutations in the gene for gap-junction protein alpha-3 (GJA3), or connexin46 (Cx46). Linkage analysis gave a significantly positive two-point LOD score (Z) at marker D13S175 (maximum Z [Z(max)] = > 7.0; maximum recombination frequency [theta(max)] = 0). Haplotyping indicated that CZP3 probably lies in the genetic interval D1381236-D13S175-D13S1316-cen-13pter, close to GJA3. Sequencing of a genomic clone isolated from the CZP3 candidate region identified an open reading frame coding for a protein of 435 amino acids (47,435 D) that shared similar to 88% homology with rat Cx46. Mutation analysis of GJA3 in two families with CZP3 detected distinct sequence changes that were not present in a panel of 105 normal, unrelated individuals. In family B, an A-->G transition resulted in an asparagine-to-serine substitution at codon 63 (N63S) and introduced a novel MwoI restriction site. In family E, insertion of a C at nucleotide 1137 (1137insC) introduced a novel BstXI site, causing a frameshift at codon 380. Restriction analysis confirmed that the novel MwoI and BstXI sites cosegregated with the disease in families B and E, respectively. This study identities GJA3 as the sixth member of the connexin gene family to be implicated in human disease, and it highlights the physiological importance of gap-junction communication in the development of a transparent eye lens.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Inst Ophthalmol, Dept Mol Genet, London, England; Moorfields Eye Hosp, London, England; McGill Univ, Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	Washington University (WUSTL); University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; McGill University	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Box 8096,660 S Euclid Ave, St Louis, MO 63110 USA.		Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Mackay, Donna/0000-0002-2499-1203	NATIONAL EYE INSTITUTE [R01EY012284, R01EY011411] Funding Source: NIH RePORTER; NEI NIH HHS [EY12284, EY11411] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; ATWOOD MM, 1988, ANN HUM GENET, V52, P259; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Berry V, 1996, HUM MOL GENET, V5, P415, DOI 10.1093/hmg/5.3.415; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; Brown N. P., 1996, LENS DISORDERS CLIN, V3rd; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EIBERG H, 1988, CLIN GENET, V34, P272; EIBERG H, 1995, HUM GENET, V96, P33, DOI 10.1007/BF00214183; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Hejtmancik JF, 1998, AM J HUM GENET, V62, P520, DOI 10.1086/301774; Ionides ACW, 1997, HUM MOL GENET, V6, P47, DOI 10.1093/hmg/6.1.47; Jiang JX, 1996, P NATL ACAD SCI USA, V93, P1287, DOI 10.1073/pnas.93.3.1287; KANABIRAN C, 1998, MOL VIS, V4, P21; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kibar Z, 1996, HUM MOL GENET, V5, P543, DOI 10.1093/hmg/5.4.543; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Mackay D, 1997, AM J HUM GENET, V60, P1474, DOI 10.1086/515468; Merin S., 1991, INHERITED EYE DIS, P86; Mignon C, 1996, CYTOGENET CELL GENET, V72, P185, DOI 10.1159/000134183; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Steele EC, 1998, CURR EYE RES, V17, P883, DOI 10.1076/ceyr.17.9.883.5144; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Taylor TD, 1998, J INVEST DERMATOL, V111, P83, DOI 10.1046/j.1523-1747.1998.00245.x; Toth T, 1998, CIRCULATION, V97, P117; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202; WHITE TW, 1994, J CELL BIOL, V125, P879, DOI 10.1083/jcb.125.4.879; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845	40	234	248	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1357	1364		10.1086/302383	http://dx.doi.org/10.1086/302383			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205266	Bronze, Green Published			2022-12-18	WOS:000080093000013
J	Campbell, L; Potter, A; Ignatius, J; Dubowitz, V; Davies, K				Campbell, L; Potter, A; Ignatius, J; Dubowitz, V; Davies, K			Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOTOR-NEURON GENE; UNSTABLE REGION; 5Q13; DELETIONS; CONTIG; SMA; IDENTIFICATION; ASSOCIATION; INDIVIDUALS; DIAGNOSIS	Autosomal recessive spinal muscular atrophy (SMA) is classified, on the basis of age at onset and severity, into three types: type I, severe; type II, intermediate; and type III, mild. The critical region in 5q13 contains an inverted repeat harboring several genes, including the survival motor neuron (SMN) gene, the neuronal apoptosis inhibitory protein (NAIP) gene, and the p44 gene, which encodes a transcription-factor subunit. Deletion of NAIP and p44 is observed more often in severe SMA, but there is no evidence that these genes play a role in the pathology of the disease. In >90% of all SMA patients, exons 7 and 8 of the telomeric SMN gene (SMNtel) are not detectable, and this is also observed in some normal siblings and parents. Point mutations and gene conversions in SMNtel suggest that it plays a major role in the disease. To define a correlation between genotype and phenotype, we mapped deletions, using pulsed-field gel electrophoresis. Surprisingly, our data show that mutations in SMA types II and III, previously classed as deletions, are in fact due to gene-conversion events in which SMNtel is replaced by its centromeric counterpart, SMNcen. This results in a greater number of SMNcen copies in type II and type III patients compared with type I patients and enables a genotype/phenotype correlation to be made. We also demonstrate individual DNA-content variations of several hundred kilobases, even in a relatively isolated population from Finland. This explains why no consensus map of this region has been produced. This DNA variation may be due to a midisatellite repeat array, which would promote the observed high deletion and gene-conversion rate.	UNIV OXFORD,DEPT BIOCHEM,GENET UNIT,OXFORD OX1 3QU,ENGLAND; FAMILY FEDERAT FINLAND,DEPT MED GENET,HELSINKI,FINLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT PEDIAT,NEUROMUSCULAR UNIT,LONDON,ENGLAND	University of Oxford; Family Federation of Finland; Imperial College London				Tinsley, Louise/0000-0002-6893-2096				Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Burglen L, 1997, AM J HUM GENET, V60, P72; Burlet P, 1996, J MED GENET, V33, P281, DOI 10.1136/jmg.33.4.281; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; CARPTEN JD, 1994, GENOMICS, V24, P351, DOI 10.1006/geno.1994.1626; COBBEN JM, 1995, AM J HUM GENET, V57, P805; COLLIER S, 1989, EMBO J, V8, P1393, DOI 10.1002/j.1460-2075.1989.tb03520.x; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Devriendt K, 1996, ANN NEUROL, V40, P731, DOI 10.1002/ana.410400509; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; Dubowitz V., 1995, MUSCLE DISORDERS CHI; Emery A E, 1991, Neuromuscul Disord, V1, P307, DOI 10.1016/0960-8966(91)90106-3; FRANCIS MJ, 1995, GENOMICS, V27, P366, DOI 10.1006/geno.1995.1059; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; IGNATIUS J, 1992, THESISU TAMPERE TAMP, V358; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lefebvre S., 1996, American Journal of Human Genetics, V59, pA268; LEISTI J, 1990, ANN MED, V22, P123, DOI 10.3109/07853899009147254; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Matthijs G, 1996, J MED GENET, V33, P469, DOI 10.1136/jmg.33.6.469; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P2537, DOI 10.1093/nar/15.6.2537; PARSONS WD, 1996, HUM MOL GENET, V5, P1727; Rodrigues NR, 1996, J MED GENET, V33, P93, DOI 10.1136/jmg.33.2.93; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; ROY N, 1995, GENOMICS, V26, P451, DOI 10.1016/0888-7543(95)80162-F; SARGENT CA, 1994, MAMM GENOME, V5, P791, DOI 10.1007/BF00292015; Schwartz M, 1997, HUM MOL GENET, V6, P99, DOI 10.1093/hmg/6.1.99; SELIG S, 1995, P NATL ACAD SCI USA, V92, P3702, DOI 10.1073/pnas.92.9.3702; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; Talbot K, 1996, J MED GENET, V33, P1019, DOI 10.1136/jmg.33.12.1019; TALBOT K, IN PRESS NEUROMUSCUL; THEODOSIOU AM, 1994, AM J HUM GENET, V55, P1209; vanderSteege G, 1996, AM J HUM GENET, V59, P834; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273	49	234	245	1	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					40	50		10.1086/513886	http://dx.doi.org/10.1086/513886			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245983	Green Published, Bronze			2022-12-18	WOS:A1997XM72800010
J	TRASK, BJ; MASSA, H; KENWRICK, S; GITSCHIER, J				TRASK, BJ; MASSA, H; KENWRICK, S; GITSCHIER, J			MAPPING OF HUMAN-CHROMOSOME XQ28 BY 2-COLOR FLUORESCENCE INSITU HYBRIDIZATION OF DNA-SEQUENCES TO INTERPHASE CELL-NUCLEI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-X-CHROMOSOME; COLOR-VISION; LONG ARM; LINKAGE; REGION; GENES; SITE; MARKERS; G6PD; MAP	We have used the proximity of probe hybridization sites in interphase chromatin to derive the order of DNA sequences in a 2-3-Mbp region of human chromosome Xq28. The map generated bridges the results of genetic and pulsed-field gel electrophoresis mapping to produce a more complete map of Xq28 than possible with either of these other techniques alone. Two-color fluorescence in situ hybridization (FISH) was used to detect the positions of two or more probes in G1 male interphase nuclei. We show that cosmids that are 50 kbp to 2-3 Mbp apart can be ordered rapidly with two alternative approaches: (1) by comparing the average measured distance between two probes and (2) simply by scoring the order of red and green fluorescent dots after detection of three or more probes with two fluorochromes. The validity of these approaches is demonstrated using five cosmids from a region spanning almost-equal-to-800 kbp that includes the factor VIII (F8), glucose-6-phosphate dehydrogenase (G6PD), and color-vision pigment (CV) genes. The cosmid map derived from interphase mapping is consistent with the map determined by restriction-fragment analysis. The two interphase mapping approaches were then used (1) to orient the F8/CV cluster relative to two markers, c1A1 and st14c, which we show by metaphase mapping to be proximal to the F8/CV cluster, (2) to position st14c (DXS52) between c1A1 and F8, and (3) to orient the CV gene cluster relative to G6PD by using two CV-flanking cosmids, 18b41 and fr7. The probe order in Xq28 derived from interphase proximity is cen-c1A1-st14c-5'F8 (p624-p542-p625)-G6PD-18b41-3' green-green-red-fr7-tel. We also show that, to determine their order by using metaphase chromosomes, sequences must be at least 1 Mbp apart, an order of magnitude greater than required in interphase chromatin. The data show that FISH mapping is a simple way to order sequences separated by greater-than-or-equal-to 50 kbp for the construction of long-range maps of mammalian genomes.	UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	TRASK, BJ (corresponding author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,L-452,POB 5507,LIVERMORE,CA 94550, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17665] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARVEILER B, 1989, GENOMICS, V4, P460, DOI 10.1016/0888-7543(89)90269-3; AUBOURG P, 1990, AM J HUM GENET, V46, P459; AUBOURG PR, 1987, ANN NEUROL, V21, P349, DOI 10.1002/ana.410210406; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BOSWINKEL E, 1985, CYTOGENET CELL GENET, V40, P586; BUCAN M, 1990, GENOMICS, V6, P1; CARROLL MC, 1987, P NATL ACAD SCI USA, V84, P8535, DOI 10.1073/pnas.84.23.8535; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; DRUMMONDBORG M, 1989, P NATL ACAD SCI USA, V86, P983, DOI 10.1073/pnas.86.3.983; FEIL R, 1990, AM J HUM GENET, V46, P720; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; GITSCHIER J, 1984, NATURE, V312, P336; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; KENWRICK S, 1989, AM J HUM GENET, V45, P873; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KNOERS N, 1988, HUM GENET, V80, P31, DOI 10.1007/BF00451451; LAWRENCE JB, 1990, SCIENCE, V249, P928, DOI 10.1126/science.2203143; LAWRENCE JB, 1988, CELL, V52, P51; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LUDECKE HJ, 1990, HUM GENET, V84, P512; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NELSON WG, 1986, ANNU REV BIOPHYS BIO, V15, P457, DOI 10.1146/annurev.bb.15.060186.002325; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; PATTERSON M, 1988, AM J MED GENET, V30, P581, DOI 10.1002/ajmg.1320300159; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PATTERSON M, 1989, AM J HUM GENET, V44, P679; PATTERSON MN, 1989, GENOMICS, V4, P570, DOI 10.1016/0888-7543(89)90281-4; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; WADA M, 1990, AM J HUM GENET, V46, P95; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029	35	234	245	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					1	15						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985451				2022-12-18	WOS:A1991ET18800001
J	GOLDGAR, DE				GOLDGAR, DE			MULTIPOINT ANALYSIS OF HUMAN QUANTITATIVE GENETIC-VARIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											GOLDGAR, DE (corresponding author), UNIV UTAH,DEPT MED INFORMAT,420 CHIPETA WAY,SUITE 180,SALT LAKE CITY,UT 84108, USA.				NCI NIH HHS [CA-36362, CA-48711] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R23CA036362, P01CA048711, R01CA036362] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; DEMENAIS FM, 1989, MULTIPOINT MAPPING L, V6, P201; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Feller W., 1968, INTRO PROBABILITY TH, V1; GIBSON JB, 1962, HEREDITY, V17, P1, DOI 10.1038/hdy.1962.1; GOLDGAR DE, 1980, AM J HUM GENET, V32, pA143; GOLDGAR DE, 1981, THESIS U COLORADO BO; Haldane JBS, 1919, J GENET, V8, P299; HARRISON BJ, 1950, HEREDITY, V4, P295, DOI 10.1038/hdy.1950.23; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HILL AP, 1975, ANN HUM GENET, V38, P443; LANDER ES, 1989, GENETICS, V121, P185; OTT J, 1985, ANAL HUMAN GENETIC L; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PENROSE LS, 1983, ANN EUGEN, V9, P133; RISCH N, 1979, ANN HUM GENET, V43, P177, DOI 10.1111/j.1469-1809.1979.tb02010.x; SUAREZ BK, 1979, HUM HERED, V29, P37, DOI 10.1159/000153013; WILKS SS, 1962, MATH STATISTICS	19	234	242	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					957	967						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	2239972				2022-12-18	WOS:A1990EK40000012
J	HARADA, S; MISAWA, S; AGARWAL, DP; GOEDDE, HW				HARADA, S; MISAWA, S; AGARWAL, DP; GOEDDE, HW			LIVER ALCOHOL-DEHYDROGENASE AND ALDEHYDE DEHYDROGENASE IN THE JAPANESE - ISOENZYME VARIATION AND ITS POSSIBLE ROLE IN ALCOHOL-INTOXICATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TSUKUBA, DEPT LEGAL MED, SAKURA, IBARAKI 30031, JAPAN	University of Tsukuba	HARADA, S (corresponding author), UNIV HAMBURG, INST HUMAN GENET, D-2000 HAMBURG 13, GERMANY.							AZEVEDO ES, 1976, ANN HUM GENET, V39, P321, DOI 10.1111/j.1469-1809.1976.tb00136.x; FUKUI M, 1972, JAP J LEGAL MED, V26, P46; GOEDDE HW, 1979, CLIN GENET, V16, P29; GOEDDE HW, HUM GENET; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HARADA S, 1978, HUM GENET, V40, P215, DOI 10.1007/BF00272304; HARADA S, 1978, HUM GENET, V44, P181, DOI 10.1007/BF00295411; KORSTEN MA, 1975, NEW ENGL J MED, V292, P386, DOI 10.1056/NEJM197502202920802; PETERSEN DR, 1977, J PHARMACOL EXP THER, V201, P471; RASKIN NH, 1975, NEW ENGL J MED, V292, P422, DOI 10.1056/NEJM197502202920811; SCHENKER TM, 1971, EUR J BIOCHEM, V24, P271, DOI 10.1111/j.1432-1033.1971.tb19681.x; SMITH M, 1973, ANN HUM GENET, V37, P49, DOI 10.1111/j.1469-1809.1973.tb01814.x; SMITH M, 1972, ANN HUM GENET, V35, P243, DOI 10.1111/j.1469-1809.1957.tb01398.x; SMITH M, 1971, ANN HUM GENET, V34, P251, DOI 10.1111/j.1469-1809.1971.tb00238.x; STAMATOYANNOPOULOS G, 1975, AM J HUM GENET, V27, P789; VONWARTBURG JP, 1965, CAN J BIOCHEM CELL B, V43, P889, DOI 10.1139/o65-102	16	234	237	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					8	15						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	6987864				2022-12-18	WOS:A1980JH29600002
J	WEINSHILBOUM, RM; RAYMOND, FA				WEINSHILBOUM, RM; RAYMOND, FA			INHERITANCE OF LOW ERYTHROCYTE CATECHOL-O-METHYLTRANSFERASE ACTIVITY IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN, DEPT PHARMACOL, CLIN PHARMACOL UNIT, ROCHESTER, MN 55901 USA; MAYO CLIN & MAYO FDN, DEPT INTERNAL MED, ROCHESTER, MN 55901 USA	Mayo Clinic; Mayo Clinic								ASSICOT M, 1971, BIOCHIMIE, V53, P871, DOI 10.1016/S0300-9084(71)80150-5; AXELROD J, 1958, J BIOL CHEM, V233, P702; AZELROD J, 1971, J PHARMACOL EXP THER, V176, P650; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; COHN CK, 1970, SCIENCE, V170, P1323, DOI 10.1126/science.170.3964.1323; GERSHON ES, 1975, ARCH GEN PSYCHIAT, V32, P1351; GUSTAVSON KH, 1973, CLIN GENET, V4, P279; LI CC, 1961, HUMAN GENETICS; QUIRAM DR, 1976, J NEUROCHEM, V27, P1197, DOI 10.1111/j.1471-4159.1976.tb00327.x; RAYMOND FA, 1975, CLIN CHIM ACTA, V58, P185, DOI 10.1016/S0009-8981(75)80012-X; WEINSHILBOUM RM, 1974, NATURE, V252, P490, DOI 10.1038/252490a0; WEINSHILBOUM RM, 1975, AM J HUM GENET, V27, P573; WEINSHILBOUM RM, 1976, BIOCHEM PHARMACOL, V25, P573, DOI 10.1016/0006-2952(76)90390-7; WYATT RJ, 1973, SCIENCE, V179, P916, DOI 10.1126/science.179.4076.916	14	234	234	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	2					125	135						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB507	848488				2022-12-18	WOS:A1977DB50700001
J	Sato, D; Lionel, AC; Leblond, CS; Prasad, A; Pinto, D; Walker, S; O'Connor, I; Russell, C; Drmic, IE; Hamdan, FF; Michaud, JL; Endris, V; Roeth, R; Delorme, R; Huguet, G; Leboyer, M; Rastam, M; Gillberg, C; Lathrop, M; Stavropoulos, DJ; Anagnostou, E; Weksberg, R; Fombonne, E; Zwaigenbaum, L; Fernandez, BA; Roberts, W; Rappold, GA; Marshall, CR; Bourgeron, T; Szatmari, P; Scherer, SW				Sato, Daisuke; Lionel, Anath C.; Leblond, Claire S.; Prasad, Aparna; Pinto, Dalila; Walker, Susan; O'Connor, Irene; Russell, Carolyn; Drmic, Irene E.; Hamdan, Fadi F.; Michaud, Jacques L.; Endris, Volker; Roeth, Ralph; Delorme, Richard; Huguet, Guillaume; Leboyer, Marion; Rastam, Maria; Gillberg, Christopher; Lathrop, Mark; Stavropoulos, Dimitri J.; Anagnostou, Evdokia; Weksberg, Rosanna; Fombonne, Eric; Zwaigenbaum, Lonnie; Fernandez, Bridget A.; Roberts, Wendy; Rappold, Gudrun A.; Marshall, Christian R.; Bourgeron, Thomas; Szatmari, Peter; Scherer, Stephen W.			SHANK1 Deletions in Males with Autism Spectrum Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; SCAFFOLDING PROTEIN SHANK3; GENOME-WIDE ASSOCIATION; DE-NOVO; MUTATIONS; VARIANTS; COMMON; GENE; PROSAP/SHANK; POPULATION	Recent studies have highlighted the involvement of rare (<1% frequency) copy-number variations and point mutations in the genetic etiology of autism spectrum disorder (ASD); these variants particularly affect genes involved in the neuronal synaptic complex. The SHANK gene family consists of three members (SHANK1, SHANK2, and SHANK3), which encode scaffolding proteins required for the proper formation and function of neuronal synapses. Although SHANK2 and SHANK3 mutations have been implicated in ASD and intellectual disability, the involvement of SHANK1 is unknown. Here, we assess microarray data from 1,158 Canadian and 456 European individuals with ASD to discover microdeletions at the SHANK1 locus on chromosome 19. We identify a hemizygous SHANK1 deletion that segregates in a four-generation family in which male carriers-but not female carriers-have ASD with higher functioning. A de novo SHANK1 deletion was also detected in an unrelated male individual with ASD with higher functioning, and no equivalent SHANK1 mutations were found in >15,000 controls (p = 0.009). The discovery of apparent reduced penetrance of ASD in females bearing inherited autosomal SHANK1 deletions provides a possible contributory model for the male gender bias in autism. The data are also informative for clinical-genetics interpretations of both inherited and sporadic forms of ASD involving SHANK1.	[Sato, Daisuke; Lionel, Anath C.; Prasad, Aparna; Pinto, Dalila; Walker, Susan; Marshall, Christian R.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Sato, Daisuke; Lionel, Anath C.; Prasad, Aparna; Pinto, Dalila; Walker, Susan; Marshall, Christian R.; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Lionel, Anath C.; Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Lionel, Anath C.; Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 1L7, Canada; [Leblond, Claire S.; Delorme, Richard; Huguet, Guillaume; Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, F-75015 Paris, France; [Leblond, Claire S.; Delorme, Richard; Huguet, Guillaume; Bourgeron, Thomas] Univ Paris Diderot, F-75013 Paris, France; [O'Connor, Irene; Russell, Carolyn; Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Offord Ctr Child Studies, Hamilton, ON L8S 4K1, Canada; [Drmic, Irene E.; Roberts, Wendy] Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Hamdan, Fadi F.; Michaud, Jacques L.] Univ Montreal, St Justine Hosp, Res Ctr, Ctr Excellence Neurosci, Montreal, PQ H2L 2W5, Canada; [Endris, Volker; Roeth, Ralph; Rappold, Gudrun A.] Heidelberg Univ, Dept Human Mol Genet, D-69120 Heidelberg, Germany; [Delorme, Richard] Robert Debre Hosp, AP HP, Dept Child & Adolescent Psychiat, F-75019 Paris, France; [Leboyer, Marion] INSERM, U955, Psychiat Genet Team, F-94010 Creteil, France; [Leboyer, Marion] Fdn FondaMental, F-94000 Creteil, France; [Rastam, Maria] Lund Univ, Dept Clin Sci Lund, SE-22100 Lund, Sweden; [Gillberg, Christopher] Univ Gothenburg, Gillberg Neuropsychiat Ctr, SE-41119 Gothenburg, Sweden; [Gillberg, Christopher] Univ London, Inst Child Hlth, London WC1N 1EH, England; [Lathrop, Mark] Ctr Natl Genotypage, F-91057 Evry, France; [Stavropoulos, Dimitri J.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1L7, Canada; [Anagnostou, Evdokia] Univ Toronto, Bloorview Res Inst, Toronto, ON M4G 1R8, Canada; [Weksberg, Rosanna] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Weksberg, Rosanna] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Fombonne, Eric] Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3Z 1P2, Canada; [Fombonne, Eric] McGill Univ, Montreal, PQ H3Z 1P2, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T5G 0B7, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3V6, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF A1B 3V6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Lund University; University of Gothenburg; University of London; University College London; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; University of Alberta; Memorial University Newfoundland; Memorial University Newfoundland	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada.	szatmar@mcmaster.ca; stephen.scherer@sickkids.ca	Huguet, Guillaume/GPX-3656-2022; Pinto, Dalila/C-4218-2016; Scherer, Stephen W./B-3785-2013; Leboyer, Marion/AAW-3648-2021; Fombonne, Eric/M-4893-2018; Prasad, Aparna/N-4253-2015	Huguet, Guillaume/0000-0002-4746-6030; Pinto, Dalila/0000-0002-8769-0846; Scherer, Stephen W./0000-0002-8326-1999; Leboyer, Marion/0000-0001-5473-3697; Fombonne, Eric/0000-0002-8605-3538; Prasad, Aparna/0000-0002-6786-2313; Delorme, Richard/0000-0002-5614-3663; Bourgeron, Thomas/0000-0001-8164-9220	University of Toronto McLaughlin Centre; NeuroDevNet; Genome Canada; Ontario Genomics Institute; Canadian Institutes for Health Research (CIHR); Canadian Institute for Advanced Research; Canada Foundation for Innovation; government of Ontario; Autism Speaks; Hospital for Sick Children Foundation; Deutsche Forschungsgemeinschaft; BMBF/NGFNplus (German Mental-Retardation Network); Agence Nationale de la Recherche [ANR-08-MNPS-037-01-SynGen]; Neuron-ERANET (EUHF-AUTISM); Fondation Orange	University of Toronto McLaughlin Centre; NeuroDevNet; Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); government of Ontario; Autism Speaks; Hospital for Sick Children Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF/NGFNplus (German Mental-Retardation Network); Agence Nationale de la Recherche(French National Research Agency (ANR)); Neuron-ERANET (EUHF-AUTISM); Fondation Orange	This work was supported by grants from the University of Toronto McLaughlin Centre, NeuroDevNet, Genome Canada and the Ontario Genomics Institute, the Canadian Institutes for Health Research (CIHR), the Canadian Institute for Advanced Research, the Canada Foundation for Innovation, the government of Ontario, Autism Speaks, and The Hospital for Sick Children Foundation. S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children. G.A.R. was supported by Deutsche Forschungsgemeinschaft and the BMBF/NGFNplus (German Mental-Retardation Network). T.B. was supported by Agence Nationale de la Recherche (ANR-08-MNPS-037-01-SynGen), Neuron-ERANET (EUHF-AUTISM), and Fondation Orange. We are indebted to the individuals and their families for participating in this study and to The Centre for Applied Genomics at The Hospital for Sick Children. We thank A. Fiebig, A. Franke, and S. Schreiber at POPGEN (University of Kiel, Kiel, Germany), A. Stewart, R. McPherson, and R. Roberts of the University of Ottawa Heart Institute (University of Ottawa, Ottawa, Canada), the Wellcome Trust Case Control Consortium, and the Study of Addiction: Genetics and Environment consortium for providing control data. A provisional patent has been filed for The Hospital for Sick Children in S.W. Scherer's name.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Berkel S, 2012, HUM MOL GENET, V21, P344, DOI 10.1093/hmg/ddr470; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gillberg C, 2006, J AUTISM DEV DISORD, V36, P429, DOI 10.1007/s10803-006-0081-6; Grabrucker AM, 2011, TRENDS CELL BIOL, V21, P594, DOI 10.1016/j.tcb.2011.07.003; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Losh M, 2008, AM J MED GENET B, V147B, P424, DOI 10.1002/ajmg.b.30612; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Phillips GR, 2003, J NEUROSCI, V23, P5096; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Sheng M, 2000, J CELL SCI, V113, P1851; Stewart AFR, 2009, J AM COLL CARDIOL, V53, P1471, DOI 10.1016/j.jacc.2008.12.051; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	50	233	240	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					879	887		10.1016/j.ajhg.2012.03.017	http://dx.doi.org/10.1016/j.ajhg.2012.03.017			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22503632	Green Published, Bronze			2022-12-18	WOS:000303907500012
J	Upadhyaya, M; Huson, SM; Davies, M; Thomas, N; Chuzhanova, N; Giovannini, S; Evans, DG; Howard, E; Kerr, B; Griffiths, S; Consoli, C; Side, L; Adams, D; Pierpont, M; Hachen, R; Barnicoat, A; Li, H; Wallace, P; Van Biervliet, JP; Stevenson, D; Viskochil, D; Baralle, D; Haan, E; Riccardi, V; Turnpenny, P; Lazaro, C; Messiaen, L				Upadhyaya, M.; Huson, S. M.; Davies, M.; Thomas, N.; Chuzhanova, N.; Giovannini, S.; Evans, D. G.; Howard, E.; Kerr, B.; Griffiths, S.; Consoli, C.; Side, L.; Adams, D.; Pierpont, M.; Hachen, R.; Barnicoat, A.; Li, H.; Wallace, P.; Van Biervliet, J. P.; Stevenson, D.; Viskochil, D.; Baralle, D.; Haan, E.; Riccardi, V.; Turnpenny, P.; Lazaro, C.; Messiaen, L.			An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE SEQUENCE-ANALYSIS; GAP-RELATED DOMAIN; AU-LAIT SPOTS; TYPE-1 NF1; CARDIOVASCULAR MALFORMATIONS; SPINAL NEUROFIBROMATOSIS; MUTATIONAL SPECTRUM; WATSON SYNDROME; MESSENGER-RNA; SCHWANN-CELLS	Neurofibromatosis type 1 (NF1) is characterized by cafe-au-lait spots, skinfold freckling, and cutaneous neurofibromas. No obvious relationships between small mutations (! 20 bp) of the NF1 gene and a specific phenotype have previously been demonstrated, which suggests that interaction with either unlinked modifying genes and/or the normal NF1 allele may be involved in the development of the particular clinical features associated with NF1. We identified 21 unrelated probands with NF1 ( 14 familial and 7 sporadic cases) who were all found to have the same c. 2970-2972 delAAT(p.990delM) mutation but no cutaneous neurofibromas or clinically obvious plexiform neurofibromas. Molecular analysis identified the same 3-bp inframe deletion (c. 2970-2972 delAAT) in exon 17 of the NF1 gene in all affected subjects. The Delta AAT mutation is predicted to result in the loss of one of two adjacent methionines (codon 991 or 992) (Delta Met991), in conjunction with silent ACA -> ACG change of codon 990. These two methionine residues are located in a highly conserved region of neurofibromin and are expected, therefore, to have a functional role in the protein. Our data represent results from the first study to correlate a specific small mutation of the NF1 gene to the expression of a particular clinical phenotype. The biological mechanism that relates this specific mutation to the suppression of cutaneous neurofibroma development is unknown.	Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; John Radcliffe Hosp, Dept Clin Genet, Oxford OX3 9DU, England; Albany Med Ctr, Albany, NY USA; Childrens Hosp & Clin, Minneapolis, MN USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ London, Inst Child Hlth, London WC1N 1EH, England; Univ Florida, Gainesville, FL 32611 USA; Acad Hosp St Jan, Brugge, Belgium; Univ Utah, Div Med Genet, Salt Lake City, UT USA; Addenbrookes Hosp, Dept Med Genet, Cambridge, England; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia; Neurofibromatosis Inst, Crescenta, Italy; Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; Inst Catala Oncol, Barcelona, Spain; Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	Cardiff University; University of Manchester; University of Manchester; University of Oxford; Albany Medical College; Children's Hospitals & Clinics of Minnesota; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of London; University College London; State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Adelaide; Womens & Childrens Hospital Australia; University of Exeter; Catalan Institute of Oncology; University of Alabama System; University of Alabama Birmingham	Upadhyaya, M (corresponding author), Cardiff Univ, Inst Med Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	Upadhyaya@cardiff.ac.uk	Evans, D Gareth/AAB-4308-2022; Side, Lucy/A-6990-2011; GARCIA, CONXI LAZARO/Q-2410-2016	Evans, D Gareth/0000-0002-8482-5784; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Baralle, Diana/0000-0003-3217-4833; Chuzhanova, Nadia/0000-0002-4655-3618; Davies, Mark/0000-0002-0688-3129				ABELIOVICH D, 1995, J MED GENET, V32, P985, DOI 10.1136/jmg.32.12.985; ALLANSON JE, 1991, J MED GENET, V28, P752, DOI 10.1136/jmg.28.11.752; Ars E, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.6.e82; Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Arun D, 2004, CURR OPIN NEUROL, V17, P101, DOI 10.1097/00019052-200404000-00004; Ball EV, 2005, HUM MUTAT, V26, P205, DOI 10.1002/humu.20212; Baralle D, 2003, AM J MED GENET A, V119A, P1, DOI 10.1002/ajmg.a.20023; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; BRUNNER HG, 1993, AM J MED GENET, V46, P472, DOI 10.1002/ajmg.1320460428; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; CALLADINE CR, 2004, UNDERSTANDING DNA MO, P334; Carey JC, 1998, AM J MED GENET, V75, P263, DOI 10.1002/(SICI)1096-8628(19980123)75:3<263::AID-AJMG7>3.0.CO;2-R; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Castle B, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e109; CHARROW J, 1993, AM J MED GENET, V45, P606, DOI 10.1002/ajmg.1320450518; Chuzhanova NA, 2003, HUM MUTAT, V21, P28, DOI 10.1002/humu.10146; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cnossen MH, 1998, J MED GENET, V35, P624, DOI 10.1136/jmg.35.8.624; Cnossen MH, 1997, HUM MUTAT, V9, P458, DOI 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1; Colley A, 1996, CLIN GENET, V49, P59; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; De Luca A, 2005, AM J HUM GENET, V77, P1092, DOI 10.1086/498454; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; DeBella K, 2000, PEDIATRICS, V105, P608, DOI 10.1542/peds.105.3.608; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; EASTON DF, 1993, AM J HUM GENET, V53, P305; EASTON DF, 1998, NEUROFIBROMATOSIS TY, P167; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; GRIFFITHS S, 2006, MOL DIAGNOSIS NEUROF; Gusev VD, 1999, BIOINFORMATICS, V15, P994; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; HUSON SM, 1989, THESIS U EDINBURGH E; Izawa I, 1996, FEBS LETT, V382, P53, DOI 10.1016/0014-5793(96)00137-8; KAYES LM, 1994, AM J HUM GENET, V54, P424; Khosrotehrani K, 2005, AM J MED GENET A, V132A, P49, DOI 10.1002/ajmg.a.30394; Klose A, 1999, AM J MED GENET, V83, P6, DOI 10.1002/(SICI)1096-8628(19990305)83:1<6::AID-AJMG3>3.3.CO;2-5; Kluwe Lan, 2003, Hum Mutat, V22, P420, DOI 10.1002/humu.9193; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Lin AE, 2000, AM J MED GENET, V95, P108, DOI 10.1002/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Maertens O, 2006, HUM MUTAT, V27, P1030, DOI 10.1002/humu.20389; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mattocks C, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011890; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Messiaen LM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029629; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Poyhonen M, 1997, J MED GENET, V34, P184, DOI 10.1136/jmg.34.3.184; PULST SM, 1991, NEUROLOGY, V41, P1923, DOI 10.1212/WNL.41.12.1923; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Riccardi VM, 1999, NEUROFIBROMATOSIS PH; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Schorry EK, 1997, AM J MED GENET, V74, P533, DOI 10.1002/(SICI)1096-8628(19970919)74:5<533::AID-AJMG16>3.0.CO;2-D; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; SHEN MH, 1993, HUM MOL GENET, V2, P1861, DOI 10.1093/hmg/2.11.1861; Spiegel M, 2005, EUR J HUM GENET, V13, P883, DOI 10.1038/sj.ejhg.5201419; Stevenson DA, 2006, CLIN GENET, V69, P246, DOI 10.1111/j.1399-0004.2006.00576.x; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Szudek J, 2002, GENET EPIDEMIOL, V23, P150, DOI 10.1002/gepi.1129; Szudek J, 2000, J MED GENET, V37, P933, DOI 10.1136/jmg.37.12.933; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; Thakker SD, 1999, NEURORADIOLOGY, V41, P625, DOI 10.1007/s002340050814; Tonsgard JH, 1998, NEUROLOGY, V50, P1755, DOI 10.1212/WNL.50.6.1755; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; UPADHYAYA A, 1998, NEUROFIBROMATOSIS TY; Upadhyaya M, 1997, HUM GENET, V99, P88; Upadhyaya M, 2004, HUM MUTAT, V23, P134, DOI 10.1002/humu.10305; Upadhyaya M, 2003, HUM GENET, V112, P12, DOI 10.1007/s00439-002-0840-1; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; Upadhyaya M., 1992, Human Molecular Genetics, V1, P735; Upadhyaya M, 1998, NEUROFIBROMATOSIS TY, P65; Upadhyaya M, 2006, HUM MUTAT, V27, P716, DOI 10.1002/humu.9429; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; VISKOCHIL DH, 1998, NEUROFIBROMATOSIS TY, P39; Wimmer K, 2006, GENE CHROMOSOME CANC, V45, P265, DOI 10.1002/gcc.20289; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	84	233	255	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					140	151		10.1086/510781	http://dx.doi.org/10.1086/510781			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160901	Green Published, Bronze			2022-12-18	WOS:000243102500013
J	Wu, XF; Gu, J; Grossman, HB; Amos, CI; Etzel, C; Huang, MS; Zhang, Q; Millikan, RE; Lerner, S; Dinney, CP; Spitz, MR				Wu, XF; Gu, J; Grossman, HB; Amos, CI; Etzel, C; Huang, MS; Zhang, Q; Millikan, RE; Lerner, S; Dinney, CP; Spitz, MR			Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; LUNG-CANCER; DIOL EPOXIDE; SUSCEPTIBILITY; RISK; POLYMORPHISMS; ASSOCIATION; SENSITIVITY; BLEOMYCIN; VARIANTS	The candidate-gene approach in association studies of polygenic diseases has often yielded conflicting results. In this hospital-based case-control study with 696 white patients newly diagnosed with bladder cancer and 629 unaffected white controls, we applied a multigenic approach to examine the associations with bladder cancer risk of a comprehensive panel of 44 selected polymorphisms in two pathways, DNA repair and cell-cycle control, and to evaluate higher-order gene-gene interactions, using classification and regression tree (CART) analysis. Individually, only XPD Asp312Asn, RAG1 Lys820Arg, and a p53 intronic SNP exhibited statistically significant main effects. However, we found a significant gene-dosage effect for increasing numbers of potential high-risk alleles in DNA-repair and cell-cycle pathways separately and combined. For the nucleotide-excision repair pathway, compared with the referent group (fewer than four adverse alleles), individuals with four (odds ratio [OR] = 1.52, 95% CI 1.05-2.20), five to six (OR = 1.81, 95% CI 1.31-2.50), and seven or more adverse alleles (OR = 2.50, 95% CI 1.69-3.70) had increasingly elevated risks of bladder cancer (P for trend <.001). Each additional adverse allele was associated with a 1.21-fold increase in risk (95% CI 1.12-1.29). For the combined analysis of DNA-repair and cell-cycle SNPs, compared with the referent group (< 13 adverse alleles), the ORs for individuals with 13-15, 16-17, and >= 18 adverse alleles were 1.22 (95% CI 0.84-1.76), 1.57 (95% CI 1.05-2.35), and 1.77 (95% CI 1.19-2.63), respectively (P for trend = .002). Each additional high-risk allele was associated with a 1.07-fold significant increase in risk. In addition, we found that smoking had a significant multiplicative interaction with SNPs in the combined DNA-repair and cell-cycle-control pathways (P < .01). All genetic effects were evident only in "ever smokers" (persons who had smoked >= 100 cigarettes) and not in "never smokers." A cross-validation statistical method developed in this study confirmed the above observations. CART analysis revealed potential higher-order gene-gene and gene-smoking interactions and categorized a few higher-risk subgroups for bladder cancer. Moreover, subgroups identified with higher cancer risk also exhibited higher levels of induced genetic damage than did subgroups with lower risk. There was a significant trend of higher numbers of bleomycin- and benzo[a]pyrene diol-epoxide (BPDE)-induced chromatid breaks (by mutagen-sensitivity assay) and DNA damage ( by comet assay) for individuals in higher-risk subgroups among cases of bladder cancer in smokers. The P for the trend was .0348 for bleomycin- induced chromosome breaks, .0036 for BPDE-induced chromosome breaks, and .0397 for BPDE-induced DNA damage, indicating that these higher-order gene-gene and gene-smoking interactions included SNPs that modulated repair and resulted in diminished DNA-repair capacity. Thus, genotype/phenotype analyses support findings from CART analyses. This is the first comprehensive study to use a multigenic analysis for bladder cancer, and the data suggest that individuals with a higher number of genetic variations in DNA-repair and cell-cycle control genes are at an increased risk for bladder cancer, confirming the importance of taking a multigenic pathway-based approach to risk assessment.	Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Wu, XF (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, 1155 Pressler Blvd, Houston, TX 77030 USA.	xwu@mdanderson.org	Millikan, Randall/AAL-9377-2021; Gu, Jian/Q-4780-2018	Gu, Jian/0000-0003-3499-0973; Dinney, Colin/0000-0002-8969-711X	NATIONAL CANCER INSTITUTE [P50CA091846, R01CA074880] Funding Source: NIH RePORTER; NCI NIH HHS [CA 91846, R01 CA074880, P50 CA091846, CA 74880] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Benhamou S, 2005, AM J EPIDEMIOL, V161, P1, DOI 10.1093/aje/kwi018; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Cheng TC, 2005, INT J CANCER, V113, P345, DOI 10.1002/ijc.20630; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Gu J, 2005, CLIN CANCER RES, V11, P1408, DOI 10.1158/1078-0432.CCR-04-1101; Han JL, 2004, CANCER RES, V64, P3009, DOI 10.1158/0008-5472.CAN-04-0246; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horne BD, 2005, ANN HUM GENET, V69, P176, DOI 10.1046/j.1529-8817.2005.00155.x; HSU TC, 1989, INT J CANCER, V43, P403, DOI 10.1002/ijc.2910430310; Hu Z, 2004, LUNG CANCER, V46, P1, DOI 10.1016/j.lungcan.2004.03.016; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Matullo G, 2003, CANCER EPIDEM BIOMAR, V12, P674; Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6; Neumann AS, 2005, MOL CARCINOGEN, V42, P65, DOI 10.1002/mc.20069; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Schabath MB, 2003, J NATL CANCER I, V95, P540, DOI 10.1093/jnci/95.7.540; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Spitz MR, 2001, CANCER RES, V61, P1354; Stern MC, 2002, CANCER EPIDEM BIOMAR, V11, P1004; Wu XF, 1998, J NATL CANCER I, V90, P1393, DOI 10.1093/jnci/90.18.1393; Wu XF, 1998, CANCER-AM CANCER SOC, V83, P1118, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1118::AID-CNCR10>3.3.CO;2-1; Wu XF, 2004, ONCOGENE, V23, P6500, DOI 10.1038/sj.onc.1207811; Wu XF, 2003, CARCINOGENESIS, V24, P505, DOI 10.1093/carcin/24.3.505; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681	30	233	242	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					464	479		10.1086/500848	http://dx.doi.org/10.1086/500848			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16465622	Bronze, Green Published			2022-12-18	WOS:000236747500013
J	Tao, J; Van Esch, H; Hagedorn-Greiwe, M; Hoffmann, K; Moser, B; Raynaud, M; Sperner, J; Fryns, JP; Schwinger, E; Gecz, J; Ropers, HH; Kalscheuer, VM				Tao, J; Van Esch, H; Hagedorn-Greiwe, M; Hoffmann, K; Moser, B; Raynaud, M; Sperner, J; Fryns, JP; Schwinger, E; Gecz, J; Ropers, HH; Kalscheuer, VM			Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETT-SYNDROME PATIENTS; CPG-BINDING-PROTEIN; MENTAL-RETARDATION; MECP2 GENE; METHYLATED DNA; KINASE; PHOSPHORYLATION; IDENTIFICATION; ENCEPHALOPATHY; ACTIVATION	Recently, we showed that truncation of the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene caused mental retardation and severe neurological symptoms in two female patients. Here, we report that de novo missense mutations in CDKL5 are associated with a severe phenotype of early-onset infantile spasms and clinical features that overlap those of other neurodevelopmental disorders, such as Rett syndrome and Angelman syndrome. The mutations are located within the protein kinase domain and affect highly conserved amino acids; this strongly suggests that impaired CDKL5 catalytic activity plays an important role in the pathogenesis of this neurodevelopmental disorder. In view of the overlapping phenotypic spectrum of CDKL5 and MECP2 mutations, it is tempting to speculate that these two genes play a role in a common pathogenic process.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium; Inst Human Genet Lubeck, Lubeck, Germany; Univ Lubeck, Sch Med, Dept Pediat, Lubeck, Germany; CHU Bretonneau, INSERM, U316, Serv Genet, F-37044 Tours, France; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Adelaide, SA, Australia	Max Planck Society; Universite Catholique Louvain; University of Lubeck; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Womens & Childrens Hospital Australia; University of Adelaide	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kalscheu@molgen.mpg.de	Gecz, Jozef/X-3469-2019; Van+Esch, Hilde/AAU-5688-2020; Raynaud, Martine/R-9811-2019	Gecz, Jozef/0000-0002-7884-6861; Raynaud, Martine/0000-0002-6888-6480; Van Esch, Hilde/0000-0002-9604-5726; Kalscheuer, Vera/0000-0001-6898-3259				Ben Zeev B, 2002, J CHILD NEUROL, V17, P20, DOI 10.1177/088307380201700105; Bourdon V, 2001, HUM GENET, V108, P43, DOI 10.1007/s004390000422; Buyse IM, 2000, AM J HUM GENET, V67, P1428, DOI 10.1086/316913; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; GOUTIERES F, 1986, AM J MED GENET, V24, P183; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; HANEFELD F, 1985, BRAIN DEV-JPN, V7, P320, DOI 10.1016/S0387-7604(85)80037-1; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Imessaoudene B, 2001, J MED GENET, V38, P171, DOI 10.1136/jmg.38.3.171; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Midmer M, 1999, CANCER RES, V59, P4069; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schanen NC, 1998, J CHILD NEUROL, V13, P229, DOI 10.1177/088307389801300507; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Taglienti CA, 1996, ONCOGENE, V13, P2563; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; YEN SH, 1995, J NEUROCHEM, V65, P2577; Yntema HG, 2002, AM J MED GENET, V107, P81, DOI 10.1002/ajmg.10085	28	233	242	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1149	1154		10.1086/426460	http://dx.doi.org/10.1086/426460			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15499549	Green Published, Bronze			2022-12-18	WOS:000224866400021
J	Lange, C; DeMeo, D; Silverman, EK; Weiss, ST; Laird, NM				Lange, C; DeMeo, D; Silverman, EK; Weiss, ST; Laird, NM			PBAT: Tools for family-based association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENERALIZED ESTIMATING EQUATIONS; TESTS; POWER		Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Lange, C (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 665 Huntington Ave, Boston, MA 02115 USA.	clange@hsph.harvard.edu			NHLBI NIH HHS [T32 HL07427, P01 HL067664, T32 HL007427, P01 HL67664, N01 HR16049, N01HR16049, N01 HLC6795] Funding Source: Medline; NIMH NIH HHS [R01 MH59532, R01 MH059532] Funding Source: Medline; DIVISION OF LUNG DISEASES [N01HR016049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, P01HL067664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059532] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; DeMeo DL, 2002, GENET EPIDEMIOL, V23, P335, DOI 10.1002/gepi.10182; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lange C, 2003, HUM HERED, V56, P10, DOI 10.1159/000073728; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; LANGE C, IN PRESS STAT MED; Lange C, 2002, STAT MODEL, V2, P163, DOI 10.1191/1471082x02st031oa; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LYON H, IN PRESS GENET EPIDE; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918	18	233	234	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					367	369		10.1086/381563	http://dx.doi.org/10.1086/381563			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14740322	Bronze, Green Published			2022-12-18	WOS:000188860000017
J	Jordan, BK; Mohammed, M; Ching, ST; Delot, E; Chen, XN; Dewing, P; Swain, A; Rao, PN; Elejalde, BR; Vilain, E				Jordan, BK; Mohammed, M; Ching, ST; Delot, E; Chen, XN; Dewing, P; Swain, A; Rao, PN; Elejalde, BR; Vilain, E			Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE CONGENITAL-ANOMALIES; DETERMINING GENES; EXPRESSION; DAX-1; SRY; CHROMOSOME-1; DUPLICATION; CHILD; SOX9; XY	Wnt-4, a member of the Wnt family of locally acting secreted growth factors, is the first signaling molecule shown to influence the sex-determination cascade. In mice, a targeted deletion of Wnt-4 causes the masculinization of XX pups. Therefore, WNT-4, the human homologue of murine Wnt-4, is a strong candidate gene for sex-reversal phenotypes in humans. In this article, we show that, in testicular Sertoli and Leydig cells, Wnt-4 up-regulates Dax1, a gene known to antagonize the testis-determining factor, Sry. Furthermore, we elucidate a possible mechanism for human XY sex reversal associated with a 1p31-p35 duplication including WNT-4. Overexpression of WNT-4 leads to up-regulation of DAX1, which results in an XY female phenotype. Thus, WNT-4, a novel sex-determining gene, and DAX1 play a concerted role in both the control of female development and the prevention of testes formation. These observations suggest that mammalian sex determination is sensitive to dosage, at multiple steps in its pathway.	Univ Calif Los Angeles, Dept Human Genet, Gonda Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Cedars Sinai Med Ctr, Ctr Med Genet Birth Defects, Los Angeles, CA 90048 USA; Chester Beatty Labs, Sect Gene Funct & Regulat, London, England; Univ Wisconsin, Inst Med Genet, Dept Obstet Gynecol, Milwaukee, WI 53201 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of London; Institute of Cancer Research - UK; University of Wisconsin System; University of Wisconsin Milwaukee	Vilain, E (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Gonda Ctr, 695 Charles E Young Dr S,Room 6357A, Los Angeles, CA 90095 USA.			Elejalde, Rafael/0000-0002-2875-001X; Jordan, Brian/0000-0002-1553-8503; Delot, Emmanuele/0000-0003-3541-3190; Swain, Amanda/0000-0001-8666-1608				Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; COUSINEAU AJ, 1981, ANN HUM GENET, V45, P337, DOI 10.1111/j.1469-1809.1981.tb00347.x; Dale TC, 1998, BIOCHEM J, V329, P209; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; ELEJALDE BR, 1984, AM J MED GENET, V17, P723, DOI 10.1002/ajmg.1320170403; Goodfellow PN, 1999, CELL MOL LIFE SCI, V55, P857, DOI 10.1007/PL00013201; Graves JAM, 1998, J EXP ZOOL, V281, P472, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;472::AID-JEZ12&gt;3.0.CO;2-B; HACKER A, 1995, DEVELOPMENT, V121, P1603; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Kawabe K, 1999, MOL ENDOCRINOL, V13, P1267, DOI 10.1210/me.13.8.1267; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Korenberg JR, 1999, GENOME RES, V9, P994, DOI 10.1101/gr.9.10.994; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; McElreavey K, 1995, HEREDITY, V75, P599, DOI 10.1038/hdy.1995.179; MOHAMMED FMA, 1989, AM J MED GENET, V32, P353, DOI 10.1002/ajmg.1320320316; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vilain E, 1997, BIOCHEM MOL MED, V61, P1, DOI 10.1006/bmme.1997.2601; Vilain E, 1998, MOL GENET METAB, V65, P74, DOI 10.1006/mgme.1998.2749; Wieacker P, 1996, CLIN GENET, V49, P271; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	28	233	249	0	15	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1102	1109		10.1086/320125	http://dx.doi.org/10.1086/320125			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283799	Green Published, Bronze			2022-12-18	WOS:000168171200004
J	Zabetian, CP; Anderson, GM; Buxbaum, SG; Elston, RC; Ichinose, H; Nagatsu, T; Kim, KS; Kim, CH; Malison, RT; Gelernter, J; Cubells, JF				Zabetian, CP; Anderson, GM; Buxbaum, SG; Elston, RC; Ichinose, H; Nagatsu, T; Kim, KS; Kim, CH; Malison, RT; Gelernter, J; Cubells, JF			A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; LINKAGE ANALYSIS; GENE REQUIRES; SEGREGATION; NOREPINEPHRINE; LOCALIZATION; INDIVIDUALS; EXPRESSION; ELEMENTS	Dopamine-beta -hydroxylase (D betaH) catalyzes the conversion of dopamine to norepinephrine and is released from sympathetic neurons into the circulation. Plasma-D betaH activity varies widely between individuals, and a subgroup of the population has very low activity levels. Mounting evidence suggests that the DBH structural gene is itself the major quantitative-trait locus (QTL) for plasma-D betaH activity, and a single unidentified polymorphism may account for a majority of the variation in activity levels. Through use of both sequencing-based mutational analysis of extreme phenotypes and genotype/phenotype correlations in samples from African American, European American (EA), and Japanese populations, we have identified a novel polymorphism (-1021C-->T), in the 5' flanking region of the DBH gene, that accounts for 35%-52% of the variation in plasma-DbH activity in these populations. In EAs, homozygosity at the T allele predicted the very low D betaH-activity trait, and activity values in heterozygotes formed an intermediate distribution, indicating codominant inheritance. Our findings demonstrate that -1021C-->T is a major genetic marker for plasma-D betaH activity and provide new tools for investigation of the role of both DbH and the DBH gene in human disease.	Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Connecticut Mental Hlth Ctr, New Haven, CT USA; Yale Univ, Sch Med, VACHS, Dept Psychiat, W Haven, CT 06516 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; Harvard Univ, McLean Hosp, Sch Med, Mol Neurobiol Lab, Belmont, MA 02178 USA	Yale University; Yale University; Yale University; Case Western Reserve University; Fujita Health University; Harvard University; McLean Hospital	Cubells, JF (corresponding author), Yale Univ, Sch Med, VACHS, Dept Psychiat, 950 Campbell Ave,116A2, W Haven, CT 06516 USA.	joseph.cubells@yale.edu	Cubells, Joe F./V-2543-2018; Buxbaum, Sarah G./E-1970-2013; Ichinose, Hiroshi/D-8986-2015	Buxbaum, Sarah G./0000-0002-4886-3564; Ichinose, Hiroshi/0000-0001-6008-6860; Zabetian, Cyrus/0000-0002-7739-4306; Gelernter, Joel/0000-0002-4067-1859	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K12DA000167, T32DA007238, R01DA012422] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655] Funding Source: Medline; NIAAA NIH HHS [R01 AA011330] Funding Source: Medline; NIDA NIH HHS [5T32-DA-07238, R01 DA012422, T32 DA007238, R01-DA12422, K-12-DA-00167, K12 DA000167] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, R01 GM028356] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARATO M, 1983, PHARMACOPSYCHIATRIA, V16, P19, DOI 10.1055/s-2007-1017442; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; CRAIG SP, 1988, CYTOGENET CELL GENET, V48, P48, DOI 10.1159/000132584; Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P; Cubells JF, 1998, HUM GENET, V102, P533, DOI 10.1007/s004390050736; Cubells JF, 2000, MOL PSYCHIATR, V5, P56, DOI 10.1038/sj.mp.4000657; DEGROOT MH, 1989, PROBABILITY STAT; Druschky A, 2000, J NEUROL SCI, V175, P3, DOI 10.1016/S0022-510X(00)00279-3; DUNNETTE J, 1976, AM J HUM GENET, V28, P155; ELSTON RC, 1979, HUM HERED, V29, P284, DOI 10.1159/000153059; FAHNDRICH E, 1982, INT PHARMACOPSYCHIAT, V17, P8; FUJITA K, 1978, J NEUROCHEM, V30, P1569, DOI 10.1111/j.1471-4159.1978.tb10494.x; GELERNTER J, 1991, NUCLEIC ACIDS RES, V19, P1957, DOI 10.1093/nar/19.8.1957; GOLDIN LR, 1982, AM J HUM GENET, V34, P250; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HOYLE GW, 1994, J NEUROSCI, V14, P2455; ISHIGURO H, 1993, J BIOL CHEM, V268, P17987; KEMPER CM, 1987, NEUROSCIENCE, V23, P981, DOI 10.1016/0306-4522(87)90173-4; Kim HS, 1998, J NEUROSCI, V18, P8247; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; LIEBERMAN AN, 1972, LANCET, V1, P153; MAGALHAES M, 1995, ACTA NEUROL SCAND, V91, P98; MATHEW RJ, 1981, PSYCHIAT RES, V5, P331, DOI 10.1016/0165-1781(81)90080-9; MATUZAS W, 1982, BIOL PSYCHIAT, V17, P1415; MELTZER HY, 1980, BIOL PSYCHIAT, V15, P781; NAGATSU T, 1982, BIOMED RES-TOKYO, V3, P95, DOI 10.2220/biomedres.3.95; OKA M., 1967, LIFE SCI, V6, P461, DOI 10.1016/0024-3205(67)90048-3; OXENSTIERNA G, 1986, J PSYCHIAT RES, V20, P19, DOI 10.1016/0022-3956(86)90020-8; PERONNET F, 1985, MED SCI SPORT EXER, V17, P683, DOI 10.1249/00005768-198512000-00011; PERRY SE, 1991, GENOMICS, V10, P493, DOI 10.1016/0888-7543(91)90339-G; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROSS SB, 1973, LIFE SCI, V12, P529, DOI 10.1016/0024-3205(73)90056-8; TURKKA JT, 1986, EUR NEUROL, V25, P355, DOI 10.1159/000116034; VIVEROS OH, 1968, LIFE SCI PT 1 PHYSI, V7, P609, DOI 10.1016/0024-3205(68)90186-0; Wakabayashi K, 1997, EUR NEUROL, V38, P2, DOI 10.1159/000113469; Wei J, 1997, HUM GENET, V99, P52; WEINSHILBOUM R, 1971, CIRC RES, V28, P307, DOI 10.1161/01.RES.28.3.307; WEINSHILBOUM RM, 1975, AM J HUM GENET, V27, P573; WEINSHILBOUM RM, 1978, PHARMACOL REV, V30, P133; WEINSHILBOUM RM, 1973, SCIENCE, V181, P943, DOI 10.1126/science.181.4103.943; WEINSHILBOUM RM, 1971, NEW ENGL J MED, V285, P938, DOI 10.1056/NEJM197110212851703; WEINSHILBOUM RM, 1983, MAYO CLIN PROC, V58, P319; WILSON AF, 1988, AM J HUM GENET, V42, P160; WILSON AF, 1990, AM J MED GENET, V35, P425, DOI 10.1002/ajmg.1320350321; WINER N, 1977, LIFE SCI, V20, P887, DOI 10.1016/0024-3205(77)90042-X; Zabetian CP, 2000, AM J MED GENET, V96, P638, DOI 10.1002/1096-8628(20001009)96:5<638::AID-AJMG9>3.0.CO;2-R	47	233	250	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					515	522		10.1086/318198	http://dx.doi.org/10.1086/318198			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11170900	Green Published, Bronze			2022-12-18	WOS:000166524800023
J	Joenje, H; Oostra, AB; Wijker, M; diSumma, FM; vanBerkel, CGM; Rooimans, MA; Ebell, W; vanWeel, M; Pronk, JC; Buchwald, M; Arwert, F				Joenje, H; Oostra, AB; Wijker, M; diSumma, FM; vanBerkel, CGM; Rooimans, MA; Ebell, W; vanWeel, M; Pronk, JC; Buchwald, M; Arwert, F			Evidence for at least eight Fanconi anemia genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENTATION GROUP-A; FACC; MUTATION; PATHWAY	Fanconi anemia (FA) is an autosomal recessive chromosomal breakage disorder with diverse clinical symptoms including progressive bone marrow failure and increased cancer risk. FA cells are hypersensitive to crosslinking agents, which has been exploited to assess genetic heterogeneity through complementation analysis. Five complementation groups (FA-A through FA-E) have so far been distinguished among the first 20 FA patients analyzed. Complementation groups in FA are likely to represent distinct disease genes, two of which (FAG and EAA) have been cloned. Following the identification of the first FA-E patient, additional patients were identified whose cell lines complemented groups A-D. To assess their possible assignment to the E group, we introduced selection markers into the original FA-E cell line and analyzed fusion hybrids with three cell lines classified as non-ABCD. All hybrids were complemented for crosslinker sensitivity, indicating nonidentity with group E. We then marked the three non-ABCDE cell lines and examined all possible hybrid combinations for complementation, which indicated that each individual cell line represented a separate complementation group. These results thus define three new groups, FA-F, FA-G, and FA-H, providing evidence for a minimum of eight distinct FA genes.	HUMBOLDT UNIV BERLIN, CHARITE VIRCHOW KLINIKUM, KINDERKLIN, D-1086 BERLIN, GERMANY; AKAD ZIEKENHUIS, AFDELING KINDERGENEESKUNDE, LEIDEN, NETHERLANDS; HOSP SICK CHILDREN, RES INST, TORONTO, ON M5G 1X8, CANADA; UNIV TORONTO, DEPT MOL & MED GENET, TORONTO, ON, CANADA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Joenje, H (corresponding author), FREE UNIV AMSTERDAM, DEPT HUMAN GENET, VAN DER BOECHORSTSTR 7, NL-1081 BT AMSTERDAM, NETHERLANDS.				NHLBI NIH HHS [HL51031] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051031] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; BUCHWALD M, 1997, METABOLIC MOL BASIS; CUMMING RC, 1996, BLOOD, V88, P4588; DAndrea AD, 1996, NAT GENET, V14, P240, DOI 10.1038/ng1196-240; DUCKWORTHRYSIECKI G, 1985, SOMAT CELL MOLEC GEN, V11, P35, DOI 10.1007/BF01534732; HOEIJMAKERS JHJ, 1994, NATURE, V371, P654, DOI 10.1038/371654a0; ISHIDA R, 1982, CANCER RES, V42, P4000; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1996, HUM GENET, V97, P280, DOI 10.1007/BF02185753; Kruyt FAE, 1996, BLOOD, V87, P938, DOI 10.1182/blood.V87.3.938.bloodjournal873938; LIU JM, 1994, BLOOD, V84, P3995, DOI 10.1182/blood.V84.12.3995.bloodjournal84123995; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; Savoia A, 1996, HUM GENET, V97, P599; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Whitney MA, 1996, BLOOD, V88, P49; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202	21	233	236	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					940	944		10.1086/514881	http://dx.doi.org/10.1086/514881			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382107	Green Published, Bronze			2022-12-18	WOS:A1997YA59100023
J	FEINGOLD, E; BROWN, PO; SIEGMUND, D				FEINGOLD, E; BROWN, PO; SIEGMUND, D			GAUSSIAN MODELS FOR GENETIC-LINKAGE ANALYSIS USING COMPLETE HIGH-RESOLUTION MAPS OF IDENTITY BY DESCENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT LENGTH POLYMORPHISMS; AFFECTED RELATIVE PAIRS; TRAITS; STRATEGIES; HUMANS; POWER	Gaussian-process models are developed to detect genetic linkage using complete high-resolution maps of identity by descent between affected relative pairs. Approximations are given for the significance level and power of the likelihood-ratio test of no linkage and for likelihood-ratio confidence regions for trait loci. The sample sizes required to detect linkage by using different classes of affected relative pairs are compared, and the problem of combining data from different classes of relatives is discussed.	STANFORD UNIV,DEPT STAT,SEQUOIA HALL,STANFORD,CA 94305; STANFORD UNIV,DEPT PEDIAT,STANFORD,CA 94305; STANFORD UNIV,DEPT BIOCHEM,STANFORD,CA 94305; STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University				Feingold, Eleanor/0000-0003-2898-6484				Aldous D., 1989, PROBABILITY APPROXIM, DOI [10.1007/978-1-4757-6283-9, DOI 10.1007/978-1-4757-6283-9]; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; FEINGOLD E, 1993, THESIS STANFORD U ST; FEINGOLD E, IN PRESS J APPL PROB; JAMES B, 1987, BIOMETRIKA, V74, P71, DOI 10.2307/2336022; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KEMPTHORNE O, 1957, INTRO GENETIC STATIS; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leadbetter M. R., 1983, EXTREMES RELATED PRO; NELSON SF, IN PRESS NATURE GENE; Ott J., 1991, ANAL HUMAN GENETIC L; PARZEN E, 1961, ANN MATH STAT, V32, P951, DOI 10.1214/aoms/1177704840; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; SIEGMUND D, 1988, INT STAT REV, V56, P31, DOI 10.2307/1403360; Siegmund DO, 1985, SEQUENTIAL ANAL TEST; WOODROOFE M, 1976, ANN PROBAB, V4, P67, DOI 10.1214/aop/1176996181; Woodroofe M, 1982, SOC IND APPL MATH	23	233	238	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					234	251						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317489				2022-12-18	WOS:A1993LJ38500027
J	HOTAMISLIGIL, GS; BREAKEFIELD, XO				HOTAMISLIGIL, GS; BREAKEFIELD, XO			HUMAN MONOAMINE OXIDASE-A GENE DETERMINES LEVELS OF ENZYME-ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORRIE DISEASE; PEPTIDE SEQUENCES; PLATELET; DELETION; AMINE; BRAIN; DNA; AMPLIFICATION; PLASMA; MAO	Monoamine oxidase (MAO) is a critical enzyme in the degradative deamination of biogenic amines throughout the body. Two biochemically distinct forms of the enzyme, A and B, are encoded in separate genes on the human X chromosome. In these studies we investigated the role of the structural gene for MAO-A in determining levels of activity in humans, as measured in cultured skin fibroblasts. The coding sequence of the mRNA for MAO-A was determined by first-strand cDNA synthesis, PCR amplification, and direct dideoxy sequencing. Two single-basepair substitutions were observed in cDNAs from cells with a 30-fold difference in activity levels. These two substitutions were in the third base of a triplet codon and hence did not affect the deduced amino acid sequence but did affect the presence or absence of restriction-enzyme sites for EcoRV and Fnu4HI, which could be elucidated on PCR fragments derived from genomic DNA or cDNAs. A third polymorphism for MspI in the noncoding region of the MAOA gene was also evaluated by Southern blot analysis using genomic DNA. Statistically significant associations were observed between the alleles for MAOA and levels of MAO activity in human male fibroblast lines. This association indicates that the MAOA gene itself is a major determinant of activity levels, apparently, in part, through noncoding, regulatory elements.	HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School					NIAAA NIH HHS [R3AA08683-01] Funding Source: Medline; NINDS NIH HHS [NS21921] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA008683] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; BOND PA, 1977, CLIN CHIM ACTA, V80, P317, DOI 10.1016/0009-8981(77)90039-0; BREAKEFIELD XO, 1976, SCIENCE, V192, P1018, DOI 10.1126/science.1273584; BREAKEFIELD XO, 1980, PSYCHIAT RES, V2, P307, DOI 10.1016/0165-1781(80)90022-0; CAMPBELL IC, 1979, J NEUROCHEM, V32, P49, DOI 10.1111/j.1471-4159.1979.tb04508.x; CHEN ZY, IN PRESS NUCLEIC ACI; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COSTA M R C, 1980, Biochemical Genetics, V18, P577, DOI 10.1007/BF00484403; DELACHAPELLE A, 1985, CLIN GENET, V28, P317; DIERGAARDE PJ, 1989, HUM GENET, V84, P22, DOI 10.1007/BF00210665; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; DONNELLY CH, 1977, BIOCHEM PHARMACOL, V26, P853, DOI 10.1016/0006-2952(77)90398-7; DRETZEN G, 1981, ANAL BIOCHEM, V112, P295, DOI 10.1016/0003-2697(81)90296-7; EDELSTEIN SB, 1986, CELL MOL NEUROBIOL, V6, P121, DOI 10.1007/BF00711066; EDELSTEIN SB, 1978, J NEUROCHEM, V31, P1247, DOI 10.1111/j.1471-4159.1978.tb06249.x; FOWLER JS, 1987, SCIENCE, V235, P481, DOI 10.1126/science.3099392; GAL A, 1986, CYTOGENET CELL GENET, V42, P219, DOI 10.1159/000132282; GARRICK NA, 1982, BIOCHEM PHARMACOL, V31, P4061, DOI 10.1016/0006-2952(82)90656-6; GERSHON ES, 1980, ENZYMES NEUROTRANSMI, P281; GORMAN KB, 1989, BIOTECHNIQUES, V7, P326; HSU YPP, 1988, J NEUROCHEM, V51, P1321, DOI 10.1111/j.1471-4159.1988.tb03105.x; HSU YPP, 1989, J NEUROCHEM, V53, P12, DOI 10.1111/j.1471-4159.1989.tb07289.x; HUANG J, 1989, SOC NEUR ABSTR, V393, P14; KUPFER DJ, 1972, PSYCHOPHARMACOLOGIA, V27, P183, DOI 10.1007/BF00422798; LAN NC, 1989, GENOMICS, V4, P552, DOI 10.1016/0888-7543(89)90279-6; LEVITT P, 1982, P NATL ACAD SCI-BIOL, V79, P6385, DOI 10.1073/pnas.79.20.6385; LEVY ER, 1989, GENOMICS, V5, P368, DOI 10.1016/0888-7543(89)90072-4; Maniatis T, 1989, DECONTAMINATION DILU; MURPHY DL, 1976, BIOCHEM MED METAB B, V16, P254, DOI 10.1016/0006-2944(76)90031-4; MURPHY DL, 1977, J NERV MENT DIS, V164, P129, DOI 10.1097/00005053-197702000-00008; MURPHY DL, 1991, J NEURAL TRANSM-GEN, V83, P1, DOI 10.1007/BF01244447; MURPHY DL, 1980, SCHIZOPHRENIA BULL, V6, P355, DOI 10.1093/schbul/6.2.355; MURPHY DL, 1990, J NEUROCHEM, V54, P242, DOI 10.1111/j.1471-4159.1990.tb13307.x; MURPHY DL, 1983, ANTIDEPRESSANTS, P209; NEWMAN PJ, 1988, J CLIN INVEST, V82, P739, DOI 10.1172/JCI113656; OZELIUS L, 1988, Genomics, V3, P53, DOI 10.1016/0888-7543(88)90159-0; OZELIUS L, 1989, NUCLEIC ACIDS RES, V17, P10516, DOI 10.1093/nar/17.24.10516; POWELL JF, 1989, BIOCHEM J, V259, P407, DOI 10.1042/bj2590407; RICE J, 1984, AM J HUM GENET, V36, P36; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMS KB, 1989, AM J HUM GENET, V45, P424; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; SQUIRES RF, 1978, JHDB PSYCHOPHARMACOL, P1; SULLIVAN JL, 1990, BIOL PSYCHIAT, V27, P911, DOI 10.1016/0006-3223(90)90473-F; TABAKOFF B, 1988, NEW ENGL J MED, V318, P134, DOI 10.1056/NEJM198801213180302; Thorpe LW, 1987, J HISTOCHEM CYTOCHEM, V35, P23, DOI 10.1177/35.1.3025289; WARBURG M, 1975, ACTA OPHTHALMOL, V53, P217; WESTLUND KN, 1985, SCIENCE, V230, P181, DOI 10.1126/science.3875898; WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9; WEYLER W, 1985, J BIOL CHEM, V260, P3199; WURTMAN RJ, 1963, BIOCHEM PHARMACOL, V12, P1439, DOI 10.1016/0006-2952(63)90215-6	52	233	252	0	14	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					383	392						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1678250				2022-12-18	WOS:A1991GA86600015
J	Delaneau, O; Howie, B; Cox, AJ; Zagury, JF; Marchini, J				Delaneau, Olivier; Howie, Bryan; Cox, Anthony J.; Zagury, Jean-Francois; Marchini, Jonathan			Haplotype Estimation Using Sequencing Reads	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE IMPUTATION; HUMAN GENOMES; INFERENCE; VARIANTS; ASSOCIATION; DISEASE	High-throughput sequencing technologies produce short sequence reads that can contain phase information if they span two or more heterozygote genotypes. This information is not routinely used by current methods that infer haplotypes from genotype data: We have extended the SHAPEIT2 method to use phase-informative sequencing reads to improve phasing accuracy. Our model incorporates the read information in a probabilistic model through base quality scores within each read. The method is primarily designed for high-coverage sequence data or data sets that already have genotypes called. One important application is phasing of single samples sequenced at high coverage for use in medical sequencing and studies of rare diseases. Our method can also use existing panels of reference haplotypes. We tested the method by using a mother-father-child trio sequenced at high-coverage by Illumina together with the low-coverage sequence data from the 1000 Genomes Project (1000GP). We found that use of phase-informative reads increases the mean distance between switch errors by 22% from 274.4 kb to 328.6 kb. We also used male chromosome X haplotypes from the 1000GP samples to simulate sequencing reads with varying insert size, read length, and base error rate. When using short 100 bp paired-end reads, we found that using mixtures of insert sizes produced the best results. When using longer reads with high error rates (5-20 kb read with 4%-15% error per base), phasing performance was substantially improved.	[Delaneau, Olivier; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Howie, Bryan] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Cox, Anthony J.] Illumina Cambridge Ltd, UK Computat Biol Grp, Cambridge CB10 1XL, England; [Zagury, Jean-Francois] Conservatoire Natl Arts & Metiers, Lab Genom Bioinformat & Applicat EA 4627, Chaire Bioinformat, F-75141 Paris 03, France; [Marchini, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; University of Chicago; Illumina; heSam Universite; Conservatoire National Arts & Metiers (CNAM); University of Oxford; Wellcome Centre for Human Genetics	Marchini, J (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	marchini@stats.ox.ac.uk	Marchini, Jonathan/ABE-9024-2020; /AAR-2792-2021	Marchini, Jonathan/0000-0003-0610-8322; Delaneau, Olivier/0000-0002-3906-8446; Cox, Anthony/0000-0002-6534-749X	United Kingdom Medical Research Council [G0801823]; Medical Research Council [G0801823] Funding Source: researchfish; MRC [G0801823] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study makes use of sequence and genotype data made available from the 1000 Genomes Project. J.M. was supported by United Kingdom Medical Research Council grant number G0801823. A.J.C. is an employee of Illumina Inc., a public company that develops and markets systems for genetic analysis, and receives shares as part of his compensation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bacanu SA, 2013, GENET EPIDEMIOL, V37, P522, DOI 10.1002/gepi.21732; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Morris AP, 2006, AM J HUM GENET, V79, P679, DOI 10.1086/508264; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Pasaniuc B, 2009, BIOINFORMATICS, V25, pI213, DOI 10.1093/bioinformatics/btp197; Schneider GF, 2012, NAT BIOTECHNOL, V30, P326, DOI 10.1038/nbt.2181; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Wang Y, 2013, GENOME RES, V23, P833, DOI 10.1101/gr.146084.112	18	232	232	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					687	696		10.1016/j.ajhg.2013.09.002	http://dx.doi.org/10.1016/j.ajhg.2013.09.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24094745	Green Published, Bronze			2022-12-18	WOS:000326305600010
J	Elpeleg, O; Miller, C; Hershkovitz, E; Bitner-Glindzicz, M; Bondi-Rubenstein, G; Rahman, S; Pagnamenta, A; Eshhar, S; Saada, A				Elpeleg, O; Miller, C; Hershkovitz, E; Bitner-Glindzicz, M; Bondi-Rubenstein, G; Rahman, S; Pagnamenta, A; Eshhar, S; Saada, A			Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; THYMIDINE KINASE; MUTATIONS; GENE; SYNTHETASES; THIOKINASE; EXPRESSION; EUKARYOTES; PROTEINS; DISEASES	The mitochondrial DNA (mtDNA) depletion syndrome is a quantitative defect of mtDNA resulting from dysfunction of one of several nuclear-encoded factors responsible for maintenance of mitochondrial deoxyribonucleoside triphosphate (dNTP) pools or replication of mtDNA. Markedly decreased succinyl-CoA synthetase activity due to a deleterious mutation in SUCLA2, the gene encoding the beta subunit of the ADP-forming succinyl-CoA synthetase ligase, was found in muscle mitochondria of patients with encephalomyopathy and mtDNA depletion. Succinyl-CoA synthetase is invariably in a complex with mitochondrial nucleotide diphosphate kinase; hence, we propose that a defect in the last step of mitochondrial dNTP salvage is a novel cause of the mtDNA depletion syndrome.	Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel; Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; Ben Gurion Univ Negev, Fac Med, Soroka Med Ctr, Dept Pediat, IL-84105 Beer Sheva, Israel; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; UCL, Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Ben Gurion University; Soroka Medical Center; University of London; University College London; University of London; University College London	Elpeleg, O (corresponding author), Shaare Zedek Med Ctr, Metab Dis Unit, IL-91031 Jerusalem, Israel.	Elpeleg@cc.huji.ac.il	Herskowitz, eli/F-1922-2012; Bitner-Glindzicz, Maria/A-4231-2009; Rahman, Shamima/C-5232-2008; Saada, Ann/J-6864-2017; Rahman, Shamima/M-7904-2019	Herskowitz, eli/0000-0003-1624-1960; Rahman, Shamima/0000-0003-2088-730X; Saada, Ann/0000-0003-2951-0656; 				ALLEN DA, 1986, FEBS LETT, V194, P171, DOI 10.1016/0014-5793(86)80071-0; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; BRADSHAW PC, 2005, AM J PHYSL CELL PHYS; CHA S, 1964, J BIOL CHEM, V239, P1961; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; DOOIJEWAARD G, 1976, BIOCHIM BIOPHYS ACTA, V440, P1, DOI 10.1016/0005-2728(76)90109-2; Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1; Elpeleg O, 2003, PEDIATR RES, V54, P153, DOI 10.1203/01.PDR.0000072796.25097.A5; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573; KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S; KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883; Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Milon L, 1997, HUM GENET, V99, P550, DOI 10.1007/s004390050405; MORAES CT, 1991, AM J HUM GENET, V48, P492; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Saada A, 2004, DNA CELL BIOL, V23, P797; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SANADI DR, 1954, BIOCHIM BIOPHYS ACTA, V14, P434, DOI 10.1016/0006-3002(54)90205-X; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209; Vu TH, 1998, NEUROLOGY, V50, P1783, DOI 10.1212/WNL.50.6.1783; WEITZMAN PDJ, 1986, FEBS LETT, V199, P57, DOI 10.1016/0014-5793(86)81223-6	33	232	239	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1081	1086		10.1086/430843	http://dx.doi.org/10.1086/430843			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15877282	Bronze, Green Published			2022-12-18	WOS:000229047900014
J	Zerjal, T; Dashnyam, B; Pandya, A; Kayser, M; Roewer, L; Santos, FR; Schiefenhovel, W; Fretwell, N; Jobling, MA; Harihara, S; Shimizu, K; Semjidmaa, D; Sajantila, A; Salo, P; Crawford, MH; Ginter, EK; Evgrafov, OV; TylerSmith, C				Zerjal, T; Dashnyam, B; Pandya, A; Kayser, M; Roewer, L; Santos, FR; Schiefenhovel, W; Fretwell, N; Jobling, MA; Harihara, S; Shimizu, K; Semjidmaa, D; Sajantila, A; Salo, P; Crawford, MH; Ginter, EK; Evgrafov, OV; TylerSmith, C			Genetic relationships of Asians and northern Europeans, revealed by Y-chromosomal DNA analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCES	We have identified a new T-->C transition on the human Y chromosome. C-allele chromosomes have been found only in a subset of the populations from Asia and northern Europe and reach their highest frequencies in Yakut, Buryats, and Finns. Examination of the microsatellite haplotypes of the C-allele chromosomes suggests that the mutation occurred recently in Asia. The Y chromosome thus provides both information about population relationships in Asia and evidence for a substantial paternal genetic contribution of Asians to northern European populations such as the Finns.	UNIV OXFORD, DEPT BIOCHEM, CRC, CHROMOSOME MOL BIOL GRP, OXFORD OX1 3QU, ENGLAND; HUMBOLDT UNIV BERLIN, INST GERICHTLICHE MED, BERLIN, GERMANY; MAX PLANCK GESELL, FORSCH STELLE HUMANETHOL, KLOSTER ANDECHS, GERMANY; UNIV LEICESTER, DEPT GENET, LEICESTER LE1 7RH, LEICS, ENGLAND; UNIV TOKYO, DEPT BIOL SCI, TOKYO, JAPAN; NARUTO UNIV EDUC, DEPT BIOL, NARUTO, TOKUSHIMA, JAPAN; MONGOLIAN ACAD SCI, INST BIOTECHNOL, DEPT MOL BIOL, ULAANBAATAR, MONGOLIA; UNIV HELSINKI, DEPT FORENS MED, HELSINGOR, DENMARK; UNIV HELSINKI, DEPT MED GENET, HELSINGOR, DENMARK; UNIV KANSAS, DEPT ANTHROPOL, LAB BIOL ANTHROPOL, LAWRENCE, KS 66045 USA; RUSSIAN ACAD MED SCI, MED GENET RES CTR, MOSCOW, RUSSIA	University of Oxford; Humboldt University of Berlin; Max Planck Society; University of Leicester; University of Tokyo; Naruto University of Education; Mongolian Academy of Sciences; University of Helsinki; University of Helsinki; University of Kansas; Research Centre for Medical Genetics; Russian Academy of Medical Sciences			zerjal, tatiana/AAO-9473-2020; Santos, Fabrício Rodrigues/H-2370-2011; Sajantila, Antti/AAY-9084-2021	Santos, Fabrício Rodrigues/0000-0001-9088-1750; Jobling, Mark/0000-0002-8061-1308; Roewer, Lutz/0000-0001-9383-4941; Sajantila, Antti/0000-0003-4117-5248	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bertranpetit J, 1996, CIBA F SYMP, V197, P97; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; FAGAN BM, 1995, PEOPLE EARTH; Forsyth James, 1992, HIST PEOPLES SIBERIA; FRETWELL N, 1997, THESIS U LEICESTER L; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GRIMES BF, 1996, ETHNOLOGUE LANGUAGES; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HAMMER MF, 1995, YCC NEWSLETTER, V2, P8; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Kolman CJ, 1996, GENETICS, V142, P1321; Lahermo P, 1996, AM J HUM GENET, V58, P1309; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; NEVANLINNA H R, 1980, Haematologia, V13, P65; NOVORADOVSKY AG, 1993, HUM BIOL, V65, P689; NUNEZ M, 1987, FENNOSCANDIA ARCHAEO, V4, P3; ROEWER L, 1992, HUM GENET, V89, P389; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; SAJANTILA A, 1995, NAT GENET, V11, P359, DOI 10.1038/ng1295-359; Santos FR, 1996, HUM GENET, V97, P309, DOI 10.1007/BF02185760; Semino O, 1996, AM J HUM GENET, V59, P964; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; Tegelstrom Hakan, 1992, P89; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	32	232	241	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1174	1183						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150165				2022-12-18	WOS:A1997WX76000018
J	BUDOWLE, B; GIUSTI, AM; WAYE, JS; BAECHTEL, FS; FOURNEY, RM; ADAMS, DE; PRESLEY, LA; DEADMAN, HA; MONSON, KL				BUDOWLE, B; GIUSTI, AM; WAYE, JS; BAECHTEL, FS; FOURNEY, RM; ADAMS, DE; PRESLEY, LA; DEADMAN, HA; MONSON, KL			FIXED-BIN ANALYSIS FOR STATISTICAL EVALUATION OF CONTINUOUS DISTRIBUTIONS OF ALLELIC DATA FROM VNTR LOCI, FOR USE IN FORENSIC COMPARISONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GEL-ELECTROPHORESIS; FRAGMENT LENGTH; HUMAN DNA; POLYMORPHISMS; FINGERPRINTS; CHROMOSOME	The detection of DNA polymorphisms by RFLP analysis is having a major impact on identity testing in forensic science. At present, this approach is the best effort a forensic scientist can make to exclude an individual who has been falsely associated with an evidentiary sample found at a crime scene. When an analysis fails to exclude a suspect as a potential contributor of an evidentiary sample, a means should be provided to assess suitable weight to the putative match. Most important, the statistical analysis should not place undue weight on a genetic profile derived from an unknown sample that is attributed to an accused individual. The method must allow for limitations in conventional agarose-submarine-gel electrophoresis and Southern blotting procedure, limited sample population data, possible subpopulation differences, and potential sampling error. A conservative statistical method was developed based on arbitrarily defined fixed bins. This approach permits classification of continuous allelic data, provides for a simple and portable data-base system, and is unlikely to underestimate the frequency of occurrence of a set of alleles. This will help ensure that undue weight is not placed on a sample attributed to an accused individual.	ROYAL CANADIAN MOUNTED POLICE,CENT FORENS LAB,OTTAWA,ONTARIO,CANADA; FED BUR INVEST,DIV LAB,DNA ANAL UNIT,WASHINGTON,DC		BUDOWLE, B (corresponding author), FED BUR INVEST ACAD,CTR FORENS SCI RES & TRAINING,DIV LAB,QUANTICO,VA 22135, USA.			Monson, Keith/0000-0001-7126-4247				ADAMS DE, IN PRESS J FORENSIC; ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; BALAZS I, 1989, AM J HUM GENET, V44, P182; BRENNER C, 1990, 1989 P INT S HUM ID, P21; BUDOWLE B, 1988, CRIME LAB DIGEST, V15, P8; BUDOWLE B, 1990, Applied and Theoretical Electrophoresis, V1, P181; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; BUDOWLE B, IN PRESS METHODS MOL, V9; BUDOWLE B, 1990, 1989 P INT S HUM ID, P103; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; DEVLIN B, 1991, AM J HUM GENET, V48, P662; DEVLIN B, IN PRESS J AM STAT A; ELDER JK, 1983, ANAL BIOCHEM, V128, P227, DOI 10.1016/0003-2697(83)90369-X; EVETT IW, IN PRESS ELECTROPHOR; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; GILL P, 1987, ELECTROPHORESIS, V8, P38, DOI 10.1002/elps.1150080109; GIUSTI A, 1986, J FORENSIC SCI, V31, P409; GOODMAN LA, 1965, TECHNOMETRICS, V7, P247, DOI 10.2307/1266673; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; KANTER E, 1986, J FORENSIC SCI, V31, P403; LANDER ES, 1989, BANBURY REPORT, V32, P143; MILLNER ECB, 1989, NUCLEIC ACIDS RES, V17, P4002; MONSON KL, 1989, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON THE FORENSIC ASPECTS OF DNA ANALYSIS, P127; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P381, DOI 10.1093/nar/16.1.381; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9364, DOI 10.1093/nar/16.19.9364; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10073, DOI 10.1093/nar/15.23.10073; ODELBERG SJ, 1989, GENOMICS, V5, P915, DOI 10.1016/0888-7543(89)90134-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WAINSCOAT JS, 1987, HUM GENET, V75, P384, DOI 10.1007/BF00284114; WAYE JS, 1987, MOL CELL BIOL, V7, P349, DOI 10.1128/MCB.7.1.349; Willis C E, 1988, Appl Theor Electrophor, V1, P11; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	35	232	233	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					841	855						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1673286				2022-12-18	WOS:A1991FK89700003
J	Porath, B; Gainullin, VG; Cornec-Le Gall, E; Dillinger, EK; Heyer, CM; Hopp, K; Edwards, ME; Madsen, CD; Mauritz, SR; Banks, CJ; Baheti, S; Reddy, B; Herrero, JI; Banales, JM; Hogan, MC; Tasic, V; Watnick, TJ; Chapman, AB; Vigneau, C; Lavainne, F; Audrezet, MP; Ferec, C; Le Meur, Y; Torres, VE; Harris, PC				Porath, Binu; Gainullin, Vladimir G.; Cornec-Le Gall, Emilie; Dillinger, Elizabeth K.; Heyer, Christina M.; Hopp, Katharina; Edwards, Marie E.; Madsen, Charles D.; Mauritz, Sarah R.; Banks, Carly J.; Baheti, Saurabh; Reddy, Bharathi; Ignacio Herrero, Jose; Banales, Jesus M.; Hogan, Marie C.; Tasic, Velibor; Watnick, Terry J.; Chapman, Arlene B.; Vigneau, Cecile; Lavainne, Frederic; Audrezet, Marie-Pierre; Ferec, Claude; Le Meur, Yannick; Torres, Vicente E.; Harris, Peter C.		Genkyst Study Grp; HALT Progression Polycystic Kidney; Consortium Radiologic Imaging Stud	Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOPLASMIC-RETICULUM; HETERODIMERIC STRUCTURE; QUALITY-CONTROL; GENE; PROTEINS; GLYCOSYLATION; DIAGNOSIS; PRKCSH; VOLUME; SEC63	Autosomal-dominant polycystic kidney disease (ADPKD) is a common, progressive, adult-onset disease that is an important cause of end-stage renal disease (ESRD), which requires transplantation or dialysis. Mutations in PKD1 or PKD2 (similar to 85% and similar to 15% of resolved cases, respectively) are the known causes of ADPKD. Extrarenal manifestations include an increased level of intracranial aneurysms and polycystic liver disease (PLD), which can be severe and associated with significant morbidity. Autosomal-dominant PLD (ADPLD) with no or very few renal cysts is a separate disorder caused by PRKCSH, SEC63, or LRP5 mutations. After screening, 7%-10% of ADPKD-affected and similar to 50% of ADPLD-affected families were genetically unresolved (GUR), suggesting further genetic heterogeneity of both disorders. Whole-exome sequencing of six GUR ADPKD-affected families identified one with a missense mutation in GANAB, encoding glucosidase II subunit alpha (GII alpha). Because PRKCSH encodes GII beta, GANAB is a strong ADPKD and ADPLD candidate gene. Sanger screening of 321 additional GUR families identified eight further likely mutations (six truncating), and a total of 20 affected individuals were identified in seven ADPKD-and two ADPLD-affected families. The phenotype was mild PKD and variable, including severe, PLD. Analysis of GANAB-null cells showed an absolute requirement of GII alpha for maturation and surface and ciliary localization of the ADPKD proteins (PC1 and PC2), and reduced mature PC1 was seen in GANAB(+/-) cells. PC1 surface localization in GANAB(-/-) cells was rescued by wild-type, but not mutant, GIIa. Overall, we show that GANAB mutations cause ADPKD and ADPLD and that the cystogenesis is most likely driven by defects in PC1 maturation.	[Porath, Binu; Gainullin, Vladimir G.; Cornec-Le Gall, Emilie; Heyer, Christina M.; Hopp, Katharina; Edwards, Marie E.; Madsen, Charles D.; Mauritz, Sarah R.; Banks, Carly J.; Hogan, Marie C.; Torres, Vicente E.; Harris, Peter C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Cornec-Le Gall, Emilie; Audrezet, Marie-Pierre; Ferec, Claude] Univ Bretagne Occidentale, Dept Mol Genet, INSERM 1078, F-29200 Brest, Brittany, France; [Cornec-Le Gall, Emilie; Le Meur, Yannick] Univ Hosp, Dept Nephrol, F-29200 Brest, Brittany, France; [Dillinger, Elizabeth K.; Harris, Peter C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Hopp, Katharina] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80202 USA; [Baheti, Saurabh] Mayo Clin, Div Biostat & Informat, Rochester, MN 55905 USA; [Reddy, Bharathi; Chapman, Arlene B.] Univ Chicago, Nephrol Sect, Chicago, IL 60637 USA; [Ignacio Herrero, Jose] Univ Navarra Clin, Liver Unit, Navarra 31009, Spain; [Ignacio Herrero, Jose] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid 28029, Spain; [Ignacio Herrero, Jose] Inst Invest Sanitaria Navarra, Navarra 31008, Spain; [Banales, Jesus M.] Univ Basque Country, Donostia Univ Hosp, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian 20014, Spain; [Tasic, Velibor] Univ Childrens Hosp, Dept Pediat Nephrol, Skopje 1010, North Macedonia; [Watnick, Terry J.] Univ Maryland, Sch Med, Div Nephrol, Baltimore, MD 21201 USA; [Vigneau, Cecile] Univ Hosp, Dept Nephrol, F-35000 Rennes, Bretagne, France; [Lavainne, Frederic] Univ Hosp, Dept Nephrol, F-44000 Nantes, Pays De La Loir, France	Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Mayo Clinic; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Mayo Clinic; University of Chicago; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; University System of Maryland; University of Maryland Baltimore; CHU Rennes; Nantes Universite; CHU de Nantes	Harris, PC (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Harris, PC (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	harris.peter@mayo.edu	Gall, Emilie Cornec-Le/AAJ-8467-2020; Ferec, Claude/ABG-9699-2020; vigneau, cecile/I-3178-2015; Tasic, Velibor/H-8714-2019; Banales, Jesus M/R-9739-2019	Ferec, Claude/0000-0002-2325-0710; Tasic, Velibor/0000-0002-3377-1245; CORNEC-LE GALL, Emilie/0000-0003-1958-4459; Torres, Vicente/0000-0003-2008-1576; Senum, Sarah/0000-0002-5489-9117; Le Meur, Yannick/0000-0001-8913-415X; Banales, Jesus/0000-0002-5224-2373	NIDDK [DK058816, DK056943, DK056956, DK056957, DK056961, DK062410, DK062408, DK062402, DK082230, DK062411, DK062401]; Mayo PKD Translational Center [DK090728]; American Heart Association; Mayo Clinic Nephrology Training Grant [T32DK007013]; American Society of Nephrology (ASN) Foundation Kidney Research Fellowship; Ben J. Lipps Research Fellowship; Mayo Graduate School; Zell Family Foundation; National Center for Research Resources General Clinical Research Centers; National Center for Advancing Translational Sciences Clinical and Translational Science Awards; National Plans for Clinical Research, Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI Grand Ouest); French Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK056943, U01DK062402, U01DK062401, P30DK090728, U01DK056956, U01DK082230, P30DK090868, U01DK062408, R01DK044863, U01DK062410, U01DK056957, R01DK058816, T32DK007013, U01DK062411, U01DK056961] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo PKD Translational Center; American Heart Association(American Heart Association); Mayo Clinic Nephrology Training Grant; American Society of Nephrology (ASN) Foundation Kidney Research Fellowship; Ben J. Lipps Research Fellowship; Mayo Graduate School; Zell Family Foundation; National Center for Research Resources General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences Clinical and Translational Science Awards; National Plans for Clinical Research, Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI Grand Ouest); French Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the families and coordinators for involvement in the study, the Exome Aggregation Consortium, Tatyana Masyuk, and other HALT Progression of Polycystic Kidney Disease (HALT-PKD) and Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) investigators: Drs. Grantham, Yu, and Winklehofer (Kansas Medical Center), Bae, Abebe, and Landsittel (University of Pittsburgh), Schrier and Brosnahan (University of Colorado Denver), Perrone and Miskulin (Tufts University), Braun (Cleveland Clinic), Steinman (Beth Israel Deaconess Medical Center), Mrug (University of Alabama at Birmingham), Rahbari-Oskoui (Emory University), Bennett (Legacy Health, Portland), Flessner (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK]), Moore (Carolinas HealthCare, Charlotte), and Czarnecki (Brigham and Women's Hospital). This study received support from NIDDK grant DK058816, the Mayo PKD Translational Center (DK090728), an American Heart Association postdoctoral fellowship (B.P.), the Mayo Clinic Nephrology Training Grant (T32DK007013 to V.G.G.), an American Society of Nephrology (ASN) Foundation Kidney Research Fellowship (E.C.-L.G.) and Ben J. Lipps Research Fellowship (K.H.), the Mayo Graduate School (E.K.D.), the Zell Family Foundation, and Robert M. and Billie Kelley Pirnie. The CRISP and HALT-PKD studies were supported by NIDDK cooperative agreements (DK056943, DK056956, DK056957, DK056961, DK062410, DK062408, DK062402, DK082230, DK062411, and DK062401), National Center for Research Resources General Clinical Research Centers, and National Center for Advancing Translational Sciences Clinical and Translational Science Awards. The Genkyst cohort was supported by National Plans for Clinical Research, Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI Grand Ouest), and the French Society of Nephrology.	Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; Chebib F. T., 2016, NEPHROL DIAL TRANSPL; Cheong B, 2007, CLIN J AM SOC NEPHRO, V2, P38, DOI 10.2215/CJN.00930306; Cnossen WR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-69; Cnossen WR, 2014, P NATL ACAD SCI USA, V111, P5343, DOI 10.1073/pnas.1309438111; Consugar MB, 2008, KIDNEY INT, V74, P1468, DOI 10.1038/ki.2008.485; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; D'Alessio C, 2015, CURR PROTEIN PEPT SC, V16, P31, DOI 10.2174/1389203716666150213160438; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; Fedeles SV, 2015, J CLIN INVEST, V125, P1955, DOI 10.1172/JCI78863; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Gainullin VG, 2015, J CLIN INVEST, V125, P607, DOI 10.1172/JCI76972; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Harris PC, 2006, J AM SOC NEPHROL, V17, P3013, DOI 10.1681/ASN.2006080835; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Heidet L, 2010, CLIN J AM SOC NEPHRO, V5, P1079, DOI 10.2215/CJN.06810909; Hennet T, 2015, TRENDS BIOCHEM SCI, V40, P377, DOI 10.1016/j.tibs.2015.03.002; Heyer C. M., 2016, J AM SOC NEPHROL; Hoevenaren IA, 2008, LIVER INT, V28, P264, DOI 10.1111/j.1478-3231.2007.01595.x; Hofherr A, 2014, J BIOL CHEM, V289, P14854, DOI 10.1074/jbc.M114.562264; Hogan MC, 2015, CLIN GASTROENTEROL H, V13, P155, DOI 10.1016/j.cgh.2014.07.051; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6482; Kline TL, 2016, NEPHROL DIAL TRANSPL, V31, P241, DOI 10.1093/ndt/gfv314; Kurbegovic A, 2014, MOL CELL BIOL, V34, P3341, DOI 10.1128/MCB.00687-14; Lek M., 2015, ANAL PROTEIN CODING; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Paul BM, 2014, KIDNEY INT, V85, P383, DOI 10.1038/ki.2013.227; Pei Y, 2015, J AM SOC NEPHROL, V26, P746, DOI 10.1681/ASN.2014030297; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Pelletier MF, 2000, GLYCOBIOLOGY, V10, P815, DOI 10.1093/glycob/10.8.815; Pirson Y, 2002, J AM SOC NEPHROL, V13, P269, DOI 10.1681/ASN.V131269; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; REITMAN ML, 1982, J BIOL CHEM, V257, P357; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; SADLER I, 1989, J CELL BIOL, V109, P2665, DOI 10.1083/jcb.109.6.2665; SAKAI K, 1989, GENOMICS, V5, P309, DOI 10.1016/0888-7543(89)90063-3; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Skowronek MH, 1999, BIOL CHEM, V380, P1133, DOI 10.1515/BC.1999.142; Takakura A, 2009, HUM MOL GENET, V18, P2523, DOI 10.1093/hmg/ddp147; Tan AY, 2015, CLIN GENET, V87, P373, DOI 10.1111/cge.12383; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Treml K, 2000, GLYCOBIOLOGY, V10, P493, DOI 10.1093/glycob/10.5.493; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Urribarri AD, 2014, GUT, V63, P1658, DOI 10.1136/gutjnl-2013-305281; Waanders E, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9441; WARD CJ, 1994, CELL, V77, P881; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073	66	231	245	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1193	1207		10.1016/j.ajhg.2016.05.004	http://dx.doi.org/10.1016/j.ajhg.2016.05.004			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27259053	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000377286000013
J	Browning, BL; Browning, SR				Browning, Brian L.; Browning, Sharon R.			A Fast, Powerful Method for Detecting Identity by Descent	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; HAPLOTYPE; RELATEDNESS; GENES; MODEL	We present a method, fastIBID, for finding tracts of identity by descent (IBD) between pairs of individuals. FastIBD can be applied to thousands of samples across genome-wide SNP data and is significantly more powerful for finding short tracts of IBD than existing methods for finding IBD tracts in such data. We show that fastIBD can detect facets of population structure that are not revealed by other methods. In the Wellcome Trust Case Control Consortium bipolar disorder case-control data, we find a genome-wide excess of IBD in case-case pairs of individuals compared to control-control pairs. We show that this excess can be explained by the geographical clustering of cases. We also show that it is possible to use fast! BD to generate highly accurate estimates of genome-wide IBD sharing between pairs of distant relatives. This is useful for estimation of relationship and for adjusting for relatedness in association studies. FastIBD is incorporated in the freely available Beagle software package.	[Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98105 USA; [Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Browning, BL (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98105 USA.	browning@uw.edu; sguy@uw.edu	Browning, Sharon/B-1530-2008; Browning, Brian L/A-1178-2010	Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633	Wellcome Trust [076113]; National Institutes of Health [R01GM075091, R01HG005701, R01004960]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075091] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study makes use of data generated by the Wellcome Trust Case Control Consortium and the Wellcome Trust Sanger Institute. The Illumina 550K genotype data for individuals in the 1958 British birth cohort were generated by the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the Wellcome Trust Case Control Consortium data is available from www.wtccc.org.uk. Funding for the Wellcome Trust Case Control Consortium project was provided by the Wellcome Trust under award 076113. This work was supported by National Institutes of Health awards R01GM075091, R01HG005701, and R01004960. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Wellcome Trust.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Albrechtsen A, 2009, GENET EPIDEMIOL, V33, P266, DOI 10.1002/gepi.20378; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Browning SR, 2005, GENET EPIDEMIOL, V28, P110, DOI 10.1002/gepi.20051; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Choi Y, 2009, GENET EPIDEMIOL, V33, P668, DOI 10.1002/gepi.20418; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Kenny EE, 2009, P NATL ACAD SCI USA, V106, P13886, DOI 10.1073/pnas.0907336106; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Leibon G, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1340; Lynch M, 1999, GENETICS, V152, P1753; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Thomas A, 2008, ANN HUM GENET, V72, P279, DOI 10.1111/j.1469-1809.2007.00406.x; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	26	231	237	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					173	182		10.1016/j.ajhg.2011.01.010	http://dx.doi.org/10.1016/j.ajhg.2011.01.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21310274	Green Published, Bronze			2022-12-18	WOS:000287684100005
J	Bergmann, C; Fliegauf, M; Bruchle, NO; Frank, V; Olbrich, H; Kirschner, J; Schermer, B; Schmedding, I; Kispert, A; Kranzlin, B; Nurnberg, G; Becker, C; Grimm, T; Girschick, G; Lynch, SA; Kelehan, P; Senderek, J; Neuhaus, TJ; Stallmach, T; Zentgraf, H; Nurnberg, P; Gretz, N; Lo, C; Lienkamp, S; Schafer, T; Walz, G; Benzing, T; Zerres, K; Omran, H				Bergmann, Carsten; Fliegauf, Manfred; Bruechle, Nadina Ortiz; Frank, Valeska; Olbrich, Heike; Kirschner, Jan; Schermer, Bernhard; Schmedding, Ingolf; Kispert, Andreas; Kraenzlin, Bettina; Nuernberg, Gudrun; Becker, Christian; Grimm, Tiemo; Girschick, Gundula; Lynch, Sally A.; Kelehan, Peter; Senderek, Jan; Neuhaus, Thomas J.; Stallmach, Thomas; Zentgraf, Hanswalter; Nuernberg, Peter; Gretz, Norbert; Lo, Cecilia; Lienkamp, Soeren; Schaefer, Tobias; Walz, Gerd; Benzing, Thomas; Zerres, Klaus; Omran, Heymut			Loss of nephrocystin-3 function can cause embryonic lethality, meckel-gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; BARDET-BIEDL-SYNDROME; RIGHT AXIS DETERMINATION; BASAL BODY PROTEIN; JOUBERT-SYNDROME; PRIMARY CILIA; ADOLESCENT NEPHRONOPHTHISIS; SYNDROME GENE; PCY MICE; MUTATIONS	Many genetic diseases have been linked to the dysfunction of primary cilia, which occur nearly ubiquitously in the body and act as solitary cellular mechanosensory organelles. The list of clinical manifestations and affected tissues in cilia-related disorders (ciliopathies) such as nephronophthisis is broad and has been attributed to the wide expression pattern of ciliary proteins. However, little is known about the molecular mechanisms leading to this dramatic diversity of phenotypes. We recently reported hypomorpoic NPHP3 mutations in children and young adults with isolated nephronophthisis and associated hepatic fibrosis or tapetoretinal degeneration. Here, we chose a combinatorial approach in mice and humans to define the phenotypic spectrum of NPHP3/Nphp3 mutations and the role of the nephrocystin-3 protein. We demonstrate that the pcy mutation generates a hypomorphic Nphp3 allele that is responsible for the cystic kidney disease phenotype, whereas complete loss of Nphp3 function results in situs inversus, congenital heart defects, and embryonic lethality in mice. In humans, we show that NPHP3 mutations can cause a broad clinical spectrum of early embryonic patterning defects comprising situs inversus, polydactyly, central nervous system malformations, structural heart defects, preauricular fistulas, and a wide range of congenital anomalies of the kidney and urinary tract (CAKUT). On the functional level, we show that nephrocystin-3 directly interacts with inversin and can inhibit like inversin canonical Writ signaling, whereas nephrocystin-3 deficiency leads in Xenopus laevis to typical planar cell polarity defects, suggesting a role in the control of canonical and noncanonical (planar cell polarity) Writ signaling.	[Bergmann, Carsten; Bruechle, Nadina Ortiz; Frank, Valeska; Zerres, Klaus] Rhein Westfal TH Aachen, Dept Human Genet, D-52074 Aachen, Germany; [Fliegauf, Manfred; Olbrich, Heike; Kirschner, Jan; Omran, Heymut] Univ Freiburg, Med Ctr, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Schermer, Bernhard; Schmedding, Ingolf; Benzing, Thomas] Univ Cologne, Dept Med 4, D-50924 Cologne, Germany; [Schermer, Bernhard; Schmedding, Ingolf; Benzing, Thomas] Univ Cologne, Kidney Res Ctr Cologne, D-50924 Cologne, Germany; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; [Kraenzlin, Bettina; Gretz, Norbert] Univ Heidelberg, Klinikum Mannheim, Med Res Ctr, D-68167 Mannheim, Germany; [Nuernberg, Gudrun; Becker, Christian; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Nuernberg, Gudrun; Becker, Christian] RZPD Deutsch Ressourcenzentrum Genomforsch Gmbh, D-13125 Berlin, Germany; [Grimm, Tiemo] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Nuernberg, Gudrun] Univ Wurzburg, Dept Obstet & Gynecol, D-97080 Wurzburg, Germany; [Lynch, Sally A.] Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin 12, Ireland; [Kelehan, Peter] Natl Matern Hosp, Dept Histopathol, Dublin 2, Ireland; [Neuhaus, Thomas J.] Univ Zurich, Childrens Hosp, Nephrol Unit, CH-8032 Zurich, Switzerland; [Stallmach, Thomas] Univ Zurich, Dept Pathol, CH-8091 Zurich, Switzerland; [Zentgraf, Hanswalter] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; [Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Lo, Cecilia] NHLBI, Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Lienkamp, Soeren; Schaefer, Tobias; Walz, Gerd] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany	RWTH Aachen University; University of Freiburg; University of Cologne; University of Cologne; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Cologne; University of Wurzburg; University of Wurzburg; Our Ladys Children Hospital Crumlin; National Maternity Hospital, Dublin; University Children's Hospital Zurich; University of Zurich; University of Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Freiburg	Bergmann, C (corresponding author), Rhein Westfal TH Aachen, Dept Human Genet, D-52074 Aachen, Germany.	cbergmann@ukaachen.de	Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; Kirschner, Janbernd/Q-1493-2019; Lienkamp, Soeren/AAH-6296-2020; Kirschner, Janbernd/H-7418-2016; Senderek, Jan/F-8405-2015	Schermer, Bernhard/0000-0002-5194-9000; Kirschner, Janbernd/0000-0003-1618-7386; Lienkamp, Soeren/0000-0003-2963-6865; Kirschner, Janbernd/0000-0003-1618-7386; Senderek, Jan/0000-0002-8263-1783; Lynch, Sally Ann/0000-0003-3540-1333; Omran, Heymut/0000-0003-0282-6765	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005701, Z01HL005701] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Christensen ST, 2007, TRAFFIC, V8, P97, DOI 10.1111/j.1600-0854.2006.00516.x; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Frank V, 2007, HUM MUTAT, V28, P638, DOI 10.1002/humu.9496; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Harris PC, 2006, CURR OPIN NEPHROL HY, V15, P456, DOI 10.1097/01.mnh.0000232888.65895.e7; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Jaeken J, 2004, CURR OPIN PEDIATR, V16, P434, DOI 10.1097/01.mop.0000133636.56790.4a; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Mykytyn K, 2007, NAT GENET, V39, P818, DOI 10.1038/ng0707-818; Neuhaus TJ, 1996, EUR J PEDIATR, V155, P791, DOI 10.1007/BF02002909; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkopp P. D., 1967, NORMAL TABLE XENOPUS; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Omran H, 2001, J AM SOC NEPHROL, V12, P107, DOI 10.1681/ASN.V121107; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Rankin J, 2006, CLIN GENET, V70, P261, DOI 10.1111/j.1399-0004.2006.00677.x; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724	37	231	245	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					959	970		10.1016/j.ajhg.2008.02.017	http://dx.doi.org/10.1016/j.ajhg.2008.02.017			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18371931	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000255103900014
J	Wooding, S; Kim, UK; Bamshad, MJ; Larsen, J; Jorde, LB; Drayna, D				Wooding, S; Kim, UK; Bamshad, MJ; Larsen, J; Jorde, LB; Drayna, D			Natural selection and molecular evolution in PTC, a bitter-taste receptor gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA SEQUENCES; POPULATION-GROWTH; GEOGRAPHIC SUBDIVISION; PAIRWISE COMPARISONS; NATIVE-AMERICANS; HUMAN ORIGINS; PLEISTOCENE; COALESCENT; PATTERNS; LOCUS	The ability to taste phenylthiocarbamide (PTC) is a classic phenotype that has long been known to vary in human populations. This phenotype is of genetic, epidemiologic, and evolutionary interest because the ability to taste PTC is correlated with the ability to taste other bitter substances, many of which are toxic. Thus, variation in PTC perception may reflect variation in dietary preferences throughout human history and could correlate with susceptibility to diet-related diseases in modern populations. To test R. A. Fisher's long-standing hypothesis that variability in PTC perception has been maintained by balancing natural selection, we examined patterns of DNA sequence variation in the recently identified PTC gene, which accounts for up to 85% of phenotypic variance in the trait. We analyzed the entire coding region of PTC ( 1,002 bp) in a sample of 330 chromosomes collected from African (n=62), Asian (n=138), European (n=110), and North American (n=20) populations by use of new statistical tests for natural selection that take into account the potentially confounding effects of human population growth. Two intermediate-frequency haplotypes corresponding to "taster" and "nontaster" phenotypes were found. These haplotypes had similar frequencies across Africa, Asia, and Europe. Genetic differentiation between the continental population samples was low (F-ST = 0.056) in comparison with estimates based on other genes. In addition, Tajima's D and Fu and Li's D and F statistics demonstrated a significant deviation from neutrality because of an excess of intermediate-frequency variants when human population growth was taken into account (P<.01). These results combine to suggest that balancing natural selection has acted to maintain " taster" and " nontaster" alleles at the PTC locus in humans.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; NIDCD, NIH, Rockville, MD USA	Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Wooding, S (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	swooding@genetics.utah.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES012125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000046, Z01DC000046] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES12125, F32 ES012125] Funding Source: Medline; NIGMS NIH HHS [R01 GM059290, GM59290] Funding Source: Medline; PHS HHS [Z01-000046-04] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BARNICOT NA, 1951, ANN EUGENIC, V16, P119, DOI 10.1111/j.1469-1809.1951.tb02464.x; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Blakeslee AF, 1932, P NATL ACAD SCI USA, V18, P120, DOI 10.1073/pnas.18.1.120; Cavalli-Sforza L., HIST GEOGRAPHY HUMAN; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P506, DOI 10.1093/ajcn/62.3.506; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; EXCOFFIER L, 1992, GENETICS, V131, P479; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; FU YX, 1993, GENETICS, V133, P693; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Guo SW, 2001, ANN HUM BIOL, V28, P111; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Harris EE, 1999, EVOL ANTHROPOL, V8, P81, DOI 10.1002/(SICI)1520-6505(1999)8:3<81::AID-EVAN3>3.0.CO;2-4; HARRIS H, 1949, ANN EUGENIC, V14, P309, DOI 10.1111/j.1469-1809.1949.tb02420.x; Hartl DL, 1997, PRINCIPLES POPULATIO; Hey J, 1999, MOL BIOL EVOL, V16, P1423, DOI 10.1093/oxfordjournals.molbev.a026054; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; KAPLAN N, 1991, GENET RES, V57, P83, DOI 10.1017/S0016672300029074; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KLEIN RG, 1999, HUMAN CAREER HUMAN B; Laporte V, 2002, GENETICS, V162, P501; LI WH, 1985, MOL BIOL EVOL, V2, P150; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; MARJORAM P, 1994, GENETICS, V136, P673; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Nettle D, 1999, P NATL ACAD SCI USA, V96, P3325, DOI 10.1073/pnas.96.6.3325; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Roessli D, 2000, ARLEQUIN VERSION 2 0; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruhlen M., 1994, ORIGIN LANGUAGE; Schneider JA, 2003, MECH AGEING DEV, V124, P17, DOI 10.1016/S0047-6374(02)00165-3; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; TAJIMA F, 1989, GENETICS, V123, P585; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; Wakeley J, 2001, THEOR POPUL BIOL, V59, P133, DOI 10.1006/tpbi.2000.1495; Wall JD, 2000, GENETICS, V155, P1865; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Wooding S, 2000, HUM BIOL, V72, P693; Wooding S, 2002, GENETICS, V161, P1641; Wooding SP, 2002, AM J HUM GENET, V71, P528, DOI 10.1086/342260; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yu N, 2002, GENETICS, V161, P269; 1931, SCIENCE S, V73, P14	62	231	242	3	188	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					637	646		10.1086/383092	http://dx.doi.org/10.1086/383092			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	14997422	Bronze, Green Published			2022-12-18	WOS:000220280800004
J	Ming, JE; Muenke, M				Ming, JE; Muenke, M			Multiple hits during early embryonic development: Digenic diseases and holoprosencephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							BARDET-BIEDL-SYNDROME; PRIMARY CONGENITAL GLAUCOMA; LEMLI-OPITZ-SYNDROME; SONIC-HEDGEHOG GENE; JUNCTIONAL EPIDERMOLYSIS-BULLOSA; SIMPLE MENDELIAN DISORDERS; POLYCYSTIC KIDNEY-DISEASE; VENTRAL MIDLINE CELLS; OPEN-ANGLE GLAUCOMA; ONE-EYED PINHEAD		NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Muenke, M (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr MSC 1852,Bldg 10 Room 10C103, Bethesda, MD 20892 USA.	muenke@nih.gov		Muenke, Maximilian/0000-0002-7719-6545	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000209, Z01HG000115] Funding Source: NIH RePORTER; NICHD NIH HHS [HD01218] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adato A, 1999, AM J HUM GENET, V65, P261, DOI 10.1086/302438; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Balciuniene J, 1998, AM J HUM GENET, V63, P786, DOI 10.1086/302012; BARR M, 1983, J PEDIATR-US, V102, P565, DOI 10.1016/S0022-3476(83)80185-1; Beaudet AL, 2001, METABOLIC MOL BASES, P3; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bisgrove BW, 2001, AM J MED GENET, V101, P315, DOI 10.1002/ajmg.1180; Blader P, 1998, NATURE, V395, P112, DOI 10.1038/25836; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; BOLK S, 2002, NAT GENET, V31, P89; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Brower V, 2001, EMBO REP, V2, P10, DOI 10.1093/embo-reports/kve013; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cohen MM, 2002, AM J MED GENET, V109, P1, DOI 10.1002/ajmg.10258; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Croen LA, 2000, AM J MED GENET, V90, P320, DOI 10.1002/(SICI)1096-8628(20000214)90:4<320::AID-AJMG11>3.3.CO;2-#; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; Dale K, 1999, DEVELOPMENT, V126, P397; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; dela Cruz JM, 2000, AM J HUM GENET, V67, P385; Dipple KM, 2001, MOL GENET METAB, V74, P45, DOI 10.1006/mgme.2001.3227; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Floeth M, 1999, AM J HUM GENET, V65, P1530, DOI 10.1086/302672; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Jin O, 2001, INT J DEV BIOL, V45, P357; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KEELER RF, 1968, TERATOLOGY, V1, P5, DOI 10.1002/tera.1420010103; Kelley RI, 1996, AM J MED GENET, V66, P478, DOI 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO;2-Q; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Kivirikko S, 1996, HUM MOL GENET, V5, P231, DOI 10.1093/hmg/5.2.231; Klingensmith J, 2001, DEV BIOL, V235, P283; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Koptides M, 2000, HUM GENET, V107, P115, DOI 10.1007/s004390000347; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; Martinez-Frias ML, 1998, AM J MED GENET, V78, P140, DOI 10.1002/(SICI)1096-8628(19980630)78:2<140::AID-AJMG8>3.0.CO;2-S; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; McCabe ERB, 2002, LANCET, V359, P1169, DOI 10.1016/S0140-6736(02)08249-1; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; Ming JE, 1998, MOL MED TODAY, V4, P343, DOI 10.1016/S1357-4310(98)01299-4; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Ming JE, 1998, CLIN GENET, V53, P155; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; MUENKE M, 2001, METABOLIC MOL BASES, P6203; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nanni L, 2001, AM J MED GENET, V102, P1, DOI 10.1002/1096-8628(20010722)102:1<1::AID-AJMG1336>3.0.CO;2-U; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Parisi MA, 2000, CURR OPIN PEDIATR, V12, P610, DOI 10.1097/00008480-200012000-00017; Pei Y, 2001, AM J HUM GENET, V68, P355, DOI 10.1086/318188; Plasterk RHA, 1999, NAT GENET, V21, P63, DOI 10.1038/4996; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Roach E, 1975, Birth Defects Orig Artic Ser, V11, P294; Roessler E, 1998, J INHERIT METAB DIS, V21, P481, DOI 10.1023/A:1005406719292; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; RONEN GM, 1991, AM J MED GENET, V40, P151, DOI 10.1002/ajmg.1320400206; ROUX C, 1979, TERATOLOGY, V19, P35, DOI 10.1002/tera.1420190106; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Savage DB, 2002, NAT GENET, V31, P379, DOI 10.1038/ng926; Schier AF, 1996, DEVELOPMENT, V123, P165; Schier AF, 1997, DEVELOPMENT, V124, P327; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Scriver CR, 2002, J PEDIATR-US, V140, P502, DOI 10.1067/mpd.2002.124316; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Sheffield VC, 2001, CURR OPIN GENET DEV, V11, P317, DOI 10.1016/S0959-437X(00)00196-9; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; SPRITZ RA, 1990, NEW ENGL J MED, V322, P1724, DOI 10.1056/NEJM199006143222407; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; SULIK KK, 1982, SCAN ELECTRON MICROS, P309; SULIK KK, 1995, TERATOLOGY, V51, P398, DOI 10.1002/tera.1420510605; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Varlet I, 1997, COLD SPRING HARB SYM, V62, P105; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	123	231	236	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1017	1032		10.1086/344412	http://dx.doi.org/10.1086/344412			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12395298	Bronze, Green Published			2022-12-18	WOS:000178884300002
J	Elson, JL; Samuels, DC; Turnbull, DM; Chinnery, PF				Elson, JL; Samuels, DC; Turnbull, DM; Chinnery, PF			Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; DISEASE; DELETION; CELLS; MTDNA; REPLICATION; INCREASE; GENETICS; TISSUES; FIBERS	Human tissues acquire somatic mitochondrial DNA (mtDNA) mutations with age. Very high levels of specific mtDNA mutations accumulate within individual cells, causing a defect of mitochondrial oxidative metabolism. This is a fundamental property of nondividing tissues, but it is not known how it comes about. To explore this problem, we developed a model of mtDNA replication within single human cells. Using this model, we show that relaxed replication of mtDNA alone can lead, through random genetic drift, to the clonal expansion of single mutant events during human life. Significant expansions primarily develop from mutations acquired during a critical period in childhood or early adult life.	Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Math, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, MRC, Dev Ctr Clin Brain Aging, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle Upon Tyne, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Samuels, David C/A-5393-2008; Samuels, David/C-1365-2012; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; /0000-0002-3551-5624; Chinnery, Patrick/0000-0002-7065-6617				BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Blume G, 1997, BRAIN, V120, P39, DOI 10.1093/brain/120.1.39; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Cottrell DA, 2000, J NEUROPATH EXP NEUR, V59, P621, DOI 10.1093/jnen/59.7.621; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kubota N, 1997, RADIAT RES, V148, P395, DOI 10.2307/3579525; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122; MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shenkar R, 1996, AM J HUM GENET, V59, P772; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Weber K, 1997, AM J HUM GENET, V60, P373; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	30	231	235	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					802	806		10.1086/318801	http://dx.doi.org/10.1086/318801			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179029	Green Published, Bronze			2022-12-18	WOS:000166994200026
J	Boehnke, M; Cox, NJ				Boehnke, M; Cox, NJ			Accurate inference of relationships in sib-pair linkage studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME; TRAITS	Relative-pair designs are routinely employed in linkage studies of complex genetic diseases and quantitative traits. Valid application of these methods requires correct specification of the relationships of the pairs. For example, within a sibship, presumed full sibs actually might be MZ twins, half sibs, or unrelated. Misclassification of half-sib pairs or unrelated individuals as full sibs can result in reduced power to detect linkage. When other family members, such as parents or additional siblings, are available, incorrectly specified relationships usually will be detected through apparent incompatibilities with Mendelian inheritance. Without other family members, sibling relationships cannot be determined absolutely, but they still can be inferred probabilistically if sufficient genetic marker data are available. In this paper, we describe a simple likelihood ratio method to infer the true relationship of a putative sibling pair. We explore the number of markers required to accurately infer relationships typically encountered in a sib-pair study, as a function of marker allele frequencies, marker spacing, and genotyping error rate, and we conclude that very accurate inference of relationships can be achieved, given the marker data from even part of a genome scan. We compare our method to related methods of relationship inference that have been suggested. Finally, we demonstrate the value of excluding non-full sibs in a genetic linkage study of non-insulin-dependent diabetes mellitus.	UNIV CHICAGO, DEPT MED, CHICAGO, IL 60637 USA	University of Chicago	Boehnke, M (corresponding author), UNIV MICHIGAN, SCH PUBL HLTH, DEPT BIOSTAT, 1420 WASHINGTON HTS, ANN ARBOR, MI 48109 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000376, R01HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046800] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00376] Funding Source: Medline; NIDDK NIH HHS [DK20595] Funding Source: Medline; NIGMS NIH HHS [GM46800] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baum LE, 1972, INEQUALITIES, V3, P1; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; CHAKRABORTY R, 1993, EXS, V67, P153; Ehm M. G., 1996, American Journal of Human Genetics, V59, pA217; Goring H. H. H., 1995, American Journal of Human Genetics, V57, pA192; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANGE K, 1995, GENOME RES, V5, P136, DOI 10.1101/gr.5.2.136; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Stivers D. N., 1996, American Journal of Human Genetics, V59, pA190; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; WEEKS DE, 1988, AM J HUM GENET, V42, P315	17	231	233	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					423	429		10.1086/514862	http://dx.doi.org/10.1086/514862			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311748	Bronze, Green Published			2022-12-18	WOS:A1997XX70100021
J	JORDE, LB				JORDE, LB			LINKAGE DISEQUILIBRIUM AS A GENE-MAPPING TOOL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							DIASTROPHIC DYSPLASIA; POPULATIONS; FINLAND				JORDE, LB (corresponding author), UNIV UTAH,SCH MED,HLTH SCI CTR,ECCLES INST HUMAN GENET,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112, USA.							BARKER D, 1984, AM J HUM GENET, V36, P1159; BONNETAMIR B, 1992, GENETIC DIVERSITY JE; CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F; DEBRAEKELEER M, 1991, HUM HERED, V41, P141, DOI 10.1159/000153992; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; HUDSON RR, 1985, GENETICS, V109, P611; HUSSELS I, 1969, HUM BIOL, V41, P469; JORDE JB, 1994, AM J HUM GENET, V54, P884; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KESTILA M, 1994, AM J HUM GENET, V54, P757; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LITT M, 1986, AM J HUM GENET, V39, P166; McKusick Victor., 1978, MED GENETIC STUDIES; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEI M, 1973, GENETICS, V75, P213; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SULISALO T, 1994, AM J HUM GENET, V55, P937; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; WATKINS WS, 1994, AM J HUM GENET, V55, P348; Weir BS, 1990, GENETIC DATA ANAL	26	231	236	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					11	14						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825565				2022-12-18	WOS:A1995QC10100002
J	MCSHANE, MA; HAMMANS, SR; SWEENEY, M; HOLT, IJ; BEATTIE, TJ; BRETT, EM; HARDING, AE				MCSHANE, MA; HAMMANS, SR; SWEENEY, M; HOLT, IJ; BEATTIE, TJ; BRETT, EM; HARDING, AE			PEARSON SYNDROME AND MITOCHONDRIAL ENCEPHALOMYOPATHY IN A PATIENT WITH A DELETION OF MTDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REFRACTORY SIDEROBLASTIC ANEMIA; EXOCRINE PANCREATIC DYSFUNCTION; KEARNS-SAYRE SYNDROME; MARROW PRECURSORS; DNA; MYOPATHIES; OPHTHALMOPLEGIA; VACUOLIZATION; FEATURES	A patient is described who has features of Pearson syndrome and who presented in the neonatal period with a hypoplastic anemia. He later developed hepatic, renal, and exocrine pancreatic dysfunction. At the age of 5 years he developed visual impairment, tremor, ataxia, proximal muscle weakness, external ophthalmoplegia, and a pigmentary retinopathy (Kearns-Sayre syndrome). Muscle biopsy confirmed the diagnosis of mitochondrial myopathy. Analysis of mtDNA from leukocytes and muscle showed mtDNA heteroplasmy in both tissues, with one population of mtDNA deleted by 4.9 kb. The deleted region was bridged by a 13-nucleotide sequence occurring as a direct repeat in normal mtDNA. Both Pearson syndrome and Kearns-Sayre syndrome have been noted to be associated with deletions of mtDNA; they have not previously been described in the same patient. These observations indicate that the two disorders have the same molecular basis; the different phenotypes are probably determined by the initial proportion of deleted mtDNAs and modified by selection against them in different tissues.	UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND; HOSP SICK CHILDREN,DEPT NEUROL,LONDON WC1N 3JH,ENGLAND; ROYAL HOSP SICK CHILDREN,GLASGOW G3 8SJ,SCOTLAND	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Glasgow				holt, ian/0000-0001-5468-0193				BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; RAWLES JM, 1974, AM J MED, V56, P891, DOI 10.1016/0002-9343(74)90820-1; ROTIG A, 1989, LANCET, V1, P902; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; STODDARD RA, 1981, J PEDIATR-US, V99, P259, DOI 10.1016/S0022-3476(81)80470-2; VANBIERVLIET JPGM, 1977, PEDIATR RES, V11, P1088, DOI 10.1203/00006450-197711100-00005	16	231	234	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					39	42						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985462				2022-12-18	WOS:A1991ET18800006
J	Jun, G; Flickinger, M; Hetrick, KN; Romm, JM; Doheny, KF; Abecasis, GR; Boehnke, M; Kang, HM				Jun, Goo; Flickinger, Matthew; Hetrick, Kurt N.; Romm, Jane M.; Doheny, Kimberly F.; Abecasis, Goncalo R.; Boehnke, Michael; Kang, Hyun Min			Detecting and Estimating Contamination of Human DNA Samples in Sequencing and Array-Based Genotype Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								DNA sample contamination is a serious problem in DNA sequencing studies and may result in systematic genotype misclassification and false positive associations. Although methods exist to detect and filter out cross-species contamination, few methods to detect within-species sample contamination are available. In this paper, we describe methods to identify within-species DNA sample contamination based on (1) a combination of sequencing reads and array-based genotype data, (2) sequence reads alone, and (3) array-based genotype data alone. Analysis of sequencing reads allows contamination detection after sequence data is generated but prior to variant calling; analysis of array-based genotype data allows contamination detection prior to generation of costly sequence data. Through a combination of analysis of in silico and experimentally contaminated samples, we show that our methods can reliably detect and estimate levels of contamination as low as 1%. We evaluate the impact of DNA contamination on genotype accuracy and propose effective strategies to screen for and prevent DNA contamination in sequencing studies.	[Jun, Goo; Flickinger, Matthew; Abecasis, Goncalo R.; Boehnke, Michael; Kang, Hyun Min] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Jun, Goo; Flickinger, Matthew; Abecasis, Goncalo R.; Boehnke, Michael; Kang, Hyun Min] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Hetrick, Kurt N.; Romm, Jane M.; Doheny, Kimberly F.] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD 21224 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University	Kang, HM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA.	hmkang@umich.edu	Jun, Goo/F-1941-2017; Abecasis, Goncalo R/B-7840-2010; Jun, Goo/M-5235-2016	Jun, Goo/0000-0003-0891-0204; Jun, Goo/0000-0003-0891-0204; Abecasis, Goncalo/0000-0003-1509-1825	NIH [DK088398, HG000376, MH084698, HG006513, HG005214, HHSN268200782096C, HHSN268201100011I]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007022, R29HG000376, R56HG000376, U01HG006513, U01HG005214, R01HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R13DK088398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants DK088398 and HG000376 (to M.B.), by NIH grants MH084698, HG006513, and HG005214 (to G.R.A.), and by NIH contract numbers HHSN268200782096C and HHSN268201100011I to support the Center for Inherited Disease Research.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Brent R.P., 2002, ALGORITHMS MINIMIZAT; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Gordon D., 2004, STAT APPL GENET MOL, V3, pe26; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	12	230	237	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					839	848		10.1016/j.ajhg.2012.09.004	http://dx.doi.org/10.1016/j.ajhg.2012.09.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23103226	Bronze, Green Published			2022-12-18	WOS:000311011400006
J	Ragge, NK; Brown, AG; Poloschek, CM; Lorenz, B; Henderson, RA; Clarke, MP; Russell-Eggitt, I; Fielder, A; Gerrelli, D; Martinez-Barbera, JP; Ruddle, P; Hurst, J; Collin, JRO; Salt, A; Cooper, ST; Thompson, PJ; Sisodiya, SM; Williamson, KA; FitzPatrick, DR; van Heyningen, V; Hanson, IM				Ragge, NK; Brown, AG; Poloschek, CM; Lorenz, B; Henderson, RA; Clarke, MP; Russell-Eggitt, I; Fielder, A; Gerrelli, D; Martinez-Barbera, JP; Ruddle, P; Hurst, J; Collin, JRO; Salt, A; Cooper, ST; Thompson, PJ; Sisodiya, SM; Williamson, KA; FitzPatrick, DR; van Heyningen, V; Hanson, IM			Heterozygous mutations of OTX2 cause severe ocular malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; TRANSCRIPTION-FACTOR; ANTERIOR NEUROECTODERM; RETINITIS-PIGMENTOSA; HOMEOBOX GENE; NEURAL RETINA; EXPRESSION; EYE; PHOTORECEPTOR; SPECIFICATION	Major malformations of the human eye, including microphthalmia and anophthalmia, are examples of phenotypes that recur in families yet often show no clear Mendelian inheritance pattern. Defining loci by mapping is therefore rarely feasible. Using a candidate-gene approach, we have identified heterozygous coding-region changes in the homeobox gene OTX2 in eight families with ocular malformations. The expression pattern of OTX2 in human embryos is consistent with the eye phenotypes observed in the patients, which range from bilateral anophthalmia to retinal defects resembling Leber congenital amaurosis and pigmentary retinopathy. Magnetic resonance imaging scans revealed defects of the optic nerve, optic chiasm, and, in some cases, brain. In two families, the mutations appear to have occurred de novo in severely affected offspring, and, in two other families, the mutations have been inherited from a gonosomal mosaic parent. Data from these four families support a simple model in which OTX2 heterozygous loss-of-function mutations cause ocular malformations. Four additional families display complex inheritance patterns, suggesting that OTX2 mutations alone may not lead to consistent phenotypes. The high incidence of mosaicism and the reduced penetrance have implications for genetic counseling.	Moorfields Eye Hosp, Dept Adnexal Surg, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England; Inst Child Hlth, Neural Dev Unit, London, England; UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; Univ Oxford, Dept Human Anat & Genet, Oxford, England; Oxford Radcliffe Hosp, NHS Trust, Dept Clin Genet, Oxford, England; Diana Princess Wales Childrens Hosp, Birmingham Childrens Hosp NHS Trust, Birmingham, W Midlands, England; Univ Edinburgh, Sch Mol & Clin Med, Edinburgh EH8 9YL, Midlothian, Scotland; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Univ Regensburg, Dept Pediat Ophthalmol & Ophthalmogenet, D-8400 Regensburg, Germany; Royal Victoria Infirm, Inst Human Genet, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Royal Victoria Infirm, Claremont Wing Eye Dept, Newcastle Upon Tyne, Tyne & Wear, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; City University London; University of London; University College London; University of London; University College London; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Edinburgh; University of Edinburgh; University of Regensburg; Newcastle University - UK; Newcastle University - UK	van Heyningen, V (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	v.vanheyningen@hgu.mrc.ac.uk	Poloschek, Charlotte M/B-3097-2010; FitzPatrick, David R/B-8311-2008; Martinez-Barbera, Juan Pedro/AAE-9284-2020; van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022; FitzPatrick, David R/C-7301-2013	Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; van Heyningen, Veronica/0000-0003-0359-0141; Hanson, Isabel/0000-0002-1878-0530; FitzPatrick, David R./0000-0003-4861-969X	Medical Research Council [MC_U127527199, G9826762, G9900837] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U127527199, G9900837, G9826762] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Aijaz S, 2004, INVEST OPHTH VIS SCI, V45, P3871, DOI 10.1167/iovs.04-0641; Ang SL, 1996, DEVELOPMENT, V122, P243; Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; D'Elia AV, 2001, HUM MUTAT, V18, P361, DOI 10.1002/humu.1207; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; EDWARDS JH, 1989, ANN HUM GENET, V53, P33, DOI 10.1111/j.1469-1809.1989.tb01120.x; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fernandez-Garre P, 2002, DEVELOPMENT, V129, P2807; FINKELSTEIN R, 1994, TRENDS GENET, V10, P310, DOI 10.1016/0168-9525(94)90033-7; FLAMME C, 2004, UM MUTAT, V24, P502; Fledelius HC, 1996, BRIT J OPHTHALMOL, V80, P918, DOI 10.1136/bjo.80.10.918; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Germot A, 2001, MOL BIOL EVOL, V18, P1668, DOI 10.1093/oxfordjournals.molbev.a003955; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Hanson IM, 2003, PEDIATR RES, V54, P791, DOI 10.1203/01.PDR.0000096455.00657.98; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kurokawa D, 2004, DEVELOPMENT, V131, P3319, DOI 10.1242/dev.01220; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Leuer M, 2001, AM J HUM GENET, V69, P75, DOI 10.1086/321285; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Nachman MW, 2000, GENETICS, V156, P297; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NUSSBAUM RL, 2001, GENET MED, P54; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; RAGGE NK, 2005, AM J MED GENET; Rasband K, 2003, NEURON, V39, P885, DOI 10.1016/S0896-6273(03)00563-4; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Rivolta C, 2001, HUM MUTAT, V18, P488, DOI 10.1002/humu.1226; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; van Heyningen V, 2004, HUM MOL GENET, V13, pR225, DOI 10.1093/hmg/ddh254; Vithana EN, 2003, INVEST OPHTH VIS SCI, V44, P4204, DOI 10.1167/iovs.03-0253; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	54	230	236	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1008	1022		10.1086/430721	http://dx.doi.org/10.1086/430721			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15846561	Green Published, Bronze			2022-12-18	WOS:000229047900007
J	Escayg, A; Heils, A; MacDonald, BT; Haug, K; Sander, T; Meisler, MH				Escayg, A; Heils, A; MacDonald, BT; Haug, K; Sander, T; Meisler, MH			A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus - and prevalence of variants in patients with epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SODIUM-CHANNEL; GENE; SUSCEPTIBILITY	We recently described mutations of the neuronal sodium-channel alpha -subunit gene, SCN1A, on chromosome 2q24 in two families with generalized epilepsy with febrile seizures plus (GEFS+) type 2. To assess the contribution that SCN1A makes to other types of epilepsy, 226 patients with either juvenile myoclonic epilepsy, absence epilepsy, or febrile convulsions were screened by conformation-sensitive gel electrophoresis and manual sequencing of variants; the sample included 165 probands from multiplex families and 61 sporadic cases. The novel mutation W1204R was identified in a family with GEFS+. Seven other coding changes were observed; three of these are potential disease-causing mutations. Two common haplotypes, with frequencies of .67 and .33, were defined by five single-nucleotide polymorphisms (SNPs) spanning a 14-kb region of linkage disequilibrium. An SNP located 18 bp upstream of the splice-acceptor site for exon 3 was observed in 7 of the 226 patients but was not present in 185 controls, suggesting possible association with a disease mutation. This work has confirmed the role of SCN1A in GEFS+, by identification of a novel mutation in a previously undescribed family. Although a few candidate disease alleles were identified, the patient survey suggests that SCN1A is not a major contributor to idiopathic generalized epilepsy. The SCN1A haplotypes and SNPs identified here will be useful in future association and linkage studies.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Bonn, Univ Clin Epileptol, D-5300 Bonn, Germany; Univ Bonn, Dept Human Genet, D-5300 Bonn, Germany; Humboldt Univ, Campus Virchow Clin, Univ Hosp Charite, Dept Neurol, Berlin, Germany	University of Michigan System; University of Michigan; University of Bonn; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, 4708 Med Sci 2, Ann Arbor, MI 48109 USA.	meislerm@umich.edu			NIGMS NIH HHS [T32 GM07544] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1980, Pediatrics, V66, P1009; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bulman DE, 1997, HUM MOL GENET, V6, P1679, DOI 10.1093/hmg/6.10.1679; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Haug K, 2000, EPILEPSY RES, V42, P57, DOI 10.1016/S0920-1211(00)00164-9; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Kohrman DC, 1996, J NEUROSCI, V16, P5993; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Meisler MH, 1997, ANN MED, V29, P569, DOI 10.3109/07853899709007484; MEISLER MH, IN PRESS NEUROSCIENT; Peiffer A, 1999, ANN NEUROL, V46, P671, DOI 10.1002/1531-8249(199910)46:4<671::AID-ANA20>3.0.CO;2-5; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; Sampo B, 2000, P NATL ACAD SCI USA, V97, P3666, DOI 10.1073/pnas.97.7.3666; Sander T, 2000, EPILEPSY RES, V41, P75, DOI 10.1016/S0920-1211(00)00120-0; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Smith RD, 1997, J NEUROSCI, V17, P6086; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	19	230	253	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					866	873		10.1086/319524	http://dx.doi.org/10.1086/319524			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254445	Green Published, Bronze			2022-12-18	WOS:000167666000008
J	Krawczak, M; Ball, EV; Cooper, DN				Krawczak, M; Ball, EV; Cooper, DN			Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CPG DINUCLEOTIDE; DNA METHYLATION; HUMAN CANCERS; TRANSCRIPTION; MUTATION; SPECIFICITY; DEAMINATION; SEQUENCE; DISEASE; STRAND	The spectrum of single-base-pair substitutions logged in The Human Gene Mutation Database (HGMD), comprising 7,271 different lesions in the coding regions of 547 different human genes, was analyzed for nearest-neighbor effects on relative mutation rates. Owing to its retrospective nature, HGMD allows mutation rates to be estimated only in relative terms. Therefore, a novel methodology was devised in order to obtain these estimates in iterative fashion, correcting, at the same time, for the confounding effects of differential codon usage and for the fact that different types of amino acid replacement come to clinical attention with different probabilities. Over and above the hypermutability of CpG dinucleotides, reflected in transition rates five times the lease mutation rate, only a subtle and locally confined influence of the surrounding DNA sequence on relative single-base-pair substitution rates was observed, which extended no farther than 2 bp from the substitution site. A disparity between the two DNA strands was evidenced by the fact that, when substitution rates were estimated conditional on the 5' and 3' flanking nucleotides, a significant rate difference emerged for 10 of 96 possible pairs of complementary substitutional events. Mutational bias, favoring substitutions toward flanking bases, kla phenomenon reminiscent of misalignment mutagenesis, was apparent and exhibited both directionality and reading-frame sensitivity. No specific preponderance of repeat-sequence motifs was observed in the vicinity of nucleotide substitutions, but a moderate correlation between the relative mutability and thermodynamic stability of DNA triplets emerged, suggesting either inefficient DNA replication in regions of high stability or the transient stabilization of misaligned intermediates.	Cardiff Univ, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales	Cardiff University	Krawczak, M (corresponding author), Cardiff Univ, Inst Med Genet, Heath Pk, Cardiff CF4 4XN, S Glam, Wales.	krawczak@cardiff.ac.uk	Cooper, David N/H-4384-2011; Krawczak, Michael/A-8964-2010	Cooper, David N/0000-0002-8943-8484; Krawczak, Michael/0000-0003-2603-1502				Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Bhatia PK, 1996, CURR OPIN GENET DEV, V6, P146, DOI 10.1016/S0959-437X(96)80043-8; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOLDEN AH, 1985, NUCLEIC ACIDS RES, V13, P3479, DOI 10.1093/nar/13.10.3479; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; CHEN YZ, 1992, J BIOMOL STRUCT DYN, V10, P415, DOI 10.1080/07391102.1992.10508656; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; CLAY O, 1995, SOMAT CELL MOLEC GEN, V21, P91, DOI 10.1007/BF02255784; Cooper D. N., 1993, HUMAN GENE MUTATION; COOPER DN, 1990, HUM GENET, V85, P55; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cooper DN, 1995, METABOLIC MOL BASES, P259; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DRAPKIN R, 1994, CELL, V77, P9, DOI 10.1016/0092-8674(94)90228-3; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; GOLDING GB, 1986, CAN J GENET CYTOL, V28, P483, DOI 10.1139/g86-072; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; HJORTH JSU, 1994, COMPUTER INTENSIVE S, P85; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HORNSTRA IK, 1994, MOL CELL BIOL, V14, P1419, DOI 10.1128/MCB.14.2.1419; Jamieson RV, 1996, INT J DEV BIOL, V40, P1065; KAINZ M, 1992, SCIENCE, V255, P838, DOI 10.1126/science.1536008; Kay PH, 1997, GENE, V184, P45, DOI 10.1016/S0378-1119(96)00572-0; KRAWCZAK M, 1995, HUM MUTAT, V5, P48, DOI 10.1002/humu.1380050107; Krawczak M, 1996, HUM GENET, V98, P351, DOI 10.1007/s004390050222; Krawczak M, 1996, HUM MUTAT, V8, P23; KRAWCZAK M, 1997, HUM MUTAT, V13, P121; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; LEADER DP, 1995, FEBS LETT, V376, P125, DOI 10.1016/0014-5793(95)01268-3; Lin MMQ, 1997, P NATL ACAD SCI USA, V94, P5284, DOI 10.1073/pnas.94.10.5284; Nakamura Y, 1996, NUCLEIC ACIDS RES, V24, P214, DOI 10.1093/nar/24.1.214; Ollila J, 1996, FEBS LETT, V396, P119, DOI 10.1016/0014-5793(96)01075-7; PETRUSKA J, 1985, J BIOL CHEM, V260, P7533; Rodenhiser D, 1996, ONCOGENE, V12, P2623; Rodenhiser DI, 1997, MUTAT RES-FUND MOL M, V373, P185, DOI 10.1016/S0027-5107(96)00171-6; Rodin SN, 1998, INT J MOL MED, V1, P191; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SIBGHATULLAH, 1993, NUCLEIC ACIDS RES, V21, P1281, DOI 10.1093/nar/21.5.1281; SKANDALIS A, 1994, MUTAT RES, V314, P21, DOI 10.1016/0921-8777(94)90057-4; SMITH SS, 1994, PROG NUCLEIC ACID RE, V49, P65; Smith SS, 1997, BIOCHEM BIOPH RES CO, V234, P73, DOI 10.1006/bbrc.1997.6581; Todorova A, 1997, HUM MUTAT, V9, P537; TORNALETTI S, 1995, ONCOGENE, V10, P1493; WOODCOCK DM, 1988, GENE, V74, P151, DOI 10.1016/0378-1119(88)90273-9; WU CI, 1987, NATURE, V327, P169, DOI 10.1038/327169a0	50	230	235	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					474	488		10.1086/301965	http://dx.doi.org/10.1086/301965			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683596	Bronze, Green Published			2022-12-18	WOS:000075360800023
J	Neuhausen, SL; Mazoyer, S; Friedman, L; Stratton, M; Offit, K; Caligo, A; Tomlinson, G; CannonAlbright, L; Bishop, T; Kelsell, D; Solomon, E; Weber, B; Couch, F; Struewing, J; Tonin, P; Durocher, F; Narod, S; Skolnick, MH; Lenoir, G; Serova, O; Ponder, B; StoppaLyonnet, D; Easton, D; King, MC; Goldgar, DE				Neuhausen, SL; Mazoyer, S; Friedman, L; Stratton, M; Offit, K; Caligo, A; Tomlinson, G; CannonAlbright, L; Bishop, T; Kelsell, D; Solomon, E; Weber, B; Couch, F; Struewing, J; Tonin, P; Durocher, F; Narod, S; Skolnick, MH; Lenoir, G; Serova, O; Ponder, B; StoppaLyonnet, D; Easton, D; King, MC; Goldgar, DE			Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER	Several BRCA1 mutations have now been found to occur in geographically diverse breast and ovarian cancer families. To investigate mutation origin and mutation-specific phenotypes due to BRCA1, we constructed a haplotype of nine polymorphic markers within or immediately flanking the BRCA1 locus in a set of 61 breast/ovarian cancer families selected for having one of six recurrent BRCA1 mutations. Tests of both mutations and family-specific differences in age at diagnosis were not significant. A comparison of the six mutations in the relative proportions of cases of breast and ovarian cancer was suggestive of an effect (P = .069), with 57% of women presumed affected because of the 1294 del 40 BRCA1 mutation having ovarian cancer, compared with 14% of affected women with the splice-site mutation in intron 5 of BRCA1. For the BRCA1 mutations studied here, the individual mutations are estimated to have arisen 9-170 generations ago. In general, a high degree of haplotype conservation across the region was observed, with haplotype differences most often due to mutations in the short-tandem-repeat markers, although some likely instances of recombination also were observed. For several of the instances, there was evidence for multiple, independent, BRCA1 mutational events.	UNIV UTAH,SCH MED,DEPT MED INFORMAT,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT 84108; UNIV UTAH,SCH MED,DEPT INTERNAL MED,SALT LAKE CITY,UT; MYRIAD GENET,SALT LAKE CITY,UT; UNIV CAMBRIDGE,DEPT PATHOL,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE,ENGLAND; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720; UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720; INST CANC RES,SECT MOLEC CARCINOGENESIS,SUTTON,SURREY,ENGLAND; INST CANC RES,EPIDEMIOL SECT,SUTTON,SURREY,ENGLAND; MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021; INST ANAT PATOL,PISA,ITALY; SW TEXAS STATE UNIV,DEPT PEDIAT,DALLAS,TX; IMPERIAL CANC RES FUND,GENET EPIDEMIOL LAB,LEEDS,W YORKSHIRE,ENGLAND; IMPERIAL CANC RES FUND,CLARE HALL LABS,LONDON,ENGLAND; IMPERIAL CANC RES FUND,LINCOLNS INN FIELDS,LONDON,ENGLAND; UNIV PENN,DEPT HEMATOL ONCOL,PHILADELPHIA,PA 19104; NATL CANC INST,GENET EPIDEMIOL BRANCH,BETHESDA,MD; NIH,BETHESDA,MD; MCGILL UNIV,DEPT MED GENET,MONTREAL,PQ,CANADA; CHU LAVAL,RES CTR,DEPT MOLEC ENDOCRINOL,QUEBEC CITY,PQ,CANADA; UNIV LAVAL,QUEBEC CITY,PQ,CANADA; INT AGCY RES CANC,F-69372 LYON,FRANCE; INST CURIE,UNITE GENET ONCOL,PARIS,FRANCE	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Myriad Genetics, Inc; University of Cambridge; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Memorial Sloan Kettering Cancer Center; Texas State University System; Texas State University San Marcos; Cancer Research UK; Cancer Research UK; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; McGill University; Laval University; Laval University; World Health Organization; International Agency for Research on Cancer (IARC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie			Narod, Steven A/AAA-6112-2022; Mazoyer, Sylvie/N-7559-2017; Struewing, Jeffery P/C-3221-2008; Struewing, Jeffery P/I-7502-2013; Caligo, Adelaide Maria/K-4289-2018; Tomlinson, Gail/AAR-9776-2020; Kelsell, David P/F-8767-2011	Struewing, Jeffery P/0000-0002-4848-3334; Caligo, Adelaide Maria/0000-0003-0589-1829; Bishop, Tim/0000-0002-8752-8785; Durocher, Francine/0000-0001-8012-4641; Kelsell, David/0000-0002-9910-7144; Mazoyer, Sylvie/0000-0002-2135-0160; albright, lisa/0000-0003-2602-3668	NCI NIH HHS [CA-55914] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055914] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; EASTON DF, 1995, AM J HUM GENET, V56, P265; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GOLDGAR DE, IN PRESS 4TH HHMT FO; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; NAROD SA, 1991, LANCET, V338, P82; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; THOMAS GR, 1995, AM J HUM GENET, V56, P1315; TONIN P, 1995, AM J HUM GENET, V57, P189; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	22	230	232	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					271	280						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571953				2022-12-18	WOS:A1996TR79100003
J	Peloso, GM; Auer, PL; Bis, JC; Voorman, A; Morrison, AC; Stitziel, NO; Brody, JA; Khetarpal, SA; Crosby, JR; Fomage, M; Isaacs, A; Jakobsdottir, J; Feitosa, MF; Davies, G; Huffman, JE; Manichaikul, A; Davis, B; Lohman, K; Joon, AY; Smith, AV; Grove, ML; Zanoni, P; Redon, V; Demissie, S; Lawson, K; Peters, U; Carlson, C; Jackson, RD; Ryckman, KK; Mackey, RH; Robinson, JG; Siscovick, DS; Schreiner, PJ; Mychaleckyj, JC; Pankow, JS; Holman, A; Uitterlinden, AG; Harris, TB; Taylor, KD; Stafford, JM; Reynolds, LM; Marioni, RE; Dehghan, A; Franco, OH; Patele, AP; Lu, YC; Hindy, G; Gottesman, O; Bottinger, EP; Melander, O; Orho-Melander, M; Loos, RJF; Duga, S; Merlini, PA; Farrall, M; Goel, A; Asselta, R; Girelli, D; Martinelli, N; Shah, SH; Kraus, WE; Li, MY; Rader, DJ; Reilly, MP; McPherson, R; Watkins, H; Ardissino, D; Zhang, QY; Wang, JD; Tsai, MY; Taylor, HA; Correa, A; Griswold, ME; Lange, LA; Starr, JM; Rudan, I; Eiriksdottir, G; Launer, LJ; Ordovas, JM; Levy, D; Chen, YDI; Reiner, AP; Hayward, C; Polasek, O; Deary, IJ; Borecki, IB; Liu, YM; Gudnason, V; Wilson, JG; van Duijn, CM; Kooperberg, C; Rich, SS; Psaty, BM; Rotter, JI; O'Donnell, CJ; Rice, K; Boerwinkle, E; Kathiresan, S; Cupples, LA				Peloso, Gina M.; Auer, Paul L.; Bis, Joshua C.; Voorman, Arend; Morrison, Alanna C.; Stitziel, Nathan O.; Brody, Jennifer A.; Khetarpal, Sumeet A.; Crosby, Jacy R.; Fomage, Myriam; Isaacs, Aaron; Jakobsdottir, Johanna; Feitosa, Mary F.; Davies, Gail; Huffman, Jennifer E.; Manichaikul, Ani; Davis, Brian; Lohman, Kurt; Joon, Aron Y.; Smith, Albert V.; Grove, Megan L.; Zanoni, Paolo; Redon, Valeska; Demissie, Serkalem; Lawson, Kim; Peters, Ulrike; Carlson, Christopher; Jackson, Rebecca D.; Ryckman, Kelli K.; Mackey, Rachel H.; Robinson, Jennifer G.; Siscovick, David S.; Schreiner, Pamela J.; Mychaleckyj, Josyf C.; Pankow, James S.; Holman, Albert; Uitterlinden, Andre G.; Harris, Tamara B.; Taylor, Kent D.; Stafford, Jeanette M.; Reynolds, Lindsay M.; Marioni, Riccardo E.; Dehghan, Abbas; Franco, Oscar H.; Patele, Aniruddh P.; Lu, Yingchang; Hindy, George; Gottesman, Omri; Bottinger, Erwin P.; Melander, Olle; Orho-Melander, Marju; Loos, Ruth J. F.; Duga, Stefano; Merlini, Piera Angelica; Farrall, Martin; Goel, Anuj; Asselta, Rosanna; Girelli, Domenico; Martinelli, Nicola; Shah, Svati H.; Kraus, William E.; Li, Mingyao; Rader, Daniel J.; Reilly, Muredach P.; McPherson, Ruth; Watkins, Hugh; Ardissino, Diego; Zhang, Qunyuan; Wang, Judy; Tsai, Michael Y.; Taylor, Herman A.; Correa, Adolfo; Griswold, Michael E.; Lange, Leslie A.; Starr, John M.; Rudan, Igor; Eiriksdottir, Gudny; Launer, Lenore J.; Ordovas, Jose M.; Levy, Daniel; Chen, Y. -D. Ida; Reiner, Alexander P.; Hayward, Caroline; Polasek, Ozren; Deary, Ian J.; Borecki, Ingrid B.; Liu, Yongmei; Gudnason, Vilmundur; Wilson, James G.; van Duijn, Cornelia M.; Kooperberg, Charles; Rich, Stephen S.; Psaty, Bruce M.; Rotter, Jerome I.; O'Donnell, Christopher J.; Rice, Kenneth; Boerwinkle, Eric; Kathiresan, Sekar; Cupples, L. Adrienne		NHLBI GO Exome Sequencing Project	Association of Low-Frequency and Rare Coding-Sequence Variants with Blood Lipids and Coronary Heart Disease in 56,000 Whites and Blacks	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLATELET-ACTIVATING-FACTOR; DENSITY-LIPOPROTEIN CHOLESTEROL; PCSK9; PROTEIN; LDL	Low-frequency coding DNA sequence variants in the proprotein convertase subtilisin/kexin type 9 gene (PCSK9) lower plasma low-density lipoprotein cholesterol (LDL-C), protect against risk of coronary heart disease (CHD), and have prompted the development of a new class of therapeutics. It is uncertain whether the PCSK9 example represents a paradigm or an isolated exception. We used the "Exome Array" to genotype >200,000 low-frequency and rare coding sequence variants across the genome in 56,538 individuals (42,208 European ancestry [EA] and 14,330 African ancestry [AA]) and tested these variants for association with LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglycerides. Although we did not identify new genes associated with LDL-C, we did identify four low-frequency (frequencies between 0.1% and 2%) variants (ANGPTL8 rs145464906 [c.361C>T; p.Gln121*], PAFAH1B2 rs186808413 [c.482C>T; p.Ser161Leu], COL18A1 rs114139997 [c.331G>A; p.Gly111Arg], and PCSK7 rs142953140 [c.1511G>A; p.Arg504His]) with large effects on HDL-C and/or triglycerides. None of these four variants was associated with risk for CHD, suggesting that examples of low-frequency coding variants with robust effects on both lipids and CHD will be limited.	[Peloso, Gina M.; Patele, Aniruddh P.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Peloso, Gina M.; O'Donnell, Christopher J.; Kathiresan, Sekar] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Peloso, Gina M.; Patele, Aniruddh P.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Auer, Paul L.; Peters, Ulrike; Carlson, Christopher; Reiner, Alexander P.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, Seattle, WA 98109 USA; [Auer, Paul L.] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Bis, Joshua C.; Brody, Jennifer A.; Siscovick, David S.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Voorman, Arend; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Morrison, Alanna C.; Crosby, Jacy R.; Fomage, Myriam; Davis, Brian; Grove, Megan L.; Lawson, Kim; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Cardiovasc, Dept Med, St Louis, MO 63110 USA; [Stitziel, Nathan O.; Feitosa, Mary F.; Zhang, Qunyuan; Wang, Judy; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Khetarpal, Sumeet A.; Zanoni, Paolo; Redon, Valeska; Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Crosby, Jacy R.] Univ Texas Grad Sch Biomed Sci Houston, Dept Biostat Bioinformat & Syst Biol, Houston, TX 77030 USA; [Fomage, Myriam; Joon, Aron Y.] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Isaacs, Aaron; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, Genet Epidemiol Unit, NL-3015 CN Rotterdam, Netherlands; [Jakobsdottir, Johanna; Smith, Albert V.; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Davies, Gail; Marioni, Riccardo E.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Davies, Gail; Marioni, Riccardo E.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Huffman, Jennifer E.; Hayward, Caroline] Univ Edinburgh, MRC IGMM, MRC Human Genet, Edinburgh EH4 2XU, Midlothian, Scotland; [Manichaikul, Ani; Mychaleckyj, Josyf C.; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Manichaikul, Ani; Mychaleckyj, Josyf C.; Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Lohman, Kurt; Stafford, Jeanette M.; Reynolds, Lindsay M.; Liu, Yongmei] Wake Forest Sch Med, Winston Salem, NC 27106 USA; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Demissie, Serkalem; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Demissie, Serkalem; Levy, Daniel; O'Donnell, Christopher J.; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Dept Internal Med, Columbus, OH 43210 USA; [Ryckman, Kelli K.; Robinson, Jennifer G.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA; [Mackey, Rachel H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Siscovick, David S.; Reiner, Alexander P.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Schreiner, Pamela J.; Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN 55454 USA; [Holman, Albert; Uitterlinden, Andre G.; Dehghan, Abbas; Franco, Oscar H.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3015 CN Rotterdam, Netherlands; [Harris, Tamara B.; Launer, Lenore J.] NIA, NIH, Bethesda, MD 20892 USA; [Taylor, Kent D.; Chen, Y. -D. Ida; Rotter, Jerome I.] Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Los Angeles BioMed Res Inst, Torrance, CA 90502 USA; [Patele, Aniruddh P.] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Lu, Yingchang; Gottesman, Omri; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Hindy, George; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Clin Res Ctr, S-20502 Malmo, Sweden; [Orho-Melander, Marju] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Duga, Stefano; Asselta, Rosanna] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, I-20133 Milan, Italy; [Merlini, Piera Angelica; Ardissino, Diego] ASTC, I-27100 Pavia, Italy; [Merlini, Piera Angelica] Osped Maggiore Niguarda, Div Cardiol, I-20162 Milan, Italy; [Farrall, Martin; Goel, Anuj; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; [Girelli, Domenico; Martinelli, Nicola] Univ Verona, Sch Med, Dept Med, I-37134 Verona, Italy; [Shah, Svati H.] Duke Univ, Div Urogynecol, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Shah, Svati H.; Kraus, William E.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Kraus, William E.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Li, Mingyao] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Atherogen Lab, Ottawa, ON K1Y 4W7, Canada; [Watkins, Hugh] Merck Sharp & Dohme Corp, Rahway, NJ 07065 USA; [Ardissino, Diego] Azienda Osped Univ Parma, Div Cardiol, I-43100 Parma, Italy; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; [Taylor, Herman A.] Jackson State Univ, Jackson, MS 39217 USA; [Taylor, Herman A.] Tougaloo Coll, Tougaloo, MS 39174 USA; [Taylor, Herman A.; Correa, Adolfo; Griswold, Michael E.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Lange, Leslie A.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Igor] Univ Split, Croatian Ctr Global Hlth, Fac Med, Split 21000, Croatia; [Ordovas, Jose M.] Natl Ctr Cardiovasc Investigat, Dept Cardiovasc Epidemiol & Populat Genet, Madrid 28049, Spain; [Ordovas, Jose M.] IMDEA Alimentac, Madrid 28049, Spain; [Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr & Genom Lab, Medford, MA 02155 USA; [Ordovas, Jose M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Polasek, Ozren] Univ Split, Fac Med, Dept Publ Hlth, Split 21000, Croatia; [Wilson, James G.] Univ Mississippi, Dept Physiol & Biophys, Med Ctr, Jackson, MS 39216 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [O'Donnell, Christopher J.; Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health Science Center Houston; Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Virginia; University of Virginia; Wake Forest University; University of Iceland; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Ohio; Ohio State University; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Lund University; Lund University; Skane University Hospital; Icahn School of Medicine at Mount Sinai; University of Milan; University of Oxford; Wellcome Centre for Human Genetics; University of Verona; Duke University; Duke University; Duke University; University of Pennsylvania; University of Ottawa; University of Ottawa Heart Institute; Merck & Company; University of Parma; University Hospital of Parma; University of Minnesota System; University of Minnesota Twin Cities; Jackson State University; Tougaloo College; University of Mississippi; University of Mississippi Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of Edinburgh; University of Edinburgh; University of Split; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Split; University of Mississippi; University of Mississippi Medical Center; Group Health Cooperative; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Baylor College of Medicine	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	skathiresan@partners.org; skathiresan@partners.org; adrienne@bu.edu	Smith, Albert Vernon/K-5150-2015; Levy, Daniel/ABB-2752-2021; , Jennifer/AAD-8336-2019; Stitziel, Nathan/AAL-8413-2021; Gudnason, Vilmundur/K-6885-2015; Feitosa, Mary F/K-8044-2012; Dehghan, Abbas/ABE-7377-2020; Asselta, Rosanna/AAC-2367-2019; Hayward, Caroline/M-8818-2016; Gudnason, Vilmundur/AAE-7126-2019; Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Auer, Paul/AAC-5060-2019; Levy, Daniel/ABF-6873-2021; Ardissino, Diego/AAC-4041-2022; Deary, Ian J/C-6297-2009; Girelli, Domenico/B-1183-2008; Franco, Óscar H/ABE-2305-2020; Rudan, Igor/I-1467-2012; Martinelli, Nicola/J-5622-2016; Duga, Stefano/F-8173-2014; Polasek, Ozren/B-6002-2011; Rotter, Jerome/AAY-6598-2021; Ordovas, Jose/B-8727-2013; Dehghan, Abbas/B-9896-2008	Smith, Albert Vernon/0000-0003-1942-5845; Stitziel, Nathan/0000-0002-4963-8211; Gudnason, Vilmundur/0000-0001-5696-0084; Feitosa, Mary F/0000-0002-0933-2410; Asselta, Rosanna/0000-0001-5351-0619; Hayward, Caroline/0000-0002-9405-9550; Gudnason, Vilmundur/0000-0001-5696-0084; Loos, Ruth J F/0000-0002-8532-5087; Levy, Daniel/0000-0003-1843-8724; Deary, Ian J/0000-0002-1733-263X; Girelli, Domenico/0000-0001-9684-1899; Franco, Óscar H/0000-0002-4606-4929; Rudan, Igor/0000-0001-6993-6884; Martinelli, Nicola/0000-0001-6465-5119; Duga, Stefano/0000-0003-3457-1410; Polasek, Ozren/0000-0002-5765-1862; Ordovas, Jose/0000-0002-7581-5680; solinas, emilia/0000-0003-3532-1317; Marioni, Riccardo/0000-0003-4430-4260; Pankow, James/0000-0001-7076-483X; Dehghan, Abbas/0000-0001-6403-016X; Goel, Anuj/0000-0003-2307-4021; Mackey, Rachel/0000-0001-6088-2664; Reynolds, Lindsay/0000-0001-6157-0144; Cupples, L. Adrienne/0000-0003-0273-7965; Rich, Stephen/0000-0003-3872-7793; Morrison, Alanna/0000-0001-6381-4296; Jakobsdottir, Johanna/0000-0002-8019-9683; Watkins, Hugh/0000-0002-5287-9016; Hindy, George/0000-0002-7257-9299; Van Duijn, Cornelia/0000-0002-2374-9204; Melander, Olle/0000-0002-2581-484X; Reilly, Muredach/0000-0002-3035-9386; Schreiner, Pamela/0000-0002-9920-6257; Tsai, Michael/0000-0001-7553-3408; Manichaikul, Ani/0000-0002-5998-795X; Joon, Aron/0000-0003-2615-2179; Ryckman, Kelli/0000-0002-9496-4147	National Heart, Lung, and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926, T32HL007208]; National Heart, Lung, and Blood Institute [HL105756]; Massachusetts General Hospital (MGH); Howard Goodman Fellowship from MGH; Donovan Family Foundation [R01HL107816]; Fondation Leducq; NIH [RC2 HL-102925]; Merck; NIH/NHLBI [K08-HL114642]; NWO grant (veni) [916.12.154]; EUR Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006173, K08HL114642, ZIAHL006175, R21HL121422, RC2HL102925, R01HL107816, T32HL007208, R01HL120393, RC2HL102924, RC2HL102923, RC2HL102926, ZIAHL006001, ZIAHL006002, RC2HL103010, R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704, MR/K026992/1, MC_PC_U127561128] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005339, NNF14OC0009819] Funding Source: researchfish; Chief Scientist Office [ETM/55, CZB/4/505] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704, MC_PC_U127561128] Funding Source: UKRI	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts General Hospital (MGH); Howard Goodman Fellowship from MGH; Donovan Family Foundation; Fondation Leducq(Leducq Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NWO grant (veni); EUR Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute (NHLBI) and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO), and RC2 HL-102924 (WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). Infrastructure for the CHARGE Consortium is supported, in part, by the National Heart, Lung, and Blood Institute (grant HL105756). G.M.P. is supported by award number T32HL007208 from the NHLBI. S.K. is supported by a Research Scholar award from the Massachusetts General Hospital (MGH), the Howard Goodman Fellowship from MGH, the Donovan Family Foundation, R01HL107816, and a grant from Fondation Leducq. Exome Array genotyping in case-control studies of coronary heart disease was supported by NIH RC2 HL-102925 and an investigator-initiated research grant from Merck to S.K. N.O.S. is supported, in part, by a career development award from the NIH/NHLBI K08-HL114642. A.D. is supported by NWO grant (veni, 916.12.154) and the EUR Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHLBI or NIH. A full listing of acknowledgements is provided in Supplemental Data.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bishop JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013919; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2013, SCIENCE, V340, P689, DOI 10.1126/science.1239101; Derewenda ZS, 1998, CELL MOL LIFE SCI, V54, P446, DOI 10.1007/s000180050172; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; PEDERSEN TR, 1994, LANCET, V344, P1383; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; WARNICK GR, 1990, CLIN CHEM, V36, P15; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2013, BIOCHEM BIOPH RES CO, V432, P401, DOI 10.1016/j.bbrc.2013.01.129	28	229	234	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					223	232		10.1016/j.ajhg.2014.01.009	http://dx.doi.org/10.1016/j.ajhg.2014.01.009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24507774	Green Published, Bronze			2022-12-18	WOS:000331419500006
J	Ritchie, MD; Denny, JC; Crawford, DC; Ramirez, AH; Weiner, JB; Pulley, JM; Basford, MA; Brown-Gentry, K; Balser, JR; Masys, DR; Haines, JL; Roden, DM				Ritchie, Marylyn D.; Denny, Joshua C.; Crawford, Dana C.; Ramirez, Andrea H.; Weiner, Justin B.; Pulley, Jill M.; Basford, Melissa A.; Brown-Gentry, Kristin; Balser, Jeffrey R.; Masys, Daniel R.; Haines, Jonathan L.; Roden, Dan M.			Robust Replication of Genotype-Phenotype Associations across Multiple Diseases in an Electronic Medical Record	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ADVERSE DRUG EVENTS; ORDER ENTRY; CROHNS-DISEASE; HEALTH RECORDS; RISK; LOCI; SUSCEPTIBILITY; VARIANTS; GENE	Large-scale DNA databanks linked to electronic medical record (EMR) systems have been proposed as an approach for rapidly generating large, diverse cohorts for discovery and replication of genotype-phenotype associations. However, the extent to which such resources are capable of delivering on this promise is unknown. We studied whether an EMR-linked DNA biorepository can be used to detect known genotype-phenotype associations for five diseases. Twenty-one SNPs previously implicated as common variants predisposing to atrial fibrillation, Crohn disease, multiple sclerosis, rheumatoid arthritis, or type 2 diabetes were successfully genotyped in 9483 samples accrued over 4 mo into BioVU, the Vanderbilt University Medical Center DNA biobank. Previously reported odds ratios (ORPR) ranged from 1.14 to 2.36. For each phenotype, natural language processing techniques and billing-code queries were used to identify cases (n = 70-698) and controls (n = 808-3818) from deidentified health records. Each of the 21 tests of association yielded point estimates in the expected direction. Previous genotype-phenotype associations were replicated (p < 0.05) in 8/14 cases when the ORPR( was > 1.25, and in 0/7 with lower ORPR). Statistically significant associations were detected in all analyses that were adequately powered. In each of the five diseases studied, at least one previously reported association was replicated. These data demonstrate that phenotypes representing clinical diagnoses can be extracted from EMR systems, and they support the use of DNA resources coupled to EMR systems as tools for rapid generation of large data sets required for replication of associations found in research cohorts and for discovery in genome science.	[Basford, Melissa A.; Roden, Dan M.] Vanderbilt Univ, Off Personalized Med, Sch Med, Nashville, TN 37232 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Brown-Gentry, Kristin; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Sch Med, Nashville, TN 37232 USA; [Pulley, Jill M.; Basford, Melissa A.; Balser, Jeffrey R.] Vanderbilt Univ, Res Off, Sch Med, Nashville, TN 37232 USA; [Balser, Jeffrey R.] Vanderbilt Univ, Dept Anesthesiol, Sch Med, Nashville, TN 37232 USA; [Denny, Joshua C.; Masys, Daniel R.] Vanderbilt Univ, Dept Biomed Informat, Sch Med, Nashville, TN 37232 USA; [Denny, Joshua C.; Ramirez, Andrea H.; Weiner, Justin B.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37232 USA; [Ritchie, Marylyn D.; Crawford, Dana C.; Haines, Jonathan L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Balser, Jeffrey R.; Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Roden, DM (corresponding author), Vanderbilt Univ, Off Personalized Med, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	dan.roden@vanderbilt.edu	Roden, Dan/ABD-5412-2021; Denny, Josh/AAL-3359-2021; Haines, Jonathan/C-3374-2012; Greiver, Michelle/N-8764-2015; Ritchie, Marylyn/C-1114-2012; Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012	Denny, Josh/0000-0002-3049-7332; Haines, Jonathan/0000-0002-4351-4728; Greiver, Michelle/0000-0001-8957-0285; Crawford, Dana/0000-0002-6437-6248; 	National Human Genome Research Institute [U01 HG04603]; Vanderbilt Institute for Clinical and Translational Research (VICTR); National Center for Research Resources and the National Institutes of Health [NIRR/NIH] [1UL1 RR024975-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004603] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Vanderbilt Institute for Clinical and Translational Research (VICTR); National Center for Research Resources and the National Institutes of Health [NIRR/NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Development of each phenotype definition required input from clinicians who were expert in that disease: C. Michael Stein, Subramaniam Sriram, David Schwartz, Hiroshi Watanabe, Dawood Darbar, and Prince Kannankeril (all from Vanderbilt University School of Medicine), as well as William Lowe and Abel Kho (from Northwestern University). The Vanderbilt DNA Core Resource that houses all of the samples also performed the geno-typing under the supervision of Cara Sutcliffe. The Vanderbilt University Center for Human Genetics Research, Computational Genomics Core provided computational and analytical support for this work. Deede Wang and Sunny Wang assisted with the phenotype algorithms. This work was supported in part by U01 HG04603, a site of the National Human Genome Research Institute's eMERGE Network. The data sets used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU biobank, supported in part by the Vanderbilt Institute for Clinical and Translational Research (VICTR), as well as a a Clinical and Translational Science Award (CTSA) grant (1UL1 RR024975-01 from the National Center for Research Resources and the National Institutes of Health [NIRR/NIH])	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ammenwerth E, 2008, J AM MED INFORM ASSN, V15, P585, DOI 10.1197/jamia.M2667; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Denny J. C., 2008, INT J MED INFORM S1, V78, pS34; Denny JC, 2003, J AM MED INFORM ASSN, V10, P351, DOI 10.1197/jamia.M1176; DENNY JC, 2008, AMIA ANN S P, V156; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; GALANTER WL, 2008, INT J MED INFORM; Ginsburg GS, 2008, JAMA-J AM MED ASSOC, V299, P1359, DOI 10.1001/jama.299.11.1359; GIUSE DA, 2003, AMIA ANN S P, V1065; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hoffman MA, 2007, J BIOMED INFORM, V40, P44, DOI 10.1016/j.jbi.2006.02.010; Holdsworth MT, 2007, PEDIATRICS, V120, P1058, DOI 10.1542/peds.2006-3160; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Kaushal R, 2006, J AM MED INFORM ASSN, V13, P261, DOI 10.1197/jamia.M1984; Kazley AS, 2008, MED CARE RES REV, V65, P496, DOI 10.1177/1077558707313437; Mahoney CD, 2007, AM J HEALTH-SYST PH, V64, P1969, DOI 10.2146/ajhp060617; Manolio TA, 2009, PHARMACOGENOMICS, V10, P235, DOI 10.2217/14622416.10.2.235; Mitchell DR, 2007, J BIOMED INFORM, V40, P47, DOI 10.1016/j.jbi.2006.02.012; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Sax U, 2005, METHOD INFORM MED, V44, P546; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Stead WW, 2007, ANNU REV MED, V58, P35, DOI 10.1146/annurev.med.58.061705.144942; Walsh KE, 2008, PEDIATRICS, V121, pE421, DOI 10.1542/peds.2007-0220; Wilke RA, 2007, CLIN MED RES, V5, P1, DOI 10.3121/cmr.2007.726; Wood G Craig, 2008, Genomic Med, V2, P33, DOI 10.1007/s11568-008-9023-z; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	34	229	231	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					560	572		10.1016/j.ajhg.2010.03.003	http://dx.doi.org/10.1016/j.ajhg.2010.03.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20362271	Bronze, Green Published			2022-12-18	WOS:000276716800006
J	Thompson, EE; Kuttab-Boulos, H; Witonsky, D; Yang, L; Roe, BA; Di Rienzo, A				Thompson, EE; Kuttab-Boulos, H; Witonsky, D; Yang, L; Roe, BA; Di Rienzo, A			CYP3A variation and the evolution of salt-sensitivity variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; HUMAN ANGIOTENSINOGEN GENE; LINKAGE-DISEQUILIBRIUM; NATURAL-SELECTION; POSITIVE SELECTION; STATISTICAL-METHOD; BLOOD-PRESSURE; DNA-SEQUENCES; POPULATION; POLYMORPHISM	Members of the cytochrome P450 3A subfamily catalyze the metabolism of endogenous substrates, environmental carcinogens, and clinically important exogenous compounds, such as prescription drugs and therapeutic agents. In particular, the CYP3A4 and CYP3A5 genes play an especially important role in pharmacogenetics, since they metabolize >50% of the drugs on the market. However, known genetic variants at these two loci are not sufficient to account for the observed phenotypic variability in drug response. We used a comparative genomics approach to identify conserved coding and noncoding regions at these genes and resequenced them in three ethnically diverse human populations. We show that remarkable interpopulation differences exist with regard to frequency spectrum and haplotype structure. The non-African samples are characterized by a marked excess of rare variants and the presence of a homogeneous group of long-range haplotypes at high frequency. The CYP3A5*1/*3 polymorphism, which is likely to influence salt and water retention and risk for salt-sensitive hypertension, was genotyped in 11,000 individuals from 52 worldwide population samples. The results reveal an unusual geographic pattern whereby the CYP3A5*3 frequency shows extreme variation across human populations and is significantly correlated with distance from the equator. Furthermore, we show that an unlinked variant, AGT M235T, previously implicated in hypertension and pre-eclampsia, exhibits a similar geographic distribution and is significantly correlated in frequency with CYP3A5*1/*3. Taken together, these results suggest that variants that influence salt homeostasis were the targets of a shared selective pressure that resulted from an environmental variable correlated with latitude.	Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Oklahoma, Dept Chem & Biochem, Adv Ctr Genome Technol, Norman, OK 73019 USA	University of Chicago; University of Chicago; University of Oklahoma System; University of Oklahoma - Norman	Di Rienzo, A (corresponding author), 920 E 58th St, Chicago, IL 60637 USA.	dirienzo@bsd.uchicago.edu		Di Rienzo, Anna/0000-0002-8982-9098	NHGRI NIH HHS [HG02152] Funding Source: Medline; NIDDK NIH HHS [R01 DK055889, DK55889] Funding Source: Medline; NIGMS NIH HHS [U01 GM061393, GM07197, GM61393, T32 GM007197] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Fay JC, 2000, GENETICS, V155, P1405; FRANTZ AG, 1960, P SOC EXP BIOL MED, V105, P41; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Fukuen S, 2002, PHARMACOGENETICS, V12, P331, DOI 10.1097/00008571-200206000-00009; GHOSH SS, 1995, BIOCHEM PHARMACOL, V50, P49, DOI 10.1016/0006-2952(95)00110-L; Givens RC, 2003, J APPL PHYSIOL, V95, P1297, DOI 10.1152/japplphysiol.00322.2003; GLEIBERMANN L., 1973, Ecology of Food and Nutrition, V2, P143, DOI 10.1080/03670244.1973.9990329; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HUDSON RR, 1994, GENETICS, V136, P1329; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENETICS, V116, P153; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Lamba JK, 2002, PHARMACOGENETICS, V12, P121, DOI 10.1097/00008571-200203000-00006; LIFTON RP, 1993, CLIN RES A, V260; Luft FC, 2001, DRUG METAB DISPOS, V29, P500; Matsumura K, 2004, MOL PHARMACOL, V65, P326, DOI 10.1124/mol.65.2.326; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Nebert DW, 1997, AM J HUM GENET, V60, P265; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Przeworski M, 2002, GENETICS, V160, P1179; Roe Bruce A, 2004, Methods Mol Biol, V255, P171; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; RUSS AP, 1993, HUM MOL GENET, V2, P609, DOI 10.1093/hmg/2.5.609; SCHENKMAN JB, 1989, DRUG METAB REV, V20, P557, DOI 10.3109/03602538909103562; SCHUETZ EG, 1992, ARCH BIOCHEM BIOPHYS, V294, P206, DOI 10.1016/0003-9861(92)90159-T; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thomas JW, 2002, GENOME RES, V12, P1277, DOI 10.1101/gr.283202; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; WATLINGTON CO, 1992, AM J PHYSIOL, V262, pF927, DOI 10.1152/ajprenal.1992.262.6.F927; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wu SJ, 2004, PHYSIOL GENOMICS, V17, P79, DOI 10.1152/physiolgenomics.00133.2003	45	229	245	1	17	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1059	1069		10.1086/426406	http://dx.doi.org/10.1086/426406			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15492926	Green Published, Bronze			2022-12-18	WOS:000224866400010
J	Ferreiro, A; Quijano-Roy, S; Pichereau, C; Moghadaszadeh, B; Goemans, N; Bonnemann, C; Jungbluth, H; Straub, V; Villanova, M; Leroy, JP; Romero, NB; Martin, JJ; Muntoni, F; Voit, T; Estournet, B; Richard, P; Fardeau, M; Guicheney, P				Ferreiro, A; Quijano-Roy, S; Pichereau, C; Moghadaszadeh, B; Goemans, N; Bonnemann, C; Jungbluth, H; Straub, V; Villanova, M; Leroy, JP; Romero, NB; Martin, JJ; Muntoni, F; Voit, T; Estournet, B; Richard, P; Fardeau, M; Guicheney, P			Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: Reassessing the nosology of early-onset myopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SELENIUM DEFICIENCY; RETICULUM	Multiminicore disease (MmD) is an autosomal recessive congenital myopathy characterized by the presence of multiple, short core lesions (known as "minicores") in most muscle fibers. MmD is a clinically heterogeneous condition, in which four subgroups have been distinguished. Homozygous RYR1 mutations have been recently identified in the moderate form of MmD with hand involvement. The genes responsible for the three other forms (including the most prevalent phenotype, termed the "classical" phenotype) remained, so far, unknown. To further characterize the genetic basis of MmD, we analyzed a series of 62 patients through a combined positional/candidate-gene approach. On the basis of clinical and morphological data, we suspected a relationship between classical MmD and the selenoprotein N gene (SEPN1), which is located on chromosome 1p36 (RSMD1 locus) and is responsible for the congenital muscular dystrophy with rigid spine syndrome (RSMD). A genomewide screening, followed by the analysis of 1p36 microsatellite markers in 27 informative families with MmD, demonstrated linkage to RSMD1 in eight families. All showed an axial myopathy with scoliosis and respiratory failure, consistent with the most severe end of the classical MmD spectrum; spinal rigidity was evident in some, but not all, patients. We excluded linkage to RSMD1 in 19 families with MmD, including 9 with classical MmD. Screening of SEPN1 in the 8 families that showed linkage and in 14 patients with classical sporadic disease disclosed 9 mutations affecting 17 patients (12 families); 6 were novel mutations, and 3 had been described in patients with RSMD. Analysis of three deltoid biopsy specimens from patients with typical RSMD revealed a wide myopathological variability, ranging from a dystrophic to a congenital myopathy pattern. A variable proportion of minicores was found in all the samples. The present study represents the first identification of a gene responsible for classical MmD, demonstrates its genetic heterogeneity, and reassesses the nosological boundaries between MmD and RSMD.	Grp Hosp Pitie Salpetriere, INSERM, U523, Inst Mycol,Inst Federatif Rech 14, F-75651 Paris, France; Grp Hosp Pitie Salpetriere, Serv Biochim B, F-75651 Paris, France; Hop R Poincare, Serv Neuropediat & Reanimat Infantile, Garches, France; Univ Hosp Gasthuisberg, Dept Paediat, B-3000 Louvain, Belgium; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Gottingen, Kinderklin & Poliklin, D-3400 Gottingen, Germany; Univ London Imperial Coll Sci Technol & Med, Dept Paediat & Neonatal Med, Hammersmith Hosp, Fac Med, London, England; Univ Essen Gesamthsch, Dept Pediat, Essen, Germany; Univ Siena, Inst Neurol Sci, I-53100 Siena, Italy; Ctr Hosp Univ Brest, Serv Anat Pathol, Brest, France; Born Bunge Fdn, Neuropathol Lab, Antwerp, Belgium; Univ Antwerp Hosp, Dept Neurol, Edegem, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; KU Leuven; University Hospital Leuven; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Gottingen; Imperial College London; University of Duisburg Essen; University of Siena; CHU Brest; University of Antwerp	Ferreiro, A (corresponding author), Grp Hosp Pitie Salpetriere, INSERM, U523, Inst Mycol,Inst Federatif Rech 14, 47 Blvd Hop, F-75651 Paris, France.		Guicheney, Pascale/D-1034-2017; Jungbluth, Heinz/B-8893-2012; Quijano-Roy, Susana/GRF-6829-2022; Ferreiro, Ana/F-5371-2011	Guicheney, Pascale/0000-0002-7663-2050; Ferreiro, Ana/0000-0003-2806-5386; Straub, Volker/0000-0001-9046-3540; Moghadaszadeh, Behzad/0000-0001-9787-0106				Banker BQ, 1994, MYOLOGY, V2; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; BENHAMIDA M, 1987, REV NEUROL, V143, P284; BROWN MR, 1986, AM J CLIN NUTR, V43, P549, DOI 10.1093/ajcn/43.4.549; DUBOWITZ V, 1973, P ROY SOC MED, V66, P219, DOI 10.1177/003591577306600304; DUBOWITZ V, 1995, MUSCLE DISORDERS CHI, P93; ECHENNE B, 1983, NEUROPEDIATRICS, V14, P97, DOI 10.1055/s-2008-1059561; ENGEL AG, 1971, MAYO CLIN PROC, V46, P666; Fadic R, 1997, MUSCLE NERVE, V20, P364, DOI 10.1002/(SICI)1097-4598(199703)20:3<364::AID-MUS16>3.0.CO;2-0; Fagegaltier D, 2000, NUCLEIC ACIDS RES, V28, P2679, DOI 10.1093/nar/28.14.2679; FARDEAU M, 1994, MYOLOGY BASIC CLIN, V2, P1487; Ferreiro A, 2002, ANN NEUROL, V51, P750, DOI 10.1002/ana.10231; Ferreiro A, 2000, ANN NEUROL, V48, P745, DOI 10.1002/1531-8249(200011)48:5<745::AID-ANA8>3.0.CO;2-F; FERREIRO A, 2002, 80 ENMC INT WORKSH M, V12, P60; GOTO I, 1981, J NEUROL, V226, P143, DOI 10.1007/BF00313443; GOTO I, 1979, J NEUROL NEUROSUR PS, V42, P276, DOI 10.1136/jnnp.42.3.276; Jungbluth H, 2002, NEUROLOGY, V59, P284, DOI 10.1212/WNL.59.2.284; Jungbluth H, 2000, NEUROMUSCULAR DISORD, V10, P264, DOI 10.1016/S0960-8966(99)00125-X; Kubo S, 1998, NEUROMUSCULAR DISORD, V8, P502, DOI 10.1016/S0960-8966(98)00069-8; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; MERLINI L, 1989, J CHILD NEUROL, V4, P274, DOI 10.1177/088307388900400405; Moghadaszadeh B, 1998, AM J HUM GENET, V62, P1439, DOI 10.1086/301882; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Muntoni Francesco, 2002, Neuromuscul Disord, V12, P69, DOI 10.1016/S0960-8966(01)00209-7; MUSSINI JM, 1982, REV NEUROL, V138, P25; Osaki Y, 1998, MUSCLE NERVE, V21, P637, DOI 10.1002/(SICI)1097-4598(199805)21:5<637::AID-MUS10>3.0.CO;2-S; Pacher P, 2002, P NATL ACAD SCI USA, V99, P2380, DOI 10.1073/pnas.032423699; POEWE W, 1985, J NEUROL NEUROSUR PS, V48, P887, DOI 10.1136/jnnp.48.9.887; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; SCHUBERT JR, 1961, FED PROC, V20, P689; SEAY AR, 1977, ARCH NEUROL-CHICAGO, V34, P119, DOI 10.1001/archneur.1977.00500140073016; SERRATRICE G, 1984, PRESSE MED, V13, P1129; TOPALOGLU H, 1994, NEUROMUSCULAR DISORD, V4, P263, DOI 10.1016/0960-8966(94)90028-0; TRIPP MJ, 1993, J TRACE ELEM ELECT H, V7, P75; VANMUNSTER ETL, 1986, J NEUROL NEUROSUR PS, V49, P1292, DOI 10.1136/jnnp.49.11.1292; VOGEL P, 1982, J NEUROL, V228, P259, DOI 10.1007/BF00313416; Xiao W, 2001, BIOTECHNIQUES, V30, P1332, DOI 10.2144/01306rr01; Xu GL, 1997, BIOMED ENVIRON SCI, V10, P316	39	229	238	0	13	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					739	749		10.1086/342719	http://dx.doi.org/10.1086/342719			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12192640	Green Published, Bronze			2022-12-18	WOS:000178613800004
J	Vermeire, S; Wild, G; Kocher, K; Cousineau, J; Dufresne, L; Bitton, A; Langelier, D; Pare, P; Lapointe, G; Cohen, A; Daly, MJ; Rioux, JD				Vermeire, S; Wild, G; Kocher, K; Cousineau, J; Dufresne, L; Bitton, A; Langelier, D; Pare, P; Lapointe, G; Cohen, A; Daly, MJ; Rioux, JD			CARD15 genetic variation in a Quebec population: Prevalence, genotype-phenotype relationship, and haplotype structure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE SEARCH; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; PROVIDES EVIDENCE; NOD2; EPIDEMIOLOGY; MUTATION; ASSOCIATION; DIVERSITY	The caspase recruitment domain gene (CARD15) was recently identified as the underlying gene associated with the IBD1 locus that confers susceptibility to Crohn disease (CD). CARD15 is related to the NOD1/Apaf-1 family of apoptosis regulators, and three sequence variants (Arg702Trp, Gly908Arg, and Leu1007fsinsC) in the gene were demonstrated to be associated with CD. We collected a cohort of 231 patients with CD and 71 healthy control individuals from the Canadian province of Quebec, to determine the prevalence of these sequence variants in an independent population. Clinical records of all patients were systematically reviewed, and detailed phenotypic information was obtained. All patient DNA samples were genotyped for the three variants, thus enabling an analysis of genotype-phenotype correlations. In this cohort, 45.0% of patients with CD carried at least one variant in the CARD15 gene, compared with 9.0% of control individuals (P<10(-7)). Allele frequencies of Arg702Trp, Gly908Arg, and Leu1007fsinsC were 12.9%, 5.2%, and 10.3% in patients with CD, compared with 4.2%, 0.7%, and 0.7% in control individuals, respectively. Importantly, CARD15 mutants were seen with equal frequency in patients with familial and sporadic CD. Analysis of the relationship between genotype and phenotype convincingly demonstrates that CARD15 variants are significantly associated with ileal disease involvement, as opposed to strictly colonic disease (P<.001). Moreover, we were able to determine the haplotype structure surrounding this disease gene by genotyping 45 single-nucleotide polymorphisms (SNPs) in a 177-kb region that contained the CARD15 gene. This structure helps clarify the history of these causal mutations. Finally, this analysis shows that CARD15 involvement with CD is detectable by use of publicly available SNPs alone.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; McGill Univ, Dept Gastroenterol, Ctr Hlth, Montreal, PQ, Canada; Ctr Hosp Sherbrooke, Dept Gastroenterol, Sherbrooke, PQ, Canada; CHU Quebec, Hop Hotel Dieu, Dept Gastroenterol, Quebec City, PQ, Canada; Ctr Hosp Sagamie, Dept Gastroenterol, Chicoutimi, PQ, Canada	Massachusetts Institute of Technology (MIT); Whitehead Institute; McGill University; Laval University	Rioux, JD (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 1 Kendall Sq,Bldg 300, Cambridge, MA 02139 USA.		Rioux, John D/A-9599-2015; Daly, Mark J/B-2453-2017	Rioux, John D/0000-0001-7560-8326; Daly, Mark J/0000-0002-0949-8752; Vermeire, Severine/0000-0001-9942-3019				Ahmad T, 2001, ALIMENT PHARM THER, V15, P731, DOI 10.1046/j.1365-2036.2001.00981.x; Andres PG, 1999, GASTROENTEROL CLIN N, V28, P255, DOI 10.1016/S0889-8553(05)70056-X; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; EKBOM A, 1991, GASTROENTEROLOGY, V100, P350, DOI 10.1016/0016-5085(91)90202-V; Elson CO, 2002, NEW ENGL J MED, V346, P614, DOI 10.1056/NEJM200202213460812; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Goldstein AM, 2001, BRIT J CANCER, V85, P527, DOI 10.1054/bjoc.2001.1944; Greenbloom SL, 1998, CAN J GASTROENTEROL, V12, P53, DOI 10.1155/1998/349460; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Peeters M, 2000, INFLAMM BOWEL DIS, V6, P314; PINCHBECK BR, 1988, J CLIN GASTROENTEROL, V10, P505, DOI 10.1097/00004836-198810000-00007; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7	34	229	242	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2002	71	1					74	83		10.1086/341124	http://dx.doi.org/10.1086/341124			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	564GY	12019468	Green Published, Bronze			2022-12-18	WOS:000176307700008
J	Moslehi, R; Chu, W; Karlan, B; Fishman, D; Risch, H; Fields, A; Smotkin, D; Ben-David, Y; Rosenblatt, J; Russo, D; Schwartz, P; Tung, N; Warner, E; Rosen, B; Friedman, J; Brunet, JS; Narod, SA				Moslehi, R; Chu, W; Karlan, B; Fishman, D; Risch, H; Fields, A; Smotkin, D; Ben-David, Y; Rosenblatt, J; Russo, D; Schwartz, P; Tung, N; Warner, E; Rosen, B; Friedman, J; Brunet, JS; Narod, SA			BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; GENETIC-HETEROGENEITY; GERMLINE MUTATIONS; 185DELAG MUTATION; CARRIER FREQUENCY; FAMILY HISTORY; POPULATION; PENETRANCE; 6174DELT; INDIVIDUALS	Ovarian cancer is a component of the autosomal-dominant hereditary breast-ovarian cancer syndrome and may be due to a mutation in either the BRCA1 or BRCA2 genes. Two mutations in BRCA1 (185delAG and 5382insC) and one mutation in BRCA2 (6174delT) are common in the Ashkenazi Jewish population. One of these three mutations is present in similar to 2% of the Jewish population, Each mutation is associated with an increased risk of ovarian cancer, and it is expected that a significant proportion of Jewish women with ovarian cancer will carry one of these mutations. To estimate the proportion of ovarian cancers attributable to founding mutations in BRCA1 and BRCA2. in the Jewish population and the familial cancer risks associated with each, we interviewed 213 Jewish women with ovarian cancer at 11 medical centers in North America and Israel and offered these women genetic testing for the three founder mutations. To establish the presence of nonfounder mutations in this population, we also completed the protein-truncation test on exon 11 of BRCA1 and exons 10 and 11 of BRCA2, We obtained a detailed family history on all women we studied who had cancer and on a control population of 386 Ashkenazi Jewish women without ovarian or breast cancer. A founder mutation was present in 41.3% of the women we studied, The cumulative incidence of ovarian cancer to age 75 years was found to be 6.3% for female first-degree relatives of the patients with ovarian cancer, compared with 2.0% for the female relatives of healthy controls (relative risk 3.2; 95% CI 1.5-6.8; P = .002). The relative risk to age 75 years for breast cancer among the female first-degree relatives was 2.0 (95% CI 1.4-3.0; P = .0001). Only one nonfounder mutation was identified (in this instance, in a woman of mixed ancestry), and the three founding mutations accounted for most of the observed excess risk of ovarian and breast cancer in relatives.	Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON M5S 1B2, Canada; Univ Toronto, Toronto, ON M5S 1B2, Canada; Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada; Toronto Hosp, Dept Obstet & Gynecol, Toronto, ON M5T 2S8, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; Northwestern Univ, Med Ctr, Dept Obstet & Gynecol, Chicago, IL 60611 USA; Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT USA; Yale Univ, Dept Obstet & Gynecol, New Haven, CT USA; Albert Einstein Coll Med, Brooklyn, NY USA; Long Isl Jewish Med Ctr, Long Isl City, NY USA; Cent Emek Hosp, Haifa, Israel; McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada; Columbia Presbyterian Med Ctr, New York, NY 10032 USA; Beth Israel Deaconess Med Ctr, Boston, MA USA	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia; Cedars Sinai Medical Center; Northwestern University; Yale University; Yale University; Yeshiva University; Northwell Health; Emek Medical Center; McGill University; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Beth Israel Deaconess Medical Center	Narod, SA (corresponding author), Ctr Res Womens Hlth, 790 Bay St,Suite 750A, Toronto, ON M5G 1N8, Canada.	narod@ftn.net	Narod, Steven A/AAA-6112-2022	Friedman, Jan/0000-0002-7482-9570	NATIONAL CANCER INSTITUTE [R01CA063678] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 63678-05, R01 CA063678] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abeliovich D, 1997, AM J HUM GENET, V60, P505; AMOS CI, 1993, CANCER-AM CANCER SOC, V71, P566; Beller U, 1997, GYNECOL ONCOL, V67, P123, DOI 10.1006/gyno.1997.4844; Boyd Jeff, 1999, Gynecologic Oncology, V72, P444; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brunet JS, 1997, NEW ENGL J MED, V336, P1256; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Janezic SA, 1999, HUM MOL GENET, V8, P889, DOI 10.1093/hmg/8.5.889; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Modan B, 1996, JAMA-J AM MED ASSOC, V276, P1823, DOI 10.1001/jama.276.22.1823; Modan B, 1997, NEW ENGL J MED, V336, P1255; Muto MG, 1996, CANCER RES, V56, P1250; NAROD S, 1995, AM J HUM GENET, V57, P957; NAROD S, 1993, LANCET, V341, P1101, DOI 10.1016/0140-6736(93)92468-9; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; NAROD SA, 1995, AM J HUM GENET, V56, P254; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Ozcelik H, 1997, NAT GENET, V16, P17, DOI 10.1038/ng0597-17; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Stratton JF, 1997, NEW ENGL J MED, V336, P1125, DOI 10.1056/NEJM199704173361602; Struewing J P, 1995, J Natl Cancer Inst Monogr, P33; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; Wacholder S, 1998, AM J EPIDEMIOL, V148, P623, DOI 10.1093/aje/148.7.623; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241	35	229	231	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1259	1272		10.1086/302853	http://dx.doi.org/10.1086/302853			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739756	Green Published, Bronze			2022-12-18	WOS:000088373400010
J	Andresen, BS; Olpin, S; Poorthuis, BJHM; Scholte, HR; Vianey-Saban, C; Wanders, R; Ijlst, L; Morris, A; Pourfarzam, M; Bartlett, K; Baumgartner, ER; deKlerk, JBC; Schroeder, LD; Corydon, TJ; Lund, H; Winter, V; Bross, P; Bolund, L; Gregersen, N				Andresen, BS; Olpin, S; Poorthuis, BJHM; Scholte, HR; Vianey-Saban, C; Wanders, R; Ijlst, L; Morris, A; Pourfarzam, M; Bartlett, K; Baumgartner, ER; deKlerk, JBC; Schroeder, LD; Corydon, TJ; Lund, H; Winter, V; Bross, P; Bolund, L; Gregersen, N			Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A DEHYDROGENASE; FATTY-ACID OXIDATION; PALMITOYLTRANSFERASE-II DEFICIENCY; DRIED BLOOD SPOTS; MCAD DEFICIENCY; MOLECULAR-BASIS; RECURRENT MYOGLOBINURIA; CULTURED FIBROBLASTS; ESCHERICHIA-COLI; GENE	Very-long-chain acyl-CoA dehydrogenase (VLCAD) catalyzes the initial rate-limiting step in mitochondrial fatty acid P-oxidation. VLCAD deficiency is clinically heterogenous, with three major phenotypes: a severe childhood form, with early onset, high mortality, and high incidence of cardiomyopathy; a milder childhood form, with later onset, usually with hypoketotic hypoglycemia as the main presenting feature, low mortality and rare cardiomyopathy; and an adult form, with isolated skeletal muscle involvement, rhabdomyolysis, and myoglobinuria, usually triggered by exercise or fasting. To examine whether these different phenotypes are due to differences in the VLCAD genotype, we investigated 58 different mutations in 55 unrelated patients representing all known clinical phenotypes and correlated the mutation type with the clinical phenotype. Our results show a clear relationship between the nature of the mutation and the severity of disease. Patients with the severe childhood phenotype have mutations that result in no residual enzyme activity, whereas patients with the milder childhood and adult phenotypes have mutations that may result in residual enzyme activity. This clear genotype-phenotype relationship is in sharp contrast to what has been observed in medium-chain acyl-CoA dehydrogenase deficiency, in which no correlation between genotype and phenotype can be established.	Skejby Sygehus, Mol Biol Unit, Fac Hlth Sci, DK-8200 Aarhus N, Denmark; Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark; Univ Aarhus, Inst Human Genet, Aarhus, Denmark; Sheffield Childrens Hosp, Neonatal Screening Lab, Sheffield S10 2TH, S Yorkshire, England; Royal Victoria Infirm, Dept Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; Erasmus Univ, Dept Biochem, NL-3000 DR Rotterdam, Netherlands; Sophia Childrens Univ Hosp, Rotterdam, Netherlands; Univ Hosp Amsterdam, Dept Pediat, Amsterdam, Netherlands; Hop Debrousse, Unite Etud Malad Metab, Lyon, France; Univ Basel, Childrens Hosp, Basel, Switzerland	Aarhus University; Aarhus University; Aarhus University; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; CHU Lyon; University of Basel	Andresen, BS (corresponding author), Skejby Sygehus, Mol Biol Unit, Fac Hlth Sci, DK-8200 Aarhus N, Denmark.	brage@biobase.dk	Andresen, Brage/D-2515-2012; pourfarzam, morteza/A-8211-2017; Bross, Peter/B-7219-2013	Andresen, Brage/0000-0001-7488-3035; pourfarzam, morteza/0000-0002-9563-8044; Bross, Peter/0000-0001-9526-8525; Corydon, Thomas Juhl/0000-0003-3588-6350				AMENDT BA, 1987, J CLIN INVEST, V79, P1303, DOI 10.1172/JCI112953; ANDRESEN BS, 1994, AM J HUM GENET, V54, P975; ANDRESEN BS, 1993, AM J HUM GENET, V53, P730; Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461; Andresen BS, 1997, HUM MOL GENET, V6, P695, DOI 10.1093/hmg/6.5.695; Andresen BS, 1996, J INHERIT METAB DIS, V19, P169, DOI 10.1007/BF01799421; ANDRESEN BS, 1992, CLIN CHEM, V38, P2100; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1995, AM J HUM GENET, V57, P273; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; Beinert H., 1963, ENZYMES, P447; BERTRAND C, 1993, BIOCHIM BIOPHYS ACTA, V1180, P327, DOI 10.1016/0925-4439(93)90058-9; Bonnefont JP, 1996, AM J HUM GENET, V58, P971; Bross P, 1998, PROG NUCLEIC ACID RE, V58, P301; BROSS P, 1993, BIOCHIM BIOPHYS ACTA, V1182, P264, DOI 10.1016/0925-4439(93)90068-C; BrownHarrison MC, 1996, BIOCHEM MOL MED, V58, P59, DOI 10.1006/bmme.1996.0033; CORDON MJ, 1996, PEDIATR RES, V39, P1; CORR PB, 1989, J CLIN INVEST, V83, P927, DOI 10.1172/JCI113978; Costa CG, 1998, J INHERIT METAB DIS, V21, P391, DOI 10.1023/A:1005354624735; Costa CG, 1997, J LIPID RES, V38, P173; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Desviat LR, 1997, EUR J HUM GENET, V5, P196, DOI 10.1159/000484763; Fitzsimmons TJ, 1997, J BIOL CHEM, V272, P31435, DOI 10.1074/jbc.272.50.31435; FRERMAN FE, 1985, BIOCHEM MED METAB B, V33, P38, DOI 10.1016/0006-2944(85)90124-3; GILLETT GT, 1996, J INHER METAB S1, V19, P108; Goodman SI, 1998, HUM MUTAT, V12, P141, DOI 10.1002/(SICI)1098-1004(1998)12:3<141::AID-HUMU1>3.0.CO;2-K; GREGERSEN N, 1991, HUM GENET, V86, P545; Gregersen N, 1998, HUM MOL GENET, V7, P619, DOI 10.1093/hmg/7.4.619; GREGERSEN N, 1991, CLIN CHIM ACTA, V203, P23, DOI 10.1016/0009-8981(91)90153-4; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HALE DE, 1985, PEDIATR RES, V19, P666, DOI 10.1203/00006450-198507000-00006; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; INDO Y, 1991, PEDIATR RES, V30, P211, DOI 10.1203/00006450-199109000-00001; JENSEN TG, 1992, BIOCHIM BIOPHYS ACTA, V1180, P65, DOI 10.1016/0925-4439(92)90028-L; Kayaalp E, 1997, AM J HUM GENET, V61, P1309, DOI 10.1086/301638; Kim JK, 1996, DIABETES, V45, P446, DOI 10.2337/diabetes.45.4.446; KOLVRAA S, 1982, CLIN CHIM ACTA, V126, P53, DOI 10.1016/0009-8981(82)90361-8; LARGILLIERE C, 1995, ARCH DIS CHILD-FETAL, V73, pF103, DOI 10.1136/fn.73.2.F103; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; MANNING NJ, 1990, J INHERIT METAB DIS, V13, P58, DOI 10.1007/BF01799333; MAQUAT LE, 1995, RNA, V1, P453; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Merinero B, 1996, J INHERIT METAB DIS, V19, P173, DOI 10.1007/BF01799422; MILLINGTON DS, 1992, PROG CLIN BIOL RES, V375, P339; Minetti C, 1998, NEUROMUSCULAR DISORD, V8, P3, DOI 10.1016/S0960-8966(97)00121-1; Nada MA, 1996, PRENATAL DIAG, V16, P117, DOI 10.1002/(SICI)1097-0223(199602)16:2<117::AID-PD820>3.0.CO;2-Z; OGILVIE I, 1994, NEUROLOGY, V44, P467, DOI 10.1212/WNL.44.3_Part_1.467; Olpin SE, 1997, J INHERIT METAB DIS, V20, P415, DOI 10.1023/A:1005358802096; ONKENHOUT W, 1995, CLIN CHEM, V41, P1467; PAUMEN MB, 1997, J BIOL CHEM, V272, P33224; Roe C. R., 1995, METABOLIC MOL BASES, P1501; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P347, DOI 10.1007/BF02435973; Smelt AHM, 1998, ANN NEUROL, V43, P540, DOI 10.1002/ana.410430422; Souri M, 1996, AM J HUM GENET, V58, P97; Souri M, 1998, J BIOL CHEM, V273, P4227, DOI 10.1074/jbc.273.7.4227; Souri M, 1998, FEBS LETT, V426, P187, DOI 10.1016/S0014-5793(98)00343-3; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; Straussberg R, 1997, PEDIATRICS, V99, P894, DOI 10.1542/peds.99.6.894; Tanaka K, 1997, PEDIATR RES, V41, P201, DOI 10.1203/00006450-199702000-00008; TARONI F, 1993, NAT GENET, V4, P314, DOI 10.1038/ng0793-314; VERDERIO E, 1995, HUM MOL GENET, V4, P19, DOI 10.1093/hmg/4.1.19; Vianey-Saban C, 1998, CLIN CHIM ACTA, V269, P43, DOI 10.1016/S0009-8981(97)00185-X; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; ZHANG ZF, 1992, BIOCHEMISTRY-US, V31, P81, DOI 10.1021/bi00116a013	65	229	243	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					479	494		10.1086/302261	http://dx.doi.org/10.1086/302261			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973285	Bronze, Green Published			2022-12-18	WOS:000078740600017
J	Cooper, TA; Mattox, W				Cooper, TA; Mattox, W			The regulation of splice-site selection, and its role in human disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; SOMATIC REVERSION SUPPRESSION; BECKER MUSCULAR-DYSTROPHY; T ALTERNATIVE EXON; OF-WHITE-APRICOT; PREMESSENGER RNA; SR-PROTEINS; ADHESION MOLECULE; SKELETAL-MUSCLE; CELL-ADHESION		BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOL GENET,HOUSTON,TX 77030	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Cooper, TA (corresponding author), BAYLOR COLL MED,DEPT PATHOL,ROOM S201,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.			Mattox, William/0000-0001-8084-9677				AMREIN H, 1994, CELL, V76, P735, DOI 10.1016/0092-8674(94)90512-6; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; COOPER DL, 1995, NAT MED, V1, P635, DOI 10.1038/nm0795-635; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; DAS S, 1994, AM J HUM GENET, V55, P883; DEMEIRLEIR L, 1994, PEDIATR RES, V36, P707, DOI 10.1203/00006450-199412000-00004; DENHEZ F, 1994, J BIOL CHEM, V269, P16170; DIRKSEN WP, 1994, J BIOL CHEM, V269, P6431; DOUGHERTY G J, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P35; FU XD, 1995, RNA, V1, P663; GOODING C, 1994, EMBO J, V13, P3861, DOI 10.1002/j.1460-2075.1994.tb06697.x; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; GUO W, 1991, GENE DEV, V5, P2096, DOI 10.1101/gad.5.11.2096; HAMPSON RK, 1989, MOL CELL BIOL, V9, P1604, DOI 10.1128/MCB.9.4.1604; HASEGAWA Y, 1994, HUM GENET, V93, P415; HEINRICHS V, 1995, EMBO J, V14, P3987, DOI 10.1002/j.1460-2075.1995.tb00070.x; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; HUH GS, 1994, GENE DEV, V8, P1561, DOI 10.1101/gad.8.13.1561; HUMPHREY MB, 1995, MOL CELL BIOL, V15, P3979; INOUE K, 1992, P NATL ACAD SCI USA, V89, P8092, DOI 10.1073/pnas.89.17.8092; Jin Y, 1996, J CLIN INVEST, V98, P1745, DOI 10.1172/JCI118973; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KOENIG M, 1989, AM J HUM GENET, V45, P498; KRAWCZAK M, 1992, HUM GENET, V90, P41; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; LIGTENBERG MJL, 1990, NUCLEIC ACIDS RES, V19, P297; Llewellyn DH, 1996, J MED GENET, V33, P437, DOI 10.1136/jmg.33.5.437; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MAQUAT LE, 1995, RNA, V1, P453; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; MERZAK A, 1994, CANCER RES, V54, P3988; MOCHIZUKI H, 1992, MOL CARCINOGEN, V6, P83, DOI 10.1002/mc.2940060203; OYAMA F, 1993, CANCER RES, V53, P2005; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; RAMCHATESINGH J, 1995, CURR OPIN GENE DEV, V14, P4898; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Ryan KJ, 1996, MOL CELL BIOL, V16, P4014; RYNER LC, 1991, GENE DEV, V5, P2071, DOI 10.1101/gad.5.11.2071; SALMI M, 1993, J CELL BIOL, V122, P431, DOI 10.1083/jcb.122.2.431; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; Sarkissian M, 1996, J BIOL CHEM, V271, P31106, DOI 10.1074/jbc.271.49.31106; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; SEITER S, 1993, J EXP MED, V177, P443, DOI 10.1084/jem.177.2.443; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; Sierakowska H, 1996, P NATL ACAD SCI USA, V93, P12840, DOI 10.1073/pnas.93.23.12840; SPIKES DA, 1994, NUCLEIC ACIDS RES, V22, P4510, DOI 10.1093/nar/22.21.4510; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; TACKE R, 1991, GENE DEV, V5, P1416, DOI 10.1101/gad.5.8.1416; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; TANABE KK, 1993, LANCET, V341, P725, DOI 10.1016/0140-6736(93)90490-8; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; TIAN HC, 1995, MOL CELL BIOL, V15, P6291; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; vanAmstel JKP, 1996, HUM GENET, V97, P51, DOI 10.1007/BF00218833; VANOERS CCM, 1994, MOL CELL BIOL, V14, P951, DOI 10.1128/MCB.14.2.951; WAKAMATSU N, 1992, J BIOL CHEM, V267, P2406; WANG Z, 1995, RNA, V1, P21; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; ZACHAR ZZ, 1987, EMBO J, V6, P4105, DOI 10.1002/j.1460-2075.1987.tb02756.x; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	73	229	245	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					259	266		10.1086/514856	http://dx.doi.org/10.1086/514856			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311728	Bronze, Green Published			2022-12-18	WOS:A1997XX70100001
J	NEI, M; ROYCHOUD.AK				NEI, M; ROYCHOUD.AK			GENIC VARIATION WITHIN AND BETWEEN 3 MAJOR RACES OF MAN, CAUCASOIDS, NEGROIDS, AND MONGOLOIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,CTR DEMOG & POPULATION GENET,HOUSTON,TX 77025	University of Texas System								ALPER CA, 1968, J CLIN INVEST, V47, P2181, DOI 10.1172/JCI105904; AZEN EA, 1972, SCIENCE, V176, P673, DOI 10.1126/science.176.4035.673; AZEN EA, 1969, BIOCHEM GENET, V3, P215, DOI 10.1007/BF00521138; BAUR EW, 1963, SCIENCE, V140, P816, DOI 10.1126/science.140.3568.816; BECKMAN L, 1966, ACTA GENET STAT MED, V16, P223; BEUTLER E, 1972, AM J HUM GENET, V24, P237; BEUTLER E, 1966, J LAB CLIN MED, V68, P646; BIRDSELL JB, 1972, HUMAN EVOLUTION; BLAKE N M, 1969, Japanese Journal of Human Genetics, V13, P243; BLUMBERG BS, 1964, NATURE, V202, P561, DOI 10.1038/202561a0; BOWMAN JE, 1967, NATURE, V214, P1156, DOI 10.1038/2141156a0; CAVALLISFORZA LL, 1969, 12 P INT C GEN TOK, V3, P405; CHARLESWORTH D, 1972, ANN HUM GENET, V35, P477, DOI 10.1111/j.1469-1809.1957.tb01873.x; CHEN S, 1971, BIOCHEM GENET, V5, P481, DOI 10.1007/BF00487137; CHEN SH, 1971, SCIENCE, V173, P148, DOI 10.1126/science.173.3992.148; CHEN SH, 1972, AM J HUM GENET, V24, P325; CHEN SH, 1971, AM J HUM GENET, V23, P419; CHEN SH, 1972, AM J HUM GENET, V24, P229; COATES PM, 1972, SCIENCE, V175, P1466, DOI 10.1126/science.175.4029.1466; Cohen P T, 1972, Biochem Genet, V7, P303, DOI 10.1007/BF00484830; COOPER AJ, 1963, AM J HUM GENET, V15, P420; DAVIDSON RG, 1967, ANN HUM GENET, V30, P355, DOI 10.1111/j.1469-1809.1967.tb00037.x; DAVIDSON RG, 1970, SCIENCE, V169, P391, DOI 10.1126/science.169.3943.391; DAVIDSON RG, 1967, NATURE, V215, P761, DOI 10.1038/215761a0; DAVIDSON RG, 1967, SCIENCE, V157, P1569, DOI 10.1126/science.157.3796.1569; DETTER JC, 1968, ANN HUM GENET, V31, P329, DOI 10.1111/j.1469-1809.1968.tb00565.x; DETTER JC, 1970, AM J HUM GENET, V22, P100; FURUHATA T, 1961, P JPN ACAD, V37, P319, DOI 10.2183/pjab1945.37.319; FURUHJELM U, 1968, VOX SANG, V15, P118, DOI 10.1111/j.1423-0410.1968.tb03416.x; GIBLETT E. R., 1962, PROGR MED GENET, V2, P34; GIBLETT ER, 1965, AM J HUM GENET, V17, P425; GILES CM, 1967, VOX SANG, V13, P171, DOI 10.1111/j.1423-0410.1967.tb03946.x; HARADA S, 1969, JPN J HUM GENET, V14, P248; HARRIS H, 1969, BRIT MED BULL, V25, P5, DOI 10.1093/oxfordjournals.bmb.a070670; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; HARRIS H, 1970, PRINCIPLES HUMAN BIO; HOPKINSO.DA, 1970, ANN HUM GENET, V34, P1, DOI 10.1111/j.1469-1809.1970.tb00214.x; HOPKINSON DA, 1966, ANN HUM GENET, V30, P167, DOI 10.1111/j.1469-1809.1966.tb00016.x; HOPKINSON DA, 1969, ANN HUM GENET, V32, P361, DOI 10.1111/j.1469-1809.1969.tb00087.x; HOPKINSON DA, 1968, ANN HUM GENET, V31, P359, DOI 10.1111/j.1469-1809.1968.tb00567.x; ISHIMOTO G, 1969, JPN J HUM GENET, V14, P183; ISHIMOTO G, 1969, HUM HERED, V19, P198, DOI 10.1159/000152218; JOHNSON AM, 1969, J CLIN INVEST, V48, P2293, DOI 10.1172/JCI106195; KALOUSTIAN VMD, 1969, BIOCHEM GENET, V3, P299; KELLERMA.G, 1970, HUMANGENETIK, V10, P145, DOI 10.1007/BF00295513; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; LATTER BDH, 1972, GENETICS, V70, P475; LAYRISSE M, 1958, AM J PHYS ANTHROPOL, V16, P173, DOI 10.1002/ajpa.1330160203; LEWIS M, 1957, AM J HUM GENET, V9, P274; LEWIS WHP, 1969, ANN HUM GENET, V32, P317, DOI 10.1111/j.1469-1809.1969.tb00081.x; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; LEWIS WHP, 1971, EXCERPTA MEDICA  233, P111; LEWONTIN RC, 1967, AM J HUM GENET, V19, P681; LEWONTIN RC, 1972, EVOLUTIONARY BIOLOGY, V6; LISKER R, 1967, AM J HUM GENET, V19, P174; MACVIE SI, 1967, VOX SANG, V13, P485, DOI 10.1111/j.1423-0410.1967.tb03795.x; MATSUNAGA E, 1964, ANNU REP NAT I GENET, V15, P150; MELARTIN L, 1967, NATURE, V215, P1288, DOI 10.1038/2151288a0; MERRITT AD, 1971, EXCERPTA MEDICA  233, P120; Miller EB, 1954, AM J PHYS ANTHROP-NE, V12, P427, DOI 10.1002/ajpa.1330120316; MOWBRAY S, 1972, ANN HUM GENET, V36, P153, DOI 10.1111/j.1469-1809.1972.tb00766.x; NAKAJIMA H, 1971, J ANTHROPOL SOC NIP, V79, P178; NAKAJIMA H, 1962, P JPN ACAD, V38, P690, DOI 10.2183/pjab1945.38.690; NAKAJIMA HACHIRO, 1967, JAP J HUM GENET, V12, P29; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, J MOL EVOL, V2, P323, DOI 10.1007/BF01654100; NEI M, 1974, GENETICS, V76, P379; NEI M, 1972, THEOR POPUL BIOL, V3, P460, DOI 10.1016/0040-5809(72)90017-2; NEI M, 1966, HEREDITY, V21, P9, DOI 10.1038/hdy.1966.2; NEI M, 1971, AM NAT, V105, P385, DOI 10.1086/282732; NEI M, 1972, SCIENCE, V177, P434, DOI 10.1126/science.177.4047.434; NEI M, 1973, GENETICS POPULATION; NEI M, IN PRESS; NEVO E, 1974, EVOLUTION, V28, P1, DOI 10.1111/j.1558-5646.1974.tb00722.x; OHKURA K, 1967, JAP J HUM GENET, V12, P101; OMENN GS, 1971, EXCERPTA MEDICA  233, P135; OMOTO K, 1969, JPN J HUM GENET, V14, P241; OMOTO K, 1972, ANN HUM GENET, V36, P61, DOI 10.1111/j.1469-1809.1972.tb00581.x; POVEY S, 1972, ANN HUM GENET, V35, P455, DOI 10.1111/j.1469-1809.1957.tb01870.x; Race R. R, 1968, BLOOD GROUPS MAN; RAUSEN AR, 1967, TRANSFUSION, V7, P336, DOI 10.1111/j.1537-2995.1967.tb04864.x; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; ROBSON EB, 1967, ANN HUM GENET, V30, P219, DOI 10.1111/j.1469-1809.1967.tb00023.x; SAMLOFF IM, 1973, AM J HUM GENET, V25, P178; SAMLOFF IM, 1970, SCIENCE, V168, P144, DOI 10.1126/science.168.3927.144; SHINODA T, 1970, JPN J HUM GENET, V15, P133; SHINODA T, 1969, Japanese Journal of Human Genetics, V13, P249; SHINODA T, 1969, ANN REP NATL I GENET, V20, P101; Shreffler D C, 1967, Biochem Genet, V1, P101, DOI 10.1007/BF00486512; SMITH M, 1972, ANN HUM GENET, V35, P243, DOI 10.1111/j.1469-1809.1957.tb01398.x; SMITH M, 1971, ANN HUM GENET, V34, P251, DOI 10.1111/j.1469-1809.1971.tb00238.x; STEINBERG A. G., 1964, HUM BIOL, V36, P77; STERN C, 1970, HUM HERED, V20, P165, DOI 10.1159/000152305; SUTTON H. ELDON, 1967, ANNU REV GENET, V1, P1, DOI 10.1146/annurev.ge.01.120167.000245; SUYAMA H, 1969, HUM HERED, V19, P74, DOI 10.1159/000152202; TASHIAN RE, 1969, BIOCHEMICAL METHODS; TOWNES PL, 1968, LANCET, V1, P920; VESELL ELLIOT S., 1965, PROGR MED GENET, V4, P128; WALTER H, 1970, HUMANGENETIK, V10, P298, DOI 10.1007/BF00278766; WARD JC, 1971, AM J HUM GENET, V23, P403; WIENER AS, 1956, ANN INTERN MED, V44, P221, DOI 10.7326/0003-4819-44-2-221; WIENER AS, 1971, COMPARATIVE GENETICS; YAMAMOTO M, 1969, Japanese Journal of Human Genetics, V13, P256; YANASE T, 1968, Japanese Journal of Human Genetics, V13, P40	105	229	236	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	4					421	443						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	T5051	4841634				2022-12-18	WOS:A1974T505100001
J	Ben Khelifa, M; Coutton, C; Zouari, R; Karaouzene, T; Rendu, J; Bidart, M; Yassine, S; Pierre, V; Delaroche, J; Hennebicq, S; Grunwald, D; Escalier, D; Pernet-Gallay, K; Jouk, PS; Thierry-Mieg, N; Toure, A; Arnoult, C; Ray, PF				Ben Khelifa, Mariem; Coutton, Charles; Zouari, Raoudha; Karaouzene, Thomas; Rendu, John; Bidart, Marie; Yassine, Sandra; Pierre, Virginie; Delaroche, Julie; Hennebicq, Sylviane; Grunwald, Didier; Escalier, Denise; Pernet-Gallay, Karine; Jouk, Pierre-Simon; Thierry-Mieg, Nicolas; Toure, Aminata; Arnoult, Christophe; Ray, Pierre F.			Mutations in DNAH1, which Encodes an Inner Arm Heavy Chain Dynein, Lead to Male Infertility from Multiple Morphological Abnormalities of the Sperm Flagella	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CILIARY DYSKINESIA; OF-FUNCTION MUTATIONS; FIBROUS SHEATH; HOMOZYGOUS MUTATION; PROTEIN; SPERMATOZOA; EXPRESSION; DYSPLASIA; ASTHENOZOOSPERMIA; IDENTIFICATION	Ten to fifteen percent of couples are confronted with infertility and a male factor is involved in approximately half the cases. A genetic etiology is likely in most cases yet only few genes have been formally correlated with male infertility. Homozygosity mapping was carried out on a cohort of 20 North African individuals, including 18 index cases, presenting with primary infertility resulting from impaired sperm motility caused by a mosaic of multiple morphological abnormalities of the flagella (MMAF) including absent, short, coiled, bent, and irregular flagella. Five unrelated subjects out of 18 (28%) carried a homozygous variant in DNAH1, which encodes an inner dynein heavy chain and is expressed in testis. RT-PCR, immunostaining, and electronic microscopy were carried out on samples from one of the subjects with a mutation located on a donor splice site. Neither the transcript nor the protein was observed in this individual, confirming the pathogenicity of this variant. A general axonemal disorganization including mislocalization of the microtubule doublets and loss of the inner dynein arms was observed. Although DNAH1 is also expressed in other ciliated cells, infertility was the only symptom of primary ciliary dyskinesia observed in affected subjects, suggesting that DNAH1 function in cilium is not as critical as in sperm flagellum.	[Ben Khelifa, Mariem; Coutton, Charles; Karaouzene, Thomas; Rendu, John; Bidart, Marie; Yassine, Sandra; Pierre, Virginie; Delaroche, Julie; Hennebicq, Sylviane; Grunwald, Didier; Pernet-Gallay, Karine; Arnoult, Christophe; Ray, Pierre F.] Univ Grenoble 1, F-38000 Grenoble, France; [Ben Khelifa, Mariem; Coutton, Charles; Karaouzene, Thomas; Yassine, Sandra; Pierre, Virginie; Hennebicq, Sylviane; Arnoult, Christophe; Ray, Pierre F.] CNRS, FRE3405, Lab AGIM, Equipe Androl & Genet, F-38700 La Tronche, France; [Ben Khelifa, Mariem] Inst Pasteur Tunis, Lab Genom Biomed & Oncogenet, Tunis 1002, Tunisia; [Coutton, Charles] CHU Grenoble, Hop Couple Enfant, Dept Genet & Procreat, Lab Genet Chromosom, F-38000 Grenoble, France; [Zouari, Raoudha] Clin Jasmins, Tunis 1002, Tunisia; [Rendu, John; Ray, Pierre F.] CHU Grenoble, Inst Biol & Pathol, DBTP, UF Biochim & Genet Mol, F-38000 Grenoble, France; [Rendu, John; Bidart, Marie; Delaroche, Julie; Grunwald, Didier; Pernet-Gallay, Karine] Grenoble Inst Neurosci, INSERM, U836, F-38700 La Tronche, France; [Hennebicq, Sylviane] CHU Grenoble, Hop Couple Enfant, Dept Genet & Procreat, Lab Aide Procreat CECOS, F-38000 Grenoble, France; [Escalier, Denise] Univ Paris 06, INSERM, UMR S933, F-75012 Paris, France; [Jouk, Pierre-Simon; Thierry-Mieg, Nicolas] Univ Grenoble 1, CNRS, TIMC IMAG UMR 5525, F-38041 Grenoble, France; [Jouk, Pierre-Simon] CHU Grenoble, Hop Couple Enfant, Dept Genet & Procreat, Serv Genet Clin, F-38000 Grenoble, France; [Toure, Aminata] INSERM, U1016, Inst Cochin, F-75014 Paris, France; [Toure, Aminata] CNRS, UMR8104, F-75014 Paris, France; [Toure, Aminata] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75014 Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ray, PF (corresponding author), Univ Grenoble 1, F-38000 Grenoble, France.	pray@chu-grenoble.fr	TOURE, Aminata/B-3236-2018; Ray, Pierre F/D-7315-2019; Thierry-Mieg, Nicolas/M-6007-2014; Jouk, Pierre-Simon/AAB-5262-2022; COUTTON, Charles/G-2859-2014; hennebicq, sylviane/A-6564-2012; Jouk, Pierre-Simon/M-7367-2014; ARNOULT, christophe/E-8312-2013	TOURE, Aminata/0000-0001-5629-849X; Ray, Pierre F/0000-0003-1544-7449; Thierry-Mieg, Nicolas/0000-0002-7667-2853; Jouk, Pierre-Simon/0000-0001-8301-320X; hennebicq, sylviane/0000-0002-1851-6932; ARNOULT, christophe/0000-0002-3753-5901; Coutton, Charles/0000-0002-8873-8098; Delaroche, Julie/0000-0003-2529-0270	French Research Agency (ANR);  [ICG2I]	French Research Agency (ANR)(French National Research Agency (ANR)); 	This work was supported by the research grant ICG2I funded by the program GENOPAT 2009 from the French Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to Frederic Plewniak, IGBMC, Strasbourg, who developed the homoSNP software used in this study (the software is available on request to plewniak@igbmc.u-strasbg.fr).	Antony D, 2013, HUM MUTAT, V34, P462, DOI 10.1002/humu.22261; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; CHEMES HE, 1987, FERTIL STERIL, V48, P664; DAVID G, 1993, B ACAD NAT MED PARIS, V177, P263; DAVID G, 1993, B ACAD NATL MED, V177, P272; Demonchy R, 2009, J CELL BIOL, V187, P615, DOI 10.1083/jcb.200903139; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Escalier D, 2006, ANDROLOGIA, V38, P54, DOI 10.1111/j.1439-0272.2006.00711.x; Escalier D, 1997, J HISTOCHEM CYTOCHEM, V45, P909, DOI 10.1177/002215549704500701; Escalier D, 2006, FERTIL STERIL, V86, DOI 10.1016/j.fertnstert.2005.12.042; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Freshour J, 2007, J BIOL CHEM, V282, P5404, DOI 10.1074/jbc.M607509200; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Hook P, 2012, NAT STRUCT MOL BIOL, V19, P467, DOI 10.1038/nsmb.2290; King SM, 2013, J CELL BIOL, V201, P173, DOI 10.1083/jcb.201302077; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Maiti AK, 2000, EUR J HUM GENET, V8, P923, DOI 10.1038/sj.ejhg.5200555; MARMOR D, 1991, INT J ANDROL, V14, P108, DOI 10.1111/j.1365-2605.1991.tb01072.x; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Moretti E, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.11.027; Myster SH, 1999, J CELL BIOL, V146, P801, DOI 10.1083/jcb.146.4.801; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; NEUGEBAUER DC, 1990, HUM REPROD, V5, P981, DOI 10.1093/oxfordjournals.humrep.a137232; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Olmedo SB, 2000, ASIAN J ANDROL, V2, P125; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; Rawe VY, 2001, HUM REPROD, V16, P879, DOI 10.1093/humrep/16.5.879; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; STALF T, 1995, HUM REPROD, V10, P2112, DOI 10.1093/oxfordjournals.humrep.a136244; World Health Organization, 2010, WHO LAB MAN EX PROC, V5	42	228	238	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					95	104		10.1016/j.ajhg.2013.11.017	http://dx.doi.org/10.1016/j.ajhg.2013.11.017			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24360805	Green Published, Bronze			2022-12-18	WOS:000329888400010
J	Sen, SK; Han, KD; Wang, JX; Lee, J; Wang, H; Callinan, PA; Dyer, M; Cordaux, R; Liang, P; Batzer, MA				Sen, Shurjo K.; Han, Kyudong; Wang, Jianxin; Lee, Jungnam; Wang, Hui; Callinan, Pauline A.; Dyer, Matthew; Cordaux, Richard; Liang, Ping; Batzer, Mark A.			Human genomic deletions mediated by recombination between Alu elements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							L1 RETROTRANSPOSITION; DNA-SEQUENCES; GENE; EVOLUTION; POLYMORPHISM; EXPANSION; INSERTION; REPEATS; EXONS; REARRANGEMENTS	Recombination between Alu elements results in genomic deletions associated with many human genetic disorders. Here, we compare the reference human and chimpanzee genomes to determine the magnitude of this recombination process in the human lineage since the human-chimpanzee divergence similar to 6 million years ago. Combining computational data mining and wet-bench experimental verification, we identified 492 human-specific deletions ( for a total of similar to 400 kb) attributable to this process, a significant component of the insertion/deletion spectrum of the human genome. The majority of the deletions ( 295 of 492) coincide with known or predicted genes ( including 3 that deleted functional exons, as compared with orthologous chimpanzee genes), which implicates this process in creating a substantial portion of the genomic differences between humans and chimpanzees. Overall, we found that Alu recombination-mediated genomic deletion has had a much higher impact than was inferred from previously identified isolated events and that it continues to contribute to the dynamic nature of the human genome.	Louisiana State Univ, Dept Biol Sci, Biol Comp & Visualizat Ctr, Ctr Biomol Multi Scale Syst, Baton Rouge, LA 70803 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Louisiana State University System; Louisiana State University; Roswell Park Cancer Institute	Batzer, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Biol Comp & Visualizat Ctr, Ctr Biomol Multi Scale Syst, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Liang, Ping/S-3790-2018; Liang, Ping/D-2709-2009; Han, Kyudong/AAF-1788-2019	Liang, Ping/0000-0003-4423-0636; Liang, Ping/0000-0003-4423-0636; Han, Kyudong/0000-0001-6791-2408	NATIONAL CANCER INSTITUTE [R03CA101515, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; NCI NIH HHS [R03 CA101515, P30 CA16056, P30 CA016056] Funding Source: Medline; NIGMS NIH HHS [R01 GM59290, R01 GM059290] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babcock M, 2003, GENOME RES, V13, P2519, DOI 10.1101/gr.1549503; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Brookfield JFY, 2001, CURR BIOL, V11, pR900, DOI 10.1016/S0960-9822(01)00547-4; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Carter Anthony B., 2004, Human Genomics, V1, P167; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; CORDAUX R, GENE; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Hackenberg M, 2005, J MOL EVOL, V60, P365, DOI 10.1007/s00239-004-0197-2; Hamaker H.C., 1978, J R STAT SOC C-APPL, V27, P76, DOI [https://doi.org/10.2307/2346231, DOI 10.2307/2346231]; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Hattori Y, 1999, HEMOGLOBIN, V23, P239, DOI 10.3109/03630269909005704; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; HUANG LS, 1989, J BIOL CHEM, V264, P11394; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levran O, 1998, HUM MUTAT, V12, P145, DOI 10.1002/(SICI)1098-1004(1998)12:3<145::AID-HUMU2>3.3.CO;2-S; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Lustig LR, 2002, CYTOGENET GENOME RES, V98, P154, DOI 10.1159/000069804; Marshall B, 1996, GENE, V174, P175, DOI 10.1016/0378-1119(96)00515-X; Martinez I, 2004, P NATL ACAD SCI USA, V101, P9976, DOI 10.1073/pnas.0403595101; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Otieno AC, 2004, J MOL BIOL, V342, P109, DOI 10.1016/j.jmb.2004.07.016; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Rohlfs EM, 2000, GENE CHROMOSOME CANC, V28, P300, DOI 10.1002/1098-2264(200007)28:3<300::AID-GCC8>3.0.CO;2-1; Rothberg PG, 1997, MOL CARCINOGEN, V19, P69, DOI 10.1002/(SICI)1098-2744(199707)19:2<69::AID-MC1>3.0.CO;2-G; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Szabo Z, 1999, J MOL EVOL, V49, P664, DOI 10.1007/PL00006587; Tvrdik T, 1998, HUM GENET, V103, P311, DOI 10.1007/s004390050822; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Wildman DE, 2003, P NATL ACAD SCI USA, V100, P7181, DOI 10.1073/pnas.1232172100; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	60	228	239	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					41	53		10.1086/504600	http://dx.doi.org/10.1086/504600			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773564	Green Published, Bronze			2022-12-18	WOS:000238341200005
J	Marchini, J; Cutler, D; Patterson, N; Stephens, M; Eskin, E; Halperin, E; Lin, S; Qin, ZS; Munro, HM; Abecasis, GR; Donnelly, P				Marchini, J; Cutler, D; Patterson, N; Stephens, M; Eskin, E; Halperin, E; Lin, S; Qin, ZS; Munro, HM; Abecasis, GR; Donnelly, P		Intl HapMap Consortium	A comparison of phasing algorithms for trios and unrelated individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPECTATION-MAXIMIZATION ALGORITHM; SINGLE-NUCLEOTIDE POLYMORPHISMS; MARKER LINKAGE DISEQUILIBRIUM; MAXIMUM-LIKELIHOOD-ESTIMATION; HUMAN GENOME; HAPLOTYPE RECONSTRUCTION; GENOTYPE DATA; RECOMBINATION RATES; DIPLOID POPULATIONS; INFERENCE	Knowledge of haplotype phase is valuable for many analysis methods in the study of disease, population, and evolutionary genetics. Considerable research effort has been devoted to the development of statistical and computational methods that infer haplotype phase from genotype data. Although a substantial number of such methods have been developed, they have focused principally on inference from unrelated individuals, and comparisons between methods have been rather limited. Here, we describe the extension of five leading algorithms for phase inference for handling father-mother-child trios. We performed a comprehensive assessment of the methods applied to both trios and to unrelated individuals, with a focus on genomic-scale problems, using both simulated data and data from the HapMap project. The most accurate algorithm was PHASE (v2.1). For this method, the percentages of genotypes whose phase was incorrectly inferred were 0.12%, 0.05%, and 0.16% for trios from simulated data, HapMap Centre d'Etude du Polymorphisme Humain (CEPH) trios, and HapMap Yoruban trios, respectively, and 5.2% and 5.9% for unrelated individuals in simulated data and the HapMap CEPH data, respectively. The other methods considered in this work had comparable but slightly worse error rates. The error rates for trios are similar to the levels of genotyping error and missing data expected. We thus conclude that all the methods considered will provide highly accurate estimates of haplotypes when applied to trio data sets. Running times differ substantially between methods. Although it is one of the slowest methods, PHASE (v2.1) was used to infer haplotypes for the 1 million-SNP HapMap data set. Finally, we evaluated methods of estimating the value of r(2) between a pair of SNPs and concluded that all methods estimated r(2) well when the estimated value was similar to 0.8.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02138 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Hebrew Univ Jerusalem, Dept Comp Sci, Jerusalem, Israel; Int Comp Sci Inst, Berkeley, CA USA; Univ Michigan, Dept Biostat, Ctr State Genet, Ann Arbor, MI 48109 USA	University of Oxford; Johns Hopkins University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Washington; University of Washington Seattle; Hebrew University of Jerusalem; University of Michigan System; University of Michigan	Marchini, J (corresponding author), Univ Oxford, Dept Stat, 1 S Pk Rd, Oxford OX1 3TG, England.	marchini@stats.ox.ac.uk	Abecasis, Goncalo R/B-7840-2010; Eskin, Eleazar/J-9187-2012; Qin, Zhaohui S/E-8196-2011; Qin, Zhaohui/Q-3133-2019; Marchini, Jonathan/ABE-9024-2020	Eskin, Eleazar/0000-0003-1149-4758; Qin, Zhaohui S/0000-0002-1583-146X; Qin, Zhaohui/0000-0002-1583-146X; Marchini, Jonathan/0000-0003-0610-8322; Lin, Shin/0000-0003-0118-0413; Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651, R01HG002585] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR008605, P41 RR08605] Funding Source: Medline; NHGRI NIH HHS [1R01HG/LM02585-01, HG02651, R01 HG002651] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; De Iorio M, 2004, ADV APPL PROBAB, V36, P434, DOI 10.1239/aap/1086957580; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eskin Eleazar, 2003, J Bioinform Comput Biol, V1, P1, DOI 10.1142/S0219720003000174; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fearnhead P, 2001, GENETICS, V159, P1299; Gusfield D, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P183; Gusfield D, 2001, J COMPUT BIOL, V8, P305, DOI 10.1089/10665270152530863; GUSFIELD D, 2003, P 6 ANN INT C COMP B; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HOPPE FM, 1987, J MATH BIOL, V25, P123, DOI 10.1007/BF00276386; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Lazzeroni LC, 2001, STAT METHODS MED RES, V10, P57, DOI 10.1191/096228001666442347; LEWONTIN RC, 1988, GENETICS, V120, P849; Li N, 2003, GENETICS, V165, P2213; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lin S, 2004, GENOME RES, V14, P1624, DOI 10.1101/gr.2204604; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; LONG JC, 1995, AM J HUM GENET, V56, P799; MACLEAN C J, 1985, Genetic Epidemiology, V2, P263, DOI 10.1002/gepi.1370020304; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morris AP, 2004, AM J HUM GENET, V74, P945, DOI 10.1086/420773; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers SR, 2003, GENETICS, V163, P375; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Salem Rany M., 2005, Human Genomics, V2, P39; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Weir B., 1996, GENETIC DATA ANAL; Zhang K, 2005, BIOINFORMATICS, V21, P90, DOI 10.1093/bioinformatics/bth388; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	49	228	234	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					437	450		10.1086/500808	http://dx.doi.org/10.1086/500808			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16465620	Green Published, Bronze			2022-12-18	WOS:000236747500011
J	Fisher, SE; Francks, C; McCracken, JT; McGough, JJ; Marlow, AJ; MacPhie, IL; Newbury, DF; Crawford, LR; Palmer, CGS; Woodward, JA; Del'Homme, M; Cantwell, DP; Nelson, SF; Monaco, AP; Smalley, SL				Fisher, SE; Francks, C; McCracken, JT; McGough, JJ; Marlow, AJ; MacPhie, IL; Newbury, DF; Crawford, LR; Palmer, CGS; Woodward, JA; Del'Homme, M; Cantwell, DP; Nelson, SF; Monaco, AP; Smalley, SL			A genomewide scan for loci involved in attention-deficit hyperactivity disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOPAMINE-D4 RECEPTOR GENE; QUANTITATIVE-TRAIT LOCUS; SUSCEPTIBILITY LOCI; TOURETTE-SYNDROME; COMPLEX TRAITS; SEVERE SPEECH; LINKAGE; ASSOCIATION; TWIN; POLYMORPHISM	Attention deficit/hyperactivity disorder (ADHD) is a common heritable disorder with a childhood onset. Molecular genetic studies of ADHD have previously focused on examining the roles of specific candidate genes, primarily those involved in dopaminergic pathways. We have performed the first systematic genomewide linkage scan for loci influencing ADHD in 126 affected sib pairs, using a similar to10-cM grid of microsatellite markers. Allele-sharing linkage methods enabled us to exclude any loci with a lambda(s) of greater than or equal to3 from 96% of the genome and those with a lambda(s) of greater than or equal to2.5 from 91%, indicating that there is unlikely to be a major gene involved in ADHD susceptibility in our sample. Under a strict diagnostic scheme we could exclude all screened regions of the X chromosome for a locus-specific lambda(s) of greater than or equal to2 in brother-brother pairs, demonstrating that the excess of affected males with ADHD is probably not attributable to a major X-linked effect. Qualitative trait maximum LOD score analyses pointed to a number of chromosomal sites that may contain genetic risk factors of moderate effect. None exceeded genomewide significance thresholds, but LOD scores were >1.5 for regions on 5p12, 10q26, 12q23, and 16p13. Quantitative-trait analysis of ADHD symptom counts implicated a region on 12p13 (maximum LOD 2.6) that also yielded a LOD>1 when qualitative methods were used. A survey of regions containing 36 genes that have been proposed as candidates for ADHD indicated that 29 of these genes, including DRD4 and DAT1, could be excluded for a lambda(s) of 2. Only three of the candidates-DRD5, 5HTT, and CALCYON-coincided with sites of positive linkage identified by our screen. Two of the regions highlighted in the present study, 2q24 and 16p13, coincided with the top linkage peaks reported by a recent genome-scan study of autistic sib pairs.	Univ Calif Los Angeles, Neuropsychiat Res Inst, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oxford; Wellcome Centre for Human Genetics	Smalley, SL (corresponding author), Univ Calif Los Angeles, Neuropsychiat Res Inst, Ctr Neurobehav Genet, 760 Westwood Plaza, Los Angeles, CA 90024 USA.	ssmalley@mednet.ucla.edu	Fisher, Simon E./E-9130-2012; Francks, Clyde/AGU-8875-2022; Francks, Clyde/E-1384-2012; Nelson, Stanley F/D-4771-2009; Monaco, Anthony P/A-4495-2010	Fisher, Simon E./0000-0002-3132-1996; Francks, Clyde/0000-0002-9098-890X; Nelson, Stanley F/0000-0002-2082-3114; Monaco, Anthony P/0000-0001-7480-3197	NIMH NIH HHS [MH58277, MH01966, K23 MH001966, R01 MH058277] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058277, K23MH001966] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Achenbach T., 2007, CBCL PROFILE SCORING; Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Barr CL, 2001, BIOL PSYCHIAT, V49, P333, DOI 10.1016/S0006-3223(00)01053-2; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Brown RT, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e43; Cantwell DP, 1996, J AM ACAD CHILD PSY, V35, P978, DOI 10.1097/00004583-199608000-00008; COOK EH, 1995, AM J HUM GENET, V56, P993; CORDELL HJ, 1995, ANN HUM GENET, V59, P435, DOI 10.1111/j.1469-1809.1995.tb00761.x; Curran S, 2001, MOL PSYCHIATR, V6, P425, DOI 10.1038/sj.mp.4000914; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eaves L, 2000, BEHAV GENET, V30, P321, DOI 10.1023/A:1026553518272; EDELBROCK C, 1995, J CHILD PSYCHOL PSYC, V36, P775, DOI 10.1111/j.1469-7610.1995.tb01328.x; Elston RC, 1997, AM J HUM GENET, V60, P255; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; FARAONE SV, 1992, PSYCHIATR GENET, V2, P257, DOI 10.1097/00041444-199210000-00004; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; FISHER SE, 2001, DYSLEXIA THEORY GOOD, P39; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gjone H, 1996, J AM ACAD CHILD PSY, V35, P588, DOI 10.1097/00004583-199605000-00013; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hollingshead A.B., 1957, 2 FACTOR INDEX SOCIA; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmes J, 2000, MOL PSYCHIATR, V5, P523, DOI 10.1038/sj.mp.4000751; Hudziak JJ, 1998, J AM ACAD CHILD PSY, V37, P848, DOI 10.1097/00004583-199808000-00015; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Manor I, 2001, AM J MED GENET, V105, P91; MARKWARDT FC, 1989, EXAMINERS MANUAL PEA; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; Merette C, 2000, AM J HUM GENET, V67, P1008, DOI 10.1086/303093; Mill J, 2001, MOL PSYCHIATR, V6, P440, DOI 10.1038/sj.mp.4000881; Newbury DF, 2002, AM J HUM GENET, V70, P384; Palferman S, 2001, AM J HUM GENET, V69, P570; Palmer CGS, 1999, PSYCHIATR GENET, V9, P157, DOI 10.1097/00041444-199909000-00009; Payton A, 2001, AM J MED GENET, V105, P464, DOI 10.1002/ajmg.1407; RISCH N, 1990, AM J HUM GENET, V46, P242; Scahill L, 2000, CHILD ADOL PSYCH CL, V9, P541; Sherman DK, 1997, J AM ACAD CHILD PSY, V36, P745, DOI 10.1097/00004583-199706000-00010; Simonic I, 2001, AM J MED GENET, V105, P163, DOI 10.1002/ajmg.1192; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; Smalley SL, 2000, J AM ACAD CHILD PSY, V39, P1135, DOI 10.1097/00004583-200009000-00013; Smalley SL, 1998, MOL PSYCHIATR, V3, P427, DOI 10.1038/sj.mp.4000457; Spencer T, 1996, J AM ACAD CHILD PSY, V35, P409, DOI 10.1097/00004583-199604000-00008; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Swanson JM., 1995, SNAP 4 SCALE; Thapar A, 2000, J AM ACAD CHILD PSY, V39, P1528, DOI 10.1097/00004583-200012000-00015; THAPAR A, 1995, BEHAV GENET, V25, P537, DOI 10.1007/BF02327577; Wechsler D., 1991, EXAMINERS MANUAL WEC; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Willcutt EG, 2000, AM J MED GENET, V96, P293, DOI 10.1002/1096-8628(20000612)96:3<293::AID-AJMG12>3.0.CO;2-C; Wolraich ML, 1996, J AM ACAD CHILD PSY, V35, P319, DOI 10.1097/00004583-199603000-00013	61	228	234	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1183	1196		10.1086/340112	http://dx.doi.org/10.1086/340112			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11923911	Green Published, Bronze			2022-12-18	WOS:000175012400009
J	Vincent, AL; Billingsley, G; Buys, Y; Levin, AV; Priston, M; Trope, G; Williams-Lyn, D; Heon, E				Vincent, AL; Billingsley, G; Buys, Y; Levin, AV; Priston, M; Trope, G; Williams-Lyn, D; Heon, E			Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; PRIMARY CONGENITAL GLAUCOMA; CYTOCHROME P4501B1 CYP1B1; DOMINANT IRIS HYPOPLASIA; RIEGER-SYNDROME; CLINICAL-FEATURES; ANTERIOR SEGMENT; MUTATIONS; LOCUS; IDENTIFICATION	"Early-onset glaucoma" refers to genetically heterogeneous conditions for which glaucoma manifests at age 5-40 years and for which only a small subset is molecularly characterized. We studied the role of MYOC, CYP1B1, and PITX2 in a population (n = 60) affected with juvenile or early-onset glaucoma from the greater Toronto area. By a combination of single-strand conformation polymorphism and direct cycle sequencing, MYOC mutations were detected in 8 (13.3%) of the 60 individuals, CYP1B1 mutations were detected in 3 (5%) of the 60 individuals, and no PITX2 mutations were detected. The range of phenotypic expression associated with MYOC and CYP1B1 mutations was greater than expected. MYOC mutations included cases of juvenile glaucoma with or without pigmentary glaucoma and mixed-mechanism glaucoma. CYP1B1 mutations involved cases of juvenile open-angle glaucoma, as well as cases of congenital glaucoma. The study of a family with autosomal dominant glaucoma showed the segregation of both MYOC and CYP1B1 mutations with disease; however, in this family, the mean age at onset of carriers of the MYOC mutation alone was 51 years (range 48-64 years), whereas carriers of both the MYOC and CYP1B1 mutations had an average age at onset of 27 years (range 23-38 years) (P = .001). This work emphasizes the genetic heterogeneity of juvenile glaucoma and suggests, for the first time, that (1) congenital glaucoma and juvenile glaucoma are allelic variants and (2) the spectrum of expression of MYOC and CYP1B1 mutations is greater than expected. We also propose that CYP1B1 may act as a modifier of MYOC expression and that these two genes may interact through a common pathway.	Univ Toronto, Toronto Western Hosp, Dept Ophthalmol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Univ Hlth Network, Vis Sci Res Program, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Heon, E (corresponding author), Univ Toronto, Toronto Western Hosp, Dept Ophthalmol, 399 Bathurst St,Room 6-412 MP, Toronto, ON M5T 2S8, Canada.		Vincent, Andrea L/A-5389-2013	Vincent, Andrea L/0000-0002-4185-3267				Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Aithal GP, 2001, GENES IMMUN, V2, P44, DOI 10.1038/sj.gene.6363730; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Andersen J, 1998, AM J HUM GENET, V63, pA279; Andersen JS, 1997, ARCH OPHTHALMOL-CHIC, V115, P384, DOI 10.1001/archopht.1997.01100150386012; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Buchs N, 2001, GENES IMMUN, V2, P222, DOI 10.1038/sj.gene.6363766; Craig JE, 2001, OPHTHALMOLOGY, V108, P1607, DOI 10.1016/S0161-6420(01)00654-6; Crespi CL, 1997, MUTAGENESIS, V12, P83, DOI 10.1093/mutage/12.2.83; Davies E, 2001, CLIN ENDOCRINOL, V54, P813, DOI 10.1046/j.1365-2265.2001.01264.x; DELUISE VP, 1983, SURV OPHTHALMOL, V28, P1, DOI 10.1016/0039-6257(83)90174-1; Doward W, 1999, J MED GENET, V36, P152; ELLIS OH, 1948, AM J OPHTHALMOL, V31, P1589, DOI 10.1016/S0002-9394(48)91298-7; ELSTAN J, 1997, PAEDIAT OPHTHALMOLOG, P252; Fautsch MP, 2000, INVEST OPHTH VIS SCI, V41, P4163; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Hanna IH, 2000, CANCER RES, V60, P3440; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; Heon E, 2000, INVEST OPHTH VIS SCI, V41, pS527; HEON E, 1995, HUM MOL GENET, V4, P1435, DOI 10.1093/hmg/4.8.1435; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Huang W, 2000, Ophthalmic Genet, V21, P155, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT155; Hulsman CAA, 2001, AM J EPIDEMIOL, V154, P138, DOI 10.1093/aje/154.2.138; Ingelman-Sundberg M, 2001, MUTAT RES-FUND MOL M, V482, P11, DOI 10.1016/S0027-5107(01)00205-6; Jazwinska-Tarnawska E, 2001, INT J CLIN PHARM TH, V39, P288; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; Kakiuchi-Matsumoto T, 2001, AM J OPHTHALMOL, V131, P345, DOI 10.1016/S0002-9394(00)00808-4; Kita T, 2001, PHARMACEUT RES, V18, P615, DOI 10.1023/A:1011025125163; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kubota R, 1998, BIOCHEM BIOPH RES CO, V242, P396, DOI 10.1006/bbrc.1997.7972; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; Li DN, 2000, PHARMACOGENETICS, V10, P343, DOI 10.1097/00008571-200006000-00008; Luch A, 1998, CHEM RES TOXICOL, V11, P686, DOI 10.1021/tx970236p; Martin SN, 2000, J MED GENET, V37, P422, DOI 10.1136/jmg.37.6.422; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murray GI, 2001, ANNU REV PHARMACOL, V41, P297, DOI 10.1146/annurev.pharmtox.41.1.297; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Noda S, 2000, BIOCHEM BIOPH RES CO, V276, P1129, DOI 10.1006/bbrc.2000.3591; Panicker SG, 2001, INVEST OPHTH VIS SCI, V42, pS530; Plasilova M, 1999, J MED GENET, V36, P290; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Priston M, 2001, HUM MOL GENET, V10, P1631, DOI 10.1093/hmg/10.16.1631; Rozsa F W, 1998, Mol Vis, V4, P20; Salmon JF, 1999, PROG RETIN EYE RES, V18, P121, DOI 10.1016/S1350-9462(98)00007-X; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Shimada T, 2001, XENOBIOTICA, V31, P163, DOI 10.1080/00498250110043490; Shimada T, 1996, CANCER RES, V56, P2979; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Shintani M, 2001, CLIN PHARMACOL THER, V70, P175, DOI 10.1067/mcp.2001.117367; Simm R M, 1999, Ophthalmic Genet, V20, P205, DOI 10.1076/opge.20.3.205.2279; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilov IR, 2001, INVEST OPHTH VIS SCI, V42, pS530; Stoilova D, 1998, J MED GENET, V35, P989, DOI 10.1136/jmg.35.12.989; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; SUTTER T, 1994, J BIOL CHEM, V169, P13092; Suzuki Y, 1997, AM J HUM GENET, V61, P1202, DOI 10.1086/301612; Talluto D, 1998, J GLAUCOMA, V7, P68; Tang YM, 2000, PHARMACOGENETICS, V10, P761, DOI 10.1097/00008571-200012000-00001; Taniguchi F, 1999, JPN J OPHTHALMOL, V43, P80, DOI 10.1016/S0021-5155(98)00074-4; Taniguchi F, 2000, JPN J OPHTHALMOL, V44, P445, DOI 10.1016/S0021-5155(00)00201-X; Vincent A, 2001, J MED GENET, V38, P324, DOI 10.1136/jmg.38.5.324; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221	72	228	241	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					448	460		10.1086/338709	http://dx.doi.org/10.1086/338709			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11774072	Green Published, Bronze			2022-12-18	WOS:000173254300016
J	Shaw, GM; Wasserman, CR; Lammer, EJ; OMalley, CD; Murray, JC; Basart, AM; Tolarova, MM				Shaw, GM; Wasserman, CR; Lammer, EJ; OMalley, CD; Murray, JC; Basart, AM; Tolarova, MM			Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL SMOKING; CONGENITAL-MALFORMATIONS; BIRTH-DEFECTS; ORAL CLEFTS; PALATE; LIP; PREGNANCY; ASSOCIATION; POPULATION; CONSUMPTION	Results of studies to determine whether women who smoke during early pregnancy are at increased risk of delivering infants with orofacial clefts have been mixed, and recently a gene-environment interaction between maternal smoking, transforming growth factor-alpha (TGFa), and clefting has been reported. Using a large population-based case-control study, we investigated whether parental periconceptional cigarette smoking was associated with an increased risk for having offspring with orofacial clefts. We also investigated the influence of genetic variation of the TGFa locus on the relation between smoking and clefting. Parental smoking information was obtained from telephone interviews with mothers of 731 (84.7% of eligible) orofacial cleft case infants and with mothers of 734 (78.2%) nonmalformed control infants. DNA was obtained from newborn screening blood spots and genotyped for the allelic variants of TGFa. We found that risks associated with maternal smoking were most elevated for isolated cleft lip with our without cleft palate, (odds ratio 2.1 [95% confidence interval 1.3-3.6]) and for isolated cleft palate (odds ratio 2.2 [1.1-4.5]) when mothers smoked greater than or equal to 20 cigarettes/d. Analyses controlling for the potential influence of other variables did not reveal substantially different results. Clefting risks were even greater for infants with the TGFa allele previously associated with clefting whose mothers smoked greater than or equal to 20 cigarettes/d. These risks for white infants ranged from 3-fold to Ii-fold across phenotypic groups. Paternal smoking was not associated with clefting among the offspring of nonsmoking mothers, and passive smoke exposures were associated with at most slightly increased risks. This study offers evidence that the risk for orofacial clefting in infants may be influenced by maternal smoke exposures alone as well as in combination (gene-environment interaction) with the presence of the uncommon TGFa allele.	CHILDRENS HOSP OAKLAND, DIV MED GENET, OAKLAND, CA USA; UNIV IOWA, DIV MED GENET, IOWA CITY, IA 52242 USA; UNIV IOWA, DIV NEONATOL, IOWA CITY, IA 52242 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Iowa; University of Iowa	Shaw, GM (corresponding author), MARCH DIMES BIRTH DEFECTS FDN, CALIF BIRTH DEFECTS MONITORING PROGRAM, 1900 POWELL ST, SUITE 1050, EMERYVILLE, CA 94608 USA.			Reis, AlessanRSS/0000-0001-8486-7469; Shaw, Gary/0000-0001-7438-4914				ANDREWS J, 1972, J OBSTET GYN BR COMM, V79, P1057; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; ASTRUP P, 1972, LANCET, V2, P1220; BASART AM, 1994, HUM MOL GENET, V3, P678, DOI 10.1093/hmg/3.4.678-a; BRONSKY PT, 1986, J CRAN GENET DEV BIO, P113; CARMICHAEL NG, 1982, HUM TOXICOL, V1, P159, DOI 10.1177/096032718200100209; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; Croen L A, 1991, Paediatr Perinat Epidemiol, V5, P423, DOI 10.1111/j.1365-3016.1991.tb00728.x; CZEIZEL A, 1986, Acta Paediatrica Hungarica, V27, P145; DIXON MJ, 1991, ANAT EMBRYOL, V184, P83, DOI 10.1007/BF01744264; DRUCKREY H, 1966, NATURE, V210, P1378, DOI 10.1038/2101378a0; EMANUEL I, 1973, TERATOLOGY, V7, P271, DOI 10.1002/tera.1420070308; ERICSON A, 1979, AM J OBSTET GYNECOL, V135, P348, DOI 10.1016/0002-9378(79)90703-8; EVANS DR, 1979, BRIT MED J, V2, P171, DOI 10.1136/bmj.2.6183.171; Fogh-Andersen P., 1967, SCAND J PLAST RECONS, V1, P22, DOI 10.3109/02844316709006555; FOX SH, 1994, AM J EPIDEMIOL, V139, P1008, DOI 10.1093/oxfordjournals.aje.a116940; FOX SH, 1987, PUBLIC HEALTH REP, V102, P73; GIVELBER HM, 1969, CANCER RES, V29, P1151; Gorlin RJ, 1990, PLAST RECONSTR SURG; Hanson JW, 1990, MULTIDISCIPLINARY MA, P121; HATCH MC, 1991, AM J EPIDEMIOL, V133, P826, DOI 10.1093/oxfordjournals.aje.a115962; HAYWARD NK, 1987, NUCLEIC ACIDS RES, V15, P5503, DOI 10.1093/nar/15.13.5503; HEMMINKI K, 1983, AM J OBSTET GYNECOL, V145, P61, DOI 10.1016/0002-9378(83)90340-X; HOLDER SE, 1992, J MED GENET, V29, P390, DOI 10.1136/jmg.29.6.390; HWANG SJ, 1995, AM J EPIDEMIOL, V141, P629, DOI 10.1093/oxfordjournals.aje.a117478; KELSEY JL, 1978, J EPIDEMIOL COMMUN H, V32, P102, DOI 10.1136/jech.32.2.102; KHOURY MJ, 1987, AM J PUBLIC HEALTH, V77, P623, DOI 10.2105/AJPH.77.5.623; KHOURY MJ, 1989, AM J DIS CHILD, V143, P333, DOI 10.1001/archpedi.1989.02150150091023; LAMBERT GH, 1977, TERATOLOGY, V16, P147, DOI 10.1002/tera.1420160206; LONGO LD, 1982, BIRTH DEFECTS-ORIG, V18, P13; MALLOY MH, 1989, AM J PUBLIC HEALTH, V79, P1243, DOI 10.2105/AJPH.79.9.1243; MANCHESTER D, 1984, TERATOLOGY, V30, P31, DOI 10.1002/tera.1420300105; MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P91, DOI 10.2105/AJPH.82.1.91; MILLICOVSKY G, 1981, P NATL ACAD SCI-BIOL, V78, P5722, DOI 10.1073/pnas.78.9.5722; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; QIAN JF, 1993, AM J HUM GENET, V53, P168; SASSANI R, 1993, AM J MED GENET, V45, P565, DOI 10.1002/ajmg.1320450508; SAVITZ DA, 1991, TERATOLOGY, V44, P429, DOI 10.1002/tera.1420440409; SAXEN I, 1975, BRIT J PREV SOC MED, V29, P103; SAXEN I, 1974, INT J EPIDEMIOL, V3, P263, DOI 10.1093/ije/3.3.263; SCHWARTZ EI, 1990, LANCET, V336, P639, DOI 10.1016/0140-6736(90)93446-V; SEIDMAN DS, 1990, OBSTET GYNECOL, V76, P1046; SELVIN S, 1991, STATISTICAL ANAL EPI; SHAW GM, 1995, LANCET, V346, P393, DOI 10.1016/S0140-6736(95)92778-6; SHAW GM, 1991, TERATOLOGY, V43, P225, DOI 10.1002/tera.1420430306; SHIANG R, 1993, AM J HUM GENET, V53, P836; SHIONO PH, 1986, TERATOLOGY, V34, P65, DOI 10.1002/tera.1420340109; UPSHALL DG, 1972, TERATOLOGY, V5, P287, DOI 10.1002/tera.1420050303; Van den Eeden S K, 1990, Paediatr Perinat Epidemiol, V4, P147; WERLER MM, 1990, AM J EPIDEMIOL, V132, P926, DOI 10.1093/oxfordjournals.aje.a115735; WINDHAM GC, 1992, AM J EPIDEMIOL, V135, P1394, DOI 10.1093/oxfordjournals.aje.a116250; WITTER FR, 1982, AM J OBSTET GYNECOL, V144, P857, DOI 10.1016/0002-9378(82)90369-6; ZHANG J, 1992, INT J EPIDEMIOL, V21, P273, DOI 10.1093/ije/21.2.273; 1991, STATISTICS EPIDEMIOL	55	228	242	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					551	561						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	TV564	8644715				2022-12-18	WOS:A1996TV56400014
J	Kalscheuer, VM; Tao, J; Donnelly, A; Hollway, G; Schwinger, E; Kubart, S; Menzel, C; Hoeltzenbein, M; Tommerup, N; Eyre, H; Harbord, M; Haan, E; Sutherland, GR; Ropers, HH; Gecz, J				Kalscheuer, VM; Tao, J; Donnelly, A; Hollway, G; Schwinger, E; Kubart, S; Menzel, C; Hoeltzenbein, M; Tommerup, N; Eyre, H; Harbord, M; Haan, E; Sutherland, GR; Ropers, HH; Gecz, J			Disruption of the Serine/Threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMEOBOX GENE; MOLECULAR-CLONING; PROTEIN-KINASE; ARX; IDENTIFICATION; KKIAMRE; MUTATIONS; EPILEPSY; LINKAGE; FAMILY	X-linked West syndrome, also called "X-linked infantile spasms" (ISSX), is characterized by early-onset generalized seizures, hvpsarrhythmia, and mental retardation. Recently, we have shown that the majority of the X-linked families with infantile spasms carry mutations in the aristaless-related homeobox gene (ARX), which maps to the Xp21.3-p22.1 interval, and that the clinical picture in these patients can vary from mild mental retardation to severe ISSX with additional neurological abnormalities. Here, we report a study of two severely affected female patients with apparently de novo balanced X;autosome translocations, both disrupting the serine-threonine kinase 9 (STK9) gene, which maps distal to ARX in the Xp22.3 region. We show that STK9 is subject to X-inactivation in normal female somatic cells and is functionally absent in the two patients, because of preferential inactivation of the normal X. Disruption of the same gene in two unrelated patients who have identical phenotypes (consisting of early-onset severe infantile spasms, profound global developmental arrest, hypsarrhythmia, and severe mental retardation) strongly suggests that lack of functional STK9 protein causes severe ISSX and that STK9 is a second X-chromosomal locus for this disorder.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA, Australia; Womens & Childrens Hosp, Dept Neurol, Adelaide, SA, Australia; Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA, Australia; Univ Adelaide, Dept Pediat, Adelaide, SA, Australia; Inst Human Genet, Lubeck, Germany; Univ Copenhagen, Panum Inst, Wilhelm Johannsen Ctr Funct Genome Res, Inst Med Biochem & Genet, DK-2200 Copenhagen, Denmark	Max Planck Society; Womens & Childrens Hospital Australia; Womens & Childrens Hospital Australia; Womens & Childrens Hospital Australia; University of Adelaide; University of Copenhagen	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.		Sutherland, Grant Robert/D-2606-2012; Tommerup, Niels/T-8776-2017; Hoeltzenbein, Maria/B-1134-2016; Gecz, Jozef/X-3469-2019; Hoeltzenbein, Maria/AAP-4145-2020; Hollway, Georgina E/E-6764-2010	Tommerup, Niels/0000-0003-2304-0112; Hoeltzenbein, Maria/0000-0002-2451-4247; Gecz, Jozef/0000-0002-7884-6861; Hoeltzenbein, Maria/0000-0002-2451-4247; Kalscheuer, Vera/0000-0001-6898-3259; Harbord, Michael/0000-0002-3128-4670				Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Brunner B, 1999, GENOME RES, V9, P437; Bruyere H, 1999, CLIN GENET, V55, P173, DOI 10.1034/j.1399-0004.1999.550305.x; Claes S, 1997, ANN NEUROL, V42, P360, DOI 10.1002/ana.410420313; DUTRILLAUX B, 1981, HUM GENET, V57, P93; Gecz J, 1997, GENOMICS, V44, P201, DOI 10.1006/geno.1997.4867; GIACALONE JP, 1992, AM J HUM GENET, V50, P725; Gomi H, 1999, J NEUROSCI, V19, P9530; Huopaniemi L, 2000, HUM MUTAT, V16, P307, DOI 10.1002/1098-1004(200010)16:4<307::AID-HUMU3>3.0.CO;2-L; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Nothwang HG, 2000, CYTOGENET CELL GENET, V90, P126, DOI 10.1159/000015647; Sassa T, 2000, J NEUROCHEM, V74, P1809, DOI 10.1046/j.1471-4159.2000.0741809.x; Scheffer IE, 2002, NEUROLOGY, V59, P348, DOI 10.1212/WNL.59.3.348; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Stromme P, 1999, J MED GENET, V36, P374; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Taglienti CA, 1996, ONCOGENE, V13, P2563; Warneke-Wittstock R, 1998, GENOMICS, V51, P59, DOI 10.1006/geno.1998.5382; Wirth J, 1999, J MED GENET, V36, P271; Wong M, 2001, PEDIATR NEUROL, V24, P89, DOI 10.1016/S0887-8994(00)00238-1; YEN SH, 1995, J NEUROCHEM, V65, P2577	24	227	243	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1401	1411		10.1086/375538	http://dx.doi.org/10.1086/375538			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12736870	Bronze, Green Published			2022-12-18	WOS:000183275500004
J	Bamshad, MJ; Wooding, S; Watkins, WS; Ostler, CT; Batzer, MA; Jorde, LB				Bamshad, MJ; Wooding, S; Watkins, WS; Ostler, CT; Batzer, MA; Jorde, LB			Human population genetic structure and inference of group membership	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS GENOTYPES; HUMAN-DIVERSITY; RACE; MITOCHONDRIAL; PATTERNS; ORIGINS	A major goal of biomedical research is to develop the capability to provide highly personalized health care. To do so, it is necessary to understand the distribution of interindividual genetic variation at loci underlying physical characteristics, disease susceptibility, and response to treatment. Variation at these loci commonly exhibits geographic structuring and may contribute to phenotypic differences between groups. Thus, in some situations, it may be important to consider these groups separately. Membership in these groups is commonly inferred by use of a proxy such as place-of-origin or ethnic affiliation. These inferences are frequently weakened, however, by use of surrogates, such as skin color, for these proxies, the distribution of which bears little resemblance to the distribution of neutral genetic variation. Consequently, it has become increasingly controversial whether proxies are sufficient and accurate representations of groups inferred from neutral genetic variation. This raises three questions: how many data are required to identify population structure at a meaningful level of resolution, to what level can population structure be resolved, and do some proxies represent population structure accurately? We assayed 100 Alu insertion polymorphisms in a heterogeneous collection of similar to565 individuals, similar to200 of whom were also typed for 60 microsatellites. Stripped of identifying information, correct assignment to the continent of origin (Africa, Asia, or Europe) with a mean accuracy of at least 90% required a minimum of 60 Alu markers or microsatellites and reached 99%-100% when greater than or equal to100 loci were used. Less accurate assignment (87%) to the appropriate genetic cluster was possible for a historically admixed sample from southern India. These results set a minimum for the number of markers that must be tested to make strong inferences about detecting population structure among Old World populations under ideal experimental conditions. We note that, whereas some proxies correspond crudely, if at all, to population structure, the heuristic value of others is much higher. This suggests that a more flexible framework is needed for making inferences about population structure and the utility of proxies.	Univ Utah, Dept Pediat, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, Baton Rouge, LA 70803 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Louisiana State University System; Louisiana State University	Bamshad, MJ (corresponding author), Univ Utah, Dept Pediat, Eccles Inst Human Genet, 15 North 2030 East, Salt Lake City, UT 84112 USA.	mike@genetics.utah.edu			NCRR NIH HHS [RR-00064, M01 RR000064] Funding Source: Medline; NIGMS NIH HHS [GM-59290, R01 GM059290] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aspinall PJ, 1998, SOC SCI MED, V47, P1797, DOI 10.1016/S0277-9536(98)00239-1; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; COOPER RS, 1994, PUBLIC HEALTH REP, V109, P46; Evett IW, 1996, AM J HUM GENET, V58, P398; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Goodman AH, 2000, AM J PUBLIC HEALTH, V90, P1699, DOI 10.2105/AJPH.90.11.1699; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; JORDE LB, 1995, AM J HUM GENET, V57, P523; Laveist Thomas A., 1996, Ethnicity and Disease, V6, P21; Lee S S, 2001, Yale J Health Policy Law Ethics, V1, P33; Lewis PO, 2001, GENETIC DATA ANAL GD; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; PerezLezaun A, 1997, HUM GENET, V99, P1; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; REED TE, 1973, NATURE, V244, P575, DOI 10.1038/244575a0; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2001, GENETICS, V159, P699; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shriver MD, 1997, AM J HUM GENET, V60, P957; SLATKIN M, 1995, GENETICS, V139, P457; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Thio CL, 2001, J INFECT DIS, V184, P16, DOI 10.1086/321005; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; WIJSMAN EM, 1986, AFRICAN PYGMIES, P347; Williams DR, 1997, ANN EPIDEMIOL, V7, P322, DOI 10.1016/S1047-2797(97)00051-3; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008	37	227	233	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					578	589		10.1086/368061	http://dx.doi.org/10.1086/368061			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12557124	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000181152600008
J	Schmidt, LS; Warren, MB; Nickerson, ML; Weirich, G; Matrosova, V; Toro, JR; Turner, ML; Duray, P; Merino, M; Hewitt, S; Pavlovich, CP; Glenn, G; Greenberg, CR; Linehan, WM; Zbar, B				Schmidt, LS; Warren, MB; Nickerson, ML; Weirich, G; Matrosova, V; Toro, JR; Turner, ML; Duray, P; Merino, M; Hewitt, S; Pavlovich, CP; Glenn, G; Greenberg, CR; Linehan, WM; Zbar, B			Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY MULTIPLE FIBROFOLLICULOMAS; SMITH-MAGENIS MICRODELETION; MULTILOCUS LINKAGE ANALYSIS; HOMOLOGOUS RECOMBINATION; UNSTABLE REGION; GENE; ACROCHORDONS; PROTEIN; TRICHODISCOMAS; IDENTIFICATION	Birt-Hogg-Dube' syndrome (BHD), an inherited autosomal genodermatosis characterized by benign tumors of the hair follicle, has been associated with renal neoplasia, lung cysts, and spontaneous pneumothorax. To identify the BHD locus, we recruited families with cutaneous lesions and associated phenotypic features of the BHD syndrome. We performed a genomewide scan in one large kindred with BHD and, by linkage analysis, localized the gene locus to the pericentromeric region of chromosome 17p, with a LOD score of 4.98 at D17S740 (recombination fraction 0). Two-point linkage analysis of eight additional families with BHD produced a maximum LOD score of 16.06 at D17S2196. Haplotype analysis identified critical recombinants and defined the minimal region of nonrecombination as being within a <4-cM distance between D17S1857 and D17S805. One additional family, which had histologically proved fibrofolliculomas, did not show evidence of linkage to chromosome 17p, suggesting genetic heterogeneity for BHD. The BHD locus lies within chromosomal band 17p11.2, a genomic region that, because of the presence of low-copy-number repeat elements, is unstable and that is associated with a number of diseases. Identification of the gene for BHD may reveal a new genetic locus responsible for renal neoplasia and for lung and hair-follicle developmental defects.	Natl Canc Inst, Intramural Res Support Program, IRSP, SAIC, Frederick, MD 21702 USA; Natl Canc Inst, Immunobiol Lab, Frederick, MD 21702 USA; Natl Canc Inst, Natl Inst Hlth, Dermatol Branch, Bethesda, MD USA; Natl Canc Inst, Natl Inst Hlth, Genet Epidemiol Branch, Bethesda, MD USA; Natl Canc Inst, Natl Inst Hlth, Pathol Lab, Bethesda, MD USA; Natl Canc Inst, Natl Inst Hlth, Urolog Oncol Branch, Bethesda, MD USA; Tech Univ Munich, Inst Pathol, Munich, Germany; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Technical University of Munich; University of Manitoba; University of Manitoba	Schmidt, LS (corresponding author), Natl Canc Inst, Intramural Res Support Program, IRSP, SAIC, Bldg 560, Room 12-69, Frederick, MD 21702 USA.		Matrosova, Vera/AAX-4125-2020	Hewitt, Stephen/0000-0001-8283-1788	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; CHEN KS, 1995, AM J HUM GENET, V56, P175; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Chung JY, 1996, INT J DERMATOL, V35, P365, DOI 10.1111/j.1365-4362.1996.tb03642.x; COHEN PR, 1995, DERMATOL CLIN, V13, P211, DOI 10.1016/S0733-8635(18)30121-9; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELSEA SH, 1995, AM J HUM GENET, V57, P1342; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; RONGIOLETTI F, 1989, CLIN EXP DERMATOL, V14, P72, DOI 10.1111/j.1365-2230.1989.tb00890.x; ROTH JS, 1993, J AM ACAD DERMATOL, V29, P1055, DOI 10.1016/S0190-9622(08)82049-X; Scalvenzi M, 1998, J EUR ACAD DERMATOL, V11, P45, DOI 10.1111/j.1468-3083.1998.tb00952.x; Scheurlen WG, 1999, GENE CHROMOSOME CANC, V25, P230, DOI 10.1002/(SICI)1098-2264(199907)25:3<230::AID-GCC5>3.0.CO;2-E; Scheurlen WG, 1997, GENE CHROMOSOME CANC, V18, P50, DOI 10.1002/(SICI)1098-2264(199701)18:1<50::AID-GCC6>3.0.CO;2-0; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seranski P, 1999, GENOMICS, V56, P1, DOI 10.1006/geno.1998.5647; STRAND D, 1995, ONCOGENE, V11, P291; Toro JR, 1999, ARCH DERMATOL, V135, P1195, DOI 10.1001/archderm.135.10.1195; Walkey CJ, 1999, BBA-MOL CELL BIOL L, V1436, P405, DOI 10.1016/S0005-2760(98)00147-7; Weirich G, 1998, J UROLOGY, V160, P335, DOI 10.1016/S0022-5347(01)62888-X; Wilgenbus KK, 1997, GENOMICS, V42, P1, DOI 10.1006/geno.1997.4707	28	227	235	1	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					876	882		10.1086/323744	http://dx.doi.org/10.1086/323744			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11533913	Bronze, Green Published			2022-12-18	WOS:000171008200020
J	Koprivica, V; Stone, DL; Park, JK; Callahan, M; Frisch, A; Cohen, IJ; Tayebi, N; Sidransky, E				Koprivica, V; Stone, DL; Park, JK; Callahan, M; Frisch, A; Cohen, IJ; Tayebi, N; Sidransky, E			Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID BETA-GLUCOSIDASE; NON-JEWISH PATIENTS; GLUCOCEREBROSIDASE GENE; GENOTYPE/PHENOTYPE CORRELATIONS; PHENOTYPIC VARIATION; MUTATION PROFILE; IDENTIFICATION; EXPRESSION; PSEUDOGENE; DEFICIENCY	Gaucher disease results from the inherited deficiency of the enzyme glucocerebrosidase (EC 3.2.1.45). Although >100 mutations in the gene for human glucocerebrosidase have been described, most genotype-phenotype studies have focused upon screening for a few common mutations. In this study, we used several approaches-including direct sequencing, Southern blotting, long-template PCR, restriction digestions, and the amplification refraction mutation system (ARMS)-to genotype 128 patients with type 1 Gaucher disease (64 of Ashkenazi Jewish ancestry and 64 of non-Jewish extraction) and 24 patients with type 3 Gaucher disease. More than 97% of the mutant alleles were identified. Fourteen novel mutations (A90T, N117D, T134I, Y135X, R170C, W184R, A190T, Y304X, A341T, D399Y, c.153-154insTACAGC, c.203-204insC, c.222-224delTAC, and c.1122-1123insTG) and many rare mutations were detected. Recombinant alleles were found in 19% of the patients. Although 93% of the mutant alleles in our Ashkenazi Jewish type 1 patients were N370S, c.84-85insG, IVS2+1G-->A or L444P, these four mutations accounted for only 49% of mutant alleles in the non-Jewish type 1 patients. Genotype-phenotype correlations were attempted, Homozygosity or heterozygosity for N370S resulted in type 1 Gaucher disease, whereas homozygosity for L444P was associated with type 3. Genotype L444P/recombinant allele resulted in type 2 Gaucher disease, and homozygosity for a recombinant allele was associated with perinatal lethal disease. The phenotypic consequences of other mutations, particularly R463C, were more inconsistent. Our results demonstrate a high rate of mutation detection, a large number of novel and rare mutations, and an accurate assessment of the prevalence of recombinant alleles, Although some genotype-phenotype correlations do exist, other genetic and environmental factors must also contribute to the phenotypes encountered, and we caution against relying solely upon genotype for prognostic or therapeutic judgements.	NIMH, Clin Neurosci Branch, NIH, Bethesda, MD 20892 USA; Tel Aviv Univ, Rabin Med Ctr, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Schneiders Childrens Med Ctr Israel, Rabin Med Ctr, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Sidransky, E (corresponding author), NIMH, Clin Neurosci Branch, NIH, Bldg 49,Room B1EE16,49 Convent Dr,MSC4405, Bethesda, MD 20892 USA.	sidranse@irp.nimh.nih.gov	Cohen, Ian/H-3358-2013	Park, Joseph/0000-0003-1699-3951	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002667] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAMOV A, 1995, LANCET, V346, P1000, DOI 10.1016/S0140-6736(95)91688-1; AMARAL O, 1993, BIOCHEM MED METAB B, V49, P97, DOI 10.1006/bmmb.1993.1011; Amaral O, 1999, CLIN GENET, V56, P100, DOI 10.1034/j.1399-0004.1999.560117.x; Azuri J, 1998, GENET TEST, V2, P297, DOI 10.1089/gte.1998.2.297; BEUTLER E, 1993, BRIT J HAEMATOL, V85, P401, DOI 10.1111/j.1365-2141.1993.tb03185.x; BEUTLER E, 1992, BLOOD, V79, P1662; Beutler E, 1998, BLOOD CELL MOL DIS, V24, P2, DOI 10.1006/bcmd.1998.0165; Choy FYM, 1996, AM J MED GENET, V65, P184, DOI 10.1002/(SICI)1096-8628(19961028)65:3<184::AID-AJMG3>3.3.CO;2-R; Choy FYM, 1999, AM J MED GENET, V84, P484, DOI 10.1002/(SICI)1096-8628(19990611)84:5<484::AID-AJMG14>3.0.CO;2-W; Cox TM, 1997, BAILLIERE CLIN HAEM, V10, P657, DOI 10.1016/S0950-3536(97)80033-9; DAHL N, 1990, AM J HUM GENET, V47, P275; Diaz A, 1999, AM J HUM GENET, V64, P1233, DOI 10.1086/302341; DIAZ GA, 1998, AM J HUM GENET S, V63, pA211; ERIKSON A, 1986, ACTA PAEDIATR SCAND, P1; Estivill X, 1996, NAT GENET, V12, P348, DOI 10.1038/ng0496-348; Eto Y, 1999, NEUROCHEM RES, V24, P207, DOI 10.1023/A:1022553819241; Germain DP, 1998, AM J HUM GENET, V63, P415, DOI 10.1086/301969; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; Grabowski GA, 2000, PRENATAL DIAG, V20, P60, DOI 10.1002/(SICI)1097-0223(200001)20:1<60::AID-PD763>3.3.CO;2-I; Grace ME, 1997, J CLIN INVEST, V99, P2530, DOI 10.1172/JCI119437; Grace ME, 1999, J CLIN INVEST, V103, P817, DOI 10.1172/JCI5168; Gurakan F, 1999, J INHERIT METAB DIS, V22, P947, DOI 10.1023/A:1005668230365; Hatton CE, 1997, ARCH DIS CHILD, V77, P17, DOI 10.1136/adc.77.1.17; Hodanova K, 1999, BLOOD CELL MOL DIS, V25, P287, DOI 10.1006/bcmd.1999.0256; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Ida H, 1999, HUM GENET, V105, P120, DOI 10.1007/s004390051073; KAWAME H, 1993, HUM MUTAT, V2, P362, DOI 10.1002/humu.1380020507; Kim JW, 1996, HUM MUTAT, V7, P214, DOI 10.1002/(SICI)1098-1004(1996)7:3<214::AID-HUMU5>3.0.CO;2-A; Lau EK, 1999, HUM GENET, V104, P293, DOI 10.1007/s004390050957; LAUBSCHER KH, 1994, HUM MUTAT, V3, P411, DOI 10.1002/humu.1380030418; MISTRY PK, 1992, LANCET, V339, P889, DOI 10.1016/0140-6736(92)90928-V; MORIMOTO S, 1990, P NATL ACAD SCI USA, V87, P3493, DOI 10.1073/pnas.87.9.3493; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Orvisky E, 1999, AM J HUM GENET, V65, pA427; Pampols T, 1999, ACTA NEUROPATHOL, V97, P91, DOI 10.1007/s004010050960; PasmanikChor M, 1997, HUM MOL GENET, V6, P887, DOI 10.1093/hmg/6.6.887; Perlmutter DH, 1998, SEMIN LIVER DIS, V18, P217, DOI 10.1055/s-2007-1007158; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; SIDRANSKY E, 1994, HUM MUTAT, V3, P25, DOI 10.1002/humu.1380030105; Stone DL, 2000, HUM MUTAT, V15, P181, DOI 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S; STONE DL, IN PRESS J MED GENET; Tayebi N, 1999, MOL GENET METAB, V68, P209, DOI 10.1006/mgme.1999.2918; Tayebi N, 1999, AM J HUM GENET, V65, pA493; Tayebi N, 1998, PEDIATR RES, V43, P571, DOI 10.1203/00006450-199805000-00003; Tayebi N, 1996, AM J HUM GENET, V59, P740; Tayebi N, 1996, AM J MED GENET, V66, P316, DOI 10.1002/(SICI)1096-8628(19961218)66:3<316::AID-AJMG15>3.0.CO;2-P; Timms KM, 1997, HUM MOL GENET, V6, P479, DOI 10.1093/hmg/6.3.479; Uyama E, 1997, J MED GENET, V34, P175, DOI 10.1136/jmg.34.2.175; Winfield SL, 1997, GENOME RES, V7, P1020, DOI 10.1101/gr.7.10.1020; Zimmer KP, 1999, J PATHOL, V188, P407	52	227	241	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1777	1786		10.1086/302925	http://dx.doi.org/10.1086/302925			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10796875	Bronze, Green Published			2022-12-18	WOS:000088373800006
J	Karafet, TM; Zegura, SL; Posukh, O; Osipova, L; Bergen, A; Long, J; Goldman, D; Klitz, W; Harihara, S; de Knijff, P; Wiebe, V; Griffiths, RC; Templeton, AR; Hammer, MF				Karafet, TM; Zegura, SL; Posukh, O; Osipova, L; Bergen, A; Long, J; Goldman, D; Klitz, W; Harihara, S; de Knijff, P; Wiebe, V; Griffiths, RC; Templeton, AR; Hammer, MF			Ancestral Asian source(s) of New World Y-chromosome founder haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA ANALYSIS; NATIVE-AMERICAN; MTDNA VARIATION; POPULATIONS; ORIGIN; NORTH; POLYMORPHISMS; AFFINITIES; EVOLUTION; LINEAGES	Haplotypes constructed from Y-chromosome markers were used to trace the origins of Native Americans. Our sample consisted of 2,198 males from 60 global populations, including 19 Native American and 15 indigenous North Asian groups. A set of 12 biallelic polymorphisms gave rise to 14 unique Y-chromosome haplotypes that were unevenly distributed among the populations. Combining multiallelic variation at two Y-linked microsatellites (DYS19 and DXYS156Y) with the unique haplotypes results in a total of 95 combination haplotypes. Contra previous findings based on Y- chromosome data, our new results suggest the possibility of more than one Native American paternal founder haplotype. We postulate that, of the nine unique haplotypes found in Native Americans, haplotypes 1C and 1F are the best candidates for major New World founder haplotypes, whereas haplotypes 1B, 1I, and 1U may either be founder haplotypes and/or have arrived in the New World via recent admixture. Two of the other four haplotypes (YAP(+) haplotypes 4 and 5) are probably present because of post-Columbian admixture, whereas haplotype 1G may have originated in the New World, and the Old World source of the final New World haplotype (1D) remains unresolved. The contrasting distribution patterns of the two major candidate founder haplotypes in Asia and the New World, as well as the results of a nested cladistic analysis, suggest the possibility of more than one paternal migration from the general region of Lake Baikal to the Americas.	Univ Arizona, Lab Mol Systemat & Evoulut, Tucson, AZ 85721 USA; Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA; Russian Acad Sci, Inst Cytol & Genet, Lab Human Mol & Evolut Genet, Novosibirsk 630090, Russia; NIAAA, Sect Populat Genet & Linkage, NIH, Bethesda, MD USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Tokyo, Dept Biol Sci, Tokyo, Japan; Leiden Univ, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Monash Univ, Dept Math, Clayton, Vic 3168, Australia	University of Arizona; University of Arizona; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of California System; University of California Berkeley; University of Tokyo; Leiden University; Leiden University - Excl LUMC; Washington University (WUSTL); Monash University	Hammer, MF (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Biosci W, Tucson, AZ 85721 USA.	mhammer@u.arizona.edu	Osipova, Ludmila P/O-6480-2014; Posukh, Olga L/Q-6065-2016; Majid, Salma/AAT-2616-2020; de Knijff, Peter/Y-2519-2018; Griffiths, Robert/AAT-8278-2021; Goldman, David/F-9772-2010; Templeton, Alan R./F-5963-2011	Osipova, Ludmila P/0000-0001-7602-1156; Posukh, Olga L/0000-0003-1352-3591; Majid, Salma/0000-0002-1724-5405; de Knijff, Peter/0000-0002-0899-771X; Griffiths, Robert/0000-0001-7190-5104; Goldman, David/0000-0002-1724-5405; Bergen, Andrew/0000-0002-1237-7644; Templeton, Alan/0000-0002-0167-845X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000281, Z01AA000295, Z01AA000281, Z01AA000017] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; BERGEN A, IN PRESS ANN HUM GEN; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Forster P, 1996, AM J HUM GENET, V59, P935; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Greenberg Joseph H., 1996, P525; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; HAJDU P, 1975, FINNOUGARIAN LANGUAG; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Karafet T, 1998, HUM BIOL, V70, P979; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; KARAFET T, 1999, MICROSATELLITES EVOL; Kolman CJ, 1996, GENETICS, V142, P1321; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Levin MG, 1964, PEOPLES SIBERIA; LORENZ JC, 1994, SPE FORMATION EVAL, V9, P66, DOI 10.2118/21877-PA; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Morell V, 1998, SCIENCE, V280, P190, DOI 10.1126/science.280.5361.190; POPOV AA, 1964, PEOPLES SIBERIA, P607; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; Santos FR, 1996, AM J HUM GENET, V58, P1369; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Stone AC, 1998, AM J HUM GENET, V62, P1153, DOI 10.1086/301838; Swofford D., 1990, B ILL NAT HIST SURV; SZATHMARY EJE, 1993, AM J HUM GENET, V53, P793; TEMPLETON AR, 1995, GENETICS, V140, P767; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1998, BIOL BASIS HUMAN BEH, P180; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174; [No title captured]; [No title captured]	49	227	234	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					817	831		10.1086/302282	http://dx.doi.org/10.1086/302282			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	177HN	10053017	Bronze, Green Published			2022-12-18	WOS:000079204700020
J	Smolarek, TA; Wessner, LL; McCormack, FX; Mylet, JC; Menon, AG; Henske, EP				Smolarek, TA; Wessner, LL; McCormack, FX; Mylet, JC; Menon, AG; Henske, EP			Evidence that lymphangiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOMYOMATOSIS; RENAL ANGIOMYOLIPOMAS; GROWTH SUPPRESSOR; SOMATIC MOSAICISM; SMOOTH-MUSCLE; LINKAGE MAP; LYMPHANGIOLEIOMYOMATOSIS; GENE; REGION	Lymphangiomyomatosis (LAM) is a rare disease, of unknown etiology, affecting women almost exclusively. Lung transplantation is the only consistently effective therapy for LAM. Microscopically, LAM consists of a diffuse proliferation of smooth muscle cells. LAM can occur without evidence of other disease (referred to as "sporadic LAM") or in association with tuberous sclerosis complex (TSC). TSC is an autosomal dominant tumor suppressor gene syndrome characterized by seizures, mental retardation, and tumors in the brain, heart, skin, and kidney. Renal angiomyolipomas occur in similar to 50% of sporadic LAM patients and in 70% of TSC patients. Loss of heterozygosity (LOH) in the chromosomal region for the TSC2 gene occurs in 60% of TSC-associated angiomyolipomas. Because of the similar pulmonary and renal manifestations of TSC and sporadic LAM, we hypothesized that LAM and TSC have a common genetic basis. We analyzed renal angiomyolipomas, from 13 women with sporadic LAM, for LOH in the regions of the TSC1 (chromosome 9q34) and TSC2 (chromosome 16p13) genes. TSC2 LOH was detected in seven (54%) of the angiomyolipomas. We also found TSC2 LOH in four lymph nodes from a woman with retroperitoneal LAM. No TSC1 LOH was found. Our findings indicate that the TSC2 gene may be involved in the pathogenesis of sporadic LAM. However, genetic transmission of LAM has not been reported. Women with LAM may have low-penetrance germ-line TSC2 mutations, or they may be mosaic, with TSC2 mutations in the lung and the kidney but not in other organs.	Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; Univ Cincinnati, Dept Mol Genet, Cincinnati, OH USA; Univ Cincinnati, Dept Biochem & Microbiol, Cincinnati, OH USA; Univ Cincinnati, Dept Med, Cincinnati, OH 45221 USA	Fox Chase Cancer Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Henske, EP (corresponding author), Fox Chase Canc Ctr, Dept Med Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	EP_Henske@fccc.edu	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464				BERNSTEIN SM, 1995, AM J RESP CRIT CARE, V152, P2138, DOI 10.1164/ajrccm.152.6.8520787; BJORNSSON J, IN PRESS TUBEROUS SC; Boehler A, 1996, NEW ENGL J MED, V335, P1275, DOI 10.1056/NEJM199610243351704; Bonetti F, 1996, EUR RESPIR J, V9, P399, DOI 10.1183/09031936.96.09030399; CARBONARA C, 1994, HUM MOL GENET, V3, P1829, DOI 10.1093/hmg/3.10.1829; Carbonara C, 1996, GENE CHROMOSOME CANC, V15, P18, DOI 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7; CASTRO M, 1995, CHEST, V107, P189, DOI 10.1378/chest.107.1.189; CHAN JKC, 1993, HISTOPATHOLOGY, V22, P445, DOI 10.1111/j.1365-2559.1993.tb00158.x; COLLINS N, 1995, ONCOGENE, V10, P1673; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; CORRIN B, 1975, AM J PATHOL, V79, P348; Evans DGR, 1997, AM J HUM GENET, V61, pA97; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HALL JG, 1988, AM J HUM GENET, V43, P355; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; Henske EP, 1996, AM J HUM GENET, V59, P400; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; HENSKE EP, 1993, GENOMICS, V17, P587, DOI 10.1006/geno.1993.1376; HENSKE EP, 1998, HUMAN GENOME METHODS, P3; Heppner C, 1997, NAT GENET, V16, P375, DOI 10.1038/ng0897-375; JOHNSON SF, 1993, AM SURGEON, V59, P395; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; KAISERLING E, 1994, HISTOPATHOLOGY, V25, P41, DOI 10.1111/j.1365-2559.1994.tb00596.x; Kalassian KG, 1997, AM J RESP CRIT CARE, V155, P1183, DOI 10.1164/ajrccm.155.4.9105053; KERR LA, 1993, UROLOGY, V41, P440, DOI 10.1016/0090-4295(93)90504-4; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; LUSTBADER ED, 1995, GENET EPIDEMIOL, V12, P339, DOI 10.1002/gepi.1370120402; Maziak DE, 1996, EUR RESPIR J, V9, P402, DOI 10.1183/09031936.96.09030402; NELLIST M, 1993, CELL, V75, P1305; PEYROL S, 1992, J PATHOL, V168, P387, DOI 10.1002/path.1711680409; POVEY S, 1994, ANN HUM GENET, V58, P107, DOI 10.1111/j.1469-1809.1994.tb01881.x; Rohde K, 1997, AM J HUM GENET, V61, P418, DOI 10.1086/514849; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; Sippel KC, 1997, AM J HUM GENET, V61, pA16; SNAREY A, 1994, AM J HUM GENET, V55, P365; TAYLOR JR, 1990, NEW ENGL J MED, V323, P1254, DOI 10.1056/NEJM199011013231807; TORRES VE, 1995, MAYO CLIN PROC, V70, P641, DOI 10.4065/70.7.641; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; VANSTOSSEL E, 1937, BEITR KLIN TUBERK, V90, P432; VERHOEF S, 1995, LANCET, V345, P202, DOI 10.1016/S0140-6736(95)90213-9; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	43	227	235	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					810	815		10.1086/301804	http://dx.doi.org/10.1086/301804			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529362	Green Published, Bronze			2022-12-18	WOS:000073514400011
J	Bejjani, BA; Lewis, RA; Tomey, KF; Anderson, KL; Dueker, DK; Jabak, M; Astle, WF; Otterud, B; Leppert, M; Lupski, JR				Bejjani, BA; Lewis, RA; Tomey, KF; Anderson, KL; Dueker, DK; Jabak, M; Astle, WF; Otterud, B; Leppert, M; Lupski, JR			Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; BARDET-BIEDL-SYNDROME; CHROMOSOME 1Q; LINKAGE; LOCUS; JUVENILE; MAPS; BUPHTHALMOS; GROWTH; DIOXIN	The autosomal recessive disorder primary congenital glaucoma (PCG) is caused by unknown developmental defect(s) of the trabecular meshwork and anterior chamber angle of the eye. Homozygosity mapping with a DNA pooling strategy in three large consanguineous Saudi PCG families identified the GLC3A locus on chromosome 2p21 in a region tightly linked to PCG in another population. Formal linkage analysis in 25 Saudi PCG families confirmed both significant linkage to polymorphic markers in this region and incomplete penetrance, but it showed no evidence of genetic heterogeneity. For these 25 families, the maximum combined two-point LOD score was 15.76 at a recombination fraction of .021, with the polymorphic marker D2S177. Both haplotype analysis and homozygosity mapping in these families localized GLC3A to a 5-cM critical interval delineated by markers D2S2186 and D2S1356. Sequence analysis of the coding exons for cytochrome P4501B1 (CYP1B1) in these 25 families revealed three distinctive mutations that segregate with the phenotype in 24 families. Additional clinical and molecular data on some mildly affected relatives showed variable expressivity of PCG in this population. These results should stimulate a study of the genetic and environmental events that modify the effects of CYP1B1 mutations in ocular development. Furthermore, the small number of PCG mutations identified in this Saudi population makes both neonatal and population screening attractive public health measures.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; King Khaled Eye Specialist Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu			NATIONAL EYE INSTITUTE [T32EY007102, R01EY011780, K08EY000370] Funding Source: NIH RePORTER; NEI NIH HHS [EY11780, K08 EY00370, EY07102] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMSON D, 1995, AM J HUM GENET, V57, P619; Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; ALLINGHAM RR, 1994, PRINCIPLES PRACTICE, V3, P1291; ANDERSON KL, 1995, AM J HUM GENET, V57, P1351; Anderson KL, 1996, J GLAUCOMA, V5, P416; BUYSE ML, 1990, BIRTH DEFECTS ENCY, P782; DELUISE VP, 1983, SURV OPHTHALMOL, V28, P1, DOI 10.1016/0039-6257(83)90174-1; DICKENS CJ, 1989, GLAUCOMAS, P761; FRANCOIS J, 1980, OPHTHALMOLOGICA, V181, P61, DOI 10.1159/000309028; GELATT KN, 1976, T AM ACAD OPHTHALMOL, V81, P636; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; HANNA BL, 1962, GENETICS, V47, P519; HOSKINS HD, 1984, ARCH OPHTHALMOL-CHIC, V102, P1331; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; LEWIS RA, 1990, GENOMICS, V7, P250, DOI 10.1016/0888-7543(90)90547-8; LICHTER PR, 1994, AM J OPHTHALMOL, V117, P706, DOI 10.1016/S0002-9394(14)70314-9; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Mckusick V.A., 1994, MENDELIAN INHERITANC; MORISSETTE J, 1995, AM J HUM GENET, V56, P1431; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEBERT DW, 1990, NATURE, V347, P709, DOI 10.1038/347709a0; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; SUTTER TR, 1991, SCIENCE, V254, P415, DOI 10.1126/science.1925598; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Tang WM, 1996, J BIOL CHEM, V271, P28324, DOI 10.1074/jbc.271.45.28324; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269	33	227	236	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					325	333		10.1086/301725	http://dx.doi.org/10.1086/301725			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463332	Green Published, Bronze			2022-12-18	WOS:000072416000016
J	van den Heuvel, L; Ruitenbeek, W; Smeets, R; Gelman-Kohan, Z; Elpeleg, O; Loeffen, J; Trijbels, F; Mariman, E; de Bruijn, D; Smeitink, J				van den Heuvel, L; Ruitenbeek, W; Smeets, R; Gelman-Kohan, Z; Elpeleg, O; Loeffen, J; Trijbels, F; Mariman, E; de Bruijn, D; Smeitink, J			Demonstration of a new pathogenic mutation in human complex I deficiency: A 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; UBIQUINONE OXIDOREDUCTASE; CDNA SEQUENCE; COENZYME-Q; NADH; PROTEIN; ENCEPHALOMYOPATHY; MUSCLE; NDUFV2; MAPS	We report the cDNA cloning, chromosomal localization, and a mutation in the human nuclear gene encoding the 18-kD (AQDQ) subunit of the mitochondrial respiratory chain complex I, The cDNA has an open reading frame of 175 amino acids and codes for a protein with a molecular mass of 23.2 kD. Its gene was mapped to chromosome 5. A homozygous 5-bp duplication, destroying a consensus phosphorylation site, in the 18-kD cDNA was found in a complex I-deficient patient. The patient showed normal muscle morphology and a remarkably nonspecific fatal progressive phenotype without increased lactate concentrations in body fluids, The child's parents were heterozygous for the mutation. In 19 other complex I-deficient patients, no mutations were found in the 18-kD gene.	Univ Nijmegen Hosp, Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Kaplan Med Ctr, Clin Genet Unit, Rehovot, Israel; Shaare Zedek Med Ctr, Metab Dis Unit, Jerusalem, Israel	Radboud University Nijmegen; Radboud University Nijmegen; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Smeitink, J (corresponding author), Univ Nijmegen Hosp, Ctr Mitochondrial Disorders, Dept Pediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.		de Bruijn, D.R.H./L-4233-2015; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Smeitink, Jan/C-1351-2013	van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; 				ADAMS MD, 1995, NATURE, V377, P3; Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brown MD, 1997, AM J HUM GENET, V60, P381; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOW W, 1991, EUR J BIOCHEM, V201, P547, DOI 10.1111/j.1432-1033.1991.tb16313.x; DECOO R, 1995, GENOMICS, V26, P461, DOI 10.1016/0888-7543(95)80163-G; DiMauro S, 1993, MOL GENETIC BASIS NE, P665; Elpeleg ON, 1997, MUSCLE NERVE, V20, P238; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735; Gu JZ, 1996, GENOMICS, V35, P6, DOI 10.1006/geno.1996.0316; Guenebaut V, 1997, J MOL BIOL, V265, P409, DOI 10.1006/jmbi.1996.0753; HATTORI N, 1995, BIOCHEM BIOPH RES CO, V216, P771, DOI 10.1006/bbrc.1995.2688; Hyslop SJ, 1996, GENOMICS, V37, P375, DOI 10.1006/geno.1996.0572; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; KORENKE GC, 1990, EUR J PEDIATR, V150, P104, DOI 10.1007/BF02072049; MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603; Papa S, 1996, FEBS LETT, V379, P299, DOI 10.1016/0014-5793(95)01532-9; PATA I, 1997, BIOCHEM SOC T, V21, P23; Ruitenbeek W, 1996, PHYSICIANS GUIDE LAB, P391; SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535; SPENCER SR, 1992, GENOMICS, V14, P1116, DOI 10.1016/S0888-7543(05)80144-2; Trijbels JMF, 1996, J INHERIT METAB DIS, V19, P149, DOI 10.1007/BF01799416; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; YAMAGUCHI M, 1993, BIOCHEMISTRY-US, V32, P1935, DOI 10.1021/bi00059a008; Zhuchenko O, 1996, GENOMICS, V37, P281, DOI 10.1006/geno.1996.0561	29	227	230	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					262	268		10.1086/301716	http://dx.doi.org/10.1086/301716			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463323	Bronze, Green Published			2022-12-18	WOS:000072416000008
J	POLLTHE, BT; ROELS, F; OGIER, H; SCOTTO, J; VAMECQ, J; SCHUTGENS, RBH; WANDERS, RJA; VANROERMUND, CWT; VANWIJLAND, MJA; SCHRAM, AW; TAGER, JM; SAUDUBRAY, JM				POLLTHE, BT; ROELS, F; OGIER, H; SCOTTO, J; VAMECQ, J; SCHUTGENS, RBH; WANDERS, RJA; VANROERMUND, CWT; VANWIJLAND, MJA; SCHRAM, AW; TAGER, JM; SAUDUBRAY, JM			A NEW PEROXISOMAL DISORDER WITH ENLARGED PEROXISOMES AND A SPECIFIC DEFICIENCY OF ACYL-COA OXIDASE (PSEUDO NEONATAL ADRENOLEUKODYSTROPHY)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP NECKER ENFANTS MALAD,INSERM,U12,F-75730 PARIS 15,FRANCE; HOP BICETRE,PARIS,FRANCE; INSERM,U56,F-75005 PARIS,FRANCE; VRIJE UNIV BRUSSEL,FAK GENEESKUNDE & FARM,MENSELIJKE ANAT LAB,B-1050 BRUSSELS,BELGIUM; CATHOLIC UNIV LOUVAIN,CHIM PHYSIOL LAB,B-1200 BRUSSELS,BELGIUM; INST CELLULAR & MOLEC PATHOL,BRUSSELS,BELGIUM; UNIV AMSTERDAM HOSP,DEPT PEDIAT,AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,BIOCHEM LAB,AMSTERDAM,NETHERLANDS	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Vrije Universiteit Brussel; Universite Catholique Louvain; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	POLLTHE, BT (corresponding author), HOP NECKER ENFANTS MALAD,GENET MED CLIN,149 RUE SEVRES,F-75730 PARIS 15,FRANCE.		Vamecq, Joseph/M-4953-2018	Vamecq, Joseph/0000-0002-4089-7663				AUBOURG P, 1986, J NEUROL NEUROSUR PS, V49, P77, DOI 10.1136/jnnp.49.1.77; BROWN FR, 1982, JOHNS HOPKINS MED J, V151, P344; CHEN WW, 1987, P NATL ACAD SCI USA, V84, P1425, DOI 10.1073/pnas.84.5.1425; FARRELL K, 1983, ANN NEUROL, V14, P379; GOLDFISCHER S, 1986, J PEDIATR-US, V108, P25, DOI 10.1016/S0022-3476(86)80764-8; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; GOLDFISCHER S, 1985, SCIENCE, V227, P67, DOI 10.1126/science.3964959; HASHMI M, 1986, FEBS LETT, V196, P247, DOI 10.1016/0014-5793(86)80256-3; KELLEY RI, 1986, AM J MED GENET, V23, P869, DOI 10.1002/ajmg.1320230404; MARLER JR, 1983, NEUROLOGY, V33, P1203, DOI 10.1212/WNL.33.9.1203; MOSER AE, 1984, NEW ENGL J MED, V310, P1141, DOI 10.1056/NEJM198405033101802; MOSER HW, 1982, PEDIATR RES, V16, P172, DOI 10.1203/00006450-198203000-00002; OSMUNDSEN H, 1980, INT J BIOCHEM, V12, P625, DOI 10.1016/0020-711X(80)90015-4; PARTIN JS, 1983, PEDIATR RES, V17, pA294; POLLTHE BT, 1987, J INHERIT METAB DIS, V10, P229, DOI 10.1007/BF01811412; POLLTHE BT, 1987, EUR J PEDIATR, V146, P477, DOI 10.1007/BF00441598; POLLTHE BT, 1986, J INHERIT METAB DIS, V9, P169, DOI 10.1007/BF01799455; POULOS A, 1986, EUR J PEDIATR, V145, P507, DOI 10.1007/BF02429053; ROELS F, 1986, AM J MED GENET, V25, P257, DOI 10.1002/ajmg.1320250210; ROELS F, 1979, J HISTOCHEM CYTOCHEM, V27, P1471, DOI 10.1177/27.11.92501; SCHRAM AW, 1987, P NATL ACAD SCI USA, V84, P2494, DOI 10.1073/pnas.84.8.2494; SCHUTGENS RBH, 1985, PRENATAL DIAG, V5, P337, DOI 10.1002/pd.1970050506; SCHUTGENS RBH, 1986, EUR J PEDIATR, V144, P430, DOI 10.1007/BF00441734; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; TAGER JM, 1985, BIOCHEM BIOPH RES CO, V126, P1269, DOI 10.1016/0006-291X(85)90322-5; TAGER JM, 1987, PEROXISOMES BIOL MED, P353; VAMECQ J, 1984, BIOCHEM J, V221, P203, DOI 10.1042/bj2210203; WANDERS RJA, 1986, NEW ENGL J MED, V314, P787; WANDERS RJA, 1986, CLIN CHIM ACTA, V159, P1, DOI 10.1016/0009-8981(86)90160-9; WANDERS RJA, 1987, CLIN CHIM ACTA, V166, P255, DOI 10.1016/0009-8981(87)90428-1; WANDERS RJA, 1987, J INHERIT METAB DIS, V10, P220, DOI 10.1007/BF01811410; Wolff J, 1986, Pediatr Neurol, V2, P141, DOI 10.1016/0887-8994(86)90004-4	32	227	230	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1988	42	3					422	434						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6206	2894756				2022-12-18	WOS:A1988M620600004
J	Kelsell, DP; Norgett, EE; Unsworth, H; Teh, MT; Cullup, T; Mein, CA; Dopping-Hepenstal, PJ; Dale, BA; Tadini, G; Fleckman, P; Stephens, KG; Sybert, VP; Mallory, SB; North, BV; Witt, DR; Sprecher, E; Taylor, AEM; Ilchyshyn, A; Kennedy, CT; Goodyear, H; Moss, C; Paige, D; Harper, JI; Young, BD; Leigh, IM; Eady, RAJ; O'Toole, EA				Kelsell, DP; Norgett, EE; Unsworth, H; Teh, MT; Cullup, T; Mein, CA; Dopping-Hepenstal, PJ; Dale, BA; Tadini, G; Fleckman, P; Stephens, KG; Sybert, VP; Mallory, SB; North, BV; Witt, DR; Sprecher, E; Taylor, AEM; Ilchyshyn, A; Kennedy, CT; Goodyear, H; Moss, C; Paige, D; Harper, JI; Young, BD; Leigh, IM; Eady, RAJ; O'Toole, EA			Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-ENVELOPE PROTEINS; LAMELLAR BODIES; HUMAN KERATINOCYTES; PRENATAL-DIAGNOSIS; TANGIER-DISEASE; HUMAN EPIDERMIS; FETAL SKIN; ABNORMALITY; EXPRESSION; GENE	Harlequin ichthyosis (HI) is the most severe and frequently lethal form of recessive congenital ichthyosis. Although defects in lipid transport, protein phosphatase activity, and differentiation have been described, the genetic basis underlying the clinical and cellular phenotypes of HI has yet to be determined. By use of single-nucleotide-polymorphism chip technology and homozygosity mapping, a common region of homozygosity was observed in five patients with HI in the chromosomal region 2q35. Sequencing of the ABCA12 gene, which maps within the minimal region defined by homozygosity mapping, revealed disease-associated mutations, including large intragenic deletions and frameshift deletions in 11 of the 12 screened individuals with HI. Since HI epidermis displays abnormal lamellar granule formation, ABCA12 may play a critical role in the formation of lamellar granules and the discharge of lipids into the intercellular spaces, which would explain the epidermal barrier defect seen in this disorder. This finding paves the way for early prenatal diagnosis. In addition, functional studies of ABCA12 will lead to a better understanding of epidermal differentiation and barrier formation.	Univ London, Queen Mary, Barts & London Sch Med & Dent, Ctr Cutaneous Res,Inst Cell & Mol Sci, London E1 2AT, England; Univ London, Queen Mary, Barts & London Sch Med & Dent, Inst Canc,Mol Oncol Unit, London, England; Univ London, Queen Mary, Barts & London Sch Med & Dent, Acad Dept Psychiat, London, England; St Thomas Hosp, Guys Kings & St Thomas Sch Med, Div Skin Sci, Genet Skin Dis Grp, London, England; Royal London Hosp, Dept Dermatol, London E1 1BB, England; Great Ormond St Hosp Children, Dept Paediat, London WC1N 3JH, England; Univ Washington, Dept Oral Biol, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Med Dermatol, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Grp Hlth Permanente, Dept Dermatol, Seattle, WA USA; Univ Milan, Inst Dermatol Sci, Milan, Italy; Washington Univ, Sch Med, Dept Internal Med, Div Dermatol, St Louis, MO 63110 USA; Kaiser Permanente, Dept Genet, San Jose, Costa Rica; Rambam Med Ctr, Dept Dermatol, Haifa, Israel; Rambam Med Ctr, Lab Mol Dermatol, Haifa, Israel; Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Walsgrave Gen Hosp, Dept Dermatol, Coventry CV2 2DY, W Midlands, England; Southmead Gen Hosp, Dept Dermatol, Bristol, Avon, England; Birmingham Heartlands Hosp, Dept Paediat, Birmingham B9 5ST, W Midlands, England; Brimingham Childrens Hosp, Dept Dermatol, Birmingham, W Midlands, England; Univ London, Queen Mary, Barts & London Sch Med & Dent, William Harvey Res Inst,Genome Ctr, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Barts Health NHS Trust; Royal London Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Milan; Washington University (WUSTL); Kaiser Permanente; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Newcastle University - UK; Southmead Hospital; Heart of England NHS Foundation Trust; University of Birmingham; University of London; Queen Mary University London	Kelsell, DP (corresponding author), Univ London, Queen Mary, Barts & London Sch Med & Dent, Ctr Cutaneous Res,Inst Cell & Mol Sci, 2 Newark St, London E1 2AT, England.	d.p.kelsell@qmul.ac.uk	Teh, Muy-Teck/B-9284-2016; Kelsell, David P/F-8767-2011	Teh, Muy-Teck/0000-0002-7725-8355; O'Toole, Edel/0000-0002-4084-4836; Kelsell, David/0000-0002-9910-7144; Mein, Charles/0000-0003-0811-9658	NIAMS NIH HHS [2P01 AR 21557, P01 AR021557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akiyama M, 1997, DERMATOLOGY, V195, P164, DOI 10.1159/000245724; Akiyama M, 1996, J CUTAN PATHOL, V23, P571, DOI 10.1111/j.1600-0560.1996.tb01452.x; AKIYAMA M, 1994, J INVEST DERMATOL, V102, P210, DOI 10.1111/1523-1747.ep12371764; Akiyama M, 1998, PRENATAL DIAG, V18, P425, DOI 10.1002/(SICI)1097-0223(199805)18:5<425::AID-PD284>3.3.CO;2-2; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BUXMAN MM, 1979, ARCH DERMATOL, V115, P189, DOI 10.1001/archderm.115.2.189; Choate KA, 1998, J AM ACAD DERMATOL, V38, P325, DOI 10.1016/S0190-9622(98)70575-4; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Dahlstrom JE, 1995, PATHOLOGY, V27, P289, DOI 10.1080/00313029500169143; DALE BA, 1990, J INVEST DERMATOL, V94, P6, DOI 10.1111/1523-1747.ep12873301; Elias PM, 2000, J INVEST DERMATOL, V115, P765, DOI 10.1046/j.1523-1747.2000.00124-5.x; ELIAS S, 1980, CLIN GENET, V17, P275; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Haftek M, 1996, BRIT J DERMATOL, V135, P448, DOI 10.1046/j.1365-2133.1996.d01-1019.x; Hsu W Y, 1989, Zhonghua Yi Xue Za Zhi (Taipei), V43, P63; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kam E, 1997, BRIT J DERMATOL, V137, P874; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; MENON GK, 1992, BRIT J DERMATOL, V126, P337, DOI 10.1111/j.1365-2133.1992.tb00675.x; Michel M, 1999, BRIT J DERMATOL, V141, P1017, DOI 10.1046/j.1365-2133.1999.03199.x; Moreau S, 1999, SURG RADIOL ANAT, V21, P215, DOI 10.1007/s00276-999-0215-6; Moskowitz DG, 2004, J PEDIATR-US, V145, P82, DOI 10.1016/j.jpeds.2004.03.052; ODLAND GF, 1960, J INVEST DERMATOL, V34, P11, DOI 10.1038/jid.1960.4; Oren A, 2003, EXP MOL PATHOL, V74, P180, DOI 10.1016/S0014-4800(02)00023-0; Rassner U, 1999, TISSUE CELL, V31, P489, DOI 10.1054/tice.1999.0050; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sarkar R, 2000, J Dermatol, V27, P609; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Stefkova J, 2004, PHYSIOL RES, V53, P235; SUZUMORI K, 1991, PRENATAL DIAG, V11, P451, DOI 10.1002/pd.1970110707; Vohra N, 2003, J ULTRAS MED, V22, P737, DOI 10.7863/jum.2003.22.7.737	36	226	243	1	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					794	803						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15756637				2022-12-18	WOS:000228198300007
J	Dixon-Salazar, T; Silhavy, JL; Marsh, SE; Louie, CM; Scott, LC; Gururaj, A; Al-Gazali, L; Al-Tawari, AA; Kayserili, H; Sztriha, L; Gleeson, JG				Dixon-Salazar, T; Silhavy, JL; Marsh, SE; Louie, CM; Scott, LC; Gururaj, A; Al-Gazali, L; Al-Tawari, AA; Kayserili, H; Sztriha, L; Gleeson, JG			Mutations in the AHI1 gene, encoding Jouberin, cause Joubert syndrome with cortical polymicrogyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEPHRONOPHTHISIS; LOCUS; FAMILIES; PROTEIN	Joubert syndrome (JS) is an autosomal recessive disorder marked by agenesis of the cerebellar vermis, ataxia, hypotonia, oculomotor apraxia, neonatal breathing abnormalities, and mental retardation. Despite the fact that this condition was described >30 years ago, the molecular basis has remained poorly understood. Here, we identify two frameshift mutations and one missense mutation in the AHI1 gene in three consanguineous families with JS, some with cortical polymicrogyria. AHI1, encoding the Jouberin protein, is an alternatively spliced signaling molecule that contains seven Trp-Asp (WD) repeats, an SH3 domain, and numerous SH3-binding sites. The gene is expressed strongly in embryonic hindbrain and forebrain, and our data suggest that AHI1 is required for both cerebellar and cortical development in humans. The recently described mutations in NPHP1, encoding a protein containing an SH3 domain, in a subset of patients with JS plus nephronophthisis, suggest a shared pathway.	Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Al Sabah Hosp, Childrens Unit, Dept Neurol, Safat, Kuwait; Univ Istanbul, Prenatal Diag Res Ctr, Inst Child Hlth, Div Med Genet, Istanbul, Turkey	University of California System; University of California San Diego; United Arab Emirates University; Al Sabah Hospital; Istanbul University	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, Leichtag 332,9500 Gilman Dr, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Kayserili, Hülya/AAA-5593-2021; Marsh, Sarah/E-9164-2010	Kayserili, Hülya/0000-0003-0376-499X; Marsh, Sarah/0000-0003-4194-043X	NINDS NIH HHS [R01 NS048453, R01 NS052455] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, R01NS048453] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1814; Chance PF, 1999, J CHILD NEUROL, V14, P660, DOI 10.1177/088307389901401007; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Goffinet A., 2000, MOUSE BRAIN DEV; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Jiang XY, 2004, BLOOD, V103, P3897, DOI 10.1182/blood-2003-11-4026; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Lagier-Tourenne C, 2004, J MED GENET, V41, P273, DOI 10.1136/jmg.2003.014787; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; MONTERO RR, 2002, SEIZURE SA, V11, P298; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; Satran D, 1999, AM J MED GENET, V86, P459; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241	19	226	230	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					979	987		10.1086/425985	http://dx.doi.org/10.1086/425985			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15467982	Bronze, Green Published			2022-12-18	WOS:000224866400004
J	Wissinger, B; Gamer, D; Jagle, H; Giorda, R; Marx, T; Mayer, S; Tippmann, S; Broghammer, M; Jurklies, B; Rosenberg, T; Jacobson, SG; Sener, EC; Tatlipinar, S; Hoyng, CB; Castellan, C; Bitoun, P; Andreasson, S; Rudolph, G; Kellner, U; Lorenz, B; Wolff, G; Verellen-Dumoulin, C; Schwartz, M; Cremers, FPM; Apfelstedt-ylla, E; Zrenner, E; Salati, R; Sharpe, LT; Kohl, S				Wissinger, B; Gamer, D; Jagle, H; Giorda, R; Marx, T; Mayer, S; Tippmann, S; Broghammer, M; Jurklies, B; Rosenberg, T; Jacobson, SG; Sener, EC; Tatlipinar, S; Hoyng, CB; Castellan, C; Bitoun, P; Andreasson, S; Rudolph, G; Kellner, U; Lorenz, B; Wolff, G; Verellen-Dumoulin, C; Schwartz, M; Cremers, FPM; Apfelstedt-ylla, E; Zrenner, E; Salati, R; Sharpe, LT; Kohl, S			CNGA3 mutations in hereditary cone photoreceptor disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CGMP-GATED CHANNEL; ALPHA-SUBUNIT; TOTAL COLOURBLINDNESS; COLOR-VISION; ACHROMATOPSIA; GENE; PINGELAPESE; LOCUS; EYE	We recently showed that mutations in the CNGA3 gene encoding the alpha -subunit of the cone photoreceptor cGMP-gated channel cause autosomal recessive complete achromatopsia linked to chromosome 2q11. We now report the results of a first comprehensive screening for CNGA3 mutations in a cohort of 258 additional independent families with hereditary cone photoreceptor disorders. CNGA3 mutations were detected not only in patients with the complete form of achromatopsia but also in incomplete achromats with residual cone photoreceptor function and (rarely) in patients with evidence for severe progressive cone dystrophy. In total, mutations were identified in 53 independent families comprising 38 new CNGA3 mutations, in addition to the 8 mutations reported elsewhere. Apparently, both mutant alleles were identified in 47 families, including 16 families with presumed homozygous mutations and 31 families with two heterozygous mutations. Single heterozygous mutations were identified in six additional families. The majority of all known CNGA3 mutations (39/46) are amino acid substitutions compared with only four stop-codon mutations, two 1-bp insertions and one 3-bp in-frame deletion. The missense mutations mostly affect amino acids conserved among the members of the cyclic nucleotide gated (CNG) channel family and cluster at the cytoplasmic face of transmembrane domains (TM) S1 and S2, in TM S4, and in the cGMP-binding domain. Several mutations were identified recurrently (e.g., R277C, R283W, R436W, and F547L). These four mutations account for 41.8% of all detected mutant CNGA3 alleles. Haplotype analysis suggests that the R436W and F547L mutant alleles have multiple origins, whereas we found evidence that the R283W alleles, which are particularly frequent among patients from Scandinavia and northern Italy, have a common origin.	Univ Tubingen, Augenklin, Genet Mol Lab, Abt Pathophysiol Sehens & Neurophthalmol, D-72076 Tubingen, Germany; Univ Tubingen, Augenklin, Psychophys Lab, Abt Pathophysiol Sehens & Neurophthalmol, D-72076 Tubingen, Germany; IRCCS Eugenio Medea, Dept Pediat Ophthalmol, Bosisio Parini, Italy; IRCCS Eugenio Medea, Mol Biol Lab, Bosisio Parini, Italy; Univ Essen Gesamthsch, Augenklin, Essen, Germany; Natl Eye Clin, Copenhagen, Denmark; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; Hacettepe Univ, TR-06100 Ankara, Turkey; Univ Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Genet Beratungsstelle, Bolzano, Italy; Univ Hosp Jean Verdier Paris Nord, Bondy, France; Lund Univ, Hosp Eye, Lund, Sweden; Univ Munich, Augenklin, D-8000 Munich, Germany; Free Univ Berlin, Klinikum Benjamin Franklin, Augenklin, D-12200 Berlin, Germany; Univ Regensburg, Augenklin, Abt Kinderophthalmol Strabismol & Ophthalmogenet, D-8400 Regensburg, Germany; Catholic Univ Louvain, Ctr Genet Humaine, B-1348 Louvain, Belgium; Newcastle Univ, Dept Psychol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; IRCCS Eugenio Medea; IRCCS Eugenio Medea; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Pennsylvania; Pennsylvania Medicine; Hacettepe University; Radboud University Nijmegen; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Lund University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; Universite Catholique Louvain; Newcastle University - UK	Wissinger, B (corresponding author), Univ Tubingen, Augenklin, Genet Mol Lab, Abt Pathophysiol Sehens & Neurophthalmol, Morgenstelle 15, D-72076 Tubingen, Germany.	wissinger@uni-tuebingen.de	Hoyng, C.B./H-8050-2014; Giorda, Roberto/J-1052-2014; Cremers, Frans/A-5625-2014; Jägle, Herbert/GPP-2945-2022; Giorda, Roberto/Q-6010-2019	Giorda, Roberto/0000-0001-8175-9606; Cremers, Frans/0000-0002-4954-5592; Giorda, Roberto/0000-0001-8175-9606; Kohl, Susanne/0000-0002-6438-6331; Jacobson, Samuel/0000-0003-2122-169X; Bitoun, Pierre/0000-0001-6557-6826				ANDREASSON S, 1991, ACTA OPHTHALMOL, V69, P711; Arbour NC, 1997, HUM MOL GENET, V6, P689, DOI 10.1093/hmg/6.5.689; Ayyagari R, 1999, MOL VIS, V5; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; BIEL M, 1994, P NATL ACAD SCI USA, V91, P3505, DOI 10.1073/pnas.91.9.3505; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FALLS HF, 1965, ARCH OPHTHALMOL-CHIC, V74, P610, DOI 10.1001/archopht.1965.00970040612005; Francois J., 1961, HEREDITY OPHTHALMOLO; Gingrich JC, 1996, GENOMICS, V32, P65, DOI 10.1006/geno.1996.0077; GLICKSTEIN M, 1975, VISION RES, V15, P633, DOI 10.1016/0042-6989(75)90276-X; GOODMAN G, 1963, ARCH OPHTHALMOL-CHIC, V70, P214; Hagstrom SA, 1998, NEUROREPORT, V9, P1963, DOI 10.1097/00001756-199806220-00009; HANSEN E, 1979, ACTA OPHTHALMOL, V57, P211; HARRISON R, 1960, ARCH OPHTHALMOL-CHIC, V64, P685, DOI 10.1001/archopht.1960.01840010687010; Ioannou P.A., 1996, CURRENT PROTOCOLS HU; JAGER W, 1953, BERL DTSCH OPHTHALMO, V58, P44; Jagle H, 2001, COLOR RES APPL, V26, pS96, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL22>3.0.CO;2-L; KELLNER U, 1996, PROGR ZAPFENDYSTROPH, V135; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; LARSEN H, 1921, KLINISCHE MONATSBLAT, V67, P301; Milunsky A, 1999, CLIN GENET, V56, P82, DOI 10.1034/j.1399-0004.1999.560112.x; Muller F, 1998, NATURWISSENSCHAFTEN, V85, P49, DOI 10.1007/s001140050453; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; Nathans J., 1999, COLOR VISION GENES P, P3; NEUHANN T, 1978, A GRAEF ARCH KLIN EX, V209, P19, DOI 10.1007/BF00419159; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Sharpe LT, 1990, NIGHT VISION BASIC C, P253; STOCKMAN A, 1999, COLOR VISION GENES P, P53; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; WEITZ CJ, 1992, AM J HUM GENET, V50, P498; Winick JD, 1999, AM J HUM GENET, V64, P1679, DOI 10.1086/302423; Wissinger B, 1997, EUR J NEUROSCI, V9, P2512, DOI 10.1111/j.1460-9568.1997.tb01680.x; Wissinger B, 1998, GENOMICS, V51, P325, DOI 10.1006/geno.1998.5390; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZRENNER E, 1988, KLIN MONATSBL AUGENH, V193, P510, DOI 10.1055/s-2008-1050292	37	226	233	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					722	737		10.1086/323613	http://dx.doi.org/10.1086/323613			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11536077	Green Published, Bronze			2022-12-18	WOS:000171008200006
J	Fisher, SE; Marlow, AJ; Lamb, J; Maestrini, E; Williams, DF; Richardson, AJ; Weeks, DE; Stein, JF; Monaco, AP				Fisher, SE; Marlow, AJ; Lamb, J; Maestrini, E; Williams, DF; Richardson, AJ; Weeks, DE; Stein, JF; Monaco, AP			A quantitative-trait locus on chromosome 6p influences different aspects of developmental dyslexia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							READING-DISABILITY; LINKAGE ANALYSIS; CHILDREN; COMPLEX; MICROSATELLITES; RECOMBINATION; COMPONENTS; DISEASES; IMMUNE; RATES	Recent application of nonparametric-linkage analysis to reading disability has implicated a putative quantitative-trait locus (QTL) on the short arm of chromosome 6. In the present study, we use QTL methods to evaluate linkage to the 6p25-21.3 region in a sample of 181 sib pairs from 82 nuclear families that were selected on the basis of a dyslexic proband. We have assessed linkage directly for several quantitative measures that should correlate with different components of the phenotype, rather than using a single composite measure or, employing categorical definitions of subtypes, Our measures include the traditional IQ/reading discrepancy score, as well as tests of word recognition, irregular-word reading, and nonword reading. Pointwise analysis by means of sib-pair trait differences suggests the presence, in 6p21.3, of a QTL influencing multiple components of dyslexia, in particular the reading of irregular words (P =.0016) and nonwords (P =,0024). A complementary statistical approach involving estimation of variance components supports these findings (irregular words, P=.007; nonwords, P=.0004). Multipoint analyses place the QTL within the D6S422-D6S291 interval, with a peak around markers D6S276 and D6S105 consistently identified by approaches based on trait differences (irregular words, P=.00035; nonwords, P =.0035) and variance components (irregular words, P =.007; nonwords, P =.0038). Our findings indicate that the QTL affects both phonological and orthographic skills and is not specific to phoneme awareness, as has been previously suggested. Further studies will be necessary to obtain a more precise localization of this QTL, which may lead to the isolation of one of the genes involved in developmental dyslexia.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Physiol, Oxford, England; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Weeks, Daniel E/B-2995-2012; Fisher, Simon E./E-9130-2012; Maestrini, Elena/K-7508-2012; Monaco, Anthony P/A-4495-2010	Weeks, Daniel E/0000-0001-9410-7228; Fisher, Simon E./0000-0002-3132-1996; Maestrini, Elena/0000-0001-5924-3179; Monaco, Anthony P/0000-0001-7480-3197; Richardson, Alex/0000-0001-5650-4409; Lamb, Janine/0000-0002-7248-0539	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission)		AMOS CI, 1994, AM J HUM GENET, V54, P535; BISGAARD ML, 1987, CLIN GENET, V32, P118; BROWN BS, 1978, DYSLEXIA APPRAISAL C, pR5; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Coltheart M, 1996, AUST J PSYCHOL, V48, P136, DOI 10.1080/00049539608259520; Defries J.C., 2015, DEV DISABIL RES REV, V2, P39, DOI [DOI 10.1002/(SICI)1098-2779(1996)2:1<39::AID-MRDD7>3.0.CO;2-S, 10.1002/(sici)1098-2779(1996)2:13.0.co;2-s, DOI 10.1002/(SICI)1098-2779(1996)2:13.0.CO;2-S]; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; DEFRIES JC, 1993, NATURE NURTURE PSYCH, P121; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Elliot C. D., 1979, BRIT ABILITY SCALES; Elston RC, 1997, AM J HUM GENET, V60, P255; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Field LL, 1998, AM J HUM GENET, V63, P1448, DOI 10.1086/302107; FROSTER U, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91385-Y; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Hallgren B., 1950, ACTA PSYCHIAT NEUROL, V65, P2; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HUGDAHL K, 1990, NEUROPSYCHOLOGIA, V28, P673, DOI 10.1016/0028-3932(90)90122-5; Iyengar S, 1997, GENET EPIDEMIOL, V14, P809, DOI 10.1002/(SICI)1098-2272(1997)14:6<809::AID-GEPI41>3.3.CO;2-I; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEWITTER FI, 1980, BEHAV GENET, V10, P9, DOI 10.1007/BF01067316; LUBS HA, 1993, ANN DYSLEXIA, V43, P44, DOI 10.1007/BF02928173; Malfroy L, 1997, GENOMICS, V43, P226, DOI 10.1006/geno.1997.4800; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; OLSON RK, IN PRESS CONVERGING; OLSON RK, 1994, VARIETIES ORTHOGRAPH, V1, P27; PENNINGTON BF, 1987, ARCH NEUROL-CHICAGO, V44, P634, DOI 10.1001/archneur.1987.00520180054016; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; Pennington BF, 1997, AM J HUM GENET, V60, P13; RABIN M, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91384-X; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RUTTER M, 1975, J CHILD PSYCHOL PSYC, V16, P181, DOI 10.1111/j.1469-7610.1975.tb01269.x; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; SIEGEL LS, 1998, DYSLEXIA, V4, P90, DOI DOI 10.1002/(SICI)1099-0909(199806)4:2<90::AID-DYS105>3.0.CO;2-3; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; SMITH SD, 1996, PRINCIPLES PRACTICE, P1767; Sobel E, 1996, AM J HUM GENET, V58, P1323; Thomas C. J., 1905, OPHTHALMOSCOPE, V3, P380; THOMSON ME, 1982, BRIT J PSYCHOL, V73, P461, DOI 10.1111/j.2044-8295.1982.tb01828.x; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WILSON AF, 1993, GENET EPIDEMIOL, V10, P593, DOI 10.1002/gepi.1370100644	48	226	228	1	15	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					146	156		10.1086/302190	http://dx.doi.org/10.1086/302190			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	164RM	9915953	Green Published, Bronze			2022-12-18	WOS:000078477400019
J	Bleyl, SB; Mumford, BR; Thompson, V; Carey, JC; Pysher, TJ; Chin, TK; Ward, K				Bleyl, SB; Mumford, BR; Thompson, V; Carey, JC; Pysher, TJ; Chin, TK; Ward, K			Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE; GENE; MAPS; XQ28	Loss-of-function mutations in the G4.5 gene have been shown to cause Earth syndrome (BTHS), an X-linked disorder characterized by cardiac and skeletal myopathy, short stature, and neutropenia. We recently reported a family with a severe X-linked cardiomyopathy described as isolated noncompaction of the left ventricular myocardium (INVM). Other findings associated with BTHS (skeletal myopathy, neutropenia, growth retardation, elevated urinary organic acids, and mitochondrial abnormalities) were either absent or inconsistent, A linkage study of the X chromosome localized INVM to the Xq28 region near the BTHS locus, suggesting that these disorders are allelic. We screened the G4.5 gene for mutations in this family with SSCP and direct sequencing and found a novel glycine-to-arginine substitution at position 197. This position is conserved in a homologous Caenorhabditis elegans protein. We conclude that INVM is a severe allelic variant of BTHS with a specific effect on the heart. This finding provides further structure-function information about the G4.5 gene product and has implications for unexplained cases of severe infantile hypertrophic cardiomyopathy in males.	UNIV UTAH, SCH MED, DEPT OBSTET & GYNECOL, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, DEPT PEDIAT, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, DEPT PATHOL, SALT LAKE CITY, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLEYL S, 1995, AM J HUM GENET, V56, P408; Bleyl SB, 1997, AM J MED GENET, V72, P257, DOI 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.3.CO;2-F; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; GEDEON AK, 1995, J MED GENET, V32, P383, DOI 10.1136/jmg.32.5.383; LATHROP GM, 1985, AM J HUM GENET, V37, P482; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	14	226	236	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					868	872		10.1086/514879	http://dx.doi.org/10.1086/514879			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382097	Green Published, Bronze			2022-12-18	WOS:A1997YA59100013
J	Horai, S; Murayama, K; Hayasaka, K; Matsubayashi, S; Hattori, Y; Fucharoen, G; Harihara, S; Park, KS; Omoto, K; Pan, IH				Horai, S; Murayama, K; Hayasaka, K; Matsubayashi, S; Hattori, Y; Fucharoen, G; Harihara, S; Park, KS; Omoto, K; Pan, IH			mtDNA polymorphism in East Asian populations, with special reference to the peopling of Japan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; AMERICAN POPULATIONS; HUMAN-EVOLUTION; 9-BP DELETION; ANCIENT; AMPLIFICATION; MIGRATIONS; SEQUENCES; LINEAGES; PACIFIC	Nucleotide sequences of the major noncoding (D-loop) region of human mtDNA from five East Asian populations including mainland Japanese, Ainu, Ryukyuans, Koreans, and Chinese were analyzed. On the basis of a comparison of 482-bp sequences in 293 East Asians, 207 different sequence types were observed. Of these, 189 were unique to their respective populations, whereas 18 were shared between two or three populations. Among the shared types, eight were found in common between the mainland Japanese and Koreans, which is the largest number in the comparison. The intergenic COII/tRNA(Lys) 9-bp deletion was observed in every East Asian population with varying frequencies. The D-loop sequence variation suggests that the deletion event occurred only once in the ancestry of East Asians. Phylogenetic analysis revealed that East Asian lineages were classified into at least 18 monophyletic clusters, though lineages from the five populations were completely intermingled in the phylogenetic tree. However, we assigned 14 of the 18 clusters for their specificity on the basis of the population from which the maximum number of individuals in each cluster was derived. Of note is the finding that 50% of the mainland Japanese had continental specificity in which Chinese or Koreans were dominant, while <20% of either Ryukyuans or Ainu possessed continental specificity. Phylogenetic analysis of the entire human population revealed the closest genetic affinity between the mainland Japanese and Koreans. Thus, the results of this study are compatible with the hybridization model on the origin of modern Japanese. It is suggested that similar to 65% of the gene pool in mainland Japanese was derived from the continental gene how after the Yayoi Age.	KHON KAEN UNIV, KHON KAEN, THAILAND; UNIV TOKYO, GRAD SCH SCI, DEPT ANTHROPOL, TOKYO 113, JAPAN; SUNG SHIN WOMENS UNIV, DEPT BIOL, SEOUL, SOUTH KOREA; NATL TAIWAN UNIV, TAIPEI 10764, TAIWAN; INT CTR JAPANESE STUDIES, KYOTO, JAPAN	Khon Kaen University; University of Tokyo; National Taiwan University	Horai, S (corresponding author), NATL INST GENET, DEPT HUMAN GENET, YATA 1111, MISHIMA, SHIZUOKA 411, JAPAN.		Fucharoen, Goonnapa/E-9569-2010					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; Bellwood Peter S., 1995, AUSTRONESIANS HIST C; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chard C.S., 1974, NE ASIA PREHISTORY; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HAMMER MF, 1995, AM J HUM GENET, V56, P951; HANIHARA K, 1987, J ANTHROPOL SOC NIP, V95, P391; HANIHARA K, 1992, JAPANESE MEMBER ASIA, P245; Hanihara K., 1991, JAPAN REV, V2, P1, DOI [DOI 10.1537/ASE.102.455, 10.15055/00003292]; HARIHARA S, 1992, HUM BIOL, V64, P161; HARIHARA S, 1988, AM J HUM GENET, V43, P134; Hasebe K, 1940, JINRUIGAKU ZASSHI, V55, P27; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1986, JPN J GENET, V61, P271, DOI 10.1266/jjg.61.271; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1991, PHILOS T ROY SOC B, V333, P409, DOI 10.1098/rstb.1991.0091; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1991, NEW ERA BIOENERGETIC, P273; HORAI S, 1991, NEW ASPECTS GENETICS, P135; HORAI S, 1987, HUM GENET, P177; HUTCHINSON SA, 1974, NATURE, V251, P536; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KOZINTSEV AG, 1993, HOMO, V44, P105; LUM JK, 1994, HUM BIOL, V66, P567; Mizoguchi Y., 1986, PREHISTORIC HUNTER G, P107; NEI M, 1989, HUM HERED, V39, P276, DOI 10.1159/000153872; NEI M, 1993, MOL BIOL EVOL, V10, P927; NEI M, 1990, GENETICS, V125, P873; Nei M, 1995, ORIGIN PAST MODERN H, P71; Nei M., 1987, MOL EVOLUT GENET, P293; OMOTO K, 1995, ORIGIN PAST MODERN H, P92; OMOTO K, 1992, JAPANESE MEMBER ASIA, P139; PASSARINO G, 1993, AM J HUM GENET, V53, P609; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; STONEKING M, 1989, COLONIZATION PACIFIC, P215; Suzuki H, 1969, J FS U TOKYO, V3, P279; Suzuki H, 1981, RASSENGESCHICHTE MEN, P7; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1992, GENETICS, V130, P153; TURNER CG, 1976, SCIENCE, V193, P911; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIGILANT L, 1990, THESIS U CALIFORNIA; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; YAMAGUCHI B, 1982, J ANTHROPOL SOC NIP, V90, P77	63	226	247	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					579	590						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751859				2022-12-18	WOS:A1996VN62500012
J	GUO, SW; THOMPSON, EA				GUO, SW; THOMPSON, EA			A MONTE-CARLO METHOD FOR COMBINED SEGREGATION AND LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAITS; COMPLEX SEGREGATION; FAMILY RESEMBLANCE; REGRESSIVE MODELS; HUMAN PEDIGREES; LIKELIHOOD; MATRIX; GENE; SIMULATION; SCORES	We introduce a Monte Carlo approach to combined segregation and linkage analysis of a quantitative trait observed in an extended pedigree. In conjunction with the Monte Carlo method of likelihood-ratio evaluation proposed by Thompson and Guo, the method provides for estimation and hypothesis testing. The greatest attraction of this approach is its ability to handle complex genetic models and large pedigrees. Two examples illustrate the practicality of the method. One is of simulated data on a large pedigree; the other is a reanalysis of published data previously analyzed by other methods.	UNIV WASHINGTON,DEPT STAT,GN-22,SEATTLE,WA 98195; UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48109	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046255] Funding Source: NIH RePORTER; NHGRI NIH HHS [P30-HG00209] Funding Source: Medline; NHLBI NIH HHS [HL30086] Funding Source: Medline; NIGMS NIH HHS [GM-46255] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; Breiman L, 1968, PROBABILITY THEORY; EAVES LJ, 1983, AM J HUM GENET, V35, P1179; ELSTER J, 1989, SOC PHILOS POLICY, V6, P93, DOI 10.1017/S0265052500000650; Elston R C, 1984, Genet Epidemiol, V1, P175, DOI 10.1002/gepi.1370010210; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; GEYER CJ, 1988, 153 U WASH DEP STAT; GO RCP, 1978, AM J HUM GENET, V30, P28; GUO SW, 1991, IMA J MATH APPL MED, V8, P171; GUO SW, 1991, THESIS U WASHINGTON; GUO SW, UNPUB MONTE CARLO ES; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; KONG A, 1991, GENETIC ANAL WORKSHO, V7; KONIGSBERG LW, 1989, GENET EPIDEMIOL, V6, P713, DOI 10.1002/gepi.1370060608; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1989, AM J HUM GENET, V45, P959; LEPPERT MF, 1986, AM J HUM GENET, V39, P300; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MORTON NE, 1974, AM J HUM GENET, V26, P489; OTT J, 1979, AM J HUM GENET, V31, P161; OTT J, 1990, AM J HUM GENET, V46, P219; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; RISCH N, 1984, AM J HUM GENET, V36, P363; SHEEHAN N, IN PRESS BIOMETRICS; Sundberg R., 1974, SCAND J STAT, V1, P49; THOMAS DC, 1991, 13 U SO CAL DEP PREV; THOMPSON EA, 1991, IMA J MATH APPL MED, V8, P149; THOMPSON EA, 1990, BIOMETRICS, V46, P399, DOI 10.2307/2531445; THOMPSON EA, 1991, COMPUTER SCI STAT, P321; [No title captured]	40	226	229	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1111	1126						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	JU840	1415253				2022-12-18	WOS:A1992JU84000022
J	AUSTIN, MA; KING, MC; VRANIZAN, KM; NEWMAN, B; KRAUSS, RM				AUSTIN, MA; KING, MC; VRANIZAN, KM; NEWMAN, B; KRAUSS, RM			INHERITANCE OF LOW-DENSITY LIPOPROTEIN SUBCLASS PATTERNS - RESULTS OF COMPLEX SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, DONNER LAB, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, SCH PUBL HLTH, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley				King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038760, P01HL018574] Funding Source: NIH RePORTER; NCI NIH HHS [CA-27632] Funding Source: Medline; NHLBI NIH HHS [HL-18574, HL-38760] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; AUSTIN MA, 1987, AM J EPIDEMIOL, V125, P308, DOI 10.1093/oxfordjournals.aje.a114531; AUSTIN MA, 1986, LANCET, V2, P592; BERG K, 1983, PROG MED GENET, V5, P35; BERG K, 1976, P NATL ACAD SCI USA, V73, P937, DOI 10.1073/pnas.73.3.937; BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BRUNZELL JD, 1984, ARTERIOSCLEROSIS, V4, P79, DOI 10.1161/01.ATV.4.2.79; BRUNZELL JD, 1983, J LIPID RES, V4, P614; CANNINGS C, 1977, CLIN GENET, V12, P208; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CASTELLI WP, 1977, LANCET, V2, P153; CRIQUI MH, 1980, CIRCULATION, V62, P70; CRIQUI MH, 1987, 27TH AM HEART ASS C; DECKELBAUM RJ, 1984, ARTERIOSCLEROSIS, V4, P225, DOI 10.1161/01.ATV.4.3.225; EISENBERG S, 1984, J CLIN INVEST, V74, P470, DOI 10.1172/JCI111444; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ERNST N, 1980, CIRCULATION, V62, P41; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; FISHER WR, 1975, P NATL ACAD SCI USA, V72, P2347, DOI 10.1073/pnas.72.6.2347; GARRISON RJ, 1979, AM J EPIDEMIOL, V110, P313, DOI 10.1093/oxfordjournals.aje.a112816; GOLDBOURT U, 1977, AM J EPIDEMIOL, V105, P75, DOI 10.1093/oxfordjournals.aje.a112358; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; HAMMOND M G, 1971, Journal of Biological Chemistry, V246, P5454; HASSTEDT SJ, 1987, GENET EPIDEMIOL, V4, P67, DOI 10.1002/gepi.1370040202; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KING MC, 1984, ANNU REV PUBL HEALTH, V5, P1; KRAUSS RM, 1983, CLIN RES, V31, pA503; KRAUSS RM, 1987, AM HEART J, V113, P578, DOI 10.1016/0002-8703(87)90636-3; KRAUSS RM, 1980, CLIN CHIM ACTA, V104, P275, DOI 10.1016/0009-8981(80)90385-X; KRAUSS RM, 1982, J LIPID RES, V23, P97; KRAUSS RM, 1987, LANCET, V2, P62; KRAUSS RM, 1988, ARTERIOSCLEROSIS, V8, P155, DOI 10.1161/01.ATV.8.2.155; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LAW A, 1986, LANCET, V1, P1301; LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, P181; MCNAMARA JR, 1987, ARTERIOSCLEROSIS, V7, P483, DOI 10.1161/01.ATV.7.5.483; MILLER GJ, 1975, LANCET, V1, P16; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1983, CONTRIBUTIONS EPIDEM, V4, P62; MORTON NE, 1982, OUTLINE GENETIC EPID, P69; NAMBOODIRI KK, 1984, AM J EPIDEMIOL, V119, P975, DOI 10.1093/oxfordjournals.aje.a113818; NEUFELD HN, 1983, CIRCULATION, V67, P943, DOI 10.1161/01.CIR.67.5.943; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; ORDOVAS JM, 1986, NEW ENGL J MED, V314, P671, DOI 10.1056/NEJM198603133141102; PEARSON TA, 1979, AM J EPIDEMIOL, V109, P285, DOI 10.1093/oxfordjournals.aje.a112682; PERKINS KA, 1986, AM J EPIDEMIOL, V124, P182, DOI 10.1093/oxfordjournals.aje.a114377; RAO DC, 1979, ANN HUM GENET, V42, P467, DOI 10.1111/j.1469-1809.1979.tb00680.x; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; ROBERTSON FW, 1981, GENET RES, V37, P1, DOI 10.1017/S0016672300019972; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SCHAEFER EJ, 1987, CIRCULATION, V76, P531; SEGAL P, 1982, EPIDEMIOL REV, V4, P137, DOI 10.1093/oxfordjournals.epirev.a036244; SHEN MMS, 1981, J LIPID RES, V22, P236; SING CF, 1978, AM J HUM GENET, V30, P491; SOSENKO JM, 1980, AM J EPIDEMIOL, V112, P656, DOI 10.1093/oxfordjournals.aje.a113038; TERRY RB, 1985, CIRCULATION, V72, P452; WILLIAMS PT, 1985, JAMA-J AM MED ASSOC, V253, P1407, DOI 10.1001/jama.253.10.1407	61	226	228	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					838	846						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	3195585				2022-12-18	WOS:A1988R344900005
J	WILLARD, HF				WILLARD, HF			CHROMOSOME-SPECIFIC ORGANIZATION OF HUMAN ALPHA SATELLITE DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WILLARD, HF (corresponding author), UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A8,ONTARIO,CANADA.							BEAUCHAMP RS, 1979, CHROMOSOMA, V71, P153, DOI 10.1007/BF00292820; BONNER TI, 1973, J MOL BIOL, V81, P123, DOI 10.1016/0022-2836(73)90184-8; BROWN SDM, 1980, NUCLEIC ACIDS RES, V8, P781; COOKE H, 1976, NATURE, V262, P182, DOI 10.1038/262182a0; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; DARLING SM, 1982, J MOL BIOL, V154, P51, DOI 10.1016/0022-2836(82)90416-8; DORMAN BP, 1978, P NATL ACAD SCI USA, V75, P2363, DOI 10.1073/pnas.75.5.2363; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; JABS EW, 1984, P NATL ACAD SCI-BIOL, V81, P4884, DOI 10.1073/pnas.81.15.4884; LEE TNH, 1982, J MOL BIOL, V161, P323, DOI 10.1016/0022-2836(82)90156-5; LEWIN B, 1980, GENE EXPRESSION, V2; MAIO JJ, 1971, J MOL BIOL, V56, P579, DOI 10.1016/0022-2836(71)90403-7; MANUELIDIS L, 1978, NATURE, V276, P92, DOI 10.1038/276092a0; MANUELIDIS L, 1978, CHROMOSOMA, V66, P23, DOI 10.1007/BF00285813; MANUELIDIS L, 1978, CHROMOSOMA, V66, P1, DOI 10.1007/BF00285812; MANUELIDIS L, 1976, NUCLEIC ACIDS RES, V3, P3063, DOI 10.1093/nar/3.11.3063; MARCUS M, 1976, NATURE, V272, P65; MUSICH PR, 1980, CHROMOSOMA, V80, P331, DOI 10.1007/BF00292688; POTTER SS, 1983, NUCLEIC ACIDS RES, V11, P3137, DOI 10.1093/nar/11.10.3137; ROSENBERG H, 1978, SCIENCE, V200, P394, DOI 10.1126/science.205944; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P507; WILLARD HF, 1984, HUM GENET, V66, P272, DOI 10.1007/BF00286615; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; WILLARD HF, 1984, CYTOGENET CELL GENET, V37, P610; WU JC, 1980, J MOL BIOL, V142, P363, DOI 10.1016/0022-2836(80)90277-6; YANG TP, 1982, P NATL ACAD SCI-BIOL, V79, P6593, DOI 10.1073/pnas.79.21.6593	28	226	233	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					524	532						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	2988334				2022-12-18	WOS:A1985AKE0700008
J	Moreno-De-Luca, D; Mulle, JG; Kaminsky, EB; Sanders, SJ; Myers, SM; Adam, MP; Pakula, AT; Eisenhauer, NJ; Uhas, K; Weik, L; Guy, L; Care, ME; Morel, CF; Boni, C; Salbert, BA; Chandrareddy, A; Demmer, LA; Chow, EWC; Surti, U; Aradhya, S; Pickering, DL; Golden, DM; Sanger, WG; Aston, E; Brothman, AR; Gliem, TJ; Thorland, EC; Ackley, T; Iyer, R; Huang, SW; Barber, JC; Crolla, JA; Warren, ST; Martin, CL; Ledbetter, DH				Moreno-De-Luca, Daniel; Mulle, Jennifer G.; Kaminsky, Erin B.; Sanders, Stephan J.; Myers, Scott M.; Adam, Margaret P.; Pakula, Amy T.; Eisenhauer, Nancy J.; Uhas, Kim; Weik, LuAnn; Guy, Lisa; Care, Melanie E.; Morel, Chantal F.; Boni, Charlotte; Salbert, Bonnie Anne; Chandrareddy, Ashadeep; Demmer, Laurie A.; Chow, Eva W. C.; Surti, Urvashi; Aradhya, Swaroop; Pickering, Diane L.; Golden, Denae M.; Sanger, Warren G.; Aston, Emily; Brothman, Arthur R.; Gliem, Troy J.; Thorland, Erik C.; Ackley, Todd; Iyer, Ram; Huang, Shuwen; Barber, John C.; Crolla, John A.; Warren, Stephen T.; Martin, Christa L.; Ledbetter, David H.		SGENE Consortium; Simons Simplex Collection Genetics; GeneSTAR	Deletion 17q12 Is a Recurrent Copy Number Variant that Confers High Risk of Autism and Schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIDDEN-MARKOV MODEL; GENOME-WIDE SCAN; SPECTRUM DISORDERS; COMMON VARIANTS; GENETICS; MICRODELETION; ASSOCIATION; POPULATION; DUPLICATIONS; CRITERIA	Autism spectrum disorders (ASD) and schizophrenia are neurodevelopmental disorders for which recent evidence indicates an important etiologic role for rare copy number variants (CNVs) and suggests common genetic mechanisms We performed cytogenomic array analysis in a discovery sample of patients with neurodevelopmental disorders referred for clinical testing We detected a recurrent 1 4 Mb deletion at 17q12 which harbors HNF1B, the gene responsible for renal cysts and diabetes syndrome (RCAD), in 18/15,749 patients including several with ASD, but 0/4 519 controls We identified additional shared phenotypic features among nine patients available for clinical assessment including macrocephaly characteristic facial features renal anomalies, and neurocognitive impairments In a large follow up sample the same deletion was identified in 2/1,182 ASD/neurocognitive impairment and in 4/6 340 schizophrenia patients, but in 0/47 929 controls (corrected p = 7 37 x 10(-5)) These data demonstrate that deletion 17q12 is a recurrent, pathogenic CNV that confers a very high risk for ASD and schizophrenia and show that one or more of the 15 genes in the deleted Interval is dosage sensitive and essential for normal brain development and function In addition the phenotypic features of patients with this CNV are consistent with a contiguous gene syndrome that extends beyond RCAD which is caused by HNF1B mutations only	[Moreno-De-Luca, Daniel; Mulle, Jennifer G.; Kaminsky, Erin B.; Adam, Margaret P.; Uhas, Kim; Warren, Stephen T.; Martin, Christa L.; Ledbetter, David H.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA; [Sanders, Stephan J.] Yale Univ, Sch Med, Ctr Child Study, Dept Genet, New Haven, CT 06504 USA; [Myers, Scott M.; Eisenhauer, Nancy J.; Boni, Charlotte; Salbert, Bonnie Anne] Geisinger Med Ctr, Danville, PA 17821 USA; [Pakula, Amy T.; Guy, Lisa] Emory Univ, Sch Med, Marcus Autism Ctr, Dept Pediat, Atlanta, GA 30329 USA; [Weik, LuAnn] Childrens Hosp Wisconsin, Milwaukee, WI 53233 USA; [Care, Melanie E.; Morel, Chantal F.] Univ Hlth Network, Fred A Litwin Family Ctr Genet Med, Toronto, ON M5T 3I9, Canada; [Care, Melanie E.; Morel, Chantal F.] Mt Sinai Hosp, Toronto, ON M5T 3I9, Canada; [Chandrareddy, Ashadeep; Demmer, Laurie A.] Tufts Univ, Div Genet, Boston, MA 02111 USA; [Chow, Eva W. C.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M6J 1H4, Canada; [Surti, Urvashi] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Aradhya, Swaroop] GeneDx, Gaithersburg, MD 20877 USA; [Pickering, Diane L.; Golden, Denae M.; Sanger, Warren G.] Univ Nebraska Med Ctr, Human Genet Lab, Omaha, NE 68102 USA; [Aston, Emily; Brothman, Arthur R.] Univ Utah, ARUP Labs, Salt Lake City, UT 84108 USA; [Gliem, Troy J.; Thorland, Erik C.] Mayo Clin, Rochester, MN 55905 USA; [Ackley, Todd; Iyer, Ram] Michigan Med Genet Labs, Ann Arbor, MI 48109 USA; [Huang, Shuwen; Barber, John C.; Crolla, John A.] Salisbury NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Yale University; Geisinger Medical Center; Emory University; Children's Hospital of Wisconsin; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Tufts University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Nebraska System; University of Nebraska Medical Center; Utah System of Higher Education; University of Utah; ARUP Laboratories; Mayo Clinic; Salisbury District Hospital; Emory University; Emory University	Moreno-De-Luca, D (corresponding author), Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA.		Warren, Stephen T/A-2498-2012; /AAD-2060-2020; Myers, Scott/AAE-6398-2019; Sanders, Stephan/S-8645-2019	/0000-0003-4651-0084; ARADHYA, SWAROOP/0000-0001-6219-2931; Sanders, Stephan/0000-0001-9112-5148	NIH [MH074090, HD064525, MH080583, MH080129, MH071425]; EU [LSHM CT 2006 037761]; NIMH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC2HD064525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH080583, R01MH081754, R01MH071425, R01MH080129, R01MH074090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded in part by NIH grants MH074090 (D H L and C L M), HD064525 (D H L and C I M) MH080583 U G M) MH080129 (S T W), and MH071425 (K Stefansson) The SGFNT project was sponsored by EU grant LSHM CT 2006 037761 (Project SGENE); Funding support for the genome wide association of schizo phrenia study was provided by the NIMH, and the genotyping of samples was provided through GAIN this data set was obtained from dbGaP through accession number phs000021 v Samples and associated phenotype data for the genome wide association of schizophrenia study were provided by the Molecular Genetics of Schizophrenia Collaboration (PI P V Gejman, Evanston North western Healthcare [ENH]] and Northwestern University Evan ston Illinois USA)	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Addington AM, 2009, CURR PSYCHIAT REP, V11, P156, DOI 10.1007/s11920-009-0024-y; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; Baldwin EL, 2008, GENET MED, V10, P415, DOI 10.1097/GIM.0b013e318177015c; Bassett AS, 2010, J PSYCHIATR RES, V44, P1005, DOI 10.1016/j.jpsychires.2010.06.013; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Ben-Shachar S, 2009, J MED GENET, V46, P382, DOI 10.1136/jmg.2008.064378; Bingham C, 2002, KIDNEY INT, V61, P1243, DOI 10.1046/j.1523-1755.2002.00272.x; Boydell J, 2007, SCHIZOPHR RES, V93, P203, DOI 10.1016/j.schres.2007.03.014; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Cantor RM, 2008, NEURON, V58, P165, DOI 10.1016/j.neuron.2008.04.007; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; CHANTELOT CB, 2005, DIABETES, V54, P3126; Cheroki C, 2008, J MED GENET, V45, P228, DOI 10.1136/jmg.2007.051839; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Lindner TH, 1999, HUM MOL GENET, V8, P2001, DOI 10.1093/hmg/8.11.2001; Loirat C, 2010, NEPHROL DIAL TRANSPL, V25, P3430, DOI 10.1093/ndt/gfq380; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martin Christa Lese, 2007, Curr Psychiatry Rep, V9, P141; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Muller D, 2006, KIDNEY INT, V70, P1656, DOI 10.1038/sj.ki.5001746; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Nagamani SCS, 2010, EUR J HUM GENET, V18, P278, DOI 10.1038/ejhg.2009.174; Palferman S, 2001, AM J HUM GENET, V69, P570; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Rosa A, 2002, SCHIZOPHRENIA BULL, V28, P697, DOI 10.1093/oxfordjournals.schbul.a006973; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Shen YP, 2010, PEDIATRICS, V125, pE727, DOI 10.1542/peds.2009-1684; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; SPITZER R. L., 1994, STRUCTURED CLIN INTE; SPITZER REJ, 1977, SCHEDULE AFFECTIVE D; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stone JL, 2007, HUM MOL GENET, V16, P704, DOI 10.1093/hmg/ddm015; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Toulopoulou T, 2003, SCHIZOPHR RES, V63, P261, DOI 10.1016/S0920-9964(02)00324-9; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; World Health Organization, 1994, SCHED CLIN ASS NEUR; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	70	225	236	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					618	630		10.1016/j.ajhg.2010.10.004	http://dx.doi.org/10.1016/j.ajhg.2010.10.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21055719	Green Published, hybrid			2022-12-18	WOS:000284668400007
J	Christiansen, HE; Schwarze, U; Pyott, SM; AlSwaid, A; Al Balwi, M; Alrasheed, S; Pepin, MG; Weis, MA; Eyre, DR; Byers, PH				Christiansen, Helena E.; Schwarze, Ulrike; Pyott, Shawna M.; AlSwaid, Abdulrahman; Al Balwi, Mohammed; Alrasheed, Shatha; Pepin, Melanie G.; Weis, Mary Ann; Eyre, David R.; Byers, Peter H.			Homozygosity for a Missense Mutation in SERPINH1, which Encodes the Collagen Chaperone Protein HSP47, Results in Severe Recessive Osteogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR CHAPERONE; I COLLAGEN; PROCOLLAGEN; PROPEPTIDE; DEFICIENCY; CHAIN; CRTAP; BONE	Osteogenesis imperfecta (OI) is characterized by bone fragility and fractures that may be accompanied by bone deformity, dentinogenesis imperfecta, short stature, and shortened life span. About 90% of individuals with 01 have dominant mutations in the type I collagen genes COL1A1 and COL1A2. Recessive forms of OI resulting from Mutations in collagen-modifying enzymes and chaperones CRTAP, LEPRE1, PPIB, and FKBP10 have recently been identified. We have identified an autosomal-recessive missense mutation (c.233T>C, pLeu78Pro) in SERPINH1, which encodes the collagen chaperone-like protein HSP47, that leads to a severe 01 phenotype. The mutation results in degradation of the endoplasmic reticulum resident HSP47 via the proteasome. Type 1 procollagen accumulates in the Golgi of fibroblasts from the affected individual and a population of the secreted type I procollagen is protease sensitive. These findings suggest that HSP47 monitors the integrity of the triple helix of type I procollagen at the ER/cis-Golgi boundary and, when absent, the rate of transit from the ER to the Golgi is increased and helical structure is compromised. The normal 3-hydroxylation of the prolyl residue at position 986 of the triple helical domain of pro alpha 1(1) chains places the role of HSP47 downstream from the CRTAP/P3H1/CyPB complex that is involved in prolyl 3-hydroxylation. Identification of this mutation in SERPINH1 gives further insight into critical steps of the collagen biosynthetic pathway and the molecular pathogenesis of OI.	[Schwarze, Ulrike; Pyott, Shawna M.; Pepin, Melanie G.; Byers, Peter H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Christiansen, Helena E.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [AlSwaid, Abdulrahman; Alrasheed, Shatha] King Abdul Aziz Med City, Dept Pediat, Riyadh 11426, Saudi Arabia; [Al Balwi, Mohammed] King Abdul Aziz Med City, Dept Pathol & Lab Med, Riyadh 11426, Saudi Arabia; [Weis, Mary Ann; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Byers, Peter H.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	pbyers@u.washington.edu		Al Balwi, Mohammed/0000-0003-2910-0390; Byers, Peter H./0000-0001-7786-7030; Alrasheed, Shatha/0000-0002-8713-9317	NIH [1 F31 AG032825-01, AR051582]; HHMI Molecular Medicine Program; Osteogenesis Imperfecta Foundation, Inc.; Freudmann Fund at the University of Washington; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR051582, R01AR036794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Molecular Medicine Program; Osteogenesis Imperfecta Foundation, Inc.; Freudmann Fund at the University of Washington; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported in part by funds from the NIH (1 F31 AG032825-01, AR051582), graduate student fellowship support from the HHMI Molecular Medicine Program, a research grant from the Osteogenesis Imperfecta Foundation, Inc., and the Freudmann Fund at the University of Washington. We thank Deborah Hoyer and Alex Lauderdale for initial analysis of protein production. We appreciate the participation in and support from the family in the Study. No conflicts of interest are noted by any of the authors.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Bodian DL, 2009, HUM MOL GENET, V18, P463, DOI 10.1093/hmg/ddn374; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; FISHER LW, 1987, J BIOL CHEM, V262, P13457; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; NAGATA K, 1986, J BIOL CHEM, V261, P7531; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001	22	225	239	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					389	398		10.1016/j.ajhg.2010.01.034	http://dx.doi.org/10.1016/j.ajhg.2010.01.034			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20188343	Bronze, Green Published			2022-12-18	WOS:000275678800010
J	Kolehmainen, J; Black, GCM; Saarinen, A; Chandler, K; Clayton-Smith, J; Traskelin, AL; Perveen, R; Kivitie-Kallio, S; Norio, R; Warburg, M; Fryns, JP; de la Chapelle, A; Lehesjoki, AE				Kolehmainen, J; Black, GCM; Saarinen, A; Chandler, K; Clayton-Smith, J; Traskelin, AL; Perveen, R; Kivitie-Kallio, S; Norio, R; Warburg, M; Fryns, JP; de la Chapelle, A; Lehesjoki, AE			Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; ENDOPLASMIC-RETICULUM; CHOREA-ACANTHOCYTOSIS; ASCORBATE PEROXIDASE; MEMBRANE-PROTEINS; PTS2 RECEPTOR; JEWISH TYPE; HUMAN PEX7; LOCALIZATION; SIGNAL	Cohen syndrome is an uncommon autosomal recessive disorder whose diagnosis is based on the clinical picture of nonprogressive psychomotor retardation and microcephaly, characteristic facial features, retinal dystrophy, and intermittent neutropenia. We have refined the critical region on chromosome 8q22 by haplotype analysis, and we report the characterization of a novel gene, COH1, that is mutated in patients with Cohen syndrome. The longest transcript (14,093 bp) is widely expressed and is transcribed from 62 exons that span a genomic region of similar to864 kb. COH1 encodes a putative transmembrane protein of 4,022 amino acids, with a complex domain structure. Homology to the Saccharomyces cerevisiae VPS13 protein suggests a role for COH1 in vesicle-mediated sorting and transport of proteins within the cell.	Haartman Inst, Folkhalsan Inst Genet, Helsinki, Finland; Haartman Inst, Dept Med Genet, Helsinki, Finland; Hosp Children & Adolescents, Helsinki, Finland; Univ Helsinki, Cent Hosp, Helsinki, Finland; Family Federat Finland, Dept Med Genet, Helsinki, Finland; Univ Manchester, Manchester Royal Eye Hosp, Acad Unit Ophthalmol, Manchester, Lancs, England; Univ Dept Med Genet, Manchester, Lancs, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Univ Copenhagen, Glostrup Hosp, Ctr Disabled Persons, DK-2600 Glostrup, Denmark; Univ Leuven, Ctr Human Genet, Louvain, Belgium; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Helsinki; Helsinki University Central Hospital; Family Federation of Finland; Manchester Royal Eye Hospital; University of Manchester; University of Manchester; University of Manchester; University of Copenhagen; KU Leuven; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lehesjoki, AE (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Biomedicum Helsinki, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	anna-elina.lehesjoki@helsinki.fi	Black, Graeme/K-7374-2015	Black, Graeme/0000-0001-8727-6592; Seitsonen, Anne/0000-0001-5488-0291	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA 16058, P30 CA016058] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; CAREY JC, 1978, J PEDIATR-US, V93, P239, DOI 10.1016/S0022-3476(78)80504-6; Chandler KE, 2003, J MED GENET, V40, P233, DOI 10.1136/jmg.40.4.233; Chandler KE, 2002, AM J MED GENET, V111, P453, DOI 10.1002/ajmg.10611; COHEN MM, 1973, J PEDIATR-US, V83, P280; ERDMANN R, 1994, YEAST, V10, P935, DOI 10.1002/yea.320100708; Fryns JP, 1996, CLIN GENET, V49, P237; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gouzy J, 1999, COMPUT CHEM, V23, P333, DOI 10.1016/S0097-8485(99)00011-X; HIGGINS CF, 1990, J BIOENERG BIOMEMBR, V22, P571, DOI 10.1007/BF00762962; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; Kivitie-Kallio S, 2001, AM J MED GENET, V102, P125, DOI 10.1002/1096-8628(20010801)102:2<125::AID-AJMG1439>3.0.CO;2-0; Kivitie-Kallio S, 2000, OPHTHALMOLOGY, V107, P1737, DOI 10.1016/S0161-6420(00)00279-7; Kolehmainen J, 1997, EUR J HUM GENET, V5, P206, DOI 10.1159/000484765; KONDO I, 1990, AM J MED GENET, V37, P109, DOI 10.1002/ajmg.1320370126; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; McNew JA, 1996, TRENDS BIOCHEM SCI, V21, P54, DOI 10.1016/S0968-0004(96)80181-2; Mullen RT, 1999, PLANT CELL, V11, P2167, DOI 10.1105/tpc.11.11.2167; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NORIO R, 1984, CLIN GENET, V25, P1; Norio R, 2003, HUM GENET, V112, P441, DOI 10.1007/s00439-002-0875-3; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Redding K, 1996, MOL CELL BIOL, V16, P6208; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; TAHVANAINEN E, 1994, NAT GENET, V7, P201, DOI 10.1038/ng0694-201; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825	37	225	232	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1359	1369		10.1086/375454	http://dx.doi.org/10.1086/375454			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12730828	Green Published, Bronze			2022-12-18	WOS:000183275500001
J	Bonaglia, MC; Giorda, R; Borgatti, R; Felisari, G; Gagliardi, C; Selicorni, A; Zuffardi, O				Bonaglia, MC; Giorda, R; Borgatti, R; Felisari, G; Gagliardi, C; Selicorni, A; Zuffardi, O			Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSPECIFIC MENTAL-RETARDATION; POSTSYNAPTIC DENSITY; MOLECULAR CHARACTERIZATION; CHROMOSOME 22Q13.3; SYNAPTIC PROTEINS; 22Q TELOMERE; SEQUENCE; FAMILY; TRANSLOCATIONS; MUTATIONS	The terminal 22q13.3 deletion syndrome is characterized by severe expressive-language delay, mild mental retardation, hypotonia, joint laxity, dolichocephaly, and minor facial dysmorphisms. We identified a child with all the features of 22q13.3 deletion syndrome. The patient's karyotype showed a de novo balanced translocation between chromosomes 12 and 22, with the breakpoint in the 22q13.3 critical region of the 22q distal deletion syndrome [46, XY, t(12;22)(q24.1;q13.3)]. FISH investigations revealed that the translocation was reciprocal, with the chromosome 22 breakpoint within the 22q subtelomeric cosmid 106G1220 and the chromosome 12q breakpoint near STS D12S317. Using Southern blot analysis and inverse PCR, we located the chromosome 12 breakpoint in an intron of the FLJ10659 gene and located the chromosome 22 breakpoint within exon 21 of the human homologue of the ProSAP2 gene. Short homologous sequences (5-bp, CTG[C/A]C) were found at the breakpoint on both derivative chromosomes. The translocation does not lead to the loss of any portion of DNA. Northern blot analysis of human tissues, using the rat ProSAP2 cDNA, showed that full-length transcripts were found only in the cerebral cortex and the cerebellum. The FLJ10659 gene is expressed in various tissues and does not show tissue-specific isoforms. The finding that ProSAP2 is included in the critical region of the 22q deletion syndrome and that our proband displays all signs and symptoms of the syndrome suggests that ProSAP2 haploinsufficiency is the cause of the 22q13.3 deletion syndrome. ProSAP2 is a good candidate for this syndrome, because it is preferentially expressed in the cerebral cortex and the cerebellum and encodes a scaffold protein involved in the postsynaptic density of excitatory synapses.	IRCCS E Medea, I-23842 Bosisio Parini, Lecco, Italy; Univ Milan, Osped San Raffaele, Clin Pediat Marchi, I-20127 Milan, Italy; Univ Milan, Osped San Raffaele, Lab Citogenet, I-20127 Milan, Italy; Univ Pavia, I-27100 Pavia, Italy	IRCCS Eugenio Medea; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia	Bonaglia, MC (corresponding author), IRCCS E Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, Lecco, Italy.	bonaglia@bp.lnf.it	Giorda, Roberto/J-1052-2014; Bonaglia, Maria Clara/K-2775-2016; Giorda, Roberto/Q-6010-2019; Borgatti, Renato/AEY-4481-2022; Borgatti, Renato/K-5139-2018; Borgatti, Renato/AAA-4108-2022	Giorda, Roberto/0000-0001-8175-9606; Bonaglia, Maria Clara/0000-0002-7121-7712; Giorda, Roberto/0000-0001-8175-9606; Borgatti, Renato/0000-0001-8165-4994; Borgatti, Renato/0000-0001-8165-4994; Borgatti, Renato/0000-0001-8165-4994; Gagliardi, Chiara/0000-0001-9931-9879; zuffardi, orsetta/0000-0002-1466-4559				Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; De Vries BBA, 2001, J MED GENET, V38, P175, DOI 10.1136/jmg.38.3.175; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; DUTRILLAUX B, 1981, HUM GENET, V57, P93; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; GIACALONE JP, 1992, AM J HUM GENET, V50, P725; Goizet C, 2000, AM J MED GENET, V96, P839, DOI 10.1002/1096-8628(20001204)96:6<839::AID-AJMG29>3.0.CO;2-R; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Knight SJL, 2000, J MED GENET, V37, P401, DOI 10.1136/jmg.37.6.401; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NESSLINGER NJ, 1994, AM J HUM GENET, V54, P464; Ning Y, 1996, HUM GENET, V97, P765; Nothwang HG, 2000, CYTOGENET CELL GENET, V90, P126, DOI 10.1159/000015647; Praphanphoj V, 2000, J MED GENET, V37, P58, DOI 10.1136/jmg.37.1.58; Prasad C, 2000, CLIN GENET, V57, P103, DOI 10.1034/j.1399-0004.2000.570203.x; Precht KS, 1998, J MED GENET, V35, P939, DOI 10.1136/jmg.35.11.939; Sapir T, 1999, EUR J BIOCHEM, V266, P1011, DOI 10.1046/j.1432-1327.1999.00942.x; Toniolo D, 2000, CURR OPIN GENET DEV, V10, P280, DOI 10.1016/S0959-437X(00)00080-0; Wong ACC, 1997, AM J HUM GENET, V60, P113; Wong ACC, 1999, GENOMICS, V59, P326, DOI 10.1006/geno.1999.5889; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	28	225	239	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					261	268		10.1086/321293	http://dx.doi.org/10.1086/321293			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11431708	Bronze, Green Published			2022-12-18	WOS:000170108200002
J	Ferrante, MI; Giorgio, G; Feather, SA; Bulfone, A; Wright, V; Ghiani, M; Selicorni, A; Gammaro, L; Scolari, F; Woolf, AS; Sylvie, O; Bernard, LM; Malcolm, S; Winter, R; Ballabio, A; Franco, B				Ferrante, MI; Giorgio, G; Feather, SA; Bulfone, A; Wright, V; Ghiani, M; Selicorni, A; Gammaro, L; Scolari, F; Woolf, AS; Sylvie, O; Bernard, LM; Malcolm, S; Winter, R; Ballabio, A; Franco, B			Identification of the gene for oral-facial-digital type I syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; X-CHROMOSOME; MUS-SPRETUS; SYSTEM; MALFORMATIONS; LOCALIZATION; DOMAIN; DNA	Oral-facial-digital type 1 syndrome (OFD1 [MIM 311200]) is transmitted as an X-linked dominant condition with lethality in males and is characterized by malformations of the face, oral cavity, and digits, and by a highly variable expressivity even within the same family. Malformation of the brain and polycystic kidneys are commonly associated with this disorder. The locus for OFD1 was mapped by linkage analysis to a 12-Mb interval, flanked by markers DXS85 and DXS7105 in the Xp22 region. To identify the gene responsible for this syndrome, we analyzed several transcripts mapping to the region and found mutations in OFD1 (formerly named "Cxorf5/71-7a"), encoding a protein containing coiled-coil alpha -helical domains. Seven patients with OFD1, including three with familial and four with sporadic cases, were analyzed. Analysis of the familial cases revealed a missense mutation, a 19-bp deletion, and a single base-pair deletion leading to a frameshift. In the sporadic cases, we found a missense (de novo), a nonsense, a splice, and a frameshift mutation. RNA in situ studies on mouse embryo tissue sections show that Ofd1 is developmentally regulated and is expressed in all tissues affected in OFD1 syndrome. The involvement of OFD1 in oral-facial-digital type I syndrome demonstrates an important role of this gene in human development.	Telethon Inst Genet & Med, I-80131 Naples, Italy; Clin Pediat Marchi, Milan, Italy; Univ London, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; Univ London, Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England; Univ Verona, Sch Med, I-37100 Verona, Italy; Spedali Civili, Div Nephrol, I-25125 Brescia, Italy; Univ Brescia, Brescia, Italy; Univ Hosp Pontchaillou, Dept Pediat & Genet, Rennes, France; Univ Naples, Fac Med, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of London; University College London; University of London; University College London; University of Verona; Hospital Spedali Civili Brescia; University of Brescia; CHU Rennes; University of Naples Federico II	Franco, B (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.		Woolf, Adrian S./AAZ-1075-2020; BALLABIO, Andrea/AAL-2672-2020; scolari, francesco/AAC-5957-2022; FRANCO, Brunella/S-2882-2018	Woolf, Adrian S./0000-0001-5541-1358; BALLABIO, Andrea/0000-0003-1381-4604; FRANCO, Brunella/0000-0001-5588-4569; Ferrante, Maria Immacolata/0000-0002-8102-8018; Scolari, Francesco/0000-0003-0233-9705	Telethon [TGM06S01, F.2] Funding Source: Medline	Telethon(Fondazione Telethon)		Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Buchner G, 2000, GENOMICS, V65, P16, DOI 10.1006/geno.2000.6146; Coll E, 1997, NEPHROL DIAL TRANSPL, V12, P1040, DOI 10.1093/ndt/12.5.1040; CONNACHER AA, 1987, J MED GENET, V24, P116, DOI 10.1136/jmg.24.2.116; de Conciliis L, 1998, GENOMICS, V51, P243, DOI 10.1006/geno.1998.5348; DOEGE TC, 1964, NEW ENGL J MED, V271, P1073, DOI 10.1056/NEJM196411192712101; DONNAI D, 1987, J MED GENET, V24, P84, DOI 10.1136/jmg.24.2.84; Feather SA, 1997, NEPHROL DIAL TRANSPL, V12, P1354, DOI 10.1093/ndt/12.7.1354; Feather SA, 1997, HUM MOL GENET, V6, P1163, DOI 10.1093/hmg/6.7.1163; Gedeon AK, 1999, AM J MED GENET, V82, P352, DOI 10.1002/(SICI)1096-8628(19990212)82:4<352::AID-AJMG15>3.0.CO;2-G; GORLIN RJ, 1962, J PEDIATR-US, V61, P520, DOI 10.1016/S0022-3476(62)80143-7; KUNKEL LM, 1983, NUCLEIC ACIDS RES, V11, P7961, DOI 10.1093/nar/11.22.7961; Odent S, 1998, AM J MED GENET, V75, P389, DOI 10.1002/(SICI)1096-8628(19980203)75:4<389::AID-AJMG8>3.0.CO;2-L; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAPILLONLEAGE PJ, 1954, REV STOMAT PARIS, V55, P209; Prakash SK, 1999, GENOMICS, V59, P77, DOI 10.1006/geno.1999.5844; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; RUGARLI EI, 1995, NAT GENET, V10, P466, DOI 10.1038/ng0895-466; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Scolari F, 1997, NEPHROL DIAL TRANSPL, V12, P1247, DOI 10.1093/ndt/12.6.1247; SWEET HO, 1980, J HERED, V71, P207, DOI 10.1093/oxfordjournals.jhered.a109349; Toriello H V, 1993, Clin Dysmorphol, V2, P95; TOWFIGHI J, 1985, ARCH PATHOL LAB MED, V109, P642; WETTKESCHAFER R, 1983, HUM GENET, V64, P1, DOI 10.1007/BF00289472	25	225	232	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					569	576		10.1086/318802	http://dx.doi.org/10.1086/318802			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179005	Green Published, Bronze			2022-12-18	WOS:000166994200002
J	MACIEL, P; GASPAR, C; DESTEFANO, AL; SILVEIRA, I; COUTINHO, P; RADVANY, J; DAWSON, DM; SUDARSKY, L; GUIMARAES, J; LOUREIRO, JEL; NEZARATI, MM; CORWIN, LI; LOPESCENDES, I; ROOKE, K; ROSENBERG, R; MACLEOD, P; FARRER, LA; SEQUEIROS, J; ROULEAU, GA				MACIEL, P; GASPAR, C; DESTEFANO, AL; SILVEIRA, I; COUTINHO, P; RADVANY, J; DAWSON, DM; SUDARSKY, L; GUIMARAES, J; LOUREIRO, JEL; NEZARATI, MM; CORWIN, LI; LOPESCENDES, I; ROOKE, K; ROSENBERG, R; MACLEOD, P; FARRER, LA; SEQUEIROS, J; ROULEAU, GA			CORRELATION BETWEEN CAG REPEAT LENGTH AND CLINICAL-FEATURES IN MACHADO-JOSEPH DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; MYOTONIC-DYSTROPHY; GENETIC DISORDER; INSTABILITY; FAMILY; DEGENERATION; STABILITY; PHENOTYPE; SYSTEM	Machado-Joseph disease (MJD) is associated with the expansion of a CAG trinucleotide repeat in a novel gene on 14q32.1. We confirmed the presence of this expansion in 156 MJD patients from 33 families of different geographic origins: 15 Portuguese Azorean, 2 Brazilian, and 16 North American of Portuguese Azorean descent. Normal chromosomes contain between 12 and 37 CAG repeats in the MJD gene, whereas MJD gene carriers have alleles within the expanded range of 62-84 CAG units. The distribution of expanded alleles and the gap between normal and expanded allele sizes is either inconsistent with a premutation hypothesis or most (if not all) of the alleles we studied descend from a common ancestor. There is a strong correlation between the expanded repeat size and the age at onset of the disease as well as the clinical presentation. There is mild instability of the CAG tract length with transmission of the expanded alleles; both increase and decrease in size between parents and progeny occur, with Larger variations in male than in female transmissions. Together, these effects can partly explain the variability of age at onset and of phenotypic features in MJD; however, other modifying factors must exist.	MCGILL UNIV, MONTREAL GEN HOSP, CTR RES NEUROSCI, RES INST, MONTREAL, PQ H3G 1A4, CANADA; UNIV PORTO, ICBAS, MED GENET LAB, P-4100 OPORTO, PORTUGAL; UNIV PORTO, IBMC, UNIGENE, P-4100 OPORTO, PORTUGAL; BOSTON UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02118 USA; BRIGHAM & WOMENS HOSP, DIV NEUROL, BOSTON, MA 02115 USA; HOSP SANTO ANTONIO, SERV NEUROL, OPORTO, PORTUGAL; HOSP ISRAELITA ALBERT EINSTEIN, SAO PAULO, BRAZIL; VET ADM MED CTR, SERV NEUROL, BOSTON, MA USA; HOSP EGAS MONIZ, LISBON, PORTUGAL; HOSP VILA REAL, VILA REAL, PORTUGAL; MCMASTER UNIV, FAC HLTH SCI, HAMILTON, ON, CANADA; SE NEUROL ASSOCIATES, PLYMOUTH, MA USA; UNIV TEXAS, SW MED CTR, DEPT NEUROL, DALLAS, TX 75235 USA; VICTORIA GEN HOSP, DEPT LAB MED, GENET SECT, VICTORIA, BC, CANADA	McGill University; Universidade do Porto; Universidade do Porto; Boston University; Harvard University; Brigham & Women's Hospital; Hospital Israelita Albert Einstein; US Department of Veterans Affairs; Veterans Health Administration (VHA); Egas Moniz Hospital; McMaster University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Victoria			Lopes-Cendes, Iscia/B-9416-2013; Maciel, Patricia/AAH-2102-2020; Coutinho, Paula/K-6053-2013; Farrer, Lindsay/AAS-1035-2020; Loureiro, José Leal/K-6379-2013; Silveira, Isabel/D-6881-2012	Lopes-Cendes, Iscia/0000-0002-6221-6822; Maciel, Patricia/0000-0002-0920-6350; Loureiro, José Leal/0000-0002-6195-5412; Silveira, Isabel/0000-0002-2610-5260; Coutinho, Paula/0000-0002-3461-230X; Sequeiros, Jorge/0000-0002-9846-1037; DeStefano, Anita/0000-0002-9335-2819; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031687] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 31687] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ANDREW SE, 1994, AM J HUM GENET, V54, P852; Aoki M., 1994, American Journal of Human Genetics, V55, pA210; BARCELO JM, 1993, HUM MOL GENET, V2, P705, DOI 10.1093/hmg/2.6.705; CHONG SS, 1994, AM J HUM GENET S, V55, pA213; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; COUTINHO P, 1982, ACTA NEUROPATHOL, V58, P48, DOI 10.1007/BF00692697; COUTINHO P, 1977, O MEDICO, V82, P1; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Goldfarb L. G., 1994, American Journal of Human Genetics, V55, pA221; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; JODICE C, 1994, AM J HUM GENET, V54, P959; KANDA T, 1989, CLIN NEUROPATHOL, V8, P134; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; NETER J, 1985, APPLIED LINEAR STATI; Radvany J, 1993, Arq Neuropsiquiatr, V51, P21; RANUM LPW, 1994, AM J HUM GENET, V55, P244; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; Sambrook J., 1989, MOL CLONING LAB MANU; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; SEQUEIROS J, 1994, GENOMICS, V21, P645, DOI 10.1006/geno.1994.1327; SEQUEIROS J, 1981, GENETIC ASPECTS MACH, V2, P137; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; SUDARSKY L, 1992, MOVEMENT DISORD, V7, P204, DOI 10.1002/mds.870070303; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TWIST EC, 1995, J MED GENET, V31, P823	37	225	230	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					54	61						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611296				2022-12-18	WOS:A1995RE62900007
J	SHIELDS, GF; SCHMIECHEN, AM; FRAZIER, BL; REDD, A; VOEVODA, MI; REED, JK; WARD, RH				SHIELDS, GF; SCHMIECHEN, AM; FRAZIER, BL; REDD, A; VOEVODA, MI; REED, JK; WARD, RH			MTDNA SEQUENCES SUGGEST A RECENT EVOLUTIONARY DIVERGENCE FOR BERINGIAN AND NORTHERN NORTH-AMERICAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; 9-BP DELETION; ESKIMOS; AMPLIFICATION; MUTATIONS; INDIANS	Conventional descriptions of the pattern and process of human entry into the New World from Asia are incomplete and controversial. In order to gain an evolutionary insight into this process, we have sequenced the control region of mtDNA in samples of contemporary tribal populations of eastern Siberia, Alaska, and Greenland and have compared them with those of Amerind speakers of the Pacific Northwest and with those of the Altai of central Siberia. Specifically, we have analyzed sequence diversity in 33 mitochondrial lineages identified in 90 individuals belonging to five Circumpolar populations of Beringia, North America, and Greenland: Chukchi from Siberia, Inupiaq Eskimos and Athapaskans from Alaska, Eskimos from West Greenland, and Haida from Canada. Hereafter, we refer to these five populations as ''Circumarctic peoples.'' These data were then compared with the sequence diversity in 47 mitochondrial lineages identified in a sample of 145 individuals from three Amerind-speaking tribes (Bella Coola, Nuu-Chah-Nulth, and Yakima) of the Pacific Northwest, plus 16 mitochondrial lineages identified in a sample of 17 Altai from central Siberia. Sequence diversity within and among Circumarctic populations is considerably less than the sequence diversity observed within and among the three Amerind tribes. The similarity of sequences found among the geographically dispersed Circumarctic groups, plus the small values of mean pairwise sequence differences within Circumarctic populations, suggest a recent and rapid evolutionary radiation of these populations. In addition, Circumarctic populations lack the 9-bp deletion which has been used to trace various migrations out of Asia, while populations of southeastern Siberia possess this deletion. On the basis of these observations, while the evolutionary affinities of Native Americans extend west to the Circumarctic populations of eastern Siberia, they do not include the Altai of central Siberia.	UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA; UNIV ALASKA, INST ARCTIC BIOL, FAIRBANKS, AK 99701 USA; RUSSIAN ACAD MED SCI, INST INTERNAL MED, NOVOSIBIRSK, RUSSIA	Utah System of Higher Education; University of Utah; University of Alaska System; University of Alaska Fairbanks; Russian Academy of Medical Sciences			Voevoda, Mikhail/N-6713-2015	Voevoda, Mikhail/0000-0001-9425-413X	NIGMS NIH HHS [R01 GM 41746] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041746] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEKSEYEV VP, 1979, ARCTIC ANTHROPOL, V16, P147; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BURCH ES, 1979, ARCTIC ANTHROPOL, V16, P62; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CARR SM, 1987, BIOCHEM GENET, V25, P385, DOI 10.1007/BF00554547; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CRAWFORD MH, 1982, CURRENT DEV ANTHR GE, V2, P51; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DUMOND DE, 1987, AM ANTHROPOL, V89, P32, DOI 10.1525/aa.1987.89.1.02a00020; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERRELL RE, 1981, AM J PHYS ANTHROPOL, V55, P351, DOI 10.1002/ajpa.1330550309; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1992, SCI AM, V267, P94, DOI 10.1038/scientificamerican1192-94; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; HARIHARA S, 1992, HUM BIOL, V64, P161; HARPER AB, 1980, ANN HUM BIOL, V7, P547, DOI 10.1080/03014468000004661; HARPER AB, 1982, HIST AM PHYSICAL ANT, P281; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HEY J, 1991, GENETICS, V128, P831; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; HORAI S, 1993, MOL BIOL EVOL, V10, P23; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Krauss ME, 1988, CROSSROADS CONTINENT, P145; KRAUSS ME, 1979, MAY JOINT US USSR S; LEVIN MG, 1963, ARCTIC I N AM ANTHR, V3; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; Nei M., 1987, MOL EVOLUTIONARY GEN; OWEN RC, 1984, ORIGINS MODERN HUMAN, P517; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAMBUUGHIN N, 1991, GENETIKA+, V27, P2143; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHANFIELD MS, 1980, HUM HERED, V30, P343, DOI 10.1159/000153155; SCHELL LM, 1978, AM J PHYS ANTHROPOL, V49, P111, DOI 10.1002/ajpa.1330490117; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1987, J MOL EVOL, V24, P212, DOI 10.1007/BF02111234; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; STONEKING M, 1986, COLD SPRING HARB SYM, V51, P433, DOI 10.1101/SQB.1986.051.01.052; STONEKING M, 1989, COLONIZATION PACIFIC, P215; SWADESH Morris, 1964, PREHISTORIC MAN NEW, P527; SZATHMARY EJE, 1978, CURR ANTHROPOL, V19, P673, DOI 10.1086/202192; SZATHMARY EJE, 1985, J PAC HIST, V19, P79; SZATHMARY EJE, IN PRESS GENETICS CE; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; TORRONI A, 1992, GENETICS, V130, P153; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WARD RH, IN PRESS P NATL ACAD; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; [No title captured]	58	225	229	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					549	562						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352271				2022-12-18	WOS:A1993LU55900001
J	Aoki, Y; Niihori, T; Banjo, T; Okamoto, N; Mizuno, S; Kurosawa, K; Ogata, T; Takada, F; Yano, M; Ando, T; Hoshika, T; Barnett, C; Ohashi, H; Kawame, H; Hasegawa, T; Okutani, T; Nagashima, T; Hasegawa, S; Funayama, R; Nagashima, T; Nakayama, K; Inoue, SI; Watanabe, Y; Ogura, T; Matsubara, Y				Aoki, Yoko; Niihori, Tetsuya; Banjo, Toshihiro; Okamoto, Nobuhiko; Mizuno, Seiji; Kurosawa, Kenji; Ogata, Tsutomu; Takada, Fumio; Yano, Michihiro; Ando, Toru; Hoshika, Tadataka; Barnett, Christopher; Ohashi, Hirofumi; Kawame, Hiroshi; Hasegawa, Tomonobu; Okutani, Takahiro; Nagashima, Tatsuo; Hasegawa, Satoshi; Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko; Inoue, Shin-ichi; Watanabe, Yusuke; Ogura, Toshihiko; Matsubara, Yoichi			Gain-of-Function Mutations in RIT1 Cause Noonan Syndrome, a RAS/MAPK Pathway Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; JUVENILE MYELOMONOCYTIC LEUKEMIA; GERMLINE MUTATIONS; COSTELLO-SYNDROME; CLINICAL-MANIFESTATIONS; LEOPARD SYNDROMES; SEQUENCING DATA; RAF1 MUTATIONS; CFC SYNDROME; RAS	RAS GTPases mediate a wide variety of cellular functions, including cell proliferation, survival, and differentiation. Recent studies have revealed that germline mutations and mosaicism for classical RAS mutations, including those in HRAS, KRAS, and NRAS, cause a wide spectrum of genetic disorders. These include Noonan syndrome and related disorders (RAS/mitogen-activated protein kinase [RAS/MAPK] pathway syndromes, or RASopathies), nevus sebaceous, and Schimmelpenning syndrome. In the present study, we identified a total of nine missense, nonsynonymous mutations in RIT1, encoding a member of the RAS subfamily, in 17 of 180 individuals (9%) with Noonan syndrome or a related condition but with no detectable mutations in known Noonan-related genes. Clinical manifestations in the RIT1-mutation-positive individuals are consistent with those of Noonan syndrome, which is characterized by distinctive facial features, short stature, and congenital heart defects. Seventy percent of mutation-positive individuals presented with hypertrophic cardiomyopathy; this frequency is high relative to the overall 20% incidence in individuals with Noonan syndrome. Luciferase assays in NIH 3T3 cells showed that five RIT1 alterations identified in children with Noonan syndrome enhanced ELK1 trans-activation. The introduction of mRNAs of mutant RIT1 into 1-cell-stage zebrafish embryos was found to result in a significant increase of embryos with craniofacial abnormalities, incomplete looping, a hypoplastic chamber in the heart, and an elongated yolk sac. These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes.	[Aoki, Yoko; Niihori, Tetsuya; Inoue, Shin-ichi; Matsubara, Yoichi] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 9808574, Japan; [Banjo, Toshihiro] Tohoku Univ, Inst Dev Aging & Canc, Dept Dev Neurobiol, Sendai, Miyagi 9808575, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Dept Med Genet, Izumi 5941101, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Osaka Med Ctr, Izumi 5941101, Japan; [Mizuno, Seiji] Cent Hosp Kasugai, Aichi Human Serv Ctr, Dept Pediat, Kasugai, Aichi 4800392, Japan; [Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa 2328555, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan; [Takada, Fumio] Kitasato Univ, Grad Sch Med Sci, Dept Med Genet, Sagamihara, Kanagawa 2520373, Japan; [Yano, Michihiro] Akita Univ, Sch Med, Dept Pediat, Akita 0108543, Japan; [Ando, Toru] Municipal Tsuruga Hosp, Dept Pediat, Tsuruga, Fukui 9148502, Japan; [Hoshika, Tadataka] Tottori Prefectural Cent Hosp, Dept Pediat, Tottori 6800901, Japan; [Barnett, Christopher] Womens & Childrens Hosp, South Australian Clin Genet Serv, SA Pathol, Adelaide, SA 5006, Australia; [Barnett, Christopher] Univ Adelaide, Sch Paediat & Reproduct Hlth, Adelaide, SA 5005, Australia; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama 3398551, Japan; [Ohashi, Hirofumi] Ochanomizu Univ, Dept Genet Counseling, Tokyo 1128610, Japan; [Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Okutani, Takahiro] Wakayama Med Univ, Gen Perinatal Med Ctr, Div Neonatal Intens Care Unit, Wakayama 6418510, Japan; [Nagashima, Tatsuo] Jikei Univ, Sch Med, Dept Pediat, Tokyo 1058461, Japan; [Hasegawa, Satoshi] Niigata Grad Sch Med & Dent Sci, Dept Pediat, Niigata 9518510, Japan; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Cell Proliferat, Sendai, Miyagi 9808575, Japan; [Matsubara, Yoichi] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	Tohoku University; Tohoku University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Hamamatsu University School of Medicine; Kitasato University; Akita University; SA Pathology; University of Adelaide; Saitama Children's Medical Center; Ochanomizu University; Keio University; Wakayama Medical University; Jikei University; Niigata University; Tohoku University; National Center for Child Health & Development - Japan	Aoki, Y (corresponding author), Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 9808574, Japan.	aokiy@med.tohoku.ac.ip	Niihori, Tetsuya/ABE-2350-2021; Kurosawa, Kenji/B-6561-2016; Hasegawa, Tomonobu/L-3331-2013	Niihori, Tetsuya/0000-0002-2118-9776; Kurosawa, Kenji/0000-0002-6817-7748; Banjo, Toshihiro/0000-0001-6210-7506; Ogata, Tsutomu/0000-0001-7178-9991	Biomedical Research Core of Tohoku University Graduate School of Medicine; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [LS004]; MEXT; Japan Society for the Promotion of Science; Ministry of Health, Labor, and Welfare; National Cancer Center Research and Development Fund [23-22-11]; Grants-in-Aid for Scientific Research [22227002, 23390268, 24790189, 24116503] Funding Source: KAKEN	Biomedical Research Core of Tohoku University Graduate School of Medicine; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the families and the doctors who participated in this study. We are grateful to Jun-ichi Miyazaki at Osaka University for supplying the pCAGGS expression vector. We thank Yoko Narumi, Tomoko Kobayashi, Shoko Komatsuzaki, Yu Abe, Yuka Saito, Rumiko Izumi, Mitsuji Moriya, and Masako Yaoita for contributing to routine diagnostic work and Yoko Tateda, Kumi Kato, and Riyo Takahashi for their technical assistance. We are grateful to Eric Haan for sending samples of Noonan syndrome and related disorders. We also acknowledge the support of the Biomedical Research Core of Tohoku University Graduate School of Medicine. This work was supported by the Funding Program for the Next Generation of World-Leading Researchers (NEXT Program) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) to Y.A. (LS004), by Grants-in-Aids from MEXT, from the Japan Society for the Promotion of Science, and from the Ministry of Health, Labor, and Welfare to Y.M. and T.N. This work was supported in part by the National Cancer Center Research and Development Fund (23-22-11).	Abe Y, 2012, AM J MED GENET A, V158A, P1083, DOI 10.1002/ajmg.a.35292; Anastasaki C, 2009, HUM MOL GENET, V18, P2543, DOI 10.1093/hmg/ddp186; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; BURCH M, 1993, J AM COLL CARDIOL, V22, P1189, DOI 10.1016/0735-1097(93)90436-5; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Denayer E, 2010, GENE CHROMOSOME CANC, V49, P242, DOI 10.1002/gcc.20735; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Groesser L, 2012, NAT GENET, V44, P783, DOI 10.1038/ng.2316; Hynds DL, 2003, J CELL SCI, V116, P1925, DOI 10.1242/jcs.00401; Jongmans MCJ, 2010, GENE CHROMOSOME CANC, V49, P635, DOI 10.1002/gcc.20773; Kobayashi T, 2010, HUM MUTAT, V31, P284, DOI 10.1002/humu.21187; Komatsuzaki S, 2010, J HUM GENET, V55, P801, DOI 10.1038/jhg.2010.116; Kratz CP, 2011, AM J MED GENET C, V157C, P83, DOI 10.1002/ajmg.c.30300; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Narumi Y, 2008, J HUM GENET, V53, P834, DOI 10.1007/s10038-008-0320-0; Narumi Y, 2007, AM J MED GENET A, V143A, P799, DOI 10.1002/ajmg.a.31658; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Niihori T, 2011, J HUM GENET, V56, P707, DOI 10.1038/jhg.2011.85; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Perez B, 2010, J MED GENET, V47, P686, DOI 10.1136/jmg.2010.076836; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Romano AA, 2010, PEDIATRICS, V126, P746, DOI 10.1542/peds.2009-3207; Runtuwene V, 2011, DIS MODEL MECH, V4, P393, DOI 10.1242/dmm.007112; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Saito Y, 2012, LEUKEMIA RES, V36, P1009, DOI 10.1016/j.leukres.2012.04.018; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4; van der Burgt I, 2007, J MED GENET, V44, P459, DOI 10.1136/jmg.2007.049270; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x	48	224	235	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					173	180		10.1016/j.ajhg.2013.05.021	http://dx.doi.org/10.1016/j.ajhg.2013.05.021			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23791108	Bronze, Green Published			2022-12-18	WOS:000321804500018
J	Gillis, LA; McCallum, J; Kaur, M; DeScipio, C; Yaeger, D; Mariani, A; Kline, AD; Li, HH; Devoto, M; Jackson, LG; Krantz, ID				Gillis, LA; McCallum, J; Kaur, M; DeScipio, C; Yaeger, D; Mariani, A; Kline, AD; Li, HH; Devoto, M; Jackson, LG; Krantz, ID			NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRACHMANN-DELANGE-SYNDROME; AUTOSOMAL-DOMINANT INHERITANCE; SISTER-CHROMATID COHESION; NIPPED-B; NORMAL PARENTS; HOMOLOG; TRANSMISSION; VARIABILITY; ACTIVATION; SIBS	The Cornelia de Lange syndrome (CdLS) is a multisystem developmental disorder characterized by facial dysmorphia, upper-extremity malformations, hirsutism, cardiac defects, growth and cognitive retardation, and gastrointestinal abnormalities. Both missense and protein-truncating mutations in NIPBL, the human homolog of the Drosophila melanogaster Nipped-B gene, have recently been reported to cause CdLS. The function of NIPBL in mammals is unknown. The Drosophila Nipped-B protein facilitates long-range enhancer-promoter interactions and plays a role in Notch signaling and other developmental pathways, as well as being involved in mitotic sister-chromatid cohesion. We report the spectrum and distribution of NIPBL mutations in a large well-characterized cohort of individuals with CdLS. Mutations were found in 56 (47%) of 120 unrelated individuals with sporadic or familial CdLS. Statistically significant phenotypic differences between mutation-positive and mutation-negative individuals were identified. Analysis also suggested a trend toward a milder phenotype in individuals with missense mutations than in those with other types of mutations.	Childrens Hosp Philadelphia, Div Human & Mol Genet, Abramson Res Ctr 1002, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Drexel Univ, Sch Med, Div Obstet & Gynecol, Philadelphia, PA 19104 USA; Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Div Genet, Nashville, TN USA; Greater Baltimore Med Ctr, Harvey Inst Human Genet, Baltimore, MD USA; Nemours Childrens Clin, Wilmington, DE USA; Univ Genoa, Dept Biol Oncol & Genet, Genoa, Italy	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Drexel University; Vanderbilt University; Vanderbilt University; Greater Baltimore Medical Center; University of Genoa	Krantz, ID (corresponding author), Childrens Hosp Philadelphia, Div Human & Mol Genet, Abramson Res Ctr 1002, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ian2@mail.med.upenn.edu	Devoto, Marcella/AAP-7595-2021	DEVOTO, MARCELLA/0000-0002-4431-5114	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039323] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD039323, 1 R01 HD39323] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BANKIER A, 1986, AM J MED GENET, V25, P163, DOI 10.1002/ajmg.1320250119; BERATIS N G, 1971, Clinical Genetics, V2, P170; Brachmann W., 1916, JB KINDERHEILK PHYS, V84, P225; CHODIRKER BN, 1994, AM J MED GENET, V52, P331, DOI 10.1002/ajmg.1320520315; De Lange C., 1933, ARCH MED ENFANTS, V36, P713; FEINGOLD M, 1993, AM J MED GENET, V47, P1064, DOI 10.1002/ajmg.1320470726; FRYNS JP, 1987, CLIN GENET, V31, P413; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; HALAL F, 1992, AM J MED GENET, V42, P381, DOI 10.1002/ajmg.1320420328; Hulinsky R, 2003, AM J HUM GENET, V73, P602; IRELAND M, 1991, J MED GENET, V28, P639, DOI 10.1136/jmg.28.9.639; IRELAND M, 1993, AM J MED GENET, V47, P959, DOI 10.1002/ajmg.1320470705; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; KLINE AD, 1993, AM J MED GENET, V47, P1053, DOI 10.1002/ajmg.1320470724; KLINE AD, 1993, AM J MED GENET, V47, P1042, DOI 10.1002/ajmg.1320470722; Kozma C, 1996, AM J MED GENET, V66, P445, DOI 10.1002/(SICI)1096-8628(19961230)66:4<445::AID-AJMG12>3.3.CO;2-S; KRAJEWSKAWALASEK M, 1995, CLIN GENET, V47, P324; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Krantz ID, 1997, AM J MED GENET, V70, P80, DOI 10.1002/(SICI)1096-8628(19970502)70:1<80::AID-AJMG15>3.0.CO;2-T; Krantz ID, 2001, AM J MED GENET, V101, P120, DOI 10.1002/1096-8628(20010615)101:2<120::AID-AJMG1319>3.3.CO;2-7; LIEBER E, 1973, AM J DIS CHILD, V125, P717, DOI 10.1001/archpedi.1973.04160050065013; McConnell V, 2003, CLIN DYSMORPHOL, V12, P241, DOI 10.1097/00019605-200310000-00006; NAGUIB KK, 1987, J MED GENET, V24, P627, DOI 10.1136/jmg.24.10.627; OPITZ JM, 1985, AM J MED GENET, V22, P89, DOI 10.1002/ajmg.1320220110; ROBINSON LK, 1985, AM J MED GENET, V22, P109, DOI 10.1002/ajmg.1320220112; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Russell KL, 2001, AM J MED GENET, V104, P267, DOI 10.1002/ajmg.10066; SAUL RA, 1993, AM J MED GENET, V47, P999, DOI 10.1002/ajmg.1320470712; SELICORNI A, 1993, AM J MED GENET, V47, P977, DOI 10.1002/ajmg.1320470708; Tonkin E, 2001, AM J HUM GENET, V69, P618; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; VANALLEN MI, 1993, AM J MED GENET, V47, P947, DOI 10.1002/ajmg.1320470704; WILSON WG, 1983, J MED GENET, V20, P469, DOI 10.1136/jmg.20.6.469	34	224	236	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					610	623		10.1086/424698	http://dx.doi.org/10.1086/424698			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15318302	Bronze, Green Published			2022-12-18	WOS:000223634100007
J	Kim, HG; Kurth, I; Lan, F; Meliciani, I; Wenzel, W; Eom, SH; Kang, GB; Rosenberger, G; Tekin, M; Ozata, M; Bick, DP; Sherins, RJ; Walker, SL; Shi, Y; Gusella, JF; Layman, LC				Kim, Hyung-Goo; Kurth, Ingo; Lan, Fei; Meliciani, Irene; Wenzel, Wolfgang; Eom, Soo Hyun; Kang, Gil Bu; Rosenberger, Georg; Tekin, Mustafa; Ozata, Metin; Bick, David P.; Sherins, Richard J.; Walker, Steven L.; Shi, Yang; Gusella, James F.; Layman, Lawrence C.			Mutations in CHD7, Encoding a Chromatin-Remodeling Protein, Cause Idiopathic Hypogonadotropic Hypogonadism and Kallmann Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHARGE-SYNDROME; HORMONE RECEPTOR; HISTONE H3; GENE; CHROMODOMAINS; FAMILY; PREVALENCE; MOLECULES; ADHESION; NEURONS	CHARGE syndrome and Kallmann syndrome (KS) are two distinct developmental disorders sharing overlapping features of impaired olfaction and hypogonadism. KS is a genetically heterogeneous disorder consisting of idiopathic hypogonadotropic hypogonadism (IHH) and anosmia, and is most commonly due to KAL1 or FGFR1 mutations. CHARGE syndrome, a multisystem autosomal-dominant disorder, is caused by CHD7 mutations. We hypothesized that CHD7 would be involved in the pathogenesis of IHH and KS (IHH/KS) without the CHARGE phenotype and that IHH/KS represents a milder allelic variant of CHARGE syndrome. Mutation screening of the 37 protein-coding exons of CHD7 was performed in 101 IHH/KS patients without a CHARGE phenotype. In an additional 96 IHH/KS patients, exons 6-10, encoding the conserved chromodomains, were sequenced. RT-PCR, SIFT, protein-structure analysis, and in situ hybridization were performed for additional supportive evidence. Seven heterozygous mutations, two splice and five missense, which were absent in >= 180 controls, were identified in three sporadic KS and four sporadic normosmic IHH patients. Three mutations affect chromodomains critical for proper CHD7 function in chromatin remodeling and transcriptional regulation, whereas the other four affect conserved residues, suggesting that they are deleterious. CHD7's role is further corroborated by specific expression in IHH/KS-relevant tissues and appropriate developmental expression. Sporadic CHD7 mutations occur in 6% of IHH/KS patients. CHD7 represents the first identified chromatin-remodeling protein with a role in human puberty and the second gene to cause both normosmic IHH and KS in humans. Our findings indicate that both normosmic IHH and KS are mild allelic variants of CHARGE syndrome and are caused by CHD7 mutations.	[Walker, Steven L.; Layman, Lawrence C.] Med Coll Georgia, Dept Obstet & Gynecol, Sect Reprod Endocrinol Infertil & Genet, Augusta, GA 30912 USA; [Walker, Steven L.; Layman, Lawrence C.] Med Coll Georgia, Inst Mol Med & Genet, Reprod Med Program, Augusta, GA 30912 USA; [Walker, Steven L.; Layman, Lawrence C.] Med Coll Georgia, Inst Mol Med & Genet, Dev Neuobiol Program, Augusta, GA 30912 USA; [Kim, Hyung-Goo; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Kim, Hyung-Goo; Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Kurth, Ingo; Rosenberger, Georg] Univ Klinikum Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Lan, Fei; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Meliciani, Irene] Univ Roma La Sapienza, Fac Sci, I-00185 Rome, Italy; [Wenzel, Wolfgang] Forschungszentrum Karlsruhe, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Eom, Soo Hyun; Kang, Gil Bu] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Dept Life Sci, Kwangju 500712, South Korea; [Tekin, Mustafa] Ankara Univ, Sch Med, Dept Pediat, Div Clin Mol Pathol & Genet, TR-06100 Ankara, Turkey; [Ozata, Metin] GATA Haydarpasa Training Hosp, Dept Endocrinol, TR-34660 Istanbul, Turkey; [Bick, David P.] Med Coll Wisconsin, Dept Pediat, Div Med Genet, Milwaukee, WI 53226 USA; [Bick, David P.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Sherins, Richard J.] Columbia Fertil Associates, Washington, DC 20037 USA; [Walker, Steven L.; Layman, Lawrence C.] Med Coll Georgia, Neurosci Program, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Harvard Medical School; Sapienza University Rome; Helmholtz Association; Karlsruhe Institute of Technology; Gwangju Institute of Science & Technology (GIST); Ankara University; Gulhane Military Medical Academy; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Medical College of Wisconsin; Medical College of Wisconsin; University System of Georgia; Augusta University	Layman, LC (corresponding author), Med Coll Georgia, Dept Obstet & Gynecol, Sect Reprod Endocrinol Infertil & Genet, 1120 15th st, Augusta, GA 30912 USA.	Ilayman@mcg.edu	Tekin, Mustafa/ABG-7627-2020; Wenzel, Wolfgang/B-3207-2009	Wenzel, Wolfgang/0000-0001-9487-4689; Tekin, Mustafa/0000-0002-3525-7960; Kurth, Ingo/0000-0002-5642-8378	National Institutes of Health (NIH) [HD33004, HD040287]; Medical College of Georgia Research Institute (MCGRI); NIH [GM061354]; Deutsche Forschungsgemeinschaft (DFG) [WE1863/10-2]; DFG Center for Functional Nanostructures; EU Leonardo program "Unipharm Graduates; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033004] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD040287, R29HD033004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Georgia Research Institute (MCGRI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Center for Functional Nanostructures(German Research Foundation (DFG)); EU Leonardo program "Unipharm Graduates; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all affected individuals and their families for their cooperation. The authors also thank I. Hermans-Borgmeyer for unrestricted support with the in situ hybridizations and interpretation of the data; B. Dierkes for excellent technical assistance; G. Schnitzler for helpful discussions; E. Moutevelis for leucine-zipper-domain structure analysis; the Computational Science Center, KIST (Seoul, Korea), and the volunteers from POEM@HOME for computational resources; Y. Shen for RT-MLPA; S. West for zinc-finger prediction analysis; L. Chorich for her efforts in supervising and running the laboratory; and E. Shah for RT-PCR analysis.; We also acknowledge support to L.C.L. from National Institutes of Health (NIH) grants HD33004 and HD040287, as well as the Medical College of Georgia Research Institute (MCGRI), Dean D.D. Miller, Institute of Molecular Medicine and Genetics (IM-MAG) director R. Yu, and ob/gyn chair A.A. Murphy at MCG. J.F.G. has support from NIH grant GM061354, W.W. from Deutsche Forschungsgemeinschaft (DFG) grant WE1863/10-2 and the DFG Center for Functional Nanostructures, and I.M. from the EU Leonardo program "Unipharm Graduates."	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bhagavath B, 2006, FERTIL STERIL, V85, P706, DOI 10.1016/j.fertnstert.2005.08.044; Bhagavath B, 2005, FERTIL STERIL, V84, P951, DOI 10.1016/j.fertnstert.2005.04.029; Bhagavath B, 2007, MOL HUM REPROD, V13, P165, DOI 10.1093/molehr/gal108; Blake KD, 2005, CLIN PEDIATR, V44, P151, DOI 10.1177/000992280504400207; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Chalouhi C, 2005, PEDIATRICS, V116, pE81, DOI 10.1542/peds.2004-1970; Delaney KR, 2007, ARCH PSYCHIAT NURS, V21, P112, DOI 10.1016/j.apnu.2006.12.002; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Jongmans MCJ, 2008, AM J MED GENET A, V146A, P43, DOI 10.1002/ajmg.a.31921; Kim HG, 2005, J MED GENET, V42, P666, DOI 10.1136/jmg.2004.026989; Kim HG, 2008, NEUROSIGNALS, V16, P165, DOI 10.1159/000111561; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ogata T, 2006, ENDOCR J, V53, P741, DOI 10.1507/endocrj.K06-099; Pedersen-White JR, 2008, MOL HUM REPROD, V14, P367, DOI 10.1093/molehr/gan027; Pinto G, 2005, J CLIN ENDOCR METAB, V90, P5621, DOI 10.1210/jc.2004-2474; Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Schwarting GA, 2007, SEMIN REPROD MED, V25, P305, DOI 10.1055/s-2007-984736; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wheeler PG, 2000, AM J MED GENET, V94, P228, DOI 10.1002/1096-8628(20000918)94:3<228::AID-AJMG8>3.0.CO;2-H; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xu N, 2005, AM J OBSTET GYNECOL, V192, P1274, DOI 10.1016/j.ajog.2004.12.066; Xu N, 2007, J CLIN ENDOCR METAB, V92, P1155, DOI 10.1210/jc.2006-1183	42	223	234	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					511	519		10.1016/j.ajhg.2008.09.005	http://dx.doi.org/10.1016/j.ajhg.2008.09.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18834967	Bronze, Green Published			2022-12-18	WOS:000260239200009
J	Sankararaman, S; Sridhar, S; Kimmel, G; Halperin, E				Sankararaman, Sriram; Sridhar, Srinath; Kimmel, Gad; Halperin, Eran			Estimating local ancestry in admixed populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-POLYMORPHISM PANEL; LINKAGE DISEQUILIBRIUM; GENOMIC CONTROL; ADMIXTURE MAP; WHOLE-GENOME; STRATIFICATION; DISEASE; ASSOCIATION; INFERENCE; HOTSPOTS	Large-scale genotyping of SNPs has shown a great promise in identifying markers that could be linked to diseases. One of the major obstacles involved in performing these studies is that the underlying population substructure could produce spurious associations. Population substructure can be caused by the presence of two distinct subpopulations or a single pool of admixed individuals. In this work, we focus on the latter, which is significantly harder to detect in practice. New advances in this research direction are expected to play a key role in identifying loci that are different among different populations and are still associated with a disease. We evaluated current methods for inference of population substructure in such cases and show that they might be quite inaccurate even in relatively simple scenarios. We therefore introduce a new method, LAMP (Local Ancestry in adMixed Populations), which infers the ancestry of each individual at every single-nucleotide polymorphism (SNP). LAMP computes the ancestry structure for overlapping windows of contiguous SNPs and combines the results with a majority vote. Our empirical results show that LAMP is significantly more accurate and more efficient than existing methods for inferrring locus-specific ancestries, enabling it to handle large-scale datasets. We further show that LAMP can be used to estimate the individual admixture of each individual. Our experimental evaluation indicates that this extension yields a considerably more accurate estimate of individual admixture than state-of-the-art methods such as STRUCTURE or EIGENSTRAT, which are frequently used for the correction of population stratification in association studies.	[Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Sridhar, Srinath] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Sankararaman, Sriram; Kimmel, Gad] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA	Carnegie Mellon University; University of California System; University of California Berkeley	Halperin, E (corresponding author), Int Comp Sci Inst, Berkeley, CA 94704 USA.	heran@icsi.berkeley.edu			NHGRI NIH HHS [R33 HG003070] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BESAG J, 1986, J R STAT SOC B, V48, P259; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; CHERNOFF H, 1952, ANN MATH STAT, V23, P493, DOI 10.1214/aoms/1177729330; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Collins-Schramm HE, 2003, HUM GENET, V113, P211, DOI 10.1007/s00439-003-0961-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Falush D, 2003, GENETICS, V164, P1567; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Haldane JBS, 1919, J GENET, V8, P299; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li N, 2003, GENETICS, V165, P2213; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nachman MW, 2000, GENETICS, V156, P297; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sridhar S, 2007, LECT NOTES COMPUT SC, V4453, P503; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	37	223	239	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					290	303		10.1016/j.ajhg.2007.09.022	http://dx.doi.org/10.1016/j.ajhg.2007.09.022			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252211	Green Published, Bronze			2022-12-18	WOS:000253223900003
J	Cartegni, L; Hastings, ML; Calarco, JA; de Stanchina, E; Krainer, AR				Cartegni, L; Hastings, ML; Calarco, JA; de Stanchina, E; Krainer, AR			Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; IMMUNODEFICIENCY-VIRUS TYPE-1; MOTOR-NEURON SMN; HNRNP A1; PREMESSENGER RNA; COOPERATIVE BINDING; SECONDARY STRUCTURE; SINGLE NUCLEOTIDE; ENHANCER MOTIFS; HUMAN-DISEASE	Spinal muscular atrophy is a neurodegenerative disorder caused by the deletion or mutation of the survival-of-motor-neuron gene, SMN1. An SMN1 paralog, SMN2, differs by a C -> T transition in exon 7 that causes substantial skipping of this exon, such that SMN2 expresses only low levels of functional protein. A better understanding of SMN splicing mechanisms should facilitate the development of drugs that increase survival motor neuron ( SMN) protein levels by improving SMN2 exon 7 inclusion. In addition, exonic mutations that cause defective splicing give rise to many genetic diseases, and the SMN1/2 system is a useful paradigm for understanding exon-identity determinants and alternative-splicing mechanisms. Skipping of SMN2 exon 7 was previously attributed either to the loss of an SF2/ASF-dependent exonic splicing enhancer or to the creation of an hnRNP A/B-dependent exonic splicing silencer, as a result of the CrT transition. We report the extensive testing of the enhancer-loss and silencer-gain models by mutagenesis, RNA interference, overexpression, RNA splicing, and RNA-protein interaction experiments. Our results support the enhancer-loss model but also demonstrate that hnRNP A/B proteins antagonize SF2/ASF-dependent ESE activity and promote exon 7 skipping by a mechanism that is independent of the CrT transition and is, therefore, common to both SMN1 and SMN2. Our findings explain the basis of defective SMN2 splicing, illustrate the fine balance between positive and negative determinants of exon identity and alternative splicing, and underscore the importance of antagonistic splicing factors and exonic elements in a disease context.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	krainer@cshl.edu	Hastings, MICHELLE L./AAK-6627-2021	Hastings, Michelle L./0000-0002-4253-9261; Krainer, Adrian/0000-0001-9024-9501	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041621] Funding Source: NIH RePORTER; NINDS NIH HHS [NS041621, R01 NS041621] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; HABETS WJ, 1989, J IMMUNOL, V143, P2560; Hanamura A, 1998, RNA, V4, P430; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; HOCKENSMITH JW, 1991, METHOD ENZYMOL, V208, P211; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Miyajima H, 2002, J BIOL CHEM, V277, P23271, DOI 10.1074/jbc.M200851200; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Monani UR, 2000, HUM MOL GENET, V9, P2451, DOI 10.1093/hmg/9.16.2451; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; Sendtner M, 2001, CURR OPIN NEUROL, V14, P629, DOI 10.1097/00019052-200110000-00012; Si ZH, 1998, MOL CELL BIOL, V18, P5404, DOI 10.1128/MCB.18.9.5404; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Singh NN, 2004, BIOCHEM BIOPH RES CO, V315, P381, DOI 10.1016/j.bbrc.2004.01.067; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Tange TO, 2001, EMBO J, V20, P5748; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhu J, 2001, NANO LETT, V1, P8, DOI 10.1021/nl005512q	63	223	231	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					63	77		10.1086/498853	http://dx.doi.org/10.1086/498853			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385450	Green Published, Bronze			2022-12-18	WOS:000233930400007
J	Dode, C; Le Du, N; Cuisset, L; Letourneur, F; Berthelot, JM; Vaudour, G; Meyrier, A; Watts, RA; Scott, DGI; Nicholls, A; Granel, B; Frances, C; Garcier, F; Edery, P; Boulinguez, S; Domergues, JP; Delpech, M; Grateau, G				Dode, C; Le Du, N; Cuisset, L; Letourneur, F; Berthelot, JM; Vaudour, G; Meyrier, A; Watts, RA; Scott, DGI; Nicholls, A; Granel, B; Frances, C; Garcier, F; Edery, P; Boulinguez, S; Domergues, JP; Delpech, M; Grateau, G			New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: A novel mutation underlies both syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT PERIODIC FEVER; AA AMYLOIDOSIS; AUTOINFLAMMATORY SYNDROME; CHROMOSOME 1Q44; CROHNS-DISEASE; SUSCEPTIBILITY; IDENTIFICATION; ARTHRITIS; DEAFNESS; PROTEIN	Mutations of CIAS1 have recently been shown to underlie familial cold urticaria (FCU) and Muckle-Wells syndrome (MWS), in three families and one family, respectively. These rare autosomal dominant diseases are both characterized by recurrent inflammatory crises that start in childhood and that are generally associated with fever, arthralgia, and urticaria. The presence of sensorineural deafness that occurs later in life is characteristic of MWS. Amyloidosis of the amyloidosis-associated type is the main complication of MWS and is sometimes associated with FCU. In FCU, cold exposure is the triggering factor of the inflammatory crisis. We identified CIAS1 mutations, all located in exon 3, in nine unrelated families with MWS and in three unrelated families with FCU, originating from France, England, and Algeria. Five mutations-namely, R260W, D303N, T348M, A439T, and G569R-were novel. The R260W mutation was identified in two families with MWS and in two families with FCU, of different ethnic origins, thereby demonstrating that a single CIAS1 mutation may cause both syndromes. This result indicates that modifier genes are involved in determining either a MWS or a FCU phenotype. The finding of the G569R mutation in an asymptomatic individual further emphasizes the importance of such modifier a gene (or genes) in determining the disease phenotype. Identification of this gene (or these genes) is likely to have significant therapeutic implications for these severe diseases.	Univ Paris 05, Hop Cochin, Inst Cochin, INSERM, Paris, France; Hop Europeen Georges Pompidou, Inst Cochin, Serv Sequencage, Paris, France; Hop Europeen Georges Pompidou, Serv Nephrol, Paris, France; Hop La Pitie Salpetriere, Serv Med Interne, Paris, France; Hop Hotel Dieu, Serv Med Interne, Paris, France; Hop Hotel Dieu, Serv Rhumatol, Nantes, France; Ctr Hosp, Serv Pediat, Saint Quentin, France; Ipswich Hosp, Dept Rheumatol, Ipswich, Suffolk, England; Norfolk & Norwich Hosp, Dept Rheumatol, Norwich NR1 3SR, Norfolk, England; W Suffolk Hosp, Dept Rheumatol, Bury St Edmunds, Suffolk, England; Hop La Timone, Serv Med Interne, Marseille, France; Hop Nord St Etienne, Serv Dermatol, St Etienne, France; Hop Hotel Dieu, Serv Genet, Lyon, France; Hop Dupuytren, Serv Dermatol, Limoges, France; Hop Bicetre, Serv Pediat, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Ipswich Hospital NHS Trust; Ipswich Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de St Etienne; CHU Lyon; CHU Limoges; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Dode, C (corresponding author), Univ Paris 05, Hop Cochin, Inst Cochin, INSERM, EMI 00-05, Paris, France.	catherine.dode@cch.ap-hop-paris.fr	granel, brigitte/A-8000-2010; Meyrier, Alain/GWQ-3527-2022					BaderMeunier B, 1996, ANN DERMATOL VENER, V123, P398; BARRIERE H, 1977, ANN DERMATOL VENER, V104, P664; Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299; Cazeneuve C, 2000, AM J HUM GENET, V67, P1136, DOI 10.1016/S0002-9297(07)62944-9; Cuisset L, 1999, AM J HUM GENET, V65, P1054, DOI 10.1086/302589; Delpech M, 2001, CURR OPIN IMMUNOL, V13, P539, DOI 10.1016/S0952-7915(00)00255-7; Drenth JPH, 2001, NEW ENGL J MED, V345, P1748, DOI 10.1056/NEJMra010200; HEDON V, 1983, TISSUE ANTIGENS, V21, P318; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kile RL., 1940, J AM MED ASS, V114, P1067, DOI [10.1001/jama.1940.62810120003010b, DOI 10.1001/JAMA.1940.62810120003010B]; KOONIN EV, 2001, TRENDS BIOCHEM SCI, V5, P223; LAGRUE G, 1972, NOUV PRESSE MED, V1, P2223; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; McDermott MF, 2000, ARTHRITIS RHEUM-US, V43, P2034, DOI 10.1002/1529-0131(200009)43:9<2034::AID-ANR14>3.0.CO;2-J; MESSIER G, 1988, KIDNEY INT, V34, P566; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Moriguchi M, 1999, HUM GENET, V105, P360, DOI 10.1007/s004390051115; Moriguchi M, 2001, ARTHRITIS RHEUM, V44, P1266, DOI 10.1002/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3; MUCKLE TJ, 1979, BRIT J DERMATOL, V100, P87, DOI 10.1111/j.1365-2133.1979.tb03572.x; MUCKLE TJ, 1962, Q J MED, V31, P235; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; PROST A, 1976, REV RHUM, V43, P201; WATTS RA, 1994, BRIT J RHEUMATOL, V33, P1184	27	223	231	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1498	1506		10.1086/340786	http://dx.doi.org/10.1086/340786			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992256	Green Published, Bronze			2022-12-18	WOS:000175445700011
J	Dryja, TP; Adams, SM; Grimsby, JL; McGee, TL; Hong, DH; Li, TS; Andreasson, S; Berson, EL				Dryja, TP; Adams, SM; Grimsby, JL; McGee, TL; Hong, DH; Li, TS; Andreasson, S; Berson, EL			Null RPGRIP1 alleles in patients with Leber congenital amaurosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGMENTOSA GTPASE REGULATOR; LINKED RETINITIS-PIGMENTOSA; NUCLEOTIDE-EXCHANGE FACTOR; GENE; MUTATIONS; CRX; HOMOLOGY; RCC1	We isolated and characterized the entire coding sequence of a human gene encoding a protein that interacts with RPGR, a protein that is absent or mutant in many cases of X-linked retinitis pigmentosa. The newly identified gene, called "RPGRIP1" for RPGR-interacting protein (MIM 605446), is located within 14q11, and it encodes a protein predicted to contain 1, 259 amino acids. Previously published work showed that both proteins, RPGR and RPGRIP1, are present in the ciliary structure that connects the inner and outer segments of rod and cone photoreceptors. We surveyed 57 unrelated patients who had Leber congenital amaurosis for mutations in RPGRIP1 and found recessive mutations involving both RPGRIP1 alleles in 3 (6%) patients. The mutations all create premature termination codons and are likely to be null alleles. Patients with RPGRIP1 mutations have a degeneration of both rod and cone photoreceptors, and, early in life, they experience a severe loss of central acuity, which leads to nystagmus.	Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Harvard Univ, Sch Med, Ocular Mol Genet Inst, Boston, MA USA; Harvard Univ, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA USA; Univ Lund Hosp, Dept Ophthalmol, S-22185 Lund, Sweden	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Lund University; Skane University Hospital	Dryja, TP (corresponding author), Massachusetts Eye & Ear Infirm, 243 Charles St, Boston, MA 02114 USA.	dryja@helix.mgh.harvard.edu			NEI NIH HHS [R37 EY000169, R01 EY008683, R01 EY000169, EY00169, EY08683] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008683, R37EY000169, R01EY000169] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDREASSON SOL, 1988, AM J OPHTHALMOL, V105, P500, DOI 10.1016/0002-9394(88)90241-3; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; HONG DH, 2001, IN PRESS J BIOL CHEM; Jacobson SG, 1998, INVEST OPHTH VIS SCI, V39, P2417; Linari M, 1999, P NATL ACAD SCI USA, V96, P1315, DOI 10.1073/pnas.96.4.1315; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182	19	223	225	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1295	1298		10.1086/320113	http://dx.doi.org/10.1086/320113			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283794	Bronze, Green Published			2022-12-18	WOS:000168171200024
J	EIBEN, B; BARTELS, I; BAHRPORSCH, S; BORGMANN, S; GATZ, G; GELLERT, G; GOEBEL, R; HAMMANS, W; HENTEMANN, M; OSMERS, R; RAUSKOLB, R; HANSMANN, I				EIBEN, B; BARTELS, I; BAHRPORSCH, S; BORGMANN, S; GATZ, G; GELLERT, G; GOEBEL, R; HAMMANS, W; HENTEMANN, M; OSMERS, R; RAUSKOLB, R; HANSMANN, I			CYTOGENETIC ANALYSIS OF 750 SPONTANEOUS-ABORTIONS WITH THE DIRECT-PREPARATION METHOD OF CHORIONIC VILLI AND ITS IMPLICATIONS FOR STUDYING GENETIC CAUSES OF PREGNANCY WASTAGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV GOTTINGEN,INST HUMANGENET,GOSSLERSTR 12D,W-3400 GOTTINGEN,GERMANY; UNIV GOTTINGEN,FRAUENKLIN,W-3400 GOTTINGEN,GERMANY; EVANGEL KRANKENHAUS,INST KLIN GENET & ZYTOL,OBERHAUSEN,GERMANY; ALBERT SCHWEITZER KRANKENHAUS,NORTHEIM,GERMANY	University of Gottingen; University of Gottingen								ADINOLFI M, 1986, HUM REPROD, V1, P45, DOI 10.1093/oxfordjournals.humrep.a136342; BARTELS I, 1990, AM J MED GENET, V5, P297; BOUE A, 1985, ADV HUM GENET, V14, P1; CARR DH, 1963, LANCET, V2, P603; CARR DH, 1965, OBSTET GYNECOL, V26, P308; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; EIBEN B, 1986, LANCET, V1, P1273; EIBEN B, 1987, HUM GENET, V77, P137, DOI 10.1007/BF00272380; HANSMANN I, 1986, HUM GENET, V72, P189; HANSMANN I, 1989, BIOL ZBL, V108, P323; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1984, CYTOGENET CELL GENET, V38, P200, DOI 10.1159/000132060; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1983, ANN HUM GENET, V47, P39, DOI 10.1111/j.1469-1809.1983.tb00968.x; HASSOLD TJ, 1986, TRENDS GENET, V2, P105, DOI 10.1016/0168-9525(86)90194-0; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HUNT PA, 1985, CYTOGENET CELL GENET, V39, P7, DOI 10.1159/000132096; HUNT PA, 1985, CYTOGENET CELL GENET, V39, P1, DOI 10.1159/000132095; Jacobs P.A., 1987, HUM GENET, P233; KAJII T, 1980, HUM GENET, V55, P87, DOI 10.1007/BF00329132; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; KALOUSEK DK, 1989, AM J HUM GENET, V44, P338; Kline JS, 1985, REPROD TOXICOL, V1985, P251; MACHIN GA, 1974, HUM GENET, V23, P182; MINGUILLON C, 1989, HUM GENET, V82, P373; MORTON NE, 1987, AM J MED GENET, V28, P353, DOI 10.1002/ajmg.1320280213; MOWBRAY JF, 1987, LANCET, V2, P679; REHDER H, 1989, HUM GENET, V82, P377; ROSSANT J, 1989, TRENDS GENET, V5, P277, DOI 10.1016/0168-9525(89)90102-9; SCHEINFELD A, 1958, SCI AM, V198, P22, DOI 10.1038/scientificamerican0258-22; SEARLE AG, 1985, ANEUPLOIDY ETIOLOGY, P363; Short R. V., 1978, CIBA F S, V64, P377; SIMONI G, 1983, HUM GENET, V63, P349, DOI 10.1007/BF00274761; SUTHERLAND GR, 1978, ANN HUM GENET, V42, P173, DOI 10.1111/j.1469-1809.1978.tb00647.x; THOMAS ML, 1985, AM J OBSTET GYNECOL, V151, P1053, DOI 10.1016/0002-9378(85)90379-5; VISARIA PM, 1967, EUGEN QUART, V14, P132, DOI 10.1080/19485565.1967.9987713; WARBURTON D, 1987, AM J HUM GENET, V41, P465; WARBURTON D, 1980, HUMAN EMBRYONIC FETA, P261; WARBURTON D, 1985, ANEUPLOIDY ETIOLOGY, P133; YAMAMOTO M, 1982, HUM GENET, V60, P360, DOI 10.1007/BF00569219; ZHOU XT, 1989, HUM GENET, V83, P277, DOI 10.1007/BF00285172	41	223	237	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					656	663						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	2220806				2022-12-18	WOS:A1990EB31900010
J	SMITHIES, O; CONNELL, GE; DIXON, GH				SMITHIES, O; CONNELL, GE; DIXON, GH			INHERITANCE OF HAPTOGLOBIN SUBTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CONNELL GE, 1961, CAN J BIOCHEM PHYS, V39, P1013, DOI 10.1139/o61-101; CONNELL GE, 1961, NATURE; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; HORSFALL WR, 1958, SCIENCE, V128, P35, DOI 10.1126/science.128.3314.35; SMITHIES O, 1959, BIOCHEM J, V72, P121, DOI 10.1042/bj0720121; SMITHIES O, 1955, NATURE, V176, P1265, DOI 10.1038/1761265a0; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SMITHIES O, TO BE PUBLISHED	10	223	223	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	1					14	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2966A	13914473				2022-12-18	WOS:A19622966A00010
J	Price, AL; Weale, ME; Patterson, N; Myers, SR; Need, AC; Shianna, KV; Ge, DL; Rotter, JI; Torres, E; Taylor, KD; Goldstein, DB; Reich, D				Price, Alkes L.; Weale, Michael E.; Patterson, Nick; Myers, Simon R.; Need, Anna C.; Shianna, Kevin V.; Ge, Dongliang; Rotter, Jerome I.; Torres, Esther; Taylor, Kent D.; Goldstein, David B.; Reich, David			Long-range LD can confound genome scans in admixed populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ADMIXTURE MAP; BLOCKS		[Price, Alkes L.; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Price, Alkes L.; Patterson, Nick; Myers, Simon R.; Reich, David] Broad Inst Harvard, Cambridge, MA 02142 USA; [Price, Alkes L.; Patterson, Nick; Myers, Simon R.; Reich, David] MIT, Cambridge, MA 02142 USA; [Weale, Michael E.; Patterson, Nick; Need, Anna C.; Shianna, Kevin V.; Ge, Dongliang; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Myers, Simon R.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Rotter, Jerome I.; Taylor, Kent D.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Torres, Esther] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Duke University; University of Oxford; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu	Goldstein, David/AAY-8125-2020; Myers, Simon R/A-6792-2015; Weale, Michael E/F-2587-2010; Rotter, Jerome/AAY-6598-2021	Myers, Simon R/0000-0002-2585-9626; Weale, Michael E/0000-0003-4593-1186; Need, Anna/0000-0003-3955-8207	NCRR NIH HHS [M01-RR00425, M01 RR000425] Funding Source: Medline; NHGRI NIH HHS [U-01 HG004168, U01 HG004168] Funding Source: Medline; NIDDK NIH HHS [DK62413, U01 DK062413, P01DK46763, P01 DK046763] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, U01DK062413] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tang H, 2007, AM J HUM GENET, V81, P626, DOI 10.1086/520769; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123	11	222	227	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					132	135		10.1016/j.ajhg.2008.06.005	http://dx.doi.org/10.1016/j.ajhg.2008.06.005			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18606306	Green Published			2022-12-18	WOS:000257784000020
J	Hellmann, I; Ebersberger, I; Ptak, SE; Paabo, S; Przeworski, M				Hellmann, I; Ebersberger, I; Ptak, SE; Paabo, S; Przeworski, M			A neutral explanation for the correlation of diversity with recombination rates in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRAND-BREAK REPAIR; HUMAN GENOME; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; DNA-SEQUENCES; MUTATION-RATE; GENE; VARIABILITY; MAP; POLYMORPHISMS	One of the most striking findings to emerge from the study of genomic patterns of variation is that regions with lower recombination rates tend to have lower levels of intraspecific diversity but not of interspecies divergence. This uncoupling of variation within and between species has been widely interpreted as evidence that natural selection shapes patterns of genetic variability genomewide. We revisited the relationship between diversity, divergence, and recombination in humans, using data from closely related species and better estimates of recombination rates than previously available. We show that regions that experience less recombination have reduced divergence to chimpanzee and to baboon, as well as lower levels of diversity. This observation suggests that mutation and recombination are associated processes in humans, so that the positive correlation between diversity and recombination may have a purely neutral explanation. Consistent with this hypothesis, diversity levels no longer increase significantly with recombination rates after correction for divergence to chimpanzee.	Max Planck Inst Evolut Anthropol, D-04103 Leipzig, Germany; Interdisciplinary Ctr Bioinformat, Leipzig, Germany	Max Planck Society	Przeworski, M (corresponding author), Max Planck Inst Evolut Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andolfatto P, 2001, CURR OPIN GENET DEV, V11, P635, DOI 10.1016/S0959-437X(00)00246-X; Andolfatto P, 2001, GENETICS, V158, P657; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Betancourt AJ, 2002, P NATL ACAD SCI USA, V99, P13616, DOI 10.1073/pnas.212277199; Castresana J, 2002, NUCLEIC ACIDS RES, V30, P1751, DOI 10.1093/nar/30.8.1751; CHARLESWORTH B, 1993, GENETICS, V134, P1289; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; LI WH, 1987, J MOL EVOL, V24, P337, DOI 10.1007/BF02134132; Nachman MW, 1998, GENETICS, V150, P1133; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; NEI M, 2000, MOL EVOLUTION GENETI; Payseur BA, 2002, GENE, V300, P31, DOI 10.1016/S0378-1119(02)00849-1; Payseur BA, 2002, MOL BIOL EVOL, V19, P336, DOI 10.1093/oxfordjournals.molbev.a004086; Perry J, 1999, CURR BIOL, V9, P987, DOI 10.1016/S0960-9822(99)80430-8; Petes TD, 2002, GENETICS, V162, P2049; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Rattray AJ, 2002, GENETICS, V162, P1063; Rattray AJ, 2001, GENETICS, V158, P109; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; RESNICK MA, 1989, P NATL ACAD SCI USA, V86, P2276, DOI 10.1073/pnas.86.7.2276; Rogers J, 2000, GENOMICS, V67, P237, DOI 10.1006/geno.2000.6245; Schiebel K, 2000, CYTOGENET CELL GENET, V91, P224, DOI 10.1159/000056849; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STRATHERN JN, 1995, GENETICS, V140, P965; TAJIMA F, 1983, GENETICS, V105, P437; True JR, 1996, GENETICS, V142, P507; Wall JD, 2003, GENETICS, V163, P395; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber JL, 2002, NAT GENET, V31, P225, DOI 10.1038/ng920; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	43	222	225	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1527	1535		10.1086/375657	http://dx.doi.org/10.1086/375657			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12740762	Bronze, Green Published			2022-12-18	WOS:000183275500015
J	Heath, KE; Campos-Barros, A; Toren, A; Rozenfeld-Granot, G; Carlsson, LE; Savige, J; Denison, JC; Gregory, MC; White, JG; Barker, DF; Greinacher, A; Epstein, CJ; Glucksman, MJ; Martignetti, JA				Heath, KE; Campos-Barros, A; Toren, A; Rozenfeld-Granot, G; Carlsson, LE; Savige, J; Denison, JC; Gregory, MC; White, JG; Barker, DF; Greinacher, A; Epstein, CJ; Glucksman, MJ; Martignetti, JA			Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUKOCYTE INCLUSIONS; GENETIC-LINKAGE; GIANT PLATELETS; A GENE; DEAFNESS; REGION; IDENTIFICATION; PROTEIN; VARIANT; MICE	May-Hegglin anomaly (MHA) and Fechtner (FTNS) and Sebastian (SBS) syndromes are autosomal dominant platelet disorders that share macrothrombocytopenia and characteristic leukocyte inclusions. FTNS has the additional clinical features of nephritis, deafness, and cataracts. Previously, mutations in the nonmuscle myosin heavy chain 9 gene (MYH9), which encodes nonmuscle myosin heavy chain IIA (MYHIIA), were identified in all three disorders. The spectrum of mutations and the genotype-phenotype and structure-function relationships in a large cohort of affected individuals (n=27) has now been examined. Moreover, it is demonstrated that MYH9 mutations also result in two other FTNS-like macrothrombocytopenia syndromes: Epstein syndrome (EPS) and Alport syndrome with macrothrombocytopenia (APSM). In all five disorders, MYH9 mutations were identified in 20/27 (74%) affected individuals. Four mutations, R702C, D1424N, E1841K, and R1933X, were most frequent. R702C and R702H mutations were only associated with FTNS, EPS, or APSM, thus defining a region of MYHIIA critical in the combined pathogenesis of macrothrombocytopenia, nephritis, and deafness. The E1841K, D1424N, and R1933X coiled-coil domain mutations were common to both MHA and FTNS. Haplotype analysis using three novel microsatellite markers revealed that three E1841K carriers-one with MHA and two with FTNS-shared a common haplotype around the MYH9 gene, suggesting a common ancestor. The two new globular-head mutations, K371N and R702H, as well as the recently identified MYH9 mutation, R705H, which results in DFNA17, were modeled on the basis of X-ray crystallographic data. Altogether, our data suggest that MHA, SBS, FTNS, EPS, and APSM comprise a phenotypic spectrum of disorders, all caused by MYH9 mutations. On the basis of our genetic analyses, the name "MYHIIA syndrome" is proposed to encompass all of these disorders.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Struct Neurobiol & Proteom Lab, New York, NY USA; Hosp Univ Nino Jesus, Dept Pediat Endocrinol, Madrid, Spain; Chaim Sheba Med Ctr, Dept Pediat Hematooncol, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Inst Hematol, IL-52621 Tel Hashomer, Israel; Ernst Moritz Arndt Univ Greifswald, Dept Immunol & Transfus Med, Greifswald, Germany; Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med, Heidelberg, Vic, Australia; Univ Utah, Sch Med, Dept Physiol, Salt Lake City, UT 84108 USA; Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Finch Univ Hlth Sci Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ernst Moritz Arndt Universitat Greifswald; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Chicago Medical School	Martignetti, JA (corresponding author), Mt Sinai Sch Med, Dept Human Genet, 5th Ave & 100th St,Box 1498, New York, NY 10029 USA.	john.martignetti@mssm.edu	Heath, Karen Elise/K-7760-2014; Barros, Angel Campos/E-6427-2018; Heath, K. E./ABG-4658-2020	Heath, Karen Elise/0000-0002-5816-7044; Barros, Angel Campos/0000-0003-4649-2971; Heath, K. E./0000-0002-5816-7044; Barker, David/0000-0002-1438-4100; Savige, Judy/0000-0002-6813-0288	NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; ATKIN CL, 1986, STRAUSS WELTS DISEAS, P617; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; BAIN BJ, 1985, SCAND J HAEMATOL, V35, P77; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Beohar N, 1998, J BIOL CHEM, V273, P9168, DOI 10.1074/jbc.273.15.9168; Choy YS, 1999, ANN HUM GENET, V63, P383, DOI 10.1046/j.1469-1809.1999.6350383.x; Colville D, 2000, Ophthalmic Genet, V21, P217; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; GREINACHER A, 1992, EUR J PEDIATR, V151, P668, DOI 10.1007/BF01957570; GREINACHER A, 1990, BLUT, V61, P282, DOI 10.1007/BF01732878; GREINACHER A, 1990, BLUT, V60, P53, DOI 10.1007/BF01720508; HARRINGTON WF, 1984, ANNU REV BIOCHEM, V53, P35, DOI 10.1146/annurev.bi.53.070184.000343; HEGGLIN R, 1945, Helv Med Acta, V12, P439; Houdusse A, 2001, CURR OPIN STRUC BIOL, V11, P182, DOI 10.1016/S0959-440X(00)00188-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWAMOTO S, 1994, J BIOL CHEM, V269, P15101; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 2001, BLOOD, V97, P1147, DOI 10.1182/blood.V97.4.1147; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; LU RC, 1989, BIOCHEMISTRY-US, V28, P4826, DOI 10.1021/bi00437a046; Martignetti JA, 2000, AM J HUM GENET, V66, P1449, DOI 10.1086/302873; May R, 1909, DTSCH ARCH KLIN MED, V96, P1; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Mhawech P, 2000, AM J CLIN PATHOL, V113, P176, DOI 10.1309/FC4H-LM5V-VCW8-DNJU; Moxey-Mims MM, 1999, PEDIATR NEPHROL, V13, P782, DOI 10.1007/s004670050700; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; NICOLAIDES NC, 1990, BIOTECHNIQUES, V8, P154; Nurden P, 1996, CR ACAD SCI III-VIE, V319, P717; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PETERSON LC, 1985, BLOOD, V65, P397; ROCCA B, 1993, BRIT J HAEMATOL, V85, P423, DOI 10.1111/j.1365-2141.1993.tb03193.x; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seri M, 2000, NAT GENET, V26, P103; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Tiepold M, 2000, BIOCHEMISTRY-US, V39, P1305, DOI 10.1021/bi991199z; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Toren A, 2000, BLOOD, V96, P3447; Toren A, 1999, AM J HUM GENET, V65, P1711, DOI 10.1086/302654; Velasco F, 2000, Haematologica, V85, P988; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	47	222	248	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1033	1045		10.1086/324267	http://dx.doi.org/10.1086/324267			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11590545	Green Published, Bronze			2022-12-18	WOS:000171413400011
J	Agarwal, AK; Xing, C; DeMartino, GN; Mizrachi, D; Hernandez, MD; Sousa, AB; de Villarreal, LM; dos Santos, HG; Garg, A				Agarwal, Anil K.; Xing, Chao; DeMartino, George N.; Mizrachi, Dario; Dolores Hernandez, Maria; Sousa, Ana Berta; Martinez de Villarreal, Laura; dos Santos, Heloisa G.; Garg, Abhimanyu			PSMB8 Encoding the beta 5i Proteasome Subunit Is Mutated in Joint Contractures, Muscle Atrophy, Microcytic Anemia, and Panniculitis-Induced Lipodystrophy Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPER-GAMMA-GLOBULINEMIA; MUSCULAR-ATROPHY; IMMUNOPROTEASOME; MICE; LMP7; INFECTION; CLEAVAGE; COMPLEX; DNA	We performed homozygosity mapping in two recently reported pedigrees from Portugal and Mexico with an autosomal-recessive auto-inflammatory syndrome characterized by joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy (JMP). This revealed only one homozygous region spanning 2.4 Mb (5818 SNPs) on chromosome 6p21 shared by all three affected individuals from both families. We directly sequenced genes involved in immune response located in this critical region, excluding the HLA complex genes. We found a homozygous missense mutation c.224C>T (p.Thr75Met) in the proteasome subunit, beta-type, 8 (PSMB8) gene in affected patients from both pedigrees. The mutation segregated in an autosomal-recessive fashion and was not detected in 275 unrelated ethnically matched healthy subjects. PSMB8 encodes a catalytic subunit of the 20S immunoproteasomes called beta 5i. Immunoproteasome-mediated proteolysis generates immunogenic epitopes presented by major histocompatibility complex (MHC) class I molecules. Threonine at position 75 is highly conserved and its substitution with methionine disrupts the tertiary structure of PSMB8. As compared to normal lymphoblasts, those from an affected patient showed significantly reduced chymotrypsin-like proteolytic activity mediated by immunoproteasomes. We conclude that mutations in PSMB8 cause JMP syndrome, most probably by affecting MHC class I antigen processing.	[Agarwal, Anil K.; Garg, Abhimanyu] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nutr & Metab Dis, Dallas, TX 75390 USA; [Agarwal, Anil K.; Garg, Abhimanyu] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Mizrachi, Dario] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA; [Dolores Hernandez, Maria; Martinez de Villarreal, Laura] Univ Autonoma Nuevo Leon, Fac Med, Dept Genet, Monterrey 66603, Nuevo Leon, Mexico; [Sousa, Ana Berta; dos Santos, Heloisa G.] Hosp Santa Maria, Serv Genet Med, P-1649035 Lisbon, Portugal	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidad Autonoma de Nuevo Leon; Universidade de Lisboa; Hospital Santa Maria	Garg, A (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Nutr & Metab Dis, Dallas, TX 75390 USA.	abhimanyu.garg@utsouthwestern.edu	de Villarreal, Laura Elia Martínez/ABD-2697-2020	de Villarreal, Laura Elia Martínez/0000-0003-1442-9089; Xing, Chao/0000-0002-1838-0502; Sousa, Ana Berta/0000-0001-5889-2492	National Institutes of Health [R01-DK54387, DK46181]; CTSA [UL1 RR024982]; Southwest Medical Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054387, R56DK046181, R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Southwest Medical Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Sarah Masood and Katie Tunison for help with illustrations and mutational screening; Shyam Murali, Prateek Sharma, and Marquis Harris for sequencing candidate genes in the critical region; Helen Hobbs, M.D., for providing DNA samples of the Hispanic controls; Tommy Hyatt for genotyping; Laurie Davis, Ph.D., for providing control lymphoblasts; David Thompson for help with the proteasomal activity assay; Beverley Adams-Huet, M.S., for statistical analysis; Andrew Zinn, M.D., Ph.D., for helpful suggestions; and Michael S. Brown, M.D., for critical review of the manuscript. This work was supported by the National Institutes of Health grants R01-DK54387 and DK46181 and CTSA Grant UL1 RR024982 and Southwest Medical Foundation.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], PROTEIN; [Anonymous], PLINK; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Fabunmi RP, 2001, J CELL SCI, V114, P29; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Garg A, 2010, J CLIN ENDOCR METAB, V95, pE58, DOI 10.1210/jc.2010-0488; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Henderson C, 2010, CURR OPIN RHEUMATOL, V22, P567, DOI 10.1097/BOR.0b013e32833ceff4; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Horikoshi A, 1980, Rinsho Shinkeigaku, V20, P173; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; OYANAGI K, 1987, ACTA NEUROPATHOL, V73, P313, DOI 10.1007/BF00688252; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivett AJ, 2004, CURR PROTEIN PEPT SC, V5, P153, DOI 10.2174/1389203043379774; TANAKA M, 1993, INTERNAL MED, V32, P42, DOI 10.2169/internalmedicine.32.42; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tu L, 2009, EUR J IMMUNOL, V39, P3385, DOI 10.1002/eji.200839117; Unno M, 2002, J BIOCHEM, V131, P171, DOI 10.1093/oxfordjournals.jbchem.a003084; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Yamada S, 1984, Rinsho Shinkeigaku, V24, P703; PROCHEK; MERLIN	36	221	228	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					866	872		10.1016/j.ajhg.2010.10.031	http://dx.doi.org/10.1016/j.ajhg.2010.10.031			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129723	Bronze, Green Published			2022-12-18	WOS:000285564600014
J	Tucker, T; Marra, M; Friedman, JM				Tucker, Tracy; Marra, Marco; Friedman, Jan M.			Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							COPY-NUMBER-VARIATION; HUMAN GENOME; MULTIPLEX AMPLIFICATION; STRUCTURAL VARIATION; MENTAL-RETARDATION; HYBRID SELECTION; LARGE SETS; ARRAY CGH; DNA; GENERATION		[Tucker, Tracy; Marra, Marco; Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Marra, Marco] BC Canc Agcy Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Friedman, Jan M.] Child & Family Res Inst, Vancouver, BC V6H 3N1, Canada	University of British Columbia; Child & Family Research Institute	Tucker, T (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada.	tbtucker@interchange.ubc.ca	Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Friedman, Jan/0000-0002-7482-9570				Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bau S, 2009, ANAL BIOANAL CHEM, V393, P171, DOI 10.1007/s00216-008-2460-7; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; de Smith AJ, 2008, CYTOGENET GENOME RES, V123, P17, DOI 10.1159/000184688; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fedurco M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj023; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gratacos M, 2009, AM J MED GENET B, V150B, P808, DOI 10.1002/ajmg.b.30902; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Holtz LR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-159; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Krishnakumar S, 2008, P NATL ACAD SCI USA, V105, P9296, DOI 10.1073/pnas.0803240105; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; Lopez J, 2009, BRIT J CANCER, V100, P571, DOI 10.1038/sj.bjc.6604930; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Oetting William S, 2009, Hum Mutat, V30, P852, DOI 10.1002/humu.20987; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sargent R, 2009, J MOL DIAGN, V11, P25, DOI 10.2353/jmoldx.2009.080037; Schwaenen C, 2009, GENE CHROMOSOME CANC, V48, P39, DOI 10.1002/gcc.20617; Shaffer LG, 2007, AM J MED GENET C, V145C, P335, DOI 10.1002/ajmg.c.30152; Shen YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004012; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; SWERDLOW H, 1990, J CHROMATOGR, V516, P61, DOI 10.1016/S0021-9673(01)90204-3; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Varley KE, 2008, GENOME RES, V18, P1844, DOI 10.1101/gr.078204.108; Vecsler M, 2006, THROMB HAEMOSTASIS, V95, P205, DOI 10.1160/TH05-06-0446; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Yoshihashi H, 2000, AM J HUM GENET, V67, P476, DOI 10.1086/302997; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108	74	221	261	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					142	154		10.1016/j.ajhg.2009.06.022	http://dx.doi.org/10.1016/j.ajhg.2009.06.022			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19679224	Green Published, Bronze			2022-12-18	WOS:000269332900004
J	Castleman, VH; Romio, L; Chodhari, R; Hirst, RA; de Castro, SCP; Parker, KA; Ybot-Gonzalez, P; Emes, RD; Wilson, SW; Wallis, C; Johnson, CA; Herrera, RJ; Rutman, A; Dixon, M; Shoemark, A; Bush, A; Hogg, C; Gardiner, RM; Reish, O; Greene, NDE; O'Callaghan, C; Purton, S; Chung, EMK; Mitchison, HM				Castleman, Victoria H.; Romio, Leila; Chodhari, Rahul; Hirst, Robert A.; de Castro, Sandra C. P.; Parker, Keith A.; Ybot-Gonzalez, Patricia; Emes, Richard D.; Wilson, Stephen W.; Wallis, Colin; Johnson, Colin A.; Herrera, Rene J.; Rutman, Andrew; Dixon, Mellisa; Shoemark, Amelia; Bush, Andrew; Hogg, Claire; Gardiner, R. Mark; Reish, Orit; Greene, Nicholas D. E.; O'Callaghan, Christopher; Purton, Saul; Chung, Eddie M. K.; Mitchison, Hannah M.			Mutations in Radial Spoke Head Protein Genes RSPH9 and RSPH4A Cause Primary Ciliary Dyskinesia with Central-Microtubular-Pair Abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OUTER DYNEIN ARM; CHLAMYDOMONAS-REINHARDTII; FLAGELLAR MOTILITY; SEQUENCE-ANALYSIS; IMMOTILE CILIA; BEAT PATTERN; DEFECTS; FLOW; RANDOMIZATION; DYSFUNCTION	primary ciliary dyskinesia (PCD) is a genetically heterogeneous inherited disorder arising from dysmotility of motile cilia and sperm. This is associated with a variety of ultrastructural defects of the cilia and sperm axoneme that affect movement, leading to clinical consequences on respiratory-tract mucociliary clearance and lung function, fertility, and left-right body-axis determination. We performed whole-genome SNP-based linkage analysis in seven consanguineous families with PCD and central-microtubular-pair abnormalities. This identified two loci, in two families with intermittent absence of the central-pair structure (chromosome 6p21.1, Zmax 6.7) and in five families with complete absence of the central pair (chromosome 6q22.1, Zmax 7.0). Mutations were subsequently identified in two positional candidate genes, RSPH9 on chromosome 6p21.1 and RSPH4A on chromosome 6q22.1. Haplotype analysis identified a common ancestral founder effect RSPH4A mutation present in UK-Pakistani pedigrees. Both RSPH9 and RSPH4A encode protein components of the axonemal radial spoke head. In situ hybridization of murine Rsph9 shows gene expression restricted to regions containing motile cilia. Investigation of the effect of knockdown or mutations of RSPH9 orthologs in zebrafish and Chlamydomonas indicate that radial spoke head proteins are important in maintaining normal movement In motile, "9+2"-structure cilia and flagella. This effect is rescued by reintroduction of gene expression for restoration of a normal beat pattern in zebrafish. Disturbance in function of these genes was not associated with defects in left-right axis determination in humans or zebrafish.	[Castleman, Victoria H.; Chodhari, Rahul; Parker, Keith A.; Gardiner, R. Mark; Chung, Eddie M. K.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, London WC1E 6JJ, England; [Romio, Leila] UCL, Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England; [Hirst, Robert A.; Rutman, Andrew; O'Callaghan, Christopher] Univ Leicester, Leicester Royal Infirm, Dept Infect Immun & Inflammat, Div Child Hlth, Leicester LE2 7LX, Leics, England; [de Castro, Sandra C. P.; Ybot-Gonzalez, Patricia; Greene, Nicholas D. E.] UCL, Inst Child Hlth, Neurol Dev Unit, London WC1N 1EH, England; [Emes, Richard D.] Keele Univ, Sch Med, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England; [Wilson, Stephen W.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Wallis, Colin] Great Ormond St Hosp Sick Children, Dept Paediat Resp Med, London WC1N 3JH, England; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Herrera, Rene J.] Florida Int Univ, Dept Mol & Human Genet, Coll Med, Human Divers Unit, Miami, FL 33199 USA; [Dixon, Mellisa; Shoemark, Amelia; Bush, Andrew; Hogg, Claire] Royal Brompton & Harefield NHS Trust, Dept Paediat Resp Med, London SW3 6NP, England; [Reish, Orit] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Reish, Orit] Assaf Harofeh Med Ctr, Genet Inst, IL-70300 Zerifin, Israel; [Purton, Saul] UCL, Inst Struct & Mol Biol, Algal Res Grp, London WC1E 6BT, England; [Castleman, Victoria H.] Univ London, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London; University of Leicester; University of London; University College London; Keele University; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Saint James's University Hospital; University of Leeds; State University System of Florida; Florida International University; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; University of London; Birkbeck University London; University College London; University of London; University College London	Mitchison, HM (corresponding author), UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, Rayne Bldg,5 Univ St, London WC1E 6JJ, England.	h.mitchison@ich.ucl.ac.uk	Emes, Richard D/C-5341-2008; Wilson, Stephen W/B-9404-2008; Shoemark, Amelia/I-4068-2019; ybot-gonzalez, patricia/C-9625-2016; Mitchison, Hannah M./C-1891-2008; Zebrafish, UCL/A-3125-2009; IBIS, NEUROCIENCIA APLICAD/C-2516-2016; Hirst, Robert/AAD-1649-2022; Ybot-González, Patricia/D-6947-2014	Emes, Richard D/0000-0001-6855-5481; Wilson, Stephen W/0000-0002-8557-5940; Shoemark, Amelia/0000-0001-7360-6060; Ybot-González, Patricia/0000-0001-7836-2659; Greene, Nicholas D.E./0000-0002-4170-5248; Johnson, Colin/0000-0002-2979-8234; Mitchison, Hannah/0000-0002-3163-6293; Hirst, Robert Anthony/0000-0003-1989-1790; Purton, Saul/0000-0002-9342-1773; reish, orit/0000-0002-9483-238X	Medical Research Council (UK); Wellcome Trust (UK); Milena Carvajal-Prokartagener Foundation (Switzerland); PCD Foundation (USA); PCD Family Support Group (UK); MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (UK)(Wellcome Trust); Milena Carvajal-Prokartagener Foundation (Switzerland); PCD Foundation (USA); PCD Family Support Group (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the families for their involvement in this study. We thank the physicians involved in patient recruitment and sampling, in particular Robert Mueller, Maggie Meeks, Astrid Weber, and Yannick Crow. We thank Sandra Strautnieks for providing Arabic control samples. We are grateful to Peter Scambler for critical reading of the manuscript. We thank Lucille Fressynet, Chloe Cheung, Chloe McCann, Kate Everett, and Barry Choiza for technical assistance. We thank E.Ispeth Bruford at the HUGO Gene Nomenclature Committee, European Molecular Biology Laboratory-European Biomformatics Institute, for Much help with radial-spoke nomenclature and renaming. We are grateful to A. Rodaway, King's College London, for the pRUT3 rescue vector, to [I. Onlran for the Dnah5 in situ probe, anti to the following for release of prepublication proteomic and genomic data sets, in addition to bioinformatics; help: G. Pazour, K. Gull, R McKean, and S. Brody. This Work was supported by the Medical Research Council (UK), the Wellcome Trust (UK), the Milena Carvajal-Prokartagener Foundation (Switzerland), the PCD Foundation (USA), and the PCD Family Support Group (UK).	Abdulrazzaq YM, 1997, CLIN GENET, V51, P167; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; BUSH A, 2008, CLIN PULM M IN PRESS; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; CURRY AM, 1992, MOL CELL BIOL, V12, P3967, DOI 10.1128/MCB.12.9.3967; DAVIES JP, 1994, MOL CELL BIOL, V14, P5165, DOI 10.1128/MCB.14.8.5165; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Failly M, 2008, RESPIRATION, V76, P198, DOI 10.1159/000128567; Geremek M, 2008, EUR J HUM GENET, V16, P688, DOI 10.1038/ejhg.2008.5; Geremek Maciej, 2004, Journal of Applied Genetics, V45, P347; Gingras D, 1998, MOL BIOL CELL, V9, P513, DOI 10.1091/mbc.9.2.513; GOLDSCHMIDTCLERMONT M, 1990, MOL GEN GENET, V223, P417, DOI 10.1007/BF00264448; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; HUANG B, 1981, J CELL BIOL, V88, P80, DOI 10.1083/jcb.88.1.80; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jeganathan D, 2004, J MED GENET, V41, P233, DOI 10.1136/jmg.2003.014084; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kosaki K, 2004, AM J MED GENET A, V129A, P308, DOI 10.1002/ajmg.a.30177; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Meeks M, 2000, J MED GENET, V37, P241, DOI 10.1136/jmg.37.4.241; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; O'Callaghan C, 2004, PEDIATR PULM, P72, DOI 10.1002/ppul.70057; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; ROTT HD, 1979, HUM GENET, V46, P249, DOI 10.1007/BF00273308; SAEKI H, 1984, J UROLOGY, V132, P1165, DOI 10.1016/S0022-5347(17)50080-4; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Stannard W, 2004, AM J RESP CRIT CARE, V169, P634, DOI 10.1164/rccm.200306-782OC; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Ybot-Gonzalez P, 2005, DEV DYNAM, V233, P1013, DOI 10.1002/dvdy.20383; Zariwala MA, 2006, AM J RESP CRIT CARE, V174, P858, DOI 10.1164/rccm.200603-370OC	45	221	230	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					197	209		10.1016/j.ajhg.2009.01.011	http://dx.doi.org/10.1016/j.ajhg.2009.01.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200523	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000263799700010
J	Zweier, C; Peippo, MM; Hoyer, J; Sousa, S; Bottani, A; Clayton-Smith, J; Reardon, W; Saraiva, J; Cabral, A; Gohring, I; Devriendt, K; de Ravel, T; Bijlsma, EK; Hennekam, RCM; Orrico, A; Cohen, M; Dreweke, A; Reis, A; Nurnberg, P; Rauch, A				Zweier, Christiane; Peippo, Maarit M.; Hoyer, Juliane; Sousa, Sergio; Bottani, Armand; Clayton-Smith, Jill; Reardon, William; Saraiva, Jorge; Cabral, Alexandra; Goehring, Ina; Devriendt, Koen; de Ravel, Thomy; Bijlsma, Emilia K.; Hennekam, Raoul C. M.; Orrico, Alfredo; Cohen, Monika; Dreweke, Alexander; Reis, Andre; Nuernberg, Peter; Rauch, Anita			Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTRAL HYPOVENTILATION SYNDROME; LYMPHOCYTE DEVELOPMENT; HIRSCHSPRUNG-DISEASE; E-BOX; E2-2; MUTATIONS; PHENOTYPE; PROMOTER; BINDING; HASH-1	Pitt-Hopkins syndrome is a rarely reported syndrome of so-far-unknown etiology characterized by mental retardation, wide mouth, and intermittent hyperventilation. By molecular karyotyping with GeneChip Human Mapping 100K SNP arrays, we detected a 1.2-Mb deletion on 18q21.2 in one patient. Sequencing of the TCF4 transcription factor gene, which is contained in the deletion region, in 30 patients with significant phenotypic overlap revealed heterozygous stop, splice, and missense mutations in five further patients with severe mental retardation and remarkable facial resemblance. Thus, we establish the Pitt-Hopkins syndrome as a distinct but probably heterogeneous entity caused by autosomal dominant de novo mutations in TCF4. Because of its phenotypic overlap, Pitt-Hopkins syndrome evolves as an important differential diagnosis to Angelman and Rett syndromes. Both null and missense mutations impaired the interaction of TCF4 with ASCL1 from the PHOX-RET pathway in transactivating an E box-containing reporter construct; therefore, hyperventilation and Hirschsprung disease in patients with Pitt-Hopkins syndrome might be explained by altered development of noradrenergic derivatives.	Univ Erlangen Nurnberg, Inst Human Genet, Comp Sci Dept 2, D-91054 Erlangen, Germany; Univ Hosp Erlangen, Inst Human Genet, Erlangen, Germany; Family Federat Finland, Dept Med Genet, Helsinki, Finland; Pediat Hosp Coimbra, Dept Med Genet, Coimbra, Portugal; Pediat Hosp Coimbra, Neuropediat Unit, Coimbra, Portugal; Geneva Sch Med, Div Med Genet, Geneva, Switzerland; Univ Hosp Geneva, Geneva, Switzerland; St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; Our Ladys Hosp Sick Children, Dublin, Ireland; Katholieke Univ Leuven Hosp, Ctr Human Genet, Louvain, Belgium; Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Clin Genet, NL-2300 RA Leiden, Netherlands; UCL, Great Ormond St Hosp Children, Inst Child Hlth, Dept Clin Genet & Dysmorphol, London WC1E 6BT, England; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1012 WX Amsterdam, Netherlands; Azienda Osped Univ Senese, Policlin S Maria alle Scotte, Unita Operat Mol Med, Siena, Italy; Kinderzentrum Munchen, Munich, Germany; Univ Cologne, Cologne Ctr Genom, D-5000 Cologne 41, Germany; Univ Cologne, Genet Inst, D-5000 Cologne 41, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Family Federation of Finland; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Geneva; University of Geneva; University of Manchester; Our Ladys Children Hospital Crumlin; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam; University of Siena; University Hospital of Siena; University of Cologne; University of Cologne	Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Comp Sci Dept 2, Schwabachanlage 10, D-91054 Erlangen, Germany.	arauch@humgenet.uni-erlangen.de	Zweier, Christiane/F-2202-2015; Rauch, Anita/C-5568-2014; Reis, André/D-2309-2009	Zweier, Christiane/0000-0001-8002-2020; Rauch, Anita/0000-0003-2930-3163; Reis, André/0000-0002-6301-6363; Saraiva, Jorge Manuel/0000-0002-7232-3509; Reardon, Willie/0000-0001-7329-9179; de Ravel, Thomy/0000-0002-3361-3781				Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Berry-Kravis EM, 2006, AM J RESP CRIT CARE, V174, P1139, DOI 10.1164/rccm.200602-305OC; CORNELIUSSEN B, 1991, J VIROL, V65, P6084, DOI 10.1128/JVI.65.11.6084-6093.1991; Dauger S, 2001, PHYSIOL GENOMICS, V7, P149, DOI 10.1152/physiolgenomics.00056.2001; de Pontual L, 2003, HUM MOL GENET, V12, P3173, DOI 10.1093/hmg/ddg339; Gustavsson P, 1999, AM J MED GENET, V82, P348, DOI 10.1002/(SICI)1096-8628(19990212)82:4<348::AID-AJMG14>3.3.CO;2-U; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Liu WS, 1998, EUR PHYS J D, V2, P1, DOI 10.1007/s100530050101; Liu Y, 1998, J BIOL CHEM, V273, P19269, DOI 10.1074/jbc.273.30.19269; Moal FDL, 2007, HUM MUTAT, V28, P313, DOI 10.1002/humu.20452; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Orrico A, 2001, AM J MED GENET, V103, P157, DOI 10.1002/ajmg.1523; Peippo MM, 2006, CLIN DYSMORPHOL, V15, P47, DOI 10.1097/01.mcd.0000184973.14775.32; Persson P, 2000, BIOCHEM BIOPH RES CO, V274, P22, DOI 10.1006/bbrc.2000.3090; Petersson K, 2002, EUR J IMMUNOL, V32, P911, DOI 10.1002/1521-4141(200203)32:3<911::AID-IMMU911>3.0.CO;2-H; PITT D, 1978, AUST PAEDIATR J, V14, P182; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Sanlaville D, 2005, EUR J MED GENET, V48, P214, DOI 10.1016/j.ejmg.2005.04.013; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; SINGH HA, 1993, J PAEDIATR CHILD H, V29, P156; Van Balkom IDC, 1998, AM J MED GENET, V75, P273, DOI 10.1002/(SICI)1096-8628(19980123)75:3<273::AID-AJMG9>3.0.CO;2-R; Vermeesch JR, 2005, J HISTOCHEM CYTOCHEM, V53, P413, DOI 10.1369/jhc.4A6436.2005; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zweier C, 2005, EUR J MED GENET, V48, P97, DOI 10.1016/j.ejmg.2005.01.003	28	221	225	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					994	1001		10.1086/515583	http://dx.doi.org/10.1086/515583			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436255	Bronze, Green Published			2022-12-18	WOS:000245973200019
J	Laumonnier, F; Ronce, N; Hamel, BCJ; Thomas, P; Lespinasse, J; Raynaud, M; Paringaux, C; van Bokhoven, H; Kalscheuer, V; Fryns, JP; Chelly, J; Moraine, C; Briault, S				Laumonnier, F; Ronce, N; Hamel, BCJ; Thomas, P; Lespinasse, J; Raynaud, M; Paringaux, C; van Bokhoven, H; Kalscheuer, V; Fryns, JP; Chelly, J; Moraine, C; Briault, S			Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENES; MUTATIONS; FAMILY; REGION; SRY; BREAKPOINTS; DYSPLASIA	Physical mapping of the breakpoints of a pericentric inversion of the X chromosome (46,X,inv[X][p21q27]) in a female patient with mild mental retardation revealed localization of the Xp breakpoint in the IL1RAPL gene at Xp21.3 and the Xq breakpoint near the SOX3 gene (SRY [sex determining region Y]-box 3) (GenBank accession number NM_005634) at Xq26.3. Because carrier females with microdeletion in the IL1RAPL gene do not present any abnormal phenotype, we focused on the Xq breakpoint. However, we were unable to confirm the involvement of SOX3 in the mental retardation in this female patient. To validate SOX3 as an X-linked mental retardation (XLMR) gene, we performed mutation analyses in families with XLMR whose causative gene mapped to Xq26q27. We show here that the SOX3 gene is involved in a large family in which affected individuals have mental retardation and growth hormone deficiency. The mutation results in an in-frame duplication of 33 bp encoding for 11 alanines in a polyalanine tract of the SOX3 gene. The expression pattern during neural and pituitary development suggests that dysfunction of the SOX3 protein caused by the polyalanine expansion might disturb transcription pathways and the regulation of genes involved in cellular processes and functions required for cognitive and pituitary development.	CHU Bretonneau, INSERM, U316, Serv Genet, F-37044 Tours 1, France; CHU Bretonneau, INSERM, U316, Serv Pedopsychiat, F-37044 Tours, France; Univ Hosp, Dept Human Genet, Nijmegen, Netherlands; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; CH Chambery, Lab Genet Chromosom, Chambery, France; Max Planck Inst Mol Genet, Berlin, Germany; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; CHU Cochin Port Royal, Inst Cochin, Paris, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Radboud University Nijmegen; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Max Planck Society; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Briault, S (corresponding author), CHU Bretonneau, INSERM, U316, Serv Genet, 2 Bd Tonnelle, F-37044 Tours 1, France.		Laumonnier, Frederic/N-1165-2016; Bokhoven, J.H.L.M. van van/H-8015-2014; van Bokhoven, Hans/D-8764-2012; Thomas, Paul Q/K-4497-2012; Chelly, Jamel/J-7528-2015; Raynaud, Martine/R-9811-2019	Laumonnier, Frederic/0000-0003-2567-0708; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Chelly, Jamel/0000-0002-0939-8719; Raynaud, Martine/0000-0002-6888-6480; Kalscheuer, Vera/0000-0001-6898-3259				Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brower V, 2001, EMBO REP, V2, P10, DOI 10.1093/embo-reports/kve013; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chiurazzi P, 2001, EUR J HUM GENET, V9, P71, DOI 10.1038/sj.ejhg.5200603; Collignon J, 1996, DEVELOPMENT, V122, P509; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; des Portes V, 1998, CLIN GENET, V53, P136; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Hamel BCJ, 1996, AM J MED GENET, V64, P35, DOI 10.1002/(SICI)1096-8628(19960712)64:1<35::AID-AJMG5>3.0.CO;2-Q; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Hol FA, 2000, GENOMICS, V69, P174, DOI 10.1006/geno.2000.6327; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Koster RW, 2000, MECH DEVELOP, V95, P175, DOI 10.1016/S0925-4773(00)00356-7; McElreavey K, 1996, P NATL ACAD SCI USA, V93, P8590, DOI 10.1073/pnas.93.16.8590; MCELREAVY K, 1992, P NATL ACAD SCI USA, V89, P11016, DOI 10.1073/pnas.89.22.11016; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Raynaud M, 1998, AM J MED GENET, V76, P255, DOI 10.1002/(SICI)1096-8628(19980319)76:3<255::AID-AJMG10>3.0.CO;2-G; ROUSSEAU F, 1991, AM J HUM GENET, V48, P108; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; STEVANOVIC M, 1993, HUM MOL GENET, V2, P2007; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Xiang FQ, 2000, J MED GENET, V37, P250, DOI 10.1136/jmg.37.4.250; ZIPF WB, 1977, CLIN GENET, V11, P249	28	221	228	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1450	1455		10.1086/344661	http://dx.doi.org/10.1086/344661			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12428212	Green Published, Bronze			2022-12-18	WOS:000179586800019
J	Frisse, L; Hudson, RR; Bartoszewicz, A; Wall, JD; Donfack, J; Di Rienzo, A				Frisse, L; Hudson, RR; Bartoszewicz, A; Wall, JD; Donfack, J; Di Rienzo, A			Gene conversion and different population histories may explain the contrast between polymorphism and linkage disequilibrium levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODERN HUMAN ORIGINS; DROSOPHILA-MELANOGASTER; MICROSATELLITE MUTATIONS; ROSY LOCUS; RECOMBINATION; EVOLUTION; REGION; GENOME; SELECTION; EXPANSION	To characterize linkage disequilibrium (LD) levels in human populations, we have analyzed 10 independent noncoding segments in three population samples from the major ethnic groups-that is, Africans, Asians, and Europeans. Descriptive statistics show that LD decays much faster in the African samples than in the non-African ones. With the assumption of an equilibrium model, we estimated the population crossing-over parameter (4N(e)r(bp), where N-e is the effective population size and r(bp) is the crossing-over rate per generation between adjacent base pairs) in the presence of gene conversion. In the African sample, LD and polymorphism levels lead to similar estimates of effective population size, as expected under an equilibrium model. Conversely, in both non-African samples, LD levels suggest a smaller effective population size than that implied by polymorphism levels. This observation is paralleled by significant departures from an equilibrium model in the spectrum of allele frequencies of the non-African samples. Besides ruling out the possibility that non-African populations are at equilibrium, these results suggest different demographic history (temporal and spatial) of these groups. Interestingly, the African sample fits the expectations of an equilibrium model based on polymorphism and divergence levels and on frequency spectrum. For this sample, the estimated ratio of gene conversion to crossing-over rates is 7.3 for a mean tract length of 500 bp, suggesting that gene conversion may be more frequent than previously thought. These findings imply that disease-association studies will require a much denser map of polymorphic sites in African than in non-African populations.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 507F, Chicago, IL 60637 USA.			Di Rienzo, Anna/0000-0002-8982-9098	NHGRI NIH HHS [F32 HG00219, F32 HG000219, R01 HG02098, R01 HG10847] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002098, F32HG000219] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Andolfatto P, 1998, GENETICS, V148, P1397; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cooper DN, 1995, METABOLIC MOL BASES, P259; Di Rienzo A, 1998, GENETICS, V148, P1269; Fogel S, 1983, YEAST GENETICS, P67; FOSS E, 1993, GENETICS, V133, P681; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gonser R, 2000, GENETICS, V154, P1793; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HILLIKER AJ, 1994, GENETICS, V137, P1019; HILLIKER AJ, 1991, GENETICS, V129, P779; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1985, GENETICS, V109, P611; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, IN PRESS GENETICS; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JORDE LB, 1993, AM J HUM GENET, V53, P1038; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kimmel M, 1998, GENETICS, V148, P1921; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Langley CH, 2000, GENETICS, V156, P1837; Mateu E, 2001, AM J HUM GENET, V68, P103, DOI 10.1086/316940; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roessli D, 2000, ARLEQUIN VERSION 2 0; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAVATIER P, 1985, J MOL BIOL, V182, P21, DOI 10.1016/0022-2836(85)90024-5; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Wall JD, 2000, GENETICS, V155, P1865; Wiehe T, 2000, GENET RES, V75, P61, DOI 10.1017/S0016672399004036; Wiuf C, 2000, GENETICS, V155, P451; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Yang AS, 1996, J MOL BIOL, V258, P240, DOI 10.1006/jmbi.1996.0246; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407	51	221	224	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					831	843		10.1086/323612	http://dx.doi.org/10.1086/323612			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11533915	Bronze, Green Published			2022-12-18	WOS:000171008200015
J	Adamec, J; Rusnak, F; Owen, WG; Naylor, S; Benson, LM; Gacy, AM; Isaya, G				Adamec, J; Rusnak, F; Owen, WG; Naylor, S; Benson, LM; Gacy, AM; Isaya, G			Iron-dependent self assembly of recombinant yeast frataxin: Implications for Friedreich ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL PROCESSING PEPTIDASE; ATOMIC-FORCE MICROSCOPE; HOMOLOG; ACCUMULATION; HOMEOSTASIS; DEFICIENCY; MATURATION; MEMBRANES; ACONITASE; PROTEINS	Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiodegenerative and neurodegenerative disease. Frataxin is a nuclear-encoded mitochondrial protein that is widely conserved among eukaryotes. Genetic inactivation of the yeast frataxin homologue (Yfh1p) results in mitochondrial iron accumulation and hypersensitivity to oxidative stress. Increased iron deposition and evidence of oxidative damage have also been observed in cardiac tissue and cultured fibroblasts from patients with FRDA. These findings indicate that frataxin is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals. The functional mechanism of frataxin, however, is still unknown. We have expressed the mature form of Yfh1p (mYfh1p) in Escherichia coli and have analyzed its function in vitro. Isolated mYfh1p is a soluble monomer (13,783 Da) that contains no iron and shows no significant tendency to self-associate. Aerobic addition of ferrous iron to mYfh1p results in assembly of regular spherical multimers with a molecular mass of similar to 1.1 MDa (megadaltons) and a diameter of 13 +/- 2 nm. Each multimer consists of similar to 60 subunits and can sequester >3,000 atoms of iron. Titration of mYfh1p with increasing iron concentrations supports a stepwise mechanism of multimer assembly. Sequential addition of an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the multimer, indicating that mYfh1p sequesters iron in an available form. In yeast mitochondria, native mYfh1p exists as monomer and a higher-order species with a molecular weight >600,000. After addition of Fe-55 to the medium, immunoprecipitates of this species contain >16 atoms of Fe-55 per molecule of mYfh1p. We propose that iron-dependent self-assembly of recombinant mYfh1p reflects a physiological role for frataxin in mitochondrial iron sequestration and bioavailability.	Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pharmacol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, 200 1st St SW,Hilton 210, Rochester, MN 55905 USA.				NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG015709, AG15709] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; CHASTEEN ND, 1985, J BIOL CHEM, V260, P2926; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; FENTON WA, 1996, ADV MOL CEL, V17, P163; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; HANSMA HG, 1994, ANNU REV BIOPH BIOM, V23, P115, DOI 10.1146/annurev.bb.23.060194.000555; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NIXON DE, 1986, CLIN CHEM, V32, P1660; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; Richards TD, 1996, J INORG BIOCHEM, V61, P1, DOI 10.1016/0162-0134(95)00029-1; ROMSLO I, 1980, IRON BIOCH MED, P325; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sanders-Loehr J., 1989, IRON CARRIERS IRON P, V5, P373; TANGERAS A, 1985, BIOCHIM BIOPHYS ACTA, V843, P199, DOI 10.1016/0304-4165(85)90140-0; Veenstra TD, 1998, NAT BIOTECHNOL, V16, P262, DOI 10.1038/nbt0398-262; Wallace DC, 1998, NAT GENET, V19, P105, DOI 10.1038/448; WILLIAMS JW, 1958, CHEM REV, V58, P715, DOI 10.1021/cr50022a005; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425	33	221	226	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					549	562		10.1086/303056	http://dx.doi.org/10.1086/303056			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10930361	Green Published, Bronze			2022-12-18	WOS:000089002300002
J	Cazeneuve, C; Sarkisian, T; Pecheux, C; Dervichian, M; Nedelec, B; Reinert, P; Ayvazyan, A; Kouyoumdjian, JC; Ajrapetyan, H; Delpech, M; Goossens, M; Dode, C; Grateau, G; Amselem, S				Cazeneuve, C; Sarkisian, T; Pecheux, C; Dervichian, M; Nedelec, B; Reinert, P; Ayvazyan, A; Kouyoumdjian, JC; Ajrapetyan, H; Delpech, M; Goossens, M; Dode, C; Grateau, G; Amselem, S			MEFV-gene analysis in Armenian patients with familial Mediterranean fever: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype - Genetic and therapeutic implications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATIONS; COLCHICINE; FMF; INHERITANCE; AMYLOIDOSIS; TRIAL	Familial Mediterranean fever (FMF) is a recessively inherited disorder that is common in patients of Armenian ancestry. To date, its diagnosis, which can be made only retrospectively, is one of exclusion, based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery. Renal amyloidosis, prevented by colchicine, is the most severe complication of FMF, a disorder associated with mutations in the MEFV gene. To evaluate the diagnostic and prognostic value of MEFV-gene analysis, we investigated 90 Armenian FMF patients from 77 unrelated families that were not selected through genetic-linkage analysis. Eight mutations, one of which (R408Q) is new were found to account for 93% of the 163 independent FMF alleles, with both FMF alleles identified in 89% of the patients. In several instances, family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype. The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P = .0002 and P = .006, respectively). The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF-including genetic counseling and therapeutic decisions in affected families.	Hop Henri Mondor, Serv Biochim & Genet Mol, F-94010 Creteil, France; Hop Henri Mondor, Inst Natl Sante & Rech Med, Unite 468, F-94010 Creteil, France; Ctr Hosp Intercommunal Creteil, Serv Pediat, Creteil, France; Yerevan State Univ, Dept Genet, Yerevan, Armenia; Erebuni Med Ctr, Yerevan, Armenia; Hop Cochin, Serv Biochim Genet, Paris, France; Hop Hotel Dieu, Serv Med Interne, F-75181 Paris, France; Ctr Hosp, Serv Hepatogastroenterol, Villeneuve St Georges, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Yerevan State University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Amselem, S (corresponding author), Hop Henri Mondor, Serv Biochim & Genet Mol, 51 Ave du Marechal de Lattre de Tassigny, F-94010 Creteil, France.	amselem@im3.inserm.fr	nedelec, brigitte/H-3002-2017	nedelec, brigitte/0000-0002-4487-9438; Sarkisian, Tamara/0000-0002-4767-7567				Aksentijevich I, 1999, AM J HUM GENET, V64, P949, DOI 10.1086/302327; Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; BLUM A, 1962, ANN INTERN MED, V57, P795, DOI 10.7326/0003-4819-57-5-795; CAZENEUVE C, 1998, AM J HUM GENET S, V63, pA355; Cotton RGH, 1997, TRENDS GENET, V13, P43, DOI 10.1016/S0168-9525(97)01011-1; Dewalle M, 1998, EUR J HUM GENET, V6, P95, DOI 10.1038/sj.ejhg.5200170; DINARELLO CA, 1974, NEW ENGL J MED, V291, P934, DOI 10.1056/NEJM197410312911804; Eisenberg S, 1998, ANN INTERN MED, V129, P539, DOI 10.7326/0003-4819-129-7-199810010-00005; FRENCH FMF, 1996, AM J HUM GENET, V59, P603; Levy EN, 1996, AM J HUM GENET, V58, P523; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; PARTACA R, 1988, P NATL ACAD SCI USA, V85, P2733; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; Saatci U, 1997, EUR J PEDIATR, V156, P619, DOI 10.1007/s004310050677; Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; YUVAL Y, 1995, AM J MED GENET, V57, P455, DOI 10.1002/ajmg.1320570319; ZEMER D, 1974, NEW ENGL J MED, V291, P932, DOI 10.1056/NEJM197410312911803; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601	25	221	231	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					88	97		10.1086/302459	http://dx.doi.org/10.1086/302459			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364520	Bronze, Green Published			2022-12-18	WOS:000081224300012
J	Johnson, ML; Gong, GD; Kimberling, W; Recker, SM; Kimmel, DB; Recker, RR				Johnson, ML; Gong, GD; Kimberling, W; Recker, SM; Kimmel, DB; Recker, RR			Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MINERAL DENSITY; PREMENOPAUSAL WOMEN; ALLELES; DETERMINANTS; TWIN; OSTEOPOROSIS; FRACTURE; VIEW	The purpose of this paper is to report the linkage of a genetic locus (designated ''HBM'') in the human genome to a phenotype of very high spinal bone density, using a single extended pedigree. We measured spinal bone-mineral density, spinal Z(BMD), and collected blood from 22 members of this kindred. DNA was genotyped on an Applied Biosystems model 377 (ABI PRISM Linkage Mapping Sets; Perkin Elmer Applied Biosystems), by use of fluorescence-based marker sets that included 345 markers. Both two-point and multipoint linkage analyses were performed, by use of affected/unaffected and quantitative-trait models. Spinal Z(BMD) for affected individuals (N = 12) of the kindred was 5.54 +/- 1.40; and for unaffected individuals (N = 16) it was 0.41 +/- 0.81. The trait was present in affected individuals 18-86 years of age, suggesting that HEM influences peak bone mass. The only region of linkage was to a series of markers on chromosome 11 (11q12-13). The highest LOD score (5.21) obtained in two-point analysis, when a quantitative-trait model was used, was at D11S987. Multipoint analysis using a quantitative-trait model confirmed the linkage, with a LOD score of 5.74 near marker D11S387. HEM demonstrates the utility of spinal Z(BMD) as a quantitative bone phenotype that can be used for linkage analysis. Osteoporosis pseudoglioma syndrome also has been mapped to this region of chromosome 11. Identification of the causal gene for both traits will be required for determination of whether a single gene with different alleles that determine a wide range of peak bone densities exists in this region.	CREIGHTON UNIV,OSTEOPOROSIS RES CTR,OMAHA,NE 68131; BOYS TOWN NATL RES HOSP,DIV HEREDITARY COMMUN DISORDERS,OMAHA,NE	Creighton University; Boys Town National Research Hospital								CANCAMP G, IN PRESS TRENDS GENE; CHESNUT CH, 1991, AM J MED, V5, pS2; DEQUEKER J, 1985, NEW ENGL J MED, V313, P453; DEQUEKER J, 1987, BONE, V8, P207, DOI 10.1016/8756-3282(87)90166-9; EISMAN JA, 1995, J BONE MINER RES, V10, P1289; GARNERO P, 1995, J BONE MINER RES, V10, P1283; Gong YQ, 1996, AM J HUM GENET, V59, P146; HOWARD G, 1995, J CLIN ENDOCR METAB, V80, P2800, DOI 10.1210/jc.80.9.2800; Hui S L, 1990, Osteoporos Int, V1, P30, DOI 10.1007/BF01880413; HUI SL, 1989, ANN INTERN MED, V111, P355, DOI 10.7326/0003-4819-111-5-355; HUSTMYER FG, 1994, J CLIN INVEST, V94, P2130, DOI 10.1172/JCI117568; JOHNSTON CC, 1990, NEW ENGL J MED, V323, P1271, DOI 10.1056/NEJM199011013231809; KANDERS B, 1988, J BONE MINER RES, V3, P145; KRALL EA, 1993, J BONE MINER RES, V8, P1; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOOKER AC, 1995, OSTEOPOROSIS INT, V5, P389, DOI 10.1007/BF01622262; MATKOVIC V, 1979, AM J CLIN NUTR, V32, P540, DOI 10.1093/ajcn/32.3.540; MOLLER M, 1978, CALC TISS RES, V25, P197, DOI 10.1007/BF02010768; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; NILAS L, 1987, J CLIN ENDOCR METAB, V65, P697, DOI 10.1210/jcem-65-4-697; PEACOCK M, 1995, J BONE MINER RES, V10, P1294; POCOCK M, 1991, J CLIN INVEST, V80, P706; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RICHELSON LS, 1984, NEW ENGL J MED, V311, P1273, DOI 10.1056/NEJM198411153112002; RIGGS BL, 1995, J BONE MINER RES, V10, P991; SLEMENDA CW, 1991, J BONE MINER RES, V6, P561; SMITH DM, 1973, J CLIN INVEST, V52, P2800, DOI 10.1172/JCI107476; SPECTOR TD, 1995, BRIT MED J, V310, P1357, DOI 10.1136/bmj.310.6991.1357; Spotila LD, 1996, MOL MED, V2, P313, DOI 10.1007/BF03401629; YOUNG D, 1995, J BONE MINER RES, V10, P558	30	221	239	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1326	1332		10.1086/515470	http://dx.doi.org/10.1086/515470			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199553	Green Published, Bronze			2022-12-18	WOS:A1997XE29400010
J	HOTH, CF; MILUNSKY, A; LIPSKY, N; SHEFFER, R; CLARREN, SK; BALDWIN, CT				HOTH, CF; MILUNSKY, A; LIPSKY, N; SHEFFER, R; CLARREN, SK; BALDWIN, CT			MUTATIONS IN THE PAIRED DOMAIN OF THE HUMAN PAX3 GENE CAUSE KLEIN-WAARDENBURG SYNDROME (WS-III) AS WELL AS WAARDENBURG SYNDROME TYPE-I (WS-I)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-BINDING; MOUSE; TRANSCRIPTION; CONSERVATION; DELETION; PROTEINS; BOX; RNA	Waardenburg syndrome type I (WS-I) is an autosomal dominant disorder characterized by sensorineural hearing loss, dystopia canthorum, pigmentary disturbances, and other developmental defects. Klein-Waardenburg syndrome (WS-III) is a disorder with many of the same characteristics as WS-I and includes musculoskeletal abnormalities. We have recently reported the identification and characterization of one of the first gene defects, in the human PAX3 gene, which causes WS-I. PAX3 is a DNA-binding protein that contains a structural motif known as the paired domain and is believed to regulate the expression of other genes. In this report we describe two new mutations, in the human PAX3 gene, that are associated with WS. One mutation was found in a family with WS-I, while the other mutation was found in a family with WS-III. Both mutations were in the highly conserved paired domain of the human PAX3 gene and are similar to other mutations that cause WS. The results indicate that mutations in the PAX3 gene can cause both WS-I and WS-III.	BOSTON UNIV,SCH MED,CTR HUMAN GENET,80 E CONCORD ST,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02118; HEBREW UNIV JERUSALEM,HADASSH MED CTR,DEPT HUMAN GENET,JERUSALEM,ISRAEL; UNIV WASHINGTON,SCH MED,DEPT PEDIAT,DIV EMBRYOL TERATOL & CONGENITAL DEFECTS,SEATTLE,WA 98195	Boston University; Boston University; Hebrew University of Jerusalem; University of Washington; University of Washington Seattle				Sheffer, Ruth/0000-0002-3623-8016; Baldwin, Clinton/0000-0002-3275-9463; Milunsky, Aubrey/0000-0003-2114-4823	NIAMS NIH HHS [AR 40152] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040152] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CAREZANIGAVIN M, 1992, AM J MED GENET, V42, P135, DOI 10.1002/ajmg.1320420127; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHAN D, 1991, J BIOL CHEM, V266, P12487; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; DASILVA EO, 1991, AM J MED GENET, V40, P65, DOI 10.1002/ajmg.1320400113; EPSTEIN DJ, 1991, GENOMICS, V10, P89, DOI 10.1016/0888-7543(91)90488-Z; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FARRER LA, 1992, AM J HUM GENET, V50, P902; FOY C, 1990, AM J HUM GENET, V46, P1017; GANGULY A, 1991, J BIOL CHEM, V266, P12035; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; ISHIKIRIYAMA S, 1989, AM J MED GENET, V33, P505, DOI 10.1002/ajmg.1320330419; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; JOSTES B, 1991, MECH DEVELOP, V33, P27; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MORELL J, 1992, HUM MOL GENET, V1, P243; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864; SHEFFER R, 1992, AM J MED GENET, V42, P320, DOI 10.1002/ajmg.1320420312; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WITKOP C, 1990, PRINCIPLES PRACTICE, P797	35	221	234	1	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					455	462						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447316				2022-12-18	WOS:A1993KR72000002
J	CHRISTIAN, JC; YU, PL; SLEMENDA, CW; JOHNSTON, CC				CHRISTIAN, JC; YU, PL; SLEMENDA, CW; JOHNSTON, CC			HERITABILITY OF BONE MASS - A LONGITUDINAL-STUDY IN AGING MALE TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis	CHRISTIAN, JC (corresponding author), INDIANA UNIV,SCH MED,DEPT MED GENET,702 BARNHILL DR,INDIANAPOLIS,IN 46223, USA.				NCRR NIH HHS [RR750] Funding Source: Medline; NHLBI NIH HHS [N01 HC 55027] Funding Source: Medline; NIA NIH HHS [P01 AG 05793] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG005793] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CHRISTIAN JC, 1979, ACTA GENET MED GEMEL, V28, P35, DOI 10.1017/S0001566000009314; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1987, GENET EPIDEMIOL, V4, P433, DOI 10.1002/gepi.1370040605; CULLITON BJ, 1987, SCIENCE, V235, P833, DOI 10.1126/science.3810166; DEQUEKER J, 1987, BONE, V8, P207, DOI 10.1016/8756-3282(87)90166-9; FABSITZ RR, IN PRESS ACTA GENET; FEINLEIB M, 1974, ACTA GEN MED GEMELLO, V25, P125; GALLAGHER JC, 1980, CLIN ORTHOP RELAT R, V150, P163; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; HUI SL, 1985, J CLIN ENDOCR METAB, V60, P74, DOI 10.1210/jcem-60-1-74; MEIR DE, 1984, AN INT MED, V101, P605; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; SCHLENKER RA, 1976, CALC TISS RES, V20, P41, DOI 10.1007/BF02546396; SLEMENDA C, 1987, J CLIN INVEST, V80, P1261, DOI 10.1172/JCI113201; SMITH DM, 1973, J CLIN INVEST, V52, P2800, DOI 10.1172/JCI107476; Snedecor G.W., 1980, STAT METHODS, V7; SUZUKI DT, 1981, INTRO GENETIC ANAL; VASSART G, 1987, SCIENCE, V235, P683, DOI 10.1126/science.2880398; Wasnich R.D., 1987, CLIN ORTHOP RELAT R, V216, P262	19	221	224	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					429	433						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2916585				2022-12-18	WOS:A1989T353500018
J	del Castillo, I; Moreno-Pelayo, MA; del Castillo, FJ; Brownstein, Z; Marlin, S; Adina, Q; Cockburn, DJ; Pandya, A; Siemering, KR; Chamberlin, GP; Ballana, E; Wuyts, W; Maciel-Guerra, AT; Alvarez, A; Villamar, M; Shohat, M; Abeliovich, D; Dahl, HHM; Estivill, X; Gasparini, P; Hutchin, T; Nance, WE; Sartorato, EL; Smith, RJH; Van Camp, G; Avraham, KB; Petit, C; Moreno, F				del Castillo, I; Moreno-Pelayo, MA; del Castillo, FJ; Brownstein, Z; Marlin, S; Adina, Q; Cockburn, DJ; Pandya, A; Siemering, KR; Chamberlin, GP; Ballana, E; Wuyts, W; Maciel-Guerra, AT; Alvarez, A; Villamar, M; Shohat, M; Abeliovich, D; Dahl, HHM; Estivill, X; Gasparini, P; Hutchin, T; Nance, WE; Sartorato, EL; Smith, RJH; Van Camp, G; Avraham, KB; Petit, C; Moreno, F			Prevalence and evolutionary origins of the del(GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: a multicenter study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERICENTROMERIC REGION; MOLECULAR-GENETICS; RAT COCHLEA; CONNEXIN-30; DEAFNESS; EXPRESSION; COMMUNICATION; GJB6; MAP	Mutations in GJB2, the gene encoding connexin-26 at the DFNB1 locus on 13q12, are found in as many as 50% of subjects with autosomal recessive, nonsyndromic prelingual hearing impairment. However, genetic diagnosis is complicated by the fact that 10%-50% of affected subjects with GJB2 mutations carry only one mutant allele. Recently, a deletion truncating the GJB6 gene (encoding connexin-30), near GJB2 on 13q12, was shown to be the accompanying mutation in similar to50% of these deaf GJB2 heterozygotes in a cohort of Spanish patients, thus becoming second only to 35delG at GJB2 as the most frequent mutation causing prelingual hearing impairment in Spain. Here, we present data from a multicenter study in nine countries that shows that the deletion is present in most of the screened populations, with higher frequencies in France, Spain, and Israel, where the percentages of unexplained GJB2 heterozygotes fell to 16.0%-20.9% after screening for the del(GJB6-D13S1830) mutation. Our results also suggest that additional mutations remain to be identified, either in DFNB1 or in other unlinked genes involved in epistatic interactions with GJB2. Analysis of haplotypes associated with the deletion revealed a founder effect in Ashkenazi Jews and also suggested a common founder for countries in Western Europe. These results have important implications for the diagnosis and counseling of families with DFNB1 deafness.	Hosp Ramon y Cajal, Unidad Genet Mol, E-28034 Madrid, Spain; Inst Pasteur, INSERM, U587, Unite Genet Deficits Sensoriels, F-75724 Paris, France; Hop Trousseau, Unite Genet Med, F-75571 Paris, France; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel; St James Univ Hosp, DNA Lab, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Iowa, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Iowa, Interdepartmental Human Genet Program, Iowa City, IA 52242 USA; Pompeu Fabra Univ, Ctr Genom Regulat, Genes & Dis Program, Barcelona, Spain; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil; Rabin Med Ctr, Dept Med Genet, Petah Tiqwa, Israel; Univ Naples 2, Naples, Italy; Telethon Inst Genet & Med, Naples, Italy	Hospital Universitario Ramon y Cajal; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Saint James's University Hospital; Saint James's University Hospital; University of Leeds; Virginia Commonwealth University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Iowa; University of Iowa; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Antwerp; Universidade Estadual de Campinas; Rabin Medical Center; Universita della Campania Vanvitelli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Moreno, F (corresponding author), Hosp Ramon y Cajal, Unidad Genet Mol, Carretera Colmenar,Km 9, E-28034 Madrid, Spain.		Gasparini, Paolo/B-6173-2014; wuyts, wim/B-1346-2012; Guix, Ester Ballana/R-4117-2018; wuyts, wim/B-6262-2017; Estivill, Xavier/E-2957-2012; Van Camp, Guy/F-3386-2013; Maciel-Guerra, Andrea T/E-9130-2016; Estivill, Xavier/A-3125-2013; Villamar, Manuela/AAD-3842-2020; del Castillo, Francisco J./A-6467-2013; del Castillo, Ignacio/B-4314-2013	wuyts, wim/0000-0002-4349-9038; wuyts, wim/0000-0002-4349-9038; Van Camp, Guy/0000-0001-5105-9000; Maciel-Guerra, Andrea T/0000-0002-4850-8079; Estivill, Xavier/0000-0002-0723-2256; Villamar, Manuela/0000-0002-5115-4937; del Castillo, Francisco J./0000-0003-0467-4320; del Castillo, Ignacio/0000-0003-1188-3665; Avraham, Karen B/0000-0002-4913-251X; Gasparini, Paolo/0000-0002-0859-0856; Smith, Richard/0000-0003-1201-6731; marlin, sandrine/0000-0002-4115-9806; Ballana, Ester/0000-0002-5215-7363; Petit, Christine/0000-0002-9069-002X; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098	NIDCD NIH HHS [R01 DC002842] Funding Source: Medline; Telethon [TGM06S01, TGM03P12, E.0813] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Dahl E, 1996, J BIOL CHEM, V271, P17903, DOI 10.1074/jbc.271.30.17903; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kibar Z, 1999, GENOMICS, V56, P127, DOI 10.1006/geno.1998.5698; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I; Stevenson VA, 2003, GENET TEST, V7, P151, DOI 10.1089/109065703322146867; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845	21	220	230	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1452	1458		10.1086/380205	http://dx.doi.org/10.1086/380205			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14571368	Green Published, Bronze			2022-12-18	WOS:000187491100020
J	Antonicka, H; Mattman, A; Carlson, CG; Glerum, DM; Hoffbuhr, KC; Leary, SC; Kennaway, NG; Shoubridge, EA				Antonicka, H; Mattman, A; Carlson, CG; Glerum, DM; Hoffbuhr, KC; Leary, SC; Kennaway, NG; Shoubridge, EA			Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; OXIDATIVE-PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; NATIVE-ELECTROPHORESIS; A-FARNESYLTRANSFERASE; LEIGH-SYNDROME; YEAST COX10; DEFICIENCY; GENE; EXPRESSION	Deficiencies in the activity of cytochrome c oxidase (COX), the terminal enzyme in the respiratory chain, are a frequent cause of autosomal recessive mitochondrial disease in infants. These patients are clinically and genetically heterogeneous, and all defects so far identified in this group have been found in genes coding for accessory proteins that play important roles in the assembly of the COX holoenzyme complex. Many patients, however, remain without a molecular diagnosis. We have used a panel of retroviral vectors expressing human COX assembly factors in these patients to identify the molecular basis for the COX deficiency by functional complementation. Here we show that overexpression of COX15, a protein involved in the synthesis of heme A, the heme prosthetic group for COX, can functionally complement the isolated COX deficiency in fibroblasts from a patient with fatal, infantile hypertrophic cardiomyopathy. Mutation analysis of COX15 in the patient identified a missense mutation (C700T) on one allele, changing a conserved arginine to tryptophan (R217W), and a splice-site mutation in intron 3 on the other allele (C447-3G), resulting in a deletion of exon 4. This splicing error introduces a frameshift and a premature stop codon, resulting in an unstable mRNA and, likely, a null allele. Mitochondrial heme A content was reduced in the patient's heart and fibroblast mitochondria, and levels of heme O were increased in the patient's heart. COX activity and the total amount of fully assembled enzyme were reduced by 50%-70% in patient fibroblasts. Expression of COX15 increased heme A content and rescued COX activity. These results suggest that reduced availability of heme A stalls the assembly of COX. This study establishes COX15 as an additional cause, along with SCO2, of fatal infantile, hypertrophic cardiomyopathy associated with isolated COX deficiency.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	McGill University; McGill University; University of Alberta; Oregon Health & Science University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.		Leary, Scot/B-3036-2012; Glerum, Moira/AHD-3271-2022	Antonicka, Hana/0000-0002-2525-2867				Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Coenen MJH, 1999, BIOCHEM BIOPH RES CO, V265, P339, DOI 10.1006/bbrc.1999.1662; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025; Jaksch M, 1998, J MED GENET, V35, P895, DOI 10.1136/jmg.35.11.895; KENNAWAY NG, 1990, PEDIATR RES, V28, P529; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; Matthews JL, 1971, ATLAS HUMAN HISTOLOG; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Papadopoulou LC, 1999, NAT GENET, V23, P333; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Srere P.A., 1969, METHODS ENZYM, V13, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; TZAGOLOFF A, 1993, BIOCHEM MOL BIOL INT, V31, P593; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Valnot I, 2000, AM J HUM GENET, V67, P1104; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	37	220	225	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					101	114		10.1086/345489	http://dx.doi.org/10.1086/345489			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12474143	Green Published, Bronze			2022-12-18	WOS:000180186800010
J	Waterham, HR; Wijburg, FA; Hennekam, RCM; Vreken, P; Poll-The, BT; Dorland, L; Duran, M; Jira, PE; Smeitink, JAM; Wevers, RA; Wanders, RJA				Waterham, HR; Wijburg, FA; Hennekam, RCM; Vreken, P; Poll-The, BT; Dorland, L; Duran, M; Jira, PE; Smeitink, JAM; Wevers, RA; Wanders, RJA			Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSITU HYBRIDIZATION; YEAST	Smith-Lemli-Opitz syndrome is a frequently occurring autosomal recessive developmental disorder characterized by facial dysmorphisms, mental retardation, and multiple congenital anomalies. Biochemically, the disorder is caused by deficient activity of 7-dehydrocholesterol reductase, which catalyzes the final step in the cholesterol-biosynthesis pathway-that is, the reduction of the Delta 7 double bond of 7-dehydrocholestero to produce cholesterol. We identified a partial transcript coding for human 7-dehydrocholesterol reductase by searching the database of expressed sequence tags with the amino acid sequence for the Arabidopsis thaliana sterol Delta 7-reductase and isolated the remaining 5' sequence by the "rapid amplification of cDNA ends" method, or 5'-RACE. The cDNA has an open reading frame of 1,425 bp coding for a polypeptide of 475 amino acids with a calculated molecular weight of 54.5 kD. Heterologous expression of the cDNA in the yeast Saccharomyces cerevisiae confirmed that it codes for 7-dehydrocholesterol reductase. Chromosomal mapping experiments localized the gene to chromosome 11q13. Sequence analysis of fibroblast 7-dehydrocholesterol reductase cDNA from three patients with Smith-Lemli-Opitz syndrome revealed distinct mutations, including a 134-bp insertion and three different point mutations, each of which was heterozygous in cDNA from the respective parents. Our data demonstrate that Smith-Lemli-Opitz syndrome is caused by mutations in the gene coding for 7-dehydrocholesterol reductase.	Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1100 DE Amsterdam, Netherlands; Univ Utrecht, Childrens Hosp, Dept Metab Dis, Utrecht, Netherlands; Univ Nijmegen Hosp, Lab Pediat & Neurol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Radboud University Nijmegen; Radboud University Nijmegen	Waterham, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, POB 22700, NL-1100 DE Amsterdam, Netherlands.		Smeitink, Jan A.M./D-6064-2011; Smeitink, Jan/C-1351-2013; Wevers, Ron A./H-8116-2014	Wevers, Ron A./0000-0003-2278-9746; Poll-The, Bwee Tien/0000-0002-8118-5419; Wijburg, Frits/0000-0002-0950-1368				Alley TL, 1997, AM J MED GENET, V68, P279, DOI 10.1002/(SICI)1096-8628(19970131)68:3<279::AID-AJMG6>3.0.CO;2-H; ALLEY TL, 1995, AM J HUM GENET, V56, P1411; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.3.CO;2-5; CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110; DONNAI D, 1986, J MED GENET, V23, P64, DOI 10.1136/jmg.23.1.64; Farese RV, 1998, TRENDS GENET, V14, P115, DOI 10.1016/S0168-9525(97)01377-2; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; Honda M, 1996, J LIPID RES, V37, P2433; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Kelley RI, 1997, AM J MED GENET, V68, P251, DOI 10.1002/(SICI)1096-8628(19970131)68:3<251::AID-AJMG1>3.0.CO;2-P; Kelley RI, 1996, AM J MED GENET, V66, P478, DOI 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO;2-Q; Lanoue L, 1997, AM J MED GENET, V73, P24; Lecain E, 1996, J BIOL CHEM, V271, P10866, DOI 10.1074/jbc.271.18.10866; Moebius FF, 1998, P NATL ACAD SCI USA, V95, P1899, DOI 10.1073/pnas.95.4.1899; OPITZ JM, 1994, AM J MED GENET, V50, P326, DOI 10.1002/ajmg.1320500406; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; SHEFER S, 1995, J CLIN INVEST, V96, P1779, DOI 10.1172/JCI118223; SMITH DW, 1964, J PEDIATR-US, V64, P210, DOI 10.1016/S0022-3476(64)80264-X; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; TINT GS, 1995, J PEDIATR-US, V127, P82, DOI 10.1016/S0022-3476(95)70261-X; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; vanRooij A, 1997, J INHERIT METAB DIS, V20, P578, DOI 10.1023/A:1005355026186; WALLACE M, 1994, AM J MED GENET, V50, P368, DOI 10.1002/ajmg.1320500414; Wanders RJA, 1997, J INHERIT METAB DIS, V20, P432, DOI 10.1023/A:1005371104822; YE Q, 1994, J BIOL CHEM, V269, P11306	27	220	230	2	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					329	338		10.1086/301982	http://dx.doi.org/10.1086/301982			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683613	Green Published, Bronze			2022-12-18	WOS:000075360800008
J	SILVESTRI, G; MORAES, CT; SHANSKE, S; OH, SJ; DIMAURO, S				SILVESTRI, G; MORAES, CT; SHANSKE, S; OH, SJ; DIMAURO, S			A NEW MTDNA MUTATION IN THE TRANS RNALYS GENE ASSOCIATED WITH MYOCLONIC EPILEPSY AND RAGGED-RED FIBERS (MERRF)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATION; TRANSFER RNALEU(UUR) GENE; STROKE-LIKE EPISODES; LACTIC-ACIDOSIS; KEARNS-SAYRE; MELAS; ENCEPHALOPATHY; MYOPATHY; DISEASE	Myoclonic epilepsy with ragged-red fibers (MERRF) has been associated with an A-->G transition at mtDNA nt 8344, within a conserved region of the tRNA(Lys) gene. Although the 8344 mutation is highly prevalent in patients with MERRF, it is not observed in 10%-20% of the cases, suggesting genetic heterogeneity. We have sequenced the tRNA(Lys) gene of five MERRF patients lacking the common 8344 mutation. One of these showed a novel T-->C transition at nucleotide position 8356, disrupting a highly conserved base pair in the TpsiC stem. The mutant mtDNA population was essentially homoplasmic in muscle but was heteroplasmic in blood (47%). Neither 20 patients with other mitochondrial diseases nor 25 controls carried this mutation. These findings suggest that tRNA(Lys) alterations may play a specific role in the pathogenesis of MERRF syndrome.	COLUMBIA UNIV COLL PHYS & SURG, H HOUSTON MERRITT CLIN RES CTR MUSCULAR DYSTROPHY, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA; UNIV ALABAMA, DEPT NEUROL, BIRMINGHAM, AL 35294 USA	Columbia University; Columbia University; Columbia University; University of Alabama System; University of Alabama Birmingham	DIMAURO, S (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, H HOUSTON MERRITT CLIN RES CTR MUSCULAR DYSTROPHY, NEW YORK, NY 10032 USA.		Moraes, Carlos/AAT-3818-2021; Silvestri, Gabriella/J-8713-2018; Silvestri, Gabriella/N-6588-2013	Silvestri, Gabriella/0000-0002-1950-1468; 	NINDS NIH HHS [NS11766] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H; CIACCI F, 1992, Neurology, V42, P417; GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; MORAES CT, 1991, CURRENT NEUROLOGY, V11, P83; NOER AS, 1991, AM J HUM GENET, V49, P715; SEIBEL P, 1991, J NEUROL SCI, V105, P217, DOI 10.1016/0022-510X(91)90148-Z; SHIH KD, 1991, BIOCHEM BIOPH RES CO, V174, P1109, DOI 10.1016/0006-291X(91)91535-K; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SILVESTRI G, 1992, Neurology, V42, P417; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; TANNO Y, 1991, BIOCHEM BIOPH RES CO, V179, P880, DOI 10.1016/0006-291X(91)91900-W; YONEDA M, 1990, BIOCHEM INT, V21, P789; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1991, AM J HUM GENET, V48, P203; ZEVIANI M, IN PRESS EUR J HUM G; ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619	21	220	222	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1213	1217						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1361099				2022-12-18	WOS:A1992KC99500004
J	OTT, J				OTT, J			STRATEGIES FOR CHARACTERIZING HIGHLY POLYMORPHIC MARKERS IN HUMAN GENE-MAPPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Before new markers are thoroughly characterized, they are usually screened for high polymorphism on the basis of a small panel of individuals. Four commonly used screening strategies are compared in terms of their power to correctly classify a marker as having heterozygosity of 70% or higher. A small number of typed individuals (10, say) are shown to provide good discrimination power between low- and high-heterozygosity markers when the markers have a small number of alleles. Characterizing markers in more detail requires larger sample sizes (e.g., at least 80-100 individuals) if there is to be a high probability of detecting most or all alleles. For linkage analyses involving highly polymorphic markers, the practice of arbitrarily assuming equal gene frequencies can cause serious trouble. In the presence of untyped individuals, when gene frequencies are unequal but are assumed to be equal in the analysis, recombination-fraction estimates tend to be badly biased, leading to strong false-positive evidence for linkage.			OTT, J (corresponding author), COLUMBIA UNIV,DEPT PSYCHIAT,BOX 58,722 W 168TH ST,NEW YORK,NY 10032, USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG000424] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008, HG00424] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BOEHNKE M, 1991, AM J HUM GENET, V48, P22; CHAKRABORTY R, 1990, AM J HUM GENET S, V47, pA129; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; MERETTE C, IN PRESS MOL GENETIC; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; Ott J., 1991, ANAL HUMAN GENETIC L; TERWILLIGER JD, IN PRESS GENOMICS; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Weir BS, 1990, GENETIC DATA ANAL	9	220	229	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					283	290						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1642229				2022-12-18	WOS:A1992JF77600007
J	HITTNER, HM				HITTNER, HM			CORRECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction																		HITTNER HM, 1982, AM J HUM GENET, V34, P966	1	220	220	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					330	330		10.2307/252360	http://dx.doi.org/10.2307/252360			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265		Bronze			2022-12-18	WOS:A1983QJ26500015
J	KAUR, H				KAUR, H			CORRECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction																		KAUR H, 1982, AM J HUM GENET, V34, P972	1	220	220	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					330	331		10.2307/252360	http://dx.doi.org/10.2307/252360			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265		Bronze			2022-12-18	WOS:A1983QJ26500016
J	JABLON, S; NEEL, JV; GERSHOWITZ, H; ATKINSON, GF				JABLON, S; NEEL, JV; GERSHOWITZ, H; ATKINSON, GF			NAS-NRC TWIN PANEL - METHODS OF CONSTRUCTION OF PANEL ZYGOSITY DIAGNOSIS AND PROPOSED USE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEEBE GW, UNPUBLISHED; CEDERLOEF R, 1961, ACTA GENET STAT MED, V11, P338; GEDDA L, 1956, NOVANT ANNI LEGGI ED; Harvald B, 1965, GENETICS EPIDEMIOLOG; KALLMANN FJ, 1949, AM J PSYCHIAT, V106, P29, DOI 10.1176/ajp.106.1.29; MAYNARD SMITH SHEILA, 1955, ANN HUMAN GENETICS, V19, P273; Mourant A., 1954, DISTRIBUTION HUMAN B; NEEL J, 1965, GENETICS EPIDEMIO ED; NEEL JV, 1962, GENETICS DENTAL HEAL, P17; NICHOLS RC, 1966, ACTA GENET STAT MED, V16, P265; NIXON WLB, 1956, NOVANT ANNI LEGGI ME; RALSTON A, 1960, MATHEMATICAL METH ED, P191; SLATER E, 1963, ACTA PSYCHIAT SCAND, V39, P78, DOI 10.1111/j.1600-0447.1963.tb07457.x; SLATER P, 1964, J Med Genet, V1, P42, DOI 10.1136/jmg.1.1.42; SUTTON H. ELDON, 1962, AMER JOUR HUMAN GENET, V14, P52; SUTTON HE, 1955, AM J HUM GENET, V7, P180; Wilf, 1960, MATH METHODS DIGITAL, P191; WITKOP CJ, 1962, GENETICS DENTAL H ED, P17; 1966, ACTA GENET MED GEMEL, V15, P109; 1963, SCIENCE FINGERPRINTS	20	220	220	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	2					133	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	91653	6067093				2022-12-18	WOS:A19679165300007
J	Lesage, S; Drouet, V; Majounie, E; Deramecourt, V; Jacoupy, M; Nicolas, A; Cormier-Dequaire, F; Hassoun, SM; Pujol, C; Ciura, S; Erpapazoglou, Z; Usenko, T; Maurage, CA; Sahbatou, M; Liebau, S; Ding, JH; Bilgic, B; Emre, M; Erginel-Unaltuna, N; Guven, G; Tison, F; Tranchant, C; Vidailhet, M; Corvol, JC; Krack, P; Leutenegger, AL; Nalls, MA; Hernandez, DG; Heutink, P; Gibbs, JR; Hardy, J; Wood, NW; Gasser, T; Durr, A; Deleuze, JF; Tazir, M; Destee, A; Lohmann, E; Kabashi, E; Singleton, A; Corti, O; Brice, A				Lesage, Suzanne; Drouet, Valerie; Majounie, Elisa; Deramecourt, Vincent; Jacoupy, Maxime; Nicolas, Aude; Cormier-Dequaire, Florence; Hassoun, Sidi Mohamed; Pujol, Claire; Ciura, Sorana; Erpapazoglou, Zoi; Usenko, Tatiana; Maurage, Claude-Alain; Sahbatou, Mourad; Liebau, Stefan; Ding, Jinhui; Bilgic, Basar; Emre, Murat; Erginel-Unaltuna, Nihan; Guven, Gamze; Tison, Francois; Tranchant, Christine; Vidailhet, Marie; Corvol, Jean-Christophe; Krack, Paul; Leutenegger, Anne-Louise; Nalls, Michael A.; Hernandez, Dena G.; Heutink, Peter; Gibbs, J. Raphael; Hardy, John; Wood, Nicholas W.; Gasser, Thomas; Durr, Alexandra; Deleuze, Jean-Francois; Tazir, Meriem; Destee, Alain; Lohmann, Ebba; Kabashi, Edor; Singleton, Andrew; Corti, Olga; Brice, Alexis		French Parkinson's Dis Genetics St; IPDGC	Loss of VPS1 3C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCING DATA; NITRIC-OXIDE; DISEASE; PROTEIN; MUTATIONS; PINK1; GENE; INTERACT; ASSOCIATION; CLEARANCE	Autosomal-recessive early-onset parkinsonism is clinically and genetically heterogeneous. The genetic causes of approximately 50% of autosomal-recessive early-onset forms of Parkinson disease (PD) remain to be elucidated. Homozygozity mapping and exome sequencing in 62 isolated individuals with early-onset parkinsonism and confirmed consanguinity followed by data mining in the exomes of 1,348 PD-affected individuals identified, in three isolated subjects, homozygous or compound heterozygous truncating mutations in vacuolar protein sorting 13C (VPS13C). VPS13C mutations are, associated with a distinct form of early-onset parkinsonism characterized by rapid and severe disease progression and early cognitive decline; the pathological features were striking and reminiscent of diffuse Lewy body disease. In cell models, VPS13C partly localized to the outer membrane of mitochondria. Silencing of VPS13C was associated with lower mitochondrial membrane potential, mitochondrial fragmentation, increased respiration rates, exacerbated PINK1/Parkin-dependent initophagy, and transcriptional upregulation of PARK2 in response to mitochondrial damage. This work suggests that loss of function of VPS13C is a cause of autosomal-recessive early-onset parkinsonism with a distinctive phenotype of rapid and severe progression.	[Lesage, Suzanne; Drouet, Valerie; Jacoupy, Maxime; Nicolas, Aude; Cormier-Dequaire, Florence; Hassoun, Sidi Mohamed; Pujol, Claire; Ciura, Sorana; Erpapazoglou, Zoi; Usenko, Tatiana; Vidailhet, Marie; Corvol, Jean-Christophe; Durr, Alexandra; Kabashi, Edor; Corti, Olga; Brice, Alexis] Univ Paris 06, Sorbonne Univ, UMR S 1127, F-75013 Paris, France; [Lesage, Suzanne; Drouet, Valerie; Jacoupy, Maxime; Nicolas, Aude; Cormier-Dequaire, Florence; Hassoun, Sidi Mohamed; Pujol, Claire; Ciura, Sorana; Erpapazoglou, Zoi; Usenko, Tatiana; Vidailhet, Marie; Corvol, Jean-Christophe; Durr, Alexandra; Kabashi, Edor; Corti, Olga; Brice, Alexis] Inserm U 1127, F-75013 Paris, France; [Lesage, Suzanne; Drouet, Valerie; Jacoupy, Maxime; Nicolas, Aude; Cormier-Dequaire, Florence; Hassoun, Sidi Mohamed; Pujol, Claire; Ciura, Sorana; Erpapazoglou, Zoi; Usenko, Tatiana; Vidailhet, Marie; Corvol, Jean-Christophe; Durr, Alexandra; Kabashi, Edor; Corti, Olga; Brice, Alexis] CNRS UMR 7225, F-75013 Paris, France; [Lesage, Suzanne; Drouet, Valerie; Jacoupy, Maxime; Nicolas, Aude; Cormier-Dequaire, Florence; Hassoun, Sidi Mohamed; Pujol, Claire; Ciura, Sorana; Erpapazoglou, Zoi; Usenko, Tatiana; Vidailhet, Marie; Corvol, Jean-Christophe; Durr, Alexandra; Kabashi, Edor; Corti, Olga; Brice, Alexis] ICM, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Majounie, Elisa; Ding, Jinhui; Nalls, Michael A.; Hernandez, Dena G.; Gibbs, J. Raphael] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Deramecourt, Vincent; Maurage, Claude-Alain] Univ Lille Nord France, Lille Univ Hosp, Dept Histol & Pathol, F-59000 Lille, France; [Corvol, Jean-Christophe] Ctr Invest Clin Pitie Neurosci CIC 1422, F-75013 Paris, France; [Sahbatou, Mourad] Fdn Jean Dausset, CEPH, F-75010 Paris, France; [Liebau, Stefan] Univ Tubingen, Inst Neuroanat, D-72074 Tubingen, Germany; [Bilgic, Basar; Emre, Murat; Lohmann, Ebba] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Behav Neurol & Movement Disorders Unit, TR-34390 Istanbul, Turkey; [Erginel-Unaltuna, Nihan; Guven, Gamze] Istanbul Univ, Inst Expt Med, Dept Genet, TR-34390 Istanbul, Turkey; [Tison, Francois] Univ Bordeaux, Inst Malad Neurodegenerat, F-33000 Bordeaux, France; [Tison, Francois] CHU Bordeaux, F-33000 Bordeaux, France; [Tranchant, Christine] Hop Univ, Serv Neurol, Pole Tete Cou CETD, F-67000 Strasbourg, France; [Vidailhet, Marie] Hop La Pitie Salpetriere, Federat Neurol, Pole Malad Syst Nerveux, F-75013 Paris, France; [Krack, Paul] Univ Grenoble 1, CHU Grenoble, Dept Neurol, F-38000 Grenoble, France; [Krack, Paul] INSERM U836, F-38000 Grenoble, France; [Leutenegger, Anne-Louise] Inserm U946, F-75010 Paris, France; [Leutenegger, Anne-Louise] Univ Paris Diderot, Inst Univ Hernatol, UMR946, F-75010 Paris, France; [Heutink, Peter; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, D-72074 Tubingen, Germany; [Heutink, Peter; Gasser, Thomas; Lohmann, Ebba] German Ctr Neurodegenerat Dis, DZNE, D-72074 Tubingen, Germany; [Hardy, John; Wood, Nicholas W.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Durr, Alexandra; Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75013 Paris, France; [Deleuze, Jean-Francois] Ctr Natl Genotypage, Inst Genom, CEA, F-91000 Evry, France; [Tazir, Meriem] CHU Mustapha, Serv Neurol, Algiers 16000, Algeria; [Destee, Alain] Univ Lille, Lille Univ Hosp, Inserm U837, Movement Disorders Unit, F-59000 Lille, France; [Lohmann, Ebba] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Lille - ISITE; CHU Lille; Universite de Lille; UDICE-French Research Universities; Sorbonne Universite; Foundation Jean Dausset-CEPH; Eberhard Karls University of Tubingen; Istanbul University; Istanbul University; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Corti, O; Brice, A (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S 1127, F-75013 Paris, France.; Corti, O; Brice, A (corresponding author), Inserm U 1127, F-75013 Paris, France.; Corti, O; Brice, A (corresponding author), CNRS UMR 7225, F-75013 Paris, France.; Corti, O; Brice, A (corresponding author), ICM, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France.	olga.corti@upmc.fr; alexis.brice@upmc.fr	Hardy, John/C-2451-2009; Erginel-Unaltuna, Nihan/A-4885-2018; Brice, Alexis/A-2170-2009; Corti, Olga/I-4981-2016; Singleton, Andrew B/C-3010-2009; Deuschl, Gunther/A-7986-2010; Morris, Huw R/B-8527-2008; Deloukas, Panos/B-2922-2013; Guven, Gamze/Q-4560-2016; Kabashi, Edor/C-5408-2014; Guven, Gamze/AAB-7548-2020; brice, alexis/AAE-8275-2019; Liebau, Stefan/C-3374-2015; Deramecourt, Vincent/G-5504-2018; Gasser, Thomas/GNH-5293-2022; Maetzler, Walter/A-6796-2011; Lubbe, Steven/L-8261-2013; van de Warrenburg, Bart PC/D-1935-2010; Leutenegger, Anne-Louise/B-5597-2009; Scheffer, Hans/E-4644-2012; Berg, Daniela/A-8728-2019; Broussolle, Emmanuel/H-1592-2017; Corvol, Jean-Christophe/F-2124-2017; Erpapazoglou, Zoi/X-8497-2019; Gibbs, J. Raphael/A-3984-2010; Corti, Olga/AAC-3160-2019; Wood, Nicholas W/C-2505-2009; Revesz, Tamas/A-8732-2010; Bilgic, Basar/E-4821-2012; Ryten, Mina/Q-8419-2016; corvol, jean-christophe/I-6387-2012; Schapira, Anthony/A-1245-2010	Hardy, John/0000-0002-3122-0423; Erginel-Unaltuna, Nihan/0000-0003-0562-0455; Corti, Olga/0000-0003-2093-7389; Deuschl, Gunther/0000-0002-4176-9196; Morris, Huw R/0000-0002-5473-3774; Deloukas, Panos/0000-0001-9251-070X; Kabashi, Edor/0000-0003-4118-251X; brice, alexis/0000-0002-0941-3990; Liebau, Stefan/0000-0003-0721-8187; Deramecourt, Vincent/0000-0001-9742-7833; Gasser, Thomas/0000-0002-1069-1146; Maetzler, Walter/0000-0002-5945-4694; Lubbe, Steven/0000-0002-7103-6671; van de Warrenburg, Bart PC/0000-0003-4412-1616; Leutenegger, Anne-Louise/0000-0002-1302-4357; Scheffer, Hans/0000-0002-2986-0915; Berg, Daniela/0000-0001-5796-5442; Broussolle, Emmanuel/0000-0002-0410-9519; Corvol, Jean-Christophe/0000-0001-7325-0199; Gibbs, J. Raphael/0000-0002-6985-0658; Wood, Nicholas W/0000-0002-9500-3348; Revesz, Tamas/0000-0003-2501-0259; Bilgic, Basar/0000-0001-6032-0856; corvol, jean-christophe/0000-0001-7325-0199; Simon Sanchez, Javier/0000-0001-5141-5829; Chinnery, Patrick/0000-0002-7065-6617; Hudson, Gavin/0000-0001-7210-2733; Talbot, Kevin/0000-0001-5490-1697; Chen, Honglei/0000-0003-3446-7779; van Hilten, Jacobus/0000-0002-7030-0362; Anheim, Mathieu/0000-0001-8121-0605; Williams-Gray, Caroline/0000-0002-2648-9743; Schapira, Anthony/0000-0002-3018-3966; Guerreiro, Rita/0000-0001-5879-3486; Burn, David/0000-0001-7658-1209; Barker, Roger Alistair/0000-0001-8843-7730; de Bie, Rob/0000-0001-5267-0784; tranchant, christine/0000-0002-2895-1292; Hu, Michele/0000-0001-6382-5841; Heutink, Peter/0000-0001-5218-1737; Bras, Jose/0000-0001-8186-0333; Dong, Jing/0000-0001-9856-5963; Krack, Paul/0000-0002-3508-7295; Schulte, Claudia/0000-0003-4006-1265; Morrison, Karen Elaine/0000-0003-0216-5717	National Research Funding Agency [ANR-08-NEUR-004-01]; ERA-NET NEURON; France-Parkinson Association; Roger de Spoelberch Foundation [R12123DD]; French Academy of Sciences; French program "Investissements d'avenir" [ANR-10-IAIHU-06]; European Joint Programme - Neurodegenerative Disease Research (JPND-COURAGE-PD) project; National Institute on Aging; National Institutes of Neurological Disorders and Stroke, NIH; Department of Health and Human Services [Z01 AG000958]; Department of Health and Human Services (MRC) [G1100643/1]; European Social Fund; Ministry of Science, Research, and the Arts, Baden-Wurttemberg; Department of Defense [10064005/11348001]; French Health Ministry (PHRC); France Parkinson Association; Lille University Hospital; Atip/Avenir from the National Institute of Health and Medical Research (INSERM); ANR; ERA-NET E-rare program; France Alzheimer Association; Marie Curie Actions; Cognacq-Jay Foundation; EMBO; AFM-Telethon; MRC [G0700943, G1100643] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000958, Z01AG000958] Funding Source: NIH RePORTER; Medical Research Council [MR/L501554/1, G1100643, G0700943] Funding Source: researchfish; Parkinson&quot;s UK [G-0909, K-1501, G-1107, J-1402, F-1202] Funding Source: researchfish	National Research Funding Agency; ERA-NET NEURON; France-Parkinson Association; Roger de Spoelberch Foundation; French Academy of Sciences; French program "Investissements d'avenir"(French National Research Agency (ANR)); European Joint Programme - Neurodegenerative Disease Research (JPND-COURAGE-PD) project; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Health and Human Services; Department of Health and Human Services (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Social Fund(European Social Fund (ESF)); Ministry of Science, Research, and the Arts, Baden-Wurttemberg; Department of Defense(United States Department of Defense); French Health Ministry (PHRC); France Parkinson Association; Lille University Hospital; Atip/Avenir from the National Institute of Health and Medical Research (INSERM); ANR(French National Research Agency (ANR)); ERA-NET E-rare program; France Alzheimer Association; Marie Curie Actions(European Commission); Cognacq-Jay Foundation; EMBO(European Molecular Biology Organization (EMBO)); AFM-Telethon(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors are grateful to the families for their participation in this study. We thank Merle Ruberg for critical reading of the manuscript, the DNA and Cell Bank of ICM, the Plate-Forme d'Imagerie Cellulaire de la Pitie-Salpetriere (PICPS), and Ebru Ozer and Meltem Pak for sample preparation. We are grateful to the Lille brain bank for the gift of a brain ("Lille Neurobank," BB-0033-00030). This study was supported by the National Research Funding Agency (ANR-08-NEUR-004-01) in association with ERA-NET NEURON, the France-Parkinson Association, the Roger de Spoelberch Foundation (R12123DD), the French Academy of Sciences, the French program "Investissements d'avenir" (ANR-10-IAIHU-06), and the European Joint Programme - Neurodegenerative Disease Research (JPND-COURAGE-PD) project. This study was also supported by the Intramural Research Program of the National Institute on Aging and the National Institutes of Neurological Disorders and Stroke, NIH, Department of Health and Human Services (project Z01 AG000958 and by MRC Grant G1100643/1), by the European Social Fund, and by the Ministry of Science, Research, and the Arts, Baden-Wurttemberg. This work was also supported by the Department of Defense, including grant 10064005/11348001, the French Health Ministry (PHRC), France Parkinson Association, Lille University Hospital (A. Destee), the Atip/Avenir from the National Institute of Health and Medical Research (INSERM), the ANR in association with the ERA-NET E-rare program, the France Alzheimer Association, and a Career Integration Grant from Marie Curie Actions (E.K.). C.P. received a postdoctoral fellowship from the Cognacq-Jay Foundation. S.C. received postdoctoral fellowships from EMBO and AFM-Telethon.	Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; An CH, 2012, HUM PATHOL, V43, P40, DOI 10.1016/j.humpath.2010.03.015; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; Bertolin G, 2015, CELL DEATH DIFFER, V22, P1563, DOI 10.1038/cdd.2014.224; Bertolin G, 2013, AUTOPHAGY, V9, P1801, DOI 10.4161/auto.25884; Bonifati Vincenzo, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS23, DOI 10.1016/S1353-8020(13)70009-9; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; Buhlman L, 2014, BBA-MOL CELL RES, V1843, P2012, DOI 10.1016/j.bbamcr.2014.05.012; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deramecourt V, 2012, J ALZHEIMERS DIS, V31, P741, DOI 10.3233/JAD-2012-120160; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Doherty KM, 2013, JAMA NEUROL, V70, P571, DOI 10.1001/jamaneurol.2013.172; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibanez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	43	219	223	3	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					500	513		10.1016/j.ajhg.2016.01.014	http://dx.doi.org/10.1016/j.ajhg.2016.01.014			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942284	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000372383100013
J	Tuschl, K; Clayton, PT; Gospe, SM; Gulab, S; Ibrahim, S; Singhi, P; Aulakh, R; Ribeiro, RT; Barsottini, OG; Zaki, MS; Del Rosario, ML; Dyack, S; Price, V; Rideout, A; Gordon, K; Wevers, RA; Chong, WK; Mills, PB				Tuschl, Karin; Clayton, Peter T.; Gospe, Sidney M., Jr.; Gulab, Shamshad; Ibrahim, Shahnaz; Singhi, Pratibha; Aulakh, Roosy; Ribeiro, Reinaldo T.; Barsottini, Orlando G.; Zaki, Maha S.; Luz Del Rosario, Maria; Dyack, Sarah; Price, Victoria; Rideout, Andrea; Gordon, Kevin; Wevers, Ron A.; Chong, W. K. 'Kling'; Mills, Philippa B.			Syndrome of Hepatic Cirrhosis, Dystonia, Polycythemia, and Hypermanganesemia Caused by Mutations in SLC30A10, a Manganese Transporter in Man	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAMMALIAN ZINC; HEAVY-METALS; IRON; YEAST; EXPOSURE; EXPRESSION; INTERFACE; TOXICITY; URINE; BRAIN	Environmental manganese (Mn) toxicity causes an extrapyramidal, parkinsonian-type movement disorder with characteristic magnetic resonance images of Mn accumulation in the basal ganglia. We have recently reported a suspected autosomal recessively inherited syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia in cases without environmental Mn exposure. Whole-genome mapping of two consanguineous families identified SLC30A10 as the affected gene in this inherited type of hypermanganesemia. This gene was subsequently sequenced in eight families, and homozygous sequence changes were identified in all affected individuals. The function of the wild-type protein and the effect of sequence changes were studied in the manganese-sensitive yeast strain Delta pmr1. Expressing human wild-type SLC30A10 in the Delta pmr1 yeast strain rescued growth in high Mn conditions, confirming its role in Mn transport. The presence of missense (c.266T>C [p.Leu89Pro]) and nonsense (c.585del [p.Thr196Profs*17]) mutations in SLC30A10 failed to restore Mn resistance. Previously, SLC30A10 had been presumed to be a zinc transporter. However, this work has confirmed that SLC30A10 functions as a Mn transporter in humans that, when defective, causes Mn accumulation in liver and brain. This is an important step toward understanding Mn transport and its role in neurodegenerative processes.	[Tuschl, Karin; Clayton, Peter T.; Mills, Philippa B.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Gospe, Sidney M., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98105 USA; [Gospe, Sidney M., Jr.] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Gospe, Sidney M., Jr.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Gulab, Shamshad; Ibrahim, Shahnaz] Aga Khan Univ Hosp, Dept Pediat Neurol, Karachi 75800, Pakistan; [Singhi, Pratibha] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India; [Aulakh, Roosy] Govt Med Coll & Hosp, Dept Pediat, Chandigarh 160030, India; [Ribeiro, Reinaldo T.; Barsottini, Orlando G.] Univ Fed Sao Paulo, Dept Neurol, BR-04038030 Sao Paulo, Brazil; [Zaki, Maha S.] Natl Res Ctr, Clin Genet Dept, Cairo 12311, Egypt; [Luz Del Rosario, Maria] St Lukes Med Ctr, Dept Pediat, Quezon City 1112, Philippines; [Dyack, Sarah; Price, Victoria; Rideout, Andrea; Gordon, Kevin] Izaak Walton Killam Hlth Ctr, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 GA Nijmegen, Netherlands; [Chong, W. K. 'Kling'] Great Ormond St Hosp Sick Children, Dept Radiol, London WC1N 3JH, England	University of London; University College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Aga Khan University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Universidade Federal de Sao Paulo (UNIFESP); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Saint Lukes Medical Center - Philippines; Dalhousie University; Radboud University Nijmegen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Tuschl, K (corresponding author), UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England.	k.tuschl@ucl.ac.uk	Zaki, Maha S/B-9361-2013; Gospe, Sidney M/G-6080-2010; Barsottini, O/E-9117-2010; Wevers, Ron A./H-8116-2014; Dyack, Sarah/AAD-4347-2020; Gospe, Sidney/AAR-4967-2020; Clayton, Peter T/C-1523-2008	Barsottini, O/0000-0002-0107-0831; Wevers, Ron A./0000-0003-2278-9746; Gospe, Sidney/0000-0002-0099-109X; Mills, Philippa/0000-0002-9704-1268; Clayton, Peter/0000-0001-7592-4302; Tuschl, Karin/0000-0001-8599-8516; Zaki, Maha/0000-0001-7840-0002; Aulakh, Roosy/0000-0002-7715-5268	National Institute for Health Research; Great Ormond Street Hospital Children's charity; NHS Executive; Great Ormond Street Hospital Childrens Charity [V1228] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Children's charity; NHS Executive; Great Ormond Street Hospital Childrens Charity	Karin Tuschl and Philippa Mills are funded by the National Institute for Health Research. Peter Clayton is funded by the Great Ormond Street Hospital Children's charity. Research at the University College London Institute of Child Health and Great Ormond Street Hospital for Children National Health Service (NHS) Trust benefits from research and development funding received from the NHS Executive. We are grateful to K. Pearce for her technical assistance and to Prof G. Moore for provision of control samples.	ANGLE CR, 1995, OCCUP ENVIRON MED, V52, P846, DOI 10.1136/oem.52.12.846; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Au C, 2008, NEUROTOXICOLOGY, V29, P569, DOI 10.1016/j.neuro.2008.04.022; Brna P, 2011, J CHILD NEUROL, V26, P891, DOI 10.1177/0883073810393962; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Campellone JV, 1996, CLIN NEUROL NEUROSUR, V98, P242, DOI 10.1016/0303-8467(96)00018-2; Chalela JA, 2011, NEUROCRIT CARE, V14, P456, DOI 10.1007/s12028-010-9476-5; Crooks DR, 2007, J NEUROSCI RES, V85, P1797, DOI 10.1002/jnr.21321; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Ebert BL, 1999, BLOOD, V94, P1864; Fernandez-Rodriguez R, 2010, EUR J NEUROL, V17, P1463, DOI 10.1111/j.1468-1331.2010.03076.x; Ferrara J, 2009, J NEUROL, V256, P320, DOI 10.1007/s00415-009-0144-7; Fitsanakis VA, 2010, NEUROTOX RES, V18, P124, DOI 10.1007/s12640-009-9130-1; Fukushima T, 2010, NEUROEPIDEMIOLOGY, V34, P18, DOI 10.1159/000255462; Furbee B, 2011, NEUROL CLIN, V29, P623, DOI 10.1016/j.ncl.2011.05.007; Gikovate CG, 1999, NEURORADIOLOGY, V41, P288, DOI 10.1007/s002340050750; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gospe SM, 2000, ARCH DIS CHILD, V83, P439, DOI 10.1136/adc.83.5.439; Hansen SL, 2010, J DAIRY SCI, V93, P656, DOI 10.3168/jds.2009-2341; Hernandez EH, 2006, NEUROTOXICOLOGY, V27, P333, DOI 10.1016/j.neuro.2005.09.003; Huang P., 2010, EXP TOXICOL PATHOL; Klos KJ, 2006, NEUROLOGY, V67, P1984, DOI 10.1212/01.wnl.0000247037.37807.76; Kwik-Uribe CL, 2003, BRAIN RES, V973, P1, DOI 10.1016/S0006-8993(03)02457-0; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lucchini RG, 2009, NEUROMOL MED, V11, P311, DOI 10.1007/s12017-009-8108-8; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Olanow CW, 1996, NEUROLOGY, V46, P492, DOI 10.1212/WNL.46.2.492; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Quaghebeur G, 1996, NEURORADIOLOGY, V38, P680, DOI 10.1007/s002340050333; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-1; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Roth JA, 2010, J NEUROCHEM, V113, P454, DOI 10.1111/j.1471-4159.2010.06607.x; Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8; Sahni V, 2007, ENVIRON HEALTH PERSP, V115, P1776, DOI 10.1289/ehp.10421; Sata F, 1998, J TOXICOL ENV HEAL A, V54, P167; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sikk K, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/865319; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Stepens A, 2008, NEW ENGL J MED, V358, P1009, DOI 10.1056/NEJMoa072488; Sue W C, 1996, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V37, P59; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Uchino A, 1993, Radiat Med, V11, P21; Uchino A, 2007, NEURORADIOLOGY, V49, P715, DOI 10.1007/s00234-007-0243-z; Wasserman GA, 2011, NEUROTOXICOLOGY, V32, P450, DOI 10.1016/j.neuro.2011.03.009; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; WITZLEBEN CL, 1987, LAB INVEST, V56, P151; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Yokel RA, 2009, NEUROMOL MED, V11, P297, DOI 10.1007/s12017-009-8101-2	57	219	224	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					457	466		10.1016/j.ajhg.2012.01.018	http://dx.doi.org/10.1016/j.ajhg.2012.01.018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22341972	Green Published, hybrid			2022-12-18	WOS:000301762800011
J	Roberts, SB; MacLean, CJ; Neale, MC; Eaves, LJ; Kendler, KS				Roberts, SB; MacLean, CJ; Neale, MC; Eaves, LJ; Kendler, KS			Replication of linkage studies of complex traits: An examination of variation in location estimates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EYE TRACKING DYSFUNCTION; CHROMOSOME 6P; SUSCEPTIBILITY GENES; MULTIPLE-SCLEROSIS; CANDIDATE REGIONS; MAP LOCATION; SCHIZOPHRENIA; LOCUS; FAMILIES; MARKER	In linkage studies, independent replication of positive findings is crucial in order to distinguish between true positives and false positives. Recently, the following question has arisen in linkage studies of complex traits: at what distance do we reject the hypothesis that two location estimates in a genomic region represent the same gene! Here we attempt to address this question. Sampling distributions for location estimates were constructed by computer simulation. The conditions for simulation were chosen to reflect features of "typical" complex traits, including incomplete penetrance, phenocopies, and genetic heterogeneity. Our findings, which bear on what is considered a replication in linkage studies of complex traits, suggest that, even with relatively large numbers of multiplex families, chance variation in the location estimate is substantial. In addition, we report evidence that, for the conditions studied here, the standard error of a location estimate is a function of the magnitude of the expected LOD score.	Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Med Coll Virginia, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Human Genet, Virginia Inst Psychiat & Behav Genet, Med Coll Virginia, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Kendler, KS (corresponding author), Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Med Coll Virginia, POB 980126, Richmond, VA 23298 USA.		Neale, Michael/AAD-5056-2020; Kendler, Kenneth/AAF-2876-2019; Neale, Michael C/B-1418-2008					Arolt V, 1996, AM J MED GENET, V67, P564, DOI 10.1002/(SICI)1096-8628(19961122)67:6<564::AID-AJMG10>3.0.CO;2-R; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DARVASI A, 1993, GENETICS, V134, P943; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Hovatta I, 1998, MOL PSYCHIATR, V3, P452, DOI 10.1038/sj.mp.4000443; Kendall MG, 1979, ADV THEORY STAT; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; Maziade M, 1997, AM J MED GENET, V74, P311, DOI 10.1002/(SICI)1096-8628(19970531)74:3<311::AID-AJMG13>3.3.CO;2-C; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; OTT J, 1990, AM J HUM GENET, V46, P219; PRESS WH, 1986, NUMERICAL RECIPES AR; Riley BP, 1997, PSYCHIATR GENET, V7, P131, DOI 10.1097/00041444-199723000-00008; RISCH N, 1990, AM J HUM GENET, V46, P242; *SAS I, 1990, SAS, V2; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; Wilson A. F., 1996, American Journal of Human Genetics, V59, pA193	32	219	220	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					876	884		10.1086/302528	http://dx.doi.org/10.1086/302528			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441592	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000082426400031
J	GOYETTE, P; FROSST, P; ROSENBLATT, DS; ROZEN, R				GOYETTE, P; FROSST, P; ROSENBLATT, DS; ROZEN, R			7 NOVEL MUTATIONS IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE AND GENOTYPE-PHENOTYPE CORRELATIONS IN SEVERE METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIHYDROFOLATE-REDUCTASE; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURES; HOMOCYSTINURIA; FOLATE	5-Methyltetrahydrofolate, the major form of folate in plasma, is a carbon donor for the remethylation of homocysteine to methionine. This form of folate is generated from 5,10-methylenetetrahydrofolate through the action of 5,10-methylenetetrahydrofolate reductase (MTHFR), a cytosolic flavoprotein. Patients with an autosomal recessive severe deficiency of MTHFR have homocystinuria and a wide range of neurological and vascular disturbances. We have recently described the isolation of a cDNA for MTHFR and the identification of two mutations in patients with severe MTHFR deficiency. We report here the characterization of seven novel mutations in this gene: six missense mutations and a 5' splice-site defect that activates a cryptic splice site in the coding sequence. We also present a preliminary analysis of the relationship between genotype and phenotype for all nine mutations identified thus far in this gene. A nonsense mutation and two missense mutations (proline to leucine and threonine to methionine) in the homozygous state are associated with extremely low activity (0%-3%) and onset of symptoms within the Ist year of age. Other missense mutations (arginine to cysteine and arginine to glutamine) are associated with higher enzyme activity and later onset of symptoms.	MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA	McGill University; McGill University; McGill University; McGill University			Rozen, Rima/AAE-9294-2020					AHEARN JM, 1987, J BIOL CHEM, V262, P10695; Beckman D R, 1987, Birth Defects Orig Artic Ser, V23, P47; BRODERICK TP, 1987, P NATL ACAD SCI USA, V84, P3349, DOI 10.1073/pnas.84.10.3349; DAVIES JF, 1990, BIOCHEMISTRY-US, V29, P9467, DOI 10.1021/bi00492a021; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; ERBE RW, 1986, FOLATE PTERINE, V3, P413; FREEMAN JM, 1975, NEW ENGL J MED, V292, P491, DOI 10.1056/NEJM197503062921001; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; HARPEY JP, 1981, J PEDIATR-US, V98, P275, DOI 10.1016/S0022-3476(81)80660-9; JOHN SWM, 1989, AM J HUM GENET, V45, P905; KANG SS, 1991, AM J HUM GENET, V48, P536; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; KISHI T, IN PRESS J INHERIT M; MUDD SH, 1972, BIOCHEM BIOPH RES CO, V46, P905; ROSENBLATT DS, 1977, PEDIATR RES, V11, P1141, DOI 10.1203/00006450-197711000-00005; ROSENBLATT DS, 1992, BIOCHEM MED METAB B, V47, P221, DOI 10.1016/0885-4505(92)90029-X; Rosenblatt DS., 1995, METABOLIC MOL BASES, P3111; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; VOLZ KW, 1982, J BIOL CHEM, V257, P2528	19	219	242	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1052	1059						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726158				2022-12-18	WOS:A1995QU58600005
J	Storey, JD; Madeoy, J; Strout, JL; Wurfel, M; Ronald, J; Akey, JM				Storey, John D.; Madeoy, Jennifer; Strout, Jeanna L.; Wurfel, Mark; Ronald, James; Akey, Joshua M.			Gene-expression variation within and among human populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL VARIATION; ALLELIC VARIATION; EVOLUTION; DISEASE; REVEAL; COMMON	Understanding patterns of gene-expression variation within and among human populations will provide important insights into the molecular basis of phenotypic diversity and the interpretation of patterns of expression variation in disease. However, little is known about how gene-expression variation is apportioned within and among human populations. Here, we characterize patterns of natural gene-expression variation in 16 individuals of European and African ancestry. We find extensive variation in gene-expression levels and estimate that similar to 83% of genes are differentially expressed among individuals and that similar to 17% of genes are differentially expressed among populations. By decomposing total gene-expression variation into within-versus among-population components, we find that most expression variation is due to variation among individuals rather than among populations, which parallels observations of extant patterns of human genetic variation. Finally, we performed allele-specific quantitative polymerase chain reaction to demonstrate that cis-regulatory variation in the lymphocyte adaptor protein (SH2B adapter protein 3) contributes to differential expression between European and African samples. These results provide the first insight into how human population structure manifests itself in gene-expression levels and will help guide the search for regulatory quantitative trait loci.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Div Pulm & Crit Care Med, Harborview Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St,Box 357730,HSB J-279, Seattle, WA 98195 USA.	akeyj@u.washington.edu	Storey, John/B-5282-2011	Storey, John/0000-0001-5992-402X; Akey, Joshua/0000-0002-4411-1330	NHLBI NIH HHS [R01 HL089807] Funding Source: Medline; NIGMS NIH HHS [R01 GM078105] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078105] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; dos Santos KG, 2005, MOL GENET METAB, V85, P149, DOI 10.1016/j.ymgme.2005.02.010; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Dysvik B, 2006, CLIN CANCER RES, V12, P1109, DOI 10.1158/1078-0432.CCR-05-0115; Excoffier L, 2003, SCIENCE, V300; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Fruci D, 2006, J IMMUNOL, V176, P4869, DOI 10.4049/jimmunol.176.8.4869; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; GuhaThakurta D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-235; Halder Indrani, 2003, Human Genomics, V1, P52; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Leung TF, 2005, RESP MED, V99, P216, DOI 10.1016/j.rmed.2004.06.004; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STOREY JD, 2006, BIOSTATISTICS; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Yan H, 2004, CURR OPIN ONCOL, V16, P39, DOI 10.1097/00001622-200401000-00008; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	45	218	222	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					502	509		10.1086/512017	http://dx.doi.org/10.1086/512017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273971	Bronze, Green Published			2022-12-18	WOS:000244403300011
J	Hakonen, AH; Heiskanen, S; Juvonen, V; Lappalainen, I; Luoma, PT; Rantamaki, M; Van Goethem, G; Lofgren, A; Hackman, P; Paetau, A; Kaakkola, S; Majamaa, K; Varilo, T; Udd, B; Kaaiainen, H; Bindoff, LA; Suomalainen, A				Hakonen, AH; Heiskanen, S; Juvonen, V; Lappalainen, I; Luoma, PT; Rantamaki, M; Van Goethem, G; Lofgren, A; Hackman, P; Paetau, A; Kaakkola, S; Majamaa, K; Varilo, T; Udd, B; Kaaiainen, H; Bindoff, LA; Suomalainen, A			Mitochondrial DNA polymerase W748S mutation: A common cause of autosomal recessive ataxia with ancient European origin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLG MUTATIONS; GAMMA; DOMINANT; NEUROPATHY; FEATURES; ALLELES	Mutations in the catalytic subunit of the mitochondrial DNA polymerase g ( POLG) have been found to be an important cause of neurological disease. Recently, we and collaborators reported a new neurodegenerative disorder with autosomal recessive ataxia in four patients homozygous for two amino acid changes in POLG: W748S in cis with E1143G. Here, we studied the frequency of this allele and found it to be among the most common genetic causes of inherited ataxia in Finland. We identified 27 patients with mitochondrial recessive ataxia syndrome ( MIRAS) from 15 Finnish families, with a carrier frequency in the general population of 1:125. Since the mutation pair W748S+E1143G has also been described in European patients, we examined the haplotypes of 13 non-Finnish, European patients with the W748S mutation. Haplotype analysis revealed that all the chromosomes carrying these two changes, in patients from Finland, Norway, the United Kingdom, and Belgium, originate from a common ancient founder. In Finland and Norway, long, common, northern haplotypes, outside the core haplotype, could be identified. Despite having identical homozygous mutations, the Finnish patients with this adult-or juvenile-onset disease had surprisingly heterogeneous phenotypes, albeit with a characteristic set of features, including ataxia, peripheral neuropathy, dysarthria, mild cognitive impairment, involuntary movements, psychiatric symptoms, and epileptic seizures. The high carrier frequency in Finland, the high number of patients in Norway, and the ancient European founder chromosome indicate that this newly identified ataxia should be considered in the first-line differential diagnosis of progressive ataxia syndromes.	Univ Helsinki, Program Neurosci, Biomed Helsinki, Dept Pathol, Helsinki 00290, Finland; Univ Helsinki, Program Neurosci, Biomed Helsinki, Dept Med Genet, Helsinki 00290, Finland; Natl Publ Hlth Inst, Folkhalsan Inst Genet, Biomed Helsinki, Helsinki, Finland; Univ Helsinki, Dept Neurol, Cent Hosp, Natl Publ Hlth Inst, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Turku Univ, Turku Univ Hosp Labs, Dept Neurol, Turku, Finland; Turku Univ, Turku Univ Hosp Labs, Dept Med Genet, Turku, Finland; Seinajoki Cent Hosp, Dept Phys Med & Rehabil, Dept Neurol, Seinajoki, Finland; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Univ Antwerp Hosp, Neuromuscular Reference Ctr, Antwerp, Belgium; Univ Antwerp, Neurogenet Grp, Dept Mol Genet, B-2020 Antwerp, Belgium; Vaasa Cent Hosp, Dept Neurol, Vaasa, Finland; Univ Hosp Tampere, Dept Neurol, Tampere, Finland; Univ Bergen, Dept Neurol, N-5014 Bergen, Norway	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Turku; University of Turku; Seinajoki Central Hospital; University of Antwerp; University of Antwerp; University of Antwerp; Vaasa Central Hospital; Tampere University; Tampere University Hospital; University of Bergen	Suomalainen, A (corresponding author), Univ Helsinki, Program Neurosci, Biomed Helsinki, Dept Pathol, Room C523B,Haartmaninkatu 8, Helsinki 00290, Finland.	anu.wartiovaara@helsinki.fi	Majamaa, Kari/A-1344-2012	Majamaa, Kari/0000-0002-9070-3791; Varilo, Teppo/0000-0002-5839-8854; Bindoff, Laurence/0000-0003-0988-276X; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195				Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1983, LANCET, V1, P1151; Juvonen V, 2005, ACTA NEUROL SCAND, V111, P154, DOI 10.1111/j.1600-0404.2005.00349.x; Juvonen V, 2002, J MED GENET, V39, P935, DOI 10.1136/jmg.39.12.935; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Norio R, 2003, HUM GENET, V112, P441, DOI 10.1007/s00439-002-0875-3; NORIO R, 1973, ANN CLIN RES, V5, P109; Rantamaki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83; Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65; Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X; VARILO T, 1999, THESIS NATL PUBLIC H; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	30	218	225	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					430	441		10.1086/444548	http://dx.doi.org/10.1086/444548			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080118	Green Published, Bronze			2022-12-18	WOS:000231314100009
J	White, KE; Cabral, JM; Davis, SI; Fishburn, T; Evans, WE; Ichikawa, S; Fields, J; Yu, XJ; Shaw, NJ; McLellan, NJ; McKeown, C; FitzPatrick, D; Yu, K; Ornitz, DM; Econs, MJ				White, KE; Cabral, JM; Davis, SI; Fishburn, T; Evans, WE; Ichikawa, S; Fields, J; Yu, XJ; Shaw, NJ; McLellan, NJ; McKeown, C; FitzPatrick, D; Yu, K; Ornitz, DM; Econs, MJ			Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3 GENE; POINT MUTATION; ACTIVATION; TRANSMEMBRANE; ACHONDROPLASIA; SPECIFICITY; DWARFISM; SITE	Activating mutations in the genes for fibroblast growth factor receptors 1-3 (FGFR1-3) are responsible for a diverse group of skeletal disorders. In general, mutations in FGFR1 and FGFR2 cause the majority of syndromes involving craniosynostosis, whereas the dwarfing syndromes are largely associated with FGFR3 mutations. Osteoglophonic dysplasia (OD) is a "crossover" disorder that has skeletal phenotypes associated with FGFR1, FGFR2, and FGFR3 mutations. Indeed, patients with OD present with craniosynostosis, prominent supraorbital ridge, and depressed nasal bridge, as well as the rhizomelic dwarfism and nonossifying bone lesions that are characteristic of the disorder. We demonstrate here that OD is caused by missense mutations in highly conserved residues comprising the ligand-binding and transmembrane domains of FGFR1, thus defining novel roles for this receptor as a negative regulator of long-bone growth.	Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Cleveland Clin Florida, Dept Endocrinol, Weston, FL USA; Birmingham Childrens Hosp, Birmingham, W Midlands, England; Birmingham Womens Hosp, Birmingham, W Midlands, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Cleveland Clinic Foundation; University of Birmingham; Birmingham Women's Hospital; University of Edinburgh; Washington University (WUSTL)	Econs, MJ (corresponding author), 541 N Clin Dr,CL 459, Indianapolis, IN 46202 USA.	mecons@iupui.edu	FitzPatrick, David R/B-8311-2008; FitzPatrick, David R/C-7301-2013; Cabral, Joaquim M S/G-2052-2010; Evans, William E./C-2069-2012; Yu, Xijie/H-4124-2011	Cabral, Joaquim M S/0000-0002-2405-5845; Evans, William E./0000-0002-9333-5322; Yu, Xijie/0000-0002-3504-7664; FitzPatrick, David R./0000-0003-4861-969X; Ornitz, David/0000-0003-1592-7629; Econs, Michael/0000-0003-0940-1911	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002095, R01AR042228, T32AR007033, R01AR047866, R29AR042228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG018397] Funding Source: NIH RePORTER; NIAMS NIH HHS [T32 AR007033, AR42228, R01 AR047866, AR47866, AR02095, R01 AR042228] Funding Source: Medline; NIA NIH HHS [P01 AG018397, AG18397] Funding Source: Medline; NICHD NIH HHS [HD39952, P01 HD039952] Funding Source: Medline; NIDDK NIH HHS [R01 DK063934, DK063934] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; BEIGHTON P, 1980, PEDIATR RADIOL, V10, P46, DOI 10.1007/BF01644343; Delezoide AL, 1998, MECH DEVELOP, V77, P19, DOI 10.1016/S0925-4773(98)00133-6; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; HALL BD, 1992, AM J MED GENET, V44, P82, DOI 10.1002/ajmg.1320440120; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; IKEGAWA S, 1995, HUM GENET, V96, P309; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; Muenke M, 1997, AM J HUM GENET, V60, P555; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Newberry EP, 1996, MOL ENDOCRINOL, V10, P1029, DOI 10.1210/me.10.8.1029; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Paznekas WA, 1998, AM J HUM GENET, V62, P1370, DOI 10.1086/301855; PETERS KG, 1992, DEVELOPMENT, V114, P233; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTA M, 1989, P NATL ACAD SCI USA, V86, P8722, DOI 10.1073/pnas.86.22.8722; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Steinberger D, 1996, HUM MUTAT, V8, P386, DOI 10.1002/(SICI)1098-1004(1996)8:4<386::AID-HUMU18>3.3.CO;2-A; Winterpacht A, 2000, PHYSIOL GENOMICS, V2, P9, DOI 10.1152/physiolgenomics.2000.2.1.9; Xiao LP, 2004, J BIOL CHEM, V279, P27743, DOI 10.1074/jbc.M314323200; YANG XF, 1994, NEUROPROTOCOLS, V5, P157; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	31	218	230	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					361	367		10.1086/427956	http://dx.doi.org/10.1086/427956			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15625620	Green Published, Bronze			2022-12-18	WOS:000226215100022
J	Phillips, HA; Favre, I; Kirkpatrick, M; Zuberi, SM; Goudie, D; Heron, SE; Scheffer, IE; Sutherland, GR; Berkovic, SF; Bertrand, D; Mulley, JC				Phillips, HA; Favre, I; Kirkpatrick, M; Zuberi, SM; Goudie, D; Heron, SE; Scheffer, IE; Sutherland, GR; Berkovic, SF; Bertrand, D; Mulley, JC			CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION; CLONING; ALPHA-4; FAMILY; GENE	Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is an uncommon, idiopathic partial epilepsy characterized by clusters of motor seizures occurring in sleep. We describe a mutation of the beta2 subunit of the nicotinic acetylcholine receptor, effecting a V287M substitution within the M2 domain. The mutation, in an evolutionary conserved region of CHRNB2, is associated with ADNFLE in a Scottish family. Functional receptors with the V287M mutation are highly expressed in Xenopus oocytes and characterized by an similar to 10-fold increase in acetylcholine sensitivity. CHRNB2 is a new gene for idiopathic epilepsy, the second acetylcholine receptor subunit implicated in ADNFLE.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Genet Med, Adelaide, SA 5006, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Univ Geneva, Fac Med, Dept Physiol, Geneva, Switzerland; Tayside Univ Hosp NHS Trust, Ninewells Hosp & Med Sch, Dept Paediat, Dundee, Scotland; Ninewells Hosp, Dundee DD1 9SY, Scotland; Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland; Univ Melbourne, Dept Med Neurol, Parkville, Vic 3052, Australia; Austin & Repatriat Med Ctr, Melbourne, Vic, Australia	Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; University of Geneva; University of Dundee; University of Dundee; University of Glasgow; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Mulley, JC (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Genet Med, 72 King William Rd, Adelaide, SA 5006, Australia.		Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022; Heron, Sarah/F-4222-2013; Sutherland, Grant Robert/D-2606-2012	Scheffer, Ingrid E/0000-0002-2311-2174; Heron, Sarah/0000-0001-8759-6748; Berkovic, Samuel/0000-0003-4580-841X				ANAND R, 1991, J BIOL CHEM, V266, P11192; BERTRAND D, 1991, ELECTROPHYSIOLOGY NE; Bertrand S, 1998, BRIT J PHARMACOL, V125, P751, DOI 10.1038/sj.bjp.0702154; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Covernton PJO, 2000, J NEUROSCI METH, V96, P63, DOI 10.1016/S0165-0270(99)00185-5; De Fusco M, 2000, NAT GENET, V26, P275; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; Hirose S, 1999, NEUROLOGY, V53, P1749, DOI 10.1212/WNL.53.8.1749; Kuryatov A, 1997, J NEUROSCI, V17, P9035; MONTEGGIA LM, 1995, GENE, V155, P189, DOI 10.1016/0378-1119(94)00914-E; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Oldani A, 1998, BRAIN, V121, P205, DOI 10.1093/brain/121.2.205; Phillips HA, 2000, ANN NEUROL, V48, P264, DOI 10.1002/1531-8249(200008)48:2<264::AID-ANA20>3.0.CO;2-B; Phillips HA, 1998, AM J HUM GENET, V63, P1108, DOI 10.1086/302047; Rempel N, 1998, HUM GENET, V103, P645, DOI 10.1007/s004390050885; Saenz A, 1999, ARCH NEUROL-CHICAGO, V56, P1004, DOI 10.1001/archneur.56.8.1004; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 2000, EPILEPSIA, V41, P529, DOI 10.1111/j.1528-1157.2000.tb00205.x; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; WILLOUGHBY JJ, 1993, NEUROSCI LETT, V155, P136, DOI 10.1016/0304-3940(93)90691-D	22	218	237	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					225	231		10.1086/316946	http://dx.doi.org/10.1086/316946			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11104662	Bronze, Green Published			2022-12-18	WOS:000166399900022
J	Daw, EW; Payami, H; Nemens, EJ; Nochlin, D; Bird, TD; Schellenberg, GD; Wijsman, EM				Daw, EW; Payami, H; Nemens, EJ; Nochlin, D; Bird, TD; Schellenberg, GD; Wijsman, EM			The number of trait loci in late-onset Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E GENOTYPE; GENE; DEMENTIA; LINKAGE; AGE; SEX; METAANALYSIS; CHROMOSOME-1; SEGREGATION; ALLELE	Although it is clear that apoE plays an important role in the genetics of late-onset Alzheimer disease (AD), evidence exists that additional genes may play a role in AD, and estimates of the total contribution of apoE to the variance in onset of AD vary widely. Unfortunately, little information is available on the number and contribution of additional genes. We estimated the number of additional quantitative-trait loci and their contribution to the variance in age at onset of AD, as well as the contribution of apoE and sex, in an oligogenic segregation analysis of 75 families (742 individuals) ascertained for members with late-onset AD. We found evidence that four additional loci make a contribution to the variance in age at onset of late-onset AD that is similar to or greater in magnitude than that made by apoE, with one locus making a contribution several times greater than that of apoE. Additionally, we confirmed previous findings of a dose effect for the apoE epsilon 4 allele, a protective effect for the epsilon 2 allele, evidence for allelic interactions at the apoE locus, and a small protective effect for males. Furthermore, although we estimate that the apoE genotype can make a difference of less than or equal to 17 years in age at onset of AD, our estimate of the contribution of apoE (7%-9%) to total variation in onset of AD is somewhat smaller than that which has previously been reported. Our results suggest that several genes that have not yet been localized may play a larger role than does apoE in late-onset AD.	Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Dept Neurol, Seattle, WA USA; Vet Affairs Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Oregon Health & Science University; Oregon Health & Science University	Daw, EW (corresponding author), Univ Washington, Dept Med, Div Med Genet, Box 357720, Seattle, WA 98195 USA.		Payami, Haydeh/ABE-1944-2020		NIA NIH HHS [U24 AG021886, AG 05136, P50 AG005136, AG 08017, P30 AG008017] Funding Source: Medline; NIGMS NIH HHS [R37 GM046255, R01 GM046255, GM 46255] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046255, R01GM046255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136, P30AG008017, U24AG021886] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; Bergmann S, 1997, MENOPAUSE, V4, P52; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Daw EW, 1999, AM J HUM GENET, V64, P839, DOI 10.1086/302276; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; HIXSON JE, 1990, J LIPID RES, V31, P545; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Levy-Lahad E, 1998, J GERIATR PSYCH NEUR, V11, P42, DOI 10.1177/089198879801100202; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Pericak-Vance MA, 1998, NEUROBIOL AGING, V19, pS39, DOI 10.1016/S0197-4580(98)00037-2; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; *RON NANC REAG RES, 1998, CONSENSUS REPORT WOR, V19, P109; ROSES A, 1995, J HUM GENET S, V57, pA202; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964	28	218	231	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					196	204		10.1086/302710	http://dx.doi.org/10.1086/302710			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631151	Green Published, Bronze			2022-12-18	WOS:000085033600022
J	PATAU, K				PATAU, K			THE IDENTIFICATION OF INDIVIDUAL CHROMOSOMES, ESPECIALLY IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOOK J A, 1959, Acta Paediatr, V48, P453; CHU HY, 1959, AM J HUMAN GENET, V11, P63; FORD CE, 1958, NATURE, V181, P1565, DOI 10.1038/1811565a0; FORD CE, 1959, LANCET, V1, P709; LEJEUNE J, 1959, ANN GENET-PARIS, V1, P41; LEVAN A, 1959, HEREDITAS, V45, P665; PATAU K, 1960, LANCET, V1, P790; ROTHFELS KH, 1958, CHROMOSOMA, V9, P163; SMITH DW, J PEDIAT; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; TJIO JH, 1958, P NATL ACAD SCI USA, V44, P1229, DOI 10.1073/pnas.44.12.1229	11	218	221	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	3					250	276						27	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF079	14430808				2022-12-18	WOS:A1960WF07900002
J	Verlaan, DJ; Berlivet, S; Hunninghake, GM; Madore, AM; Lariviere, M; Moussette, S; Grundberg, E; Kwan, T; Ouimet, M; Ge, B; Hoberman, R; Swiatek, M; Dias, J; Lam, KCL; Koka, V; Harmsen, E; Soto-Quiros, M; Avila, L; Celedon, JC; Weiss, ST; Dewar, K; Sinnett, D; Laprise, C; Raby, BA; Pastinen, T; Naumova, AK				Verlaan, Dominique J.; Berlivet, Soizik; Hunninghake, Gary M.; Madore, Anne-Marie; Lariviere, Mathieu; Moussette, Sanny; Grundberg, Elin; Kwan, Tony; Ouimet, Manon; Ge, Bing; Hoberman, Rose; Swiatek, Marcin; Dias, Joana; Lam, Kevin C. L.; Koka, Vonda; Harmsen, Eef; Soto-Quiros, Manuel; Avila, Lydiana; Celedon, Juan C.; Weiss, Scott T.; Dewar, Ken; Sinnett, Daniel; Laprise, Catherine; Raby, Benjamin A.; Pastinen, Tomi; Naumova, Anna K.			Allele-Specific Chromatin Remodeling in the ZPBP2/GSDMB/ORMDL3 Locus Associated with the Risk of Asthma and Autoimmune Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; LINKAGE DISEQUILIBRIUM; METHYLATION; VARIANTS; SUSCEPTIBILITY; FAMILY; DOMAIN; MOUSE; IDENTIFICATION	Common SNPs in the chromosome 17q12-q21 region alter the risk for asthma, type I diabetes, primary biliary cirrhosis, and Crohn disease. Previous reports by us and others have linked the disease-associated genetic variants with changes in expression of GSDMB and ORMDL3 transcripts in human lymphoblastoid cell lines (LCLs). The variants also alter regulation of other transcripts, and this domain-wide cis-regulatory effect suggests a mechanism involving long-range chromatin interactions. Here, we further dissect the disease-linked haplotype and identify putative causal DNA variants via a combination of genetic and functional analyses. First, high-throughput resequencing of the region and genotyping of potential candidate variants were performed. Next, additional mapping of allelic expression differences in Yoruba HapMap LCLs allowed us to fine-map the basis of the cis-regulatory differences to a handful of candidate functional variants. Functional assays identified allele-specific differences in nucleosome distribution, an allele-specific association with the insulator protein CTCF, as well as a weak promoter activity for rs12936231. Overall, this study shows a common disease allele linked to changes in CTCF binding and nucleosome occupancy leading to altered domain-wide cis-regulation. Finally, a strong association between asthma and cis-regulatory haplotypes was observed in three independent family-based cohorts (p = 1.78 x 10(-8)). This study demonstrates the requirement of multiple parallel allele-specific tools for the investigation of noncoding disease variants and functional fine-mapping of human disease-associated haplotypes.	[Verlaan, Dominique J.; Grundberg, Elin; Kwan, Tony; Ge, Bing; Swiatek, Marcin; Dias, Joana; Lam, Kevin C. L.; Koka, Vonda; Harmsen, Eef; Dewar, Ken; Pastinen, Tomi] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Verlaan, Dominique J.; Grundberg, Elin; Kwan, Tony; Ge, Bing; Swiatek, Marcin; Dias, Joana; Lam, Kevin C. L.; Koka, Vonda; Harmsen, Eef; Dewar, Ken; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Verlaan, Dominique J.; Berlivet, Soizik; Grundberg, Elin; Kwan, Tony; Hoberman, Rose; Dewar, Ken; Pastinen, Tomi; Naumova, Anna K.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Verlaan, Dominique J.; Lariviere, Mathieu; Ouimet, Manon; Sinnett, Daniel] St Justine Univ, Ctr Hlth, Montreal, PQ H3T 1CS, Canada; [Berlivet, Soizik; Moussette, Sanny; Naumova, Anna K.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 1A1, Canada; [Hunninghake, Gary M.; Celedon, Juan C.; Weiss, Scott T.; Raby, Benjamin A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Madore, Anne-Marie; Laprise, Catherine] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ G7H 2B1, Canada; [Madore, Anne-Marie] Univ Laval, Dept Med, Quebec City, PQ G1V 0A6, Canada; [Soto-Quiros, Manuel; Avila, Lydiana] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Div Pediat Pulmonol, San Jose, Costa Rica; [Sinnett, Daniel] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1CS, Canada; [Naumova, Anna K.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3H 2R9, Canada	McGill University; McGill University; Universite de Montreal; McGill University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Quebec; University of Quebec Chicoutimi; Laval University; Universite de Montreal; McGill University	Pastinen, T (corresponding author), McGill Univ, Montreal, PQ H3A 1A4, Canada.	tomi.pastinen@mcgill.ca	Avila, Lydiana/D-5638-2015; Raby, Benjamin/AAK-3866-2021; sinnett, daniel/S-4589-2017	Avila, Lydiana/0000-0002-9579-1591; sinnett, daniel/0000-0003-3625-6676; Naumova, Anna K./0000-0001-8481-5765; Laprise, Catherine/0000-0001-5526-9945	Genome Quebec; Genome Canada; Canadian Institutes of Health Research (CIHR); National Heart, Lung and Blood Institute, National Institutes of Health [U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, T32 HL07427, HL04370, HL66289]; NHGRI; Burroughs Wellcome Fund; Massachusetts General Hospital; Broad Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066289, K01HL004370, T32HL007427, K08HL092222, R37HL066289, P01HL083069, R01HL086601, U01HL075419, U01HL065899] Funding Source: NIH RePORTER	Genome Quebec; Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Massachusetts General Hospital(General Electric); Broad Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank all the participants of the asthmatic cohorts and P. Giresi for helpful suggestions regarding the FAIRE assay The authors are grateful to Julie Boudreau and Donna Sinnett for performing the DNA sequencing assays at the McGill University and Genome Quebec Innovation Centre. This work is supported by Genome Quebec and Genome Canada and is part of the Gene Regulators in Disease (GRiD) project. T.P. holds a Canada Research Chair (Tier 2) in Human Genomics. D.S. holds the FKV research chair in Pediatric Oncogenomics. C.L. holds a Canada Research Chair (Tier 2) and is the director of the Inflammation and Remodeling Strategic Group of the Respiratory Health Network of the Fonds de la Recherche en Sante du Quebec (FRSQ). D.J.V. and A.-M.M. are supported by the Canadian Institutes of Health Research (CIHR). We acknowledge the CAMP investigators and research team, supported by NHLBI, for collection of CAMP Genetic Ancillary Study data. All work on data collected from the CAMP Genetic Ancillary Study was conducted at the Charming Laboratory of the Brigham and Women's Hospital under appropriate CAMP policies and human subject protections. The CAMP Genetics Ancillary study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, and T32 HL07427 from the National Heart, Lung and Blood Institute, National Institutes of Health. The Genetics of Asthma in Costa Rica study was supported by NIH/NHLBI grants HL04370 and HL66289. The authors would also like to thank the ENCODE project and the Bradley E. Bernstein laboratory located at the Massachusetts General Hospital/Harvard Medical School for making available their CHIP-seq data generated at the ZPBP2-ORMDL3 locus. The ENCODE Histone Modifications project was funded by the NHGRI, the Burroughs Wellcome Fund, the Massachusetts General Hospital, and the Broad Institute.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; American Lung Association, 2008, LUNG; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Belanger H, 2005, HUM MOL GENET, V14, P2641, DOI 10.1093/hmg/ddi298; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gabellini D, 2004, CURR OPIN GENET DEV, V14, P301, DOI 10.1016/j.gde.2004.04.010; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Georges SA, 2003, MOL CELL BIOL, V23, P3392, DOI 10.1128/MCB.23.10.3392-3404.2003; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hoberman R, 2009, GENOME RES, V19, P1542, DOI 10.1101/gr.092072.109; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V119, P654, DOI 10.1016/j.jaci.2006.12.609; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; Katoh M, 2004, INT J ONCOL, V24, P757; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Labialle S, 2008, HUM MOL GENET, V17, P15, DOI 10.1093/hmg/ddm281; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Long AD, 1999, GENOME RES, V9, P720; Madore AM, 2008, HUM GENET, V123, P93, DOI 10.1007/s00439-007-0444-x; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Paul J, 1985, Prog Clin Biol Res, V191, P29; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Rabin RL, 2008, CLIN EXP IMMUNOL, V153, P19, DOI 10.1111/j.1365-2249.2008.03679.x; Raby BA, 2004, J ALLERGY CLIN IMMUN, V113, P1071, DOI 10.1016/j.jaci.2004.03.035; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Team RC., 2022, R LANG ENV STAT COMP; Umlauf David, 2004, Methods Mol Biol, V287, P99; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang DX, 2008, BLOOD, V112, P1013, DOI 10.1182/blood-2008-03-144899; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z; 1987, AM REV RESPIR DIS, V136, P225, DOI 10.1164/ajrccm/136.1.225	70	217	228	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					377	393		10.1016/j.ajhg.2009.08.007	http://dx.doi.org/10.1016/j.ajhg.2009.08.007			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19732864	Bronze, Green Published			2022-12-18	WOS:000270104500007
J	Amos-Landgraf, JM; Cottle, A; Plenge, RM; Friez, M; Schwartz, CE; Longshore, J; Willard, HF				Amos-Landgraf, James M.; Cottle, Amy; Plenge, Robert M.; Friez, Mike; Schwartz, Charles E.; Longshore, John; Willard, Huntington F.			X chromosome-inactivation patterns of 1,005 phenotypically unaffected females	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLUCOSE-6-PHOSPHATE DEHYDROGENASE; NORMAL WOMEN; SPONTANEOUS-ABORTION; XIST GENE; EXPRESSION; RATIOS; CELLS; MOUSE; AGE; METHYLATION	X-chromosome inactivation is widely believed to be random in early female development and to result in a mosaic distribution of cells, approximately half with the paternally derived X chromosome inactive and half with the maternally derived X chromosome inactive. Significant departures from such a random pattern are hallmarks of a variety of clinical states, including being carriers for severe X-linked diseases or X-chromosome cytogenetic abnormalities. To evaluate the significance of skewed patterns of X inactivation, we examined patterns of X inactivation in a population of 11,000 phenotypically unaffected females. The data demonstrate that only a very small proportion of unaffected females show significantly skewed inactivation, especially during the neonatal period. By comparison with this data set, the degree of skewed inactivation in a given individual can now be quantified and evaluated for its potential clinical significance.	Duke Univ, Inst Gen Sci & Policy, Durham, NC 27708 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA	Duke University; Case Western Reserve University; Greenwood Genetic Center	Willard, HF (corresponding author), Duke Univ, Inst Gen Sci & Policy, CIEMAS 2376,101 Sci Dr, Durham, NC 27708 USA.	hunt.willard@duke.edu	Amos-Landgraf, James/K-9288-2013	Amos-Landgraf, James/0000-0003-2535-7746	NIGMS NIH HHS [GM45441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; AZOFEIFA J, 1995, HUM GENET, V96, P167, DOI 10.1007/BF00207374; Beever CL, 2003, AM J HUM GENET, V72, P399, DOI 10.1086/346119; BELMONT JW, 1995, TRENDS GENET, V11, P112, DOI 10.1016/S0168-9525(00)89012-5; Belmont JW, 1996, AM J HUM GENET, V58, P1101; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Brown CJ, 2000, CLIN GENET, V58, P353, DOI 10.1034/j.1399-0004.2000.580504.x; Busque L, 1996, BLOOD, V88, P59; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CATTANACH BM, 1967, GENETICS, V57, P331; Chadwick LH, 2005, MAMM GENOME, V16, P691, DOI 10.1007/s00335-005-0059-2; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; FEY MF, 1994, BLOOD, V83, P931; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; Gale RE, 1996, LEUKEMIA, V10, P362; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; GANDINI E, 1969, NATURE, V224, P599, DOI 10.1038/224599a0; GOODSHIP J, 1991, BLOOD, V77, P2677; Hatakeyama C, 2004, CLIN GENET, V66, P327, DOI 10.1111/j.1399-0004.2004.00310.x; JOSTEN KM, 1991, BLOOD, V78, P3162; Karasawa M, 2001, INT J HEMATOL, V74, P281, DOI 10.1007/BF02982062; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MATTEI MG, 1981, HUM GENET, V56, P401, DOI 10.1007/BF00274702; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; Naumova AK, 1996, AM J HUM GENET, V58, P1111; Naumova AK, 1998, EUR J HUM GENET, V6, P552, DOI 10.1038/sj.ejhg.5200255; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; Orstavik KH, 1999, J MED GENET, V36, P865; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Percec I, 2002, SCIENCE, V296, P1136, DOI 10.1126/science.1070087; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Plenge RM, 1999, AM J HUM GENET, V64, P759, DOI 10.1086/302286; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; PUCK JM, 1992, AM J HUM GENET, V50, P742; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; Rupert JL, 1995, EUR J HUM GENET, V3, P333; Sandovici I, 2004, HUM GENET, V115, P387, DOI 10.1007/s00439-004-1177-8; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Tonon L, 1998, BRIT J HAEMATOL, V102, P996, DOI 10.1046/j.1365-2141.1998.00867.x; Van den Veyver IB, 2001, SEMIN REPROD MED, V19, P183, DOI 10.1055/s-2001-15398; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; Willard HF, 2000, METABOLIC MOL BASES, P1191	45	217	222	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					493	499		10.1086/507565	http://dx.doi.org/10.1086/507565			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909387	Green Published, Bronze			2022-12-18	WOS:000239830700011
J	Trochet, D; Bourdeaut, F; Janoueix-Lerosey, I; Deville, A; de Pontual, L; Schleiermacher, G; Coze, C; Philip, N; Frebourg, T; Munnich, A; Lyonnet, S; Delattre, O; Amiel, J				Trochet, D; Bourdeaut, F; Janoueix-Lerosey, I; Deville, A; de Pontual, L; Schleiermacher, G; Coze, C; Philip, N; Frebourg, T; Munnich, A; Lyonnet, S; Delattre, O; Amiel, J			Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTRAL HYPOVENTILATION SYNDROME; FAMILIAL NEUROBLASTOMA; RET; PREDISPOSITION	Neuroblastoma ( NB) is a frequent pediatric tumor for which recurrent somatic rearrangements are known. Germline mutations of predisposing gene(s) are suspected on the basis of rare familial cases and the association of NB with other genetically determined congenital malformations of neural crest - derived cells - namely, Hirschsprung disease (HSCR) and/or congenital central hypoventilation syndrome (CCHS). We recently identified the paired - like homeobox 2B (PHOX2B) gene as the major disease-causing gene in isolated and syndromic CCHS, which prompted us to regard it as a candidate gene in NB. Here, we report on germline mutations of PHOX2B in both a familial case of NB and a patient with the HSCR-NB association. PHOX2B, therefore, stands as the first gene for which germline mutations predispose to NB.	Hop Necker Enfants Malad, Dept Genet, F-75743 Paris 15, France; INSERM, Unite Rech Handicaps Genet Enfant, U393, Paris, France; Inst Curie, INSERM, Unite Pathol Mol Canc, U509, Paris, France; Fdn Lenval, Ctr Med Infantile, Nice, France; Hop Enfants La Timone, Serv Oncol Pediat, Marseille, France; Hop Enfants La Timone, Serv Genet, Marseille, France; Hop Charles Nicolle, Serv Genet, Rouen, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Rouen	Amiel, J (corresponding author), Hop Necker Enfants Malad, Dept Genet, 149 Rue Sevres, F-75743 Paris 15, France.	amiel@necker.fr	Philip, Nicole/I-2881-2016; amiel, jeanne/H-3501-2017; Lyonnet, Stanislas/H-5483-2017; Janoueix-Lerosey, Isabelle/G-1758-2018; Frebourg, Thierry/AAK-8390-2020; amiel, jeanne/AGX-1124-2022; , Bourdeaut/AAG-8494-2019	amiel, jeanne/0000-0001-5973-4728; Lyonnet, Stanislas/0000-0001-5426-9417; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Trochet, Delphine/0000-0002-9216-6117; delattre, olivier/0000-0002-8730-2276; DE PONTUAL, LOIC/0000-0002-3123-0453				Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Banerjee-Basu S, 2003, NUCLEIC ACIDS RES, V31, P304, DOI 10.1093/nar/gkg118; BECKWITH JB, 1963, AM J PATHOL, V43, P1089; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Chappuis-Flament S, 1998, ONCOGENE, V17, P2851, DOI 10.1038/sj.onc.1202202; CHATTEN J, 1967, NEW ENGL J MED, V277, P1230, DOI 10.1056/NEJM196712072772304; CLAUSEN N, 1989, ACTA PAEDIATR SCAND, V78, P736, DOI 10.1111/j.1651-2227.1989.tb11135.x; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; Hansford JR, 2000, J MED GENET, V37, P817, DOI 10.1136/jmg.37.11.817; KNUDSON AG, 1976, JNCI-J NATL CANCER I, V57, P675, DOI 10.1093/jnci/57.3.675; Maris JM, 1997, EUR J CANCER, V33, P1923, DOI 10.1016/S0959-8049(97)00265-7; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2002, CANCER RES, V62, P6651; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; Pattyn A, 2000, MOL CELL NEUROSCI, V15, P235, DOI 10.1006/mcne.1999.0826; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Perri P, 2002, ONCOGENE, V21, P8356, DOI 10.1038/sj.onc.1206009; Rohrer T, 2002, PEDIATR PULM, V33, P71, DOI 10.1002/ppul.10031; Weinstein JL, 2003, ONCOLOGIST, V8, P278, DOI 10.1634/theoncologist.8-3-278; Yokoyama M, 1999, GENOMICS, V59, P40, DOI 10.1006/geno.1999.5845	21	217	228	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					761	764		10.1086/383253	http://dx.doi.org/10.1086/383253			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15024693	Bronze, Green Published			2022-12-18	WOS:000220280800016
J	Dong, XY; Wang, L; Taniguchi, K; Wang, XS; Cunningham, JM; McDonnell, SK; Qian, CP; Marks, AF; Slager, SL; Peterson, BJ; Smith, BI; Cheville, JC; Blute, ML; Jacobsen, SJ; Schaid, DJ; Tindall, DJ; Thibodeau, SN; Liu, WG				Dong, XY; Wang, L; Taniguchi, K; Wang, XS; Cunningham, JM; McDonnell, SK; Qian, CP; Marks, AF; Slager, SL; Peterson, BJ; Smith, BI; Cheville, JC; Blute, ML; Jacobsen, SJ; Schaid, DJ; Tindall, DJ; Thibodeau, SN; Liu, WG			Mutations in CHEK2 associated with prostate cancer risk	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LI-FRAUMENI-SYNDROME; BREAST-CANCER; DNA-DAMAGE; SUSCEPTIBILITY GENE; CHECKPOINT; P53; CHK2; KINASE; CANDIDATE; FAMILIES	The DNA-damage-signaling pathway has been implicated in all human cancers. However, the genetic defects and the mechanisms of this pathway in prostate carcinogenesis remain poorly understood. In this study, we analyzed CHEK2, the upstream regulator of p53 in the DNA-damage-signaling pathway, in several groups of patients with prostate cancer. A total of 28 (4.8%) germline CHEK2 mutations (16 of which were unique) were found among 578 patients. Additional screening for CHEK2 mutations in 149 families with familial prostate cancer revealed 11 mutations (5 unique) in nine families. These mutations included two frameshift and three missense mutations. Importantly, 16 of 18 unique CHEK2 mutations identified in both sporadic and familial cases were not detected among 423 unaffected men, suggesting a pathological effect of CHEK2 mutations in prostate cancer development. Analyses of the two frameshift mutations in Epstein Barr virus-transformed cell lines, using reverse-transcriptase polymerase chain reaction and western blot analysis, revealed abnormal splicing for one mutation and dramatic reduction of CHEK2 protein levels in both cases. Overall, our data suggest that mutations in CHEK2 may contribute to prostate cancer risk and that the DNA-damage-signaling pathway may play an important role in the development of prostate cancer.	Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Sch Med, Div Expt Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Urol, Sch Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Sch Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Liu, WG (corresponding author), Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Sch Med, Div Expt Pathol, 200 1st St SW, Rochester, MN 55905 USA.		Slager, Susan L./B-6756-2009	McDonnell, Shannon/0000-0001-6201-369X; Jacobsen, Steven/0000-0002-8174-8533	NATIONAL CANCER INSTITUTE [R01CA072818, P50CA091956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058859] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA091956, R01 CA072818, CA 72818, CA 91956] Funding Source: Medline; NIDDK NIH HHS [DK 58859, R01 DK058859] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allinen M, 2001, BRIT J CANCER, V85, P209, DOI 10.1054/bjoc.2001.1858; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; BIRCH JM, 1994, CANCER RES, V54, P1298; BIRCH JM, 1990, J CLIN ONCOL, V8, P583, DOI 10.1200/JCO.1990.8.4.583; BIRCH JM, 1984, BRIT J CANCER, V49, P325, DOI 10.1038/bjc.1984.51; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Caspari T, 2000, CURR BIOL, V10, pR315, DOI 10.1016/S0960-9822(00)00439-5; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fan ZH, 2000, CANCER GENE THER, V7, P1307, DOI 10.1038/sj.cgt.0243; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gayther SA, 2000, CANCER RES, V60, P4513; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Koivisto PA, 1999, J PATHOL, V187, P237; LI FP, 1988, CANCER RES, V48, P5358; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Liu WO, 1997, GENET TEST, V1, P237, DOI 10.1089/gte.1997.1.237; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2001, CANCER RES, V61, P5362; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miller CW, 2002, GENE CHROMOSOME CANC, V33, P17, DOI 10.1002/gcc.1207; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Roberts RO, 2000, UROLOGY, V56, P817, DOI 10.1016/S0090-4295(00)00790-1; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shieh SY, 2000, GENE DEV, V14, P289; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Vahteristo P, 2001, CANCER RES, V61, P5718; Voelkel-Johnson C, 2000, CARCINOGENESIS, V21, P1623, DOI 10.1093/carcin/21.8.1623; Wang L, 2001, CANCER RES, V61, P6494; Xu JF, 2001, AM J HUM GENET, V68, P901, DOI 10.1086/319513	45	217	227	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					270	280		10.1086/346094	http://dx.doi.org/10.1086/346094			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12533788	Bronze, Green Published			2022-12-18	WOS:000180680000009
J	Sham, PC; Purcell, S; Cherny, SS; Abecasis, GR				Sham, PC; Purcell, S; Cherny, SS; Abecasis, GR			Powerful regression-based quantitative-trait linkage analysis of general pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BY-DESCENT PROBABILITIES; HASEMAN-ELSTON METHOD; SIB PAIRS; GENETIC-LINKAGE; LOCI; MODELS; SELECTION	We present a new method of quantitative-trait linkage analysis that combines the simplicity and robustness of regression-based methods and the generality and greater power of variance-components models. The new method is based on a regression of estimated identity-by-descent (IBD) sharing between relative pairs on the squared sums and squared differences of trait values of the relative pairs. The method is applicable to pedigrees of arbitrary structure and to pedigrees selected on the basis of trait value, provided that population parameters of the trait distribution can be correctly specified. Ambiguous IBD sharing (due to incomplete marker information) can be accommodated in the method by appropriate specification of the variance-covariance matrix of IBD sharing between relative pairs. We have implemented this regression-based method and have performed simulation studies to assess, under a range of conditions, estimation accuracy, type I error rate, and power. For normally distributed traits and in large samples, the method is found to give the correct type I error rate and an unbiased estimate of the proportion of trait variance accounted for by the additive effects of the locus-although, in cases where asymptotic theory is doubtful, significance levels should be checked by simulations. In large sibships, the new method is slightly more powerful than variance-components models. The proposed method provides a practical and powerful tool for the linkage analysis of quantitative traits.	Kings Coll London, SGDP Res Ctr, Inst Psychiat, London SE5 8AF, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan	Sham, PC (corresponding author), Kings Coll London, SGDP Res Ctr, Inst Psychiat, Box P80,Denmark Hill, London SE5 8AF, England.	p.sham@iop.kcl.ac.uk	Peng, Bo/A-6920-2009; Abecasis, Goncalo R/B-7840-2010; Cherny, Stacey S/B-3315-2008	Peng, Bo/0000-0001-8225-2284; Cherny, Stacey S/0000-0002-0269-3352; Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, R29HG000376] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012562, EY 12562] Funding Source: Medline; NHGRI NIH HHS [R01 HG000376, HG 0376] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allison DB, 2000, AM J HUM GENET, V67, P249, DOI 10.1086/302966; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Chatziplis DG, 2001, GENET RES, V78, P177, DOI 10.1017/S0016672301005225; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; Dolan CV, 1999, AM J HUM GENET, V64, P268, DOI 10.1086/302189; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Dudoit S, 2000, Biostatistics, V1, P1, DOI 10.1093/biostatistics/1.1.1; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Feingold E, 2001, THEOR POPUL BIOL, V60, P167, DOI 10.1006/tpbi.2001.1545; Forrest WF, 2000, AM J HUM GENET, V66, P1642, DOI 10.1086/302897; Forrest WF, 2001, HUM HERED, V52, P47, DOI 10.1159/000053353; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; Goring HHH, 2001, GENET EPIDEMIOL, V21, pS783; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASSTEDT SJ, 1994, PAP PEDIGREE ANAL PA; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Henshall JM, 1999, GENETICS, V151, P885; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Mardia KV, 1979, MULTIVARIATE ANAL; Purcell S, 2001, HUM HERED, V52, P1, DOI 10.1159/000053350; Putter H, 2002, GENET EPIDEMIOL, V22, P345, DOI 10.1002/gepi.01104; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Sham PC, 2001, AM J HUM GENET, V68, P1527, DOI 10.1086/320593; Sham PC, 2000, GENET EPIDEMIOL, V19, pS22, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI4>3.0.CO;2-S; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Thompson EA, 2000, INT STAT REV, V68, P53, DOI 10.1111/j.1751-5823.2000.tb00387.x; Visscher PM, 2001, ANN HUM GENET, V65, P583, DOI [10.1046/j.1469-1809.2001.6560583.x, 10.1017/S0003480001008909]; Wang K, 2002, AM J HUM GENET, V70, P412, DOI 10.1086/338659; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081	40	217	219	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					238	253		10.1086/341560	http://dx.doi.org/10.1086/341560			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12111667	Green Published, Bronze			2022-12-18	WOS:000176977700003
J	Alarcon, M; Cantor, RM; Liu, JJ; Gilliam, TC; Geschwind, DH				Alarcon, M; Cantor, RM; Liu, JJ; Gilliam, TC; Geschwind, DH		Autism Genetic Resource Exchange C	Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOMIC SCREEN; LINKAGE; PHENOTYPE; GENETICS; PARENTS; HISTORY; LOCALIZATION; ASSOCIATION; DISORDER; SPECTRUM	Autism is a syndrome characterized by deficits in language and social skills and by repetitive behaviors. We hypothesized that potential quantitative trait loci (QTLs) related to component autism endophenotypes might underlie putative or significant regions of autism linkage. We performed nonparametric multipoint linkage analyses, in 152 families from the Autism Genetic Resource Exchange, focusing on three traits derived from the Autism Diagnostic Interview: "age at first word," "age at first phrase," and a composite measure of "repetitive and stereotyped behavior." Families were genotyped for 335 markers, and multipoint sib pair linkage analyses were conducted. Using nonparametric multipoint linkage analysis, we found the strongest QTL evidence for age at first word on chromosome 7q (nonparametric test statistic [Z] 2.98; P = .001), and subsequent linkage analyses of additional markers and association analyses in the same region supported the initial result (Z = 2.85 P = .002 chi (2) = 18.84, df 8, P = .016). Moreover, the peak fine- mapping result for repetitive behavior (Z = 2.48; P = .007) localized to a region overlapping this language QTL. The putative autism-susceptibility locus on chromosome 7 may be the result of separate QTLs for the language and repetitive or stereotyped behavior deficits that are associated with the disorder.	Univ Calif Los Angeles, Dept Neurol, Reed Neurol Res Ctr, Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Neuropsychiat Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Dept Genet & Dev, New York, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Columbia University; Columbia University	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Dept Neurol, Reed Neurol Res Ctr, Sch Med, 710 Westwood Plaza,1-145, Los Angeles, CA 90095 USA.	dhg@ucla.edu	Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019; Buxbaum, Joseph/0000-0001-8898-8313				Aita VM, 1999, EXP DERMATOL, V8, P439, DOI 10.1111/j.1600-0625.1999.tb00302.x; Alarcon M, 2001, GENET EPIDEMIOL, V21, pS224, DOI 10.1002/gepi.2001.21.s1.s224; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Bradford Y, 2001, AM J MED GENET, V105, P539, DOI 10.1002/ajmg.1497; Bryson SE, 1998, MENT RETARD DEV D R, V4, P97, DOI 10.1002/(SICI)1098-2779(1998)4:2<97::AID-MRDD6>3.0.CO;2-U; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Conover WJ, 1980, PRACTICAL NONPARAMET; Cook EH, 2001, CHILD ADOL PSYCH CL, V10, P333; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Folstein SE, 1999, J CHILD PSYCHOL PSYC, V40, P1117, DOI 10.1111/1469-7610.00528; Folstein SE, 1998, J AUTISM DEV DISORD, V28, P439, DOI 10.1023/A:1026008606672; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LANDA R, 1992, PSYCHOL MED, V22, P245, DOI 10.1017/S0033291700032918; LANDA R, 1991, J SPEECH HEAR RES, V34, P1339, DOI 10.1044/jshr.3406.1339; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lord C, 2001, AM J MED GENET, V105, P36, DOI 10.1002/1096-8628(20010108)105:1<36::AID-AJMG1053>3.3.CO;2-W; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestrini E, 2000, NEURON, V28, P19, DOI 10.1016/S0896-6273(00)00081-7; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; PIVEN J, 1994, PSYCHOL MED, V24, P783, DOI 10.1017/S0033291700027938; Piven J, 1997, AM J PSYCHIAT, V154, P185; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; SMALLEY SL, 1995, AM J MED GENET, V60, P19, DOI 10.1002/ajmg.1320600105; Stoltenberg SF, 2000, HUM MOL GENET, V9, P927, DOI 10.1093/hmg/9.6.927; Warburton P, 2000, AM J MED GENET, V96, P228, DOI 10.1002/(SICI)1096-8628(20000403)96:2<228::AID-AJMG20>3.0.CO;2-G	43	217	225	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					60	71		10.1086/338241	http://dx.doi.org/10.1086/338241			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	499LD	11741194	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000172571900007
J	Gorski, B; Byrski, T; Huzarski, T; Jakubowska, A; Menkiszak, J; Gronwald, J; Pluzanska, A; Bebenek, M; Fischer-Maliszewska, L; Grzybowska, E; Narod, SA; Lubinski, J				Gorski, B; Byrski, T; Huzarski, T; Jakubowska, A; Menkiszak, J; Gronwald, J; Pluzanska, A; Bebenek, M; Fischer-Maliszewska, L; Grzybowska, E; Narod, SA; Lubinski, J			Founder mutations in the BRCA1 gene in polish families with breast-ovarian cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI-JEWISH WOMEN; GERM-LINE MUTATIONS; SUSCEPTIBILITY GENE; HEREDITARY BREAST; POPULATION; FREQUENCY; DUTCH; DNA	We have undertaken a hospital-based study, to identify possible BRCA1 and BRCA2 founder mutations in the Polish population. The study group consisted of 66 Polish families with cancer who have at least three related females affected with breast or ovarian cancer and who had cancer diagnosed, in at least one of the three affected females, at age <50 years. A total of 26 families had both breast and ovarian cancers, 4 families had ovarian cancers only, and 36 families had breast cancers only. Genomic DNA was prepared from the peripheral blood leukocytes of at least one affected woman from each family. The entire coding region of BRCA1 and BRCA2 was screened for the presence of germline mutations, by use of SSCP followed by direct sequencing of observed variants. Mutations were found in 35 (53 %) of the 66 families studied. All but one of the mutations were detected within the BRCA1 gene. BRCA1 abnormalities were identified in all four families with ovarian cancer only, in 67% of 27 families with both breast and ovarian cancer, and in 34% of 35 families with breast cancer only. The single family with a BRCA2 mutation had the breast-ovarian cancer syndrome. Seven distinct mutations were identified; five of these occurred in two or more families. In total, recurrent mutations were found in 33 (94%) of the 35 families with detected mutations. Three BRCA1 abnormalities-5382insC, C61G, and 4153delA-accountcd for 51%, 20%, and 11% of the identified mutations, respectively.	Hereditary Canc Ctr, Dept Genet & Pathol, PL-70115 Szczecin, Poland; Pomeranian Acad Med, Dept Gynecol Surg, PL-70115 Szczecin, Poland; Ctr Oncol, Lodz, Poland; Ctr Oncol, Wroclaw, Poland; Inst Immunol, Wroclaw, Poland; Ctr Oncol, Gliwice, Poland; Univ Toronto, Ctr Res Womens Hlth, Toronto, ON, Canada	Pomeranian Medical University; University of Toronto	Lubinski, J (corresponding author), Hereditary Canc Ctr, Dept Genet & Pathol, Str Polabska 4, PL-70115 Szczecin, Poland.		Gronwald, Jacek/A-4576-2017; Narod, Steven A/AAA-6112-2022; Menkiszak, Janusz JM/I-4036-2014; Jakubowska, Anna/O-8050-2014; Huzarski, Tomasz/AAQ-2161-2021; BYRSKI, Tomasz/I-2844-2014	Gronwald, Jacek/0000-0002-3643-2871; Menkiszak, Janusz JM/0000-0001-8279-7196; Jakubowska, Anna/0000-0002-5650-0501; Huzarski, Tomasz/0000-0003-3857-4854; BYRSKI, Tomasz/0000-0001-9181-5026; Grzybowska, Ewa/0000-0002-7592-6604; Bebenek, Marek/0000-0001-7716-5960				Anderson TI, 1996, AM J HUM GENET, V59, P486; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Csokay B, 1999, Hum Mutat, V14, P92, DOI 10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU23>3.0.CO;2-2; Dorum A, 1999, EUR J CANCER, V35, P779, DOI 10.1016/S0959-8049(99)00050-7; Dorum A, 1997, EUR J CANCER, V33, P2390, DOI 10.1016/S0959-8049(97)00328-6; EASTON DF, 1995, AM J HUM GENET, V56, P265; Friedman LS, 1997, AM J HUM GENET, V60, P313; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gayther SA, 1997, AM J HUM GENET, V60, P1239; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Hakansson S, 1997, AM J HUM GENET, V60, P1068; JAKUBOWSKA A, 1999, HUM GENET, V105, P293; Johannsson O, 1996, AM J HUM GENET, V58, P441; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Peelen T, 1997, AM J HUM GENET, V60, P1041; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Ramus SJ, 1997, AM J HUM GENET, V60, P1242; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santarosa M, 1998, INT J CANCER, V78, P581, DOI 10.1002/(SICI)1097-0215(19981123)78:5<581::AID-IJC9>3.0.CO;2-G; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; Sobczak K, 1997, ONCOGENE, V15, P1773, DOI 10.1038/sj.onc.1201360; STREUWING JP, 1997, NEW ENGL J MED, V336, P1401; STREUWING JP, 1995, NAT GENET, V11, P198; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TONIN P, 1995, AM J HUM GENET, V57, P189; Tonin P, 1996, NAT MED, V2, P1179, DOI 10.1038/nm1196-1179; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	35	217	233	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1963	1968		10.1086/302922	http://dx.doi.org/10.1086/302922			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10788334	Green Published, Bronze			2022-12-18	WOS:000088373800024
J	Speckman, RA; Garg, A; Du, FH; Bennett, L; Veile, R; Arioglu, E; Taylor, SI; Lovett, M; Bowcock, AM				Speckman, RA; Garg, A; Du, FH; Bennett, L; Veile, R; Arioglu, E; Taylor, SI; Lovett, M; Bowcock, AM			Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERMEDIATE FILAMENT PROTEINS; NUCLEAR-ENVELOPE; CHROMOSOME 1Q21-22; ROD DOMAIN; GENE; MEMBRANE; BINDING; DNA	Familial partial lipodystrophy (FPLD), Dunnigan variety, is an autosomal dominant disorder characterized by marked loss of subcutaneous adipose tissue from the extremities and trunk but by excess fat deposition in the head and neck. The disease is frequently associated with profound insulin resistance, dyslipidemia, and diabetes. We have localized a gene for FPLD to chromosome 1q21-q23, and it has recently been proposed that nuclear lamin A/C is altered in FPLD, on the basis of a novel missense mutation (R482Q) in five Canadian probands. This gene had previously been shown to be altered in autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD-AD) and in dilated cardiomyopathy and conduction-system disease. We examined 15 families with FPLD for mutations in lamin A/C. Five families harbored the R482Q alteration that segregated with the disease phenotype. Seven families harbored an R482W alteration, and one family harbored a G465D alteration. All these mutations lie within exon 8 of the lamin A/C gene-an exon that has also been shown to harbor different missense mutations that are responsible for EDMD-AD. Mutations could not be detected in lamin A/C in one FPLD family in which there was linkage to chromosome 1q21-q23. One family with atypical FPLD harbored an R582H alteration in exon 11 of lamin A. This exon does not comprise part of the lamin C coding region. All mutations in FPLD affect the globular C-terminal domain of the lamin A/C protein. In contrast, mutations responsible for dilated cardiomyopathy and conduction-system disease are observed in the rod domain of the protein. The FPLD mutations R482Q and R482W occurred on different haplotypes, indicating that they are likely to have arisen more than once.	Washington Univ, Sch Med, Div Human Genet, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, Dept Genet, St Louis, MO 63110 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA; NIDDK, Diabet Branch, Bethesda, MD USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Speckman, RA (corresponding author), Washington Univ, Sch Med, Div Human Genet, Dept Genet, Box 8232,4566 Scott Ave, St Louis, MO 63110 USA.			Oral, Elif/0000-0002-9171-1144; Bennett, Lynda/0000-0001-7491-5797; Bowcock, Anne/0000-0001-8691-9090	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054387, Z01DK047022, Z01DK047031] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR00633, M01 RR000633] Funding Source: Medline; NIDDK NIH HHS [R01 DK054387, R01-DK54387] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson JL, 1999, AM J MED GENET, V82, P161, DOI 10.1002/(SICI)1096-8628(19990115)82:2<161::AID-AJMG12>3.3.CO;2-S; Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; DOSKOCIL J, 1962, BIOCHIM BIOPHYS ACTA, V55, P953; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; Garg A, 1999, J CLIN ENDOCR METAB, V84, P170, DOI 10.1210/jc.84.1.170; Gerace L, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 2, P967; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; GLASS JR, 1990, J CELL BIOL, V111, P1047, DOI 10.1083/jcb.111.3.1047; GRIPPO P, 1968, J MOL BIOL, V36, P195, DOI 10.1016/0022-2836(68)90375-6; HOGER TH, 1991, EXP CELL RES, V197, P280, DOI 10.1016/0014-4827(91)90434-V; Jackson SNJ, 1998, AM J HUM GENET, V63, P534, DOI 10.1086/301971; LIN F, 1993, J BIOL CHEM, V268, P16321; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; Peters JM, 1998, NAT GENET, V18, P292, DOI 10.1038/ng0398-292; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; SINENSKY M, 1994, J CELL SCI, V107, P61; Squarzoni S, 1998, NEUROMUSCULAR DISORD, V8, P338, DOI 10.1016/S0960-8966(98)00031-5; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; WORMAN HJ, 1990, J CELL BIOL, V111, P1535, DOI 10.1083/jcb.111.4.1535	26	217	225	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1192	1198		10.1086/302836	http://dx.doi.org/10.1086/302836			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739751	Green Published, Bronze			2022-12-18	WOS:000088373400003
J	Cavalier, L; Ouahchi, K; Kayden, HJ; Di Donato, S; Reutenauer, L; Mandel, JL; Koenig, M				Cavalier, L; Ouahchi, K; Kayden, HJ; Di Donato, S; Reutenauer, L; Mandel, JL; Koenig, M			Ataxia with isolated vitamin E deficiency: Heterogeneity of mutations and phenotypic variability in a large number of families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOCOPHEROL-TRANSFER PROTEIN; ALPHA-TOCOPHEROL; FRIEDREICH ATAXIA; GENE; ABSORPTION; LOCALIZATION; CLONING	Ataxia with vitamin E deficiency (AVED), or familial isolated vitamin E deficiency, is a rare autosomal recessive neurodegenerative disease characterized clinically by symptoms with often striking resemblance to those of Friedreich ataxia. We recently have demonstrated that AVED is caused by mutations in the gene for alpha-tocopherol transfer protein (alpha-TTP). We now have identified a total of 13 mutations in 27 families. Four mutations were found in greater than or equal to 2 independent families: 714delA, which is the major mutation in North Africa, and 513insTT 486delT, and R134X, in families of European origin. Compilation of the clinical records of 43 patients with documented mutation in the alpha-TTP gene revealed differences from Friedreich ataxia: cardiomyopathy was found in only 19% of cases, whereas head titubation was found in 28% of cases and dystonia in an additional 13%. This study represents the largest group of patients and mutations reported for this often misdiagnosed disease and points to the need for an early differential diagnosis with Friedreich ataxia, in order to initiate therapeutic and prophylactic vitamin E supplementation before irreversible damage develops.	Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67070 Strasbourg, France; Hop Univ Strasbourg, Fac Med, Strasbourg, France; NYU Med Ctr, Dept Med, New York, NY 10016 USA; Ist Nazl Neurol Carlo Besta, Dipartimento Biochim & Genet, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; New York University; IRCCS Istituto Neurologico Besta	Koenig, M (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,BP 163, F-67404 Illkirch Graffenstaden, France.	mkoenig@igbmc.u-strasbg.fr	Di Donato, Stefano/B-9717-2012		PHS HHS [30842] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMIEL J, 1995, J INHERIT METAB DIS, V18, P333, DOI 10.1007/BF00710425; ARITA M, 1995, BIOCHEM J, V306, P437, DOI 10.1042/bj3060437; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BENHAMIDA M, 1993, NEUROLOGY, V43, P2179, DOI 10.1212/WNL.43.11.2179; BURCK U, 1981, NEUROPEDIATRICS, V12, P267, DOI 10.1055/s-2008-1059657; DOERFLINGER N, 1995, AM J HUM GENET, V56, P1116; DUCLOS F, 1994, HUM MOL GENET, V3, P909, DOI 10.1093/hmg/3.6.909; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1985, NEW ENGL J MED, V313, P32, DOI 10.1056/NEJM198507043130107; Hentati A, 1996, ANN NEUROL, V39, P295, DOI 10.1002/ana.410390305; KAYDEN HJ, 1993, J LIPID RES, V34, P343; KAYDEN HJ, 1991, PRIMARY HYPERLIPIDEM, P249; KOHLSCHUTTER A, 1988, J INHERIT METAB DIS, V11, P149, DOI 10.1007/BF01804221; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; KRENDEL DA, 1987, NEUROLOGY, V37, P538, DOI 10.1212/WNL.37.3.538; LAPLANTE P, 1984, CAN J NEUROL SCI, V11, P561, DOI 10.1017/S0317167100035046; MARTINELLO F, IN PRESS J NEUROL SC; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; RAYNER RJ, 1993, ARCH DIS CHILD, V69, P602, DOI 10.1136/adc.69.5.602; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; Shorer Z, 1996, PEDIATR NEUROL, V15, P340, DOI 10.1016/S0887-8994(96)00223-8; SOKOL RJ, 1988, J LAB CLIN MED, V111, P548; STUMPF DA, 1987, NEUROLOGY, V37, P68, DOI 10.1212/WNL.37.1.68; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; TRABER MG, 1994, P NATL ACAD SCI USA, V91, P10005, DOI 10.1073/pnas.91.21.10005; TRABER MG, 1993, J LIPID RES, V34, P201; TRABERT W, 1989, FORTSCHR NEUROL PSYC, V57, P495, DOI 10.1055/s-2007-1001146; Yokota T, 1997, ANN NEUROL, V41, P826, DOI 10.1002/ana.410410621; YOKOTA T, 1987, ANN NEUROL, V22, P84, DOI 10.1002/ana.410220119; Yokota T, 1996, NEW ENGL J MED, V335, P1770, DOI 10.1056/NEJM199612053352315	34	217	222	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					301	310		10.1086/301699	http://dx.doi.org/10.1086/301699			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463307	Green Published, hybrid			2022-12-18	WOS:000072416000013
J	Burghes, AHM				Burghes, AHM			When is a deletion not a deletion? When it is converted	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON GENE; SMA; REGION; 5Q13; LINKAGE; CONTIG; IDENTIFICATION; ASSOCIATION; INDIVIDUALS				Burghes, AHM (corresponding author), OHIO STATE UNIV,DEPT NEUROL,400 MEANS HALL,1654 UPHAM DR,COLUMBUS,OH 43210, USA.			Burghes, Arthur/0000-0001-9031-1555				BECKER PE, 1964, Z MENSCHL VERERB KON, V37, P193; Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; BRAHE C, 1994, HUM GENET, V93, P494, DOI 10.1007/BF00202811; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; Burglen L, 1997, AM J HUM GENET, V60, P72; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Burglen L, 1996, 1 C WORLD MUSCL SOC, pS39; Burlet P, 1996, J MED GENET, V33, P281, DOI 10.1136/jmg.33.4.281; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; CARPTEN JD, 1994, GENOMICS, V24, P351, DOI 10.1006/geno.1994.1626; Carter TA, 1997, HUM MOL GENET, V6, P229, DOI 10.1093/hmg/6.2.229; COBBEN JM, 1995, AM J HUM GENET, V57, P805; COOVERT DD, IN PRESS HUM MOL GEN; Devriendt K, 1996, ANN NEUROL, V40, P731, DOI 10.1002/ana.410400509; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lefebvre S., 1996, American Journal of Human Genetics, V59, pA268; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Matthijs G, 1996, J MED GENET, V33, P469, DOI 10.1136/jmg.33.6.469; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MULLER B, 1992, AM J HUM GENET, V50, P892; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; PEARN J, 1980, LANCET, V1, P919; ROCHETTE C, IN PRESS ANN NEUROL; Rodrigues NR, 1996, J MED GENET, V33, P93, DOI 10.1136/jmg.33.2.93; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; SIMARD LR, 1992, GENOMICS, V14, P188, DOI 10.1016/S0888-7543(05)80305-2; SIMARD LR, IN PRESS AM J MED GE; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; THOMPSON TG, 1995, NAT GENET, V9, P56, DOI 10.1038/ng0195-56; vanderSteege G, 1996, AM J HUM GENET, V59, P834; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130; WIRTH B, 1995, EUR J HUM GENET, V3, P56	49	217	223	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					9	15		10.1086/513913	http://dx.doi.org/10.1086/513913			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245977	Green Published, Bronze			2022-12-18	WOS:A1997XM72800004
J	ORSTAVIK, KH; MAGNUS, P; REISNER, H; BERG, K; GRAHAM, JB; NANCE, W				ORSTAVIK, KH; MAGNUS, P; REISNER, H; BERG, K; GRAHAM, JB; NANCE, W			FACTOR-VIII AND FACTOR-IX IN A TWIN POPULATION - EVIDENCE FOR A MAJOR EFFECT OF ABO LOCUS ON FACTOR-VIII LEVEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,SCH MED,DEPT PATHOL,CHAPEL HILL,NC 27514; VIRGINIA COMMONWEALTH UNIV,RICHMOND,VA 23284	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University	ORSTAVIK, KH (corresponding author), UNIV OSLO,INST MED GENET,OSLO,NORWAY.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032115] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL06350, HL32115] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAN TM, 1968, BRIT HEART J, V30, P377; BONEU B, 1975, LANCET, V1, P1430; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; FILIPPI G, 1984, AM J HUM GENET, V36, P44; GIDDINGS JC, 1977, BRIT J HAEMATOL, V37, P257, DOI 10.1111/j.1365-2141.1977.tb06842.x; GRAHAM JB, 1975, BLOOD, V46, P175; GRAHAM JB, 1980, LANCET, V1, P340; HOLMBERG L, 1974, SCAND J HAEMATOL, V12, P221; KERR CB, 1966, BRIT J HAEMATOL, V12, P212, DOI 10.1111/j.1365-2141.1966.tb05627.x; KINGSBURY KJ, 1971, LANCET, V1, P199; LESTER RH, 1972, AM J HUM GENET, V24, P168; LUFKIN EG, 1979, METABOLISM, V28, P63, DOI 10.1016/0026-0495(79)90169-0; MAGNUS P, 1983, CLIN GENET, V24, P103; MATHER K, 1963, NATURE, V198, P314, DOI 10.1038/198314a0; MEADE TW, 1980, LANCET, V1, P1050; ORSTAVIK KH, 1979, BRIT J HAEMATOL, V42, P293, DOI 10.1111/j.1365-2141.1979.tb01133.x; ORSTAVIK KH, 1977, THROMB RES, V11, P653, DOI 10.1016/0049-3848(77)90023-8; ORSTAVIK KH, 1975, THROMB RES, V7, P373, DOI 10.1016/0049-3848(75)90031-6; PITNEY WR, 1962, BRIT J HAEMATOL, V8, P421, DOI 10.1111/j.1365-2141.1962.tb06546.x; PRESTON AE, 1964, BRIT J HAEMATOL, V10, P238, DOI 10.1111/j.1365-2141.1964.tb00698.x; RACE RR, 1968, BLOOD GROUPS MAN, P35; REISNER HM, 1979, THROMB RES, V14, P235, DOI 10.1016/0049-3848(79)90042-2; SODETZ JM, 1979, J BIOL CHEM, V254, P754; STEL HV, 1983, NATURE, V303, P530, DOI 10.1038/303530a0; STORMORKEN H, 1977, THROMB HAEMOSTASIS, V38, P864; SUNDET JM, 1981, PSYCHIATRY SOCIAL SC, V1, P241; VELTKAMP JJ, 1972, HUM HERED, V22, P102, DOI 10.1159/000152477; VENNEROD AM, 1977, THROMB RES, V11, P663, DOI 10.1016/0049-3848(77)90024-X; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed	29	217	218	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					89	101						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	3919575				2022-12-18	WOS:A1985AGY5700009
J	GLOVER, TW				GLOVER, TW			FUDR INDUCTION OF THE X-CHROMOSOME FRAGILE SITE - EVIDENCE FOR THE MECHANISM OF FOLIC-ACID AND THYMIDINE INHIBITION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822	University of Hawaii System					NICHD NIH HHS [HD-07879] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Erbe R W, 1979, Adv Hum Genet, V9, P293; FRIEDKIN M, 1973, ADV ENZYMOL RAMB, V38, P235; GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; HOPKINS RL, 1980, P NATL ACAD SCI-BIOL, V77, P1801, DOI 10.1073/pnas.77.4.1801; HOWARDPEEBLES PN, 1979, HUM GENET, V50, P247, DOI 10.1007/BF00399389; JACKY PB, 1980, HUM GENET, V53, P267; JACOBS PA, AM J MED GENET; LUBS HA, 1969, AM J HUM GENET, V21, P231; MEUTH M, 1979, P NATL ACAD SCI USA, V76, P6505, DOI 10.1073/pnas.76.12.6505; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; TURNER G, 1978, NEW ENGL J MED, V299, P1472; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X	14	217	217	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	2					234	242						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LH910	6452060				2022-12-18	WOS:A1981LH91000010
J	Vrijenhoek, T; Buizer-Voskamp, JE; van der Stelt, I; Strengman, E; Sabatti, C; van Kessel, AG; Brunner, HG; Ophoff, RA; Veltman, JA				Vrijenhoek, Terry; Buizer-Voskamp, Jacobine E.; van der Stelt, Inge; Strengman, Eric; Sabatti, Chiara; van Kessel, Ad Geurts; Brunner, Han G.; Ophoff, Roel A.; Veltman, Joris A.		Genetic Risk Outcome Psychosis Grp	Recurrent CNVs Disrupt Three Candidate Genes in Schizophrenia Patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIDDEN-MARKOV MODEL; COPY-NUMBER; STRUCTURAL VARIANTS; NEURONAL MIGRATION; MENTAL-RETARDATION; DELTA-CATENIN; ASSOCIATION; PHENOTYPE; CHROMOSOMES; ASTROTACTIN	Schizophrenia is a severe psychiatric disease with complex etiology, affecting approximately 1% of the general population. Most genetics studies so far have focused on disease association with common genetic variation, such as single-nucleotide polymorphisms (SNPs), but it has recently become apparent that large-scale genomic copy-number variants (CNVs) are involved in disease development as well. To assess the role of rare CNVs in schizophrenia, we screened 54 patients with deficit schizophrenia using Affymetrix's GeneChip 250K SNP arrays. We identified 90 CNVs in total, 77 of which have been reported previously in unaffected control cohorts. Among the genes disrupted by the remaining rare CNVs are MYT1L, CTNND2, NRXN1, and ASTN2, genes that play an important role in neuronal functioning but-except for NRXN1-have not been associated with schizophrenia before. We studied the occurrence of CNVs at these four loci in an additional cohort of 752 patients and 706 normal controls from The Netherlands. We identified eight additional CNVs, of which the four that affect coding sequences were found only in the patient cohort. Our study supports a role for rare CNVs in schizophrenia susceptibility and identifies at least three candidate genes for this complex disorder.	[Vrijenhoek, Terry; van der Stelt, Inge; van Kessel, Ad Geurts; Brunner, Han G.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Buizer-Voskamp, Jacobine E.; Ophoff, Roel A.] Univ Med Ctr, Dept Psychiat, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands; [Buizer-Voskamp, Jacobine E.; Strengman, Eric; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Div Biomed Genet, Complex Genet Sect, NL-3584 CX Utrecht, Netherlands; [Sabatti, Chiara] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Sabatti, Chiara] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ophoff, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	ophoff@ucla.edu	Veltman, Joris A/F-5128-2010; van Os, Jim/C-2113-2014; Myin-Germeys, Inez/L-5106-2014; van Os, Jim/I-9496-2012; van Kessel, Ad Geurts/A-2810-2010; Brunner, Han/C-9928-2013	Veltman, Joris A/0000-0002-3218-8250; van Os, Jim/0000-0002-7245-1586; Myin-Germeys, Inez/0000-0002-3731-4930; Bruggeman, Richard/0000-0002-3238-8471	Netherlands Organization for Health Research and Development; ZON-MW [10.000.1001]; National Institute of Mental Health [RO1 MG078075]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); ZON-MW(Netherlands Organization for Health Research and Development); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the patients for their cooperation. We thank Joseph DeYoung for technical assistance, Harry van Someren for database management, and Christian Gilissen for bioinformatic support. This work was supported by a grant from The Netherlands Organization for Health Research and Development (ZON-MW, to J.A.V.). The GROUP project was also supported by a grant from ZON-MW, within the Mental Health program (project number: 10.000.1001). In addition, genome-wide SNP genotyping of the Dutch schizophrenia sample was funded by the National Institute of Mental Health grant RO1 MG078075 to R.A.O. GROUP Consortium members: Rene S. Kahn (Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands), Don H. Linszen (Academic Medical Centre University of Amsterdam, Department of Psychiatry, Amsterdam, The Netherlands), Jim van Os (Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, Maastricht, The Netherlands), Durk Wiersma (University Medical Centre Groningen, Department of Psychiatry, University of Groningen, The Netherlands), Richard Bruggeman (University Medical Centre Groningen, Department of Psychiatry, University of Groningen, The Netherlands), Wiepke Cahn (Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Centre Utrecht, Utrecht, The Netherlands), Lieuwe de Haan (Academic Medical Centre University of Amsterdam, Department of Psychiatry, Amsterdam,The Netherlands), Lydia Krabbendam (Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, Maastricht, The Netherlands), Inez Myin-Germeys (Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, Maastricht, The Netherlands).	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; ANDREASEN NC, 1995, LANCET, V346, P477, DOI 10.1016/S0140-6736(95)91325-4; Boldt HB, 2007, GROWTH HORM IGF RES, V17, P10, DOI 10.1016/j.ghir.2006.11.003; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fink JM, 1997, GENOMICS, V40, P202, DOI 10.1006/geno.1996.4538; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Harvard C, 2005, CLIN GENET, V67, P341, DOI 10.1111/j.1399-0004.2005.00406.x; Hehir-Kwa JY, 2007, DNA RES, V14, P1, DOI 10.1093/dnares/dsm002; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kroepfl T, 2008, CLIN GENET, V73, P492, DOI 10.1111/j.1399-0004.2008.00982.x; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Marcelis CLM, 2008, HUM MUTAT, V29, P1125, DOI 10.1002/humu.20750; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	45	216	220	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 10	2008	83	4					504	510		10.1016/j.ajhg.2008.09.011	http://dx.doi.org/10.1016/j.ajhg.2008.09.011			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	363AV	18940311	Bronze, Green Published			2022-12-18	WOS:000260239200008
J	Guerrini, MM; Sobacchi, C; Cassani, B; Abinun, M; Kilic, SS; Pangrazio, A; Moratto, D; Mazzolari, E; Clayton-Smith, J; Orchard, P; Coxon, FP; Helfrich, MH; Crockett, JC; Mellis, D; Vellodi, A; Tezcan, I; Notarangelo, LD; Rogers, MJ; Vezzoni, P; Villa, A; Frattini, A				Guerrini, Matteo M.; Sobacchi, Cristina; Cassani, Barbara; Abinun, Mario; Kilic, Sara S.; Pangrazio, Alessandra; Moratto, Daniele; Mazzolari, Evelina; Clayton-Smith, Jill; Orchard, Paul; Coxon, Fraser P.; Helfrich, Miep H.; Crockett, Julie C.; Mellis, David; Vellodi, Ashok; Tezcan, Ilhan; Notarangelo, Luigi D.; Rogers, Michael J.; Vezzoni, Paolo; Villa, Anna; Frattini, Annalisa			Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; RECEPTOR ACTIVATOR; DIFFERENTIATION; DUPLICATION; DISEASE; TCIRG1; CELLS	Autosomal-Recessive Osteopetrosis (ARO) comprises a heterogeneous group of bone diseases for which mutations in five genes are known as causative. Most ARO are classified as osteoclast-rich, but recently a subset of osteoclast-poor ARO has been recognized as due to a defect in TNESF11 (also called RANKL or TRANCE, coding for the RANKL protein), a master gene driving osteoclast differentiation along the RANKL-RANK axis. RANKL and RANK (coded for by the TNFRSF11A gene) also play a role in the immune system, which raises the possibility that defects in this pathway might cause osteopetrosis with immunodeficiency. From a large series of ARO patients we selected a Turkish consanguineous family with two siblings affected by ARO and hypogammaglobulinemia with no defects in known osteopetrosis genes. Sequencing of genes involved in the RANKL downstream pathway identified a homozygous mutation in the TNERSF11A gene in both siblings. Their monocytes failed to differentiate in vitro into osteoclasts upon exposure to M-CSF and RANKL, in keeping with an osteoclast-intrinsic defect. Immunological analysis showed that their hypogammaglobulinemia was associated with impairment in immunoglobulin-secreting B cells. Investigation of other patients revealed a defect in both TNFRSF11A alleles in six additional, unrelated families. Our results indicate that TNFRSF11A mutations can cause a clinical condition in which severe ARO is associated with an immunoglobulin-production defect.	[Guerrini, Matteo M.; Sobacchi, Cristina; Pangrazio, Alessandra; Vezzoni, Paolo; Villa, Anna; Frattini, Annalisa] CNR, Ist Tecnol Biomed, I-20090 Segrate, Italy; [Guerrini, Matteo M.; Sobacchi, Cristina; Cassani, Barbara; Pangrazio, Alessandra; Vezzoni, Paolo; Villa, Anna; Frattini, Annalisa] IRCCS, Ist Clin Humanitas, I-20089 Rozzano, Italy; [Abinun, Mario] Newcastle Gen Hosp, Childrens BMT Unit, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Abinun, Mario] Univ Newcastle, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Kilic, Sara S.] Uludag Univ, Fac Med, Dept Pediat Immunol, TR-16200 Bursa, Turkey; [Moratto, Daniele; Mazzolari, Evelina] Univ Brescia, Ctr Trapianto Midollo Osseo, Pediat Clin, I-25100 Brescia, Italy; [Moratto, Daniele; Mazzolari, Evelina] Univ Brescia, Ist Med Mol Angelo Nocivelli, Pediat Clin, I-25100 Brescia, Italy; [Clayton-Smith, Jill] St Marys Hosp, Dept Clin Genet, Manchester M13 9WL, Lancs, England; [Orchard, Paul] Univ Minnesota, Dept Pediat, Program Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Coxon, Fraser P.; Helfrich, Miep H.; Crockett, Julie C.; Mellis, David] Univ Aberdeen, Bone & Musculoskeletal Programme, Sch Med & Dent, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Vellodi, Ashok] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Tezcan, Ilhan] Hacettepe Univ, Childrens Hosp Pediat Immunol Unit, TR-06100 Ankara, Turkey; [Notarangelo, Luigi D.] Harvard Univ, Div Immunol, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Villa, Anna] HSR TIGET, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); IRCCS Humanitas Research Hospital; Newcastle General Hospital; Newcastle University - UK; Uludag University; University of Brescia; University of Brescia; University of Manchester; University of Minnesota System; University of Minnesota Twin Cities; University of Aberdeen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Hacettepe University; Harvard University; Boston Children's Hospital; Harvard Medical School; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget)	Villa, A (corresponding author), CNR, Ist Tecnol Biomed, I-20090 Segrate, Italy.	anna.villa@itb.cnr.it	Cassani, Barbara/K-3871-2016; Frattini, Annalisa/B-7684-2015; SOBACCHI, CRISTINA/J-9345-2018; Vezzoni, Paolo/R-3416-2019; Vezzoni, Paolo/K-3197-2018; Notarangelo, Luigi D/F-9718-2016; Kilic, Sara Sebnem/AAH-1658-2021	Cassani, Barbara/0000-0002-4115-8109; Frattini, Annalisa/0000-0002-1166-3091; SOBACCHI, CRISTINA/0000-0002-2684-7184; Notarangelo, Luigi D/0000-0002-8335-0262; Villa, Anna/0000-0003-4428-9013; Rogers, Michael/0000-0002-1818-9249; kilic, sara sebnem/0000-0001-8571-2581; Vezzoni, Paolo/0000-0002-6382-3923	Telethon [GGP07059] Funding Source: Medline; Chief Scientist Office [CZB/4/495] Funding Source: Medline	Telethon(Fondazione Telethon); Chief Scientist Office		Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Blair HC, 2004, J BONE MINER RES, V19, P1329, DOI 10.1359/JBMR.040403; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Frattini A, 2007, CELL CYCLE, V6, P3027, DOI 10.4161/cc.6.24.5105; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Nakatsuka K, 2003, J BONE MINER RES, V18, P1381, DOI 10.1359/jbmr.2003.18.8.1381; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Taylor A, 2007, CALCIFIED TISSUE INT, V80, P132, DOI 10.1007/s00223-006-0245-6; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Whyte MP, 2002, J BONE MINER RES, V17, P26, DOI 10.1359/jbmr.2002.17.1.26; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200	23	216	226	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					64	76		10.1016/j.ajhg.2008.06.015	http://dx.doi.org/10.1016/j.ajhg.2008.06.015			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18606301	Green Published, Bronze			2022-12-18	WOS:000257784000008
J	Enattah, NS; Jensen, TGK; Nielsen, M; Lewinski, R; Kuokkanen, M; Rasinpera, H; El-Shanti, H; Seo, JK; Alifrangis, M; Khalil, IF; Natah, A; Ali, A; Natah, S; Comas, D; Mehdi, SQ; Groop, L; Vestergaard, EM; Imtiaz, F; Rashed, MS; Meyer, B; Troelsen, J; Peltonen, L				Enattah, Nabil Sabri; Jensen, Tine G. K.; Nielsen, Mette; Lewinski, Rikke; Kuokkanen, Mikko; Rasinpera, Heli; El-Shanti, Hatem; Seo, Jeong Kee; Alifrangis, Michael; Khalil, Insaf F.; Natah, Abdrazak; Ali, Ahmed; Natah, Sirajedin; Comas, David; Mehdi, S. Qasim; Groop, Leif; Vestergaard, Else Marie; Imtiaz, Faiqa; Rashed, Mohamed S.; Meyer, Brian; Troelsen, Jesper; Peltonen, Leena			Independent introduction of two lactase-persistence alleles into human populations reflects different history of adaptation to milk culture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECENT POSITIVE SELECTION; ACTIVITY IN-VITRO; HAPLOTYPE RECONSTRUCTION; LACTOSE-MALABSORPTION; HUMAN GENOME; EVOLUTION; GENE; DNA; ORIGIN; CATTLE	The T-13910 variant located in the enhancer element of the lactase (LCT) gene correlates perfectly with lactase persistence (LP) in Eurasian populations whereas the variant is almost nonexistent among Sub-Saharan African populations, showing high prevalence of LP. Here, we report identification of two new mutations among Saudis, also known for the high prevalence of LP. We confirmed the absence of the European T-13910 and established two new mutations found as a compound allete: T/G(-13915) within the -13910 enhancer region and a synonymous SNP in the exon 17 of the MCM6 gene T/C-3712, -3712 bp from the LCT gene. The compound allele is driven to a high prevalence among Middle East population(s). Our functional analyses in vitro showed that both SNPs of the compound allele, located 10 kb apart, are required for the enhancer effect, most probably mediated through the binding of the hepatic nuclear factor 1 alpha (HNF1 alpha). High selection coefficient (s) similar to 0.04 for LP phenotype was found for both T-13910 and the compound allele. The European T-13910 and the earlier identified East African G(-13907) LP allele share the same ancestral background and most likely the same history, probably related to the same cattle domestication event. In contrast, the compound Arab allele shows a different, highly divergent ancestral haplotype, suggesting that these two major global LP alleles have arisen independently, the latter perhaps in response to camel milk consumption. These results support the convergent evolution of the LP in diverse populations, most probably reflecting different histories of adaptation to milk culture.	[Enattah, Nabil Sabri; Kuokkanen, Mikko; Rasinpera, Heli; Peltonen, Leena] Biomedicum Helsinki, Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00251, Finland; [Enattah, Nabil Sabri; Kuokkanen, Mikko; Rasinpera, Heli; Peltonen, Leena] Univ Helsinki, Dept Med Genet, Biomedicum Helsinki, Helsinki 00251, Finland; [Enattah, Nabil Sabri; Kuokkanen, Mikko; Rasinpera, Heli; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Enattah, Nabil Sabri; Kuokkanen, Mikko; Rasinpera, Heli; Peltonen, Leena] MIT, Broad Inst, Cambridge, MA 02141 USA; [Jensen, Tine G. K.; Nielsen, Mette; Lewinski, Rikke; Troelsen, Jesper] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [El-Shanti, Hatem] Univ Iowa Hosp & Clin, Div Med Genet, Iowa City, IA 52242 USA; [Seo, Jeong Kee] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Pediat,Clin Res Inst, Seoul 110774, South Korea; [Alifrangis, Michael; Khalil, Insaf F.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, CSS, DK-1014 Copenhagen, Denmark; [Natah, Abdrazak] Univ Calgary, Fac Sci, Program Nat Sci, Calgary, AB T2N 1N4, Canada; [Natah, Sirajedin] Univ Calgary, Dept Physiol Biophys & Med, Gastrointestinal Div, Hlth Sci Ctr, Calgary, AB T2N 1N4, Canada; [Ali, Ahmed] Univ Helsinki, Dept Anat, Inst Clin Med, Helsinki 00014, Finland; [Comas, David] Univ Pompeu Fabra, Fac Hlth & Life Sci, Dept Evolutionary Biol, Barcelona 08003, Spain; [Mehdi, S. Qasim] Univ Karachi, Inst Biotechnol & Genet Engn KIBGE, Karachi 75270, Pakistan; [Groop, Leif] Malmo Univ Hosp, Dept Endocrinol, S-20502 Malmo, Sweden; [Vestergaard, Else Marie] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Imtiaz, Faiqa; Meyer, Brian] King Faisal Specialist Hosp & Res Ctr, Arabian Diagnost Lab, Riyadh 11211, Saudi Arabia; [Rashed, Mohamed S.] King Faisal Specialist Hosp & Res Ctr, Natl Newborn Screening Lab, Riyadh 11211, Saudi Arabia	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Copenhagen; University of Iowa; Seoul National University (SNU); Seoul National University Hospital; University of Copenhagen; University of Calgary; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Helsinki; Pompeu Fabra University; University of Karachi; Lund University; Skane University Hospital; Aarhus University; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Peltonen, L (corresponding author), Biomedicum Helsinki, Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00251, Finland.	leena@sanger.ac.uk	Troelsen, Jesper Thorvald T/B-6264-2013; El-Shanti, Hatem/O-5990-2014; Mehdi, Syed Qasim/L-2385-2015; EL-SHANTI, HATEM/Q-4932-2016; Kuokkanen, Mikko/M-8247-2016; Vestergaard, else marie/AAA-1646-2020; Comas, David/D-5382-2014; Imtiaz, Faiqa/AAD-7065-2019; Seo, Jeong Kee/J-5512-2012	Troelsen, Jesper Thorvald T/0000-0002-4177-3267; El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316; Kuokkanen, Mikko/0000-0003-4375-9327; Comas, David/0000-0002-5075-0956; Meyer, Brian/0000-0002-0388-9568; Alifrangis, Michael/0000-0002-3835-3333; Vestergaard, Else Marie/0000-0002-0469-3890				AOKI K, 1986, P NATL ACAD SCI USA, V83, P2929, DOI 10.1073/pnas.83.9.2929; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2003, AM J HUM GENET, V73, P768, DOI 10.1086/378506; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bloom G, 2005, EVOL HUM BEHAV, V26, P301, DOI 10.1016/j.evolhumbehav.2004.10.002; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; COOK GC, 1975, BMJ-BRIT MED J, V3, P135, DOI 10.1136/bmj.3.5976.135; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Hartle D. L., 1997, PRINCIPLES POPULATIO; Harvey CB, 1996, FEBS LETT, V398, P135, DOI 10.1016/S0014-5793(96)01189-1; HIJAZI SS, 1983, TROP GEOGR MED, V35, P157; HOEGERMAN SF, 1989, LANCET, V1, P493, DOI 10.1016/S0140-6736(89)91388-3; Holden C, 1997, HUM BIOL, V69, P605; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; HUDSON RR, 1994, GENETICS, V136, P1329; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUSSEIN L, 1982, HUM HERED, V32, P94, DOI 10.1159/000153266; HUSSEIN L, 1994, BIOCHEM GENET, V32, P331, DOI 10.1007/BF02426895; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; Myles S, 2005, HUM GENET, V117, P34, DOI 10.1007/s00439-005-1266-3; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; PETERS J, 1997, G GROSSTIERE NUTZTIE, V25, P559; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SAHI T, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409091740; SAHI T, 1994, SCAND J GASTROENTERO, V29, P1, DOI 10.3109/00365529409091739; SNOOK CR, 1976, TROP GEOGR MED, V28, P333; Spencer DH, 2006, AM J HUM GENET, V79, P958, DOI 10.1086/508757; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; Tag CG, 2007, CLIN CHEM, V53, P146, DOI 10.1373/clinchem.2006.077529; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Tsuruga H, 1997, GENES CELLS, V2, P381, DOI 10.1046/j.1365-2443.1997.1290327.x; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254	44	216	224	2	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					57	72		10.1016/j.ajhg.2007.09.012	http://dx.doi.org/10.1016/j.ajhg.2007.09.012			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179885	Green Published, Bronze			2022-12-18	WOS:000253223800007
J	Price, AL; Patterson, N; Yu, F; Cox, DR; Waliszewska, A; McDonald, GJ; Tandon, A; Schirmer, C; Neubauer, J; Bedoya, G; Duque, C; Villegas, A; Bortolini, MC; Salzano, FM; Gallo, C; Mazzotti, G; Tello-Ruiz, M; Riba, L; Aguilar-Salinas, CA; Canizales-Quinteros, S; Menjivar, M; Klitz, W; Henderson, B; Haiman, CA; Winkler, C; Tusie-Luna, T; Ruiz-Linares, A; Reich, D				Price, Alkes L.; Patterson, Nick; Yu, Fuli; Cox, David R.; Waliszewska, Alicja; McDonald, Gavin J.; Tandon, Arti; Schirmer, Christine; Neubauer, Julie; Bedoya, Gabriel; Duque, Constanza; Villegas, Alberto; Bortolini, Maria Catira; Salzano, Francisco M.; Gallo, Carla; Mazzotti, Guido; Tello-Ruiz, Marcela; Riba, Laura; Aguilar-Salinas, Carlos A.; Canizales-Quinteros, Samuel; Menjivar, Marta; Klitz, William; Henderson, Brian; Haiman, Christopher A.; Winkler, Cheryl; Tusie-Luna, Teresa; Ruiz-Linares, Andres; Reich, David			A genomewide admixture map for Latino populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFRICAN-AMERICAN; LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; MEXICAN-AMERICAN; PROSTATE-CANCER; ANCESTRY; MARKERS; RISK; PATTERNS; LOCUS	Admixture mapping is an economical and powerful approach for localizing disease genes in populations of recently mixed ancestry and has proven successful in African Americans. The method holds equal promise for Latinos, who typically inherit a mix of European, Native American, and African ancestry. However, admixture mapping in Latinos has not been practical because of the lack of a map of ancestry-informative markers validated in Native American and other populations. To address this, we screened multiple databases, containing millions of markers, to identify 4,186 markers that were putatively informative for determining the ancestry of chromosomal segments in Latino populations. We experimentally validated each of these markers in at least 232 new Latino, European, Native American, and African samples, and we selected a subset of 1,649 markers to form an admixture map. An advantage of our strategy is that we focused our map on markers distinguishing Native American from other ancestries and restricted it to markers with very similar frequencies in Europeans and Africans, which decreased the number of markers needed and minimized the possibility of false disease associations. We evaluated the effectiveness of our map for localizing disease genes in four Latino populations from both North and South America.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; MIT, Broad Inst, Med & Populat Genet Grp, Cambridge, MA 02139 USA; Perlegen Sci, Mountain View, CA USA; Univ Antioquia, Genet Mol Lab, Medellin, Colombia; Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Labs Invest & Desarrollo, Lima, Peru; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Nacl Autonoma Mexico, Unit Mol Biol & Genom Med, Inst Invest Biomed, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Mexico City 04510, DF, Mexico; Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Inst Publ Hlth, Oakland, CA USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; NCI, SAIC Frederick, Lab Genom Divers, Frederick, MD 21701 USA; UCL, Dept Biol, Galton Lab, London, England	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidad de Antioquia; Universidade Federal do Rio Grande do Sul; Universidad Peruana Cayetano Heredia; Cold Spring Harbor Laboratory; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of California System; University of California Berkeley; Public Health Institute; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of London; University College London	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu	Gallo, Carla/Q-4296-2019; Salzano, Francisco M/L-7916-2015; Ruiz-Linares, Andres/AAR-1104-2021; Salinas, Carlos A Aguilar/AAL-4491-2020	Ruiz-Linares, Andres/0000-0001-8372-1011; Menjivar, Marta/0000-0001-7795-1814; Gallo, Carla/0000-0001-8348-0473	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01CO12400, N01 CO12400] Funding Source: Medline; NCRR NIH HHS [U54 RR020278, U54 RR020278-01] Funding Source: Medline; NIDDK NIH HHS [R21 DK073818, F32 DK076277, DK073818] Funding Source: Medline; NINDS NIH HHS [NS043538, R01 NS043538] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK076277, R21DK073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043538] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bortolini MC, 2002, ANN HUM GENET, V66, P255, DOI 10.1017/S0003480002001148; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chen M.H., 2000, MONTE CARLO METHODS; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Collins-Schramm HE, 2004, HUM GENET, V114, P263, DOI 10.1007/s00439-003-1058-6; Collins-Schramm HE, 2003, HUM GENET, V113, P211, DOI 10.1007/s00439-003-0961-1; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haiman CA, 2003, HUM MOL GENET, V12, P2679, DOI 10.1093/hmg/ddg294; HAIMAN CA, 2007, NAT GENET       0401; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Salari K, 2005, GENET EPIDEMIOL, V29, P76, DOI 10.1002/gepi.20079; Salzano FM, 2002, EVOLUTION GENETICS L; Sans M, 2000, HUM BIOL, V72, P155; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; Williams RC, 2000, AM J HUM GENET, V66, P527, DOI 10.1086/302773; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	39	216	222	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1024	1036		10.1086/518313	http://dx.doi.org/10.1086/518313			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503322	Bronze, Green Published			2022-12-18	WOS:000246553800003
J	Sawcer, S; Ban, M; Maranian, M; Yeo, TW; Compston, A; Kirby, A; Daly, MJ; De Jager, PL; Walsh, E; Lander, ES; Rioux, JD; Hafler, DA; De Jager, PL; Rioux, JD; Hafler, DA; De Jager, PL; Ivinson, A; Lander, ES; Rioux, JD; Hafler, DA; Ivinson, A; Rimmler, J; Gregory, SG; Schmidt, S; Pericak-Vance, MA; Akesson, E; Hillert, J; Datta, P; Oturai, A; Ryder, LP; Harbo, HF; Spurkland, A; Laaksonen, M; Booth, D; Heard, R; Stewart, G; Lincoln, R; Barcellos, LF; Hauser, SL; Oksenberg, JR; Barcellos, LF; Kenealy, SJ; Haines, JL				Sawcer, S; Ban, M; Maranian, M; Yeo, TW; Compston, A; Kirby, A; Daly, MJ; De Jager, PL; Walsh, E; Lander, ES; Rioux, JD; Hafler, DA; De Jager, PL; Rioux, JD; Hafler, DA; De Jager, PL; Ivinson, A; Lander, ES; Rioux, JD; Hafler, DA; Ivinson, A; Rimmler, J; Gregory, SG; Schmidt, S; Pericak-Vance, MA; Akesson, E; Hillert, J; Datta, P; Oturai, A; Ryder, LP; Harbo, HF; Spurkland, A; Laaksonen, M; Booth, D; Heard, R; Stewart, G; Lincoln, R; Barcellos, LF; Hauser, SL; Oksenberg, JR; Barcellos, LF; Kenealy, SJ; Haines, JL			A high-density screen for linkage in multiple sclerosis - International multiple sclerosis genetics consortium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME SCREEN; DIAGNOSTIC-CRITERIA; RECURRENCE RATES; COMPLEX TRAITS; SIB-PAIRS; HLA-DR; SUSCEPTIBILITY; ASSOCIATION; POPULATION; GUIDELINES	To provide a definitive linkage map for multiple sclerosis, we have genotyped the Illumina BeadArray linkage mapping panel (version 4) in a data set of 730 multiplex families of Northern European descent. After the application of stringent quality thresholds, data from 4,506 markers in 2,692 individuals were included in the analysis. Multipoint nonparametric linkage analysis revealed highly significant linkage in the major histocompatibility complex (MHC) on chromosome 6p21 (maximum LOD score [MLS] 11.66) and suggestive linkage on chromosomes 17q23 (MLS 2.45) and 5q33 (MLS 2.18). This set of markers achieved a mean information extraction of 79.3% across the genome, with a Mendelian inconsistency rate of only 0.002%. Stratification based on carriage of the multiple sclerosis-associated DRB1*1501 allele failed to identify any other region of linkage with genomewide significance. However, ordered-subset analysis suggested that there may be an additional locus on chromosome 19p13 that acts independent of the main MHC locus. These data illustrate the substantial increase in power that can be achieved with use of the latest tools emerging from the Human Genome Project and indicate that future attempts to systematically identify susceptibility genes for multiple sclerosis will have to involve large sample sizes and an association-based methodology.	Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Sawcer, S (corresponding author), Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, Hills Rd, Cambridge CB2 2QQ, England.	sjs1016@mole.bio.cam.ac.uk	Haines, Jonathan/C-3374-2012; Myhr, Kjell-Morten/H-1528-2018; Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015; Hauser, Stephen L/J-2978-2016	Haines, Jonathan/0000-0002-4351-4728; Myhr, Kjell-Morten/0000-0002-0980-510X; Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; 	NIAID NIH HHS [U19 AI067152, P01 AI065687] Funding Source: Medline; NIDDK NIH HHS [U01 DK062432, R01 DK064869] Funding Source: Medline; NINDS NIH HHS [R01 NS032830, NS032830] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065687, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062432, R01DK064869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032830] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Akesson E, 2002, GENES IMMUN, V3, P279, DOI 10.1038/sj.gene.6363866; Ban M, 2002, GENES IMMUN, V3, P464, DOI 10.1038/sj.gene.6363910; Barcellos LF, 2002, BRAIN, V125, P150; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOYLES AL, 2005, IN PRESS HUM HERED; Broadley S, 2001, GENES IMMUN, V2, P205, DOI 10.1038/sj.gene.6363758; BRZUSTOWICZ LM, 1993, AM J HUM GENET, V53, P1137; Carton H, 1997, J NEUROL NEUROSUR PS, V62, P329, DOI 10.1136/jnnp.62.4.329; COMPSTON DAS, 1976, LANCET, V2, P1261; Coraddu F, 2001, EUR J HUM GENET, V9, P621, DOI 10.1038/sj.ejhg.5200680; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; DEAN G, 1976, BMJ-BRIT MED J, V1, P861, DOI 10.1136/bmj.1.6014.861; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Eichhorst H., 1896, VIRCHOWS ARCH PATH A, V146, P173, DOI 10.1007/BF01882681; Eraksoy M, 2003, J NEUROIMMUNOL, V143, P17, DOI 10.1016/j.jneuroim.2003.08.006; GOODKIN DE, 1991, ARCH NEUROL-CHICAGO, V48, P805, DOI 10.1001/archneur.1991.00530200041016; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hauser ER, 2004, GENET EPIDEMIOL, V27, P53, DOI 10.1002/gepi.20000; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hensiek AE, 2003, J NEUROIMMUNOL, V143, P25, DOI 10.1016/j.jneuroim.2003.08.007; Hogancamp WE, 1997, MAYO CLIN PROC, V72, P871, DOI 10.4065/72.9.871; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1177/135245859900500508; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; JERSILD C, 1972, LANCET, V1, P1240; Kenealy SJ, 2004, AM J HUM GENET, V75, P1070, DOI 10.1086/426459; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1983, AM J HUM GENET, V35, P241; Lemire M, 2004, AM J HUM GENET, V75, P571, DOI 10.1086/424528; Ligers A, 2001, AM J HUM GENET, V69, P900, DOI 10.1086/323480; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Robertson NP, 1996, BRAIN, V119, P449, DOI 10.1093/brain/119.2.449; Robertson NP, 1997, LANCET, V349, P1587, DOI 10.1016/S0140-6736(96)07317-5; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; Stewart GJ, 1997, EUR J IMMUNOGENET, V24, P81, DOI 10.1046/j.1365-2370.1997.00252.x; Terwilliger JD, 2002, CURR OPIN GENET DEV, V12, P726, DOI 10.1016/S0959-437X(02)00357-X; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; WINCHESTER RJ, 1975, LANCET, V2, P814	67	216	221	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					454	467						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080120				2022-12-18	WOS:000231314100011
J	Berends, MJW; Wu, Y; Sijmons, RH; Mensink, RGJ; van der Sluis, T; Hordijk-Hos, JM; de Vries, EGE; Hollema, H; Karrenbeld, A; Buys, CHCM; van der Zee, AGJ; Hofstra, RMW; Kleibeuker, JH				Berends, MJW; Wu, Y; Sijmons, RH; Mensink, RGJ; van der Sluis, T; Hordijk-Hos, JM; de Vries, EGE; Hollema, H; Karrenbeld, A; Buys, CHCM; van der Zee, AGJ; Hofstra, RMW; Kleibeuker, JH			Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; INTERNATIONAL-COLLABORATIVE-GROUP; MISMATCH REPAIR GENES; MICROSATELLITE INSTABILITY; ENDOMETRIAL CANCER; MUTATIONAL ANALYSIS; HEREDITARY; HMSH2; HMLH1; EXPRESSION	The MSH6 gene is one of the mismatch-repair genes involved in hereditary nonpolyposis colorectal cancer (HNPCC). Three hundred sixteen individuals who were known or suspected to have HNPCC were analyzed for MSH6 germline mutations. For 25 index patients and 8 relatives with MSH6 variants, molecular and clinical features are described. For analysis of microsatellite instability (MSI), the five consensus markers were used. Immunohistochemical analysis of the MLH1, MSH2, and MSH6 proteins was performed. Five truncating MSH6 mutations, of which one was detected seven times, were found in 12 index patients, and 10 MSH6 variants with unknown pathogenicity were found in 13 index patients. Fourteen (54%) of 26 colorectal cancers (CRCs) and endometrial cancers showed no, or only weak, MSI. Twelve of 18 tumors of truncating-mutation carriers and 3 of 17 tumors of missense-mutation carriers showed loss of MSH6 staining. Six of the families that we studied fulfilled the original Amsterdam criteria; most families with MSH6, however, were only suspected to have HNPCC. In families that did not fulfill the revised Amsterdam criteria, the prevalence of MSH6 variants is about the same as the prevalence of those in MLH1/MSH2. Endometrial cancer and/or atypical hyperplasia were diagnosed in 8 of 12 female carriers of MSH6 truncating mutations. Most CRCs were localized distally in the colon. Although, molecularly, missense variants are labeled as doubtfully pathogenic, clinical data disclose a great resemblance between missense-variant carriers and truncating-mutation carriers. We conclude that, in all patients suspected to have HNPCC, MSH6-mutation analysis should be considered. Neither MSI nor immunohistochemistry should be a definitive selection criterion for MSH6-mutation analysis.	Univ Groningen Hosp, Dept Gastroenterol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Med Genet, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Pathol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Med Oncol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Gynaecol, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kleibeuker, JH (corresponding author), Univ Groningen Hosp, Dept Gastroenterol, POB 30-001, NL-9700 RB Groningen, Netherlands.	J.H.Kleibeuker@int.azg.nl	Sijmons, Rolf/E-5829-2012	Sijmons, Rolf/0000-0001-8446-2779; de Vries, Elisabeth/0000-0002-8949-7425; Hofstra, Robert/0000-0001-7498-3829				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Akiyama Y, 1997, CANCER RES, V57, P3920; Berends MJ, 2001, GASTROENTEROLOGY, V120, pA741; Berends MJW, 2001, INT J CANCER, V92, P398, DOI 10.1002/ijc.1206; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Boland CR, 1998, CANCER RES, V58, P5248; Chadwick RB, 1999, AM J HUM GENET, V65, pA121; Charames GS, 2000, HUM GENET, V107, P623, DOI 10.1007/s004390000417; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Dietmaier W, 1997, CANCER RES, V57, P4749; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Edelmann W, 2000, CANCER RES, V60, P803; Genuardi M, 1999, EUR J HUM GENET, V7, P778, DOI 10.1038/sj.ejhg.5200363; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Ichikawa Y, 1999, CANCER GENET CYTOGEN, V112, P2, DOI 10.1016/S0165-4608(98)00252-0; Kobayashi K, 1996, JPN J CANCER RES, V87, P141, DOI 10.1111/j.1349-7006.1996.tb03151.x; Kolodner RD, 1999, CANCER RES, V59, P5068; Kowalski LD, 1997, GENE CHROMOSOME CANC, V18, P219, DOI 10.1002/(SICI)1098-2264(199703)18:3<219::AID-GCC8>3.0.CO;2-4; Kruse R, 2001, J INVEST DERMATOL, V116, P463, DOI 10.1046/j.1523-1747.2001.01265.x; Ku JL, 1999, EUR J CANCER, V35, P1724, DOI 10.1016/S0959-8049(99)00206-3; Leach FS, 1996, CANCER RES, V56, P235; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Marcus VA, 1999, AM J SURG PATHOL, V23, P1248, DOI 10.1097/00000478-199910000-00010; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Millar AL, 1999, HUM MOL GENET, V8, P823, DOI 10.1093/hmg/8.5.823; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Montera M, 2000, J Med Genet, V37, pE7, DOI 10.1136/jmg.37.7.e7; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Park JG, 1999, DIS COLON RECTUM, V42, P710, DOI 10.1007/BF02236922; PELTOMAKI P, 1993, CANCER RES, V53, P5853; Planck M, 1999, INT J CANCER, V83, P197, DOI 10.1002/(SICI)1097-0215(19991008)83:2<197::AID-IJC9>3.0.CO;2-X; Plaschke J, 2000, INT J CANCER, V85, P606, DOI 10.1002/(SICI)1097-0215(20000301)85:5<606::AID-IJC2>3.0.CO;2-B; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Shin KH, 1999, J HUM GENET, V44, P18, DOI 10.1007/s100380050099; Thibodeau SN, 1996, CANCER RES, V56, P4836; VASEN HF, 1993, DIS COLON RECTUM, V36, P1, DOI 10.1007/BF02050292; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Verma L, 1999, J MED GENET, V36, P678; Wagner A, 2001, J MED GENET, V38, P318, DOI 10.1136/jmg.38.5.318; Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067; WATSON P, 1994, AM J MED, V96, P516, DOI 10.1016/0002-9343(94)90091-4; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; Wu Y, 1997, GENE CHROMOSOME CANC, V18, P269, DOI 10.1002/(SICI)1098-2264(199704)18:4<269::AID-GCC4>3.0.CO;2-Z; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	49	216	219	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					26	37		10.1086/337944	http://dx.doi.org/10.1086/337944			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11709755	Green Published, Bronze			2022-12-18	WOS:000172571900004
J	Lake, SL; Blacker, D; Laird, NM				Lake, SL; Blacker, D; Laird, NM			Family-based tests of association in the presence of linkage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE RELATIVE RISK; ONSET ALZHEIMER-DISEASE; TRANSMISSION/DISEQUILIBRIUM TEST; GENOMIC SCREEN; CHROMOSOME-12; ALPHA-2-MACROGLOBULIN; DISEQUILIBRIUM; TRANSMISSION; LOCUS; GENE	Linkage analysis may not provide the necessary resolution for identification of the genes underlying phenotypic variation. This is especially true for gene-mapping studies that focus on complex diseases that do not exhibit Mendelian inheritance patterns. One positional genomic strategy involves application of association methodology to areas of identified linkage. Detection of association in the presence of linkage localizes the gene(s) of interest to more-refined regions in the genome than is possible through linkage analysis alone. This strategy introduces a statistical complexity when family-based association tests are used: the marker genotypes among siblings are correlated in linked regions. Ignoring this correlation will compromise the size of the statistical hypothesis test, thus clouding the interpretation of test results. We present a method for computing the expectation of a wide range of association test statistics under the null hypothesis that there is linkage but no association. To standardize the test statistic, an empirical variance-covariance estimator that is robust to the sibling marker-genotype correlation is used. This method is widely applicable: any type of phenotypic measure or family configuration can be used. For example, we analyze a deletion in the A2M gene at the 5' splice site of "exon II" of the bait region in Alzheimer disease (AD) discordant sibships. Since the A2M gene lies in a chromosomal region (chromosome 12p) that consistently has been linked to AD, association tests should be conducted under the null hypothesis that there is linkage but no association.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lake, SL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046290, R01MH060009, R01MH059532, U01MH046281, U01MH046373] Funding Source: NIH RePORTER; NIMH NIH HHS [U01 MH046290, U01 MH046281, MH 59532, R01 MH059532, R01 MH60009, R01 MH060009, U01 MH046373] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blacker D, 1999, NAT GENET, V22, P21, DOI 10.1038/8732; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Bray MS, 2000, CIRCULATION, V101, P2877, DOI 10.1161/01.CIR.101.25.2877; BROOKES AJ, 2000, INT S STAT ART GEN A; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Cox DR., 1974, THEORETICAL STAT; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dow DJ, 1999, NAT GENET, V22, P16, DOI 10.1038/8724; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kraft P, 2000, AM J HUM GENET, V66, P1119, DOI 10.1086/302808; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Martin ER, 2000, GENOMICS, V63, P7, DOI 10.1006/geno.1999.6057; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Pericak-Vance Margaret A., 1998, P323; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; RIMMLER JB, 1997, AM J HUM GENET, V61, P1705; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Rogaeva EA, 1999, NAT GENET, V22, P19, DOI 10.1038/8729; Romas SN, 2000, NEUROSCI LETT, V279, P133, DOI 10.1016/S0304-3940(99)00972-6; Rudrasingham V, 1999, NAT GENET, V22, P17, DOI 10.1038/8726; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Scott WK, 1999, JAMA-J AM MED ASSOC, V281, P513, DOI 10.1001/jama.281.6.513; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMSON G, 1995, AM J HUM GENET, V57, P474; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu WS, 1998, JAMA-J AM MED ASSOC, V280, P619, DOI 10.1001/jama.280.7.619	46	216	225	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1515	1525		10.1086/316895	http://dx.doi.org/10.1086/316895			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11058432	Green Published, Bronze			2022-12-18	WOS:000165607600016
J	Heon, E; Priston, M; Schorderet, DF; Billingsley, GD; Girard, PO; Lubsen, N; Munier, FL				Heon, E; Priston, M; Schorderet, DF; Billingsley, GD; Girard, PO; Lubsen, N; Munier, FL			The gamma-crystallins and human cataracts: A puzzle made clearer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL CATARACT; CHROMOSOME 2Q33-35; MISSENSE MUTATION; GENE FAMILY; LENS; LOCUS; DNA	Despite the fact that cataracts constitute the leading cause of blindness worldwide, the mechanisms of lens opacification remain unclear. We recently mapped the aculeiform cataract to the gamma-crystallin locus (CRYG) on chromosome 2q33-35, and mutational analysis of the CRYG-genes cluster identified the aculeiform-cataract mutation in exon 2 of gamma-crystallin D (CRYGD). This mutation occurred in a highly conserved amino acid and could be associated with an impaired folding of CRYGD. During our study, we observed that the previously reported Coppock-like-cataract mutation, the first human cataract mutation, in the pseudogene CRYGE represented a polymorphism seen in 23% of our control population. Further analysis of the original Coppock-like-cataract family identified a missense mutation in a highly conserved segment of exon 2 of CRYGC. These mutations were not seen in a large control population. There is no direct evidence, to date, that up-regulation of a pseudogene causes cataracts. To our knowledge, these findings are the first evidence of an involvement of CRYGC and support the role of CRYGD in human cataract formation.	Eye Res Inst Canada, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Hop Ophtalm Jules Gonin, Div Med Genet, Ocular Genet Unit, Lausanne, Switzerland; CHU Vaudois, Hop Ophtalm Jules Gonin, CH-1011 Lausanne, Switzerland; Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Radboud University Nijmegen	Heon, E (corresponding author), Eye Res Inst Canada, 399 Bathurst St,Room 6-412, Toronto, ON M5T 2S8, Canada.		Lubsen, Nicolette H./B-8426-2011					BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; CARTIER M, 1994, MOD GENET, V2, P413; Hejtmancik JF, 1998, AM J HUM GENET, V62, P520, DOI 10.1086/301774; Heon E, 1998, AM J HUM GENET, V63, P921, DOI 10.1086/302005; Kannabiran C, 1998, Mol Vis, V4, P21; Klopp N, 1998, GENOMICS, V52, P152, DOI 10.1006/geno.1998.5417; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; MEAKIN SO, 1985, MOL CELL BIOL, V5, P1408, DOI 10.1128/MCB.5.6.1408; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell KR, 1998, BIOTECHNIQUES, V24, P1028, DOI 10.2144/98246cr02; Nettleship E, 1906, T OPHTHAL SOC UK, V26, P191; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; PAPACONSTANTINOU J, 1967, SCIENCE, V156, P338, DOI 10.1126/science.156.3773.338; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; PIATIGORSKY J, 1984, CELL, V38, P620, DOI 10.1016/0092-8674(84)90254-X; Rogaev EI, 1996, HUM MOL GENET, V5, P699, DOI 10.1093/hmg/5.5.699; SANTHIYA ST, 1995, GRAEF ARCH CLIN EXP, V233, P795, DOI 10.1007/BF00184093; Sergeev Y V, 1998, Mol Vis, V4, P9; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Vogt A, 1922, VONGREAFES ARCH OPHT, V107, P237; WHITE HE, 1989, J MOL BIOL, V207, P217, DOI 10.1016/0022-2836(89)90452-X; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003	28	216	239	2	15	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1261	1267		10.1086/302619	http://dx.doi.org/10.1086/302619			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521291	Green Published, Bronze			2022-12-18	WOS:000083531000007
J	Thorlacius, S; Sigurdsson, S; Bjarnadottir, H; Olafsdottir, G; Jonasson, JG; Tryggvadottir, L; Tulinius, H; Eyfjord, JE				Thorlacius, S; Sigurdsson, S; Bjarnadottir, H; Olafsdottir, G; Jonasson, JG; Tryggvadottir, L; Tulinius, H; Eyfjord, JE			Study of a single BRCA2 mutation with high carrier frequency in a small population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; OVARIAN-CANCER; IDENTIFICATION; FAMILIES; LINKAGE; REGION	Germ-line changes in the cancer-predisposition gene BRCA2 are found in a small proportion of breast cancers. Mutations in the BRCA2 gene have been studied mainly in families with high risk of breast cancer in females, and male breast cancer also has been associated with BRCA2 mutations. The importance of germ-line BRCA2 mutations in individuals without a family history of breast cancer is unknown. The same BRCA2 mutation has been found in 16/21 Icelandic breast cancer families, indicating a founder effect. We determined the frequency of this mutation, 999del5, in 1,182 Icelanders, comprising 520 randomly selected individuals from the population and a series of 632 female breast cancer patients (61.4% of patients diagnosed during the study period) and all male breast cancer patients diagnosed during the past 40 years. We detected the 999del5 germ-line mutation in 0.6% of the population, in 7.7% of female breast cancer patients, and in 40% of males with breast cancer. The mutation was strongly associated with onset of female breast cancer at age <50 years, but its penetrance and expression are varied. A number of cancers other than breast cancer were found to be increased in relatives of mutation carriers, including those with prostate and pancreatic cancer. Furthermore, germ-line BRCA2 mutation can be present without a strong family history of breast cancer. Comparison of the age at onset for mother/daughter pairs with the 999de15 mutation and breast cancer indicates that age at onset is decreasing in the younger generation. Increase in breast cancer incidence and lower age at onset suggest a possible contributing environmental factor.	ICELAND CANC SOC,MOL & CELL BIOL RES LAB,IS-125 REYKJAVIK,ICELAND; ICELAND CANC SOC,CANC REGISTRY,IS-125 REYKJAVIK,ICELAND; UNIV ICELAND,DEPT PATHOL,REYKJAVIK,ICELAND; UNIV ICELAND,DEPT PREVENT MED,REYKJAVIK,ICELAND	University of Iceland; University of Iceland			Sigurdsson, Stefan/L-9820-2015	Sigurdsson, Stefan/0000-0002-5284-0058; Bjarnadottir, Helga/0000-0003-3240-3149; Tryggvadottir, Laufey/0000-0001-8067-9030; Jonasson, Jon G./0000-0002-2635-5032				BARKARDOTTIR RB, 1995, ACTA ONCOL, V34, P657, DOI 10.3109/02841869509094044; EASTON DF, 1993, AM J HUM GENET, V52, P678; EYFJORD JE, 1992, PHARMACOGENETICS, V2, P309, DOI 10.1097/00008571-199212000-00010; FORD D, 1995, BRIT J CANCER, V72, P805, DOI 10.1038/bjc.1995.417; *IC CANC SOC, 1996, ANN REP; Johannesdottir G, 1996, CANCER RES, V56, P3663; Jonasson JG, 1996, INT J CANCER, V65, P446, DOI 10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X; Kelsey JL, 1993, EPIDEMIOL REV, V15, P17; LYNCH HT, 1989, GENETIC EPIDEMIOLOGY, P289; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; *STAT IC, 1995, LANDSH, V3; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; THORLACIUS S, 1995, LANCET, V346, P544, DOI 10.1016/S0140-6736(95)91383-1; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TRYGGVADOTTIR L, 1988, INT J CANCER, V42, P499, DOI 10.1002/ijc.2910420405; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	21	216	221	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1079	1084						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150155				2022-12-18	WOS:A1997WX76000008
J	GREENBERG, DA				GREENBERG, DA			LINKAGE ANALYSIS OF NECESSARY DISEASE LOCI VERSUS SUSCEPTIBILITY LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; RECOMBINATION FRACTION; RHEUMATOID-ARTHRITIS; GRAVES-DISEASE; HLA; ASSOCIATION; INHERITANCE; IDDM; NARCOLEPSY; PEDIGREES	The association of some diseases with specific alleles of certain genetic markers has been difficult to explain. Several explanations have been proposed for the phenomenon of association, e.g., the existence of multiple, interacting genes (epistasis) or a disease locus in linkage disequilibrium with the marker locus. One might suppose that when marker data from families with associated diseases are analyzed for linkage, the existence of the association would assure that linkage will be found, and found at a tight recombination fraction. In fact, however, linkage analyses of some diseases associated with HLA, as well as diseases associated with alleles at other loci located throughout the genome, show significant evidence against linkage, and others show loose linkage, to the puzzlement of many researchers. In part, the puzzlement arises because linkage analysis is ideal for looking for loci that are necessary, even if not sufficient, for disease expression but may be much less useful for finding loci that are neither necessary nor sufficient for disease expression (so-called susceptibility loci). This work explores what happens when one looks for linkage to susceptibility loci. A susceptibility locus in this case means that the allele increases risk but is neither necessary nor sufficient for disease expression. It might be either an allele at the marker locus itself that is increasing susceptibility or an allele at a locus in linkage disequilibrium with the marker. This work uses computer simulation to examine how linkage analyses behave when confronted with data from such a model. The results show that if the probability of having the disease with the associated allele is less than 10 times greater than the probability of having the disease without the allele, then it may be difficult to detect linkage, even in data sets consisting of 30 nuclear families with at least two people affected. On the basis of these results, it would appear that doing linkage analysis on risk-factor data may not yield additional information about linkage in the usual sense but may help distinguish between different hypotheses to explain the association. As the difficulties inherent in linkage analysis for analyzing common disease become more apparent, investigators will turn to association analysis to find genes involved in disease. Before embarking on a search for a susceptibility locus, one must weigh the potential importance of such a gene against the possibility that the locus detected via association analysis may represent a relatively minor contribution to disease causality.			GREENBERG, DA (corresponding author), MT SINAI MED CTR,DEPT PSYCHIAT,UNIT 1229,NEW YORK,NY 10029, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31775] Funding Source: Medline; NIMH NIH HHS [MH45212] Funding Source: Medline; NINDS NIH HHS [NS27941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLANNIC H, 1980, J CLIN ENDOCR METAB, V51, P863, DOI 10.1210/jcem-51-4-863; BILLIARD M, 1985, LANCET, V1, P226; Bodmer WF, 1984, HISTOCOMPATIBILITY T, P11; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CLERGETDARPOUX F, 1982, ANN HUM GENET, V46, P363, DOI 10.1111/j.1469-1809.1982.tb01587.x; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; FARID NR, 1979, J CLIN INVEST, V63, P108, DOI 10.1172/JCI109263; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; GO RCP, 1987, ARTHRITIS RHEUM, V30, P1115; Greenberg D. A., 1992, American Journal of Human Genetics, V51, pA150; GREENBERG DA, 1984, AM J HUM GENET, V36, P167; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1981, AM J MED GENET, V8, P205, DOI 10.1002/ajmg.1320080211; HODGE SE, 1981, AM J HUM GENET, V33, P396; HODGE SE, 1979, NEW ENGL J MED, V301, P442; LANGDON N, 1984, LANCET, V2, P1178; MORTON NE, 1983, AM J HUM GENET, V35, P201; OTT J, 1974, AM J HUM GENET, V26, P588; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; ROMAN SH, 1992, J CLIN ENDOCR METAB, V74, P496, DOI 10.1210/jc.74.3.496; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; TIWARI JL, 1980, AM J HUM GENET, V32, P103; TIWARI JL, 1985, HLA DISEASE ASS; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WAGENER DK, 1982, DIABETES, V31, P136, DOI 10.2337/diabetes.31.2.136	27	216	219	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					135	143						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434581				2022-12-18	WOS:A1993KK90800016
J	LEDBETTER, DH; MASCARELLO, JT; RICCARDI, VM; HARPER, VD; AIRHART, SD; STROBEL, RJ				LEDBETTER, DH; MASCARELLO, JT; RICCARDI, VM; HARPER, VD; AIRHART, SD; STROBEL, RJ			CHROMOSOME-15 ABNORMALITIES AND THE PRADER-WILLI SYNDROME - A FOLLOW-UP REPORT OF 40 CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP & HLTH CTR,GENET LAB,SAN DIEGO,CA; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	Baylor College of Medicine	LEDBETTER, DH (corresponding author), BAYLOR COLL MED,KLEBERG CYTOGENET LAB,HOUSTON,TX 77030, USA.							ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; AURIAS A, 1978, HUM GENET, V45, P259, DOI 10.1007/BF00278725; DUTRILLAUX B, 1973, CR ACAD SCI D NAT, V276, P3179; EMBERGER JM, 1977, ANN GENET-PARIS, V20, P297; FLEISCHNICK E, 1979, AM J HUM GENET, V31, pA94; FRACCARO M, 1977, J MED GENET, V14, P275, DOI 10.1136/jmg.14.4.275; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FUJITA H, 1980, HUM GENET, V55, P409, DOI 10.1007/BF00290227; FUNDERBURK SJ, 1977, AM J HUM GENET, V29, P136; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; GUANTI G, 1980, CLIN GENET, V17, P423; HAWKEY CJ, 1976, J MED GENET, V14, P275; KOUSSEFF BG, 1980, CLIN GENET, V18, P364; KUCEROVA M, 1979, J MED GENET, V16, P234, DOI 10.1136/jmg.16.3.234; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEJEUNE J, 1979, ANN GENET-PARIS, V22, P210; McKusick V.A., 1978, MENDELIAN INHERITANC; MICHAELSEN KF, 1979, CLIN GENET, V16, P147; RICCARDI VM, 1979, HUM GENET, V52, P211; RIDLER MAC, 1971, ACTA PAEDIATR SCAND, V60, P222, DOI 10.1111/j.1651-2227.1971.tb06646.x; SCHWEIZER D, 1978, EXP CELL RES, V111, P327, DOI 10.1016/0014-4827(78)90177-5; SMITH A, 1980, HUM GENET, V55, P271, DOI 10.1007/BF00291777; THARAPEL AT, 1977, CLIN GENET, V11, P255; WISNIEWSKI LP, 1980, CLIN GENET, V18, P42; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; ZUFFARDI O, 1978, CLIN GENET, V14, P315	26	216	219	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					278	285						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	7072717				2022-12-18	WOS:A1982NH73200011
J	Bandelt, HJ; Quintana-Murci, L; Salas, A; Macaulay, V				Bandelt, HJ; Quintana-Murci, L; Salas, A; Macaulay, V			The fingerprint of phantom mutations in mitochondrial DNA data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE SUBSTITUTION; SEQUENCE POLYMORPHISM; CONTROL REGION; NEAR-EASTERN; MTDNA; POPULATIONS; NETWORKS; AFRICAN; PATTERN; ORIGIN	Phantom mutations are systematic artifacts generated in the course of the sequencing process itself. In sequenced mitochondrial DNA (mtDNA), they generate a hotspot pattern quite different from that of natural mutations in the cell. To identify the telltale patterns of a particular phantom mutation process, one first filters out the well-established frequent mutations (inferred from various data sets with additional coding region information). The filtered data are represented by their full (quasi-) median network, to visualize the character conflicts, which can be expressed numerically by the cube spectrum. Permutation tests are used to evaluate the overall phylogenetic content of the filtered data. Comparison with benchmark data sets helps to sort out suspicious data and to infer features and potential causes for the phantom mutation process. This approach, performed either in the lab or at the desk of a reviewer, will help to avoid errors that otherwise would go into print and could lead to erroneous evolutionary interpretations. The filtering procedure is illustrated with two mtDNA data sets that were severely affected by phantom mutations.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Hamburg, Dept Math, Hamburg, Germany; Inst Pasteur, Paris, France; CNRS, UMR 5596, Lyon, France; Univ Santiago de Compostela, Inst Legal Med, Santiago De Compostela, Spain	University of Oxford; University of Hamburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universidade de Santiago de Compostela	Macaulay, V (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	macaulay@stats.ox.ac.uk	Salas, Antonio/E-3977-2012; Quintana-Murci, Lluis/AAB-7468-2022; Schneider, Peter M./A-6661-2011	Salas, Antonio/0000-0002-2336-702X; Quintana-Murci, Lluis/0000-0003-2429-6320				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Dimo-Simonin N, 2000, INT J LEGAL MED, V113, P89, DOI 10.1007/PL00007715; Dress A.W.M., 1997, ANN COMB, V1, P329; Easton RD, 1996, AM J HUM GENET, V59, P213; Graham R. L., 1990, CONCRETE MATH FDN CO; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Herrnstadt, 2002, AM J HUM GENET, V71, P448; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1990, AM J HUM GENET, V46, P828; Imaizumi K, 2002, INT J LEGAL MED, V116, P68, DOI 10.1007/s004140100211; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Lee SD, 1997, FORENSIC SCI INT, V87, P99, DOI 10.1016/S0379-0738(97)02114-2; Malyarchuk BA, 2002, HUM GENET, V111, P46, DOI 10.1007/s00439-002-0740-4; MERRIWETHER DA, 2000, AM PAST AM PRESENT G, P89; Meyer S, 1999, GENETICS, V152, P1103; Parson W, 1998, INT J LEGAL MED, V111, P124, DOI 10.1007/s004140050132; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; Seo Y, 1998, FORENSIC SCI INT, V97, P155, DOI 10.1016/S0379-0738(98)00153-4; Skrekovski R, 2001, DISCRETE MATH, V226, P351, DOI 10.1016/S0012-365X(00)00120-5; Soltan P.S., 1987, T TBIL MAT I RAZMADZ, V85, P52; Stenico M, 1996, AM J HUM GENET, V59, P1363; Tsai LC, 2001, FORENSIC SCI INT, V119, P239, DOI 10.1016/S0379-0738(00)00439-4; Vernesi C, 2001, P NATL ACAD SCI USA, V98, P13460, DOI 10.1073/pnas.211540498; VERNESI C, IN PRESS HUM BIOL; Yang ZH, 1996, MOL BIOL EVOL, V13, P650, DOI 10.1093/oxfordjournals.molbev.a025625; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	40	215	220	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1150	1160		10.1086/344397	http://dx.doi.org/10.1086/344397			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12384858	Bronze, Green Published			2022-12-18	WOS:000178884300012
J	Box, NF; Duffy, DL; Chen, W; Stark, M; Martin, NG; Sturm, RA; Hayward, NK				Box, NF; Duffy, DL; Chen, W; Stark, M; Martin, NG; Sturm, RA; Hayward, NK			MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MELANOCORTIN-1 RECEPTOR; CUTANEOUS MELANOMA; RED HAIR; HUMAN PIGMENTATION; GERMLINE MUTATIONS; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; GENE; P16; ASSOCIATION	Mutations in the exons of the cyclin-dependent kinase inhibitor gene CDKN2A are melanoma-predisposition alleles which have high penetrance, although they have low population frequencies. In contrast, variants of the melanocortin-1 receptor gene, MC1R, confer much lower melanoma risk but are common in European populations. Fifteen Australian CDKN2A mutation-carrying melanoma pedigrees were assessed for MC1R genotype, to test for possible modifier effects on melanoma risk. A CDKN2A mutation in the presence of a homozygous consensus MC1R genotype had a raw penetrance of 50%, with a mean age at onset of 58.1 years. When an MC1R variant allele was also present, the raw penetrance of the CDKN2A mutation increased to 84%, with a mean age at onset of 37.8 years (P=0.1). The presence of a CDKN2A mutation gave a hazard ratio of 13.35, and the hazard ratio of 3.72 for MC1R variant alleles was also significant. The impact of MC1R variants on risk of melanoma was mediated largely through the action of three common alleles, Arg151Cys, Arg160Trp, and Asp294His, that have previously been associated with red hair, fair skin, and skin sensitivity to ultraviolet light.	Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Inst Mol Biosci, Ctr Funct & Appl Genom, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Hayward, NK (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	NickH@qimr.edu.au	hayward, nick/AAV-8802-2020; Duffy, David L/B-7392-2013; Sturm, Richard A/C-9943-2009; Stark, Mitchell/K-6794-2019; Stark, Mitchell S/E-3542-2010; hayward, nicholas k/C-1367-2015; Box, Neil/F-3591-2010; Stark, Mitchell/K-3874-2019	Duffy, David L/0000-0001-7227-632X; Sturm, Richard A/0000-0003-1301-0294; Stark, Mitchell/0000-0002-4510-2161; Stark, Mitchell S/0000-0002-4510-2161; hayward, nicholas k/0000-0003-4760-1033; Box, Neil/0000-0002-3486-0346; Martin, Nicholas/0000-0003-4069-8020				Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Breitbart M, 1997, ACTA DERM-VENEREOL, V77, P374; DUTTON CM, 1993, NUCLEIC ACIDS RES, V21, P2953, DOI 10.1093/nar/21.12.2953; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Flores JF, 1997, ONCOGENE, V15, P2999, DOI 10.1038/sj.onc.1201470; GARBE C, 1994, J INVEST DERMATOL, V102, P695, DOI 10.1111/1523-1747.ep12374280; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; GRANGE F, 1995, ARCH DERMATOL, V131, P1154, DOI 10.1001/archderm.131.10.1154; Grulich AE, 1996, INT J CANCER, V67, P485, DOI 10.1002/(SICI)1097-0215(19960807)67:4<485::AID-IJC4>3.0.CO;2-O; HARSANYI ZP, 1980, EXPERIENTIA, V36, P291, DOI 10.1007/BF01952282; Hayward NK, 1999, MOLECULAR PATHOLOGY OF EARLY CANCER, P207; HAYWARD NK, 1998, CURR PRAC MED, V1, P47; Healy E, 2000, LANCET, V355, P1072, DOI 10.1016/S0140-6736(00)02042-0; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Monzon J, 1998, NEW ENGL J MED, V338, P879, DOI 10.1056/NEJM199803263381305; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Spielman RS, 1996, AM J HUM GENET, V59, P983; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sturm RA, 1998, MUTAT RES-FUND MOL M, V422, P69, DOI 10.1016/S0027-5107(98)00176-6; Suzuki I, 1999, J INVEST DERM SYMP P, V4, P29, DOI 10.1038/sj.jidsp.5640177; THERNEAU T, 1999, SURVIVAL 5 COMPUTER; Thody AJ, 1998, PIGM CELL RES, V11, P265, DOI 10.1111/j.1600-0749.1998.tb00735.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; van der Velden PA, 2001, AM J HUM GENET, V69, P774, DOI 10.1086/323411; Vasen HFA, 2000, INT J CANCER, V87, P809, DOI 10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.3.CO;2-L; WALKER GJ, 1995, HUM MOL GENET, V4, P1845, DOI 10.1093/hmg/4.10.1845; Whiteman DC, 1998, INT J CANCER, V77, P843, DOI 10.1002/(SICI)1097-0215(19980911)77:6<843::AID-IJC8>3.0.CO;2-U; Whiteman DC, 1997, J NATL CANCER I, V89, P1460, DOI 10.1093/jnci/89.19.1460; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	44	215	220	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					765	773		10.1086/323412	http://dx.doi.org/10.1086/323412			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11500805	Green Published, Bronze			2022-12-18	WOS:000171008200009
J	Torroni, A; Bandelt, HJ; Macaulay, V; Richards, M; Cruciani, F; Rengo, C; Martinez-Cabrera, V; Villems, R; Kivisild, T; Metspalu, E; Parik, JR; Tolk, HV; Tambets, K; Forster, P; Karger, B; Francalacci, P; Rudan, P; Janicijevic, B; Rickards, O; Savontaus, ML; Huoponen, K; Laitinen, V; Koivumaki, S; Sykes, B; Hickey, E; Novelletto, A; Moral, P; Sellitto, D; Coppa, A; Al-Zaheri, N; Santachiara-Benerecetti, AS; Semino, O; Scozzari, R				Torroni, A; Bandelt, HJ; Macaulay, V; Richards, M; Cruciani, F; Rengo, C; Martinez-Cabrera, V; Villems, R; Kivisild, T; Metspalu, E; Parik, JR; Tolk, HV; Tambets, K; Forster, P; Karger, B; Francalacci, P; Rudan, P; Janicijevic, B; Rickards, O; Savontaus, ML; Huoponen, K; Laitinen, V; Koivumaki, S; Sykes, B; Hickey, E; Novelletto, A; Moral, P; Sellitto, D; Coppa, A; Al-Zaheri, N; Santachiara-Benerecetti, AS; Semino, O; Scozzari, R			A signal, from human mtDNA, of postglacial recolonization in Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTROL REGION SEQUENCE; MITOCHONDRIAL GENOME; PHYLOGENETIC NETWORK; NEAR-EASTERN; ORIGIN; POPULATIONS; HAPLOGROUPS; SOUTHWESTERN; EXPANSION; PATTERNS	Mitochondrial HVS-I sequences from 10,365 subjects belonging to 56 populations/geographical regions of western Eurasia and northern Africa were first surveyed for the presence of the T -->C transition at nucleotide position 16298, a mutation which has previously been shown to characterize haplogroup V mtDNAs. All mtDNAs with this mutation were then screened for a number of diagnostic RFLP sites, revealing two major subsets of mtDNAs. One is haplogroup V proper, and the other has been termed "pre* V," since it predates V phylogenetically. The rather uncommon pre* V tends to be scattered throughout Europe (and northwestern Africa), whereas V attains two peaks of frequency: one situated in southwestern Europe and one in the Saami of northern Scandinavia. Geographical distributions and ages support the scenario that pre* V originated in Europe before the Last Glacial Maximum (LGM), whereas the more recently derived haplogroup V arose in a southwestern European refugium soon after the LGM. The arrival of V in eastern/central Europe, however, occurred much later, possibly with (post-) Neolithic contacts. The distribution of haplogroup V mtDNAs in modern European populations would thus, at least in part, reflect the pattern of postglacial human recolonization from that refugium, affecting even the Saami. Overall, the present study shows that the dissection of mtDNA variation into small and well-defined evolutionary units is an essential step in the identification of spatial frequency patterns. Mass screening of a few markers identified using complete mtDNA sequences promises to be an efficient strategy for inferring features of human prehistory.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Cattolica Sacro Cuore, Inst Med Legale, Rome, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Rome, Italy; Univ Roma La Sapienza, Dipartimento Biol Anim & Uomo, Rome, Italy; Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; CNR, Ctr Genet Evoluzionist, Rome, Italy; Univ Hamburg, Fachbereich Math, Hamburg, Germany; Univ Oxford, Inst Mol Med, Oxford OX1 2JD, England; Univ Oxford, Dept Stat, Oxford OX1 2JD, England; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ La Laguna, Dept Genet, Tenerife, Spain; Univ Tartu, Inst Mol & Cellular Biol, EE-50090 Tartu, Estonia; Estonian Bioctr, Tartu, Estonia; McDonald Inst Archaeol Res, Cambridge, England; Univ Munster, Inst Legal Med, D-4400 Munster, Germany; Univ Sassari, Dipartimento Zool & Antropol Biol, I-07100 Sassari, Italy; Inst Anthropol Res, Zagreb, Croatia; Univ Turku, Dept Med Genet, Turku, Finland; Univ Calabria, Dipartimento Biol Cellulare, Arcavacata Di Rende, Italy; Univ Barcelona, Dept Biol Anim, Barcelona, Spain	University of Pavia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Sapienza University Rome; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); University of Hamburg; University of Oxford; University of Oxford; University of Huddersfield; Universidad de la Laguna; University of Tartu; Estonian Biocentre; University of Cambridge; University of Munster; University of Sassari; Institute for Anthropological Research Zagreb; University of Turku; University of Calabria; University of Barcelona	Torroni, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	Al-Zahery, Nadia/AAV-5878-2020; Tambets, Kristiina/M-2568-2019; Cruciani, Fulvio/G-6105-2012; Moral, Pedro/K-9587-2014; Torroni, Antonio/E-1557-2011; Rickards, Olga/L-7878-2015; Kivisild, Toomas/P-5889-2017	Tambets, Kristiina/0000-0002-8173-6380; Moral, Pedro/0000-0001-5072-5892; Torroni, Antonio/0000-0002-4163-4478; Rickards, Olga/0000-0003-2880-7466; Kivisild, Toomas/0000-0002-6297-7808; coppa, alfredo/0000-0002-7708-2484; SEMINO, Ornella/0000-0002-9675-9403; Cruciani, Fulvio/0000-0002-6900-024X; RICHARDS, MARTIN/0000-0003-3118-0967; Novelletto, Andrea/0000-0002-1146-7680; FRANCALACCI, Paolo/0000-0001-7912-162X	Telethon [E.0890] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANDELT HJ, 1995, GENETICS, V141, P743; BANDELT HJ, IN PRESS INT J LEGAL; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; Delfiner P, 1976, ADV GEOSTATISTICS MI, P49; Dolukhanov P. M., 2000, ROOTS PEOPLES LANGUA, P71; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Forster P, 1996, AM J HUM GENET, V59, P935; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malaspina P, 2000, ANN HUM GENET, V64, P395, DOI 10.1046/j.1469-1809.2000.6450395.x; Morelli L, 2000, HUM BIOL, V72, P585; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P563; WilkinsonHerbots HM, 1996, ANN HUM GENET, V60, P499, DOI 10.1111/j.1469-1809.1996.tb01616.x; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406	36	215	218	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					844	852		10.1086/323485	http://dx.doi.org/10.1086/323485			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11517423	Bronze, Green Published			2022-12-18	WOS:000171008200016
J	Zhu, XF; Bouzekri, N; Southam, L; Cooper, RS; Adeyemo, A; McKenzie, CA; Luke, A; Chen, GJ; Elston, RC; Ward, R				Zhu, XF; Bouzekri, N; Southam, L; Cooper, RS; Adeyemo, A; McKenzie, CA; Luke, A; Chen, GJ; Elston, RC; Ward, R			Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE POLYMORPHISM; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; LARGE-SCALE; POPULATIONS; DISEASE; HERITABILITY; SEGREGATION; NIGERIANS; PEDIGREES	Considerable effort has been expended to determine whether the gene for angiotensin I-converting enzyme (ACE) confers susceptibility to cardiovascular disease. In this study, we genotyped 13 polymorphisms in the ACE gene in 1,343 Nigerians from 332 families. To localize the genetic effect, we first performed linkage and association analysis of all the markers with ACE concentration. In multipoint variance-component analysis, this region was strongly linked to ACE concentration (maximum LOD score 7.5). Likewise, most of the polymorphisms in the ACE gene were significantly associated with ACE (P < .0013). The two most highly associated polymorphisms, ACE4 and ACE8, accounted for 6% and 19% of the variance in ACE, respectively. A two-locus additive model with an additive x additive interaction of these polymorphisms explained most of the ACE variation associated with this region. We next analyzed the relationship between these two polymorphisms (ACE4 and ACE8) and blood pressure (BP). Although no evidence of linkage was detected, significant association was found for both systolic and diastolic BP when a two-locus additive model developed for ACE concentration was used. Further analyses demonstrated that an epistasis model provided the best fit to the BP variation. In conclusion, we found that the two polymorphisms explaining the greatest variation in ACE concentration are significantly associated with BP, through interaction, in this African population sample. Our study also demonstrates that greater statistical power can be anticipated with association analysis versus linkage, when markers in strong linkage disequilibrium with a trait locus have been identified. Furthermore, allelic interaction may play an important role in the dissection of complex traits such as BP.	Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; Univ Oxford, Dept Biol Anthropol, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Ibadan, Coll Med, Inst Child Hlth, Dept Pediat, Ibadan, Nigeria; Univ W Indies, Trop Metab Res Unit, Mona, Jamaica; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Loyola University Chicago; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Ibadan; University West Indies Mona Jamaica; Case Western Reserve University	Zhu, XF (corresponding author), Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, 2160 S 1st Ave, Maywood, IL 60153 USA.		Zhu, Xiaofeng/O-6874-2019	Adeyemo, Adebowale/0000-0002-3105-3231; Zhu, Xiaofeng/0000-0003-0037-411X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL045508, R01HL047910, R01HL045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03655, P41 RR003655] Funding Source: Medline; NHLBI NIH HHS [HL45508, HL 47910, R37 HL045508] Funding Source: Medline; NIGMS NIH HHS [GM28356, R01 GM028356, R37 GM028356] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arca M, 1998, EUR J CLIN INVEST, V28, P485; Barley J, 1996, J HUM HYPERTENS, V10, P31; Borecki IB, 1997, ANN EPIDEMIOL, V7, P13, DOI 10.1016/S1047-2797(97)00155-5; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper R, 1998, J HYPERTENS, V16, P571, DOI 10.1097/00004872-199816050-00003; Cooper RS, 1999, SCI AM, V280, P56, DOI 10.1038/scientificamerican0299-56; Cooper RS, 2000, HYPERTENSION, V35, P1141, DOI 10.1161/01.HYP.35.5.1141; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; EVANS AE, 1994, Q J MED, V87, P211; Ferrieres J, 1999, ATHEROSCLEROSIS, V142, P211, DOI 10.1016/S0021-9150(98)00204-4; Fornage M, 1998, CIRCULATION, V97, P1773, DOI 10.1161/01.CIR.97.18.1773; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; Guo X, 1999, ANN HUM GENET, V63, P293, DOI 10.1046/j.1469-1809.1999.6340293.x; Kaufman JS, 1997, HYPERTENSION, V30, P1511, DOI 10.1161/01.HYP.30.6.1511; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Keavney B, 2000, LANCET, V355, P434; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; MORISE T, 1994, LANCET, V343, P125, DOI 10.1016/S0140-6736(94)90859-1; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; O'Malley JP, 1999, CURR OPIN LIPIDOL, V10, P407, DOI 10.1097/00041433-199910000-00005; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rotimi CN, 1999, HYPERTENSION, V33, P874, DOI 10.1161/01.HYP.33.3.874; *S A G E, 2000, STAT AN GEN EP REL 4; SCHMIDT S, 1993, J HYPERTENS, V11, P345, DOI 10.1097/00004872-199304000-00003; SOUBRIER F, 1994, EUR HEART J, V15, P24, DOI 10.1093/eurheartj/15.suppl_D.24; TIRET L, 1992, AM J HUM GENET, V51, P197; Vassilikioti S, 1996, AM J HYPERTENS, V9, P700, DOI 10.1016/0895-7061(95)00449-1; Villard E, 1996, AM J HUM GENET, V58, P1268; Weir B., 1996, GENETIC DATA ANAL; Zhu XF, 2000, AM J HUM GENET, V67, P1144	32	215	237	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1139	1148		10.1086/320104	http://dx.doi.org/10.1086/320104			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283791	Green Published, Bronze			2022-12-18	WOS:000168171200008
J	Allikmets, R				Allikmets, R		Int ABCR Screening Consortium	Further evidence for an association of ABCR alleles with age-related macular degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASSETTE TRANSPORTER GENE; STARGARDT-DISEASE; GEL-ELECTROPHORESIS; DNA; MACULOPATHY; MUTATIONS; SYSTEM	Age-related macular degeneration (AMD) accounts for >50% of the registered visual disability among North American and Western European populations and has been associated both with environmental factors, such as smoking, and with genetic factors. Previously we have reported disease-associated variants in the ABCR (also called ABCA4) gene in a subset of patients affected with this complex disorder. We have now tested our original hypothesis, that ABCR is a dominant susceptibility locus for AMD, by screening 1,218 unrelated AMD patients of North American and Western European origin and 1,258 comparison individuals from 15 centers in North America and Europe for the two most frequent AMD-associated variants found in ABCR. These two sequence changes, G1961E and D2177N, were found in one allele of ABCR in 40 patients (similar to 3.4%), and in 13 control subjects (similar to 0.95%). Fisher's two-sided exact test confirmed that these two variants are associated with AMD at a statistically significant level (P < .0001). The risk of AMD is elevated approximately threefold in D2177N carriers and approximately fivefold in G1961E carriers. The identification of a gene that confers risk of AMD is an important step in unraveling this complex disorder.	Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Allikmets, R (corresponding author), Columbia Univ, Dept Ophthalmol, Eye Res Addit,Room 715,630 W 168th St, New York, NY 10032 USA.		Zhang, Kang/Y-2740-2019; Martin, Rosa Maria Coco/H-4511-2015; Balcells, Susana/C-5222-2017; Allikmets, Rando/ABD-4533-2021; Testa, Francesco/J-3185-2012; Dean, Michael/G-8172-2012	Zhang, Kang/0000-0002-4549-1697; Martin, Rosa Maria Coco/0000-0002-1811-1417; Balcells, Susana/0000-0003-1211-1907; Mannik, Jaana/0000-0002-0777-7846; Udar, Nitin/0000-0001-8533-9190; Bergen, Arthur/0000-0002-6333-9576; Dean, Michael/0000-0003-2234-0631; Shroyer, Noah/0000-0002-5934-2852; Simonelli, Francesca/0000-0001-8520-6769; Testa, Francesco/0000-0002-1482-1577				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DENG G, 1988, NUCLEIC ACIDS RES, V16, P6231, DOI 10.1093/nar/16.13.6231; DRYJA T, 1998, ABCR GENE AGE RELATE; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Mata NL, 2000, INVEST OPHTH VIS SCI, V41, pS144; MEHTA C, 1995, STATXACT3 WINDOWS US, pCH13; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Souied EH, 1999, AM J OPHTHALMOL, V128, P173, DOI 10.1016/S0002-9394(99)00145-2; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sunness JS, 1999, OPHTHALMOLOGY, V106, P910, DOI 10.1016/S0161-6420(99)00509-6; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P2005; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	23	215	227	4	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					487	491		10.1086/303018	http://dx.doi.org/10.1086/303018			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10880298	Green Published, Bronze			2022-12-18	WOS:000089357800023
J	Ober, C; Leavitt, SA; Tsalenko, A; Howard, TD; Hoki, DM; Daniel, R; Newman, DL; Wu, XD; Parry, R; Lester, LA; Solway, J; Blumenthal, M; King, RA; Xu, JF; Meyers, DA; Bleecker, ER; Cox, NJ				Ober, C; Leavitt, SA; Tsalenko, A; Howard, TD; Hoki, DM; Daniel, R; Newman, DL; Wu, XD; Parry, R; Lester, LA; Solway, J; Blumenthal, M; King, RA; Xu, JF; Meyers, DA; Bleecker, ER; Cox, NJ			Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; IL4-RECEPTOR GENE; ILE50VAL VARIANT; IGE SYNTHESIS; ASSOCIATION; RECEPTOR; POLYMORPHISMS; ALLERGENS	After a genomewide screen in the Hutterites was completed, the IL4RA gene was examined as the 16p-linked susceptibility locus for asthma and atopy. Seven known variants and one novel variant, representing all nonsynonymous substitutions in the mature protein, were examined in the Hutterites; on the basis of studies in the Hutterites, outbred white, black, and Hispanic families were genotyped for selected markers. All population samples showed evidence of association to atopy or to asthma (P values .039-.0044 for atopy and .029-.0000061 for asthma), but the alleles or haplotypes showing the strongest evidence differed between the groups. Overall, these data suggest that the IL4RA gene is an atopy- and asthma-susceptibility locus but that variation outside the coding region of the gene influences susceptibility.	Univ Chicago, Dept Human Genet, Chicago, IL 60636 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Maryland, Genet Asthma Ctr, Baltimore, MD 21201 USA; Univ S Dakota, Dept Med, Sioux Falls, SD USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Chicago; University of Chicago; University of Chicago; University System of Maryland; University of Maryland Baltimore; University of South Dakota; University of Minnesota System; University of Minnesota Twin Cities	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60636 USA.	carole@genetics.uchicago.edu	Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	NHLBI NIH HHS [HL56399, U01 HL049596, U01 HL049602, HL49602, P50 HL056399] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049602, P50HL056399, U01HL049596] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLUMENTHAL MN, 1995, CLIN EXP ALLERGY, V25, P29, DOI 10.1111/j.1365-2222.1995.tb00416.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Deichmann K, 1997, BIOCHEM BIOPH RES CO, V231, P696, DOI 10.1006/bbrc.1997.6115; Deichmann KA, 1998, CLIN EXP ALLERGY, V28, P151; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Howard TD, 1999, BIOTECHNIQUES, V26, P380, DOI 10.2144/99263bm01; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kruse S, 1999, IMMUNOLOGY, V96, P365; MAK TW, 1998, HDB IMMUNE RESPONSE; Marsh DG, 1997, NAT GENET, V15, P389; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Mitsuyasu H, 1999, J IMMUNOL, V162, P1227; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Ober C, 1999, CLIN EXP ALLERGY, V29, P11; Oefner P. J., 1995, American Journal of Human Genetics, V57, pA266; PLATTSMILLS TAE, 1991, INT ARCH ALLER A IMM, V94, P339, DOI 10.1159/000235398; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; SHIRAKAWA T, IN PRESS IMMUNOL TOD; Sobel E, 1996, IMA VOLUMES MATH ITS, V81, P89; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	32	215	228	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					517	526		10.1086/302781	http://dx.doi.org/10.1086/302781			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677312	Green Published, Bronze			2022-12-18	WOS:000088373100019
J	Sampson, JR; Maheshwar, MM; Aspinwall, R; Thompson, P; Cheadle, JP; Ravine, D; Roy, S; Haan, E; Bernstein, J; Harris, PC				Sampson, JR; Maheshwar, MM; Aspinwall, R; Thompson, P; Cheadle, JP; Ravine, D; Roy, S; Haan, E; Bernstein, J; Harris, PC			Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CREATININE; MUTATIONS; DELETION; PROTEIN; MARKER	Tuberous sclerosis is an autosomal dominant trait characterized by the development of hamartomatous growths in many organs. Renal cysts are also a frequent manifestation. Major genes for tuberous sclerosis and autosomal dominant polycystic kidney disease, TSC2 and PKD1, respectively, lie adjacent to each other at chromosome 16p13.3, suggesting a role for PKD1 in the etiology of renal cystic disease in tuberous sclerosis. We studied 27 unrelated patients with tuberous sclerosis and renal cystic disease. Clinical histories and radiographic features were reviewed, and renal function was assessed. We sought mutations at the TSC2 and PKD1 loci, using pulsed field-and conventional-gel electrophoresis and FISH. Twenty-two patients had contiguous deletions of TSC2 and PKD1. In 17 patients with constitutional deletions, cystic disease was severe, with early renal insufficiency. One patient with deletion of TSC2 and of only the 3' UTR of PKD1 had few cysts. Four patients were somatic mosaics; the severity of their cystic disease varied considerably. Mosaicism and mild cystic disease also were demonstrated in parents of 3 of the constitutionally deleted patients. Five patients without contiguous deletions had relatively mild cystic disease, 3 of whom had gross rearrangements of TSC2 and 2 in whom no mutation was identified. Significant renal cystic disease in tuberous sclerosis usually reflects mutational involvement of the PKD1 gene, and mosaicism for large deletions of TSC2 and PKD1 is a frequent phenomenon.	UNIV WALES COLL MED, INST MED GENET, CARDIFF CF4 4XN, S GLAM, WALES; JOHN RADCLIFFE HOSP, INST MOL MED, OXFORD OX3 9DU, ENGLAND; INST CHILD HLTH, LONDON, ENGLAND; WOMENS & CHILDRENS HOSP, CTR GENET MED, ADELAIDE, SA, AUSTRALIA; WILLIAM BEAUMONT HOSP, ROYAL OAK, MI 48072 USA	Cardiff University; University of Oxford; University of London; University College London; Womens & Childrens Hospital Australia; Beaumont Health			Ravine, David/A-6797-2008					BERNSTEIN J, 1993, PEDIATR NEPHROL, V7, P490, DOI 10.1007/BF00857581; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; CAMPOS A, 1993, J UROLOGY, V149, P1077, DOI 10.1016/S0022-5347(17)36300-0; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cook JA, 1996, J MED GENET, V33, P480, DOI 10.1136/jmg.33.6.480; CREE JE, 1969, P ROY SOC MED, V62, P327, DOI 10.1177/003591576906200410; ELKIN M, 1969, Clinical Radiology, V20, P65, DOI 10.1016/S0009-9260(69)80061-9; *EUR CHROM 16 TUB, CELL, V75, P1305; FRYER AE, 1987, LANCET, V1, P659; Gomez MR, 1988, TUBEROUS SCLEROSIS; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; MCCRORY W W, 1972, DEV NEPHROLOGY; OCALLAGHAN TJ, 1975, ARCH INTERN MED, V135, P1082, DOI 10.1001/archinte.135.8.1082; Peral B, 1996, AM J HUM GENET, V58, P86; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; ROACH ES, 1992, J CHILD NEUROL, V7, P221, DOI 10.1177/088307389200700219; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; STAPLETON FB, 1980, J PEDIATR-US, V97, P574, DOI 10.1016/S0022-3476(80)80011-4; Torres V E, 1994, Adv Nephrol Necker Hosp, V23, P43; TURCO AE, 1995, HUM MOL GENET, V4, P1331, DOI 10.1093/hmg/4.8.1331; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WARD CJ, 1994, CELL, V77, P881; WEBB DW, 1993, BMJ-BRIT MED J, V306, P1258, DOI 10.1136/bmj.306.6887.1258; WENZL JE, 1970, J PEDIATR-US, V77, P673, DOI 10.1016/S0022-3476(70)80211-6	31	215	221	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					843	851		10.1086/514888	http://dx.doi.org/10.1086/514888			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382094	Green Published, Bronze			2022-12-18	WOS:A1997YA59100010
J	Antic, D; Keene, JD				Antic, D; Keene, JD			Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGEN; 3' UNTRANSLATED REGION; CELL LUNG-CARCINOMA; AU-RICH ELEMENTS; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; 3'-UNTRANSLATED REGION; LOCUS ELAV; IN-VITRO; DEGRADATION		DUKE UNIV, MED CTR, DEPT MICROBIOL, DURHAM, NC 27710 USA	Duke University								Abe R, 1996, NUCLEIC ACIDS RES, V24, P2011, DOI 10.1093/nar/24.11.2011; Abe R, 1996, NUCLEIC ACIDS RES, V24, P4895, DOI 10.1093/nar/24.24.4895; ANDERSON NE, 1987, CRIT REV NEUROBIOL, V3, P245; ANDREWS LD, 1997, ANAL MRNA FORMATION, P237; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CAMPOS AR, 1985, J NEUROGENET, V2, P197, DOI 10.3109/01677068509100150; Chagnovich D, 1996, J BIOL CHEM, V271, P33587, DOI 10.1074/jbc.271.52.33587; CHAMBERS JC, 1988, J BIOL CHEM, V263, P18043; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chung SM, 1996, J BIOL CHEM, V271, P11518, DOI 10.1074/jbc.271.19.11518; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; Conrad RC, 1996, METHOD ENZYMOL, V267, P336; DALMAU J, 1990, ANN NEUROL, V27, P544, DOI 10.1002/ana.410270515; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; FITZWATER T, 1996, COMBINATORIAL CHEM, V267, P275; Gao FB, 1996, J CELL SCI, V109, P579; GAO FB, 1994, P NATL ACAD SCI USA, V91, P11207, DOI 10.1073/pnas.91.23.11207; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; JANDA KD, 1994, P NATL ACAD SCI USA, V91, P10779, DOI 10.1073/pnas.91.23.10779; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Keene JD, 1996, METHOD ENZYMOL, V267, P367; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KENAN DJ, 1994, TRENDS BIOCHEM SCI, V19, P57, DOI 10.1016/0968-0004(94)90033-7; KIM YJ, 1993, J NEUROSCI, V13, P1045; King PH, 1996, ANN NEUROL, V39, P679, DOI 10.1002/ana.410390520; KING PH, 1994, GENE, V151, P261, DOI 10.1016/0378-1119(94)90668-8; KING PH, 1994, J NEUROSCI, V14, P1943; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; LIU J, 1995, NEUROLOGY, V45, P544, DOI 10.1212/WNL.45.3.544; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Okano HJ, 1997, J NEUROSCI, V17, P3024; PACHTER JS, 1987, CELL, V51, P283, DOI 10.1016/0092-8674(87)90155-3; PERRON M, 1995, MECH DEVELOP, V51, P235, DOI 10.1016/0925-4773(95)00368-1; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; SAKAI K, 1994, BIOCHEM BIOPH RES CO, V199, P1200, DOI 10.1006/bbrc.1994.1358; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; SEKIDO Y, 1994, CANCER RES, V54, P4988; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SIVE HL, 1984, MOL CELL BIOL, V4, P2723, DOI 10.1128/MCB.4.12.2723; Steller U, 1996, MOL BRAIN RES, V35, P285, DOI 10.1016/0169-328X(95)00231-G; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; TSAI DE, 1991, NUCLEIC ACIDS RES, V19, P4931, DOI 10.1093/nar/19.18.4931; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; [No title captured]	59	215	222	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					273	278		10.1086/514866	http://dx.doi.org/10.1086/514866			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311730	Bronze, Green Published			2022-12-18	WOS:A1997XX70100003
J	Vasa-Nicotera, M; Brouilette, S; Mangino, M; Thompson, JR; Braund, P; Clemitson, JR; Mason, A; Bodycote, CL; Raleigh, SM; Louis, E; Samani, NJ				Vasa-Nicotera, M; Brouilette, S; Mangino, M; Thompson, JR; Braund, P; Clemitson, JR; Mason, A; Bodycote, CL; Raleigh, SM; Louis, E; Samani, NJ			Mapping of a major locus that determines telomere length in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PULSE PRESSURE; CHROMOSOME; MATTER; YEAST; SIZE; GENE	Telomere length is a crucial factor for both normal chromosomal function and senescence. Mean telomere length in humans shows considerable interindividual variation and strong genetic determination. To see if a locus ( or loci) affecting telomere length in humans could be mapped, we performed a quantitative-trait linkage analysis of mean leukocyte telomere-restriction-fragment (TRF) lengths, measured by Southern blotting, in 383 adult subjects comprising 258 sib pairs. Heritability of mean (+/- SE) TRF was 81.9% +/- 11.8%. There was significant linkage (LOD score 3.20) of mean TRF length to a locus on chromosome 12, which explained 49% of the overall variability in mean TRF length. We present preliminary analysis of a strong candidate gene in the region, the DNA helicase DDX11. In conclusion, we report mapping of the first locus that determines mean telomere length in humans. Identification of the gene involved and elucidation of its mechanism of action could have important implications for our understanding of chromosomal assembly, telomere biology, and susceptibility to age-related diseases.	Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester; University of Leicester	Samani, NJ (corresponding author), Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Clin Sci Wing, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Mangino, Massimo/F-5134-2011; Louis, Edward/B-7920-2008	Mangino, Massimo/0000-0002-2167-7470; Louis, Edward/0000-0003-1157-3608; Nicotera, Mariuca/0000-0002-6794-4941; raleigh, stuart/0000-0002-8882-0040				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	15	214	217	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					147	151		10.1086/426734	http://dx.doi.org/10.1086/426734			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15520935	Bronze, Green Published			2022-12-18	WOS:000225643600013
J	Hamblin, MT; Thompson, EE; Di Rienzo, A				Hamblin, MT; Thompson, EE; Di Rienzo, A			Complex signatures of natural selection at the Duffy blood group locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; MOLECULAR EVOLUTION; CHEMOKINE RECEPTOR; POSITIVE SELECTION; STATISTICAL-METHOD; MALE REPRODUCTION; GENE; POPULATION; DROSOPHILA; HITCHHIKING	The Duffy blood group locus (FY) has long been considered a likely target of natural selection, because of the extreme pattern of geographic differentiation of its three major alleles (FY* B, FY* A, and FY* O). In the present study, we resequenced the FY region in samples of Hausa from Cameroon (fixed for FY* O), Han Chinese (fixed for FY* A), Italians, and Pakistanis. Our goals were to characterize the signature of directional selection on FY* O in sub-Saharan Africa and to understand the extent to which natural selection has also played a role in the extreme geographic differentiation of the other derived allele at this locus, FY* A. The data from the FY region are compared with the patterns of variation observed at 10 unlinked, putatively neutral loci from the same populations, as well as with theoretical expectations from the neutral-equilibrium model. The FY region in the Hausa shows evidence of directional selection in two independent properties of the data (i.e., level of sequence variation and frequency spectrum), observations that are consistent with the FY* O mutation being the target. The Italian and Chinese FY data show patterns of variation that are very unusual, particularly with regard to frequency spectrum and linkage disequilibrium, but do not fit the predictions of any simple model of selection. These patterns may represent a more complex and previously unrecognized signature of positive selection.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	dirienzo@genetics.uchicago.edu		Di Rienzo, Anna/0000-0002-8982-9098	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002098] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG02098] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AGUADE M, 1992, GENETICS, V132, P755; Andolfatto P, 1999, GENETICS, V153, P1297; [Anonymous], 1984, AM NAT; BERRY A, 1993, GENETICS, V134, P869; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Chen Y, 2000, GENETICS, V155, P1185; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; Fay JC, 2000, GENETICS, V155, P1405; FLINT J, 1993, HUM GENET, V91, P91; Ford MJ, 2000, MOL ECOL, V9, P843, DOI 10.1046/j.1365-294x.2000.00933.x; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, IN PRESS GENETICS; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; KIM Y, IN PRESS GENETICS; LEWONTIN RC, 1973, GENETICS, V74, P175; Liu XH, 1999, KIDNEY INT, V55, P1491, DOI 10.1046/j.1523-1755.1999.00385.x; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Luo H, 2000, MOL CELL BIOL, V20, P3097, DOI 10.1128/MCB.20.9.3097-3101.2000; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Pease JE, 1998, SEMIN IMMUNOL, V10, P169, DOI 10.1006/smim.1998.0129; POWARS DR, 1989, ANN NY ACAD SCI, V565, P262, DOI 10.1111/j.1749-6632.1989.tb24174.x; PRZEWORSKI M, IN PRESS GENETICS; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Slatkin M, 1998, GENET RES, V71, P155, DOI 10.1017/S001667239800319X; Stephan W, 1998, P NATL ACAD SCI USA, V95, P5649, DOI 10.1073/pnas.95.10.5649; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; TAYLOR MFJ, 1995, SCIENCE, V270, P1497, DOI 10.1126/science.270.5241.1497; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; TOWN M, 1992, HUM MOL GENET, V1, P171, DOI 10.1093/hmg/1.3.171; Tsaur SC, 1997, MOL BIOL EVOL, V14, P544, DOI 10.1093/oxfordjournals.molbev.a025791; Tsaur SC, 1998, MOL BIOL EVOL, V15, P1040, DOI 10.1093/oxfordjournals.molbev.a026002	45	214	223	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					369	383		10.1086/338628	http://dx.doi.org/10.1086/338628			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11753822	Bronze, Green Published			2022-12-18	WOS:000173254300010
J	Picard, C; Fieschi, C; Altare, F; Al-Jumaah, S; Al-Hajjar, S; Feinberg, J; Dupuis, S; Soudais, C; Al-Mohsen, IZ; Genin, E; Lammas, D; Kumararatne, DS; Leclerc, T; Rafii, A; Frayha, H; Murugasu, B; Wah, LB; Sinniah, R; Loubser, M; Okamoto, E; Al-Ghonaium, A; Tufenkeji, H; Abel, L; Casanova, JL				Picard, C; Fieschi, C; Altare, F; Al-Jumaah, S; Al-Hajjar, S; Feinberg, J; Dupuis, S; Soudais, C; Al-Mohsen, IZ; Genin, E; Lammas, D; Kumararatne, DS; Leclerc, T; Rafii, A; Frayha, H; Murugasu, B; Wah, LB; Sinniah, R; Loubser, M; Okamoto, E; Al-Ghonaium, A; Tufenkeji, H; Abel, L; Casanova, JL			Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERFERON-GAMMA-RECEPTOR; BACILLE CALMETTE-GUERIN; IFN-GAMMA; PROTECTIVE IMMUNITY; COMPLEX INFECTION; MYCOBACTERIAL; MUTATION; CHILD; IL-12; SUSCEPTIBILITY	Interleukin-12 (IL12) is a cytokine that is secreted by activated phagocytes and dendritic cells and that induces interferon-gamma production by natural-killer and T lymphocytes. It consists of two subunits, p35 and p40, which are encoded by IL12A and IL12B, respectively. The first reported patient with a genetic cytokine disorder was a Pakistani child, who was homozygous for a large loss-of-function deletion (g. 482+ 82_ 856-854del) in IL12B. This IL12-deficient child suffered from infections caused by bacille Calmette-Guerin (BCG) and Salmonella enteritidis. We herein report 12 additional patients from five other kindreds. In one kindred from India, the same large deletion that was described elsewhere (g. 482+ 82_ 856-854del) was identified. In four kindreds from Saudi Arabia, a recessive loss-of-function frameshift insertion (g. 315_ 316insA) was found. A conserved haplotype encompassing the IL12B gene suggested that a founder effect accounted for the recurrence of each mutation. The two founder mutational events-g. 482+ 82_ 856-854del and g. 315_ 316insA- were estimated to have occurred 700 and 1,100 years ago, respectively. Among a total of 13 patients with IL12 deficiency, 1 child had salmonellosis only and 12 suffered from clinical disease due to BCG or environmental nontuberculous mycobacteria. One patient also had clinical disease caused by virulent Mycobacterium tuberculosis, five patients had clinical disease caused by Salmonella serotypes, and one patient had clinical disease caused by Nocardia asteroides. The clinical outcome varies from case to case, since five patients (aged 2-11 years) died of overwhelming infection, whereas eight patients (aged 3-12 years) are still in good health and are not currently taking antibiotics. In conclusion, IL12 deficiency is not limited to a single kindred, shows significant variability of outcome, and should be considered in the genetic diagnosis of patients with mycobacteriosis and/or salmonellosis. To date, two founder IL12B mutations have been identified, accounting for the recurrence of a large deletion and a small insertion within populations from the Indian subcontinent and from the Arabian Peninsula, respectively.	Univ Paris 05, Fac Med Necker, INSERM,U550, Lab Genet Humaine Malad Infect, F-75015 Paris, France; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, Paris, France; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; Secur Forces Hosp, Dept Paediat, Riyadh, Saudi Arabia; INSERM, U535, F-94275 Le Kremlin Bicetre, France; Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England; Addenbrookes Hosp Natl Hlth Serv Trust, Dept Clin Immunol, Cambridge, England; Natl Univ Singapore Hosp, Dept Paediat, Singapore 117548, Singapore; Natl Univ Singapore Hosp, Dept Pathol, Singapore 117548, Singapore	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; King Faisal Specialist Hospital & Research Center; Security Forces Hospital - Saudi Arabia; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; National University of Singapore; National University of Singapore	Casanova, JL (corresponding author), Univ Paris 05, Fac Med Necker, INSERM,U550, Lab Genet Humaine Malad Infect, 156 Rue Vaugirard, F-75015 Paris, France.	casanova@necker.fr	Boisson-Dupuis, Stephanie/AAF-5066-2021; Rafii, Arash/E-4106-2013; Picard, Capucine/H-3914-2017; altare, frederic/K-8664-2015; Genin, Emmanuelle/C-4974-2013; soudais, claire/F-9756-2016; Boisson-Dupuis, Stéphanie/I-2040-2017; Casanova, Jean-Laurent/I-3418-2017; Abel, Laurent/H-8888-2017	Picard, Capucine/0000-0001-8788-5056; altare, frederic/0000-0002-5077-4616; Genin, Emmanuelle/0000-0003-4117-2813; soudais, claire/0000-0002-4387-6649; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Abel, Laurent/0000-0001-7016-6493; Casanova, Jean-Laurent/0000-0002-7782-4169; Al jumaah, Suliman/0000-0002-5526-1174				Abel L, 2000, AM J HUM GENET, V67, P274, DOI 10.1086/303033; Aksu G, 2001, PEDIATR INFECT DIS J, V20, P551, DOI 10.1097/00006454-200105000-00021; Allende LM, 2001, CLIN DIAGN LAB IMMUN, V8, P133, DOI 10.1128/CDLI.8.1.133-137.2001; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Altare F, 2001, J INFECT DIS, V184, P231, DOI 10.1086/321999; CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Casanova JL, 1996, PEDIATRICS, V98, P774; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Cunningham JA, 2000, INT J TUBERC LUNG D, V4, P791; de Jong R, 1998, SCIENCE, V280, P1435; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Doherty TM, 1998, J IMMUNOL, V160, P5428; Dorman SE, 1999, J PEDIATR-US, V135, P640, DOI 10.1016/S0022-3476(99)70064-8; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; DORMAN SF, 2000, 2 ANN M ASS PAT OR R; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; Frucht DM, 1999, CLIN IMMUNOL, V91, P234, DOI 10.1006/clim.1999.4688; Frucht DM, 1996, J IMMUNOL, V157, P411; Guo SW, 1997, HUM HERED, V47, P315, DOI 10.1159/000154431; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; McKusick V.A., 1998, MENDELIAN INHERITANC; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Murugasu B, 1988, J Singapore Paediatr Soc, V30, P139; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Piccolo F, 1996, HUM MOL GENET, V5, P2019, DOI 10.1093/hmg/5.12.2019; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Roesler J, 1999, EXP HEMATOL, V27, P1368, DOI 10.1016/S0301-472X(99)00077-6; Sakai T, 2001, BLOOD, V97, P2688, DOI 10.1182/blood.V97.9.2688; Silva RA, 2001, IMMUNOLOGY, V103, P368, DOI 10.1046/j.1365-2567.2001.01237.x; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Uzel G, 2000, PEDIATRICS, V106, P835, DOI 10.1542/peds.106.4.835; Verhagen CE, 2000, J EXP MED, V192, P517, DOI 10.1084/jem.192.4.517; Villella A, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e47; Wakeham J, 1998, J IMMUNOL, V160, P6101; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	52	214	218	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					336	348		10.1086/338625	http://dx.doi.org/10.1086/338625			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11753820	Bronze, Green Published			2022-12-18	WOS:000173254300007
J	Maugeri, A; van Driel, MA; van de Pol, DJR; Klevering, BJ; van Haren, FJJ; Tijmes, N; Bergen, AAB; Rohrschneider, K; Blankenagel, A; Pinckers, AJLG; Dahl, N; Brunner, HG; Deutman, AF; Hoyng, CB; Cremers, FPM				Maugeri, A; van Driel, MA; van de Pol, DJR; Klevering, BJ; van Haren, FJJ; Tijmes, N; Bergen, AAB; Rohrschneider, K; Blankenagel, A; Pinckers, AJLG; Dahl, N; Brunner, HG; Deutman, AF; Hoyng, CB; Cremers, FPM			The 2588G -> C mutation in the ABCR gene is a mild frequent founder mutation in the western European population and allows the classification of ABCR mutations in patients with Stargardt disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; PHOTORECEPTOR RIM PROTEIN; LINKED MIXED DEAFNESS; FUNDUS-FLAVIMACULATUS; MACULAR DYSTROPHY; CHROMOSOME 1P; TRANSPORTER; MAPS; IDENTIFICATION; FAMILIES	In 40 western European patients with Stargardt disease (STGD), we found 19 novel mutations in the retina-specific ATP-binding cassette transporter (ABCR) gene, illustrating STGD's high allelic heterogeneity. One mutation, 2588G-->C, identified in 15 (37.5%) patients, shows linkage disequilibrium with a rare polymorphism (2828G-->A) in exon 19, suggesting a founder effect. The guanine at position 2588 is part of the 3' splice site of exon 17. Analysis of the lymphoblastoid cell mRNA of two STGD patients with the 2588G-->C mutation shows that the resulting mutant ABCR proteins either lack Gly863 or contain the missense mutation Gly863Ala. We hypothesize that the 2588G-->C alteration is a mild mutation that causes STGD only in combination with a severe ABCR mutation. This is supported in that the accompanying ABCR mutations in at least five of eight STGD patients are null (severe) and that a combination of two mild mutations has not been observed among 68 STGD patients. The 2588G-->C mutation is present in 1 of every 35 western Europeans, a rate higher than that of the most frequent severe autosomal recessive mutation, the cystic fibrosis conductance regulator gene mutation Delta Phe508. Given an STGD incidence;of 1/10,000, homozygosity for the 2588G-->C mutation or compound heterozygosity for this and other mild ABCR mutations probably does not result in an STGD phenotype.	Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; Univ Heidelberg, Augenklin, Heidelberg, Germany; Univ Uppsala, Childrens Hosp, Dept Genet & Pathol, Clin Genet Unit, Uppsala, Sweden	Radboud University Nijmegen; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Uppsala University	Maugeri, A (corresponding author), Univ Nijmegen Hosp, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Klevering, B.J./L-4434-2015; Bergen, Arthur/J-3637-2013; Brunner, Han/C-9928-2013; Cremers, Frans/A-5625-2014; van Driel, Marc/D-5844-2013; Hoyng, C.B./H-8050-2014	Cremers, Frans/0000-0002-4954-5592; Rohrschneider, Klaus/0000-0003-1996-7935; Bergen, Arthur/0000-0002-6333-9576				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; ANDERSON KL, 1995, AM J HUM GENET, V57, P1351; Azarian SM, 1998, HUM GENET, V102, P699, DOI 10.1007/s004390050765; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Blacharski P.A., 1988, RETINAL DYSTROPHY DE, P135; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Dryja T. P., 1998, SCIENCE, V279; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Franceschetti A., 1963, ENTWICKLUNG FORTSCHR, P107; Gerber S, 1998, GENOMICS, V48, P139, DOI 10.1006/geno.1997.5164; GERBER S, 1995, AM J HUM GENET, V56, P396; Hoyng CB, 1996, HUM GENET, V98, P500, DOI 10.1007/s004390050247; HUBER I, 1994, HUM MOL GENET, V3, P1151, DOI 10.1093/hmg/3.7.1151; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; Klugbauer N, 1996, FEBS LETT, V391, P61, DOI 10.1016/0014-5793(96)00700-4; LEWIS RA, IN PRESS AM J HUM GE; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; MartinezMir A, 1997, GENOMICS, V40, P142, DOI 10.1006/geno.1996.4528; NOBLE KG, 1979, ARCH OPHTHALMOL-CHIC, V97, P1281; Peelen T, 1997, AM J HUM GENET, V60, P1041; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; ROZET JM, 1997, AM J HUM GENET, V61, pA105; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; Tuerlings JHAM, 1998, FERTIL STERIL, V69, P899, DOI 10.1016/S0015-0282(98)00050-8; van Driel MA, 1998, OPHTHALMIC GENET, V19, P117, DOI 10.1076/opge.19.3.117.2187; Weber BHF, 1996, BRIT J OPHTHALMOL, V80, P745, DOI 10.1136/bjo.80.8.745	33	214	227	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1024	1035		10.1086/302323	http://dx.doi.org/10.1086/302323			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090887	Green Published, Bronze			2022-12-18	WOS:000079632900013
J	Gayan, J; Smith, SD; Cherny, SS; Cardon, LR; Fulker, DW; Brower, AM; Olson, RK; Pennington, BF; DeFries, JC				Gayan, J; Smith, SD; Cherny, SS; Cardon, LR; Fulker, DW; Brower, AM; Olson, RK; Pennington, BF; DeFries, JC			Quantitative-trait locus for specific language and reading deficits on chromosome 6p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-REGRESSION ANALYSIS; SIB-PAIR ANALYSIS; DEVELOPMENTAL DYSLEXIA; PHONOLOGICAL AWARENESS; LINKAGE ANALYSIS; TWIN DATA; DISABILITY; REGION; MODEL	Reading disability (RD), or dyslexia, is a complex cognitive disorder manifested by difficulties in learning to read, in otherwise normal individuals. Individuals with RD manifest deficits in several reading and language skills. Previous research has suggested the existence of a quantitative-trait locus (QTL) for RD on the short arm of chromosome 6. In the present study, RD subjects' performance in several measures of word recognition and component skills of orthographic coding, phonological decoding, and phoneme awareness were individually subjected to QTL analysis, with a new sample of 126 sib pairs, by means of a multipoint mapping method and eight informative DNA markers on chromosome 6 (D6S461, D6S276, D6S105, D6S306, D6S258, D6S439, D6S291, and D6S1019). The results indicate significant linkage across a distance of at least 5 cM for deficits in orthographic (LOD = 3.10) and phonological (LOD = 2.42) skills, confirming previous findings.	Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Boys Town Natl Res Hosp, Ctr Hereditary Commun Disorders, Omaha, NE 68131 USA; Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Denver, Dept Psychol, Denver, CO USA	University of Colorado System; University of Colorado Boulder; Boys Town National Research Hospital; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Denver	Gayan, J (corresponding author), Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.		Cherny, Stacey S/B-3315-2008	Cherny, Stacey S/0000-0002-0269-3352	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD011681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P60DA011015] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-11681, P50 HD027802, HD-27802] Funding Source: Medline; NIDA NIH HHS [DA-11015] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wellcome Trust(Wellcome TrustEuropean Commission)		BRUCK M, 1992, DEV PSYCHOL, V28, P874, DOI 10.1037/0012-1649.28.5.874; Burt MJ, 1996, GENOMICS, V33, P153, DOI 10.1006/geno.1996.0178; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CAREY G, 1991, AM J HUM GENET, V49, P786; DeFries J. C., 1997, LEARNING DISABILITIE, V8, P7; DEFRIES JC, 1988, ACTA GENET MED GEMEL, V37, P205, DOI 10.1017/S0001566000003810; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; Dunn L. M., 1970, EXAMINERS MANUAL PEA; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GAYAN J, 1995, BEHAV GENET, V25, P266; Gayan J, 1997, BEHAV GENET, V27, P589; Gessler DDG, 1996, AM J HUM GENET, V59, P1382; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Grigorenko EL, 1998, BEHAV GENET, V28, P470; Hall JM, 1996, GENOME RES, V6, P781, DOI 10.1101/gr.6.9.781; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOHNEN B, 1995, BEHAV GENET, V25, P271; Idury RM, 1997, GENOME RES, V7, P1104, DOI 10.1101/gr.7.11.1104; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LEFLY DL, 1991, ANN DYSLEXIA, V41, P143, DOI 10.1007/BF02648083; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; Malfroy L, 1997, GENOMICS, V43, P226, DOI 10.1006/geno.1997.4800; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; Olson R., 1994, FRAMES REFERENCE ASS, P243; OLSON RK, IN PRESS CONVERGING; OLSON RK, 1994, VARIETIES ORTHOGRAPH, V1, P27; OLSON RK, 1985, READING RES ADV THEO, P1; Pennington BF, 1997, AM J HUM GENET, V60, P13; RABIN M, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91384-X; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; SMITH SD, 1991, READ WRIT, V3, P285, DOI 10.1007/BF00354963; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; WAGNER RK, 1994, DEV PSYCHOL, V30, P73, DOI 10.1037/0012-1649.30.1.73; Wechsler D, 1981, EXAMINERS MANUAL WEC; Wechsler D, 1974, EXAMINERS MANUAL WEC; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WISE BW, 1995, ANN DYSLEXIA, V45, P99, DOI 10.1007/BF02648214	44	214	218	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					157	164		10.1086/302191	http://dx.doi.org/10.1086/302191			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	164RM	9915954	Green Published, Bronze			2022-12-18	WOS:000078477400020
J	Lin, ZM; Chen, Q; Lee, MY; Cao, X; Zhang, J; Ma, DL; Chen, L; Hu, XP; Wang, HJ; Wang, XW; Zhang, P; Liu, XZ; Guan, LP; Tang, YQ; Yang, HZ; Tu, P; Bu, DF; Zhu, XJ; Wang, KW; Li, RY; Yang, Y				Lin, Zhimiao; Chen, Quan; Lee, Mingyang; Cao, Xu; Zhang, Jie; Ma, Donglai; Chen, Long; Hu, Xiaoping; Wang, Huijun; Wang, Xiaowen; Zhang, Peng; Liu, Xuanzhu; Guan, Liping; Tang, Yiquan; Yang, Haizhen; Tu, Ping; Bu, Dingfang; Zhu, Xuejun; Wang, KeWei; Li, Ruoyu; Yang, Yong			Exome Sequencing Reveals Mutations in TRPV3 as a Cause of Olmsted Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							S4-S5 LINKER; ION CHANNELS; HAIR-GROWTH; HEAT; ACTIVATION; RODENTS; PROTEIN; DOMAIN; SKIN	Olmsted syndrome (OS) is a rare congenital disorder characterized by palmoplantar and periorificial keratoderma, alopecia in most cases, and severe itching. The genetic basis for OS remained unidentified. Using whole-exome sequencing of case-parents trios, we have identified a de novo missense mutation in TRPV3 that produces p.Gly573Ser in an individual with OS. Nucleotide sequencing of five additional affected individuals also revealed missense mutations in TRPV3 (which produced p.Gly573Ser in three cases and p.Gly573Cys and p.Trp692Gly in one case each). Encoding a transient receptor potential vanilloid-3 cation channel, TRPV3 is primarily expressed in the skin, hair follicles, brain, and spinal cord. In transfected HEK293 cells expressing TRPV3 mutants, much larger inward currents were recorded, probably because of the constitutive opening of the mutants. These gain-of-function mutations might lead to elevated apoptosis of keratinocytes and consequent skin hyperkeratosis in the affected individuals. Our findings suggest that TRPV3 plays essential roles in skin keratinization, hair growth, and possibly itching sensation in humans and selectively targeting TRPV3 could provide therapeutic potential for keratinization or itching-related skin disorders.	[Lin, Zhimiao; Chen, Quan; Lee, Mingyang; Zhang, Jie; Wang, Huijun; Wang, Xiaowen; Yang, Haizhen; Tu, Ping; Bu, Dingfang; Zhu, Xuejun; Li, Ruoyu; Yang, Yong] Peking Univ, Dept Dermatol, Hosp 1, Beijing 100034, Peoples R China; [Cao, Xu; Tang, Yiquan; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China; [Ma, Donglai] Beijing Union Med Coll Hosp, Dept Dermatol, Beijing 100005, Peoples R China; [Chen, Long] Wuhan 1 Hosp, Dept Dermatol, Wuhan 430022, Peoples R China; [Hu, Xiaoping] Peking Univ, Shenzhen Hosp, Dept Dermatol, Shenzhen 518036, Peoples R China; [Zhang, Peng; Liu, Xuanzhu; Guan, Liping] Beijing Genom Inst, Dept Mendelian Disorder Res, Shenzhen 518083, Peoples R China	Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University; Beijing Genomics Institute (BGI)	Li, RY (corresponding author), Peking Univ, Dept Dermatol, Hosp 1, Beijing 100034, Peoples R China.	lry0660@gmail.com; dryongyang@bjmu.edu.cn	wang, hui/GRS-4730-2022; Cao, Xu/G-6209-2015	Cao, Xu/0000-0003-1796-2735; Tang, Yiquan/0000-0002-6639-8897; Chen, Quan/0000-0002-2094-9868	National Natural Science Foundation of China [81071289, 30970919]; Program for New Century Excellent Talents [NCET06-0015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET))	We are grateful to the patients and their family members for participation in this study. We appreciate the helpful discussions with Yan Shen, Jie Ding, Yi Rao, and Stephen G. Waxman. This work was supported in part by National Natural Science Foundation of China (81071289 for Y.Y. and 30970919 for K.W.), and the Program for New Century Excellent Talents (NCET06-0015 to Y.Y.).	Armstrong AP, 1997, J ROY SOC MED, V90, P81, DOI 10.1177/014107689709000208; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bang S, 2010, J BIOL CHEM, V285, P19362, DOI 10.1074/jbc.M109.087742; Borbiro I, 2011, J INVEST DERMATOL, V131, P1605, DOI 10.1038/jid.2011.122; CAMBIAGHI S, 1995, ARCH DERMATOL, V131, P738, DOI 10.1001/archderm.131.6.738; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Larregue M, 2000, J Dermatol, V27, P557; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mevorah B, 2005, J AM ACAD DERMATOL, V53, pS266, DOI 10.1016/j.jaad.2005.03.036; Montell C, 2010, CELL, V141, P218, DOI 10.1016/j.cell.2010.03.043; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Ogawa F, 2003, EUR J DERMATOL, V13, P524; Olmsted HC, 1927, AM J DIS CHILD, V33, P757, DOI 10.1001/archpedi.1927.04130170055008; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; RIVERS JK, 1985, J AM ACAD DERMATOL, V13, P43, DOI 10.1016/S0190-9622(85)70141-7; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Tharini G K, 2011, Indian J Dermatol, V56, P591, DOI 10.4103/0019-5154.87166; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Vosynioti V, 2010, EUR J DERMATOL, V20, P837, DOI 10.1684/ejd.2010.1088; Xiao R, 2008, CELL CALCIUM, V43, P334, DOI 10.1016/j.ceca.2007.06.004; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	31	213	225	3	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					558	564		10.1016/j.ajhg.2012.02.006	http://dx.doi.org/10.1016/j.ajhg.2012.02.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22405088	Green Published, Bronze			2022-12-18	WOS:000301762800023
J	Andrew, T; Aviv, A; Falchi, M; Surdulescu, GL; Gardner, JP; Lu, XB; Kimura, M; Kato, BS; Valdes, AM; Spector, TD				Andrew, T; Aviv, A; Falchi, M; Surdulescu, GL; Gardner, JP; Lu, XB; Kimura, M; Kato, BS; Valdes, AM; Spector, TD			Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NORMAL HUMAN-CELLS; QUANTITATIVE TRAITS; PULSE PRESSURE; LIFE-SPAN; LINKAGE; AGE; ASSOCIATION; CHROMOSOME; ATTRITION; HUMANS	Telomeres play a central role in cellular senescence and cancer pathobiology and are associated with age-related diseases such as atherosclerosis and dementia. Telomere length varies between individuals of the same age, is influenced by DNA-damaging factors such as oxidative stress, and is heritable. We performed a quantitative-trait linkage analysis using an similar to 10-cM genomewide map for mean leukocyte terminal-restriction fragment (TRF) lengths measured by Southern blotting, in 2,050 unselected women aged 18-80 years, comprising 1,025 complete dizygotic twin pairs. Heritability of mean batch-adjusted TRF was 36% (95% confidence interval [CI] 18%-48%), with a large common environmental effect of 49% (95% CI 40%-58%). Significant linkage was observed on chromosome 14 (LOD 3.9) at 14q23.2, and suggestive linkage at 10q26.13 (LOD 2.4) and 3p26.1 (LOD 2.7). This is the first report of loci, mapped in a sample of healthy individuals, that influence mean telomere variation in humans.	St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; Univ Med & Dent New Jersey, Hypertens Res Ctr, Dept Pediat, New Jersey Med Sch, Newark, NJ 07103 USA	Guy's & St Thomas' NHS Foundation Trust; Rutgers State University New Brunswick; Rutgers State University Medical Center	Andrew, T (corresponding author), St Thomas Hosp, Twin Res & Genet Epidemiol Unit, Lambeth Pl Rd, London SE1 7EH, England.	toby.andrew@kcl.ac.uk	Falchi, Mario/F-5956-2013; Spector, Tim D/F-6533-2012; Andrew, Toby/O-8868-2017	Valdes, Ana M./0000-0003-1141-4471; Falchi, Mario/0000-0002-5646-1004; Andrew, Toby/0000-0001-8838-4384	NATIONAL INSTITUTE ON AGING [R01AG021593, R01AG020132] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG021593, AG020132, R01 AG020132, AG021593] Funding Source: Medline; Wellcome Trust [074951] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Barber MJ, 2004, GENET EPIDEMIOL, V26, P97, DOI 10.1002/gepi.10299; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Harley CB, 2005, CURR MOL MED, V5, P205, DOI 10.2174/1566524053586671; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harley CB, 1997, CIBA F SYMP, V211, P129; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Marrone A, 2005, CURR OPIN GENET DEV, V15, P249, DOI 10.1016/j.gde.2005.04.004; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; NEALE MC, 1991, METHODOLOGY GENETIC; Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; PRITCHARD LE, 1995, HUM MOL GENET, V4, P197, DOI 10.1093/hmg/4.2.197; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; STRACHAN T, 2003, HUMAN MOL GENTICS; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	32	213	215	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2006	78	3					480	486		10.1086/500052	http://dx.doi.org/10.1086/500052			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032AY	16400618	Green Published, Bronze			2022-12-18	WOS:000236747500014
J	Yonan, AL; Alarcon, M; Cheng, R; Magnusson, PKE; Spence, SJ; Palmer, AA; Grunn, A; Juo, SHH; Terwilliger, JD; Liu, JJ; Cantor, RM; Geschwind, DH; Gilliam, TC				Yonan, AL; Alarcon, M; Cheng, R; Magnusson, PKE; Spence, SJ; Palmer, AA; Grunn, A; Juo, SHH; Terwilliger, JD; Liu, JJ; Cantor, RM; Geschwind, DH; Gilliam, TC			A genomewide screen of 345 families for autism-susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; LINKAGE ANALYSIS; SEROTONIN TRANSPORTER; GENOMIC SCREEN; SPECTRUM DISORDERS; GENE; STRATEGIES; DISEQUILIBRIUM; POLYMORPHISM; PREVALENCE	We previously reported a genomewide scan to identify autism-susceptibility loci in 110 multiplex families, showing suggestive evidence (P < .01) for linkage to autism-spectrum disorders (ASD) on chromosomes 5, 8, 16, 19, and X and showing nominal evidence (P < .05) on several additional chromosomes (2, 3, 4, 10, 11, 12, 15, 18, and 20). In this follow-up analysis we have increased the sample size threefold, while holding the study design constant, so that we now report 345 multiplex families, each with at least two siblings affected with autism or ASD phenotype. Along with 235 new multiplex families, 73 new microsatellite markers were also added in 10 regions, thereby increasing the marker density at these strategic locations from 10 cM to similar to2 cM and bringing the total number of markers to 408 over the entire genome. Multipoint maximum LOD scores (MLS) obtained from affected-sib-pair analysis of all 345 families yielded suggestive evidence for linkage on chromosomes 17, 5, 11, 4, and 8 (listed in order by MLS) (P < .01). The most significant findings were an MLS of 2.83 (P = .00029) on chromosome 17q, near the serotonin transporter (5-hydroxytryptamine transporter [5-HTT]), and an MLS of 2.54 (P = .00059) on 5p. The present follow-up genome scan, which used a consistent research design across studies and examined the largest ASD sample collection reported to date, gave either equivalent or marginally increased evidence for linkage at several chromosomal regions implicated in our previous scan but eliminated evidence for linkage at other regions.	Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Neuropsychiat Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gilliam, TC (corresponding author), Columbia Univ, Columbia Genome Ctr, 1150 St Nicholas Ave,Room 508, New York, NY 10032 USA.	dhg@ucla.edu	Palmer, Abraham/L-2158-2014; Magnusson, Patrik KE/C-4458-2017; Juo, Suh-Hang/C-9545-2009; Juo, Suh-Hang/A-1765-2010; Liu, Jianjun/AAK-4989-2020	Palmer, Abraham/0000-0003-3634-0747; Magnusson, Patrik KE/0000-0002-7315-7899; Liu, Jianjun/0000-0002-3255-3019	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, R01MH063749] Funding Source: NIH RePORTER; NIMH NIH HHS [MH645477, MH63749, R01 MH063749, R01 MH064547] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS P, 1994, GENET EPIDEMIOL, V11, P87, DOI 10.1002/gepi.1370110109; Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Badner JA, 2002, MOL PSYCHIATR, V7, P56, DOI 10.1038/sj/mp/4000922; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Charman T, 2002, EUR CHILD ADOLES PSY, V11, P249, DOI 10.1007/s00787-002-0297-8; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Cook EH, 1997, MOL PSYCHIATR, V2, P247; CORDELL HJ, 1995, ANN HUM GENET, V59, P435, DOI 10.1111/j.1469-1809.1995.tb00761.x; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P225, DOI 10.1002/gepi.1370100403; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fombonne E, 2002, MOL PSYCHIATR, V7, pS4, DOI 10.1038/sj.mp.4001162; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gillberg C, 1999, ACTA PSYCHIAT SCAND, V99, P399, DOI 10.1111/j.1600-0447.1999.tb00984.x; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Kim SJ, 2002, MOL PSYCHIATR, V7, P278, DOI 10.1038/sj.mp.4001033; Klauck SM, 1997, HUM MOL GENET, V6, P2233, DOI 10.1093/hmg/6.13.2233; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lauritsen MB, 2001, ACTA PSYCHIAT SCAND, V103, P411, DOI 10.1034/j.1600-0447.2001.00086.x; Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lord C, 2001, AM J MED GENET, V105, P36, DOI 10.1002/1096-8628(20010108)105:1<36::AID-AJMG1053>3.3.CO;2-W; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MEDRANO JF, 1990, BIOTECHNIQUES, V8, P43; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 1998, J AUTISM DEV DISORD, V28, P351, DOI 10.1023/A:1026096203946; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P245; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; World Health Organization, 2010, ICD 10 INT STAT CLAS; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; Yirmiya N, 2001, AM J MED GENET, V105, P381, DOI 10.1002/ajmg.1365	59	213	222	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					886	897		10.1086/378778	http://dx.doi.org/10.1086/378778			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	727TL	13680528	Green Published, Bronze			2022-12-18	WOS:000185676100015
J	Azzedine, H; Bolino, A; Taieb, T; Birouk, N; Di Duca, M; Bouhouche, A; Benamou, S; Mrabet, A; Hammadouche, T; Chkili, T; Gouider, R; Ravazzolo, R; Brice, A; Laporte, J; LeGuern, E				Azzedine, H; Bolino, A; Taieb, T; Birouk, N; Di Duca, M; Bouhouche, A; Benamou, S; Mrabet, A; Hammadouche, T; Chkili, T; Gouider, R; Ravazzolo, R; Brice, A; Laporte, J; LeGuern, E			Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; PRIMARY CONGENITAL GLAUCOMA; DIFFERENTIATION-ASSOCIATED PROTEIN-1; MYOTUBULARIN-RELATED PROTEIN-2; TRANSCRIPTION FACTOR GENE; FOCALLY FOLDED MYELIN; NEUROPATHY TYPE-I; SENSORY NEUROPATHY; HEREDITARY MOTOR; LINKAGE ANALYSIS	Charcot-Marie-Tooth disease (CMT) with autosomal recessive (AR) inheritance is a heterogeneous group of inherited motor and sensory neuropathies. In some families from Japan and Brazil, a demyelinating CMT, mainly characterized by the presence of myelin outfoldings on nerve biopsies, cosegregated as an autosomal recessive trait with early-onset glaucoma. We identified two such large consanguineous families from Tunisia and Morocco with ages at onset ranging from 2 to 15 years. We mapped this syndrome to chromosome 11p15, in a 4.6-cM region overlapping the locus for an isolated demyelinating ARCMT (CMT4B2). In these two families, we identified two different nonsense mutations in the myotubularin-related 13 gene, MTMR13. The MTMR protein family includes proteins with a phosphoinositide phosphatase activity, as well as proteins in which key catalytic residues are missing and that are thus called "pseudophosphatases." MTM1, the first identified member of this family, and MTMR2 are responsible for X-linked myotubular myopathy and Charcot-Marie-Tooth disease type 4B1, an isolated peripheral neuropathy with myelin outfoldings, respectively. Both encode active phosphatases. It is striking to note that mutations in MTMR13 also cause peripheral neuropathy with myelin outfoldings, although it belongs to a pseudophosphatase subgroup, since its closest homologue is MTMR5/Sbf1. This is the first human disease caused by mutation in a pseudophosphatase, emphasizing the important function of these putatively inactive enzymes. MTMR13 may be important for the development of both the peripheral nerves and the trabeculum meshwork, which permits the outflow of the aqueous humor. Both of these tissues have the same embryonic origin.	Grp Hosp Pitie Salpetriere, INSERM, U289, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Dept Genet Cytogenet & Embryol, Assistance Publ Hop Paris, F-75634 Paris, France; Dulbecco Telethon Inst, Genoa, Italy; Gaslini Inst, Genet Mol Lab, Genoa, Italy; Gaslini Inst, Lab Nephrol, Genoa, Italy; Univ Genoa, Dept Paediat, Genoa, Italy; Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; Ctr Hosp Univ Sahloul, Serv Neurol, Sousse, Tunisia; Hop Specialites, Serv Neurol, Rabat, Morocco; Hop Charles Nicolle, Serv Neurol, Tunis, Tunisia; Hop Razi, Serv Neurol, Tunis, Tunisia; Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, Illkirch Graffenstaden, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; Universite de Sousse; Hopital Sahloul; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Universite de Tunis-El-Manar; Hopital Charles Nicolle; Universite de Tunis-El-Manar; Hopital Razi; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	LeGuern, E (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, 47 Bd Hop, F-75651 Paris 13, France.	leguern@ccr.jussieu.fr	laporte, jocelyn/J-7008-2012; Laporte, Jocelyn/H-6801-2016; Bolino, Alessandra/AAN-5442-2020; Gouider, Riadh/AAX-2634-2020; brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Di Duca, Marco/AAB-4531-2021; laporte, jocelyn/O-4888-2019; Bolino, Alessandra/O-2933-2013	Bolino, Alessandra/0000-0002-8980-4878; Gouider, Riadh/0000-0001-9615-3797; brice, alexis/0000-0002-0941-3990; Di Duca, Marco/0000-0001-8456-7706; Bouhouche, Ahmed/0000-0001-5279-8649	Telethon [TCP00062] Funding Source: Medline	Telethon(Fondazione Telethon)		Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; Arruda WO, 1999, ARQ NEURO-PSIQUIAT, V57, P190, DOI 10.1590/S0004-282X1999000200004; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Ben Othmane K, 1999, GENOMICS, V62, P344, DOI 10.1006/geno.1999.6028; Berger P, 2002, HUM MOL GENET, V11, P1569, DOI 10.1093/hmg/11.13.1569; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; BOUCHE P, 1983, J NEUROL SCI, V61, P389, DOI 10.1016/0022-510X(83)90172-7; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Delague V, 2000, AM J HUM GENET, V67, P236, DOI 10.1086/302980; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P483, DOI 10.1016/S0968-0004(00)01664-9; Dyck PJ., 1975, PERIPHERAL NEUROPATH, P825; Firestein R, 2002, J CLIN INVEST, V109, P1165, DOI [10.1172/JCI200212589, 10.1172/JCI0212589]; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HAYASAKA K, 1993, GENOMICS, V17, P755, DOI 10.1006/geno.1993.1400; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kiwaki T, 2000, NEUROLOGY, V55, P392, DOI 10.1212/WNL.55.3.392; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Laporte J, 2002, J CELL SCI, V115, P3105; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Laporte J, 2001, TRENDS GENET, V17, P221, DOI 10.1016/S0168-9525(01)02245-4; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nandurkar HH, 2002, IUBMB LIFE, V53, P37, DOI 10.1080/15216540210812; Nandurkar HH, 2001, P NATL ACAD SCI USA, V98, P9499, DOI 10.1073/pnas.171306098; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; THOMPSON EA, 1987, IMA J MATH APPL MED, V4, P93; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIMMERMAN V, 1990, AM J HUM GENET, V47, P680; Trifan OC, 1998, AM J OPHTHALMOL, V126, P17, DOI 10.1016/S0002-9394(98)00073-7; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Wirtz MK, 1997, AM J HUM GENET, V60, P296; Wirtz MK, 1999, ARCH OPHTHALMOL-CHIC, V117, P237; Wishart MJ, 2001, CURR OPIN CELL BIOL, V13, P172, DOI 10.1016/S0955-0674(00)00195-2; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Wishart MJ, 2002, P NATL ACAD SCI USA, V99, P2112, DOI 10.1073/pnas.251686198	56	213	222	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1141	1153		10.1086/375034	http://dx.doi.org/10.1086/375034			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12687498	Bronze, Green Published			2022-12-18	WOS:000182474400007
J	Hovatta, I; Varilo, T; Suvisaari, J; Terwilliger, JD; Ollikainen, V; Arajarvi, R; Juvonen, H; Kokko-Sahin, ML; Vaisanen, L; Mannila, H; Lonnqvist, J; Peltonen, L				Hovatta, I; Varilo, T; Suvisaari, J; Terwilliger, JD; Ollikainen, V; Arajarvi, R; Juvonen, H; Kokko-Sahin, ML; Vaisanen, L; Mannila, H; Lonnqvist, J; Peltonen, L			A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; VULNERABILITY LOCUS; X-CHROMOSOME; WIDE SEARCH; DISEQUILIBRIUM; DISEASE; SCAN; MAPS; POPULATION; POLYMORPHISMS	Schizophrenia is a severe mental disorder affecting similar to 1% of the world's population. Here, we report the results from a three-stage genomewide screen performed in a study sample from an internal isolate of Finland. An effort was made to identify genes predisposing for schizophrenia that are potentially enriched in this isolate, which has an exceptionally high lifetime risk for this trait. Ancestors of the local families with schizophrenia were traced back to the foundation of the population in the 17th century. This genealogical information was used as the basis for the study strategy, which involved screening for alleles shared among affected individuals originating from common ancestors. We found four chromosomal regions with markers revealing pairwise LOD scores >1.0: 1q32.2-q41 (Z(max) = 3.82, dominant affecteds-only model), 4q31 (Z(max) = 2.74, dominant 90%-penetrance model), 9q21 (Z(max) = 1.95, dominant 90%-penetrance model), and Xp11.4-p11.3 (Z(max) = 2.01, recessive 90%-penetrance model). This finding suggests that there are several putative loci predisposing to schizophrenia, even in this isolate.	Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Dept Comp Sci, SF-00510 Helsinki, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; Univ Oulu, Dept Psychiat, Oulu, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; Columbia University; Columbia University	Peltonen, L (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Human Genet, Gonda Ctr, Suite 6506,695 Charles E Young Dr S, Los Angeles, CA USA.	lpeltonen@mednet.ucla.edu	Hovatta, Iiris/D-6871-2012	Hovatta, Iiris/0000-0002-5990-7892; Suvisaari, Jaana/0000-0001-7167-0990; Varilo, Teppo/0000-0002-5839-8854				BARR CL, 1994, AM J MED GENET, V54, P51, DOI 10.1002/ajmg.1320540110; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOOK JA, 1978, CLIN GENET, V14, P373; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; Coron B, 1996, PSYCHIAT RES, V62, P221, DOI 10.1016/0165-1781(96)02933-2; Dann J, 1997, PSYCHIAT RES, V70, P131, DOI 10.1016/S0165-1781(97)03138-7; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; DELISI LE, 1994, AM J MED GENET, V54, P113, DOI 10.1002/ajmg.1320540206; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Isohanni M, 1997, SOC PSYCH PSYCH EPID, V32, P303, DOI 10.1007/BF00789044; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; NIKALI K, 1995, AM J HUM GENET, V56, P1088; OBRIEN E, 1994, HUM BIOL, V66, P185; OKORO C, 1995, AM J MED GENET, V60, P461, DOI 10.1002/ajmg.1320600520; OTT J, 1986, GENET EPIDEMIOL, P251; PAKASLAHTI A, 1987, PSYCHIAT FENN, V18, P63; Pekkarinen P, 1998, AM J HUM GENET, V62, P362, DOI 10.1086/301722; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sobell JL, 1997, AM J MED GENET, V74, P44, DOI 10.1002/(SICI)1096-8628(19970221)74:1<44::AID-AJMG10>3.0.CO;2-R; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1998, ENCY BIOSTATISTICS, P2279; THOMPSON EA, 1978, P NATL ACAD SCI USA, V75, P1442, DOI 10.1073/pnas.75.3.1442; TIENARI P, 1987, J PSYCHIAT RES, V21, P437, DOI 10.1016/0022-3956(87)90091-4; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Varilo T, 1996, AM J HUM GENET, V58, P506; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Weir B., 1996, GENETIC DATA ANAL; Weiss KM, 1996, MOL PHYLOGENET EVOL, V5, P259, DOI 10.1006/mpev.1996.0019	45	213	219	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1114	1124		10.1086/302567	http://dx.doi.org/10.1086/302567			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	241XW	10486331	Green Published, Bronze			2022-12-18	WOS:000082910000021
J	Wicking, C; Shanley, S; Smyth, I; Gillies, S; Negus, K; Graham, S; Suthers, G; Haites, N; Edwards, M; Wainwright, B; ChenevixTrench, G				Wicking, C; Shanley, S; Smyth, I; Gillies, S; Negus, K; Graham, S; Suthers, G; Haites, N; Edwards, M; Wainwright, B; ChenevixTrench, G			Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; FAMILIES	The human homologue of the Drosophila segment polarity gene patched is implicated in the development of nevoid basal cell carcinoma syndrome (NBCCS) and in the genesis of sporadic basal cell carcinomas. In order to examine the phenotypic variability in NBCCS and to highlight functionally important domains of the PTCH protein, we have now screened 71 unrelated NBCCS individuals for mutations in the PTCH exons. We identified 28 mutations that are distributed throughout the entire gene, and most (86%) cause protein truncation. As part of this analysis, we demonstrate that failure of one NBCCS family to show clear linkage to chromosome 9q22.3-31 is most likely due to germinal mosaicism. We have identified three families bearing identical mutations with variable phenotypes, suggesting phenotypic variability in NBCCS is a complex genetic event. No phenotype genotype correlation between the position of truncation mutations and major clinical features was evident. Two missense mutations have been identified, and their location within transmembrane domains supports the notion that PTCH may have a transport function. The preponderance of truncation mutants in the germ line of NBCCS patients suggests that the developmental defects associated with the disorder are most likely due to haploinsufficiency.	UNIV QUEENSLAND,CTR CELLULAR & MOL BIOL,BRISBANE,QLD 4069,AUSTRALIA; QUEENSLAND INST MED RES,HERSTON,QLD 4006,AUSTRALIA; WOMENS & CHILDRENS HOSP,DEPT MED GENET,ADELAIDE,SA,AUSTRALIA; UNIV ABERDEEN,DEPT MED GENET,ABERDEEN AB9 1FX,SCOTLAND; HUNTER GENET,NEWCASTLE,NSW,AUSTRALIA	University of Queensland; QIMR Berghofer Medical Research Institute; Womens & Childrens Hospital Australia; University of Aberdeen			Chenevix-Trench, Georgia/AAV-2014-2020; Edwards, Matthew/L-8698-2019; Edwards, Matthew/A-7560-2011; Wicking, Carol/J-1814-2014	Chenevix-Trench, Georgia/0000-0002-1878-2587; Edwards, Matthew/0000-0001-8437-8120; Edwards, Matthew/0000-0001-8437-8120; Wicking, Carol/0000-0002-7225-3803; Wainwright, Brandon/0000-0003-0406-2092; Smyth, Ian/0000-0002-1727-7829				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; CHENEVIXTRENCH G, 1992, ONCOGENE, V7, P1059; CHIDAMBARAM A, IN PRESS CANC RES; EVANS DGR, 1993, J MED GENET, V30, P460, DOI 10.1136/jmg.30.6.460; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; FORBES AJ, 1993, DEVELOPMENT, P115; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; GORLIN RJ, 1987, MEDICINE, V66, P96; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; SHANLEY S, 1994, AM J MED GENET, V50, P282, DOI 10.1002/ajmg.1320500312; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WICKING C, 1994, GENOMICS, V22, P505, DOI 10.1006/geno.1994.1423	21	213	226	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					21	26						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981943				2022-12-18	WOS:A1997WA81800006
J	LAVEDAN, C; HOFMANNRADVANYI, H; SHELBOURNE, P; RABES, JP; DUROS, C; SAVOY, D; DEHAUPAS, I; LUCE, S; JOHNSON, K; JUNIEN, C				LAVEDAN, C; HOFMANNRADVANYI, H; SHELBOURNE, P; RABES, JP; DUROS, C; SAVOY, D; DEHAUPAS, I; LUCE, S; JOHNSON, K; JUNIEN, C			MYOTONIC-DYSTROPHY - SIZE-DEPENDENT AND SEX-DEPENDENT DYNAMICS OF CTG MEIOTIC INSTABILITY, AND SOMATIC MOSAICISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Myotonic dystrophy (DM) is a progressive neuromuscular disorder which results from elongations of an unstable (CTG)n repeat, located in the 3' untranslated region of the DM gene. A correlation has been demonstrated between the increase in the repeat number of this sequence and the severity of the disease. However, the clinical status of patients cannot be unambigously ascertained solely on the basis of the number of CTG repeats. Moreover, the exclusive maternal inheritance of the congenital form remains unexplained. Our observation of differently sized repeats in various DM tissues from the same individual may explain why the size of the mutation observed in lymphocytes does not necessarily correlate with the severity and nature of symptoms. Through a molecular and genetic study of 142 families including 418 DM patients, we have investigated the dynamics of the CTG repeat meiotic instability. A positive correlation between the size of the repeat and the intergenerational enlargement was observed similarly through male and female meioses for less-than-or-equal-to 0.5-kb CTG sequences. Beyond 0.5 kb, the intergenerational variation was more important through female meioses, whereas a tendency to compression was observed almost exclusively in male meioses, for greater-than-or-equal-to 1.5-kb fragments. This implies a size- and sex-dependent meiotic instability. Moreover, segregation analysis supports the hypothesis of a maternal as well as a familial predisposition for the occurrence of the congenital form. Finally, this analysis reveals a significant excess of transmitting grandfathers partially accounted for by increased fertility in affected males.	INSERM,U73,CHATEAU LONGCHAMP,BOIS BOULOGNE,F-75016 PARIS,FRANCE; CHARING CROSS & WESTMINSTER MED SCH,DEPT ANAT,LONDON,ENGLAND; HOP AMBROISE PARE,F-92100 BOULOGNE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP				LUCE, Sandrine/0000-0002-9519-333X; johnson, keith/0000-0002-8578-5921; Rabes, Jean-Pierre/0000-0002-1215-1493				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P709; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DAVIES J, 1992, J MED GENET, V29, P766, DOI 10.1136/jmg.29.11.766; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1992, AM J HUM GENET, V51, P10; HENRY I, 1984, AM J HUM GENET, V36, P760; KOCH MC, 1991, AM J HUM GENET, V48, P1084; LAVEDAN C, UNPUB FRENCH MYOTONI; LAVEDAN C, 1991, J MED GENET, V28, P84; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VANIER TM, 1960, BRIT MED J, V2, P1284, DOI 10.1136/bmj.2.5208.1284; YAMAGATA H, 1992, LANCET, V339, P692, DOI 10.1016/0140-6736(92)90862-W	23	213	215	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					875	883						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8098180				2022-12-18	WOS:A1993LB88900004
J	Webster, JA; Gibbs, JR; Clarke, J; Ray, M; Zhang, WX; Holmans, P; Rohrer, K; Zhao, A; Marlowe, L; Kaleem, M; McCorquodale, DS; Cuello, C; Leung, D; Bryden, L; Nath, P; Zismann, VL; Joshipura, K; Huentelman, MJ; Hu-Lince, D; Coon, KD; Craig, DW; Pearson, JV; Heward, CB; Reiman, EM; Stephan, D; Hardy, J; Myers, AJ				Webster, Jennifer A.; Gibbs, J. Raphael; Clarke, Jennifer; Ray, Monika; Zhang, Weixiong; Holmans, Peter; Rohrer, Kristen; Zhao, Alice; Marlowe, Lauren; Kaleem, Mona; McCorquodale, Donald S., III; Cuello, Cindy; Leung, Doris; Bryden, Leslie; Nath, Priti; Zismann, Victoria L.; Joshipura, Keta; Huentelman, Matthew J.; Hu-Lince, Diane; Coon, Keith D.; Craig, David W.; Pearson, John V.; Heward, Christopher B.; Reiman, Eric M.; Stephan, Dietrich; Hardy, John; Myers, Amanda J.		NACC-Neuropathol Grp	Genetic Control of Human Brain Transcript Expression in Alzheimer Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; RISK; ONSET; MAPT; INFERENCE; VARIANTS; LOCI; APOE; TAU	We recently surveyed the relationship between the human brain transcriptome and genome in a series of neuropathologically normal postmortem samples. We have now analyzed additional samples with a confirmed pathologic diagnosis of late-onset Alzheimer disease (LOAD; final n = 188 controls, 176 cases). Nine percent of the cortical transcripts that we analyzed had expression profiles correlated with their genotypes in the combined cohort, and approximately 5% of transcripts had SNP-transcript relationships that Could distinguish LOAD samples. Two of these transcripts have been previously implicated in LOAD candidate-gene SNP-expression screens. This study shows how the relationship between common inherited genetic variants and brain transcript expression can be used in the study of human brain disorders. We suggest that studying the transcriptome as a quantitative endo-phenotype has greater power for discovering risk SNPs influencing expression than the use of discrete diagnostic categories such as presence or absence of disease.	[McCorquodale, Donald S., III; Cuello, Cindy; Myers, Amanda J.] Univ Miami, Miller Sch Med, Div Neurosci, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Webster, Jennifer A.; Zismann, Victoria L.; Joshipura, Keta; Huentelman, Matthew J.; Hu-Lince, Diane; Coon, Keith D.; Craig, David W.; Pearson, John V.; Reiman, Eric M.; Stephan, Dietrich] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Webster, Jennifer A.] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Gibbs, J. Raphael; Rohrer, Kristen; Zhao, Alice; Marlowe, Lauren; Kaleem, Mona; Leung, Doris; Bryden, Leslie; Nath, Priti; Hardy, John] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Gibbs, J. Raphael; Hardy, John] UCL, Inst Neurol, Reta Lila Weston Inst, London WC1N 3BG, England; [Gibbs, J. Raphael; Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci & Neurodegenerat Dis, London WC1N 3BG, England; [Clarke, Jennifer] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Sch Med, Miami, FL 33133 USA; [Zhang, Weixiong] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ray, Monika; Zhang, Weixiong] Washington Univ, Dept Comp Sci & Engn, St Louis, MO 63130 USA; [Holmans, Peter] Cardiff Univ, Dept Psychol Med, Biostat & Bioinformat Unit, Cardiff CF14 4XN, S Glam, Wales; [Coon, Keith D.] St Josephs Hosp, Div Thorac Oncol Res, Phoenix, AZ 85013 USA; [Heward, Christopher B.] Kronos Sci Lab, Phoenix, AZ 85016 USA; [Reiman, Eric M.; Stephan, Dietrich] Banner Alzheimers Inst, Phoenix, AZ 85006 USA; [Myers, Amanda J.] Johnnie B Byrd Sr Alzheimers Ctr & Res Inst, Tampa, FL 33613 USA	University of Miami; Translational Genomics Research Institute; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; University of Miami; Washington University (WUSTL); Washington University (WUSTL); Cardiff University; St. Joseph's Hospital and Medical Center; Banner Research; Banner Health; Banner Alzheimer's Institute	Myers, AJ (corresponding author), Univ Miami, Miller Sch Med, Div Neurosci, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.	amyers@med.miami.edu	Pearson, John V/F-2249-2011; Myers, Amanda J/B-1796-2010; Hardy, John/C-2451-2009; Gibbs, J. Raphael/A-3984-2010; Leung, Doris G/R-5447-2016; Craig, David Wesley/K-6961-2019; Holmans, Peter/F-4518-2015; Pearson, John/AAT-4211-2020	Pearson, John V/0000-0003-0904-4598; Myers, Amanda J/0000-0002-3100-9396; Hardy, John/0000-0002-3122-0423; Gibbs, J. Raphael/0000-0002-6985-0658; Leung, Doris G/0000-0002-2558-7798; Craig, David Wesley/0000-0003-2040-1955; Holmans, Peter/0000-0003-0870-9412; Clarke, Jennifer/0000-0002-2723-7249; Zhang, Weixiong/0000-0002-4998-9791	Medical Research Council [G0701075, G0801418] Funding Source: Medline; NIA NIH HHS [U01 AG016976, P30 AG019610] Funding Source: Medline; NINDS NIH HHS [R01 NS059873] Funding Source: Medline; MRC [G0701075, G0801418] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610, U01AG016976] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aten JE, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-34; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Falush D, 2003, GENETICS, V164, P1567; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hamshere ML, 2007, HUM MOL GENET, V16, P2703, DOI 10.1093/hmg/ddm224; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; HOSACK DA, 2003, GENOME BIOL, V4, pP4, DOI DOI 10.1186/GB-2003-4-6-P4; Hua JP, 2007, BIOINFORMATICS, V23, P57, DOI 10.1093/bioinformatics/btl536; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Lambert JC, 2000, HUM MOL GENET, V9, P2275, DOI 10.1093/oxfordjournals.hmg.a018918; Laws SM, 2007, MOL PSYCHIATR, V12, P510, DOI 10.1038/sj.mp.4001935; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; LUDBROOK J, 1991, CLIN EXP PHARMACOL P, V18, P379, DOI 10.1111/j.1440-1681.1991.tb01468.x; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; O'Regan S, 2000, P NATL ACAD SCI USA, V97, P1835, DOI 10.1073/pnas.030339697; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Schadt EE, 2005, CURR OPIN BIOTECH, V16, P647, DOI 10.1016/j.copbio.2005.10.005; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schliekelman P, 2008, GENETICS, V178, P2201, DOI 10.1534/genetics.107.076687; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/0968-0004(96)20011-8; WORKMAN C, 2002, GENOME BIOL, V0003; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	44	212	217	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					445	458		10.1016/j.ajhg.2009.03.011	http://dx.doi.org/10.1016/j.ajhg.2009.03.011			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19361613	Green Published, Bronze			2022-12-18	WOS:000265232800003
J	Lagier-Tourenne, C; Tazir, M; Lopez, LC; Quinzii, CM; Assoum, M; Drouot, N; Busso, C; Makri, S; Ali-Pacha, L; Benhassine, T; Anheim, M; Lynch, DR; Thibault, C; Plewniak, F; Bianchetti, L; Tranchant, C; Poch, O; DiMauro, S; Mandel, JL; Barros, MH; Hirano, M; Koenig, M				Lagier-Tourenne, Clotilde; Tazir, Meriem; Lopez, Luis Carlos; Quinzii, Catarina M.; Assoum, Mirna; Drouot, Nathalie; Busso, Cleverson; Makri, Samira; Ali-Pacha, Lamia; Benhassine, Traki; Anheim, Mathieu; Lynch, David R.; Thibault, Christelle; Plewniak, Frederic; Bianchetti, Laurent; Tranchant, Christine; Poch, Olivier; DiMauro, Salvatore; Mandel, Jean-Louis; Barros, Mario H.; Hirano, Michio; Koenig, Michel			ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q(10) deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXONIC SPLICING ENHANCERS; SACCHAROMYCES-CEREVISIAE; CEREBELLAR-ATAXIA; UBIQUINONE BIOSYNTHESIS; PARA-HYDROXYBENZOATE; ESCHERICHIA-COLI; GENE ENCODES; MUTATIONS; PROTEIN; COMPLEX	Muscle coenzyme Q(10) (CoQ(10) or ubiquinone) deficiency has been identified in more than 20 patients with presumed autosomal-recessive ataxia. However, mutations in genes required for CoQ(10) biosynthetic pathway have been identified only in patients with infantile-onset multisystemic diseases or isolated nephropathy. Our SNP-based genome-wide scan in a large consanguineous family revealed a locus for autosomal-recessive ataxia at chromosome 1q41. The causative mutation is a homozygous splice-site mutation in the aarF-domain-containing kinase 3 gene (ADCK3). Five additional mutations in ADCK3 were found in three patients with sporadic ataxia, including one known to have CoQ(10) deficiency in muscle. All of the patients have childhood-onset cerebellar ataxia with slow progression, and three of six have mildly elevated lactate levels. ADCK3 is a mitochondrial protein homologous to the yeast COQ8 and the bacterial UbiB proteins, which are required for CoQ biosynthesis. Three out of four patients tested showed a low endogenous pool of CoQ(10) in their fibroblasts or lymphoblasts, and two out of three patients showed impaired ubiquinone synthesis, strongly suggesting that ADCK3 is also involved in CoQ(10) biosynthesis. The deleterious nature of the three identified missense changes was confirmed by the introduction of them at the corresponding positions of the yeast COQ8 gene. Finally, a phylogenetic analysis shows that ADCK3 belongs to the family of atypical kinases, which includes phosphomositide and choline kinases, suggesting that ADCK3 plays an indirect regulatory role in ubiquinone biosynthesis possibly as part of a feedback loop that regulates ATP production.	[Lagier-Tourenne, Clotilde; Assoum, Mirna; Drouot, Nathalie; Anheim, Mathieu; Thibault, Christelle; Plewniak, Frederic; Bianchetti, Laurent; Poch, Olivier; Mandel, Jean-Louis; Koenig, Michel] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Lagier-Tourenne, Clotilde; Assoum, Mirna; Drouot, Nathalie; Anheim, Mathieu; Thibault, Christelle; Plewniak, Frederic; Bianchetti, Laurent; Poch, Olivier; Mandel, Jean-Louis; Koenig, Michel] Coll France, Chaire Genet Humaine, F-67404 Illkirch Graffenstaden, France; [Lagier-Tourenne, Clotilde; Assoum, Mirna; Drouot, Nathalie; Anheim, Mathieu; Thibault, Christelle; Plewniak, Frederic; Bianchetti, Laurent; Poch, Olivier; Mandel, Jean-Louis; Koenig, Michel] Hop Univ Strasbourg, F-67000 Strasbourg, France; [Tazir, Meriem] Ctr Hosp Univ Mustapha, Serv Neurol, Algiers 16000, Algeria; [Lopez, Luis Carlos; Quinzii, Catarina M.; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Busso, Cleverson; Barros, Mario H.] Univ Sao Paulo, Dept Microbiol, ICB II, BR-05508900 Sao Paulo, Brazil; [Makri, Samira] Hop Ait Idir, Serv Neurol, Algiers, Algeria; [Benhassine, Traki] Inst Pasteur Alger, Algiers, Algeria; [Anheim, Mathieu; Tranchant, Christine] Hop Univ Strasbourg, Serv Neurol, F-67091 Strasbourg, France; [Lynch, David R.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Lynch, David R.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Columbia University; Universidade de Sao Paulo; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Koenig, M (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	mkoenig@igbmc.u-strasbg.fr	Barros, Mario H/B-8118-2012; Lopez, Luis Carlos/AAP-9411-2020; Lopez, Luis Carlos/L-5129-2014; Busso, Cleverson/D-6570-2014; lagier-Tourenne, Clotilde/ABE-6303-2020; Barros, Mario/Q-6358-2019; Busso, Cleverson/AAL-2054-2021; Mandel, Jean Louis/Q-2668-2016	Lopez, Luis Carlos/0000-0003-3355-0298; Lopez, Luis Carlos/0000-0003-3355-0298; lagier-Tourenne, Clotilde/0000-0002-3058-8322; Barros, Mario/0000-0003-2977-9815; BUSSO, CLEVERSON/0000-0001-9331-5850; Anheim, Mathieu/0000-0001-8121-0605; tranchant, christine/0000-0002-2895-1292; Thibault-Carpentier, Christelle/0000-0003-1562-1451; Plewniak, Frederic/0000-0001-6534-8786; Mandel, Jean Louis/0000-0002-0535-6589	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062, R01HD057543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32062, P01 HD032062, R01 HD057543] Funding Source: Medline; NINDS NIH HHS [P01 NS011766, NS11766] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Aure K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Higgins JJ, 1999, NEUROLOGY, V52, P146, DOI 10.1212/WNL.52.1.146; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; Iiizumi M, 2002, CANCER RES, V62, P1246; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Lagier-Tourenne C, 2003, EUR J HUM GENET, V11, P770, DOI 10.1038/sj.ejhg.5201068; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; Le Ber I, 2007, NEUROLOGY, V68, P295, DOI 10.1212/01.wnl.0000252366.10731.43; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Macinga DR, 1998, J BACTERIOL, V180, P128, DOI 10.1128/JB.180.1.128-135.1998; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A	37	212	220	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					661	672		10.1016/j.ajhg.2007.12.024	http://dx.doi.org/10.1016/j.ajhg.2007.12.024			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319074	Green Published, Bronze			2022-12-18	WOS:000254067800011
J	Hall, D; Dhilla, A; Charalambous, A; Gogos, JA; Karayiorgou, M				Hall, D; Dhilla, A; Charalambous, A; Gogos, JA; Karayiorgou, M			Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILY-BASED ASSOCIATION; TRANSMISSION/DISEQUILIBRIUM TEST; BIPOLAR DISORDER; DISEQUILIBRIUM; TRANSCRIPTION; TRANSMISSION; MICE	We evaluated a possible association between the brain-derived neurotrophic factor ( BDNF) gene and susceptibility to obsessive-compulsive disorder (OCD) by genotyping a number of single-nucleotide polymorphisms ( SNPs) and one microsatellite marker from the extended BDNF locus in 164 triads with OCD. Extensive background linkage disequilibrium was observed at this locus. Single-locus transmission-distortion tests revealed significant evidence of association with the disease for all the BDNF gene markers tested, including a Val66Met variation affecting the sequence of the proBDNF protein. Analysis of multi-SNP haplotypes provided similar results. Haplotype transmission comparisons in this and previous studies point to a functionally distinct BDNF haplotype uniquely marked by the rare Met66 allele, which is undertransmitted and likely confers a protective effect in OCD and other psychiatric disorders.	Rockefeller Univ, Human Neurogenet Lab, New York, NY 10021 USA; Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY USA	Rockefeller University; Columbia University; Columbia University	Karayiorgou, M (corresponding author), Rockefeller Univ, Human Neurogenet Lab, 1230 York Ave,Box 313, New York, NY 10021 USA.			Albers, Alefiya/0000-0003-2660-6927	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000102, M01 RR00102] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; GOODMAN WK, 1997, J CLIN PSYCHIAT, V58, pS32; INSEL TR, 1985, BIOL PSYCHIAT, V20, P1174, DOI 10.1016/0006-3223(85)90176-3; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEWONTIN RC, 1988, GENETICS, V120, P849; Licinio J, 2002, MOL PSYCHIATR, V7, P519, DOI 10.1038/sj.mp.4001211; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; RASMUSSEN SA, 1992, J CLIN PSYCHIAT, V55, pS5; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Sobin C, 1999, J PSYCHIAT RES, V33, P265, DOI 10.1016/S0022-3956(98)00061-2; Sobin C, 2000, COMPR PSYCHIAT, V41, P373, DOI 10.1053/comp.2000.9009; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	23	212	224	1	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					370	376		10.1086/377003	http://dx.doi.org/10.1086/377003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	702KW	12836135	Bronze, Green Published			2022-12-18	WOS:000184223900012
J	Al-Baradie, R; Yamada, K; St Hilaire, C; Chan, WM; Andrews, C; McIntosh, N; Nakano, M; Martonyi, EJ; Raymond, WR; Okumura, S; Okihiro, MM; Engle, EC				Al-Baradie, R; Yamada, K; St Hilaire, C; Chan, WM; Andrews, C; McIntosh, N; Nakano, M; Martonyi, EJ; Raymond, WR; Okumura, S; Okihiro, MM; Engle, EC			Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETRACTION SYNDROME; CONGENITAL FIBROSIS; EXTRAOCULAR-MUSCLES; GENE; SPALT	Duane syndrome is a congenital eye movement disorder characterized most typically by absence of abduction, restricted adduction, and retraction of the globe on attempted adduction. Duane syndrome can be coinherited with radial ray anomalies as an autosomal dominant trait, referred to as "Okihiro syndrome" or "Duane radial ray syndrome" (DRRS). We ascertained three pedigrees with DRRS and mapped their disease gene to a 21.6-cM region of chromosome 20 flanked by markers D20S888 and D20S102. A new member of the SAL family of proposed C2H2 zinc finger transcription factors, SALL4, falls within the region. Mutation analysis of SALL4 in the three pedigrees revealed one nonsense and two frameshift heterozygous mutations. SALL4 represents the first identified Duane syndrome gene and the second malformation syndrome resulting from mutations in SAL genes and likely plays a critical role in abducens motoneuron development.	Childrens Hosp Boston, Dept Neurol, Div Genet, Boston, MA 02115 USA; Childrens Hosp Boston, Dept Genet, Boston, MA 02115 USA; Univ Michigan, WK Kellogg Eye & Vis Res Ctr, Ann Arbor, MI 48109 USA; Madigan Army Med Ctr, Dept Ophthalmol, Tacoma, WA 98431 USA; Straub Clin & Hosp, Honolulu, HI USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; Madigan Army Medical Center	Engle, EC (corresponding author), Childrens Hosp Boston, Dept Neurol, Div Genet, Enders 551,300 Longwood Ave, Boston, MA 02115 USA.		St. Hilaire, Cynthia/I-4713-2014; St. Hilaire, Cynthia/R-8205-2017	St. Hilaire, Cynthia/0000-0003-1871-6915	NEI NIH HHS [R01 EY013583, R01 EY012498] Funding Source: Medline; NICHD NIH HHS [P30 HD018655, P30 HD18655] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012498, R01EY013583] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Appukuttan B, 1999, AM J HUM GENET, V65, P1639, DOI 10.1086/302656; Chun BB, 2001, J PEDIAT OPHTH STRAB, V38, P235; Chung M, 2000, OPHTHALMOLOGY, V107, P500, DOI 10.1016/S0161-6420(99)00090-1; ENGLE EC, 1994, NAT GENET, V7, P69, DOI 10.1038/ng0594-69; HOTCHKISS MG, 1980, ARCH OPHTHALMOL-CHIC, V98, P870, DOI 10.1001/archopht.1980.01020030864013; Kiefer SM, 2002, J BIOL CHEM, V277, P14869, DOI 10.1074/jbc.M200052200; Kohlhase J, 1999, GENOMICS, V62, P216, DOI 10.1006/geno.1999.6005; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; MILLER NR, 1982, ARCH OPHTHALMOL-CHIC, V100, P1468; Nakano M, 2001, NAT GENET, V29, P315, DOI 10.1038/ng744; Netzer C, 2001, HUM MOL GENET, V10, P3017, DOI 10.1093/hmg/10.26.3017; OKIHIRO MM, 1977, ARCH NEUROL-CHICAGO, V34, P174, DOI 10.1001/archneur.1977.00500150060012; TEMTAMY SA, 1978, BIRTH DEFECTS ORIG A, P1; VINCENT C, 1994, HUM MOL GENET, V3, P1859, DOI 10.1093/hmg/3.10.1859	15	212	236	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1195	1199		10.1086/343821	http://dx.doi.org/10.1086/343821			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12395297	Green Published, Bronze			2022-12-18	WOS:000178884300018
J	Cox, NJ; Wapelhorst, B; Morrison, VA; Johnson, L; Pinchuk, L; Spielman, RS; Todd, JA; Concannon, P				Cox, NJ; Wapelhorst, B; Morrison, VA; Johnson, L; Pinchuk, L; Spielman, RS; Todd, JA; Concannon, P			Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFFECTED-SIB-PAIR; INSULIN GENE REGION; SUSCEPTIBILITY LOCUS; MEXICAN-AMERICANS; HUMAN THYMUS; IDDM2 LOCUS; MELLITUS; HLA; ASSOCIATION; VNTR	Type 1 diabetes (T1D) is a genetically complex disorder of glucose homeostasis that results from the autoimmune destruction of the insulin-secreting cells of the pancreas. Two previous whole-genome scans for linkage to T1D in 187 and 356 families containing affected sib pairs (ASPs) yielded apparently conflicting results, despite partial overlap in the families analyzed. However, each of these studies individually lacked power to detect loci with locus-specific disease prevalence/sib-risk ratios (lambda (s))<1.4. In the present study, a third genome scan was performed using a new collection of 225 multiplex families with T1D, and the data from all three of these genome scans were merged and analyzed jointly. The combined sample of 831 ASPs, all with both parents genotyped, provided 90% power to detect linkage for loci with <lambda>(s) p 1.3 at P=7.4 x 10(-4). Three chromosome regions were identified that showed significant evidence of linkage (P<2.2 x 10(-5); LOD scores >4), 6p21 (IDDM1), 11p15 (IDDM2), 16q22- q24, and four more that showed suggestive evidence (P<7.4 x 10(-4), LOD scores <greater than or equal to>2.2), 10p11 (IDDM10), 2q31 (IDDM7, IDDM12, and IDDM13), 6q21 (IDDM15), and 1q42. Exploratory analyses, taking into account the presence of specific high-risk HLA genotypes or affected sibs' ages at disease onset, provided evidence of linkage at several additional sites, including the putative IDDM8 locus on chromosome 6q27. Our results indicate that much of the difficulty in mapping T1D susceptibility genes results from inadequate sample sizes, and the results point to the value of future international collaborations to assemble and analyze much larger data sets for linkage in complex diseases.	Virginia Mason Res Ctr, Mol Genet Program, Seattle, WA 98101 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Washington, Sch Med, Seattle, WA USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Cambridge Inst Med Res, Juvenile Diabet Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge, England	Virginia Mason Medical Center; University of Chicago; University of Chicago; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Cambridge	Concannon, P (corresponding author), Virginia Mason Res Ctr, Mol Genet Program, 1201 9th Ave, Seattle, WA 98101 USA.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Martin, Beth/0000-0002-9661-014X; Concannon, Patrick/0000-0002-5801-1859	NIDDK NIH HHS [R01 DK055889, DK55889, DK46635, R01 DK046635, U01 DK058026, DK58026, DK55970] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889, R01DK055970, R01DK046635, U01DK058026] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Cucca F, 1998, NAT GENET, V19, P301, DOI 10.1038/995; Cucca F, 2001, DIABETES, V50, P1200, DOI 10.2337/diabetes.50.5.1200; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delepine M, 1997, AM J HUM GENET, V60, P174; EASTEAL S, 1990, DIABETES, V39, P855, DOI 10.2337/diabetes.39.7.855; Erlich HA, 1996, DIABETES, V45, P610, DOI 10.2337/diabetes.45.5.610; Esposito L, 1998, DIABETES, V47, P1797, DOI 10.2337/diabetes.47.11.1797; Gu C, 1997, AM J HUM GENET, V61, P200, DOI 10.1086/513908; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; JULIER C, 1994, AM J HUM GENET, V55, P1247; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Li H, 2000, ANN HUM GENET, V64, P239, DOI 10.1017/S000348000000806X; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; LUO DF, 1995, AM J HUM GENET, V57, P911; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Noble JA, 1996, AM J HUM GENET, V59, P1134; Noble JA, 2000, DIABETES, V49, P121, DOI 10.2337/diabetes.49.1.121; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OWERBACH D, 1994, AM J HUM GENET, V54, P909; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; Owerbach D, 2000, DIABETES, V49, P508, DOI 10.2337/diabetes.49.3.508; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; REIJONEN H, 2001, IN PRESS JOSLIN DIAB; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RISCH N, 1987, AM J HUM GENET, V40, P1; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; THOMSON G, 1988, AM J HUM GENET, V43, P799; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; Verge CF, 1998, J CLIN INVEST, V102, P1569, DOI 10.1172/JCI3379	49	212	220	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					820	830		10.1086/323501	http://dx.doi.org/10.1086/323501			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11507694	Bronze, Green Published			2022-12-18	WOS:000171008200014
J	Sanghera, DK; Aston, CE; Saha, N; Kamboh, MI				Sanghera, DK; Aston, CE; Saha, N; Kamboh, MI			DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIPOPROTEIN ASSOCIATED PARAOXONASE; LOW-DENSITY-LIPOPROTEIN; MYOCARDIAL-INFARCTION; MOLECULAR-BASIS; ARTERY DISEASE; HUMAN-PLASMA; SERUM; ARYLESTERASE; HUMPONA	A common polymorphism at codon 192 in the human paraoxonase (PON) 1 gene has been shown to be associated with increased risk for coronary heart disease (CHD) in Caucasian populations. However, these findings have not been reported consistently in all Caucasian and non-Caucasian populations, suggesting that this is not a functional mutation but may mark a functional mutation present in either PON1 or a nearby gene. Recently, two other PON-like genes, designated "PON2" and "PON3," have been identified, and they are linked with the known PON1 gene on chromosome 7. Identification of additional polymorphisms in the PON-gene cluster may help to locate the functional polymorphism. In this report, we describe the existence of a common polymorphism at codon 311 (Cys-->Ser; PON2*S) in the PON2 gene, as well as its association with CHD alone and in combination with the PON1 codon 192 polymorphism in Asian Indians. The frequency of the PON2*S allele was significantly higher in cases than in controls (.71 vs. .61; P = .016). The age-and sex-adjusted odds ratio (OR) was 2.5 (95% confidence interval [95% CI] = 1.8-3.1; P = .0090) for the PON2*S allele carriers. Further stratification of the PON2*S association, on the basis of the presence or absence of the PON1*B allele, showed that the CHD risk associated with the PON2*S allele was confined to PON1*B-allele carriers. Likewise, the PON1*B-allele risk was present only among PON2*S carriers. Age-and sex-adjusted ORs for the PON2*S and PON1*B were 3.6 (95% CI = 2.6-4.6; P = .011) and 2.9 (95% CI = 2.4-3.5; P = .0002) among the PON1*B and PON2*S carriers, respectively. Our data indicate that both polymorphisms synergistically contribute to the CHD risk in this sample and that this genetic risk is independent of the conventional plasma lipid profile.	Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, 130 DeSoto St, Pittsburgh, PA 15261 USA.	ikamboh@helix.hgen.pitt.edu		Kamboh, M. Ilyas/0000-0002-3453-1438; Sanghera, Dharambir/0000-0001-7203-8655	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044672, R01HL052611, R01HL049074] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 49074, HL44672, HL52611] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADKINS S, 1993, AM J HUM GENET, V52, P598; Antikainen M, 1996, J CLIN INVEST, V98, P883, DOI 10.1172/JCI118869; Augustinsson K. B., 1968, HOMOLOGOUS ENZYMES B, P299; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; DIEPGEN TL, 1986, ARCH TOXICOL, P154; FURLONG CE, 1988, AM J HUM GENET, V43, P230; Garin MCB, 1997, J CLIN INVEST, V99, P62, DOI 10.1172/JCI119134; GARIN MCB, 1993, EUR J BIOCHEM, V211, P871; Herrmann SM, 1996, ATHEROSCLEROSIS, V126, P299, DOI 10.1016/0021-9150(96)05917-5; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; KELSO GJ, 1994, BIOCHEMISTRY-US, V33, P832, DOI 10.1021/bi00169a026; KLIMOV AN, 1993, ATHEROSCLEROSIS, V100, P13, DOI 10.1016/0021-9150(93)90063-Z; La Du BN, 1992, PHARMACOGENETICS DRU, P51; LaDu BN, 1996, NAT MED, V2, P1186, DOI 10.1038/nm1196-1186; LADU BN, 1988, ANN BIOL OLIN, V44, P369; MACKNESS MI, 1987, CLIN CHEM, V33, P587; MACKNESS MI, 1989, CLIN BIOCHEM, V22, P475, DOI 10.1016/S0009-9120(89)80101-8; MACKNESS MI, 1991, ATHEROSCLEROSIS, V86, P193, DOI 10.1016/0021-9150(91)90215-O; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; MCELVEEN J, 1986, CLIN CHEM, V32, P671; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; PARZER S, 1991, BIOCHEM J, V273, P229, DOI 10.1042/bj2730229; Primo-Parmo S. L., 1996, American Journal of Human Genetics, V59, pA406; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; ROY AC, 1991, HUM HERED, V41, P265, DOI 10.1159/000154010; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3; Sanghera DK, 1997, ARTERIOSCL THROM VAS, V17, P1067, DOI 10.1161/01.ATV.17.6.1067; Serrato M, 1995, J CLIN INVEST, V96, P3005, DOI 10.1172/JCI118373; SORENSON RC, 1995, P NATL ACAD SCI USA, V92, P7187, DOI 10.1073/pnas.92.16.7187; STAFFORINI DM, 1992, T ASSOC AM PHYSICIAN, V105, P44; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359	32	212	246	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					36	44		10.1086/301669	http://dx.doi.org/10.1086/301669			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443862	Green Published, Bronze			2022-12-18	WOS:000072127900008
J	BENDALL, KE; SYKES, BC				BENDALL, KE; SYKES, BC			LENGTH HETEROPLASMY IN THE FIRST HYPERVARIABLE SEGMENT OF THE HUMAN MTDNA CONTROL REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; D-LOOP REGION; RAPID EVOLUTION; SIZE VARIATION; SEGREGATION; SEQUENCE; GENERATION; CRICKETS; LINEAGE; NUMBER	The first hypervariable segment of the human mtDNA control region contains a homopolymeric tract of cytosines between nt 16184 and 16193, interrupted at position 16189 by a thymine, according to the Cambridge reference sequence. A variant commonly found in population screening is a T-to-C transition at nt 16189, resulting in an uninterrupted homopolymeric tract. Direct sequencing of individuals with this variant produces a characteristic blurred sequence in nucleotides beyond the tract. Sequencing clones from these individuals revealed that this is caused by high levels of length heteroplasmy in the homopolymeric tract and low levels of length heteroplasmy in the four adenines following the tract. We have developed a rapid method involving densitometry of sequencing gels to quantify the relative proportions of different length variants present in an individual. We have used this to study the proportions of length variants in individuals from three twin pairs and two maternal lineages. While unrelated individuals usually have different proportions of length variants, all maternally related individuals studied have the same proportions, even if they are only distantly related. It is not obvious how identical heteroplasmic profiles are maintained in maternally related individuals, but some possible mechanisms are suggested.	UNIV OXFORD,INST MOLEC MED,OXFORD,ENGLAND	University of Oxford								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CASANE D, 1994, GENETICS, V138, P471; DESTORDEUR E, 1989, MOL GEN GENET, V220, P127, DOI 10.1007/BF00260866; GHIVIZZANI SC, 1993, J MOL EVOL, V37, P36, DOI 10.1007/BF00170460; HARRISON RG, 1985, SCIENCE, V228, P1446, DOI 10.1126/science.228.4706.1446; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HAUSWIRTH WW, 1985, NUCLEIC ACIDS RES, V13, P8093, DOI 10.1093/nar/13.22.8093; HAUSWIRTH WW, 1984, CELL, V37, P1001, DOI 10.1016/0092-8674(84)90434-3; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOELZEL AR, 1994, J MOL EVOL, V39, P191; HORAI S, 1990, AM J HUM GENET, V46, P828; HOWELL N, 1992, HUM GENET, V90, P117; KOEHLER CM, 1991, GENETICS, V129, P247; PIKO L, 1976, DEV BIOL, V49, P1, DOI 10.1016/0012-1606(76)90253-0; RAND DM, 1989, GENETICS, V121, P551; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; VILKKI J, 1990, AM J HUM GENET, V47, P95; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018	27	212	218	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					248	256						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668250				2022-12-18	WOS:A1995RL77100007
J	FERRIE, RM; SCHWARZ, MJ; ROBERTSON, NH; VAUDIN, S; SUPER, M; MALONE, G; LITTLE, S				FERRIE, RM; SCHWARZ, MJ; ROBERTSON, NH; VAUDIN, S; SUPER, M; MALONE, G; LITTLE, S			DEVELOPMENT, MULTIPLEXING, AND APPLICATION OF ARMS TESTS FOR COMMON MUTATIONS IN THE CFTR GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS GENE; POLYMERASE CHAIN-REACTION; SICKLE-CELL ANEMIA; NUCLEOTIDE-BINDING FOLD; BETA-GLOBIN; ENZYMATIC AMPLIFICATION; GEL-ELECTROPHORESIS; POINT MUTATIONS; DNA; IDENTIFICATION	The amplification refractory mutation system (ARMS) is a simple, rapid, and reliable method for the detection of any mutation involving single base changes or small deletions. We have applied ARMS methodology to the detection of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Single ARMS tests have been developed for 11 CFTR mutations found in the northwest of England. ARMS reactions for the most common mutations have been multiplexed to give a test which will detect the presence of the DELTA-F508, G551D, G542X, and 621 + 1G --> T mutations in a DNA sample. The multiplex test has been validated by the analysis of over 500 previously genotyped samples and has been found to be completely accurate. The rapid detection of the most common mutations has enabled early molecular confirmation of suspected cystic fibrosis in neonates, rapid typing of cystic fibrosis patients and their relatives, and testing of sperm and egg donors.	ICI CELLMARK DIAGNOST,GADBROOK PK,NORTHWICH CW9 7RA,CHESHIRE,ENGLAND; ROYAL MANCHESTER CHILDRENS HOSP,PAEDIAT GENET UNIT,MANCHESTER M27 1HA,LANCS,ENGLAND	Royal Manchester Children's Hospital								BALLABIO A, 1990, NATURE, V343, P220, DOI 10.1038/343220a0; CHEHAB FF, 1987, NATURE, V329, P293, DOI 10.1038/329293b0; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; GUILLERMIT H, 1990, HUM GENET, V85, P450, DOI 10.1007/BF02428306; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P3606, DOI 10.1093/nar/17.9.3606; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; KAN Y, 1978, NATURE, V313, P369; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOBAYASHI K, 1990, AM J HUM GENET, V47, P611; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; LENCH N, 1988, LANCET, V1, P1356; MAIN BF, 1991, J LIPID RES, V32, P183; Mullis K B, 1991, PCR Methods Appl, V1, P1; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; OLD JM, 1990, LANCET, V336, P834, DOI 10.1016/0140-6736(90)92338-I; OSBORNE L, 1991, AM J HUM GENET, V48, P608; PEDERZINI F, 1987, INSIGHTS PAEDIAT, V1, P19; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SARKAR G, 1990, ANAL BIOCHEM, V186, P64, DOI 10.1016/0003-2697(90)90573-R; SCHWARZ M, 1991, IDENTIFICATION CF GE, P417; SOMMER SS, 1989, MAYO CLIN PROC, V64, P1361, DOI 10.1016/S0025-6196(12)65378-6; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WAGNER M, 1990, MOL BIOL MED, V7, P359; WENHAM PR, 1991, CLIN CHEM, V37, P241; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8	36	212	240	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1992	51	2					251	262						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JF776	1379414				2022-12-18	WOS:A1992JF77600004
J	Zhou, Q; Lee, GS; Brady, J; Datta, S; Katan, M; Sheikh, A; Martins, MS; Bunney, TD; Santich, BH; Moir, S; Kuhns, DB; Priel, DAL; Ombrello, A; Stone, D; Ombrello, MJ; Khan, J; Milner, JD; Kastner, DL; Aksentijevich, I				Zhou, Qing; Lee, Geun-Shik; Brady, Jillian; Datta, Shrimati; Katan, Matilda; Sheikh, Afzal; Martins, Marta S.; Bunney, Tom D.; Santich, Brian H.; Moir, Susan; Kuhns, Douglas B.; Priel, Debra A. Long; Ombrello, Amanda; Stone, Deborah; Ombrello, Michael J.; Khan, Javed; Milner, Joshua D.; Kastner, Daniel L.; Aksentijevich, Ivona			A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase C gamma 2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							B-CELL; ACTIVATION; AUTOIMMUNITY; TOLERANCE; SEQUENCE	Whole-exome sequencing was performed in a family affected by dominantly inherited inflammatory disease characterized by recurrent blistering skin lesions, bronchiolitis, arthralgia, ocular inflammation, enterocolitis, absence of autoantibodies, and mild immunodeficiency. Exome data from three samples, including the affected father and daughter and unaffected mother, were filtered for the exclusion of reported variants, along with benign variants, as determined by PolyPhen-2. A total of eight transcripts were identified as possible candidate genes. We confirmed a variant, c.2120C>A (p.Ser707Tyr), within PLCG2 as the only de novo variant that was present in two affected family members and not present in four unaffected members. PLCG2 encodes phospholipase C gamma 2 (PLC gamma 2), an enzyme with a critical regulatory role in various immune and inflammatory pathways. The p.Ser707Tyr substitution is located in an autoinhibitory SH2 domain that is crucial for PLC gamma 2 activation. Overexpression of the altered p.Ser707Tyr protein and ex vivo experiments using affected individuals' leukocytes showed clearly enhanced PLC gamma 2 activity, suggesting increased intracellular signaling in the PLC gamma 2-mediated pathway. Recently, our laboratory identified in individuals with cold-induced urticaria and immune dysregulation PLCG2 exon-skipping mutations resulting in protein products with constitutive phospholipase activity but with reduced intracellular signaling at physiological temperatures. In contrast, the p.Ser707Tyr substitution in PLC gamma 2 causes a distinct inflammatory phenotype that is not provoked by cold temperatures and that has different end-organ involvement and increased intracellular signaling at physiological temperatures. Our results highlight the utility of exome-sequencing technology in finding causal mutations in nuclear families with dominantly inherited traits otherwise intractable by linkage analysis.	[Zhou, Qing; Lee, Geun-Shik; Brady, Jillian; Sheikh, Afzal; Ombrello, Amanda; Stone, Deborah; Ombrello, Michael J.; Kastner, Daniel L.; Aksentijevich, Ivona] NHGRI, Inflammatory Dis Sect, Bethesda, MD 20892 USA; [Lee, Geun-Shik] Kangwon Natl Univ, Coll Vet Med, Chunchon 200701, Gangwon, South Korea; [Datta, Shrimati; Milner, Joshua D.] NIAID, Lab Allerg Dis, Bethesda, MD 20892 USA; [Katan, Matilda; Martins, Marta S.; Bunney, Tom D.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Santich, Brian H.; Moir, Susan] NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA; [Kuhns, Douglas B.; Priel, Debra A. Long] SAIC Frederick, Ft Detrick, MD 21702 USA; [Khan, Javed] NCI, Gaithersburg, MD 20877 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Aksentijevich, I (corresponding author), NHGRI, Inflammatory Dis Sect, Bethesda, MD 20892 USA.	kastnerd@mail.nih.gov; aksentii@exchange.nih.gov	Yu, Xiaomin/I-6407-2016; Aksentijevich, Ivona/AAF-1335-2019; Martins, Marta/A-9905-2013; Moir, Susan/AAC-3676-2020	Martins, Marta/0000-0003-0429-9380; Santich, Brian/0000-0001-5869-3661; Ombrello, Michael/0000-0003-3322-4089; Ombrello, Amanda/0000-0001-5563-9416; Bunney, Tom/0000-0002-0281-8813	National Human Genome Research Institute; National Institute for Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD; Cancer Research, UK; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI001183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIEAR041176] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Research, UK(Cancer Research UK); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to acknowledge Elaine Remmers and Jae Jin Chae for critical reading of the manuscript and Chyi-chia Lee for help with reviewing a histology slide. We would also like to acknowledge Nona Colbum, Maria Turner, Patrycja Hoffman, and Anne Jones for their help in caring for these affected individuals. This study has been supported by the National Human Genome Research Institute and the National Institute for Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD. Work in Matilda Katan's laboratory has been supported by Cancer Research, UK.	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Aksentijevich I, 2011, NAT REV RHEUMATOL, V7, P468, DOI 10.1038/nrrheum.2011.94; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Donjerkovic D, 2000, CELL RES, V10, P179, DOI 10.1038/sj.cr.7290047; Everett KL, 2009, J BIOL CHEM, V284, P23083, DOI 10.1074/jbc.M109.019265; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Jones DR, 2002, FASEB J, V16, P595, DOI 10.1096/fj.01-0762fje; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Meffre E, 2011, ANN NY ACAD SCI, V1246, P1, DOI 10.1111/j.1749-6632.2011.06347.x; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018	22	211	225	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					713	720		10.1016/j.ajhg.2012.08.006	http://dx.doi.org/10.1016/j.ajhg.2012.08.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23000145	Green Published, Bronze			2022-12-18	WOS:000309568500013
J	Ellinghaus, D; Ellinghaus, E; Nair, RP; Stuart, PE; Esko, T; Metspalu, A; Debrus, S; Raelson, JV; Tejasvi, T; Belouchi, M; West, SL; Barker, JN; Koks, S; Kingo, K; Balschun, T; Palmieri, O; Annese, V; Gieger, C; Wichmann, HE; Kabesch, M; Trembath, RC; Mathew, CG; Abecasis, GR; Weidinger, S; Nikolaus, S; Schreiber, S; Elder, JT; Weichenthal, M; Nothnagel, M; Franke, A				Ellinghaus, David; Ellinghaus, Eva; Nair, Rajan P.; Stuart, Philip E.; Esko, Tonu; Metspalu, Andres; Debrus, Sophie; Raelson, John V.; Tejasvi, Trilokraj; Belouchi, Majid; West, Sarah L.; Barker, Jonathan N.; Koks, Sulev; Kingo, Kuelli; Balschun, Tobias; Palmieri, Orazio; Annese, Vito; Gieger, Christian; Wichmann, H. Erich; Kabesch, Michael; Trembath, Richard C.; Mathew, Christopher G.; Abecasis, Goncalo R.; Weidinger, Stephan; Nikolaus, Susanna; Schreiber, Stefan; Elder, James T.; Weichenthal, Michael; Nothnagel, Michael; Franke, Andre			Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENETIC-ASSOCIATION; CLINICAL-FEATURES; COMMON VARIANTS; PATHOGENESIS; COMPLEX; HSP90; IL23R; POLYMORPHISMS; METAANALYSIS	Psoriasis (PS) and Crohn disease (CD) have been shown to be epidemiologically, pathologically, and therapeutically connected, but little is known about their shared genetic causes. We performed meta-analyses of five published genome-wide association studies on PS (2,529 cases and 4,955 controls) and CD (2,142 cases and 5,505 controls), followed up 20 loci that showed strongest evidence for shared disease association and, furthermore, tested cross-disease associations for previously reported PS and CD risk alleles in additional 6,115 PS cases, 4,073 CD cases, and 10,100 controls. We identified seven susceptibility loci outside the human leukocyte antigen region (9p24 near JAK2, 10q22 at ZMIZ1, 11q13 near PRDX5, 16p13 near SOCS1, 17q21 at STAT3, 19p13 near FUT2, and 22q11 at YDJC) shared between PS and CD with genome-wide significance (p < 5 x 10(-8)) and confirmed four already established PS and CD risk loci (IL23R, IL12B, REL, and TYK2). Three of the shared loci are also genome-wide significantly associated with PS alone (10q22 at ZMIZ1, p(rs1250544) = 3.53 x 10(-8), 11q13 near PRDX5, p(rs694739) = 3.71 x 10(-09), 22q11 at YDJC, p(rs181359) = 8.02 x 10(-10)). In addition, we identified one susceptibility locus for CD (16p13 near SOCS1, p(rs4780355) = 4.99 x 10(-8)). Refinement of association signals identified shared genome-wide significant associations for exonic SNPs at 10q22 (ZMIZ1) and in silico expression quantitative trait locus analyses revealed that the associations at ZMIZ1 and near SOCS1 have a potential functional effect on gene expression. Our results show the usefulness of joint analyses of clinically distinct immune-mediated diseases and enlarge the map of shared genetic risk loci.	[Ellinghaus, David; Ellinghaus, Eva; Balschun, Tobias; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Nair, Rajan P.; Stuart, Philip E.; Tejasvi, Trilokraj; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50409 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50409 Tartu, Estonia; [Raelson, John V.] PGX Serv, Montreal, PQ H2T 1S1, Canada; [Belouchi, Majid] Genizon BioSci Inc, St Laurent, PQ H4T 2C7, Canada; [West, Sarah L.; Barker, Jonathan N.; Trembath, Richard C.; Mathew, Christopher G.] Kings Coll London, Div Genet & Mol Med, London SE1 9RT, England; [Koks, Sulev] Univ Tartu, Ctr Translat Med, Dept Physiol, EE-50409 Tartu, Estonia; [Koks, Sulev] Univ Tartu, Ctr Translat Genom, EE-50409 Tartu, Estonia; [Kingo, Kuelli] Univ Tartu, Dept Dermatol & Venerol, EE-50409 Tartu, Estonia; [Palmieri, Orazio; Annese, Vito] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Div Gastroenterol, I-71013 San Giovanni Rotondo, Italy; [Annese, Vito] Azienda Osped Univ Careggi, Unit Gastroenterol SOD2, I-50134 Florence, Italy; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Wichmann, H. Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Kabesch, Michael] Hannover Med Sch, Dept Paediat Pneumol Allergy & Neonatol, D-30625 Hannover, Germany; [Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Weidinger, Stephan; Weichenthal, Michael] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venerol, D-24105 Kiel, Germany; [Nikolaus, Susanna] Univ Kiel, PopGen Biobank, D-24105 Kiel, Germany; [Nikolaus, Susanna; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Elder, James T.] Ann Arbor Vet Affairs Hop, Ann Arbor, MI 48105 USA; [Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany	University of Kiel; University of Michigan System; University of Michigan; University of Tartu; University of Tartu; University of London; King's College London; University of Tartu; University of Tartu; University of Tartu; University of Florence; Azienda Ospedaliero Universitaria Careggi; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Hannover Medical School; University of Michigan System; University of Michigan; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.	a.franke@mucosa.de	Ellinghaus, David/ABC-3610-2020; Kingo, Külli/H-3603-2012; Kabesch, Michael/AAB-5701-2020; Weidinger, Stephan/C-8461-2011; Annese, Vito/AGW-4200-2022; Franke, Andre/B-2151-2010; Koks, Sulev/H-3655-2015; Ellinghaus, Eva/E-6490-2012; Ellinghaus, David/G-4467-2012; Nothnagel, Michael/G-6545-2014; Abecasis, Goncalo R/B-7840-2010; Nothnagel, Michael/L-7187-2019; Mathew, Christopher G/G-3434-2015; Palmieri, Orazio/J-7697-2012; Nothnagel, Michael/H-6887-2012; Kabesch, Michael/GZM-1583-2022; Wichmann, Heinz Erich/AAA-5695-2022; Spain, Sarah/G-1968-2010	Ellinghaus, David/0000-0002-4332-6110; Weidinger, Stephan/0000-0003-3944-252X; Annese, Vito/0000-0002-0082-892X; Franke, Andre/0000-0003-1530-5811; Koks, Sulev/0000-0001-6087-6643; Ellinghaus, Eva/0000-0003-2914-3382; Nothnagel, Michael/0000-0001-8305-7114; Mathew, Christopher G/0000-0003-4178-1838; Palmieri, Orazio/0000-0002-0019-7929; Gieger, Christian/0000-0001-6986-9554; Spain, Sarah/0000-0002-7591-8364; Kingo, Kulli/0000-0001-6301-9612; Esko, Tonu/0000-0003-1982-6569; Trembath, Richard/0000-0003-0550-3400; Barker, Jonathan/0000-0002-9030-183X; Abecasis, Goncalo/0000-0003-1509-1825	NHGRI NIH HHS [U01 HG006513] Funding Source: Medline; NIAMS NIH HHS [R01 AR050511, R01 AR042742] Funding Source: Medline; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050511, R01AR042742] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbas-Terki T, 2002, BIOL CHEM, V383, P1335, DOI 10.1515/BC.2002.152; Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bernstein CN, 2005, GASTROENTEROLOGY, V129, P827, DOI 10.1053/j.gastro.2005.06.021; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Franke A, 2008, GASTROENTEROLOGY, V135, P1207, DOI 10.1053/j.gastro.2008.07.017; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Ikehara Y, 2001, CANCER EPIDEM BIOMAR, V10, P971; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Krebs DL, 2000, J CELL SCI, V113, P2813; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Logan I, 2010, AUTOIMMUN REV, V9, pA372, DOI 10.1016/j.autrev.2009.11.008; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Morris AP, 2010, GENET EPIDEMIOL, V34, P335, DOI 10.1002/gepi.20486; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Russell RK, 2004, BEST PRACT RES CL GA, V18, P525, DOI 10.1016/j.bpg.2003.12.006; Sagoo GS, 2004, J DERMATOL SCI, V35, P171, DOI 10.1016/j.jdermsci.2004.02.009; Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Weng X, 2007, AM J GASTROENTEROL, V102, P1429, DOI 10.1111/j.1572-0241.2007.01215.x; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; YATES VM, 1982, BRIT J DERMATOL, V106, P323; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	61	211	232	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					636	647		10.1016/j.ajhg.2012.02.020	http://dx.doi.org/10.1016/j.ajhg.2012.02.020			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22482804	Green Published, Bronze			2022-12-18	WOS:000302833400006
J	Cichon, S; Muhleisen, TW; Degenhardt, FA; Mattheisen, M; Miro, X; Strohmaier, J; Steffens, M; Meesters, C; Herms, S; Weingarten, M; Priebe, L; Haenisch, B; Aexander, M; Vollmer, J; Breuer, R; Schmal, C; Tessmann, P; Moebus, S; Wichmann, HE; Schreiber, S; Muller-Myhsok, B; Lucae, S; Jamain, S; Leboyer, M; Bellivier, F; Etain, B; Henry, C; Kahn, JP; Heath, S; Hamshere, M; O'Donovan, MC; Owen, MJ; Craddock, N; Schwarz, M; Vedder, H; Kammerer-Ciernioch, J; Reif, A; Sasse, J; Bauer, M; Hautzinger, M; Wright, A; Mitchell, PB; Schofield, PR; Montgomery, GW; Medland, SE; Gordon, SD; Martin, NG; Gustafsson, O; Andreassen, O; Djurovic, S; Sigurdsson, E; Steinberg, S; Stefansson, H; Stefansson, K; Kapur-Pojskic, L; Oruc, L; Rivas, F; Mayoral, F; Chuchalin, A; Babadjanova, G; Tiganov, AS; Pantelejeva, G; Abramova, LI; Grigoroiu-Serbanescu, M; Diaconu, CC; Czerski, PM; Hauser, J; Zimmer, A; Lathrop, M; Schulze, TG; Wienker, TF; Schumacher, J; Maier, W; Propping, P; Rietschel, M; Nothen, MM				Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska A.; Mattheisen, Manuel; Miro, Xavier; Strohmaier, Jana; Steffens, Michael; Meesters, Christian; Herms, Stefan; Weingarten, Moritz; Priebe, Lutz; Haenisch, Britta; Aexander, Michael; Vollmer, Jennifer; Breuer, Rene; Schmael, Christine; Tessmann, Peter; Moebus, Susanne; Wichmann, H. -Erich; Schreiber, Stefan; Mueller-Myhsok, Bertram; Lucae, Susanne; Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal; Kahn, Jean-Pierre; Heath, Simon; Hamshere, Marian; O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick; Schwarz, Markus; Vedder, Helmut; Kammerer-Ciernioch, Jutta; Reif, Andreas; Sasse, Johanna; Bauer, Michael; Hautzinger, Martin; Wright, Adam; Mitchell, Philip B.; Schofield, Peter R.; Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.; Gustafsson, Omar; Andreassen, Ole; Djurovic, Srdjan; Sigurdsson, Engilbert; Steinberg, Stacy; Stefansson, Hreinn; Stefansson, Kari; Kapur-Pojskic, Lejla; Oruc, Liliana; Rivas, Fabio; Mayoral, Fermin; Chuchalin, Alexander; Babadjanova, Gulja; Tiganov, Alexander S.; Pantelejeva, Galina; Abramova, Lilia I.; Grigoroiu-Serbanescu, Maria; Diaconu, Carmen C.; Czerski, Piotr M.; Hauser, Joanna; Zimmer, Andreas; Lathrop, Mark; Schulze, Thomas G.; Wienker, Thomas F.; Schumacher, Johannes; Maier, Wolfgang; Propping, Peter; Rietschel, Marcella; Noethen, Markus M.		Bipolar Disorder Genome Study BiGS	Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; DIAGNOSTIC INTERVIEW; PROCEDURAL VALIDITY; RISK-FACTORS; METAANALYSIS; RATIONALE; BRAIN; DISEASE; ANK3; TOOL	We conducted a genome-wide association study (GWAS) and a follow-up study of bipolar disorder (BD), a common neuropsychiatric disorder. In the GWAS, we investigated 499,494 autosomal and 12,484 X-chromosomal SNPs in 682 patients with BD and in 1300 controls. In the first follow-up step, we tested the most significant 48 SNPs in 1729 patients with BD and in 2313 controls. Eight SNPs showed nominally significant association with BD and were introduced to a meta-analysis of the GWAS and the first follow-up samples. Genetic variation in the neurocan gene (NCAN) showed genome-wide significant association with BD in 2411 patients and 3613 controls (rs1064395, p = 3.02 x 10(-8); odds ratio = 1.31). In a second follow-up step, we replicated this finding in independent samples of BD, totaling 6030 patients and 31,749 controls (p = 2.74 x 10(-4); odds ratio = 1.12). The combined analysis of all study samples yielded a p value of 2.14 x 10(-9) (odds ratio = 1.17). Our results provide evidence that rs1064395 is a common risk factor for BD. NCAN encodes neurocan, an extracellular matrix glycoprotein, which is thought to be involved in cell adhesion and migration. We found that expression in mice is localized within cortical and hippocampal areas. These areas are involved in cognition and emotion regulation and have previously been implicated in BD by neuropsychological, neuroimaging, and postmortem studies.	[Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany; [Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska A.; Mattheisen, Manuel; Herms, Stefan; Weingarten, Moritz; Priebe, Lutz; Haenisch, Britta; Aexander, Michael; Vollmer, Jennifer; Tessmann, Peter; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska A.; Mattheisen, Manuel; Herms, Stefan; Weingarten, Moritz; Priebe, Lutz; Haenisch, Britta; Aexander, Michael; Vollmer, Jennifer; Tessmann, Peter; Schumacher, Johannes; Propping, Peter; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Cichon, Sven; Mattheisen, Manuel; Steffens, Michael; Meesters, Christian; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53127 Bonn, Germany; [Cichon, Sven; Miro, Xavier; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-53127 Bonn, Germany; [Strohmaier, Jana; Breuer, Rene; Schmael, Christine; Rietschel, Marcella] Univ Mannheim, Dept Genet Epidemiol Psychiat, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Moebus, Susanne] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, D-45147 Essen, Germany; [Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany; [Wichmann, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Mueller-Myhsok, Bertram; Lucae, Susanne] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal] ENBREC, INSERM, U955, IMRB,Fdn Fondamental, F-94010 Creteil, France; [Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal] Univ Paris Est, Fac Med, F-75005 Paris, France; [Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal] AP HP, Dept Psychiat, Henri Mondor Albert Chenevier Grp, F-94000 Creteil, France; [Kahn, Jean-Pierre] CHU Nancy, Jeanne dArc Hosp, Dept Psychiat & Clin Psychol, F-54200 Toul, France; [Heath, Simon; Lathrop, Mark] Ctr Natl Genotypage, F-91057 Evry, France; [Hamshere, Marian; O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales; [Schwarz, Markus; Vedder, Helmut; Kammerer-Ciernioch, Jutta] Psychiat Ctr Nordbaden, D-69168 Wiesloch, Germany; [Reif, Andreas] Univ Wurzburg, Dept Psychiat, D-97070 Wurzburg, Germany; [Sasse, Johanna; Bauer, Michael] Univ Hosp Carl Gustav Carus, Dept Psychiat & Psychotherapy, D-01307 Dresden, Germany; [Hautzinger, Martin] Univ Tubingen, Inst Psychol, Dept Clin & Dev Psychol, D-72074 Tubingen, Germany; [Wright, Adam; Mitchell, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia; [Wright, Adam; Mitchell, Philip B.] Prince Wales Hosp, Black Dog Inst, Randwick, NSW 2031, Australia; [Schofield, Peter R.] Neurosci Res Australia, Randwick, NSW 2031, Australia; [Schofield, Peter R.] Univ New S Wales, Sch Med Sci, Fac Med, Sydney, NSW 2052, Australia; [Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Gustafsson, Omar; Andreassen, Ole; Djurovic, Srdjan] Oslo Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Andreassen, Ole; Djurovic, Srdjan] Univ Oslo, Inst Psychiat, N-0450 Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Sigurdsson, Engilbert] Univ Iceland, Dept Psychiat, Natl Univ Hosp, IS-101 Reykjavik, Iceland; [Steinberg, Stacy; Stefansson, Hreinn; Stefansson, Kari] DeCODE Genet, CNS Div, IS-101 Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland; [Kapur-Pojskic, Lejla] Univ Sarajevo, Lab Human Genet, INGEB, BA-71000 Sarajevo, Bosnia & Herceg; [Oruc, Liliana] Univ Sarajevo, Ctr Clin, Psychiat Clin, BA-71000 Sarajevo, Bosnia & Herceg; [Rivas, Fabio; Mayoral, Fermin] Civil Hosp Carlos Haya, ES-29010 Malaga, Spain; [Chuchalin, Alexander; Babadjanova, Gulja] Russian State Med Univ, Inst Pulmonol, Moscow 105077, Russia; [Tiganov, Alexander S.; Pantelejeva, Galina; Abramova, Lilia I.] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 115522, Russia; [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Clin Psychiat Hosp, Biometr Psychiat Genet Res Unit, RO-041914 Bucharest, Romania; [Diaconu, Carmen C.] Romanian Acad, Stefan S Nicolau Inst Virol, RO-030304 Bucharest, Romania; [Czerski, Piotr M.; Hauser, Joanna] Poznan Univ Med Sci, Dept Psychiat, PL-60572 Poznan, Poland; [Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, Univ Med Ctr, D-37075 Gottingen, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53127 Bonn, Germany	Helmholtz Association; Research Center Julich; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Central Institute of Mental Health; University of Mannheim; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Kiel; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Nancy; CEA; UDICE-French Research Universities; Universite Paris Saclay; Cardiff University; University of Wurzburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; University of New South Wales Sydney; Black Dog Institute; Neuroscience Research Australia; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; University of Oslo; University of Oslo; University of Oslo; Landspitali National University Hospital; University of Iceland; University of Iceland; University of Sarajevo; University of Sarajevo; Pirogov Russian National Research Medical University; Russian Academy of Medical Sciences; Romanian Academy of Sciences; Stefan S. Nicolau Institute of Virology; Poznan University of Medical Sciences; University of Gottingen; University of Bonn	Cichon, S (corresponding author), Res Ctr Juelich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany.	sven.cichon@uni-bonn.de	Andreassen, Ole A./AAY-7531-2020; Cichon, Sven/B-9618-2014; Grigoroiu-Serbanescu, Maria/R-3689-2019; Heath, Simon C/J-4138-2012; Institute of Virology, Stefan S Nicolau/HGE-9069-2022; Panteleeva, G/K-4636-2013; Abramova, Liliya/K-4665-2013; Müller-Myhsok, Bertram/A-3289-2013; Herms, Stefan/J-1949-2014; Leboyer, Marion/AAW-3648-2021; O'Donovan, Michael C/P-7005-2018; Smith, Erin/E-5933-2011; Czerski, Piotr M./B-8446-2011; Schumacher, Johannes/F-4970-2015; BELLIVIER, FRANK/H-5197-2012; mayoral, fermin/C-2652-2013; Medland, Sarah E/C-7630-2013; Serbanescu, Maria/D-4306-2011; Tiganov, Alexander S/B-6768-2016; Zimmer, Andreas/B-8357-2009; Schulze, Thomas G/H-2157-2013; Greenwood, Tiffany/F-6356-2012; Diaconu, Carmen Cristina/B-9119-2011; Etain, Bruno/L-6647-2017; Degenhardt, Franziska/H-4169-2017; McMahon, Francis J/A-7290-2009; Liu, Chunyu/G-7561-2012; Wichmann, Heinz Erich/AAA-5695-2022; Mahon, Pamela Belmonte/O-9806-2018; Priebe, Lutz/D-4402-2011; Medland, Sarah/AAT-7595-2020; Martin, Nicholas/R-9235-2019; Jamain, Stéphane/P-3710-2017; Montgomery, Grant W/B-7148-2008; Stefansson, Kari/AAE-7187-2019; Mattheisen, Manuel/B-4949-2012; Mattheisen, Manuel/S-3725-2019; Cichon, Sven/H-8803-2013; Sigurdsson, Engilbert/D-2486-2014; Cucalin, Aleksandr/P-5678-2018; Schofield, Peter/C-9669-2011	Cichon, Sven/0000-0002-9475-086X; Grigoroiu-Serbanescu, Maria/0000-0002-1304-6687; Heath, Simon C/0000-0002-9550-0897; Panteleeva, G/0000-0002-5001-3198; Abramova, Liliya/0000-0003-4397-924X; Herms, Stefan/0000-0002-2786-8200; Leboyer, Marion/0000-0001-5473-3697; O'Donovan, Michael C/0000-0001-7073-2379; Czerski, Piotr M./0000-0003-0745-5916; Schumacher, Johannes/0000-0001-9217-6457; Medland, Sarah E/0000-0003-1382-380X; Serbanescu, Maria/0000-0002-1304-6687; Tiganov, Alexander S/0000-0003-0148-7538; Greenwood, Tiffany/0000-0002-6080-6503; Diaconu, Carmen Cristina/0000-0002-2259-1425; Etain, Bruno/0000-0002-5377-1488; McMahon, Francis J/0000-0002-9469-305X; Liu, Chunyu/0000-0002-5986-4415; Mahon, Pamela Belmonte/0000-0002-3947-441X; Medland, Sarah/0000-0003-1382-380X; Martin, Nicholas/0000-0003-4069-8020; Jamain, Stéphane/0000-0002-4321-4100; Montgomery, Grant W/0000-0002-4140-8139; Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Sigurdsson, Engilbert/0000-0001-9404-7982; Cucalin, Aleksandr/0000-0002-6808-5528; Nothen, Markus/0000-0002-8770-2464; Bauer, Michaela/0000-0001-8717-3278; Andreassen, Ole A./0000-0002-4461-3568; Mitchell, Philip/0000-0002-7954-5235; Schofield, Peter/0000-0003-2967-9662; BELLIVIER, FRANK/0000-0002-3660-6640; Meesters, Christian/0000-0003-2408-7588; Djurovic, Srdjan/0000-0002-8140-8061; Gordon, Scott/0000-0001-7623-328X; Mayoral-Cleries, Fermin/0000-0002-9710-9672; Steffens, Michael/0000-0002-6445-8593; Stefansson, Hreinn/0000-0002-9331-6666; Moebus, Susanne/0000-0002-0072-5410	German Federal Ministry of Education and Research (BMBF) within the context the National Genome Research Network 2 (NGFN-2); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; Alfried Krupp von Bohlen und Halbach-Stiftung; Romanian Ministry for Education and Research [42151/2008]; SOP HRD; European Social Fund; Romanian Government [POSDRU/89/1.5/S/64109]; Polish Ministry of Science and Higher Education [N N402 244035]; Helmholtz Center Munich; State of Bavaria; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; ANR [ANR NEURO2006]; Fonda-Mental Foundation; Australian NHMRC [510135]; Research Council of Norway [167153/V50, 163070/V50, 175345/V50]; South-East Norway Health Authority [123-2004]; Medical Research Council [G0801418B] Funding Source: researchfish	German Federal Ministry of Education and Research (BMBF) within the context the National Genome Research Network 2 (NGFN-2)(Federal Ministry of Education & Research (BMBF)); Integrated Genome Research Network (IG) MooDS; Alfried Krupp von Bohlen und Halbach-Stiftung; Romanian Ministry for Education and Research(Ministry of Education and Research - Romania); SOP HRD; European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Helmholtz Center Munich(Helmholtz Association); State of Bavaria; Munich Center of Health Sciences (MC Health) as part of LMUinnovativ; ANR(French National Research Agency (ANR)); Fonda-Mental Foundation; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Research Council of Norway(Research Council of Norway); South-East Norway Health Authority; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to all patients who contributed to this study. We also thank all probands from the community-based cohorts of PopGen, KORA, those from the Heinz Nixdorf Recall (HNR) study, and the Munich controls. This study was supported by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2), the National Genome Research Network plus (NGFNplus), and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to S.C. and M.M.N., grant 01GS08147 to M.R.). M.M.N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. M.G.-S. was supported by the Romanian Ministry for Education and Research (grant 42151/2008). C.C.D. was supported by the SOP HRD and was financed from the European Social Fund and by the Romanian Government (contract POSDRU/89/1.5/S/64109). This study was also supported by the Polish Ministry of Science and Higher Education (grant N N402 244035 to P.M.C.) The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the BMBF and by the State of Bavaria. KORA research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The HNR cohort was established with the support of the Heinz Nixdorf Foundation. We acknowledge the Wellcome Trust Case Control Consortium (www.wtccc.org.uk), its membership, and its funder, the Wellcome Trust, for generating and publishing data used for replication. Recruitment of the French sample was supported by ANR (ANR NEURO2006, MANAGE_BPAD), INSERM, AP-HP, and the Fonda-Mental Foundation (www.fondation-fondamental.org). Recruitment of the Australian BD sample was supported by the Australian NHMRC program, grant number 510135. The Norwegian study was supported by the Research Council of Norway (#167153/V50, #163070/V50, #175345/V50) and by the South-East Norway Health Authority (#123-2004). We are grateful to A. Becker, Department of Neuropathology, University of Bonn, Germany, for providing the human hippocampus tissue that was used in the gene expression analysis.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; APA, 1994, DIAGN STAT MAN MENT; Baum AE, 2008, MOL PSYCHIATR, V13, P466, DOI 10.1038/mp.2008.16; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fangerau H, 2004, HUM HERED, V58, P122, DOI 10.1159/000083538; FARMER AE, 1992, BRIT J PSYCHIAT, V161, P824, DOI 10.1192/bjp.161.6.824; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Iwanaga Y, 2007, CANCER RES, V67, P160, DOI 10.1158/0008-5472.CAN-06-3326; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Martinowich K, 2009, J CLIN INVEST, V119, P726, DOI 10.1172/JCI37703; Maxwell M.E., 1992, FAMILY INTERVIEW GEN; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miro X, 2009, DIS MODEL MECH, V2, P412, DOI 10.1242/dmm.001602; NUMBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849; PETERS L, 1995, PSYCHOL MED, V25, P1269, DOI 10.1017/S0033291700033237; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAUCH U, 1992, J BIOL CHEM, V267, P19536; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; WATANABE E, 1995, EUR J NEUROSCI, V7, P547, DOI 10.1111/j.1460-9568.1995.tb00659.x; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wittchen H-U., 1999, INT J METHODS PSYCHI, V8, P59, DOI [10.1002/mpr.57, DOI 10.1002/MPR.57]; Wittchen HU, 1996, PSYCHOL MED, V26, P1169, DOI 10.1017/S0033291700035893; World Health Organization (WHO), 1992, ICD 10 CLASS MENT BE; Zhou XH, 2001, MOL CELL BIOL, V21, P5970, DOI 10.1128/MCB.21.17.5970-5978.2001	42	211	211	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					372	381		10.1016/j.ajhg.2011.01.017	http://dx.doi.org/10.1016/j.ajhg.2011.01.017			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21353194	Bronze, Green Published			2022-12-18	WOS:000288589000014
J	Cichon, S; Muehleisen, TW; Degenhardt, FA; Mattheisen, M; Miro, X; Strohmaier, J; Steffens, M; Meesters, C; Herms, S; Weingarten, M; Priebe, L; Haenisch, B; Alexander, M; Vollmer, J; Breuer, R; Schmal, C; Tessmann, P; Moebus, S; Wichmann, HE; Schreiber, S; Muller-Myhsok, B; Lucae, S; Jamain, S; Leboyer, M; Bellivier, F; Etain, B; Henry, C; Kahn, JP; Heath, S; Hamshere, M; O'Donovan, MC; Owen, MJ; Craddock, N; Schwarz, M; Vedder, H; Kammerer-Ciernioch, J; Reif, A; Sasse, J; Bauer, M; Hautzinger, M; Wright, A; Mitchell, PB; Schofield, PR; Montgomery, GW; Medland, SE; Gordon, SD; Martin, NG; Gustafsson, O; Andreassen, O; Djurovic, S; Sigurdsson, E; Steinberg, S; Stefansson, H; Stefansson, K; Kapur-Pojskic, L; Oruc, L; Rivas, F; Mayoral, F; Chuchalin, A; Babadjanova, G; Tiganov, AS; Pantelejeva, G; Abramova, LI; Grigoroiu-Serbanescu, M; Diaconu, CC; Czerski, PM; Hauser, J; Zimmer, A; Lathrop, M; Schulze, TG; Wienker, TF; Schumacher, J; Maier, W; Propping, P; Rietschel, M; Nothen, MM				Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska A.; Mattheisen, Manuel; Miro, Xavier; Strohmaier, Jana; Steffens, Michael; Meesters, Christian; Herms, Stefan; Weingarten, Moritz; Priebe, Lutz; Haenisch, Britta; Alexander, Michael; Vollmer, Jennifer; Breuer, Rene; Schmael, Christine; Tessmann, Peter; Moebus, Susanne; Wichmann, H. -Erich; Schreiber, Stefan; Mueller-Myhsok, Bertram; Lucae, Susanne; Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal; Kahn, Jean-Pierre; Heath, Simon; Hamshere, Marian; O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick; Schwarz, Markus; Vedder, Helmut; Kammerer-Ciernioch, Jutta; Reif, Andreas; Sasse, Johanna; Bauer, Michael; Hautzinger, Martin; Wright, Adam; Mitchell, Philip B.; Schofield, Peter R.; Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.; Gustafsson, Omar; Andreassen, Ole; Djurovic, Srdjan; Sigurdsson, Engilbert; Steinberg, Stacy; Stefansson, Hreinn; Stefansson, Kari; Kapur-Pojskic, Lejla; Oruc, Liliana; Rivas, Fabio; Mayoral, Fermin; Chuchalin, Alexander; Babadjanova, Gulja; Tiganov, Alexander S.; Pantelejeva, Galina; Abramova, Lilia I.; Grigoroiu-Serbanescu, Maria; Diaconu, Carmen C.; Czerski, Piotr M.; Hauser, Joanna; Zimmer, Andreas; Lathrop, Mark; Schulze, Thomas G.; Wienker, Thomas F.; Schumacher, Johannes; Maier, Wolfgang; Propping, Peter; Rietschel, Marcella; Noethen, Markus M.		Bipolar Disorder Genome Study BiGS	Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder (vol 88, pg 372, 2011)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction									[Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany; [Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska A.; Mattheisen, Manuel; Herms, Stefan; Weingarten, Moritz; Priebe, Lutz; Haenisch, Britta; Alexander, Michael; Vollmer, Jennifer; Tessmann, Peter; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska A.; Mattheisen, Manuel; Herms, Stefan; Weingarten, Moritz; Priebe, Lutz; Haenisch, Britta; Alexander, Michael; Vollmer, Jennifer; Tessmann, Peter; Schumacher, Johannes; Propping, Peter; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Cichon, Sven; Mattheisen, Manuel; Steffens, Michael; Meesters, Christian; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53127 Bonn, Germany; [Cichon, Sven; Miro, Xavier; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, D-53127 Bonn, Germany; [Strohmaier, Jana; Breuer, Rene; Schmael, Christine; Rietschel, Marcella] Univ Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Moebus, Susanne] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, D-45147 Essen, Germany; [Wichmann, H. -Erich] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany; [Wichmann, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Mueller-Myhsok, Bertram; Lucae, Susanne] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal] ENBREC, INSERM, IMRB, Fdn Fondamental,U955, F-94010 Creteil, France; [Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal] Univ Paris Est, Fac Med, F-75005 Paris, France; [Jamain, Stephane; Leboyer, Marion; Bellivier, Frank; Etain, Bruno; Henry, Chantal] AP HP, Dept Psychiat, Henri Mondor Albert Chenevier Grp, F-94000 Creteil, France; [Kahn, Jean-Pierre] CHU Nancy, Jeanne dArc Hosp, Dept Psychiat & Clin Psychol, F-54200 Toul, France; [Heath, Simon; Lathrop, Mark] Ctr Natl Genotypage, F-91057 Evry, France; [Hamshere, Marian; O'Donovan, Michael C.; Owen, Michael J.; Craddock, Nick] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales; [Schwarz, Markus; Vedder, Helmut; Kammerer-Ciernioch, Jutta] Psychiat Ctr Nordbaden, D-69168 Wiesloch, Germany; [Reif, Andreas] Univ Wurzburg, Dept Psychiat, D-97070 Wurzburg, Germany; [Sasse, Johanna; Bauer, Michael] Univ Hosp Carl Gustav Carus, Dept Psychiat & Psychotherapy, D-01307 Dresden, Germany; [Hautzinger, Martin] Univ Tubingen, Inst Clin & Dev Psychol, Inst Psychol, D-72074 Tubingen, Germany; [Wright, Adam; Mitchell, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia; [Wright, Adam; Mitchell, Philip B.] Prince Wales Hosp, Black Dog Inst, Randwick, NSW 2031, Australia; [Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Schofield, Peter R.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia; [Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Gustafsson, Omar; Andreassen, Ole; Djurovic, Srdjan] Oslo Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Andreassen, Ole; Djurovic, Srdjan] Univ Oslo, Inst Psychiat, N-0450 Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Sigurdsson, Engilbert] Univ Iceland, Dept Psychiat, Natl Univ Hosp, IS-101 Reykjavik, Iceland; [Steinberg, Stacy; Stefansson, Hreinn; Stefansson, Kari] DeCODE Genet, CNS Div, IS-101 Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland; [Kapur-Pojskic, Lejla] Univ Sarajevo, Lab Human Genet, INGEB, BA-71000 Sarajevo, Bosnia & Herceg; [Oruc, Liliana] Univ Sarajevo, Psychiat Clin, Ctr Clin, BA-71000 Sarajevo, Bosnia & Herceg; [Rivas, Fabio; Mayoral, Fermin] Civil Hosp Carlos Haya, ES-29010 Malaga, Spain; [Chuchalin, Alexander; Babadjanova, Gulja] Russian State Med Univ, Inst Pulmonol, Moscow 105077, Russia; [Tiganov, Alexander S.; Pantelejeva, Galina; Abramova, Lilia I.] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 115522, Russia; [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Clin Psychiat Hosp, Biometr Psychiat Genet Res Unit, RO-041914 Bucharest, Romania; [Diaconu, Carmen C.] Romanian Acad, Stefan S Nicolau Inst Virol, RO-030304 Bucharest, Romania; [Czerski, Piotr M.; Hauser, Joanna] Poznan Univ Med Sci, Dept Psychiat, PL-60572 Poznan, Poland; [Schulze, Thomas G.] Univ Gottingen, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53127 Bonn, Germany	Helmholtz Association; Research Center Julich; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Central Institute of Mental Health; University of Mannheim; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Kiel; Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Nancy; CEA; UDICE-French Research Universities; Universite Paris Saclay; Cardiff University; University of Wurzburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; University of New South Wales Sydney; Black Dog Institute; Neuroscience Research Australia; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; University of Oslo; University of Oslo; University of Oslo; Landspitali National University Hospital; University of Iceland; University of Iceland; University of Sarajevo; University of Sarajevo; Pirogov Russian National Research Medical University; Russian Academy of Medical Sciences; Romanian Academy of Sciences; Stefan S. Nicolau Institute of Virology; Poznan University of Medical Sciences; University of Gottingen; University of Bonn	Cichon, S (corresponding author), Res Ctr Juelich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany.	sven.cichon@uni-bonn.de	Andreassen, Ole A./AAY-7531-2020; Cichon, Sven/B-9618-2014; Grigoroiu-Serbanescu, Maria/R-3689-2019; Heath, Simon C/J-4138-2012; Institute of Virology, Stefan S Nicolau/HGE-9069-2022; Panteleeva, G/K-4636-2013; Abramova, Liliya/K-4665-2013; Müller-Myhsok, Bertram/A-3289-2013; Herms, Stefan/J-1949-2014; Leboyer, Marion/AAW-3648-2021; O'Donovan, Michael C/P-7005-2018; Smith, Erin/E-5933-2011; Czerski, Piotr M./B-8446-2011; Schumacher, Johannes/F-4970-2015; BELLIVIER, FRANK/H-5197-2012; mayoral, fermin/C-2652-2013; Medland, Sarah E/C-7630-2013; Serbanescu, Maria/D-4306-2011; Tiganov, Alexander S/B-6768-2016; Zimmer, Andreas/B-8357-2009; Schulze, Thomas G/H-2157-2013; Greenwood, Tiffany/F-6356-2012; Diaconu, Carmen Cristina/B-9119-2011; Etain, Bruno/L-6647-2017; Degenhardt, Franziska/H-4169-2017; McMahon, Francis J/A-7290-2009; Liu, Chunyu/G-7561-2012; Wichmann, Heinz Erich/AAA-5695-2022; Mahon, Pamela Belmonte/O-9806-2018; Priebe, Lutz/D-4402-2011; Medland, Sarah/AAT-7595-2020; Martin, Nicholas/R-9235-2019; Jamain, Stéphane/P-3710-2017; Montgomery, Grant W/B-7148-2008; Stefansson, Kari/AAE-7187-2019; Mattheisen, Manuel/B-4949-2012; Mattheisen, Manuel/S-3725-2019; Cichon, Sven/H-8803-2013; Sigurdsson, Engilbert/D-2486-2014; Cucalin, Aleksandr/P-5678-2018; Schofield, Peter/C-9669-2011	Cichon, Sven/0000-0002-9475-086X; Grigoroiu-Serbanescu, Maria/0000-0002-1304-6687; Heath, Simon C/0000-0002-9550-0897; Panteleeva, G/0000-0002-5001-3198; Abramova, Liliya/0000-0003-4397-924X; Herms, Stefan/0000-0002-2786-8200; Leboyer, Marion/0000-0001-5473-3697; O'Donovan, Michael C/0000-0001-7073-2379; Czerski, Piotr M./0000-0003-0745-5916; Schumacher, Johannes/0000-0001-9217-6457; Medland, Sarah E/0000-0003-1382-380X; Serbanescu, Maria/0000-0002-1304-6687; Tiganov, Alexander S/0000-0003-0148-7538; Greenwood, Tiffany/0000-0002-6080-6503; Diaconu, Carmen Cristina/0000-0002-2259-1425; Etain, Bruno/0000-0002-5377-1488; McMahon, Francis J/0000-0002-9469-305X; Liu, Chunyu/0000-0002-5986-4415; Mahon, Pamela Belmonte/0000-0002-3947-441X; Medland, Sarah/0000-0003-1382-380X; Martin, Nicholas/0000-0003-4069-8020; Jamain, Stéphane/0000-0002-4321-4100; Montgomery, Grant W/0000-0002-4140-8139; Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Sigurdsson, Engilbert/0000-0001-9404-7982; Cucalin, Aleksandr/0000-0002-6808-5528; Nothen, Markus/0000-0002-8770-2464; Bauer, Michaela/0000-0001-8717-3278; Andreassen, Ole A./0000-0002-4461-3568; Mitchell, Philip/0000-0002-7954-5235; Schofield, Peter/0000-0003-2967-9662; BELLIVIER, FRANK/0000-0002-3660-6640; Meesters, Christian/0000-0003-2408-7588; Djurovic, Srdjan/0000-0002-8140-8061; Gordon, Scott/0000-0001-7623-328X; Mayoral-Cleries, Fermin/0000-0002-9710-9672; Steffens, Michael/0000-0002-6445-8593; Stefansson, Hreinn/0000-0002-9331-6666; Moebus, Susanne/0000-0002-0072-5410	Medical Research Council [G0801418B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Cichon S, 2011, AM J HUM GENET, V88, P372, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]	1	211	211	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					396	396		10.1016/j.ajhg.2011.03.001	http://dx.doi.org/10.1016/j.ajhg.2011.03.001			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21353194	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000288589000019
J	Gilissen, C; Arts, HH; Hoischen, A; Spruijt, L; Mans, DA; Arts, P; van Lier, B; Steehouwer, M; van Reeuwijk, J; Kant, SG; Roepman, R; Knoers, NVAM; Veltman, JA; Brunner, HG				Gilissen, Christian; Arts, Heleen H.; Hoischen, Alexander; Spruijt, Liesbeth; Mans, Dorus A.; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; van Reeuwijk, Jeroen; Kant, Sarina G.; Roepman, Ronald; Knoers, Nine V. A. M.; Veltman, Joris A.; Brunner, Han G.			Exome Sequencing Identifies WDR35 Variants Involved in Sensenbrenner Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPHYXIATING THORACIC DYSTROPHY; CRANIOECTODERMAL DYSPLASIA; RETINAL DEGENERATION; MUTATIONS; MOUSE; CILIA; PROTEIN; OBESITY; GENOME; TULP3	Sensenbrenner syndrome/cranioectodermal dysplasia (CED) is an autosomal-recessive disease that is characterized by craniosynostosis and ectodermal and skeletal abnormalities. We sequenced the exomes of two unrelated CED patients and identified compound heterozygous mutations in WDR35 as the cause of the disease in each of the two patients independently, showing that it is possible to find the causative gene by sequencing the exome of a single sporadic patient. With RT-PCR, we demonstrate that a splice-site mutation in exon 2 of WDR35 alters splicing of RNA on the affected allele, introducing a premature stop codon. WDR35 is homologous to TULP4 (from the Tubby superfamily) and has previously been characterized as an intraflagellar transport component, confirming that Sensenbrenner syndrome is a ciliary disorder.	[Gilissen, Christian; Arts, Heleen H.; Hoischen, Alexander; Spruijt, Liesbeth; Mans, Dorus A.; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; van Reeuwijk, Jeroen; Roepman, Ronald; Knoers, Nine V. A. M.; Veltman, Joris A.; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gilissen, Christian; Arts, Heleen H.; Hoischen, Alexander; Spruijt, Liesbeth; Mans, Dorus A.; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; van Reeuwijk, Jeroen; Roepman, Ronald; Knoers, Nine V. A. M.; Veltman, Joris A.; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6525 GA Nijmegen, Netherlands; [Kant, Sarina G.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZC Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Brunner, HG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands.	h.brunner@antrg.umcn.nl	arts, heleen/ACL-6040-2022; Hoischen, Alexander/D-1282-2013; Veltman, Joris A/F-5128-2010; Gilissen, Christian/E-5246-2012; Hoischen, Alexander/AGF-7293-2022; Spruijt, L./L-4664-2015; Kant, Sarina/F-8596-2010; van Reeuwijk, Jeroen/P-8665-2015; Roepman, Ronald/B-1339-2014; Arts, Peer/Q-4139-2019; Brunner, Han/C-9928-2013	Hoischen, Alexander/0000-0002-8072-4476; Veltman, Joris A/0000-0002-3218-8250; Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; van Reeuwijk, Jeroen/0000-0002-0658-4399; Roepman, Ronald/0000-0002-5178-8163; Arts, Peer/0000-0002-6742-6239; Arts, Heleen/0000-0002-9860-3744	Dutch Kidney Foundation [KJPB09.009]; Netherlands Organization for Scientific Research (NWO/ZonMw) [Vidi 91786396]; Netherlands Organization for Health Research and Development (ZonMw) [917-66-363, 911-08-025]; European Union [Health-F5-2009-223143, Health-F5-2010-241955, LSHG-CT-2006-37627]	Dutch Kidney Foundation; Netherlands Organization for Scientific Research (NWO/ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union(European Commission)	We thank the Sensenbrenner families for their participation. We also thank E.M. Bongers and P.L. Beales for supplying the additional CED patients, B.C. Hamel for the Jeune syndrome patients, and N. Wieskamp for bioinformatics support. We thank P. Mill, I. Jackson, and P.J. Lockhart for sharing their unpublished data with us. This research was supported by grants from the Dutch Kidney Foundation (KJPB09.009 to H.H.A.), the Netherlands Organization for Scientific Research (NWO/ZonMw Vidi 91786396 to R.R.), the Netherlands Organization for Health Research and Development (ZonMw 917-66-363 and 911-08-025 to J.A.V.), the European Union-funded TECHGENE project (Health-F5-2009-223143 to RA. and J.A.V.), SYSCILIA (Health-F5-2010-241955 to R.R.), and the AnEUploidy project (LSHG-CT-2006-37627 to A.H., H.G.B., and J.A.V.).	Amar MJA, 1997, AM J MED GENET, V70, P349, DOI 10.1002/(SICI)1096-8628(19970627)70:4<349::AID-AJMG3>3.0.CO;2-O; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Cameron DA, 2009, DEV DYNAM, V238, P1140, DOI 10.1002/dvdy.21926; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Ikeda S, 2000, HUM MOL GENET, V9, P155, DOI 10.1093/hmg/9.2.155; LEVIN LS, 1977, J PEDIATR-US, V90, P55, DOI 10.1016/S0022-3476(77)80764-6; Mill P, 2009, MECH DEVELOP, V126, pS265, DOI 10.1016/j.mod.2009.06.702; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Norman RX, 2009, HUM MOL GENET, V18, P1740, DOI 10.1093/hmg/ddp113; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sensenbrenner J A, 1975, Birth Defects Orig Artic Ser, V11, P372; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	24	211	219	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					418	423		10.1016/j.ajhg.2010.08.004	http://dx.doi.org/10.1016/j.ajhg.2010.08.004			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20817137	Bronze, Green Published			2022-12-18	WOS:000281923500012
J	Alanay, Y; Avaygan, H; Camacho, N; Utine, GE; Boduroglu, K; Aktas, D; Alikasifoglu, M; Tuncbilek, E; Orhan, D; Bakar, FT; Zabel, B; Superti-Furga, A; Bruckner-Tuderman, L; Curry, CJR; Pyott, S; Byers, PH; Eyre, DR; Baldridge, D; Lee, B; Merrill, AE; Davis, EC; Cohn, DH; Akarsu, N; Krakow, D				Alanay, Yasemin; Avaygan, Hrispima; Camacho, Natalia; Utine, G. Eda; Boduroglu, Koray; Aktas, Dilek; Alikasifoglu, Mehmet; Tuncbilek, Ergul; Orhan, Diclehan; Bakar, Filiz Tiker; Zabel, Bernard; Superti-Furga, Andrea; Bruckner-Tuderman, Leena; Curry, Cindy J. R.; Pyott, Shawna; Byers, Peter H.; Eyre, David R.; Baldridge, Dustin; Lee, Brendan; Merrill, Amy E.; Davis, Elaine C.; Cohn, Daniel H.; Akarsu, Nurten; Krakow, Deborah			Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal-Recessive Osteogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRITTLE BONE-DISEASE; FK506-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; DEVELOPMENTAL REGULATION; EPIDERMOLYSIS-BULLOSA; MOLECULAR CHAPERONE; PROCOLLAGEN; COLLAGEN; ENZYMES; FAMILY	Osteogenesis imperfecta is a clinically and genetically heterogeneous brittle bone disorder that results from defects in the synthesis, structure, or posttranslational modification of type I procollagen. Dominant forms of OI result from mutations in COL1A1 or COL1A2, which encode the chains of the type I procollagen heterotrimer. The mildest form of OI typically results from diminished synthesis of structurally normal type 1 procollagen, whereas moderately severe to lethal forms of OI usually result from structural defects in one of the type 1 procollagen chains. Recessively inherited OI, usually phenotypically severe, has recently been shown to result from defects in the prolyl-3-hydroxylase complex that lead to the absence of a single 3-hydroxyproline at residue 986 of the alpha 1 (I) triple helical domain. We studied a cohort of five consanguineous Turkish families, originating from the Black Sea region of Turkey, with moderately severe recessively inherited OI and identified a novel locus for OI on chromosome 17. In these families, and in a Mexican-American family, homozygosity for mutations in FKBP10, which encodes FKBP65, a chaperone that participates in type 1 procollagen folding, was identified. Further, we determined that FKBP10 mutations affect type I procollagen secretion. These findings identify a previously unrecognized mechanism in the pathogenesis of OI.	[Avaygan, Hrispima; Camacho, Natalia; Merrill, Amy E.; Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Alanay, Yasemin; Utine, G. Eda; Boduroglu, Koray; Aktas, Dilek; Alikasifoglu, Mehmet; Tuncbilek, Ergul] Hacettepe Univ, Fac Med, Pediat Genet Unit, Dept Pediat, TR-06100 Ankara, Turkey; [Akarsu, Nurten] Hacettepe Univ, Fac Med, Gene Mapping Lab, Dept Med Genet, TR-06100 Ankara, Turkey; [Orhan, Diclehan] Hacettepe Univ, Fac Med, Pediat Pathol Unit, TR-06100 Ankara, Turkey; [Bakar, Filiz Tiker] Yeditepe Univ, Dept Pediat, TR-34755 Istanbul, Turkey; [Cohn, Daniel H.; Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Zabel, Bernard; Superti-Furga, Andrea] Univ Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, Dept Dermatol, D-79106 Freiburg, Germany; [Curry, Cindy J. R.] Cent Calif, Genet Med, Fresno, CA 93710 USA; [Pyott, Shawna; Byers, Peter H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Baldridge, Dustin; Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Cohn, Daniel H.; Krakow, Deborah] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hacettepe University; Hacettepe University; Hacettepe University; Yeditepe University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Freiburg; University of Freiburg; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine; McGill University; Cedars Sinai Medical Center	Krakow, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.	dkrakow@mednet.ucla.edu	Alanay, Yasemin/A-1516-2016; superti-furga, andrea/E-9162-2015; BODUROGLU, KORAY O/I-9094-2013; Davis, Elaine/F-3449-2012; Akarsu, Nurten/E-9758-2013; Krakow, Deborah/B-5778-2009	Alanay, Yasemin/0000-0003-0683-9731; superti-furga, andrea/0000-0002-3543-7531; Akarsu, Nurten/0000-0001-5432-0032; Krakow, Deborah/0000-0001-9906-4968; Byers, Peter H./0000-0001-7786-7030; Boduroglu, Koray/0000-0001-6260-1942; Merrill-Brugger, Amy/0000-0002-3660-1575	TUBITAK [2219]; NIHCD [HD22657]; NIH [R01DE019567]; SKELNET; EuroGrow; Facility for Electron Microscopy Research (FEMR) at McGill University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R37AR037318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019567] Funding Source: NIH RePORTER	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NIHCD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SKELNET; EuroGrow; Facility for Electron Microscopy Research (FEMR) at McGill University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Y.A. was supported by TUBITAK (2219 Program). D.K., D.H.C., D.R.E., and B.L. were supported by NIHCD HD22657. D.K. and D.H.C. were also supported by NIH R01DE019567. B.Z. and A.S.F. are supported by SKELNET and EuroGrow. E.C.D. is a Canada Research Chair. We also acknowledge the support of the Facility for Electron Microscopy Research (FEMR) at McGill University.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; BYERS P, ONLINE METABOLIC MOL, pCH205; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Land C, 2007, BONE, V40, P638, DOI 10.1016/j.bone.2006.10.010; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; Patterson CE, 2005, CELL STRESS CHAPERON, V10, P285, DOI 10.1379/CSC-118R.1; Patterson CE, 2002, GENOMICS, V79, P881, DOI 10.1006/geno.2002.6777; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; Yiasemides E, 2008, CLIN EXP DERMATOL, V33, P689, DOI 10.1111/j.1365-2230.2008.02858.x; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	27	211	220	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					551	559		10.1016/j.ajhg.2010.02.022	http://dx.doi.org/10.1016/j.ajhg.2010.02.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20362275	Bronze, Green Published			2022-12-18	WOS:000276716800005
J	Yamamoto, G; Nannya, Y; Kato, M; Sanada, M; Levine, RL; Kawamata, N; Hangaishi, A; Kurokawa, M; Chiba, S; Gilliland, DG; Koeffler, HP; Ogawa, S				Yamamoto, Go; Nannya, Yasuhito; Kato, Motohiro; Sanada, Masashi; Levine, Ross L.; Kawamata, Norihiko; Hangaishi, Akira; Kurokawa, Mineo; Chiba, Shigeru; Gilliland, D. Gary; Koeffler, H. Phillip; Ogawa, Seishi			Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE MYELOID LEUKEMIAS; LOSS-OF-HETEROZYGOSITY; TYROSINE KINASE JAK2; COPY NUMBER; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; OLIGONUCLEOTIDE ARRAYS; UNIPARENTAL DISOMY; V617F MUTATION	Loss of heterozygosity (LOH), either with or without accompanying copy-number loss, is a cardinal feature of cancer genomes that is tightly linked to cancer development. However, detection of LOH is frequently hampered by the presence of normal cell components within tumor specimens and the limitation in availability of constitutive DNA. Here, we describe a simple but highly sensitive method for genomewide detection of allelic composition, based on the Affymetrix single-nucleotide-polymorphism genotyping microarray platform, without dependence on the availability of constitutive DNA. By sensing subtle distortions in allele-specific signals caused by allelic imbalance with the use of anonymous controls, sensitive detection of LOH is enabled with accurate determination of allele-specific copy numbers, even in the presence of up to 70%-80% normal cell contamination. The performance of the new algorithm, called "AsCNAR" (allele-specific copy-number analysis using anonymous references), was demonstrated by detecting the copy-number neutral LOH, or uniparental disomy ( UPD), in a large number of acute leukemia samples. We next applied this technique to detection of UPD involving the 9p arm in myeloproliferative disorders ( MPDs), which is tightly associated with a homozygous JAK2 mutation. It revealed an unexpectedly high frequency of 9p UPD that otherwise would have been undetected and also disclosed the existence of multiple subpopulations having distinct 9p UPD within the same MPD specimen. In conclusion, AsCNAR should substantially improve our ability to dissect the complexity of cancer genomes and should contribute to our understanding of the genetic basis of human cancers.	Univ Tokyo, Grad Sch Med, Dept Cell Therapy & Transplantat Med,21st Century, Dept Regenerat Med Hematopoiesis,Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Hematol Oncol, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1138655, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Therapy & Transplantat Med,21st Century, Dept Regenerat Med Hematopoiesis,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sogawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019; levine, ross/AAE-7658-2019	Kato, Motohiro/0000-0001-5145-1774				Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beroukhim R, 2006, PLOS COMPUT BIOL, V2, P323, DOI 10.1371/journal.pcbi.0020041; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; DUGAD R, 1996, SPANN961 SIGN PROC A; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Huang Jing, 2004, Human Genomics, V1, P287; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Najfeld V, 2002, BRIT J HAEMATOL, V119, P558, DOI 10.1046/j.1365-2141.2002.03763.x; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Raghavan M, 2005, CANCER RES, V65, P375; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Wang LL, 2003, BLOOD, V102, P2597, DOI 10.1182/blood-2003-01-0031; Wang ZGC, 2006, BREAST CANCER RES TR, V97, P301, DOI 10.1007/s10549-005-9124-5; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhou XF, 2004, HUM GENET, V115, P327, DOI 10.1007/s00439-004-1163-1	27	211	215	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					114	126		10.1086/518809	http://dx.doi.org/10.1086/518809			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564968	Green Published, Bronze			2022-12-18	WOS:000247039700010
J	Amiel, J; Rio, M; de Pontual, L; Redon, R; Malan, V; Boddaert, N; Plouin, P; Carter, NP; Lyonnet, S; Munnich, A; Colleaux, L				Amiel, Jeanne; Rio, Marlene; de Pontual, Loic; Redon, Richard; Malan, Valerie; Boddaert, Nathalie; Plouin, Perrine; Carter, Nigel P.; Lyonnet, Stanislas; Munnich, Arnold; Colleaux, Laurence			Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL CENTRAL HYPOVENTILATION; MENTAL-RETARDATION; LYMPHOCYTE DEVELOPMENT; DNA-BINDING; PROTEINS; GENE; E2-2; IDENTIFICATION; SEQUENCE; COMPLEX	Pitt-Hopkins syndrome (PHS) is a rare syndromic encephalopathy characterized by daily bouts of hyperventilation and a facial gestalt. We report a 1.8-Mb de novo microdeletion on chromosome 18q21.1, identified by array - comparative genomic hybridization in one patient with PHS. We subsequently identified two de novo heterozygous missense mutations of a conserved amino acid in the basic region of the TCF4 gene in three additional subjects with PHS. These findings demonstrate that TCF4 anomalies are responsible for PHS and provide the first evidence of a human disorder related to class I basic helix-loop-helix transcription- factor defects ( also known as "E proteins"). Moreover, our data may shed new light on the normal processes underlying autonomic nervous system development and maintenance of an appropriate ventilatory neuronal circuitry.	Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, Assistance Publ Hop Paris,Fac Med, F-75743 Paris 15, France; Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Assistance Publ Hop Paris,INSERM,U781, F-75743 Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Assistance Publ Hop Paris,INSERM,U797, F-75743 Paris 15, France; Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Assistance Publ Hop Paris,INSERM,U663, F-75743 Paris 15, France; Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Assistance Publ Hop Paris,Clin Neurophysiol Unit, F-75743 Paris 15, France; Wellcome Trust Sanger Inst, Cambridge, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Wellcome Trust Sanger Institute	Amiel, J (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, Assistance Publ Hop Paris,Fac Med, 149,Rue Sevres, F-75743 Paris 15, France.	amiel@necker.fr	Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; COLLEAUX, Laurence/H-6455-2017; amiel, jeanne/H-3501-2017; boddaert, nathalie/GWV-2865-2022; Redon, Richard/F-3303-2014; Malan, Valerie/H-7423-2017; COLLEAUX, LAURENCE/AAA-8144-2022	Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; Redon, Richard/0000-0001-7751-2280; Malan, Valerie/0000-0002-3450-4958; COLLEAUX, LAURENCE/0000-0002-0987-7648; boddaert, nathalie/0000-0003-0991-7774; DE PONTUAL, LOIC/0000-0002-3123-0453; Rio, Marlene/0000-0003-2049-5058	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALL DW, 1993, P NATL ACAD SCI USA, V90, P5648, DOI 10.1073/pnas.90.12.5648; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; CORNELIUSSEN B, 1991, J VIROL, V65, P6084, DOI 10.1128/JVI.65.11.6084-6093.1991; de Pontual L, 2003, HUM MOL GENET, V12, P3173, DOI 10.1093/hmg/ddg339; DEAR TN, 1993, P NATL ACAD SCI USA, V90, P4431, DOI 10.1073/pnas.90.10.4431; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; Hosoda H, 2004, GENE, V338, P235, DOI 10.1016/j.gene.2004.05.022; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Orrico A, 2001, AM J MED GENET, V103, P157, DOI 10.1002/ajmg.1523; Pagliuca A, 2000, CANCER RES, V60, P1376; Peippo MM, 2006, CLIN DYSMORPHOL, V15, P47, DOI 10.1097/01.mcd.0000184973.14775.32; Persson P, 2000, BIOCHEM BIOPH RES CO, V274, P22, DOI 10.1006/bbrc.2000.3090; PITT D, 1978, AUST PAEDIATR J, V14, P182; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; SINGH HA, 1993, J PAEDIATR CHILD H, V29, P156; Van Balkom IDC, 1998, AM J MED GENET, V75, P273, DOI 10.1002/(SICI)1096-8628(19980123)75:3<273::AID-AJMG9>3.0.CO;2-R; ZHANG Y, 1991, NUCLEIC ACIDS RES, V19, P4555, DOI 10.1093/nar/19.16.4555; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zhuang YA, 1998, MOL CELL BIOL, V18, P3340, DOI 10.1128/MCB.18.6.3340	25	211	217	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					988	993		10.1086/515582	http://dx.doi.org/10.1086/515582			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436254	Green Published, Bronze			2022-12-18	WOS:000245973200018
J	Rootsi, S; Magri, C; Kivisild, T; Benuzzi, G; Help, H; Bermisheva, M; Kutuev, I; Barac, L; Pericic, M; Balanovsky, O; Pshenichnov, A; Dion, D; Grobei, M; Zhivotovsky, LA; Battaglia, V; Achilli, A; Al-Zahery, N; Parik, J; King, R; Cinnioglu, C; Khusnutdinova, E; Rudan, P; Balanovska, E; Scheffrahn, W; Simonescu, M; Brehm, A; Goncalves, R; Rosa, A; Moisan, JP; Chaventre, A; Ferak, V; Furedi, S; Oefner, PJ; Shen, PD; Beckman, L; Mikerezi, I; Terzic, R; Primorac, D; Cambon-Thomsen, A; Krumina, A; Torroni, A; Underhill, PA; Santachiara-Benerecetti, AS; Villems, R; Semino, O				Rootsi, S; Magri, C; Kivisild, T; Benuzzi, G; Help, H; Bermisheva, M; Kutuev, I; Barac, L; Pericic, M; Balanovsky, O; Pshenichnov, A; Dion, D; Grobei, M; Zhivotovsky, LA; Battaglia, V; Achilli, A; Al-Zahery, N; Parik, J; King, R; Cinnioglu, C; Khusnutdinova, E; Rudan, P; Balanovska, E; Scheffrahn, W; Simonescu, M; Brehm, A; Goncalves, R; Rosa, A; Moisan, JP; Chaventre, A; Ferak, V; Furedi, S; Oefner, PJ; Shen, PD; Beckman, L; Mikerezi, I; Terzic, R; Primorac, D; Cambon-Thomsen, A; Krumina, A; Torroni, A; Underhill, PA; Santachiara-Benerecetti, AS; Villems, R; Semino, O			Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-POPULATIONS; DIVERGENCE TIME; POLYMORPHISMS; MTDNA; HAPLOTYPES; SARDINIA; MICROSATELLITE; PERSPECTIVE; HISTORY; ORIGINS	To investigate which aspects of contemporary human Y-chromosome variation in Europe are characteristic of primary colonization, late-glacial expansions from refuge areas, Neolithic dispersals, or more recent events of gene flow, we have analyzed, in detail, haplogroup I (Hg I), the only major clade of the Y phylogeny that is widespread over Europe but virtually absent elsewhere. The analysis of 1,104 Hg I Y chromosomes, which were identified in the survey of 7,574 males from 60 population samples, revealed several subclades with distinct geographic distributions. Subclade I1a accounts for most of Hg I in Scandinavia, with a rapidly decreasing frequency toward both the East European Plain and the Atlantic fringe, but microsatellite diversity reveals that France could be the source region of the early spread of both I1a and the less common I1c. Also, I1b*, which extends from the eastern Adriatic to eastern Europe and declines noticeably toward the southern Balkans and abruptly toward the periphery of northern Italy, probably diffused after the Last Glacial Maximum from a homeland in eastern Europe or the Balkans. In contrast, I1b2 most likely arose in southern France/Iberia. Similarly to the other subclades, it underwent a postglacial expansion and marked the human colonization of Sardinia similar to9,000 years ago.	Univ Tartu, Estonian Bioctr, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450001, Russia; Inst Anthropol Res, Zagreb, Croatia; Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia; Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow, Russia; Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest, Romania; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Madeira, Ctr Macaronesian Studies, Human Genet Lab, Madeira, Portugal; Fac Med, Lab Etud Polymorphisme ADN, Nantes, France; Comenius Univ, Fac Nat Sci, Dept Mol Genet, Bratislava, Slovakia; Inst Forens Sci, Budapest, Hungary; Stanford DNA Sequencing & Technol Ctr, Palo Alto, CA USA; Gotland Univ, Visby, Sweden; Tirana Univ, Fac Nat Sci, Dept Biol, Tirana, Albania; Med Sch Tuzla, Dept Biol & Genet, Tuzla, Bosnia & Herceg; Split Univ, Sch Med, Split, Croatia; Osijek Univ, Sch Med, Osijek, Croatia; Fac Med Toulouse, INSERM, U558, F-31073 Toulouse, France; Med Acad Latvia, Riga, Latvia	Estonian Biocentre; University of Tartu; University of Pavia; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Institute for Anthropological Research Zagreb; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; University of Zurich; Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; Stanford University; Universidade da Madeira; Comenius University Bratislava; Stanford University; University of Tirana (UT); University of Tuzla; University of Split; University of JJ Strossmayer Osijek; Institut National de la Sante et de la Recherche Medicale (Inserm); Riga Stradins University	Rootsi, S (corresponding author), Univ Tartu, Estonian Bioctr, Dept Evolutionary Biol, Riia 23, EE-51010 Tartu, Estonia.	sroots@ebc.ee	Kivisild, Toomas/P-5889-2017; Primorac, Dragan/GYJ-1505-2022; Battaglia, Vincenza/F-6950-2017; Primorac, Dragan/I-6941-2017; Al-Zahery, Nadia/AAV-5878-2020; Primorac, Dragan/ABF-6238-2020; Torroni, Antonio/E-1557-2011; Magri, Chiara/I-4691-2017; Balanovsky, Oleg/G-1549-2014; Terzić, Rifet/AHC-7996-2022; Achilli, Alessandro/I-9236-2012; Zhivotovsky, Lev A/A-1351-2012; Rosa, Araceli/Q-2099-2016; Khusnutdinova, Elza Kamilevna/A-4810-2013	Kivisild, Toomas/0000-0002-6297-7808; Torroni, Antonio/0000-0002-4163-4478; Magri, Chiara/0000-0001-9933-8666; Achilli, Alessandro/0000-0001-6871-3451; Rosa, Araceli/0000-0001-6935-3785; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Brehm, Antonio/0000-0003-3168-5340; SEMINO, Ornella/0000-0002-9675-9403; Rosa, Alexandra/0000-0002-1827-6828	NIGMS NIH HHS [P01 GM028428] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; BANDELT HJ, 1995, GENETICS, V141, P743; Barac L, 2003, EUR J HUM GENET, V11, P535, DOI 10.1038/sj.ejhg.5200992; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Caglia A, 1997, EUR J HUM GENET, V5, P288, DOI 10.1159/000484779; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Ciminelli BM, 1995, J MOL EVOL, V41, P966; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; DJINDJIAN F, 2000, HUNTERS GOLDEN AGE M, P313; Dolukhanov P. M., 2000, ROOTS PEOPLES LANGUA, P71; DOLUKHANOV PM, 2000, ROOTS PEOPLES LANGUA, V3; Ellis N, 2002, GENOME RES, V12, P339; FLORES C, IN PRESS EUR J HUM G; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Malaspina P, 2000, ANN HUM GENET, V64, P395, DOI 10.1046/j.1469-1809.2000.6450395.x; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Nasidze I, 2003, HUM GENET, V112, P255, DOI 10.1007/s00439-002-0874-4; NEI M, 1987, MOL EVOLUTIONARY GEN, P145; Passarino G, 2002, EUR J HUM GENET, V10, P521, DOI 10.1038/sj.ejhg.5200834; Passarino G, 2001, HUM HERED, V52, P136, DOI 10.1159/000053368; PERLES C, 2000, HUNTERS GOLDEN AGE M, P375; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Quintana-Murci L, 1999, ANN HUM GENET, V63, P153, DOI 10.1046/j.1469-1809.1999.6320153.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; ROEWER L, 1992, HUM GENET, V89, P389; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Sanchez JJ, 2003, FORENSIC SCI INT, V137, P74, DOI 10.1016/S0379-0738(03)00299-8; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Ye J, 2002, J FORENSIC SCI, V47, P593; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	45	211	221	4	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					128	137		10.1086/422196	http://dx.doi.org/10.1086/422196			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15162323	Green Published, Bronze			2022-12-18	WOS:000222031300016
J	North, BV; Curtis, D; Sham, PC				North, BV; Curtis, D; Sham, PC			A note on the calculation of empirical P values from Monte Carlo procedures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TESTS		St Bartholomews & Royal London Sch Med & Dent, Joint Acad Dept Psychol Med, London E1 1BB, England; Inst Psychiat, Dept Psychol Med, London SE5 8AF, England	University of London; Queen Mary University London; University of London; King's College London	Curtis, D (corresponding author), St Bartholomews & Royal London Sch Med & Dent, Joint Acad Dept Psychol Med, 3rd Floor,Alexandra Wing,Turner St, London E1 1BB, England.		Peng, Bo/A-6920-2009; Curtis, David/HGB-3921-2022	Peng, Bo/0000-0001-8225-2284; Curtis, David/0000-0002-4089-9183				Cordell HJ, 2000, AM J HUM GENET, V66, P1273, DOI 10.1086/302847; Davison AC, 1997, BOOTSTRAP METHODS TH; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Zhao JH, 1999, AM J HUM GENET, V64, P1484, DOI 10.1086/302378	4	211	213	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					439	441		10.1086/341527	http://dx.doi.org/10.1086/341527			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12111669	Green Published, Bronze			2022-12-18	WOS:000176977700024
J	Newbury, DF; Ishikawa-Brush, Y; Marlow, AJ; Fisher, SE; Monaco, AP; Stott, CM; Merricks, MJ; Goodyer, IM; Bolton, PF; Jannoun, L; Slonims, V; Baird, G; Pickles, A; Bishop, DVM; Conti-Ramsden, G; Helms, PJ				Newbury, DF; Ishikawa-Brush, Y; Marlow, AJ; Fisher, SE; Monaco, AP; Stott, CM; Merricks, MJ; Goodyer, IM; Bolton, PF; Jannoun, L; Slonims, V; Baird, G; Pickles, A; Bishop, DVM; Conti-Ramsden, G; Helms, PJ		SLI Consortium	A genomewide scan identifies two novel loci involved in specific language impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; LINKAGE ANALYSIS; GENETIC-LINKAGE; SPEECH; AUTISM; CHILDREN; DISORDERS; DYSLEXIA; LOCALIZATION; ASSOCIATION	Approximately 4% of English-speaking children are affected by specific language impairment (SLI), a disorder in the development of language skills despite adequate opportunity and normal intelligence. Several studies have indicated the importance of genetic factors in SLI; a positive family history confers an increased risk of development, and concordance in monozygotic twins consistently exceeds that in dizygotic twins. However, like many behavioral traits, SLI is assumed to be genetically complex, with several loci contributing to the overall risk. We have compiled 98 families drawn from epidemiological and clinical populations, all with probands whose standard language scores fall greater than or equal to1.5 SD below the mean for their age. Systematic genomewide quantitative-trait-locus analysis of three language-related measures (i.e., the Clinical Evaluation of Language Fundamentals-Revised [CELF-R] receptive and expressive scales and the nonword repetition [NWR] test) yielded two regions, one on chromosome 16 and one on 19, that both had maximum LOD scores of 3.55. Simulations suggest that, of these two multipoint results, the NWR linkage to chromosome 16q is the most significant, with empirical P values reaching 10 5 5, under both Haseman-Elston (HE) analysis (LOD score 3.55; P = .00003) and variance-components (VC) analysis (LOD score 2.57; P = .00008). Single-point analyses provided further support for involvement of this locus, with three markers, under the peak of linkage, yielding LOD scores >1.9. The 19q locus was linked to the CELF-R expressive-language score and exceeds the threshold for suggestive linkage under all types of analysis performed-multipoint HE analysis (LOD score 3.55; empirical P = .00004) and VC (LOD score 2.84; empirical P = .00027) and single-point HE analysis (LOD score 2.49) and VC (LOD score 2.22). Furthermore, both the clinical and epidemiological samples showed independent evidence of linkage on both chromosome 16q and chromosome 19q, indicating that these may represent universally important loci in SLI and, thus, general risk factors for language impairment.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Guys Hosp, Newcomen Ctr, London SE1 9RT, England; Univ Manchester, Sch Epidemiol & Hlth Sci, Manchester M13 9PL, Lancs, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 2JD, England; Univ Manchester, Sch Educ, Manchester M13 9PL, Lancs, England; Univ Aberdeen, Dept Child Hlth, Aberdeen AB9 1FX, Scotland	University of Oxford; Wellcome Centre for Human Genetics; Guy's & St Thomas' NHS Foundation Trust; University of Manchester; University of Oxford; University of Manchester; University of Aberdeen	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk; pfb1000@hermes.cam.ac.uk	Fisher, Simon E./E-9130-2012; Pickles, Andrew/A-9625-2011; Monaco, Anthony P/A-4495-2010	Fisher, Simon E./0000-0002-3132-1996; Pickles, Andrew/0000-0003-1283-0346; Monaco, Anthony P/0000-0001-7480-3197; Bishop, Dorothy/0000-0002-2448-4033	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMOS CI, 1994, AM J HUM GENET, V54, P535; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 1993, Memory, V1, P65, DOI 10.1080/09658219308258225; Bailey A, 1998, HUM MOL GENET, V7, P571; BEITCHMAN JH, 1994, J AM ACAD CHILD PSY, V33, P1322, DOI 10.1097/00004583-199411000-00015; BISHOP DVM, 1990, J CHILD PSYCHOL PSYC, V31, P1027, DOI 10.1111/j.1469-7610.1990.tb00844.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Bishop DVM, 1999, J SPEECH LANG HEAR R, V42, P155, DOI 10.1044/jslhr.4201.155; BISHOP DVM, 1986, BRIT J DISORD COMMUN, V21, P321; CANTWELL DP, 1987, J COMMUN DISORD, V20, P151, DOI 10.1016/0021-9924(87)90006-2; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CATTS HW, 1993, J SPEECH HEAR RES, V36, P948, DOI 10.1044/jshr.3605.948; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Fagerheim T, 1999, J MED GENET, V36, P664; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; FISHER SE, IN PRESS NAT GENET, P30; Folstein SE, 2000, AM J HUM GENET, V67, P278, DOI 10.1086/303034; Gallagher A, 2000, J CHILD PSYCHOL PSYC, V41, P203, DOI 10.1111/1469-7610.00601; Gathercole S E, 1994, Memory, V2, P103, DOI 10.1080/09658219408258940; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; HAFEMAN L, 1999, MOL PSYCHIAT S, V4; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; Lamb JA, 2000, HUM MOL GENET, V9, P861, DOI 10.1093/hmg/9.6.861; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Law J, 1998, Health Technol Assess, V2, P1; LEWIS BA, 1992, J SPEECH HEAR RES, V35, P1086, DOI 10.1044/jshr.3505.1086; LUI J, 2001, AM J HUM GENET, V69, P327; Mukhopadhyay N, 1999, AM J HUM GENET, V65, pA436; NEILS J, 1986, PERCEPT MOTOR SKILL, V63, P655, DOI 10.2466/pms.1986.63.2.655; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Semel EM, 1992, CLIN EVALUATION LANG; Snowling M, 2000, J CHILD PSYCHOL PSYC, V41, P587, DOI 10.1111/1469-7610.00651; Snowling MJ, 2001, INT J LANG COMM DIS, V36, P173, DOI 10.1080/13682820010019892; STEVENSON J, 1976, DEV MED CHILD NEUROL, V18, P431; STOTT CM, IN PRESS INT J LANG; Stromswold K, 1998, HUM BIOL, V70, P297; TALLAL P, 1989, J SPEECH HEAR DISORD, V54, P167, DOI 10.1044/jshd.5402.167; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Tomblin JB, 1996, J SPEECH HEAR RES, V39, P1284, DOI 10.1044/jshr.3906.1284; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; Warburton P, 2000, AM J MED GENET, V96, P228, DOI 10.1002/(SICI)1096-8628(20000403)96:2<228::AID-AJMG20>3.0.CO;2-G; Wechsler D., 1992, WECHSLER INTELLIGENC; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	56	211	216	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					384	398						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	511FQ	11791209				2022-12-18	WOS:000173254300011
J	Epstein, MP; Duren, WL; Boehnke, M				Epstein, MP; Duren, WL; Boehnke, M			Improved inference of relationship for pairs of individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; HUMAN GENOME; ERRORS; TRAITS; MAPS	Linkage analyses of genetic diseases and quantitative traits generally are performed using family data. These studies assume the relationships between individuals within families are known correctly. Misclassification of relationships can lead to reduced or inappropriately increased evidence for linkage. Boehnke and Cox (1997) presented a likelihood-based method to infer the most likely relationship of a pair of putative sibs. Here, we modify this method to consider all possible pairs of individuals in the sample, to test for additional relationships, to allow explicitly for genotyping error, and to include X-linked data. Using autosomal genome scan data, our method has excellent power to differentiate monozygotic twins, full sibs, parent-offspring pairs, second-degree (2 degrees) relatives, first cousins, and unrelated pairs but is unable to distinguish accurately among the 2 degrees relationships of half sibs, avuncular pairs, and grandparent-grandchild pairs. Inclusion of X-linked data improves our ability to distinguish certain types of 2 degrees relationships. Our method also models genotyping error successfully, to judge by the recovery of MZ twins and parent-offspring pairs that are otherwise misclassified when error exists. We have included these extensions in the latest version of our computer program RELPAIR and have applied the program to data from the Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus (FUSION) study.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	boehnke@umich.edu			NHGRI NIH HHS [R01HG00376, R01 HG000376, T32 HG000040, T32HG00040] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040, R01HG000376] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baum LE, 1972, INEQUALITIES, V3, P1; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Browning S, 1998, J COMPUT BIOL, V5, P323, DOI 10.1089/cmb.1998.5.323; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Duren WL, 1997, AM J HUM GENET, V61, pA273; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Hauser ER, 1998, BIOMETRICS, V54, P1238, DOI 10.2307/2533653; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; RISCH N, 1990, AM J HUM GENET, V46, P229; Stivers D. N., 1996, American Journal of Human Genetics, V59, pA190; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; ZHAO H, IN PRESS J COMPUT BI	22	211	215	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1219	1231		10.1016/S0002-9297(07)62952-8	http://dx.doi.org/10.1016/S0002-9297(07)62952-8			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032786	Green Published, Bronze			2022-12-18	WOS:000165091600019
J	Ikeda, H; Sasaki, T; Yoshimoto, T; Fukui, M; Arinami, T				Ikeda, H; Sasaki, T; Yoshimoto, T; Fukui, M; Arinami, T			Mapping of a familial Moyamoya disease gene to chromosome 3p24.2-p26	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JAPAN	Moyamoya disease is characterized by bilateral stenosis and/or occlusion of the terminal portion of the internal carotid artery. Moyamoya disease is prevalent among patients <10 years of age. Although most cases appear to be sporadic, similar to 10% occur as familial cases. The incidence of familial cases has been increasing because noninvasive diagnostic equipment, such as magnetic-resonance imaging and magnetic-resonance angiography, can detect the disease in almost all affected patients, including asymptomatic patients, during screening studies. In this study, we performed a total genome search to identify the location of a familial moyamoya disease gene in 16 families, assuming an unknown mode of inheritance. A linkage was found between the disease and markers located at 3p24.2-26. A maximum NPL score of 3.46 was obtained with marker D3S3050. This is the first genetic locus found to be involved in the molecular pathogenesis of familial moyamoya disease.	Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 980, Japan; Kyushu Univ, Fac Med, Neurol Inst, Dept Neurosurg, Fukuoka 812, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Med Genet, Tsukuba, Ibaraki 305, Japan	Tohoku University; Kyushu University; University of Tsukuba	Ikeda, H (corresponding author), Tohoku Univ, Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 980, Japan.							COLLOD G, 1994, NAT GENET, V8, P264, DOI 10.1038/ng1194-264; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; Fukui M, 1997, SURG NEUROL, V47, P138, DOI 10.1016/S0090-3019(96)00358-8; FUKUI M, 1996, ANN REPORT 1995; FUKUYAMA S, 1990, ANN REPORT 1990, P53; Goto Yasunobu, 1992, Neurologia Medico-Chirurgica, V32, P883, DOI 10.2176/nmc.32.883; Graham JF, 1997, CLIN NEUROL NEUROSUR, V99, pS31, DOI 10.1016/S0303-8467(97)00037-1; IKEDA E, 1991, STROKE, V22, P1358, DOI 10.1161/01.STR.22.11.1358; Ikezaki K, 1997, STROKE, V28, P2513, DOI 10.1161/01.STR.28.12.2513; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; OKA K, 1981, VIRCHOWS ARCH A, V392, P247, DOI 10.1007/BF02155663; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; SUZUKI J, 1983, MOYAMOYA DIS; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P13; Yamamoto M, 1997, STROKE, V28, P1733, DOI 10.1161/01.STR.28.9.1733	17	211	226	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					533	537		10.1086/302243	http://dx.doi.org/10.1086/302243			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973290	Green Published, Bronze			2022-12-18	WOS:000078740600022
J	HARDING, AE; SWEENEY, MG; GOVAN, GG; RIORDANEVA, P				HARDING, AE; SWEENEY, MG; GOVAN, GG; RIORDANEVA, P			PEDIGREE ANALYSIS IN LEBER HEREDITARY OPTIC NEUROPATHY FAMILIES WITH A PATHOGENIC MTDNA MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATION; CLINICAL MANIFESTATIONS; GENETIC-HETEROGENEITY; JAPANESE PEDIGREES; COMPLEX-I; NEURORETINOPATHY; HETEROPLASMY; DISEASE; SUSCEPTIBILITY; GENOTYPE	Eighty-nine index patients from 85 families were defined as having Leber hereditary optic neuropathy (LHON) by the presence of one of the mtDNA mutations at positions 11778 (66 families), 3460 (8 families), or 14484 (11 families). There were 62 secondary cases. Overall, 64% of index cases had a history of similarly affected relatives. The ratios of affected males to affected females were 3.7:1 (11778), 4.3:1 (3460), and 7.7:1 (14484). The 95th centile for age at onset of symptoms was close to 50 years in index, secondary, male, and female patients. There were no differences in the distributions of age at onset between different mutation groups, between index and secondary cases, or between males and females, apart from this being slightly later in all female patients than in male 11778 patients. There was no significant correlation between age at onset in index cases and that in their affected siblings or cousins. Heteroplasmy (<96% mutant mtDNA) was detected in 4% of affected subjects (67%-90% mutant mtDNA) and in 13.6% of 140 unaffected relatives (<5%-90% mutant mtDNA). Analysis of all pedigrees, excluding sibships <50 years of age and index cases, indicated recurrence risks of 30%, 8%, 46%, 10%, 31%, and 6%, respectively, to the brothers, sisters, nephews, nieces, and male and female matrilineal first cousins of index cases. Affected females were more likely to have affected children, particularly daughters, than were unaffected female carriers. The pedigree data were entirely compatible with the previously proposed X-linked susceptibility locus, with a gene frequency of .08, penetrance of .11 in heterozygous females, and 40% of affected females being homozygous, the remainder being explained by heterozygosity and disadvantageous X inactivation.	UCL NATL HOSP NEUROL & NEUROSURG, DEPT NEUROOPHTHALMOL, LONDON WC1N 3BG, ENGLAND	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	HARDING, AE (corresponding author), UNIV LONDON, INST NEUROL, DEPT CLIN NEUROL, NEUROGENET SECT, QUEEN SQ, LONDON WC1N 3BG, ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; BROWN MD, 1992, GENETICS, V130, P163; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; CARVALHO MRS, 1992, HUM HERED, V42, P316, DOI 10.1159/000154089; CORMIER V, 1991, AM J HUM GENET, V48, P813; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1994, AM J HUM GENET, V55, P203; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1993, GENETICS, V133, P133; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; HUOPONEN K, 1993, HUM GENET, V92, P379, DOI 10.1007/BF01247339; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P1491, DOI 10.1001/archopht.1993.01090110057023; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; JOHNS DR, 1993, OPHTHALMOLOGY, V100, P981; JUVONEN V, 1993, AM J HUM GENET, V53, P289; KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121; LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8; MACKEY D, 1992, AM J HUM GENET, V51, P1218; NAKAMURA M, 1993, HUM GENET, V91, P339; NAKAMURA M, 1992, JPN J OPHTHALMOL, V36, P56; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN E, 1984, NEUROLOGY, V34, P1482, DOI 10.1212/WNL.34.11.1482; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; OBERMAIERKUSSER B, 1994, AM J HUM GENET, V55, P1063; OOSTRA RJ, 1994, J MED GENET, V31, P280, DOI 10.1136/jmg.31.4.280; OOSTRA RJ, 1994, HUM GENET, V94, P265, DOI 10.1007/BF00208281; POULTON J, 1991, J MED GENET, V28, P765, DOI 10.1136/jmg.28.11.765; RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319; SEEDORFF T, 1968, ACTA OPHTHALMOL, V46, P4; SEEDORFF T, 1985, ACTA OPHTHALMOL, V63, P135; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; SWEENEY MG, 1992, AM J HUM GENET, V51, P741; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; VILKKI J, 1990, AM J HUM GENET, V47, P95; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; ZHU DP, 1992, AM J MED GENET, V42, P173, DOI 10.1002/ajmg.1320420208	43	211	225	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					77	86						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611298				2022-12-18	WOS:A1995RE62900010
J	CLEMENS, PR; FENWICK, RG; CHAMBERLAIN, JS; GIBBS, RA; DEANDRADE, M; CHAKRABORTY, R; CASKEY, CT				CLEMENS, PR; FENWICK, RG; CHAMBERLAIN, JS; GIBBS, RA; DEANDRADE, M; CHAKRABORTY, R; CASKEY, CT			CARRIER DETECTION AND PRENATAL-DIAGNOSIS IN DUCHENNE AND BECKER MUSCULAR-DYSTROPHY FAMILIES, USING DINUCLEOTIDE REPEAT POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; SIMPLE SEQUENCES; CDNA ANALYSIS; DMD GENE; DNA; AMPLIFICATION; HETEROZYGOSITY; INDIVIDUALS; DELETIONS; FREQUENCY	To improve carrier detection and prenatal diagnosis for Duchenne and Becker muscular dystrophy families, we determined allele frequencies and measures of variation for four (dC-dA)n . (dG-dT)n loci identified within a deletion-prone region of the human dystrophin gene. The loci are highly polymorphic, with predicted heterozygosities of 71.6%-93.3%. Direct DNA sequence analysis of the (dC-dA)n . (dG-dT)n locus in intron 49 revealed an additional length polymorphism which varies by single-basepair increments, is adjacent to the dinucleotide repeat block, and enhances the polymorphic content of this marker. The four (dC-dA)n . (dG-dT)n loci are each easily amplified by PCR in two diplex reactions. The variability of allele lengths at these loci makes them ideal for carrier detection and prenatal diagnosis, often providing diagnostic information when RFLP analysis is uninformative. These markers have aided in identification of deletion mutations, exclusion of maternal cell contamination of chorionic villus samples, confirmation of paternity, and mapping of gene recombinations. The allele identification of these loci can be performed either with a radiolabel or with an automated, nonradioactive, fluorescent gel detection system.	BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; UNIV TEXAS,GRAD SCH BIOMED SCI,CTR GENET,HOUSTON,TX 77025; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48104	Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Michigan System; University of Michigan	CLEMENS, PR (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030, USA.			Chamberlain, Jeffrey/0000-0001-5299-0059				BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; CHAKRABORTY R, 1982, THEOR POPUL BIOL, V21, P205, DOI 10.1016/0040-5809(82)90014-4; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; Chamberlain JS, 1990, CURRENT NEUROLOGY, V10, P65; CHAMBERLAIN JS, UNPUB DIAGNOSIS DUCH; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FENNER CA, 1991, AM J HUM GENET, V48, P321; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; GIBBS RA, 1989, PCR TECHNOLOGY PRINC, P171; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; HU XY, 1990, AM J HUM GENET, V46, P682; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LITT M, 1989, AM J HUM GENET, V44, P397; NEI M, 1978, GENETICS, V89, P583; OUDET C, 1990, HUM GENET, V84, P283; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WARD PA, 1989, AM J HUM GENET, V44, P270; WEBER JL, 1989, AM J HUM GENET, V44, P388	23	211	233	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					951	960						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1928100				2022-12-18	WOS:A1991GM87300005
J	Li, MK; Schonberg, A; Schaeferd, M; Schroeder, R; Nasidze, I; Stoneking, M				Li, Mingkun; Schoenberg, Anna; Schaeferd, Michael; Schroeder, Roland; Nasidze, Ivane; Stoneking, Mark			Detecting Heteroplasmy from High-Throughput Sequencing of Complete Human Mitochondrial DNA Genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTROL REGION; MTDNA HETEROPLASMY; ACCURATE DETECTION; POINT MUTATIONS; HUMAN-EVOLUTION; SNP DISCOVERY; FREQUENCY; AMPLIFICATION; SELECTION; QUANTIFICATION	Heteroplasmy, the existence of multiple mtDNA types within an individual, has been previously detected by using mostly indirect methods and focusing largely on just the hypervariable segments of the control region. Next-generation sequencing technologies should enable studies of heteroplasmy across the entire mtDNA genome at much higher resolution, because many independent reads are generated for each position. However, the higher error rate associated with these technologies must be taken into consideration to avoid false detection of heteroplasmy. We used simulations and phiX174 sequence data to design criteria for accurate detection of heteroplasmy with the Illumina Genome Analyzer platform, and we used artificial mixtures and replicate data to test and refine the criteria. We then applied these criteria to mtDNA sequence reads for 131 individuals from five Eurasian populations that had been generated via a parallel tagged approach. We identified 37 heteroplasmies at 10% frequency or higher at 34 sites in 32 individuals. The mutational spectrum does not differ between heteroplasmic mutations and polymorphisms in the same individuals, but the relative mutation rate at heteroplasmic mutations is significantly higher than that estimated for all mutable sites in the human mtDNA genome. Moreover, there is also a significant excess of nonsynonymous mutations observed among heteroplasmies, compared to polymorphism data from the same individuals. Both mutation-drift and negative selection influence the fate of heteroplasmies to determine the polymorphism spectrum in humans. With appropriate criteria for avoiding false positives due to sequencing errors, next-generation technologies can provide novel insights into genome-wide aspects of mtDNA heteroplasmy.	[Li, Mingkun; Schoenberg, Anna; Schaeferd, Michael; Schroeder, Roland; Nasidze, Ivane; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany	Max Planck Society	Li, MK (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	mingkun_li@eva.mpg.de; stoneking@eva.mpg.de	Li, Mingkun/G-7161-2012		Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank all individuals who kindly donated a sample for the original study; the MPI-EVA sequencing group and M. Kircher for technical support; J. Li for producing Figure 1; and M. Whitten, R. E. Green, E. Gunnarsdottir, and D. Hughes for helpful discussion. Funding was provided by the Max Planck Society.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Ballana E, 2006, BIOCHEM BIOPH RES CO, V341, P950, DOI 10.1016/j.bbrc.2006.01.049; Ballana E, 2008, HUM MUTAT, V29, P248, DOI 10.1002/humu.20639; Bannwarth S, 2005, HUM MUTAT, V25, P575, DOI 10.1002/humu.20177; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkt1030, 10.1093/nar/gkr1202, 10.1093/nar/gkq1079, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkn723, 10.1093/nar/gkx1094]; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; BROWN GG, 1982, P NATL ACAD SCI-BIOL, V79, P3246, DOI 10.1073/pnas.79.10.3246; Burk Angela, 2002, Journal of Mammalian Evolution, V9, P225, DOI 10.1023/A:1022649516930; Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844; Cassandrini D, 2006, BIOCHEM BIOPH RES CO, V342, P387, DOI 10.1016/j.bbrc.2006.01.152; Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; Dobrowolski SF, 2009, HUM MUTAT, V30, P891, DOI 10.1002/humu.21003; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; Grzybowski T, 2003, ELECTROPHORESIS, V24, P1159, DOI 10.1002/elps.200390149; Hancock DK, 2005, GENOMICS, V86, P446, DOI 10.1016/j.ygeno.2005.06.006; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu Shumo, 2002, BMC Biotechnol, V2, P13, DOI 10.1186/1472-6750-2-13; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mashima Y, 2004, CLIN BIOCHEM, V37, P268, DOI 10.1016/j.clinbiochem.2003.11.011; Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001; Melton T, 2004, Forensic Sci Rev, V16, P1; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; *MITOMAP, 2009, HUM MIT GEN DAT; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Parr RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185; Prieto L, 2008, FORENSIC SCI INT-GEN, V2, P126, DOI 10.1016/j.fsigen.2007.10.010; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2001, INT J LEGAL MED, V114, P186, DOI 10.1007/s004140000164; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Seo SB, 2010, J FORENSIC SCI, V55, P719, DOI 10.1111/j.1556-4029.2010.01321.x; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Szibor M, 2003, BASIC RES CARDIOL, V98, P210, DOI 10.1007/s00395-003-0421-z; Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI [10.1038/nmeth.1185, 10.1038/NMETH.1185]; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Wong LJC, 2004, ELECTROPHORESIS, V25, P2602, DOI 10.1002/elps.200406016; Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007; Zhidkov I, 2009, GENOME RES, V19, P576, DOI 10.1101/gr.086462.108; ZHU DP, 1992, AM J MED GENET, V42, P173, DOI 10.1002/ajmg.1320420208; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	69	210	216	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					237	249		10.1016/j.ajhg.2010.07.014	http://dx.doi.org/10.1016/j.ajhg.2010.07.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20696290	Green Published, Bronze			2022-12-18	WOS:000281107000008
J	Schneppenheim, R; Fruhwald, MC; Gesk, S; Hasselblatt, M; Jeibmann, A; Kordes, U; Kreuz, M; Leuschner, I; Subero, JIM; Obser, T; Oyen, F; Vater, I; Siebert, R				Schneppenheim, Reinhard; Fruehwald, Michael C.; Gesk, Stefan; Hasselblatt, Martin; Jeibmann, Astrid; Kordes, Uwe; Kreuz, Markus; Leuschner, Ivo; Subero, Jose Ignacio Martin; Obser, Tobias; Oyen, Florian; Vater, Inga; Siebert, Reiner			Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SWI/SNF COMPLEX; HSNF5/INI1 GENE; BRAIN-TUMORS; CELL-LINES; CANCER; CHROMATIN; BRG1; MICE	Rhabdoid tumors of early infancy are highly aggressive with consequent poor prognosis. Most cases show inactivation of the SMARCB1 (also known as INH and hSNF5) tumor suppressor, a core member of the ATP-dependent SWI/SNF chromatin-remodeling complex. Familial cases, described as rhabdoid tumor predisposition syndrome (RTPS), have been linked to heterozygous SMARCB1 germline mutations. We identified inactivation of another member of the SWI/SNF chromatin-remodeling complex, its ATPase subunit SMARCA4 (also known as BRG1), due to a SMARCA4/BRG1 germline mutation and loss of heterozygosity by uniparental disomy in the tumor cells of two sisters with rhabdoid tumors lacking SMARCB1 mutations. SMARCA4 is thus a second member of the SWI/SNF complex involved in cancer predisposition. Its general involvement in other tumor entities remains to be established.	[Schneppenheim, Reinhard; Kordes, Uwe; Oyen, Florian; Vater, Inga] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, D-20246 Hamburg, Germany; [Schneppenheim, Reinhard] Childrens Canc Ctr Hamburg, Res Inst, D-20251 Hamburg, Germany; [Fruehwald, Michael C.] Univ Childrens Hosp Muenster, Dept Pediat Hematol & Oncol, Munster, Germany; [Gesk, Stefan; Subero, Jose Ignacio Martin; Vater, Inga; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Leuschner, Ivo] Univ Kiel, Inst Paidopathol, Pediat Tumor Registry, D-24105 Kiel, Germany; [Leuschner, Ivo] Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; [Hasselblatt, Martin; Jeibmann, Astrid] Univ Hosp Muenster, Inst Neuropathol, D-48149 Munster, Germany; [Kreuz, Markus] Univ Leipzig, IMISE, Leipzig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Kiel; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Munster; Leipzig University	Schneppenheim, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Martinistr 52, D-20246 Hamburg, Germany.	schneppenheim@uke.de	Siebert, Reiner/A-8049-2010; Leuschner, Ivo/E-9437-2010	Hasselblatt, Martin/0000-0003-2707-8484; Kordes, Uwe R./0000-0001-6375-2320; Kreuz, Markus/0000-0002-0520-8391	"Foerdergemeinschaft Kinderkrebszentrum Hamburg e.V."; "KinderKrebsInitiative Buchholz/Holm-Seppensen"; "Wasowicz-Stiftung im Stifterverband fur die Deutsche Wissenschaft"	"Foerdergemeinschaft Kinderkrebszentrum Hamburg e.V."; "KinderKrebsInitiative Buchholz/Holm-Seppensen"; "Wasowicz-Stiftung im Stifterverband fur die Deutsche Wissenschaft"	This work was supported by the "Foerdergemeinschaft Kinderkrebszentrum Hamburg e.V." (R.Sc.), the "KinderKrebsInitiative Buchholz/Holm-Seppensen" (R.Si.), and the "Wasowicz-Stiftung im Stifterverband fur die Deutsche Wissenschaft" (M.C.F.). Claudia Becher, Birgit Lechtape, Magret Ratien, and Barbara Riesmeier provided expert technical assistance. Our study is in accordance with our institutional and national ethical standards on human experimentation. Informed consent for the molecular genetic and clinical studies was obtained from both parents by M.C.F.	Ammerlaan ACJ, 2008, BRIT J CANCER, V98, P474, DOI 10.1038/sj.bjc.6604156; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chi SN, 2009, J CLIN ONCOL, V27, P385, DOI 10.1200/JCO.2008.18.7724; Fruhwald MC, 2006, PEDIATR BLOOD CANCER, V47, P273, DOI 10.1002/pbc.20526; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Jackson EM, 2009, CLIN CANCER RES, V15, P1923, DOI 10.1158/1078-0432.CCR-08-2091; Janson K, 2006, PEDIATR BLOOD CANCER, V47, P279, DOI 10.1002/pbc.20622; Kordes U, 2010, GENE CHROMOSOME CANC, V49, P176, DOI 10.1002/gcc.20729; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Medina PP, 2004, GENE CHROMOSOME CANC, V41, P170, DOI 10.1002/gcc.20068; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2009, CANCER BIOL THER, V8, P412, DOI 10.4161/cbt.8.5.8019; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Savla J, 2000, JNCI-J NATL CANCER I, V92, P648, DOI 10.1093/jnci/92.8.648; Scotting PJ, 2005, NAT REV CANCER, V5, P481, DOI 10.1038/nrc1633; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wong AKC, 2000, CANCER RES, V60, P6171; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08	23	210	218	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					279	284		10.1016/j.ajhg.2010.01.013	http://dx.doi.org/10.1016/j.ajhg.2010.01.013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137775	Green Published, Bronze			2022-12-18	WOS:000274637200019
J	Loeffen, J; Smeitink, A; Triepels, R; Smeets, R; Schuelke, M; Sengers, R; Trijbels, F; Hamel, B; Mullaart, R; van den Heuvel, L				Loeffen, J; Smeitink, A; Triepels, R; Smeets, R; Schuelke, M; Sengers, R; Trijbels, F; Hamel, B; Mullaart, R; van den Heuvel, L			The first nuclear-encoded complex I mutation in a patient with leigh syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATION; NADH-UBIQUINONE OXIDOREDUCTASE; HEREDITARY OPTIC NEUROPATHY; BOVINE HEART-MITOCHONDRIA; HUMAN SKELETAL-MUSCLE; C-OXIDASE DEFICIENCY; AMINO-ACID-SEQUENCE; TRANSFER RNALEU(UUR); SECONDARY-STRUCTURE; POINT MUTATION	Nicotinamide adenine dinucleotide (NADH):ubiquinone oxidoreductase (complex I) is the largest multiprotein enzyme complex of the respiratory chain. The nuclear-encoded NDUFS8 (TYKY) subunit of complex I is highly conserved among eukaryotes and prokaryotes and contains two 4Fe4S ferredoxin consensus patterns, which have long been thought to provide the binding site for the iron-sulfur duster N-2. The NDUFS8 cDNA contains an open reading frame of 633 bp, coding for 210 amino acids. Cycle sequencing of amplified NDUFS8 cDNA of 20 patients with isolated enzymatic complex I deficiency revealed two compound heterozygous transitions in a patient with neuropathologically proven Leigh syndrome. The first mutation was a C236T (P79L), and the second mutation was a G305A (R102H). Both mutations were absent in 70 control alleles and cosegregated within the family. A progressive clinical phenotype proceeding to death in the first months of life was expressed in the patient. In the 19 other patients with enzymatic complex T deficiency, no mutations were found in the NDUFS8 cDNA. This article describes the first molecular genetic link between a nuclear-encoded subunit of complex I and Leigh syndrome.	Univ Nijmegen St Radboud Hosp, Dept Pediat, Nijmegan Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen St Radboud Hosp, Dept Clin Genet, Nijmegan Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen St Radboud Hosp, Dept Pediat Neurol, Nijmegan Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Smeitink, A (corresponding author), Univ Nijmegen, Childrens Hosp, Nijmegan Ctr Mitochondrial Disorders, POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.Smeitink@ckskg.azn.nl	Smeitink, Jan/C-1351-2013; van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Schuelke, Markus/0000-0003-2824-3891				Adams PL, 1997, ANN NEUROL, V41, P268, DOI 10.1002/ana.410410219; Albracht SPJ, 1997, BBA-BIOENERGETICS, V1318, P92, DOI 10.1016/S0005-2728(96)00153-3; BAUMGARTNER ER, 1989, PEDIATR RES, V26, P260, DOI 10.1203/00006450-198909000-00021; Bentlage HACM, 1996, NEUROLOGY, V47, P243, DOI 10.1212/WNL.47.1.243; BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Buddiger PAL, 1997, AM J HUM GENET, V61, pA305; Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589; Chevallet M, 1997, EUR J BIOCHEM, V250, P451, DOI 10.1111/j.1432-1033.1997.0451a.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; DiMauro S, 1996, ANN NEUROL, V40, P5, DOI 10.1002/ana.410400104; Duarte M, 1997, BBA-BIOENERGETICS, V1322, P237, DOI 10.1016/S0005-2728(97)00084-4; Duarte M, 1996, BBA-BIOENERGETICS, V1275, P151, DOI 10.1016/0005-2728(96)00033-3; DUPUIS A, 1991, BIOCHEMISTRY-US, V30, P2954, DOI 10.1021/bi00225a032; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; FISCHER JC, 1986, CLIN CHIM ACTA, V155, P263, DOI 10.1016/0009-8981(86)90246-9; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Graeber MB, 1998, J NEUROL SCI, V153, P251, DOI 10.1016/S0022-510X(97)00295-5; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOLT IJ, 1990, AM J HUM GENET, V46, P428; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Loeffen J, 1998, J INHERIT METAB DIS, V21, P210, DOI 10.1023/A:1005339332062; LOEFFEN J, IN PRESS J INHERIT M; MASUI R, 1991, J BIOCHEM-TOKYO, V109, P534, DOI 10.1093/oxfordjournals.jbchem.a123416; MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; NISHIKAWA K, 1983, BIOCHIM BIOPHYS ACTA, V748, P285, DOI 10.1016/0167-4838(83)90306-0; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; POULTON J, 1989, LANCET, V1, P961; Procaccio V, 1997, BBA-GENE STRUCT EXPR, V1351, P37, DOI 10.1016/S0167-4781(97)00020-1; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Sambrook J, 1989, MOL CLONING LAB MANU; Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220; SHOFFNER JM, 1992, NEUROLOGY, V42, P2168, DOI 10.1212/WNL.42.11.2168; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; Smeitink J, 1998, HUM GENET, V103, P245, DOI 10.1007/s004390050813; Smeitink JAM, 1998, HUM MOL GENET, V7, P1573, DOI 10.1093/hmg/7.10.1573; Srere P.A., 1969, METHODS ENZYM, V13, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; TANAKA M, 1990, LANCET, V336, P1452, DOI 10.1016/0140-6736(90)93162-I; TATUCH Y, 1992, AM J HUM GENET, V50, P852; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; vanAmstel JKP, 1996, HUM GENET, V97, P51, DOI 10.1007/BF00218833; VANLAACK HLJM, 1988, CLIN CHIM ACTA, V171, P109; WALKER JE, 1995, BBA-MOL BASIS DIS, V1271, P221, DOI 10.1016/0925-4439(95)00031-X; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; WILLEMS JL, 1977, PEDIATRICS, V60, P850; YAMAGUCHI M, 1993, BIOCHEMISTRY-US, V32, P1935, DOI 10.1021/bi00059a008; ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	62	210	219	1	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1598	1608		10.1086/302154	http://dx.doi.org/10.1086/302154			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837812	Green Published, Bronze			2022-12-18	WOS:000077707700005
J	Sohocki, MM; Sullivan, LS; Mintz-Hittner, HA; Birch, D; Heckenlively, JR; Freund, CL; McInnes, RR; Daiger, SP				Sohocki, MM; Sullivan, LS; Mintz-Hittner, HA; Birch, D; Heckenlively, JR; Freund, CL; McInnes, RR; Daiger, SP			A range of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; PERIPHERIN/RDS GENE; PATTERN DYSTROPHY; HOMEOBOX GENE; RDS GENE; OTX; DEGENERATION; ASN244HIS	Mutations in the retinal-expressed gene CRX (cone-rod homeobox gene) have been associated with dominant cone-rod dystrophy and with de novo Leber congenital amaurosis. However, CRX is a transcription factor for several retinal genes, including the opsins and the gene for interphotoreceptor retinoid binding protein. Because loss of CRX function could alter the expression of a number of other retinal proteins, we screened for mutations in the CRX gene in probands with a range of degenerative retinal diseases. Of the 294 unrelated individuals screened, we identified four CRX mutations in families with clinical diagnoses of autosomal dominant cone-rod dystrophy, late-onset dominant retinitis pigmentosa, or dominant congenital Leber amaurosis (early-onset retinitis pigmentosa), and we identified four additional benign sequence variants. These findings imply that CRX mutations may be associated with a wide range of clinical phenotypes, including congenital retinal dystrophy (Leber) and progressive diseases such as cone-rod dystrophy or retinitis pigmentosa, with a wide range of onset.	Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77225 USA; Univ Texas, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77225 USA; Retina Fdn SW, Dallas, TX 90034 USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA USA; Hosp Sick Children, Program Dev Biol, Res Inst, Toronto, ON M5G 1X8, Canada	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Retina Foundation of the Southwest; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Daiger, SP (corresponding author), Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Sch Publ Hlth, POB 20334, Houston, TX 77225 USA.			Birch, David/0000-0002-6594-2897	NATIONAL EYE INSTITUTE [R01EY007142] Funding Source: NIH RePORTER; NEI NIH HHS [EY05235, EY07024, R01 EY007142, EY07412] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Daiger S. P., 1998, IOVS, V39, pS295; FINKELSTEIN R, 1994, TRENDS GENET, V10, P310, DOI 10.1016/0168-9525(94)90033-7; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; HECKENLIVELY JR, 1988, RETINITIS PIGMENTOSA, P146; HITTNER HM, 1975, DOC OPHTHALMOL, V39, P29, DOI 10.1007/BF00578758; KEEN TJ, 1994, HUM MOL GENET, V3, P367, DOI 10.1093/hmg/3.2.367; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Nakazawa M, 1996, ARCH OPHTHALMOL-CHIC, V114, P72, DOI 10.1001/archopht.1996.01100130068011; NAKAZAWA M, 1994, HUM MOL GENET, V3, P1195, DOI 10.1093/hmg/3.7.1195; Sohocki MM, 1997, AM J HUM GENET, V61, pA295; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213	16	210	234	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1307	1315		10.1086/302101	http://dx.doi.org/10.1086/302101			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792858	Bronze, Green Published			2022-12-18	WOS:000076985200007
J	Girirajan, S; Dennis, MY; Baker, C; Malig, M; Coe, BP; Campbell, CD; Mark, K; Vu, TH; Alkan, C; Cheng, Z; Biesecker, LG; Bernier, R; Eichler, EE				Girirajan, Santhosh; Dennis, Megan Y.; Baker, Carl; Malig, Maika; Coe, Bradley P.; Campbell, Catarina D.; Mark, Kenneth; Vu, Tiffany H.; Alkan, Can; Cheng, Ze; Biesecker, Leslie G.; Bernier, Raphael; Eichler, Evan E.			Refinement and Discovery of New Hotspots of Copy-Number Variation Associated with Autism Spectrum Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DE-NOVO MUTATIONS; 17Q21.31 MICRODELETION SYNDROME; STRUCTURAL VARIATION; DIAGNOSTIC INTERVIEW; HUMAN-DISEASE; KANSL1 CAUSE; GENE; DUPLICATIONS; RESOURCE	Rare copy-number variants (CNVs) have been implicated in autism and intellectual disability. These variants are large and affect many genes but lack clear specificity toward autism as opposed to developmental-delay phenotypes. We exploited the repeat architecture of the genome to target segmental duplication-mediated rearrangement hotspots (n = 120, median size 1.78 Mbp, range 240 kbp to 13 Mbp) and smaller hotspots flanked by repetitive sequence (n = 1,247, median size 79 kbp, range 3-96 kbp) in 2,588 autistic individuals from simplex and multiplex families and in 580 controls. Our analysis identified several recurrent large hotspot events, including association with 1q21 duplications, which are more likely to be identified in individuals with autism than in those with developmental delay (p = 0.01; OR = 2.7). Within larger hotspots, we also identified smaller atypical CNVs that implicated CHD1L and ACACA for the 1q21 and 17q12 deletions, respectively. Our analysis, however, suggested no overall increase in the burden of smaller hotspots in autistic individuals as compared to controls. By focusing on gene-disruptive events, we identified recurrent CNVs, including DPP10, PLCB1, TRPM1, NRXN1, FHIT, and HYDIN, that are enriched in autism. We found that as the size of deletions increases, nonverbal IQ significantly decreases, but there is no impact on autism severity; and as the size of duplications increases, autism severity significantly increases but nonverbal IQ is not affected. The absence of an increased burden of smaller CNVs in individuals with autism and the failure of most large hotspots to refine to single genes is consistent with a model where imbalance of multiple genes contributes to a disease state.	[Girirajan, Santhosh; Dennis, Megan Y.; Baker, Carl; Malig, Maika; Coe, Bradley P.; Campbell, Catarina D.; Mark, Kenneth; Vu, Tiffany H.; Alkan, Can; Cheng, Ze; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Bernier, Raphael] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Coe, Bradley/A-2878-2009; Alkan, Can/D-2982-2009	Alkan, Can/0000-0002-5443-0706; Mark, Kenneth/0000-0003-1867-6212; Coe, Bradley/0000-0001-8471-4016	US National Institutes of Health (NIH) Ruth L. Kirchstein National Research Service Award (NRSA) Fellowship through Eunice Kennedy Shriver National Institute of Child Health and Human Development [F32HD071698]; NIH National Human Genome Research Institute NRSA [F32HG006070]; Simons Foundation Autism Research Initiative award SFARI [137578]; NIH [HD065285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071698] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006070, ZIAHG200359] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Ruth L. Kirchstein National Research Service Award (NRSA) Fellowship through Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH National Human Genome Research Institute NRSA; Simons Foundation Autism Research Initiative award SFARI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Tonia Brown, Emre Karakoc, Nik Krumm, Arthur Ko, Daryl Dhanraj, Jason Lu, John Huddleston, and Ben Nelson for valuable discussions and technical assistance. We also thank the Autism Genetic Resource Exchange (AGRE) for providing DNA samples. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, and E. Wijsman). We appreciate obtaining access to phenotypic data on SFARI Base. Approved researchers can obtain the SSC population dataset described in this study by applying at Simons Simplex Collection online (see Web Resources). M.Y.D. is supported by a US National Institutes of Health (NIH) Ruth L. Kirchstein National Research Service Award (NRSA) Fellowship through Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD071698). C.D.C. was supported by NIH National Human Genome Research Institute NRSA (F32HG006070). This work was supported by Simons Foundation Autism Research Initiative award SFARI 137578 (E.E.E.) and NIH grant HD065285 (E.E.E.). E.E.E. is an investigator with the Howard Hughes Medical Institute.	Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Baldwin EL, 2008, GENET MED, V10, P415, DOI 10.1097/GIM.0b013e318177015c; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Chen PL, 2009, AM J HUM GENET, V84, P21, DOI 10.1016/j.ajhg.2008.12.005; Christian F, 2011, J BIOL CHEM, V286, P9079, DOI 10.1074/jbc.M110.160614; Coe BP, 2012, CURR OPIN NEUROBIOL, V22, P829, DOI 10.1016/j.conb.2012.04.007; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Karakoc E, 2012, NAT METHODS, V9, P176, DOI [10.1038/NMETH.1810, 10.1038/nmeth.1810]; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Koolen DA, 2012, NAT GENET, V44, P639, DOI 10.1038/ng.2262; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lo Vasco VR, 2012, J CELL MOL MED, V16, P844, DOI 10.1111/j.1582-4934.2011.01363.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Luciano M, 2012, AM J MED GENET B, V159B, P684, DOI 10.1002/ajmg.b.32072; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Moldin SO, 2003, AM J PSYCHIAT, V160, P621, DOI 10.1176/appi.ajp.160.4.621; Moreno-De-Luca D, 2012, MOL PSYCHIAT; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poduri A, 2012, EPILEPSIA, V53, pE146, DOI 10.1111/j.1528-1167.2012.03538.x; ROCHE AF, 1987, PEDIATRICS, V79, P706; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stankiewicz P, 2012, HUM MUTAT, V33, P165, DOI 10.1002/humu.21614; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Talati A, 2008, MOL PSYCHIATR, V13, P122, DOI 10.1038/sj.mp.4002114; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Williams SR, 2010, EUR J HUM GENET, V18, P436, DOI 10.1038/ejhg.2009.199; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; Zollino M, 2012, NAT GENET, V44, P636, DOI 10.1038/ng.2257	59	209	218	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					221	237		10.1016/j.ajhg.2012.12.016	http://dx.doi.org/10.1016/j.ajhg.2012.12.016			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23375656	Green Published, Bronze			2022-12-18	WOS:000315179600006
J	Williams, SR; Aldred, MA; Kaloustian, VMD; Halal, F; Gowans, G; McLeod, DR; Zondag, S; Toriello, HV; Magenis, RE; Elsea, SH				Williams, Stephen R.; Aldred, Micheala A.; Kaloustian, Vazken M. Der; Halal, Fahed; Gowans, Gordon; McLeod, D. Ross; Zondag, Sara; Toriello, Helga V.; Magenis, R. Ellen; Elsea, Sarah H.			Haploinsufficiency of HDAC4 Causes Brachydactyly Mental Retardation Syndrome, with Brachydactyly Type E, Developmental Delays, and Behavioral Problems	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALBRIGHT HEREDITARY OSTEODYSTROPHY; CONTROLS CHONDROCYTE HYPERTROPHY; 2Q37.3 DELETION; AUTISM; DIFFERENTIATION; DELINEATION; CBFA1; MEF2; GENE	Brachydactyly mental retardation syndrome (BDMR) is associated with a deletion involving chromosome 2q37. BDMR presents with a range of features, including intellectual disabilities, developmental delays, behavioral abnormalities, sleep disturbance, craniofacial and skeletal abnormalities (including brachydactyly type E), and autism spectrum disorder. To date, only large deletions of 2q37 have been reported, making delineation of a critical region and subsequent identification of candidate genes difficult. We present clinical and molecular analysis of six individuals with overlapping deletions involving 2q37.3 that refine the critical region, reducing the candidate genes from >20 to a single gene, histone deacetylase 4 (HDAC4). Driven by the distinct hand and foot anomalies and similar cognitive features, we identified other cases with clinical findings consistent with BDMR but without a 2q37 deletion, and sequencing of HDAC4 identified de novo mutations, including one intragenic deletion probably disrupting normal splicing and one intragenic insertion that results in a frameshift and premature stop codon. HDAC4 is a histone deacetylase that regulates genes important in bone, muscle, neurological, and cardiac development. Reportedly, Hdac4(-/-) mice have severe bone malformations resulting from premature ossification of developing bones. Data presented here show that deletion or mutation of HDAC4 results in reduced expression of RAI1, which causes Smith-Magenis syndrome when haploinsufficient, providing a link to the overlapping findings in these disorders. Considering the known molecular function of HDAC4 and the mouse knockout phenotype, taken together with deletion or mutation of HDAC4 in multiple subjects with BDMR, we conclude that haploinsufficiency of HDAC4 results in brachydactyly mental retardation syndrome.	[Williams, Stephen R.; Elsea, Sarah H.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23298 USA; [Elsea, Sarah H.] Virginia Commonwealth Univ, Dept Pediat, Sch Med, Richmond, VA 23298 USA; [Aldred, Micheala A.] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; [Kaloustian, Vazken M. Der] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Halal, Fahed] McGill Univ, Montreal Childrens Hosp, Div Med Genet, Montreal, PQ H3H 1P3, Canada; [Kaloustian, Vazken M. Der] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Gowans, Gordon] Univ Louisville, Dept Pediat, Weisskopf Child Evaluat Ctr, Louisville, KY 40202 USA; [McLeod, D. Ross] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Zondag, Sara; Toriello, Helga V.] Spectrum Hlth, Genet Serv, Grand Rapids, MI 49503 USA; [Magenis, R. Ellen] Oregon Hlth & Sci Univ, Dept Genet, Portland, OR 97239 USA	Virginia Commonwealth University; Virginia Commonwealth University; Cleveland Clinic Foundation; McGill University; McGill University; McGill University; University of Louisville; University of Calgary; Michigan State University; Michigan State University College of Human Medicine; Oregon Health & Science University	Elsea, SH (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	selsea@vcu.edu		Williams, Stephen/0000-0003-2108-2757; Elsea, Sarah/0000-0002-1400-8519	Fondation Jerome Lejeune	Fondation Jerome Lejeune	We thank all of the patients and families involved with this study. We thank Emily Edelman for data collection efforts and Jackie Morris for sample and data collection efforts. This work was supported, in part, by a grant from the Fondation Jerome Lejeune.	Aldred MA, 2004, J MED GENET, V41, P433, DOI 10.1136/jmg.2003.017202; Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Falk RE, 2007, AM J MED GENET C, V145C, P357, DOI 10.1002/ajmg.c.30153; Felder B, 2009, AM J MED GENET A, V149A, P952, DOI 10.1002/ajmg.a.32779; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2009, CLIN GENET, V75, P364, DOI 10.1111/j.1399-0004.2008.01135.x; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guo J, 2006, DEV BIOL, V292, P116, DOI 10.1016/j.ydbio.2005.12.044; Klopocki E, 2010, AM J HUM GENET, V86, P434, DOI 10.1016/j.ajhg.2010.01.023; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Munoz JP, 2009, BIOCHEM BIOPH RES CO, V388, P155, DOI 10.1016/j.bbrc.2009.07.147; PHELAN MC, 1995, AM J MED GENET, V58, P1, DOI 10.1002/ajmg.1320580102; Reddy KS, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-3; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shrimpton AE, 2004, CLIN GENET, V66, P537, DOI 10.1111/j.1399-0004.2004.00363.x; Smith M, 2001, CYTOGENET CELL GENET, V94, P15, DOI 10.1159/000048775; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wassink TH, 2005, AM J MED GENET B, V136B, P36, DOI 10.1002/ajmg.b.30180; Williams SR, 2010, J MED GENET, V47, P223, DOI 10.1136/jmg.2009.068072; WILSON LC, 1995, AM J HUM GENET, V56, P400; Wolff DJ, 2002, GENET MED, V4, P10, DOI 10.1097/00125817-200201000-00002; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	29	209	222	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					219	228		10.1016/j.ajhg.2010.07.011	http://dx.doi.org/10.1016/j.ajhg.2010.07.011			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20691407	Bronze, Green Published			2022-12-18	WOS:000281107000006
J	Antoniou, AC; Spurdle, AB; Sinilnikova, OM; Healey, S; Pooley, KA; Schmutzler, RK; Versmold, B; Engel, C; Meindl, A; Arnold, N; Hofmann, W; Sutter, C; Niederacher, D; Deissler, H; Caldes, T; Kampjarvi, K; Nevanlinna, H; Simard, J; Beesley, J; Chen, XQ; Neuhausen, SL; Rebbeck, TR; Wagner, T; Lynch, HT; Isaacs, C; Weitzel, J; Ganz, PA; Daly, MB; Tomlinson, G; Olopade, OI; Bium, JL; Couch, FJ; Peterlongo, P; Manoukian, S; Barile, M; Radice, P; Szabo, CI; Pereira, LHM; Greene, MH; Rennert, G; Leibkowicz, F; Barnett-Griness, O; Andrulis, IL; Ozcelik, H; Gerdes, AM; Caligo, MA; Laitman, Y; Kaufman, B; Milgrom, R; Friedman, E; Domchek, SM; Nathanson, KL; Osorio, A; Llort, G; Milne, RL; Benitez, J; Hamann, U; Hogervorst, FBL; Manders, P; Ligtenberg, MJL; van den Ouweland, AMW; Peock, S; Cook, M; Platte, R; Evans, DG; Eeles, R; Pichert, G; Chu, C; Eccles, D; Davidson, R; Douglas, F; Godwin, AK; Barjhoux, L; Mazoyer, S; Sobol, H; Bourdon, V; Eisinger, F; Chompret, A; Capoulade, C; Paillerets, BBD; Lenoir, GM; Gauthier-Villars, M; Houdayer, C; Stoppa-Lyonnet, D; Easton, DF				Antoniou, Antonis C.; Spurdle, Amanda B.; Sinilnikova, Olga M.; Healey, Sue; Pooley, Karen A.; Schmutzler, Rita K.; Versmold, Beatrix; Engel, Christoph; Meindl, Alfons; Arnold, Norbert; Hofmann, Wera; Sutter, Christian; Niederacher, Dieter; Deissler, Helmut; Caldes, Trinidad; Kampjarvi, Kati; Nevanlinna, Heli; Simard, Jacques; Beesley, Jonathan; Chen, Xiaoqing; Neuhausen, Susan L.; Rebbeck, Timothy R.; Wagner, Theresa; Lynch, Henry T.; Isaacs, Claudine; Weitzel, Jeffrey; Ganz, Patricia A.; Daly, Mary B.; Tomlinson, Gail; Olopade, Olufunmilayo I.; Bium, Joanne L.; Couch, Fergus J.; Peterlongo, Paolo; Manoukian, Siranoush; Barile, Monica; Radice, Paolo; Szabo, Csilla I.; Pereira, Lutecia H. Mateus; Greene, Mark H.; Rennert, Gad; Leibkowicz, Flavio; Barnett-Griness, Ofra; Andrulis, Irene L.; Ozcelik, Hilmi; Gerdes, Anne-Marie; Caligo, Maria A.; Laitman, Yael; Kaufman, Bella; Milgrom, Roni; Friedman, Eitan; Domchek, Susan M.; Nathanson, Katherine L.; Osorio, Ana; Llort, Gemma; Milne, Roger L.; Benitez, Javier; Hamann, Ute; Hogervorst, Frans B. L.; Manders, Peggy; Ligtenberg, Marjolijn J. L.; van den Ouweland, Ans M. W.; Peock, Susan; Cook, Margaret; Platte, Radka; Evans, D. Gareth; Eeles, Rosalind; Pichert, Gabriella; Chu, Carol; Eccles, Diana; Davidson, Rosemarie; Douglas, Fiona; Godwin, Andrew K.; Barjhoux, Laure; Mazoyer, Sylyie; Sobol, Hagay; Bourdon, Violaine; Eisinger, Francois; Chompret, Agnes; Capoulade, Corinne; Paillerets, Brigitte Bressac-de; Lenoir, Gilbert M.; Gauthier-Villars, Marion; Houdayer, Claude; Stoppa-Lyonnet, Dominique; Easton, Douglas F.		Kathleen Cuningharn Consortium Res; OCGN; Swedish BRCA1; DNA-HEBON Collaborators; EMBRACE; GEMO; CIMBA	Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROPHYLACTIC OOPHORECTOMY; GENES; INVESTIGATORS; PENETRANCE; CONSORTIUM; MODIFIERS; MODEL	Germline mutations in BRCA1 and BRCA2 confer high risks of breast cancer. However, evidence suggests that these risks are modified by other genetic or environmental factors that cluster in families. A recent genome-wide association study has shown that common alleles at single nucleotide polymorphisms (SNPs) in FGFR2 (rs2981582), TNRC9 (rs3803662), and MAP3K1 (rs889312) are associated with increased breast cancer risks in the general population. To investigate whether these loci are also associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers, we genotyped these SNPs in a sample of 10,358 mutation carriers from 23 studies. The minor alleles of SNP rs2981582 and rs889312 were each associated with increased breast cancer risk in BRCA2 mutation carriers (per-allele hazard ratio [HR] = 1.32, 95% CI: 1.20-1.45, p(trend) = 1.7 x 10(-8) and HR = 1.12, 95% CI: 1.02-1.24, P-trend = 0.02) but not in BRCA1 carriers. rs3803662 was associated with increased breast cancer risk in both BRCA1 and BRCA2 mutation carriers (per-allele HR = 1.13, 95% CI: 1.06-1.20, P-trend = 5 x 10(-5) in BRCA1 and BRCA2 combined). These loci appear to interact multiplicatively on breast cancer risk in BRCA2 mutation carriers. The differences in the effects of the FGFR2 and MAP3K1 SNPs between BRCA1 and BRCA2 carriers point to differences in the biology of BRCA1 and BRCA2 breast cancer tumors and confirm the distinct nature of breast cancer in BRCA1 mutation carriers.	[Antoniou, Antonis C.; Pooley, Karen A.; Peock, Susan; Cook, Margaret; Platte, Radka; DNA-HEBON Collaborators] Univ Cambridge, Dept Publ Hlth & Primary Care, Genet Epidemiol Unit, Canc Res UK, Cambridge CB2 1TN, England; [Spurdle, Amanda B.; Healey, Sue; Beesley, Jonathan; Chen, Xiaoqing] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Sinilnikova, Olga M.; Barjhoux, Laure] Hosp Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitutionnelle Canc Frequent, Lyon, France; [Sinilnikova, Olga M.; Barjhoux, Laure; Mazoyer, Sylyie] Univ Lyon 1, CNRS, Lab Genet Mol Signalisat & Canc, UMR5201, F-69365 Lyon, France; [Pooley, Karen A.] Univ Cambridge, Dept Oncol, Human Canc Genet Grp, Canc Res UK, Cambridge CB2 1TN, England; [Schmutzler, Rita K.; Versmold, Beatrix] Univ Cologne, Div Mol Gynaecooncol, Dept Obstet & Gynaecol, D-5000 Cologne 41, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Arnold, Norbert] Univ Schleswig Holstein, Dept Obstet & Gynaecol, Kiel, Germany; [Hofmann, Wera] Charite Univ Med Ctr, Inst Human Genet, Berlin, Germany; [Sutter, Christian] Univ Heidelberg, Inst Human Genet, D-6900 Heidelberg, Germany; [Niederacher, Dieter] Univ Dusseldorf, Dept Obstet & Gynaecol, Mol Genet Lab, D-4000 Dusseldorf, Germany; [Deissler, Helmut] Univ Ulm, Dept Obstet & Gynaecol, D-89069 Ulm, Germany; [Caldes, Trinidad] Hosp Clin San Carlos, Madrid, Spain; [Kampjarvi, Kati; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Simard, Jacques] Univ Quebec, Ctr Hosp, Canc Genom Lab, Canada Res Chair Oncogenet, Ste Foy, PQ G1V 2M3, Canada; [Simard, Jacques] Univ Laval, Quebec City, PQ G1K 7P4, Canada; [Kathleen Cuningharn Consortium Res] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia; [Neuhausen, Susan L.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Wagner, Theresa] Univ Vienna, Vienna, Austria; [Lynch, Henry T.] Creighton Univ, Omaha, NE 68178 USA; [Isaacs, Claudine] Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Fisher Ctr Familial Canc Res, Washington, DC USA; [Weitzel, Jeffrey] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Familial Canc Registry, Los Angeles, CA 90024 USA; [Daly, Mary B.; Godwin, Andrew K.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Tomlinson, Gail] Univ Texas Dallas, Dallas, TX 75230 USA; [Olopade, Olufunmilayo I.] Univ Chicago, Chicago, IL 60637 USA; [Bium, Joanne L.] Baylor Sammons Canc Ctr, Dallas, TX USA; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Peterlongo, Paolo; Radice, Paolo] Ist Nazl Tumori, Fdn IRCCS, Dept Expt Oncol, Unit Genet Susceptibil Canc, I-20133 Milan, Italy; [Manoukian, Siranoush] Fdn Ist FIRC Oncol Med, Med Genet Serv, Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Szabo, Csilla I.] Mayo Clin, Coll Med, Dept Lab Med & Expt Pathol, Rochester, MN USA; [Pereira, Lutecia H. Mateus] US NCI, Lab Populat Genet, NIH, Rockville, MD USA; [Greene, Mark H.] NCI, Clin Genet Branch, Rockville, MD USA; [Rennert, Gad; Leibkowicz, Flavio; Barnett-Griness, Ofra] CHS Natl Canc Control Ctr, Haifa, Israel; [Rennert, Gad; Leibkowicz, Flavio; Barnett-Griness, Ofra] Carmel Med Ctr & B Rappaport, Fac Med, Dept Commun Med & Epidemiol, Haifa, Israel; [Andrulis, Irene L.; OCGN] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Andrulis, Irene L.; OCGN] Ontario Canc Genet Network, Canc Care Ontario, Toronto, ON, Canada; [Andrulis, Irene L.; Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A1, Canada; [Andrulis, Irene L.; Ozcelik, Hilmi] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gerdes, Anne-Marie] Odense Univ Hosp, Dept Biochem Pharmacol & Genet, Odense, Denmark; [Caligo, Maria A.] Univ Pisa, Dept Oncol, Div Surg Mol & Ultrastruct, Pisa, Italy; [Caligo, Maria A.] Pisa Univ Hosp, Pisa, Italy; [Laitman, Yael; Milgrom, Roni; Friedman, Eitan] Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, IL-52621 Tel Hashomer, Israel; [Kaufman, Bella; Friedman, Eitan] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Tel Hashomer, Israel; [Domchek, Susan M.; Nathanson, Katherine L.] Univ Penn, Sch Med, Dept Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Osorio, Ana; Benitez, Javier] Spanish Natl Canc Ctr, Human Canc Genet Programme, Human Genet Grp, Madrid, Spain; [Llort, Gemma] Inst Catala Oncol, Genet Counselling Unit, Prevent & Canc Control Ser, Barcelona, Spain; [Milne, Roger L.; Benitez, Javier] Spanish Natl Canc Ctr, Human Canc Genet Programme, Genotyping Unit, Madrid, Spain; [Hamann, Ute] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Hogervorst, Frans B. L.] Netherlands Canc Inst, Dept Pathol, Family Canc Clin, NL-1066 CX Amsterdam, Netherlands; [Manders, Peggy] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Ligtenberg, Marjolijn J. L.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Ligtenberg, Marjolijn J. L.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [van den Ouweland, Ans M. W.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Evans, D. Gareth] St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; [Evans, D. Gareth] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; [Eeles, Rosalind] Inst Canc Res, Translat Canc Genet Team, New York, NY USA; [Eeles, Rosalind] Royal Marsden NHS Fdn Trust, London, England; [Pichert, Gabriella] Guys Hosp, London, England; [Chu, Carol] Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Eccles, Diana] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Davidson, Rosemarie] Ferguson Smith Ctr Clin Geneet, Glasgow, Lanark, Scotland; [Douglas, Fiona] Inst Human Genet, Ctr Life, Newcastle Upon Tyne, Tyne & Wear, England; [Sobol, Hagay; Bourdon, Violaine; Eisinger, Francois] Inst J Paoli I Calmettes, INSERM UMR599, Dept Oncol Genet, F-13275 Marseille, France; [Chompret, Agnes] Inst Gustave Roussy, Dept Med, Villejuif, France; [Capoulade, Corinne; Paillerets, Brigitte Bressac-de; Lenoir, Gilbert M.] Inst Gustave Roussy, Dept Genet, CNRS FRE2939, Villejuif, France; [Gauthier-Villars, Marion; Houdayer, Claude; Stoppa-Lyonnet, Dominique] Univ Paris 05, Dept Genet, Inst Curie, Paris, France	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; QIMR Berghofer Medical Research Institute; CHU Lyon; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cologne; Leipzig University; Technical University of Munich; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Ulm University; Hospital Clinico San Carlos; University of Helsinki; Helsinki University Central Hospital; Laval University; University of Quebec; Laval University; Peter Maccallum Cancer Center; University of California System; University of California Irvine; University of Pennsylvania; Pennsylvania Medicine; University of Vienna; Creighton University; Georgetown University; City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Fox Chase Cancer Center; University of Texas System; University of Texas Dallas; University of Chicago; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; Mayo Clinic; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Clalit Health Services; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Toronto; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Southern Denmark; Odense University Hospital; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Chaim Sheba Medical Center; Chaim Sheba Medical Center; University of Pennsylvania; Pennsylvania Medicine; Centro Nacional de Investigaciones Oncologicas (CNIO); Catalan Institute of Oncology; Centro Nacional de Investigaciones Oncologicas (CNIO); Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands Cancer Institute; Netherlands Cancer Institute; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; University of Manchester; University of Manchester; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Antoniou, AC (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Genet Epidemiol Unit, Canc Res UK, Cambridge CB2 1TN, England.	antonis@srl.cam.ac.uk	Spurdle, Amanda B/A-4978-2011; Ligtenberg, Marjolijn/N-9666-2013; Rebbeck, Timothy/GLU-8348-2022; Tomlinson, Gail/AAR-9776-2020; Peterlongo, Paolo/Q-4717-2018; Arnold, Norbert/E-3012-2010; Manders, P./L-4501-2015; Osorio, Ana/I-4324-2014; Andrulis, Irene L./E-7267-2013; Caligo, Adelaide Maria/K-4289-2018; Mazoyer, Sylvie/N-7559-2017; Tobias, Edward/D-4246-2009; Evans, D Gareth/AAB-4308-2022; Ozcelik, Hilmi/A-3952-2011; Paillerets, Brigitte Bressac-de/D-8954-2018; Eccles, Diana/K-6327-2019; manoukian, siranoush/E-7132-2017; Radice, Paolo/O-3119-2013	Spurdle, Amanda B/0000-0003-1337-7897; Ligtenberg, Marjolijn/0000-0003-1290-1474; Rebbeck, Timothy/0000-0002-4799-1900; Peterlongo, Paolo/0000-0001-6951-6855; Arnold, Norbert/0000-0003-4523-8808; Osorio, Ana/0000-0001-8124-3984; Caligo, Adelaide Maria/0000-0003-0589-1829; Tobias, Edward/0000-0003-2649-7695; Evans, D Gareth/0000-0002-8482-5784; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Eccles, Diana/0000-0002-9935-3169; manoukian, siranoush/0000-0002-6034-7562; Eisinger, Francois/0000-0002-8794-0681; Nathanson, Katherine/0000-0002-6740-0901; Chenevix-Trench, Georgia/0000-0002-1878-2587; Engel, Christoph/0000-0002-7247-282X; Mazoyer, Sylvie/0000-0002-2135-0160; Rennert, Gad/0000-0002-8512-068X; Radice, Paolo/0000-0001-6298-4111; Houdayer, Claude/0000-0002-5190-0389; Simard, Jacques/0000-0001-6906-3390; Thorne, Heather/0000-0003-3610-2511; Gerdes, Anne-Marie/0000-0002-0328-3320; Durocher, Francine/0000-0001-8012-4641; Eeles, Rosalind/0000-0002-3698-6241; Beesley, Jonathan/0000-0003-1942-325X; Nevanlinna, Heli/0000-0002-0916-2976	Cancer Research UK [10118] Funding Source: Medline; NCI NIH HHS [R01 CA122340, P50 CA083638, N02CP65504, R01-CA083855, U01 CA113916, P50 CA116201, P50-CA116201, R01 CA074415, R01-CA102776, RC4 CA153828, U01 CA086389, 5U01 CA113916, CA122340, N02-CP-11019-50, N02CP11019, U01 CA69631, R01 CA102776, U01 CA086389-09, U01 CA069631, P30 CA051008, R01 CA083855, 1U01 CA 86389, P30 CA51008-12, R01-CA74415, P-50 CA 83638] Funding Source: Medline; NCRR NIH HHS [M01 RR000043, M01 RR00043] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP011019] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA102776, U01CA086389, R01CA074415, R01CA122340, U01CA069631, R01CA083855, RC4CA153828, P50CA116201, P50CA083638, Z01CP010144, U01CA113916] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; ANTONIOU AC, IN PRESS BR J CANC; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Chenevix-Trench G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1670; Couch FJ, 2007, CANCER EPIDEM BIOMAR, V16, P1416, DOI 10.1158/1055-9965.EPI-07-0129; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; GARCIACLOSAS M, IN PRESS PLOS GENETI; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kramer JL, 2005, J CLIN ONCOL, V23, P8629, DOI 10.1200/JCO.2005.02.9199; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; RISCH N, 1990, AM J HUM GENET, V46, P222; Simchoni S, 2006, P NATL ACAD SCI USA, V103, P3770, DOI 10.1073/pnas.0511301103	20	209	218	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					937	948		10.1016/j.ajhg.2008.02.008	http://dx.doi.org/10.1016/j.ajhg.2008.02.008			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18355772	Green Published, Bronze			2022-12-18	WOS:000255103900012
J	Antoniou, AC; Sinilnikova, OM; Simard, J; Leone, M; Dumont, M; Neuhausen, SL; Struewing, JP; Stoppa-Lyonnet, D; Barjhoux, L; Hughes, DJ; Coupier, I; Belotti, M; Lasset, C; Rebbeck, TR; Wagner, T; Lynch, HT; Domchek, SM; Nathanson, KL; Garber, JE; Weitzel, J; Narod, SA; Tomlinson, G; Olopade, OI; Godwin, A; Isaacs, C; Jakubowska, A; Lubinski, J; Gronwald, J; Gorski, B; Byrski, T; Huzarski, T; Peock, S; Cook, M; Baynes, C; Murray, A; Rogers, M; Daly, PA; Dorkins, H; Schmutzler, RK; Versmold, B; Engel, C; Meindl, A; Arnold, N; Niederacher, D; Deissler, H; Spurdle, AB; Chen, XQ; Waddell, N; Cloonan, N; Kirchhoff, T; Offit, K; Friedman, E; Kaufmann, B; Laitman, Y; Galore, G; Rennert, G; Lejbkowicz, F; Raskin, L; Andrulis, IL; Ilyushik, E; Ozcelik, H; Devilee, P; Vreeswijk, MPG; Greene, MH; Prindiville, SA; Osorio, A; Benitez, J; Zikan, M; Szabo, CI; Kilpivaara, O; Nevanlinna, H; Hamann, U; Durocher, F; Arason, A; Couch, FJ; Easton, DF; Chenevix-Trench, G				Antoniou, Antonis C.; Sinilnikova, Olga M.; Simard, Jacques; Leone, Melanie; Dumont, Martine; Neuhausen, Susan L.; Struewing, Jeffery P.; Stoppa-Lyonnet, Dominique; Barjhoux, Laure; Hughes, David J.; Coupier, Isabelle; Belotti, Muriel; Lasset, Christine; Rebbeck, Timothy R.; Wagner, Theresa; Lynch, Henry T.; Domchek, Susan M.; Nathanson, Katherine L.; Garber, Judy E.; Weitzel, Jeffrey; Narod, Steven A.; Tomlinson, Gail; Olopade, Olufunmilayo I.; Godwin, Andrew; Isaacs, Claudine; Jakubowska, Anna; Lubinski, Jan; Gronwald, Jacek; Gorski, Bohdan; Byrski, Tomasz; Huzarski, Tomasz; Peock, Susan; Cook, Margaret; Baynes, Caroline; Murray, Alexandra; Rogers, Mark; Daly, Peter A.; Dorkins, Huw; Schmutzler, Rita K.; Versmold, Beatrix; Engel, Christoph; Meindl, Alfons; Arnold, Norbert; Niederacher, Dieter; Deissler, Helmut; Spurdle, Amanda B.; Chen, Xiaoqing; Waddell, Nicola; Cloonan, Nicole; Kirchhoff, Tomas; Offit, Kenneth; Friedman, Eitan; Kaufmann, Bella; Laitman, Yael; Galore, Gilli; Rennert, Gad; Lejbkowicz, Flavio; Raskin, Leon; Andrulis, Irene L.; Ilyushik, Eduard; Ozcelik, Hilmi; Devilee, Peter; Vreeswijk, Maaike P. G.; Greene, Mark H.; Prindiville, Sheila A.; Osorio, Ana; Benitez, Javier; Zikan, Michal; Szabo, Csilla I.; Kilpivaara, Outi; Nevanlinna, Heli; Hamann, Ute; Durocher, Francine; Arason, Adalgeir; Couch, Fergus J.; Easton, Douglas F.; Chenevix-Trench, Georgia		Genetic Modifiers Cancer Risk BRC; Epidemiological Study BRCA1 BRCA2; GCHBOC; Kathleen Cuningham Consortium Res; Consortium Invest Modifiers BRCA1	RAD51 135G -> C modifies breast cancer risk among BRCA2 mutation carriers: Results from a combined analysis of 19 studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; UNKNOWN CLINICAL-SIGNIFICANCE; DNA-SEQUENCE VARIANTS; OVARIAN-CANCER; PROPHYLACTIC OOPHORECTOMY; SUSCEPTIBILITY GENES; FAMILY-HISTORY; POPULATION; REPAIR; PENETRANCE	RAD51 is an important component of double-stranded DNA-repair mechanisms that interacts with both BRCA1 and BRCA2. A single-nucleotide polymorphism (SNP) in the 5' untranslated region (UTR) of RAD51, 135G -> C, has been suggested as a possible modifier of breast cancer risk in BRCA1 and BRCA2 mutation carriers. We pooled genotype data for 8,512 female mutation carriers from 19 studies for the RAD51 135G -> C SNP. We found evidence of an increased breast cancer risk in CC homozygotes (hazard ratio [HR] 1.92 [95% confidence interval {Cl} 1.25-2.94) but not in heterozygotes (HR 0.95 [95% Cl 0.83-1.07]; P =.002, by heterogeneity test with 2 degrees of freedom [df]). When BRCA1 and BRCA2 mutation carriers were analyzed separately, the increased risk was statistically significant only among BRCA2 mutation carriers, in whom we observed HRs of 1.17 (95% Cl 0.91-1.51) among heterozygotes and 3.18 (95% Cl 1.39-7.27) among rare homozygotes (P =.0007, by heterogeneity test with 2 df). In addition, we determined that the 135G -> C variant affects RAD51 splicing within the 5' UTR. Thus, 135G -> C may modify the risk of breast cancer in BRCA2 mutation carriers by altering the expression of RAD51. RAD51 is the first gene to be reliably identified as a modifier of risk among BRCA1/ 2 mutation carriers.	Strangeways Res Lab, Genet Epidemiol Unit, Cambridge CB1 8RN, England		Antoniou, AC (corresponding author), Strangeways Res Lab, Genet Epidemiol Unit, Worts Causeway, Cambridge CB1 8RN, England.	antonis@srl.cam.ac.uk	Gronwald, Jacek/A-4576-2017; DEVILEE, PETER/ABR-2140-2022; Rebbeck, Timothy/GLU-8348-2022; BYRSKI, Tomasz/I-2844-2014; Devilee, Peter/GXV-8005-2022; Raskin, Leon/P-5765-2015; Jakubowska, Anna/O-8050-2014; Struewing, Jeffery P/I-7502-2013; Osorio, Ana/I-4324-2014; Ozcelik, Hilmi/A-3952-2011; Cloonan, Nicole/B-5272-2008; Arnold, Norbert/E-3012-2010; Waddell, Nicola/H-4929-2015; Andrulis, Irene L./E-7267-2013; Tobias, Edward/D-4246-2009; Huzarski, Tomasz/AAQ-2161-2021; Zikan, Michal/M-4073-2017; Chenevix-Trench, Georgia/AAV-2014-2020; Tomlinson, Gail/AAR-9776-2020; Narod, Steven A/AAA-6112-2022; Spurdle, Amanda B/A-4978-2011; Lucassen, Anneke/D-7764-2017	Gronwald, Jacek/0000-0002-3643-2871; Rebbeck, Timothy/0000-0002-4799-1900; BYRSKI, Tomasz/0000-0001-9181-5026; Raskin, Leon/0000-0003-1195-7214; Jakubowska, Anna/0000-0002-5650-0501; Struewing, Jeffery P/0000-0002-4848-3334; Osorio, Ana/0000-0001-8124-3984; Cloonan, Nicole/0000-0001-7802-6647; Arnold, Norbert/0000-0003-4523-8808; Waddell, Nicola/0000-0002-3950-2476; Tobias, Edward/0000-0003-2649-7695; Huzarski, Tomasz/0000-0003-3857-4854; Zikan, Michal/0000-0001-5266-8895; Chenevix-Trench, Georgia/0000-0002-1878-2587; Spurdle, Amanda B/0000-0003-1337-7897; Eisinger, Francois/0000-0002-8794-0681; Hughes, David John/0000-0003-1668-8770; Burn, John/0000-0002-9823-2322; Rennert, Gad/0000-0002-8512-068X; Ellis, Ian/0000-0001-5292-8474; Nevanlinna, Heli/0000-0002-0916-2976; Lucassen, Anneke/0000-0003-3324-4338; Thorne, Heather/0000-0003-3610-2511; Eccles, Diana M/0000-0002-9935-3169; Vreeswijk, Maaike P.G./0000-0003-4068-9271; Kirchhoff, Tomas/0000-0002-9055-2364; Evans, Gareth/0000-0002-8482-5784; Arason, Adalgeir/0000-0003-0480-886X; Durocher, Francine/0000-0001-8012-4641; Engel, Christoph/0000-0002-7247-282X; Bishop, Tim/0000-0002-8752-8785; Simard, Jacques/0000-0001-6906-3390; Nathanson, Katherine/0000-0002-6740-0901	Cancer Research UK [10118] Funding Source: Medline; NCI NIH HHS [R01-CA74415, R01-CA102776, 5UO1 CA86389, N02-CP-11019-50, U01 CA086389, R01 CA083855, P50 CA116201, R01-CA083855, R01 CA102776, N02CP11019, R01 CA074415, CA-95-003, P50-CA116201] Funding Source: Medline; NCRR NIH HHS [M01 RR000043, MO1 RR00043] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP011019] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA074415, P50CA116201, Z01CP010144, R01CA102776, U01CA086389, R01CA095003, R01CA083855] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andrieu N, 2006, JNCI-J NATL CANCER I, V98, P535, DOI 10.1093/jnci/djj132; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Bonadona V, 2007, BREAST CANCER RES TR, V101, P233, DOI 10.1007/s10549-006-9288-7; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; Buisson M, 2006, HUM MUTAT, V27, P1024, DOI 10.1002/humu.20384; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Chenevix-Trench G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1670; Chinwalla V, 2003, ONCOGENE, V22, P1400, DOI 10.1038/sj.onc.1206273; COX D, 1984, ANAL SURVIVAL DATAT; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; Hayette S, 2000, ONCOGENE, V19, P4446, DOI 10.1038/sj.onc.1203789; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Jakubowska A, 2003, CANCER EPIDEM BIOMAR, V12, P457; Jakubowska A, 2007, CANCER EPIDEM BIOMAR, V16, P270, DOI 10.1158/1055-9965.EPI-06-0562; Kadouri L, 2001, BRIT J CANCER, V85, P36, DOI 10.1054/bjoc.2001.1777; Kadouri L, 2004, BRIT J CANCER, V90, P2002, DOI 10.1038/sj.bjc.6601837; Kadouri L, 2004, INT J CANCER, V108, P399, DOI 10.1002/ijc.11531; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kramer JL, 2005, J CLIN ONCOL, V23, P8629, DOI 10.1200/JCO.2005.02.9199; Kuefer MU, 2003, ONCOGENE, V22, P1418, DOI 10.1038/sj.onc.1206272; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Lalloo F, 2003, LANCET, V361, P1101, DOI 10.1016/S0140-6736(03)12856-5; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Levy-Lahad E, 2001, P NATL ACAD SCI USA, V98, P3232, DOI 10.1073/pnas.051624098; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Mikaelsdottir EK, 2004, BREAST CANCER RES, V6, pR284, DOI 10.1186/bcr785; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Shu ZG, 1999, MOL CELL BIOL, V19, P8686; Simchoni S, 2006, P NATL ACAD SCI USA, V103, P3770, DOI 10.1073/pnas.0511301103; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Wang RZ, 2001, RENEW SUST ENERG REV, V5, P1, DOI 10.1016/S1364-0321(00)00009-5; Ware MD, 2006, ONCOGENE, V25, P323, DOI 10.1038/sj.onc.1209033; Webb PM, 2005, CANCER EPIDEM BIOMAR, V14, P319, DOI 10.1158/1055-9965.EPI-04-0335; Wongchanapai W, 1999, J FOOD DRUG ANAL, V7, P1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	209	212	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1186	1200		10.1086/522611	http://dx.doi.org/10.1086/522611			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999359	Bronze, Green Published			2022-12-18	WOS:000251098800006
J	Klopocki, E; Schulze, H; Strauss, G; Ott, CE; Hall, J; Trotier, F; Fleischhauer, S; Greenhalgh, L; Newbury-Ecob, RA; Neumann, LM; Habenicht, R; Konig, R; Seemanova, E; Megarbane, A; Ropers, HH; Ullmann, R; Horn, D; Mundlos, S				Klopocki, Eva; Schulze, Harald; Strauss, Gabriele; Ott, Claus-Eric; Hall, Judith; Trotier, Fabienne; Fleischhauer, Silke; Greenhalgh, Lynn; Newbury-Ecob, Ruth A.; Neumann, Luitgard M.; Habenicht, Rolf; Koenig, Rainer; Seemanova, Eva; Megarbane, Andre; Ropers, Hans-Hilger; Ullmann, Reinhard; Horn, Denise; Mundlos, Stefan			Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL THROMBOCYTOPENIA; ROBERTS-SYNDROME; C-MPL; GENE; THROMBOPOIETIN; EXPRESSION; DACTYLAPLASIA; MUTATIONS; STAT3	Thrombocytopenia-absent radius (TAR) syndrome is characterized by hypomegakaryocytic thrombocytopenia and bilateral radial aplasia in the presence of both thumbs. Other frequent associations are congenital heart disease and a high incidence of cow's milk intolerance. Evidence for autosomal recessive inheritance comes from families with several affected individuals born to unaffected parents, but several other observations argue for a more complex pattern of inheritance. In this study, we describe a common interstitial microdeletion of 200 kb on chromosome 1q21.1 in all 30 investigated patients with TAR syndrome, detected by microarray-based comparative genomic hybridization. Analysis of the parents revealed that this deletion occurred de novo in 25% of affected individuals. Intriguingly, inheritance of the deletion along the maternal line as well as the paternal line was observed. The absence of this deletion in a cohort of control individuals argues for a specific role played by the microdeletion in the pathogenesis of TAR syndrome. We hypothesize that TAR syndrome is associated with a deletion on chromosome 1q21.1 but that the phenotype develops only in the presence of an additional as-yet-unknown modifier (mTAR).	Univ Med Berlin, Charite, Inst Med Genet, D-13353 Berlin, Germany; Univ Med Berlin, Charite, Klin Allgemeine Pediat, D-13353 Berlin, Germany; Univ Med Berlin, Charite, Inst Human Genet, D-13353 Berlin, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Royal Liverpool Childrens Hosp, Liverpool L7 7DG, Merseyside, England; Bristol Royal Hosp Children, Bristol, Avon, England; Kinderkrankenhaus Wilhelmstift, Hamburg, Germany; Univ Frankfurt Klinikum, Inst Human Genet, D-6000 Frankfurt, Germany; Charles Univ Prague, Inst Biol & Med Genet, Prague, Czech Republic; Univ St Joseph, Serv Genet Med, Beirut, Lebanon	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of British Columbia; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Bristol Royal Hospital For Children; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Charles University Prague; Saint Joseph University Beirut	Mundlos, S (corresponding author), Univ Med Berlin, Charite, Inst Med Genet, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Mundlos, Stefan/ABH-9585-2020; Ott, Claus/U-8226-2019; Klopocki, Eva/B-6823-2017; Megarbane, Andre/ABD-5574-2021; Ott, Claus E/G-1936-2011	Ott, Claus/0000-0003-3627-3791; Klopocki, Eva/0000-0003-1438-2081; Ott, Claus E/0000-0003-3627-3791; Mundlos, Stefan/0000-0002-9788-3166; Hall, Judith G./0000-0001-5062-491X				Ballmaier M, 1998, Stem Cells, V16 Suppl 2, P177; Ballmaier M, 1997, BLOOD, V90, P612, DOI 10.1182/blood.V90.2.612.612_612_619; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; CHAI CK, 1981, J HERED, V72, P234, DOI 10.1093/oxfordjournals.jhered.a109486; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Erdogan F, 2006, CYTOGENET GENOME RES, V115, P247, DOI 10.1159/000095921; EZUMI Y, 1995, FEBS LETT, V374, P48, DOI 10.1016/0014-5793(95)01072-M; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fleischman RA, 2002, BRIT J HAEMATOL, V116, P367, DOI 10.1046/j.1365-2141.2002.03263.x; Geddis AE, 2006, SEMIN HEMATOL, V43, P196, DOI 10.1053/j.seminhematol.2006.04.003; Greenhalgh KL, 2002, J MED GENET, V39, P876, DOI 10.1136/jmg.39.12.876; HALL JG, 1987, J MED GENET, V24, P79, DOI 10.1136/jmg.24.2.79; HALL JG, 1969, MEDICINE, V48, P411, DOI 10.1097/00005792-196948060-00001; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; JOHNSON KR, 1995, GENOMICS, V29, P457, DOI 10.1006/geno.1995.9981; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Klopocki E, 2006, AM J MED GENET A, V140A, P873, DOI 10.1002/ajmg.a.31163; Krzywinski M, 2004, NUCLEIC ACIDS RES, V32, P3651, DOI 10.1093/nar/gkh700; Letestu R, 2000, BLOOD, V95, P1633; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Miura Y, 2000, HUM GENET, V107, P205, DOI 10.1007/s004390000369; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Raslova H, 2004, J CLIN INVEST, V114, P77, DOI 10.1172/JCI200421197; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; SCHNUR RE, 1987, AM J MED GENET, V28, P117, DOI 10.1002/ajmg.1320280117; Seemanova E, 1985, Cesk Pediatr, V40, P511; Sidow A, 1999, NAT GENET, V23, P104, DOI 10.1038/12709; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Strippoli P, 1998, BRIT J HAEMATOL, V103, P311, DOI 10.1046/j.1365-2141.1998.00991.x; Swindell EC, 2001, MECH DEVELOP, V109, P405, DOI 10.1016/S0925-4773(01)00535-4; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban M, 1998, AM J MED GENET, V79, P155, DOI 10.1002/(SICI)1096-8628(19980923)79:3<155::AID-AJMG1>3.0.CO;2-M; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Ward R E, 1986, Am J Med Genet Suppl, V2, P207; Wassink TH, 2005, HUM GENET, V117, P200, DOI 10.1007/s00439-005-1257-4; Zeng WQ, 2006, AM J MED GENET A, V140A, P1004, DOI 10.1002/ajmg.a.31186	40	209	218	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					232	240		10.1086/510919	http://dx.doi.org/10.1086/510919			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236129	Green Published, Bronze			2022-12-18	WOS:000243729500003
J	Steinfeld, R; Reinhardt, K; Schreiber, K; Hillebrand, M; Kraetzner, R; Bruck, W; Saftig, P; Gartner, J				Steinfeld, R; Reinhardt, K; Schreiber, K; Hillebrand, M; Kraetzner, R; Bruck, W; Saftig, P; Gartner, J			Cathepsin D deficiency is associated with a human neurodegenerative disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL CEROID-LIPOFUSCINOSES; LYSOSOMAL STORAGE; PROTEINASE; DISEASE; CELLS	Cathepsin D is a ubiquitously expressed lysosomal protease that is involved in proteolytic degradation, cell invasion, and apoptosis. In mice and sheep, cathepsin D deficiency is known to cause a fatal neurodegenerative disease. Here, we report a novel disorder in a child with early blindness and progressive psychomotor disability. Two missense mutations in the CTSD gene, F229I and W383C, were identified and were found to cause markedly reduced proteolytic activity and a diminished amount of cathepsin D in patient fibroblasts. Expression of cathepsin D mutants in cathepsin D-/- mouse fibroblasts revealed disturbed posttranslational processing and intracellular targeting for W383C and diminished maximal enzyme velocity for F229I. The structural effects of cathepsin D mutants were estimated by computer modeling, which suggested larger structural alterations for W383C than for F229I. Our studies broaden the group of human neurodegenerative disorders and add new insight into the cellular functions of human cathepsin D.	Univ Gottingen, Zentrum Kinderheilkunde & Jugendmed, Bereich Humanmed, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; Univ Gottingen, Dept Mol Pharmacol, D-37075 Gottingen, Germany; Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany; Univ Kiel, Inst Biochem, D-2300 Kiel, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Kiel	Steinfeld, R (corresponding author), Univ Gottingen, Zentrum Kinderheilkunde & Jugendmed, Bereich Humanmed, Dept Pediat & Pediat Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.	rsteinfeld@med.uni-goettingen.de	Saftig, Paul/A-7966-2010	Steinfeld, Robert/0000-0003-0956-6601				AWANO T, 2005, MOL GENET METAB; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DeLano W. L, 2002, PYMOL MOL GENETICS G; Egberts F, 2004, J CELL SCI, V117, P2295, DOI 10.1242/jcs.01075; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hausmann M, 2004, CLIN EXP IMMUNOL, V136, P157, DOI 10.1111/j.1365-2249.2004.02420.x; HOFMANN SL, 2001, METABOLIC MOL BASES, P3877; HORST M, 1991, BIOCHEM J, V273, P355, DOI 10.1042/bj2730355; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Lee AY, 1998, NAT STRUCT BIOL, V5, P866, DOI 10.1038/2306; LIAUDETCOOPMAN E, 2005, CANC LETT; Mole SE, 2004, BRAIN PATHOL, V14, P70, DOI 10.1111/j.1750-3639.2004.tb00500.x; Myllykangas L, 2005, NEUROBIOL DIS, V19, P194, DOI 10.1016/j.nbd.2004.12.019; Nomura T, 2005, J MED INVESTIG, V52, P1, DOI 10.2152/jmi.52.1; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Tyynela J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786; Vivanco F, 2005, J PROTEOME RES, V4, P1181, DOI 10.1021/pr0500197; Yasuda Y, 1999, J BIOCHEM-TOKYO, V126, P260; Yasuda Y, 1999, J BIOCHEM-TOKYO, V125, P1137, DOI 10.1093/oxfordjournals.jbchem.a022396	21	209	214	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					988	998		10.1086/504159	http://dx.doi.org/10.1086/504159			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685649	Green Published, Bronze			2022-12-18	WOS:000237553800008
J	Uhlenberg, B; Schuelke, M; Ruschendorf, F; Ruf, N; Kaindl, AM; Henneke, M; Thiele, H; Stoltenburg-Didinger, G; Aksu, F; Topaloglu, H; Nurnberg, P; Hubner, C; Weschke, B; Gartner, J				Uhlenberg, B; Schuelke, M; Ruschendorf, F; Ruf, N; Kaindl, AM; Henneke, M; Thiele, H; Stoltenburg-Didinger, G; Aksu, F; Topaloglu, H; Nurnberg, P; Hubner, C; Weschke, B; Gartner, J			Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; PROTEOLIPID PROTEIN; LINKAGE ANALYSIS; EXPRESSION; PHENOTYPE; MYELIN; MICE; CNS; TRANSIENT; ASTROCYTE	The hypomyelinating leukodystrophies X-linked Pelizaeus-Merzbacher disease (PMD) and Pelizaeus-Merzbacher like disease (PMLD) are characterized by nystagmus, progressive spasticity, and ataxia. In a consanguineous family with PMLD, we performed a genomewide linkage scan using the GeneChip Mapping EA 10K Array (Affymetrix) and detected a single gene locus on chromosome 1q41-q42. This region harbors the GJA12 gene, which encodes gap junction protein alpha12 (or connexin 46.6). Gap junction proteins assemble into intercellular channels through which signaling ions and small molecules are exchanged. GJA12 is highly expressed in oligodendrocytes, and, therefore, it serves as an excellent candidate for hypomyelination in PMLD. In three of six families with PMLD, we detected five different GJA12 mutations, including missense, nonsense, and frameshift mutations. We thereby confirm previous assumptions that PMLD is genetically heterogeneous. Although the murine Gja12 ortholog is not expressed in sciatic nerve, we did detect GJA12 transcripts in human sciatic and sural nerve tissue by reverse-transcriptase polymerase chain reaction. These results are in accordance with the electrophysiological finding of reduced motor and sensory nerve conduction velocities in patients with PMLD, which argues for a demyelinating neuropathy. In this study, we demonstrate that GJA12 plays a key role in central myelination and is involved in peripheral myelination in humans.	Univ Med Sch Berlin, Charite, Dept Neuropediat, D-13353 Berlin, Germany; Univ Med Sch Berlin, Charite, Dept Neuropathol, D-13353 Berlin, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Gottingen, Clin Pediat & Pediat Neurol, D-3400 Gottingen, Germany; Univ Witten Herdecke, Dept Neuropediat, Datteln, Germany; Hacettepe Childrens Hosp Med Ctr, Dept Child Neurol, Ankara, Turkey	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen; Witten Herdecke University; Hacettepe University	Hubner, C (corresponding author), Univ Med Sch Berlin, Charite, Dept Neuropediat, Augustenburger Pl 1, D-13353 Berlin, Germany.	christoph.huebner@charite.de	Thiele, Holger/ABE-6792-2020; TOPALOGLU, HALUK AYDIN/I-9318-2013	Thiele, Holger/0000-0002-0169-998X; Kaindl, Angela/0000-0001-9454-206X; Weschke, Bernhard/0000-0003-4533-0743; Schuelke, Markus/0000-0003-2824-3891				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrams CK, 2002, P NATL ACAD SCI USA, V99, P3980, DOI 10.1073/pnas.261713499; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Cailloux F, 2000, EUR J HUM GENET, V8, P837, DOI 10.1038/sj.ejhg.5200537; Garbern JY, 1997, NEURON, V19, P205, DOI 10.1016/S0896-6273(00)80360-8; Hahn AF, 2000, MUSCLE NERVE, pS39; Hanemann CO, 2003, ARCH NEUROL-CHICAGO, V60, P605, DOI 10.1001/archneur.60.4.605; Hudson LD, 2003, J CHILD NEUROL, V18, P616, DOI 10.1177/08830738030180090801; Kleopa KA, 2002, J NEUROSCI RES, V68, P522, DOI 10.1002/jnr.10255; Koeppen AH, 2002, J NEUROPATH EXP NEUR, V61, P747, DOI 10.1093/jnen/61.9.747; Lagree V, 2003, J CELL SCI, V116, P3189, DOI 10.1242/jcs.00604; Lazzarini A, 1997, NEUROLOGY, V49, P824, DOI 10.1212/WNL.49.3.824; Lin CQ, 1999, TOHOKU J EXP MED, V188, P239, DOI 10.1620/tjem.188.239; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Nagy JI, 2003, CELL COMMUN ADHES, V10, P401, DOI 10.1080/15419060390263191; Nagy JI, 2003, GLIA, V44, P205, DOI 10.1002/glia.10278; Nezu A, 1996, BRAIN DEV-JPN, V18, P114, DOI 10.1016/0387-7604(95)00078-X; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Odermatt B, 2003, J NEUROSCI, V23, P4549; Paulson HL, 2002, ANN NEUROL, V52, P429, DOI 10.1002/ana.10305; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Plecko B, 2003, NEUROPEDIATRICS, V34, P127; Rouan F, 2001, J CELL SCI, V114, P2105; Samoilova M, 2003, J NEUROCHEM, V86, P687, DOI 10.1046/j.1471-4159.2003.01893.x; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; Schiffmann R, 2001, CURR OPIN NEUROL, V14, P789, DOI 10.1097/00019052-200112000-00018; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Takashima H, 2003, ACTA NEUROL SCAND, V107, P31, DOI 10.1034/j.1600-0404.2003.01317.x; Teubner B, 2001, J NEUROSCI, V21, P1117; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	31	209	217	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					251	260		10.1086/422763	http://dx.doi.org/10.1086/422763			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15192806	Green Published, Bronze			2022-12-18	WOS:000222702000009
J	Carvajal-Carmona, LG; Soto, ID; Pineda, N; Ortiz-Barrientos, D; Duque, C; Ospina-Duque, J; McCarthy, M; Montoya, P; Alvarez, VM; Bedoya, G; Ruiz-Linares, A				Carvajal-Carmona, LG; Soto, ID; Pineda, N; Ortiz-Barrientos, D; Duque, C; Ospina-Duque, J; McCarthy, M; Montoya, P; Alvarez, VM; Bedoya, G; Ruiz-Linares, A			Strong Amerind/white sex bias and a possible sephardic contribution among the founders of a population in northwest Colombia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-DISTANCE; MUTATION; DISEASE; HAPLOTYPES; MITOCHONDRIAL; ANCESTRY; ORIGINS; ONSET	Historical and genetic evidences suggest that the recently founded population of Antioquia (Colombia) is potentially useful for the genetic mapping of complex traits. This population was established in the 16th-17th centuries through the admixture of Amerinds, Europeans, and Africans and grew in relative isolation until the late 19th century. To examine the origin of the founders of Antioquia, we typed 11 markers on the nonrecombining portion of the Y chromosome and four markers on mtDNA in a sample of individuals with confirmed Antioquian ancestry, The polymorphisms on the Y chromosome (five biallelic markers and six microsatellites) allow an approximation to the origin of founder men, and those on mtDNA identify the four major founder Native American lineages. These data indicate that similar to 94% of the Y chromosomes are European, 5% are African, and 1% are Amerind. Y-chromosome data are consistent with an origin of founders predominantly in southern Spain but also suggest that a fraction came from northern Iberia and that some possibly had a Sephardic origin. In stark contrast with the Y-chromosome, similar to 90% of the mtDNA gene pool of Antioquia is Amerind, with the frequency of the four Amerind founder lineages being closest to Native Americans currently living in the area. These results indicate a highly asymmetric pattern of mating in early Antioquia, involving mostly immigrant men and local native women. The discordance of our data with blood-group estimates of admixture suggests that the number of founder men was larger than that of women.	Univ Antioquia, Genet Mol Lab, Medellin, Colombia; Univ Antioquia, Dept Psiquiat, Medellin, Colombia; Univ Antioquia, Dept Hist, Medellin, Colombia; Northwick Pk Hosp & Clin Res Ctr, Imperial Coll, Sch Med, Dept Med & Community Genet, Harrow HA1 3UJ, Middx, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Genet & Genom Res Inst, Complex Trait Anal Grp, London, England	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Imperial College London; Imperial College London	Ruiz-Linares, A (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	andres.ruiz@ic.ac.uk	Ortiz-Barrientos, Daniel/B-2274-2010; Ortiz-Barrientos, Daniel/N-3294-2019; Carvajal-Carmona, Luis G/B-3882-2010; Soto-Calderón, Iván/P-2639-2019; Ruiz-Linares, Andres/AAR-1104-2021	Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Soto-Calderón, Iván/0000-0002-6311-8378; Ruiz-Linares, Andres/0000-0001-8372-1011; Pineda Trujillo, Nicolas/0000-0002-8342-2510	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome Trust)		ALVAREZ VM, 1996, HIST MEDELLIN; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; BAILLIET G, 1994, AM J HUM GENET, V55, P27; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; BOYDBOWMAN P, 1976, HISPANIC AM HIST REV, V56, P580, DOI 10.2307/2514194; Busnell D., 1993, MAKING MODERN COLOMB; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Curtin PD, 1969, ATLANTIC SLAVE TRADE, Vxix; Ellis NA, 1998, AM J HUM GENET, V63, P1685, DOI 10.1086/302167; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1997, GENETICS, V145, P787; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Lee HS, 1999, AM J HUM GENET, V64, P1063, DOI 10.1086/302340; Lendon CL, 1997, HUM MUTAT, V10, P186; LONG JC, 1991, GENETICS, V127, P417; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; Merriwether DA, 1997, AM J PHYS ANTHROPOL, V102, P153, DOI 10.1002/(SICI)1096-8644(199702)102:2<153::AID-AJPA1>3.0.CO;2-#; Mesa Bernal Daniel, 1996, JUDIOS HIST COLOMBIA; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; NEI M, 1978, GENETICS, V89, P583; PARSONS JJ, 1968, ANTIOQUENO COLONIZAT, V32; PerezLezaun A, 1997, J MOL EVOL, V45, P265, DOI 10.1007/PL00006229; REYNOLDS J, 1983, GENETICS, V105, P767; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SANCHEZALBORNOZ N, 1977, POBLACION AM LATINA; SANDOVAL C, 1993, ESTRUCTURA GENETICA, V41, P3; Schneider S, 2000, ARLEQUIN 2000 SOFTWA; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Tirado Mejia, 1989, NUEVA HIST COLOMBIA; TORRONI A, 1993, AM J HUM GENET, V53, P563; TWINAM A, 1980, J INTERAM STUD WORLD, V22, P81, DOI 10.2307/165613	41	209	229	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1287	1295		10.1016/S0002-9297(07)62956-5	http://dx.doi.org/10.1016/S0002-9297(07)62956-5			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032790	Green Published, Bronze			2022-12-18	WOS:000165091600023
J	Ianakiev, P; Kilpatrick, MW; Toudjarska, I; Basel, D; Beighton, P; Tsipouras, P				Ianakiev, P; Kilpatrick, MW; Toudjarska, I; Basel, D; Beighton, P; Tsipouras, P			Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EEC-SYNDROME; LOCUS; SHFM3; LIMB; F-BOX/WD40; DEFECT; MOUSE; 10Q24; MAPS	Split-hand/split-foot malformation (SHFM), a limb malformation involving the central rays of the autopod and presenting with syndactyly, median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals, is phenotypically analogous to the naturally occurring murine Dactylaplasia mutant (Dac). Results of recent studies have shown that, in heterozygous Dac embryos, the central segment of the apical ectodermal ridge (AER) degenerates, leaving the anterior and posterior segments intact; this finding suggests that localized failure of ridge maintenance activity is the fundamental developmental defect in Dac and, by inference, in SHFM. Results of gene-targeting studies have demonstrated that p63, a homologue of the cell-cycle regulator TP53, plays a critically important role in regulation of the formation and differentiation of the AER. Two missense mutations, 724A-->G, which predicts amino acid substitution K194E, and 982T-->C, which predicts amino acid substitution R280C, were identified in exons 5 and 7, respectively, of the p63 gene in two families with SHFM. Two additional mutations (279R-->H and 304R-->Q) were identified in families with EEC (ectrodactyly, ectodermal dysplasia, and facial cleft) syndrome. All four mutations are found in exons that fall within the DNA-binding domain of p63. The two amino acids mutated in the families with SHFM appear to be primarily involved in maintenance of the overall structure of the domain, in contrast to the p63 mutations responsible for EEC syndrome, which reside in amino acid residues that directly interact with the DNA.	Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT 06030 USA; Univ Cape Town, Dept Human Genet, ZA-7925 Cape Town, South Africa	University of Connecticut; University of Cape Town	Tsipouras, P (corresponding author), Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT 06030 USA.	tsipouras@nso1.uchc.edu						BOLES RG, 1995, AM J MED GENET, V55, P155, DOI 10.1002/ajmg.1320550204; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; CHAI CK, 1981, J HERED, V72, P234, DOI 10.1093/oxfordjournals.jhered.a109486; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Crackower M, 1998, DEV BIOL, V201, P78, DOI 10.1006/dbio.1998.8938; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; Gorlin RJ, 1990, PLAST RECONSTR SURG; Gurrieri F, 1996, AM J MED GENET, V62, P427; GURRIERI F, 1995, AM J MED GENET, V55, P315, DOI 10.1002/ajmg.1320550314; HAQUE MFU, 1993, HUM GENET, V91, P17; Ianakiev P, 1999, BIOCHEM BIOPH RES CO, V261, P64, DOI 10.1006/bbrc.1999.0963; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lund O, 1997, PROTEIN ENG, V10, P1241, DOI 10.1093/protein/10.11.1241; Mckusick V.A., 1994, MENDELIAN INHERITANC; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; NUNES ME, 1995, HUM MOL GENET, V4, P2165, DOI 10.1093/hmg/4.11.2165; Ozen RS, 1999, AM J HUM GENET, V64, P1646, DOI 10.1086/302403; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; RaasRothschild A, 1996, J MED GENET, V33, P996, DOI 10.1136/jmg.33.12.996; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Roelfsema NM, 1996, CLIN DYSMORPHOL, V5, P115, DOI 10.1097/00019605-199604000-00003; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SCHERER SW, 1994, AM J HUM GENET, V55, P12; Sidow A, 1999, NAT GENET, V23, P104, DOI 10.1038/12709; SPRANGER M, 1988, EUR J PEDIATR, V147, P202, DOI 10.1007/BF00442225; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	27	209	221	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					59	66		10.1086/302972	http://dx.doi.org/10.1086/302972			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10839977	Bronze, Green Published			2022-12-18	WOS:000088926900009
J	MORROW, B; GOLDBERG, R; CARLSON, C; DASGUPTA, R; SIROTKIN, H; COLLINS, J; DUNHAM, I; ODONNELL, H; SCAMBLER, P; SHPRINTZEN, R; KUCHERLAPATI, R				MORROW, B; GOLDBERG, R; CARLSON, C; DASGUPTA, R; SIROTKIN, H; COLLINS, J; DUNHAM, I; ODONNELL, H; SCAMBLER, P; SHPRINTZEN, R; KUCHERLAPATI, R			MOLECULAR DEFINITION OF THE 22Q11 DELETIONS IN VELO-CARDIO-FACIAL SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOMES; PRADER-WILLI SYNDROME; DIGEORGE-SYNDROME; DNA MARKERS; TRANSPEPTIDASE GENES; NEURAL CREST; HUMAN GENOME; MICRODELETIONS; REGION; LOCALIZATION	Velo-cardio-facial syndrome (VCFS) is a common genetic disorder among individuals with cleft palate and is associated with hemizygous deletions in human chromosome 22q11. Toward the molecular definition of the deletions, we constructed a physical map of 22q11 in the form of overlapping YACs. The physical map covers >9 cM of genetic distance, estimated to span 5 Mb of DNA, and contains a total of 64 markers. Eleven highly polymorphic short tandem-repeat polymorphic (STRP) markers were placed on the physical map, and 10 of these were unambiguously ordered. The 11 polymorphic markers were used to type the DNA from a total of 61 VCFS patients and 49 unaffected relatives. Comparison of levels of heterozygosity of these markers in VCFS patients and their unaffected relatives revealed that four of these markers are commonly hemizygous among VCFS patients. To confirm these results and to define further the breakpoints in VCFS patients, 15 VCFS individuals and their unaffected parents were genotyped for the 11 STRP markers. Haplotypes generated from this study revealed that 82% of the patients have deletions that can be defined by the STRP markers. The results revealed that ah patients who have a deletion share a common proximal breakpoint, while there are two distinct distal breakpoints. Markers D22S941 and D22S944 appear to be consistently hemizygous in patients with deletions. Both of these markers are located on a single nonchimeric YAC that is 400 kb long. The results also show that the parental origin of the deleted chromosome does not have any effect on the phenotypic manifestation.	MONTEFIORE MED CTR,CTR CRANIOFACIAL DISORDERS,BRONX,NY; SANGER CTR,CAMBRIDGE,ENGLAND; INST CHILD HLTH,MOLEC MED UNIT,LONDON,ENGLAND	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Wellcome Trust Sanger Institute; University of London; University College London	MORROW, B (corresponding author), ALBERT EINSTEIN COLL MED,DEPT MOLEC GENET,1300 MORRIS PK AVE,BRONX,NY 10461, USA.		Scambler, Peter/AAZ-6026-2020; Kucherlapati, Raju/ABC-8807-2021; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Morrow, Bernice/0000-0002-8076-4726; Dunham, Ian/0000-0003-2525-5598	NICHD NIH HHS [R01HD31601] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031601] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARVYSTAS M, 1984, J CRAN GENET DEV BIO, V4, P39; AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BELLANNECHANTEL.C, 1992, CELL, V70, P1059; BOCKMAN DE, 1987, SCIENCE, V223, P498; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BUDARF ML, 1991, GENOMICS, V10, P996, DOI 10.1016/0888-7543(91)90190-P; BUETOW KH, 1993, GENOMICS, V18, P329, DOI 10.1006/geno.1993.1473; CAREY AH, 1990, GENOMICS, V7, P299, DOI 10.1016/0888-7543(90)90161-M; CHOW WC, 1994, AM J MED GENET, V54, P107; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; COLLINS JE, 1992, GENOMICS, V14, P1098, DOI 10.1016/S0888-7543(05)80137-5; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DESMAZE C, 1993, AM J HUM GENET, V53, P1239; DiGeorge A, 1965, J PEDIAT, V67, P907, DOI [DOI 10.1016/S0022-3476(65)81796-6, 10.1016/S0022-3476(65)82145-X]; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DRISCOLL DA, 1993, J MED GENET, V30, P813, DOI 10.1136/jmg.30.10.813; FIGLEWICZ DA, 1993, GENOMICS, V17, P299, DOI 10.1006/geno.1993.1325; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; GOLDBERG R, 1985, American Journal of Human Genetics, V37, pA54; GOLDINGKUSHNER KJ, 1985, J CRAN GENET DEV BIO, V5, P259; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALFORD S, 1993, HUM MOL GENET, V2, P1577, DOI 10.1093/hmg/2.10.1577; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HEISTERKAMP N, 1988, NUCLEIC ACIDS RES, V16, P8045, DOI 10.1093/nar/16.16.8045; HUDSON TJ, 1994, GENOMICS, V24, P588, DOI 10.1006/geno.1994.1671; JEDELE KB, 1992, PEDIATRICS, V89, P915; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KELLY D, 1993, AM J MED GENET, V45, P308, DOI 10.1002/ajmg.1320450306; KIRBY ML, 1984, ANAT RECORD, V209, P1, DOI 10.1002/ar.1092090102; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEBLANCSTRACESK.JM, 1994, GENOMICS, V19, P341; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEDOUARIN NM, 1980, NEURAL CREST; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; LINDSAY EA, IN PRESS AM J MED GE; LIPSON AH, 1991, J MED GENET, V28, P596, DOI 10.1136/jmg.28.9.596; LODEWYK H, 1986, AM J CARDIOL, V58, P133; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OSTER G, 1983, CLIN IMMUNOL IMMUNOP, V28, P128, DOI 10.1016/0090-1229(83)90196-4; PORTER JC, 1993, GENOMICS, V15, P57, DOI 10.1006/geno.1993.1009; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SCAMBLER PJ, 1993, ANN CARDIAC SURGERY; Shprintzen R J, 1985, Birth Defects Orig Artic Ser, V21, P85; SHPRINTZEN RJ, 1981, PEDIATRICS, V67, P167; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; VANBIEZEN NA, 1993, GENOMICS, V15, P206, DOI 10.1006/geno.1993.1036; WILLIAMS MA, 1985, J CRAN GENET DEV BIO, V5, P175; WILLIAMS MA, 1987, J CRAN GENET DEV BIO, V7, P23; WILSON DI, 1992, AM J HUM GENET, V51, P957; YOUNG D, 1980, AM J CARDIOL, V46, P643, DOI 10.1016/0002-9149(80)90515-9	58	209	217	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1391	1403						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762562				2022-12-18	WOS:A1995RA79400018
J	Janssens, ACJW; Gwinn, M; Bradley, LA; Oostra, BA; van Duijn, CM; Khoury, MJ				Janssens, A. Cecile J. W.; Gwinn, Marta; Bradley, Linda A.; Oostra, Ben A.; van Duijn, Cornelia M.; Khoury, Muin J.			A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOKINE GENE POLYMORPHISMS; ASSOCIATIONS; METAANALYSIS; DISEASE; OBESITY; CYP2C9	Predictive genomic profiling used to produce personalized nutrition and other lifestyle health recommendations is currently offered directly to consumers. By examining previous meta-analyses and HuGE reviews, we assessed the scientific evidence supporting the purported gene-disease associations for genes included in genomic profiles offered online. We identified seven companies that offer predictive genomic profiling. We searched PubMed for meta-analyses and HuGE reviews of studies of gene-disease associations published from 2000 through June 2007 in which the genotypes of people with a disease were compared with those of a healthy or general-population control group. The seven companies tested at least 69 different polymorphisms in 56 genes. Of the 56 genes tested, 24 (43%) were not reviewed in meta-analyses. For the remaining 32 genes, we found 260 meta-analyses that examined 160 unique polymorphism-disease associations, of which only 60 (38%) were found to be statistically significant. Even the 60 significant associations, which involved 29 different polymorphisms and 28 different diseases, were generally modest, with synthetic odds ratios ranging from 0.54 to 0.88 for protective variants and from 1.04 to 3.2 for risk variants. Furthermore, genes in cardiogenomic profiles were more frequently associated with noncardiovascular diseases than with cardiovascular diseases, and though two of the five genes of the osteogenomic profiles did show significant associations with disease, the associations were not with bone diseases. There is insufficient scientific evidence to conclude that genomic profiles are useful in measuring genetic risk for common diseases or in developing personalized diet and lifestyle recommendations for disease prevention.	[Janssens, A. Cecile J. W.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Gwinn, Marta; van Duijn, Cornelia M.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA 30341 USA; [Bradley, Linda A.] Erasmus MC Univ Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Oostra, Ben A.] Univ Med Ctr, Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Centers for Disease Control & Prevention - USA; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Janssens, ACJW (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.janssens@erasmusmc.nl	janssens, cecile c/L-1075-2015	Van Duijn, Cornelia/0000-0002-2374-9204; Janssens, A Cecile/0000-0002-6153-4976				Blum K, 2007, MED HYPOTHESES, V68, P844, DOI 10.1016/j.mehy.2006.08.041; Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Daher S, 2003, J REPROD IMMUNOL, V58, P69, DOI 10.1016/S0165-0378(02)00059-1; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; *GOV ACC OFF, 2006, NUTR TEST TESTS PURC; Haddow J, 2003, ACCE MODEL PROCESS E, P217; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Hu YM, 2006, J LIPID RES, V47, P1908, DOI 10.1194/jlr.M600108-JLR200; Hudson K, 2007, AM J HUM GENET, V81, P635, DOI 10.1086/521634; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; IOANNIDIS JP, 2007, INP RESS INT J EPIDE; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Janssens ACJW, 2006, BMJ-BRIT MED J, V333, P509, DOI 10.1136/bmj.38953.598947.80; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kaput J, 2005, BRIT J NUTR, V94, P623, DOI 10.1079/BJN20051585; Munafo MR, 2004, NICOTINE TOB RES, V6, P583, DOI 10.1080/14622200410001734030; Ordovas JM, 2004, CURR OPIN LIPIDOL, V15, P101, DOI 10.1097/00041433-200404000-00002; Padol S, 2006, AM J GASTROENTEROL, V101, P1467, DOI 10.1111/j.1572-0241.2006.00717.x; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Vineis P, 2004, EPIDEMIOLOGY, V15, P3, DOI 10.1097/01.ede.0000101961.86080.f8; Vineis P, 2001, LANCET, V357, P709, DOI 10.1016/S0140-6736(00)04136-2; Wallace H. M., 2006, YOUR DIET TAILORED Y; Warle MC, 2005, LIVER TRANSPLANT, V11, P19, DOI 10.1002/lt.20316; Yang QH, 2006, INT J EPIDEMIOL, V35, P498, DOI 10.1093/ije/dyi289; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; Yin T, 2007, THROMB RES, V120, P1, DOI 10.1016/j.thromres.2006.10.021	30	208	213	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					593	599		10.1016/j.ajhg.2007.12.020	http://dx.doi.org/10.1016/j.ajhg.2007.12.020			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319070	Green Published, Bronze			2022-12-18	WOS:000254067800004
J	Burgess, R; Millar, ID; Leroy, BP; Urquhart, JE; Fearon, IM; De Baere, E; Brown, PD; Robson, AG; Wright, GA; Kestelyn, P; Holder, GE; Webster, AR; Manson, FDC; Black, GCM				Burgess, Rosemary; Millar, Ian D.; Leroy, Bart P.; Urquhart, Jill E.; Fearon, Ian M.; De Baere, Elfrida; Brown, Peter D.; Robson, Anthony G.; Wright, Genevieve A.; Kestelyn, Philippe; Holder, Graham E.; Webster, Andrew R.; Manson, Forbes D. C.; Black, Graeme C. M.			Biallelic mutation of BEST1 causes a distinct retinopathy in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VITELLIFORM MACULAR DYSTROPHY; RETINAL-PIGMENT EPITHELIUM; BESTROPHIN GENE-MUTATIONS; VMD2 GENE; CHANNELS; DISEASE; IDENTIFICATION; DEGENERATION; PHENOTYPE; MEMBRANE	We describe a distinct retinal disorder, autosomal-recessive bestrophinopathy (ARB), that is consequent upon biallelic mutation in BEST1 and is associated with central visual loss, a characteristic retinopathy, an absent electro-oculogram light rise, and a reduced electroretinogram. Heterozygous mutations in BEST1 have previously been found to cause the two dominantly inherited disorders, Best macular dystrophy and autosomal-dominant vitreoretinochoroidopathy. The transmembrane protein bestrophin-1, encoded by BEST1, is located at the basolateral membrane of the retinal pigment epithelium in which it probably functions as a Cl(-) channel. We sequenced BEST1 in five families, identifying DNA variants in each of ten alleles. These encoded six different missense variants and one nonsense variant. The alleles segregated appropriately for a recessive disorder in each family. No clinical or electrophysiological abnormalities were identified in any heterozygotes. We conducted whole-cell patch-clamping of HEK293 cells transfected with bestrophin-1 to measure the Cl- current. Two ARB missense isoforms severely reduced channel activity. However, unlike two other alleles previously associated with Best disease, cotransfection with wild-type bestrophin-1 did not impair the formation of active wild-type bestrophin-1 channels, consistent with the recessive nature of the condition. We propose that ARB is the null phenotype of bestrophin-1 in humans.	[Burgess, Rosemary; Urquhart, Jill E.; Manson, Forbes D. C.; Black, Graeme C. M.] St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; [Burgess, Rosemary; Urquhart, Jill E.; Manson, Forbes D. C.; Black, Graeme C. M.] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; [Millar, Ian D.; Fearon, Ian M.; Brown, Peter D.] Univ Manchester, Fac Life Sci, Core Technol Facil, Manchester M13 9NT, Lancs, England; [Leroy, Bart P.; Kestelyn, Philippe] State Univ Ghent Hosp, Dept Ophthalmol, B-9000 Ghent, Belgium; [Leroy, Bart P.; De Baere, Elfrida] State Univ Ghent Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Robson, Anthony G.; Wright, Genevieve A.; Holder, Graham E.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Robson, Anthony G.; Holder, Graham E.; Webster, Andrew R.] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Manson, Forbes D. C.; Black, Graeme C. M.] Manchester Royal Eye Hosp, Acad Dept Ophthalmol, Manchester M13 9WH, Lancs, England; [Burgess, Rosemary; Urquhart, Jill E.; Manson, Forbes D. C.; Black, Graeme C. M.] Univ Manchester, Ctr Mol Med, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Manchester Royal Eye Hospital; University of Manchester	Black, GCM (corresponding author), St Marys Hosp, Acad Unit Med Genet, Hathersage Rd, Manchester M13 0JH, Lancs, England.	gblack@man.ac.uk	Manson, Forbes/G-2222-2015; Urquhart, Jill/G-2282-2015; Black, Graeme/K-7374-2015	Manson, Forbes/0000-0002-8342-660X; Urquhart, Jill/0000-0002-5788-5511; Robson, Anthony/0000-0002-8391-6123; Black, Graeme/0000-0001-8727-6592	Wellcome Trust [070139/Z/02, 070139] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Afzal AR, 2003, HUM MUTAT, V22, P1, DOI 10.1002/humu.10233; Bach Michael, 2000, Documenta Ophthalmologica, V101, P11, DOI 10.1023/A:1002732114721; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Caldwell GM, 1999, GENOMICS, V58, P98, DOI 10.1006/geno.1999.5808; Campanucci VA, 2005, NEUROSCIENCE, V135, P1087, DOI 10.1016/j.neuroscience.2005.07.009; Downs K, 2007, ARCH OPHTHALMOL-CHIC, V125, P252, DOI 10.1001/archopht.125.2.252; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Holder GE, 2007, DOC OPHTHALMOL, V114, P111, DOI 10.1007/s10633-007-9053-1; Hudasek K, 2004, BIOCHEM BIOPH RES CO, V318, P135, DOI 10.1016/j.bbrc.2004.04.011; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Kramer Franziska, 2003, Hum Mutat, V22, P418, DOI 10.1002/humu.9189; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, P1291; Marchant D, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044511; MARMOR MF, 1993, DOC OPHTHALMOL, V85, P115, DOI 10.1007/BF01371127; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein LY, 2002, J BIOL CHEM, V277, P30591, DOI 10.1074/jbc.M204269200; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Milenkovic VM, 2007, J BIOL CHEM, V282, P1313, DOI 10.1074/jbc.M607383200; Mullins RF, 2005, ARCH OPHTHALMOL-CHIC, V123, P1588, DOI 10.1001/archopht.123.11.1588; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Schatz P, 2006, OPHTHALMIC GENET, V27, P51, DOI 10.1080/13816810600677990; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Wabbels B, 2006, GRAEF ARCH CLIN EXP, V244, P1453, DOI 10.1007/s00417-006-0286-6; Yardley J, 2004, INVEST OPHTH VIS SCI, V45, P3683, DOI 10.1167/iovs.04-0550	29	208	219	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					19	31		10.1016/j.ajhg.2007.08.004	http://dx.doi.org/10.1016/j.ajhg.2007.08.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179881	Green Published, Bronze			2022-12-18	WOS:000253223800003
J	Hattori, E; Liu, CY; Badner, JA; Bonner, TI; Christian, SL; Maheshwari, M; Detera-Wadleigh, SD; Gibbs, RA; Gershon, ES				Hattori, E; Liu, CY; Badner, JA; Bonner, TI; Christian, SL; Maheshwari, M; Detera-Wadleigh, SD; Gibbs, RA; Gershon, ES			Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article; Proceedings Paper	52nd Annual Meeting of the American-Society-of-Human-Genetics	OCT 15-19, 2002	BALTIMORE, MD	Amer Soc Human Genet, NICHHD, NCI, NIMH, Affymetrix Inc, Gentra Syst, NIDCD			LINKAGE DISEQUILIBRIUM; INITIATIVE PEDIGREES; SUSCEPTIBILITY LOCUS; HAPLOTYPE; GENOTYPE; DISEASE; ILLNESS; REGION	Linkage evidence suggests that chromosome 13 (13q32-33) contains susceptibility genes for both bipolar disorder and schizophrenia. Recently, genes called "G72" and "G30" were identified, and polymorphisms of these overlapping genes were reported to be associated with schizophrenia. We studied two series of pedigrees with bipolar disorder: the Clinical Neurogenetics (CNG) pedigrees ( in which linkage to illness had been previously reported at 13q32-33), with 83 samples from 22 multiplex families, and the National Institute of Mental Health (NIMH) Genetics Initiative pedigrees, with 474 samples from 152 families. Sixteen single-nucleotide polymorphisms (SNPs) were genotyped at and around the G72/G30 locus, which covered a 157-kb region encompassing the entire complementary DNA sequences of G72 and G30. We performed transmission/disequilibrium testing (TDT) and haplotype analysis, since a linkage-disequilibrium block was present at this gene locus. In the CNG and NIMH data sets, the results of global TDT of the entire haplotype set were significant and consistent (P = .0004 and P = .008, respectively). In the CNG series, the associated genotypes divided the families into those with linkage and those without linkage ( partitioned by the linkage evidence). Analysis of the decay of haplotype sharing gave a location estimate that included G72/G30 in its 95% confidence interval. Although statistically significant association was not detected for individual SNPs in the NIMH data set, the same haplotype was consistently overtransmitted in both series. These data suggest that a susceptibility variant for bipolar illness exists in the vicinity of the G72/G30 genes. Taken together with the earlier report, this is the first demonstration of a novel gene(s), discovered through a positional approach, independently associated with both bipolar illness and schizophrenia.	Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; RIKEN, Lab Mol Psychiat, Brain Sci Inst, Wako, Saitama 35101, Japan; Cent S Univ, Natl Lab Med Genet China, Changsha, Hunan, Peoples R China; NIMH, Intramural Res Program, Bethesda, MD 20892 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Chicago; RIKEN; Central South University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Baylor College of Medicine	Hattori, E (corresponding author), Univ Chicago, Dept Psychiat, 924 E 57th St,Room R022, Chicago, IL 60637 USA.	ehattori@yoda.bsd.uchicago.edu	Liu, chunyu/Q-3901-2017; Liu, Chunyu/G-7561-2012	Liu, Chunyu/0000-0002-5986-4415	NIMH NIH HHS [U01 MH46280, R01 MH065560, R01 MH65560-01, R01 MH59535, R01 MH059535] Funding Source: Medline; PHS HHS [U01 H46274, U01 H46282] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065560, U01MH046280, Z01MH002774, R01MH059535] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Badner JA, 1998, AM J HUM GENET, V63, P880, DOI 10.1086/302007; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Berrettini Wade H., 1991, Psychiatric Genetics, V2, P125, DOI 10.1097/00041444-199124000-00002; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Christian SL, 2002, GENOMICS, V79, P635, DOI 10.1006/geno.2002.6765; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; COHN CK, 1970, SCIENCE, V170, P1323, DOI 10.1126/science.170.3964.1323; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Craddock N, 2001, BIPOLAR DISORD, V3, P284, DOI 10.1034/j.1399-5618.2001.30604.x; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Gershon ES, 2000, BIOL PSYCHIAT, V47, P240, DOI 10.1016/S0006-3223(99)00299-1; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Liu C, 2001, AM J HUM GENET, V69, P449; Liu CY, 2001, AM J MED GENET, V105, P375, DOI 10.1002/ajmg.1358; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Niculescu AB, 2000, PHYSIOL GENOMICS, V4, P83, DOI 10.1152/physiolgenomics.2000.4.1.83; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Rozen S, 2000, Methods Mol Biol, V132, P365; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stine OC, 1997, AM J MED GENET, V74, P263, DOI 10.1002/(SICI)1096-8628(19970531)74:3<263::AID-AJMG5>3.3.CO;2-S; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	33	208	214	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1131	1140		10.1086/374822	http://dx.doi.org/10.1086/374822			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Genetics & Heredity	671PZ	12647258	Green Published, Bronze			2022-12-18	WOS:000182474400006
J	Van de Putte, T; Maruhashi, M; Francis, A; Nelles, L; Kondoh, H; Huylebroeck, D; Higashi, Y				Van de Putte, T; Maruhashi, M; Francis, A; Nelles, L; Kondoh, H; Huylebroeck, D; Higashi, Y			Mice lacking Zfhx1b, the gene that codes for Smad- interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							E-CADHERIN; MOUSE DEVELOPMENT; SOX3 GENES; EXPRESSION; MUTATIONS; SIP1; BINDING; DIFFERENTIATION; EMBRYOGENESIS; DELTA-EF1	Recently, mutations in ZFHX1B, the gene that encodes Smad-interacting protein-1 (SIP1), were found to be implicated in the etiology of a dominant form of Hirschsprung disease-mental retardation syndrome in humans. To clarify the molecular mechanisms underlying the clinical features of SIP1 deficiency, we generated mice that bear a mutation comparable to those found in several human patients. Here, we show that Zfhx1b-knockout mice do not develop postotic vagal neural crest cells, the precursors of the enteric nervous system that is affected in patients with Hirschsprung disease, and they display a delamination arrest of cranial neural crest cells, which form the skeletomuscular elements of the vertebrate head. This suggests that Sip1 is essential for the development of vagal neural crest precursors and the migratory behavior of cranial neural crest in the mouse. Furthermore, we show that Sip1 is involved in the specification of neuroepithelium.	Katholieke Univ Leuven VIB, Dept Dev Biol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Lab Mol Biol Celgen, B-3000 Louvain, Belgium; Osaka Univ, Dev Biol Lab, Grad Sch Frontier Biosci, Osaka, Japan	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Osaka University	Huylebroeck, D (corresponding author), Katholieke Univ Leuven VIB, Dept Dev Biol, Campus Gasthuisberg,Bldg O&N,Herestr 49, B-3000 Louvain, Belgium.	danny.huylebroeck@med.kuleuven.ac.be	Higashi, Yukihito/G-5343-2019	Huylebroeck, Danny/0000-0003-4862-1079				Amiel J, 2001, AM J HUM GENET, V69, P1370, DOI 10.1086/324342; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; Houzelstein D, 1997, MECH DEVELOP, V65, P123, DOI 10.1016/S0925-4773(97)00065-8; Kishi M, 2000, DEVELOPMENT, V127, P791; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Pinco KA, 2001, MECH DEVELOP, V100, P99, DOI 10.1016/S0925-4773(00)00503-7; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Postigo AA, 1997, EMBO J, V16, P3924, DOI 10.1093/emboj/16.13.3924; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.0.CO;2-K; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; SHIMAMURA K, 1992, DEVELOPMENT, V116, P1011; Smith A, 2001, DEV DYNAM, V220, P276, DOI 10.1002/1097-0177(20010301)220:3<276::AID-DVDY1110>3.0.CO;2-5; Southard-Smith EM, 1999, GENOME RES, V9, P215; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Wartiovaara K, 1998, ANN MED, V30, P66, DOI 10.3109/07853899808999386; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yamada K, 2001, AM J HUM GENET, V69, P1178, DOI 10.1086/324343; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zweier C, 2002, AM J MED GENET, V108, P177, DOI 10.1002/ajmg.10226	32	208	211	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					465	470		10.1086/346092	http://dx.doi.org/10.1086/346092			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12522767	Green Published, Bronze			2022-12-18	WOS:000180680000026
J	CHAKRABORTY, R; KAMBOH, MI; NWANKWO, M; FERRELL, RE				CHAKRABORTY, R; KAMBOH, MI; NWANKWO, M; FERRELL, RE			CAUCASIAN GENES IN AMERICAN BLACKS - NEW DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-PLASMA PROTEINS; COAGULATION FACTOR-XIIIB; BLOOD-PRESSURE; HUMAN APOLIPOPROTEINS; POPULATION-GENETICS; HYBRID POPULATIONS; MEXICAN-AMERICANS; ADMIXTURE; POLYMORPHISM; VARIANTS	Data on 15 polymorphic protein-coding loci are used to estimate the proportion of Caucasian genes in U.S. blacks from the greater-metropolitan area of Pittsburgh. Allele frequencies from U.S. whites of the same region and from a sample of Nigerians are used as representatives of the genetic contributions of the source populations between which admixture has occurred. These materials provide 18 unique variants that occur exclusively in the blacks and 5 variants that are restricted to the Caucasians only. As a result, when all segregating alleles (52) at these 15 loci are considered, the proportion (mean +/- SE) of Caucasian genes in U.S. blacks (25.2% +/- 2.7%) is estimated with a precision much better than that of all other previous estimates. The estimate based on the frequencies of these 18 unique variants of African origin (24.8% +/- 6.2%) is also consistent with the pooled estimate obtained from the 15 loci by the weighted least-square method. The homogeneity of locus-specific estimates of admixture indicates that these loci are appropriate for studying the proportion of black genes in any admixed population involving African admixture. The advantages of employing such loci for genetic-epidemiologic studies in U.S. blacks is discussed in the context of the availability of these large number of unique African variants at these protein loci.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15260; UNIV BENIN,BENIN CITY,NIGERIA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Benin	CHAKRABORTY, R (corresponding author), UNIV TEXAS,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,POB 20334,HOUSTON,TX 77025, USA.			Kamboh, M. Ilyas/0000-0002-3453-1438	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-41399] Funding Source: Medline; CSRD VA [NIJIJ-90-CX-0038] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CSRD VA		ABRAHAMS D G, 1960, West Afr Med J, V9, P45; ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; ADAMSCAMPBELL LL, 1988, ARTERIOSCLEROSIS, V8, P793, DOI 10.1161/01.ATV.8.6.793; BROWN ML, 1982, J AM STAT ASSOC, V77, P71, DOI 10.2307/2287771; BUNKER CH, 1990, J HUM HYPERTENS, V4, P82; BYARD PJ, 1985, J BIOSOC SCI, V15, P207; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CHAKRABORTY R, 1986, AM J PHYS ANTHROPOL, V70, P489, DOI 10.1002/ajpa.1330700408; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; CHAKRABORTY R, 1991, Ethnicity and Disease, V1, P245; Chakraborty R., 1985, GENETIC MICRODIFFERE, P171; CREASY MA, 1956, J ROY STAT SOC B, V18, P65; DECROO S, IN PRESS HUM HERED; DISCHINGER PC, 1981, J CHRON DIS, V34, P405, DOI 10.1016/0021-9681(81)90039-4; ESCALLON MH, 1987, AM J HUM GENET, V41, P418; GLASS B, 1955, AM J HUM GENET, V7, P368; GLASS B, 1953, AM J HUM GENET, V5, P1; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; HARBURG E, 1978, AM J PUBLIC HEALTH, V68, P1177, DOI 10.2105/AJPH.68.12.1177; KAMBOH MI, 1986, BIOCHEM GENET, V24, P273, DOI 10.1007/BF00502794; KAMBOH MI, 1989, AM J HUM GENET, V44, P148; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; KAMBOH MI, 1987, HUM HERED, V37, P65, DOI 10.1159/000153680; KAMBOH MI, 1990, HUM HERED, V40, P193, DOI 10.1159/000153931; KAMBOH MI, 1987, AM J HUM GENET, V41, P645; KAMBOH MI, 1989, AM J HUM GENET, V45, P147; KAMBOH MI, 1986, AM J HUM GENET, V39, P817; KAMBOH MI, 1989, ELECTROPHORESIS, V10, P53, DOI 10.1002/elps.1150100113; KAMINER B, 1960, CIRCULATION, V22, P289, DOI 10.1161/01.CIR.22.2.289; LONG JC, 1983, AM J PHYS ANTHROPOL, V61, P411, DOI 10.1002/ajpa.1330610403; LONG JC, 1991, GENETICS, V127, P417; MACLEAN CJ, 1974, AM J HUM GENET, V26, P614; MADANSKY A, 1959, J AM STAT ASSOC, V54, P173, DOI 10.2307/2282145; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; OVIASU VO, 1978, AFR J MED MED SCI, V7, P137; OYEDIRAN A B O O, 1976, Nigerian Medical Journal, V6, P248; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; ROBERTS DF, 1955, AM J HUM GENET, V7, P361; Snedecor G.W., 1980, STAT METHODS, V7; SZATHMARY EJE, 1978, AM J PHYS ANTHROPOL, V48, P29, DOI 10.1002/ajpa.1330480106; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409	43	208	210	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					145	155						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HA040	1729885				2022-12-18	WOS:A1992HA04000015
J	PRICE, B				PRICE, B			PRIMARY BIASES IN TWIN STUDIES - A REVIEW OF PRENATAL AND NATAL DIFFERENCE-PRODUCING FACTORS IN MONOZYGOTIC PAIRS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		ABT IA, 1925, N YORK STATE J M, V25, P511; Adair FL, 1930, AM J OBSTET GYNECOL, V20, P539, DOI 10.1016/S0002-9378(16)42566-4; Adams F., 1849, GENUINE WORKS HIPPOC, V1; AHLFELD F, 1902, Z GEBURTSH, V47, P230; AHLFELD F, 1903, LEHRBUCH GEBURTSHILF; AHLFELD F, 1875, ARCH GYNAEK, V7, P210; AHLFELD F, 1875, ARCH GYN BERL, V11, P160; AHLFELD F, 1875, ARCH GYN BERL, V9, P196; AHLFELD F, 1875, ARCH GYN BERL, V14, P321; AHLFELD F, 1900, RUKOVODSTVO AKUSHERS; Ardashnikov SN, 1936, J HERED, V27, P465; ARESTAD FH, 1949, JAMA-J AM MED ASSOC, V140, P23; BALLANTYNE JW, 1905, MANUAL ANTENATAL PAT, V2; BENDA CE, 1945, MEDICINE, V24, P71, DOI 10.1097/00005792-194502000-00002; BERTILLON LA, 1874, B SOC ANTHROPOL PAR, V9, P267; BLAKESLEE ALBERT F., 1930, PROC AMER PHILOSOPH SOC, V69, P379; Blatz W. E., 1937, COLLECTED STUDIES DI; BOSSIK LJ, 1934, P GORKY MED BIOL I, V3; Bradway KP, 1937, AM J ORTHOPSYCHIAT, V7, P194, DOI 10.1111/j.1939-0025.1937.tb05276.x; BRANDER T, 1937, Z MENSCHLICHE VERERB, V21, P306; BRANDER T, 1937, ACTA PAEDIATR, V21, P5; BRANDER T, 1940, ACTA PAEDIAT S1, V28, P100; BRANDER T, 1935, MSCHR KINDERHEILK, V63, P276; Brody D, 1937, CHILD DEV, V8, P207; BROWNE FJ, 1946, ANTENATAL POSTNATAL; Brucker W. H., 1944, JOUR AMER DENTAL ASSOC, V31, P931; BUHL L, 1861, KLINIK GEBURTSKUNDE, V1; BURGER R, 1945, SCHWEIZ MED WSCHR, V75, P288; BURKS BS, 1928, NAT SOC STUDY ED Y 2, V27, P248; BURNHAM RW, 1940, J GENET PSYCHOL, V57, P323; BUTTNER O, 1841, ZBL GYN, V44, P745; Carter H. D., 1940, NATL SOC STUDY ED YB, V39, P235; Carter HD, 1934, PEDAGOG SEMIN J GEN, V44, P154; Carter HD, 1932, J HERED, V23, P53, DOI 10.1093/oxfordjournals.jhered.a103558; Cattell RB, 1940, PEDAGOG SEMIN J GEN, V57, P31; Clark John, 1793, PHILOS T R SOC LOND, V83, P154; CLAUDIUS M, 1859, ENTWICKLUNG HERZLOSE; Cockayne EA, 1940, BIOMETRIKA, V31, P287; Cohen J. T., 1942, JOUR DENTAL RES, V21, P413, DOI 10.1177/00220345420210041101; Cohen J. T., 1942, JOUR DENTAL RES, V21, P233; Conrad K, 1937, FORTSCHR NEUROL P I, V9, P197; Cooper W., 1775, PHILOS T R SOC LOND, V65, P311; CREIP LH, 1942, J ALLERGY, V13, P591; Critchley M, 1939, Proc R Soc Med, V32, P1417; Cronin HJ, 1933, PSYCHOANAL REV, V20, P375; Cummins H, 1934, J HERED, V25, P237, DOI 10.1093/oxfordjournals.jhered.a103931; Cummins H, 1930, ANAT REC, V46, P179, DOI 10.1002/ar.1090460209; CURTIUS FRIEDRICH, 1930, ARCH GYNAEKOL, V140, P361, DOI 10.1007/BF02129892; DAHLBERG G., 1943, Proceedings of the Royal Society of Edinburgh. Section B., V62, P20; Dahlberg G., 1930, Zeitschrift fuer Induktive Abstammungs- und Vererbungslehre, V53, P133, DOI 10.1007/BF01741354; Dahlberg G., 1926, TWIN BIRTHS TWINS HE; DAHLBERG GUNNAR, 1948, ACTA GENET ET STATIST MED, V1, P104; Dahlberg Gunnar, 1942, UPSALA LAKAREFOREN FORHANDL, V47, P395; DAHR P, 1941, Z RASSENPHYSIOL, V12, P1; Danforth CH, 1919, AM J PHYS ANTHROPOL, V2, P147, DOI 10.1002/ajpa.1330020217; Danforth CH, 1916, J HERED, V7, P195, DOI 10.1093/oxfordjournals.jhered.a110689; Danforth CH, 1932, P SOC EXP BIOL MED, V30, P143; Danforth CH, 1925, P SOC EXP BIOL MED, V23, P145; Danforth CH, 1919, J HERED, V10, P399, DOI 10.1093/oxfordjournals.jhered.a101956; Danforth CH, 1924, GENETICS, V9, P0199; DESUPERVILLE D, 1739, PHILOS T R SOC LOND, V41, P294; DIEHL K, 1933, ZWILLINGSTUBERKULOSE; Dods Marcus, 1871, CITY GOD; Edmonds HW, 1941, CANCER RES, V1, P896; ELSASSER K, 1906, ZBL GYN, V30, P422; ENGLEHORN E, 1927, BIOL PATHOLOGIE WEIB, V7; Essen-Moller E, 1941, HEREDITAS, V27, P1; ESSENMOLLER E, 1941, ACTA PSYCHIAT SCAND, V23, P7; FAXEN N, 1935, ACTA PAEDIATR, V17, P565; FELDMAN WM, 1937, BRIT ENCY MED PRACTI, V5, P334; Ford FR, 1926, MEDICINE, V5, P120; Ford N, 1941, AM J DIS CHILD, V61, P747; Fortuyn ABD, 1932, Q REV BIOL, V7, P298, DOI 10.1086/394409; FOWLER EP, 1947, ANN OTO RHINOL LARYN, V56, P368; Freeman FN, 1941, J EDUC RES, V34, P321, DOI 10.1080/00220671.1941.10881007; Freeman W, 1935, J NEUROL PSYCHOPATHO, V15, P210; Friedman M, 1943, ARCH INTERN MED, V72, P767, DOI 10.1001/archinte.1943.00210120061005; Gallon F, 1909, MEMORIES MY LIFE; Galton F., 1875, J ANTHR I, V5, P329; Galton F., 1983, INQUIRY HUMAN FACULT; Galton F, 1875, FRASERS MAGAZINE, V12, P566; Galton Francis, 1907, INQUIRIES HUMAN FACU; Galton Francis., 1876, J ANTHR I GREAT BRIT, V5, P324; Gardner IC, 1944, J HERED, V35, P83, DOI 10.1093/oxfordjournals.jhered.a105359; Gates R. R., 1946, HUMAN GENETICS, VII; GESELL A, 1931, HDB CHIL PSYCHOL; Gesell A, 1929, GENET PSYCHOL MONOGR, V6; Gesell A, 1922, SCI MON, V14, P415; Gesell A, 1922, SCI MON, V14, P305; Geyer H., 1940, ZEITSCHR MENSCHL VER ERBUNGS U KONSTITUTIONSL, V24, P536; GIBSON J, 1733, MED ESSAYS OBSERV ED, V1, P171; Goldschmidt R, 1927, PHYSL THEORIE VERERB; GOLDSCHMIDT R, 1920, ROUX VORTRAGE AUFSAT, V24, P1; Goldschmidt R., 1938, PHYSL GENETICS; GOLDSCHMIDT RB, 1940, MATERIAL BASIS EVOLU; GOLDSCHMIDT RICHARD, 1935, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V69, P38, DOI 10.1007/BF01762870; Gordon R G, 1938, Arch Dis Child, V13, P79; Greulich WW, 1934, AM J PHYS ANTHROPOL, V19, P391, DOI 10.1002/ajpa.1330190316; GRUENWALD P, 1947, ARCH PATHOL, V44, P398; GRUENWALD P, 1947, ARCH PATHOL, V44, P648; GRUENWALD P, 1947, ARCH PATHOL, V44, P495; Gruneberg H, 1947, ANIMAL GENETICS MED; GULDBERG E, 1938, ACTA PATH MICROBIO S, V37, P197; Guttmacher AF, 1939, AM J OBSTET GYNECOL, V38, P277, DOI 10.1016/S0002-9378(39)90828-8; Guttmacher AF, 1937, AM J OBSTET GYNECOL, V34, P76, DOI 10.1016/S0002-9378(37)90511-8; GUTTMACHER AF, 1933, LIFE MAKING; HALL M, 1844, LONDON EDINBURGH MON, V3, P541; Hamilton WJ, 1993, HUMAN EMBRYOLOGY PRE, V4th, P325; Hamlett GWD, 1934, ANAT REC, V61, P81, DOI 10.1002/ar.1090610109; Hart D Berry, 1912, Trans Edinb Obstet Soc, V37, P89; HART DB, 1918, EDINBURGH MED J, V20, P84; Hartman CG, 1926, AM J ANAT, V37, P1, DOI 10.1002/aja.1000370102; Hartman CG, 1920, SCIENCE, V52, P469, DOI 10.1126/science.52.1350.469-a; Hartman GG, 1925, ANAT REC, V29, P283; Hartmann G, 1939, ANN EUGENIC, V9, P123, DOI 10.1111/j.1469-1809.1939.tb02202.x; HECKER C, 1864, KLINIK GEBURTSKUNDE; HENSEN V, 1881, HDB PHYSL, V6; HERRMAN LOUIS, 1932, PROC ROY SOC EDINBURGH, V53, P105; Hirsch Nathaniel D. M., 1930, TWINS HEREDITY ENV, P20; Hobbs GE, 1941, AM J PSYCHIAT, V98, P447, DOI 10.1176/ajp.98.3.447; HODGKIN, 1836, GUYS HOSP REP LOND, V1, P218; Holzinger KJ, 1929, J EDUC PSYCHOL, V20, P241, DOI 10.1037/h0072484; HOUSTON J, 1844, LONDON EDINBURGH MON, V4, P238; HOUSTON J, 1836, DUBLIN J M SC, V10, P204; HUBNER H, 1912, ERG ALLG PATH, V15, P1; HUBNER H, 1912, ERG ALLG PATH, V15, P922; Hunter William, 1774, ANATOMY HUMAN GRAVID; HUTER CC, 1845, EINFACHE MUTTERKUCHE; Huxley J.S., 1934, ELEMENTS EXPT EMBRYO; Hyrtl J., 1870, BLUTGEFASSE MENSCHLI; IDELBERGER KARLHEINZ, 1939, ARCH ROSS U GES BIOL, V33, P304; IGNATIEV MV, 1936, P GORKY MED GENET I, V4; Jenkins RL, 1935, AM J ORTHOPSYCHIAT, V5, P39, DOI 10.1111/j.1939-0025.1935.tb06321.x; Jenkins RL, 1934, AM J DIS CHILD, V48, P130; Jennings D, 1937, LANCET, V2, P655; KABAKOFF IB, 1934, P GORKY MED BIOL I, V3; KADJAR MK, 1927, GYNECOLOGIE, V26, P449; KAHLER O. H., 1940, ZEITSCHR KLIN MED, V137, P380; KAHLER OH, 1940, Z KLIN MED, V137, P508; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; KALLMANN FJ, 1946, AM J PSYCHIAT, V103, P309, DOI 10.1176/ajp.103.3.309; Kallmann FJ, 1942, AM J PSYCHIAT, V98, P544, DOI 10.1176/ajp.98.4.544; Kallmann FJ, 1943, J HERED, V34, P293, DOI 10.1093/oxfordjournals.jhered.a105222; KALLMANN FJ, 1941, J GENET S; Kasanin J, 1934, AM J PSYCHIAT, V91, P21, DOI 10.1176/ajp.91.1.21; Keeler CE, 1929, P NATL ACAD SCI USA, V15, P839, DOI 10.1073/pnas.15.11.839; KIFFNER FRITZ, 1929, ARCH GYNAKOL, V136, P111, DOI 10.1007/BF01701687; Kindred JE, 1944, AM J OBSTET GYNECOL, V48, P642, DOI 10.1016/S0002-9378(44)90397-2; Kleinwachter L, 1871, LEHRE ZWILLINGEN; Knauer A, 1939, Z GESAMTE NEUROL PSY, V165, P436, DOI 10.1007/BF02871535; Koch HL, 1927, J COMP PSYCHOL, V7, P313, DOI 10.1037/h0073286; Komai T, 1934, J HERED, V25, P423, DOI 10.1093/oxfordjournals.jhered.a103861; KUSTNER O, 1883, ARCH GYN BERL, V21, P1; LANDAUER W, 1948, GENETICS, V33, P133; LANDAUER W, 1947, J EXP ZOOL, V105, P145, DOI 10.1002/jez.1401050202; LANDAUER W, 1941, J GENET S; LANGE J, 1931, CRIME DESTINY; LANGE J, 1928, Z KINDERF, V34, P377; LASCH W, 1925, MUNCH MED WSCHR, V72, P1155; LASSEN MT, 1931, ARCH GYNAKOLOGIE, V147, P48; LEHMANN W, 1937, Z KONSTLEHRE, V20, P237; LEMSER H, 1941, J GENET S; LENNOX WG, 1945, AM J PSYCHIAT, V101, P764, DOI 10.1176/ajp.101.6.764; LENZ F, 1935, DEUT MED WOCHENSCHR, V61, P873; Levit SG, 1935, J GENET, V30, P389, DOI 10.1007/BF02982247; LEVRET A, 1766, ART ACCOUCHEMENS DEM; Lewis A, 1934, J NEUROL PSYCHOPATHO, V15, P1; Lewis F L, 1944, Br Med J, V1, P221; Lillie FR, 1923, BIOL BULL-US, V44, P47, DOI 10.2307/1536513; Lillie FR, 1917, J EXP ZOOL, V23, P371, DOI 10.1002/jez.1400230208; Littre E., 1853, OEUVRES COMPLETES HI, VVIII; LOTZE R, 1937, ZWILLINGE EINFUHRUNG; LUNDSTROM A, 1948, TOOTH SIZE OCCLUSION; LUNEBERG H, 1894, GYNAEKOLOGIE GEBURTS; LUXENBURGER H, 1932, Z IND ABSTAMM VERERB, V61, P223; LUXENBURGER H, 1930, ZBL GES NEUROL PSYCH, V56, P145; MacArthur JW, 1938, J HERED, V29, P323, DOI 10.1093/oxfordjournals.jhered.a104530; MacArthur JW, 1939, J HERED, V30, P359, DOI 10.1093/oxfordjournals.jhered.a104763; Macklin MT, 1941, CAN MED ASSOC J, V44, P604; MARCHAND F, 1897, REAL ENCY GESAMMTEN, V15; Margolis HM, 1933, ANN INTERN MED, V6, P1489, DOI 10.7326/0003-4819-6-11-1489; MCCLINTOCK K, 1945, ARCH DIS CHILD, V20, P47, DOI 10.1136/adc.20.101.47; McNemar Q, 1933, PEDAGOG SEMIN J GEN, V42, P70; MECKEL H, 1850, MULLERS ARCH, V3, P235; Meckel JF, 1815, DUPLICITATE MONSTROS; Merriman C, 1924, PSYCHOL MONOGR, V33, P3; MERY J, 1720, HIST ACAD ROY SC, V2, P8; Misbach L, 1941, PEDAGOG SEMIN J GEN, V59, P249; MONRO A, 1792, T R SOC EDINBURGH, V3, P215; MONTAGU MFA, 1944, MED PHYSICS; Moore C. R., 1947, EMBRYONIC SEX HORMON; Morgan T. H., 1934, EMBRYOLOGY GENETICS; MORIKAWA N, 1939, OKAJIMAS FOL ANAT, V18, P1; MORISON JE, 1949, ARCH DIS CHILD, V24, P214, DOI 10.1136/adc.24.119.214; Morrill CV, 1919, ANAT REC, V16, P265, DOI 10.1002/ar.1090160405; Muller HJ, 1925, J HERED, V16, P433, DOI 10.1093/oxfordjournals.jhered.a102537; MULLER HJ, 1947, GENETICS MED MAN; NETTLESHIP E, 1912, T OPHTHAL SOC UK, V32, P309; Newell HW, 1930, AM J ORTHOPSYCHIAT, V1, P61, DOI 10.1111/j.1939-0025.1930.tb04802.x; NEWMAN H. H., 1940, HUMAN BIOL, V12, P21; Newman H. H., 1917, BIOL TWINS; Newman H. H, 1923, PHYSL TWINNING; Newman HH, 1931, J HERED, V22, P201, DOI 10.1093/oxfordjournals.jhered.a103475; Newman HH, 1911, J MORPHOL, V22, P855, DOI 10.1002/jmor.1050220402; Newman HH, 1928, BIOL BULL-US, V55, P298, DOI 10.2307/1537082; Newman HH, 1915, BIOL BULL-US, V29, P1, DOI 10.2307/1536256; Newman HH, 1934, J HERED, V25, P37, DOI 10.1093/oxfordjournals.jhered.a103839; Newman HH, 1931, J HERED, V22, P41, DOI 10.1093/oxfordjournals.jhered.a103426; Newman HH, 1944, J HERED, V35, P309, DOI 10.1093/oxfordjournals.jhered.a105322; Newman HH., 1937, TWINS STUDY HEREDITY; NEWMAN HH, 1915, BIOL BULL, V30, P173; NEWMAN HH, 1940, MULTIPLE HUMAN BIRTH; NEWMAN HH, 1922, AM SOCIOL SOC PUBLIC, V17, P51; NUMAN A, 1844, J VET AGR BELG, V3, P155; NUMAN A, 1844, J VET AGR BELG, V3, P75; NUMAN A, 1844, J VET AGR BELG, V3, P115; OLDAG, 1920, MSCHR GEBURTSH GYN, V52, P268; OREL HERBERT, 1929, ZEITSCHR KINDERHEILK, V48, P1, DOI 10.1007/BF02248414; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; PARPART AK, 1946, PRINCETON U BICENT 1; PATERSON JH, 1949, J NEUROL NEUROSUR PS, V12, P160, DOI 10.1136/jnnp.12.2.160; Pearson K., 1924, LIFE LETT LABOURS FR; PEREZ M L, 1947, Obstet Ginecol Lat Am, V5, P5; Popenoe P, 1922, J HERED, V13, P142, DOI 10.1093/oxfordjournals.jhered.a102184; PORTAL P, 1685, PRACTIQUE ACCOUCHEME; PRICE B, 1949, HEREDITAS S; PROCHOWNIK, 1920, ARCH GYN BERL, V113, pR5; Quigley JK, 1935, AM J OBSTET GYNECOL, V29, P354, DOI 10.1016/S0002-9378(15)31355-7; RAMON G, 1945, CR HEBD ACAD SCI, V221, P213, DOI 10.1093/brain/68.3.213; Reed GE, 1935, CAN MED ASSOC J, V32, P180; Reichle HS, 1934, J HERED, V25, P33, DOI 10.1093/oxfordjournals.jhered.a103838; Reichle HS, 1929, BIOL BULL-US, V56, P164, DOI 10.2307/1536934; Reichle HS, 1929, BIOL BULL-US, V56, P313, DOI 10.2307/1537070; REINHARD W E, 1948, Dtsch Med Rundsch, V2, P130; RENSSEN W, 1942, GENETICA GRAVENH, V23, P247; Rexroad CN, 1932, PSYCHOL BULL, V29, P204, DOI 10.1037/h0072726; Riddle O, 1923, AM J ANAT, V32, P199, DOI 10.1002/aja.1000320205; RIFE D. C., 1938, JOUR HEREDITY, V29, P83; RIFE D. C., 1938, OHIO JOUR SCI, V38, P281; RIFE DAVID C., 1950, HUMAN BIOL, V22, P136; Rife DC, 1941, SCI MON, V53, P148; Rife DC, 1940, GENETICS, V25, P0178; Rife DC, 1943, GENETICS, V28, P41; Rife DC, 1933, J HERED, V24, P443, DOI 10.1093/oxfordjournals.jhered.a103698; Rife DC, 1933, J HERED, V24, P339, DOI 10.1093/oxfordjournals.jhered.a103823; Roberts JAF, 1935, EUGEN REV, V27, P25; ROBERTS JAF, 1947, J MENT SCI, V93, P289, DOI 10.1192/bjp.93.391.289; ROBERTSON EC, 1947, J NUTR, V34, P691, DOI 10.1093/jn/34.6.691; ROMANUS T, 1947, HEREDITAS, V33, P297; Rosanoff AJ, 1935, PSYCHIAT QUART, V9, P116, DOI 10.1007/BF01562817; Rosanoff AJ, 1934, ARCH NEURO PSYCHIATR, V31, P1165, DOI 10.1001/archneurpsyc.1934.02250060051004; ROSANOFF AJ, 1937, PSYCHOL MONOGR 216, V48; Roux Wilhelm., 1888, VIRCHOWS ARCH, V114, P113; Rush Benjamin, 1812, MED INQUIRIES OBSERV; Sangvichien S, 1937, ANAT REC, V67, P157, DOI 10.1002/ar.1090670203; SCHATZ F, 1897, ARCH GYN BERL, V60, P81; SCHATZ F, 1910, ARCH GYNAK, V92, P13; SCHATZ F, 1982, ARCH GYNAEKOL, V19, P329; SCHATZ F, 1897, ARCH GYN BERL, V55, P485; SCHATZ F, 1900, ARCH GYNAEK, V60, P559; SCHATZ F, 1897, ARCH GYN BERL, V60, P201; SCHATZ F, 1887, ARCH GYNAK, V30, P169; SCHATZ F, 1897, ARCH GYNAK, V53, P144; Schatz F., 1900, KLINISCHE BEITRAGE P; SCHATZ F, 1910, KLINISCHE BEITRAGE P; SCHATZ F, 1885, ARCH GYN BERL, V27, P1; SCHATZ F, 1887, ARCH GYN BERL, V30, P335; SCHATZ F, 1897, ARCH GYN BERL, V58, P1; Schatz F., 1884, ARCH GYNAK, V24, P337; SCHATZ F, 1875, ARCH GYNAEKOL, V7, P336; SCHATZ F, 1887, ARCH GYN BERL, V29, P419; SCHIFF F, 1931, KLIN WOCHENSCHR, V10, P723; SCHULTZE B, 1856, MSCHR GEBURTSKR FRAU, V7, P247; SCHULTZE B, 1854, VIRCHOWS ARCH, V7, P479; Schwalbe E., 1907, MORPHOLOGIE MISSBILD; SCIPIADES E, 1930, ARCH GYNAEK, V141, P577; Sheldon W, 1938, LANCET, V1, P1048; Shuttleworth FK, 1935, J EDUC PSYCHOL, V26, P655, DOI 10.1037/h0057378; Shuttleworth FK, 1935, J EDUC PSYCHOL, V26, P561, DOI 10.1037/h0061615; SHUTTLEWORTH FK, 1935, J EDUC PSYCHOL, V29, P374; Siemens H., 1924, ZWILLINGSPATHOLOGIE; Siemens HW, 1927, VIRCHOWS ARCH A, V264, P323, DOI 10.1007/BF01995214; Siemens HW, 1927, J HERED, V18, P201, DOI 10.1093/oxfordjournals.jhered.a102846; Siemens HW, 1924, VIRCHOWS ARCH A, V253, P746; SIEMENS HW, 1925, Z INDUKT ABSTAMM, V37, P122; SIEMENS HW, 1925, ARCH GYNAEKOL, V126, P623; SIEMENS HW, 1923, EINFUHRUNG ALLGEMEIN; Simpson James Y, 1844, Edinb Med Surg J, V61, P107; Simpson James Y, 1836, CYLOPEDIA ANATOMY PH, VII, P684; SINCLAIR JG, 1949, TEX REP BIOL MED, V7, P50; Slater ETO, 1938, J NEUROL PSYCHIATRY, V1, P239, DOI 10.1136/jnnp.1.3.239; Smellie WA., 1752, TREATISE THEORY PRAC; Smith JC, 1930, Z GESAMTE NEUROL PSY, V125, P678, DOI 10.1007/BF02880293; SMITH JC, 1929, MEDDELELSER DANMARKS, V3, P83; SPAETH J, 1860, Z GESELL AERZTE WIEN, V3, P225; SPAETH J, 1860, Z GESELL AERZTE WIEN, V3, P241; SPAICH DIETER, 1936, ZEITSCHR MENSCHL VERERBUNGS U KON STITUTIONSL, V19, P731; Spemann H., 1938, EMBRYONIC DEV INDUCT; STALPART VC, 1687, OBSERVATIONES RARIOR; STEINER F, 1935, ARCH GYNAEK, V159, P509; STERN C, 1948, GENETICS, V33, P215; Stern C., 1949, PRINCIPLES HUMAN GEN; Stockard CR, 1921, AM J ANAT, V28, P115, DOI 10.1002/aja.1000280202; Stockard CR, 1921, AM NAT, V55, P62, DOI 10.1086/279791; Stocks P, 1930, ANN EUGENIC, V4, P49, DOI 10.1111/j.1469-1809.1930.tb02074.x; Stocks P, 1933, ANN EUGENIC, V5, P1; STRANDSKOV HH, 1946, GENETICS, V31, P438; STRASSMANN P, 1904, HDB GEBURTSHULFE, V1; Streeter GL, 1919, B JOHNS HOPKINS HOSP, V30, P235; SZENDI B, 1938, ARCH GYNAK, V167, P108; SZENDI B, 1938, ARCH GYN BERL, V165, P624; SZENDI B, 1939, J OBSTET GYN BR COMM, V46, P836; SZENDI B, 1936, ORVOSI HETILAP, V80, P389; THORNDIKE EL, 1905, ARCH PHILOS PSYCHOL; TIMOFEEFFRESSOV.NW, 1931, NATURWISSENSCHAFTEN, V19, P493; TSHETVERIKOV NS, 1936, P GORKY MED GENET I, V4; TSUCHIYA S, 1939, OKAJIMAS FOL ANAT, V18, P81; TUSCHER H, 1936, DEUT AERZTEBL S, V66, P148; Uehlinger E, 1938, BEITR KLIN TUBERK, V92, P275; VACCAREZZA RF, 1944, AN CATED PAT CLIN TU, V6, P181; VERSCHUER OV, 1939, P ROY SOC          B, V128, P62; VIGNES H, 1925, REV ANTHR PARIS, V35, P211; Vogt A., 1939, ARCH JULIUS KLAUS STIFT, V14, P475; VONVERSCHUER O, 1931, VERH GES PHYS ANTHR, V6, P1; VONVERSCHUER O, 1940, STATISTIK DTSCH IHRE, V1; VONVERSCHUER O, 1927, ERG INN MED KINDERHK, V31, P35; VONVERSCHUER O, 1925, MUNCH MED WSCHR, V72, P184; VONVERSCHUER O, 1934, ARCH GYN BERL, V156, P362; VOUTE PA, 1936, MSCHR KINDERGENEESK, V5, P202; Waddington C. H., 1939, INTRO MODERN GENETIC; Waddington C. H, 1940, ORG AND GENES; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; WAGNER GA, 1927, MED KLIN BERL, V23, P936; WALCHER G, 1905, ZBL GYN, V29, P193; WALKER NF, 1947, AM J OBSTET GYNECOL, V54, P266; WEBER F, 1924, HDB GEBURTSHILFE, V1; Weinberg W, 1901, ARCH GESAMTE PHYSIOL, V88, P346, DOI 10.1007/BF01657695; Weismann A, 1893, GERMPLASM THEORY HER; Weiss P. A., 1939, PRINCIPLES DEV TEXT; WEITZ W, 1925, Z KLIN MED, V101, P115; WENNER R, 1947, SCHWEIZ MED WSCHR, V77, P140; WESTPHALEN F, 1897, ARCH GYN BERL, V53, P31; Wiener AS, 1940, GENETICS, V25, P0187; Wilder HH, 1904, AM J ANAT, V3, P387, DOI 10.1002/aja.1000030403; WILLIAMS JW, 1941, OBSTETRICS; WILSON P. T., 1931, HUMAN BIOL, V3, P270; WILSON P. T., 1934, HUMAN BIOL, V6, P324; Wilson PT, 1932, GENETICS, V17, P0560; WILSON WL, 1946, J AM DENT ASSOC, V33, P455, DOI 10.14219/jada.archive.1946.0078; WINCKEL F, 1890, TXB OBSTETRICS; WINGFIELD AH, 1928, TWINS ORPHANS; Wise NB, 1939, AM HEART J, V17, P701; Wislocki GB, 1939, AM J ANAT, V64, P445, DOI 10.1002/aja.1000640305; Woodworth R. S., 1941, HEREDITY ENV CRITICA; WRIGHT S, 1945, AM NAT, V79, P289, DOI 10.1086/281266; YERUSHALMY J., 1940, HUMAN BIOL, V12, P247; ZAZZO R, 1942, ANN PSYCHOL, P227	357	208	210	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1950	2	4					293	352						60	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS391	14837903				2022-12-18	WOS:A1950XS39100001
J	Wang, K; Zhang, H; Kugathasan, S; Annese, V; Bradfield, JR; Russell, RK; Sleiman, PMA; Imielinski, M; Glessner, J; Hou, C; Wilson, DC; Walters, T; Kim, C; Frackelton, EC; Lionetti, P; Barabino, A; Van Limbergen, J; Guthery, S; Denson, L; Piccoli, D; Li, M; Dubinsky, M; Silverberg, M; Griffiths, A; Grant, SFA; Satsangi, J; Baldassano, R; Hakonarson, H				Wang, Kai; Zhang, Haitao; Kugathasan, Subra; Annese, Vito; Bradfield, Jonathan R.; Russell, Richard K.; Sleiman, Patrick M. A.; Imielinski, Marcin; Glessner, Joseph; Hou, Cuiping; Wilson, David C.; Walters, Thomas; Kim, Cecilia; Frackelton, Edward C.; Lionetti, Paolo; Barabino, Arrigo; Van Limbergen, Johan; Guthery, Stephen; Denson, Lee; Piccoli, David; Li, Mingyao; Dubinsky, Marla; Silverberg, Mark; Griffiths, Anne; Grant, Stiruan F. A.; Satsangi, Jack; Baldassano, Robert; Hakonarson, Hakon			Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; VARIANTS; METAANALYSIS; EXPRESSION; ANTIBODY; RECEPTOR; GENES; IL-23; TOOL	Previous genome-wide association (GWA) studies typically focus on single-locus analysis, which may not have the power to detect the majority of genuinely associated loci. Here, we applied pathway analysis using Affymetrix SNP genotype data from the Wellcome Trust Case Control Consortium (WTCCC) and uncovered significant association between Crohn Disease (CD) and the IL12/IL23 pathway, harboring 20 genes (p = 8 X 10 (5)). Interestingly, the pathway contains multiple genes (IL12B and JAK2) or homologs of genes (STAT3 and CCR6) that were recently Identified as genuine susceptibility genes only through meta-analysis of several GWA Studies. In addition, the pathway contains other susceptibility genes for CID, including IL18R1, JUN, IL12RB1, and TYK2, which do not reach genome-wide significance by single-marker association tests.The observed path way-specific association signal was subsequently replicated in three additional GWA studies of European and African American ancestry generated on the Illumina HumanHap550 platform. Our Study suggests that examination beyond individual SNP hits, by focusing on genetic networks and pathways, is important to unleashing the true power of GWA studies.	[Wang, Kai; Zhang, Haitao; Bradfield, Jonathan R.; Sleiman, Patrick M. A.; Imielinski, Marcin; Glessner, Joseph; Hou, Cuiping; Kim, Cecilia; Frackelton, Edward C.; Grant, Stiruan F. A.; Hakonarson, Hakon] Childrens Hosp, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Kugathasan, Subra] Emory Clin, Sch Med & Childrens Hlth Care Atlanta, Dept Pediat, Atlanta, GA 30322 USA; [Annese, Vito] CSS Hosp, IRCCS, Units Gastroenterol & Endoscopy, I-71013 San Giovanni Rotondo, Italy; [Russell, Richard K.] Yorkhill Hosp, Dept Paediat Gastroenterrol, Glasgow G3 8SJ, Lanark, Scotland; [Walters, Thomas] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wilson, David C.] Univ Edinburgh, Edinburgh EI14 2XU, Midlothian, Scotland; [Lionetti, Paolo] Univ Hosp Meyer, Dept Pediat, I-50139 Florence, Italy; [Barabino, Arrigo] Gaslini Hosp, Unit Pediat 3, I-16147 Genoa, Italy; [Van Limbergen, Johan] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Guthery, Stephen] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84132 USA; [Guthery, Stephen] Primary Childrens Med Ctr, Salt Lake City, UT 84132 USA; [Denson, Lee] Cincinnati Childrens Hosp, Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; [Piccoli, David; Baldassano, Robert] Childrens Hosp Philadelphia, Div Gastroenterol, Philadelphia, PA 19104 USA; [Piccoli, David; Baldassano, Robert] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Dubinsky, Marla] Cedars Sinai Med Ctr, Dept Pediat & Common Dis Genet, Los Angeles, CA 90048 USA; [Silverberg, Mark] Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; [Grant, Stiruan F. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Emory University; IRCCS Casa Sollievo Della Sofferenza; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Edinburgh; University of Florence; University of Edinburgh; Utah System of Higher Education; University of Utah; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Cedars Sinai Medical Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Van Limbergen, Johan/L-1855-2019; Lionetti, Paolo/AAC-2626-2019; Silverberg, Mark/B-4183-2008; Annese, Vito/AGW-4200-2022	Van Limbergen, Johan/0000-0001-5822-4371; Annese, Vito/0000-0002-0082-892X; Lionetti, Paolo/0000-0001-8029-3904; Glessner, Joseph/0000-0001-5131-2811	Medical Research Council [G0600329, G0800759, G0800675] Funding Source: Medline; NCATS NIH HHS [UL1 TR000077] Funding Source: Medline; NCRR NIH HHS [C06 RR011234, M01 RR002172, M01 RR002172-26, M01-RR00064, M01 RR000064] Funding Source: Medline; NIDDK NIH HHS [DK069513, P30 DK063491, P30 DK063491-049004, K23 DK069513] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline; MRC [G0600329, G0800759, G0800675] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064, C06RR011234, M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, K23DK069513] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Ardizzone S, 2007, INFLAMM BOWEL DIS, V13, P516, DOI 10.1002/ibd.20108; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baum AE, 2008, MOL PSYCHIATR, V13, P466, DOI 10.1038/mp.2008.16; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casci T, 2007, NAT REV GENET, V8, P907, DOI 10.1038/nrg2280; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hollander M., 1999, NONPARAMETRIC STAT M; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mitsuhashi M, 2008, INFLAMM BOWEL DIS, V14, P1061, DOI 10.1002/ibd.20428; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Onnie CM, 2006, INFLAMM BOWEL DIS, V12, P263, DOI 10.1097/01.MIB.0000209791.98866.ba; Pang YH, 2007, CELL IMMUNOL, V248, P115, DOI 10.1016/j.cellimm.2007.10.003; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Romagnani P, 1997, CURR OPIN IMMUNOL, V9, P793, DOI 10.1016/S0952-7915(97)80180-X; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	35	207	213	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					399	405		10.1016/j.ajhg.2009.01.026	http://dx.doi.org/10.1016/j.ajhg.2009.01.026			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19249008	Green Published, Bronze			2022-12-18	WOS:000264304200010
J	Gazda, HT; Grabowska, A; Merida-Long, LB; Latawiec, E; Schneider, HE; Lipton, JM; Vlachos, A; Atsidaftos, E; Ball, SE; Orfali, KA; Niewiadomska, E; Da Costa, L; Tchernia, G; Niemeyer, C; Meerpohl, JJ; Stahl, J; Schratt, G; Glader, B; Backer, K; Wong, C; Nathan, DG; Beggs, AH; Sieff, CA				Gazda, Hanna T.; Grabowska, Agnieszka; Merida-Long, Lilia B.; Latawiec, Elzbieta; Schneider, Hal E.; Lipton, Jeffrey M.; Vlachos, Adrianna; Atsidaftos, Eva; Ball, Sarah E.; Orfali, Karen A.; Niewiadomska, Edyta; Da Costa, Lydie; Tchernia, Gil; Niemeyer, Charlotte; Meerpohl, Joerg J.; Stahl, Joachim; Schratt, Gerhard; Glader, Bertil; Backer, Karen; Wong, Carolyn; Nathan, David G.; Beggs, Alan H.; Sieff, Colin A.			Ribosomal protein S24 gene is mutated in diamond-blackfan anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPLICED MESSENGER-RNAS; EXPRESSION; REGISTRY; TRANSLATION; MUTATIONS; YEAST; S19; UK	Diamond-Blackfan anemia (DBA) is a rare congenital red-cell aplasia characterized by anemia, bone-marrow erythroblastopenia, and congenital anomalies and is associated with heterozygous mutations in the ribosomal protein (RP) S19 gene (RPS19) in similar to 25% of probands. We report identification of de novo nonsense and splice-site mutations in another RP, RPS24 (encoded by RPS24 [10q22-q23]) in similar to 2% of RPS19 mutation-negative probands. This finding strongly suggests that DBA is a disorder of ribosome synthesis and that mutations in other RP or associated genes that lead to disrupted ribosomal biogenesis and/or function may also cause DBA.	Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Neurol Program, Boston, MA 02115 USA; Childrens Hosp, Div Pediat Hematol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Schneider Childrens Hosp, Albert Einstein Coll Med, Div Pediat Hematol Oncol & Stem Cell Transplantat, New Hyde Pk, NY 11042 USA; Univ London St Georges Hosp, Dept Cellular & Mol Med, London, England; Univ Warsaw, Sch Med, Dept Paediat Haematol Oncol, PL-00325 Warsaw, Poland; Univ Paris 11, Inst Gustave Roussy, INSERM U790, Villejuif, France; Hop Bicetre, Le Kremlin Bicetre, France; Univ Freiburg, Dept Paediat, Div Paediat Hematol & Oncol, D-7800 Freiburg, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; Univ Heidelberg, Interdisciplinary Res Neurosci, D-6900 Heidelberg, Germany; Stanford Univ, Sch Med, Div Pediat Hematol Oncol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Clin Labs, Stanford, CA 94305 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yeshiva University; St Georges University London; University of Warsaw; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Stanford University; Stanford University	Gazda, HT (corresponding author), Childrens Hosp, Div Genet, Enders 6,Room 650,300 Longwood Ave, Boston, MA 02115 USA.	hanna.gazda@childrens.harvard.edu	Meerpohl, Joerg J/J-4224-2013	Meerpohl, Joerg J/0000-0002-1333-5403; Niewiadomska, Edyta/0000-0003-2045-6278; Beggs, Alan/0000-0001-8818-0568	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044345] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR018535] Funding Source: Medline; NHLBI NIH HHS [R01HL079571, R01 HL079571-03, 1R01HL07956501, R01 HL079571] Funding Source: Medline; NIAMS NIH HHS [R01AR044345, R01 AR044345] Funding Source: Medline; NICHD NIH HHS [P30 HD18655, P30 HD018655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Alter BP, 1998, NATHAN OSKIS HEMATOL, P237; Ball SE, 1996, BRIT J HAEMATOL, V94, P645, DOI 10.1046/j.1365-2141.1996.d01-1839.x; Cmejla R, 2001, BLOOD, V97, P579, DOI 10.1182/blood.V97.2.579; Da Costa L, 2003, BLOOD, V101, P318, DOI 10.1182/blood-2002-04-1131; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Gazda HT, 2006, STEM CELLS, V24, P2034, DOI 10.1634/stemcells.2005-0554; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; GLADER BE, 1983, NEW ENGL J MED, V309, P1486, DOI 10.1056/NEJM198312153092404; GORENSTEIN C, 1976, P NATL ACAD SCI USA, V73, P1547, DOI 10.1073/pnas.73.5.1547; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Lipton JM, 2001, J PEDIAT HEMATOL ONC, V23, P39, DOI 10.1097/00043426-200101000-00009; LUTSCH G, 1990, EUR J CELL BIOL, V51, P140; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; MAGER WH, 1991, MOL CELL BIOCHEM, V104, P181; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; Orfali KA, 2004, BRIT J HAEMATOL, V125, P243, DOI 10.1111/j.1365-2141.2004.04890.x; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Vlachos A, 2001, J PEDIAT HEMATOL ONC, V23, P377, DOI 10.1097/00043426-200108000-00015; Willig TN, 1999, BLOOD, V94, P4294; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011; XU L, 1994, NUCLEIC ACIDS RES, V22, P646, DOI 10.1093/nar/22.4.646; Xu WB, 1996, GENE, V169, P257, DOI 10.1016/0378-1119(96)88652-5	24	207	213	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1110	1118		10.1086/510020	http://dx.doi.org/10.1086/510020			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186470	Bronze, Green Published			2022-12-18	WOS:000242131600013
J	Richter, S; Vandezande, K; Chen, N; Zhang, K; Sutherland, J; Anderson, J; Han, LP; Panton, R; Branco, P; Gallie, B				Richter, S; Vandezande, K; Chen, N; Zhang, K; Sutherland, J; Anderson, J; Han, LP; Panton, R; Branco, P; Gallie, B			Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONCOGENIC POINT MUTATIONS; HEREDITARY RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; INCOMPLETE PENETRANCE; GEL-ELECTROPHORESIS; GERMLINE MUTATIONS; RNA SURVEILLANCE; BREAST-CANCER; EXPRESSION; DELETIONS	Timely molecular diagnosis of RB1 mutations enables earlier treatment, lower risk, and better health outcomes for patients with retinoblastoma; empowers families to make informed family-planning decisions; and costs less than conventional surveillance. However, complexity has hindered clinical implementation of molecular diagnosis. The majority of RB1 mutations are unique and distributed throughout the RB1 gene, with no real hot spots. We devised a sensitive and efficient strategy to identify RB1 mutations that combines quantitative multiplex polymerase chain reaction (QM-PCR), double-exon sequencing, and promoter-targeted methylation-sensitive PCR. Optimization of test order by stochastic dynamic programming and the development of allele-specific PCR for four recurrent point mutations decreased the estimated turnaround time to <3 wk and decreased direct costs by one-third. The multistep method reported here detected 89% (199/224) of mutations in bilaterally affected probands and both mutant alleles in 84% (112/134) of tumors from unilaterally affected probands. For 23 of 27 exons and the promoter region, QM-PCR was a highly accurate measure of deletions and insertions (accuracy 95%). By revealing those family members who did not carry the mutation found in the related proband, molecular analysis enabled 97 at-risk children from 20 representative families to avoid 313 surveillance examinations under anesthetic and 852 clinic visits. The average savings in direct costs from clinical examinations avoided by children in these families substantially exceeded the cost of molecular testing. Moreover, health care savings continue to accrue, as children in succeeding generations avoid unnecessary repeated anaesthetics and examinations.	Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Univ Toronto, Univ Hlth Network, Vis Sci Res Program, Toronto, ON M5S 1A1, Canada; Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Toronto, Retinoblastoma Solut, Toronto, ON, Canada; Univ Western Ontario, Fac Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Western University (University of Western Ontario)	Gallie, B (corresponding author), Princess Margaret Hosp, 610 Univ Ave,Room 8-415, Toronto, ON M5G 2M9, Canada.		Branco, Paula/I-6567-2012	Branco, Paula/0000-0002-7312-8596; Gallie, Brenda/0000-0002-9697-9211				Alonso J, 2000, Hum Mutat, V15, P583, DOI 10.1002/1098-1004(200006)15:6<583::AID-HUMU22>3.0.CO;2-2; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Asher JH, 1996, HUM MUTAT, V7, P30, DOI 10.1002/(SICI)1098-1004(1996)7:1<30::AID-HUMU4>3.3.CO;2-H; BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308; Bennett RR, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-17; BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; BLANQUET V, 1991, AM J MED GENET, V39, P355, DOI 10.1002/ajmg.1320390321; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chen D, 2002, CANCER RES, V62, P967; Cowell John K., 1994, European Journal of Human Genetics, V2, P281; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DiCiommo D, 2000, SEMIN CANCER BIOL, V10, P255, DOI 10.1006/scbi.2000.0326; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; DUNN JM, 1989, RECESSIVE ONCOGENES; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FOREMAN J, 2001, 4 HSURC HLTH SERV UT; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gad S, 2001, GENE CHROMOSOME CANC, V31, P75, DOI 10.1002/gcc.1120; Gallie BL, 1999, AM J HUM GENET, V65, pA62; GALLIE BL, 1988, IDENTIFICATION MUTAT; GALLIE BL, 1995, CANC GENETICS, P1; Ganguly A, 1997, HUM MUTAT, V9, P339, DOI 10.1002/(SICI)1098-1004(1997)9:4<339::AID-HUMU6>3.0.CO;2-0; GILL RM, 1994, CELL GROWTH DIFFER, V5, P467; Han S, 2001, HUM GENET, V109, P487, DOI 10.1007/s004390100594; Harbour JW, 1998, OPHTHALMOLOGY, V105, P1442, DOI 10.1016/S0161-6420(98)98025-3; Hegde MR, 2000, HUM MUTAT, V16, P422, DOI 10.1002/1098-1004(200011)16:5<422::AID-HUMU7>3.0.CO;2-3; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HOGG A, 1992, ONCOGENE, V7, P1445; JANSON M, 1994, CLIN GENET, V45, P5; KATO MV, 1994, HUM MUTAT, V3, P44, DOI 10.1002/humu.1380030108; KLOSS K, 1991, AM J MED GENET, V39, P196, DOI 10.1002/ajmg.1320390215; Klutz M, 2002, AM J HUM GENET, V71, P174, DOI 10.1086/341284; Kutner SE, 1999, CANCER, V86, P2570, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2570::AID-CNCR14>3.0.CO;2-X; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Liede A, 2002, AM J HUM GENET, V71, P595, DOI 10.1086/342506; LOHMANN D, 1992, HUM GENET, V89, P49, DOI 10.1007/BF00207041; LOHMANN D, 2002, BEST PRACTICE GUIDEL; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; LOHMANN DR, 1994, HUM GENET, V94, P349; Mateu E, 1997, CANCER GENET CYTOGEN, V95, P40, DOI 10.1016/S0165-4608(96)00387-1; MCFALL RC, 1977, CANCER RES, V37, P1003; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Najera C, 2001, MED CLIN-BARCELONA, V116, P365, DOI 10.1016/S0025-7753(01)71832-5; Nakagawa H, 2002, CANCER RES, V62, P4579; Noorani HZ, 1996, AM J HUM GENET, V59, P301; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; Orjuela M, 2000, CLIN CANCER RES, V6, P4010; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; Rebbeck TR, 1997, GENET TEST, V1, P157, DOI 10.1089/gte.1997.1.157; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Schmutte C, 1998, BIOL CHEM, V379, P377; *SECR ADV COMM GEN, 2000, ENH OV GEN TESTS REC; SHIMIZU T, 1994, AM J HUM GENET, V54, P793; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Smith JH, 2000, AM J OPHTHALMOL, V129, P396, DOI 10.1016/S0002-9394(99)00385-2; SZIJAN I, 1995, J MED GENET, V32, P475, DOI 10.1136/jmg.32.6.475; TANG A, 1989, ONCOGENE, V4, P401; Whitaker LL, 1998, MOL CELL BIOL, V18, P4032, DOI 10.1128/MCB.18.7.4032; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; Zajaczek S, 1999, EUR J CANCER, V35, P1824, DOI 10.1016/S0959-8049(99)00171-9; Zeschnigk M, 1999, J MED GENET, V36, P793, DOI 10.1136/jmg.36.10.793; Zhang QJ, 1995, JPN J OPHTHALMOL, V39, P432; Zhou W, 2002, LANCET, V359, P219, DOI 10.1016/S0140-6736(02)07448-2	65	207	220	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					253	269		10.1086/345651	http://dx.doi.org/10.1086/345651			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12541220	Green Published, Bronze			2022-12-18	WOS:000180680000008
J	Ghosh, S; Watanabe, RM; Valle, TT; Hauser, ER; Magnuson, VL; Langefeld, CD; Ally, DS; Mohlke, KL; Silander, K; Kohtamaki, K; Chines, P; Balow, J; Birznieks, G; Chang, J; Eldridge, W; Erdos, MR; Karanjawala, ZE; Knapp, JI; Kudelko, K; Martin, C; Morales-Mena, A; Musick, A; Musick, T; Pfahl, C; Porter, R; Rayman, JB; Rha, D; Segal, L; Shapiro, S; Sharaf, R; Shurtleff, B; So, A; Tannenbaum, J; Te, C; Tovar, J; Unni, A; Welch, C; Whiten, R; Witt, A; Blaschak-Harvan, J; Douglas, JA; Duren, WL; Epstein, MP; Fingerlin, TE; Kaleta, HS; Lange, EM; Li, C; McEachin, RC; Stringham, HM; Trager, E; White, PP; Eriksson, J; Toivanen, L; Vidgren, G; Nylund, SJ; Tuomilehto-Wolf, E; Ross, EH; Demirchyan, E; Hagopian, WA; Buchanan, TA; Tuomilehto, J; Bergman, RN; Collins, FS; Boehnke, M				Ghosh, S; Watanabe, RM; Valle, TT; Hauser, ER; Magnuson, VL; Langefeld, CD; Ally, DS; Mohlke, KL; Silander, K; Kohtamaki, K; Chines, P; Balow, J; Birznieks, G; Chang, J; Eldridge, W; Erdos, MR; Karanjawala, ZE; Knapp, JI; Kudelko, K; Martin, C; Morales-Mena, A; Musick, A; Musick, T; Pfahl, C; Porter, R; Rayman, JB; Rha, D; Segal, L; Shapiro, S; Sharaf, R; Shurtleff, B; So, A; Tannenbaum, J; Te, C; Tovar, J; Unni, A; Welch, C; Whiten, R; Witt, A; Blaschak-Harvan, J; Douglas, JA; Duren, WL; Epstein, MP; Fingerlin, TE; Kaleta, HS; Lange, EM; Li, C; McEachin, RC; Stringham, HM; Trager, E; White, PP; Eriksson, J; Toivanen, L; Vidgren, G; Nylund, SJ; Tuomilehto-Wolf, E; Ross, EH; Demirchyan, E; Hagopian, WA; Buchanan, TA; Tuomilehto, J; Bergman, RN; Collins, FS; Boehnke, M			The Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB-PAIR LINKAGE; MAJOR SUSCEPTIBILITY LOCUS; PIMA-INDIANS; MEXICAN-AMERICANS; COMPLEX TRAITS; MAPPING GENES; WIDE SEARCH; ONSET; NIDDM; MAPS	We performed a genome scan at an average resolution of 8 cM in 719 Finnish sib pairs with type 2 diabetes. Our strongest results are for chromosome 20, where we observe a weighted maximum LOD score (MLS) of 2.15 at map position 69.5 cM from pter and secondary weighted LOD-score peaks of 2.04 at 56.5 cM and 1.99 at 17.5 cM. Our next largest MLS is for chromosome 11 (MLS = 1.75 at 84.0 cM), followed by chromosomes 2 (MLS = 0.87 at 5.5 cM), 10 (MLS = 0.77 at 75.0 cM), and 6 (MLS = 0.61 at 112.5 cM), all under an additive model. When we condition on chromosome 2 at 8.5 cM, the MLS for chromosome 20 increases to 5.50 at 69.0 cM (P = .0014). An ordered-subsets analysis based on families with high or low diabetes-related quantitative traits yielded results that support the possible existence of disease-predisposing genes on chromosomes 6 and 10. Genomewide linkage-disequilibrium analysis using microsatellite marker data revealed strong evidence of association for D22S423 (P = .00007). Further analyses are being carried out to confirm and to refine the location of these putative diabetes-predisposing genes.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidmiol Unit, Helsinki, Finland; Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA; Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA USA; Univ Washington, Dept Med, Seattle, WA USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Finland National Institute for Health & Welfare; University of Southern California; University of Southern California; University of Washington; University of Washington Seattle	Boehnke, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.		Li, Chun/R-1095-2019; Addington, Anjene/C-3460-2008; Li, Chun/B-8388-2012	Li, Chun/0000-0002-8819-2443; Rayman, Joseph/0000-0003-0149-0024; Hauser, Elizabeth/0000-0003-0367-9189	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R56HG000376, Z01HG000040, R01HG000376, T32HG000040, R29HG000376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029867, R01DK027619, R37DK027619, F32DK009525] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG000040] Funding Source: Medline; NHGRI NIH HHS [HG00376, R56 HG000376, T32 HG000040, R01 HG000376] Funding Source: Medline; NIDDK NIH HHS [DK27619, R01 DK027619, DK09525, F32 DK009525, R01 DK029867, R37 DK027619] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENNETT PH, 1992, INT TXB DIABETES MEL, P147; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; BOEHNKE M, 1998, AM J HUM GENET S, V63, pA282; Bowden DW, 1997, DIABETES, V46, P882, DOI 10.2337/diabetes.46.5.882; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Delepine M, 1997, AM J HUM GENET, V60, P174; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; Elbein SC, 1997, J NUTR, V127, pS1891, DOI 10.1093/jn/127.9.1891S; Ghosh S, 1998, J CLIN INVEST, V102, P704, DOI 10.1172/JCI2512; Ghosh S, 1996, DIABETES, V45, P1, DOI 10.2337/diabetes.45.1.1; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hauser ER, 1998, BIOMETRICS, V54, P1238, DOI 10.2307/2533653; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HAUSER ER, 1998, AM J HUM GENET S, V63, pA45; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; Kahn CR, 1996, ANNU REV MED, V47, P509; Kenny S.J., 1995, NIH PUBLICATION, P47; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Meunier F, 1997, GENET EPIDEMIOL, V14, P1107, DOI 10.1002/(SICI)1098-2272(1997)14:6<1107::AID-GEPI91>3.0.CO;2-K; MITCHELL BD, 1994, DIABETES CARE, V17, P567, DOI 10.2337/diacare.17.6.567; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; Norman RA, 1997, AM J HUM GENET, V60, P166; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RISCH N, 1990, AM J HUM GENET, V46, P229; Shuldiner Alan R., 1996, P565; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; SUAREZ BK, 1979, CLIN GENET, V15, P126; TUOMILEHTO J, 1991, INT J EPIDEMIOL, V20, P1010, DOI 10.1093/ije/20.4.1010; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; VALLE T, 1997, INT TXB DIABETES MEL, P125; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; *WHO, 1985, 727 WHO; WORKMAN PL, 1976, AM J PHYS ANTHROPOL, V44, P341, DOI 10.1002/ajpa.1330440216; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401	56	207	217	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1174	1185		10.1016/S0002-9297(07)62948-6	http://dx.doi.org/10.1016/S0002-9297(07)62948-6			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11032783	Green Published, Bronze			2022-12-18	WOS:000165091600015
J	Schneider, JA; Rees, DC; Liu, YT; Clegg, JB				Schneider, JA; Rees, DC; Liu, YT; Clegg, JB			Worldwide distribution of a common methylenetetrahydrofolate reductase mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NEURAL-TUBE DEFECTS; RISK		John Radcliffe Hosp, Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England	University of Oxford	Schneider, JA (corresponding author), John Radcliffe Hosp, Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.		Rees, David/B-6789-2011	Rees, David/0000-0003-3647-1050; Schneider, Julie/0000-0003-0756-5007				Chen J, 1996, CANCER RES, V56, P4862; ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Murray CJL, 1996, GLOBAL HLTH STAT; Papapetrou C, 1996, LANCET, V348, P58, DOI 10.1016/S0140-6736(05)64382-6; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; SEVER LE, 1982, TERATOLOGY, V25, P323, DOI 10.1002/tera.1420250309; SMITHELLS RW, 1980, LANCET, V1, P339; Sohda S, 1997, J MED GENET, V34, P525, DOI 10.1136/jmg.34.6.525; Stevenson RE, 1997, AM J HUM GENET, V60, P229; Thompson EA, 1997, AM J HUM GENET, V60, P197; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; Wilcken DEL, 1997, LANCET, V350, P603, DOI 10.1016/S0140-6736(05)63320-X	15	207	220	0	10	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1258	1260		10.1086/301836	http://dx.doi.org/10.1086/301836			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545406	Bronze, Green Published			2022-12-18	WOS:000073487000032
J	Soemedi, R; Wilson, IJ; Bentham, J; Darlay, R; Topf, A; Zelenika, D; Cosgrove, C; Setchfield, K; Thornborough, C; Granados-Riveron, J; Blue, GM; Breckpot, J; Hellens, S; Zwolinkski, S; Glen, E; Mamasoula, C; Rahman, TJ; Hall, D; Rauch, A; Devriendt, K; Gewillig, M; O' Sullivan, J; Winlaw, DS; Bu'Lock, F; Brook, JD; Bhattacharya, S; Lathrop, M; Santibanez-Koref, M; Cordell, HJ; Goodship, JA; Keavney, BD				Soemedi, Rachel; Wilson, Ian J.; Bentham, Jamie; Darlay, Rebecca; Toepf, Ana; Zelenika, Diana; Cosgrove, Catherine; Setchfield, Kerry; Thornborough, Chris; Granados-Riveron, Javier; Blue, Gillian M.; Breckpot, Jeroen; Hellens, Stephen; Zwolinkski, Simon; Glen, Elise; Mamasoula, Chrysovalanto; Rahman, Thahira J.; Hall, Darroch; Rauch, Anita; Devriendt, Koenraad; Gewillig, Marc; O' Sullivan, John; Winlaw, David S.; Bu'Lock, Frances; Brook, J. David; Bhattacharya, Shoumo; Lathrop, Mark; Santibanez-Koref, Mauro; Cordell, Heather J.; Goodship, Judith A.; Keavney, Bernard D.			Contribution of Global Rare Copy-Number Variants to the Risk of Sporadic Congenital Heart Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIDDEN-MARKOV MODEL; GENOME-WIDE; RECURRENT MICRODELETIONS; CRITICAL REGION; DUPLICATIONS; GATA4; ASSOCIATION; MUTATIONS; DELETIONS; DEFECTS	Previous studies have shown that copy-number variants (CNVs) contribute to the risk of complex developmental phenotypes. However, the contribution of global CNV burden to the risk of sporadic congenital heart disease (CHD) remains incompletely defined. We generated genome-wide CNV data by using Illumina 660W-Quad SNP arrays in 2,256 individuals with CHD, 283 trio CHD-affected families, and 1,538 controls. We found association of rare genic deletions with CHD risk (odds ratio [OR] = 1.8, p = 0.0008). Rare deletions in study participants with CHI) had higher gene content (p = 0.001) with higher haploinsufficiency scores (p = 0.03) than they did in controls, and they were enriched with Wnt-signaling genes (p = 1 x 10(-5)). Recurrent 15q11.2 deletions were associated with CHD risk (OR = 8.2, p = 0.02). Rare de novo CNVs were observed in similar to 5% of CHD trios; 10 out of 11 occurred on the paternally transmitted chromosome (p = 0.01). Some of the rare de novo CNVs spanned genes known to be involved in heart development (e.g., HAND2 and (VAS). Rare genic deletions contribute similar to 4% of the population-attributable risk of sporadic CHI). Second to previously described CNVs at 1q21.1, deletions at 15q11.2 and those implicating Wnt signaling are the most significant contributors to the risk of sporadic CHD. Rare de novo CNVs identified in CHI) trios exhibit paternal origin bias.	[Soemedi, Rachel; Wilson, Ian J.; Darlay, Rebecca; Toepf, Ana; Glen, Elise; Mamasoula, Chrysovalanto; Rahman, Thahira J.; Hall, Darroch; Santibanez-Koref, Mauro; Cordell, Heather J.; Goodship, Judith A.; Keavney, Bernard D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Bentham, Jamie; Cosgrove, Catherine; Bhattacharya, Shoumo] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England; [Bentham, Jamie; Cosgrove, Catherine; Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Zelenika, Diana; Lathrop, Mark] Commissariat Energie Atom, Ctr Natl Genotypage, F-91057 Evry, France; [Zelenika, Diana; Lathrop, Mark] Ceph Fondat Jean Dausset, F-75010 Paris, France; [Setchfield, Kerry; Granados-Riveron, Javier; Brook, J. David] Univ Nottingham, Sch Biol, Nottingham NG7 2UH, England; [Thornborough, Chris; Bu'Lock, Frances] Glenfield Gen Hosp, E Midlands Congenital Heart Ctr, Leicester LE3 9QP, Leics, England; [Blue, Gillian M.; Winlaw, David S.] Childrens Hosp Westmead, Heart Ctr Children, Sydney, NSW 2145, Australia; [Breckpot, Jeroen; Devriendt, Koenraad] Univ Hosp Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Hellens, Stephen; Zwolinkski, Simon] Inst Med Genet, No Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Zurich, Switzerland; [Gewillig, Marc] Univ Louvain, B-3000 Louvain, Belgium; [O' Sullivan, John] Natl Hlth Serv Fdn Trust, Freeman Hosp, Newcastle Upon Tyne Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Nottingham; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Sydney; KU Leuven; University Hospital Leuven; Newcastle University - UK; University of Zurich; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Goodship, JA (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	j.a.goodship@newcastle.ac.uk; b.d.keavney@newcastle.ac.uk	Bhattacharya, Shoumo/F-4127-2010; Granados-Riverón, Javier T/F-9768-2010; Winlaw, David/B-9405-2019; Rauch, Anita/C-5568-2014; Winlaw, David S/F-8365-2016	Bhattacharya, Shoumo/0000-0002-5571-0478; Winlaw, David/0000-0001-8005-3361; Rauch, Anita/0000-0003-2930-3163; Winlaw, David S/0000-0001-8005-3361; Granados-Riveron, Javier T./0000-0002-0368-225X; Gewillig, Marc/0000-0002-4595-5922; Blue, Gillian M/0000-0002-1480-9535; Cordell, Heather/0000-0002-1879-5572; Keavney, Bernard/0000-0001-9573-0812; Wilson, Ian/0000-0001-6893-2873; Brook, John David/0000-0002-5946-6740; Granados-Riveron, Javier Tadeo/0000-0001-5485-654X	British Heart Foundation (BHF); European Community [HEALTH-F2-2008-223040]; Heart Research UK; Federated Foundation; Wellcome Trust; National Institute for Health Research through the Northumberland, Tyne, and Wear Comprehensive Local Research Network; IMF personal chairs; British Heart Foundation [RG/10/17/28553, RG/08/012/25941, RG/07/010/23676, PG/07/045/22690] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); European Community(European Commission); Heart Research UK; Federated Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research through the Northumberland, Tyne, and Wear Comprehensive Local Research Network; IMF personal chairs; British Heart Foundation(British Heart Foundation)	We thank all the participants in the study and Linda Sneddon for assistance with sample collection. This work was funded by the British Heart Foundation (BHF), European Community's 7th Framework Programme contract ("CHeartED") HEALTH-F2-2008-223040, Heart Research UK, the Federated Foundation, and the Wellcome Trust. We acknowledge the support of the National Institute for Health Research through the Northumberland, Tyne, and Wear Comprehensive Local Research Network. B.D.K. and S.B. are supported by IMF personal chairs. We acknowledge the Wellcome Trust Case Control Consortium for making available data about SNP tagging of common copy-number variants.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Fan YF, 2008, BRAIN RES, V1219, P1, DOI 10.1016/j.brainres.2008.05.003; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Glessner JT, 2010, AM J HUM GENET, V87, P661, DOI 10.1016/j.ajhg.2010.09.014; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Gu H, 2003, CIRC RES, V93, P201, DOI 10.1161/01.RES.0000084852.65396.70; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Henderson DJ, 2006, TRENDS CARDIOVAS MED, V16, P38, DOI 10.1016/j.tcm.2005.11.005; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerstjens-Frederikse WS, 2011, HEART, V97, P1228, DOI 10.1136/hrt.2010.211433; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Nemer Georges, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9410; OLSHAN AF, 1994, TERATOLOGY, V50, P80, DOI 10.1002/tera.1420500111; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Salyakina D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026049; Sibbons C, 2012, EUR J HUM GENET, V20, P155, DOI 10.1038/ejhg.2011.182; Soemedi R, 2012, HUM MOL GENET, V21, P1513, DOI 10.1093/hmg/ddr589; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Tsai CH, 1999, AM J MED GENET, V82, P336, DOI 10.1002/(SICI)1096-8628(19990212)82:4<336::AID-AJMG11>3.3.CO;2-9; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Zhi JZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-407; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112	55	206	215	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					489	501		10.1016/j.ajhg.2012.08.003	http://dx.doi.org/10.1016/j.ajhg.2012.08.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22939634	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000308683100009
J	Nitschke, Y; Baujat, G; Botschen, U; Wittkampf, T; du Moulin, M; Stella, J; Le Merrer, M; Guest, G; Lambot, K; Tazarourte-Pinturier, MF; Chassaing, N; Roche, O; Feenstra, I; Loechner, K; Deshpande, C; Garber, SJ; Chikarmane, R; Steinmann, B; Shahinyan, T; Martorell, L; Davies, J; Smith, WE; Kahler, SG; McCulloch, M; Wraige, E; Loidi, L; Hohne, W; Martin, L; Hadj-Rabia, S; Terkeltaub, R; Rutsch, F				Nitschke, Yvonne; Baujat, Genevieve; Botschen, Ulrike; Wittkampf, Tanja; du Moulin, Marcel; Stella, Jacqueline; Le Merrer, Martine; Guest, Genevieve; Lambot, Karen; Tazarourte-Pinturier, Marie-Frederique; Chassaing, Nicolas; Roche, Olivier; Feenstra, Ilse; Loechner, Karen; Deshpande, Charu; Garber, Samuel J.; Chikarmane, Rashmi; Steinmann, Beat; Shahinyan, Tatevik; Martorell, Loreto; Davies, Justin; Smith, Wendy E.; Kahler, Stephen G.; McCulloch, Mignon; Wraige, Elizabeth; Loidi, Lourdes; Hoehne, Wolfgang; Martin, Ludovic; Hadj-Rabia, Smail; Terkeltaub, Robert; Rutsch, Frank			Generalized Arterial Calcification of Infancy and Pseudoxanthoma Elasticum Can Be Caused by Mutations in Either ENPP1 or ABCC6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VITAMIN-K; MOUSE MODEL; MOLECULAR-GENETICS; MINERALIZATION; DEFICIENCY; PHENOTYPE; SPECTRUM; CARBOXYLATION; TRANSPORTER; COUNTERACT	Spontaneous pathologic arterial calcifications in childhood can occur in generalized arterial calcification of infancy (GACI) or in pseudoxanthoma elasticum (PXE). GACI is associated with biallelic mutations in ENPP1 in the majority of cases, whereas mutations in ABCC6 are known to cause PXE. However, the genetic basis in subsets of both disease phenotypes remains elusive. We hypothesized that GACI and PXE are in a closely related spectrum of disease. We used a standardized questionnaire to retrospectively evaluate the phenotype of 92 probands with a clinical history of GACI. We obtained the ENPP1 genotype by conventional sequencing. In those patients with less than two disease-causing ENPP1 mutations, we sequenced ABCC6. We observed that three GACI patients who carried biallelic ENPP1 mutations developed typical signs of PXE between 5 and 8 years of age; these signs included angioid streaks and pseudoxanthomatous skin lesions. In 28 patients, no disease-causing ENPP1 mutation was found. In 14 of these patients, we detected pathogenic ABCC6 mutations (biallelic mutations in eight patients, monoallelic mutations in six patients). Thus, ABCC6 mutations account for a significant subset of GACI patients, and ENPP1 mutations can also be associated with PXE lesions in school-aged children. Based on the considerable overlap of genotype and phenotype of GACI and PXE, both entities appear to reflect two ends of a clinical spectrum of ectopic calcification and other organ pathologies, rather than two distinct disorders. ABCC6 and ENPP1 mutations might lead to alterations of the same physiological pathways in tissues beyond the artery.	[Nitschke, Yvonne; Botschen, Ulrike; Wittkampf, Tanja; du Moulin, Marcel; Stella, Jacqueline; Rutsch, Frank] Univ Munster, Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [Baujat, Genevieve; Le Merrer, Martine] Univ Paris 05, Necker Hosp, Ctr Reference Malad Osseuses Constitut, Dept Genet, F-75743 Paris 15, France; [Guest, Genevieve] Univ Paris 05, Necker Hosp, Nephrol Unit, F-75743 Paris 15, France; [Lambot, Karen] Univ Paris 05, Necker Hosp, Dept Radiol, F-75743 Paris 15, France; [Tazarourte-Pinturier, Marie-Frederique] Ctr Hosp Montreuil, Pediat Unit, F-93100 Montreuil, France; [Chassaing, Nicolas] CHU Toulouse, Dept Med Genet, F-31400 Toulouse, France; [Chassaing, Nicolas] Univ Toulouse 3, EA 4555, F-31400 Toulouse, France; [Roche, Olivier] Univ Paris 05, Necker Hosp, Dept Ophthalmol, Ctr Reference Malad Rares Ophtalmol, F-75743 Paris 15, France; [Feenstra, Ilse] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Loechner, Karen] Univ N Carolina, NC Pediat Osteoporosis Clin, Pediat Endocrine Unit, Chapel Hill, NC 27599 USA; [Deshpande, Charu] Guys & St Thomas NHS Fdn Trust, Dept Clin Genet, Guys Hosp, London SE1 9RT, England; [Garber, Samuel J.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Neonatol,Dept Pediat, Philadelphia, PA 19104 USA; [Chikarmane, Rashmi] St Peters Univ Hosp, Inst Med Genet, New Brunswick, NJ 08901 USA; [Steinmann, Beat] Univ Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland; [Shahinyan, Tatevik] Arabkir Joint Med Ctr, Yerevan 0014, Armenia; [Martorell, Loreto] Hosp St Joan de Deu, Dept Genet, Barcelona 08950, Spain; [Davies, Justin] Cardiff Univ, Cardiff CF4 4XN, S Glam, Wales; [Smith, Wendy E.] Barbara Bush Childrens Hosp, Maine Med Ctr, Maine Pediat Specialty Grp, Div Genet, Portland, ME 04102 USA; [Kahler, Stephen G.] Arkansas Childrens Hosp, Div Med Genet, Little Rock, AR 72202 USA; [McCulloch, Mignon] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Evelina Childrens Hosp, Dept Pediat Nephrol, London SE1 7EH, England; [Wraige, Elizabeth] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Evelina Childrens Hosp, Dept Pediat Neurol, London SE1 7EH, England; [Loidi, Lourdes] Hosp Clin Univ, Unidad Med Mol, Fdn Publ Galega Med Xen, E-15706 Santiago De Compostela, Spain; [Hoehne, Wolfgang] Charite, Dept Biochem, D-13347 Berlin, Germany; [Martin, Ludovic] Angers Univ Hosp, Dept Dermatol, F-49933 Angers 9, France; [Hadj-Rabia, Smail] Univ Paris 05, Necker Hosp, Dept Dermatol, Ctr Reference Malad Genet Express Cutanee, F-75743 Paris 15, France; [Terkeltaub, Robert] Univ Calif San Diego, VA Med Ctr, Dept Rheumatol Allergy & Immunol, San Diego, CA 92161 USA	University of Munster; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; University of North Carolina; University of North Carolina Chapel Hill; Guy's & St Thomas' NHS Foundation Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Saint Peter's University Hospital; University Children's Hospital Zurich; Cardiff University; Maine Medical Center; Arkansas Children's Hospital; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Complexo Hospitalario Universitario de Santiago de Compostela; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego	Rutsch, F (corresponding author), Univ Munster, Childrens Hosp, Dept Gen Pediat, Albert Schweitzer Campus 1,Gbde A1, D-48149 Munster, Germany.	rutschf@ukmuenster.de	Martin, Ludovic/K-2674-2015; Feenstra, I./L-4303-2015; McCulloch, Mignon I/U-3288-2019	Hadj-Rabia, Smail/0000-0001-6801-7106; Davies, Justin/0000-0001-7560-6320; Martorell, Loreto/0000-0003-0898-7332; McCulloch, Mignon/0000-0003-2876-4785	VA Research Service; National Institutes of Health [HL087252, HL077360]; Interdisciplinary Center for Clinical Research (IZKF), Munster; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077360, R01HL087252] Funding Source: NIH RePORTER	VA Research Service(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Center for Clinical Research (IZKF), Munster; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the patients and their parents who participated in the study for their continuous support. R.T. was supported by the VA Research Service and the National Institutes of Health (HL087252 and HL077360). Y.N. and F.R. were supported by the Interdisciplinary Center for Clinical Research (IZKF), Munster. Part of this study was made possible by the Partnership Program of the Arabkir Hospital with the University Children's Hospital in Zurich, Switzerland.	Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Borst P, 2008, CELL CYCLE, V7, P1575, DOI 10.4161/cc.7.11.6005; Brampton C, 2011, CELL CYCLE, V10, P1810, DOI 10.4161/cc.10.11.15681; CHALLENOR VF, 1988, BRIT HEART J, V59, P266; Chassaing N, 2005, J MED GENET, V42, P881, DOI 10.1136/jmg.2004.030171; Chassaing N, 2004, J INVEST DERMATOL, V122, P608, DOI 10.1111/j.0022-202X.2004.22312.x; Dlamini N, 2009, AM J MED GENET A, V149A, P456, DOI 10.1002/ajmg.a.32646; Fabre B, 2005, J EUR ACAD DERMATOL, V19, P212, DOI 10.1111/j.1468-3083.2005.01007.x; FUKUDA K, 1992, CHEST, V101, P1706, DOI 10.1378/chest.101.6.1706; Georgalas Ilias, 2009, Ther Clin Risk Manag, V5, P81; Gheduzzi Dealba, 2004, Hum Mutat, V24, P438, DOI 10.1002/humu.9284; Glatz AC, 2006, PEDIATR TRANSPLANT, V10, P225, DOI 10.1111/j.1399-3046.2005.00414.x; Gorgels TGMF, 2011, J MOL MED, V89, P1125, DOI 10.1007/s00109-011-0782-y; Hamlin N, 2003, BRIT J HAEMATOL, V122, P852, DOI 10.1046/j.1365-2141.2003.04484.x; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Hornstrup L.S., 2011, CIRCULATION CARDIOVA, DOI [10.1161/CIRC-GENETICS.110.958801, DOI 10.1161/CIRC-GENETICS.110.958801]; Hu XF, 2003, SURV OPHTHALMOL, V48, P424, DOI 10.1016/S0039-6257(03)00053-5; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jiang QJ, 2011, CELL CYCLE, V10, P701, DOI 10.4161/cc.10.4.14862; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Le Boulanger G, 2010, AM J MED GENET A, V152A, P118, DOI 10.1002/ajmg.a.33162; Le Saux O, 2001, AM J HUM GENET, V69, P749, DOI 10.1086/323704; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Le Saux O, 2006, J INVEST DERMATOL, V126, P1497, DOI 10.1038/sj.jid.5700201; LEBWOHL M, 1994, J AM ACAD DERMATOL, V30, P103, DOI 10.1016/S0190-9622(08)81894-4; Leftheriotis G, 2011, J VASC SURG, V54, P1390, DOI 10.1016/j.jvs.2011.04.041; Leftheriotis G, 2011, MOL GENET METAB, V103, P199, DOI 10.1016/j.ymgme.2011.03.014; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Li QL, 2007, BIOCHEM BIOPH RES CO, V364, P208, DOI 10.1016/j.bbrc.2007.09.122; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Li QL, 2009, J INVEST DERMATOL, V129, P553, DOI 10.1038/jid.2008.271; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; Martin L, 2008, ARCH DERMATOL, V144, P301, DOI 10.1001/archderm.144.3.301; Miksch S, 2005, HUM MUTAT, V26, P235, DOI 10.1002/humu.20206; Moran J J, 1975, Pathol Annu, V10, P393; MORTON R, 1978, HISTOPATHOLOGY, V2, P423, DOI 10.1111/j.1365-2559.1978.tb01736.x; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Naouri M, 2009, BRIT J DERMATOL, V161, P635, DOI 10.1111/j.1365-2133.2009.09298.x; Patel M, 2004, PEDIATR RADIOL, V34, P652, DOI 10.1007/s00247-004-1166-z; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; Plomp AS, 2004, AM J MED GENET A, V126A, P403, DOI 10.1002/ajmg.a.20632; Pulkkinen L, 2001, HUM GENET, V109, P356, DOI 10.1007/s004390100582; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Ramsay M, 2009, J DERMATOL SCI, V54, P198, DOI 10.1016/j.jdermsci.2009.02.008; Rigal D., 1881, ANN DERMATOL SYPHIL, V2, P491; Ringpfeil F, 2000, P NATL ACAD SCI USA, V97, P6001, DOI 10.1073/pnas.100041297; RONGIOLETTI F, 1989, J AM ACAD DERMATOL, V21, P1150, DOI 10.1016/S0190-9622(89)70320-0; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2011, CIRC RES, V109, P578, DOI 10.1161/CIRCRESAHA.111.247965; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; Saxena A, 2003, PEDIATR CARDIOL, V24, P80, DOI 10.1007/s00246-001-0067-2; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; STUART G, 1990, BRIT HEART J, V64, P156; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Uitto J, 2011, AM J MED GENET A, V155A, P3176, DOI [10.1002/ajmg.a.34243, 10.1002/ajmg.a.34067]; Vanakker OM, 2007, J INVEST DERMATOL, V127, P581, DOI 10.1038/sj.jid.5700610; Vanakker OM, 2010, LAB INVEST, V90, P895, DOI 10.1038/labinvest.2010.68; VANOORT AM, 1979, HELV PAEDIATR ACTA, V34, P369; Wax JR, 2001, AM J OBSTET GYNECOL, V185, P1267, DOI 10.1067/mob.2001.117186	63	206	222	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					25	39		10.1016/j.ajhg.2011.11.020	http://dx.doi.org/10.1016/j.ajhg.2011.11.020			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22209248	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000299409100002
J	Abecasis, GR; Wigginton, JE				Abecasis, GR; Wigginton, JE			Handling marker-marker linkage disequilibrium: Pedigree analysis with clustered markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HAPLOTYPE FREQUENCIES; MAXIMUM-LIKELIHOOD; GENOME SCANS; ASSOCIATION; MAPS; POPULATION; ALGORITHM; GENE; SNPS	Single-nucleotide polymorphisms (SNPs) are rapidly replacing microsatellites as the markers of choice for genetic linkage studies and many other studies of human pedigrees. Here, we describe an efficient approach for modeling linkage disequilibrium (LD) between markers during multipoint analysis of human pedigrees. Using a gene-counting algorithm suitable for pedigree data, our approach enables rapid estimation of allele and haplotype frequencies within clusters of tightly linked markers. In addition, with the use of a hidden Markov model, our approach allows for multipoint pedigree analysis with large numbers of SNP markers organized into clusters of markers in LD. Simulation results show that our approach resolves previously described biases in multipoint linkage analysis with SNPs that are in LD. An updated version of the freely available Merlin software package uses the approach described here to perform many common pedigree analyses, including haplotyping and haplotype frequency estimation, parametric and nonparametric multipoint linkage analysis of discrete traits, variance-components and regression-based analysis of quantitative traits, calculation of identity-by-descent or kinship coefficients, and case selection for follow-up association studies. To illustrate the possibilities, we examine a data set that provides evidence of linkage of psoriasis to chromosome 17.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr State Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Abecasis, GR (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr State Genet, Ann Arbor, MI 48109 USA.	goncalo@umich.edu	Abecasis, Goncalo R/B-7840-2010; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Abecasis, Goncalo/0000-0003-1509-1825				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2005, HUM HERED, V59, P118, DOI 10.1159/000085226; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, AM J HUM GENET, V69, P198; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Broman KW, 2004, NAT METHODS, V1, P104, DOI 10.1038/nmeth1104-104; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; Cantor RM, 2005, AM J HUM GENET, V76, P538, DOI 10.1086/428628; CEPPELLINI R, 1955, ANN HUM GENET, V20, P97; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goddard KAB, 2002, GENET EPIDEMIOL, V22, P205, DOI 10.1002/gepi.0177; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HEDRICK PW, 1987, GENETICS, V117, P331; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Idury RM, 1997, HUM HERED, V47, P197, DOI 10.1159/000154413; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kwok PY, 2001, ANNU REV GENOM HUM G, V2, P235, DOI 10.1146/annurev.genom.2.1.235; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lange K., 1997, MATH STAT METHODS GE; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; O'Connell JR, 2000, GENET EPIDEMIOL, V19, pS64, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI10>3.0.CO;2-G; Ott J., 1991, ANAL HUMAN GENETIC L; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schaid DJ, 2002, AM J HUM GENET, V71, P992, DOI 10.1086/342666; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; SHAW SS, 2004, NAT METHODS, V1, P113; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STUART P, 2005, IN PRESS J MED GENET; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	50	206	209	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					754	767		10.1086/497345	http://dx.doi.org/10.1086/497345			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252236	Bronze, Green Published			2022-12-18	WOS:000232569600006
J	Tatton-Brown, K; Douglas, J; Coleman, K; Baujat, G; Cole, TRP; Das, S; Horn, D; Hughes, HE; Temple, IK; Faravelli, F; Waggoner, D; Turkmen, S; Cormier-Daire, V; Irrthum, A; Rahman, N				Tatton-Brown, K; Douglas, J; Coleman, K; Baujat, G; Cole, TRP; Das, S; Horn, D; Hughes, HE; Temple, IK; Faravelli, F; Waggoner, D; Turkmen, S; Cormier-Daire, V; Irrthum, A; Rahman, N		Childhood Overgrowth Collaboration	Genotype-phenotype associations in Sotos syndrome: An analysis of 266 individuals with NSD1 aberrations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVERGROWTH PHENOTYPES; MUTATIONS; GENE; HAPLOINSUFFICIENCY; MICRODELETIONS; FEATURES; PROTEIN; DOMAIN	We identified 266 individuals with intragenic NSD1 mutations or 5q35 microdeletions encompassing NSD1 (referred to as "NSD1-positive individuals"), through analyses of 530 subjects with diverse phenotypes. Truncating NSD1 mutations occurred throughout the gene, but pathogenic missense mutations occurred only in functional domains (p < 2 x 10(-16)). Sotos syndrome was clinically diagnosed in 99% of NSD1-positive individuals, independent of the molecular analyses, indicating that NSD1 aberrations are essentially specific to this condition. Furthermore, our data suggest that 93% of patients who have been clinically diagnosed with Sotos syndrome have identifiable NSD1 abnormalities, of which 83% are intragenic mutations and 10% are 5q35 microdeletions. We reviewed the clinical phenotypes of 239 NSD1-positive individuals. Facial dysmorphism, learning disability, and childhood over-growth were present in 90% of the individuals. However, both the height and head circumference of 10% of the individuals were within the normal range, indicating that overgrowth is not obligatory for the diagnosis of Sotos syndrome. A broad spectrum of associated clinical features was also present, the occurrence of which was largely independent of genotype, since individuals with identical mutations had different phenotypes. We compared the phenotypes of patients with intragenic NSD1 mutations with those of patients with 5q35 microdeletions. Patients with microdeletions had less-prominent overgrowth (P = .0003) and more-severe learning disability (P = 3 x 10(-9)) than patients with mutations. However, all features present in patients with microdeletions were also observed in patients with mutations, and there was no correlation between deletion size and the clinical phenotype, suggesting that the deletion of additional genes in patients with 5q35 microdeletions has little specific effect on phenotype. We identified only 13 familial cases. The reasons for the low vertical transmission rate are unclear, although familial cases were more likely than nonfamilial cases (P = .005) to carry missense mutations, suggesting that the underlying NSD1 mutational mechanism in Sotos syndrome may influence reproductive fitness.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Hop Necker Enfants Malad, Dept Med Genet, Paris, France; Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Humboldt Univ, Charite, Inst Med Genet, Berlin, Germany; Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; Southampton Univ Hosp, Dept Human Genet, Southampton, Hants, England; Osped Galliera, Lab Genet Umana, Genoa, Italy	University of London; Institute of Cancer Research - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital; University of Chicago; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cardiff University; University of Southampton; Ente Ospedaliero Ospedali Galliera	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	temple, isabel K/K-2391-2015; Rahman, Nazneen/B-8890-2012; cormier-daire, valerie/H-6520-2017; Rahman, Nazneen/D-2802-2013	cormier-daire, valerie/0000-0002-2839-9856; Rahman, Nazneen/0000-0003-4376-0440	Medical Research Council [G0400188] Funding Source: Medline; MRC [G0400188] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Baujat G, 2004, AM J HUM GENET, V74, P715, DOI 10.1086/383093; Cecconi M, 2005, AM J MED GENET A, V134A, P247, DOI 10.1002/ajmg.a.30492; de Boer L, 2004, EUR J ENDOCRINOL, V151, P333, DOI 10.1530/eje.0.1510333; Devriendt Koen, 2004, Human Genomics, V1, P126; Douglas J, 2005, EUR J HUM GENET, V13, P150, DOI 10.1038/sj.ejhg.5201298; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; DOUGLAS J, IN PRESS J MED GENET; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Nagai T, 2003, J MED GENET, V40, P285, DOI 10.1136/jmg.40.4.285; Niikawa N, 2004, HORM RES, V62, P60, DOI 10.1159/000080501; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rio M, 2003, J MED GENET, V40, P436, DOI 10.1136/jmg.40.6.436; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Tatton-Brown K, 2004, CLIN DYSMORPHOL, V13, P199, DOI 10.1097/00019605-200410000-00001; Tatton-Brown K, 2005, J MED GENET, V42, P307, DOI 10.1136/jmg.2004.027755; Turkmen S, 2003, EUR J HUM GENET, V11, P858, DOI 10.1038/sj.ejhg.5201050; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; WAGGONER G, IN PRESS GENET MED	22	206	219	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					193	204		10.1086/432082	http://dx.doi.org/10.1086/432082			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	15942875	Bronze, Green Published			2022-12-18	WOS:000230387200002
J	JORDE, LB; BAMSHAD, MJ; WATKINS, WS; ZENGER, R; FRALEY, AE; KRAKOWIAK, PA; CARPENTER, KD; SOODYALL, H; JENKINS, T; ROGERS, AR				JORDE, LB; BAMSHAD, MJ; WATKINS, WS; ZENGER, R; FRALEY, AE; KRAKOWIAK, PA; CARPENTER, KD; SOODYALL, H; JENKINS, T; ROGERS, AR			ORIGINS AND AFFINITIES OF MODERN HUMANS - A COMPARISON OF MITOCHONDRIAL AND NUCLEAR GENETIC DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-EVOLUTION; DNA POLYMORPHISMS; POPULATIONS; MUTATION; SEQUENCES; GENOME; LOCI	To test hypotheses about the origin of modern humans, we analyzed mtDNA sequences, 30 nuclear restriction-site polymorphisms (RSPs), and 30 tetranucleotide short tandem repeat (STR) polymorphisms in 243 Africans, Asians, and Europeans. An evolutionary tree based on mtDNA displays deep African branches, indicating greater genetic diversity for African populations. This finding, which is consistent with previous mtDNA analyses, has been interpreted as evidence for an African origin of modern humans. Both sets of nuclear polymorphisms, as well as a third set of trinucleotide polymorphisms, are highly consistent with one another but fail to show deep branches for African populations. These results, which represent the first direct comparison of mtDNA and nuclear genetic data in major continental populations, undermine the genetic evidence for an African origin of modern humans.	UNIV UTAH, DEPT ANTHROPOL, SALT LAKE CITY, UT 84112 USA; UNIV WITWATERSRAND, SCH PATHOL, S AFRICAN INST MED RES, DEPT HUMAN GENET, JOHANNESBURG, SOUTH AFRICA; PENN STATE UNIV, DEPT ANTHROPOL, UNIVERSITY PK, PA 16802 USA	Utah System of Higher Education; University of Utah; University of Witwatersrand; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	JORDE, LB (corresponding author), UNIV UTAH, HLTH SCI CTR, ECCLES INST HUMAN GENET, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA.				NCRR NIH HHS [RR-00064] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAMSHAD M, IN PRESS HUM BIOL; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BIRKY CW, 1983, GENETICS, V103, P513; BOWCOCK A, 1991, GENOMICS, V11, P491, DOI 10.1016/0888-7543(91)90170-J; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; DEKA R, 1991, GENOMICS, V11, P83, DOI 10.1016/0888-7543(91)90104-M; DEKA R, 1995, AM J HUM GENET, V56, P461; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; HARPENDING H, IN PRESS MOL BIOL HU; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; JIN L, IN PRESS HEREDIRY; Jorde L., 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; KIDD JR, 1991, HUM BIOL, V63, P775; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; MANTEL N, 1967, CANCER RES, V27, P209; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; NEI M, 1989, HUM HERED, V39, P276, DOI 10.1159/000153872; NEI M, 1982, EVOL BIOL, V14, P1; NEI M, 1993, MOL BIOL EVOL, V10, P927; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei Masatoshi, 1993, P239; OBRIEN E, 1994, HUM BIOL, V66, P743; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P249; ROGERS AR, 1995, HUM BIOL, V67, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROGERS AR, IN PRESS EVOLUTION; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHERRY ST, 1994, HUM BIOL, V66, P761; SHRIVER MD, 1993, GENETICS, V134, P983; SHRIVER MD, 1995, IN PRESS MOL BIOL EV, V12; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spuhler James N., 1993, P262; Spurdle AB, 1992, CURR OPIN GENET DEV, V2, P487, DOI 10.1016/S0959-437X(05)80162-5; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1993, EVOLUTIONARY ANTHR, V2, P60; SYKES BC, 1983, LANCET, V2, P787; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1985, GENETICS, V109, P441; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WATKINS WS, INPRESS HUM MOL GENE; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	55	206	206	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					523	538						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668280				2022-12-18	WOS:A1995RR60500001
J	Piskol, R; Ramaswami, G; Li, JB				Piskol, Robert; Ramaswami, Gokul; Li, Jin Billy			Reliable Identification of Genomic Variants from RNA-Seq Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACCURATE IDENTIFICATION; MUTATIONAL EVOLUTION; SPLICE JUNCTIONS; READ ALIGNMENT; TRANSCRIPTOME; DNA; POLYMORPHISM; MECHANISMS; EXPRESSION; LANDSCAPE	Identifying genomic variation is a crucial step for unraveling the relationship between genotype and phenotype and can yield important insights into human diseases. Prevailing methods rely on cost-intensive whole-genome sequencing (WGS) or whole-exome sequencing (WES) approaches while the identification of genomic variants from often existing RNA sequencing (RNA-seq) data remains a challenge because of the intrinsic complexity in the transcriptome. Here, we present a highly accurate approach termed SNPiR to identify SNPs in RNA-seq data. We applied SNPiR to RNA-seq data of samples for which WGS and WES data are also available and achieved high specificity and sensitivity. Of the SNPs called from the RNA-seq data, >98% were also identified by WGS or WES. Over 70% of all expressed coding variants were identified from RNA-seq, and comparable numbers of exonic variants were identified in RNA-seq and WES. Despite our method's limitation in detecting variants in expressed regions only, our results demonstrate that SNPiR outperforms current state-of-the-art approaches for variant detection from RNA-seq data and offers a cost-effective and reliable alternative for SNP discovery.	[Piskol, Robert; Ramaswami, Gokul; Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Li, JB (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jin.billy.li@stanford.edu			German Academic Exchange Service; Stanford Genome Training Program; National Institutes of Health (NIH); Stanford Graduate Fellowship; Stanford University Department of Genetics; NIH; Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102484] Funding Source: NIH RePORTER	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Stanford Genome Training Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Stanford University Department of Genetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.P. was supported by a fellowship from the German Academic Exchange Service. G.R. was supported by the Stanford Genome Training Program, funded by the National Institutes of Health (NIH) and a Stanford Graduate Fellowship. This work was supported by the Stanford University Department of Genetics, NIH, and Ellison Medical Foundation (to J.B.L.).	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Au KF, 2010, NUCLEIC ACIDS RES, V38, P4570, DOI 10.1093/nar/gkq211; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen LY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1248; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Kridel R, 2012, BLOOD, V119, P1963, DOI 10.1182/blood-2011-11-391474; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	53	205	209	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					641	651		10.1016/j.ajhg.2013.08.008	http://dx.doi.org/10.1016/j.ajhg.2013.08.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24075185	Bronze, Green Published			2022-12-18	WOS:000326305600006
J	Ladd-Acosta, C; Pevsner, J; Sabunciyan, S; Yolken, RH; Webster, MJ; Dinkins, T; Callinan, PA; Fan, JB; Potash, JB; Feinberg, AP				Ladd-Acosta, Christine; Pevsner, Jonathan; Sabunciyan, Sarven; Yolken, Robert H.; Webster, Maree J.; Dinkins, Tiffany; Callinan, Pauline A.; Fan, Jian-Bing; Potash, James B.; Feinberg, Andrew P.			DNA methylation signatures within the human brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; RETT-SYNDROME; EPIGENETICS; ENGRAILED-2; IDENTIFY	DNA methylation is a heritable modification of genomic DNA central to development, imprinting, transcriptional regulation, chromatin structure, and overall genomic stability. Aberrant DNA methylation of individual genes is a hallmark of cancer and has been shown to play an important role in neurological disorders such as Rett syndrome. Here, we asked whether normal DNA methylation might distinguish individual brain regions. We determined the quantitative DNA methylation levels of 1,505 CpG sites representing 807 genes with diverse functions, including proliferation and differentiation, previously shown to be implicated in human cancer. We initially analyzed 76 brain samples representing cerebral cortex (n = 35), cerebellum (n = 34), and pons (n = 7), along with liver samples (n = 3) from 43 individuals. Unsupervised hierarchical analysis showed clustering of 33 of 35 cerebra distinct from the clustering of 33 of 34 cerebella, 7 of 7 pons, and all 3 livers. By use of comparative marker selection and permutation testing, 156 loci representing 118 genes showed statistically significant differences - a >= 17% absolute change in DNA methylation (P<.004) - among brain regions. These results were validated for all six genes tested in a replicate set of 57 samples. Our data suggest that DNA methylation signatures distinguish brain regions and may help account for region-specific functional specialization.	Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Stanley Div Dev Neurovirol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA; Kennedy Krieger Inst, Dept Neurol, Baltimore, MD USA; Univ Hlth Sci, Dept Psychiat, Stanley Lab Brain Res, Uninformed Serv, Bethesda, MD USA; Univ Hlth Sci, Dept Psychiat, Stanley Lab Brain Res, Uninformed Serv, San Diego, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute	Potash, JB (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Meyer 4-119, Baltimore, MD 21287 USA.	jpotash@jhmi.edu	Feinberg, Andrew/AAY-7666-2020; yolken, robert/AAW-2556-2021	Feinberg, Andrew/0000-0002-8364-1991; Sabunciyan, Sarven/0000-0002-7231-0820	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083283] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG003233, P50 HG003233] Funding Source: Medline; NICHD NIH HHS [N01-HD-8-3283] Funding Source: Medline; NIMH NIH HHS [R24 MH068855, MH68855] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; BACH MA, 1991, MOL BRAIN RES, V10, P43; Benayed R, 2005, AM J HUM GENET, V77, P851, DOI 10.1086/497705; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Kato MV, 1996, AM J HUM GENET, V59, P1084; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; LAZAR A, 2007, NOVEL MUTATIONS EXTR; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Letwin NE, 2006, J NEUROSCI, V26, P5277, DOI 10.1523/JNEUROSCI.4602-05.2006; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Norton N, 2005, ANN MED, V37, P121, DOI 10.1080/07853890510037347; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Vaccarino FM, 1999, CURR TOP DEV BIOL, V46, P179, DOI 10.1016/S0070-2153(08)60329-4; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	25	205	208	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1304	1315		10.1086/524110	http://dx.doi.org/10.1086/524110			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999367	Green Published, Bronze			2022-12-18	WOS:000251098800017
J	Rebbeck, TR; Kantoff, PN; Krithivas, K; Neuhausen, S; Blackwood, MA; Godwin, AK; Daly, MB; Narod, SA; Garber, JE; Lynch, HT; Weber, BL; Brown, M				Rebbeck, TR; Kantoff, PN; Krithivas, K; Neuhausen, S; Blackwood, MA; Godwin, AK; Daly, MB; Narod, SA; Garber, JE; Lynch, HT; Weber, BL; Brown, M			Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROSTATE-CANCER; BRCA1; MUTATIONS; TRANSACTIVATION; CARRIERS; CELLS; GENE	Compared with the general population, women who have inherited a germline mutation in the BRCA1 gene have a greatly increased risk of developing breast cancer. However, there is also substantial interindividual variability in the occurrence of breast cancer among BRCA1 mutation carriers. We hypothesize that other genes, particularly those involved in endocrine signaling, may modify the BRCA1-associated age-specific breast cancer risk. We studied the effect of the CAG repeat-length polymorphism found in exon 1 of the androgen-receptor (AR) gene (AR-CAG). AR alleles containing longer CAG repeat lengths are associated with a decreased ability to activate androgen-responsive genes. Using a sample of women who inherited germline BRCA1 mutations, we compared AR-CAG repeat length in 165 women with and 139 women without breast cancer. We found that women were at significantly increased risk of breast cancer if they carried at least one AR allele with greater than or equal to 28 CAG repeats. Women who carried an AR-CAG allele of greater than or equal to 28, greater than or equal to 29, or greater than or equal to 30 repeats were given a diagnosis 0.8, 1.8, or 6.3 years earlier than women who did not carry at least one such allele. All 11 women in our sample who carried at least one AR-CAG allele with greater than or equal to 29 repeats had breast cancer. Our results support the hypothesis that age at breast cancer diagnosis is earlier among BRCA1 mutation carriers who carry very long AR-CAG repeats. These results suggest that pathways involving androgen signaling may affect the risk of BRCA1-associated breast cancer.	Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med & Genet, Philadelphia, PA 19104 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Canc, Boston, MA 02115 USA; Univ Utah, Salt Lake City, UT USA; Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; Creighton Univ, Dept Prevent Med, Omaha, NE 68178 USA	University of Pennsylvania; University of Pennsylvania; Fox Chase Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Utah System of Higher Education; University of Utah; University of Toronto; University Toronto Affiliates; Womens College Hospital; Creighton University	Rebbeck, TR (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, 904 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.		Narod, Steven A/AAA-6112-2022; Rebbeck, Timothy/GLU-8348-2022; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008	Rebbeck, Timothy/0000-0002-4799-1900; Brown, Myles/0000-0002-8213-1658; Kantoff, Philip/0000-0001-7275-0597	NATIONAL CANCER INSTITUTE [R01CA057601] Funding Source: NIH RePORTER; NCI NIH HHS [CA57601, CA737370] Funding Source: Medline; NIEHS NIH HHS [ES97939] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Birrell SN, 1998, J MAMMARY GLAND BIOL, V3, P95, DOI 10.1023/A:1018730519839; BIRRELL SN, 1995, J STEROID BIOCHEM, V52, P459, DOI 10.1016/0960-0760(95)00005-K; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; EASTON DF, 1995, AM J HUM GENET, V56, P265; EELES RA, 1998, AM J HUM GENET, V63, pA21; Elhaji Y, 1997, AM J HUM GENET, V61, pA64; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; GOLDENBERG IS, 1973, JAMA-J AM MED ASSOC, V223, P1267, DOI 10.1001/jama.223.11.1267; GUDAS JM, 1995, CANCER RES, V55, P4561; Hackenberg R, 1996, J STEROID BIOCHEM, V56, P113, DOI 10.1016/0960-0760(95)00228-6; Hakimi JM, 1997, CLIN CANCER RES, V3, P1599; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; LA SA, 1991, NATURE, V352, P77; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Marks JR, 1997, ONCOGENE, V14, P115, DOI 10.1038/sj.onc.1200808; Narod SA, 1995, INT J CANCER, V64, P394, DOI 10.1002/ijc.2910640608; REBBECK TR, 1999, P IUCC S FAM CANC PR; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Szelei J, 1997, ENDOCRINOLOGY, V138, P1406, DOI 10.1210/en.138.4.1406; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; ZeleniuchJacquotte A, 1997, AM J EPIDEMIOL, V145, P1030, DOI 10.1093/oxfordjournals.aje.a009059; Zhu X, 1997, INT J CANCER, V72, P574, DOI 10.1002/(SICI)1097-0215(19970807)72:4<574::AID-IJC4>3.3.CO;2-Y	25	205	209	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1371	1377		10.1086/302366	http://dx.doi.org/10.1086/302366			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205268	Bronze, Green Published			2022-12-18	WOS:000080093000015
J	PEARSON, WR; VORACHEK, WR; XU, SJ; BERGER, R; HART, I; VANNAIS, D; PATTERSON, D				PEARSON, WR; VORACHEK, WR; XU, SJ; BERGER, R; HART, I; VANNAIS, D; PATTERSON, D			IDENTIFICATION OF CLASS-MU GLUTATHIONE TRANSFERASE GENES GSTM1-GSTM5 ON HUMAN CHROMOSOME-1P13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANS-STILBENE OXIDE; HUMAN MONONUCLEAR LEUKOCYTES; S-TRANSFERASE; LUNG-CANCER; HUMAN-MUSCLE; EXPRESSION; YEAST; SUSCEPTIBILITY; DELETION; CLONING	The GSTM1, GSTM2, GSTM3, GSTM4, and GSTM5 glutathione transferase genes have been mapped to human chromosome 1 by using locus-specific PCR primer pairs spanning exon 6, intron,6, and exon 7, as probes on DNA from human/hamster somatic cell hybrids. For GSTM1, the assignment was confirmed by Southern blot hybridization to a pair of 12.5/2.4-kb HindIII fragments. The GSTM1-specific primer pairs can be used to identify individuals carrying non-null GSTM1 alleles. The organization of these five genes was confirmed by the isolation of a yeast artificial chromosome clone (GSTM-YAC2) that contains all five genes. With this clone, the location of the GSTM1-GSTM5 gene cluster on chromosome 1 was confirmed by fluorescence in situ hybridization. Both regional assignment using the fractional length method and examination of probe signal with reference to R-banded chromosomes induced by BrdU places the gene cluster in or near the 1p13.3 region. The close physical proximity of the GSTM1 and GSTM2 loci, which share 99% nucleotide sequence identity over 460 nucleotides of 3'-untranslated mRNA, suggests that the GSTM1-null allele may result from unequal crossing-over.	ELEANOR ROOSEVELT INST,DENVER,CO; UNIV COLORADO,CTR CANC,DENVER,CO 80202	University of Colorado System; University of Colorado Denver	PEARSON, WR (corresponding author), UNIV VIRGINIA,DEPT BIOCHEM,BOX 440 JORDAN HALL,CHARLOTTESVILLE,VA 22908, USA.		Pearson, William/K-4908-2019	Pearson, William/0000-0002-0727-3680	NIA NIH HHS [AG00029] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AYESH R, 1984, NATURE, V312, P169, DOI 10.1038/312169a0; BARTON JW, 1991, GENOMICS, V9, P314, DOI 10.1016/0888-7543(91)90259-H; BOARD P, 1990, PHARMACOL THERAPEUT, V48, P357, DOI 10.1016/0163-7258(90)90054-6; BOARD PG, 1981, AM J HUM GENET, V33, P36; BOARD PG, 1981, FEBS LETT, V135, P12, DOI 10.1016/0014-5793(81)80933-7; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAMPBELL E, 1990, J BIOL CHEM, V265, P9188; CHERIF D, 1990, P NATL ACAD SCI USA, V87, P6639, DOI 10.1073/pnas.87.17.6639; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DEJONG JL, 1991, BIOCHEM BIOPH RES CO, V180, P15, DOI 10.1016/S0006-291X(05)81248-3; DEJONG JL, 1989, GLUTATHIONE S TRANSF, P250; DEJONG JL, 1988, NUCLEIC ACIDS RES, V16, P8543; DRABKIN HA, 1985, P NATL ACAD SCI USA, V82, P464, DOI 10.1073/pnas.82.2.464; GARDINER K, 1988, SOMAT CELL MOLEC GEN, V14, P623, DOI 10.1007/BF01535316; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARRIS JM, 1991, BIOCHEM J, V278, P137, DOI 10.1042/bj2780137; HAYASHI S, 1992, JPN J CANCER RES, V83, P866, DOI 10.1111/j.1349-7006.1992.tb01992.x; HUSSEY AJ, 1991, BIOCHEM J, V273, P323, DOI 10.1042/bj2730323; ISLAM MQ, 1989, HUM GENET, V82, P338; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LAI HCJ, 1988, J BIOL CHEM, V263, P11389; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; METZENBERG AB, 1991, GENETICS, V128, P143; PATTERSON D, IN PRESS GENOMICS; REINHART J, IN PRESS ARCH BIOCH; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; SEIDEGARD J, 1985, HUM GENET, V69, P66, DOI 10.1007/BF00295531; SEIDEGARD J, 1986, CARCINOGENESIS, V7, P751, DOI 10.1093/carcin/7.5.751; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; SEIDEGARD J, 1990, CARCINOGENESIS, V11, P33, DOI 10.1093/carcin/11.1.33; SEIDEGARD J, 1987, BIOCHEM J, V246, P783, DOI 10.1042/bj2460783; SHAN Z, 1992, HUM GENET, V90, P435; SINGH SV, 1988, ARCH BIOCHEM BIOPHYS, V264, P13, DOI 10.1016/0003-9861(88)90564-4; SINNOTT P, 1990, P NATL ACAD SCI USA, V87, P2107, DOI 10.1073/pnas.87.6.2107; STRANGE RC, 1991, CARCINOGENESIS, V12, P25, DOI 10.1093/carcin/12.1.25; SUGIMURA H, 1990, CARCINOGENESIS, V11, P1527, DOI 10.1093/carcin/11.9.1527; SUZUKI T, 1987, ANN HUM GENET, V51, P95, DOI 10.1111/j.1469-1809.1987.tb01051.x; TAKAHASHI Y, IN PRESS J BIOL CHEM; TAYLOR JB, 1991, BIOCHEM J, V274, P587, DOI 10.1042/bj2740587; TSUCHIDA S, 1990, J BIOL CHEM, V265, P7150; VNENCAKJONES CL, 1990, SCIENCE, V250, P1745, DOI 10.1126/science.1980158; VORACHEK WR, 1991, P NATL ACAD SCI USA, V88, P4443, DOI 10.1073/pnas.88.10.4443; WIDERSTEN M, 1991, BIOCHEM J, V276, P519, DOI 10.1042/bj2760519; ZHONG S, IN PRESS BIOCH J	49	205	219	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					220	233						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317488				2022-12-18	WOS:A1993LJ38500026
J	PLOUGHMAN, LM; BOEHNKE, M				PLOUGHMAN, LM; BOEHNKE, M			ESTIMATING THE POWER OF A PROPOSED LINKAGE STUDY FOR A COMPLEX GENETIC TRAIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,109 S OBSERV,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan			Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023410] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29-GM41440] Funding Source: Medline; NINDS NIH HHS [R01-NS23410] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1984, GENETIC EPIDEMIOLOGY, P349; GOLDIN LR, 1988, GENET EPIDEMIOL, V5, P35, DOI 10.1002/gepi.1370050104; HODGE SE, 1983, AM J HUM GENET, V35, P1139; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; LANGE K, 1983, HUM HERED, V33, P291, DOI 10.1159/000153393; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; OTT J, 1986, AM J HUM GENET, V39, P159; OTT J, 1984, AM J HUM GENET, V588, P74; SKOLNICK MH, 1984, GENETIC EPIDEMIOLOGY, P271; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; THOMPSON EA, 1978, ANN HUM GENET, V42, P95, DOI 10.1111/j.1469-1809.1978.tb00934.x; TRHOMPSON EA, 1978, GENETIC EPIDEMIOLOGY, P247; WHITE R, 1987, CYTOGENET CELL GENET, V46, P715; WONG FL, 1986, AM J HUM GENET, V39, P25	19	205	207	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					543	551						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2929597				2022-12-18	WOS:A1989T810900014
J	Navarro-Sastre, A; Tort, F; Stehling, O; Uzarska, MA; Arranz, JA; del Toro, M; Labayru, MT; Landa, J; Font, A; Garcia-Villoria, J; Merinero, B; Ugarte, M; Gutierrez-Solana, LG; Campistol, J; Garcia-Cazorla, A; Vaquerizo, J; Riudor, E; Briones, P; Elpeleg, O; Ribes, A; Lill, R				Navarro-Sastre, Aleix; Tort, Frederic; Stehling, Oliver; Uzarska, Marta A.; Antonio Arranz, Jose; del Toro, Mireia; Teresa Labayru, M.; Landa, Joseba; Font, Aida; Garcia-Villoria, Judit; Merinero, Begona; Ugarte, Magdalena; Gonzalez Gutierrez-Solana, Luis; Campistol, Jaume; Garcia-Cazorla, Angels; Vaquerizo, Julian; Riudor, Encarnacio; Briones, Paz; Elpeleg, Orly; Ribes, Antonia; Lill, Roland			A Fatal Mitochondrial Disease Is Associated with Defective NFU1 Function in the Maturation of a Subset of Mitochondrial Fe-S Proteins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IRON-SULFUR CLUSTER; SCAFFOLD PROTEIN; LIPOIC ACID; ISCU; BIOGENESIS; FERREDOXIN; ACONITASE; 4FE-4S; HOMEOSTASIS; ACTIVATION	We report on ten individuals with a fatal infantile encephalopathy and/or pulmonary hypertension, leading to death before the age of 15 months. Hyperglycinemia and lactic acidosis were common findings. Glycine cleavage system and pyruvate dehydrogenase complex (PDHC) activities were low. Homozygosity mapping revealed a perfectly overlapping homozygous region of 1.24 Mb corresponding to chromosome 2 and led to the identification of a homozygous missense mutation (c.622G>T) in NFU1, which encodes a conserved protein suggested to participate in Fe-S cluster biogenesis. Nine individuals were homozygous for this mutation, whereas one was compound heterozygous for this and a splice-site (c.545+5G>A) mutation. The biochemical phenotype suggested an impaired activity of the Fe-S enzyme lipoic acid synthase (LAS). Direct measurement of protein-bound lipoic acid in individual tissues indeed showed marked decreases. Upon depletion of NFU1 by RNA interference in human cell culture, LAS and, in turn, PDHC activities were largely diminished. In addition, the amount of succinate dehydrogenase, but no other Fe-S proteins, was decreased. In contrast, depletion of the general Fe-S scaffold protein ISCU severely affected assembly of all tested Fe-S proteins, suggesting that NFU1 performs a specific function in mitochondrial Fe-S cluster maturation. Similar biochemical effects were observed in Saccharomyces cerevisiae upon deletion of NFU1, resulting in lower lipoylation and SDH activity. Importantly, yeast Nfu1 protein carrying the individuals' missense mutation was functionally impaired. We conclude that NFU1 functions as a late-acting maturation factor for a subset of mitochondrial Fe-S proteins.	[Navarro-Sastre, Aleix; Tort, Frederic; Font, Aida; Garcia-Villoria, Judit; Briones, Paz; Ribes, Antonia] Inst Invest Biomed Pi Sunyer, Hosp Clin, Dept Biochem & Mol Genet, Div Inborn Errors Metab, Barcelona 08028, Spain; [Navarro-Sastre, Aleix; Tort, Frederic; Font, Aida; Garcia-Villoria, Judit; Merinero, Begona; Ugarte, Magdalena; Campistol, Jaume; Garcia-Cazorla, Angels; Briones, Paz; Ribes, Antonia] Ctr Invest Biomed Red Enfermedades Raras, Barcelona 08028, Spain; [Stehling, Oliver; Uzarska, Marta A.; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35033 Marburg, Germany; [Antonio Arranz, Jose; Riudor, Encarnacio] Hosp Valle De Hebron, Metab Lab, Barcelona 08035, Spain; [del Toro, Mireia] Hosp Valle De Hebron, Dept Pediat Neurol, Barcelona 08035, Spain; [Teresa Labayru, M.] Hosp Cruces, Dept Pediat, Bilbao 48903, Spain; [Landa, Joseba] Hosp Ntra Sra de Aranzazu, Dept Pediat, San Sebastian 20017, Spain; [Merinero, Begona; Ugarte, Magdalena] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Ctr Diagnost Enfermedades Mol, E-28049 Madrid, Spain; [Gonzalez Gutierrez-Solana, Luis] Hosp Nino Jesus, Dept Pediat, Madrid 28009, Spain; [Campistol, Jaume; Garcia-Cazorla, Angels] Hosp St Joan de Deu, Dept Neurol, Barcelona 08950, Spain; [Vaquerizo, Julian] Hosp Materno Infantil Infanta Cristina, Dept Pediat, Badajoz 06007, Spain; [Briones, Paz] CSIC, E-08028 Barcelona, Spain; [Elpeleg, Orly] Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Philipps University Marburg; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitario Cruces; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC)	Ribes, A (corresponding author), IDIBAPS Mejia Lequerica, Hosp Clin, Dept Biochem & Mol Genet, Div Inborn Errors Metab, S-N Helios 3, Barcelona 08028, Spain.	aribes@clinic.ub.es; lill@staff.uni-marburg.de	Garcia, Judit/AAN-1753-2021	Garcia Villoria, Judit/0000-0003-2132-4138; Tort, Frederic/0000-0003-2733-1603; Lill, Roland/0000-0002-8345-6518; Ribes Rubio, Antonia/0000-0002-2249-246X	Centro de Investigacion Biomedica En Red de Enfermedades Raras (CIBERER) an initiative of the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, Spain); Association Francaise contre Myopathie; Israeli Ministry of Health; Deutsche Forschungsgemeinschaft [SFB 593, GRK 1216]; von Behring-Rontgen Stiftung; state Hessen; Max-Planck Gesellschaft;  [FIS PI08/90348];  [FIS PI08/0307]	Centro de Investigacion Biomedica En Red de Enfermedades Raras (CIBERER) an initiative of the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Association Francaise contre Myopathie; Israeli Ministry of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Rontgen Stiftung; state Hessen; Max-Planck Gesellschaft(Max Planck Society); ; 	We are grateful to the families involved in this study and for helpful discussion with U. Muhlenhoff. This research was supported in part by Centro de Investigacion Biomedica En Red de Enfermedades Raras (CIBERER), an initiative of the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, Spain), and by the grants FIS PI08/90348 and FIS PI08/0307. We acknowledge the technical support of Angela Arias, Carlota Ogg, Sonia Moliner, and Patricia Alcala. O.E. acknowledges the support of the Association Francaise contre Myopathie and the Israeli Ministry of Health. R.L. acknowledges generous support from Deutsche Forschungsgemeinschaft (SFB 593 and GRK 1216), von Behring-Rontgen Stiftung, the LOEWE program of state Hessen, and Max-Planck Gesellschaft. Thanks are due to M.O. Rolland and C. Acquaviva (Hospices des Civils de Lyon) for glycine cleavage system analysis. Part of this work has been performed in the context of the PhD program of the Autonomous University of Barcelona.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; [Anonymous], HOMOLOGENE; [Anonymous], CLUSTALW2; [Anonymous], POLYPHEN PREDICTION; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Booker SJ, 2007, CURR OPIN CHEM BIOL, V11, P543, DOI 10.1016/j.cbpa.2007.08.028; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; DURAN M, 1984, J INHERIT METAB DIS, V7, P61, DOI 10.1007/BF01805803; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; GenBank, GENBANK; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Muhlenhoff U, 2007, EUKARYOT CELL, V6, P495, DOI 10.1128/EC.00191-06; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Padmalayam I, 2009, DIABETES, V58, P600, DOI 10.2337/db08-0473; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Rodriguez-Ezpeleta N, 2010, HUM GENET, V128, P113, DOI 10.1007/s00439-010-0833-4; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Seyda A, 2001, AM J HUM GENET, V68, P386, DOI 10.1086/318196; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stehling O, 2009, METHOD ENZYMOL, V456, P209, DOI 10.1016/S0076-6879(08)04412-1; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yeh AP, 2000, J MOL BIOL, V300, P587, DOI 10.1006/jmbi.2000.3871; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599	42	204	214	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					656	667		10.1016/j.ajhg.2011.10.005	http://dx.doi.org/10.1016/j.ajhg.2011.10.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22077971	Green Published, Bronze			2022-12-18	WOS:000297090100008
J	CHEN, X; PROSSER, R; SIMONETTI, S; SADLOCK, J; JAGIELLO, G; SCHON, EA				CHEN, X; PROSSER, R; SIMONETTI, S; SADLOCK, J; JAGIELLO, G; SCHON, EA			REARRANGED MITOCHONDRIAL GENOMES ARE PRESENT IN HUMAN OOCYTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MARROW-PANCREAS SYNDROME; DNA DELETIONS; TANDEM DUPLICATION; PARKINSONS-DISEASE; DIABETES-MELLITUS; COPY NUMBER; MTDNA; ORGANIZATION	Using quantitative PCR, we have determined that a human oocyte contains similar to 100,000 mitochondrial genomes (mtDNAs). We have also found that some oocytes harbor measurable levels (up to 0.1%) of the so-called common deletion, an mtDNA molecule containing a 4,977-bp rearrangement that is present in high amounts in many patients with ''sporadic'' Kearns-Sayre syndrome (KSS) and progressive external ophthalmoplegia (PEO). This is the first demonstration that rearranged mtDNAs are present in human oocytes, and it provides experimental support for the supposition that pathogenic deletions associated with the ontogeny of sporadic KSS and PEO can be transmitted in the female germ line, from mother to child. The relevance of these findings to the accumulation of extremely low levels of deleted mtDNAs in both somatic and germ-line tissues during normal human aging is also discussed.	COLUMBIA UNIV,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT OBSTET & GYNECOL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,CTR REPROD SCI,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Columbia University								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BAUMER A, 1994, AM J HUM GENET, V54, P618; BAVISTER BD, 1989, GAMETE RES, V23, P139, DOI 10.1002/mrd.1120230202; BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X; BIRKY CW, 1983, SCIENCE, V222, P468, DOI 10.1126/science.6353578; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; CHEN X, 1993, B MOL BIOL MED, V18, P57; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; CUMMINS JM, 1994, MOL REPROD DEV, V37, P345, DOI 10.1002/mrd.1080370314; DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; HANDYSIDE AH, 1989, LANCET, V1, P347; Hauswirth W. W., 1985, ACHIEVEMENTS PERSPEC, P49; HOWELL N, 1992, HUM GENET, V90, P117; IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B; KOEHLER CM, 1991, GENETICS, V129, P247; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; LARSSON NG, 1992, AM J HUM GENET, V50, P360; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; Nagley Phillip, 1993, P137; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; ROTIG A, 1992, AM J HUM GENET, V50, P364; ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C; SANDY MS, 1993, MOVEMENT DISORD, V8, P74, DOI 10.1002/mds.870080114; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100; SCHON EA, 1991, MOL GENETIC APPROACH, P57; SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24; SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V; Veeck LL, 1991, ATLAS HUMAN OOCYTE E, V2; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7	43	204	214	0	9	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					239	247						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668249				2022-12-18	WOS:A1995RL77100006
J	KORENBERG, JR; KAWASHIMA, H; PULST, SM; IKEUCHI, T; OGASAWARA, N; YAMAMOTO, K; SCHONBERG, SA; WEST, R; ALLEN, L; MAGENIS, E; IKAWA, K; TANIGUCHI, N; EPSTEIN, CJ				KORENBERG, JR; KAWASHIMA, H; PULST, SM; IKEUCHI, T; OGASAWARA, N; YAMAMOTO, K; SCHONBERG, SA; WEST, R; ALLEN, L; MAGENIS, E; IKAWA, K; TANIGUCHI, N; EPSTEIN, CJ			MOLECULAR DEFINITION OF A REGION OF CHROMOSOME-21 THAT CAUSES FEATURES OF THE DOWN-SYNDROME PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048; KANAZAWA UNIV,KANAZAWA,ISHIKAWA 920,JAPAN; ISHIKAWA HLTH SERV,KANAZAWA,JAPAN; TOKYO MED & DENT UNIV,BUNKYO KU,TOKYO 113,JAPAN; AICHI PREFECTURAL COLONY,INST DEV RES,KASUGAI,AICHI 48003,JAPAN; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; OREGON HLTH SCI UNIV,PORTLAND,OR 97201	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Kanazawa University; Tokyo Medical & Dental University (TMDU); University of California System; University of California San Francisco; Oregon Health & Science University					NIA NIH HHS [AG-08938] Funding Source: Medline; NICHD NIH HHS [HD-17001] Funding Source: Medline; PHS HHS [MCH 920] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD017001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG008938] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AVRAHAM KB, 1988, CELL, V54, P23; DANIEL A, 1979, J MED GENET, V16, P227, DOI 10.1136/jmg.16.3.227; DUTRILLAUX B, 1973, ANN GENET-PARIS, V16, P11; ELROYSTEIN O, 1988, CELL, V52, P259, DOI 10.1016/0092-8674(88)90515-6; Epstein C.J, 1986, CONSEQUENCES CHROMOS; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; EPSTEIN CJ, IN PRESS AM J MED GE; FRYNS JP, 1981, ANN GENET-PARIS, V24, P187; HARNDEN DG, 1985, BIRTH DEFECTS; HURET JL, 1987, HUM GENET, V75, P251, DOI 10.1007/BF00281069; JACKSON JF, 1976, CLIN GENET, V9, P483; KORENBERG J R, 1986, American Journal of Human Genetics, V39, pA119; KORENBERG J R, 1988, American Journal of Human Genetics, V43, pA110; KORENBERG JR, 1988, CLIN RES, V36, pA404; KORENBERG JR, 1987, AM J HUM GENET, V41, P963; KORENBERG JR, 1989, GENOMICS, V5, P124, DOI 10.1016/0888-7543(89)90095-5; KORENBERG JR, IN PRESS HUM GENET; MAGENIS RE, 1985, HUM GENET, V69, P300, DOI 10.1007/BF00291645; Maniatis T., 1982, MOL CLONING; MATTEI JF, 1981, HUM GENET, V56, P409, DOI 10.1007/BF00274703; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MITCHELL JA, 1981, AM J MED GENET, V8, P3; MIYAZAKI K, 1987, CLIN GENET, V32, P383; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; PARK JP, 1987, CLIN GENET, V32, P342; PATTERSON D, 1988, P NATL ACAD SCI USA, V85, P8266, DOI 10.1073/pnas.85.21.8266; POISSONNIER M, 1976, ANN GENET-PARIS, V19, P69; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; SINET PM, 1976, EXP CELL RES, V97, P47, DOI 10.1016/0014-4827(76)90653-4; STAMBERG J, 1982, CLIN GENET, V21, P125; SUMMITT RL, 1981, TRISOMY, V21, P225; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267	34	204	207	0	15	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					236	246						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2143053				2022-12-18	WOS:A1990DT87100008
J	Ali, M; McKibbin, M; Booth, A; Parry, DA; Jain, P; Riazuddin, SA; Hejtmancik, JF; Khan, SN; Firasat, S; Shires, M; Gilmour, DF; Towns, K; Murphy, AL; Azmanov, D; Tournev, I; Cherninkova, S; Jafri, H; Raashid, Y; Toomes, C; Craig, J; Mackey, DA; Kalaydjieva, L; Riazuddin, S; Inglehearn, CF				Ali, Manir; McKibbin, Martin; Booth, Adam; Parry, David A.; Jain, Payal; Riazuddin, S. Amer; Hejtmancik, J. Fielding; Khan, Shaheen N.; Firasat, Sabika; Shires, Mike; Gilmour, David F.; Towns, Katherine; Murphy, Anna-Louise; Azmanov, Dimitar; Tournev, Ivailo; Cherninkova, Sylvia; Jafri, Hussain; Raashid, Yasmin; Toomes, Carmel; Craig, Jamie; Mackey, David A.; Kalaydjieva, Luba; Riazuddin, Sheikh; Inglehearn, Chris F.			Null Mutations in LTBP2 Cause Primary Congenital Glaucoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; LATENT TGF-BETA; GENOME-WIDE SCAN; BINDING-PROTEIN; DEVELOPMENTAL EXPRESSION; GENETIC-HETEROGENEITY; CYTOCHROME P4501B1; MOLECULAR-CLONING; MARFAN-SYNDROME; CYP1B1	Primary congenital glaucoma (PCG) is an autosomal-recessive condition characterized by high intraocular pressure (IOP), usually within the first year of life, which potentially could lead to optic nerve damage, globe enlargement, and permanent loss of vision. To date, PCG has been linked to three loci: 2p21 (GLC3A), for which the responsible gene is CYP1B1, and 1p36 (GLC3B) and 14q24 (GLC3C), for which the genes remain to be identified. Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity. LTBP2 maps to chromosome 14q24.3 but is around 1.3 Mb proximal to the documented GLC3C locus. Therefore, it remains to be determined whether LTBP2 is the GLC3C gene or whether a second adjacent gene is also implicated in PCG. LTBP2 is the largest member of the latent transforming growth factor (TGF)-beta binding protein family, which are extracellular matrix proteins with multidomain structure. It has homology to fibrillins and may have roles in cell adhesion and as a structural component of microfibrils. We confirmed localization of LTBP2 in the anterior segment of the eye, at the ciliary body, and particularly the ciliary process. These findings reveal that LTBP2 is essential for normal development of the anterior chamber of the eye, where it may have a structural role in maintaining ciliary muscle tone.	[Ali, Manir; McKibbin, Martin; Booth, Adam; Parry, David A.; Jain, Payal; Shires, Mike; Gilmour, David F.; Towns, Katherine; Murphy, Anna-Louise; Toomes, Carmel; Inglehearn, Chris F.] Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [McKibbin, Martin; Gilmour, David F.] St James Univ Hosp, Eye Dept, Leeds LS9 7TF, W Yorkshire, England; [Booth, Adam] Peninsula Med Sch, Plymouth PL6 8BU, Devon, England; [Riazuddin, S. Amer; Khan, Shaheen N.; Firasat, Sabika; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, Bethesda, MD 20892 USA; [Azmanov, Dimitar; Kalaydjieva, Luba] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Perth, WA 6009, Australia; [Tournev, Ivailo; Cherninkova, Sylvia] Med Univ, Dept Neurol, Sofia 1431, Bulgaria; [Jafri, Hussain] Gene Tech Lab, Lahore 54000, Pakistan; [Raashid, Yasmin] King Edward Med Univ, Dept Obstet & Gynaecol, Lahore 54000, Pakistan; [Craig, Jamie] Flinders Med Ctr, Dept Ophthalmol, Bedford Pk, SA 5042, Australia	University of Leeds; Saint James's University Hospital; University of Plymouth; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Western Australia; Lions Eye Institute; University of Western Australia; Medical University Sofia; Flinders Medical Centre	Ali, M (corresponding author), Univ Leeds, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	medma@leeds.ac.uk	Firasat, Sabika/AAW-4775-2021; Inglehearn, Chris/GYD-9783-2022; Nasim Khan, Shaheen/F-2135-2015; Ali, Manir/ABE-5251-2020; Mackey AO, David/H-5340-2014	Firasat, Sabika/0000-0003-4959-7832; Ali, Manir/0000-0003-3204-3788; Parry, David/0000-0003-0376-7736; Craig, Jamie/0000-0001-9955-9696; Mackey AO, David/0000-0001-7914-4709; Toomes, Carmel/0000-0001-8373-9545	MRC [G0501050]; Yorkshire Eye Research [009]; Higher Education Commission (Islamabad, Pakistan); Ministry of Science and Technology (Islamabad, Pakistan); Australia India Strategic Research Fund [BF020055]; COMSTECH.EMRO project of the World Health Organization [GH 06-0724]; Medical Research Council [G0501050] Funding Source: researchfish; NATIONAL EYE INSTITUTE [ZIAEY000272, Z01EY000272] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Yorkshire Eye Research; Higher Education Commission (Islamabad, Pakistan)(Higher Education Commission of Pakistan); Ministry of Science and Technology (Islamabad, Pakistan); Australia India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science); COMSTECH.EMRO project of the World Health Organization; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the families for their support and cooperation in this work. This research was supported by the MRC (grant G0501050), the Yorkshire Eye Research (grant 009), the Higher Education Commission (Islamabad, Pakistan), the Ministry of Science and Technology (Islamabad, Pakistan), the Australia India Strategic Research Fund (grant BF020055), and the COMSTECH.EMRO project of the World Health Organization (No., RAB and GH 06-0724). C.T. is a Royal Society University Research Fellow.	Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; Anderson D R, 1981, Trans Am Ophthalmol Soc, V79, P458; Buys Y, 2008, ACTA OPHTHALMOL, V86, P124, DOI 10.1111/j.1755-3768.2008.01219.x; Challa P, 2006, MOL VIS, V12, P1009; Cheung CL, 2008, J CLIN ENDOCR METAB, V93, P4448, DOI 10.1210/jc.2007-2836; Dandona L, 1998, ARCH OPHTHALMOL-CHIC, V116, P545, DOI 10.1001/archopht.116.4.514; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; EPSTEIN DL, 1997, CHANDLER GRANTS GLAU, P22; Fang JM, 1997, BBA-GENE STRUCT EXPR, V1354, P219, DOI 10.1016/S0167-4781(97)00104-8; Firasat S, 2008, MOL VIS, V14, P1659; FRANCOIS J, 1980, OPHTHALMOLOGICA, V181, P61, DOI 10.1159/000309028; GENCIK A, 1982, HUM GENET, V61, P193, DOI 10.1007/BF00296440; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; GRIERSON I, 1978, BRIT J OPHTHALMOL, V62, P302, DOI 10.1136/bjo.62.5.302; Hancock Ian, 2000, SCHOLARSHIP GYPSY ST, P1; Hewitt AW, 2006, CLIN EXP OPHTHALMOL, V34, P472, DOI 10.1111/j.1442-9071.2006.01268.x; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Ho CL, 2004, J PEDIAT OPHTH STRAB, V41, P271, DOI 10.3928/01913913-20040901-11; Izquierdo N J, 1992, Trans Am Ophthalmol Soc, V90, P111; Jaafar MS, 1988, CARE INFANTILE GLAUC, V7, P15; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KOUSSEFF BG, 1980, ACTA PAEDIATR BELG, V33, P57; KUPFER C, 1979, AM J OPHTHALMOL, V88, P424, DOI 10.1016/0002-9394(79)90643-3; Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Nemesure B, 2003, HUM GENET, V112, P600, DOI 10.1007/s00439-003-0910-z; PFEIFFER RA, 1973, HUMANGENETIK, V20, P187, DOI 10.1007/BF00284860; Rotimi CN, 2006, INVEST OPHTH VIS SCI, V47, P3262, DOI 10.1167/iovs.05-1537; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; Schlotzer-Schrehardt U, 2001, EXP EYE RES, V73, P765, DOI 10.1006/exer.2001.1084; Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000; Sivadorai P, 2008, CLIN GENET, V74, P82, DOI 10.1111/j.1399-0004.2008.01024.x; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; TANDON PN, 1989, MATH BIOSCI, V93, P53, DOI 10.1016/0025-5564(89)90013-8; Vehvilainen P, 2003, J BIOL CHEM, V278, P24705, DOI 10.1074/jbc.M212953200; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109	41	203	211	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					664	671		10.1016/j.ajhg.2009.03.017	http://dx.doi.org/10.1016/j.ajhg.2009.03.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19361779	Bronze, Green Published			2022-12-18	WOS:000266338800011
J	Beecham, GW; Martin, ER; Li, YJ; Slifer, MA; Gilbert, JR; Haines, JL; Pericak-Vance, MA				Beecham, Gary W.; Martin, Eden R.; Li, Yi-Ju; Slifer, Michael A.; Gilbert, John R.; Haines, Jonathan L.; Pericak-Vance, Margaret A.			Genome-wide Association Study Implicates a Chromosome 12 Risk Locus for Late-Onset Alzheimer Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LR11/SORLA EXPRESSION; APOLIPOPROTEIN-E; CANDIDATE GENES; LINKAGE PHASE; SORL1; HAPLOTYPE; MEMORY; DISC1; TESTS; SCHIZOPHRENIA	Only Apolipoprotein E polymorphisms have been consistently associated with the risk of late-onset Alzheimer disease (LOAD), but they represent only a minority of the underlying genetic effect. To identify additional LOAD risk loci, we performed a genome-wide association study (GWAS) on 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip. An additional 238 cases and 220 controls were used as a validation data set for single-nucleotide polymorphisms (SNPs) that met genome-wide significance. To validate additional associated SNPs (p < 0.0001) and nominally associated candidate genes, we imputed SNPs from our GWAS using a previously published LOAD GWAS(1) and the IMPUTE program. Association testing was performed with the Cochran-Armitage trend test and logistic regression, and genome-wide significance was determined with the False Discovery Rate-Beta Uniform Mixture method. Extensive quality-control methods were performed at both the sample and the SNP level. The GWAS confirmed the known APOE association and identified association with a 12q13 locus at genome-wide significance; the 12q13 locus was confirmed in our validation data set. Four additional highly associated signals (1q42, 4q28, 6q14, 19q13) were replicated with the use of the imputed data set, and six candidate genes had SNPs with nominal association in both the GWAS and the joint imputated data set. These results help to further define the genetic architecture of LOAD.	[Beecham, Gary W.; Martin, Eden R.; Slifer, Michael A.; Gilbert, John R.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33101 USA; [Li, Yi-Ju] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; [Li, Yi-Ju] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Human Genet Res, Nashville, TN 37232 USA	University of Miami; Duke University; Duke University; Vanderbilt University	Pericak-Vance, MA (corresponding author), Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33101 USA.	mpericak@med.miami.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Li, Yi-Ju/0000-0001-6996-4834	National Institute on Aging [AG20135, AG19757]; National Institute of Neurological Disorders and Stroke [NS31153]; National Institutes of Health; Alzheimer's Association; Institut de France; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, R01AG019757, R01AG027944, R01AG020135] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Institut de France; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the AD patients and their families for participating in our study. We also thank the clinical and research staff of the Miami Institute for Human Genomics and the Vanderbilt Center for Human Genetics Research; particularly Paul Gallins, Carol Haynes, Chris Potocky, Karen Soldano, Heidi Munger, Simon Gregory, and Susan Slifer. This work was supported by the National Institute on Aging (grants AG20135 and AG19757) and the National Institute of Neurological Disorders and Stroke (grant NS31153), both of the National Institutes of Health; the Alzheimer's Association; and the Louis D. Scientific Award of the Institut de France. A subset of the participants was ascertained while M.A.P.-V. was a faculty member at Duke University.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERGEM ALM, 1994, CLIN GENET, V46, P144; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bettens K, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20725; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gezen-Ak D, 2007, TOHOKU J EXP MED, V212, P275, DOI 10.1620/tjem.212.275; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hennah W, 2005, MOL PSYCHIATR, V10, P1097, DOI 10.1038/sj.mp.4001731; HERBERT A, 2006, OBESITY SILVER SPRIN, V8, P1454; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lange C, 2004, STAT MED, V23, P179, DOI 10.1002/sim.1707; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Li Y, 2008, NEUROBIOL DIS, V29, P293, DOI 10.1016/j.nbd.2007.09.001; Liang X, 2006, MOL PSYCHIATR, V11, P280, DOI 10.1038/sj.mp.4001766; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Luedecking EK, 2000, HUM GENET, V106, P565, DOI 10.1007/s004390050026; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mayeux R, 2002, AM J HUM GENET, V70, P237, DOI 10.1086/324773; Mayeux R, 2008, LANCET NEUROL, V7, P2, DOI 10.1016/S1474-4422(07)70298-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Minster RL, 2008, NEUROSCI LETT, V440, P190, DOI 10.1016/j.neulet.2008.05.082; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P53, DOI 10.1001/archgenpsychiatry.2007.15; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Przybelski RJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P202, DOI 10.1016/j.abb.2006.12.018; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Rodriguez-Rodriguez E., 2007, NEUROBIOL AGING, V30, P322; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; RYCKMANN K, 2008, CURR PROTOC HUM GENE; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shibata N, 2008, DEMENT GERIATR COGN, V26, P161, DOI 10.1159/000149821; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Taguchi K, 2005, ANN NEUROL, V57, P585, DOI 10.1002/ana.20433; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Zhao YH, 2007, NEUROREPORT, V18, P1187, DOI 10.1097/WNR.0b013e32821c56c4	57	203	211	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					35	43		10.1016/j.ajhg.2008.12.008	http://dx.doi.org/10.1016/j.ajhg.2008.12.008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19118814	Bronze, Green Published			2022-12-18	WOS:000262679500004
J	Bykhovskaya, Y; Casas, K; Mengesha, E; Inbal, A; Fischel-Ghodsian, N				Bykhovskaya, Y; Casas, K; Mengesha, E; Inbal, A; Fischel-Ghodsian, N			Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED DYSKERATOSIS-CONGENITA; HOYERAAL-HREIDARSSON-SYNDROME; RIBOSOMAL-RNA; GENE; DKC1; IDENTIFICATION; SEQUENCES; CLONING; OVERLAP	Mitochondrial myopathy and sideroblastic anemia (MLASA) is a rare, autosomal recessive oxidative phosphorylation disorder specific to skeletal muscle and bone marrow. Linkage analysis and homozygosity testing of two families with MLASA localized the candidate region to 1.2 Mb on 12q24.33. Sequence analysis of each of the six known genes in this region, as well as four putative genes with expression in bone marrow or muscle, identified a homozygous missense mutation in the pseudouridine synthase 1 gene (PUS1) in all patients with MLASA from these families. The mutation is the only amino acid coding change in these 10 genes that is not a known polymorphism, and it is not found in 934 controls. The amino acid change affects a highly conserved amino acid, and appears to be in the catalytic center of the protein, PUS1p. PUS1 is widely expressed, and quantitative expression analysis of RNAs from liver, brain, heart, bone marrow, and skeletal muscle showed elevated levels of expression in skeletal muscle and brain. We propose deficient pseudouridylation of mitochondrial tRNAs as an etiology of MLASA. Identification of the pathophysiologic pathways of the mutation in these families may shed light on the tissue specificity of oxidative phosphorylation disorders.	Cedars Sinai Med Ctr, Ahmanson Dept Pediat, Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Med Genet Birth Defects Ctr, Los Angeles, CA 90048 USA; Sheba Med Ctr, Inst Thrombosis & Hemostasis, Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Fischel-Ghodsian, N (corresponding author), Cedars Sinai Med Ctr, Ahmanson Dept Pediat, Steven Spielberg Pediat Res Ctr, 8700 Beverly Blvd,Suite 1165 WT, Los Angeles, CA 90048 USA.	nathan.fischel@cshs.org		Mengesha, Emebet/0000-0001-7830-1557	NIDCD NIH HHS [R01 DC001402, R01DC01402] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001402] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Betts M. J., 2003, BIOINFORMATICS GENET, DOI 10.1002/0470867302.ch14; CASAS K, IN PRESS AM J MED GE; Casas KA, 2004, AM J MED GENET A, V125A, P201, DOI 10.1002/ajmg.a.20368; Chen JG, 1999, RNA, V5, P409, DOI 10.1017/S1355838299981591; Chen JG, 2000, BIOCHEM J, V352, P465, DOI 10.1042/0264-6021:3520465; Fey J, 2002, GENE, V286, P21, DOI 10.1016/S0378-1119(01)00817-4; Foster PG, 2000, NAT STRUCT BIOL, V7, P23; Grosshans H, 2001, J BIOL CHEM, V276, P46333, DOI 10.1074/jbc.M107141200; Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hellmuth K, 2000, NUCLEIC ACIDS RES, V28, P4604, DOI 10.1093/nar/28.23.4604; Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+; INBAL A, 1995, AM J MED GENET, V55, P372, DOI 10.1002/ajmg.1320550325; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Luzzatto L, 1998, NAT GENET, V19, P6, DOI 10.1038/ng0598-6; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Ramamurthy V, 1999, J BIOL CHEM, V274, P22225, DOI 10.1074/jbc.274.32.22225; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Yaghmai R, 2000, J PEDIATR-US, V136, P390, DOI 10.1067/mpd.2000.104295; ZEVIANI M, 1993, EUR J HUM GENET, V1, P124; Zeviani Massimo, 1993, European Journal of Human Genetics, V1, P80	30	203	211	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1303	1308		10.1086/421530	http://dx.doi.org/10.1086/421530			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15108122	Green Published, Bronze			2022-12-18	WOS:000221651900025
J	Amor, DJ; Choo, KHA				Amor, DJ; Choo, KHA			Neocentromeres: Role in human disease, evolution, and centromere study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							DETECTABLE ALPHA-SATELLITE; ACENTRIC MARKER CHROMOSOME; ENGINEERING HUMAN-CHROMOSOMES; B NULL MICE; PREFERENTIAL SEGREGATION; FUNCTIONAL CENTROMERE; ARTIFICIAL CHROMOSOME; INVERTED DUPLICATION; CYTOGENETIC ANALYSIS; MOSAIC TETRASOMY	The centromere is essential for the proper segregation and inheritance of genetic information. Neocentromeres are ectopic centromeres that originate occasionally from noncentromeric regions of chromosomes. Despite the complete absence of normal centromeric alpha-satellite DNA, human neocentromeres are able to form a primary constriction and assemble a functional kinetochore. Since the discovery and characterization of the first case of a human neocentromere in our laboratory a decade ago, 60 examples of constitutional human neocentromeres distributed widely across the genome have been described. Typically, these are located on marker chromosomes that have been detected in children with developmental delay or congenital abnormalities. Neocentromeres have also been detected in at least two types of human cancer and have been experimentally induced in Drosophila. Current evidence from human and fly studies indicates that neocentromere activity is acquired epigenetically rather than by any alteration to the DNA sequence. Since human neocentromere formation is generally detrimental to the individual, its biological value must lie beyond the individual level, such as in karyotype evolution and speciation.	Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Choo, KHA (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	choo@cryptic.rch.unimelb.edu.au	Amor, David J/A-6478-2018	Amor, David J/0000-0001-7191-8511				Aagaard L, 2000, J CELL SCI, V113, P817; Abeliovich D, 1996, CANCER GENET CYTOGEN, V89, P1, DOI 10.1016/0165-4608(95)00300-2; Ananiev EV, 1998, P NATL ACAD SCI USA, V95, P10785, DOI 10.1073/pnas.95.18.10785; ASSUMPCAO JG, IN PRESS AM J MED GE; Barbi G, 2000, AM J MED GENET, V91, P116, DOI 10.1002/(SICI)1096-8628(20000313)91:2<116::AID-AJMG7>3.0.CO;2-Q; BLENNOW E, 1994, AM J HUM GENET, V54, P877; Bukvic N, 1996, HUM GENET, V97, P453; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Choo KHA, 2001, TRENDS MOL MED, V7, P235, DOI 10.1016/S1471-4914(01)01951-7; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; Choo KHA., 1997, CENTROMERE; Cockwell AE, 2000, J MED GENET, V37, P807, DOI 10.1136/jmg.37.10.807; Conde C, 2001, AM J HUM GENET, V69, P314; Dawe RK, 1999, PLANT CELL, V11, P1227, DOI 10.1105/tpc.11.7.1227; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dufke A, 2001, EUR J HUM GENET, V9, P572, DOI 10.1038/sj.ejhg.5200673; Ebersole TA, 2000, HUM MOL GENET, V9, P1623, DOI 10.1093/hmg/9.11.1623; Floridia G, 2000, CHROMOSOMA, V109, P318, DOI 10.1007/s004120000081; Forus A, 2001, CANCER GENET CYTOGEN, V131, P13, DOI 10.1016/S0165-4608(01)00516-7; Fritz B, 2001, J MED GENET, V38, P559, DOI 10.1136/jmg.38.8.559; GARDNER RJM, 1996, CHROMOSOME ABNORMALI, V2; Gimelli G, 2000, CHROMOSOMA, V109, P328, DOI 10.1007/s004120000082; Gisselsson D, 1998, GENE CHROMOSOME CANC, V23, P203, DOI 10.1002/(SICI)1098-2264(199811)23:3<203::AID-GCC1>3.0.CO;2-5; Gisselsson D, 1999, HUM GENET, V104, P315, DOI 10.1007/s004390050960; GODAY C, 1992, J CELL BIOL, V118, P23, DOI 10.1083/jcb.118.1.23; Grimbacher B, 1999, GENET MED, V1, P213; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; HEIM S, 1987, CANCER GENET CYTOGEN, V24, P319, DOI 10.1016/0165-4608(87)90114-2; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Henning KA, 1999, P NATL ACAD SCI USA, V96, P592, DOI 10.1073/pnas.96.2.592; Hiatt EN, 2002, PLANT CELL, V14, P407, DOI 10.1105/tpc.010373; Higgins RR, 2000, AM J HUM GENET, V67, P149; Hu J, 2001, AM J HUM GENET, V69, P293; Huang B, 1998, AM J MED GENET, V80, P368, DOI 10.1002/(SICI)1096-8628(19981204)80:4<368::AID-AJMG12>3.3.CO;2-2; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; KAISERROGERS KA, 1995, AM J HUM GENET, V57, P658; Kapoor M, 1998, CHROMOSOMA, V107, P570, DOI 10.1007/s004120050343; Levy B, 2000, CYTOGENET CELL GENET, V91, P165, DOI 10.1159/000056839; Li SL, 2002, AM J MED GENET, V110, P258, DOI 10.1002/ajmg.10454; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Maggert KA, 2001, GENETICS, V158, P1615; Maraschio P, 1996, HUM GENET, V97, P382; Morrissette JJD, 2001, AM J MED GENET, V99, P21, DOI 10.1002/1096-8628(20010215)99:1<21::AID-AJMG1122>3.0.CO;2-X; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; OHASHI H, 1994, AM J HUM GENET, V55, P1202; PEACOCK WJ, 1981, P NATL ACAD SCI-BIOL, V78, P4490, DOI 10.1073/pnas.78.7.4490; PEDEUTOUR F, 1994, GENE CHROMOSOME CANC, V10, P85, DOI 10.1002/gcc.2870100203; Pedeutour F, 1999, GENE CHROMOSOME CANC, V24, P30, DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; Petit P, 1997, GENET COUNSEL, V8, P341; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Portnoi MF, 1999, J MED GENET, V36, P246; Ravnan JB, 1999, AM J HUM GENET, V65, pA356; Reddy KS, 2000, AM J MED GENET, V92, P69, DOI 10.1002/(SICI)1096-8628(20000501)92:1<69::AID-AJMG12>3.0.CO;2-O; RHOADES MM, 1966, GENETICS, V53, P989; Rhoades MM, 1942, GENETICS, V27, P0395; RHOADES MM, 1950, J HERED, V41, P58, DOI 10.1093/oxfordjournals.jhered.a106089; Rivera H, 1996, ANN GENET-PARIS, V39, P236; Rivera H, 1999, AM J MED GENET, V85, P385, DOI 10.1002/(SICI)1096-8628(19990806)85:4<385::AID-AJMG15>3.0.CO;2-P; Rooades MM, 1942, P NATL ACAD SCI USA, V28, P433, DOI 10.1073/pnas.28.10.433; Rosai J, 1996, AM J SURG PATHOL, V20, P1182, DOI 10.1097/00000478-199610000-00002; Rowe AG, 2000, AM J MED GENET, V93, P393, DOI 10.1002/1096-8628(20000828)93:5<393::AID-AJMG9>3.0.CO;2-Z; Rubin BP, 1997, HISTOPATHOLOGY, V30, P507, DOI 10.1046/j.1365-2559.1997.5680797.x; Sacchi N, 1996, CYTOGENET CELL GENET, V73, P123, DOI 10.1159/000134322; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Saffery R, 2002, J GENE MED, V4, P5, DOI 10.1002/jgm.236; Saffery R, 2001, P NATL ACAD SCI USA, V98, P5705, DOI 10.1073/pnas.091468498; Satinover DL, 2001, CHROMOSOMA, V110, P275, DOI 10.1007/s004120100143; Satinover DL, 2001, AM J HUM GENET, V69, P215; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shen MH, 2001, CHROMOSOMA, V110, P421, DOI 10.1007/s004120100160; Sirvent N, 2000, GENE CHROMOSOME CANC, V29, P117, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1014>3.0.CO;2-Q; Slater HR, 1999, J MED GENET, V36, P914; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SPIEGEL M, IN PRESS AM J MED GE; SREEKANTAIAH C, 1992, CANCER, V69, P2484; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Sulcova V, 1999, AM J HUM GENET, V65, pA358; Teshima I, 2000, AM J MED GENET, V94, P113, DOI 10.1002/1096-8628(20000911)94:2<113::AID-AJMG3>3.0.CO;2-Q; Tyler-Smith C, 1998, CHROMOSOME RES, V6, P65; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Vance GH, 1997, AM J MED GENET, V71, P436, DOI 10.1002/(SICI)1096-8628(19970905)71:4<436::AID-AJMG13>3.0.CO;2-H; VandenEnden A, 1996, AM J MED GENET, V63, P482, DOI 10.1002/(SICI)1096-8628(19960614)63:3<482::AID-AJMG13>3.0.CO;2-I; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Voullaire L, 1999, AM J MED GENET, V85, P403, DOI 10.1002/(SICI)1096-8628(19990806)85:4<403::AID-AJMG18>3.3.CO;2-I; Voullaire L, 2001, AM J MED GENET, V102, P86, DOI 10.1002/1096-8628(20010722)102:1<86::AID-AJMG1390>3.0.CO;2-T; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; Wandall A, 1998, CHROMOSOMA, V107, P359, DOI 10.1007/s004120050319; Warburton PE, 2000, AM J HUM GENET, V66, P1794, DOI 10.1086/302924; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Weiss S W, 1996, Monogr Pathol, V38, P207; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30; Winters J, 2000, AM J HUM GENET, V67, P153; Yu HG, 1997, J CELL BIOL, V139, P831, DOI 10.1083/jcb.139.4.831; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	99	203	215	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					695	714		10.1086/342730	http://dx.doi.org/10.1086/342730			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12196915	Green Published, Bronze			2022-12-18	WOS:000178613800001
J	Lynch, ED; Ostermeyer, EA; Lee, MK; Arena, JF; Ji, HL; Dann, J; Swisshelm, K; Suchard, D; MacLeod, PM; Kvinnsland, S; Gjertsen, BT; Heimdal, K; Lubs, H; Moller, P; King, MC				Lynch, ED; Ostermeyer, EA; Lee, MK; Arena, JF; Ji, HL; Dann, J; Swisshelm, K; Suchard, D; MacLeod, PM; Kvinnsland, S; Gjertsen, BT; Heimdal, K; Lubs, H; Moller, P; King, MC			Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLATIONAL TERMINATION CODON; MESSENGER-RNA DEGRADATION; GENES	PTEN, a protein tyrosine phosphatase with homology to tensin, is a tumor-suppressor gene on chromosome 10q23. Somatic mutations in PTEN occur in multiple tumors, most markedly glioblastomas. Germ-line mutations in PTEN are responsible for Cowden disease (CD), a rare autosomal dominant multiple-hamartoma syndrome. PTEN was sequenced from constitutional DNA from 25 families. Germ-line PTEN mutations were detected in all of live families with both breast cancer and CD, in one family with juvenile polyposis syndrome, and in one of four families with breast and thyroid tumors. In this last case, signs of CD were subtle and were diagnosed only in the context of mutation analysis. PTEN mutations were not detected in 13 families at high risk of breast and/or ovarian cancer. No PTEN-coding-sequence polymorphisms were detected in 70 independent chromosomes. Seven PTEN germ-line mutations occurred, five nonsense and two missense mutations, in six of nine PTEN exons. The wild-type PTEN allele was lost from renal, uterine, breast, and thyroid tumors from a single patient. Loss of PTEN expression was an early event, reflected in loss of the wild-type allele in DNA from normal tissue adjacent to the breast and thyroid tumors. In RNA from normal tissues from three families, mutant transcripts appeared unstable. Germ-line PTEN mutations predispose to breast cancer in association with CD, although the signs of CD may be subtle.	Univ Washington, Div Med Genet, Dept Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98195 USA; Univ Miami, Dept Pediat, Miami, FL 33152 USA; Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33152 USA; Victoria Gen Hosp, Genet Sect, Victoria, BC, Canada; Norwegian Radium Hosp, Div Oncol, Unit Med Genet, Oslo, Norway; Sogn & Fjordane Cty Hosp, Forde, Norway; Univ Tromso, Tromso, Norway	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Miami; University of Miami; University of Victoria; University of Oslo; UiT The Arctic University of Tromso	Lynch, ED (corresponding author), Univ Washington, Div Med Genet, Dept Med Genet, K160 Hlth Sci,Box 357720, Seattle, WA 98195 USA.	genemap@u.washington.edu	Heimdal, Ketil Riddervold/H-3038-2019; Gjertsen, Bjørn T/AAP-3281-2020; Gjertsen, Bjorn T/O-1542-2015	Heimdal, Ketil Riddervold/0000-0002-8911-3508; Gjertsen, Bjørn T/0000-0001-9358-9704; Gjertsen, Bjorn T/0000-0001-9358-9704; King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [P30CA014395, R01CA027632] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA27632, P30-CA14395] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBRECHT S, 1992, CANCER-AM CANCER SOC, V70, P869, DOI 10.1002/1097-0142(19920815)70:4<869::AID-CNCR2820700424>3.0.CO;2-E; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Guldberg P, 1997, CANCER RES, V57, P3660; HANSSEN AMN, 1995, J MED GENET, V32, P117, DOI 10.1136/jmg.32.2.117; HENLE W, 1970, COMPARATIVE LEUKEMIA, P706; JONES MH, 1994, GENE CHROMOSOME CANC, V9, P119, DOI 10.1002/gcc.2870090207; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Lhermitte J., 1920, B ASS FR CANC, V9, P99; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; Maquat LE, 1996, AM J HUM GENET, V59, P279; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; MENON KP, 1994, CELL MOL BIOL, V40, P999; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; RASKIND WH, 1984, BLOOD, V63, P1318; Rhei E, 1997, CANCER RES, V57, P3657; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Zedenius J, 1996, HUM GENET, V97, P299, DOI 10.1007/BF02185758	25	203	208	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1254	1260		10.1086/301639	http://dx.doi.org/10.1086/301639			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399897	hybrid, Green Published			2022-12-18	WOS:000071555900007
J	Boycott, KM; Rath, A; Chong, JX; Hartley, T; Alkuraya, FS; Baynam, G; Brookes, AJ; Brudno, M; Carracedo, A; den Dunnen, JT; Dyke, SOM; Estivill, X; Goldblatt, J; Gonthier, C; Groft, SC; Gut, I; Hamosh, A; Hieter, P; Hohn, S; Hurles, ME; Kaufmann, P; Knoppers, BM; Krischer, JP; Macek, M; Matthijs, G; Olry, A; Parker, S; Paschall, J; Philippakis, AA; Rehm, HL; Robinson, PN; Sham, PC; Stefanov, R; Taruscio, D; Unni, D; Vanstone, MR; Zhang, F; Brunner, H; Bamshad, MJ; Lochmuller, H				Boycott, Kym M.; Rath, Ana; Chong, Jessica X.; Hartley, Taila; Alkuraya, Fowzan S.; Baynam, Gareth; Brookes, Anthony J.; Brudno, Michael; Carracedo, Angel; den Dunnen, Johan T.; Dyke, Stephanie O. M.; Estivill, Xavier; Goldblatt, Jack; Gonthier, Catherine; Groft, Stephen C.; Gut, Ivo; Hamosh, Ada; Hieter, Philip; Hoehn, Sophie; Hurles, Matthew E.; Kaufmann, Petra; Knoppers, Bartha M.; Krischer, Jeffrey P.; Macek, Milan, Jr.; Matthijs, Gert; Olry, Annie; Parker, Samantha; Paschall, Justin; Philippakis, Anthony A.; Rehm, Heidi L.; Robinson, Peter N.; Sham, Pak-Chung; Stefanov, Rumen; Taruscio, Domenica; Unni, Divya; Vanstone, Megan R.; Zhang, Feng; Brunner, Han; Bamshad, Michael J.; Lochmueller, Hanns			International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN PHENOTYPE ONTOLOGY; INTELLECTUAL DISABILITY; MATCHMAKER EXCHANGE; IDENTIFICATION; DATABASES; NETWORK; COLLABORATION; INHERITANCE; CHALLENGES; REGISTRIES	Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with rare genetic diseases shortens their "diagnostic odyssey,'' improves disease management, and fosters genetic counseling with respect to recurrence risks while assuring reproductive choices. In a general clinical genetics setting, the current diagnostic rate is approximately 50%, but for those who do not receive a molecular diagnosis after the initial genetics evaluation, that rate is much lower. Diagnostic success for these more challenging affected individuals depends to a large extent on progress in the discovery of genes associated with, and mechanisms underlying, rare diseases. Thus, continued research is required for moving toward a more complete catalog of disease-related genes and variants. The International Rare Diseases Research Consortium (IRDiRC) was established in 2011 to bring together researchers and organizations invested in rare disease research to develop a means of achieving molecular diagnosis for all rare diseases. Here, we review the current and future bottlenecks to gene discovery and suggest strategies for enabling progress in this regard. Each successful discovery will define potential diagnostic, preventive, and therapeutic opportunities for the corresponding rare disease, enabling precision medicine for this patient population.	[Boycott, Kym M.; Hartley, Taila; Vanstone, Megan R.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Rath, Ana; Gonthier, Catherine; Hoehn, Sophie; Olry, Annie; Unni, Divya] Inst Natl Sante Rech Med US14, Orphanet, F-75014 Paris, France; [Chong, Jessica X.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Alkuraya, Fowzan S.] King Faisal Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 11442, Saudi Arabia; [Baynam, Gareth; Goldblatt, Jack] Genet Serv Western Australia, Perth, WA 6008, Australia; [Brookes, Anthony J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Brudno, Michael] Univ Toronto, Dept Comp Sci, Toronto M5S IA1, ON, Canada; [Carracedo, Angel] Galician Fdn Genom Med & Univ Santiago Compostela, Genom Med Grp, Santiago De Compostela 15782, Spain; [den Dunnen, Johan T.] Leiden Univ, Med Ctr, Dept Human Genet & Clin Genet, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Dyke, Stephanie O. M.; Knoppers, Bartha M.] McGill Univ, Fac Med, Ctr Genom & Policy, Dept Human Genet, Montreal, PQ H3A 1A4, Canada; [Estivill, Xavier] Sidra Med & Res Ctr, Expt Div, POB 26999, Doha, Qatar; [Estivill, Xavier] Dexeus Womans Hlth, Genet Unit, Barcelona 08028, Spain; [Groft, Stephen C.] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Gut, Ivo] Univ Pompeu Fabra, Univ Pompeu Fabra, Ctr Nacl Anal Genom, Ctr Genom Regulat, Barcelona 08028, Spain; [Hamosh, Ada] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21286 USA; [Hieter, Philip] Univ British Columbia, Dept Med Genet, Michael Smith Labs, Vancouver, BC V6T IZ4, Canada; [Hurles, Matthew E.; Paschall, Justin] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Kaufmann, Petra] NIH, Natl Ctr Adv Translat Sci, Off Rare Dis Res, Bethesda, MD 20892 USA; [Krischer, Jeffrey P.] Univ S Florida, Hlth Informat Inst, Tampa, FL 33620 USA; [Macek, Milan, Jr.] Charles Univ Prague, Fac Med 2, Dept Biol & Med Genet, Prague 15006, Czech Republic; [Macek, Milan, Jr.] Univ Hosp Motol, Prague 15006, Czech Republic; [Matthijs, Gert] Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Parker, Samantha] Lysogene, F-92200 Neuilly Sur Seine, France; [Philippakis, Anthony A.; Rehm, Heidi L.] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Robinson, Peter N.] Charite Univ Med Berlin, Inst Med Genet & Humangenet, D-13353 Berlin, Germany; [Robinson, Peter N.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Sham, Pak-Chung] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Stefanov, Rumen] Med Univ Plovdiv, Fac Publ Hlth, Dept Social Med & Publ Hlth, Plovdiv 4002, Bulgaria; [Taruscio, Domenica] Ist Super Sanita, Natl Ctr Rare Dis, I-29900161 Rome, Italy; [Zhang, Feng] WuXi AppTec, Waigaoqiao Free Trade Zone, Shanghai 200131, Peoples R China; [Zhang, Feng] WuXi NextCODE, Cambridge, MA 02142 USA; [Brunner, Han] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Brunner, Han] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 GT Maastricht, Netherlands; [Bamshad, Michael J.] Seattle Childrens Hosp, Div Med Genet, Seattle, WA 98105 USA; [Lochmueller, Hanns] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, MRC Ctr Neuromuscular Dis, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of Ottawa; Children's Hospital of Eastern Ontario; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Washington; University of Washington Seattle; University of Leicester; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; McGill University; Sidra Medical & Research Center; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Johns Hopkins University; University of British Columbia; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); State University System of Florida; University of South Florida; Charles University Prague; Motol University Hospital; KU Leuven; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jackson Laboratory; University of Hong Kong; Medical University Plovdiv; Istituto Superiore di Sanita (ISS); Radboud University Nijmegen; Maastricht University; Seattle Children's Hospital; Newcastle University - UK	Boycott, KM (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.	kboycott@cheo.on.ca	Chong, Jessica/GZH-1625-2022; dunnen, johan den/ABH-4228-2020; Stefanov, Rumen/W-7961-2019; Gut, Ivo/ABF-3188-2020; Carracedo, Angel/D-4257-2012; Taruscio, Domenica/A-6646-2015; Estivill, Xavier/A-3125-2013	dunnen, johan den/0000-0002-6304-1710; Stefanov, Rumen/0000-0003-3587-7278; Gut, Ivo/0000-0001-7219-632X; Carracedo, Angel/0000-0003-1085-8986; Chong, Jessica/0000-0002-1616-2448; Taruscio, Domenica/0000-0001-5403-233X; Estivill, Xavier/0000-0002-0723-2256; Matthijs, Gert/0000-0001-6710-1912; Rehm, Heidi L./0000-0002-6025-0015	AFM-Telethon; European Union [677024/RD-ACTION, 305444, 305121]; Care4Rare Canada Consortium; Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; University of Washington Center for Mendelian Genomics though National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute [U54HG006493]; OMIM through NHGRI grant [1U41HG006627]; Baylor-Hopkins Center for Mendelian Genomics through NHGRI grant [1U54HG006542]; Medical Research Council [G1002274, 98482]; Wellcome Trust [201064/Z/16/Z];  [00064203];  [16-30880A];  [15-34904A];  [OPPK CZ.2.16/3.1.00/24022];  [NF-CZ11-PDP-3-003-2014];  [UM1HG008900]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG008900, U54HG006542, UM1HG006493, U41HG006627] Funding Source: NIH RePORTER	AFM-Telethon(Association Francaise contre les Myopathies); European Union(European Commission); Care4Rare Canada Consortium; Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; University of Washington Center for Mendelian Genomics though National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OMIM through NHGRI grant; Baylor-Hopkins Center for Mendelian Genomics through NHGRI grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the present and former staff of the IRDiRC Scientific Secretariat, Segolene Ayme, Lilian Lau, Anneliene Jonker, Antonia Mills, Barbara Cagniard, and members of the scientific committees, working groups, and task forces. We also thank the former chairs of the IRDiRC Therapies Scientific Committee (Yann Le Cam and Josep Torrent i Farnell) for helpful discussions. We thank Rachel Thompson, Emma Heslop, Victoria Hedley, and Lena Dolman for their support. Orphanet was supported in part by funding from AFM-Telethon and the Joint action "677024/RD-ACTION," which received funding from the European Union's Health Programme (2014-2020). T.H. and M.R.V. were supported by the Care4Rare Canada Consortium, funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, and Children's Hospital of Eastern Ontario Foundation. J.X.C. and M.J.B. were supported by the University of Washington Center for Mendelian Genomics though the National Human Genome Research Institute (NHGRI) and National Heart, Lung, and Blood Institute (grant U54HG006493) to Drs. Debbie Nickerson, Michael Bamshad, and Suzanne Leal. A.H. was supported by OMIM through NHGRI grant 1U41HG006627 and the Baylor-Hopkins Center for Mendelian Genomics through NHGRI grant 1U54HG006542 to Drs. David Valle and James Lupski. M.M. was supported by funding from 00064203, 16-30880A, 15-34904A, OPPK CZ.2.16/3.1.00/24022, and NF-CZ11-PDP-3-003-2014. H.L.R. was supported by UM1HG008900. H.L. was supported by funding from the Medical Research Council (reference G1002274, grant 98482), the Wellcome Trust (reference 201064/Z/16/Z), and the European Union Seventh Framework Programme (FP7/2007-2013) under grants 305444 (RD-Connect) and 305121 (NeurOmics).	Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Akle S, 2015, HUM MUTAT, V36, P998, DOI 10.1002/humu.22847; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Allanson JE, 2009, AM J MED GENET A, V149A, P2, DOI 10.1002/ajmg.a.32601; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Au PYB, 2015, HUM MUTAT, V36, P1009, DOI 10.1002/humu.22837; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252; Bladen CL, 2013, HUM MUTAT, V34, P1449, DOI 10.1002/humu.22390; Brookes AJ, 2015, NAT REV GENET, V16, P702, DOI 10.1038/nrg3932; Brownstein CA, 2015, HUM MUTAT, V36, P985, DOI 10.1002/humu.22840; Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851; Buske OJ, 2015, HUM MUTAT, V36, P922, DOI 10.1002/humu.22850; Chatzimichali EA, 2015, HUM MUTAT, V36, P941, DOI 10.1002/humu.22842; Chong JX, 2016, GENET MED, V18, P788, DOI 10.1038/gim.2015.161; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Dyke S.O.M., 2017, HUM MUTAT IN PRESS; Dyke SOM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005772; European Commission, 2009, NAT PLANS STRAT RAR; Evangelista Teresinha, 2015, J Neuromuscul Dis, V2, pS21; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Foley KE, 2015, NAT MED, V21, P1242, DOI 10.1038/nm1115-1242; Gahl WA, 2015, JAMA-J AM MED ASSOC, V314, P1797, DOI 10.1001/jama.2015.12249; Global Alliance Genomics Hlth, 2016, SCIENCE, V352, P1278, DOI 10.1126/science.aaf6162; Gonzalez M, 2015, HUM MUTAT, V36, P950, DOI 10.1002/humu.22836; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Harrison Steven M, 2016, Curr Protoc Hum Genet, V89, DOI 10.1002/0471142905.hg0816s89; Jurgens J, 2015, HUM MUTAT, V36, P1004, DOI 10.1002/humu.22839; Kirkpatrick BE, 2015, HUM MUTAT, V36, P974, DOI 10.1002/humu.22838; Knoppers Bartha Maria, 2014, Hugo J, V8, P3, DOI 10.1186/s11568-014-0003-1; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Krawitz P, 2015, HUM MUTAT, V36, P989, DOI 10.1002/humu.22848; Lambertson KF, 2015, HUM MUTAT, V36, P965, DOI 10.1002/humu.22852; Lancaster O, 2015, HUM MUTAT, V36, P957, DOI 10.1002/humu.22841; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lochmuller H, 2017, EUR J HUM GENET, V25, P162, DOI 10.1038/ejhg.2016.137; Loucks CM, 2015, HUM MUTAT, V36, P1015, DOI 10.1002/humu.22843; Mascalzoni D, 2015, EUR J HUM GENET, V23, P721, DOI 10.1038/ejhg.2014.197; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Mungall CJ, 2015, HUM MUTAT, V36, P979, DOI 10.1002/humu.22857; Peplow M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1757; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Rath Ana, 2014, ORPHANET REPORT SERI; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Shamseldin H.E., 2016, GENET MED; Smedley D, 2016, AM J HUM GENET, V99, P595, DOI 10.1016/j.ajhg.2016.07.005; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003; The Matchmaker Exchange, 2016, MATCHM EXCH TIER INF; Thompson R, 2014, J GEN INTERN MED, V29, pS780, DOI 10.1007/s11606-014-2908-8; Vasant D., 2014, P 22 ANN INT C INT S; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zemojtel T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009262	63	202	207	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2017	100	5					695	705		10.1016/j.ajhg.2017.04.003	http://dx.doi.org/10.1016/j.ajhg.2017.04.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET8OV	28475856	hybrid, Green Published			2022-12-18	WOS:000400560000001
J	Lin, DY; Tang, ZZ				Lin, Dan-Yu; Tang, Zheng-Zheng			A General Framework for Detecting Disease Associations with Rare Variants in Sequencing Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STATISTICAL SIGNIFICANCE; COMMON DISEASES; RISK	Biological and empirical evidence suggests that rare variants account for a large proportion of the genetic contributions to complex human diseases. Recent technological advances in high-throughput sequencing platforms have made it possible for researchers to generate comprehensive information on rare variants in large samples. We provide a general framework for association testing with rare variants by combining mutation information across multiple variant sites within a gene and relating the enriched genetic information to disease phenotypes through appropriate regression models. Our framework covers all major study designs (i.e., case-control, cross-sectional, cohort and family studies) and all common phenotypes (e.g., binary, quantitative, and age at onset), and it allows arbitrary covariates (e.g., environmental factors and ancestry variables). We derive theoretically optimal procedures for combining rare mutations and construct suitable test statistics for various biological scenarios. The allele-frequency threshold can be fixed or variable. The effects of the combined rare mutations on the phenotype can be in the same direction or different directions. The proposed methods are statistically more powerful and computationally more efficient than existing ones. An application to a deep-resequencing study of drug targets led to a discovery of rare variants associated with total cholesterol. The relevant software is freely available.	[Lin, Dan-Yu; Tang, Zheng-Zheng] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu	Tang, Zheng-Zheng/F-6642-2014	Tang, Zheng-Zheng/0000-0003-3802-8087	National Institutes of Health [R01 CA082659, R37 GM047845, P01 CA142538]; NATIONAL CANCER INSTITUTE [P01CA142538, R01CA082659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health grants R01 CA082659, R37 GM047845, and P01 CA142538. The authors thank GlaxoSmithKline, especially Matthew R. Nelson, Margaret G. Ehm, and Li Li, and the co-principal investigators of the CoLaus study, Gerard Waeber and Peter Vollenweider, for the use of the resequencing data. They are also grateful to Yun Li and Kuo-Ping Li for their assistance with the preparation of the data.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1974, THEORETICAL STAT; Davison AC, 1997, BOOTSTRAP METHODS TH; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; King CR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001202; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; LI L, 2011, PLOS ONE IN PRESS; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Lin DY, 2005, BIOINFORMATICS, V21, P781, DOI 10.1093/bioinformatics/bti053; Lin DY, 2006, AM J HUM GENET, V78, P505, DOI 10.1086/500812; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Schaid DJ, 2005, AM J HUM GENET, V76, P780, DOI 10.1086/429838; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tzeng JY, 2007, AM J HUM GENET, V81, P927, DOI 10.1086/521558; Wessel J, 2006, AM J HUM GENET, V79, P792, DOI 10.1086/508346; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	30	202	210	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					354	367		10.1016/j.ajhg.2011.07.015	http://dx.doi.org/10.1016/j.ajhg.2011.07.015			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21885029	Green Published, Bronze			2022-12-18	WOS:000294939800001
J	Mollet, J; Delahodde, A; Serre, V; Chretien, D; Schlemmer, D; Lombes, A; Boddaert, N; Desguerre, I; de Lonlay, P; de Baulny, HO; Munnich, A; Rotig, A				Mollet, Julie; Delahodde, Agnes; Serre, Valerie; Chretien, Dominique; Schlemmer, Dimitri; Lombes, Anne; Boddaert, Nathalie; Desguerre, Isabelle; de Lonlay, Pascale; de Baulny, Helene Ogier; Munnich, Arnold; Roetig, Agnes			CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-Q; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; MYOPATHIC FORM; BC1 COMPLEX; BIOSYNTHESIS; DEFECT; IDENTIFICATION; MITOCHONDRIA; NEPHROPATHY	Coenzyme Q(10) (CoQ(10)) plays a pivotal role in oxidative phosphorylation (OXPHOS) in that it distributes electrons between the various dehydrogenases and the cytochrome segments of the respiratory chain. Primary coenzyme Q10 deficiency represents a clinically heterogeneous condition suggestive of genetic heterogeneity, and several disease genes have been previously identified. The CABC1 gene, also called COQ8 or ADCK3, is the human homolog of the yeast ABC1/COQ8 gene, one of the numerous genes involved in the ubiquinone biosynthesis pathway. The exact function of the Abc1/Coq8 protein is as yet unknown, but this protein is classified as a putative protein kinase. We report here CABC1 gene mutations in four ubiquinone-deficient patients in three distinct families. These patients presented a similar progressive neurological disorder with cerebellar atrophy and seizures. In all cases, enzymological studies pointed to ubiquinone deficiency. CoQ(10) deficiency was confirmed by decreased content of ubiquinone in muscle. Various missense mutations (R213W, G272V, G272D, and E551K) modifying highly conserved amino acids of the protein and a 1 bp frameshift insertion c.[1812_1813insG] were identified. The missense mutations were introduced into the yeast ABC1/COQ8 gene and expressed in a Saccharomyces cerevisiae strain in which the ABC1/COQ8 gene was deleted. All the missense mutations resulted in a respiratory phenotype with no or decreased growth on glycerol medium and a severe reduction in ubiquinone synthesis, demonstrating that these mutations alter the protein function.	[Mollet, Julie; Serre, Valerie; Chretien, Dominique; Schlemmer, Dimitri; Munnich, Arnold; Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Mollet, Julie; Serre, Valerie; Chretien, Dominique; Schlemmer, Dimitri; Munnich, Arnold; Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Delahodde, Agnes] CNRS, UMR 8621, F-91405 Orsay, France; [Delahodde, Agnes] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Lombes, Anne] Hop La Pitie Salpetriere, INSERM, U582, F-75013 Paris, France; [Boddaert, Nathalie] Hop Necker Enfants Malad, Serv Radiol Pediat, F-75015 Paris, France; [de Baulny, Helene Ogier] Hop Robert Debre, Serv Neurol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Rotig, A (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.	roetig@necker.fr	Rötig, Agnès/G-9592-2017; Lombes, Anne/G-4684-2014; boddaert, nathalie/GWV-2865-2022	Rötig, Agnès/0000-0003-0589-0703; Lombes, Anne/0000-0002-9064-0399; boddaert, nathalie/0000-0003-0991-7774				Aure K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Iiizumi M, 2002, CANCER RES, V62, P1246; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Macinga DR, 1998, J BACTERIOL, V180, P128, DOI 10.1128/JB.180.1.128-135.1998; Mamnun YM, 2002, MOL MICROBIOL, V46, P1429, DOI 10.1046/j.1365-2958.2002.03262.x; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Papadopoulou LC, 1999, NAT GENET, V23, P333; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; POON WW, 1995, ARCH BIOCHEM BIOPHYS, V320, P305, DOI 10.1016/0003-9861(95)90014-4; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007	21	202	210	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					623	630		10.1016/j.ajhg.2007.12.022	http://dx.doi.org/10.1016/j.ajhg.2007.12.022			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18319072	Bronze, Green Published			2022-12-18	WOS:000254067800007
J	Vorgerd, M; van der Ven, PFM; Bruchertseifer, V; Lowe, T; Kley, RA; Schroder, R; Lochmuller, H; Himmel, M; Koehler, K; Furst, DO; Huebner, A				Vorgerd, M; van der Ven, PFM; Bruchertseifer, V; Lowe, T; Kley, RA; Schroder, R; Lochmuller, H; Himmel, M; Koehler, K; Furst, DO; Huebner, A			A mutation in the dimerization domain of filamin C causes a novel type of autosomal dominant myofibrillar myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DESMIN; MYOTILIN; PROTEIN; ISOFORM; HUMANS	Myofibrillar myopathy (MFM) is a human disease that is characterized by focal myofibrillar destruction and pathological cytoplasmic protein aggregations. In an extended German pedigree with a novel form of MFM characterized by clinical features of a limb-girdle myopathy and morphological features of MFM, we identified a cosegregating, heterozygous nonsense mutation (8130G -> A; W2710X) in the filamin c gene ( FLNC) on chromosome 7q32.1. The mutation is the first found in FLNC and is localized in the dimerization domain of filamin c. Functional studies showed that, in the truncated mutant protein, this domain has a disturbed secondary structure that leads to the inability to dimerize properly. As a consequence of this malfunction, the muscle fibers of our patients display massive cytoplasmic aggregates containing filamin c and several Z-disk-associated and sarcolemmal proteins.	Tech Univ Dresden, Childrens Hosp, D-01307 Dresden, Germany; Ruhr Univ Bochum, Dept Neurol, Neuromuscular Ctr Ruhrgebeit, D-4630 Bochum, Germany; Univ Potsdam, Dept Cell Biol, Potsdam, Germany; Univ Bonn, Dept Mol Cell Biol, Bonn, Germany; Univ Bonn, Dept Neurol, Bonn, Germany; Univ Cologne, Ctr Biochem, Cologne, Germany; Friedrich Baur Inst, Dept Neurol, Munich, Germany	Technische Universitat Dresden; Ruhr University Bochum; University of Potsdam; University of Bonn; University of Bonn; University of Cologne; University of Munich	Huebner, A (corresponding author), Tech Univ Dresden, Childrens Hosp, Fetscherstasse 74, D-01307 Dresden, Germany.	angela.huebner@mailbox.tu-dresden.de	Kley, Rudolf Andre/AAT-8094-2020; Fürst, Dieter O./H-8561-2013; Vorgerd, Matthias/GRS-7540-2022; Schröder, Rolf/B-2774-2011	Fürst, Dieter O./0000-0001-8805-6444; Vorgerd, Matthias/0000-0002-1782-4642; van der Ven, Peter/0000-0002-9750-8913; Huebner, Angela/0000-0003-1338-5192; Koehler, Katrin/0000-0002-9407-1410; Schroder, Rolf/0000-0002-2772-2615; Lochmuller, Hanns/0000-0003-2324-8001; Himmel, Mirko/0000-0001-7872-8016				Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gamez J, 2001, NEUROLOGY, V56, P450, DOI 10.1212/WNL.56.4.450; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; Himmel M, 2003, BIOCHEMISTRY-US, V42, P430, DOI 10.1021/bi026501+; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Obermann WMJ, 1998, MOL BIOL CELL, V9, P829, DOI 10.1091/mbc.9.4.829; Palenzuela L, 2003, NEUROLOGY, V61, P404, DOI 10.1212/01.WNL.0000073984.46546.4F; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Schroder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Selcen D, 2004, MYOLOGY, P1187; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	24	202	216	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					297	304		10.1086/431959	http://dx.doi.org/10.1086/431959			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	15929027	Green Published, Bronze			2022-12-18	WOS:000230387200010
J	Niemann, S; Zhao, CF; Pascu, F; Stahl, U; Aulepp, U; Niswander, L; Weber, JL; Muller, U				Niemann, S; Zhao, CF; Pascu, F; Stahl, U; Aulepp, U; Niswander, L; Weber, JL; Muller, U			Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VERTEBRATE LIMB DEVELOPMENT; MULTIPLE MALFORMATIONS; PULMONARY HYPOPLASIA; CHICK; TETRAAMELIA; MODELS	Tetra-amelia is a rare human genetic disorder characterized by complete absence of all four limbs and other anomalies. We studied a consanguineous family with four affected fetuses displaying autosomal recessive tetraamelia and craniofacial and urogenital defects. By homozygosity mapping, the disease locus was assigned to chromosome 17q21, with a maximum multipoint LOD score of 2.9 at markers D17S931, D17S1785, D17SS1827, and D17S1868. Further fine mapping defined a critical interval of similar to 8.9 Mb between D17S1299 and D17S797. We identified a homozygous nonsense mutation ( Q83X) in the WNT3 gene in affected fetuses of the family. WNT3, a human homologue of the Drosophila wingless gene, encodes a member of the WNT family known to play key roles in embryonic development. The Q83X mutation truncates WNT3 at its amino terminus, suggesting that loss of function is the most likely cause of the disorder. Our findings contrast with the observation of early lethality in mice homozygous for null alleles of Wnt3. To our knowledge, this is the first report of a mutation in a WNT gene associated with a Mendelian disorder. The identification of a WNT3 mutation in tetra-amelia indicates that WNT3 is required at the earliest stages of human limb formation and for craniofacial and urogenital development.	Univ Giessen, Inst Humangenet, D-35392 Giessen, Germany; Univ Giessen, Inst Pathol, Giessen, Germany; Marshfield Clin Res Fdn, Ctr Genet Med, Marshfield, WI USA; Sloan Kettering Inst, Dev Biol Program, Howard Hughes Med Inst, New York, NY USA	Justus Liebig University Giessen; Justus Liebig University Giessen; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Niemann, S (corresponding author), Univ Giessen, Inst Humangenet, Schlangenzahl 14, D-35392 Giessen, Germany.	Stephan.Niemann@humangenetik.med.uni-giessen.de	Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594				Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; BASARAN S, 1994, AM J MED GENET, V51, P77, DOI 10.1002/ajmg.1320510116; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; GERSHONIBARUCH R, 1990, AM J MED GENET, V37, P569, DOI 10.1002/ajmg.1320370430; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; KLINGENSMITH J, 1994, DEV BIOL, V166, P396, DOI 10.1006/dbio.1994.1325; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; ROSENAK D, 1991, AM J MED GENET, V38, P25, DOI 10.1002/ajmg.1320380107; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Tickle C, 2002, AM J MED GENET, V112, P250, DOI 10.1002/ajmg.10774; Tickle C, 2001, CURR OPIN GENET DEV, V11, P476, DOI 10.1016/S0959-437X(00)00220-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; ZIMMER EZ, 1985, EUR J PEDIATR, V144, P412, DOI 10.1007/BF00441792; ZLOTOGORA J, 1993, AM J MED GENET, V47, P570, DOI 10.1002/ajmg.1320470427	22	202	269	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					558	563		10.1086/382196	http://dx.doi.org/10.1086/382196			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14872406	Green Published, Bronze			2022-12-18	WOS:000220118500022
J	Salas, A; Richards, M; Lareu, MV; Scozzari, R; Coppa, A; Torroni, A; Macaulay, V; Carracedo, A				Salas, A; Richards, M; Lareu, MV; Scozzari, R; Coppa, A; Torroni, A; Macaulay, V; Carracedo, A			The African diaspora: Mitochondrial DNA and the Atlantic slave trade	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTROL-REGION SEQUENCES; MTDNA VARIATION; EUROPEAN VARIATION; GENETIC DIVERSITY; NEAR-EASTERN; POPULATIONS; POLYMORPHISMS; ADMIXTURE; EVOLUTIONARY; PROPORTIONS	Between the 15th and 19th centuries AD, the Atlantic slave trade resulted in the forced movement of similar to 13 million people from Africa, mainly to the Americas. Only similar to 11 million survived the passage, and many more died in the early years of captivity. We have studied 481 mitochondrial DNAs (mtDNAs) of recent African ancestry in the Americas and in Eurasia, in an attempt to trace them back to particular regions of Africa. Our results show that mtDNAs in America and Eurasia can, in many cases, be traced to broad geographical regions within Africa, largely in accordance with historical evidence, and raise the possibility that a greater resolution may be possible in the future. However, they also indicate that, at least for the moment, considerable caution is warranted when assessing claims to be able to trace the ancestry of particular lineages to a particular locality within modern-day Africa.	Univ Santiago de Compostela, Inst Med Legal, Unidad Genet Forense, Galicia, Spain; Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Rome, Italy; Univ Roma La Sapienza, Dipartimento Biol Anim & Uomo, Rome, Italy; Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Glasgow, Dept Stat, Glasgow, Lanark, Scotland	Universidade de Santiago de Compostela; University of Huddersfield; University of Oxford; University of Leeds; University of Leeds; Sapienza University Rome; Sapienza University Rome; University of Pavia; University of Glasgow	Salas, A (corresponding author), Univ Santiago de Compostela, Inst Med Legal, Unidad Genet Forense, Galicia, Spain.	apimlase@usc.es	Carracedo, Angel/D-4257-2012; Torroni, Antonio/E-1557-2011; Lareu, Maviky/E-4909-2013; Salas, Antonio/E-3977-2012	Carracedo, Angel/0000-0003-1085-8986; Torroni, Antonio/0000-0002-4163-4478; Lareu, Maviky/0000-0002-6165-9795; Salas, Antonio/0000-0002-2336-702X; coppa, alfredo/0000-0002-7708-2484; RICHARDS, MARTIN/0000-0003-3118-0967				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2001, ANN HUM GENET, V65, P549, DOI 10.1017/S0003480001008892; Bortolini MC, 1997, HUM BIOL, V69, P141; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Brehm A, 2002, ANN HUM GENET, V66, P49, DOI 10.1017/S0003480001001002; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; CURTIN PD, 1969, DIMENSIONS ATLANTIC; FAGE JD, 1969, J AFR HIST, V3, P393; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; Helgason A, 2003, ANN HUM GENET, V67, P281, DOI 10.1046/j.1469-1809.2003.00046.x; Iliffe J., 1995, AFRICANS HIST CONTIN; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Lewis Bernard, 1990, RACE SLAVERY MIDDLE; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Monsalve MV, 1997, P ROY SOC B-BIOL SCI, V264, P1217, DOI 10.1098/rspb.1997.0168; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Salas A, 1998, EUR J HUM GENET, V6, P365, DOI 10.1038/sj.ejhg.5200202; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Sans M, 2000, HUM BIOL, V72, P155; SANTOS MV, 2002, C GEP ISFG SPAN PORT; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; Thomas Hugh, 1998, SLAVE TRADE HIST ATL; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Watson E, 1996, AM J HUM GENET, V59, P437	46	202	204	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					454	465		10.1086/382194	http://dx.doi.org/10.1086/382194			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14872407	Green Published, Bronze			2022-12-18	WOS:000220118500012
J	Berry, V; Francis, P; Reddy, MA; Collyer, D; Vithana, E; MacKay, I; Dawson, G; Carey, AH; Moore, A; Bhattacharya, SS; Quinlan, RA				Berry, V; Francis, P; Reddy, MA; Collyer, D; Vithana, E; MacKay, I; Dawson, G; Carey, AH; Moore, A; Bhattacharya, SS; Quinlan, RA			Alpha-b crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAPERONE-LIKE ACTIVITY; MISSENSE MUTATION; MOLECULAR CHAPERONE; LENS TRANSPARENCY; PROTEINS; CHAIN	Congenital cataracts are an important cause of bilateral visual impairment in infants. In a four-generation family of English descent, we mapped dominant congenital posterior polar cataract to chromosome 11q22-q22.3. The maximum LOD score, 3.92 at recombination fraction 0, was obtained for marker D11S898, near the gene that encodes crystallin alpha-B protein (CRYAB). By sequencing the coding regions of CRYAB, we found in exon 3 a deletion mutation, 450delA, that is associated with cataract in this family. The mutation resulted in a frameshift in codon 150 and produced an aberrant protein consisting of 184 residues. This is the first report of a mutation, in this gene, resulting in isolated congenital cataract.	Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; Moorfields Eye Hosp, London, England; Oxagen Ltd, Oxford, England; Univ Durham, Dept Biol Sci, Durham, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Oxagen Limited; Durham University	Bhattacharya, SS (corresponding author), Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England.	smbcssb@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016; Quinlan, Roy/A-1348-2012	Bhattacharya, Shom/0000-0002-1601-6344; Quinlan, Roy/0000-0003-0644-4123				Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Carver JA, 1998, INT J BIOL MACROMOL, V22, P197, DOI 10.1016/S0141-8130(98)00017-8; CHIESA R, 1987, BIOCHEM BIOPH RES CO, V144, P1340, DOI 10.1016/0006-291X(87)91457-4; de Jong W.W., 1988, Advances in Experimental Medicine and Biology, V231, P95; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Heon E, 1998, AM J HUM GENET, V63, P921, DOI 10.1086/302005; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ionides A, 1999, BRIT J OPHTHALMOL, V83, P802, DOI 10.1136/bjo.83.7.802; Jakobs PM, 2000, AM J HUM GENET, V66, P1432, DOI 10.1086/302872; KANNABIRAN C, 1998, MOL VIS, V4, P18; Lin PP, 1997, EXP EYE RES, V65, P673, DOI 10.1006/exer.1997.0376; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; MARNER E, 1989, ACTA OPHTHALMOL, V67, P151; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Quinlan R, 1999, NAT MED, V5, P25, DOI 10.1038/4704; RICHARDS J, 1984, CYTOGENET CELL GENET, V37, P570; ROQUEMORE EP, 1992, J BIOL CHEM, V267, P555; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; SMITH JB, 1992, PROTEIN SCI, V1, P601, DOI 10.1002/pro.5560010506; TAKEMOTO L, 1994, EXP EYE RES, V59, P239, DOI 10.1006/exer.1994.1103; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	31	202	219	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1141	1145		10.1086/324158	http://dx.doi.org/10.1086/324158			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11577372	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000171413400021
J	FRASER, FC				FRASER, FC			CURRENT ISSUES IN MEDICAL GENETICS - GENETIC-COUNSELING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV, DEPT BIOL, MONTREAL, QUEBEC, CANADA; MONTREAL CHILDRENS HOSP, MONTREAL, QUEBEC, CANADA	McGill University; McGill University								BERGSMA D, 1973, BIRTH DEFECTS ATLAS; CARR EF, 1971, LANCET, V2, P1075; CARTER CO, 1971, LANCET, V1, P281, DOI 10.1016/S0140-6736(71)91016-6; Clifford E, 1971, Cleft Palate J, V8, P298; CLOW CL, 1973, PROG MED GENET, V9, P159; EMERY AEH, 1972, CLIN GENET, V3, P147; EMERY AEH, 1972, INT J ENVIRON STUD, V3, P37, DOI 10.1080/00207237208709490; EMERY AEH, 1973, BMJ-BRIT MED J, V1, P724, DOI 10.1136/bmj.1.5855.724; EPSTEIN C J, 1973, Birth Defects Original Article Series, V9, P39; Fraser F C, 1970, Birth Defects Orig Artic Ser, V6, P7; Fraser F. Clarke, 1973, ETHICAL ISSUES HUMAN, P7; FRASER FC, 1956, EUGEN QUART, V3, P45, DOI 10.1080/19485565.1956.9987264; FRASER FC, 1968, AM J MENT DEF, V72, P883; FRASER FC, 1971, HOSP PRACT, V6, P49; FREEMAN RD, 1971, J SPEC EDUC, V5, P389, DOI 10.1177/002246697100500415; GELLIS SS, 1968, ATLAS MENTAL RETARDA; GORLIN RJ, 1971, SYNDROMES HEAD NECK; HECHT F, 1972, NEW ENGL J MED, V287, P464, DOI 10.1056/NEJM197208312870911; HOLMES LB, 1972, MENTAL RETARDATION A; HSIA YE, 1973, YALE MED, V8, P14; KIMBERLING WJ, 1972, PERSPECTIVES CYTOGEN, P131; KRUSH A J, 1970, American Journal of Human Genetics, V22, p21A; LEONARD CO, 1972, NEW ENGL J MED, V287, P433, DOI 10.1056/NEJM197208312870904; LYNCH HT, 1974, INT DIRECTORY GENETI; MADDISON D, 1971, MED J AUSTRALIA, V2, P1265, DOI 10.5694/j.1326-5377.1971.tb92842.x; MCCOLLUM AT, 1970, J PEDIATR-US, V77, P571, DOI 10.1016/S0022-3476(70)80196-2; MCKUSICK VA, 1969, J CHRON DIS, V22, P1, DOI 10.1016/0021-9681(69)90081-2; MCKUSICK VA, 1971, MENDELIAN INHERITANC; MURPHY E A, 1973, Birth Defects Original Article Series, V9, P19; MURPHY EA, 1969, HUM HERED, V19, P126, DOI 10.1159/000152210; MURRAY R, 1973, ETHICAL ISSUES HUMAN, P121; NANCE WE, 1971, AUDIOLOGY, V10, P222; REISS JA, 1972, J PEDIATR-US, V80, P655, DOI 10.1016/S0022-3476(72)80069-6; RICHARDS ID, 1973, DEV MED CHILD NEUROL, V15, P292; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; SLY W S, 1973, Birth Defects Original Article Series, V9, P5; SMITH C, 1971, J MED GENET, V8, P458; Smith D.W., 1970, RECOGNIZABLE PATTERN; THOMPSON MW, 1967, CLIN PEDIATR, V6, P199, DOI 10.1177/000992286700600405; TIPS RL, 1964, AM J DIS CHILD, V107, P67, DOI 10.1001/archpedi.1964.02080060069010; TIPS RL, 1963, AM J MENT DEF, V68, P334; VALENTI C, 1973, AM J OBSTET GYNECOL, V115, P851, DOI 10.1016/0002-9378(73)90532-2	42	202	204	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	5					636	659						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U0241	4609197				2022-12-18	WOS:A1974U024100011
J	Goriely, A; Wilkie, AOM				Goriely, Anne; Wilkie, Andrew O. M.			Paternal Age Effect Mutations and Selfish Spermatogonial Selection: Causes and Consequences for Human Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GROWTH-FACTOR RECEPTOR-3; COPY-NUMBER VARIATION; DE-NOVO MUTATIONS; NEOPLASIA TYPE 2B; MEDULLARY-THYROID CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISMS; GENOTYPE-PHENOTYPE CORRELATION; AUTISM SPECTRUM DISORDERS; GENOME-WIDE ASSOCIATION; URINARY-BLADDER CANCER	Advanced paternal age has been associated with an increased risk for spontaneous congenital disorders and common complex diseases (such as some cancers, schizophrenia, and autism), but the mechanisms that mediate this effect have been poorly understood. A small group of disorders, including Apert syndrome (caused by FGFR2 mutations), achondroplasia, and thanatophoric dysplasia (FGFR3), and Costello syndrome (HRAS), which we collectively term "paternal age effect" (PAE) disorders, provides a good model to study the biological and molecular basis of this phenomenon. Recent evidence from direct quantification of PAE mutations in sperm and testes suggests that the common factor in the paternal age effect lies in the dysregulation of spermatogonial cell behavior, an effect mediated molecularly through the growth factor receptor-RAS signal transduction pathway. The data show that PAE mutations, although arising rarely, are positively selected and expand clonally in normal testes through a process akin to oncogenesis. This clonal expansion, which is likely to take place in the testes of all men, leads to the relative enrichment of mutant sperm over time explaining the observed paternal age effect associated with these disorders and in rare cases to the formation of testicular tumors. As regulation of RAS and other mediators of cellular proliferation and survival is important in many different biological contexts, for example during tumorigenesis, organ homeostasis and neurogenesis, the consequences of selfish mutations that hijack this process within the testis are likely to extend far beyond congenital skeletal disorders to include complex diseases, such as neurocognitive disorders and cancer predisposition.	[Goriely, Anne; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Goriely, A (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	anne.goriely@imm.ox.ac.uk; awilkie@hammer.imm.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020; Goriely, Anne/AAR-1133-2020	Wilkie, Andrew/0000-0002-2972-5481; Goriely, Anne/0000-0001-9229-7216	Wellcome Trust [091182]	Wellcome Trust(Wellcome TrustEuropean Commission)	This review is dedicated to the memory of James F. Crow (19162012), a pioneer in the study of paternal age effects. We thank Gil McVean (Oxford, UK) and Ewa Rajpert-DeMeyts (Copenhagen, Denmark) for their long-term collaboration in this work, members of the Wilkie lab for critical reading of the manuscript and the Wellcome Trust (091182) for financial support.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bartsch DK, 2000, EXP CLIN ENDOCR DIAB, V108, P128, DOI 10.1055/s-2000-5806; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Berk DR, 2007, ARCH DERMATOL, V143, P1153, DOI 10.1001/archderm.143.9.1153; Bohm J, 2006, AM J MED GENET A, V140A, P1904, DOI 10.1002/ajmg.a.31383; Bray I, 2006, J EPIDEMIOL COMMUN H, V60, P851, DOI 10.1136/jech.2005.045179; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Byrne M, 2003, ARCH GEN PSYCHIAT, V60, P673, DOI 10.1001/archpsyc.60.7.673; Cancilla B, 2000, J ENDOCRINOL, V164, P149, DOI 10.1677/joe.0.1640149; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; Chen PC, 2010, J CLIN INVEST, V120, P4353, DOI 10.1172/JCI43910; Chen XK, 2008, HUM REPROD, V23, P1290, DOI 10.1093/humrep/dem403; Chen ZB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007220; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Choi JY, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-143; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cornejo-Roldan LR, 1999, HUM GENET, V104, P425, DOI 10.1007/s004390050979; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; Dong-ling T, 2009, EUR J OBSTET GYN R B, V144, P35, DOI 10.1016/j.ejogrb.2009.02.002; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; EBLE JN, 1994, HUM PATHOL, V25, P1035, DOI 10.1016/0046-8177(94)90062-0; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gimm O, 1997, J CLIN ENDOCR METAB, V82, P3902, DOI 10.1210/jc.82.11.3902; Girard M, 2001, EUR J HUM GENET, V9, P231, DOI 10.1038/sj.ejhg.5200618; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Giudicelli MD, 2008, FERTIL STERIL, V89, P1651, DOI 10.1016/j.fertnstert.2007.04.037; Glaser RL, 2000, AM J HUM GENET, V66, P768, DOI 10.1086/302831; Glaser RL, 2003, AM J HUM GENET, V73, P939, DOI 10.1086/378419; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Goriely A, 2010, AM J MED GENET A, V152A, P2067, DOI 10.1002/ajmg.a.33513; Goriely A, 2010, NAT REV GENET, V11, P589, DOI 10.1038/nrg2809-c1; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Gorlov IP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-292; Green RF, 2010, ANN EPIDEMIOL, V20, P241, DOI 10.1016/j.annepidem.2009.10.009; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; Gripp KW, 2006, AM J MED GENET A, V140A, P2163, DOI 10.1002/ajmg.a.31456; Gripp KW, 2011, AM J MED GENET A, V155A, P706, DOI 10.1002/ajmg.a.33884; Hafner C, 2007, J INVEST DERMATOL, V127, P1883, DOI 10.1038/sj.jid.5700804; Hansen R.M.S., 2006, THESIS U OXFORD OXFO; Hansen RM, 2005, J PATHOL, V207, P27, DOI 10.1002/path.1816; Hassold T, 2009, CURR OPIN PEDIATR, V21, P703, DOI 10.1097/MOP.0b013e328332c6ab; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P409, DOI 10.1002/jemt.20786; Heron SE, 2010, J MED GENET, V47, P137, DOI 10.1136/jmg.2008.065912; Hodgkinson A, 2010, GENOME BIOL EVOL, V2, P547, DOI 10.1093/gbe/evq039; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Iwashita T, 2000, BIOCHEM BIOPH RES CO, V268, P804, DOI 10.1006/bbrc.2000.2227; Jasim S, 2011, THYROID, V21, P189, DOI 10.1089/thy.2010.0328; Johne A, 2003, CANCER EPIDEM BIOMAR, V12, P68; Juul A, 2007, HUM REPROD, V22, P1907, DOI 10.1093/humrep/dem126; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kalkman HO, 2006, PHARMACOL THERAPEUT, V110, P117, DOI 10.1016/j.pharmthera.2005.10.014; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Kasprzak L, 2001, J MED GENET, V38, P784, DOI 10.1136/jmg.38.11.784; Keri S, 2009, NEUROCHEM INT, V55, P606, DOI 10.1016/j.neuint.2009.06.002; Kerr B, 2006, J MED GENET, V43, P401, DOI 10.1136/jmg.2005.040352; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; KITAMURA Y, 1995, HUM MOL GENET, V4, P1987, DOI 10.1093/hmg/4.10.1987; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Klejbor I, 2006, J NEUROCHEM, V97, P1243, DOI 10.1111/j.1471-4159.2006.03754.x; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kondrashov FA, 2010, PHILOS T R SOC B, V365, P1169, DOI 10.1098/rstb.2009.0286; Krab LC, 2008, TRENDS GENET, V24, P498, DOI 10.1016/j.tig.2008.07.005; Krajewska M, 2008, AM J PATHOL, V172, P1312, DOI 10.2353/ajpath.2008.070594; Kratz CP, 2009, AM J MED GENET A, V149A, P1036, DOI 10.1002/ajmg.a.32786; Krejci P, 2010, BONE, V47, P102, DOI 10.1016/j.bone.2010.03.021; Krenz M, 2005, CIRC RES, V97, P813, DOI 10.1161/01.RES.0000186194.06514.b0; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lajeunie E, 1999, J NEUROSURG, V90, P443, DOI 10.3171/jns.1999.90.3.0443; Lappalainen T, 2010, EUR J HUM GENET, V18, P471, DOI 10.1038/ejhg.2009.184; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li R, 2006, HUM GENET, V119, P137, DOI 10.1007/s00439-005-0116-7; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; Lim JH, 2011, J ASSIST REPROD GEN, V28, P167, DOI 10.1007/s10815-010-9489-1; LIPS CJM, 1994, NEW ENGL J MED, V331, P828, DOI 10.1056/NEJM199409293311302; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Malaspina D, 2002, AM J MED GENET, V114, P299, DOI 10.1002/ajmg.1701; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Meng XJ, 2001, CANCER RES, V61, P3267; Menko FH, 2002, J CLIN ENDOCR METAB, V87, P393, DOI 10.1210/jc.87.1.393; Meyts ERD, 2007, INT J ANDROL, V30, P192, DOI 10.1111/j.1365-2605.2007.00810.x; Miyauchi A, 1999, JPN J CANCER RES, V90, P1; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, NAT GENET, V6, P70, DOI 10.1038/ng0194-70; Murray L, 2002, BRIT J CANCER, V86, P356, DOI 10.1038/sj.bjc.6600012; Nachman MW, 2000, GENETICS, V156, P297; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nowell PC, 2002, SEMIN CANCER BIOL, V12, P261, DOI 10.1016/S1044-579X(02)00012-3; O'Donovan MC, 2009, MOL PSYCHIATR, V14, P30, DOI 10.1038/mp.2008.108; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328; ORIOLI IM, 1995, AM J MED GENET, V59, P209, DOI 10.1002/ajmg.1320590218; Ota S, 2009, HUM MOL GENET, V18, P2609, DOI 10.1093/hmg/ddp195; Pannier S, 2009, AM J MED GENET A, V149A, P1296, DOI 10.1002/ajmg.a.32880; Pauli S, 2012, CLIN GENET, V81, P234, DOI 10.1111/j.1399-0004.2011.01701.x; PENROSE LS, 1955, LANCET, V2, P312; Petersen L, 2011, AM J PSYCHIAT, V168, P82, DOI 10.1176/appi.ajp.2010.10020252; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Qin J, 2007, PLOS BIOL, V5, P1912, DOI 10.1371/journal.pbio.0050224; Rannan-Eliya SV, 2004, HUM GENET, V115, P200, DOI 10.1007/s00439-004-1151-5; Raue F, 2010, FAM CANCER, V9, P449, DOI 10.1007/s10689-010-9320-2; RISCH N, 1987, AM J HUM GENET, V41, P218; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rosenberger G, 2009, HUM MUTAT, V30, P352, DOI 10.1002/humu.20855; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Rump P, 2006, AM J MED GENET A, V140A, P284, DOI 10.1002/ajmg.a.31084; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Santos HG, 2007, AM J MED GENET A, V143A, P355, DOI 10.1002/ajmg.a.31556; Sathyan KM, 2006, ORAL ONCOL, V42, P607, DOI 10.1016/j.oraloncology.2005.10.019; Schuffenecker I, 1997, AM J HUM GENET, V60, P233; Schulz AL, 2008, CLIN GENET, V73, P62, DOI 10.1111/j.1399-0004.2007.00931.x; SHARLAND M, 1992, ARCH DIS CHILD, V67, P178, DOI 10.1136/adc.67.2.178; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Smith DP, 1997, ONCOGENE, V15, P1213, DOI 10.1038/sj.onc.1201481; Sol-Church K, 2006, HUM MUTAT, V27, P736, DOI 10.1002/humu.20381; Sovik O, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049361; Splendore A, 2003, EUR J HUM GENET, V11, P718, DOI 10.1038/sj.ejhg.5201029; Sun HH, 2010, J HUM GENET, V55, P421, DOI 10.1038/jhg.2010.39; Tartaglia M, 2004, AM J HUM GENET, V75, P492, DOI 10.1086/423493; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Thomas NS, 2010, J MED GENET, V47, P112, DOI 10.1136/jmg.2009.069716; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; To MD, 2006, NAT GENET, V38, P926, DOI 10.1038/ng1836; Tolarova MM, 1997, AM J MED GENET, V72, P394, DOI 10.1002/(SICI)1096-8628(19971112)72:4<394::AID-AJMG4>3.0.CO;2-R; Toriello HV, 2008, GENET MED, V10, P457, DOI 10.1097/GIM.0b013e318176fabb; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; Tsuchiya KJ, 2008, BRIT J PSYCHIAT, V193, P316, DOI 10.1192/bjp.bp.107.045120; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Twigg SRF, 2006, AM J HUM GENET, V78, P999, DOI 10.1086/504440; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; van der Burgt I, 2007, J MED GENET, V44, P459, DOI 10.1136/jmg.2007.049270; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; VOGEL F, 1975, ADV HUM GENET, V5, P223; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; von Kopylow K, 2010, HUM REPROD, V25, P1104, DOI 10.1093/humrep/deq053; Waller DK, 2008, AM J MED GENET A, V146A, P2385, DOI 10.1002/ajmg.a.32485; Weinberg W, 1912, ARCH RASSEN U GESELL, V9, P710; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Wohllk N, 1996, J CLIN ENDOCR METAB, V81, P3740, DOI 10.1210/jc.81.10.3740; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yip BH, 2006, INT J EPIDEMIOL, V35, P1495, DOI 10.1093/ije/dyl177; Yoon SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000558; Zampino G, 2007, HUM MUTAT, V28, P265, DOI 10.1002/humu.20431; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang YJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-256; Zhu XW, 2010, J CHILD NEUROL, V25, P842, DOI 10.1177/0883073809350722	198	201	211	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					175	200		10.1016/j.ajhg.2011.12.017	http://dx.doi.org/10.1016/j.ajhg.2011.12.017			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22325359	Bronze, Green Published			2022-12-18	WOS:000300742200001
J	Walsh, T; Shahin, H; Elkan-Miller, T; Lee, MK; Thornton, AM; Roeb, W; Abu Rayyan, A; Loulus, S; Avraham, KB; King, MC; Kanaan, M				Walsh, Tom; Shahin, Hashem; Elkan-Miller, Tal; Lee, Ming K.; Thornton, Anne M.; Roeb, Wendy; Abu Rayyan, Amal; Loulus, Suheir; Avraham, Karen B.; King, Mary-Claire; Kanaan, Moien			Whole Exome Sequencing and Homozygosity Mapping Identify Mutation in the Cell Polarity Protein GPSM2 as the Cause of Nonsyndromic Hearing Loss DFNB82	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LGN; IDENTIFICATION; AGS3	Massively parallel sequencing of targeted regions, exomes, and complete genomes has begun to dramatically increase the pace of discovery of genes responsible for human disorders. Here we describe how exome sequencing in conjunction with homozygosity mapping led to rapid identification of the causative allele for nonsyndromic hearing loss DFNB82 in a consanguineous Palestinian family. After filtering out worldwide and population-specific polymorphisms from the whole exome sequence, only a single deleterious mutation remained in the homozygous region linked to DFNB82. The nonsense mutation leads to an early truncation of the G protein signaling modulator GPSM2, a protein that is essential for maintenance of cell polarity and spindle orientation. In the mouse inner ear, GPSM2 is localized to apical surfaces of hair cells and supporting cells and is most highly expressed during embryonic development. Identification of GPSM2 as essential to the development of normal hearing suggests dysregulation of cell polarity as a mechanism underlying hearing loss.	[Walsh, Tom; Lee, Ming K.; Thornton, Anne M.; Roeb, Wendy; King, Mary-Claire] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Shahin, Hashem; Abu Rayyan, Amal; Loulus, Suheir; Kanaan, Moien] Bethlehem Univ, Dept Life Sci, Bethlehem, Palestine; [Elkan-Miller, Tal; Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	University of Washington; University of Washington Seattle; Tel Aviv University; Sackler Faculty of Medicine	Walsh, T (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	twalsh@uw.edu; mkanaan@bethlehem.edu		King, Mary-Claire/0000-0001-9426-1743; Kanaan, Moien/0000-0002-3227-4685; Avraham, Karen B/0000-0002-4913-251X; Walsh, Tom/0000-0002-8875-0310	National Institute of Deafness and Other Communication Disorders of the National Institutes of Health (NIH) [R01DC005641]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005641] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Michel Rahil for analysis of hearing loss in members of family CG and Michael Jacobs, Brian Fritz, Ping Chen, and Amiel Dror for excellent advice. This work was supported by the National Institute of Deafness and Other Communication Disorders of the National Institutes of Health (NIH) (R01DC005641), with a supplement from the American Recovery and Reinvestment Act.	Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Guo XZ, 2009, CELL RES, V19, P838, DOI 10.1038/cr.2009.54; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kelley MW, 2006, BRAIN RES, V1091, P172, DOI 10.1016/j.brainres.2006.02.062; Kelly MC, 2009, CURR OPIN NEUROBIOL, V19, P395, DOI 10.1016/j.conb.2009.07.010; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Masmoudi S, 2003, EUR J HUM GENET, V11, P185, DOI 10.1038/sj.ejhg.5200934; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Shahin H, 2010, EUR J HUM GENET, V18, P407, DOI 10.1038/ejhg.2009.190; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433	22	201	227	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					90	94		10.1016/j.ajhg.2010.05.010	http://dx.doi.org/10.1016/j.ajhg.2010.05.010			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20602914	Bronze, Green Published			2022-12-18	WOS:000280029200008
J	Zhernakova, A; Festen, EM; Franke, L; Trynka, G; van Diemen, CC; Monsuur, AJ; Bevova, M; Nijmeijer, RM; van't Slot, R; Heijmans, R; Boezen, HM; van Heel, DA; van Bodegraven, AA; Stokkers, PCF; Wijmenga, C; Crusius, JBA; Weersma, RK				Zhernakova, Alexandra; Festen, Eleanora M.; Franke, Lude; Trynka, Gosia; van Diemen, Cleo C.; Monsuur, Alienke J.; Bevova, Marianna; Nijmeijer, Rian M.; van't Slot, Ruben; Heijmans, Roel; Boezen, H. Marike; van Heel, David A.; van Bodegraven, Adriaan A.; Stokkers, Pieter C. F.; Wijmenga, Cisca; Crusius, J. Bart A.; Weersma, Rinse K.			Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; TOLL-LIKE RECEPTORS; ADAPTER PROTEIN CARD9; RISK VARIANTS; EXPRESSION; IL-18; CELLS; PATHOGENESIS; POPULATION	The two main phenotypes of inflammatory bowel disease (IBD)-Crohn's disease (CD) and ulcerative colitis (UC)-are chronic intestinal inflammatory disorders with a complex genetic background. Using a three-stage design, we performed a functional candidate-gene analysis of innate immune pathway in IBD. In phase 1, we typed 354 SNPs from 85 innate immunity genes in 520 Dutch IBD patients (284 CD, 236 UC) and 808 controls. In phase 11, ten autosomal SNPs showing association at p < 0.006 in phase I were replicated in a second cohort of 545 IBD patients (326 CD, 219 UC) and 360 controls. In phase 111, four SNPs with p < 0.01 in the combined phase I and phase 11 analysis were genotyped in an additional 786 IBD samples (452 CD, 334 UC) and 768 independent controls. Joint analysis of 1851 IBD patients (1062 CD, 789 UC) and 1936 controls demonstrated strong association to the IL18RAP rs917997 SNP for both CD and UC (p(IBD) 1.9 x 10(-8); OR 1.35). Association in CD is independently supported by the Crohn's disease dataset of the Wellcome Trust Case Control Consortium (imputed SNP rs917997, p = 9.19 x 10(-4)). In addition, an association of the CARD9 rs10870077 SNP to CD and UC was observed (p(IBD) = 3.25 x 10(-5); OR 1.21). Both genes are located in extended haplotype blocks on 2q11-2q12 and 9q34.3, respectively. Our results indicate two IBD loci and further support the importance of the innate immune system in the predisposition to both CD and UC.	[Zhernakova, Alexandra; Franke, Lude; Monsuur, Alienke J.; Bevova, Marianna; van't Slot, Ruben; Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, Utrecht, Netherlands; [Nijmeijer, Rian M.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Festen, Eleanora M.; Weersma, Rinse K.] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 AV Groningen, Netherlands; [Festen, Eleanora M.; Franke, Lude; Trynka, Gosia; van Diemen, Cleo C.; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Boezen, H. Marike] Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [Boezen, H. Marike] Univ Groningen, Groningen, Netherlands; [Heijmans, Roel; Crusius, J. Bart A.] Vrije Univ Med Ctr, Dept Pathol, Lab Immunogenet, Amsterdam, Netherlands; [van Bodegraven, Adriaan A.] Vrije Univ Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England; [Stokkers, Pieter C. F.] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; Queen Mary University London; University of Amsterdam; Academic Medical Center Amsterdam	Wijmenga, C (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Complex Genet Sect, Utrecht, Netherlands.	c.wijmenga@umcutrecht.nl	van Bodegraven, Ad/ABG-4367-2020; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019; Weersma, Rinse/ABE-3807-2021; Zhernakova, Alexandra/ABA-9372-2020; van Bodegraven, Ad A/L-3180-2013; Franke, Lude/P-7036-2016; Festen, Eleonora A.M./S-3557-2016	Wijmenga, Cisca/0000-0002-5635-1614; Franke, Lude/0000-0002-5159-8802; van Heel, David/0000-0002-0637-2265; Zhernakova, Alexandra/0000-0002-4574-0841; Festen, Eleonora/0000-0002-3255-6930; Trynka, Gosia/0000-0002-6955-9529				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; BINDER V, 1982, GASTROENTEROLOGY, V83, P563; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Corbaz A, 2002, J IMMUNOL, V168, P3608, DOI 10.4049/jimmunol.168.7.3608; Cummings JAF, 2007, INFLAMM BOWEL DIS, V13, P1063, DOI 10.1002/ibd.20180; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Harris G, 2006, WORLD J GASTROENTERO, V12, P2149, DOI 10.3748/wjg.v12.i14.2149; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Kanai T, 2000, GASTROENTEROLOGY, V119, P1514, DOI 10.1053/gast.2000.20260; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monteleone G, 1999, J IMMUNOL, V163, P143; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oostenbrug LE, 2005, INFLAMM BOWEL DIS, V11, P567, DOI 10.1097/01.MIB.0000161305.81198.0f; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; RIJCKEN B, 1993, AM REV RESPIR DIS, V147, P1447, DOI 10.1164/ajrccm/147.6_Pt_1.1447; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Stokkers PCF, 2000, INFLAMM BOWEL DIS, V6, P92, DOI 10.1097/00054725-200005000-00004; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Underhill DM, 2007, NAT IMMUNOL, V8, P122, DOI 10.1038/ni0207-122; Van Bodegraven AA, 2006, GASTROENTEROLOGY, V131, P1768, DOI 10.1053/j.gastro.2006.09.011; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Wu CB, 2003, J IMMUNOL, V170, P5571, DOI 10.4049/jimmunol.170.11.5571; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto-Furusho JK, 2007, WORLD J GASTROENTERO, V13, P5577, DOI 10.3748/wjg.v13.i42.5577; Zhernakova A, 2005, HUM GENET, V118, P58, DOI 10.1007/s00439-005-0006-z	53	201	208	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1202	1210		10.1016/j.ajhg.2008.03.016	http://dx.doi.org/10.1016/j.ajhg.2008.03.016			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439550	Green Published, Bronze			2022-12-18	WOS:000255923600021
J	Epstein, MP; Satten, GA				Epstein, MP; Satten, GA			Inference on haplotype effects in case-control studies using unphased genotype data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; UNRELATED INDIVIDUALS; DISEASE ASSOCIATIONS; SCORE TESTS; ALGORITHM; FREQUENCIES; ALLELES; TRAITS; FUTURE; MODELS	A variety of statistical methods exist for detecting haplotype-disease association through use of genetic data from a case-control study. Since such data often consist of unphased genotypes (resulting in haplotype ambiguity), such statistical methods typically apply the expectation-maximization (EM) algorithm for inference. However, the majority of these methods fail to perform inference on the effect of particular haplotypes or haplotype features on disease risk. Since such inference is valuable, we develop a retrospective likelihood for estimating and testing the effects of specific features of single-nucleotide polymorphism (SNP)-based haplotypes on disease risk using unphased genotype data from a case-control study. Our proposed method has a flexible structure that allows, among other choices, modeling of multiplicative, dominant, and recessive effects of specific haplotype features on disease risk. In addition, our method relaxes the requirement of Hardy-Weinberg equilibrium of haplotype frequencies in case subjects, which is typically required of EM-based haplotype methods. Also, our method easily accommodates missing SNP information. Finally, our method allows for asymptotic, permutation-based, or bootstrap inference. We apply our method to case-control SNP genotype data from the Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus (FUSION) Genetics study and identify two haplotypes that appear to be significantly associated with type 2 diabetes. Using the FUSION data, we assess the accuracy of asymptotic P values by comparing them with P values obtained from a permutation procedure. We also assess the accuracy of asymptotic confidence intervals for relative-risk parameters for haplotype effects, by a simulation study based on the FUSION data.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Epstein, MP (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St,Suite 301, Atlanta, GA 30322 USA.			Satten, Glen/0000-0001-7275-5371				Akaike H., 1985, CELEBRATION STAT, P1; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; CARROLL RJ, 1995, J AM STAT ASSOC, V90, P157, DOI 10.2307/2291139; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EFFRON B, 1998, INTRO BOOTSTRAP; Eitan Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf062; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Joosten PHLJ, 2001, NAT GENET, V27, P215, DOI 10.1038/84867; LONG JC, 1995, AM J HUM GENET, V56, P799; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.1093/biomet/80.2.267; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satten GA, 2000, BIOMETRICS, V56, P384, DOI 10.1111/j.0006-341X.2000.00384.x; SATTEN GA, 1993, J AM STAT ASSOC, V88, P200, DOI 10.2307/2290714; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	31	201	214	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1316	1329		10.1086/380204	http://dx.doi.org/10.1086/380204			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14631556	Bronze, Green Published			2022-12-18	WOS:000187491100009
J	Uhl, GR; Liu, QR; Walther, D; Hess, J; Naiman, D				Uhl, GR; Liu, QR; Walther, D; Hess, J; Naiman, D			Polysubstance abuse-vulnerability genes: Genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROTROPHIC FACTOR; ALCOHOL DEPENDENCE; SUBSTANCE-ABUSE; DRUG-ABUSE; ENVIRONMENTAL-INFLUENCES; LINKAGE DISEQUILIBRIUM; LOCOMOTOR-ACTIVITY; FEMALE TWINS; RAT-BRAIN; BDNF-GENE	Strong genetic contributions to drug abuse vulnerability are well documented, but few chromosomal locations for human drug-abuse vulnerability alleles have been confirmed. We now identify chromosomal markers whose alleles distinguish drug abusers from control individuals in each of two samples, on the basis of pooled-sample microarray and association analyses. Reproducibly positive chromosomal regions defined by these markers in conjunction with previous results were especially unlikely to have been identified by chance. Positive markers identify the alcohol dehydrogenase (ADH) locus, flank the brain-derived neurotropic factor (BDNF) locus, and mark seven other regions previously linked to vulnerability to nicotine or alcohol abuse. These data support polygenic contributions of common allelic variants to polysubstance abuse vulnerability.	NIDA, Mol Neurobiol Branch, NIH, Baltimore, MD USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Johns Hopkins University	Uhl, GR (corresponding author), Box 5180, Baltimore, MD 21224 USA.		Naiman, Daniel Q/A-3304-2010; Liu, Qing-Rong/A-3059-2012	Naiman, Daniel Q/0000-0001-6504-9081; Liu, Qing-Rong/0000-0001-8477-6452				Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; Bhagwat SV, 1998, BIOCHEM PHARMACOL, V56, P831, DOI 10.1016/S0006-2952(98)00228-7; Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P42; CADORET RJ, 1986, ARCH GEN PSYCHIAT, V43, P1131; Cervino ACL, 2000, AM J HUM GENET, V67, P120, DOI 10.1086/302992; Dluzen DE, 1999, EXP NEUROL, V160, P500, DOI 10.1006/exnr.1999.7225; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; GOLDBERG J, 1993, BEHAV GENET, P552; GROVE WM, 1990, BIOL PSYCHIAT, V27, P1293, DOI 10.1016/0006-3223(90)90500-2; GYNTHER LM, 1995, PSYCHIAT RES, V56, P213, DOI 10.1016/0165-1781(94)02609-M; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Horger BA, 1999, J NEUROSCI, V19, P4110; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; Karkowski LM, 2000, AM J MED GENET, V96, P665, DOI 10.1002/1096-8628(20001009)96:5<665::AID-AJMG13>3.0.CO;2-O; Kendler KS, 1999, BRIT J PSYCHIAT, V175, P351, DOI 10.1192/bjp.175.4.351; Kendler KS, 1998, BRIT J PSYCHIAT, V173, P345, DOI 10.1192/bjp.173.4.345; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Krebs MO, 2000, MOL PSYCHIATR, V5, P558, DOI 10.1038/sj.mp.4000749; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MARSELOS M, 1991, Reviews on Environmental Health, V9, P31; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Persico AM, 1996, BIOL PSYCHIAT, V40, P776, DOI 10.1016/0006-3223(95)00483-1; PICKENS RW, 1991, ARCH GEN PSYCHIAT, V48, P19; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schork NJ, 2000, AM J HUM GENET, V67, P1208, DOI 10.1086/321201; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; SHINTANI A, 1992, BIOCHEM BIOPH RES CO, V182, P325, DOI 10.1016/S0006-291X(05)80148-2; SMITH AP, 1992, HDB HUMAN PERFORMANC, V2, P1; Stallings MC, 1999, BEHAV GENET, V29, P409, DOI 10.1023/A:1021622820644; Straub RE, 1999, MOL PSYCHIATR, V4, P129, DOI 10.1038/sj.mp.4000518; *SUBST AB MENT HLT, 1995, NAT HOUS SURV DRUG A; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; True WR, 1999, AM J MED GENET, V88, P391, DOI 10.1002/(SICI)1096-8628(19990820)88:4<391::AID-AJMG17>3.0.CO;2-L; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Tsuang MT, 1999, BEHAV GENET, V29, P473, DOI 10.1023/A:1021635223370; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Uhl George R., 1995, P1793; Uhl GR, 1997, P NATL ACAD SCI USA, V94, P2785, DOI 10.1073/pnas.94.7.2785; Uhl GR, 1999, NEUROPSYCHOPHARMACOL, V20, P3, DOI 10.1016/S0893-133X(98)00061-X; WOODWARD CE, 1996, NIDA RES MONOGR, P309; XU Y, 1988, Genomics, V2, P209, DOI 10.1016/0888-7543(88)90004-3	49	201	206	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1290	1300		10.1086/324467	http://dx.doi.org/10.1086/324467			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	491AY	11704927	Green Published, Bronze			2022-12-18	WOS:000172086900014
J	Leegwater, PAJ; Yuan, BQ; van der Steen, J; Mulders, J; Konst, AAM; Boor, PKI; Mejaski-Bosnjak, V; van der Maarel, S; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS				Leegwater, PAJ; Yuan, BQ; van der Steen, J; Mulders, J; Konst, AAM; Boor, PKI; Mejaski-Bosnjak, V; van der Maarel, S; Frants, RR; Oudejans, CBM; Schutgens, RBH; Pronk, JC; van der Knaap, MS			Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MILD CLINICAL COURSE; GROUP-A GENE; DNA-SEQUENCE; LEUKODYSTROPHY; DELETIONS	Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is an autosomal recessive disorder characterized by macrocephaly, deterioration of motor functions with ataxia, and spasticity, eventuating in mental decline. The brain appears swollen on magnetic resonance imaging, with diffuse white-matter abnormalities and the invariable presence of subcortical cysts. MLC was recently localized on chromosome 22q(tel). We have narrowed down the critical region by linkage analysis of 11 informative families with MLC to a region of similar to 250 kb, containing four known genes. One family with two patients who were siblings did not display linkage between the MLC phenotype and any of the analyzed microsatellite markers on chromosome 22q(tel), suggesting genetic heterogeneity and the existence of at least a second MLC locus. The maximum two-point LOD score for the 11 families was 6.6 at recombination fraction .02. Twelve different mutations in seven informative and six uninformative families were found in one of the candidate genes, KIAA0027, which we renamed "MLC1." The gene encodes a putative membrane protein with eight predicted transmembrane domains. The patients of one family were compound heterozygotes for mutations that both introduced stop codons. The mutations further included frameshifts, splice-acceptor mutations, a putative splice-donor mutation, and amino acid substitutions of residues in predicted transmembrane domains. These data provide strong evidence that mutations of MLC1 cause the disease.	Free Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1007 MB Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1007 MB Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Dept Human Genet, NL-1007 MB Amsterdam, Netherlands; Childrens Hosp, Dept Pediat, Zagreb, Croatia; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Leegwater, PAJ (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Clin Chem, POB 7057, NL-1007 MB Amsterdam, Netherlands.		van der Maarel, Silvere/X-3631-2018	van der Maarel, Silvere/0000-0001-8103-711X; Oudejans, Cees/0000-0003-0717-4946; Leegwater, Peter/0000-0002-4100-015X				Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; KRAWCZAK M, 1991, HUM GENET, V86, P425; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Singhal BS, 1996, PEDIATR NEUROL, V14, P291, DOI 10.1016/0887-8994(96)00048-3; Topcu M, 2000, AM J HUM GENET, V66, P733, DOI 10.1086/302758; Topcu M, 1998, BRAIN DEV-JPN, V20, P142, DOI 10.1016/S0387-7604(98)00002-3; vanderKnaap MS, 1996, ACTA NEUROPATHOL, V92, P206, DOI 10.1007/s004010050510; VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308; Wijker M, 1999, EUR J HUM GENET, V7, P52, DOI 10.1038/sj.ejhg.5200248; [No title captured]	14	201	216	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					831	838		10.1086/319519	http://dx.doi.org/10.1086/319519			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254442	Bronze, Green Published			2022-12-18	WOS:000167666000004
J	Payami, H; Zareparsi, S; Montee, KR; Sexton, GJ; Kaye, JA; Bird, TD; Yu, CE; Wijsman, EM; Heston, LL; Litt, M; Schellenberg, GD				Payami, H; Zareparsi, S; Montee, KR; Sexton, GJ; Kaye, JA; Bird, TD; Yu, CE; Wijsman, EM; Heston, LL; Litt, M; Schellenberg, GD			Gender difference in Apolipoprotein E-associated risk for familial Alzheimer disease: A possible clue to the higher incidence of Alzheimer disease in women	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESTROGEN REPLACEMENT THERAPY; E POLYMORPHISM; DEMENTING ILLNESSES; SENILE DEMENTIA; PREVALENCE; POPULATION; ONSET; RELATIVES; ALLELE	Late-onset Alzheimer disease (AD) is associated with the Apolipoprotein E (APOE)-epsilon 4 allele. In late-onset familial AD, women have a significantly higher risk of developing the disease than do men. The aim of this study was to determine whether the gender difference in familial AD is a function of APOE genotype. We studied 58 late-onset familial AD kindreds. Kaplan-Meier survival analysis was used to assess genotype-specific distributions of age at onset. Odds ratios were estimated by logistic regression with adjustment for age and by conditional logistic regression with stratification on families. All methods detected a significant gender difference for the epsilon 4 heterozygous genotype. Zn women, epsilon 4 heterozygotes had higher risk than those without epsilon 4; there was no significant difference between epsilon 4 heterozygotes and epsilon 4 homozygotes. In men, epsilon 4 heterozygotes had lower risk than epsilon 4 homozygotes; there was no significant difference between epsilon 4 heterozygotes and those without epsilon 4. A direct comparison of epsilon 4 heterozygous men and women revealed a significant twofold increased risk in women. We confirmed these results in 15 autopsy-confirmed AD kindreds from the National Cell Repository at Indiana University Alzheimer Disease Center. These observations are consistent with the increased incidence of familial AD in women and may be a critical clue to the role of gender in the pathogenesis of AD.	OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT SURG,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED & PREVENT MED,PORTLAND,OR 97201; VET AFFAIRS MED CTR,PORTLAND,OR; UNIV WASHINGTON,DIV NEUROL,WASHINGTON,DC; UNIV WASHINGTON,DIV MED GENET,WASHINGTON,DC; UNIV WASHINGTON,DEPT BIOSTAT,WASHINGTON,DC; UNIV WASHINGTON,DEPT PSYCHIAT,WASHINGTON,DC; VET AFFAIRS MED CTR,SEATTLE,WA 98108	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington; University of Washington; University of Washington; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Payami, H (corresponding author), OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,CDW-2,745 SW GAINES RD,PORTLAND,OR 97201, USA.			Kaye, Jeffrey/0000-0002-9971-3478	NATIONAL INSTITUTE ON AGING [U24AG021886, P50AG005136] Funding Source: NIH RePORTER; NIA NIH HHS [U24 AG021886, AG05136, AG0817] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARONSON MK, 1990, NEUROLOGY, V40, P1102, DOI 10.1212/WNL.40.7.1102; BACHMAN DL, 1992, NEUROLOGY, V42, P115, DOI 10.1212/WNL.42.1.115; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; BARRETTCONNOR E, 1993, JAMA-J AM MED ASSOC, V269, P2637, DOI 10.1001/jama.269.20.2637; BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; BREITNER JCS, 1988, NEUROLOGY, V38, P207; BRENNER DE, 1994, AM J EPIDEMIOL, V140, P262, DOI 10.1093/oxfordjournals.aje.a117245; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORDER EH, 1995, JAMA-J AM MED ASSOC, V273, P373, DOI 10.1001/jama.273.5.373; COUDERC R, 1993, STROKE, V24, P661, DOI 10.1161/01.STR.24.5.661; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EDWARDS JK, 1991, J AM GERIATR SOC, V39, P477, DOI 10.1111/j.1532-5415.1991.tb02493.x; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FITCH N, 1988, ANN NEUROL, V23, P14, DOI 10.1002/ana.410230104; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; HIXSON JE, 1990, J LIPID RES, V31, P545; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; HONJO H, 1989, J STEROID BIOCHEM, V34, P521; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; KAMINO K, 1992, AM J HUM GENET, V51, P998; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; KATZMAN R, 1994, ALZHEIMERS DISEASE S; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; Kleinbaum DG, 1994, LOGISTIC REGRESSION; KOKMEN E, 1988, NEUROLOGY, V38, P975, DOI 10.1212/WNL.38.6.975; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; PAYAMI H, 1994, AM J HUM GENET, V54, P650; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Payami H, 1996, NEUROLOGY, V46, P126, DOI 10.1212/WNL.46.1.126; PAYAMI H, 1993, LANCET, V342, P737; PAYNE MN, 1992, LANCET, V340, P1350, DOI 10.1016/0140-6736(92)92532-K; PEDROBOTET J, 1992, STROKE, V23, P1556, DOI 10.1161/01.STR.23.11.1556; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; RAO VS, 1994, AM J HUM GENET, V55, P991; REILLY SL, 1994, AM J HUM GENET, V55, P1001; ROBINSON D, 1994, J AM GERIATR SOC, V42, P919, DOI 10.1111/j.1532-5415.1994.tb06580.x; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; SILVERMAN JM, 1994, NEUROLOGY, V44, P1253, DOI 10.1212/WNL.44.7.1253; TSAI MS, 1994, AM J HUM GENET, V54, P643; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; VONBOCKXMEER FM, 1992, LANCET, V340, P879; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; YASUDA M, 1995, ALZHEIMER RES, V1, P77	53	201	201	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					803	811						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644745				2022-12-18	WOS:A1996UA38000019
J	ENG, CM; RESNICKSILVERMAN, LA; NIEHAUS, DJ; ASTRIN, KH; DESNICK, RJ				ENG, CM; RESNICKSILVERMAN, LA; NIEHAUS, DJ; ASTRIN, KH; DESNICK, RJ			NATURE AND FREQUENCY OF MUTATIONS IN THE ALPHA-GALACTOSIDASE-A GENE THAT CAUSE FABRY DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							A-GENE; NUCLEOTIDE-SEQUENCE; ATYPICAL VARIANT; POINT MUTATIONS; DNA; SUBSTITUTION; DIAGNOSIS; REARRANGEMENTS; IDENTIFICATION; HETEROZYGOTES	Fabry disease, an X-linked inborn error of glycosphingolipid catabolism, results from mutations in the alpha-galactosidase A (alpha-Gal A) gene at Xq22.1. To determine the nature and frequency of the molecular lesions causing the classical and milder-variant Fabry phenotypes, and for precise carrier detection in Fabry families, the alpha-Gal A transcripts or genomic sequences from unrelated Fabry hemizygotes were analyzed. In patients with the classical phenotype, 18 new mutations were identified: N34S, C56G, W162R, R227X, R227X, D264V, D266V, S237F, D313Y, G328A, W340X, E398X, IVS2+2, IVS5 Delta-2,3, 773 Delta 2, 954 Delta 5, 1016 Delta 11, and 1123 Delta 53. Unrelated asymptomatic or mildly affected patients with symptoms confined to the heart had a missense mutation, N215S, that expressed residual enzymatic activity. Related, moderately affected patients with late-onset cardiac and pulmonary manifestations had a small deletion, 1208 Delta 3, that predicted the in-frame deletion of arginine 404 near the terminus of the 429 residue enzyme polypeptide. In addition, five small gene rearrangements involving exonic sequences were identified in unrelated classically affected patients. Two small deletions and one small duplication had short direct repeats at their respective breakpoint junctions and presumably resulted from slipped mispairing. A deletion occurred at alpha potential polymerase a arrest site, while the breakpoints of another deletion occurred at an inverted tetranucleotide repeat. Screening of unrelated Fabry patients with allele-specific oligonucleotides for seven mutations revealed that these were private, with the notable exception of N215S, R227Q, and R227X, which were each found in several unrelated families from different ethnic backgrounds. The CpG dinucleotide at codon 227 was the most common site of mutation, having been altered in 5% of the 148 unrelated Fabry alleles. These studies revealed that most alpha-Gal A lesions were private, that codon 227 was a mutational hot spot, and that certain mutations predicted a milder disease phenotype.	MT SINAI SCH MED,DEPT HUMAN GENET,NEW YORK,NY 10029	Icahn School of Medicine at Mount Sinai				Niehaus, Dana/0000-0001-9696-5605	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [5 MO1 RR00071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [5 RO1 DK34045] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEAUDET AL, 1978, CLIN GENET, V13, P251; BERNSTEIN HS, 1989, J CLIN INVEST, V83, P1390, DOI 10.1172/JCI114027; BISHOP DF, 1981, AM J HUM GENET, V33, pA71; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; BISHOP DF, 1986, P NATL ACAD SCI USA, V83, P4859, DOI 10.1073/pnas.83.13.4859; BISHOP DF, 1988, LIPID STORAGE DISORD, P809; BOTTEMA CDK, 1989, NUCLEIC ACIDS RES, V17, P10139, DOI 10.1093/nar/17.23.10139; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER DN, 1991, HUM GENET, V87, P409; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DEPAMPHILIS ML, 1980, ANNU REV BIOCHEM, V49, P627, DOI 10.1146/annurev.bi.49.070180.003211; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; DESNICK RJ, IN PRESS METABOLIC B; Desnick RJBD., 1989, METABOLIC BASIS INHE, V6, P1751; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Eng Christine M., 1993, Pediatric Research, V33, p128A; HOWELLS DW, 1990, AM J HUM GENET, V47, P279; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; ISHII S, 1992, HUM GENET, V89, P29, DOI 10.1007/BF00207037; ISHII S, 1991, ANN NEUROL, V29, P560, DOI 10.1002/ana.410290517; KOIDE T, 1990, FEBS LETT, V259, P353, DOI 10.1016/0014-5793(90)80046-L; KORNREICH R, 1990, J BIOL CHEM, V265, P9319; KORNREICH R, 1993, HUM MUTAT, V2, P108, DOI 10.1002/humu.1380020208; KORNREICH R, 1989, NUCLEIC ACIDS RES, V17, P3301, DOI 10.1093/nar/17.8.3301; KORNREICH R, 1989, T ASSOC AM PHYSICIAN, V102, P30; KRAWCZAK M, 1991, HUM GENET, V86, P425; ROMEO G, 1970, SCIENCE, V170, P180, DOI 10.1126/science.170.3954.180; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAKURABA H, 1992, GENOMICS, V12, P643, DOI 10.1016/0888-7543(92)90288-4; SAKURABA H, 1990, AM J HUM GENET, V47, P784; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VETRIE D, 1993, GENOMICS, V15, P631, DOI 10.1006/geno.1993.1118; VONSCHEIDT W, 1991, NEW ENGL J MED, V324, P395, DOI 10.1056/NEJM199102073240607; WANG AM, 1990, J CLIN INVEST, V86, P1752, DOI 10.1172/JCI114901; WEAVER DT, 1982, J BIOL CHEM, V257, P2075	40	201	213	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1186	1197						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	7504405				2022-12-18	WOS:A1993MJ81800005
J	LEDBETTER, DH; RICH, DC; OCONNELL, P; LEPPERT, M; CAREY, JC				LEDBETTER, DH; RICH, DC; OCONNELL, P; LEPPERT, M; CAREY, JC			PRECISE LOCALIZATION OF NFI TO 17Q11.2 BY BALANCED TRANSLOCATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	LEDBETTER, DH (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20619] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BLOOMFIELD CD, 1987, CYTOGENET CELL GENET, V46, P344, DOI 10.1159/000132485; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; BOYD Y, 1987, CLIN GENET, V31, P265; BOYD Y, 1986, J MED GENET, V23, P484, DOI 10.1136/jmg.23.6.484; FERRO MT, 1981, CANCER GENET CYTOGEN, V4, P89; FOUNTAIN JW, 1989, AM J HUM GENET, V44, P58; Harnden DG, 1985, INT SYSTEM HUMAN CYT; LEBEAU MM, 1986, CANCER GENET CYTOGEN, V20, P175, DOI 10.1016/0165-4608(86)90124-X; MITELMAN F, 1986, CANCER GENET CYTOGEN, V22, P95, DOI 10.1016/0165-4608(86)90168-8; OCONNELL P, 1989, AM J HUM GENET, V44, P51; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEIZINGER BR, 1987, CELL, V49, P389; SHEER D, 1985, ANN HUM GENET, V49, P167, DOI 10.1111/j.1469-1809.1985.tb01690.x; Skolnick M H, 1987, Genomics, V1, P382, DOI 10.1016/0888-7543(87)90043-7; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1	17	201	203	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					20	24						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2491776				2022-12-18	WOS:A1989R559600004
J	KULOZIK, AE; WAINSCOAT, JS; SERJEANT, GR; KAR, BC; ALAWAMY, B; ESSAN, GJF; FALUSI, AG; HAQUE, SK; HILALI, AM; KATE, S; RANASINGHE, WAEP; WEATHERALL, DJ				KULOZIK, AE; WAINSCOAT, JS; SERJEANT, GR; KAR, BC; ALAWAMY, B; ESSAN, GJF; FALUSI, AG; HAQUE, SK; HILALI, AM; KATE, S; RANASINGHE, WAEP; WEATHERALL, DJ			GEOGRAPHICAL SURVEY OF BETA-S-GLOBIN GENE HAPLOTYPES - EVIDENCE FOR AN INDEPENDENT ASIAN ORIGIN OF THE SICKLE-CELL MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHN RADCLIFFE HOSP, DEPT HAEMATOL, OXFORD OX3 9DU, ENGLAND; UNIV W INDIES, MRC LAB, KINGSTON 7, JAMAICA; VSS MED COLL, DEPT MED, BURLA, ORISSA, INDIA; KING FAISAL UNIV, DEPT PAEDIAT, DAMMAM, SAUDI ARABIA; UNIV IBADAN, DEPT HAEMATOL, IBADAN, NIGERIA; RIYADH ARMED FORCES HOSP, DEPT HAEMATOL, RIYADH, SAUDI ARABIA; BJ MED COLL, DEPT PAEDIAT, PUNA, INDIA; ABDULLA FOUAD HOSP, DEPT HAEMATOL, DAMMAM, SAUDI ARABIA	University of Oxford; University West Indies Mona Jamaica; Imam Abdulrahman Bin Faisal University; King Faisal University; University of Ibadan; Prince Sultan Military Medical City	KULOZIK, AE (corresponding author), UNIV OXFORD, JOHN RADCLIFFE HOSP, NUFFIELD DEPT MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND.		Kulozik, Andreas/AAO-2432-2020					ACQUAYE JK, 1985, BRIT J HAEMATOL, V60, P99, DOI 10.1111/j.1365-2141.1985.tb07390.x; ALI SA, 1970, BRIT J HAEMATOL, V19, P613, DOI 10.1111/j.1365-2141.1970.tb01645.x; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; BAKIOGLU I, 1985, AM J HEMATOL, V20, P297, DOI 10.1002/ajh.2830200313; Bodmer W. F., 1976, GENETICS EVOLUTION M; Bowles G., 1977, PEOPLE ASIA; BRITTENHAM G, 1979, AM J HEMATOL, V6, P107, DOI 10.1002/ajh.2830060203; GILMAN JG, 1985, ANN NY ACAD SCI, V445, P235, DOI 10.1111/j.1749-6632.1985.tb17193.x; HAGHSHENASS M, 1977, J MED GENET, V14, P168, DOI 10.1136/jmg.14.3.168; KAN YW, 1980, SCIENCE, V209, P388, DOI 10.1126/science.7384810; LABIE D, 1985, P NATL ACAD SCI USA, V82, P2111, DOI 10.1073/pnas.82.7.2111; LEHMANN H, 1963, NATURE, V198, P492, DOI 10.1038/198492b0; MEARS JG, 1981, BLOOD, V58, P599; MEARS JG, 1981, J CLIN INVEST, V68, P606, DOI 10.1172/JCI110294; MILLER BA, 1985, BLOOD, V66, pA62; MOURANT AE, 1983, BLOOD RELATIONS BLOO, P67; NAGEL R L, 1984, Einstein Quarterly Journal of Biology and Medicine, V2, P53; NAGEL RL, 1985, NEW ENGL J MED, V312, P880, DOI 10.1056/NEJM198504043121403; OLD JM, 1982, METHODS HAEMATOLOGY, P74; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; PEMBREY ME, 1978, BRIT J HAEMATOL, V40, P415, DOI 10.1111/j.1365-2141.1978.tb05813.x; PERRINE RP, 1978, ANN INTERN MED, V88, P1, DOI 10.7326/0003-4819-88-1-1; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; Wainscoat J S, 1983, Mol Biol Med, V1, P191; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WAINSCOAT JS, 1985, BRIT J HAEMATOL, V60, P261, DOI 10.1111/j.1365-2141.1985.tb07412.x; WEATHERALL DJ, 1985, ANN NY ACAD SCI, V445, P68, DOI 10.1111/j.1749-6632.1985.tb17176.x; WEATHERALL DJ, 1981, THALASSAEMIA SYNDROM, P108	29	201	209	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					239	244						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E1459	3752087				2022-12-18	WOS:A1986E145900010
J	Saxena, R; Elbers, CC; Guo, YR; Peter, I; Gaunt, TR; Mega, JL; Lanktree, MB; Tare, A; Castillo, BA; Li, YR; Johnson, T; Bruinenberg, M; Gilbert-Diamond, D; Rajagopalan, R; Voight, BF; Balasubramanyam, A; Barnard, J; Bauer, F; Baumert, J; Bhangale, T; Bohm, BO; Braund, PS; Burton, PR; Chandrupatla, HR; Clarke, R; Cooper-DeHoff, RM; Crook, ED; Davey-Smith, G; Day, IN; de Boer, A; de Groot, MCH; Drenos, F; Ferguson, J; Fox, CS; Furlong, CE; Gibson, Q; Gieger, C; Gilhuijs-Pederson, LA; Glessner, JT; Goel, A; Gong, Y; Grant, SFA; Grobbee, DE; Hastie, C; Humphries, SE; Kim, CE; Kivimaki, M; Kleber, M; Meisinger, C; Kumari, M; Langaee, TY; Lawlor, DA; Li, MY; Lobmeyer, MT; Maitland-van der Zee, AH; Meijs, MFL; Molony, CM; Morrow, DA; Murugesan, G; Musani, SK; Nelson, CP; Newhouse, SJ; O'Connell, JR; Padmanabhan, S; Palmen, J; Patel, SR; Pepine, CJ; Pettinger, M; Price, TS; Rafelt, S; Ranchalis, J; Rasheed, A; Rosenthal, E; Ruczinski, I; Shah, S; Shen, HQ; Silbernagel, G; Smith, EN; Spijkerman, AWM; Stanton, A; Steffes, MW; Thorand, B; Trip, M; van der Harst, P; van der A, DL; van Iperen, EPA; van Setten, J; van Vliet-Ostaptchouk, JV; Verweij, N; Wolffenbuttel, BHR; Young, T; Zafarmand, MH; Zmuda, JM; Boehnke, M; Altshuler, D; McCarthy, M; Kao, WHL; Pankow, JS; Cappola, TP; Sever, P; Poulter, N; Caulfield, M; Dominiczak, A; Shields, DC; Bhatt, DL; Zhang, L; Curtis, SP; Danesh, J; Casas, JP; van der Schouw, YT; Onland-Moret, NC; Doevendans, PA; Dorn, GW; Farrall, M; FitzGerald, GA; Hamsten, A; Hegele, R; Hingorani, AD; Hofker, MH; Huggins, GS; Illig, T; Jarvik, GP; Johnson, JA; Klungel, OH; Knowler, WC; Koenig, W; Marz, W; Meigs, JB; Melander, O; Munroe, PB; Mitchell, BD; Bielinski, SJ; Rader, DJ; Reilly, MP; Rich, SS; Rotter, JI; Saleheen, D; Samani, NJ; Schadt, EE; Shuldiner, AR; Silverstein, R; Kottke-Marchant, K; Talmud, PJ; Watkins, H; Asselbergs, FW; de Bakker, PIW; McCaffery, J; Wijmenga, C; Sabatine, MS; Wilson, JG; Reiner, A; Bowden, DW; Hakonarson, H; Siscovick, DS; Keating, BJ				Saxena, Richa; Elbers, Clara C.; Guo, Yiran; Peter, Inga; Gaunt, Tom R.; Mega, Jessica L.; Lanktree, Matthew B.; Tare, Archana; Almoguera Castillo, Berta; Li, Yun R.; Johnson, Toby; Bruinenberg, Marcel; Gilbert-Diamond, Diane; Rajagopalan, Ramakrishnan; Voight, Benjamin F.; Balasubramanyam, Ashok; Barnard, John; Bauer, Florianne; Baumert, Jens; Bhangale, Tushar; Boehm, Bernhard O.; Braund, Peter S.; Burton, Paul R.; Chandrupatla, Hareesh R.; Clarke, Robert; Cooper-DeHoff, Rhonda M.; Crook, Errol D.; Davey-Smith, George; Day, Ian N.; de Boer, Anthonius; de Groot, Mark C. H.; Drenos, Fotios; Ferguson, Jane; Fox, Caroline S.; Furlong, Clement E.; Gibson, Quince; Gieger, Christian; Gilhuijs-Pederson, Lisa A.; Glessner, Joseph T.; Goel, Anuj; Gong, Yan; Grant, Struan F. A.; Grobbee, Diederick E.; Hastie, Claire; Humphries, Steve E.; Kim, Cecilia E.; Kivimaki, Mika; Kleber, Marcus; Meisinger, Christa; Kumari, Meena; Langaee, Taimour Y.; Lawlor, Debbie A.; Li, Mingyao; Lobmeyer, Maximilian T.; Maitland-van der Zee, Anke-Hilse; Meijs, Matthijs F. L.; Molony, Cliona M.; Morrow, David A.; Murugesan, Gurunathan; Musani, Solomon K.; Nelson, Christopher P.; Newhouse, Stephen J.; O'Connell, Jeffery R.; Padmanabhan, Sandosh; Palmen, Jutta; Patel, Sanjey R.; Pepine, Carl J.; Pettinger, Mary; Price, Thomas S.; Rafelt, Suzanne; Ranchalis, Jane; Rasheed, Asif; Rosenthal, Elisabeth; Ruczinski, Ingo; Shah, Sonia; Shen, Haiqing; Silbernagel, Guenther; Smith, Erin N.; Spijkerman, Annemieke W. M.; Stanton, Alice; Steffes, Michael W.; Thorand, Barbara; Trip, Mieke; van der Harst, Pim; van der A, Daphne L.; van Iperen, Erik P. A.; van Setten, Jessica; van Vliet-Ostaptchouk, Jana V.; Verweij, Niek; Wolffenbuttel, Bruce H. R.; Young, Taylor; Zafarmand, M. Hadi; Zmuda, Joseph M.; Boehnke, Michael; Altshuler, David; McCarthy, Mark; Kao, W. H. Linda; Pankow, James S.; Cappola, Thomas P.; Sever, Peter; Poulter, Neil; Caulfield, Mark; Dominiczak, Anna; Shields, Denis C.; Bhatt, Deepak L.; Zhang, Li; Curtis, Sean P.; Danesh, John; Casas, Juan P.; van der Schouw, Yvonne T.; Onland-Moret, N. Charlotte; Doevendans, Pieter A.; Dorn, Gerald W., II; Farrall, Martin; FitzGerald, Garret A.; Hamsten, Anders; Hegele, Robert; Hingorani, Aroon D.; Hofker, Marten H.; Huggins, Gordon S.; Illig, Thomas; Jarvik, Gail P.; Johnson, Julie A.; Klungel, Olaf H.; Knowler, William C.; Koenig, Wolfgang; Maerz, Winfried; Meigs, James B.; Melander, Olle; Munroe, Patricia B.; Mitchell, Braxton D.; Bielinski, Susan J.; Rader, Daniel J.; Reilly, Muredach P.; Rich, Stephen S.; Rotter, Jerome I.; Saleheen, Danish; Samani, Nilesh J.; Schadt, Eric E.; Shuldiner, Alan R.; Silverstein, Roy; Kottke-Marchant, Kandice; Talmud, Philippa J.; Watkins, Hugh; Asselbergs, Folkert W.; de Bakker, Paul I. W.; McCaffery, Jeanne; Wijmenga, Cisca; Sabatine, Marc S.; Wilson, James G.; Reiner, Alex; Bowden, Donald W.; Hakonarson, Hakon; Siscovick, David S.; Keating, Brendan J.		Look AHEAD Res Grp; Diagram Consortium; ASCOT Investigators; PROCARDIS	Large-Scale Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; COMMON VARIANTS; SUSCEPTIBILITY LOCI; EUROPEAN AMERICANS; AFRICAN-AMERICANS; BLOOD-PRESSURE; RISK LOCI; SNP ARRAY; POPULATION	To identify genetic factors contributing to type 2 diabetes (T2D), we performed large-scale meta-analyses by using a custom similar to 50,000 SNP genotyping array (the ITMAT-Broad-CARe array) with similar to 2000 candidate genes in 39 multiethnic population-based studies, case-control studies, and clinical trials totaling 17,418 cases and 70,298 controls. First, meta-analysis of 25 studies comprising 14,073 cases and 57,489 controls of European descent confirmed eight established T2D loci at genome-wide significance. In silico follow-up analysis of putative association signals found in independent genome-wide association studies (including 8,130 cases and 38,987 controls) performed by the DIAGRAM consortium identified a T2D locus at genome-wide significance (GATAD2A/CILP2/PBX4; p = 5.7 x 10(-9)) and two loci exceeding study-wide significance (SREBF1, and TH/INS; p < 2.4 x 10(-6)). Second, meta-analyses of 1,986 cases and 7,695 controls from eight African-American studies identified study-wide-significant (p = 2.4 x 10(-7)) variants in HMGA2 and replicated variants in TCF7L2 (p = 5.1 x 10(-15)). Third, conditional analysis revealed multiple known and novel independent signals within five T2D-associated genes in samples of European ancestry and within HMGA2 in African-American samples. Fourth, a multiethnic meta-analysis of all 39 studies identified T2D-associated variants in BCL2 (p = 2.1 x 10(-8)). Finally, a composite genetic score of SNPs from new and established T2D signals was significantly associated with increased risk of diabetes in African-American, Hispanic, and Asian populations. In summary, large-scale meta-analysis involving a dense gene-centric approach has uncovered additional loci and variants that contribute to T2D risk and suggests substantial overlap of T2D association signals across multiple ethnic groups.	[Saxena, Richa; Tare, Archana; Voight, Benjamin F.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Saxena, Richa; Tare, Archana; Voight, Benjamin F.; Young, Taylor; Altshuler, David; de Bakker, Paul I. W.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Saxena, Richa] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Elbers, Clara C.] Univ Penn, Dept Genet, Sch Med, Philadelphia, PA 19104 USA; [Elbers, Clara C.; Bauer, Florianne; Onland-Moret, N. Charlotte; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Complex Genet Sect, Dept Med Genet, Utrecht, Netherlands; [Elbers, Clara C.; Bauer, Florianne; Grobbee, Diederick E.; van der Schouw, Yvonne T.; Onland-Moret, N. Charlotte; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Guo, Yiran; Almoguera Castillo, Berta; Li, Yun R.; Glessner, Joseph T.; Grant, Struan F. A.; Kim, Cecilia E.; Hakonarson, Hakon; Keating, Brendan J.] Childrens Hosp, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Guo, Yiran] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Peter, Inga] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Gaunt, Tom R.; Davey-Smith, George; Day, Ian N.; Lawlor, Debbie A.] Univ Bristol, Med Res Council Ctr Causal Anal Translat Epidemio, Dept Social Med, Bristol BS8 2BN, Avon, England; [Mega, Jessica L.; Morrow, David A.; Sabatine, Marc S.] Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct Study Grp, Boston, MA 02115 USA; [Lanktree, Matthew B.; Hegele, Robert] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Almoguera Castillo, Berta] Fdn Jimenez Diaz, Serv Genet, Inst Invest Sanitaria, Madrid 228040, Spain; [Johnson, Toby; Newhouse, Stephen J.; Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Genome Ctr, London EC1M 6BQ, England; [Johnson, Toby; Newhouse, Stephen J.; Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England; [Bruinenberg, Marcel] Univ Groningen, LifeLines Cohort Study & Biobank, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Gilbert-Diamond, Diane] Childrens Environm Hlth & Dis Prevent Ctr Dartmou, Hanover, NH 03755 USA; [Gilbert-Diamond, Diane] Dartmouth Med Sch, Sect Biostat & Epidemiol, Dept Community & Family Med, Hanover, NH 03756 USA; [Rajagopalan, Ramakrishnan; Furlong, Clement E.; Ranchalis, Jane; Rosenthal, Elisabeth; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Balasubramanyam, Ashok] Baylor Coll Med, Translat Metab Unit, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Barnard, John; Zhang, Li] Cleveland Clin, Dept Quantitat Hlth Sci, Lerner Res Inst, Cleveland, OH 44195 USA; [Baumert, Jens; Meisinger, Christa; Thorand, Barbara] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Bhangale, Tushar; Furlong, Clement E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Boehm, Bernhard O.] Cardiol Grp Frankfurt Sachsenhausen, D-60598 Frankfurt, Germany; [Braund, Peter S.; Nelson, Christopher P.; Rafelt, Suzanne; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England; [Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Chandrupatla, Hareesh R.; Ferguson, Jane; Li, Mingyao; Cappola, Thomas P.; Rader, Daniel J.; Reilly, Muredach P.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Clarke, Robert] Clin Trial Serv Unit, Oxford OX3 7LF, England; [Cooper-DeHoff, Rhonda M.; Langaee, Taimour Y.; Johnson, Julie A.] Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, Gainesville, FL 32610 USA; [Cooper-DeHoff, Rhonda M.; Gong, Yan; Lobmeyer, Maximilian T.; Pepine, Carl J.; Johnson, Julie A.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA; [Crook, Errol D.] Univ S Alabama, Mobile, AL 36608 USA; [de Boer, Anthonius; de Groot, Mark C. H.; Gilhuijs-Pederson, Lisa A.; Maitland-van der Zee, Anke-Hilse; Klungel, Olaf H.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, Fac Sci, Utrecht, Netherlands; [Drenos, Fotios; Humphries, Steve E.; Palmen, Jutta; Talmud, Philippa J.] UCL, Ctr Cardiovasc Genet, Dept Med, London WC1E 6JF, England; [Fox, Caroline S.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Gibson, Quince; O'Connell, Jeffery R.; Shen, Haiqing; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Gieger, Christian; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Goel, Anuj; McCarthy, Mark; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Hastie, Claire; Padmanabhan, Sandosh; Dominiczak, Anna] Univ Glasgow, British Heart Fdn Glasgow, Cardiovasc Res Ctr, Div Cardiovasc & Med Sci,Western Infirm, Glasgow G12 8TA, Lanark, Scotland; [Kivimaki, Mika; Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kivimaki, Mika; Kumari, Meena] UCL, Genet Epidemiol Grp, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Kleber, Marcus] LURIC Study, D-79098 Freiburg, Germany; [Kleber, Marcus; Maerz, Winfried] Synlab Ctr Lab Diagnost Heidelberg, D-69037 Heidelberg, Germany; [Meijs, Matthijs F. L.; Zafarmand, M. Hadi; Doevendans, Pieter A.; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Molony, Cliona M.] Rosetta Inpharmat, Dept Genet, Seattle, WA 98109 USA; [Murugesan, Gurunathan] Cleveland Clin, Dept Clin Pathol, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Musani, Solomon K.; Wilson, James G.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Patel, Sanjey R.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Pettinger, Mary; Reiner, Alex] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Price, Thomas S.] Kings Coll London, Med Res Council, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Rasheed, Asif; Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Ruczinski, Ingo] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Shah, Sonia] UCL, Univ Coll Genet Inst, London WC1E 6BT, England; [Silbernagel, Guenther] Univ Tubingen, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, Dept Internal Med, D-72074 Tubingen, Germany; [Smith, Erin N.] Scripps Genom Med, La Jolla, CA 92037 USA; [Spijkerman, Annemieke W. M.; van der A, Daphne L.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Stanton, Alice] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Steffes, Michael W.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Trip, Mieke] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [van der Harst, Pim; Verweij, Niek] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [van der Harst, Pim; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [van Iperen, Erik P. A.] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [van Setten, Jessica; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Zmuda, Joseph M.] Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Boehnke, Michael] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Altshuler, David; Meigs, James B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [McCarthy, Mark] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Kao, W. H. Linda] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; [Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN 55454 USA; [Sever, Peter; Poulter, Neil] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1PG, England; [Shields, Denis C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Cambridge, MA 02115 USA; [Curtis, Sean P.; Saleheen, Danish] Merck Res Labs, Rahway, NJ 07065 USA; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Dorn, Gerald W., II; Watkins, Hugh] Washington Univ, Ctr Pharmacogenet, St Louis, MO 63110 USA; [Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Oxford OX3 9DU, England; [FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Sch Med, Philadelphia, PA 19146 USA; [Hamsten, Anders] Karolinska Inst, Cardiovasc Genet Grp, Atherosclerosis Res Unit, Dept Med Solna, SE-17176 Stockholm, Sweden; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, Dept Med, London WC1E 6JF, England; [Huggins, Gordon S.] Tufts Med Ctr, Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA 02114 USA; [Huggins, Gordon S.] Tufts Univ, Boston, MA 02114 USA; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Knowler, William C.] NIDDK, Phoenix, AZ 85104 USA; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Maerz, Winfried] Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Med Fac Mannheim, D-68167 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8010 Graz, Austria; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Melander, Olle] Malmo Univ Hosp, Clin Res Ctr, SE-20502 Malmo, Sweden; [Bielinski, Susan J.] Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN 55905 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22902 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA 98109 USA; [Silverstein, Roy] Case Western Reserve Univ, Dept Cell Biol, Lerner Res Inst,Dept Mol Med, Cleveland Clin Fdn,Cleveland Clin Lerner Coll Med, Cleveland, OH 44195 USA; [Kottke-Marchant, Kandice] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA; [McCaffery, Jeanne] Brown Univ, Miriam Hosp, Weight Control & Diabet Res Ctr, Providence, RI 02906 USA; [McCaffery, Jeanne] Brown Univ, Warren Alpert Sch Med, Providence, RI 02906 USA; [Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27106 USA; [Hakonarson, Hakon; Keating, Brendan J.] Childrens Hosp, Div Human Genet, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; Keating, Brendan J.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Beijing Genomics Institute (BGI); Icahn School of Medicine at Mount Sinai; University of Bristol; Harvard University; Brigham & Women's Hospital; Western University (University of Western Ontario); Fundacion Jimenez Diaz; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Groningen; Dartmouth College; University of Washington; University of Washington Seattle; Baylor College of Medicine; Cleveland Clinic Foundation; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Washington; University of Washington Seattle; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester; University of Pennsylvania; University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of South Alabama; Utrecht University; University of London; University College London; Boston University; University System of Maryland; University of Maryland Baltimore; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; Wellcome Centre for Human Genetics; University of Glasgow; University of London; University College London; University of London; University College London; SYNLAB Group; Utrecht University; Utrecht University Medical Center; Merck & Company; Cleveland Clinic Foundation; University of Mississippi; University of Mississippi Medical Center; Harvard University; Brigham & Women's Hospital; Fred Hutchinson Cancer Center; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; University College London; Eberhard Karls University of Tubingen; Netherlands National Institute for Public Health & the Environment; Royal College of Surgeons - Ireland; University of Minnesota System; University of Minnesota Twin Cities; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of Groningen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Imperial College London; University College Dublin; Harvard University; Merck & Company; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Washington University (WUSTL); University of Oxford; University of Pennsylvania; Pennsylvania Medicine; Karolinska Institutet; University of London; University College London; Tufts Medical Center; Tufts University; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Ulm University; Ruprecht Karls University Heidelberg; Medical University of Graz; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; Mayo Clinic; University of Virginia; Cedars Sinai Medical Center; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Wake Forest University; Wake Forest Baptist Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Saxena, R (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	rsaxena@chgr.mgh.harvard.edu; keatingb@email.chop.edu	Hegele, Robert/G-3301-2011; Meitinger, Thomas/O-1318-2015; Mitchell, Braxton/CAF-0876-2022; Verweij, Niek/A-4499-2017; Smith, Erin/E-5933-2011; Meisinger, Christine/B-5358-2014; Asselbergs, Folkert W./ABD-6752-2021; Guo, Yiran/H-4120-2011; Wijmenga, Cisca/AAE-7719-2019; Saxena, Richa/AAG-7279-2020; Onland-Moret, N. Charlotte/G-9185-2011; Altshuler, David M/A-4476-2009; Kivimaki, Mika/B-3607-2012; Rotter, Jerome/AAY-6598-2021; Ferguson, Jane/C-7154-2011; Gaunt, Tom R/O-3918-2014; van der Schouw, Yvonne T./F-8327-2014; Stanton, Alice V/F-4697-2012; Price, Thomas S./B-7372-2008; Burton, Paul R/H-7527-2016; Grobbee, Diederick/C-7651-2014; Sabatine, Marc/AAJ-6751-2020; de Bakker, Paul IW/B-8730-2009; Newhouse, Stephen J/C-9330-2011; Padmanabhan, Sandosh/S-3963-2016; Dominiczak, Anna F/P-9390-2017; Rajagopalan, Ramakrishnan/I-4349-2019; Verweij, Niek/ABC-6249-2021; de Groot, Mark CH/A-9891-2012; Wolffenbuttel, Bruce/A-8419-2011; Bielinski, Suzette/A-2238-2009; Lanktree, Matthew Bruce/I-9790-2019; Davey Smith, George/A-7407-2013; Wijmenga, Cisca/D-2173-2009; Meigs, James/P-3927-2019; Hegele, Robert/AAF-6482-2020; Jarvik, Gail P/N-6476-2014; Shah, Sonia/N-7547-2013; Thorand, Barbara/B-5349-2014; Rajagopalan, Ramakrishnan/Q-9018-2016; Maitland-van der Zee, Anke/I-9572-2016; McCarthy, Mark/M-3763-2015	Asselbergs, Folkert W./0000-0002-1692-8669; Wijmenga, Cisca/0000-0002-5635-1614; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Altshuler, David M/0000-0002-7250-4107; Kivimaki, Mika/0000-0002-4699-5627; Ferguson, Jane/0000-0001-6896-1025; Gaunt, Tom R/0000-0003-0924-3247; van der Schouw, Yvonne T./0000-0002-4605-435X; Price, Thomas S./0000-0001-7356-2109; Grobbee, Diederick/0000-0003-4472-4468; Sabatine, Marc/0000-0002-0691-3359; de Bakker, Paul IW/0000-0001-7735-7858; Newhouse, Stephen J/0000-0002-1843-9842; Dominiczak, Anna F/0000-0003-4913-3608; Verweij, Niek/0000-0002-4303-7685; de Groot, Mark CH/0000-0002-5764-5788; Wolffenbuttel, Bruce/0000-0001-9262-6921; Bielinski, Suzette/0000-0002-2905-5430; Lanktree, Matthew Bruce/0000-0002-5750-6286; Davey Smith, George/0000-0002-1407-8314; Meigs, James/0000-0002-2439-2657; Hegele, Robert/0000-0003-2861-5325; Jarvik, Gail P/0000-0002-6710-8708; Shah, Sonia/0000-0001-5860-4526; Thorand, Barbara/0000-0002-8416-6440; Patel, Sanjay/0000-0002-9142-5172; Shields, Denis/0000-0003-4015-2474; Padmanabhan, Sandosh/0000-0003-3869-5808; Drenos, Fotios/0000-0003-2469-5516; Kleber, Marcus/0000-0003-0663-7275; Rich, Stephen/0000-0003-3872-7793; Johnson, Toby/0000-0002-5998-3270; Talmud, Philippa/0000-0002-5560-1933; Reilly, Muredach/0000-0002-3035-9386; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Mitchell, Braxton/0000-0003-4920-4744; s, hema/0000-0002-3440-9475; Goel, Anuj/0000-0003-2307-4021; Pankow, James/0000-0001-7076-483X; Silbernagel, Guenther/0000-0001-9323-329X; Voight, Benjamin/0000-0002-6205-9994; Meisinger, Christa/0000-0002-9026-6544; Melander, Olle/0000-0002-2581-484X; Saxena, Richa/0000-0003-2233-1065; Stanton, Alice/0000-0002-4961-165X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; McCaffery, Jeanne/0000-0002-2166-5840; van Iperen, Erik/0000-0001-7107-3168; Hingorani, Aroon/0000-0001-8365-0081; Li, Yun Rose/0000-0002-8077-4975; Nelson, Christopher/0000-0001-8025-2897; Lawlor, Debbie A/0000-0002-6793-2262; Humphries, Stephen E/0000-0002-8221-6547; Gieger, Christian/0000-0001-6986-9554; Caulfield, Mark/0000-0001-9295-3594; Rajagopalan, Ramakrishnan/0000-0002-5751-9239; Glessner, Joseph/0000-0001-5131-2811; Watkins, Hugh/0000-0002-5287-9016; Koenig, Wolfgang/0000-0002-2064-9603; Shuldiner, Alan/0000-0001-9921-4305; Maitland-van der Zee, Anke/0000-0002-0414-3442; Kumari, Meena/0000-0001-9716-1035; Munroe, Patricia/0000-0002-4176-2947; McCarthy, Mark/0000-0002-4393-0510	National Heart, Lung, and Blood Institute; NIDDK NIH [DK089378]; Netherlands Organization for Scientific Research (NWO); Massachusetts Institute of Technology [N01-HC-65226]; MRC [G9521010, MC_U137686857, G0902037, G0600705] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/07/008/23674, RG/10/12/28456, RG/08/008/25291, PG/09/022/26739] Funding Source: researchfish; Medical Research Council [G9521010, G9817803B, G0902037, G19/35, MC_U137686857, G8802774, G0100222, G0600705] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074730, R01HL065226, ZIAHL006094, R01HL088577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK089378, K24DK080140, P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Massachusetts Institute of Technology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The CARe Consortium wishes to acknowledge the support of the National Heart, Lung, and Blood Institute and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. The following nine parent studies have contributed parent study data, ancillary study data, and DNA samples through the Broad Institute of Harvard University and the Massachusetts Institute of Technology (N01-HC-65226) to create this genotype/phenotype database for wide dissemination to the biomedical research community: the Atherosclerosis Risk in Communities (ARIC) study, the Cardiovascular Health Study (CHS), the Cleveland Family Study (CFS), the Cooperative Study of Sickle Cell Disease (CSSCD), the Coronary Artery Risk Development in Young Adults (CARDIA) study, the Framingham Heart Study (FHS), the Jackson Heart Study OHS), the Multi-Ethnic Study of Atherosclerosis (MESA), and the Sleep Heart Health Study (SHHS). R.S. is partially supported by NIDDK NIH R21 (DK089378). C.C.E is supported by a Rubicon grant from the Netherlands Organization for Scientific Research (NWO). Additional acknowledgements for each cohort are listed in the Supplemental Data. Also see the Supplemental Data for conflict-of-interest disclosures for some of the authors.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc13-S067, 10.2337/dc10-S062]; Barakat K, 2001, BEST PRACT RES CL EN, V15, P359, DOI 10.1053/beem.2001.0151; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bowden Donald W, 2010, Rev Diabet Stud, V7, P188, DOI 10.1900/RDS.2010.7.188; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Das Swapan Kumar, 2007, Curr Diab Rep, V7, P154, DOI 10.1007/s11892-007-0025-3; Diaz-Apodaca BA, 2010, REV PANAM SALUD PUBL, V28, P174, DOI 10.1590/S1020-49892010000900007; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153; Espeland MA, 2006, CLIN TRIALS, V3, P443, DOI 10.1177/1740774506070727; Espeland M, 2007, DIABETES CARE, V30, P1374; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Felder TK, 2007, INT J OBESITY, V31, P1099, DOI 10.1038/sj.ijo.0803505; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Gloyn AL, 2001, DIABETIC MED, V18, P206, DOI 10.1046/j.1464-5491.2001.00449.x; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grant SFA, 2010, ENDOCR REV, V31, P183, DOI 10.1210/er.2009-0029; Grarup N, 2008, DIABETES, V57, P1136, DOI 10.2337/db07-1534; Guo TW, 2007, DIABETES, V56, P3082, DOI 10.2337/db07-0621; Hansen SK, 2004, DIABETOLOGIA, V47, P1079, DOI 10.1007/s00125-004-1418-3; Harding AH, 2006, DIABETOLOGIA, V49, P2642, DOI 10.1007/s00125-006-0430-1; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Laudes M, 2004, DIABETES, V53, P842, DOI 10.2337/diabetes.53.3.842; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Lehtovirta M, 2010, DIABETOLOGIA, V53, P1314, DOI 10.1007/s00125-010-1746-4; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Meigs JB, 2005, J CLIN ENDOCR METAB, V90, P1137, DOI 10.1210/jc.2004-1212; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; North KE, 2003, INT J OBESITY, V27, P491, DOI 10.1038/sj.ijo.0802261; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Parra EJ, 2011, DIABETOLOGIA, V54, P2038, DOI 10.1007/s00125-011-2172-y; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulit SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012600; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Rao FW, 2010, CELL MOL NEUROBIOL, V30, P1391, DOI 10.1007/s10571-010-9535-7; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; She JX, 1996, IMMUNOL TODAY, V17, P323, DOI 10.1016/0167-5699(96)10014-1; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Stark K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001167; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wassel CL, 2011, BLOOD, V117, P268, DOI 10.1182/blood-2010-06-289546; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Williams RC, 2011, DIABETOLOGIA, V54, P1684, DOI 10.1007/s00125-011-2122-8; Winckler W, 2005, DIABETES, V54, P2336, DOI 10.2337/diabetes.54.8.2336; Winckler W, 2005, DIABETES, V54, P886, DOI 10.2337/diabetes.54.3.886; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang KX, 2010, CIRC-CARDIOVASC GENE, V3, P187, DOI 10.1161/CIRCGENETICS.109.904813	80	200	204	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					410	425		10.1016/j.ajhg.2011.12.022	http://dx.doi.org/10.1016/j.ajhg.2011.12.022			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22325160	Bronze, Green Published			2022-12-18	WOS:000301762800007
J	Farrington, SM; Tenesa, A; Barnetson, R; Wiltshire, A; Prendergast, J; Porteous, M; Campbell, H; Farrington, SM				Farrington, SM; Tenesa, A; Barnetson, R; Wiltshire, A; Prendergast, J; Porteous, M; Campbell, H; Farrington, SM			Germline susceptibility to colorectal cancer due to base-excision repair gene defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENOMATOUS POLYPOSIS; MYH; MUTATIONS; ASSOCIATION; NEOPLASIA; VARIANTS	DNA repair is a key process in the maintenance of genome integrity. Here, we present a large, systematically collected population- based association study ( 2,239 cases; 1,845 controls) that explores the contribution to colorectal cancer incidence of inherited defects in base- excision repair ( BER) genes. We show that biallelic MUTYH defects impart a 93- fold ( 95% CI 42 - 213) excess risk of colorectal cancer, which accounts for 0.8% of cases aged ! 55 years and 0.54% of the entire cohort. Penetrance for homozygous carriers was almost complete by age 60 years. Significantly more biallelic carriers had coexisting adenomatous polyps. However, notably, 36% of biallelic carriers had no polyps. Three patients with heterozygous MUTYH defects carried monoallelic mutations in other BER genes ( OGG1 and MTH1). Recessive inheritance accounted for the elevated risk for those aged ! 55 years. However, there was also a 1.68- fold ( 95% CI 1.07 - 2.95) excess risk for heterozygous carriers aged 155 years, with a population attributable risk in this age group of 0.93% ( 95% CI 0% - 2.0%). These data provide the strongest evidence to date for a causative role of BER defects in colorectal cancer etiology and show, to our knowledge for the first time, that heterozygous MUTYH mutations predispose to colorectal cancer later in life. These findings have clinical relevance for BER gene testing for patients with colorectal cancer and for genetic counseling of their relatives.	Univ Edinburgh, Sch Clin & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Dept Clin Genet, Edinburgh, Midlothian, Scotland; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Farrington, SM (corresponding author), Western Gen Hosp, MRC Human Genet Unit, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland.	Susan.Farrington@hgu.mrc.ac.uk		Tenesa, Albert/0000-0003-4884-4475; Prendergast, James/0000-0001-8916-018X	Medical Research Council [MC_U127527198] Funding Source: Medline; MRC [MC_U127527198] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Croitoru ME, 2004, JNCI-J NATL CANCER I, V96, P1631, DOI 10.1093/jnci/djh288; Enholm S, 2003, AM J PATHOL, V163, P827, DOI 10.1016/S0002-9440(10)63443-8; Fleischmann C, 2004, INT J CANCER, V109, P554, DOI 10.1002/ijc.20020; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Sampson JR, 2003, LANCET, V362, P39, DOI 10.1016/S0140-6736(03)13805-6; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Sieber OM, 2004, CANCER RES, V64, P8876, DOI 10.1158/0008-5472.CAN-04-2958; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070	10	200	204	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					112	119		10.1086/431213	http://dx.doi.org/10.1086/431213			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15931596	Green Published, Bronze			2022-12-18	WOS:000229794500010
J	Rees, JL				Rees, JL			The genetics of sun sensitivity in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MELANOCORTIN 1 RECEPTOR; NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMA; GLOBAL GENOME REPAIR; ULTRAVIOLET-RADIATION; INDUCED ERYTHEMA; COAT COLOR; RED HAIR; CONSTITUTIVE PIGMENTATION; QUANTITATIVE MEASURES	Humans vary >100-fold in their sensitivity to the harmful effects of ultraviolet radiation. The main determinants of sensitivity are melanin pigmentation and less-well-characterized differences in skin inflammation and repair processes. Pigmentation has a high heritability, but susceptibility to cancers of the skin, a key marker of sun sensitivity, is less heritable. Despite a large number of murine coat-color mutations, only one gene in humans, the melanocortin 1 receptor (MC1R), is known to account for substantial variation in skin and hair color and in skin cancer incidence. MC1R encodes a 317-amino acid G-coupled receptor that controls the relative amounts of the two major melanin classes, eumelanin and pheomelanin. Most persons with red hair are homozygous for alleles of the MC1R gene that show varying degrees of diminished function. More than 65 human MC1R alleles with nonsynonymous changes have been identified, and current evidence suggests that many of them vary in their physiological activity, such that a graded series of responses can be achieved on the basis of (i) dosage effects (of one or two alleles) and (ii) individual differences in the pharmacological profile in response to ligand. Thus, a single locus, identified within a Mendelian framework, can contribute significantly to human pigmentary variation.	Univ Edinburgh, Syst Grp, Grant Chair Dermatol, Edinburgh EH3 9HA, Midlothian, Scotland	University of Edinburgh	Rees, JL (corresponding author), Univ Edinburgh, Syst Grp, Grant Chair Dermatol, Room 4 018,1st Floor,Lauriston Bldg,Lauriston Pl, Edinburgh EH3 9HA, Midlothian, Scotland.	jonathan.rees@ed.ac.uk						Akey JM, 2001, HUM GENET, V108, P516, DOI 10.1007/s004390100524; Alaluf S, 2003, PIGM CELL RES, V16, P35, DOI 10.1034/j.1600-0749.2003.00005.x; Alaluf S, 2002, PIGM CELL RES, V15, P112, DOI 10.1034/j.1600-0749.2002.1o071.x; Alaluf S, 2002, PIGM CELL RES, V15, P119, DOI 10.1034/j.1600-0749.2002.1o072.x; Alaluf S, 2001, PIGM CELL RES, V14, P337, DOI 10.1034/j.1600-0749.2001.140505.x; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bastiaens M, 2001, HUM MOL GENET, V10, P1701, DOI 10.1093/hmg/10.16.1701; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Berg RJW, 1998, J INVEST DERMATOL, V110, P405, DOI 10.1111/j.1523-1747.1998.00173.x; BERTOLOTTO C, 2002, MECH SUNTANNING, P99; Bessou-Touya S, 1998, J INVEST DERMATOL, V111, P1103, DOI 10.1046/j.1523-1747.1998.00405.x; Bodmer W. F., 1976, GENETICS EVOLUTION M; Bohm M, 2004, J BIOL CHEM, V279, P6959, DOI 10.1074/jbc.M312549200; Bohm M, 2002, J INVEST DERMATOL, V118, P533, DOI 10.1046/j.0022-202x.2001.01704.x; Bohm M, 1999, EXP DERMATOL, V8, P453, DOI 10.1111/j.1600-0625.1999.tb00303.x; Bootsma D., 2001, METABOLIC MOL BASES, V1, P677; Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; CLARK P, 1981, ANN HUM BIOL, V8, P529, DOI 10.1080/03014468100005371; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Dwyer T, 1998, CANCER EPIDEM BIOMAR, V7, P203; Dwyer T, 2004, AM J EPIDEMIOL, V159, P826, DOI 10.1093/aje/kwh120; Dybdahl M, 1999, CANCER EPIDEM BIOMAR, V8, P77; EVERETT MA, 1961, ARCH DERMATOL, V84, P997, DOI 10.1001/archderm.1961.01580180113017; FARR PM, 1985, BRIT J DERMATOL, V113, P65, DOI 10.1111/j.1365-2133.1985.tb02045.x; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; GILCHREST BA, 1981, J AM ACAD DERMATOL, V5, P411, DOI 10.1016/S0190-9622(81)70103-8; Ha T, 2003, ANN NY ACAD SCI, V994, P339, DOI 10.1111/j.1749-6632.2003.tb03198.x; Ha T, 2003, PIGM CELL RES, V16, P477, DOI 10.1034/j.1600-0749.2003.00076.x; Ha T, 2000, ACTA DERM-VENEREOL, V80, P401; Ha TKK, 2003, EXP DERMATOL, V12, P514, DOI 10.1034/j.1600-0625.2003.00076.x; Hajeer AH, 2000, BRIT J DERMATOL, V142, P441, DOI 10.1046/j.1365-2133.2000.03353.x; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; HARRISON GA, 1964, ANN HUM GENET, V28, P27, DOI 10.1111/j.1469-1809.1964.tb00457.x; Hawk J.L.M., 1999, PHOTODERMATOLOGY, P5; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Healy E, 2000, LANCET, V355, P1072, DOI 10.1016/S0140-6736(00)02042-0; Hemminki K, 2001, GENET EPIDEMIOL, V20, P107, DOI 10.1002/1098-2272(200101)20:1<107::AID-GEPI9>3.0.CO;2-4; Holick MF, 2001, LANCET, V357, P4, DOI 10.1016/S0140-6736(00)03560-1; Hoover RN, 2000, NEW ENGL J MED, V343, P135, DOI 10.1056/NEJM200007133430210; HUNT G, 1994, J ENDOCRINOL, V140, pR1, DOI 10.1677/joe.0.140R001; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Kerb Reinhold, 2002, Am J Pharmacogenomics, V2, P147, DOI 10.2165/00129785-200202020-00007; Kijas JMH, 1998, GENETICS, V150, P1177; King RA, 2003, AM J HUM GENET, V73, P638, DOI 10.1086/377569; KING RA, 2001, METABOLIC MOL BASES, P5587; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Kolgen W, 2003, J INVEST DERMATOL, V121, P751, DOI 10.1046/j.1523-1747.2003.12476.x; KROMBERG JGR, 1989, CLIN GENET, V36, P43; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lear JT, 1997, J INVEST DERMATOL, V108, P519, DOI 10.1111/1523-1747.ep12289738; Liem EB, 2004, ANESTHESIOLOGY, V101, P279, DOI 10.1097/00000542-200408000-00006; Ling MK, 2003, EUR J BIOCHEM, V270, P1441, DOI 10.1046/j.1432-1033.2003.03506.x; LockAndersen J, 1997, ACTA DERM-VENEREOL, V77, P219; LOOKINGBILL DP, 1995, J AM ACAD DERMATOL, V32, P653, DOI 10.1016/0190-9622(95)90352-6; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Makova KD, 2001, GENETICS, V158, P1253; Manson C, 2004, J INVEST DERMATOL, V122, P1334, DOI 10.1111/j.0022-202X.2004.22526.x; Marks D F, 1996, J Health Psychol, V1, P7, DOI 10.1177/135910539600100102; McGregor JM, 2002, J INVEST DERMATOL, V119, P84, DOI 10.1046/j.1523-1747.2002.01655.x; McKenzie CA, 2003, J INVEST DERMATOL, V121, P207, DOI 10.1046/j.1523-1747.2003.12314.x; Milan T, 1998, BRIT J CANCER, V78, P1516, DOI 10.1038/bjc.1998.716; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Neel JV, 1943, J HERED, V34, P93, DOI 10.1093/oxfordjournals.jhered.a105256; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; OH C, IN PRESS J INVEST DE; Ortonne JP, 2002, BRIT J DERMATOL, V146, P11, DOI 10.1046/j.1365-2133.146.s61.4.x; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Ramsay HM, 2001, J INVEST DERMATOL, V117, P251, DOI 10.1046/j.0022-202x.2001.01357.x; Rana BK, 1999, GENETICS, V151, P1547; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; REES JL, 2002, GENETIC BASIS HUMAN, P529; REES JL, 2002, MELANOMA CRITICAL DE, P49; REES JL, 2002, MECH SUNTANNING, P333; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Relethford JH, 2000, HUM BIOL, V72, P773; RHODES LE, 1994, J INVEST DERMATOL, V103, P151, DOI 10.1111/1523-1747.ep12392604; RINGHOLM A, IN PRESS J INVEST DE; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; SOTER NA, 1990, SEMIN DERMATOL, V9, P11; STIERNER U, 1989, J INVEST DERMATOL, V92, P561, DOI 10.1111/1523-1747.ep12709572; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; THODY AJ, 1991, J INVEST DERMATOL, V97, P340, DOI 10.1111/1523-1747.ep12480680; Tomescu D, 2001, CARCINOGENESIS, V22, P403, DOI 10.1093/carcin/22.3.403; URBACH F, 1999, PHOTODERMATOLOGY, P89; Vage DI, 2003, PIGM CELL RES, V16, P693, DOI 10.1046/j.1600-0749.2003.00090.x; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Vage DI, 1999, MAMM GENOME, V10, P39, DOI 10.1007/s003359900939; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; van der Velden PA, 2001, AM J HUM GENET, V69, P774, DOI 10.1086/323411; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wagner JK, 2002, PIGM CELL RES, V15, P385, DOI 10.1034/j.1600-0749.2002.02046.x; Wagner JK, 2002, PIGM CELL RES, V15, P379, DOI 10.1034/j.1600-0749.2002.02042.x; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P837, DOI 10.1067/mjd.2001.114594; WATERSTON K, IN PRESS J INVEST DE; Winsey SL, 2000, CANCER RES, V60, P5612; Zeigler-Johnson C, 2004, PIGM CELL RES, V17, P185, DOI 10.1111/j.1600-0749.2004.00134.x	116	200	216	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					739	751		10.1086/425285	http://dx.doi.org/10.1086/425285			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15372380	Green Published, Bronze			2022-12-18	WOS:000224303500001
J	Heilstedt, HA; Ballif, BC; Howard, LA; Lewis, RA; Stal, S; Kashork, CD; Bacino, CA; Shapira, SK; Shaffer, LG				Heilstedt, HA; Ballif, BC; Howard, LA; Lewis, RA; Stal, S; Kashork, CD; Bacino, CA; Shapira, SK; Shaffer, LG			Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DELETION SYNDROME; MOLECULAR CHARACTERIZATION; BAND 1P36; GENE; ABNORMALITIES; TELOMERES; REARRANGEMENTS; NEUROBLASTOMA; CHROMOSOMES; MECHANISMS	Monosomy 1p36 is the most common terminal deletion syndrome. This contiguous gene deletion syndrome is presumably caused by haploinsufficiency of a number of genes. We have constructed a contig of overlapping large-insert clones for the most distal 10.5 Mb of 1p36, evaluated the deletion sizes in 61 subjects with monosomy 1p36 from 60 families, and created a natural deletion panel. We found pure terminal deletions, interstitial deletions, derivative chromosomes, and more complex rearrangements. Breakpoints were "binned" into 0.5-Mb regions. Analyses revealed some clustering of breakpoints but no single common breakpoint. Determination of the parental origin showed that 60% of de novo 1p36 terminal deletions arose from the maternally inherited chromosome. Of the 61 subjects, 30 were examined systematically through a protocol at the Texas Children's Hospital General Clinical Research Center. Specifically, we report hearing evaluations, palatal and ophthalmological examinations, echocardiograms, neurological assessments, and thyroid function tests. To our knowledge, this systematic molecular and clinical characterization of monosomy 1p36 is the largest and most comprehensive study of this deletion syndrome to date. Many cytogenetically visible, apparent terminal deletions are more complex than anticipated by cytogenetics, as revealed at the molecular level by our study. Our clinical findings allow for the more accurate recognition of the syndrome and for proper medical evaluation.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Plast Surg, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, San Antonio, TX 78284 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio	Shaffer, LG (corresponding author), Washington State Univ, Hlth Res & Educ Ctr, 310 N Riverpoint Blvd,Box 1495, Spokane, WA 99210 USA.	lshaffer@wsu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000169, K08DC000163] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00188, M01 RR000188] Funding Source: Medline; NICHD NIH HHS [P01 HD039420, P01 HD39420, P30 HD24064, P30 HD024064] Funding Source: Medline; NIDCD NIH HHS [F32 DC000169, K08 DC00163] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ballif BC, 2000, EUR J HUM GENET, V8, P764, DOI 10.1038/sj.ejhg.5200536; Ballif BC, 2000, AM J HUM GENET, V67, P1356; Blatt J, 2001, PEDIATR HEMAT ONCOL, V18, P3, DOI 10.1080/088800101750059800; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; KEPPLERNOREUIL KM, 1995, J MED GENET, V32, P619, DOI 10.1136/jmg.32.8.619; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 1997, EUR J HUM GENET, V5, P1; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nelson MA, 1999, CANCER GENET CYTOGEN, V108, P91, DOI 10.1016/S0165-4608(98)00122-8; Nelson MA, 2000, CANCER GENET CYTOGEN, V122, P101, DOI 10.1016/S0165-4608(00)00281-8; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SHAFFER LG, 1993, AM J MED GENET, V47, P383, DOI 10.1002/ajmg.1320470317; Shaffer LG, 2001, LANCET, pS9, DOI 10.1016/S0140-6736(01)07022-2; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Slavotinek A, 1999, J MED GENET, V36, P657; Thompson FH, 1997, CANCER GENET CYTOGEN, V96, P106, DOI 10.1016/S0165-4608(96)00307-X; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Zenker M, 2002, CLIN DYSMORPHOL, V11, P43, DOI 10.1097/00019605-200201000-00009	25	200	206	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1200	1212		10.1086/375179	http://dx.doi.org/10.1086/375179			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12687501	Bronze, Green Published			2022-12-18	WOS:000182474400012
J	Nair, RP; Stuart, P; Henseler, T; Jenisch, S; Chia, NVC; Westphal, E; Schork, NJ; Kim, J; Lim, HW; Christophers, E; Voorhees, JJ; Elder, JT				Nair, RP; Stuart, P; Henseler, T; Jenisch, S; Chia, NVC; Westphal, E; Schork, NJ; Kim, J; Lim, HW; Christophers, E; Voorhees, JJ; Elder, JT			Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; LINKAGE DISEQUILIBRIUM; ANCESTRAL HAPLOTYPES; FAMILIAL PSORIASIS; MHC HAPLOTYPES; CHROMOSOME 6P; GENE; ASSOCIATION; VULGARIS; IDENTIFICATION	Recent genome scans have established the presence of a major psoriasis-susceptibility locus in the human leukocyte antigen (HLA) complex on chromosome 6p21.3. To narrow the interval for candidate gene testing, we performed a linkage-disequilibrium analysis of 339 families, with the use of 62 physically mapped microsatellite markers spanning the major histocompatibility complex (MHC). As detected by use of the transmission/disequilibrium test (TDT), individual markers yielded significant linkage disequilibrium across most of the MHC. However, the strongest evidence for marker-trait disequilibrium was found in an similar to 300-kb region extending from the MICA gene to the corneodesmosin gene. Maximum-likelihood haplotypes were constructed across the entire MHC in the original sample and across a 1.2-Mb region of the central MHC in an expanded sample containing 139 additional families. Short (two- to five-marker) haplotypes were subjected to the TDT using a "moving-window" strategy that reduced the variability of TDT P values relative to the single-locus results. Furthermore, the expanded sample yielded a sharp peak of evidence for linkage disequilibrium that spanned similar to 170 kb and that was centered 100 kb telomeric to HLA-C. The 1.2-Mb interval was further dissected by means of recombinant ancestral haplotype analysis. This analysis identified risk haplotype 1 (RH1), which is a GO-kb fragment of ancestral haplotype 57.1, on all identifiable HLA risk haplotypes. One of these haplotypes exhibits significant linkage disequilibrium with psoriasis but does not carry Cw6, which is the HLA allele most strongly associated with the disease. These results demonstrate that RH1 is highly likely to carry the disease allele at PSORS1, and they exclude HLA-C and corneodesmosin with a high degree of confidence.	Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; Univ Kiel, Dept Dermatol, Kiel, Germany; Univ Kiel, Dept Immunol, Kiel, Germany; Case Western Reserve Univ, Dept Biostat, Cleveland, OH 44106 USA; Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kiel; University of Kiel; Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital	Elder, JT (corresponding author), Univ Michigan, Dept Dermatol, 3312 Canc Ctr & Geriatr Bldg,box 0932,1500 E Med, Ann Arbor, MI 48109 USA.		Lim, HW/GRY-3517-2022; Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X; Schork, Nicholas/0000-0003-0920-5013	NHGRI NIH HHS [P30 HG00209-03] Funding Source: Medline; NIAMS NIH HHS [R01 AR4274-01] Funding Source: Medline; PHS HHS [M01EE00042] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000209] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ahnini RT, 1999, HUM MOL GENET, V8, P1135, DOI 10.1093/hmg/8.6.1135; Allen MH, 1999, LANCET, V353, P1589, DOI 10.1016/S0140-6736(99)01618-9; Balendran N, 1999, J INVEST DERMATOL, V113, P322, DOI 10.1046/j.1523-1747.1999.00710.x; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Burden AD, 1998, J INVEST DERMATOL, V110, P958, DOI 10.1046/j.1523-1747.1998.00213.x; CHRISTOPHERS E, 1999, DERMATOLOGY GEN MED, V1, P495; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; DEGLIESPOSTI MA, 1992, HUM IMMUNOL, V34, P242, DOI 10.1016/0198-8859(92)90023-G; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V35, P355; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Enerback C, 1997, ACTA DERM-VENEREOL, V77, P273; FARBER EM, 1974, DERMATOLOGICA, V148, P1, DOI 10.1159/000251595; Gaudieri S, 1997, J MOL EVOL, V45, P17, DOI 10.1007/PL00006194; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Ikaheimo I, 1996, ARCH DERMATOL RES, V288, P63, DOI 10.1007/s004030050024; Jenisch S, 1999, TISSUE ANTIGENS, V54, P439, DOI 10.1034/j.1399-0039.1999.540501.x; Jenisch S, 1999, TISSUE ANTIGENS, V53, P135, DOI 10.1034/j.1399-0039.1999.530203.x; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; JENISCH S, 1997, GENETIC DIVERSITY HL, P712; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kim TG, 2000, J INVEST DERMATOL, V114, P309, DOI 10.1046/j.1523-1747.2000.00863.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Leder RO, 1998, HUM HERED, V48, P198, DOI 10.1159/000022802; Leder RO, 1997, INT J DERMATOL, V36, P911, DOI 10.1046/j.1365-4362.1997.00251.x; Mallon E, 1999, J INVEST DERMATOL, V113, P693, DOI 10.1046/j.1523-1747.1999.00724.x; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; NAIR RP, 1995, HUM HERED, V45, P219, DOI 10.1159/000154293; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; OZAWA A, 1981, J AM ACAD DERMATOL, V4, P205, DOI 10.1016/S0190-9622(81)70024-0; ROITBERGTAMBUR A, 1994, J AM ACAD DERMATOL, V31, P964, DOI 10.1016/S0190-9622(94)70265-9; SchmittEgenolf M, 1996, J INVEST DERMATOL, V106, P711, DOI 10.1111/1523-1747.ep12345600; Schork NJ, 1998, J EXP ZOOL, V282, P133, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;133::AID-JEZ15&gt;3.0.CO;2-V; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TODD JA, IN PRESS METABOLIC M; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; TSUJI K, 1992, P 11 INT HIST WORKSH, V1, P1091; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; YIP SY, 1984, J AM ACAD DERMATOL, V10, P965, DOI 10.1016/S0190-9622(84)80314-X; Youn Jai Il, 1999, Journal of Dermatology (Tokyo), V26, P647; ZHOU YQ, 1993, P NATL ACAD SCI USA, V90, P9470, DOI 10.1073/pnas.90.20.9470	48	200	205	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1833	1844		10.1086/302932	http://dx.doi.org/10.1086/302932			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10801386	Green Published, Bronze			2022-12-18	WOS:000088373800011
J	SZABO, J; HEATH, B; HILL, VM; JACKSON, CE; ZARBO, RJ; MALLETTE, LE; CHEW, SL; BESSER, GM; THAKKER, RV; HUFF, V; LEPPERT, MF; HEATH, H				SZABO, J; HEATH, B; HILL, VM; JACKSON, CE; ZARBO, RJ; MALLETTE, LE; CHEW, SL; BESSER, GM; THAKKER, RV; HUFF, V; LEPPERT, MF; HEATH, H			HEREDITARY HYPERPARATHYROIDISM JAW TUMOR SYNDROME - THE ENDOCRINE TUMOR GENE HRPT2 MAPS TO CHROMOSOME IQ21-Q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HYPERPARATHYROIDISM; LINKAGE ANALYSIS; HYPERCALCEMIA; LESIONS	The syndrome of hereditary hyperparathyroidism and jaw tumors (HPT-JT) is characterized by inheritance, in an autosomal dominant pattern, of recurrent parathyroid adenomas, fibro-osseous tumors of the mandible and/or maxilla, Wilms tumor, and parathyroid carcinoma. This syndrome is clinically and genetically distinct from other endocrine neoplasia syndromes and appears to result from mutation of an endocrine tumor gene designated ''HRPT2.'' We studied five HPT-JT families (59 persons, 20 affected); using PCR-based markers, we instituted a genomewide linkage search after excluding several candidate genes. Lod scores were calculated at various recombination fractions (theta), penetrance 90%. We mapped HRPT2 to the long arm of chromosome 1 (1q21-q31). The maximal lod score was 6.10 at theta = .0 with marker D1S212, or >10(6) odds in favor of linkage. In six hereditary Wilms tumor families (96 persons, 29 affected), we found no linkage to Iq markers closely linked with HRPT2 (led scores -15.6 [D1S191] and -17.8 [D1S196], theta = .001). Nine parathyroid adenomas and one Wilms tumor from nine members of three HPT-JT families were examined for loss of heterozygosity at linked loci. The parathyroid adenomas and Wilms tumor showed no loss of heterozygosity for these DNA markers. Our data establish that HRPT2, an endocrine tumor gene on the long arm of chromosome 1, is responsible for the HPT-JT syndrome but not for the classical hereditary Wilms tumor syndrome.	UNIV UTAH, SCH MED, HOWARD HUGHES MED INST, ECCLES INST HUMAN GENET, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, VET AFFAIRS MED CTR, ENDOCRINOL SECT, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, DEPT INTERNAL MED, DIV ENDOCRINOL DIABET & METAB, SALT LAKE CITY, UT 84132 USA; HENRY FORD HOSP, DEPT MED, DETROIT, MI 48202 USA; HENRY FORD HOSP, DEPT PATHOL, DETROIT, MI 48202 USA; VET AFFAIRS MED CTR, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOUSTON, TX 77030 USA; UNIV TEXAS, MD ANDERSON CANC CTR, DEPT EXPTL PEDIAT, HOUSTON, TX USA; ST BARTHOLOMEWS HOSP, DEPT ENDOCRINOL, LONDON, ENGLAND; ROYAL POSTGRAD MED SCH, MRC, MOLEC MED GRP, LONDON, ENGLAND	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of London; Queen Mary University London; Imperial College London				Thakker, Rajesh/0000-0002-1438-3220	NCI NIH HHS [CA34936, CA60114] Funding Source: Medline; NIDDK NIH HHS [DK-38855] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA060114, P01CA034936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038855] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CRYNS VL, 1994, NEW ENGL J MED, V330, P757, DOI 10.1056/NEJM199403173301105; DINNEN JS, 1977, J CLIN PATHOL, V30, P966, DOI 10.1136/jcp.30.10.966; EVERSOLE LR, 1985, ORAL SURG ORAL MED O, V60, P505, DOI 10.1016/0030-4220(85)90239-7; Friedman Eitan, 1994, P647; Gagel Robert F., 1994, P681; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HEATH H, 1992, J CLIN ENDOCR METAB, V75, P846, DOI 10.1210/jc.75.3.846; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; HEATH H, 1993, AM J HUM GENET, V53, P193; HEIGHWAY J, 1991, NUCLEIC ACIDS RES, V19, P5451, DOI 10.1093/nar/19.19.5451-a; JACKSON CE, 1967, AM J MED, V43, P727, DOI 10.1016/0002-9343(67)90114-3; JACKSON CE, 1990, SURGERY, V108, P1006; JACKSON CE, 1958, ANN INTERN MED, V49, P829, DOI 10.7326/0003-4819-49-4-829; KAKINUMA A, 1994, INTERNAL MED, V33, P123, DOI 10.2169/internalmedicine.33.123; KASSEM M, 1992, J BONE MINER RES, V7, pS249; KENNETT S, 1971, ORAL SURG ORAL MED O, V31, P502, DOI 10.1016/0030-4220(71)90347-1; LAW WM, 1983, NEW ENGL J MED, V309, P650, DOI 10.1056/NEJM198309153091107; Mallette Lawrence E., 1994, P423; MALLETTE LE, 1987, ANN INTERN MED, V107, P54, DOI 10.7326/0003-4819-107-1-54; MATSUNAGA E, 1981, HUM GENET, V57, P231; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Ott J., 1991, ANAL HUMAN GENETIC L; ROSEN IB, 1981, AM J SURG, V142, P494, DOI 10.1016/0002-9610(81)90382-2; ROSENBERG EH, 1962, ORAL SURG ORAL MED O, V2, P84; SLOOTWEG PJ, 1990, J CRANIO MAXILL SURG, V18, P210, DOI 10.1016/S1010-5182(05)80413-5; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; Szabo Jozsef, 1993, P164; WARNAKULASURIYA S, 1985, ORAL SURG ORAL MED O, V59, P269, DOI 10.1016/0030-4220(85)90165-3; WASSIF WS, 1993, J CLIN ENDOCR METAB, V77, P1485, DOI 10.1210/jc.77.6.1485; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153; ZARBO RJ, 1993, MODERN PATHOL, V6, pA42	32	200	204	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					944	950						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717405				2022-12-18	WOS:A1995QP66300016
J	Riazuddin, S; Ahmed, ZM; Fanning, AS; Lagziel, A; Kitajiri, S; Ramzan, K; Khan, SN; Chattaraj, P; Friedman, PL; Anderson, JM; Belyantseva, IA; Forge, A; Riazuddin, S; Friedman, TB				Riazuddin, Saima; Ahmed, Zubair M.; Fanning, Alan S.; Lagziel, Ayala; Kitajiri, Shin-ichiro; Ramzan, Khushnooda; Khan, Shaheen N.; Chattaraj, Parna; Friedman, Penelope L.; Anderson, James M.; Belyantseva, Inna A.; Forge, Andrew; Riazuddin, Sheikh; Friedman, Thomas B.			Tricellulin is a tight-junction protein necessary for hearing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE DEAFNESS DFNB29; INTERCELLULAR-JUNCTIONS; INNER-EAR; MOLECULAR PHYSIOLOGY; STRIA VASCULARIS; EPITHELIAL-CELLS; FREEZE-FRACTURE; MUTATIONS; OCCLUDIN; GENE	The inner ear has fluid-filled compartments of different ionic compositions, including the endolymphatic and perilymphatic spaces of the organ of Corti; the separation from one another by epithelial barriers is required for normal hearing. TRIC encodes tricellulin, a recently discovered tight-junction (TJ) protein that contributes to the structure and function of tricellular contacts of neighboring cells in many epithelial tissues. We show that, in humans, four different recessive mutations of TRIC cause nonsyndromic deafness (DFNB49), a surprisingly limited phenotype, given the widespread tissue distribution of tricellulin in epithelial cells. In the inner ear, tricellulin is concentrated at the tricellular TJs in cochlear and vestibular epithelia, including the structurally complex and extensive junctions between supporting and hair cells. We also demonstrate that there are multiple alternatively spliced isoforms of TRIC in various tissues and that mutations of TRIC associated with hearing loss remove all or most of a conserved region in the cytosolic domain that binds to the cytosolic scaffolding protein ZO-1. A wild-type isoform of tricellulin, which lacks this conserved region, is unaffected by the mutant alleles and is hypothesized to be sufficient for structural and functional integrity of epithelial barriers outside the inner ear.	Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; NIH, Internal Med Consult Serv, Hatfield Clin Res Ctr, Bethesda, MD 20892 USA; UCL, Ear Inst, Ctr Auditory Res, London WC1E 6BT, England	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of North Carolina; University of North Carolina Chapel Hill; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; University of London; University College London	Friedman, TB (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, Mol Genet Lab, NIH, 5 Res Court,Room 2A-19, Rockville, MD 20850 USA.	friedman@nidcd.nih.gov	Nasim Khan, Shaheen/F-2135-2015	Forge, Andrew/0000-0002-0995-0219; Anderson, James/0000-0003-2765-7996	Intramural NIH HHS [Z01 DC000039] Funding Source: Medline; NIDCD NIH HHS [T32 DC000035, Z01 DC000039-08, Z01 DC000035-08] Funding Source: Medline; NIDDK NIH HHS [DK61397, R56 DK061397, R01 DK061397] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061397, R01DK061397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000035, T32DC000035, Z01DC000039] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; FORGE A, 1991, J NEUROCYTOL, V20, P471, DOI 10.1007/BF01252275; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Jahnke K, 1975, Acta Otolaryngol Suppl, V336, P1; Kitajiri S, 2004, HEARING RES, V187, P25, DOI 10.1016/S0378-5955(03)00338-1; Kitajiri SI, 2004, J CELL SCI, V117, P5087, DOI 10.1242/jcs.01393; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kovach MJ, 1999, AM J HUM GENET, V64, P1580, DOI 10.1086/302420; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Notterpek L, 2001, P NATL ACAD SCI USA, V98, P14404, DOI 10.1073/pnas.251548398; PINTO DS, 1982, CELL, V28, P441; Ramzan K, 2005, HUM GENET, V116, P17, DOI 10.1007/s00439-004-1205-8; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Sears CL, 2000, AM J PHYSIOL-GASTR L, V279, pG1129, DOI 10.1152/ajpgi.2000.279.6.G1129; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; STERKERS O, 1988, PHYSIOL REV, V68, P1083, DOI 10.1152/physrev.1988.68.4.1083; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; WALKER DC, 1985, ACTA ANAT, V122, P35; WALKER DC, 1994, MICROVASC RES, V48, P259, DOI 10.1006/mvre.1994.1054; Weber S, 2001, J AM SOC NEPHROL, V12, P2664, DOI 10.1681/ASN.V12122664; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8	43	199	205	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1040	1051		10.1086/510022	http://dx.doi.org/10.1086/510022			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186462	Bronze, Green Published			2022-12-18	WOS:000242131600005
J	Buiting, K; Gross, S; Lich, C; Gillessen-Kaesbach, G; El-Maarri, O; Horsthemke, B				Buiting, K; Gross, S; Lich, C; Gillessen-Kaesbach, G; El-Maarri, O; Horsthemke, B			Epimutations in Prader-Willi and Angelman syndromes: A molecular study of 136 patients with an imprinting defect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHYLATION; REGION; MECHANISMS; LOCUS; SNRPN; HUMAN-CHROMOSOME-15; INHERITANCE; DIAGNOSIS; FAMILIES; PATTERNS	Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are neurogenetic disorders that are caused by the loss of function of imprinted genes in 15q11-q13. In a small group of patients, the disease is due to aberrant imprinting and gene silencing. Here, we describe the molecular analysis of 51 patients with PWS and 85 patients with AS who have such a defect. Seven patients with PWS (14%) and eight patients with AS (9%) were found to have an imprinting center (IC) deletion. Sequence analysis of 32 patients with PWS and no IC deletion and 66 patients with AS and no IC deletion did not reveal any point mutation in the critical IC elements. The presence of a faint methylated band in 27% of patients with AS and no IC deletion suggests that these patients are mosaic for an imprinting defect that occurred after fertilization. In patients with AS, the imprinting defect occurred on the chromosome that was inherited from either the maternal grandfather or grandmother; however, in all informative patients with PWS and no IC deletion, the imprinting defect occurred on the chromosome inherited from the paternal grandmother. These data suggest that this imprinting defect results from a failure to erase the maternal imprint during spermatogenesis.	Univ Essen Gesamthsch Klinikum, Inst Humangenet, D-45122 Essen, Germany; Univ Bonn, Inst Expt Hamatol & Transfus Med, D-5300 Bonn, Germany	University of Duisburg Essen; University of Bonn	Buiting, K (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Humangenet, Hufelandstr 55, D-45122 Essen, Germany.			El-Maarri, Osman/0000-0002-6859-5819				Buiting K, 2000, CLIN GENET, V58, P284, DOI 10.1034/j.1399-0004.2000.580406.x; Buiting K, 1998, AM J HUM GENET, V63, P170, DOI 10.1086/301935; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; Buiting K, 2001, AM J HUM GENET, V68, P1290, DOI 10.1086/320120; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burger J, 1997, AM J HUM GENET, V61, P88, DOI 10.1086/513900; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; DITTRICH B, 1993, HUM MOL GENET, V2, P1509, DOI 10.1093/hmg/2.9.1509; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Kearns M, 2000, NUCLEIC ACIDS RES, V28, P3301, DOI 10.1093/nar/28.17.3301; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Ohta T, 1999, AM J HUM GENET, V64, P385, DOI 10.1086/302232; Rakyan VK, 2001, BIOCHEM J, V356, P1, DOI 10.1042/0264-6021:3560001; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Schumacher A, 1998, NAT GENET, V19, P324, DOI 10.1038/1211; Schweizer J, 1999, HUM MOL GENET, V8, P555, DOI 10.1093/hmg/8.4.555; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469; Zeschnigk M, 1997, EUR J HUM GENET, V5, P94, DOI 10.1159/000484740	22	199	213	0	27	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					571	577		10.1086/367926	http://dx.doi.org/10.1086/367926			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12545427	Green Published, Bronze			2022-12-18	WOS:000181152600007
J	Kan, S; Elankko, N; Johnson, D; Cornejo-Roldan, L; Cook, J; Reich, EW; Tomkins, S; Verloes, A; Twigg, SRF; Rannan-Eliya, S; McDonald-McGinn, DM; Zackai, EH; Wall, SA; Muenke, M; Wilkie, AOM				Kan, S; Elankko, N; Johnson, D; Cornejo-Roldan, L; Cook, J; Reich, EW; Tomkins, S; Verloes, A; Twigg, SRF; Rannan-Eliya, S; McDonald-McGinn, DM; Zackai, EH; Wall, SA; Muenke, M; Wilkie, AOM			Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANTLEY-BIXLER-SYNDROME; AUTOSOMAL-DOMINANT CRANIOSYNOSTOSIS; KINASE DOMAIN MUTATIONS; CROUZON-SYNDROME; PFEIFFER-SYNDROME; TYROSINE KINASE; APERT-SYNDROME; FGFR2 GENE; CORONAL CRANIOSYNOSTOSIS; ACTIVATING MUTATIONS	It has been known for several years that heterozygous mutations of three members of the fibroblast growth-factor-receptor family of signal-transduction molecules-namely, FGFR1, FGFR2, and FGFR3-contribute significantly to disorders of bone patterning and growth. FGFR3 mutations, which predominantly cause short-limbed bone dysplasia, occur in all three major regions (i.e., extracellular, transmembrane, and intracellular) of the protein. By contrast, most mutations described in FGFR2 localize to just two exons (IIIa and IIIc), encoding the IgIII domain in the extracellular region, resulting in syndromic craniosynostosis including Apert, Crouzon, or Pfeiffer syndromes. Interpretation of this apparent clustering of mutations in FGFR2 has been hampered by the absence of any complete FGFR2-mutation screen. We have now undertaken such a screen in 259 patients with craniosynostosis in whom mutations in other genes (e. g., FGFR1, FGFR3, and TWIST) had been excluded; part of this screen was a cohort-based study, enabling unbiased estimates of the mutation distribution to be obtained. Although the majority (61/62 in the cohort sample) of FGFR2 mutations localized to the IIIa and IIIc exons, we identified mutations in seven additional exons-including six distinct mutations of the tyrosine kinase region and a single mutation of the IgII domain. The majority of patients with atypical mutations had diagnoses of Pfeiffer syndrome or Crouzon syndrome. Overall, FGFR2 mutations were present in 9.8% of patients with craniosynostosis who were included in a prospectively ascertained sample, but no mutations were found in association with isolated fusion of the metopic or sagittal sutures. We conclude that the spectrum of FGFR2 mutations causing craniosynostosis is wider than previously recognized but that, nevertheless, the IgIIIa/IIIc region represents a genuine mutation hotspot.	John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Radcliffe Infirm, Oxford Craniofacial Unit, Oxford OX2 6HE, England; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; Sheffield Childrens Hosp, N Trent Clin Genet Serv, Sheffield, S Yorkshire, England; NYU, Sch Med, New York, NY USA; Univ Wales Hosp, Med Genet Serv Wales, Cardiff CF4 4XW, S Glam, Wales; Hop Robert Debre, Clin Genet Unit, F-75019 Paris, France; Childrens Hosp Philadelphia, Clin Genet Ctr, Philadelphia, PA 19104 USA	University of Oxford; Radcliffe Infirmary; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; New York University; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wilkie, AOM (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.		Wilkie, Andrew/AAC-3820-2020; /AAK-8500-2021; Twigg, Stephen/AAU-1135-2021; McDonald-McGinn, Donna/L-8643-2019; Kan, Shih-hsin/GLT-3129-2022; VERLOES, Alain/E-7287-2014	Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X; Kan, Shih-hsin/0000-0003-0209-4963; Muenke, Maximilian/0000-0002-7719-6545; VERLOES, Alain/0000-0003-4819-0264; McDonald-McGinn, Donna/0000-0003-4077-250X				Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; BATEMAN A, 1995, NAT STRUCT BIOL, V2, P1068, DOI 10.1038/nsb1295-1068; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; Chun K, 1998, AM J MED GENET, V77, P219, DOI 10.1002/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K; Cohen MM, 2001, AM J MED GENET, V100, P325, DOI 10.1002/ajmg.1271; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Cornejo-Roldan LR, 1999, HUM GENET, V104, P425, DOI 10.1007/s004390050979; Coulier F, 1997, J MOL EVOL, V44, P43, DOI 10.1007/PL00006120; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; Elanko N, 2001, HUM MUTAT, V18, P535, DOI 10.1002/humu.1230; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Feldman GJ, 1997, HUM MOL GENET, V6, P1937, DOI 10.1093/hmg/6.11.1937; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Glaser RL, 2000, AM J HUM GENET, V66, P768, DOI 10.1086/302831; Gripp KW, 1999, AM J MED GENET, V83, P65, DOI 10.1002/(SICI)1096-8628(19990305)83:1<65::AID-AJMG12>3.3.CO;2-Z; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; HUNTER AGW, 1976, TERATOLOGY, V14, P185, DOI 10.1002/tera.1420140209; INGERSOLL RG, IN PRESS CYTOGENET C; ITOH H, 1994, CANCER RES, V54, P3237; Iwashita T, 1999, ONCOGENE, V18, P3919, DOI 10.1038/sj.onc.1202742; Iwashita T, 2001, GASTROENTEROLOGY, V121, P24, DOI 10.1053/gast.2001.25515; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Jang JH, 2001, CANCER RES, V61, P3541; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Johnson D, 2000, EUR J HUM GENET, V8, P571, DOI 10.1038/sj.ejhg.5200499; Johnson D, 1998, AM J HUM GENET, V63, P1282, DOI 10.1086/302122; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KATOH M, 1992, P NATL ACAD SCI USA, V89, P2960, DOI 10.1073/pnas.89.7.2960; Krepelova A, 1998, AM J MED GENET, V76, P362, DOI 10.1002/(SICI)1096-8628(19980401)76:4<362::AID-AJMG15>3.3.CO;2-Z; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Moloney DM, 1997, LANCET, V349, P1059, DOI 10.1016/S0140-6736(96)09082-4; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Mortier G, 2000, J MED GENET, V37, P220, DOI 10.1136/jmg.37.3.220; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MUENKE M, 2001, METABOLIC MOL BASES, P6117; Munro CS, 1998, LANCET, V352, P704, DOI 10.1016/S0140-6736(05)60820-3; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; OLDRIDGE M, 1995, HUM MOL GENET, V4, P1077; OLDRIDGE NB, 1997, WIEN KLIN WOCHENSC S, V2, P6; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pelet A, 1998, J CLIN INVEST, V101, P1415, DOI 10.1172/JCI375; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; PFEIFFER R A, 1964, Z Kinderheilkd, V90, P301, DOI 10.1007/BF00447500; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; PRZYLEPA KA, 1998, J CRANIOFAC GENET DE, V18, P6; Pulleyn LJ, 1996, EUR J HUM GENET, V4, P283; Raffioni S, 1998, J BIOL CHEM, V273, P35250, DOI 10.1074/jbc.273.52.35250; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Reardon W, 2000, J MED GENET, V37, P26, DOI 10.1136/jmg.37.1.26; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; Slaney SF, 1996, AM J HUM GENET, V58, P923; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Steinberger D, 1996, AM J MED GENET, V66, P81, DOI 10.1002/(SICI)1096-8628(19961202)66:1<81::AID-AJMG19>3.3.CO;2-A; Stenberg KAE, 1999, NUCLEIC ACIDS RES, V27, P362, DOI 10.1093/nar/27.1.362; Tavormina PL, 1999, AM J HUM GENET, V64, P722, DOI 10.1086/302275; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Tsai Fuu-Jen, 2000, European Journal of Human Genetics, V8, P120; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WILKIE AOM, IN PRESS AM J MED GE; Wong LJC, 2001, AM J MED GENET, V102, P282, DOI 10.1002/ajmg.1461; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Xu XL, 1998, DEVELOPMENT, V125, P753; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zhang YZ, 1999, GENE, V230, P69, DOI 10.1016/S0378-1119(99)00047-5	82	199	214	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					472	486		10.1086/338758	http://dx.doi.org/10.1086/338758			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11781872	Green Published, Bronze			2022-12-18	WOS:000173254300018
J	Broman, KW; Weber, JL				Broman, KW; Weber, JL			Long homozygous chromosomal segments in reference families from the Centre d'Etude du Polymorphisme Humain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR AFFECTIVE-DISORDER; OLD-ORDER AMISH; HUMAN GENOME; PARENTAL CONSANGUINITY; SUSCEPTIBILITY GENE; MARKERS; LINKAGE; MAP; TRINUCLEOTIDE; SEARCH	Using genotypes from nearly 8,000 short tandem-repeat polymorphisms typed in eight of the reference families from the Centre d'Etude du Polymorphisme Humain (CEPH), we identified numerous long chromosomal segments of marker homozygosity in many CEPH individuals. These segments are likely to represent autozygosity, the result of the mating of related individuals. Confidence that the complete segment is homozygous is gained only with markers of high density. The longest segment in the eight families spanned 77 cM and included 118 homozygous markers. All individuals in family 884 showed at least one segment of homozygosity: the father and mother were homozygous in 8 and 10 segments with an average length of 13 and 16 cM, respectively, and covering a total of 105 and 160 cM, respectively. The progeny in family 884 were homozygous over 5-16 segments with average length 11 cM. The progeny in family 102 were homozygous over 4-12 segments with average length 19 cM. Of the 100 individuals in the other six families, 1 had especially long homozygous segments, and 19 had short but significant homozygous segments. Our results indicate that long homozygous segments are common in humans and that these segments could have a substantial impact on gene mapping and health.	Marshfield Med Res Fdn, Marshfield, WI 54449 USA		Broman, KW (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.			Broman, Karl/0000-0002-4914-6671	DIVISION OF HEART AND VASCULAR DISEASES [N01HV048141] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000198] Funding Source: NIH RePORTER; NHGRI NIH HHS [F32 HG000198, F32HG000198] Funding Source: Medline; NHLBI NIH HHS [N01HV48141] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMSON D, 1995, AM J HUM GENET, V57, P619; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Bugge M, 1998, HUM MOL GENET, V7, P661, DOI 10.1093/hmg/7.4.661; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EGELAND JA, 1972, DESCENDENTS C FISHER; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; FREIHERR G, 1996, MED DEVICE DIAGN IND, V18, P12; Ginns EI, 1998, P NATL ACAD SCI USA, V95, P15531, DOI 10.1073/pnas.95.26.15531; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; Hartl DL, 1997, PRINCIPLES POPULATIO; JABER L, 1992, AM J MED GENET, V44, P1, DOI 10.1002/ajmg.1320440102; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; McMahon FJ, 1997, AM J HUM GENET, V61, P1397, DOI 10.1086/301630; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; PAULS DL, 1995, AM J HUM GENET, V57, P636; Polymeropoulos MH, 1996, MOL PSYCHIATR, V1, P404; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; Rosendaal FR, 1997, SEMIN HEMATOL, V34, P171; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SMITH CAB, 1953, J R STAT SOC B, V15, P153; STINE OC, 1995, AM J HUM GENET, V57, P1384; STOLL C, 1994, AM J MED GENET, V49, P114, DOI 10.1002/ajmg.1320490123; Sunden SLF, 1996, GENOMICS, V32, P15, DOI 10.1006/geno.1996.0071; Vogel F., 1997, HUMAN GENETICS PROBL; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WHITE R, 1988, ANNU REV GENET, V22, P259	31	199	208	0	19	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1493	1500		10.1086/302661	http://dx.doi.org/10.1086/302661			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577902	Green Published, Bronze			2022-12-18	WOS:000084282500003
J	Knoppers, BM; Strom, C; Clayton, EW; Murray, T; Fibison, W; Luther, L; Billings, PR; Godmilow, L; Handelin, B				Knoppers, BM; Strom, C; Clayton, EW; Murray, T; Fibison, W; Luther, L; Billings, PR; Godmilow, L; Handelin, B		Amer Soc Human Genetics Social Issues	Professional disclosure of familial genetic information	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIVACY		Univ Montreal, CRDP, Fac Droit, Montreal, PQ H3C 3J7, Canada; Illinois Masonic Med Ctr, Chicago, IL 60657 USA; Vanderbilt Univ, Nashville, TN USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA; NIH, Natl Human Genome Res Inst, Bethesda, MD 20892 USA; Vet Affairs Med Ctr, Palo Alto, CA 94304 USA; Univ Penn, Philadelphia, PA 19104 USA	Universite de Montreal; Vanderbilt University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania	Knoppers, BM (corresponding author), Univ Montreal, CRDP, Fac Droit, CP 6128,Succursale A, Montreal, PQ H3C 3J7, Canada.							Abbott A, 1996, NATURE, V379, P390; *AM MED ASS COUNC, 1996, COD MED ETH CURR OP, P624; Andrews LB., 1997, HUMAN DNA LAW POLICY, P133; Annas GJ, 1995, J LAW MED ETHICS, V23, P360, DOI 10.1111/j.1748-720X.1995.tb01378.x; Beardsley T, 1996, SCI AM, V274, P100, DOI 10.1038/scientificamerican0396-100; Black H, 1990, BLACKS LAW DICT, V6th; Canadian Medical Association, 1996, CAN MED ASSOC J, V155, p1176A; *COM CONS NAT ETH, 1991, MED SCI, V7, P843; *COMM HLTH COUNC N, 1989, HER SCI SOC; *COUNC EUR, 1990, INT DIG HLTH LEGIS, V41, P614; *COUNC EUR, 1997, INT DIG HLTH LEG, V48, P99; COUNCIL OF EUROPE, 1992, INT DIGEST HLTH LEGI, V43, P284; DDEWACHTER MAM, 1997, HUMAN DNA LAW POLICY, P145; Gevers J K, 1988, Med Law, V7, P161; Gostin LO, 1995, J LAW MED ETHICS, V23, P320, DOI 10.1111/j.1748-720X.1995.tb01374.x; *HOUS COMM SCI TEC, 1995, 4 HOUS COMM SCI TECH, V4, P227; *I MED COMM ASS GE, 1994, ASS GEN RISKS IMPL H; *JAP SOC HUM GEN, 1996, DUBOIS J ASIAN INT B, V6, P137; Knoppers B. M., 1995, American Journal of Human Genetics, V57, pA296; KNOPPERS BM, 1997, MICROB COMP GENOMICS, V2, P37; LeBris S., 1997, GENETIC SECRETS, P418; LINDEN AM, 1993, CAANADIAN TORT LAW; MACKLIN R, 1992, GENE MAPPING USING L, P157; *MED RES ETH COMM, 1991, GUID US GEN REG MED; MILLER MI, 1994, ADV APPL STAT SER, V2, P141; *MRC CAN NAT SCI E, 1996, DRAFT COD COND RES I; MURRAY TH, 1997, GENETIC SECRETS PROT, P60; *NOW MIN HLTH SOC, 1993, 25 MIN HLTH SOC AFF; Nuffield Council on Bioethics, 1993, GEN SCREEN ETH ISS; PARK N, 1995, INT RES POL S TOR; PELIAS MZ, 1991, AM J MED GENET, V39, P347, DOI 10.1002/ajmg.1320390320; PELIAS MZ, 1992, AM J MED GENET, V42, P758; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, SCREEN COUNS GEN CON; *PRIV COMM AUSTR, 1996, 5 PRIV COMM AUSTR HU, P33; REILLY P, 1991, AM J HUM GENET, V48, P1009; REILLY PR, 1997, GENETIC SECRETS PROT, P369; Rothstein, 1997, GENETIC SECRETS PROT, P255; *SCI COUNC CAN, 1992, 42 MIN SUPPL SERV SC; STEELE LJ, 1990, J LEGAL MED, V11, P451, DOI 10.1080/01947649009510838; SUTER S, 1993, MICH LAW REV, V91, P1881; *SWISS AC MED SCI, 1993, B MED SUISSES, V74, P1454; Wachbroit R, 1989, Md Med J, V38, P957; WACHBROIT R, 1993, SUFFOLK LAW REV, V20, P1391; Wertz D, 1995, GUIDELINES ETHICAL I; 1994, B MED ETHICS, P8; 1992, INT DIGEST HLTH LEGI, V44, P150	46	199	199	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					474	483						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	ZA927	9537923	Bronze			2022-12-18	WOS:000072416000030
J	Xue, YL; Chen, Y; Ayub, Q; Huang, N; Ball, EV; Mort, M; Phillips, AD; Shaw, K; Stenson, PD; Cooper, DN; Tyler-Smith, C				Xue, Yali; Chen, Yuan; Ayub, Qasim; Huang, Ni; Ball, Edward V.; Mort, Matthew; Phillips, Andrew D.; Shaw, Katy; Stenson, Peter D.; Cooper, David N.; Tyler-Smith, Chris		1000 Genomes Project Consortium	Deleterious- and Disease-Allele Prevalence in Healthy Individuals: Insights from Current Predictions, Mutation Databases, and Population-Scale Resequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-VARIATION; HUMAN GENOME; COPY NUMBER; VARIANTS	We have assessed the numbers of potentially deleterious variants in the genomes of apparently healthy humans by using (1) low-coverage whole-genome sequence data from 179 individuals in the 1000 Genomes Pilot Project and (2) current predictions and databases of deleterious variants. Each individual carried 281-515 missense substitutions, 40-85 of which were homozygous, predicted to be highly damaging. They also carried 40-110 variants classified by the Human Gene Mutation Database (HGMD) as disease-causing mutations (DMs), 3-24 variants in the homozygous state, and many polymorphisms putatively associated with disease. Whereas many of these DMs are likely to represent disease-allele-annotation errors, between 0 and 8 DMs (0-1 homozygous) per individual are predicted to be highly damaging, and some of them provide information of medical relevance. These analyses emphasize the need for improved annotation of disease alleles both in mutation databases and in the primary literature; some HGMD mutation data have been recategorized on the basis of the present findings, an iterative process that is both necessary and ongoing. Our estimates of deleterious-allele numbers are likely to be subject to both overcounting and undercounting. However, our current best mean estimates of similar to 400 damaging variants and similar to 2 bona fide disease mutations per individual are likely to increase rather than decrease as sequencing studies ascertain rare variants more effectively and as additional disease alleles are discovered.	[Xue, Yali; Chen, Yuan; Ayub, Qasim; Huang, Ni; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Ball, Edward V.; Mort, Matthew; Phillips, Andrew D.; Shaw, Katy; Stenson, Peter D.; Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales	Wellcome Trust Sanger Institute; Cardiff University	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	cts@sanger.ac.uk	Cooper, David N/H-4384-2011; Mills, Ryan/F-4225-2010	Cooper, David N/0000-0002-8943-8484; Mills, Ryan/0000-0003-3425-6998; Keinan, Alon/0000-0002-9760-1122; MacArthur, Daniel/0000-0002-5771-2290; Ayub, Qasim/0000-0003-3291-0917; Clarke, Laura/0000-0002-5989-6898	Wellcome Trust [WT098051]; BIOBASE GmbH	Wellcome Trust(Wellcome TrustEuropean Commission); BIOBASE GmbH	We thank Ville Mustonen for discussion and suggestions about estimating selective coefficients, A. Kondrashov and two other reviewers for comments, Sarah Ratzel for help with nomenclatural complexities, and the donors of samples used by the 1000 Genomes Project, whose generosity made this study possible. Work at the Wellcome Trust Sanger Institute was supported by the Wellcome Trust (WT098051), and BIOBASE GmbH provides funding for the Human Gene Mutation Database.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Ballas SK, 2011, HEMOGLOBIN, V35, P511, DOI 10.3109/03630269.2011.610477; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bhattacharya G, 2004, J CELL SCI, V117, P233, DOI 10.1242/jcs.00850; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Chong JX, 2012, AM J HUM GENET, V91, P608, DOI 10.1016/j.ajhg.2012.08.007; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Dreyer B, 2001, AM J HUM GENET, V69, P228, DOI 10.1086/321269; Dreyer B, 2000, EUR J HUM GENET, V8, P500, DOI 10.1038/sj.ejhg.5200491; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Hikiba J, 2008, NUCLEIC ACIDS RES, V36, P4181, DOI 10.1093/nar/gkn362; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lazarin G.A., 2012, GENET MED IN PRESS; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mandon-Pepin B, 2008, EUR J ENDOCRINOL, V158, P107, DOI 10.1530/EJE-07-0400; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Najera Carmen, 2002, Hum Mutat, V20, P76, DOI 10.1002/humu.9042; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nothnagel M, 2011, HUM GENET, V130, P505, DOI 10.1007/s00439-011-0971-3; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rochette J, 2010, HUM GENET, V128, P233, DOI 10.1007/s00439-010-0852-1; Rosenberg T, 1997, CLIN GENET, V51, P314; Rossi E, 2008, EXPERT REV HEMATOL, V1, P205, DOI 10.1586/17474086.1.2.205; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; van Dijk M, 2005, NAT GENET, V37, P514, DOI 10.1038/ng1541; van Dijk M, 2010, HUM MOL GENET, V19, P2658, DOI 10.1093/hmg/ddq152; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; Yngvadottir B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-237; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008	43	198	200	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1022	1032		10.1016/j.ajhg.2012.10.015	http://dx.doi.org/10.1016/j.ajhg.2012.10.015			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23217326	Green Published, hybrid			2022-12-18	WOS:000312417400005
J	Heinzen, EL; Radtke, RA; Urban, TJ; Cavalleri, GL; Depondt, C; Need, AC; Walley, NM; Nicoletti, P; Ge, DL; Catarino, CB; Duncan, JS; Kasperaviciute, D; Tate, SK; Caboclo, LO; Sander, JW; Clayton, L; Linney, KN; Shianna, KV; Gumbs, CE; Smith, J; Cronin, KD; Maia, JM; Doherty, CP; Pandolfo, M; Leppert, D; Middleton, LT; Gibson, RA; Johnson, MR; Matthews, PM; Hosford, D; Kalviainen, R; Eriksson, K; Kantanen, AM; Dorn, T; Hansen, J; Kramer, G; Steinhoff, BJ; Wieser, HG; Zumsteg, D; Ortega, M; Wood, NW; Huxley-Jones, J; Mikati, M; Gallentine, WB; Husain, AM; Buckley, PG; Stallings, RL; Podgoreanu, MV; Delanty, N; Sisodiya, SM; Goldstein, DB				Heinzen, Erin L.; Radtke, Rodney A.; Urban, Thomas J.; Cavalleri, Gianpiero L.; Depondt, Chantal; Need, Anna C.; Walley, Nicole M.; Nicoletti, Paola; Ge, Dongliang; Catarino, Claudia B.; Duncan, John S.; Kasperaviciute, Dalia; Tate, Sarah K.; Caboclo, Luis O.; Sander, Josemir W.; Clayton, Lisa; Linney, Kristen N.; Shianna, Kevin V.; Gumbs, Curtis E.; Smith, Jason; Cronin, Kenneth D.; Maia, Jessica M.; Doherty, Colin P.; Pandolfo, Massimo; Leppert, David; Middleton, Lefkos T.; Gibson, Rachel A.; Johnson, Michael R.; Matthews, Paul M.; Hosford, David; Kalviainen, Reetta; Eriksson, Kai; Kantanen, Anne-Mari; Dorn, Thomas; Hansen, Joerg; Kraemer, Guenter; Steinhoff, Bernhard J.; Wieser, Heinz-Gregor; Zumsteg, Dominik; Ortega, Marcos; Wood, Nicholas W.; Huxley-Jones, Julie; Mikati, Mohamad; Gallentine, William B.; Husain, Aatif M.; Buckley, Patrick G.; Stallings, Ray L.; Podgoreanu, Mihai V.; Delanty, Norman; Sisodiya, Sanjay M.; Goldstein, David B.			Rare Deletions at 16p13.11 Predispose to a Diverse Spectrum of Sporadic Epilepsy Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHILDHOOD ABSENCE EPILEPSY; 15Q13.3 MICRODELETIONS; GENERALIZED EPILEPSY; MUTATION; ASSOCIATION; GENES	Deletions at 16p13.11 are associated with schizophrenia, mental retardation, and most recently idiopathic generalized epilepsy. To evaluate the role of 16p13.11 deletions, as well as other structural variation, in epilepsy disorders, we used genome-wide screens to identify copy number variation in 3812 patients with a diverse spectrum of epilepsy syndromes and in 1299 neurologically-normal controls. Large deletions (> 100 kb) at 16p13.11 were observed in 23 patients, whereas no control had a deletion greater than 16 kb. Patients, even those with identically sized 16p13.11 deletions, presented with highly variable epilepsy phenotypes. For a subset of patients with a 16p13.11 deletion, we show a consistent reduction of expression for included genes, suggesting that haploinsufficiency might contribute to pathogenicity. We also investigated another possible mechanism of pathogenicity by using hybridization-based capture and next-generation sequencing of the homologous chromosome for ten 16p13.11-deletion patients to look for unmasked recessive mutations. Follow-up genotyping of suggestive polymorphisms tailed to identity any convincing recessive-acting mutations in the homologous interval corresponding to the deletion. The observation that two of the 16p13.11 deletions were larger than 2 Mb in size led us to screen for other large deletions. We found 12 additional genomic regions harboring deletions > 2 Mb in epilepsy patients, and none in controls. Additional evaluation is needed to characterize the role of these exceedingly large, non-locus-specific deletions in epilepsy. Collectively, these data implicate 16p13.11 and possibly other large deletions as risk factors for a wide range of epilepsy disorders, and they appear to point toward haploinsufficiency as a contributor to the pathogenicity of deletions.	[Catarino, Claudia B.; Duncan, John S.; Kasperaviciute, Dalia; Tate, Sarah K.; Caboclo, Luis O.; Sander, Josemir W.; Clayton, Lisa; Sisodiya, Sanjay M.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; [Heinzen, Erin L.; Urban, Thomas J.; Need, Anna C.; Walley, Nicole M.; Nicoletti, Paola; Ge, Dongliang; Linney, Kristen N.; Shianna, Kevin V.; Gumbs, Curtis E.; Smith, Jason; Cronin, Kenneth D.; Maia, Jessica M.; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Radtke, Rodney A.; Hosford, David; Husain, Aatif M.] Duke Univ, Sch Med, Dept Med Neurol, Durham, NC 27710 USA; [Mikati, Mohamad; Gallentine, William B.] Duke Univ, Med Ctr, Div Pediat Neurol, Durham, NC 27710 USA; [Podgoreanu, Mihai V.] Duke Univ, Med Ctr, Dept Anesthesiol, Div Cardiothorac Anesthesia & Crit Care, Durham, NC 27710 USA; [Cavalleri, Gianpiero L.; Delanty, Norman] Beaumont Hosp, Dept Clin Neurol Sci & Mol & Cellular Therapeut, Res Inst, Royal Coll Surg Ireland, Dublin 9, Ireland; [Cavalleri, Gianpiero L.; Delanty, Norman] Beaumont Hosp, Div Neurol, Dublin 9, Ireland; [Doherty, Colin P.] St James Hosp, Dept Neurol, Dublin 8, Ireland; [Buckley, Patrick G.; Stallings, Ray L.] Royal Coll Surgeons Ireland, Dublin 12, Ireland; [Buckley, Patrick G.; Stallings, Ray L.] Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland; [Depondt, Chantal; Pandolfo, Massimo] Univ Libre Bruxelles, Hop Erasme, Dept Neurol, B-1070 Brussels, Belgium; [Wood, Nicholas W.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Catarino, Claudia B.; Duncan, John S.; Sander, Josemir W.; Sisodiya, Sanjay M.] Natl Soc Epilepsy, Gerrards Cross SL9 0RJ, Bucks, England; [Sander, Josemir W.] Netherlands Fdn, SEIN Epilepsy Inst, NL-2103 SW Heemstede, Netherlands; [Leppert, David; Gibson, Rachel A.; Johnson, Michael R.; Matthews, Paul M.] GlaxoSmithKline, Drug Discovery, Div Genet, Brentford TW8 9GS, Middx, England; [Huxley-Jones, Julie] GlaxoSmithKline, Drug Discovery, Quantitat Sci, Computat Biol, Harlow CM19 5AW, Essex, England; [Leppert, David] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Middleton, Lefkos T.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Sch Publ Hlth, London W2 1PG, England; [Johnson, Michael R.; Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Clin Neurosci, London W12 0NN, England; [Kalviainen, Reetta; Kantanen, Anne-Mari] Kuopio Univ Hosp, Kuopio Epilepsy Ctr, Kuopio 70211, Finland; [Eriksson, Kai] Tampere Univ Hosp, Pediat Neurol Unit, FIN-33521 Tampere, Finland; [Dorn, Thomas; Hansen, Joerg; Kraemer, Guenter] Swiss Epilepsy Ctr, CH-8008 Zurich, Switzerland; [Steinhoff, Bernhard J.] Kork Epilepsy Ctr, D-77694 Kehl, Germany; [Wieser, Heinz-Gregor; Zumsteg, Dominik; Ortega, Marcos] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland	University of London; University College London; Duke University; Duke University; Duke University; Duke University; Royal College of Surgeons - Ireland; Trinity College Dublin; Royal College of Surgeons - Ireland; Our Ladys Children Hospital Crumlin; Universite Libre de Bruxelles; University of London; University College London; GlaxoSmithKline; GlaxoSmithKline; University of Basel; Imperial College London; Imperial College London; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital; University of Zurich; University Zurich Hospital	Sisodiya, SM (corresponding author), UCL Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.	s.sisodiya@ion.ucl.ac.uk; d.goldstein@duke.edu	Caboclo, Luis Otavio S F/G-6880-2012; Catarino, Claudia Bacanhim/ABC-2316-2021; Kasperaviciute, Dalia/D-1493-2009; Husain, Aatif/AAN-7058-2021; Stallings, Raymond/A-7213-2008; Delanty, Norman/F-8756-2011; Goldstein, David/AAY-8125-2020; Wood, Nicholas W/C-2505-2009; Sander, Josemir/C-1576-2008; Cavalleri, Gianpiero/A-6632-2010; Catarino, Claudia B/A-7719-2010	Wood, Nicholas W/0000-0002-9500-3348; Sander, Josemir/0000-0001-6041-9661; Catarino, Claudia B/0000-0002-6528-7570; Duncan, John S/0000-0002-1373-0681; Need, Anna/0000-0003-3955-8207; Matthews, Paul M/0000-0002-1619-8328; Gibson, Rachel/0000-0002-1338-1290; Mikati, Mohamad/0000-0003-0363-8715; Doherty, Colin/0000-0002-8869-8567; Cavalleri, Gianpiero/0000-0002-9802-0506; Delaney, Norman/0000-0002-3953-9842; Podgoreanu, Mihai/0000-0001-5539-4674	UK Medical Research Council [G0400126]; The Wellcome Trust [084730]; National Institute for Health Research (NIHR) [08-08-SCC]; University College London Hospitals Clinical Research and Development Committee [F136]; National Society for Epilepsy, UK; Department of Health's NIHR; Fonds National de la Recherche Scientifique; Fondation Erasme, Universite Libre de Bruxelles; Irish Higher Education Authority; Children's Medical and Research Foundation; Irish Research Council for Science, Engineering and Technology; GlaxoSmithKline; American Epilepsy Society; Medical Research Council [G9805989, G0400126] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish; MRC [G0400126, G9805989] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); University College London Hospitals Clinical Research and Development Committee; National Society for Epilepsy, UK; Department of Health's NIHR(National Institute for Health Research (NIHR)); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fondation Erasme, Universite Libre de Bruxelles; Irish Higher Education Authority; Children's Medical and Research Foundation; Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); GlaxoSmithKline(GlaxoSmithKline); American Epilepsy Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the UK Medical Research Council (G0400126), The Wellcome Trust (084730), the National Institute for Health Research (NIHR) (08-08-SCC), University College London Hospitals Clinical Research and Development Committee (F136), and the National Society for Epilepsy, UK. This work was partly undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The collection of the Belgian patients was supported by the Fonds National de la Recherche Scientifique and the Fondation Erasme, Universite Libre de Bruxelles. The collection of the Irish patient cohort was supported as part of the Programme for Human Genomics and the Programme for Research in Third Level Institutions (PRTLI3) funded by the Irish Higher Education Authority and in part by the Children's Medical and Research Foundation and the Irish Research Council for Science, Engineering and Technology. GlaxoSmithKline funded the recruitment and the phenotypic data collection of the GenEpA Consortium samples used in this study and contributed to the genotyping costs associated with their study.; We also acknowledge Leslie Hall, Siwan Oldham, Linda Surh, Rachel Taylor (GlaxoSmithKline), and Dan Lowenstein (University of California, San Francisco) for contributing to the GenEpA steering committee. T.J.U. was supported by the American Epilepsy Society postdoctoral research fellowship.	Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Diani E, 2008, EPILEPSY RES, V80, P1, DOI 10.1016/j.eplepsyres.2008.03.001; Dibbens LM, 2009, HUM MOL GENET, V18, P3626, DOI 10.1093/hmg/ddp311; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Harkin LA, 2002, AM J HUM GENET, V70, P530, DOI 10.1086/338710; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; LaFrance WC, 2008, INT REV NEUROBIOL, V83, P347, DOI 10.1016/S0074-7742(08)00020-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	24	198	204	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					707	718		10.1016/j.ajhg.2010.03.018	http://dx.doi.org/10.1016/j.ajhg.2010.03.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20398883	Green Published, hybrid			2022-12-18	WOS:000278045300007
J	Neilson, DE; Adams, MD; Orr, CMD; Schelling, DK; Eiben, RM; Kerr, DS; Anderson, J; Bassuk, AG; Bye, AM; Childs, AM; Clarke, A; Crow, YJ; Di Rocco, M; Dohna-Schwake, C; Dueckers, G; Fasano, AE; Gika, AD; Gionnis, D; Gorman, MP; Grattan-Smith, PJ; Hackenberg, A; Kuster, A; Lentschig, MG; Lopez-Laso, E; Marco, EJ; Mastroyianni, S; Perrier, J; Schmitt-Mechelke, T; Servidei, S; Skardoutsou, A; Uldall, P; van der Knaap, MS; Goglin, KC; Tefft, DL; Aubin, C; de Jager, P; Hafler, D; Warman, ML				Neilson, Derek E.; Adams, Mark D.; Orr, Caitlin M. D.; Schelling, Deborah K.; Eiben, Robert M.; Kerr, Douglas S.; Anderson, Jane; Bassuk, Alexander G.; Bye, Ann M.; Childs, Anne-Marie; Clarke, Antonia; Crow, Yanick J.; Di Rocco, Maja; Dohna-Schwake, Christian; Dueckers, Gregor; Fasano, Alfonso E.; Gika, Artemis D.; Gionnis, Dimitris; Gorman, Mark P.; Grattan-Smith, Padraic J.; Hackenberg, Annette; Kuster, Alice; Lentschig, Markus G.; Lopez-Laso, Eduardo; Marco, Elysa J.; Mastroyianni, Sotiria; Perrier, Julie; Schmitt-Mechelke, Thomas; Servidei, Serenella; Skardoutsou, Angeliki; Uldall, Peter; van der Knaap, Mario S.; Goglin, Karrie C.; Tefft, David L.; Aubin, Cristin; de Jager, Philip; Hafler, David; Warman, Matthew L.			Infection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; INFLUENZA; CHILDHOOD; RECEPTOR; COMPLEX	Acute necrotizing encephalopathy (ANE) is a rapidly progressive encephalopathy that can occur in otherwise healthy children after common viral infections such as influenza and parainfluenza. Most ANE is sporadic and nonrecurrent (isolated ANE). However, we identified a 7 Mb interval containing a susceptibility locus (ANE1) in a family segregating recurrent ANE as an incompletely penetrant, autosomal-dominant trait. We now report that all affected individuals and obligate carriers in this family are heterozygous for a missense mutation (c.1880C -> T, p.Thr585Met) in the gene encoding the nuclear pore protein Ran Binding Protein 2 (RANBP2). To determine whether this mutation is the susceptibility allele, we screened controls and other patients with ANE who are unrelated to the index family. Patients from 9 of 15 additional kindreds with familial or recurrent ANE had the identical mutation. It arose de novo in two families and independently in several other families. Two other patients with familial ANE had different RANBP2 missense Mutations that altered conserved residues. None of the three RANBP2 missense mutations were found in 19 patients with isolated ANE or in unaffected controls. We conclude that missense mutations in RANBP2 are susceptibility alleles for familial and recurrent cases of ANE.	[Neilson, Derek E.; Adams, Mark D.; Orr, Caitlin M. D.; Schelling, Deborah K.; Goglin, Karrie C.; Tefft, David L.; Warman, Matthew L.] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Dept Genet, Cleveland, OH 44106 USA; [Neilson, Derek E.; Warman, Matthew L.] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Ctr Human Genet, Cleveland, OH 44106 USA; [Neilson, Derek E.; Eiben, Robert M.; Kerr, Douglas S.; Warman, Matthew L.] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Eiben, Robert M.] Metrohlth Med Ctr, Cleveland, OH 44109 USA; [Anderson, Jane] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94118 USA; [Marco, Elysa J.] Univ Calif San Francisco, Div Child Neurol, San Francisco, CA 94118 USA; [Bassuk, Alexander G.] Univ Iowa, Childrens Hosp, Dept Pediat, Iowa City, IA 52242 USA; [Bye, Ann M.; Grattan-Smith, Padraic J.] Sydney Childrens Hosp, Randwick, NSW 2031, Australia; [Childs, Anne-Marie] Leeds Teaching Hosp, Dept Paediat Neurol, Leeds LS2 9NS, W Yorkshire, England; [Clarke, Antonia] St George Hosp, Dept Paediat Neurol, London SW17 0QT, England; [Crow, Yanick J.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Di Rocco, Maja] Gaslini Inst Genoa, Div Pediat 2, Unit Rare Dis, I-16147 Genoa, Italy; [Dohna-Schwake, Christian; Dueckers, Gregor] Univ Childrens Hosp, Dept Pediat Neuropediat Neonatal & Pediat Intens, D-45130 Essen, Germany; [Fasano, Alfonso E.; Servidei, Serenella] Univ Cattolica Sacro Cuore, Gemelli Hosp, Dept Neurol, I-00168 Rome, Italy; [Gionnis, Dimitris] Univ Athens, P&A Kyriakou Childrens Hosp, Pediat Intens Care Unit, Athens 11527, Greece; [Mastroyianni, Sotiria] Univ Athens, P&A Kyriakou Childrens Hosp, Dept Neurol, Athens 11527, Greece; [Skardoutsou, Angeliki] Univ Athens, P&A Kyriakou Childrens Hosp, Dept Pediat 2, Athens 11527, Greece; [Gorman, Mark P.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hackenberg, Annette] Klinikum Bremen Mitte, Prof Hess Kinderklin, D-28177 Bremen, Germany; [Kuster, Alice] Univ Hosp, Metab Unit, F-44093 Nantes, France; [Perrier, Julie] Univ Hosp, Dept Pediat Neurol, F-44093 Nantes, France; [Lentschig, Markus G.] MR & PET CT Ctr Bremen Mitte, D-28177 Bremen, Germany; [Lopez-Laso, Eduardo] Univ Hosp Reina Sofia, Dept Pediat, Pediat Neurol Unit, Cordoba 14004, Spain; [Schmitt-Mechelke, Thomas] Childrens Hosp, Neuropediat Dept, CH-6000 Luzern, Switzerland; [Uldall, Peter] Rigshosp, Dept Child Neurol, DK-2100 Copenhagen, Denmark; [van der Knaap, Mario S.] Vrije Univ Amsterdam Med Ctr, Dept Child Neurol, NL-1081 HV Amsterdam, Netherlands; [Aubin, Cristin] Harvard Univ, Cambridge, MA 02142 USA; [Aubin, Cristin] MIT, Broad Inst, Cambridge, MA 02142 USA; [de Jager, Philip; Hafler, David] Harvard Univ, Sch Med, Boston, MA 02115 USA; [de Jager, Philip; Hafler, David] Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; MetroHealth System; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa; University of Leeds; St Georges University London; Saint James's University Hospital; University of Leeds; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Harvard University; Boston Children's Hospital; Klinikum Bremen-Mitte; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Hospital Universitario Reina Sofia - Cordoba; Rigshospitalet; University of Copenhagen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Neilson, DE (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.	derek.neilson@cchmc.org	Neilson, Derek/AAM-9450-2021; Resource Center, NINDS Human Genetics/AGF-2474-2022; Dohna-Schwake, Christian/ABI-7392-2020; Sander-Effron, Samuel/AAX-2231-2020; López-Laso, Eduardo/B-8700-2014; Crow, Yanick J/N-6120-2014; Servidei, Serenella/ABC-4262-2021; Fasano, Alfonso/K-2558-2018	Dohna-Schwake, Christian/0000-0001-8973-5406; López-Laso, Eduardo/0000-0001-7732-6277; Crow, Yanick J/0000-0001-7211-7564; Fasano, Alfonso/0000-0001-5346-0180; MASTROYIANNI, SOTIRIA/0000-0002-7165-3784; Bassuk, Alexander/0000-0002-4067-2157; Hackenberg, Annette/0000-0003-3161-8703; SERVIDEI, Serenella/0000-0001-8478-2799	NIH [NINDS K08NS050331]; Burroughs Wellcome Fund; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050331] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the research subjects and families for their participation. We thank Masaya Kubota, David Michelson, Nancy Leslie, Lazlo Sztriha, Timothy Chin, Muge Calikoglu, Yoshihiro Maegaki, Yusuke Goto, Tomohide Goto, Vivian Wong, Dragana Josifova, Peter van Hasselt, and Hitoshi Osaka for patient referrals. We thank Jeffrey Murray and Hatern el-Shanti for their generous assistance in testing control samples. This work was supported by NIH grant NINDS K08NS050331, by a Clinician Scientist Award in Translational Research to M.L.W. from the Burroughs Wellcome Fund, and by the Howard Hughes Medical Institute. The authors report no conflicts of interest.	Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177; Cho KI, 2009, CELL DEATH DIFFER, V16, P287, DOI 10.1038/cdd.2008.153; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Ichiyama T, 2003, SCAND J INFECT DIS, V35, P59, DOI 10.1080/0036554021000026986; Ichiyama T, 2003, PEDIATR INT, V45, P734, DOI 10.1111/j.1442-200X.2003.01822.x; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2008, FEBS LETT, V582, P190, DOI 10.1016/j.febslet.2007.11.087; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mastroyianni SD, 2006, J CHILD NEUROL, V21, P872, DOI 10.1177/08830738060210101401; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Mizuguchi M, 1997, BRAIN DEV-JPN, V19, P81, DOI 10.1016/S0387-7604(96)00063-0; Mori I, 2001, MICROBES INFECT, V3, P475, DOI 10.1016/S1286-4579(01)01403-4; Mori SI, 1999, ARCH VIROL, V144, P147, DOI 10.1007/s007050050491; Neilson DE, 2004, ANN NEUROL, V55, P291, DOI 10.1002/ana.10849; Neilson DE, 2003, NEUROLOGY, V61, P226, DOI 10.1212/01.WNL.0000073544.28775.1A; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Prunuske AJ, 2006, MOL BIOL CELL, V17, P760, DOI 10.1091/mbc.E05-06-0485; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwartz RS, 2003, NEW ENGL J MED, V348, P1017, DOI 10.1056/NEJMsa022766; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	25	198	213	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					44	51		10.1016/j.ajhg.2008.12.009	http://dx.doi.org/10.1016/j.ajhg.2008.12.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19118815	Green Published, Bronze			2022-12-18	WOS:000262679500005
J	Hucthagowder, V; Sausgruber, N; Kim, KH; Angle, B; Marmorstein, LY; Urban, Z				Hucthagowder, Vishwanathan; Sausgruber, Nina; Kim, Katherine H.; Angle, Brad; Marmorstein, Lihua Y.; Urban, Zsolt			Fibulin-4: A novel gene for an autosomal recessive cutis laxa syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ELASTIN GENE; MARFAN-SYNDROME; IN-VIVO; MUTATIONS; DISEASE; ELASTOGENESIS; TROPOELASTIN; FORM	Cutis laxa is a condition characterized by redundant, pendulous, and inelastic skin. We identified a patient with recessive inheritance of a missense mutation (169G -> A; E57K) in the Fibulin-4 gene. She had multiple bone fractures at birth and was diagnosed with cutis laxa, vascular tortuosity, ascending aortic aneurysm, developmental emphysema, inguinal and diaphragmatic hernia, joint laxity, and pectus excavatum by age 2 years. Her skin showed markedly underdeveloped elastic fibers, and the extracellular matrix laid down by her skin fibroblasts contained dramatically reduced amounts of fibulin-4. We conclude that fibulin-4 is necessary for elastic fiber formation and connective tissue development.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Childrens Mem Hosp, Chicago, IL 60614 USA; Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA	Washington University (WUSTL); Washington University (WUSTL); Ann & Robert H. Lurie Children's Hospital of Chicago; University of Arizona	Urban, Z (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	urban_z@kids.wustl.edu	Urban, Zsolt/B-1977-2008; Hucthagowder, Vishwanathan/C-9831-2009; Urban, Zsolt/A-2018-2013	Urban, Zsolt/0000-0003-3890-1843	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073703] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL073703, R01 HL073703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; DAS S, 1995, AM J HUM GENET, V56, P570; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Markova D, 2003, AM J HUM GENET, V72, P998, DOI 10.1086/373940; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Rodriguez-Revenga L, 2004, ARCH DERMATOL, V140, P1135, DOI 10.1001/archderm.140.9.1135; Szabo Z, 2006, J MED GENET, V43, P255, DOI 10.1136/jmg.2005.034157; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Urban Z, 2005, J INVEST DERMATOL, V124, P1193, DOI 10.1111/j.0022-202X.2005.23758.x; Xiang Y, 2006, J IMMUNOL, V176, P3196, DOI 10.4049/jimmunol.176.5.3196; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	18	198	204	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1075	1080		10.1086/504304	http://dx.doi.org/10.1086/504304			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685658	Green Published, Bronze			2022-12-18	WOS:000237553800017
J	Miretti, MM; Walsh, EC; Ke, XY; Delgado, M; Griffiths, M; Hunt, S; Morrison, J; Whittaker, P; Lander, ES; Cardon, LR; Bentley, DR; Rioux, JD; Beck, S; Deloukas, P				Miretti, MM; Walsh, EC; Ke, XY; Delgado, M; Griffiths, M; Hunt, S; Morrison, J; Whittaker, P; Lander, ES; Cardon, LR; Bentley, DR; Rioux, JD; Beck, S; Deloukas, P			A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II REGION; MULTIPLE-SCLEROSIS; HUMAN GENOME; MEIOTIC RECOMBINATION; HAPLOTYPE STRUCTURE; HUMAN MHC; DISEASE; SUSCEPTIBILITY; ASSOCIATION; POPULATION	Autoimmune, inflammatory, and infectious diseases present a major burden to human health and are frequently associated with loci in the human major histocompatibility complex (MHC). Here, we report a high-resolution (1.9 kb) linkage-disequilibrium (LD) map of a 4.46-Mb fragment containing the MHC in U. S. pedigrees with northern and western European ancestry collected by the Centre d'Etude du Polymorphisme Humain ( CEPH) and the first generation of haplotype tag single-nucleotide polymorphisms (tagSNPs) that provide up to a fivefold increase in genotyping efficiency for all future MHC-linked disease-association studies. The data confirm previously identified recombination hotspots in the class II region and allow the prediction of numerous novel hotspots in the class I and class III regions. The region of longest LD maps outside the classic MHC to the extended class I region spanning the MHC-linked olfactory-receptor gene cluster. The extended haplotype homozygosity analysis for recent positive selection shows that all 14 outlying haplotype variants map to a single extended haplotype, which most commonly bears HLA-DRB1*1501. The SNP data, haplotype blocks, and tagSNPs analysis reported here have been entered into a multidimensional Web-based database (GLOVAR), where they can be accessed and viewed in the context of relevant genome annotation. This LD map allowed us to give coordinates for the extremely variable LD structure underlying the MHC.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02138 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Oxford; Wellcome Centre for Human Genetics	Beck, S (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	beck@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Collins, Andrew/A-6595-2010; Miretti, Marcos M./AAY-5895-2020; Ke, Xiayi/C-7674-2009; Rioux, John D/A-9599-2015	Deloukas, Panos/0000-0001-9251-070X; Collins, Andrew/0000-0001-7108-0771; Miretti, Marcos M./0000-0001-8179-1606; Rioux, John D/0000-0001-7560-8326; Hunt, Sarah/0000-0002-8350-1235	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK64869, R01 DK064869] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; CULLEN M, 1995, AM J HUM GENET, V56, P1350; Cullen M, 1997, AM J HUM GENET, V60, P397; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Ehlers A, 2000, GENOME RES, V10, P1968, DOI 10.1101/gr.10.12.1968; Fearnhead P, 2001, GENETICS, V159, P1299; Fust G, 2004, INT IMMUNOL, V16, P1507, DOI 10.1093/intimm/dxh152; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2003, TRENDS GENET, V19, P615, DOI 10.1016/j.tig.2003.09.006; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Heggarty S, 2003, J NEUROIMMUNOL, V143, P93, DOI 10.1016/j.jneuroim.2003.08.019; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Larsen CE, 2004, CURR OPIN IMMUNOL, V16, P660, DOI 10.1016/j.coi.2004.07.014; LEWONTIN RC, 1964, GENETICS, V49, P49; Li N, 2003, GENETICS, V165, P2213; Marchini M, 2003, HUM IMMUNOL, V64, P462, DOI 10.1016/S0198-8859(03)00017-X; Marrosu MG, 2004, NEUROLOGY, V63, P1084, DOI 10.1212/01.WNL.0000138493.04890.7C; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Oliphant A, 2002, BIOTECHNIQUES, P56; Pettersson F, 2004, BIOINFORMATICS, V20, P3241, DOI 10.1093/bioinformatics/bth341; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Walsh EC, 2003, AM J HUM GENET, V73, P580, DOI 10.1086/378101; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x	50	198	207	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					634	646		10.1086/429393	http://dx.doi.org/10.1086/429393			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15747258	Green Published, Bronze			2022-12-18	WOS:000227516000009
J	Dagoneau, N; Benoist-Lasselin, C; Huber, C; Faivre, L; Megarbane, A; Alswaid, A; Dollfus, H; Alembik, Y; Munnich, A; Legeai-Mallet, L; Cormier-Daire, V				Dagoneau, N; Benoist-Lasselin, C; Huber, C; Faivre, L; Megarbane, A; Alswaid, A; Dollfus, H; Alembik, Y; Munnich, A; Legeai-Mallet, L; Cormier-Daire, V			ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEASE ACTIVITY; FAMILY; GENE; DISINTEGRIN; CARTILAGE	Weill-Marchesani syndrome (WMS) is characterized by the association of short stature; brachydactyly; joint stiffness; eye anomalies, including microspherophakia and ectopia of the lenses; and, occasionally, heart defects. We have recently mapped a gene for the autosomal recessive form of WMS to chromosome 19p13.3-p13.2, in a 12.4-cM interval. Here, we report null mutations in a member of the extracellular matrix protease family, the gene encoding ADAMTS10, a disintegrin and metalloprotease with thrombospondin motifs. A total of three distinct mutations were identified in two consanguineous families and in one sporadic WMS case, including one nonsense mutation (R237X) and two splice mutations (1190+1G-->A and 810+1G-->A). ADAMTS10 expression studies using reverse-transcriptase polymerase chain reaction, northern blot, and dot-blot analyses showed that ADAMTS10 is expressed in skin, fetal chondrocytes, and fetal and adult heart. Moreover, electron microscopy and immunological studies of the skin fibroblasts from the patients confirmed impairment of the extracellular matrix. We conclude, therefore, that ADAMTS10 plays a major role in growth and in skin, lens, and heart development in humans.	Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; St Josephs Univ, Unite Genet Med, Beirut, Lebanon; Riyadh Armed Forces Hosp, Riyadh, Saudi Arabia; Hop Hautepierre, Serv Genet Med, Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut; Prince Sultan Military Medical City; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cormier-Daire, V (corresponding author), Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.	cormier@necker.fr	Legeai-Mallet, Laurence/E-6112-2016; Megarbane, Andre/ABD-5574-2021; cormier-daire, valerie/H-6520-2017	Legeai-Mallet, Laurence/0000-0003-4989-5856; BENOIST, Catherine/0000-0003-1779-0312; Dollfus, Helene/0000-0002-2249-895X; cormier-daire, valerie/0000-0002-2839-9856; Faivre, Laurence/0000-0001-9770-444X; huber, celine/0000-0002-8601-9655				Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2002, HUM GENET, V110, P366, DOI 10.1007/s00439-002-0689-3; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3	10	198	204	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					801	806		10.1086/425231	http://dx.doi.org/10.1086/425231			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15368195	Green Published, Bronze			2022-12-18	WOS:000224303500005
J	Kivisild, T; Reidla, M; Metspalu, E; Rosa, A; Brehm, A; Pennarun, E; Parik, J; Geberhiwot, T; Usanga, E; Villems, R				Kivisild, T; Reidla, M; Metspalu, E; Rosa, A; Brehm, A; Pennarun, E; Parik, J; Geberhiwot, T; Usanga, E; Villems, R			Ethiopian mitochondrial DNA heritage: Tracking gene flow across and around the gate of tears	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLEISTOCENE HOMO-SAPIENS; CONTROL-REGION SEQUENCE; Y-CHROMOSOME; AFRICAN POPULATIONS; MTDNA VARIATION; NEAR-EASTERN; CASTE POPULATIONS; MIGRATORY EVENTS; MIDDLE AWASH; SLAVE-TRADE	Approximately 10 miles separate the Horn of Africa from the Arabian Peninsula at Bab-el-Mandeb ( the Gate of Tears). Both historic and archaeological evidence indicate tight cultural connections, over millennia, between these two regions. High-resolution phylogenetic analysis of 270 Ethiopian and 115 Yemeni mitochondrial DNAs was performed in a worldwide context, to explore gene flow across the Red and Arabian Seas. Nine distinct subclades, including three newly defined ones, were found to characterize entirely the variation of Ethiopian and Yemeni L3 lineages. Both Ethiopians and Yemenis contain an almost-equal proportion of Eurasian-specific M and N and African-specific lineages and therefore cluster together in a multidimensional scaling plot between Near Eastern and sub-Saharan African populations. Phylogeographic identification of potential founder haplotypes revealed that approximately one-half of haplogroup L0-L5 lineages in Yemenis have close or matching counterparts in southeastern Africans, compared with a minor share in Ethiopians. Newly defined clade L6, the most frequent haplogroup in Yemenis, showed no close matches among 3,000 African samples. These results highlight the complexity of Ethiopian and Yemeni genetic heritage and are consistent with the introduction of maternal lineages into the South Arabian gene pool from different source populations of East Africa. A high proportion of Ethiopian lineages, significantly more abundant in the northeast of that country, trace their western Eurasian origin in haplogroup N through assorted gene flow at different times and involving different source populations.	Estonian Bioctr, EE-51010 Tartu, Estonia; Univ Tartu, EE-50090 Tartu, Estonia; Univ Madeira Penteada, Ctr Macronesian Studies, Funchal, Portugal; Birmingham & Solihull Teaching Hosp, Birmingham, W Midlands, England; Univ Calabar, Dept Haematol, Calabar, Nigeria	Estonian Biocentre; University of Tartu; University of Calabar	Kivisild, T (corresponding author), Estonian Bioctr, Riia 23, EE-51010 Tartu, Estonia.	tkivisil@ebc.ee	Kivisild, Toomas/P-5889-2017; Pennarun, Erwan/AAW-7041-2020; Rosa, Alexandra/AAA-3224-2022	Kivisild, Toomas/0000-0002-6297-7808; Pennarun, Erwan/0000-0002-8267-883X; Rosa, Alexandra/0000-0002-1827-6828; Brehm, Antonio/0000-0003-3168-5340				Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Corbo RM, 1999, AM J HUM BIOL, V11, P297, DOI 10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; DERBENEVA OA, 2002, J GENETIKA, V38, P1554; Diakonoff Igor M., 1988, AFRASIAN LANGUAGES; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ehret Christopher, 1995, RECONSTRUCTING PROTO; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Forster P, 1996, AM J HUM GENET, V59, P935; Fort M, 1998, TISSUE ANTIGENS, V51, P327; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Harris Joseph E., 1971, AFRICAN PRESENCE ASI; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2003, EXAMINING FARMING LA, P215; Knight A, 2003, CURR BIOL, V13, P464, DOI 10.1016/S0960-9822(03)00130-1; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Levine Donald, 1974, GREATER ETHIOPIA EVO; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; Metspalu E, 1999, GENOMIC DIVERSITY, P121; Militarev A., 2003, EXAMINING FARMING LA, P135; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Munro-Hay S., 1991, AKSUM AFRICAN CIVILI; Nei M., 1987, MOL EVOLUTIONARY GEN; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Roessli D, 2000, ARLEQUIN VERSION 2 0; Rosa A, 2004, ANN HUM GENET, V68, P340, DOI 10.1046/j.1529-8817.2004.00100.x; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; SAUER CARL O., 1962, PROC AMER PHIL SOC, V106, P41; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shen PD, 2004, HUM MUTAT, V24, P248, DOI 10.1002/humu.20077; Soodyall H, 1996, AM J HUM GENET, V58, P595; Stevanovitch A, 2004, ANN HUM GENET, V68, P23, DOI 10.1046/j.1529-8817.2003.00057.x; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Tambets K, 2003, MCDONALD I ARCHAEOLO, P449; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669	77	198	198	0	19	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					752	770		10.1086/425161	http://dx.doi.org/10.1086/425161			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15457403	Green Published, Bronze			2022-12-18	WOS:000224303500002
J	Douglas, J; Hanks, S; Temple, IK; Davies, S; Murray, A; Upadhyaya, M; Tomkins, S; Hughes, HE; Cole, TRP; Rahman, N				Douglas, J; Hanks, S; Temple, IK; Davies, S; Murray, A; Upadhyaya, M; Tomkins, S; Hughes, HE; Cole, TRP; Rahman, N			NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of weaver syndrome but are rare in other overgrowth phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DEFECTS; DOMAIN-CONTAINING GENE; SET; METHYLTRANSFERASES; MYELOMA; PROTEIN; MAPS	Sotos syndrome is a childhood overgrowth syndrome characterized by a distinctive facial appearance, height and head circumference >97th percentile, advanced bone age, and developmental delay. Weaver syndrome is characterized by the same criteria but has its own distinctive facial gestalt. Recently, a 2.2-Mb chromosome 5q35 microdeletion, encompassing NSD1, was reported as the major cause of Sotos syndrome, with intragenic NSD1 mutations identified in a minority of cases. We evaluated 75 patients with childhood overgrowth, for intragenic mutations and large deletions of NSD1. The series was phenotypically scored into four groups, prior to the molecular analyses: the phenotype in group 1 (n = 37) was typical of Sotos syndrome; the phenotype in group 2 (n = 13) was Sotos-like but with some atypical features; patients in group 3 (n = 7) had Weaver syndrome, and patients in group 4 (n = 18) had an overgrowth condition that was neither Sotos nor Weaver syndrome. We detected three deletions and 32 mutations (13 frameshift, 8 nonsense, 2 splice-site, and 9 missense) that are likely to impair NSD1 functions. The truncating mutations were spread throughout NSD1, but there was evidence of clustering of missense mutations in highly conserved functional domains between exons 13 and 23. There was a strong correlation between presence of an NSD1 alteration and clinical phenotype, in that 28 of 37 (76%) patients in group 1 had NSD1 mutations or deletions, whereas none of the patients in group 4 had abnormalities of NSD1. Three patients with Weaver syndrome had NSD1 mutations, all between amino acids 2142 and 2184. We conclude that intragenic mutations of NSD1 are the major cause of Sotos syndrome and account for some Weaver syndrome cases but rarely occur in other childhood overgrowth phenotypes.	Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; Inst Canc Res, Sect Canc Genet, Surrey, England; Southampton Univ Hosp, Dept Human Genet, Southampton, Hants, England; Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England	Birmingham Women's Hospital; University of London; Institute of Cancer Research - UK; University of Southampton; Cardiff University; Saint James's University Hospital	Cole, TRP (corresponding author), Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England.	trevor.cole@bham-womens.thenhs.com; nazneen@icr.ac.uk	Rahman, Nazneen/B-8890-2012; temple, isabel K/K-2391-2015; Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440; Temple, Isabel Karen/0000-0002-6045-1781				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; Charbonnier F, 2002, CANCER RES, V62, P848; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Cole T, 1998, ARCH DIS CHILD, V78, P200, DOI 10.1136/adc.78.3.200; COLE T, 1995, CONGENITAL MALFORMAT, P267; COLE TRP, 1992, J MED GENET, V29, P332, DOI 10.1136/jmg.29.5.332; COLE TRP, 1994, J MED GENET, V31, P20, DOI 10.1136/jmg.31.1.20; COLE TRP, 1991, AM J MED GENET, V41, P115, DOI 10.1002/ajmg.1320410128; COLE TRP, 1990, J MED GENET, V27, P571, DOI 10.1136/jmg.27.9.571; COLE TRP, 1995, CONGENITAL MALFORMAT, P254; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; HERSH JH, 1992, J PEDIATR-US, V120, P572, DOI 10.1016/S0022-3476(10)80004-6; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Imaizumi K, 2002, AM J MED GENET, V107, P58, DOI 10.1002/ajmg.10080; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; KANEKO H, 1987, AM J MED GENET, V26, P569, DOI 10.1002/ajmg.1320260310; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Kurotaki N, 2001, GENE, V279, P197, DOI 10.1016/S0378-1119(01)00750-8; Noreau DR, 1998, AM J MED GENET, V79, P327, DOI 10.1002/(SICI)1096-8628(19981002)79:4<327::AID-AJMG16>3.0.CO;2-T; Opitz JM, 1998, AM J MED GENET, V79, P294, DOI 10.1002/(SICI)1096-8628(19981002)79:4<294::AID-AJMG12>3.0.CO;2-M; Proud VK, 1998, AM J MED GENET, V79, P305, DOI 10.1002/(SICI)1096-8628(19981002)79:4<305::AID-AJMG13>3.0.CO;2-V; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; SOTOS JF, 1964, NEW ENGL J MED, V271, P109, DOI 10.1056/NEJM196407162710301; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Sweeney E, 2002, CLIN DYSMORPHOL, V11, P121, DOI 10.1097/00019605-200204000-00009; WEAVER DD, 1974, J PEDIATR-US, V84, P547, DOI 10.1016/S0022-3476(74)80675-X	31	198	206	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					132	143		10.1086/345647	http://dx.doi.org/10.1086/345647			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12464997	Green Published, Bronze			2022-12-18	WOS:000180186800013
J	Benit, P; Chretien, D; Kadhom, N; de Lonlay-Debeney, P; Cormier-Daire, V; Cabral, A; Peudenier, S; Rustin, P; Munnich, A; Rotig, A				Benit, P; Chretien, D; Kadhom, N; de Lonlay-Debeney, P; Cormier-Daire, V; Cabral, A; Peudenier, S; Rustin, P; Munnich, A; Rotig, A			Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; DISEASE; DISORDER; ATAXIA	Reduced nicotinamide adenine dinucleotide (NADH): ubiquinone oxidoreductase (complex I) is the largest complex of the mitochondrial respiratory chain and complex I deficiency accounts for similar to 30% cases of respiratory-chain deficiency in humans. Only seven mitochondrial DNA genes, but >35 nuclear genes encode complex I subunits. In an attempt to elucidate the molecular bases of complex I deficiency, we studied the six most-conserved complex I nuclear genes (NDUFV1, NDUFS8, NDUFS7, NDUFS1, NDUFA8, and NDUFB6) in a series of 36 patients with isolated complex I deficiency by denaturing high-performance liquid chromatography and by direct sequencing of the corresponding cDNA from cultured skin fibroblasts. In 3/36 patients, we identified, for the first time, five point mutations (del222, D252G, M707V, R241W, and R557X) and one large-scale deletion in the NDUFS1 gene. In addition, we found six novel NDUFV1 mutations (Y204C, C206G, E214K, IVS 8+41, A432P, and del nt 989-990) in three other patients. The six unrelated patients presented with hypotonia, ataxia, psychomotor retardation, or Leigh syndrome. These results suggest that screening for complex I nuclear gene mutations is of particular interest in patients with complex I deficiency, even when normal respiratory-chain-enzyme activities in cultured fibroblasts are observed.	Hop Necker Enfants Malad, Serv Genet, INSERM, U393, F-75015 Paris, France; Hosp Santa Maria, Lisbon, Portugal; Hop Sud, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Lisboa; Hospital Santa Maria; CHU Rennes	Rotig, A (corresponding author), Hop Necker Enfants Malad, Serv Genet, INSERM, U393, 149 Rue Sevres, F-75015 Paris, France.		Rötig, Agnès/G-9592-2017; cormier-daire, valerie/H-6520-2017	Rötig, Agnès/0000-0003-0589-0703; cormier-daire, valerie/0000-0002-2839-9856				Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; AMIEL J, IN PRESS PRENATAL DI; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P; Munnich A., 2001, METABOLIC MOL BASES, P2261; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Papadopoulou LC, 1999, NAT GENET, V23, P333; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Valnot I, 2000, AM J HUM GENET, V67, P1104; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	21	198	206	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1344	1352		10.1086/320603	http://dx.doi.org/10.1086/320603			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349233	Bronze, Green Published			2022-12-18	WOS:000169094600005
J	Laval, SH; Timms, A; Edwards, S; Bradbury, L; Brophy, S; Milicic, A; Rubin, L; Siminovitch, KA; Weeks, DE; Calin, A; Wordsworth, BP; Brown, MA				Laval, SH; Timms, A; Edwards, S; Bradbury, L; Brophy, S; Milicic, A; Rubin, L; Siminovitch, KA; Weeks, DE; Calin, A; Wordsworth, BP; Brown, MA			Whole-genome screening in ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-B27 POSITIVE INDIVIDUALS; COMPLEX TRAITS; LINKAGE ANALYSIS; WIDE SEARCH; CHROMOSOME; DISEASE; PSORIASIS; FAMILIES; REGION; RISK	Ankylosing spondylitis (AS) is a common inflammatory arthritis predominantly affecting the axial skeleton. Susceptibility to the disease is thought to be oligogenic. To identify the genes involved, we have performed a genomewide scan in 185 families containing 255 affected sibling pairs. Two-point and multipoint nonparametric linkage analysis was performed. Regions were identified showing "suggestive" or stronger linkage with the disease on chromosomes 1p, 2q, 6p, 9q, 10q, 16q, and 19q. The MHC locus was identified as encoding the greatest component of susceptibility, with an overall LOD score of 15.6. The strongest non-MHC linkage lies on chromosome 16q (overall LOD score 4.7). These results strongly support the presence of non-MHC genetic-susceptibility factors in AS and point to their likely locations.	Wellcome Trust Ctr Human Genet, Spondyloarthrit & Bone Dis Res Grp, Headington OX3 7BN, England; Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; St Michaels Hosp, Div Rheumatol, Toronto, ON M5B 1W8, Canada; Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	University of Oxford; Wellcome Centre for Human Genetics; Royal National Hospital for Rheumatic Diseases (RNHRD); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brown, MA (corresponding author), Wellcome Trust Ctr Human Genet, Spondyloarthrit & Bone Dis Res Grp, Roosevelt Dr, Headington OX3 7BN, England.		Weeks, Daniel E/B-2995-2012; Milicic, Anita/B-7693-2011; Brown, Matthew A/E-5749-2010; Siminovitch, Katherine/K-1475-2013	Weeks, Daniel E/0000-0001-9410-7228; Milicic, Anita/0000-0002-7984-1317; Brown, Matthew A/0000-0003-0538-8211; Brophy, Sinead/0000-0001-7417-2858				Beyeler C, 1996, ANN RHEUM DIS, V55, P66, DOI 10.1136/ard.55.1.66; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 2000, HUM MOL GENET, V9, P1563, DOI 10.1093/hmg/9.11.1563; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; Brown MA, 1998, ARTHRITIS RHEUM, V41, P588, DOI 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; CALIN A, 1983, ARTHRITIS RHEUM, V26, P1460, DOI 10.1002/art.1780261207; Calin A, 1998, OXFORD TXB RHEUMATOL, P1058; Cordell HJ, 1997, GENET EPIDEMIOL, V14, P593, DOI 10.1002/(SICI)1098-2272(1997)14:6<593::AID-GEPI7>3.0.CO;2-0; DEBLECOURT J, 1961, ANN RHEUM DIS, V20, P215, DOI 10.1136/ard.20.3.215; DESHAYES P, 1987, REV RHUM, V54, P171; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Ehm MG, 1998, AM J HUM GENET, V62, P181, DOI 10.1086/301668; Enlund F, 1999, EUR J HUM GENET, V7, P783, DOI 10.1038/sj.ejhg.5200365; GLADMAN DD, 1986, J RHEUMATOL, V13, P129; Hohler T, 1998, ARTHRITIS RHEUM, V41, P1489, DOI 10.1002/1529-0131(199808)41:8<1489::AID-ART20>3.0.CO;2-5; Hoyle E, 2000, ARTHRITIS RHEUM, V43, P1353, DOI 10.1002/1529-0131(200006)43:6<1353::AID-ANR19>3.0.CO;2-B; Hsieh SL, 1997, J RHEUMATOL, V24, P220; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LAVAL SH, 2000, RHEUMATOLOGY S1, V39, P64; Lee YA, 2000, AM J HUM GENET, V67, P1020, DOI 10.1086/303075; MCGARRY F, 2000, RHEUMATOLOGY, V39, P63; MIELANTS H, 1991, J RHEUMATOL, V18, P1542; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1987, AM J HUM GENET, V40, P1; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; RUBIN LA, 1994, ARTHRITIS RHEUM, V37, P1212, DOI 10.1002/art.1780370816; Said-Nahal R, 2000, ARTHRITIS RHEUM-US, V43, P1356, DOI 10.1002/1529-0131(200006)43:6<1356::AID-ANR20>3.0.CO;2-Y; Samuelsson L, 1999, HUM GENET, V105, P523, DOI 10.1007/s004390051141; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; SKOMSVOLL JF, 1995, SCAND J RHEUMATOL, V24, P321, DOI 10.3109/03009749509095173; Sobel E, 1996, AM J HUM GENET, V58, P1323; Van der Paardt M, 2000, ARTHRITIS RHEUM, V43, pS264; VANDERLINDEN JMJ, 1975, ANN RHEUM DIS     S1, V34, P53; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; WOODROW JC, 1988, BAILLIERE CLIN RHEUM, V2, P603, DOI 10.1016/S0950-3579(88)80031-1	45	198	224	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					918	926		10.1086/319509	http://dx.doi.org/10.1086/319509			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11231900	Green Published, Bronze			2022-12-18	WOS:000167666000014
J	MACKEY, D; HOWELL, N				MACKEY, D; HOWELL, N			A VARIANT OF LEBER HEREDITARY OPTIC NEUROPATHY CHARACTERIZED BY RECOVERY OF VISION AND BY AN UNUSUAL MITOCHONDRIAL GENETIC ETIOLOGY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNDUS FINDINGS; MUTATION; DNA; NEURORETINOPATHY; DISEASE; MTDNA	The Tas2 and Vic2 Australian families are affected with a variant of Leber hereditary optic neuropathy (LHON). The risk of developing the optic neuropathy shows strict maternal inheritance, and the ophthalmological changes in affected family members are characteristic of LHON. However, in contrast to the common form of the disease, members of these two families show a high frequency of vision recovery. To ascertain the mitochondrial genetic etiology of the LHON in these families, both (a) the the nucleotide sequences of the seven mitochondrial genes encoding subunits of respiratory-chain complex I and (b) the mitochondrial cytochrome b gene were determined for representatives of both families. Neither family carries any of the previously identified primary mitochondrial LHON mutations: ND4/11778, ND1/3460, or ND1/4160. Instead, both LHON families carry multiple nucleotide changes in the mitochondrial complex I genes, which produce conservative amino acid changes. From the available sequence data, it is inferred that the Vic2 and Tas2 LHON families are phylogenetically related to each other and to a cluster of LHON families in which mutations in the mitochondrial cytochrome b gene have been hypothesized to play a primary etiological role. However, sequencing analysis establishes that the Vic2 and Tas2 LHON families do not carry these cytochrome b mutations. There are two hypotheses to account for the unusual mitochondrial genetic etiology of the LHON in the Tas2 and Vic2 LHON families. One possibility is that there is a primary LHON mutation within the mitochondrial genome but that it is at a site that was not included in the sequencing analyses. Alternatively, the disease in these families may result from the cumulative effects of multiple secondary LHON mutations that have less severe phenotypic consequences.	UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL F56,GALVESTON,TX 77550; ROYAL CHILDRENS HOSP,MURDOCH INST,PARKVILLE,VIC 3052,AUSTRALIA; UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550	University of Texas System; University of Texas Medical Branch Galveston; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Texas System; University of Texas Medical Branch Galveston	HOWELL, N (corresponding author), UNIV TEXAS,MED BRANCH,DEPT RADIAT THERAPY,DIV BIOL F56,GALVESTON,TX 77550, USA.		Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709	NICHD NIH HHS [P01 HD08315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BELL J, 1931, TREASURY HUMAN INHER, P325; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1992, GENETICS, V130, P163; BRUNETTE JR, 1970, UNION MED CAN, V99, P643; CONSTANTINE EF, 1955, ARCH OPHTHALMOL-CHIC, V53, P608; EVANS JJ, 1917, BIRMINGHAM MED REV, V81, P95; HAMILTON JB, 1938, BR J OPHTHALMOL, P19; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1989, J MOL EVOL, V29, P157, DOI 10.1007/BF02100114; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1992, AM J HUM GENET, V50, P1333; HOWELL N, 1990, AM J HUM GENET, V47, P629; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; Leber T., 1871, GRAEFES ARCH OPHTHAL, V17, P249, DOI 10.1007/BF01694557; LESSELL S, 1983, ARCH NEUROL-CHICAGO, V40, P2, DOI 10.1001/archneur.1983.04050010022005; LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6; MACKEY DA, IN PRESS AUST NZ J O; NIKOSKELAINEN E, 1984, ARCH OPHTHALMOL-CHIC, V102, P981, DOI 10.1001/archopht.1984.01040030783017; NIKOSKELAINEN E, 1983, ARCH OPHTHALMOL-CHIC, V101, P1059, DOI 10.1001/archopht.1983.01040020061011; NOER AS, 1991, AM J HUM GENET, V49, P715; OZAWA T, 1991, BIOCHEM BIOPH RES CO, V176, P938, DOI 10.1016/S0006-291X(05)80276-1; SMITH JL, 1973, ARCH OPHTHALMOL-CHIC, V90, P349; STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231	29	198	202	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1218	1228						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463007				2022-12-18	WOS:A1992KC99500005
J	COMINGS, DE; COMINGS, BG				COMINGS, DE; COMINGS, BG			A CONTROLLED-STUDY OF TOURETTE SYNDROME .1. ATTENTION-DEFICIT DISORDER, LEARNING-DISORDERS, AND SCHOOL PROBLEMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR, DEPT MED GENET, 1500 E DUARTE RD, DUARTE, CA 91010 USA.							BACHMAN DS, 1981, AM J PSYCHIAT, V138, P1116; BADIAN NA, 1984, J LEARN DISABIL, V17, P129, DOI 10.1177/002221948401700301; BARON M, 1981, AM J HUM GENET, V33, P767; BERGER M, 1975, BRIT J PSYCHIAT, V126, P510, DOI 10.1192/bjp.126.6.510; BORNSTEIN RA, 1983, J NERV MENT DIS, V171, P497, DOI 10.1097/00005053-198308000-00007; BREMNESS AB, 1979, AM J PSYCHIAT, V136, P1334; BURNS D, 1978, BIOL PSYCHIAT, V13, P255; CADORET RJ, 1975, J PEDIATR-US, V87, P301; CANTWELL DP, 1976, J AM ACAD CHILD PSY, V15, P214, DOI 10.1016/S0002-7138(09)61483-7; COHEN DJ, 1982, GILLES TOURETTE SYND, P31; COHEN DJ, 1983, CLIN GUIDE CHILD PSY, P3; COMINGS D E, 1986, American Journal of Human Genetics, V39, pA151; COMINGS DE, 1985, AM J HUM GENET, V37, P435; COMINGS DE, 1982, AM J PSYCHIAT, V139, P913; COMINGS DE, 1987, AM J HUM GENET, V41, P742; COMINGS DE, 1987, AM J HUM GENET, V41, P761; COMINGS DE, 1986, P NATL ACAD SCI USA, V83, P2551, DOI 10.1073/pnas.83.8.2551; COMINGS DE, 1984, J AM ACAD CHILD PSY, V23, P138, DOI 10.1097/00004583-198403000-00004; COMINGS DE, 1987, AM J HUM GENET, V41, P839; COMINGS DE, 1984, AM J HUM GENET, V36, P586; COMINGS DE, 1987, IN PRESS BR J PSYCHI, V148; COMINGS DE, IN PRESS ARCH GEN PS; COMINGS DE, 1986, 7TH INT C HUM GEN BE, P620; DEVOR EJ, 1984, AM J HUM GENET, V36, P704; ELDRIDGE R, 1977, NEUROLOGY, V27, P115, DOI 10.1212/WNL.27.2.115; Finucci J. M, 1983, GENETIC ASPECTS SPEE, P157; FINUCCI JM, 1976, ANN HUM GENET, V40, P1, DOI 10.1111/j.1469-1809.1976.tb00161.x; FRIEDHOFF AJ, 1982, GILLES TOURETTE SYND; GOLDEN GS, 1978, ANN NEUROL, V4, P145, DOI 10.1002/ana.410040208; GOLDEN GS, 1974, DEV MED CHILD NEUROL, V16, P76; HAGIN RA, 1982, GILLES TOURETTE SYND, P323; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; HERSCHEL M, 1978, HUM GENET, V40, P115, DOI 10.1007/BF00272293; HIER DB, 1980, BEHAV BRAIN SCI, V3, P238, DOI 10.1017/S0140525X00004544; JACKSON DM, 1975, PSYCHOPHARMACOLOGIA, V45, P139, DOI 10.1007/BF00429052; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; KIDD KK, 1982, NEUROGENETICS GENETI, P311; LOWE TL, 1982, JAMA-J AM MED ASSOC, V247, P1729, DOI 10.1001/jama.247.12.1729; LUCAS AR, 1967, INT J NEUROPSYCHIAT, V3, P96; MERALI Z, 1983, PEPTIDES, V4, P693, DOI 10.1016/0196-9781(83)90020-7; MIKKELSEN EJ, 1981, AM J PSYCHIAT, V138, P1572; MORRISON JR, 1974, J NERV MENT DIS, V158, P226, DOI 10.1097/00005053-197403000-00009; MORRISON JR, 1971, BIOL PSYCHIAT, V3, P189; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; OMENN GS, 1978, AM J MED GENET, V1, P333, DOI 10.1002/ajmg.1320010310; PARKER K, 1985, J SCHOOL HEALTH, V55, P30, DOI 10.1111/j.1746-1561.1985.tb04071.x; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1177; PAULS DL, 1981, ARCH GEN PSYCHIAT, V38, P1091; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PERT A, 1980, BRAIN RES, V193, P209, DOI 10.1016/0006-8993(80)90958-0; POLLACK MA, 1977, ARCH NEUROL-CHICAGO, V34, P630, DOI 10.1001/archneur.1977.00500220064011; PRICE RA, 1986, NEUROLOGY, V36, P232, DOI 10.1212/WNL.36.2.232; QUINN AN, 1980, PEDIATRICS, V66, P420; QUINN PT, 1973, BRIT J PSYCHIAT, V123, P247, DOI 10.1192/bjp.123.2.247; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SAFER DJ, 1973, BEHAV GENET, V3, P175, DOI 10.1007/BF01067657; SCHULZ DW, 1984, BRAIN RES, V304, P377, DOI 10.1016/0006-8993(84)90343-3; Shapiro A. K., 1978, GILLES TOURETTE SYND; SHAPIRO AK, 1973, BRIT J PSYCHIAT, V122, P659, DOI 10.1192/bjp.122.6.659; SHAPIRO AK, 1981, COMPR PSYCHIAT, V22, P265, DOI 10.1016/0010-440X(81)90084-5; SLEATOR EK, 1980, CLIN PEDIATR, V19, P453, DOI 10.1177/000992288001900704; SMITH SD, 1987, AM J HUM GENET S, V39, pA169; STEFL ME, 1985, J SCHOOL HEALTH, V55, P72, DOI 10.1111/j.1746-1561.1985.tb04083.x; SUTHERLAND RJ, 1982, GILLES TOURETTE SYND, P311; TAPIA F, 1969, PSYCHIAT QUART, V43, P647, DOI 10.1007/BF01564276; WELLS PG, 1971, BRIT J PSYCHIAT, V119, P603, DOI 10.1192/bjp.119.553.603; WELNER Z, 1977, J NERV MENT DIS, V165, P110, DOI 10.1097/00005053-197708000-00004; ZAHALKOVA M, 1972, J MED GENET, V9, P48, DOI 10.1136/jmg.9.1.48; 1980, DIAGNOSTIC STATISTIC	69	198	207	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					701	741						41	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	2890294				2022-12-18	WOS:A1987K936100001
J	ZLOTOGORA, J; SAGI, M; COHEN, T				ZLOTOGORA, J; SAGI, M; COHEN, T			THE BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS SYNDROME - DELINEATION OF 2 TYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											ZLOTOGORA, J (corresponding author), HEBREW UNIV JERUSALEM, HADASSAH MED CTR, DEPT HUMAN GENET, JERUSALEM, ISRAEL.			Zlotogora, Joel/0000-0001-6293-2979				AUBERT L, 1967, MARSEILLE MED, V104, P694; BIRO I, 1934, KLIN MONATSBL AUGENH, V92, P677; BRAUN G, 1922, KLIN MONATSBL AUGENH, V68, P110; BRUCKNER H, 1906, ARCH AUGENHEILKD, V55, P23; CALMETTES L, 1957, B SOC BELGE OPHTALMO, V114, P516; Cockayne E A, 1931, Proc R Soc Med, V24, P847; DEGOS R, 1957, Bull Soc Fr Dermatol Syphiligr, V64, P279; FONTAINE G, 1974, J GENET HUM, V22, P233; GEDDA L, 1959, A GE ME GE, V8, P1; GIVENS JR, 1971, AM J OBSTET GYNECOL, V110, P959, DOI 10.1016/0002-9378(71)90550-3; HUTTEMANN R, 1911, GRAEFES ARCH OPHTHAL, V80, P280; KLEIN M, 1950, P ROY SOC MED, V43, P1025, DOI 10.1177/003591575004301216; KOHN R, 1971, AM J OPHTHALMOL, V72, P625, DOI 10.1016/0002-9394(71)90864-6; KRAMER R, 1925, WIEN MED WSCHR, V75, P2533; LARMANDE AM, 1978, B MEM SOC FR OPHTALM, V9, P257; Lenz W., 1963, MED GENETICS; MACILROY JH, 1930, P ROY SOC MED, V23, P285; OWENS N, 1960, J Int Coll Surg, V33, P558; RANK B K, 1959, Aust N Z J Surg, V28, P274, DOI 10.1111/j.1445-2197.1959.tb06969.x; RAVERDINO E, 1950, ACTA CONCIL OPHTHAL, P522; ROSS N, 1932, BMJ-BRIT MED J, V1, P378; SACHS, 1913, Z AUGENHEILKD, V29, P200; SACREZ R, 1963, ANN PEDIATR, V39, P493; Snedecor G.W., 1980, STAT METHODS, V7; STOLL C, 1974, J GENET HUM, V22, P353; TOWNES PL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1664, DOI 10.1001/archopht.1979.01020020232010; Usher CH, 1925, ANN EUGENIC, V1, P128, DOI 10.1111/j.1469-1809.1925.tb02039.x; VIGNES, 1889, REV GEN OPHTHAL PARI, V8, P438; WAARDENBURG PJ, 1961, GENET OPHTHALMOL, P415	29	198	218	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					1020	1027						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6613996				2022-12-18	WOS:A1983RK60400021
J	Chen, H; Wang, CL; Conomos, MP; Stilp, AM; Li, ZL; Sofer, T; Szpiro, AA; Chen, W; Brehm, JM; Celedon, JC; Redline, S; Papanicolaou, GJ; Thornton, TA; Laurie, CC; Rice, K; Lin, XH				Chen, Han; Wang, Chaolong; Conomos, Matthew P.; Stilp, Adrienne M.; Li, Zilin; Sofer, Tamar; Szpiro, Adam A.; Chen, Wei; Brehm, John M.; Celedon, Juan C.; Redline, Susan; Papanicolaou, George J.; Thornton, Timothy A.; Laurie, Cathy C.; Rice, Kenneth; Lin, Xihong			Control for Population Structure and Relatedness for Binary Traits in Genetic Association Studies via Logistic Mixed Models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; STRATIFICATION; POWER; LOCI; LATINOS; SUSCEPTIBILITY; REGRESSION; DISEASE; TESTS	Linear mixed models (LMMs) are widely used in genome-wide association studies (GWASs) to account for population structure and relatedness, for both continuous and binary traits. Motivated by the failure of LMMs to control type I errors in a GWAS of asthma, a binary trait, we show that LMMs are generally inappropriate for analyzing binary traits when population stratification leads to violation of the LMM's constant-residual variance assumption. To overcome this problem, we develop a computationally efficient logistic mixed model approach for genome-wide analysis of binary traits, the generalized linear mixed model association test (GMMAT). This approach fits a logistic mixed model once per GWAS and performs score tests under the null hypothesis of no association between a binary trait and individual genetic variants. We show in simulation studies and real data analysis that GMMAT effectively controls for population structure and relatedness when analyzing binary traits in a wide variety of study designs.	[Chen, Han; Wang, Chaolong; Li, Zilin; Lin, Xihong] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Chaolong] Genome Inst Singapore, Computat & Syst Biol, Singapore 138672, Singapore; [Conomos, Matthew P.; Stilp, Adrienne M.; Sofer, Tamar; Szpiro, Adam A.; Thornton, Timothy A.; Laurie, Cathy C.; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Li, Zilin] Tsinghua Univ, Dept Math, Beijing 100084, Peoples R China; [Chen, Wei; Brehm, John M.; Celedon, Juan C.] Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Div Pediat Pulm Med Allergy & Immunol, Pittsburgh, PA 15224 USA; [Redline, Susan] Brigham & Womens Hosp, Dept Med & Neurol, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Papanicolaou, George J.] NHLBI, Prevent & Populat Sci Program, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA	Harvard University; Harvard T.H. Chan School of Public Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Washington; University of Washington Seattle; Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lin, XH (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	xlin@hsph.harvard.edu	Chen, Wei/AAX-5994-2020; Li, Zilin/AAB-1216-2019; Conomos, Matthew P./A-8136-2019; Li, Zilin/AAG-8038-2021	Chen, Wei/0000-0001-7196-8703; Conomos, Matthew P./0000-0001-9744-0851; Li, Zilin/0000-0003-1521-8945; Chen, Han/0000-0002-9510-4923; Sofer, Tamar/0000-0001-8520-8860	China Scholarship Council; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233]; University of Miami [N01-HC65234]; Albert Einstein College of Medicine [N01-HC65235]; Northwestern University [N01-HC65236]; San Diego State University [N01-HC65237]; NHLBI: National Institute on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research (NIDCR); National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; NIH Office of Dietary Supplements; NIDCR [HHSN268201300005C AM03, MOD03]; NHLBI [HSN26220/20054C]; National Center for Advancing Translational Science Clinical Translational Science Institute [UL1TR000124]; NIDDK Diabetes Research Center [DK063491];  [P01 CA134294];  [R35 CA197449];  [R01 HL113338];  [K99 HL130593];  [R37 CA076404]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC065233] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K01CA148958, R35CA197449, P01CA134294, R37CA076404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065233, R01HL065234, R00HL130593, K99HL130593, R01HL113338] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, T32GM081062] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Miami; Albert Einstein College of Medicine; Northwestern University; San Diego State University; NHLBI: National Institute on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Science Clinical Translational Science Institute; NIDDK Diabetes Research Center; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants P01 CA134294, R35 CA197449, and R01 HL113338 (to H.C., Z.L., and X.L.), K99 HL130593 (to H.C.), and R37 CA076404 (to C.W., Z.L., and X.L.). Z.L. was also supported in part by a scholarship from the China Scholarship Council. We thank the participants and staff of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) for their contributions to this study. The baseline examination of HCHS/SOL was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following institutes, centers, and offices contributed to the first phase of HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, and NIH Office of Dietary Supplements. The Genetic Analysis Center at the University of Washington was supported by NHLBI and NIDCR contracts (HHSN268201300005C AM03 and MOD03). Genotyping efforts were supported by NHLBI (HSN26220/20054C), National Center for Advancing Translational Science Clinical Translational Science Institute (UL1TR000124), and NIDDK Diabetes Research Center (DK063491). This manuscript has been reviewed by the HCHS/SOL Publications Committee for scientific content and consistency of data interpretation with previous HCHS/SOL publications.	Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barr RG, 2016, AM J RESP CRIT CARE, V193, P386, DOI 10.1164/rccm.201506-1211OC; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Hayeck TJ, 2015, AM J HUM GENET, V96, P720, DOI 10.1016/j.ajhg.2015.03.004; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Lea AJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005650; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; MACCLUER JW, 1986, ZOO BIOL, V5, P147, DOI 10.1002/zoo.1430050209; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; Pfeffermann D, 2011, SURV METHODOL, V37, P115; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; RAO CR, 1948, P CAMB PHILOS SOC, V44, P50; Song MS, 2015, NAT GENET, V47, P550, DOI 10.1038/ng.3244; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Tucker G, 2014, GENETICS, V197, P1045, DOI 10.1534/genetics.114.164285; Wang CL, 2014, NAT GENET, V46, P409, DOI 10.1038/ng.2924; Weissbrod O, 2015, NAT METHODS, V12, P332, DOI [10.1038/NMETH.3285, 10.1038/nmeth.3285]; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	38	197	199	6	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					653	666		10.1016/j.ajhg.2016.02.012	http://dx.doi.org/10.1016/j.ajhg.2016.02.012			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27018471	Bronze, Green Published			2022-12-18	WOS:000374203800005
J	Schalkwyk, LC; Meaburn, EL; Smith, R; Dempster, EL; Jeffries, AR; Davies, MN; Plomin, R; Mill, J				Schalkwyk, Leonard C.; Meaburn, Emma L.; Smith, Rebecca; Dempster, Emma L.; Jeffries, Aaron R.; Davies, Matthew N.; Plomin, Robert; Mill, Jonathan			Allelic Skewing of DNA Methylation Is Widespread across the Genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; STABILITY; SEQUENCE; COMMON	DNA methylation is assumed to be complementary on both alleles across the genome, although there are exceptions, notably in regions subject to genomic imprinting. We present a genome-wide survey of the degree of allelic skewing of DNA methylation with the aim of identifying previously unreported differentially methylated regions (DMRs) associated primarily with genomic imprinting or DNA sequence variation acting in cis. We used SNP microarrays to quantitatively assess allele-specific DNA methylation (ASM) in amplicons covering 7.6% of the human genome following cleavage with a cocktail of methylation-sensitive restriction enzymes (MSREs). Selected findings were verified using bisulfite-mapping and gene-expression analyses, subsequently tested in a second tissue from the same individuals, and replicated in DNA obtained from 30 parent-child trios. Our approach detected clear examples of ASM in the vicinity of known imprinted loci, highlighting the validity of the method. In total, 2,704 (1.5%) of our 183,605 informative and stringently filtered SNPs demonstrate an average relative allele score (RAS) change >= 0.10 following MSRE digestion. In agreement with previous reports, the majority of ASM (similar to 90%) appears to be cis in nature, and several examples of tissue-specific ASM were identified. Our data show that ASM is a widespread phenomenon, with >35,000 such sites potentially occurring across the genome, and that a spectrum of ASM is likely, with heterogeneity between individuals and across tissues. These findings impact Our understanding about the origin of individual phenotypic differences and have implications for genetic studies of complex disease.	[Schalkwyk, Leonard C.; Meaburn, Emma L.; Smith, Rebecca; Dempster, Emma L.; Davies, Matthew N.; Plomin, Robert; Mill, Jonathan] Kings Coll London, MRC, SGDP Res Ctr, London SE5 8AF, England; [Jeffries, Aaron R.] Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England; [Meaburn, Emma L.] Univ London Birkbeck Coll, London WC1E 7HX, England	University of London; King's College London; University of London; King's College London; University of London; Birkbeck University London	Mill, J (corresponding author), Kings Coll London, MRC, SGDP Res Ctr, London SE5 8AF, England.	jonathan.mill@kcl.ac.uk	Dempster, Emma L/C-8592-2014; Plomin, Robert/B-8911-2008; Mill, Jonathan S/B-3276-2010; Mill, Jonathan/B-5678-2014; Schalkwyk, Leonard C/A-2150-2010; Smith, Rebecca G/C-1978-2012; Jeffries, Aaron/D-1256-2014; Meaburn, Emma/D-5433-2011	Dempster, Emma L/0000-0003-1257-5314; Mill, Jonathan S/0000-0003-1115-3224; Mill, Jonathan/0000-0003-1115-3224; Schalkwyk, Leonard C/0000-0001-7030-5756; Smith, Rebecca G/0000-0001-9264-1056; Jeffries, Aaron/0000-0002-1235-8291; Meaburn, Emma/0000-0001-8096-9089; Plomin, Robert/0000-0002-0756-3629	Royal Society; MRC [G19/2, G0500079] Funding Source: UKRI; Medical Research Council [G9817803B, G19/2, G0500079] Funding Source: researchfish	Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This Study was funded by a Royal Society Research Grant to J.M. The authors declare no conflict of interest.	Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen H, 2007, EUR J GYNAECOL ONCOL, V28, P464; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaminsky ZA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni094; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meaburn EL, 2008, MOL PSYCHIATR, V13, P729, DOI 10.1038/sj.mp.4002063; Meaburn EL, 2009, TWIN RES HUM GENET, V12, P372, DOI 10.1375/twin.12.4.372; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Oliver BR, 2007, TWIN RES HUM GENET, V10, P96, DOI 10.1375/twin.10.1.96; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	37	197	198	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					196	212		10.1016/j.ajhg.2010.01.014	http://dx.doi.org/10.1016/j.ajhg.2010.01.014			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20159110	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000274637200009
J	van Dijk, FS; Nesbitt, IM; Zwikstra, EH; Nikkels, PGJ; Piersma, SR; Fratantoni, SA; Jimenez, CR; Huizer, M; Morsman, AC; Cobben, JM; van Roij, MHH; Elting, MW; Verbeke, JIML; Wijnaendts, LCD; Shaw, NJ; Hogler, W; McKeown, C; Sistermans, EA; Dalton, A; Meijers-Heijboer, H; Pals, G				van Dijk, Fleur S.; Nesbitt, Isabel M.; Zwikstra, Eline H.; Nikkels, Peter G. J.; Piersma, Sander R.; Fratantoni, Silvina A.; Jimenez, Connie R.; Huizer, Margriet; Morsman, Alice C.; Cobben, Jan M.; van Roij, Miriam H. H.; Elting, Mariet W.; Verbeke, Jonathan I. M. L.; Wijnaendts, Liliane C. D.; Shaw, Nick J.; Hoegler, Wolfgang; McKeown, Carole; Sistermans, Erik A.; Dalton, Ann; Meijers-Heijboer, Hanne; Pals, Gerard			PPIB Mutations Cause Severe Osteogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYCLOPHILIN-B; PROLYL; IDENTIFICATION; PROCOLLAGEN; DEFICIENCY; STABILITY; ISOMERASE; COMPLEX; PROTEIN; FAMILY	Deficiency of cartilage-associated protein (CRTAP) or prolyl 3-hydroxylase 1(P3H1) has been reported in autosomal-recessive lethal or severe osteogenesis imperfecta (OI). CRTAP, P3H1, and cyclophilin B (CyPB) form an intracellular collagen-modifying complex that 3-hydroxylates proline at position 986 (P986) in the alpha 1 chains of collagen type I. This 3-prolyl hydroxylation is decreased in patients with CRTAP and P3H1 deficiency. It was suspected that mutations in the PPIB gene encoding CyPB would also cause OI with decreased collagen 3-prolyl hydroxylation. To our knowledge we present the first two families with recessive OI caused by PPIB gene mutations. The clinical phenotype is compatible with OI Sillence type II-B/III as seen with COL1A1/2, CRTAP, and LEPRE1 mutations. The percentage of 3-hydroxylated P986 residues in patients with PPIB mutations is decreased in comparison to normal, but it is higher than in patients with CRTAP and LEPRE1 mutations. This result and the fact that CyPB is demonstrable independent of CRTAP and P3H1, along with reported decreased 3-prolyl hydroxylation due to deficiency of CRTAP lacking the catalytic hydroxylation domain and the known function of CyPB as a cis-trans isomerase, suggest that recessive OI is caused by a dysfunctional P3H1/CRTAP/CyPB complex rather than by the lack of 3-prolyl hydroxylation of a single proline residue in the alpha 1 chains of collagen type I.	[Pals, Gerard] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Ctr Connect Tissue Res, NL-1007 MB Amsterdam, Netherlands; [Piersma, Sander R.; Fratantoni, Silvina A.; Jimenez, Connie R.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Oncoprote Lab, NL-1007 MB Amsterdam, Netherlands; [Verbeke, Jonathan I. M. L.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, NL-1007 MB Amsterdam, Netherlands; [Wijnaendts, Liliane C. D.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Nesbitt, Isabel M.; Morsman, Alice C.; Dalton, Ann] Sheffield Childrens Hosp, Sheffield Childrens Natl Hlth Serv Fdn Trust, Sheffield Mol Genet Serv, Western Bank Sheffield, Sheffield S10 2TH, S Yorkshire, England; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, NL-3508 GA Utrecht, Netherlands; [Cobben, Jan M.] Acad Med Ctr, Emma Children Hosp, Dept Pediat Genet, NL-1100 DD Amsterdam, Netherlands; [Shaw, Nick J.; Hoegler, Wolfgang] Birmingham Childrens Hosp, Dept Pediat Endocrinol, Birmingham B4 6NH, W Midlands, England; [McKeown, Carole] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15, W Midlands, England	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Utrecht University; Utrecht University Medical Center; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; Birmingham Women's Hospital	Pals, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Ctr Connect Tissue Res, Boelelaan 1117,POB 7057, NL-1007 MB Amsterdam, Netherlands.	g.pals@vumc.nl	Sistermans, Erik/B-1109-2009; Jimenez, Connie/AAI-3763-2020; Pals, Gerard/A-5198-2011; Hoegler, Wolfgang/S-7987-2019	Sistermans, Erik/0000-0001-7187-4563; Pals, Gerard/0000-0003-4091-7115; Jimenez, Connie R/0000-0002-3103-4508				Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Groenendaal F, 2008, NEONATOLOGY, V93, P1, DOI 10.1159/000106432; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Krane SM, 2008, AMINO ACIDS, V35, P703, DOI 10.1007/s00726-008-0073-2; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; VANDIJK FS, 2009, EUR J HUM GENET; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Yao QZ, 2005, WORLD J SURG, V29, P276, DOI 10.1007/s00268-004-7812-7; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	20	197	202	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 9	2009	85	4					521	527		10.1016/j.ajhg.2009.09.001	http://dx.doi.org/10.1016/j.ajhg.2009.09.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	507FA	19781681	Bronze, Green Published			2022-12-18	WOS:000270836000009
J	Barcellos, LF; Oksenberg, JR; Begovich, AB; Martin, ER; Schmidt, S; Vittinghoff, E; Goodin, DS; Pelletier, D; Lincoln, RR; Bucher, P; Swerdlin, A; Perick-Vance, MA; Haines, JL; Hauser, SL				Barcellos, LF; Oksenberg, JR; Begovich, AB; Martin, ER; Schmidt, S; Vittinghoff, E; Goodin, DS; Pelletier, D; Lincoln, RR; Bucher, P; Swerdlin, A; Perick-Vance, MA; Haines, JL; Hauser, SL		Multiple Sclerosis Genetics Grp	HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELIN BASIC-PROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX; NECROSIS-FACTOR-ALPHA; T-CELLS; HLA-DR; ASSOCIATION; LINKAGE; PEPTIDES; RECOGNITION; LYMPHOTOXIN	Models of disease susceptibility in multiple sclerosis (MS) often assume a dominant action for the HLA-DRB1* 1501 allele and its associated haplotype (DRB1* 1501-DQB1* 0602 or DR2). A robust and phenotypically well-characterized MS data set was used to explore this model in more detail. A dose effect of HLA-DR2 haplotypes on MS susceptibility was revealed. This observation suggests that, in addition to the role of HLA-DR2 in MS, two copies of a susceptibility haplotype further increase disease risk. Second, we report that DR2 haplotypes modify disease expression. There is a paucity of benign MS and an increase of severe MS in individuals homozygous for DR2. Concepts of the molecular mechanisms that underlie linkage and association of the human leukocyte antigen (HLA) region to MS need to be revised to accommodate these data.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Roche Mol Syst, Dept Human Genet, Alameda, CA USA; Duke Univ, Med Ctr, Dept Med, Ctr Human Genet, Durham, NC 27710 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Program Human Genet, Nashville, TN 37232 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Duke University; Vanderbilt University	Hauser, SL (corresponding author), Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave, San Francisco, CA 94143 USA.	hauser@itsa.ucsf.edu	Haines, Jonathan/C-3374-2012; Hauser, Stephen L/J-2978-2016	Haines, Jonathan/0000-0002-4351-4728; 	NIA NIH HHS [R01 AG020135, AG-20135-01] Funding Source: Medline; NINDS NIH HHS [NS32830, R01 NS026799, R01 NS032830, NS26799] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS032830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLEGRETTA M, 1990, SCIENCE, V247, P718, DOI 10.1126/science.1689076; Barcellos LF, 2000, IMMUNOGENETICS, V51, P281, DOI 10.1007/s002510050621; Barcellos LF, 2002, BRAIN, V125, P150; BECK J, 1988, ACTA NEUROL SCAND, V78, P318, DOI 10.1111/j.1600-0404.1988.tb03663.x; BERTRAMS J, 1972, EUR NEUROL, V7, P74, DOI 10.1159/000114414; Chataway J, 1998, BRAIN, V121, P1869, DOI 10.1093/brain/121.10.1869; DOOLITTLE TH, 1990, NEUROLOGY, V40, P1546, DOI 10.1212/WNL.40.10.1546; El-Gabalawy HS, 1999, ARTHRITIS RHEUM-US, V42, P1696, DOI 10.1002/1529-0131(199908)42:8<1696::AID-ANR19>3.0.CO;2-K; GarciaMerino A, 1996, HUM IMMUNOL, V50, P11, DOI 10.1016/0198-8859(96)00064-X; GOODKIN DE, 1991, ARCH NEUROL-CHICAGO, V48, P805, DOI 10.1001/archneur.1991.00530200041016; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Kantarci OH, 2002, J NEUROIMMUNOL, V123, P144, DOI 10.1016/S0165-5728(01)00481-7; Kira J, 1996, ANN NEUROL, V40, P569; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Ligers A, 2001, AM J HUM GENET, V69, P900, DOI 10.1086/323480; Marrosu MG, 2002, LANCET, V359, P1461, DOI 10.1016/S0140-6736(02)08431-3; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; MARTIN R, 1990, J IMMUNOL, V145, P540; McWeeney S, 2000, AM J HUM GENET, V67, P52; *MSG GROUP, 1998, ANN NEUROL, V43, P530; NAITO S, 1972, TISSUE ANTIGENS, V2, P1; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; POWELL MB, 1990, INT IMMUNOL, V2, P539, DOI 10.1093/intimm/2.6.539; Rasmussen HB, 2001, MULT SCLER, V7, P91, DOI 10.1191/135245801678227595; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Scholz C, 1998, J IMMUNOL, V160, P1532; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; SVEJGAARD A, 1983, IMMUNOL REV, V70, P193, DOI 10.1111/j.1600-065X.1983.tb00715.x; Tejada-Simon MV, 2001, EUR J IMMUNOL, V31, P907, DOI 10.1002/1521-4141(200103)31:3<907::AID-IMMU907>3.0.CO;2-1; THOMSON G, 1995, AM J HUM GENET, V57, P487; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; VALLI A, 1993, J CLIN INVEST, V91, P616, DOI 10.1172/JCI116242; van der Horst-Bruinsma IE, 1999, HUM IMMUNOL, V60, P152, DOI 10.1016/S0198-8859(98)00101-3; Weinshenker BG, 1998, NEUROLOGY, V51, P742, DOI 10.1212/WNL.51.3.742; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814; WUCHERPFENNIG KW, 1995, P NATL ACAD SCI USA, V92, P11935, DOI 10.1073/pnas.92.25.11935; Zanelli E, 2000, RHEUMATOLOGY, V39, P1060, DOI 10.1093/rheumatology/39.10.1060; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406; ZIPP F, 1995, ANN NEUROL, V38, P723, DOI 10.1002/ana.410380506	45	197	204	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					710	716		10.1086/367781	http://dx.doi.org/10.1086/367781			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12557126	Green Published, Bronze			2022-12-18	WOS:000181152600020
J	DeBaun, MR; Niemitz, EL; McNeil, DE; Brandenburg, SA; Lee, MP; Feinberg, AP				DeBaun, MR; Niemitz, EL; McNeil, DE; Brandenburg, SA; Lee, MP; Feinberg, AP			Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILMS-TUMOR; P57(KIP2); KVLQT1; IGF2; GENE; TRANSCRIPT; RELAXATION; MUTATIONS; TISSUE; LOCUS	Beckwith-Wiedemann syndrome (BWS) is a congenital cancer-predisposition syndrome associated with embryonal cancers, macroglossia, macrosomia, ear pits or ear creases, and midline abdominal-wall defects. The most common constitutional abnormalities in BWS are epigenetic, involving abnormal methylation of either H19 or LIT1, which encode untranslated RNAs on 11p15. We hypothesized that different epigenetic alterations would be associated with specific phenotypes in BWS. To test this hypothesis, we performed a case-cohort study, using the BWS Registry. The cohort consisted of 92 patients with BWS and molecular analysis of both H19 and LIT1, and these patients showed the same frequency of clinical phenotypes as those patients in the Registry from whom biological samples were not available. The frequency of altered DNA methylation of H19 in patients with cancer was significantly higher, 56% (9/16), than the frequency in patients without cancer, 17% (13/76; P = .002), and cancer was not associated with LIT1 alterations. Furthermore, the frequency of altered DNA methylation of LIT1 in patients with midline abdominal-wall defects and macrosomia was significantly higher, 65% (41/63) and 60% (46/77), respectively, than in patients without such defects, 34% (10/29) and 18% (2/11), respectively (P = .012 and P = .002, respectively). Additionally, paternal uniparental disomy (UPD) of 11p15 was associated with hemihypertrophy (P = .003), cancer (P = .03), and hypoglycemia (P = .05). These results define an epigenotype- phenotype relationship in BWS, in which aberrant methylation of H19 and LIT1 and UPD are strongly associated with cancer risk and specific birth defects.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21204 USA; Johns Hopkins Univ, Sch Med, Predoctoral Program Human Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA; NCI, Genet Epidemiol Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 1064 Ross,720 Rutland Ave, Baltimore, MD 21204 USA.		Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [R37 CA054358, R01 CA054358, CA54358, R37 CA054358-12] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bliek J, 2001, HUM MOL GENET, V10, P467, DOI 10.1093/hmg/10.5.467; Buiting K, 2000, CLIN GENET, V58, P284, DOI 10.1034/j.1399-0004.2000.580406.x; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2001, CANCER RES, V61, P4947; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; ELIAS ER, 1998, PRINCIPLES MOL MED, P1047; Engel JR, 2000, J MED GENET, V37, P921, DOI 10.1136/jmg.37.12.921; Feinberg AP, 1999, CANCER RES, V59, p1743S; Feinberg AP, 2001, P NATL ACAD SCI USA, V98, P392, DOI 10.1073/pnas.98.2.392; Glantz SA., 2012, PRIMER BIOSTATISTICS, V7; Henry I., 1993, European Journal of Human Genetics, V1, P19; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; Lee MP, 1997, AM J HUM GENET, V61, P304, DOI 10.1086/514858; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; Moore GE, 2001, DIABETES, V50, P199, DOI 10.2337/diabetes.50.1.199; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; NIEMITZ EL, 2001, P AM ASSOC CANC RES, V42, P3796; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OKeefe D, 1997, AM J HUM GENET, V61, P295, DOI 10.1086/514854; Onyango P, 2000, GENOME RES, V10, P1697, DOI 10.1101/gr.161800; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Reid LH, 1996, CANCER RES, V56, P1214; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	32	197	211	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					604	611		10.1086/338934	http://dx.doi.org/10.1086/338934			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11813134	Green Published, Bronze			2022-12-18	WOS:000173880000005
J	Rivolta, C; Sweklo, EA; Berson, EL; Dryja, TP				Rivolta, C; Sweklo, EA; Berson, EL; Dryja, TP			Missense mutation in the USH2A gene: Association with recessive retinitis pigmentosa without hearing loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOSIN-VIIA GENE; SYNDROME TYPE-IIA; USHER-SYNDROME; DEAFNESS; PREVALENCE; PROTEIN; 1B	Microdeletions Glu767(1-bp del), Thr967(1-bp del), and Leu1446(2-bp del) in the human USH2A gene have been reported to cause Usher syndrome type II, a disorder characterized by retinitis pigmentosa (RP) and mild-to-severe hearing loss. Each of these three frameshift mutations is predicted to lead to an unstable mRNA transcript that, if translated, would result in a truncated protein lacking the carboxy terminus. Here, we report Cys759Phe, a novel missense mutation in this gene that changes an amino-acid residue within the fifth laminin-epidermal growth factor-like domain of the USH2A gene and that is associated with recessive RP without hearing loss. This single mutation was found in 4.5% of 224 patients with recessive RP, suggesting that USH2A could cause more cases of nonsyndromic recessive RP than does any other gene identified to date.	Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, Boston, MA 02114 USA; Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Dryja, TP (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, 243 Charles St, Boston, MA 02114 USA.	dryja@helix.mgh.harvard.edu		Rivolta, Carlo/0000-0002-0733-9950	NEI NIH HHS [EY08683, EY00169] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000169, R37EY000169, R01EY008683] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Jain PK, 1998, GENOMICS, V50, P290, DOI 10.1006/geno.1998.5320; Liu XZ, 1999, AM J HUM GENET, V64, P1221, DOI 10.1086/302332; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Wagenaar M, 1999, ARCH OTOLARYNGOL, V125, P441, DOI 10.1001/archotol.125.4.441; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	12	197	204	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1975	1978		10.1086/302926	http://dx.doi.org/10.1086/302926			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775529	Green Published, Bronze			2022-12-18	WOS:000088373800026
J	Weinberg, CR				Weinberg, CR			Methods for detection of parent-of-origin effects in genetic studies of case-parents triads	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; RELATIVE RISKS; ASSOCIATION	When affected probands and their biological parents are genotyped at a candidate gene or a marker, the resulting case-parents-triad data enable powerful tests for linkage in the presence of association. When linkage disequilibrium has been detected in such a study, the investigator may wish to look further for possible parent-of-origin effects. If, for example, the transmission/disequilibrium test restricted to fathers is statistically significant, whereas that restricted to mothers is not, the investigator might interpret this as evidence for nonexpression of the maternally derived disease gene-that is, imprinting. This report reviews existing methods for detection of parent-of-origin effects, showing that each can be invalid under certain scenarios. Two new methods are proposed, based on application of likelihood-based inference after stratification on both the parental mating type and the inherited number of copies of the allele under study. If there are no maternal genetic effects expressed prenatally during gestation, the parental-asymmetry test is powerful and provides valid estimation of a parent-of-origin parameter. For diseases for which there could be maternal effects on risk, the parent-of-origin likelihood-ratio test provides a robust alternative. Simulations based on an admired population demonstrate good operating characteristics for these procedures, under diverse scenarios.	NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Weinberg, CR (corresponding author), NIEHS, Biostat Branch, POB 12233,MD A3-03, Res Triangle Pk, NC 27709 USA.			Weinberg, Clarice/0000-0002-7713-8556	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES040007, ZIAES040007] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Schaid DJ, 1999, GENET EPIDEMIOL, V16, P250, DOI 10.1002/(SICI)1098-2272(1999)16:3<250::AID-GEPI2>3.0.CO;2-T; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893	9	197	202	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					229	235		10.1086/302466	http://dx.doi.org/10.1086/302466			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364536	Bronze, Green Published			2022-12-18	WOS:000081224300028
J	Ruttledge, MH; Andermann, AA; Phelan, CM; Claudio, JO; Han, FY; Chretien, N; Rangaratnam, S; MacCollin, M; Short, P; Parry, D; Michels, V; Riccardi, VM; Weksberg, R; Kitamura, K; Bradburn, JM; Hall, BD; Propping, P; Rouleau, GA				Ruttledge, MH; Andermann, AA; Phelan, CM; Claudio, JO; Han, FY; Chretien, N; Rangaratnam, S; MacCollin, M; Short, P; Parry, D; Michels, V; Riccardi, VM; Weksberg, R; Kitamura, K; Bradburn, JM; Hall, BD; Propping, P; Rouleau, GA			Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILATERAL ACOUSTIC NEUROFIBROMATOSIS; TUMOR-SUPPRESSOR GENE; UNITED-KINGDOM; LENS OPACITIES; CHROMOSOME-22; DIAGNOSIS; INDIVIDUALS; ASSOCIATION; NEUROMAS; MARKERS	The gene predisposing to neurofibromatosis type 2 (NF2) on human chromosome 22 has revealed a wide variety of different mutations in NF2 individuals. These patients display a marked variability in clinical presentation, ranging from very severe disease with numerous tumors at a young age to a relatively mild condition much later in life. To investigate whether this phenotypic heterogeneity is determined by the type of mutation in NF2, we have collected clinical information on 111 NF2 cases from 73 different families on whom we have performed mutation screening in this gene. Sixty-seven individuals (56.2%) from 41 of these kindreds revealed 36 different putative disease-causing mutations. These include 26 proposed protein-truncating alterations (frameshift deletions/insertions and nonsense mutations), 6 splice-site mutations, 2 missense mutations, 1 base substitution in the 3' UTR of the NF2 cDNA, and a single 3-bp in-frame insertion. Seventeen of these mutations are novel, whereas the remaining 19 have been described previously in other NF2 individuals or sporadic tumors. When individuals harboring protein-truncating mutations are compared with cases with single codon alterations, a significant correlation (P < .001) with clinical outcome is observed. Twenty-four of 28 patients with mutations that cause premature truncation of the NF2 protein, schwannomin, present with severe phenotypes. In contrast, all 16 cases from three families with mutations that affect only a single amino acid have mild NF2. These data provide conclusive evidence that a phenotype/genotype correlation exists for certain NF2 mutations.	MCGILL UNIV,UNIV DIV MED GENET,MONTREAL,PQ,CANADA; KAROLINSKA HOSP,DEPT MOL MED,ENDOCRINE TUMOR UNIT,S-10401 STOCKHOLM,SWEDEN; MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,CHARLESTOWN,MA; NATL CANC INST,GENET EPIDEMIOL BRANCH,BETHESDA,MD; MAYO CLIN,DEPT GENET,ROCHESTER,MN; NEUROFIBROMATOSIS INST,LA CRESCENTA,CA; HOSP SICK CHILDREN,GENET CLIN,TORONTO,ON M5G 1X8,CANADA; JICHI MED SCH,DEPT OTOLARYNGOL,MINAMI KAWACHI,TOCHIGI,JAPAN; UNIV KENTUCKY,KENTUCKY CLIN,DEPT PEDIAT GENET,LEXINGTON,KY; UNIV BONN,INST HUMAN GENET,D-5300 BONN,GERMANY	McGill University; Karolinska Institutet; Karolinska University Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Jichi Medical University; University of Kentucky; University of Bonn	Ruttledge, MH (corresponding author), MONTREAL GEN HOSP,RES INST,CTR RES NEUROSCI,7TH FLOOR,LIVINGSTON HALL,1650 CEDAR AVE,MONTREAL,PQ H3G 1A4,CANADA.							BOURN D, 1994, HUM MOL GENET, V3, P813, DOI 10.1093/hmg/3.5.813; BOURN D, 1994, AM J HUM GENET, V55, P69; Eldridge R, 1981, Adv Neurol, V29, P57; ELDRIDGE R, 1991, AM J HUM GENET S, V49, pA133; EVANS DGR, 1992, J MED GENET, V29, P847, DOI 10.1136/jmg.29.12.847; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; FOULKES WD, IN PRESS Q J MED; KAISERKUPFER MI, 1989, ARCH OPHTHALMOL-CHIC, V107, P541, DOI 10.1001/archopht.1989.01070010555030; KANTER WR, 1980, NEUROLOGY, V30, P851, DOI 10.1212/WNL.30.8.851; MACCOLLIN M, 1993, JAMA-J AM MED ASSOC, V270, P2316, DOI 10.1001/jama.270.19.2316; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; NAROD SA, 1992, AM J HUM GENET, V51, P486; PASTORES GM, 1991, AM J MED GENET, V41, P325, DOI 10.1002/ajmg.1320410313; PEARSONWEBB MA, 1986, NEW ENGL J MED, V315, P1553; ROULEAU GA, 1990, AM J HUM GENET, V46, P323; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; RUTTLEDGE MH, 1994, NAT GENET, V6, P180, DOI 10.1038/ng0294-180; RUTTLEDGE MH, 1993, NEUROLOGY, V43, P1753, DOI 10.1212/WNL.43.9.1753; RUTTLEDGE MH, 1994, GENOMICS, V19, P52, DOI 10.1006/geno.1994.1012; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WERTELECKI W, 1988, NEW ENGL J MED, V319, P278, DOI 10.1056/NEJM198808043190505	24	197	206	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					331	342						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755919				2022-12-18	WOS:A1996VM28800008
J	WHALEY, JM; NAGLICH, J; GELBERT, L; HSIA, YE; LAMIELL, JM; GREEN, JS; COLLINS, D; NEUMANN, HPH; LAIDLAW, J; LI, FP; KLEINSZANTO, AJP; SEIZINGER, BR; KLEY, N				WHALEY, JM; NAGLICH, J; GELBERT, L; HSIA, YE; LAMIELL, JM; GREEN, JS; COLLINS, D; NEUMANN, HPH; LAIDLAW, J; LI, FP; KLEINSZANTO, AJP; SEIZINGER, BR; KLEY, N			GERM-LINE MUTATIONS IN THE VON HIPPEL-LINDAU TUMOR-SUPPRESSOR GENE ARE SIMILAR TO SOMATIC VON HIPPEL-LINDAU ABERRATIONS IN SPORADIC RENAL-CELL CARCINOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE GENE; CEREBELLAR HEMANGIOBLASTOMA; MOLECULAR CHARACTERIZATION; GEL-ELECTROPHORESIS; SHORT ARM; PCR-SSCP; VONHIPPEL; CHROMOSOME-3; DNA; DELETION	von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome predisposing to multifocal bilateral renal. cell carcinomas (RCCs), pheochromocytomas, and pancreatic tumors, as well as angiomas and hemangioblastomas of the CNS. A candidate gene for VHL was recently identified, which led to the isolation of a partial cDNA clone with extended open reading frame, without significant homology to known genes or obvious functional motifs, except for an acidic pentamer repeat domain. To further characterize the functional domains of the VHL gene and assess its involvement in hereditary and nonhereditary tumors, we performed mutation analyses and studied its expression in normal and tumor tissue. We identified germline mutations in 39% of VHL disease families. Moreover, 33% of sporadic RCCs and ah (6/6) sporadic RCC cell lines analyzed showed mutations within the VHL gene. Both germ-line and somatic mutations included deletions, insertions, splice-site mutations, and missense and nonsense mutations, all of which clustered at the 3' end of the corresponding partial VHL cDNA open reading frame, including an alternatively spliced exon 123 nt in length, suggesting functionally important domains encoded by the VHL gene in this region. Over 180 sporadic tumors of other types have shown no detectable base changes within the presumed coding sequence of the VHL gene to date. We conclude that the gene causing VHL has an important and specific role in the etiology of sporadic RCCs, acts as a recessive tumor-suppressor gene, and appears to encode important functional domains within the 3' end of the known open reading frame.	UNIV HAWAII, JOHN A BURNS SCH MED, HONOLULU, HI USA; BROOKE ARMY MED CTR, DEPT CLIN INVEST, FT SAM HOUSTON, TX USA; MEM UNIV NEWFOUNDLAND, HLTH SCI CTR, St John, NF, CANADA; UNIV KANSAS, MED CTR, DIV ENDOCRINOL METAB & GENET, KANSAS CITY, KS USA; UNIV FREIBURG, DEPT MED, FREIBURG, GERMANY; DANA FARBER CANC INST, BOSTON, MA USA; FOX CHASE CANC CTR, PHILADELPHIA, PA USA	University of Hawaii System; San Antonio Military Medical Center; United States Department of Defense; United States Army; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Kansas; University of Kansas Medical Center; University of Freiburg; Harvard University; Dana-Farber Cancer Institute; Fox Chase Cancer Center	WHALEY, JM (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT MOLEC GENET & CELL BIOL, POB 4000, PRINCETON, NJ 08543 USA.							ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BERGERHEIM U, 1989, CANCER RES, V49, P1390; BINKOVITZ LA, 1990, AM J ROENTGENOL, V155, P501, DOI 10.2214/ajr.155.3.1974734; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; CROSSEY PA, 1993, AM J HUM GENET, V53, P25; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOSTER K, 1994, BRIT J CANCER, V69, P230, DOI 10.1038/bjc.1994.44; GLENN GM, 1991, HUM GENET, V87, P207, DOI 10.1007/BF00204184; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; GO RCP, 1984, AM J HUM GENET, V36, P131; GREEN JS, 1986, CAN MED ASSOC J, V134, P133; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; Hayashi K, 1991, PCR Methods Appl, V1, P34; HOSOE S, 1990, GENOMICS, V8, P634, DOI 10.1016/0888-7543(90)90249-T; HUSON SM, 1986, BRAIN, V109, P1297, DOI 10.1093/brain/109.6.1297; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KOVACS G, 1989, INT J CANCER, V43, P422, DOI 10.1002/ijc.2910430313; KOVACS G, 1988, P NATL ACAD SCI USA, V85, P1571, DOI 10.1073/pnas.85.5.1571; LAMIELL JM, 1989, MEDICINE, V68, P1; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MAHER ER, 1990, J MED GENET, V27, P311, DOI 10.1136/jmg.27.5.311; MAHER ER, 1991, J MED GENET, V28, P443, DOI 10.1136/jmg.28.7.443; MAHER ER, 1990, Q J MED, V77, P1151, DOI 10.1093/qjmed/77.2.1151; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; MORITA R, 1991, CANCER RES, V51, P820; NEUMANN HPH, 1993, NEW ENGL J MED, V329, P1531, DOI 10.1056/NEJM199311183292103; NEUMANN HPH, 1991, LANCET, V337, P1052, DOI 10.1016/0140-6736(91)91705-Y; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PRESTI JC, 1991, CANCER RES, V51, P1544; RICHARDS FM, 1993, HUM MOL GENET, V2, P879, DOI 10.1093/hmg/2.7.879; RICHARDS FM, 1993, HUM MOL GENET, V2, P1750, DOI 10.1093/hmg/2.10.1750; Sambrook J., 1989, MOL CLONING LAB MANU; SEIZINGER BR, 1991, P NATL ACAD SCI USA, V88, P2864, DOI 10.1073/pnas.88.7.2864; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; SUN Y, 1993, P NATL ACAD SCI USA, V90, P2827, DOI 10.1073/pnas.90.7.2827; TORY K, 1989, J NATL CANCER I, V81, P1097, DOI 10.1093/jnci/81.14.1097; YAMAKAWA K, 1991, CANCER RES, V51, P4707; YANO T, 1989, J NATL CANCER I, V81, P518, DOI 10.1093/jnci/81.7.518; YOSHIDA MA, 1986, CANCER RES, V46, P2139; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	45	197	200	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1092	1102						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977367				2022-12-18	WOS:A1994QB68400004
J	SNOW, K; DOUD, LK; HAGERMAN, R; PERGOLIZZI, RG; ERSTER, SH; THIBODEAU, SN				SNOW, K; DOUD, LK; HAGERMAN, R; PERGOLIZZI, RG; ERSTER, SH; THIBODEAU, SN			ANALYSIS OF A CGG SEQUENCE AT THE FMR-I LOCUS IN FRAGILE-X FAMILIES AND IN THE GENERAL-POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; SITE; INSTABILITY; EXPRESSION; DIAGNOSIS; MUTATION; METHYLATION; PHENOTYPE; ABSENCE; XQ27.3	In this study, we have characterized a CGG repeat at the FMR-1 locus in more than 100 families (more than 500 individuals) presenting for fragile X testing and in 247 individuals from the general population. Both Southern blot and PCR-based assays were evaluated for their ability to detect premutations, full mutations, and variability in normal allele sizes. Among the Southern blot assays, the probes Ox1.9 or StB12.3 with a double restriction-enzyme digest were the most sensitive in detecting both small and large amplifications and, in addition, provided information on methylation of an adjacent CpG island. In the PCR-based assays, analysis of PCR products on denaturing DNA sequencing gels allowed the most accurate determination of CGG repeat number up to approximately 130 repeats. A combination of a Southern blot assay with a double digest and the PCR-sequencing-gel assay detected the spectrum of amplification-type mutations at the FMR-1 locus. In the patient population, a CGG repeat of 51 was the largest to be stably inherited, and a repeat of 57 was the smallest size of premutation to be unstably inherited. When premutations were transmitted by females, the size of repeat correlated with risk of expansion to a full mutation in the next generation. Full mutations (large repeats typically associated with an abnormal methylation pattern and mitotic instability) were associated with clinical and cytogenetic manifestations in males but not necessarily in females. In the control population, the CGG repeat ranged from 13 to 61, but 94% of alleles had fewer than 40 repeats. The most frequent allele (34%) was a repeat of 30. One female had an allele (61 repeats) within a range consistent with fragile X premutations, while two other individuals each had a repeat of 52. This suggests that the frequency of unstable alleles in the general population may be approximately 1%.	MAYO CLIN & MAYO FDN,GENET LAB,ROCHESTER,MN 55905; DENVER CHILDRENS HOSP,DENVER,CO; CORNELL UNIV,N SHORE UNIV HOSP,COLL MED,MANHASSET,NY	Mayo Clinic; Children's Hospital Colorado; Cornell University; Northwell Health; North Shore University Hospital					NIMH NIH HHS [NIMH MH-45916] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045916] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; Brown W. T., 1992, American Journal of Human Genetics, V51, pA20; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DENNIS NR, 1992, AM J MED GENET, V43, P232, DOI 10.1002/ajmg.1320430137; ERSTER SH, 1992, HUM GENET, V90, P55; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; HAUGE XY, 1993, HUM MOL GENET, V2, P411, DOI 10.1093/hmg/2.4.411; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1993, HUM MOL GENET, V2, P197, DOI 10.1093/hmg/2.2.197; HIRST MC, 1991, J MED GENET, V28, P824, DOI 10.1136/jmg.28.12.824; JACKY PB, 1991, AM J MED GENET, V38, P400, DOI 10.1002/ajmg.1320380249; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LATIMER LJP, 1991, J BIOL CHEM, V266, P13849; MACPHERSON JN, 1992, J MED GENET, V29, P802, DOI 10.1136/jmg.29.11.802; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1992, AM J MED GENET, V43, P224, DOI 10.1002/ajmg.1320430136; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OUDET C, 1993, AM J HUM GENET, V52, P297; PERGOLIZZI RG, 1992, LANCET, V339, P271, DOI 10.1016/0140-6736(92)91334-5; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SMITS A, 1992, AM J MED GENET, V43, P345, DOI 10.1002/ajmg.1320430153; SNOW K, 1992, AM J MED GENET, V43, P244, DOI 10.1002/ajmg.1320430139; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; Sutherland Grant R., 1992, Human Molecular Genetics, V1, P111, DOI 10.1093/hmg/1.2.111; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	34	197	199	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1217	1228						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	7902673				2022-12-18	WOS:A1993MJ81800008
J	HU, XY; RAY, PN; MURPHY, EG; THOMPSON, MW; WORTON, RG				HU, XY; RAY, PN; MURPHY, EG; THOMPSON, MW; WORTON, RG			DUPLICATIONAL MUTATION AT THE DUCHENNE MUSCULAR-DYSTROPHY LOCUS - ITS FREQUENCY, DISTRIBUTION, ORIGIN, AND PHENOTYPE GENOTYPE CORRELATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT PEDIAT,DIV NEUROL,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)								ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BERTELSON CJ, 1986, J MED GENET, V23, P531, DOI 10.1136/jmg.23.6.531; BOBROW M, 1988, ARCH NEUROL-CHICAGO, V45, P85, DOI 10.1001/archneur.1988.00520250091027; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DARRAS BT, 1988, AM J HUM GENET, V43, P612; DAVIES KE, 1988, J MED GENET, V25, P9, DOI 10.1136/jmg.25.1.9; DAVIES KE, 1985, NUCLEIC ACIDS RES, V13, P155, DOI 10.1093/nar/13.1.155; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; DORKINS H, 1985, HUM GENET, V71, P103, DOI 10.1007/BF00283362; DOVER GA, 1989, TRENDS GENET, V5, P100, DOI 10.1016/0168-9525(89)90038-3; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORREST SM, 1987, LANCET, V2, P1294; GILGENKRANTZ H, 1989, GENOMICS, V5, P574, DOI 10.1016/0888-7543(89)90025-6; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GITSCHIER J, 1988, AM J HUM GENET, V43, P274; GREENBERG CR, 1988, LANCET, V2, P425; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HAMMONDS RG, 1987, CELL, V51, P1, DOI 10.1016/0092-8674(87)90002-X; HART KA, 1987, HUM GENET, V75, P281, DOI 10.1007/BF00281075; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; HU XY, 1988, J MED GENET, V25, P369, DOI 10.1136/jmg.25.6.369; HU XY, 1989, AM J HUM GENET, V44, P855; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LIECHTIGALLATI S, 1987, HUM GENET, V77, P267, DOI 10.1007/BF00284483; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; ROSES AD, 1988, ARCH NEUROL-CHICAGO, V45, P84, DOI 10.1001/archneur.1988.00520250090026; THOMPSON MW, 1986, J MED GENET, V23, P548, DOI 10.1136/jmg.23.6.548; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; VOGEL F, 1975, ADV HUM GENET, V5, P223; VOGEL F, 1986, HUMAN GENETICS PROBL, P168; WAGSTAFF JE, 1985, MOL CELL BIOL, V5, P3532, DOI 10.1128/MCB.5.12.3532; WAPENAAR M C, 1988, Genomics, V2, P101, DOI 10.1016/0888-7543(88)90090-0; WEATHERALL DJ, 1979, CELL, V16, P467, DOI 10.1016/0092-8674(79)90022-9; WILSON JM, 1986, J CLIN INVEST, V77, P188, DOI 10.1172/JCI112275; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125; YANG TP, 1988, SOMAT CELL MOLEC GEN, V14, P293, DOI 10.1007/BF01534590; YANG TP, 1984, NATURE, V310, P412, DOI 10.1038/310412a0	49	197	204	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					682	695						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2316519				2022-12-18	WOS:A1990CW54900007
J	NAKAMURA, Y; LATHROP, M; LEPPERT, M; DOBBS, M; WASMUTH, J; WOLFF, E; CARLSON, M; FUJIMOTO, E; KRAPCHO, K; SEARS, T; WOODWARD, S; HUGHES, J; BURT, R; GARDNER, E; LALOUEL, JM; WHITE, R				NAKAMURA, Y; LATHROP, M; LEPPERT, M; DOBBS, M; WASMUTH, J; WOLFF, E; CARLSON, M; FUJIMOTO, E; KRAPCHO, K; SEARS, T; WOODWARD, S; HUGHES, J; BURT, R; GARDNER, E; LALOUEL, JM; WHITE, R			LOCALIZATION OF THE GENETIC-DEFECT IN FAMILIAL ADENOMATOUS POLYPOSIS WITHIN A SMALL REGION OF CHROMOSOME-5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; UNIV UTAH,HLTH SCI CTR,DIV GASTROENTEROL,SALT LAKE CITY,UT 84132; ST MARKS HOSP,SALT LAKE CITY,UT; CALIF COLL MED,DEPT BIOL CHEM,IRVINE,CA; UTAH STATE UNIV,DEPT BIOL,LOGAN,UT 84322	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; Utah State University	NAKAMURA, Y (corresponding author), UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,603 WINTROBE BLDG,SALT LAKE CITY,UT 84132, USA.							BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; CIRULLO RE, 1983, MOL CELL BIOL, V3, P892, DOI 10.1128/MCB.3.5.892; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEINBERG A, 1984, ANAL BIOCH, V137, pP266; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; HAYASHI K, 1986, NUCLEIC ACIDS RES, V14, P7617, DOI 10.1093/nar/14.19.7617; HERRERA L, 1986, AM J MED GENET, V25, P473, DOI 10.1002/ajmg.1320250309; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP M, 1988, GENOMICS, V2, P157; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0	16	197	199	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					638	644						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903664				2022-12-18	WOS:A1988Q933600010
J	Kaufman, DJ; Murphy-Bollinger, J; Scott, J; Hudson, KL				Kaufman, David J.; Murphy-Bollinger, Juli; Scott, Joan; Hudson, Kathy L.			Public Opinion about the Importance of Privacy in Biobank Research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Concerns about privacy may deter people from participating in genetic research. Recruitment and retention of biobank participants requires understanding the nature and magnitude of these concerns. Potential participants in a proposed biobank were asked about their willingness to participate, their privacy concerns, informed consent, and data sharing. A representative survey of 4659 U.S. adults was conducted. Ninety percent of respondents would be concerned about privacy, 56% would be concerned about researchers having their information, and 37% would worry that study data could be used against them. However, 60% would participate in the biobank if asked. Nearly half (48%) would prefer to provide consent once for all research approved by an oversight panel, whereas 42% would prefer to provide consent for each project separately. Although 92% would allow academic researchers to use study data, 80% and 75%, respectively, would grant access to government and industry researchers. Concern about privacy was related to lower willingness to participate only when respondents were told that they would receive $50 for participation and would not receive individual research results back. Among respondents who were told that they would receive $200 or individual research results, privacy concerns were not related to willingness. Survey respondents valued both privacy and participation in biomedical research. Despite pervasive privacy concerns, 60% would participate in a biobank. Assuring research participants that their privacy will be protected to the best of researchers' abilities may increase participants' acceptance of consent for broad research uses of biobank data by a wide range of researchers.	[Kaufman, David J.; Murphy-Bollinger, Juli; Scott, Joan; Hudson, Kathy L.] Johns Hopkins Univ, Genet & Publ Policy Ctr, Washington, DC 20036 USA	Johns Hopkins University	Kaufman, DJ (corresponding author), Johns Hopkins Univ, Genet & Publ Policy Ctr, Washington, DC 20036 USA.	dkaufma2@jhu.edu			National Human Genome Research Institute [1 U01 HG004206-0]; Public Consultation to Inform the Design of Possible Large Scale Studies of Genes and Environment in Common Disease; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004206] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Public Consultation to Inform the Design of Possible Large Scale Studies of Genes and Environment in Common Disease; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Human Genome Research Institute under grant number 1 U01 HG004206-0, Public Consultation to Inform the Design of Possible Large Scale Studies of Genes and Environment in Common Disease. The authors wish to thank our anonymous reviewers for providing advice to improve this manuscript.	[Anonymous], 2009, HIPAA PRIVACY RULE E; Baker LC, 2003, VALIDITY SURVEY HLTH; Baker R, 2000, BRIT J GEN PRACT, V50, P655; BARUCH S, 2007, US PUBLIC OPINION US; Baruch S, 2008, AM J HUM GENET, V83, P435, DOI 10.1016/j.ajhg.2008.09.003; Beskow LM, 2008, CANCER EPIDEM BIOMAR, V17, P1440, DOI 10.1158/1055-9965.EPI-08-0086; Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; BIOBANK UK, 2008, UK BIOBANK; Bogner HR, 2004, COMMUNITY GENET, V7, P202, DOI 10.1159/000082263; Buchwald D, 2006, J GEN INTERN MED, V21, P648, DOI 10.1111/j.1525-1497.2006.00449.x; Damschroder LJ, 2007, SOC SCI MED, V64, P223, DOI 10.1016/j.socscimed.2006.08.045; Dickson MR, 2008, GENET TEST, V12, P501, DOI 10.1089/gte.2008.0028; *FORR RES, 2005, NAT CONS HLTH PRIV S; *GEN PUBL POL CTR, 2008, PROP STUD VID; Godard B, 2007, COMMUNITY GENET, V10, P147, DOI 10.1159/000101756; GREELY HT, 2007, ANNU REV GENOM HUM G, P343; Hadley DW, 2003, ARCH INTERN MED, V163, P573, DOI 10.1001/archinte.163.5.573; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hoop JG, 2009, GENET TEST MOL BIOMA, V13, P331, DOI 10.1089/gtmb.2008.0117; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; Hull SC, 2008, AM J BIOETHICS, V8, pW7, DOI 10.1080/15265160802519538; Hull SC, 2008, AM J BIOETHICS, V8, P62, DOI 10.1080/15265160802478404; *I MED, 2009, HIPAA PRIV RUL ENH P, P320; *INT RTI, 2008, SUDAAN VERS 9 0 ONL; Issa AM, 2009, PUBLIC HEALTH GENOM, V12, P163, DOI 10.1159/000189629; *KAIS PERM, 2008, DIV RES RES PROGR GE; Kass NE, 2004, AM J MED GENET A, V128A, P261, DOI 10.1002/ajmg.a.30057; Kass NE, 2003, J LAW MED ETHICS, V31, P429, DOI 10.1111/j.1748-720X.2003.tb00105.x; Kaufman D, 2008, AM J MED GENET C, V148C, P31, DOI 10.1002/ajmg.c.30159; Kaufman D, 2008, GENET MED, V10, P331, DOI 10.1097/GIM.0b013e31818bb3ab; Kettis-Lindblad A, 2007, SCAND J PUBLIC HEALT, V35, P148, DOI 10.1080/14034940600868572; Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Lowrance WW, 2006, SUMM NHGRI WORKSH PR; Lowstuter KJ, 2008, GENET MED, V10, P691, DOI [10.1097/GIM.0b013e3181837246, 10.1097GIM.0b013e3181837246]; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; McCarty CA, 2007, COMMUNITY GENET, V10, P2, DOI 10.1159/000096274; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; McGuire AL, 2008, GENET MED, V10, P495, DOI [10.1097/GIM.0b013e31817a8aaa, 10.1097GIM.0b013e31817a8aaa]; McGuire AL, 2008, GENET MED, V10, P46, DOI 10.1097/GIM.0b013e31815f1e00; MURPHY J, 2009, AM J PUBLIC IN PRESS; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; *NAT CHILDR STUD, 2007, NAT CHILDR STUD; Ormond KE, 2009, AM J MED GENET A, V149A, P188, DOI 10.1002/ajmg.a.32635; PAGE SA, 2006, CHRONIC DIS CAN, V2, P60; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; PRITTS J, 2008, IMPORTANCE VALUE PRO; RACHELS J, 1975, PHILOS PUBLIC AFF, V4, P322; Robling MR, 2004, J MED ETHICS, V30, P104, DOI 10.1136/jme.2003.005157; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; *RW JOHNS FDN, 2005, AM SUPP ONL PERS HLT; Satia JA, 2006, PREV MED, V42, P51, DOI 10.1016/j.ypmed.2005.10.004; Schmidt S, 2008, NEUROEPIDEMIOLOGY, V30, P191, DOI 10.1159/000126911; Stone MA, 2005, BRIT J GEN PRACT, V55, P783; US Department of Health & Human Services, SUMM HIPAA PRIV RUL; WATTS G, 2007, BMJ-BRIT MED J, V7595, P659; Whiddett R, 2006, INT J MED INFORM, V75, P530, DOI 10.1016/j.ijmedinf.2005.08.009; Willison DJ, 2007, J AM MED INFORM ASSN, V14, P706, DOI 10.1197/jamia.M2457; Wong ML, 2004, CLIN GENET, V65, P45, DOI 10.1111/j..2004.00192.x; [No title captured]	62	196	197	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					643	654		10.1016/j.ajhg.2009.10.002	http://dx.doi.org/10.1016/j.ajhg.2009.10.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	521JH	19878915	Green Published, Bronze			2022-12-18	WOS:000271916500011
J	Bailey-Wilson, JE; Amos, CI; Pinney, SM; Petersen, GM; de Andrade, M; Wiest, JS; Fain, P; Schwartz, AG; You, M; Franklin, W; Klein, C; Gazdar, A; Rothschild, H; Mandal, D; Coons, T; Slusser, J; Lee, J; Gaba, C; Kupert, E; Perez, A; Zhou, X; Zeng, D; Liu, Q; Zhang, Q; Seminara, D; Minna, J; Anderson, MW				Bailey-Wilson, JE; Amos, CI; Pinney, SM; Petersen, GM; de Andrade, M; Wiest, JS; Fain, P; Schwartz, AG; You, M; Franklin, W; Klein, C; Gazdar, A; Rothschild, H; Mandal, D; Coons, T; Slusser, J; Lee, J; Gaba, C; Kupert, E; Perez, A; Zhou, X; Zeng, D; Liu, Q; Zhang, Q; Seminara, D; Minna, J; Anderson, MW			A major lung cancer susceptibility locus maps to chromosome 6q23-25	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; IN-SITU HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; PROSTATE-CANCER; ALLELIC LOSS; LOD SCORES; MENDELIAN INHERITANCE; SEGREGATION ANALYSIS; BREAST-CANCER; LONG ARM	Lung cancer is a major cause of death in the United States and other countries. The risk of lung cancer is greatly increased by cigarette smoking and by certain occupational exposures, but familial factors also clearly play a major role. To identify susceptibility genes for familial lung cancer, we conducted a genomewide linkage analysis of 52 extended pedigrees ascertained through probands with lung cancer who had several first-degree relatives with the same disease. Multipoint linkage analysis, under a simple autosomal dominant model, of all 52 families with three or more individuals affected by lung, throat, or laryngeal cancer, yielded a maximum heterogeneity LOD score (HLOD) of 2.79 at 155 cM on chromosome 6q (marker D6S2436). A subset of 38 pedigrees with four or more affected individuals yielded a multipoint HLOD of 3.47 at 155 cM. Analysis of a further subset of 23 multigenerational pedigrees with five or more affected individuals yielded a multipoint HLOD score of 4.26 at the same position. The 14 families with only three affected relatives yielded negative LOD scores in this region. A predivided samples test for heterogeneity comparing the LOD scores from the 23 multigenerational families with those from the remaining families was significant (P=.007). The 1-HLOD multipoint support interval from the multigenerational families extends from C6S1848 at 146 cM to 164 cM near D6S1035, overlapping a genomic region that is deleted in sporadic lung cancers as well as numerous other cancer types. Parametric linkage and variance-components analysis that incorporated effects of age and personal smoking also supported linkage in this region, but with somewhat diminished support. These results localize a major susceptibility locus influencing lung cancer risk to 6q23-25.	Univ Cincinnati, Med Ctr, Dept Environm Hlth, Kettering Lab, Cincinnati, OH 45267 USA; NHGRI, NIH, Bethesda, MD 20892 USA; NCI, NIH, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Mayo Clin, Coll Med, Rochester, MN USA; Univ Colorado, Denver, CO 80202 USA; Karmanos Canc Inst, Detroit, MI USA; Washington Univ, St Louis, MO USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; Saccomanno Res Inst, Grand Junction, CO USA; Med Coll Ohio, Toledo, OH 43699 USA	University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Colorado System; University of Colorado Denver; Barbara Ann Karmanos Cancer Institute; Washington University (WUSTL); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Anderson, MW (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Kettering Lab, ML-56,3223 Eden Ave, Cincinnati, OH 45267 USA.	andermw@ucmail.uc.edu	Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Bailey-Wilson, Joan/0000-0002-9153-2920; Pinney, Susan/0000-0003-3491-1980	NCI NIH HHS [P50 CA070907, U01 CA076293, P50 CA058184, U01 CA76293, R01 CA060691, R01 CA87895, R01 CA087895, N01 CN065064, R01 CA60691, R01 CA637000] Funding Source: Medline; NCRR NIH HHS [RR03655, P41 RR003655] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NHLBI NIH HHS [R01 HL 71197] Funding Source: Medline; NIEHS NIH HHS [P30 ES006096, P30-ES06096] Funding Source: Medline; PHS HHS [P50 058187] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000074] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abe T, 1999, GENE CHROMOSOME CANC, V25, P60, DOI 10.1002/(SICI)1098-2264(199905)25:1<60::AID-GCC9>3.0.CO;2-Y; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Abreu PC, 2002, GENET EPIDEMIOL, V22, P156, DOI 10.1002/gepi.0155; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 2001, GENET EPIDEMIOL, V21, pS768, DOI 10.1002/gepi.2001.21.s1.s768; Bailey-Wilson J. E., 1992, American Journal of Human Genetics, V51, pA145; Bailey-Wilson JE, 1998, LUNG BIOL HEALTH DIS, V122, P53; Barghorn A, 2001, AM J PATHOL, V158, P1903, DOI 10.1016/S0002-9440(10)64658-5; BECKETT WS, 1993, CLIN CHEST MED, V14, P1; Berrieman HK, 2004, BRIT J CANCER, V90, P900, DOI 10.1038/sj.bjc.6601569; BLOT WJ, 1976, AM J EPIDEMIOL, V103, P539, DOI 10.1093/oxfordjournals.aje.a112258; BLOT WJ, 1978, NEW ENGL J MED, V299, P620, DOI 10.1056/NEJM197809212991202; BLOT WJ, 1996, CANC EPIDEMIOLOGY PR, P637; BURCH PRJ, 1980, J CHRON DIS, V33, P221, DOI 10.1016/0021-9681(80)90067-3; CARBONE D, 1992, AM J MED, V93, P13; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; CHEN PL, 1991, AM J HUM GENET, V49, P15; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAW EW, IN PRESS EUR J HUM G; DIZIER MH, 1993, AM J HUM GENET, V53, P1338; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 1981, CAUSES CANC QUANTITA; DUFFY DL, 2002, SIBPAIR RELEASE 0 99; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Etzel CJ, 2003, CANCER RES, V63, P8531; FRAUMENI JF, 1975, AM J MED, V59, P145, DOI 10.1016/0002-9343(75)90333-2; FRIBERG L, 1959, BRIT MED J, V1, P1090, DOI 10.1136/bmj.1.5129.1090; *GAS, 1998, GEN ANAL SYST REL; Gauderman WJ, 1997, GENET EPIDEMIOL, V14, P199; Goeze A, 2002, J PATHOL, V196, P8, DOI 10.1002/path.1009; GOTTLIEB MS, 1979, SOUTHERN MED J, V72, P1099, DOI 10.1097/00007611-197909000-00003; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Hansen LL, 2002, CANCER GENET CYTOGEN, V139, P1, DOI 10.1016/S0165-4608(02)00620-9; HEATH CW, 1958, ARCH INTERN MED, V101, P377, DOI 10.1001/archinte.1958.00260140209031; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; Hwang SJ, 2003, HUM GENET, V113, P238, DOI 10.1007/s00439-003-0968-7; Hyytinen ER, 2002, GENE CHROMOSOME CANC, V34, P306, DOI 10.1002/gcc.10065; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jensen RH, 2003, ANTICANCER RES, V23, P2281; King TM, 2002, UROLOGY, V59, P546, DOI 10.1016/S0090-4295(01)01598-9; Konishi N, 2003, CANCER SCI, V94, P764, DOI 10.1111/j.1349-7006.2003.tb01516.x; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MERLO A, 1994, CANCER RES, V54, P2322; Merup M, 1998, BLOOD, V91, P3397, DOI 10.1182/blood.V91.9.3397.3397_3397_3400; MILLIKIN D, 1991, CANCER RES, V51, P5449; MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016; Noviello C, 1996, CLIN CANCER RES, V2, P1601; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT L, 1999, ANAL HUMAN LINKAGE; PANKRATZ VS, IN PRESS EPIDEMIOL; Petersen I, 1997, CANCER RES, V57, P2331; Re D, 2003, CANCER RES, V63, P2606; Ries L.A.G., 2000, NIH PUB, V00-2789; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; *SAGE, 2002, STAT AN GEN EP COMP; SEATON A, 1984, OCCUPATIONAL LUNG DI, P657; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; SELLERS TA, 1992, GENET EPIDEMIOL, V9, P261, DOI 10.1002/gepi.1370090405; SELLERS TA, 1991, ORIGINS OF HUMAN CANCER, P775; SELLERS TA, 1987, AM J EPIDEMIOL, V126, P237, DOI 10.1093/aje/126.2.237; SELLERS TA, 1998, LUNG CANCER, P57; Shete S, 2002, AM J HUM GENET, V70, P813, DOI 10.1086/339370; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Srikantan V, 1999, INT J CANCER, V84, P331, DOI 10.1002/(SICI)1097-0215(19990621)84:3<331::AID-IJC23>3.0.CO;2-J; TERWILLIGER JD, 1994, HDB GENETIC LINKAGE; THERNEAU TM, 2003, MIXED EFFECT COX MOD; Tibiletti MB, 2000, CLIN CANCER RES, V6, P1422; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Tong BC, 2004, HEAD NECK-J SCI SPEC, V26, P345, DOI 10.1002/hed.10391; Utada Y, 2000, JPN J CANCER RES, V91, P293, DOI 10.1111/j.1349-7006.2000.tb00944.x; Verhagen PCMS, 2002, INT J CANCER, V102, P142, DOI 10.1002/ijc.10677; Vieland VJ, 2002, HUM HERED, V53, P23, DOI 10.1159/000048601; Virmani AK, 1998, GENE CHROMOSOME CANC, V21, P308, DOI 10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Whittemore AS, 2001, AM J HUM GENET, V68, P457, DOI 10.1086/318186; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; WRIGHT DK, 1990, SAMPLE PREPARATION P, P153; Yang P, 1999, GENET EPIDEMIOL, V17, P253, DOI 10.1002/(SICI)1098-2272(199911)17:4<253::AID-GEPI2>3.0.CO;2-K; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhang YM, 2000, GENE CHROMOSOME CANC, V27, P52, DOI 10.1002/(SICI)1098-2264(200001)27:1<52::AID-GCC7>3.0.CO;2-X	88	196	205	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					460	474		10.1086/423857	http://dx.doi.org/10.1086/423857			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15272417	Bronze, Green Published			2022-12-18	WOS:000223272200010
J	Sham, PC; Cherny, SS; Purcell, S; Hewitt, JK				Sham, PC; Cherny, SS; Purcell, S; Hewitt, JK			Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB-PAIR ANALYSIS; GENETIC-LINKAGE; LOCI; DISEQUILIBRIUM; POLYMORPHISMS; PHENOTYPES; PEDIGREES; SELECTION; DETECT; REGION	Optimal design of quantitative-trait loci (QTL) mapping studies requires a precise understanding of the power of QTL linkage versus QTL association analysis, under a range of different conditions. In this article, we investigate the power of QTL linkage and association analyses for simple random sibship samples, under the variance-components model proposed by Fulker et al. After a brief description of an extension of this variance-components model, we show that the powers of both linkage and association analyses are crucially dependent on the proportion of phenotypic variance attributable to the QTL. The main difference between the two tests is that, whereas the power of association is directly related to the QTL heritability, the power of linkage is related more closely to the square of the QTL heritability. We also describe both how the power of linkage is attenuated by incomplete linkage and incomplete marker information and how the power of association is attenuated by incomplete linkage disequilibrium.	Inst Psychiat, SGDP Res Ctr, London SE5 8AF, England; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of London; King's College London; University of Colorado System; University of Colorado Boulder	Sham, PC (corresponding author), Inst Psychiat, SGDP Res Ctr, De Crespigny Pk, Denmark Hill, London SE5 8AF, England.	spjupcs@iop.kcl.ac.uk	Cherny, Stacey S/B-3315-2008	Cherny, Stacey S/0000-0002-0269-3352	NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010556, R37AA010556] Funding Source: NIH RePORTER; NEI NIH HHS [EY12562] Funding Source: Medline; NIAAA NIH HHS [AA10556, AA07330] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; BISHOP YMM, 1975, DISCRETE MULTIVARTIA; Boomsma DI, 1998, BEHAV GENET, V28, P329, DOI 10.1023/A:1021665501312; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Comuzzie AG, 1997, GENET EPIDEMIOL, V14, P975, DOI 10.1002/(SICI)1098-2272(1997)14:6<975::AID-GEPI69>3.0.CO;2-I; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; Dolan CV, 1998, BEHAV GENET, V28, P197, DOI 10.1023/A:1021423214032; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; Falconer DS, 1996, INTRO QUANTITATIVE G; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JORDE LB, 1994, AM J HUM GENET, V54, P884; KEMPTHORNE O, 1957, INTRO HGENETIC STT; Kendall M. G, 1979, ADV THEORY STAT, V4th; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1988, AM J HUM GENET, V42, P173; NEI M, 1984, EVOL BIOL, V17, P73; OHTA T, 1969, GENETICS, V63, P229; Ott J, 1997, GENETICS, V147, P927; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1996, AM J HUM GENET, V58, P836; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Sham P., 1998, STAT HUMAN GENETICS; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SVED J A, 1971, Theoretical Population Biology, V2, P125; Todorov AA, 1998, GENET EPIDEMIOL, V15, P263, DOI 10.1002/(SICI)1098-2272(1998)15:3<263::AID-GEPI5>3.0.CO;2-5; Vogler GP, 1997, GENET EPIDEMIOL, V14, P921, DOI 10.1002/(SICI)1098-2272(1997)14:6<921::AID-GEPI60>3.3.CO;2-1; Weiss K. M., 1993, GENETIC VARIATION HU; WILLS C, 1990, NATURE, V348, P398, DOI 10.1038/348398a0	45	196	200	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1616	1630		10.1086/302891	http://dx.doi.org/10.1086/302891			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762547	Bronze, Green Published			2022-12-18	WOS:000088373700016
J	Villard, E; Tiret, L; Visvikis, S; Rakotovao, R; Cambien, F; Soubrier, F				Villard, E; Tiret, L; Visvikis, S; Rakotovao, R; Cambien, F; Soubrier, F			Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSERTION DELETION POLYMORPHISM; MODELS; PROMOTER; SERUM	Plasma angiotensin I-converting enzyme (ACE) levels are highly genetically determined. A previous segregation-linkage analysis suggested the existence of a functional mutation located within or close to the ACE locus, in almost complete linkage desequilibrium (LD) with the ACE insertion/deletion (I/D) polymorphism and accounting for half the ACE variance. In order to identify the functional variant at the molecular level, we compared ACE gene sequences between four subjects selected for having contrasted ACE levels and I/D genotypes. We identified 10 new polymorphisms, among which 8 were genotyped in 95 healthy nuclear families, in addition to the VD polymorphism. These polymorphisms could be divided into two groups: five polymorphisms in the 5' region and three in the coding sequence and the 3' UTR. Within each group, polymorphisms were in nearly complete association, whereas polymorphisms from the two groups were in strong negative LD. After adjustment for the I/D polymorphism, all polymorphisms of the 5' group remained significantly associated with ACE levels, which suggests the existence of two quantitative trait loci (QTL) acting additively on ACE levels. Segregation-linkage analyses including one or two ACE-Linked QTLs in LD with two ACE markers were performed to test this hypothesis. The two QTLs and the two markers were assumed to be in complete LD. Results supported the existence of two ACE-linked QTLs, which would explain 38% and 49% of the ACE variance in parents and offspring, respectively. One of these QTLs might be the I/D polymorphism itself or the newly characterized 4656(CT)(2/3) polymorphism. The second QTL, would have a frequency of similar to.20, which is incompatible with any of the yet-identified polymorphisms. More extensive sequencing and extended analyses in larger samples and in other populations will be necessary to characterize definitely the functional variants.	HOP BROUSSAIS, INSERM, U258, F-75674 PARIS 14, FRANCE; HOP ST LOUIS, INSERM, U358, PARIS, FRANCE; INSERM, SC7, PARIS, FRANCE; CTR MED PREVENT, VANDOEUVRE LES NANCY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)			Villard, Eric/AAI-2464-2021; Cambien, Francois/AAP-9751-2020; Visvikis-Siest, Sophie/H-2324-2014; villard, eric/AAH-2868-2021	Villard, Eric/0000-0001-9801-7297; Visvikis-Siest, Sophie/0000-0001-8104-8425; 				ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; BENETEAU B, 1986, CLIN CHEM, V32, P884; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOHN M, 1993, CLIN GENET, V44, P292; BONITHONKOPP C, 1994, CIRCULATION, V89, P952, DOI 10.1161/01.CIR.89.3.952; BONNEY GE, 1988, AM J HUM GENET, V43, P29; CAMBIEN F, 1994, CIRCULATION, V90, P669, DOI 10.1161/01.CIR.90.2.669; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CAMBIEN F, 1988, AM J HUM GENET, V43, P774; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORNEL MJ, 1995, J BIOL CHEM, V270, P13613, DOI 10.1074/jbc.270.23.13613; DIZIER MH, 1993, AM J HUM GENET, V53, P1338; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; HUBERT C, 1991, J BIOL CHEM, V266, P15377; KREUTZ R, 1995, CIRCULATION, V92, P2381, DOI 10.1161/01.CIR.92.9.2381; LALOUEL JM, 1981, 14 U UT DEP MED BIOP; LATTION AL, 1989, FEBS LETT, V252, P99, DOI 10.1016/0014-5793(89)80897-X; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; MCKENZIE CA, 1995, J HUM GENET, V57, P1426; NADAUD S, 1992, BIOCHEM BIOPH RES CO, V189, P134, DOI 10.1016/0006-291X(92)91535-X; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; SIBONY M, 1993, HYPERTENSION, V21, P827, DOI 10.1161/01.HYP.21.6.827; TESTUT P, 1993, BIOCHEM J, V293, P843, DOI 10.1042/bj2930843; THEIN SL, 1994, AM J HUM GENET, V54, P214; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; TIRET L, 1991, AM J HUM GENET, V48, P926; TIRET L, 1992, AM J HUM GENET, V51, P197	30	196	202	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1268	1278						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651305				2022-12-18	WOS:A1996UM27100021
J	NICKERSON, E; GREENBERG, F; KEATING, MT; MCCASKILL, C; SHAFFER, LG				NICKERSON, E; GREENBERG, F; KEATING, MT; MCCASKILL, C; SHAFFER, LG			DELETIONS OF THE ELASTIN GENE AT 7Q11.23 OCCUR IN SIMILAR-TO-90-PERCENT OF PATIENTS WITH WILLIAMS-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; TOOTH DISEASE TYPE-1A; CHROMOSOME-7; LOCALIZATION; DISORDER	To investigate the frequency of deletions of the elastin gene in patients with Williams syndrome (WS), we screened 44 patients by both FISH and PCR amplification of a dinucleotide repeat polymorphism FISH was performed using cosmids containing either the 5' or the 3' end of the elastin gene. PCR analysis was performed on the patients and their parents with a (CA), repeat polymorphism found in intron 17 of the elastin locus. Of the 44 patients screened, 91% were shown to be deleted by FISH. Using the DNA polymorphism, both maternally (39%) and paternally (61%) derived deletions were found. Four patients were not deleted for eIastin but have clinical features of WS. Since deletions of elastin cannot account for several features found in WS, these patients will be valuable in further delineation of the critical region responsible for the WS phenotype. Although PCR can be useful for determining the parental origin of the deletion, our results demonstrate that FISH analysis of the elastin locus provides a more rapid and informative test to confirm a clinical diagnosis of WS. The presence of two copies of the elastin locus in a patient does not, however, rule out WS as a diagnosis.	BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; UNIV UTAH, HOWARD HUGHES MED INST, DEPT MED & HUMAN GENET, ECCLES PROGRAM HUMAN MOLEC BIOL & GENET, SALT LAKE CITY, UT USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah					NHLBI NIH HHS [R01 HL50343] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050343] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHIARELLA F, 1989, J MED GENET, V26, P86, DOI 10.1136/jmg.26.2.86; CONWAY EE, 1990, J PEDIATR-US, V117, P593, DOI 10.1016/S0022-3476(05)80696-1; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; ENSING GJ, 1989, J AM COLL CARDIOL, V13, P413, DOI 10.1016/0735-1097(89)90520-2; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; EWART AK, 1993, P NATL ACAD SCI USA, V90, P3226, DOI 10.1073/pnas.90.8.3226; FAZIO MJ, 1991, AM J HUM GENET, V48, P696; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; GIDDINS NG, 1989, BRIT HEART J, V62, P315; GREEN JE, 1990, AIDS RES HUM RETROV, V6, P85; GREENBERG F, 1988, AM J MED GENET, V30, P993, DOI 10.1002/ajmg.1320300423; INDIK Z, 1989, AM J MED GENET, V34, P81, DOI 10.1002/ajmg.1320340115; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MORRIS CA, 1993, AM J MED GENET, V47, P478, DOI 10.1002/ajmg.1320470409; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; OLSON TM, 1993, HUM MOL GENET, V2, P869, DOI 10.1093/hmg/2.7.869; SCHINZEL A, 1988, J MED GENET, V25, P454, DOI 10.1136/jmg.25.7.454; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHAFFER LG, 1993, AM J MED GENET, V47, P383, DOI 10.1002/ajmg.1320470317; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; UITTO J, 1991, BIOCHEM SOC T, V19, P824, DOI 10.1042/bst0190824	25	196	207	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1156	1161						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726172				2022-12-18	WOS:A1995QU58600019
J	FLINT, J; CRADDOCK, CF; VILLEGAS, A; BENTLEY, DP; WILLIAMS, HJ; GALANELLO, R; CAO, A; WOOD, WG; AYYUB, H; HIGGS, DR				FLINT, J; CRADDOCK, CF; VILLEGAS, A; BENTLEY, DP; WILLIAMS, HJ; GALANELLO, R; CAO, A; WOOD, WG; AYYUB, H; HIGGS, DR			HEALING OF BROKEN HUMAN-CHROMOSOMES BY THE ADDITION OF TELOMERIC REPEATS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ALPHA-GLOBIN; GENE-CLUSTER; LENGTH POLYMORPHISM; MOLECULAR ANALYSIS; THALASSEMIA; DELETIONS; DNA; TRUNCATION; SEQUENCES; COMPLEX	We have characterized and compared a series of naturally occurring chromosomal truncations involving the terminal region of the short arm of human chromosome 16 (16p13.3). All six broken chromosomes appear to have been stabilized by the direct addition of telomeric repeats (TTAGGG)(n) to nontelomeric DNA. In five of the six chromosomes, sequence analysis shows that the three or four nucleotides preceding the point of telomere addition are complementary to and in phase with the putative RNA template of human telomerase. Otherwise me have found no common structural features around the breakpoint regions. These findings, together with previously reported in vitro data, suggest that chromosome-healing events in man can be mediated by telomerase and that a small region of complementarity to the RNA template of telomerase at the end of a broken chromosome may be sufficient to prime healing in vivo.	JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; UNIV COMPLUTENSE MADRID,HOSP SAN CARLOS,INST NACL SALUD,MADRID,SPAIN; LLANDOUGH HOSP,PENARTH,S GLAM,WALES; MAIDSTONE HLTH AUTHOR,DEPT HAEMATOL,KENT,ENGLAND; UNIV CAGLIARI,INST CLIN & BIOL ETA EVOLUTTIVA,CAGLIARI,ITALY	University of Oxford; Complutense University of Madrid; Hospital Clinico San Carlos; University of Cagliari				Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BROWN W R A, 1992, Current Biology, V2, P127, DOI 10.1016/0960-9822(92)90248-9; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; BUCKLE VJ, 1988, J MED GENET, V25, P847, DOI 10.1136/jmg.25.12.847; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; FISCHELGHODSIAN N, 1988, BRIT J HAEMATOL, V70, P233, DOI 10.1111/j.1365-2141.1988.tb02469.x; GILLEY D, 1988, MOL CELL BIOL, V8, P4765, DOI 10.1128/MCB.8.11.4765; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803; HARRINGTON LA, 1991, NATURE, V353, P451, DOI 10.1038/353451a0; HARRIS PC, 1990, GENOMICS, V7, P195, DOI 10.1016/0888-7543(90)90541-2; HATTON CSR, 1990, BLOOD, V76, P221; HIGGS DR, 1989, BLOOD, V73, P1081; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; JARMAN AP, 1988, AM J HUM GENET, V43, P249; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; LAMB J, 1989, LANCET, V2, P819; LAMB J, 1993, AM J HUM GENET, V52, P668; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; MATSUMOTO T, 1987, MOL CELL BIOL, V7, P4424, DOI 10.1128/MCB.7.12.4424; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MULLER F, 1991, CELL, V67, P815, DOI 10.1016/0092-8674(91)90076-B; MURNANE JP, 1993, MOL CELL BIOL, V13, P977, DOI 10.1128/MCB.13.2.977; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; OLD JM, 1983, THALASSAEMIAS METHOD, P74; POLOGE LG, 1988, CELL, V55, P869, DOI 10.1016/0092-8674(88)90142-0; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; RACK KA, 1993, AM J HUM GENET, V52, P987; ROMAO L, 1992, HUM GENET, V89, P323; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Sambrook J., 1989, MOL CLONING LAB MANU; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; WANG SS, 1990, NATURE, V345, P456, DOI 10.1038/345456a0; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; YU GL, 1991, CELL, V67, P823, DOI 10.1016/0092-8674(91)90077-C; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579; Zeitlin H C, 1983, Mol Biol Med, V1, P489	44	196	197	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					505	512						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	7521575				2022-12-18	WOS:A1994PF50900012
J	WARD, BE; GERSEN, SL; CARELLI, MP; MCGUIRE, NM; DACKOWSKI, WR; WEINSTEIN, M; SANDLIN, C; WARREN, R; KLINGER, KW				WARD, BE; GERSEN, SL; CARELLI, MP; MCGUIRE, NM; DACKOWSKI, WR; WEINSTEIN, M; SANDLIN, C; WARREN, R; KLINGER, KW			RAPID PRENATAL-DIAGNOSIS OF CHROMOSOMAL ANEUPLOIDIES BY FLUORESCENCE INSITU HYBRIDIZATION - CLINICAL-EXPERIENCE WITH 4,500 SPECIMENS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERPHASE; ABERRATIONS; METAPHASE; DNA; AMNIOCENTESIS; TRISOMY-18; LIBRARIES; ANXIETY; REPEAT; CELLS	Detection of chromosome aneuploidies in uncultured amniocytes is possible using fluorescence in situ hybridization (FISH). We herein describe the results of the first clinical program which utilized FISH for the rapid detection of chromosome aneuploidies in uncultured amniocytes. FISH was performed on physician request, as an adjunct to cytogenetics in 4,500 patients. Region-specific DNA probes to chromosomes 13, 18, 21, X, and Y were used to determine ploidy by analysis of signal number in hybridized nuclei. A sample was considered to be euploid when all autosomal probes generated two hybridization signals and when a normal sex chromosome pattern was observed in greater than or equal to 80% of hybridized nuclei. A sample was considered to be aneuploid when greater than or equal to 70% of hybridized nuclei displayed the same abnormal hybridization pattern for a specific probe. Of the attempted analyses, 90.2% met these criteria and were reported as informative to referring physicians within 2 d of receipt. Based on these reporting parameters, the overall detection rate for aneuploidies was 73.3% (107/146), with an accuracy of informative results for aneuploidies of 93.9% (107/114). Compared to cytogenetics, the accuracy of all informative FISH results, euploid and aneuploid, was 99.8%, and the specificity was 99.9%. In those pregnancies where fetal abnormalities had been observed by ultrasound, referring physicians requested FISH plus cytogenetics at a significantly higher rate than they requested cytogenetics alone. The current prenatal FISH protocol is not designed to detect all chromosome abnormalities and should only be utilized as an adjunctive test to cytogenetics. This experience demonstrates that FISH can provide a rapid and accurate clinical method for prenatal identification of chromosome aneuploidies.	INTEGRAT GENET,W PATERSON,NJ; INTEGRAT GENET,LONG BEACH,CA; INTEGRAT GENET,MIAMI,FL		WARD, BE (corresponding author), INTEGRATED GENET INC,1 MT RD,FRAMINGHAM,MA 01701, USA.							ABUELO DN, 1991, PRENATAL DIAG, V11, P381, DOI 10.1002/pd.1970110607; BAJALICA S, 1992, PRENATAL DIAG, V12, P61, DOI 10.1002/pd.1970120109; CACCIA N, 1991, AM J OBSTET GYNECOL, V165, P1122, DOI 10.1016/0002-9378(91)90484-9; CANICK JA, 1990, PRENATAL DIAG, V10, P546, DOI 10.1002/pd.1970100813; CHRISTENSEN B, 1992, PRENATAL DIAG, V12, P241, DOI 10.1002/pd.1970120403; CREMER T, 1986, HUM GENET, V74, P346, DOI 10.1007/BF00280484; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; EVERSKIEBOOMS G, 1988, CLIN GENET, V33, P196; FERGUSONSMITH MA, 1991, PRENATAL DIAG, V11, P489, DOI 10.1002/pd.1970110802; Goldstein Laurence, 1987, PRINCIPLES INTERNAL, P5; KLEVER M, 1992, PRENATAL DIAG, V12, P53, DOI 10.1002/pd.1970120108; KLINGER K, 1992, AM J HUM GENET, V51, P55; KLINGER KW, 1990, AM J HUM GENET S, V47, pA224; KUO WL, 1991, AM J HUM GENET, V49, P112; LANDEGENT JE, 1987, HUM GENET, V77, P366, DOI 10.1007/BF00291428; LEBO RV, 1992, AM J MED GENET, V43, P848, DOI 10.1002/ajmg.1320430519; Ledbetter David H., 1992, Human Molecular Genetics, V1, P297, DOI 10.1093/hmg/1.5.297; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; LICHTER P, 1990, NATURE, V345, P93, DOI 10.1038/345093a0; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LICHTER P, 1990, MOL GENETICS CHROMOS, P69; MCNEIL JA, 1991, GENET ANAL-BIOMOL E, V8, P41, DOI 10.1016/1050-3862(91)90049-W; PENKETH RJA, 1989, PRENATAL DIAG, V9, P489, DOI 10.1002/pd.1970090706; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RHOADS GG, 1989, NEW ENGL J MED, V320, P609, DOI 10.1056/NEJM198903093201001; RICHKIND K, 1992, APPL CYTOGENET, V18, P6; Robinson A, 1979, Birth Defects Orig Artic Ser, V15, P203; ROBINSON A, 1991, AM J HUM GENET S, V49, pA43; SAWYER JR, 1992, J REPROD MED, V37, P485; TKACHUK DC, 1991, GENET ANAL-BIOMOL E, V8, P67, DOI 10.1016/1050-3862(91)90051-R; TRASK BJ, 1991, TRENDS GENET, V7, P149, DOI 10.1016/0168-9525(91)90378-4; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; WARD BE, 1992, NEW ENGL J MED, V326, P1639; WAYE JS, 1985, NUCLEIC ACIDS RES, V13, P2731, DOI 10.1093/nar/13.8.2731; WEST J D, 1989, Molecular Reproduction and Development, V1, P129, DOI 10.1002/mrd.1080010208; WHITEMAN DAH, 1991, AM J HUM GENET S, V49, pA1279; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7; YU LC, 1990, AM J HUM GENET S, V47, pA287; ZAHED L, 1992, PRENATAL DIAG, V12, P483, DOI 10.1002/pd.1970120603; ZHENG YL, 1992, PRENATAL DIAG, V12, P931, DOI 10.1002/pd.1970121113	40	196	224	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					854	865						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488836				2022-12-18	WOS:A1993LB88900002
J	BARTELS, CF; JENSEN, FS; LOCKRIDGE, O; VANDERSPEK, AFL; RUBINSTEIN, HM; LUBRANO, T; LADU, BN				BARTELS, CF; JENSEN, FS; LOCKRIDGE, O; VANDERSPEK, AFL; RUBINSTEIN, HM; LUBRANO, T; LADU, BN			DNA MUTATION ASSOCIATED WITH THE HUMAN BUTYRYLCHOLINESTERASE K-VARIANT AND ITS LINKAGE TO THE ATYPICAL VARIANT MUTATION AND OTHER POLYMORPHIC SITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SERUM-CHOLINESTERASE; AMINO-ACID-SEQUENCE; QUANTITATIVE VARIANT; MOLECULAR-CLONING; ACETYLCHOLINESTERASE; IDENTIFICATION; LOCUS-1; GENE; SUCCINYLCHOLINE; PHENOTYPES	Genomic DNA from two families exhibiting the K-variant phenotype of serum butyrylcholinesterase was amplified by PCR and sequenced to determine the molecular basis of this variant. The K-variant phenotype was found to be associated with a DNA transition from guanine to adenine at nucleotide 1615, which caused an amino acid change from alanine 539 to threonine (GCA --> ACA; Ala539 --> Thr). There was a 30% reduction of serum butyrylcholinesterase activity associated with this mutation. Amplification and sequencing of DNA from a random sample of 47 unrelated people gave a frequency of .128 for the K-variant allele. Thus, 1 person in 63 should be homozygous for the K-variant, making the K-variant the most common butyrylcholinesterase variant. The K-variant mutation was also found to be present in 17 (89%) of 19 butyrylcholinesterase genes containing the point mutation which causes the atypical phenotype of butyrylcholinesterase (GAT --> GGT; Asp70 --> Gly). The presence of the K-variant in the same molecule as the atypical variant does not contribute to the qualitative change in the atypical enzyme, but it most likely accounts for the approximately one-third reduction in V(max) of butyrylcholinesterase activity in atypical serum. Two additional point mutations located in noncoding regions of the gene were also observed to be in linkage disequilibrium with the K-variant mutation. As many as four different point mutations have been identified within a single butyrylcholinesterase gene. Inhibition tests of the enzyme in plasma are usually used to distinguish the K-variant from the usual enzyme when the former is present with the heterozygous atypical variant (AK phenotype vs. UA phenotype). Inhibition tests were performed on plasma enzyme from the four possible genotypic combinations of the heterozygous atypical mutation with or without the K-variant mutation on either allele; we found that the AK phenotype was caused by three genotypes (A/K, AK/K, and U/A) and that the UA phenotype was caused by two genotypes (U/A and U/AK).	UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48104; UNIV MICHIGAN,SCH MED,DEPT ANESTHESIOL,ANN ARBOR,MI 48104; UNIV COPENHAGEN,RIGSHOSP,DEPT ANAESTHESIA,DK-2100 COPENHAGEN,DENMARK; VET ADM MED CTR,SERV MED,HINES,IL 60141; VET ADM MED CTR,SERV RES,HINES,IL 60141; LOYOLA UNIV,STRITCH SCH MED,DEPT MED,MAYWOOD,IL 60153	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rigshospitalet; University of Copenhagen; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Loyola University Chicago					NIGMS NIH HHS [GM44887, GM27028] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044887, P01GM027028] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALCANTARA VM, 1990, HUM HERED, V40, P386, DOI 10.1159/000153963; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; BARTELS CF, 1990, NUCLEIC ACIDS RES, V18, P6171, DOI 10.1093/nar/18.20.6171-a; BARTELS CF, 1992, AM J HUM GENET, V50, P1104; DOCTOR BP, 1990, FEBS LETT, V266, P123, DOI 10.1016/0014-5793(90)81522-P; ECKERSON HW, 1983, BIOCHEM GENET, V21, P93, DOI 10.1007/BF02395394; EVANS RT, 1984, J MED GENET, V21, P99, DOI 10.1136/jmg.21.2.99; GIBNEY G, 1990, J BIOL CHEM, V265, P12576; GNATT A, 1990, CANCER RES, V50, P1983; HARRIS H, 1961, NATURE, V191, P496, DOI 10.1038/191496a0; JBILO O, 1990, NUCLEIC ACIDS RES, V18, P3990, DOI 10.1093/nar/18.13.3990; JENSEN FS, 1991, CHOLINESTERASES; KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305; KALOW W, 1957, J PHARMACOL EXP THER, V120, P203; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P339, DOI 10.1139/o57-041; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LADU BN, 1991, CELL MOL NEUROBIOL, V11, P79, DOI 10.1007/BF00712801; LEHMANN H, 1956, LANCET, V2, P124; LIDDELL J, 1963, ACTA GENET STAT MED, V13, P95; LOCKRIDGE O, 1990, PHARMACOL THERAPEUT, V47, P35, DOI 10.1016/0163-7258(90)90044-3; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; LOCKRIDGE O, 1978, J BIOL CHEM, V253, P362; LUDU BN, 1990, CLIN BIOCHEM, V23, P423; MCALPINE PJ, 1991, NUCLEIC ACIDS RES, V19, P5088, DOI 10.1093/nar/19.18.5088; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; MCTIERNAN C, 1987, P NATL ACAD SCI USA, V84, P6682, DOI 10.1073/pnas.84.19.6682; MULLENBACH R, 1989, TRENDS GENET, V5, P391; NEVILLE LF, 1990, J BIOL CHEM, V265, P20735; NOGUEIRA CP, 1990, AM J HUM GENET, V46, P934; NOGUEIRA CP, UNPUB IDENTIFICATION; PRODY CA, 1987, P NATL ACAD SCI USA, V84, P3555, DOI 10.1073/pnas.84.11.3555; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; REYNOLDS PI, 1988, CAN J ANAESTH, V35, P576, DOI 10.1007/BF03020343; RUBINSTEIN HM, 1976, J MED GENET, V13, P43, DOI 10.1136/jmg.13.1.43; RUBINSTEIN HM, 1978, J MED GENET, V15, P27, DOI 10.1136/jmg.15.1.27; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; VIBYMOGENSEN J, 1980, ANESTHESIOLOGY, V53, P517, DOI 10.1097/00000542-198012000-00017; WHITTAKER M, 1987, HUM HERED, V37, P54, DOI 10.1159/000153677; WHITTAKER M, 1985, HUM HERED, V35, P364, DOI 10.1159/000153581; WHITTAKER M, 1986, MONOGRAPHS HUMAN GEN, V11	45	196	203	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1086	1103						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1570838				2022-12-18	WOS:A1992HR47300025
J	VOSS, R; BENSIMON, E; AVITAL, A; GODFREY, S; ZLOTOGORA, J; DAGAN, J; TIKOCHINSKI, Y; HILLEL, J				VOSS, R; BENSIMON, E; AVITAL, A; GODFREY, S; ZLOTOGORA, J; DAGAN, J; TIKOCHINSKI, Y; HILLEL, J			ISODISOMY OF CHROMOSOME-7 IN A PATIENT WITH CYSTIC-FIBROSIS - COULD UNIPARENTAL DISOMY BE COMMON IN HUMANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HEBREW UNIV JERUSALEM,HADASSAH MED CTR,DEPT PEDIAT,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT GENET,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,FAC AGR,GENET & ANIM BREEDING UNIT,IL-76100 REHOVOT,ISRAEL	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem	VOSS, R (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED CTR,DEPT HUMAN GENET,POB 12000,IL-91120 JERUSALEM,ISRAEL.			Schiff, Elena/0000-0002-9848-1302				ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BARTELS I, 1986, AM J HUM GENET, V38, P280; BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HELMINEN P, 1988, LANCET, V1, P574; JEFFREYS AJ, 1987, BIOCHEM SOC T, V15, P309, DOI 10.1042/bst0150309; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; Maniatis T., 1982, MOL CLONING; NGO KY, 1986, AM J HUM GENET, V38, P407; PALMER CG, 1980, CLIN GENET, V17, P418; SEARLE AG, IN PRESS ANN HUM GEN; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPENCE MA, 1987, CYTOGENET CELL GENET, V46, P170; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; TSUI LC, 1987, CYTOGENET CELL GENET, V46, P442; WARBURTON D, 1988, AM J HUM GENET, V42, P215; WHITE R, 1986, AM J HUM GENET, V39, P694; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	27	196	197	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					373	380						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2570528				2022-12-18	WOS:A1989AN87900006
J	Wang, L; Guo, DC; Cao, JM; Gong, LM; Kamm, KE; Regalado, E; Li, L; Shete, S; He, WQ; Zhu, MS; Offermanns, S; Gilchrist, D; Elefteriades, J; Stull, JT; Milewicz, DM				Wang, Li; Guo, Dong-chuan; Cao, Jiumei; Gong, Limin; Kamm, Kristine E.; Regalado, Ellen; Li, Li; Shete, Sanjay; He, Wei-Qi; Zhu, Min-Sheng; Offermanns, Stephan; Gilchrist, Dawna; Elefteriades, John; Stull, James T.; Milewicz, Dianna M.			Mutations in Myosin Light Chain Kinase Cause Familial Aortic Dissections	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMOOTH-MUSCLE CONTRACTION; ANGIOTENSIN-II; ANEURYSMS; TISSUES; MOUSE; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; EXPRESSION; PATHOLOGY	Mutations in smooth muscle cell (SMC) specific isoforms of a actin and B myosin heavy chain, two major components of the SMC contractile unit cause familial thoracic aortic aneurysms leading to acute aortic dissections (FTAAD) To investigate whether mutations in the kinase that controls SMC contractile function (myosin light chain kinase [MYLK]) cause FTAAD, we sequenced MYLK by using DNA from 193 affected probands from unrelated FTAAD families One nonsense and four missense variants were identified in MYLK and were not present in matched controls Two variants, p R1480X (c 4438C>1) and p S1759P (c 5275T>C), segregated with aortic dissections in two families with a maximum LOD score of 2 1 providing evidence of linkage of these rare variants to the disease (p = 0 0009) Both families demonstrated a similar phenotype characterized by presentation with an acute aortic dissection with little to no enlargement of the aorta The p R1480X mutation leads to a truncated protein lacking the kinase and calmodulin binding domains and p Si 759P alters amino acids in the alpha helix of the calmodulin binding sequence, which disrupts kinase binding to calmodulin and reduces kinase activity in vitro Furthermore, mice with SMC specific knockdown of Mylk demonstrate altered gene expression and pathology consistent with medial degeneration of the aorta Thus, genetic and functional studies support the conclusion that heterozygous loss of function mutations in MYLK are associated with aortic dissections	[Wang, Li; Guo, Dong-chuan; Cao, Jiumei; Gong, Limin; Regalado, Ellen; Li, Li; Milewicz, Dianna M.] Univ Texas Med Sch Houston, Dept Internal Med, Houston, TX 77030 USA; [Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [He, Wei-Qi; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [He, Wei-Qi; Zhu, Min-Sheng] Nanjing Univ, MOL Key Lab Model Anim Dis Studies, Nanjing 210061, Peoples R China; [Offermanns, Stephan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Gilchrist, Dawna] Univ Alberta, Dept Med Genet & Med, Edmonton, AB T6G 2R7, Canada; [Elefteriades, John] Yale Univ, Dept Cardiothorac Surg, New Haven, CT 06520 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Nanjing University; Nanjing University; Max Planck Society; University of Alberta; Yale University	Milewicz, DM (corresponding author), Univ Texas Med Sch Houston, Dept Internal Med, Houston, TX 77030 USA.		He, Weiqi/I-7935-2013; He, Weiqi/L-2502-2019; Offermanns, Stefan/L-3313-2017	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Offermanns, Stefan/0000-0001-8676-6805; Regalado, Ellen/0000-0002-5859-218X	National Institutes of Health [R21 HL091509, P50HL083794 01, RO1 HL62594, HL29043, UL1 RR024148]; Moss Heart Fund; Fouad A and Val Imm Bashour Distinguished Chair in Physiology; Vivian L Smith Foundation; Tex Gen Foundation; Dons Duke Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091509, R01HL029043, R01HL062594, P50HL083794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A and Val Imm Bashour Distinguished Chair in Physiology; Vivian L Smith Foundation; Tex Gen Foundation; Dons Duke Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to the families and their physicians involved in this study The following sources provided funding for these studies National Institutes of Health (R21 HL091509 [D M M], P50HL083794 01 [D M M] RO1 HL62594 [D M M] HL29043 [J T S], UL1 RR024148) the Moss Heart Fund (J T S), the Fouad A and Val Imm Bashour Distinguished Chair in Physiology (J T S), the Vivian L Smith Foundation (D M M), the Tex Gen Foundation (D M M) and the Dons Duke Charitable Trust (DMM)	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Elefteriades JA, 2005, ANN THORAC SURG, V80, P1098, DOI 10.1016/j.athoracsur.2004.02.130; Fedak PWM, 2003, J THORAC CARDIOV SUR, V126, P797, DOI 10.1016/S0022-5223(03)00398-2; FITZSIMONS DP, 1992, J BIOL CHEM, V267, P23903; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Hassane S, 2007, ARTERIOSCL THROM VAS, V27, P2177, DOI 10.1161/ATVBAHA.107.149252; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Lesauskaite V, 2001, HUM PATHOL, V32, P1003, DOI 10.1053/hupa.2001.27107; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Welsh DG, 2000, J PHYSIOL-LONDON, V527, P139, DOI 10.1111/j.1469-7793.2000.t01-1-00139.x; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	29	195	203	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					701	707		10.1016/j.ajhg.2010.10.006	http://dx.doi.org/10.1016/j.ajhg.2010.10.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21055718	Green Published, Bronze			2022-12-18	WOS:000284668400017
J	Whatley, SD; Ducamp, S; Gouya, L; Grandchamp, B; Beaumont, C; Badminton, MN; Elder, GH; Holme, A; Anstey, AV; Parker, M; Corrigall, AV; Meissner, PN; Hift, RJ; Marsden, JT; Ma, Y; Mieli-Vergani, G; Deybach, JC; Puy, H				Whatley, Sharon D.; Ducamp, Sarah; Gouya, Laurent; Grandchamp, Bernard; Beaumont, Carole; Badminton, Michael N.; Elder, George H.; Holme, Alexander; Anstey, Alexander V.; Parker, Michelle; Corrigall, Anne V.; Meissner, Peter N.; Hift, Richard J.; Marsden, Joanne T.; Ma, Yun; Mieli-Vergani, Giorgina; Deybach, Jean-Charles; Puy, Herve			C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINOLEVULINATE SYNTHASE GENE; ERYTHROPOIETIC PROTOPORPHYRIA; HEME-BIOSYNTHESIS; SIDEROBLASTIC ANEMIA; ZINC PROTOPORPHYRIN; DIFFERENTIATION; METABOLISM; MUTATION; FAMILY; MICE	All reported mutations in ALAS2, which encodes the rate-regulating enzyme of erythroid heme biosynthesis, cause X-linked sideroblastic anemia. We describe eight families with ALAS2 deletions, either c.1706-1709 delAGTG (p.E569GfsX24) or c.1699-1700 delAT (p.M567EfsX2), resulting in frameshifts that lead to replacement or deletion of the 19-20 C-terminal residues of the enzyme. Prokaryotic expression studies show that both mutations markedly increase ALAS2 activity. These gain-of-function mutations cause a previously unrecognized form of porphyria, X-linked dominant protoporphyria, characterized biochemically by a high proportion of zinc-protoporphyrin in erythrocytes, in which a mismatch between protoporphyrin production and the heme requirement of differentiating erythroid cells leads to overproduction of protoporphyrin in amounts sufficient to cause photosensitivity and liver disease.	[Ducamp, Sarah; Gouya, Laurent; Deybach, Jean-Charles; Puy, Herve] Hop Louis Mourier, Ctr Francais Porphyries, AP HP, F-92701 Colombes, France; [Whatley, Sharon D.; Badminton, Michael N.; Elder, George H.; Holme, Alexander; Anstey, Alexander V.] Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Whatley, Sharon D.; Badminton, Michael N.; Elder, George H.] Univ Wales Hosp, Dept Med Biochem & Immunol, Cardiff CF14 4XN, S Glam, Wales; [Ducamp, Sarah; Gouya, Laurent; Grandchamp, Bernard; Beaumont, Carole; Deybach, Jean-Charles; Puy, Herve] Univ Paris Diderot, Ctr Rech Biomed Bichat Beaujon, INSERM, U773, F-75018 Paris, France; [Grandchamp, Bernard] Hop Bichat Claude Bernard, Lab Biochim Hormonale & Genet, AP HP, F-75018 Paris, France; [Holme, Alexander; Anstey, Alexander V.] Univ Wales Hosp, Dept Dermatol, Cardiff CF14 4XN, S Glam, Wales; [Parker, Michelle; Corrigall, Anne V.; Meissner, Peter N.; Hift, Richard J.] Univ Cape Town, Dept Med, Liver Res Ctr, MRC,Lennox Eales Labs, ZA-7925 Cape Town, South Africa; [Marsden, Joanne T.] Kings Coll Hosp London, London SE5 9RS, England; [Ma, Yun; Mieli-Vergani, Giorgina] Kings Coll Hosp London, Sch Med, Inst Liver Studies, London SE5 9RS, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Cardiff University; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Cardiff University; University of Cape Town; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Deybach, JC (corresponding author), Hop Louis Mourier, Ctr Francais Porphyries, AP HP, 178 Rue Renouillers, F-92701 Colombes, France.	jc.deybach@wanadoo.fr	Mieli-Vergani, Giorgina/G-5616-2011; PUY, HERVE/O-1785-2017; Ducamp, Sarah/AAF-3899-2020	Mieli-Vergani, Giorgina/0000-0002-8215-4489; PUY, HERVE/0000-0003-3362-2634; Gouya, Laurent/0000-0002-1326-7025	Agence Nationale pour la Recherche-Groupement d'Interet Scientifiqe (ANR-GIS) Maladies Rares [ANR-07-MRAR-00801]; the British Skin Foundation; Royal College of Physicians; a Dorothy Hodgkin Royal Society Fellowship; Children's Liver Disease Foundation, Birmingham,UK; South African Medical Research Council	Agence Nationale pour la Recherche-Groupement d'Interet Scientifiqe (ANR-GIS) Maladies Rares(French National Research Agency (ANR)); the British Skin Foundation; Royal College of Physicians; a Dorothy Hodgkin Royal Society Fellowship; Children's Liver Disease Foundation, Birmingham,UK; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the family members for their cooperation; Yves Nordmann for his clinical contribution; David Bishop, Mount Sinai School of Medicine, New York, for kindly providing the bacterial expression vector containing the normal ALAS2 cDNA sequence; Jerome Fagart (INSERM U773) for the secondary-structure predictions; and Vasco Pereira Da Silva, Sylvie Simonin, Anne Marie Robreau Fraolini, Nicola Mason, Jacqueline Woolf, and Brandon Davidson for expert laboratory assistance. This work was supported by Agence Nationale pour la Recherche-Groupement d'Interet Scientifiqe (ANR-GIS) Maladies Rares, reference ANR-07-MRAR-00801 (C.B.); the British Skin Foundation (S.D.W); Royal College of Physicians (S.A.H.); a Dorothy Hodgkin Royal Society Fellowship (Y.M.); WellChild, Cheltenham, UK and the Children's Liver Disease Foundation, Birmingham,UK (G.M.V); and the South African Medical Research Council (A.V.C, P.N.M., and M.P.).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BOTTOMLEY SS, 2004, WINTROBES CLIN HEMAT, P1012; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; Cox TC, 2004, INT J BIOCHEM CELL B, V36, P281, DOI 10.1016/S1357-2725(03)00246-2; COX TM, 2003, PORPHYRIN HDB MED AS, V14, P121; Deacon AC, 2001, J CLIN PATHOL, V54, P500, DOI 10.1136/jcp.54.7.500; EALES L, 1978, ANN CLIN RES, V10, P205; Gouya L, 2006, AM J HUM GENET, V78, P2, DOI 10.1086/498620; Harigae H, 1999, BRIT J HAEMATOL, V106, P175, DOI 10.1046/j.1365-2141.1999.01479.x; HART D, 1981, CLIN CHEM, V27, P220; Holme SA, 2006, BRIT J DERMATOL, V155, P574, DOI 10.1111/j.1365-2133.2006.07472.x; Holme SA, 2007, BLOOD, V110, P4108, DOI 10.1182/blood-2007-04-088120; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; LABBE RF, 1989, SEMIN HEMATOL, V26, P40; Lyoumi S, 2007, BLOOD, V109, P811, DOI 10.1182/blood-2006-04-014142; Parker M, 2008, BRIT J DERMATOL, V159, P182, DOI 10.1111/j.1365-2133.2008.08580.x; Sassa S, 2006, BRIT J HAEMATOL, V135, P281, DOI 10.1111/j.1365-2141.2006.06289.x; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; TOVEY JA, 1990, ANN CLIN BIOCHEM, V27, P80, DOI 10.1177/000456329002700118; WENT LN, 1984, ANN HUM GENET, V48, P105, DOI 10.1111/j.1469-1809.1984.tb01006.x; Whatley SD, 2007, J INVEST DERMATOL, V127, P2790, DOI 10.1038/sj.jid.5700924	23	195	202	2	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					408	414		10.1016/j.ajhg.2008.08.003	http://dx.doi.org/10.1016/j.ajhg.2008.08.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18760763	Green Published, Bronze			2022-12-18	WOS:000259307200011
J	Stokowski, RP; Pant, PVK; Dadd, T; Fereday, A; Hinds, DA; Jarman, C; Filsell, W; Ginger, RS; Green, MR; van der Ouderaa, FJ; Cox, DR				Stokowski, Renee P.; Pant, P. V. Krishna; Dadd, Tony; Fereday, Amelia; Hinds, David A.; Jarman, Carl; Filsell, Wendy; Ginger, Rebecca S.; Green, Martin R.; van der Ouderaa, Frans J.; Cox, David R.			A genomewide association study of skin pigmentation in a South Asian population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MELANOCORTIN-1 RECEPTOR; OCULOCUTANEOUS ALBINISM; NICOTINE DEPENDENCE; POSITIVE SELECTION; SEQUENCE VARIATION; WIDE ASSOCIATION; COLOR VARIATION; MATP GENE; HAPLOTYPE	We have conducted a multistage genomewide association study, using 1,620,742 single-nucleotide polymorphisms to systematically investigate the genetic factors influencing intrinsic skin pigmentation in a population of South Asian descent. Polymorphisms in three genes - SLC24A5, TYR, and SLC45A2 - yielded highly significant replicated associations with skin-reflectance measurements, an indirect measure of melanin content in the skin. The associations detected in these three genes, in an additive manner, collectively account for a large fraction of the natural variation of skin pigmentation in a South Asian population. Our study is the first to interrogate polymorphisms across the genome, to find genetic determinants of the natural variation of skin pigmentation within a human population.	Perlegen Sci, Mountain View, CA 94043 USA; Unilever Corp Res, Bedford, England	Unilever	Stokowski, RP (corresponding author), Perlegen Sci, 2021 Stierlin Court, Mountain View, CA 94043 USA.	renee_stokowski@perlegen.com	Van Der Ouderaa, Frans/AAA-8580-2020	Hinds, David/0000-0002-4911-803X				Akey JM, 2001, HUM GENET, V108, P516, DOI 10.1007/s004390100524; Alaluf S, 2002, PIGM CELL RES, V15, P119, DOI 10.1034/j.1600-0749.2002.1o072.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Armstrong B K, 1997, Australas J Dermatol, V38 Suppl 1, pS1; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; BRANDA RF, 1978, SCIENCE, V201, P625, DOI 10.1126/science.675247; Chaplin G, 2004, AM J PHYS ANTHROPOL, V125, P292, DOI 10.1002/ajpa.10263; CLARK P, 1981, ANN HUM BIOL, V8, P529, DOI 10.1080/03014468100005371; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; FRISANCHO AR, 1981, AM J PHYS ANTHROPOL, V55, P203, DOI 10.1002/ajpa.1330550207; GIEBEL LB, 1990, P NATL ACAD SCI USA, V87, P3255, DOI 10.1073/pnas.87.9.3255; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Graf J, 2007, HUM MUTAT, V28, P710, DOI 10.1002/humu.20504; HARRISON GA, 1964, ANN HUM GENET, V28, P27, DOI 10.1111/j.1469-1809.1964.tb00457.x; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hinds David A., 2004, Human Genomics, V1, P421; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Majumder PP, 1998, EVOL ANTHROPOL, V6, P100, DOI 10.1002/(SICI)1520-6505(1998)6:3<100::AID-EVAN4>3.0.CO;2-I; Murray FG, 1934, AM ANTHROPOL, V36, P438, DOI 10.1525/aa.1934.36.3.02a00100; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Relethford JH, 1997, AM J PHYS ANTHROPOL, V104, P449, DOI 10.1002/(SICI)1096-8644(199712)104:4<449::AID-AJPA2>3.0.CO;2-N; Robbins AH, 1991, BIOL PERSPECTIVES HU; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sengupta S, 2004, ANN HUM GENET, V68, P574, DOI 10.1046/j.1529-8817.2003.00126.x; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yuasa I, 2006, ANN HUM GENET, V70, P802, DOI 10.1111/j.1469-1809.2006.00261.x	55	195	203	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1119	1132		10.1086/522235	http://dx.doi.org/10.1086/522235			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	233NY	17999355	Green Published			2022-12-18	WOS:000251098800001
